archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010866,0.7419,0.72551,1,1
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,3.4805e-05,0.70451,0.73643,1,1
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00031664,0.69761,0.56811,1,1
1,GO OPTIC NERVE DEVELOPMENT,0.0012758,0.66084,0.56713,1,1
1,GO RESPONSE TO POTASSIUM ION,0.0012071,0.64682,0.46673,1,1
1,GO DISTAL TUBULE DEVELOPMENT,0.0015041,0.64114,0.52728,1,1
1,GO COMMISSURAL NEURON AXON GUIDANCE,3.9936e-05,0.60691,0.57444,1,1
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0010798,0.59975,0.48588,1,1
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,8.3641e-05,0.59555,0.5293,1,1
1,GO PREPULSE INHIBITION,0.00091199,0.56294,0.4856,1,1
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00040321,0.55783,0.46141,1,1
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0049572,0.55315,0.42434,1,1
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00026348,0.55217,0.48902,1,1
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00033648,0.5503,0.52304,1,1
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0010209,0.54074,0.42119,1,1
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,3.248e-05,0.53831,0.56194,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,3.248e-05,0.53217,0.55199,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00042807,0.53012,0.55505,1,1
1,GO SYNAPTIC MEMBRANE ADHESION,0.00023283,0.52584,0.52305,1,1
1,GO HISTONE H3 K36 METHYLATION,2.636e-05,0.52168,0.53628,1,1
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00010181,0.52014,0.51633,1,1
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00051151,0.51081,0.47173,1,1
1,GO BEHAVIORAL RESPONSE TO COCAINE,8.3461e-06,0.50631,0.589,1,1
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00012367,0.50494,0.52021,1,1
1,GO URETER DEVELOPMENT,0.0038653,0.50377,0.48417,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00029789,0.49779,0.41295,1,1
1,GO MALE SEX DETERMINATION,0.0012758,0.49671,0.40433,1,1
1,GO REPLICATION FORK PROCESSING,3.9936e-05,0.49539,0.4772,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00035748,0.49299,0.54392,1,1
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0010798,0.48975,0.51902,1,1
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00018128,0.4854,0.40343,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00054254,0.48498,0.42596,1,1
1,GO STARTLE RESPONSE,0.00042807,0.47448,0.43127,1,1
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,2.4576e-05,0.47299,0.47304,1,1
1,GO DNA DOUBLE STRAND BREAK PROCESSING,4.2763e-05,0.469,0.41216,1,1
1,GO MICROTUBULE DEPOLYMERIZATION,0.00031664,0.4687,0.42737,1,1
1,GO MEIOTIC CHROMOSOME SEPARATION,0.00021879,0.46507,0.4598,1,1
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.4947e-05,0.46155,0.55799,1,1
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00054254,0.46109,0.3965,1,1
1,GO NEURAL CREST FORMATION,0.0031545,0.45937,0.38017,1,1
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00051151,0.45862,0.41707,1,1
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00010866,0.45681,0.39721,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,3.9936e-05,0.4567,0.44401,1,1
1,GO ANATOMICAL STRUCTURE REGRESSION,0.00029789,0.45632,0.47173,1,1
1,GO POSTSYNAPSE ASSEMBLY,0.0010209,0.4559,0.41583,1,1
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0060238,0.45226,0.37266,1,1
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00057531,0.45161,0.3903,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00035748,0.45142,0.425,1,1
1,GO FOREBRAIN REGIONALIZATION,0.00014989,0.45136,0.49809,1,1
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.034576,0.44539,0.30917,1,1
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00048214,0.44215,0.44774,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0034935,0.44205,0.37455,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00051151,0.4401,0.41153,1,1
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00064645,0.43945,0.3863,1,1
1,GO ASTRAL MICROTUBULE ORGANIZATION,5.9985e-05,0.43917,0.48606,1,1
1,GO HOMOLOGOUS RECOMBINATION,7.8298e-05,0.43896,0.38836,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.008797,0.43855,0.3512,1,1
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.019548,0.43584,0.38856,1,1
1,GO RETINA LAYER FORMATION,0.00023283,0.43502,0.45512,1,1
1,GO CELL PROLIFERATION IN HINDBRAIN,0.0012071,0.43498,0.37116,1,1
1,GO KINETOCHORE ORGANIZATION,5.2428e-05,0.43293,0.45226,1,1
1,GO REGULATION OF NEURON MIGRATION,0.00051151,0.4324,0.45638,1,1
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00024771,0.4306,0.45316,1,1
1,GO MAGNESIUM ION HOMEOSTASIS,0.0010798,0.42939,0.40406,1,1
1,GO REGULATION OF COLLATERAL SPROUTING,0.00028019,0.42836,0.48807,1,1
1,GO KINETOCHORE ASSEMBLY,0.00010866,0.42761,0.42622,1,1
1,GO VOCALIZATION BEHAVIOR,0.0020776,0.42682,0.39304,1,1
1,GO ACROSOME ASSEMBLY,0.00014062,0.42571,0.40027,1,1
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.034576,0.42323,0.29806,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,1.2939e-05,0.42268,0.43877,1,1
1,GO CENTRIOLE ASSEMBLY,1.4947e-05,0.4208,0.43594,1,1
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00013188,0.42052,0.49365,1,1
1,GO LIMB BUD FORMATION,0.0024341,0.41979,0.3932,1,1
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0049572,0.4177,0.41911,1,1
1,GO HISTONE H3 K27 METHYLATION,0.00014062,0.41707,0.438,1,1
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,9.5377e-05,0.41659,0.40157,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.028348,0.41634,0.28522,1,1
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,8.3641e-05,0.41519,0.44314,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,1.2939e-05,0.4132,0.40422,1,1
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00028019,0.41187,0.4437,1,1
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00024771,0.40979,0.39353,1,1
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0054671,0.40838,0.34022,1,1
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00031664,0.40825,0.38405,1,1
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00010181,0.40543,0.42493,1,1
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00013188,0.4052,0.45402,1,1
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00096503,0.40414,0.40612,1,1
1,GO SPERMATID NUCLEUS DIFFERENTIATION,4.5779e-05,0.4029,0.38167,1,1
1,GO NEURAL TUBE PATTERNING,0.00031664,0.40213,0.3365,1,1
1,GO P BODY ASSEMBLY,2.4576e-05,0.40059,0.42663,1,1
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.2907e-05,0.39996,0.40455,1,1
1,GO DOSAGE COMPENSATION,6.8565e-05,0.39986,0.40117,1,1
1,GO CENTROSOME DUPLICATION,1.6059e-05,0.39865,0.39389,1,1
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0034935,0.39856,0.35322,1,1
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00021879,0.39842,0.4211,1,1
1,GO MITOTIC RECOMBINATION,3.9936e-05,0.39775,0.39025,1,1
1,GO HISTONE H3 K9 DEMETHYLATION,0.00014062,0.39774,0.4135,1,1
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,1.6059e-05,0.3977,0.42584,1,1
1,GO RESPONSE TO AUDITORY STIMULUS,0.00033648,0.39766,0.41667,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,8.9327e-05,0.39531,0.42334,1,1
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00010181,0.39502,0.39135,1,1
1,GO MYOBLAST MIGRATION,0.0010798,0.3949,0.36796,1,1
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00020554,0.39374,0.40187,1,1
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0083971,0.39245,0.28534,1,1
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0003797,0.39154,0.36769,1,1
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00072571,0.39151,0.38792,1,1
1,GO MRNA SPLICE SITE SELECTION,8.3641e-05,0.39048,0.42625,1,1
1,GO RESPONSE TO COCAINE,1.4947e-05,0.38993,0.42877,1,1
1,GO CEREBELLAR CORTEX DEVELOPMENT,4.2763e-05,0.38898,0.3843,1,1
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.4947e-05,0.3874,0.41585,1,1
1,GO SEX DETERMINATION,0.0040644,0.38714,0.28304,1,1
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00091199,0.38675,0.47854,1,1
1,GO REGULATION OF CHROMATIN BINDING,2.636e-05,0.3862,0.40595,1,1
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0034935,0.38594,0.40115,1,1
1,GO REGULATION OF SPINDLE CHECKPOINT,5.6086e-05,0.38579,0.39493,1,1
1,GO REGULATION OF CELL CYCLE CHECKPOINT,4.8997e-05,0.38475,0.38593,1,1
1,GO HISTONE H3 K9 METHYLATION,1.7249e-05,0.38473,0.45343,1,1
1,GO NERVE DEVELOPMENT,0.00076864,0.38189,0.37511,1,1
1,GO CELL PROLIFERATION IN FOREBRAIN,0.0036751,0.38098,0.3412,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.00040321,0.38084,0.37841,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.00040321,0.38075,0.44062,1,1
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.00010866,0.37994,0.38252,1,1
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0012758,0.3798,0.37449,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,7.8298e-05,0.37889,0.3666,1,1
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00018128,0.37886,0.39931,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,4.5779e-05,0.37848,0.39076,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,2.1347e-05,0.37814,0.43801,1,1
1,GO SPINAL CORD PATTERNING,0.0021907,0.37795,0.42878,1,1
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00012367,0.37739,0.39589,1,1
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0010209,0.37718,0.36918,1,1
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0017696,0.37459,0.34889,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00029789,0.37057,0.39505,1,1
1,GO NOSE DEVELOPMENT,0.0047188,0.36949,0.3695,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.00014062,0.3684,0.37636,1,1
1,GO RESPONSE TO INSECTICIDE,0.010101,0.36781,0.28853,1,1
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,1.6059e-05,0.3676,0.37083,1,1
1,GO INHIBITORY SYNAPSE ASSEMBLY,0.00026348,0.36719,0.51255,1,1
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,2.2907e-05,0.36691,0.4159,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00010866,0.36595,0.36567,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00015974,0.36591,0.36633,1,1
1,GO LOOP OF HENLE DEVELOPMENT,0.0047188,0.3655,0.41373,1,1
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0011418,0.36487,0.3332,1,1
1,GO BRAIN MORPHOGENESIS,9.5377e-05,0.36352,0.37163,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00054254,0.36294,0.35662,1,1
1,GO REGULATION OF CHROMATIN ASSEMBLY,8.3641e-05,0.36281,0.38642,1,1
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.0012758,0.36266,0.4666,1,1
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,4.5779e-05,0.36229,0.38994,1,1
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0013481,0.36156,0.32281,1,1
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00026348,0.36006,0.34696,1,1
1,GO NUCLEUS LOCALIZATION,9.5377e-05,0.35979,0.45671,1,1
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00029789,0.35915,0.37335,1,1
1,GO MITOTIC SISTER CHROMATID COHESION,9.6689e-06,0.35885,0.41541,1,1
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0096484,0.35873,0.36095,1,1
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0010209,0.35856,0.34351,1,1
1,GO EPITHELIAL CELL CELL ADHESION,0.0029965,0.35696,0.33735,1,1
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0021907,0.35692,0.31562,1,1
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,8.3641e-05,0.35659,0.35889,1,1
1,GO VAGINA DEVELOPMENT,0.021265,0.35605,0.30875,1,1
1,GO FORELIMB MORPHOGENESIS,0.00010866,0.35579,0.41413,1,1
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00064645,0.35546,0.35146,1,1
1,GO MEIOSIS I CELL CYCLE PROCESS,3.9936e-05,0.35527,0.33904,1,1
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,7.3279e-05,0.35523,0.36929,1,1
1,GO CRANIAL NERVE MORPHOGENESIS,0.016475,0.3542,0.28653,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,3.4805e-05,0.35385,0.41643,1,1
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.00010181,0.35383,0.34708,1,1
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,6.8565e-05,0.35349,0.31833,1,1
1,GO METENCEPHALON DEVELOPMENT,3.9936e-05,0.35324,0.35867,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00068502,0.35314,0.3635,1,1
1,GO CORPUS CALLOSUM DEVELOPMENT,0.00013188,0.35251,0.39657,1,1
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0003797,0.35202,0.34624,1,1
1,GO CEREBELLAR CORTEX FORMATION,0.00019306,0.35171,0.38196,1,1
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,1.1191e-05,0.35145,0.4059,1,1
1,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0003797,0.35131,0.35631,1,1
1,GO HISTONE METHYLATION,2.4576e-05,0.3513,0.3777,1,1
1,GO GROWTH HORMONE SECRETION,0.0017696,0.35119,0.3847,1,1
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,8.9327e-05,0.3506,0.37657,1,1
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.00020554,0.35017,0.36011,1,1
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00076864,0.34996,0.41264,1,1
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,6.4139e-05,0.34985,0.44737,1,1
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00021879,0.34948,0.37031,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.018736,0.34921,0.28705,1,1
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.011574,0.34892,0.32577,1,1
1,GO OTIC VESICLE DEVELOPMENT,0.0060238,0.34837,0.29695,1,1
1,GO G0 TO G1 TRANSITION,1.3909e-05,0.3483,0.40411,1,1
1,GO ADULT BEHAVIOR,0.00014989,0.34801,0.33589,1,1
1,GO NUCLEAR MIGRATION,0.00014062,0.34743,0.45455,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.00033648,0.3471,0.31112,1,1
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00042807,0.34699,0.32736,1,1
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0013481,0.34625,0.31582,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.00026348,0.34579,0.35124,1,1
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0066311,0.34567,0.29775,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.0083971,0.34512,0.26688,1,1
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,2.4576e-05,0.34505,0.38177,1,1
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.7287e-05,0.34503,0.39815,1,1
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,3.9936e-05,0.34498,0.4046,1,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00024771,0.34452,0.30717,1,1
1,GO SISTER CHROMATID COHESION,1.8524e-05,0.34446,0.37825,1,1
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,3.4805e-05,0.34414,0.38002,1,1
1,GO CHROMOSOME SEPARATION,3.248e-05,0.34408,0.35634,1,1
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0029965,0.34384,0.32138,1,1
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0036751,0.3431,0.35393,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.006955,0.3428,0.38688,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.01266,0.34271,0.32171,1,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,6.4139e-05,0.34221,0.41164,1,1
1,GO PEPTIDYL LYSINE DIMETHYLATION,7.8298e-05,0.34197,0.37521,1,1
1,GO MICROTUBULE ANCHORING,0.00024771,0.34189,0.36237,1,1
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0036751,0.34172,0.3044,1,1
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,5.2428e-05,0.34138,0.35548,1,1
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,8.3641e-05,0.34095,0.39401,1,1
1,GO RECOMBINATIONAL REPAIR,1.3909e-05,0.34067,0.36938,1,1
1,GO PEPTIDYL LYSINE METHYLATION,2.8267e-05,0.34025,0.38244,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.6086e-05,0.34021,0.36162,1,1
1,GO HISTONE H3 K9 MODIFICATION,3.248e-05,0.33939,0.39257,1,1
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00068502,0.33864,0.32287,1,1
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.007293,0.33834,0.32367,1,1
1,GO DNA STRAND ELONGATION,0.00012367,0.3382,0.33406,1,1
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0076456,0.33818,0.30155,1,1
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00017019,0.33738,0.36049,1,1
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.00096503,0.33724,0.39419,1,1
1,GO DENDRITE MORPHOGENESIS,7.8298e-05,0.33676,0.36063,1,1
1,GO COLLATERAL SPROUTING,0.0011418,0.33669,0.39333,1,1
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.0012071,0.33545,0.33241,1,1
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.5779e-05,0.3352,0.34442,1,1
1,GO CENTROMERE COMPLEX ASSEMBLY,3.0304e-05,0.33488,0.40932,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.00018128,0.33479,0.30626,1,1
1,GO REGULATION OF CILIUM ASSEMBLY,0.00042807,0.3347,0.3351,1,1
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0047188,0.33448,0.3026,1,1
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.5779e-05,0.33429,0.37116,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,1.8524e-05,0.33392,0.33766,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.9985e-05,0.33329,0.35043,1,1
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00015974,0.33316,0.34342,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0057394,0.33224,0.28919,1,1
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0034935,0.33202,0.30128,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.00018128,0.33201,0.32965,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,6.4139e-05,0.33187,0.35923,1,1
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0060238,0.33163,0.33039,1,1
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,1.6059e-05,0.33161,0.37848,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,7.8298e-05,0.33153,0.34826,1,1
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00015974,0.33146,0.31389,1,1
1,GO INNERVATION,0.0017696,0.33106,0.45282,1,1
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.00013188,0.33075,0.35818,1,1
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.02951,0.33052,0.22886,1,1
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00051151,0.33043,0.32715,1,1
1,GO MICROTUBULE NUCLEATION,0.00021879,0.3304,0.36669,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.6086e-05,0.33003,0.35611,1,1
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,1.9888e-05,0.33001,0.40136,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0023095,0.32919,0.40825,1,1
1,GO GENITALIA MORPHOGENESIS,0.00096503,0.32868,0.37048,1,1
1,GO HISTONE H3 K9 TRIMETHYLATION,6.8565e-05,0.32802,0.37492,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0080134,0.32773,0.26727,1,1
1,GO SYNAPTIC VESICLE MATURATION,0.0076456,0.32695,0.36017,1,1
1,GO SYNAPSE ASSEMBLY,0.00054254,0.32648,0.33186,1,1
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,7.8298e-05,0.32638,0.33526,1,1
1,GO PRESYNAPSE ORGANIZATION,0.00048214,0.32604,0.34014,1,1
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00014989,0.326,0.35523,1,1
1,GO MITOTIC DNA REPLICATION,0.00010866,0.32587,0.39077,1,1
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0028457,0.32581,0.31643,1,1
1,GO INTERSTRAND CROSS LINK REPAIR,1.7249e-05,0.32566,0.37025,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,1.2939e-05,0.32551,0.35433,1,1
1,GO ACTIN CROSSLINK FORMATION,0.0014241,0.32543,0.35062,1,1
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00031664,0.32518,0.38088,1,1
1,GO LONG TERM SYNAPTIC DEPRESSION,0.0019699,0.325,0.31928,1,1
1,GO MRNA METHYLATION,3.0304e-05,0.32444,0.3598,1,1
1,GO PROTEIN HETEROTETRAMERIZATION,0.00018128,0.3238,0.30547,1,1
1,GO PROTEIN PALMITOYLATION,0.00010181,0.32361,0.38498,1,1
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.00076864,0.32298,0.30298,1,1
1,GO REGULATION OF CENTROSOME CYCLE,3.0304e-05,0.32296,0.32528,1,1
1,GO HIPPO SIGNALING,0.00021879,0.32291,0.36914,1,1
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,1.2939e-05,0.32286,0.35231,1,1
1,GO REGULATION OF RECEPTOR CLUSTERING,0.0027019,0.32266,0.4059,1,1
1,GO HISTONE H3 K4 METHYLATION,4.8997e-05,0.3226,0.36322,1,1
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.00033648,0.32257,0.33023,1,1
1,GO GOLGI RIBBON FORMATION,0.00021879,0.32253,0.37627,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,2.8267e-05,0.32226,0.32765,1,1
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,2.8267e-05,0.32213,0.35652,1,1
1,GO RESPONSE TO NICOTINE,0.00028019,0.32176,0.32827,1,1
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.007293,0.32159,0.32704,1,1
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.013235,0.32151,0.30283,1,1
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0024341,0.32127,0.28698,1,1
1,GO REGULATION OF SISTER CHROMATID COHESION,1.1191e-05,0.32027,0.42531,1,1
1,GO CHROMOSOME SEGREGATION,2.4576e-05,0.32004,0.32898,1,1
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0092139,0.31979,0.33769,1,1
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0012758,0.31877,0.31547,1,1
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00042807,0.31862,0.32322,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,0.31861,0.40002,1,1
1,GO RESPONSE TO L GLUTAMATE,0.0028457,0.31836,0.29282,1,1
1,GO KERATINOCYTE DEVELOPMENT,0.013235,0.31816,0.3106,1,1
1,GO GLIAL CELL FATE COMMITMENT,0.0028457,0.31788,0.32206,1,1
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,3.248e-05,0.31768,0.35167,1,1
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0080134,0.3172,0.40597,1,1
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00010866,0.31679,0.3241,1,1
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.4947e-05,0.31654,0.35945,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0044907,0.31649,0.28803,1,1
1,GO NOREPINEPHRINE SECRETION,0.011574,0.31638,0.31366,1,1
1,GO NON MOTILE CILIUM ASSEMBLY,9.5377e-05,0.31574,0.3396,1,1
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00096503,0.31554,0.31518,1,1
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00010181,0.31524,0.30958,1,1
1,GO HISTONE H4 K16 ACETYLATION,4.2763e-05,0.31503,0.36731,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.0031545,0.31481,0.29673,1,1
1,GO NEURON MIGRATION,0.00014062,0.31412,0.37121,1,1
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.020391,0.314,0.29759,1,1
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00048214,0.31384,0.33241,1,1
1,GO CELL JUNCTION MAINTENANCE,0.0018673,0.31372,0.33659,1,1
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.008797,0.31342,0.36456,1,1
1,GO FEAR RESPONSE,0.00072571,0.31162,0.28742,1,1
1,GO FOREBRAIN NEURON DEVELOPMENT,0.016475,0.31161,0.25182,1,1
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0057394,0.31154,0.29738,1,1
1,GO CARNITINE SHUTTLE,0.0016767,0.31149,0.29629,1,1
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,2.4576e-05,0.31136,0.37746,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,7.8298e-05,0.31113,0.36159,1,1
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0016767,0.31101,0.32284,1,1
1,GO SPINAL CORD DEVELOPMENT,0.00011593,0.31098,0.39648,1,1
1,GO THALAMUS DEVELOPMENT,0.00017019,0.31084,0.37194,1,1
1,GO MISMATCH REPAIR,1.9888e-05,0.31058,0.33732,1,1
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,9.5377e-05,0.31042,0.32429,1,1
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,8.9327e-05,0.31028,0.30645,1,1
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00057531,0.31007,0.33025,1,1
1,GO STRESS GRANULE ASSEMBLY,1.0403e-05,0.30984,0.36177,1,1
1,GO CELL CYCLE DNA REPLICATION,3.248e-05,0.30953,0.36649,1,1
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00035748,0.30889,0.32562,1,1
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,1.9888e-05,0.30884,0.36439,1,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00012367,0.30875,0.33725,1,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,5.6086e-05,0.30854,0.38774,1,1
1,GO NEUROTRANSMITTER SECRETION,0.00064645,0.30852,0.31331,1,1
1,GO PROTEIN METHYLATION,1.8524e-05,0.30811,0.35638,1,1
1,GO V D J RECOMBINATION,0.00057531,0.30804,0.31135,1,1
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00076864,0.30779,0.35135,1,1
1,GO DENDRITIC SPINE MORPHOGENESIS,0.00051151,0.30705,0.32993,1,1
1,GO REGULATION OF EXIT FROM MITOSIS,7.3279e-05,0.30694,0.3654,1,1
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,5.2428e-05,0.30671,0.36028,1,1
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.00042807,0.30657,0.30108,1,1
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0080134,0.30645,0.29214,1,1
1,GO INOSITOL METABOLIC PROCESS,0.0012071,0.30643,0.34268,1,1
1,GO REGULATION OF MRNA PROCESSING,5.9985e-05,0.30635,0.30931,1,1
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00042807,0.30623,0.34544,1,1
1,GO REGULATION OF DENDRITE MORPHOGENESIS,8.3641e-05,0.3062,0.34149,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00017019,0.30618,0.37118,1,1
1,GO POSTSYNAPSE ORGANIZATION,0.00024771,0.30607,0.31804,1,1
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0012758,0.30603,0.30632,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,2.636e-05,0.30595,0.35998,1,1
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0063209,0.30591,0.27818,1,1
1,GO RESPONSE TO HYDROXYUREA,2.8267e-05,0.30583,0.3577,1,1
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.00033648,0.30578,0.28406,1,1
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0003797,0.30577,0.3531,1,1
1,GO CHROMATIN REMODELING,1.7249e-05,0.30569,0.34266,1,1
1,GO RETINAL ROD CELL DIFFERENTIATION,0.0063209,0.30537,0.2448,1,1
1,GO CHROMATIN SILENCING AT TELOMERE,0.00033648,0.3052,0.32322,1,1
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00064645,0.3045,0.29133,1,1
1,GO HISTONE H4 DEACETYLATION,5.9985e-05,0.30412,0.29122,1,1
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0010209,0.30383,0.36955,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0017696,0.30378,0.33698,1,1
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00048214,0.30377,0.35402,1,1
1,GO NEURAL RETINA DEVELOPMENT,0.00048214,0.30351,0.31746,1,1
1,GO UTERUS DEVELOPMENT,0.00023283,0.30333,0.40971,1,1
1,GO HISTONE EXCHANGE,0.00014989,0.303,0.32654,1,1
1,GO APICAL PROTEIN LOCALIZATION,0.00042807,0.30281,0.34563,1,1
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00028019,0.30243,0.33272,1,1
1,GO ATP DEPENDENT CHROMATIN REMODELING,1.6059e-05,0.30239,0.36553,1,1
1,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0012071,0.30189,0.30707,1,1
1,GO PROTEIN LOCALIZATION TO CHROMATIN,2.2907e-05,0.30177,0.36192,1,1
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00010181,0.30147,0.3751,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,2.2907e-05,0.30128,0.32075,1,1
1,GO SYNAPTIC VESICLE PRIMING,0.010572,0.30098,0.27389,1,1
1,GO SECRETORY GRANULE LOCALIZATION,0.017954,0.30028,0.29262,1,1
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0038653,0.2997,0.26703,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.2035e-05,0.29965,0.37951,1,1
1,GO PROSTATE GLAND MORPHOGENESIS,0.02951,0.29946,0.27904,1,1
1,GO CHROMATIN SILENCING,2.2907e-05,0.29903,0.33441,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,2.1347e-05,0.299,0.32408,1,1
1,GO LEARNING,0.00021879,0.29848,0.31438,1,1
1,GO MEMBRANE DISASSEMBLY,0.00060992,0.29771,0.33287,1,1
1,GO REGULATION OF TORC1 SIGNALING,0.00011593,0.29754,0.34045,1,1
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0047188,0.29747,0.30896,1,1
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0015882,0.29741,0.32732,1,1
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.018736,0.29722,0.2477,1,1
1,GO AMMONIUM ION METABOLIC PROCESS,0.041938,0.29714,0.22703,1,1
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00064645,0.29684,0.30275,1,1
1,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00045436,0.29672,0.33817,1,1
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00015974,0.2959,0.32495,1,1
1,GO CHROMATIN REMODELING AT CENTROMERE,0.00018128,0.29542,0.37758,1,1
1,GO SYNAPTIC TRANSMISSION GABAERGIC,8.9327e-05,0.29509,0.35772,1,1
1,GO TONGUE DEVELOPMENT,0.015776,0.29505,0.2128,1,1
1,GO MICROTUBULE POLYMERIZATION,0.00051151,0.29502,0.31864,1,1
1,GO RESPONSE TO ACETYLCHOLINE,0.0012758,0.29479,0.35534,1,1
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.00048214,0.29468,0.3033,1,1
1,GO PROTEIN DEMETHYLATION,0.00031664,0.29468,0.35257,1,1
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.00023283,0.29452,0.32847,1,1
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00048214,0.29452,0.34235,1,1
1,GO DNA RECOMBINATION,3.4805e-05,0.29424,0.29828,1,1
1,GO DENDRITE DEVELOPMENT,0.00010181,0.29402,0.34108,1,1
1,GO DENDRITIC SPINE DEVELOPMENT,5.9985e-05,0.29377,0.34562,1,1
1,GO DNA GEOMETRIC CHANGE,1.1191e-05,0.29375,0.34927,1,1
1,GO PRO B CELL DIFFERENTIATION,0.00332,0.29348,0.35802,1,1
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0024341,0.29345,0.29732,1,1
1,GO DNA DEPENDENT DNA REPLICATION,2.2907e-05,0.29342,0.35329,1,1
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.00014062,0.2934,0.34209,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00021879,0.29339,0.32872,1,1
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00081392,0.29326,0.27961,1,1
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.008797,0.29315,0.32596,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0054671,0.29312,0.25362,1,1
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0012071,0.29309,0.2873,1,1
1,GO CRANIAL NERVE DEVELOPMENT,0.0042727,0.29308,0.32678,1,1
1,GO SHORT TERM MEMORY,0.0060238,0.29262,0.26958,1,1
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0047188,0.29255,0.30375,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0028457,0.29242,0.32656,1,1
1,GO ECTODERM DEVELOPMENT,0.00026348,0.2919,0.28854,1,1
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.0092139,0.29175,0.27398,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00011593,0.29171,0.30667,1,1
1,GO NOTOCHORD DEVELOPMENT,0.025096,0.29127,0.28001,1,1
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00076864,0.29054,0.31999,1,1
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.00019306,0.29051,0.38111,1,1
1,GO SISTER CHROMATID SEGREGATION,2.636e-05,0.29048,0.32221,1,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.006955,0.29012,0.29051,1,1
1,GO ADHERENS JUNCTION ASSEMBLY,0.0042727,0.28995,0.3194,1,1
1,GO SPINDLE ASSEMBLY,4.5779e-05,0.28988,0.32861,1,1
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,3.4805e-05,0.28964,0.33011,1,1
1,GO HISTONE H2A UBIQUITINATION,2.1347e-05,0.28908,0.36978,1,1
1,GO PRIMARY MIRNA PROCESSING,0.0027019,0.28891,0.24821,1,1
1,GO EPITHELIAL CELL MATURATION,0.0036751,0.28873,0.30083,1,1
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0021907,0.28863,0.37683,1,1
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.0020776,0.28858,0.27848,1,1
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0029965,0.28834,0.29426,1,1
1,GO TORC1 SIGNALING,0.00013188,0.28833,0.34347,1,1
1,GO REGULATION OF RNA SPLICING,8.3641e-05,0.28825,0.29217,1,1
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.010101,0.28749,0.29543,1,1
1,GO POSITIVE REGULATION OF CYTOKINESIS,2.1347e-05,0.28699,0.32314,1,1
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.008797,0.28675,0.29923,1,1
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.00076864,0.28602,0.32636,1,1
1,GO REGULATION OF DENDRITE DEVELOPMENT,6.8565e-05,0.2859,0.33364,1,1
1,GO RESPONSE TO VITAMIN A,0.0017696,0.28583,0.25067,1,1
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00057531,0.28573,0.37214,1,1
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.00014062,0.28557,0.29044,1,1
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0038653,0.28512,0.27158,1,1
1,GO RESPONSE TO GLUCAGON,0.0012758,0.28509,0.2988,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,4.2763e-05,0.28471,0.34893,1,1
1,GO REGULATION OF HISTONE METHYLATION,3.0304e-05,0.28446,0.35785,1,1
1,GO HISTONE H2B UBIQUITINATION,0.0015882,0.28427,0.22407,1,1
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.013235,0.28421,0.31007,1,1
1,GO TONGUE MORPHOGENESIS,0.0083971,0.28349,0.25257,1,1
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0010798,0.28329,0.3418,1,1
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0057394,0.28326,0.27366,1,1
1,GO COVALENT CHROMATIN MODIFICATION,3.9936e-05,0.28322,0.32235,1,1
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00057531,0.28308,0.28732,1,1
1,GO CHROMATIN ORGANIZATION,3.0304e-05,0.28308,0.32596,1,1
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00051151,0.28302,0.31475,1,1
1,GO ASYMMETRIC CELL DIVISION,0.00060992,0.28278,0.29299,1,1
1,GO HISTONE DEUBIQUITINATION,0.00033648,0.28211,0.36577,1,1
1,GO MITOTIC CHROMOSOME CONDENSATION,0.00035748,0.28183,0.43688,1,1
1,GO SYNAPTIC SIGNALING,0.00054254,0.2817,0.27397,1,1
1,GO DOUBLE STRAND BREAK REPAIR,1.7249e-05,0.28162,0.33115,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0066311,0.28152,0.32906,1,1
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00035748,0.28147,0.39553,1,1
1,GO MICROTUBULE BASED PROCESS,0.00021879,0.28104,0.28465,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00019306,0.281,0.37453,1,1
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0012758,0.28083,0.32078,1,1
1,GO DNA REPLICATION CHECKPOINT,0.00035748,0.28069,0.3616,1,1
1,GO REGULATION OF CYTOKINESIS,2.8267e-05,0.28065,0.32942,1,1
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00086166,0.28056,0.25289,1,1
1,GO TUBULIN DEACETYLATION,0.0024341,0.2804,0.31301,1,1
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,7.3279e-05,0.28018,0.30177,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,2.1347e-05,0.28013,0.33175,1,1
1,GO HINDBRAIN DEVELOPMENT,5.2428e-05,0.28003,0.31076,1,1
1,GO HETEROCHROMATIN ORGANIZATION,5.2428e-05,0.28,0.33762,1,1
1,GO REGULATION OF AXONOGENESIS,0.00057531,0.27998,0.32568,1,1
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0036751,0.27996,0.28086,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.00015974,0.2797,0.29312,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,5.6086e-05,0.27907,0.33646,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.008797,0.2786,0.30425,1,1
1,GO HINDBRAIN MORPHOGENESIS,0.00019306,0.27843,0.30073,1,1
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,5.2428e-05,0.2782,0.33346,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,6.8565e-05,0.27805,0.2998,1,1
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.2035e-05,0.27797,0.38499,1,1
1,GO MEIOTIC CELL CYCLE PROCESS,7.8298e-05,0.2775,0.30678,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,3.4805e-05,0.27746,0.29694,1,1
1,GO MRNA CLEAVAGE,0.00023283,0.27745,0.2825,1,1
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00076864,0.27743,0.30117,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0016767,0.27705,0.28409,1,1
1,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0047188,0.27704,0.23558,1,1
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.010572,0.27703,0.25607,1,1
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.00060992,0.27672,0.31845,1,1
1,GO REGULATION OF SPINDLE ASSEMBLY,0.00042807,0.27662,0.27813,1,1
1,GO MUSCLE FIBER DEVELOPMENT,0.0054671,0.27619,0.24992,1,1
1,GO HISTONE H3 DEACETYLATION,0.00076864,0.27579,0.2846,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.00040321,0.2755,0.32722,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.028348,0.27505,0.25232,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00013188,0.27483,0.30581,1,1
1,GO NEURON PROJECTION ORGANIZATION,0.00051151,0.27483,0.29817,1,1
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00057531,0.27475,0.35417,1,1
1,GO HISTONE DEACETYLATION,0.00064645,0.27441,0.29029,1,1
1,GO EXPLORATION BEHAVIOR,0.011063,0.27438,0.26869,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0034935,0.27435,0.29262,1,1
1,GO HISTONE H2A MONOUBIQUITINATION,3.9936e-05,0.27418,0.38416,1,1
1,GO SPINDLE ORGANIZATION,5.9985e-05,0.27391,0.32914,1,1
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.00015974,0.27347,0.32799,1,1
1,GO REGULATION OF FEEDING BEHAVIOR,0.00054254,0.27277,0.25387,1,1
1,GO DORSAL VENTRAL PATTERN FORMATION,0.00014062,0.27273,0.32555,1,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.010572,0.27262,0.32706,1,1
1,GO NEUROTRANSMITTER TRANSPORT,0.00064645,0.27236,0.29641,1,1
1,GO RECEPTOR CLUSTERING,0.0029965,0.27229,0.28841,1,1
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0003797,0.2719,0.31809,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0024341,0.27169,0.21201,1,1
1,GO MITOTIC SPINDLE ASSEMBLY,5.2428e-05,0.27164,0.32688,1,1
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00015974,0.27127,0.29221,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,1.6059e-05,0.27088,0.32061,1,1
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00024771,0.27086,0.30361,1,1
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0010209,0.27059,0.29825,1,1
1,GO NEUROMUSCULAR PROCESS,0.0021907,0.27039,0.26292,1,1
1,GO SYNAPSE ORGANIZATION,0.00045436,0.27036,0.29227,1,1
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0016767,0.26999,0.24316,1,1
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0034935,0.26982,0.18904,1,1
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.030713,0.26965,0.24043,1,1
1,GO MECHANOSENSORY BEHAVIOR,0.0083971,0.26948,0.41964,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,2.4576e-05,0.26938,0.32663,1,1
1,GO DNA REPLICATION,1.8524e-05,0.26934,0.3473,1,1
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00057531,0.26924,0.29681,1,1
1,GO MEIOTIC CELL CYCLE,4.5779e-05,0.26862,0.31395,1,1
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00060992,0.26843,0.28874,1,1
1,GO POST ANAL TAIL MORPHOGENESIS,0.0025648,0.26787,0.29934,1,1
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00086166,0.26782,0.2871,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.00010181,0.26766,0.28497,1,1
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0025648,0.26723,0.23794,1,1
1,GO CELLULAR COMPONENT MAINTENANCE,0.00029789,0.26711,0.31364,1,1
1,GO NEUROBLAST PROLIFERATION,0.00045436,0.2671,0.32333,1,1
1,GO DNA CONFORMATION CHANGE,1.3909e-05,0.2671,0.34717,1,1
1,GO FATTY ACID HOMEOSTASIS,0.025096,0.26676,0.19146,1,1
1,GO REGULATION OF DNA REPAIR,2.8267e-05,0.26665,0.30878,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,7.3279e-05,0.26646,0.3153,1,1
1,GO ACTIVATION OF JNKK ACTIVITY,0.0015041,0.26633,0.33067,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,2.636e-05,0.26622,0.31222,1,1
1,GO SOMITE DEVELOPMENT,0.00040321,0.26593,0.29464,1,1
1,GO EMBRYONIC AXIS SPECIFICATION,5.9985e-05,0.26591,0.30834,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0025648,0.26581,0.30309,1,1
1,GO NEPHRIC DUCT DEVELOPMENT,0.0172,0.26577,0.31521,1,1
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00072571,0.26557,0.30531,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.2035e-05,0.26506,0.35152,1,1
1,GO ATP TRANSPORT,0.0013481,0.26481,0.23157,1,1
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00096503,0.26448,0.28791,1,1
1,GO RNA POLYADENYLATION,6.8565e-05,0.26439,0.29138,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.00019306,0.26418,0.32953,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,4.2763e-05,0.26416,0.31069,1,1
1,GO POSITIVE REGULATION OF DNA REPAIR,2.636e-05,0.26353,0.30696,1,1
1,GO DNA REPLICATION INITIATION,0.00013188,0.26334,0.30915,1,1
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0012071,0.2631,0.28531,1,1
1,GO NUCLEOSOME ORGANIZATION,3.7287e-05,0.26297,0.31652,1,1
1,GO COCHLEA DEVELOPMENT,0.0025648,0.26279,0.27489,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00033648,0.2626,0.36238,1,1
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0012758,0.26238,0.27805,1,1
1,GO REGULATION OF MRNA POLYADENYLATION,9.5377e-05,0.26232,0.31151,1,1
1,GO MRNA PROCESSING,3.248e-05,0.26215,0.2752,1,1
1,GO OOCYTE MATURATION,0.0038653,0.2619,0.28408,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00028019,0.26178,0.30471,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0015882,0.26086,0.30799,1,1
1,GO CELL PART MORPHOGENESIS,0.00051151,0.26086,0.29533,1,1
1,GO HISTONE H4 K5 ACETYLATION,0.00015974,0.26075,0.32393,1,1
1,GO RRNA 3 END PROCESSING,0.00040321,0.26021,0.21417,1,1
1,GO CHROMOSOME ORGANIZATION,1.9888e-05,0.25997,0.30783,1,1
1,GO DNA PACKAGING,2.2907e-05,0.25987,0.34917,1,1
1,GO METHIONINE METABOLIC PROCESS,0.00035748,0.25944,0.28692,1,1
1,GO RNA INTERFERENCE,0.0023095,0.25934,0.24031,1,1
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.048745,0.25926,0.1624,1,1
1,GO SINGLE STRAND BREAK REPAIR,4.5779e-05,0.25819,0.32895,1,1
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0083971,0.25818,0.33926,1,1
1,GO EMBRYONIC BODY MORPHOGENESIS,0.0012071,0.25807,0.35305,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00033648,0.25799,0.26114,1,1
1,GO REGULATION OF CIRCADIAN RHYTHM,3.0304e-05,0.25796,0.31575,1,1
1,GO ORGANELLE FISSION,2.4576e-05,0.25792,0.27721,1,1
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00072571,0.25778,0.28081,1,1
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.0044907,0.25777,0.27873,1,1
1,GO NON RECOMBINATIONAL REPAIR,1.2939e-05,0.25763,0.30702,1,1
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00029789,0.2576,0.29431,1,1
1,GO COCHLEA MORPHOGENESIS,0.013834,0.25751,0.24401,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00051151,0.25748,0.27087,1,1
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0060238,0.25706,0.23584,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00091199,0.257,0.30546,1,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.00042807,0.25658,0.31706,1,1
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0034935,0.25654,0.32738,1,1
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0025648,0.2564,0.25866,1,1
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0012758,0.25633,0.24184,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.00031664,0.25622,0.27987,1,1
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0012758,0.25588,0.25344,1,1
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,7.3279e-05,0.25588,0.32848,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.00026348,0.25562,0.31074,1,1
1,GO RRNA CATABOLIC PROCESS,0.00031664,0.25549,0.25968,1,1
1,GO MRNA 3 END PROCESSING,2.4576e-05,0.25524,0.29547,1,1
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.011574,0.25507,0.24896,1,1
1,GO AXON DEVELOPMENT,0.00072571,0.25485,0.29559,1,1
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0020776,0.25455,0.25511,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,9.5377e-05,0.25441,0.28193,1,1
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,2.636e-05,0.25413,0.32587,1,1
1,GO REGULATION OF TUBULIN DEACETYLATION,0.0047188,0.25395,0.30472,1,1
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.0092139,0.2539,0.26145,1,1
1,GO CHROMOSOME LOCALIZATION,4.2763e-05,0.2539,0.28284,1,1
1,GO TRNA CATABOLIC PROCESS,0.0013481,0.25387,0.29654,1,1
1,GO LOCOMOTORY BEHAVIOR,0.00060992,0.25377,0.29066,1,1
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00051151,0.25328,0.27754,1,1
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00064645,0.25327,0.28167,1,1
1,GO REGULATION OF CHROMATIN ORGANIZATION,9.5377e-05,0.25304,0.27618,1,1
1,GO MEMBRANE DOCKING,0.00026348,0.25301,0.27026,1,1
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00019306,0.25287,0.29354,1,1
1,GO MAINTENANCE OF CELL POLARITY,0.0015882,0.25281,0.29999,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.024086,0.25281,0.25502,1,1
1,GO HISTONE MONOUBIQUITINATION,7.3279e-05,0.25264,0.31978,1,1
1,GO FEEDING BEHAVIOR,0.0060238,0.2525,0.20957,1,1
1,GO HISTONE UBIQUITINATION,3.9936e-05,0.25245,0.32096,1,1
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.00096503,0.25236,0.24191,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0016767,0.25228,0.2665,1,1
1,GO PROTEIN MONOUBIQUITINATION,3.248e-05,0.25151,0.29946,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0029965,0.25122,0.2902,1,1
1,GO SEGMENTATION,0.0011418,0.25088,0.24759,1,1
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0038653,0.25076,0.21804,1,1
1,GO BEHAVIOR,0.00057531,0.2507,0.25953,1,1
1,GO NEURON PROJECTION ARBORIZATION,0.0031545,0.25015,0.32287,1,1
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.017954,0.25001,0.29498,1,1
1,GO RNA SPLICING,3.0304e-05,0.25,0.26674,1,1
1,GO METAPHASE PLATE CONGRESSION,4.2763e-05,0.24995,0.28693,1,1
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0021907,0.24995,0.25839,1,1
1,GO MYOTUBE CELL DEVELOPMENT,0.0040644,0.24957,0.21564,1,1
1,GO RENAL VESICLE DEVELOPMENT,0.008797,0.24945,0.28046,1,1
1,GO EXIT FROM MITOSIS,4.8997e-05,0.24945,0.2856,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,7.8298e-05,0.24937,0.30459,1,1
1,GO CHROMOSOME CONDENSATION,0.00021879,0.24929,0.37115,1,1
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.00076864,0.2491,0.25754,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.030713,0.24899,0.27401,1,1
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.00054254,0.24883,0.2742,1,1
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0014241,0.2487,0.25455,1,1
1,GO VISUAL BEHAVIOR,0.00048214,0.24835,0.24946,1,1
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.00024771,0.24831,0.27602,1,1
1,GO ADHERENS JUNCTION ORGANIZATION,0.0047188,0.24821,0.25358,1,1
1,GO REGULATION OF DNA REPLICATION,3.4805e-05,0.24817,0.29888,1,1
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0010798,0.24805,0.27899,1,1
1,GO NUCLEOSOME ASSEMBLY,4.8997e-05,0.24803,0.33871,1,1
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00042807,0.248,0.28593,1,1
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0024341,0.24798,0.30646,1,1
1,GO MYELIN MAINTENANCE,0.016475,0.2478,0.24687,1,1
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00015974,0.24777,0.31584,1,1
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.016475,0.24775,0.22221,1,1
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.010101,0.24758,0.21595,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,1.9888e-05,0.24753,0.25841,1,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,5.6086e-05,0.24722,0.31508,1,1
1,GO RNA 3 END PROCESSING,3.248e-05,0.24721,0.25239,1,1
1,GO ESTROUS CYCLE,0.013834,0.24703,0.26391,1,1
1,GO DNA INTEGRITY CHECKPOINT,3.4805e-05,0.24686,0.33028,1,1
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0010209,0.24668,0.2582,1,1
1,GO REGULATION OF CYCLASE ACTIVITY,0.0010798,0.24636,0.2716,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,4.8997e-05,0.24615,0.30328,1,1
1,GO DNA LIGATION,0.00024771,0.24582,0.22918,1,1
1,GO STEM CELL DIVISION,0.024086,0.2457,0.24374,1,1
1,GO MITOTIC NUCLEAR DIVISION,2.636e-05,0.24561,0.2973,1,1
1,GO AXON EXTENSION,0.0025648,0.24557,0.27715,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0080134,0.24553,0.25953,1,1
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00021879,0.24543,0.27581,1,1
1,GO SPINDLE LOCALIZATION,0.00028019,0.24534,0.2834,1,1
1,GO DNA REPAIR,1.8524e-05,0.24534,0.29282,1,1
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,3.7287e-05,0.24511,0.27088,1,1
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.00024771,0.24468,0.24953,1,1
1,GO HISTONE PHOSPHORYLATION,0.00033648,0.24446,0.25517,1,1
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00023283,0.24432,0.30296,1,1
1,GO MESONEPHROS DEVELOPMENT,0.015776,0.24426,0.21911,1,1
1,GO HISTONE H4 ACETYLATION,6.4139e-05,0.24424,0.29771,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0057394,0.24398,0.27115,1,1
1,GO ADIPOSE TISSUE DEVELOPMENT,0.00054254,0.24349,0.27851,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0028457,0.24349,0.33671,1,1
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00024771,0.2432,0.28296,1,1
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.00014062,0.24307,0.25577,1,1
1,GO ACTIN FILAMENT BASED TRANSPORT,0.0066311,0.24301,0.2942,1,1
1,GO RNA METHYLATION,0.00020554,0.24252,0.22815,1,1
1,GO RNA EXPORT FROM NUCLEUS,3.248e-05,0.24232,0.27776,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.5779e-05,0.24221,0.30459,1,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.00013188,0.2422,0.2989,1,1
1,GO RESPONSE TO ALKALOID,0.00057531,0.24215,0.22616,1,1
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0036751,0.24189,0.24325,1,1
1,GO POSITIVE REGULATION OF RNA SPLICING,0.00028019,0.24184,0.26631,1,1
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0028457,0.24115,0.23594,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.010101,0.24113,0.2791,1,1
1,GO PATTERN SPECIFICATION PROCESS,0.0013481,0.24072,0.2287,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,5.9985e-05,0.2406,0.28003,1,1
1,GO REGULATION OF HELICASE ACTIVITY,0.0013481,0.24058,0.23613,1,1
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.010101,0.24048,0.21469,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0021907,0.24045,0.293,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.8298e-05,0.23979,0.2354,1,1
1,GO NEUROBLAST DIVISION,0.0040644,0.23973,0.27994,1,1
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0015882,0.23941,0.29477,1,1
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0020776,0.23906,0.28462,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0012071,0.23906,0.27722,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.050584,0.23868,0.21148,1,1
1,GO NEUROTRANSMITTER REUPTAKE,0.0015882,0.23863,0.2775,1,1
1,GO DETECTION OF VISIBLE LIGHT,0.00012367,0.23861,0.2147,1,1
1,GO CHEMOSENSORY BEHAVIOR,0.0040644,0.23846,0.22694,1,1
1,GO THYROID GLAND DEVELOPMENT,0.013235,0.23838,0.22957,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,5.6086e-05,0.23807,0.30741,1,1
1,GO NEURON PROJECTION EXTENSION,0.0015882,0.23771,0.27231,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00018128,0.23757,0.30235,1,1
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0066311,0.23756,0.30841,1,1
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00015974,0.23751,0.31505,1,1
1,GO REGULATION OF HISTONE MODIFICATION,0.00028019,0.23712,0.26006,1,1
1,GO HINDLIMB MORPHOGENESIS,0.0049572,0.23697,0.25633,1,1
1,GO PEPTIDYL LYSINE MODIFICATION,5.9985e-05,0.23695,0.28787,1,1
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00068502,0.23691,0.28297,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0015041,0.23688,0.27713,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00054254,0.23674,0.22275,1,1
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0096484,0.23651,0.22292,1,1
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0017696,0.23644,0.28757,1,1
1,GO METHYLATION,4.2763e-05,0.23643,0.26448,1,1
1,GO REGULATION OF BEHAVIOR,0.0015041,0.23622,0.23679,1,1
1,GO METANEPHROS MORPHOGENESIS,0.0040644,0.2362,0.27494,1,1
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00096503,0.23571,0.25446,1,1
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.00010866,0.23569,0.27199,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00017019,0.23558,0.3071,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.016475,0.23542,0.29403,1,1
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.031957,0.23529,0.36053,1,1
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.011063,0.23518,0.30595,1,1
1,GO RNA DESTABILIZATION,0.00072571,0.23514,0.28468,1,1
1,GO MACROMOLECULE DEACYLATION,0.00072571,0.23511,0.25828,1,1
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00048214,0.23441,0.27783,1,1
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.017954,0.23441,0.2357,1,1
1,GO PROTEIN MANNOSYLATION,0.0019699,0.23423,0.23944,1,1
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.012106,0.23398,0.20329,1,1
1,GO REGULATION OF CELL PROJECTION SIZE,0.027226,0.23396,0.2098,1,1
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0023095,0.23392,0.27091,1,1
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00081392,0.23346,0.28006,1,1
1,GO CELL CYCLE CHECKPOINT,4.2763e-05,0.23345,0.31817,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00023283,0.23328,0.23036,1,1
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.0023095,0.23324,0.30853,1,1
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0031545,0.23313,0.20875,1,1
1,GO CELLULAR RESPONSE TO ALKALOID,0.0047188,0.23273,0.20824,1,1
1,GO CYTOKINESIS,3.248e-05,0.23263,0.2758,1,1
1,GO DEVELOPMENTAL CELL GROWTH,0.0015041,0.23196,0.25397,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0003797,0.23193,0.28719,1,1
1,GO MIDGUT DEVELOPMENT,0.033245,0.23192,0.20734,1,1
1,GO REGULATION OF CHROMOSOME ORGANIZATION,2.4576e-05,0.23191,0.27846,1,1
1,GO CELL MIGRATION IN HINDBRAIN,0.012106,0.23173,0.28868,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.00035748,0.23152,0.32194,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0015882,0.23121,0.30852,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.0010209,0.2312,0.27849,1,1
1,GO NEUROTRANSMITTER UPTAKE,0.00076864,0.23077,0.25788,1,1
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00051151,0.23041,0.25541,1,1
1,GO LACTATION,0.00048214,0.23005,0.27467,1,1
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0023095,0.22989,0.28415,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,3.7287e-05,0.2295,0.30092,1,1
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00054254,0.22926,0.27172,1,1
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0010798,0.22885,0.26073,1,1
1,GO REGULATION OF GLUCONEOGENESIS,0.0060238,0.22874,0.24504,1,1
1,GO REGULATION OF NEURON DIFFERENTIATION,0.00045436,0.22866,0.27506,1,1
1,GO ASSOCIATIVE LEARNING,0.00028019,0.22862,0.26403,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.0017696,0.22831,0.24869,1,1
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0021907,0.22824,0.27816,1,1
1,GO PROTEIN ACYLATION,5.2428e-05,0.22815,0.29616,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0015041,0.22797,0.28226,1,1
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0052065,0.22793,0.30256,1,1
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,5.9985e-05,0.22763,0.26804,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00021879,0.22758,0.2708,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,7.8298e-05,0.2275,0.23752,1,1
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00068502,0.22725,0.29901,1,1
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00060992,0.22718,0.29876,1,1
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036751,0.22713,0.22369,1,1
1,GO INNER EAR MORPHOGENESIS,0.0023095,0.22712,0.26472,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,9.5377e-05,0.22694,0.28773,1,1
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0017696,0.22688,0.29006,1,1
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.037377,0.2266,0.22914,1,1
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0029965,0.22654,0.24594,1,1
1,GO RNA STABILIZATION,0.00012367,0.22651,0.26283,1,1
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,2.1347e-05,0.2264,0.2688,1,1
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.021265,0.22634,0.18346,1,1
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00072571,0.22631,0.26647,1,1
1,GO HIPPOCAMPUS DEVELOPMENT,0.00045436,0.22625,0.27005,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.021265,0.22625,0.19037,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.00045436,0.22621,0.2389,1,1
1,GO REGULATION OF TOR SIGNALING,0.00017019,0.22573,0.2642,1,1
1,GO PANCREAS DEVELOPMENT,0.00068502,0.22567,0.31903,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00018128,0.22554,0.23863,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.006955,0.22546,0.24784,1,1
1,GO CELL DIVISION,3.9936e-05,0.22538,0.26948,1,1
1,GO REGULATION OF ACTION POTENTIAL,0.0028457,0.22492,0.26051,1,1
1,GO MRNA EXPORT FROM NUCLEUS,1.9888e-05,0.22488,0.29066,1,1
1,GO CELL FATE SPECIFICATION,0.0040644,0.22438,0.24422,1,1
1,GO SNARE COMPLEX ASSEMBLY,0.0028457,0.22431,0.22545,1,1
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,3.9936e-05,0.22421,0.26906,1,1
1,GO NEURON DEVELOPMENT,0.00051151,0.22416,0.26781,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00096503,0.22378,0.27636,1,1
1,GO FEMALE GAMETE GENERATION,0.0010209,0.22362,0.21214,1,1
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.010572,0.22346,0.29009,1,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,2.1347e-05,0.22329,0.28162,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0003797,0.22324,0.28093,1,1
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0034935,0.22282,0.30358,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.011574,0.22271,0.23076,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,4.2763e-05,0.22259,0.26791,1,1
1,GO CENTROSOME SEPARATION,0.00033648,0.22257,0.28222,1,1
1,GO MRNA TRANSPORT,3.9936e-05,0.22241,0.26484,1,1
1,GO OOGENESIS,0.00048214,0.22235,0.23464,1,1
1,GO SOMITOGENESIS,0.00068502,0.22201,0.27736,1,1
1,GO DNA METHYLATION,0.00054254,0.22195,0.22583,1,1
1,GO REGIONALIZATION,0.0021907,0.22174,0.22665,1,1
1,GO ONE CARBON METABOLIC PROCESS,0.0020776,0.22147,0.19877,1,1
1,GO CELLULAR RESPONSE TO STEROL,0.0021907,0.22138,0.28319,1,1
1,GO MRNA MODIFICATION,0.00064645,0.22086,0.23028,1,1
1,GO LOCALIZATION WITHIN MEMBRANE,0.0040644,0.22028,0.24013,1,1
1,GO VIRAL LATENCY,0.0028457,0.21991,0.20084,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.052482,0.21964,0.20115,1,1
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0013481,0.21951,0.25656,1,1
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0016767,0.21946,0.26805,1,1
1,GO TELOMERE ORGANIZATION,4.2763e-05,0.21925,0.25832,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,5.9985e-05,0.21925,0.2506,1,1
1,GO PROTEIN ACETYLATION,6.8565e-05,0.21899,0.28291,1,1
1,GO C4 DICARBOXYLATE TRANSPORT,0.00091199,0.21894,0.24672,1,1
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,8.9327e-05,0.21885,0.27634,1,1
1,GO REGULATION OF SYNAPTIC PLASTICITY,0.0031545,0.21876,0.24808,1,1
1,GO EAR MORPHOGENESIS,0.0049572,0.21874,0.24017,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.019548,0.21837,0.26332,1,1
1,GO NEPHRON MORPHOGENESIS,0.007293,0.21803,0.24112,1,1
1,GO BASE EXCISION REPAIR,0.00018128,0.21774,0.24414,1,1
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0014241,0.2176,0.231,1,1
1,GO PEPTIDYL LYSINE ACETYLATION,8.3641e-05,0.21757,0.28893,1,1
1,GO ORGANIC CATION TRANSPORT,0.011063,0.21747,0.22121,1,1
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.041938,0.21744,0.20787,1,1
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00011593,0.2171,0.28466,1,1
1,GO REGULATION OF NUCLEAR DIVISION,3.4805e-05,0.21708,0.2571,1,1
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00332,0.21669,0.24444,1,1
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.028348,0.21664,0.25476,1,1
1,GO CELL PROJECTION ORGANIZATION,0.00064645,0.21661,0.24337,1,1
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0020776,0.21658,0.24375,1,1
1,GO TRNA METHYLATION,0.00035748,0.21649,0.2161,1,1
1,GO NEURON DIFFERENTIATION,0.00042807,0.21644,0.26447,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0054671,0.2164,0.26228,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0028457,0.21621,0.29157,1,1
1,GO KIDNEY MORPHOGENESIS,0.0063209,0.21615,0.25919,1,1
1,GO AXIS SPECIFICATION,0.00031664,0.21594,0.23786,1,1
1,GO GENITALIA DEVELOPMENT,0.0092139,0.21584,0.23132,1,1
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00024771,0.21583,0.24151,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0052065,0.21523,0.21535,1,1
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00017019,0.21516,0.27567,1,1
1,GO EPITHELIAL CELL FATE COMMITMENT,0.028348,0.21505,0.2282,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,6.8565e-05,0.21492,0.27789,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.006955,0.21482,0.21396,1,1
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.00086166,0.2144,0.27419,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0017696,0.21435,0.24862,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00011593,0.21407,0.25091,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00024771,0.21394,0.2492,1,1
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00042807,0.21386,0.25742,1,1
1,GO RESPONSE TO FOOD,0.0020776,0.21381,0.23463,1,1
1,GO GAMETE GENERATION,0.00015974,0.21377,0.23231,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.038848,0.21376,0.20635,1,1
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0076456,0.21345,0.23555,1,1
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2428e-05,0.21341,0.2515,1,1
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00023283,0.21334,0.24474,1,1
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0040644,0.21301,0.23685,1,1
1,GO DNA CATABOLIC PROCESS,0.00040321,0.21296,0.21569,1,1
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00018128,0.21279,0.2444,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0036751,0.21256,0.25159,1,1
1,GO DNA METABOLIC PROCESS,3.4805e-05,0.21238,0.24722,1,1
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0025648,0.21224,0.23401,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00057531,0.21207,0.23717,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0040644,0.21204,0.24212,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0003797,0.21181,0.27214,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,4.5779e-05,0.21167,0.20136,1,1
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.035953,0.21161,0.15557,1,1
1,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.012106,0.21155,0.18188,1,1
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.008797,0.2115,0.18429,1,1
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0023095,0.21136,0.33252,1,1
1,GO PROTEIN AUTOUBIQUITINATION,3.0304e-05,0.21125,0.27249,1,1
1,GO MOTOR NEURON AXON GUIDANCE,0.008797,0.21121,0.26844,1,1
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0012758,0.21118,0.26728,1,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00091199,0.21103,0.22416,1,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,6.8565e-05,0.2109,0.28858,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,7.8298e-05,0.21086,0.28057,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0016767,0.21078,0.25139,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.0011418,0.21075,0.26731,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.038848,0.21055,0.22965,1,1
1,GO MANNOSYLATION,0.00068502,0.21037,0.22428,1,1
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.014457,0.21028,0.28394,1,1
1,GO RESPONSE TO UV,0.00024771,0.21025,0.23271,1,1
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0011418,0.2098,0.25022,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,3.0304e-05,0.20955,0.28627,1,1
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.010572,0.20941,0.23472,1,1
1,GO OOCYTE DIFFERENTIATION,0.015104,0.2094,0.16752,1,1
1,GO ADULT LOCOMOTORY BEHAVIOR,0.01266,0.20933,0.20615,1,1
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00064645,0.20924,0.25215,1,1
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0027019,0.20921,0.21779,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.00014989,0.20868,0.27365,1,1
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00091199,0.20856,0.24369,1,1
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2428e-05,0.20845,0.24882,1,1
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.00033648,0.20842,0.24601,1,1
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0010798,0.20798,0.23182,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.048745,0.20789,0.20889,1,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0013481,0.20785,0.26308,1,1
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00091199,0.20778,0.28668,1,1
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00051151,0.2077,0.26336,1,1
1,GO REGULATION OF TELOMERE CAPPING,0.0057394,0.20764,0.24459,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.00029789,0.2076,0.25106,1,1
1,GO RESPONSE TO INACTIVITY,0.026142,0.20757,0.22994,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE,0.00011593,0.20731,0.23677,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00012367,0.20721,0.22512,1,1
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00014989,0.20699,0.24152,1,1
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.00332,0.20634,0.24479,1,1
1,GO COGNITION,0.00054254,0.20628,0.23212,1,1
1,GO HEAD DEVELOPMENT,0.0003797,0.20624,0.25707,1,1
1,GO UV PROTECTION,0.0083971,0.20608,0.24328,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00072571,0.20578,0.25351,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.2428e-05,0.20549,0.24681,1,1
1,GO CIRCADIAN RHYTHM,0.00020554,0.20509,0.25336,1,1
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0027019,0.20499,0.21955,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.019548,0.20478,0.21211,1,1
1,GO TRNA MODIFICATION,0.0014241,0.20442,0.17628,1,1
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00035748,0.20414,0.22428,1,1
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00332,0.20403,0.20384,1,1
1,GO SPERMATID DIFFERENTIATION,0.00064645,0.20392,0.20721,1,1
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0015882,0.2037,0.26552,1,1
1,GO RNA PROCESSING,0.00011593,0.2037,0.21349,1,1
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0020776,0.20369,0.24772,1,1
1,GO REGULATION OF LYASE ACTIVITY,0.0027019,0.20353,0.22192,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.6059e-05,0.20344,0.22633,1,1
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0029965,0.20309,0.25194,1,1
1,GO REGULATION OF DOPAMINE SECRETION,0.024086,0.20289,0.25803,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,6.4139e-05,0.20263,0.22408,1,1
1,GO HISTONE H2A ACETYLATION,0.00028019,0.20256,0.25123,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00017019,0.20242,0.24315,1,1
1,GO POSITIVE REGULATION OF FERTILIZATION,0.008797,0.20182,0.17609,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.018736,0.20179,0.22102,1,1
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00068502,0.2017,0.26733,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,3.9936e-05,0.20165,0.24591,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.013235,0.20159,0.18699,1,1
1,GO NEUROGENESIS,0.00054254,0.20138,0.24633,1,1
1,GO FOREBRAIN DEVELOPMENT,0.00018128,0.20122,0.2729,1,1
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.00040321,0.20108,0.23659,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00048214,0.20081,0.24713,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.050584,0.20067,0.18558,1,1
1,GO FAT CELL PROLIFERATION,0.0057394,0.20034,0.30639,1,1
1,GO ENERGY HOMEOSTASIS,0.013834,0.19995,0.21478,1,1
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.033245,0.19985,0.21446,1,1
1,GO MALE MEIOSIS I,0.0060238,0.19965,0.26393,1,1
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.010101,0.19955,0.21366,1,1
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0054671,0.19952,0.2192,1,1
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.024086,0.19913,0.20816,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0013481,0.19909,0.26219,1,1
1,GO GERM CELL DEVELOPMENT,0.00024771,0.19904,0.24068,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,7.3279e-05,0.19847,0.23996,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,4.8997e-05,0.19813,0.22742,1,1
1,GO NUCLEAR EXPORT,2.1347e-05,0.1981,0.2613,1,1
1,GO REGULATION OF CELL CYCLE,6.4139e-05,0.19804,0.24456,1,1
1,GO TOR SIGNALING,0.00026348,0.198,0.24559,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,2.8267e-05,0.19773,0.22827,1,1
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.048745,0.19771,0.24485,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.052482,0.19757,0.2624,1,1
1,GO ORGANELLE LOCALIZATION,0.00045436,0.19735,0.22201,1,1
1,GO REGULATION OF AXON GUIDANCE,0.020391,0.19735,0.24725,1,1
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.018736,0.19733,0.21826,1,1
1,GO FEMALE GENITALIA DEVELOPMENT,0.034576,0.19724,0.19019,1,1
1,GO TELENCEPHALON DEVELOPMENT,0.00072571,0.19718,0.25369,1,1
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0040644,0.19705,0.22153,1,1
1,GO CELL CYCLE PROCESS,3.7287e-05,0.19702,0.26369,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.00028019,0.197,0.17356,1,1
1,GO MEMORY,0.0016767,0.19698,0.24561,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,8.3641e-05,0.19695,0.21349,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00026348,0.19693,0.21398,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00096503,0.1969,0.23108,1,1
1,GO SENSORY ORGAN MORPHOGENESIS,0.00332,0.19676,0.22059,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.037377,0.1967,0.21771,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0019699,0.19665,0.2758,1,1
1,GO GENE SILENCING,0.00028019,0.19655,0.24238,1,1
1,GO MULTICELLULAR ORGANISM GROWTH,0.00029789,0.19637,0.26848,1,1
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.010572,0.1963,0.22068,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0011418,0.19607,0.22242,1,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00018128,0.19591,0.2572,1,1
1,GO SEXUAL REPRODUCTION,0.00020554,0.19548,0.21665,1,1
1,GO REGULATION OF NEURON MATURATION,0.0063209,0.19522,0.26374,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,4.5779e-05,0.19518,0.24183,1,1
1,GO CELLULAR RESPONSE TO PH,0.023112,0.19515,0.20158,1,1
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.00029789,0.19511,0.23845,1,1
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0015882,0.19508,0.2929,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,3.248e-05,0.19508,0.26019,1,1
1,GO DETECTION OF LIGHT STIMULUS,0.00020554,0.19508,0.18314,1,1
1,GO MALE GAMETE GENERATION,0.00020554,0.19502,0.22397,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0010798,0.19495,0.19465,1,1
1,GO CELL CYCLE,5.6086e-05,0.19487,0.24694,1,1
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.010572,0.19478,0.23127,1,1
1,GO TRANSMISSION OF NERVE IMPULSE,0.010572,0.19476,0.22175,1,1
1,GO MECHANORECEPTOR DIFFERENTIATION,0.0015882,0.19471,0.22113,1,1
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.00332,0.19463,0.24325,1,1
1,GO ORGANELLE ASSEMBLY,0.00040321,0.19462,0.22608,1,1
1,GO FATTY ACID BETA OXIDATION,0.0025648,0.19458,0.17855,1,1
1,GO PROTEIN SUMOYLATION,8.3641e-05,0.1943,0.26109,1,1
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.00019306,0.19422,0.25104,1,1
1,GO TELOMERE CAPPING,0.0021907,0.19422,0.23889,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.033245,0.19416,0.24801,1,1
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0015882,0.19416,0.22837,1,1
1,GO REGULATION OF CELL CYCLE ARREST,6.8565e-05,0.19388,0.25882,1,1
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0014241,0.1938,0.2553,1,1
1,GO REGULATION OF MEMBRANE POTENTIAL,0.0016767,0.19374,0.21595,1,1
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00048214,0.19368,0.25011,1,1
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.0047188,0.19344,0.20486,1,1
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00026348,0.19311,0.23075,1,1
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0096484,0.19289,0.23826,1,1
1,GO NEURAL TUBE FORMATION,0.0042727,0.19242,0.23473,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,7.8298e-05,0.19242,0.22708,1,1
1,GO REGULATION OF CELL SIZE,0.0016767,0.1924,0.2572,1,1
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.014457,0.19228,0.21543,1,1
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.00081392,0.19226,0.24606,1,1
1,GO REGULATION OF RNA BINDING,0.0015041,0.19196,0.20422,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,7.8298e-05,0.19188,0.2267,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00012367,0.19172,0.22575,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00010866,0.19084,0.21692,1,1
1,GO MITOTIC CELL CYCLE,5.6086e-05,0.19072,0.24882,1,1
1,GO DOPAMINE TRANSPORT,0.015776,0.19056,0.27385,1,1
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0011418,0.19054,0.21355,1,1
1,GO POST EMBRYONIC DEVELOPMENT,0.0010798,0.19045,0.26141,1,1
1,GO HISTONE H3 ACETYLATION,0.0011418,0.19044,0.23977,1,1
1,GO NUCLEAR TRANSPORT,3.0304e-05,0.19024,0.23546,1,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.0052065,0.19023,0.1958,1,1
1,GO PIGMENT GRANULE LOCALIZATION,0.046961,0.19021,0.14931,1,1
1,GO CAMERA TYPE EYE DEVELOPMENT,0.00091199,0.1902,0.24664,1,1
1,GO DIENCEPHALON DEVELOPMENT,0.0021907,0.19008,0.26603,1,1
1,GO POSITIVE REGULATION OF CELL MATURATION,0.011574,0.18991,0.22861,1,1
1,GO PEPTIDE HORMONE SECRETION,0.0012071,0.18989,0.2282,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00014062,0.18986,0.2415,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0083971,0.18936,0.22433,1,1
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.037377,0.18934,0.15735,1,1
1,GO HISTONE H3 K14 ACETYLATION,0.0021907,0.18916,0.26909,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0047188,0.18915,0.22,1,1
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0021907,0.1891,0.25203,1,1
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0044907,0.18897,0.23677,1,1
1,GO MAINTENANCE OF CELL NUMBER,0.0003797,0.18875,0.24367,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00096503,0.18857,0.19529,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0049572,0.18838,0.22913,1,1
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0012071,0.18831,0.23766,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00040321,0.18819,0.21782,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00064645,0.18818,0.1871,1,1
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0023095,0.18787,0.23336,1,1
1,GO REGULATION OF GLUCOSE IMPORT,0.0029965,0.18778,0.20894,1,1
1,GO RNA LOCALIZATION,6.4139e-05,0.18769,0.22268,1,1
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0038653,0.18767,0.22586,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.035953,0.1873,0.22253,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00017019,0.18719,0.2505,1,1
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.006955,0.18681,0.23239,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.013834,0.18677,0.2118,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00020554,0.18674,0.24388,1,1
1,GO TRNA TRANSPORT,0.00014989,0.18672,0.25079,1,1
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00021879,0.1867,0.23038,1,1
1,GO BILE ACID METABOLIC PROCESS,0.0060238,0.18641,0.18624,1,1
1,GO APPENDAGE MORPHOGENESIS,0.0011418,0.18636,0.28451,1,1
1,GO MESENCHYMAL CELL PROLIFERATION,0.052482,0.1862,0.21299,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.008797,0.18611,0.27627,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.0049572,0.18605,0.23672,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0015041,0.18592,0.20134,1,1
1,GO INCLUSION BODY ASSEMBLY,0.00091199,0.18558,0.28138,1,1
1,GO LYSOSOMAL TRANSPORT,0.0012071,0.18542,0.24769,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,0.0052065,0.1853,0.25517,1,1
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.00091199,0.18523,0.20442,1,1
1,GO REGULATION OF MITOPHAGY,0.008797,0.1851,0.23297,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.00019306,0.18499,0.23241,1,1
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0028457,0.18497,0.22985,1,1
1,GO PROTEIN DEPOLYMERIZATION,0.0014241,0.18452,0.25096,1,1
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0083971,0.18451,0.20666,1,1
1,GO RESPONSE TO AMINO ACID STARVATION,0.00042807,0.18445,0.22968,1,1
1,GO CHROMATIN DISASSEMBLY,0.041938,0.18409,0.19059,1,1
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00076864,0.18405,0.20026,1,1
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00060992,0.1836,0.20163,1,1
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.022172,0.18359,0.18628,1,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0012758,0.18346,0.27429,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00040321,0.18344,0.23618,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.016475,0.18326,0.18071,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0066311,0.18322,0.23738,1,1
1,GO NCRNA CATABOLIC PROCESS,0.0024341,0.18313,0.19992,1,1
1,GO LATERAL MESODERM DEVELOPMENT,0.014457,0.183,0.23974,1,1
1,GO POLYOL CATABOLIC PROCESS,0.0016767,0.18274,0.23329,1,1
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.011574,0.18273,0.20429,1,1
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.050584,0.18272,0.19578,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00064645,0.18263,0.20761,1,1
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0016767,0.18224,0.21088,1,1
1,GO HISTONE H3 K9 ACETYLATION,0.0063209,0.18219,0.19063,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0034935,0.18215,0.2032,1,1
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.015104,0.18215,0.17234,1,1
1,GO REGULATION OF CELL DIVISION,0.00021879,0.182,0.23173,1,1
1,GO MITOCHONDRIAL RNA PROCESSING,0.015776,0.18198,0.18228,1,1
1,GO IMPORT INTO NUCLEUS,0.00018128,0.18191,0.20975,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0023095,0.18186,0.24473,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0013481,0.18184,0.21032,1,1
1,GO MITOTIC CYTOKINESIS,0.00014989,0.18182,0.24303,1,1
1,GO CARNITINE METABOLIC PROCESS,0.019548,0.18169,0.17849,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0092139,0.18168,0.18688,1,1
1,GO CELLULAR RESPONSE TO UV,0.00072571,0.1814,0.2121,1,1
1,GO CELL CYCLE PHASE TRANSITION,4.5779e-05,0.18124,0.24085,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.0029965,0.18119,0.2524,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.00068502,0.18092,0.20965,1,1
1,GO ALDITOL METABOLIC PROCESS,0.034576,0.18091,0.16367,1,1
1,GO CELL JUNCTION ORGANIZATION,0.0031545,0.1809,0.23118,1,1
1,GO DENDRITIC SPINE MAINTENANCE,0.017954,0.18083,0.23333,1,1
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0010209,0.1807,0.22277,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00060992,0.18051,0.26649,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0096484,0.18048,0.23314,1,1
1,GO CAMP METABOLIC PROCESS,0.052482,0.18034,0.23361,1,1
1,GO STRIATUM DEVELOPMENT,0.034576,0.18032,0.20742,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.013834,0.18029,0.20201,1,1
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.008797,0.18024,0.19095,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,0.010572,0.18022,0.17191,1,1
1,GO SENSORY SYSTEM DEVELOPMENT,0.0031545,0.18007,0.22981,1,1
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0015882,0.17992,0.21215,1,1
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.014457,0.17972,0.19055,1,1
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.012106,0.17968,0.16224,1,1
1,GO CELL JUNCTION ASSEMBLY,0.0092139,0.17938,0.21533,1,1
1,GO CELL PROJECTION ASSEMBLY,0.00332,0.17934,0.21282,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.010101,0.17911,0.22735,1,1
1,GO REGULATION OF HORMONE SECRETION,0.0047188,0.17854,0.19785,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,4.8997e-05,0.17847,0.21706,1,1
1,GO RNA SURVEILLANCE,5.2428e-05,0.17845,0.20843,1,1
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.015776,0.17839,0.23612,1,1
1,GO RESPONSE TO LIGHT STIMULUS,0.00017019,0.17835,0.21677,1,1
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0080134,0.17829,0.19352,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00026348,0.1781,0.20631,1,1
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.041938,0.1781,0.1847,1,1
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.006955,0.17794,0.228,1,1
1,GO NCRNA TRANSCRIPTION,0.00010866,0.17793,0.21791,1,1
1,GO LIMBIC SYSTEM DEVELOPMENT,0.00051151,0.17789,0.23643,1,1
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0015882,0.17768,0.23416,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0012071,0.17715,0.20665,1,1
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0044907,0.17711,0.23143,1,1
1,GO EMBRYONIC PATTERN SPECIFICATION,0.00021879,0.17706,0.24292,1,1
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.022172,0.1767,0.24966,1,1
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0038653,0.17644,0.18137,1,1
1,GO CELL MORPHOGENESIS,0.0025648,0.17637,0.23657,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0013481,0.17616,0.25375,1,1
1,GO CELL CYCLE ARREST,0.00014062,0.17605,0.23382,1,1
1,GO MRNA METABOLIC PROCESS,5.6086e-05,0.17585,0.20305,1,1
1,GO EAR DEVELOPMENT,0.0036751,0.17582,0.21973,1,1
1,GO PROTEIN HETEROOLIGOMERIZATION,0.020391,0.17571,0.1658,1,1
1,GO SENSORY ORGAN DEVELOPMENT,0.0012758,0.17548,0.2285,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0003797,0.1754,0.19502,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0049572,0.17539,0.25303,1,1
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00024771,0.17519,0.22718,1,1
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00072571,0.17518,0.21905,1,1
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0013481,0.17515,0.23579,1,1
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.01266,0.17514,0.16276,1,1
1,GO POSTREPLICATION REPAIR,0.00013188,0.1751,0.21161,1,1
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0066311,0.17507,0.19389,1,1
1,GO RHYTHMIC PROCESS,0.00024771,0.17501,0.24183,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.014457,0.17498,0.21649,1,1
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0013481,0.17495,0.23517,1,1
1,GO RESPONSE TO AMINE,0.040368,0.17469,0.16199,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0052065,0.17464,0.24833,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00015974,0.1746,0.22209,1,1
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0096484,0.174,0.12812,1,1
1,GO NUCLEUS ORGANIZATION,0.00023283,0.17398,0.22214,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0015041,0.17386,0.23002,1,1
1,GO LACTATE METABOLIC PROCESS,0.0013481,0.17385,0.19601,1,1
1,GO RESPONSE TO CAFFEINE,0.011574,0.17382,0.18024,1,1
1,GO SYNAPTIC VESICLE RECYCLING,0.0057394,0.17369,0.23195,1,1
1,GO RRNA TRANSCRIPTION,0.00033648,0.17369,0.21381,1,1
1,GO MITOPHAGY,0.0066311,0.17367,0.21748,1,1
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.00019306,0.17365,0.23143,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.030713,0.17364,0.188,1,1
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00076864,0.17363,0.21185,1,1
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.027226,0.17344,0.19545,1,1
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.00023283,0.17325,0.22916,1,1
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0057394,0.17318,0.19516,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,5.2428e-05,0.17303,0.23742,1,1
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00064645,0.17302,0.23303,1,1
1,GO EMBRYO DEVELOPMENT,0.0049572,0.17279,0.20205,1,1
1,GO ENAMEL MINERALIZATION,0.007293,0.17278,0.23836,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012106,0.17277,0.21719,1,1
1,GO PEPTIDYL SERINE MODIFICATION,0.00081392,0.17233,0.22445,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,0.0044907,0.17177,0.21302,1,1
1,GO NUCLEAR BODY ORGANIZATION,0.0066311,0.17159,0.18796,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0063209,0.17137,0.24127,1,1
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.011574,0.1713,0.14288,1,1
1,GO STEM CELL PROLIFERATION,0.0029965,0.1712,0.24083,1,1
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.015776,0.17117,0.15818,1,1
1,GO REGULATION OF CELL DEVELOPMENT,0.0015882,0.17094,0.2211,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.033245,0.17066,0.20706,1,1
1,GO SEX DIFFERENTIATION,0.00026348,0.1705,0.22774,1,1
1,GO SNRNA TRANSCRIPTION,0.00017019,0.1705,0.21256,1,1
1,GO FEMALE SEX DIFFERENTIATION,0.00096503,0.17045,0.24295,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0066311,0.17013,0.2033,1,1
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0010798,0.17013,0.19602,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0015041,0.1701,0.19528,1,1
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.025096,0.16995,0.19253,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,9.5377e-05,0.1698,0.22867,1,1
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0038653,0.16972,0.21903,1,1
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.033245,0.16972,0.19577,1,1
1,GO REGULATION OF DEPHOSPHORYLATION,0.0028457,0.16963,0.20136,1,1
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00033648,0.16962,0.21597,1,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.00060992,0.16947,0.25231,1,1
1,GO MYOBLAST PROLIFERATION,0.028348,0.16914,0.15089,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.6086e-05,0.16913,0.21526,1,1
1,GO REGULATION OF MRNA BINDING,0.0096484,0.16888,0.16762,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,0.0063209,0.16885,0.22654,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0016767,0.1688,0.2048,1,1
1,GO PRESYNAPTIC ENDOCYTOSIS,0.0038653,0.16876,0.23465,1,1
1,GO PORE COMPLEX ASSEMBLY,0.0066311,0.16847,0.17038,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0034935,0.16833,0.19869,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0012758,0.16804,0.19972,1,1
1,GO PROSTATE GLAND GROWTH,0.0172,0.16794,0.17932,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0066311,0.16788,0.17962,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00048214,0.16775,0.22342,1,1
1,GO GMP METABOLIC PROCESS,0.0028457,0.1677,0.19085,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00091199,0.16769,0.19663,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.013235,0.1675,0.23238,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.010572,0.16744,0.21821,1,1
1,GO REGULATION OF EXOCYTOSIS,0.0036751,0.16735,0.21146,1,1
1,GO TRNA PROCESSING,0.0015882,0.16725,0.1546,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,4.8997e-05,0.16709,0.20131,1,1
1,GO PHOTOPERIODISM,0.0047188,0.16704,0.1996,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00031664,0.16684,0.20571,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.020391,0.16683,0.2551,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00017019,0.16676,0.23355,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00023283,0.16673,0.1728,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.0018673,0.16645,0.23974,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0040644,0.16631,0.22557,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0020776,0.16603,0.18622,1,1
1,GO LIPID DROPLET ORGANIZATION,0.0047188,0.16598,0.17227,1,1
1,GO PYRUVATE METABOLIC PROCESS,0.0019699,0.1657,0.19018,1,1
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0013481,0.16552,0.23184,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00060992,0.16548,0.1801,1,1
1,GO NERVOUS SYSTEM PROCESS,0.0028457,0.16537,0.1803,1,1
1,GO DEMETHYLATION,0.00068502,0.16516,0.23996,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00017019,0.16511,0.21791,1,1
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00040321,0.16509,0.20074,1,1
1,GO PURINE NUCLEOTIDE TRANSPORT,0.021265,0.16485,0.16257,1,1
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00081392,0.16479,0.24531,1,1
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.00081392,0.16467,0.21611,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00010181,0.16461,0.211,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00010866,0.16456,0.17823,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0010798,0.16429,0.20526,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0076456,0.16389,0.17053,1,1
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.0063209,0.16387,0.21512,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,5.2428e-05,0.16367,0.17697,1,1
1,GO POTASSIUM ION TRANSPORT,0.0076456,0.16348,0.19999,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.025096,0.1634,0.20468,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.013834,0.16318,0.2497,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.02951,0.16314,0.21234,1,1
1,GO BLASTOCYST GROWTH,0.0080134,0.16301,0.19764,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.00042807,0.16299,0.2063,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.022172,0.16291,0.16328,1,1
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0040644,0.16263,0.1816,1,1
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.0054671,0.16256,0.19045,1,1
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.013235,0.16248,0.20425,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,7.3279e-05,0.16235,0.2387,1,1
1,GO REGULATION OF CELL MORPHOGENESIS,0.0020776,0.16197,0.22948,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.015776,0.16185,0.17442,1,1
1,GO PHOTOTRANSDUCTION,0.00096503,0.16174,0.13819,1,1
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.019548,0.16172,0.17425,1,1
1,GO CYTOSOLIC TRANSPORT,0.0029965,0.16104,0.20463,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0014241,0.16088,0.20637,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00054254,0.16088,0.20709,1,1
1,GO EYE MORPHOGENESIS,0.0092139,0.16072,0.20948,1,1
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.018736,0.16062,0.17669,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.0020776,0.16058,0.24091,1,1
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0057394,0.16054,0.17811,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0010798,0.16048,0.17996,1,1
1,GO VACUOLAR TRANSPORT,0.0028457,0.16046,0.20494,1,1
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.027226,0.16046,0.13985,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0010209,0.16042,0.20413,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.014457,0.16035,0.16959,1,1
1,GO ADAPTATION OF SIGNALING PATHWAY,0.048745,0.16023,0.17554,1,1
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.006955,0.16009,0.17882,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.014457,0.16006,0.19615,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.010101,0.16003,0.19424,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0020776,0.15978,0.18434,1,1
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0038653,0.15976,0.13521,1,1
1,GO HORMONE TRANSPORT,0.0054671,0.1594,0.18829,1,1
1,GO L AMINO ACID TRANSPORT,0.035953,0.1593,0.16762,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.046961,0.15922,0.1529,1,1
1,GO APPENDAGE DEVELOPMENT,0.0013481,0.15903,0.25988,1,1
1,GO CYTOSKELETON ORGANIZATION,0.0025648,0.15895,0.20637,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,0.016475,0.15894,0.19835,1,1
1,GO GENETIC IMPRINTING,0.0080134,0.15889,0.2349,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.0017696,0.15842,0.24122,1,1
1,GO TRNA METABOLIC PROCESS,0.0020776,0.15829,0.1526,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.030713,0.15808,0.13893,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.006955,0.15807,0.28186,1,1
1,GO RENAL TUBULE DEVELOPMENT,0.028348,0.15789,0.1985,1,1
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0042727,0.15781,0.16397,1,1
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0031545,0.15773,0.2047,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0042727,0.15761,0.19301,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0025648,0.1575,0.1963,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00091199,0.15746,0.17462,1,1
1,GO AROMATIC AMINO ACID TRANSPORT,0.026142,0.1574,0.25158,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00072571,0.1574,0.18641,1,1
1,GO FERTILIZATION,0.0014241,0.15735,0.17464,1,1
1,GO TRANSLESION SYNTHESIS,0.00020554,0.15721,0.19809,1,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.007293,0.15691,0.24984,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.019548,0.15686,0.22163,1,1
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0063209,0.15685,0.19796,1,1
1,GO OVULATION CYCLE PROCESS,0.016475,0.15675,0.20423,1,1
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.038848,0.15658,0.1705,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.00072571,0.15657,0.23193,1,1
1,GO DNA METHYLATION OR DEMETHYLATION,0.00081392,0.15652,0.20505,1,1
1,GO SKIN EPIDERMIS DEVELOPMENT,0.010572,0.15645,0.21936,1,1
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0047188,0.15636,0.22832,1,1
1,GO REGULATION OF CELL AGING,0.0054671,0.15598,0.19678,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0057394,0.15596,0.17985,1,1
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00060992,0.15585,0.21171,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.031957,0.15577,0.20604,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0044907,0.15571,0.17267,1,1
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0060238,0.15554,0.16533,1,1
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0044907,0.15537,0.152,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00332,0.15535,0.18457,1,1
1,GO SELECTIVE AUTOPHAGY,0.0096484,0.1551,0.18886,1,1
1,GO SECRETORY GRANULE ORGANIZATION,0.038848,0.15507,0.18411,1,1
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.008797,0.15491,0.1902,1,1
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.046961,0.1547,0.21784,1,1
1,GO RNA MODIFICATION,0.00076864,0.15462,0.16085,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.007293,0.1545,0.18353,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0044907,0.15445,0.2265,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011574,0.15441,0.24005,1,1
1,GO POSITIVE REGULATION OF ACROSOME REACTION,0.030713,0.1544,0.14521,1,1
1,GO SNRNA PROCESSING,0.0028457,0.1543,0.1416,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0010798,0.15402,0.21289,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.018736,0.154,0.23464,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.016475,0.154,0.17067,1,1
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0063209,0.15392,0.21508,1,1
1,GO REPRODUCTION,0.0016767,0.15376,0.18962,1,1
1,GO REGULATION OF PROTEIN ACETYLATION,0.0023095,0.1537,0.19127,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0083971,0.15351,0.17273,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0010209,0.15336,0.16506,1,1
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0172,0.15315,0.21764,1,1
1,GO REGULATION OF INSULIN SECRETION,0.0016767,0.15315,0.21845,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011418,0.1529,0.2239,1,1
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.025096,0.1528,0.15659,1,1
1,GO MIRNA METABOLIC PROCESS,0.0080134,0.15272,0.19527,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.019548,0.15244,0.19832,1,1
1,GO ERYTHROCYTE MATURATION,0.050584,0.15236,0.16656,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.010101,0.1523,0.20602,1,1
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0011418,0.15218,0.2022,1,1
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.008797,0.15202,0.19023,1,1
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.0054671,0.15195,0.25102,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00068502,0.15186,0.165,1,1
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0172,0.15171,0.20475,1,1
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011063,0.15164,0.19733,1,1
1,GO DNA MODIFICATION,0.0011418,0.15156,0.18349,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0060238,0.15149,0.19319,1,1
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.013834,0.15139,0.17812,1,1
1,GO PROTEIN IMPORT,0.0010209,0.15093,0.17533,1,1
1,GO ENDOCYTIC RECYCLING,0.013235,0.15091,0.20866,1,1
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.00031664,0.15057,0.21627,1,1
1,GO RHYTHMIC BEHAVIOR,0.015776,0.15056,0.16861,1,1
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.02951,0.15052,0.30037,1,1
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0017696,0.15036,0.19455,1,1
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0013481,0.15014,0.19953,1,1
1,GO LIPID PHOSPHORYLATION,0.0083971,0.14986,0.2086,1,1
1,GO ACETYL COA METABOLIC PROCESS,0.0036751,0.14985,0.16606,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019306,0.14968,0.21817,1,1
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0066311,0.14949,0.17281,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.012106,0.14933,0.19038,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00332,0.1492,0.17236,1,1
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.00086166,0.1491,0.17623,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.013834,0.14863,0.24838,1,1
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0083971,0.14783,0.17601,1,1
1,GO THYMUS DEVELOPMENT,0.011063,0.14774,0.18565,1,1
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.010101,0.14757,0.18968,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.021265,0.14749,0.11878,1,1
1,GO MULTI ORGANISM PROCESS,0.0010798,0.14654,0.18148,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00081392,0.14615,0.17625,1,1
1,GO INSULIN SECRETION,0.0025648,0.1461,0.21468,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00045436,0.14592,0.1546,1,1
1,GO DEVELOPMENTAL GROWTH,0.0016767,0.14588,0.2266,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0038653,0.14579,0.18306,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.00076864,0.14575,0.24234,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0052065,0.14552,0.14625,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,3.248e-05,0.14505,0.17773,1,1
1,GO MATURATION OF 5 8S RRNA,0.012106,0.14498,0.14657,1,1
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0096484,0.14491,0.17658,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00020554,0.14481,0.20045,1,1
1,GO RESPONSE TO ACTIVITY,0.011574,0.14466,0.15841,1,1
1,GO RNA DECAPPING,0.021265,0.1445,0.18522,1,1
1,GO OVULATION CYCLE,0.019548,0.14449,0.20682,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0024341,0.14448,0.16663,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.021265,0.14442,0.14918,1,1
1,GO RESPONSE TO RADIATION,0.00068502,0.14441,0.18691,1,1
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0020776,0.1441,0.23643,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0057394,0.14403,0.17477,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00332,0.14385,0.16948,1,1
1,GO RESPONSE TO STARVATION,0.0020776,0.14377,0.18617,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00076864,0.14372,0.20204,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.013834,0.14366,0.21806,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030713,0.14365,0.21516,1,1
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0172,0.14355,0.1645,1,1
1,GO INTRACELLULAR TRANSPORT,0.00035748,0.14336,0.16653,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.021265,0.14328,0.12552,1,1
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0029965,0.14325,0.25325,1,1
1,GO GOLGI ORGANIZATION,0.0034935,0.14324,0.19978,1,1
1,GO MOLTING CYCLE,0.020391,0.14315,0.19557,1,1
1,GO SENSORY PERCEPTION OF SMELL,0.0016767,0.14291,0.14342,1,1
1,GO RRNA METHYLATION,0.02951,0.14282,0.11598,1,1
1,GO SPECIFICATION OF SYMMETRY,0.0047188,0.14257,0.20062,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0063209,0.14235,0.18447,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00072571,0.14233,0.19195,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.041938,0.14207,0.16116,1,1
1,GO SNRNA METABOLIC PROCESS,0.00054254,0.14205,0.17,1,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.050584,0.14201,0.20137,1,1
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0013481,0.14195,0.21326,1,1
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0063209,0.14188,0.19252,1,1
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.038848,0.14126,0.15424,1,1
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.007293,0.14109,0.17701,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057394,0.14109,0.21789,1,1
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0014241,0.14106,0.19267,1,1
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0076456,0.14098,0.22164,1,1
1,GO DNA BIOSYNTHETIC PROCESS,0.00045436,0.14092,0.17259,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.011063,0.14084,0.17337,1,1
1,GO LIPID MODIFICATION,0.02951,0.14076,0.14947,1,1
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046961,0.14064,0.18808,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.012106,0.14059,0.15552,1,1
1,GO DEPHOSPHORYLATION,0.0038653,0.14048,0.16948,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.040368,0.14009,0.20239,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0049572,0.14001,0.20442,1,1
1,GO NUCLEOTIDE TRANSPORT,0.02951,0.13994,0.15272,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00332,0.13989,0.12481,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.012106,0.13988,0.18957,1,1
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0010798,0.13987,0.18776,1,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0044907,0.13974,0.19794,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.023112,0.13965,0.18617,1,1
1,GO NCRNA PROCESSING,0.0012071,0.1396,0.14197,1,1
1,GO PROTEIN REFOLDING,0.030713,0.13956,0.17807,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,0.0021907,0.13944,0.21989,1,1
1,GO TOXIN TRANSPORT,0.015776,0.13934,0.1729,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.006955,0.13915,0.15506,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.043559,0.13898,0.15682,1,1
1,GO REGULATION OF PROTEIN DEACETYLATION,0.007293,0.13893,0.23362,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011574,0.13879,0.16111,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0057394,0.13878,0.16616,1,1
1,GO REGULATION OF HORMONE LEVELS,0.0172,0.13857,0.15115,1,1
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.010572,0.13852,0.18311,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00060992,0.13845,0.19721,1,1
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.023112,0.13834,0.16907,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011063,0.1382,0.15153,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.015104,0.13806,0.17698,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.021265,0.13754,0.21795,1,1
1,GO MYELIN ASSEMBLY,0.01266,0.1374,0.2514,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.023112,0.13719,0.17263,1,1
1,GO VESICLE CARGO LOADING,0.024086,0.13715,0.18609,1,1
1,GO CELLULAR RESPONSE TO STARVATION,0.0018673,0.13709,0.1951,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0034935,0.13699,0.18389,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0029965,0.13696,0.16463,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.052482,0.13672,0.17109,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.0010209,0.13656,0.19538,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.038848,0.13623,0.16831,1,1
1,GO CELL CELL SIGNALING,0.0054671,0.13619,0.17241,1,1
1,GO MATURATION OF SSU RRNA,0.0036751,0.13605,0.15163,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00068502,0.13592,0.17677,1,1
1,GO REGULATION OF CELLULAR LOCALIZATION,0.012106,0.13573,0.1552,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.046961,0.13557,0.15468,1,1
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.043559,0.13555,0.15401,1,1
1,GO SIGNAL RELEASE,0.014457,0.13553,0.15722,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0060238,0.13542,0.15898,1,1
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0063209,0.13537,0.20642,1,1
1,GO ENDOSOMAL TRANSPORT,0.0028457,0.13533,0.18596,1,1
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015104,0.13527,0.17744,1,1
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.013235,0.13504,0.16652,1,1
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.034576,0.13491,0.19453,1,1
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.02951,0.13477,0.16389,1,1
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.0172,0.13444,0.16869,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.030713,0.13441,0.13966,1,1
1,GO SINGLE FERTILIZATION,0.0011418,0.13426,0.17249,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0092139,0.13403,0.12922,1,1
1,GO REGULATION OF CELL MATURATION,0.0024341,0.13396,0.17441,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0003797,0.13379,0.17675,1,1
1,GO VESICLE LOCALIZATION,0.0031545,0.13379,0.18006,1,1
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024086,0.13372,0.2358,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.020391,0.13365,0.1827,1,1
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0016767,0.13332,0.18012,1,1
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.016475,0.13319,0.17045,1,1
1,GO SNORNA 3 END PROCESSING,0.010572,0.1331,0.16868,1,1
1,GO CELLULAR SENESCENCE,0.017954,0.13272,0.15556,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00091199,0.13253,0.176,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.027226,0.13253,0.21741,1,1
1,GO NCRNA METABOLIC PROCESS,0.0012071,0.13204,0.14143,1,1
1,GO PERICARDIUM DEVELOPMENT,0.028348,0.13203,0.25495,1,1
1,GO MONOVALENT INORGANIC CATION TRANSPORT,0.026142,0.13195,0.15388,1,1
1,GO NEURON APOPTOTIC PROCESS,0.01266,0.13194,0.15941,1,1
1,GO TRANSPOSITION,0.037377,0.13166,0.16162,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00035748,0.13143,0.15628,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0012758,0.13128,0.16734,1,1
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.0080134,0.13099,0.16654,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00054254,0.13094,0.17313,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.008797,0.13065,0.15568,1,1
1,GO COENZYME A METABOLIC PROCESS,0.040368,0.13045,0.16264,1,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0076456,0.13041,0.17783,1,1
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.038848,0.12998,0.16202,1,1
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.038848,0.12997,0.18558,1,1
1,GO EXECUTION PHASE OF APOPTOSIS,0.0172,0.12987,0.14394,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0066311,0.12969,0.19083,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0057394,0.12967,0.19513,1,1
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.023112,0.12934,0.17443,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.006955,0.1293,0.16424,1,1
1,GO MULTI ORGANISM LOCALIZATION,0.00064645,0.12926,0.17849,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.015776,0.12908,0.20153,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0025648,0.12902,0.16892,1,1
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.052482,0.12887,0.19989,1,1
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.020391,0.12885,0.14222,1,1
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0044907,0.12878,0.18519,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.0018673,0.12877,0.17533,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0015882,0.12873,0.1888,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0063209,0.1287,0.17085,1,1
1,GO POLYOL METABOLIC PROCESS,0.0063209,0.12856,0.17353,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0054671,0.12846,0.20425,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.013235,0.12834,0.18177,1,1
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0036751,0.12825,0.15331,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00012367,0.12816,0.15717,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.030713,0.1277,0.14478,1,1
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.017954,0.12769,0.1726,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0011418,0.12765,0.15776,1,1
1,GO DETECTION OF ABIOTIC STIMULUS,0.0020776,0.12763,0.18241,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0040644,0.12715,0.15955,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0038653,0.12715,0.11774,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.022172,0.12704,0.15745,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0003797,0.1267,0.15718,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.034576,0.12653,0.15125,1,1
1,GO MAGNESIUM ION TRANSPORT,0.007293,0.12651,0.19568,1,1
1,GO LIPOPROTEIN METABOLIC PROCESS,0.0040644,0.12633,0.17213,1,1
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0047188,0.12605,0.18737,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.024086,0.12571,0.21284,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.0016767,0.1252,0.17111,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031957,0.12513,0.15613,1,1
1,GO RESPONSE TO IONIZING RADIATION,0.02951,0.12513,0.14748,1,1
1,GO REGULATION OF SYSTEM PROCESS,0.014457,0.12489,0.17289,1,1
1,GO NUCLEOTIDE PHOSPHORYLATION,0.0066311,0.12488,0.17623,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0047188,0.12466,0.11789,1,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0076456,0.12449,0.17405,1,1
1,GO CELL AGING,0.023112,0.12445,0.14875,1,1
1,GO NCRNA 3 END PROCESSING,0.00086166,0.12427,0.1529,1,1
1,GO REGULATION OF CATABOLIC PROCESS,0.0063209,0.12415,0.15754,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.011063,0.12374,0.156,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0013481,0.12364,0.1832,1,1
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.045233,0.12351,0.13702,1,1
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.010101,0.12339,0.17036,1,1
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0057394,0.12331,0.1874,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.0017696,0.12324,0.16648,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.027226,0.12322,0.17054,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.00026348,0.1232,0.14695,1,1
1,GO GOLGI VESICLE TRANSPORT,0.0044907,0.12266,0.16996,1,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.02951,0.12259,0.11315,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.020391,0.12186,0.14492,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0018673,0.12184,0.15669,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.048745,0.12176,0.1682,1,1
1,GO BLASTOCYST DEVELOPMENT,0.00068502,0.12172,0.17006,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0042727,0.12164,0.16508,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.016475,0.12154,0.15014,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0011418,0.1214,0.16085,1,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.025096,0.12118,0.1512,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0003797,0.12102,0.15231,1,1
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.012106,0.12099,0.21094,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0019699,0.12097,0.16033,1,1
1,GO THIOESTER METABOLIC PROCESS,0.0024341,0.12086,0.16398,1,1
1,GO IMPORT INTO CELL,0.045233,0.12085,0.16407,1,1
1,GO REGULATION OF DNA METHYLATION,0.020391,0.12084,0.16432,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0011418,0.1207,0.14021,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.027226,0.12029,0.22889,1,1
1,GO RRNA METABOLIC PROCESS,0.0029965,0.12007,0.12891,1,1
1,GO PROTEIN CATABOLIC PROCESS,0.00332,0.12002,0.16529,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.007293,0.11976,0.18526,1,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0063209,0.11934,0.20389,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.007293,0.11927,0.1647,1,1
1,GO NEURON DEATH,0.027226,0.11925,0.15435,1,1
1,GO CATION TRANSMEMBRANE TRANSPORT,0.035953,0.11925,0.13571,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0054671,0.11923,0.15857,1,1
1,GO MALE SEX DIFFERENTIATION,0.0092139,0.11898,0.19702,1,1
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0044907,0.11875,0.16407,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0017696,0.11835,0.18354,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0021907,0.11818,0.18913,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,0.0027019,0.11784,0.14611,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.021265,0.1177,0.12286,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00068502,0.11767,0.17306,1,1
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.010572,0.11765,0.16166,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0029965,0.1174,0.16331,1,1
1,GO REGULATION OF GTPASE ACTIVITY,0.048745,0.11735,0.18881,1,1
1,GO PROTEIN DEPHOSPHORYLATION,0.0020776,0.11732,0.17044,1,1
1,GO BODY FLUID SECRETION,0.046961,0.11719,0.15468,1,1
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.010101,0.11719,0.20266,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.0057394,0.11697,0.17106,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0014241,0.11693,0.16291,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.016475,0.11691,0.19678,1,1
1,GO MITOCHONDRIAL TRANSPORT,0.00091199,0.11684,0.1457,1,1
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0060238,0.11682,0.28125,1,1
1,GO REGULATION OF GENE SILENCING,0.0016767,0.11657,0.1924,1,1
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.024086,0.11633,0.16653,1,1
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0076456,0.11633,0.1762,1,1
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0066311,0.1161,0.19444,1,1
1,GO PROTEIN STABILIZATION,0.0047188,0.11592,0.15415,1,1
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.00332,0.11585,0.2155,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0019699,0.11538,0.14311,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0054671,0.11478,0.16572,1,1
1,GO ION TRANSMEMBRANE TRANSPORT,0.026142,0.11443,0.13956,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0015882,0.11354,0.17073,1,1
1,GO PIGMENTATION,0.0172,0.1134,0.15893,1,1
1,GO CARBOHYDRATE HOMEOSTASIS,0.017954,0.11285,0.15121,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0092139,0.11284,0.14882,1,1
1,GO AMINO ACID TRANSPORT,0.015104,0.11284,0.19051,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00086166,0.11273,0.14209,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.027226,0.11258,0.13995,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.027226,0.11256,0.1895,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.0040644,0.11241,0.15314,1,1
1,GO SENSORY PERCEPTION,0.0083971,0.11189,0.14295,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.00020554,0.11174,0.1676,1,1
1,GO CELL FATE COMMITMENT,0.0172,0.11173,0.17395,1,1
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.013235,0.11169,0.15534,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00332,0.11139,0.16401,1,1
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.011574,0.11065,0.20201,1,1
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0025648,0.11064,0.12384,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.015104,0.11008,0.18137,1,1
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.018736,0.11008,0.14325,1,1
1,GO ANOIKIS,0.038848,0.10971,0.22876,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0080134,0.10969,0.15358,1,1
1,GO PROTEIN HOMOOLIGOMERIZATION,0.015776,0.10957,0.14209,1,1
1,GO RNA CAPPING,0.0014241,0.10926,0.14003,1,1
1,GO SNORNA METABOLIC PROCESS,0.0031545,0.10924,0.1755,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.033245,0.10893,0.15921,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.012106,0.10877,0.12488,1,1
1,GO UBIQUINONE METABOLIC PROCESS,0.0076456,0.10869,0.13709,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.038848,0.10846,0.19196,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0092139,0.1083,0.16501,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.038848,0.10786,0.15565,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.046961,0.10767,0.15625,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.015104,0.10754,0.15353,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.006955,0.10744,0.17482,1,1
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.013834,0.10662,0.19566,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.028348,0.10655,0.095777,1,1
1,GO BLASTOCYST FORMATION,0.026142,0.10605,0.12454,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.015104,0.10592,0.13846,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.015104,0.10555,0.16192,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0042727,0.10517,0.16335,1,1
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.006955,0.10479,0.18004,1,1
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.052482,0.10448,0.19399,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0029965,0.10447,0.15887,1,1
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.043559,0.10433,0.13019,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.010572,0.10427,0.1685,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.015776,0.10425,0.15502,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.016475,0.10399,0.17304,1,1
1,GO CLATHRIN COAT ASSEMBLY,0.017954,0.10389,0.17372,1,1
1,GO GLUTAMATE METABOLIC PROCESS,0.037377,0.10385,0.15471,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.016475,0.10341,0.12254,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.050584,0.10319,0.11377,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.035953,0.10307,0.12263,1,1
1,GO ANION TRANSMEMBRANE TRANSPORT,0.021265,0.10281,0.15632,1,1
1,GO DE NOVO PROTEIN FOLDING,0.026142,0.10232,0.14512,1,1
1,GO REGULATION OF AUTOPHAGY,0.01266,0.10136,0.15787,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02951,0.10095,0.14799,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.007293,0.10061,0.12774,1,1
1,GO MACROAUTOPHAGY,0.0080134,0.10058,0.15588,1,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.052482,0.10002,0.16293,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.008797,0.09997,0.14904,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0096484,0.099837,0.15843,1,1
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.021265,0.099601,0.17206,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0038653,0.098802,0.12356,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.013834,0.098593,0.13448,1,1
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.035953,0.098182,0.12981,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.046961,0.097774,0.1721,1,1
1,GO AMINO ACID ACTIVATION,0.050584,0.097624,0.097673,1,1
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0029965,0.097374,0.15957,1,1
1,GO RIBOSOME BIOGENESIS,0.0047188,0.09736,0.11636,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.043559,0.097167,0.14517,1,1
1,GO GLAND DEVELOPMENT,0.016475,0.09707,0.18533,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.021265,0.096754,0.16439,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00081392,0.096648,0.112,1,1
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.018736,0.096561,0.12994,1,1
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.043559,0.096447,0.1781,1,1
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.024086,0.096178,0.20309,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.026142,0.09607,0.14773,1,1
1,GO ORGANELLE DISASSEMBLY,0.015776,0.095227,0.14034,1,1
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.020391,0.094474,0.13705,1,1
1,GO GLUCOSE IMPORT,0.035953,0.093905,0.15597,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0083971,0.093898,0.13392,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.01266,0.093857,0.17569,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.041938,0.093838,0.10165,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.048745,0.093232,0.16754,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.017954,0.092534,0.14709,1,1
1,GO EPITHELIAL CELL DEVELOPMENT,0.052482,0.092361,0.18568,1,1
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.025096,0.091981,0.13885,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION,0.024086,0.091966,0.1511,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0096484,0.091888,0.15967,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.043559,0.091876,0.13912,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0040644,0.091701,0.18138,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02951,0.091621,0.094005,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.041938,0.091361,0.1481,1,1
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.020391,0.091244,0.17384,1,1
1,GO EXCRETION,0.037377,0.090571,0.19402,1,1
1,GO FATTY ACYL COA METABOLIC PROCESS,0.0042727,0.090546,0.17547,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.018736,0.090501,0.14531,1,1
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.050584,0.090236,0.13644,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.00064645,0.089516,0.10533,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.046961,0.089386,0.12696,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0021907,0.089328,0.097653,1,1
1,GO RNA CATABOLIC PROCESS,0.0012758,0.08877,0.10874,1,1
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0060238,0.088199,0.12231,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.0015882,0.087078,0.095092,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.034576,0.086284,0.11369,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.015776,0.085238,0.16738,1,1
1,GO REGULATION OF ERAD PATHWAY,0.037377,0.084496,0.14035,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.038848,0.084325,0.12839,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.015776,0.08364,0.11193,1,1
1,GO PROTEIN INSERTION INTO MEMBRANE,0.00332,0.083214,0.12345,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.043559,0.082673,0.13597,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.011063,0.082454,0.14708,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.045233,0.08135,0.12512,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.015776,0.081288,0.15992,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0036751,0.080459,0.12649,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.046961,0.079321,0.17075,1,1
1,GO RESPONSE TO INSULIN,0.027226,0.07911,0.15526,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.025096,0.078603,0.10228,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.035953,0.078335,0.13425,1,1
1,GO TRANSMEMBRANE TRANSPORT,0.048745,0.076834,0.11863,1,1
1,GO MESODERM DEVELOPMENT,0.040368,0.076717,0.15474,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0049572,0.076672,0.082748,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.037377,0.076543,0.11174,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.034576,0.076224,0.16863,1,1
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0080134,0.07562,0.11257,1,1
1,GO CYTOKINETIC PROCESS,0.013235,0.074443,0.16465,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.071854,0.10087,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.013834,0.070739,0.13386,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.050584,0.070722,0.11507,1,1
1,GO RETINA HOMEOSTASIS,0.046961,0.069635,0.094153,1,1
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.046961,0.067249,0.14276,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.045233,0.067193,0.1047,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.023112,0.066266,0.093388,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.006955,0.065855,0.099501,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.022172,0.064643,0.099585,1,1
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.020391,0.064345,0.090782,1,1
1,GO PEPTIDE METABOLIC PROCESS,0.015104,0.0605,0.073905,1,1
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.052482,0.058169,0.15777,1,1
1,GO PROTEIN TARGETING,0.0028457,0.058049,0.077029,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.033245,0.057051,0.095215,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.045233,0.05004,0.095566,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,0.013834,0.049797,0.084325,1,1
1,GO REGULATION OF SYNAPSE MATURATION,0.0024341,0.55511,0.4761,1,0
1,GO SYNAPTIC VESICLE DOCKING,0.0012071,0.48005,0.47952,1,0
1,GO SYNAPSE MATURATION,0.0023095,0.45504,0.41954,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0031545,0.41697,0.3559,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0066311,0.41187,0.3852,1,0
1,GO PROTEIN LOCALIZATION TO AXON,0.00332,0.38906,0.39498,1,0
1,GO SUCKLING BEHAVIOR,0.0019699,0.38201,0.35904,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.0012071,0.37416,0.39466,1,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.033245,0.37237,0.33551,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,0.0034935,0.35249,0.40202,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0057394,0.3418,0.31718,1,0
1,GO NEURON CELL CELL ADHESION,0.0017696,0.34118,0.40754,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.046961,0.33924,0.35692,1,0
1,GO DENDRITIC TRANSPORT,0.024086,0.33495,0.32754,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.046961,0.33487,0.23632,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.0036751,0.32611,0.27941,1,0
1,GO RESPONSE TO LEUCINE,0.00033648,0.31555,0.3747,1,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0044907,0.31548,0.32742,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.025096,0.3153,0.3236,1,0
1,GO RETROGRADE AXONAL TRANSPORT,0.0034935,0.31094,0.34665,1,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0054671,0.30627,0.32412,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0020776,0.30391,0.29512,1,0
1,GO TELENCEPHALON REGIONALIZATION,0.0076456,0.29959,0.33203,1,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.007293,0.2949,0.26315,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.0052065,0.29266,0.31728,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.022172,0.29086,0.26282,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00019306,0.2908,0.38564,1,0
1,GO AXONAL FASCICULATION,0.007293,0.289,0.28327,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.011574,0.28843,0.27655,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.016475,0.28789,0.30899,1,0
1,GO REGULATION OF MICROTUBULE BINDING,0.0054671,0.28622,0.31056,1,0
1,GO BASIC AMINO ACID TRANSPORT,0.01266,0.28511,0.2497,1,0
1,GO CARDIAC CHAMBER FORMATION,0.028348,0.28379,0.25462,1,0
1,GO NEURON FATE SPECIFICATION,0.018736,0.28159,0.30576,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0066311,0.28158,0.30655,1,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.0027019,0.28021,0.28962,1,0
1,GO MICROTUBULE SEVERING,0.0015041,0.27924,0.32979,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0083971,0.27822,0.2796,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0031545,0.27727,0.28985,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0021907,0.27489,0.3187,1,0
1,GO CATECHOLAMINE UPTAKE,0.00332,0.2736,0.35018,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0023095,0.27279,0.29224,1,0
1,GO PROTEIN POLYGLUTAMYLATION,0.0057394,0.2726,0.32589,1,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.0044907,0.27252,0.29056,1,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0020776,0.26988,0.30039,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.050584,0.26641,0.22216,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.012106,0.25864,0.2346,1,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0024341,0.25829,0.29663,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0028457,0.25753,0.32436,1,0
1,GO MICROTUBULE BASED MOVEMENT,0.0010209,0.25702,0.26293,1,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0044907,0.25541,0.27292,1,0
1,GO CILIUM ORGANIZATION,0.00072571,0.25507,0.2853,1,0
1,GO TRANSPORT ALONG MICROTUBULE,0.0013481,0.25009,0.25875,1,0
1,GO DIVALENT METAL ION EXPORT,0.011063,0.24992,0.30895,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0063209,0.24931,0.25526,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,0.0080134,0.24635,0.24828,1,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.021265,0.24524,0.38679,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.043559,0.24523,0.21626,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0038653,0.24513,0.28537,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.020391,0.24195,0.26432,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.037377,0.24147,0.34204,1,0
1,GO AXONAL TRANSPORT,0.00332,0.24067,0.27609,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0019699,0.24043,0.28601,1,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0054671,0.2389,0.35521,1,0
1,GO NEURON PROJECTION GUIDANCE,0.0029965,0.23831,0.29524,1,0
1,GO FOREBRAIN CELL MIGRATION,0.00072571,0.23816,0.30456,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.016475,0.23445,0.26368,1,0
1,GO DENSE CORE GRANULE TRANSPORT,0.052482,0.23427,0.30515,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0066311,0.23281,0.29831,1,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.014457,0.23196,0.23055,1,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.0080134,0.2286,0.31682,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.031957,0.22857,0.2305,1,0
1,GO INTRACILIARY TRANSPORT,0.0036751,0.22797,0.26792,1,0
1,GO MICROTUBULE BASED TRANSPORT,0.0023095,0.22762,0.25111,1,0
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.043559,0.22451,0.23994,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.0083971,0.22446,0.21569,1,0
1,GO LYSINE METABOLIC PROCESS,0.013834,0.22387,0.24994,1,0
1,GO PALLIUM DEVELOPMENT,0.00091199,0.22358,0.25438,1,0
1,GO NEURON MATURATION,0.0060238,0.22309,0.26101,1,0
1,GO SIALYLATION,0.027226,0.22275,0.23549,1,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.0038653,0.22036,0.27861,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0012071,0.21801,0.25796,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.021265,0.21769,0.27785,1,0
1,GO AXO DENDRITIC TRANSPORT,0.0076456,0.21713,0.25195,1,0
1,GO SPERM MOTILITY,0.0076456,0.21575,0.19679,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.030713,0.21472,0.34487,1,0
1,GO COLLECTING DUCT DEVELOPMENT,0.0096484,0.2142,0.32494,1,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0036751,0.21281,0.23918,1,0
1,GO MITOCHONDRION LOCALIZATION,0.0024341,0.2127,0.26001,1,0
1,GO LONG TERM MEMORY,0.0047188,0.21255,0.29233,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0042727,0.21112,0.34576,1,0
1,GO MATING,0.007293,0.20954,0.22011,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0023095,0.20561,0.23309,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.012106,0.20341,0.2155,1,0
1,GO MEMBRANE HYPERPOLARIZATION,0.033245,0.20308,0.23435,1,0
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0036751,0.20218,0.23987,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.0096484,0.20092,0.23698,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.040368,0.19936,0.23244,1,0
1,GO NEURON FATE COMMITMENT,0.018736,0.19895,0.23172,1,0
1,GO REGULATION OF RESPONSE TO FOOD,0.007293,0.19847,0.25554,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0047188,0.19815,0.20992,1,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.020391,0.19623,0.3268,1,0
1,GO HEART VALVE FORMATION,0.022172,0.19558,0.27382,1,0
1,GO NEURON RECOGNITION,0.038848,0.19531,0.20346,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,0.037377,0.19501,0.17049,1,0
1,GO LENS FIBER CELL DEVELOPMENT,0.023112,0.19404,0.21875,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0083971,0.19088,0.18909,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.016475,0.19035,0.21144,1,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0052065,0.18938,0.27139,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00072571,0.18863,0.25037,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.021265,0.18683,0.1797,1,0
1,GO REGULATION OF STEM CELL PROLIFERATION,0.01266,0.18589,0.21872,1,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.011574,0.18584,0.23799,1,0
1,GO REGULATION OF APPETITE,0.026142,0.18424,0.20747,1,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.025096,0.18193,0.24426,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.038848,0.18116,0.22995,1,0
1,GO FUCOSYLATION,0.020391,0.18013,0.18952,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0020776,0.17984,0.23666,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.020391,0.17984,0.18963,1,0
1,GO EPITHELIAL TUBE FORMATION,0.0019699,0.17844,0.23464,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.041938,0.17774,0.22631,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,0.015776,0.17674,0.1496,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.030713,0.17603,0.16806,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.01266,0.17525,0.2199,1,0
1,GO OXIDATIVE DEMETHYLATION,0.013834,0.17488,0.2114,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.013834,0.17348,0.21131,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0044907,0.17289,0.20957,1,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0052065,0.17185,0.20992,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.018736,0.17117,0.19655,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.010101,0.17108,0.19714,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.010572,0.1698,0.22978,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.0036751,0.16913,0.21302,1,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0083971,0.16753,0.19787,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.020391,0.16494,0.18597,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.02951,0.16469,0.27479,1,0
1,GO RESPONSE TO DOPAMINE,0.0019699,0.16445,0.21618,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.031957,0.16354,0.20873,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0021907,0.16089,0.28161,1,0
1,GO SPERM AXONEME ASSEMBLY,0.021265,0.16084,0.2167,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.015104,0.15914,0.21031,1,0
1,GO FUCOSE METABOLIC PROCESS,0.008797,0.15876,0.1919,1,0
1,GO CARDIAC CONDUCTION,0.021265,0.15729,0.18572,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.030713,0.15711,0.19547,1,0
1,GO DENDRITE EXTENSION,0.021265,0.15446,0.22818,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.040368,0.15296,0.29454,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.041938,0.15268,0.16639,1,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0031545,0.15249,0.2373,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.015776,0.15199,0.15746,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,0.011063,0.14872,0.22289,1,0
1,GO NEGATIVE CHEMOTAXIS,0.038848,0.14863,0.23249,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0092139,0.1485,0.26784,1,0
1,GO CILIUM MOVEMENT,0.023112,0.14757,0.18405,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,0.026142,0.14737,0.20133,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.02951,0.14501,0.16507,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.024086,0.1449,0.1431,1,0
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0052065,0.14421,0.16636,1,0
1,GO CATECHOLAMINE SECRETION,0.0047188,0.14332,0.28952,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.013235,0.14258,0.14323,1,0
1,GO RRNA MODIFICATION,0.011574,0.14242,0.132,1,0
1,GO MONOAMINE TRANSPORT,0.015776,0.14181,0.23749,1,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.011063,0.14135,0.18926,1,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.023112,0.14102,0.18065,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.034576,0.13952,0.203,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0027019,0.139,0.2046,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0096484,0.13881,0.16878,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.026142,0.13872,0.17298,1,0
1,GO HAIR CELL DIFFERENTIATION,0.014457,0.13846,0.21371,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.015776,0.13804,0.2256,1,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.035953,0.13763,0.14553,1,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.016475,0.13735,0.22823,1,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0042727,0.13677,0.17693,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0024341,0.13587,0.17267,1,0
1,GO EATING BEHAVIOR,0.019548,0.13365,0.20915,1,0
1,GO MEMBRANE FISSION,0.013235,0.13063,0.20517,1,0
1,GO SODIUM ION TRANSPORT,0.014457,0.13026,0.1934,1,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.008797,0.12903,0.20053,1,0
1,GO REGULATION OF DNA BINDING,0.0052065,0.12882,0.17932,1,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.031957,0.1288,0.18576,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0025648,0.12867,0.20091,1,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.037377,0.12866,0.16699,1,0
1,GO VESICLE DOCKING,0.007293,0.12847,0.19569,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.01266,0.12745,0.17185,1,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.034576,0.12738,0.1225,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.033245,0.12708,0.13752,1,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.046961,0.12686,0.14993,1,0
1,GO POSITIVE REGULATION OF MITOPHAGY,0.035953,0.12649,0.2097,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,0.015776,0.12607,0.18264,1,0
1,GO DNA DEALKYLATION,0.035953,0.12584,0.15335,1,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.038848,0.12543,0.23434,1,0
1,GO ACTION POTENTIAL,0.020391,0.12456,0.16631,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.031957,0.12444,0.17754,1,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.020391,0.12402,0.21367,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.052482,0.12377,0.18287,1,0
1,GO AMINE TRANSPORT,0.015776,0.12362,0.23252,1,0
1,GO POSITIVE REGULATION OF DNA BINDING,0.037377,0.12264,0.14717,1,0
1,GO ACROSOME REACTION,0.034576,0.12174,0.15682,1,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.041938,0.12121,0.15348,1,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0036751,0.12072,0.14399,1,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.045233,0.11799,0.16948,1,0
1,GO POSITIVE REGULATION OF BINDING,0.0092139,0.11654,0.15581,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0172,0.11641,0.16608,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.050584,0.11406,0.18891,1,0
1,GO POSITIVE REGULATION OF GROWTH,0.038848,0.11387,0.17189,1,0
1,GO DNA DEMETHYLATION,0.031957,0.11354,0.16938,1,0
1,GO RESPONSE TO CATECHOLAMINE,0.014457,0.11334,0.17088,1,0
1,GO MIDBRAIN DEVELOPMENT,0.0080134,0.11332,0.16281,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.015104,0.11311,0.19855,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.041938,0.11242,0.19246,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.026142,0.11204,0.14042,1,0
1,GO PITUITARY GLAND DEVELOPMENT,0.037377,0.11201,0.25512,1,0
1,GO DEVELOPMENTAL MATURATION,0.024086,0.11188,0.17275,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.017954,0.11146,0.17882,1,0
1,GO ENSHEATHMENT OF NEURONS,0.021265,0.111,0.18602,1,0
1,GO GROWTH,0.010572,0.11077,0.17769,1,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.046961,0.11073,0.18033,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.045233,0.11002,0.15658,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.027226,0.10907,0.14259,1,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.026142,0.10893,0.16769,1,0
1,GO HEART PROCESS,0.045233,0.10749,0.13748,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,0.040368,0.10687,0.18539,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.028348,0.10592,0.16907,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.050584,0.10514,0.15588,1,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0057394,0.10344,0.17712,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.016475,0.10253,0.15266,1,0
1,GO CHLORIDE TRANSPORT,0.045233,0.10036,0.1253,1,0
1,GO REGULATION OF BINDING,0.030713,0.099816,0.15461,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0040644,0.09842,0.17363,1,0
1,GO REGULATION OF PROTEIN TARGETING,0.050584,0.097618,0.13216,1,0
1,GO NEGATIVE REGULATION OF BINDING,0.050584,0.09565,0.15048,1,0
1,GO STRIATED MUSCLE ADAPTATION,0.045233,0.095147,0.16941,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.030713,0.094028,0.14142,1,0
1,GO PROTEIN POLYMERIZATION,0.052482,0.093565,0.13508,1,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.020391,0.093189,0.1431,1,0
1,GO RESPONSE TO MONOSACCHARIDE,0.030713,0.091984,0.14799,1,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.052482,0.091199,0.16443,1,0
1,GO GLUCOSE METABOLIC PROCESS,0.040368,0.089729,0.14771,1,0
1,GO CRISTAE FORMATION,0.038848,0.088089,0.15319,1,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.013235,0.087784,0.12881,1,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.041938,0.087676,0.15967,1,0
1,GO CELL GROWTH,0.038848,0.087539,0.15726,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.045233,0.086694,0.11165,1,0
1,GO RESPONSE TO CARBOHYDRATE,0.050584,0.08545,0.13881,1,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.023112,0.085289,0.16034,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.028348,0.084967,0.14333,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.030713,0.084785,0.14159,1,0
1,GO REGULATION OF ATPASE ACTIVITY,0.018736,0.082971,0.11286,1,0
1,GO ENDOSOME ORGANIZATION,0.019548,0.079995,0.14328,1,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.025096,0.078935,0.16312,1,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.037377,0.07878,0.25419,1,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.043559,0.078317,0.16554,1,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.02951,0.075117,0.17301,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.045233,0.073254,0.12829,1,0
1,GO VESICLE ORGANIZATION,0.050584,0.072243,0.1365,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION,0.052482,0.070839,0.13129,1,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.041938,0.067044,0.16628,1,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.046961,0.06693,0.13703,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.025096,0.057781,0.11286,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.010572,0.050479,0.070383,1,0
1,GO MITOCHONDRION ORGANIZATION,0.030713,0.049776,0.09603,1,0
1,GO PROTEIN FOLDING,0.038848,0.049388,0.094561,1,0
1,GO OXIDATIVE PHOSPHORYLATION,0.025096,-0.056919,-0.067096,1,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.046961,-0.066355,-0.068537,1,0
1,GO ELECTRON TRANSPORT CHAIN,0.01266,-0.095577,-0.084737,1,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.010572,-0.10497,-0.098588,1,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0092139,-0.16113,-0.17556,1,0
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.013235,-0.18708,-0.15423,1,0
1,GO ZINC ION HOMEOSTASIS,0.016475,-0.19788,-0.20871,1,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.052482,-0.1991,-0.18016,1,0
1,GO PLASMINOGEN ACTIVATION,0.046961,-0.20116,-0.2459,1,0
1,GO PLASMA MEMBRANE FUSION,0.050584,-0.2054,-0.21471,1,0
1,GO RESPONSE TO FUNGUS,0.052482,-0.20854,-0.21238,1,0
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.048745,-0.21921,-0.26266,1,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.038848,-0.22107,-0.20525,1,0
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.028348,-0.22326,-0.2128,1,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.048745,-0.22756,-0.22431,1,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.033245,-0.23497,-0.183,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.048745,-0.2469,-0.18926,1,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.02951,-0.24844,-0.20422,1,0
1,GO SEQUESTERING OF METAL ION,0.016475,-0.25479,-0.23801,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.045233,-0.25512,-0.2163,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.0025648,-0.27063,-0.33591,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.031957,-0.27363,-0.28146,1,0
1,GO INTERLEUKIN 17 PRODUCTION,0.027226,-0.28323,-0.31163,1,0
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.040368,-0.28735,-0.27616,1,0
1,GO PEPTIDE CROSS LINKING,0.045233,-0.29125,-0.26205,1,0
1,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.043559,-0.29196,-0.30966,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.037377,-0.29315,-0.30042,1,0
1,GO HYPERSENSITIVITY,0.041938,-0.3133,-0.4266,1,0
1,GO COLLAGEN CATABOLIC PROCESS,0.045233,-0.3163,-0.21364,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.034576,-0.31836,-0.28242,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.046961,-0.32673,-0.30696,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.048745,-0.32885,-0.32185,1,0
1,GO FIBRINOLYSIS,0.037377,-0.33361,-0.26782,1,0
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.022172,-0.36208,-0.22177,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.013834,-0.37114,-0.38259,1,0
1,GO REGULATION OF FIBRINOLYSIS,0.031957,-0.37453,-0.28239,1,0
1,GO LIPOXYGENASE PATHWAY,0.031957,-0.38533,-0.26918,1,0
1,GO MONOCYTE CHEMOTAXIS,0.024086,-0.38689,-0.38844,1,0
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.034576,-0.39161,-0.43139,1,0
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.043559,-0.40215,-0.44659,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.050584,-0.42276,-0.32329,1,0
1,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.041938,-0.43634,-0.3732,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.040368,-0.45079,-0.39548,1,0
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.020391,-0.45349,-0.45678,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.025096,-0.46017,-0.35142,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.017954,-0.463,-0.34824,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.013834,-0.47331,-0.40027,1,0
1,GO SYNAPSE PRUNING,0.013235,-0.49788,-0.55975,1,0
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0042727,-0.55436,-0.4462,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.023112,-0.57139,-0.56742,1,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.062884,0.4634,0.29107,0,1
1,GO NEPHRIC DUCT MORPHOGENESIS,0.058535,0.30489,0.21239,0,1
1,GO FACIAL NERVE MORPHOGENESIS,0.08588,0.30255,0.20711,0,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.38829,0.26802,0.10502,0,1
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.16123,0.26054,0.20395,0,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.19156,0.25507,0.13377,0,1
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.1475,0.25188,0.18509,0,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.058535,0.24821,0.17759,0,1
1,GO PARTURITION,0.067497,0.24538,0.17622,0,1
1,GO AZOLE TRANSMEMBRANE TRANSPORT,0.069906,0.24439,0.22976,0,1
1,GO CELLULAR RESPONSE TO VITAMIN D,0.11524,0.24199,0.17199,0,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.098083,0.23511,0.21239,0,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.091819,0.23051,0.20588,0,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.069906,0.22269,0.2194,0,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.08881,0.2219,0.20702,0,1
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.13885,0.21919,0.18329,0,1
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.054439,0.21665,0.2276,0,1
1,GO SKELETAL MUSCLE ADAPTATION,0.1475,0.21488,0.13341,0,1
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.072385,0.20855,0.19625,0,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.08303,0.20442,0.22377,0,1
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.15655,0.20021,0.11513,0,1
1,GO VITAMIN CATABOLIC PROCESS,0.10134,0.19309,0.19512,0,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.08588,0.19187,0.15642,0,1
1,GO BICARBONATE TRANSPORT,0.14312,0.19176,0.14439,0,1
1,GO OSTEOBLAST DEVELOPMENT,0.10811,0.19152,0.15741,0,1
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.069906,0.1903,0.17826,0,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.072385,0.18951,0.19206,0,1
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.069906,0.18823,0.20939,0,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.17591,0.18697,0.1314,0,1
1,GO CHLORIDE ION HOMEOSTASIS,0.12273,0.18683,0.1658,0,1
1,GO DETERMINATION OF ADULT LIFESPAN,0.069906,0.18318,0.18596,0,1
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.054439,0.17836,0.17718,0,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.08303,0.1781,0.21971,0,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.14312,0.17805,0.14339,0,1
1,GO AXIS ELONGATION,0.069906,0.17747,0.20313,0,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.11524,0.17526,0.13617,0,1
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.08303,0.17503,0.12528,0,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.062884,0.17443,0.17994,0,1
1,GO MRNA TRANSCRIPTION,0.13467,0.17436,0.16494,0,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.094909,0.17216,0.22079,0,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.11894,0.17198,0.14271,0,1
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.074935,0.16915,0.20011,0,1
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.15197,0.16912,0.14227,0,1
1,GO RECEPTOR RECYCLING,0.058535,0.16841,0.15551,0,1
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.056456,0.16698,0.18766,0,1
1,GO GDP METABOLIC PROCESS,0.12662,0.1658,0.14294,0,1
1,GO NEPHRON TUBULE FORMATION,0.056456,0.16416,0.17368,0,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.08303,0.16273,0.1804,0,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.15197,0.16161,0.15018,0,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.056456,0.16158,0.2196,0,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.10134,0.15733,0.19079,0,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.15197,0.15595,0.11589,0,1
1,GO XENOBIOTIC TRANSPORT,0.080256,0.15524,0.18517,0,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.21989,0.15139,0.17008,0,1
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.067497,0.14739,0.18193,0,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.072385,0.14599,0.2199,0,1
1,GO REGULATION OF TRANSPOSITION,0.098083,0.14523,0.14939,0,1
1,GO LIPOPROTEIN LOCALIZATION,0.18102,0.14449,0.14612,0,1
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.50109,0.14305,0.071617,0,1
1,GO POSITIVE REGULATION OF CELL AGING,0.44264,0.14271,0.042704,0,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.054439,0.14243,0.19901,0,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.1306,0.1419,0.15694,0,1
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.077559,0.14161,0.11886,0,1
1,GO IMP METABOLIC PROCESS,0.18624,0.13878,0.10375,0,1
1,GO FOREGUT MORPHOGENESIS,0.080256,0.13818,0.19158,0,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.11163,0.13808,0.132,0,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.12662,0.13748,0.17529,0,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.20822,0.13664,0.12869,0,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.11163,0.13518,0.13704,0,1
1,GO LEFT RIGHT PATTERN FORMATION,0.062884,0.1347,0.1761,0,1
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.16123,0.13454,0.12041,0,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.197,0.13424,0.17823,0,1
1,GO HEAT GENERATION,0.15655,0.13326,0.1362,0,1
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.16123,0.13298,0.14803,0,1
1,GO GOLGI LOCALIZATION,0.056456,0.13297,0.11715,0,1
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.069906,0.13076,0.12463,0,1
1,GO PLASMA MEMBRANE TUBULATION,0.12273,0.1296,0.16642,0,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.060677,0.12935,0.17672,0,1
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.077559,0.12812,0.13666,0,1
1,GO MANGANESE ION TRANSPORT,0.13467,0.12781,0.12481,0,1
1,GO DEVELOPMENTAL INDUCTION,0.069906,0.12555,0.14493,0,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.098083,0.12492,0.186,0,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.065157,0.12424,0.091074,0,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.197,0.12371,0.11942,0,1
1,GO LIPID OXIDATION,0.062884,0.1234,0.12232,0,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.056456,0.12307,0.15923,0,1
1,GO RETINOIC ACID METABOLIC PROCESS,0.17591,0.12283,0.11106,0,1
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.17091,0.12263,0.11615,0,1
1,GO IMP BIOSYNTHETIC PROCESS,0.23827,0.12226,0.079597,0,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.058535,0.12169,0.1554,0,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.067497,0.12169,0.15358,0,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.13467,0.12018,0.13196,0,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.060677,0.11929,0.18745,0,1
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.074935,0.11759,0.13365,0,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.091819,0.11689,0.15182,0,1
1,GO ACYLGLYCEROL HOMEOSTASIS,0.19156,0.11667,0.11289,0,1
1,GO RESPONSE TO STEROL,0.072385,0.11661,0.18529,0,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.4521,0.11655,0.12145,0,1
1,GO BONE MORPHOGENESIS,0.29248,0.11592,0.12336,0,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.10134,0.11567,0.17228,0,1
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.054439,0.11527,0.12831,0,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.15655,0.11501,0.12287,0,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.065157,0.11376,0.096479,0,1
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.57414,0.1137,0.094979,0,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.060677,0.11358,0.18818,0,1
1,GO CALCIUM ION IMPORT,0.23203,0.11337,0.10361,0,1
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.08588,0.11277,0.11107,0,1
1,GO RESPONSE TO ETHER,0.2577,0.11179,0.093659,0,1
1,GO PROTEIN ADP RIBOSYLATION,0.08588,0.11166,0.15092,0,1
1,GO PIGMENT ACCUMULATION,0.091819,0.11122,0.20511,0,1
1,GO SENSORY PERCEPTION OF TASTE,0.36271,0.1111,0.070634,0,1
1,GO LAMELLIPODIUM ASSEMBLY,0.19156,0.11086,0.12837,0,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.060677,0.11056,0.17542,0,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.3148,0.11021,0.12135,0,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.11163,0.10971,0.20805,0,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.24463,0.10926,0.14025,0,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.12662,0.1084,0.16558,0,1
1,GO ERYTHROCYTE DEVELOPMENT,0.08303,0.10816,0.15977,0,1
1,GO CELLULAR PIGMENTATION,0.054439,0.10806,0.12688,0,1
1,GO ER OVERLOAD RESPONSE,0.060677,0.10798,0.13948,0,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.18624,0.10788,0.12491,0,1
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.14312,0.1078,0.097055,0,1
1,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.18624,0.10595,0.10058,0,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.058535,0.10551,0.13292,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.23203,0.10441,0.1193,0,1
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.067497,0.10403,0.097751,0,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.11894,0.10337,0.18041,0,1
1,GO SPHINGOID METABOLIC PROCESS,0.10468,0.10325,0.1729,0,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.2259,0.10317,0.12428,0,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.27821,0.10311,0.11582,0,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.067497,0.10308,0.16579,0,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.214,0.10304,0.13832,0,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.067497,0.10195,0.13584,0,1
1,GO MICROVILLUS ASSEMBLY,0.10468,0.1007,0.1587,0,1
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.069906,0.10043,0.13866,0,1
1,GO MIDDLE EAR MORPHOGENESIS,0.27126,0.10037,0.091484,0,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,0.17591,0.097935,0.1036,0,1
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.054439,0.096577,0.14907,0,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.11894,0.096465,0.13334,0,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.10468,0.096424,0.14548,0,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.37964,0.095353,0.12886,0,1
1,GO LIPID HOMEOSTASIS,0.091819,0.0945,0.13786,0,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.24463,0.094206,0.13117,0,1
1,GO PROTEIN AUTOPROCESSING,0.27821,0.092787,0.099404,0,1
1,GO REGULATION OF TRANSPORT,0.08588,0.092735,0.12489,0,1
1,GO NEPHRON DEVELOPMENT,0.12273,0.092151,0.16535,0,1
1,GO FIBROBLAST MIGRATION,0.23203,0.091939,0.14729,0,1
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.067497,0.091884,0.16662,0,1
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.17091,0.091637,0.12983,0,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.15197,0.091578,0.1285,0,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.060677,0.090548,0.14849,0,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.64051,0.08993,0.073541,0,1
1,GO MAMMARY GLAND MORPHOGENESIS,0.25111,0.089664,0.15639,0,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.054439,0.089072,0.13807,0,1
1,GO MEMBRANE ORGANIZATION,0.074935,0.088988,0.12704,0,1
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.17591,0.0887,0.14442,0,1
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.16602,0.088474,0.14217,0,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.10468,0.088029,0.19402,0,1
1,GO HEPARIN METABOLIC PROCESS,0.2259,0.086808,0.11304,0,1
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.197,0.08637,0.12567,0,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.056456,0.086263,0.11794,0,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.10811,0.086065,0.10162,0,1
1,GO HEART DEVELOPMENT,0.056456,0.085273,0.17083,0,1
1,GO CATION TRANSPORT,0.08303,0.085014,0.11934,0,1
1,GO HAIR FOLLICLE MATURATION,0.098083,0.084964,0.16387,0,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.33821,0.084896,0.081411,0,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.10134,0.084253,0.13239,0,1
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.13885,0.08367,0.13952,0,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.14312,0.083496,0.16724,0,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.091819,0.083141,0.1124,0,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.08881,0.082337,0.11754,0,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.098083,0.082107,0.11541,0,1
1,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.26442,0.081393,0.096851,0,1
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.091819,0.081218,0.10659,0,1
1,GO HORMONE CATABOLIC PROCESS,0.33821,0.080563,0.085816,0,1
1,GO MATURATION OF LSU RRNA,0.072385,0.079504,0.084504,0,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,0.14312,0.079032,0.085397,0,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.056456,0.078741,0.14927,0,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.27126,0.078416,0.1579,0,1
1,GO RESPONSE TO COLD,0.2259,0.07732,0.10826,0,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.1306,0.077093,0.165,0,1
1,GO SPLEEN DEVELOPMENT,0.20256,0.076981,0.10095,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.069906,0.076973,0.11894,0,1
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.17091,0.076435,0.14836,0,1
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.065157,0.07596,0.18268,0,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.077559,0.075746,0.11508,0,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.25111,0.075681,0.1203,0,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.072385,0.074858,0.14218,0,1
1,GO METAL ION TRANSPORT,0.10468,0.074394,0.11579,0,1
1,GO EPITHELIUM DEVELOPMENT,0.077559,0.07364,0.14414,0,1
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.40594,0.071216,0.11415,0,1
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.12662,0.07109,0.12238,0,1
1,GO TISSUE MORPHOGENESIS,0.080256,0.070907,0.1583,0,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.074935,0.070419,0.14795,0,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.12273,0.07012,0.13608,0,1
1,GO SULFUR COMPOUND TRANSPORT,0.098083,0.069859,0.15172,0,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.30724,0.069229,0.11921,0,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.072385,0.068565,0.13533,0,1
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.067497,0.067837,0.10432,0,1
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.2259,0.067828,0.14808,0,1
1,GO PROTEIN TETRAMERIZATION,0.065157,0.067537,0.11636,0,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.094909,0.065621,0.17797,0,1
1,GO PROTEIN DESTABILIZATION,0.077559,0.065577,0.13023,0,1
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.58498,0.065212,0.06997,0,1
1,GO MITOCHONDRIAL FISSION,0.30724,0.065118,0.081986,0,1
1,GO FAT CELL DIFFERENTIATION,0.214,0.065072,0.12987,0,1
1,GO PIGMENT METABOLIC PROCESS,0.077559,0.064874,0.10191,0,1
1,GO GLUTAMINE METABOLIC PROCESS,0.08881,0.064334,0.11973,0,1
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.08303,0.06309,0.11809,0,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.11894,0.063038,0.12526,0,1
1,GO HORMONE METABOLIC PROCESS,0.19156,0.061026,0.10004,0,1
1,GO POLYOL BIOSYNTHETIC PROCESS,0.12273,0.060841,0.11798,0,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.080256,0.060816,0.11802,0,1
1,GO ACTIN FILAMENT BASED PROCESS,0.20822,0.059467,0.14023,0,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.17091,0.059396,0.081072,0,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.10134,0.057931,0.07543,0,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17591,0.054656,0.068281,0,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.10468,0.054448,0.091667,0,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.3148,0.054377,0.059869,0,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.2259,0.049339,0.07501,0,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.23203,0.048747,0.10405,0,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.17591,0.046266,0.12956,0,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.18102,0.043702,0.11768,0,1
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.20822,0.039123,0.10631,0,1
1,GO VIRAL GENE EXPRESSION,0.66333,0.035424,0.019639,0,1
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00076864,0.40634,0.42481,0,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.024086,0.38872,0.34461,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.013235,0.35041,0.28638,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.02951,0.33447,0.22882,0,0
1,GO MATING BEHAVIOR,0.0038653,0.33018,0.2891,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.058535,0.30327,0.35611,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.08588,0.30264,0.24792,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0083971,0.27389,0.33534,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.0015041,0.26225,0.40974,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0021907,0.25525,0.27442,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0066311,0.25082,0.25716,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.026142,0.24144,0.28611,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.12662,0.24139,0.15948,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.008797,0.23633,0.3528,0,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.091819,0.22846,0.25519,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.08303,0.22829,0.2048,0,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0066311,0.22824,0.23623,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.015776,0.22682,0.34691,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.010101,0.22583,0.3114,0,0
1,GO SULFATION,0.062884,0.22528,0.19872,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.13467,0.22506,0.19911,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,0.091819,0.21741,0.20148,0,0
1,GO GROOMING BEHAVIOR,0.11163,0.21228,0.12262,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.25111,0.21052,0.18492,0,0
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.28529,0.2078,0.16415,0,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.034576,0.20657,0.26029,0,0
1,GO PROSTATIC BUD FORMATION,0.062884,0.20546,0.23916,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.10468,0.20459,0.21129,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.010572,0.20025,0.19717,0,0
1,GO REGULATION OF GTP BINDING,0.052482,0.19732,0.17398,0,0
1,GO BIOLOGICAL PHASE,0.39705,0.19659,0.08876,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.045233,0.19638,0.16113,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10134,0.19478,0.2277,0,0
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.043559,0.19457,0.23677,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.25111,0.19128,0.23751,0,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.11163,0.19091,0.20782,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.038848,0.18664,0.19507,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.069906,0.18621,0.19978,0,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,0.072385,0.18061,0.22466,0,0
1,GO CELLULAR RESPONSE TO IRON ION,0.10468,0.17938,0.19393,0,0
1,GO GANGLION DEVELOPMENT,0.18624,0.17908,0.14055,0,0
1,GO PENILE ERECTION,0.10811,0.17481,0.16905,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.094909,0.17055,0.19704,0,0
1,GO INSEMINATION,0.36271,0.17031,0.099664,0,0
1,GO TUBE FORMATION,0.0014241,0.16943,0.24214,0,0
1,GO SALIVA SECRETION,0.17091,0.16932,0.14521,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.013834,0.16851,0.1931,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.094909,0.16648,0.19147,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.074935,0.16595,0.18049,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.28529,0.16507,0.14124,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.058535,0.16492,0.20527,0,0
1,GO EXTRACELLULAR TRANSPORT,0.060677,0.16482,0.19525,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.43329,0.16287,0.17171,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.011574,0.16126,0.20634,0,0
1,GO REGULATION OF OOGENESIS,0.080256,0.16093,0.14483,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.038848,0.15772,0.20791,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.010572,0.15743,0.21986,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.23203,0.15661,0.22687,0,0
1,GO PYROPTOSIS,0.13885,0.15596,0.15207,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.058535,0.15467,0.15138,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.080256,0.1546,0.1597,0,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.19156,0.15315,0.15362,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.12273,0.15277,0.20622,0,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.077559,0.15232,0.15087,0,0
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.23203,0.15205,0.13294,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.12273,0.15174,0.1292,0,0
1,GO SOMATIC STEM CELL DIVISION,0.25111,0.15135,0.18281,0,0
1,GO REFLEX,0.38829,0.15103,0.11169,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.16602,0.15075,0.17891,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.13885,0.15058,0.13655,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.080256,0.1496,0.14041,0,0
1,GO CELL AGGREGATION,0.2998,0.14703,0.073692,0,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.24463,0.14663,0.13842,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.045233,0.14599,0.14924,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.015104,0.14591,0.21059,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,0.0042727,0.14562,0.18897,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.197,0.14562,0.15802,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.065157,0.14442,0.22193,0,0
1,GO MITRAL VALVE DEVELOPMENT,0.41494,0.14433,0.12077,0,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.10811,0.14423,0.18284,0,0
1,GO EXOCYTIC PROCESS,0.054439,0.14377,0.16266,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.17591,0.1432,0.15768,0,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.069906,0.14263,0.18148,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.27126,0.14254,0.16295,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.13467,0.14205,0.12161,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.067497,0.14199,0.15877,0,0
1,GO ALANINE TRANSPORT,0.08303,0.14195,0.20555,0,0
1,GO ANIMAL ORGAN MATURATION,0.080256,0.14189,0.18647,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.13885,0.14133,0.17469,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0015041,0.13994,0.17956,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.012106,0.13939,0.16001,0,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.13885,0.13804,0.15938,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.28529,0.13745,0.093835,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.214,0.13729,0.16592,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.056456,0.13626,0.21695,0,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.10468,0.13568,0.18026,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.054439,0.13519,0.24249,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.062884,0.13494,0.1381,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.15655,0.13488,0.18249,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.27126,0.13446,0.14855,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.034576,0.13435,0.17269,0,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.36271,0.13402,0.11734,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.077559,0.13392,0.19072,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.18102,0.13373,0.17788,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.24463,0.13366,0.10919,0,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.18624,0.1321,0.14989,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.10811,0.13205,0.12269,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.074935,0.13197,0.17038,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.15197,0.1312,0.14833,0,0
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.10468,0.13091,0.12779,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.12273,0.13075,0.14506,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.11894,0.13038,0.19825,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.08303,0.13037,0.20914,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.13885,0.12989,0.15085,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.054439,0.12981,0.1814,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.069906,0.12969,0.16775,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.019548,0.12953,0.17439,0,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.20256,0.12925,0.16835,0,0
1,GO PARENTAL BEHAVIOR,0.16123,0.12925,0.19698,0,0
1,GO POSITIVE REGULATION OF ORGAN GROWTH,0.098083,0.12922,0.16406,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.10134,0.12915,0.11953,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.18102,0.12881,0.19904,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.067497,0.12875,0.14749,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.13467,0.12775,0.14937,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.067497,0.12726,0.16924,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.08588,0.12691,0.12777,0,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.067497,0.12668,0.15219,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.38829,0.12644,0.13899,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.067497,0.12637,0.1571,0,0
1,GO TRACHEA DEVELOPMENT,0.24463,0.12597,0.14885,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.0092139,0.12559,0.15987,0,0
1,GO RESPONSE TO X RAY,0.14312,0.1252,0.1287,0,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.067497,0.12509,0.20197,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.091819,0.12472,0.12971,0,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.094909,0.12339,0.16534,0,0
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.23827,0.12303,0.13106,0,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.10811,0.12224,0.1775,0,0
1,GO POSITIVE REGULATION OF HEART GROWTH,0.1306,0.12221,0.13173,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.058535,0.1221,0.1579,0,0
1,GO LIPID TRANSLOCATION,0.069906,0.12208,0.21254,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.054439,0.12153,0.15986,0,0
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.35442,0.12135,0.12124,0,0
1,GO AXONEME ASSEMBLY,0.074935,0.12132,0.18054,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.08303,0.12108,0.19308,0,0
1,GO RESPONSE TO IRON ION,0.11524,0.12103,0.15964,0,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.12273,0.12038,0.14022,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.098083,0.12007,0.16327,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.10468,0.12004,0.20971,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0011418,0.11989,0.17948,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.091819,0.11979,0.27144,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.072385,0.11944,0.10983,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.214,0.11925,0.14871,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.038848,0.11863,0.1416,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,0.27126,0.11809,0.18216,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.046961,0.11805,0.16672,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.37111,0.11803,0.043849,0,0
1,GO MEMBRANE BIOGENESIS,0.08588,0.11771,0.1504,0,0
1,GO MAST CELL MIGRATION,0.18624,0.11769,0.14323,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.069906,0.11763,0.1671,0,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.2577,0.11746,0.082102,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.091819,0.1173,0.12376,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.19156,0.11704,0.17053,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.060677,0.11703,0.14009,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.10468,0.117,0.12734,0,0
1,GO WALKING BEHAVIOR,0.094909,0.11694,0.14064,0,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.08303,0.11674,0.23931,0,0
1,GO NEURONAL ACTION POTENTIAL,0.11163,0.11674,0.13907,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.054439,0.11657,0.18441,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51122,0.11628,0.095803,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.091819,0.11627,0.14304,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.054439,0.11623,0.15361,0,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.10811,0.11577,0.13766,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.2577,0.11562,0.17129,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.058535,0.11551,0.20506,0,0
1,GO MEMBRANE DEPOLARIZATION,0.23203,0.11548,0.12637,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.015104,0.11515,0.15305,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.20822,0.11498,0.13012,0,0
1,GO RESPONSE TO UV C,0.091819,0.11497,0.14375,0,0
1,GO SUBPALLIUM DEVELOPMENT,0.33821,0.11458,0.11633,0,0
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.20822,0.11413,0.085424,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.18624,0.114,0.1739,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.18102,0.11379,0.087207,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.1475,0.11363,0.11843,0,0
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.12273,0.1134,0.13567,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.28529,0.11323,0.17195,0,0
1,GO REGULATION OF NUCLEASE ACTIVITY,0.13885,0.11318,0.13277,0,0
1,GO LIVER REGENERATION,0.08588,0.11306,0.12841,0,0
1,GO HEPATOCYTE DIFFERENTIATION,0.23827,0.113,0.082381,0,0
1,GO PEPTIDYL ARGININE METHYLATION,0.098083,0.11271,0.1235,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.15197,0.11259,0.16701,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.038848,0.11247,0.12882,0,0
1,GO DRUG CATABOLIC PROCESS,0.15197,0.11228,0.12722,0,0
1,GO PROSTATE GLAND DEVELOPMENT,0.197,0.11181,0.13768,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0010209,0.1111,0.17993,0,0
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.10811,0.111,0.12067,0,0
1,GO NEURAL CREST CELL DIFFERENTIATION,0.094909,0.11098,0.15716,0,0
1,GO RESPONSE TO AMPHETAMINE,0.21989,0.11076,0.12182,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.091819,0.11073,0.18028,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.12662,0.11056,0.13143,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.36271,0.11045,0.086919,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.065157,0.11027,0.15979,0,0
1,GO MUSCLE HYPERTROPHY,0.067497,0.11027,0.15713,0,0
1,GO STEROL HOMEOSTASIS,0.23827,0.11011,0.093642,0,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.054439,0.10995,0.12685,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.50109,0.10984,0.19084,0,0
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.21989,0.10955,0.15348,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.067497,0.1095,0.18868,0,0
1,GO VIRAL RNA GENOME REPLICATION,0.031957,0.10934,0.16508,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.34626,0.10895,0.13384,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.24463,0.10894,0.14587,0,0
1,GO THYROID HORMONE METABOLIC PROCESS,0.24463,0.10883,0.13311,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.23827,0.10848,0.1639,0,0
1,GO REGULATION OF VASCULOGENESIS,0.3148,0.10847,0.10902,0,0
1,GO RESPONSE TO SALT,0.10468,0.10842,0.10972,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.27821,0.10806,0.12542,0,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,0.11524,0.10793,0.12585,0,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.10811,0.10752,0.21381,0,0
1,GO PROTEIN KINASE C SIGNALING,0.36271,0.10751,0.14457,0,0
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.10134,0.10705,0.1284,0,0
1,GO DOPAMINE METABOLIC PROCESS,0.197,0.10677,0.13543,0,0
1,GO RECEPTOR INTERNALIZATION,0.10811,0.10673,0.13704,0,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.2998,0.10628,0.11199,0,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.054439,0.10616,0.20657,0,0
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.13467,0.10615,0.17952,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.13885,0.10574,0.14596,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.27821,0.10526,0.11758,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.041938,0.10523,0.18138,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.2577,0.10505,0.15344,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.067497,0.1048,0.12955,0,0
1,GO STEM CELL DIFFERENTIATION,0.16602,0.10477,0.12113,0,0
1,GO LOCOMOTOR RHYTHM,0.072385,0.1046,0.18237,0,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.17591,0.10422,0.12222,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.08303,0.10408,0.16027,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.14312,0.10355,0.17075,0,0
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.18624,0.10294,0.12679,0,0
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.17091,0.10287,0.14938,0,0
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.2998,0.10281,0.11015,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.10134,0.1026,0.14877,0,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.36271,0.10258,0.13124,0,0
1,GO PROTEIN DEMANNOSYLATION,0.23827,0.10249,0.12854,0,0
1,GO CYTOPLASM ORGANIZATION,0.19156,0.10232,0.15071,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,0.094909,0.10207,0.16491,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.20822,0.10202,0.16104,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.13885,0.10177,0.18755,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.00086166,0.1017,0.16121,0,0
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.43329,0.10156,0.14015,0,0
1,GO REGULATION OF HEART GROWTH,0.1306,0.10155,0.12269,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.15197,0.10137,0.14017,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.14312,0.1013,0.19414,0,0
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.5959,0.10109,0.076809,0,0
1,GO PROTEIN KINASE A SIGNALING,0.4521,0.10102,0.070814,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.065157,0.10084,0.14042,0,0
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.1306,0.10049,0.18636,0,0
1,GO REGULATION OF PROTEIN IMPORT,0.10468,0.1004,0.12872,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.058535,0.10026,0.14917,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.1306,0.10017,0.13518,0,0
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.12662,0.10011,0.16214,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.08303,0.099816,0.15243,0,0
1,GO RESPONSE TO HEAT,0.0076456,0.099816,0.14941,0,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.38829,0.099723,0.13796,0,0
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.14312,0.099617,0.14474,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.20822,0.099453,0.15823,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.022172,0.099269,0.17485,0,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.27126,0.099208,0.10818,0,0
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.069906,0.098943,0.12292,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.18624,0.0987,0.18947,0,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.23827,0.098579,0.14268,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.038848,0.098542,0.16833,0,0
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.08881,0.098497,0.11531,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.062884,0.098315,0.15293,0,0
1,GO PROTEIN NEDDYLATION,0.065157,0.098009,0.091049,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.16123,0.097968,0.13587,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.24463,0.097873,0.11078,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.16123,0.097812,0.1404,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.08588,0.097763,0.19292,0,0
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.12662,0.097686,0.13829,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.1306,0.097649,0.1712,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.37964,0.097612,0.085972,0,0
1,GO REGULATION OF HEAT GENERATION,0.10134,0.097464,0.17299,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.28529,0.097452,0.1034,0,0
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.11894,0.097327,0.18933,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.11894,0.097283,0.17539,0,0
1,GO RESPONSE TO LEAD ION,0.24463,0.097203,0.10652,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.25111,0.096955,0.097419,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.065157,0.096484,0.12344,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.08881,0.09641,0.1284,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.46168,0.096087,0.15402,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.17591,0.095968,0.13392,0,0
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00332,0.095937,0.13871,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.15655,0.095709,0.12438,0,0
1,GO L GLUTAMATE IMPORT,0.10468,0.095251,0.14696,0,0
1,GO OXYGEN TRANSPORT,0.88046,0.09515,0.020867,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.38829,0.095135,0.1069,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.13467,0.095031,0.10682,0,0
1,GO NEURAL CREST CELL MIGRATION,0.10134,0.094998,0.15605,0,0
1,GO AUTOPHAGY OF NUCLEUS,0.074935,0.094853,0.15121,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.074935,0.094484,0.14228,0,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.65188,0.094412,0.064996,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.10134,0.094318,0.17788,0,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.08303,0.094276,0.1525,0,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,0.35442,0.093865,0.11838,0,0
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.23203,0.093553,0.13681,0,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.077559,0.093287,0.0914,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.33821,0.093268,0.12749,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.25111,0.093083,0.095506,0,0
1,GO PROTEIN DEGLYCOSYLATION,0.32248,0.09304,0.10763,0,0
1,GO REGULATION OF URINE VOLUME,0.50109,0.092877,0.071747,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.214,0.092793,0.11202,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.14312,0.092617,0.11006,0,0
1,GO GLYCOSYLATION,0.077559,0.092598,0.12772,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.34626,0.092265,0.085367,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.10134,0.0921,0.16997,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.57414,0.091785,0.10193,0,0
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.28529,0.091612,0.1511,0,0
1,GO FOCAL ADHESION ASSEMBLY,0.13467,0.091576,0.18169,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.1475,0.091565,0.13736,0,0
1,GO CONVERGENT EXTENSION,0.13885,0.091266,0.18993,0,0
1,GO REGULATION OF HAIR CYCLE,0.14312,0.091263,0.12597,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.11163,0.091189,0.20979,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.27126,0.091175,0.10252,0,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.10811,0.090913,0.1502,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.065157,0.090826,0.11155,0,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.25111,0.090427,0.087553,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.12662,0.08994,0.14931,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.2259,0.089858,0.10896,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.11163,0.089537,0.16687,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.060677,0.089346,0.11529,0,0
1,GO REGULATION OF ORGAN GROWTH,0.091819,0.089249,0.13524,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.2998,0.089243,0.13805,0,0
1,GO LUNG MORPHOGENESIS,0.11894,0.089188,0.18364,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.060677,0.089099,0.14527,0,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.61803,0.088922,0.087774,0,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.38829,0.088718,0.092136,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.25111,0.088586,0.092441,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.58498,0.088497,0.053234,0,0
1,GO LUNG CELL DIFFERENTIATION,0.069906,0.088413,0.23406,0,0
1,GO HEART GROWTH,0.29248,0.088405,0.10115,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15655,0.088299,0.10644,0,0
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.23203,0.088018,0.15419,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.41494,0.087954,0.088781,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.15655,0.087881,0.14605,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.17091,0.087816,0.12118,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.26442,0.087767,0.14537,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.13885,0.087677,0.18127,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.20822,0.087518,0.10684,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.056456,0.087403,0.12461,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.072385,0.087162,0.15757,0,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.23827,0.087159,0.14497,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.19156,0.08708,0.1126,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.25111,0.087015,0.12716,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.16123,0.086996,0.13088,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.17091,0.086959,0.11318,0,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.18102,0.086858,0.13403,0,0
1,GO REGULATION OF CELL SHAPE,0.43329,0.086811,0.12684,0,0
1,GO REGULATION OF ION TRANSPORT,0.17591,0.086777,0.10476,0,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.10134,0.086681,0.15001,0,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.26442,0.086584,0.13661,0,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.10134,0.086517,0.16343,0,0
1,GO REPLICATIVE SENESCENCE,0.67486,0.086294,0.04766,0,0
1,GO COPULATION,0.34626,0.086292,0.12228,0,0
1,GO RECEPTOR METABOLIC PROCESS,0.098083,0.086189,0.13596,0,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21989,0.086164,0.11559,0,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.12273,0.085872,0.13099,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.12662,0.085833,0.14827,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.098083,0.085545,0.18193,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.62923,0.085443,0.049947,0,0
1,GO DIOL METABOLIC PROCESS,0.08303,0.085233,0.16235,0,0
1,GO N GLYCAN PROCESSING,0.20822,0.085068,0.18963,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.08881,0.085005,0.15202,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.2577,0.084895,0.1901,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.067497,0.084851,0.13028,0,0
1,GO RESPONSE TO FORSKOLIN,0.10468,0.084764,0.24163,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.094909,0.084419,0.14062,0,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.13885,0.0844,0.11611,0,0
1,GO NADH METABOLIC PROCESS,0.1306,0.084256,0.12128,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.33029,0.084158,0.10862,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.20822,0.084054,0.098031,0,0
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.79394,0.084019,0.087041,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.17091,0.083934,0.11335,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.11894,0.083719,0.13308,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.16602,0.083705,0.095775,0,0
1,GO HEART MORPHOGENESIS,0.12662,0.083688,0.15983,0,0
1,GO REGULATION OF BLOOD CIRCULATION,0.098083,0.083595,0.13321,0,0
1,GO SEGMENT SPECIFICATION,0.11524,0.083359,0.15249,0,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.18624,0.083288,0.1608,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.067497,0.083219,0.10325,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.26442,0.083161,0.13138,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.067497,0.08311,0.14391,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.10811,0.083061,0.10498,0,0
1,GO REGULATION OF MYELINATION,0.17091,0.082967,0.13786,0,0
1,GO VIRAL RELEASE FROM HOST CELL,0.18102,0.082798,0.10049,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.15655,0.082765,0.11236,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.077559,0.082741,0.14953,0,0
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.23203,0.082603,0.11824,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.08303,0.082283,0.17746,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.24463,0.082273,0.13304,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.054439,0.082248,0.087857,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.08881,0.081972,0.14354,0,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.52145,0.081704,0.073765,0,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.098083,0.081628,0.14062,0,0
1,GO RESPONSE TO BMP,0.13467,0.081449,0.18329,0,0
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.16602,0.081423,0.12659,0,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.15655,0.081356,0.14241,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.48117,0.08119,0.060975,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.15197,0.081155,0.14898,0,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.52145,0.081039,0.11218,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.1306,0.080931,0.12768,0,0
1,GO SEROTONIN TRANSPORT,0.27821,0.080828,0.1198,0,0
1,GO REGULATION OF GROWTH,0.065157,0.080796,0.1486,0,0
1,GO LYMPH VESSEL DEVELOPMENT,0.55277,0.080605,0.10886,0,0
1,GO MYOBLAST DIFFERENTIATION,0.29248,0.080501,0.10895,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.072385,0.080399,0.17208,0,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.19156,0.080248,0.1341,0,0
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.36271,0.080198,0.11605,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.20822,0.079963,0.12702,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.11524,0.079771,0.1614,0,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.30724,0.079589,0.13208,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.13467,0.079381,0.12752,0,0
1,GO REGULATION OF AMINO ACID TRANSPORT,0.12662,0.078938,0.17593,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.16123,0.078763,0.10421,0,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.42405,0.07872,0.10097,0,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.214,0.078672,0.13979,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.11163,0.078521,0.11295,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.16123,0.078366,0.12392,0,0
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.44264,0.07836,0.15204,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.2577,0.078124,0.087019,0,0
1,GO REGULATION OF PROTEIN FOLDING,0.054439,0.078123,0.12499,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.058535,0.077892,0.1725,0,0
1,GO ERBB2 SIGNALING PATHWAY,0.16123,0.077789,0.11958,0,0
1,GO METANEPHROS DEVELOPMENT,0.15655,0.077765,0.14832,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.53179,0.077761,0.10357,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.10811,0.077702,0.11765,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.85555,0.077614,0.038397,0,0
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.077559,0.077582,0.14287,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.37964,0.077468,0.10207,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.13467,0.077265,0.12304,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.08881,0.077165,0.10548,0,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.2998,0.077165,0.14665,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.043559,0.077127,0.15072,0,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.065157,0.076907,0.15171,0,0
1,GO AMINO ACID IMPORT,0.20822,0.076904,0.12712,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.065157,0.076875,0.12598,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.29248,0.076701,0.13132,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.36271,0.07663,0.12747,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.13885,0.076612,0.11078,0,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.19156,0.076579,0.11405,0,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.23203,0.076395,0.14918,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.091819,0.076211,0.1388,0,0
1,GO GLIOGENESIS,0.2259,0.075951,0.13334,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.46168,0.075884,0.091015,0,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.091819,0.075871,0.1423,0,0
1,GO RESPONSE TO OXYGEN RADICAL,0.26442,0.075843,0.079097,0,0
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.44264,0.075703,0.17375,0,0
1,GO REGULATION OF SECRETION,0.1306,0.075638,0.12698,0,0
1,GO ERYTHROCYTE HOMEOSTASIS,0.23203,0.075589,0.11804,0,0
1,GO NK T CELL DIFFERENTIATION,0.94321,0.075437,-0.0068798,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.26442,0.075425,0.1439,0,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.056456,0.075287,0.13972,0,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.13467,0.075281,0.13938,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10811,0.07512,0.19268,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.27126,0.074981,0.11172,0,0
1,GO STEROL METABOLIC PROCESS,0.27821,0.074889,0.089746,0,0
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.21989,0.074753,0.15362,0,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.14312,0.074087,0.10508,0,0
1,GO MESENCHYME DEVELOPMENT,0.29248,0.074077,0.11268,0,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.64051,0.073984,0.089327,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.16602,0.073953,0.15953,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.4521,0.073869,0.090347,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.067497,0.07386,0.17991,0,0
1,GO TRACHEA MORPHOGENESIS,0.2577,0.073785,0.15142,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.08303,0.073762,0.1208,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.14312,0.073722,0.1305,0,0
1,GO REGULATION OF ACROSOME REACTION,0.24463,0.073632,0.095448,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.067497,0.073506,0.134,0,0
1,GO NEURON PROJECTION REGENERATION,0.17091,0.073499,0.16014,0,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.2998,0.073086,0.12224,0,0
1,GO REGULATION OF PODOSOME ASSEMBLY,0.36271,0.07306,0.11764,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.18102,0.073006,0.12808,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.08588,0.072942,0.13817,0,0
1,GO HYPEROSMOTIC RESPONSE,0.20822,0.072941,0.1574,0,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.14312,0.072903,0.13831,0,0
1,GO RESPONSE TO PH,0.40594,0.07285,0.11624,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.10811,0.072735,0.12655,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.094909,0.072725,0.14131,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.25111,0.072672,0.13879,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.046961,0.072472,0.093597,0,0
1,GO RESPONSE TO UV B,0.78176,0.072434,0.053534,0,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.4521,0.07242,0.11024,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.16602,0.072418,0.11119,0,0
1,GO ODONTOGENESIS,0.41494,0.072312,0.10938,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.1475,0.072283,0.13031,0,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.74555,0.072233,0.059071,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.058535,0.072186,0.14642,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.18624,0.072093,0.10778,0,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.20256,0.072012,0.1426,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.52145,0.07192,0.082667,0,0
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.11894,0.0718,0.12889,0,0
1,GO VESICLE TARGETING,0.08303,0.071693,0.12475,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.28529,0.071653,0.12036,0,0
1,GO SKELETAL SYSTEM DEVELOPMENT,0.197,0.071652,0.1317,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.53179,0.071628,0.09702,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.29248,0.071443,0.054498,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.12662,0.071441,0.15161,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.34626,0.07137,0.14163,0,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.24463,0.071365,0.11414,0,0
1,GO GLIAL CELL DEVELOPMENT,0.2577,0.071351,0.12537,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.4521,0.071027,0.051365,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.41494,0.070864,0.13299,0,0
1,GO REGULATION OF LIGASE ACTIVITY,0.1306,0.070595,0.092892,0,0
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.17091,0.070546,0.13244,0,0
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.13467,0.070539,0.096949,0,0
1,GO AUTOPHAGOSOME MATURATION,0.18102,0.070536,0.11643,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.28529,0.070455,0.092452,0,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.85555,0.070437,0.017254,0,0
1,GO OLIGOPEPTIDE TRANSPORT,0.2577,0.070425,0.13093,0,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.17591,0.070344,0.13615,0,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.21989,0.070307,0.12946,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.35442,0.070274,0.098214,0,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.069906,0.070185,0.1101,0,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.99368,0.070099,0.027717,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.25111,0.070084,0.11812,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.16123,0.069891,0.11759,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.29248,0.06989,0.077701,0,0
1,GO REGULATION OF PINOCYTOSIS,0.54223,0.069886,0.098892,0,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.47137,0.069797,0.079462,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.21989,0.069739,0.092397,0,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.96843,0.069653,0.021871,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.091819,0.069573,0.11974,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.39705,0.069565,0.079323,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.53179,0.069349,0.083697,0,0
1,GO MITOCHONDRIAL FUSION,0.056456,0.069288,0.12502,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.24463,0.069266,0.17118,0,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.23203,0.06919,0.1141,0,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40594,0.069149,0.13612,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.16123,0.069109,0.13193,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.29248,0.069101,0.093739,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.40594,0.068956,0.10205,0,0
1,GO ERBB SIGNALING PATHWAY,0.16123,0.068938,0.14437,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.2577,0.068709,0.10035,0,0
1,GO REGULATION OF FERTILIZATION,0.23203,0.068658,0.078466,0,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.3148,0.068546,0.10293,0,0
1,GO RESPONSE TO CALCIUM ION,0.15655,0.068376,0.11306,0,0
1,GO PEROXISOME ORGANIZATION,0.072385,0.068353,0.09074,0,0
1,GO SENSORY PERCEPTION OF PAIN,0.13467,0.068266,0.12152,0,0
1,GO RESPONSE TO ESTRADIOL,0.17591,0.068243,0.11943,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.34626,0.068117,0.078688,0,0
1,GO POSITIVE REGULATION OF TRANSLATION,0.10134,0.068076,0.084167,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.16123,0.068072,0.10675,0,0
1,GO SPROUTING ANGIOGENESIS,0.80618,0.06781,0.083888,0,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.1306,0.067641,0.15742,0,0
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.24463,0.067605,0.14006,0,0
1,GO HORMONE BIOSYNTHETIC PROCESS,0.20822,0.067522,0.092421,0,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.61803,0.067357,0.057876,0,0
1,GO ORGANELLE FUSION,0.074935,0.067346,0.12139,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.55277,0.067308,0.057893,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.08303,0.067286,0.069099,0,0
1,GO MYOTUBE DIFFERENTIATION,0.57414,0.067196,0.078979,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,0.24463,0.067026,0.18535,0,0
1,GO STRESS FIBER ASSEMBLY,0.36271,0.067007,0.13786,0,0
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.08881,0.066952,0.12739,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.36271,0.066761,0.12164,0,0
1,GO CELL MATURATION,0.091819,0.066735,0.13603,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.23827,0.066717,0.1627,0,0
1,GO COPII COATED VESICLE BUDDING,0.080256,0.066656,0.11913,0,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.08303,0.06659,0.14219,0,0
1,GO FILOPODIUM ASSEMBLY,0.2998,0.066401,0.12344,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.214,0.066294,0.14241,0,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.34626,0.066025,0.12922,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.10468,0.066005,0.10413,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.57414,0.065904,0.031576,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.41494,0.065876,0.058973,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.16602,0.06587,0.10281,0,0
1,GO PEPTIDYL PROLINE MODIFICATION,0.39705,0.065857,0.058615,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.98106,0.0658,-0.0048595,0,0
1,GO BONE MATURATION,0.18624,0.065696,0.15339,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.17091,0.065178,0.14681,0,0
1,GO CGMP METABOLIC PROCESS,0.7336,0.065081,0.046848,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.24463,0.065053,0.12959,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.40594,0.064931,0.12355,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.18102,0.064728,0.10415,0,0
1,GO CELLULAR RESPONSE TO X RAY,0.37111,0.064694,0.1257,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.49108,0.064241,0.074895,0,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.70989,0.064054,0.055087,0,0
1,GO SKIN MORPHOGENESIS,0.62923,0.064037,0.10664,0,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.23827,0.064036,0.1282,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.050584,0.063951,0.13439,0,0
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.46168,0.063899,0.078438,0,0
1,GO PIRNA METABOLIC PROCESS,0.25111,0.063741,0.063251,0,0
1,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.094909,0.063716,0.11487,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.47137,0.063573,0.068498,0,0
1,GO ION TRANSPORT,0.10468,0.06351,0.11522,0,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.60692,0.063487,0.083064,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.47137,0.063245,0.11322,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.51122,0.063097,0.11091,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.074935,0.06296,0.13278,0,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.27821,0.062912,0.12028,0,0
1,GO ESTROGEN METABOLIC PROCESS,0.28529,0.062845,0.051995,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.52145,0.062798,0.069533,0,0
1,GO RECEPTOR BIOSYNTHETIC PROCESS,0.49108,0.062775,0.07506,0,0
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.66333,0.062761,0.064584,0,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.23827,0.06267,0.12496,0,0
1,GO RESPONSE TO SALT STRESS,0.52145,0.062641,0.075334,0,0
1,GO RECEPTOR CATABOLIC PROCESS,0.18624,0.062559,0.13264,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.49108,0.062524,0.050566,0,0
1,GO AMELOGENESIS,0.16123,0.062473,0.15053,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.1306,0.062466,0.1095,0,0
1,GO NAD METABOLIC PROCESS,0.30724,0.062362,0.10115,0,0
1,GO VIRAL TRANSLATION,0.046961,0.062345,0.10865,0,0
1,GO NODAL SIGNALING PATHWAY,0.091819,0.062337,0.16518,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.19156,0.062196,0.051528,0,0
1,GO RESPONSE TO ABIOTIC STIMULUS,0.098083,0.062148,0.11667,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.37111,0.062099,0.1441,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.1306,0.061993,0.11618,0,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.1475,0.061957,0.11218,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.19156,0.061882,0.10176,0,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.20256,0.06188,0.14253,0,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.1475,0.061851,0.13663,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.29248,0.06151,0.12116,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.47137,0.061365,0.039561,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.60692,0.06135,0.058389,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.16123,0.061346,0.13477,0,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.24463,0.06129,0.14008,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.214,0.061226,0.12664,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.23203,0.0612,0.11388,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.35442,0.061183,0.11234,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.12662,0.06105,0.15159,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.2577,0.060968,0.12497,0,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.24463,0.060963,0.12076,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.38829,0.060933,0.10606,0,0
1,GO NADPH REGENERATION,0.23203,0.060913,0.08579,0,0
1,GO RESPONSE TO AXON INJURY,0.3148,0.06079,0.12091,0,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.7336,0.060759,0.047921,0,0
1,GO NUCLEOSIDE SALVAGE,0.052482,0.060645,0.13123,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.08303,0.060631,0.16678,0,0
1,GO DETECTION OF CALCIUM ION,0.48117,0.060623,0.054429,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.99368,0.06059,0.020526,0,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.1306,0.06056,0.11901,0,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.18624,0.060496,0.12846,0,0
1,GO REGULATION OF DENDRITE EXTENSION,0.08588,0.060407,0.19914,0,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.28529,0.06037,0.10861,0,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.41494,0.060287,0.12296,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,0.214,0.060042,0.19867,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.28529,0.059979,0.12271,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.68646,0.059962,0.062388,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.3148,0.059933,0.13853,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.33029,0.059871,0.15588,0,0
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.2577,0.059839,0.099702,0,0
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.55277,0.059625,0.11124,0,0
1,GO DETECTION OF STIMULUS,0.058535,0.059459,0.10082,0,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.46168,0.059426,0.081598,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.2259,0.059383,0.091859,0,0
1,GO CORTICAL CYTOSKELETON ORGANIZATION,0.34626,0.05937,0.11674,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.49108,0.059318,0.043755,0,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.091819,0.059288,0.10888,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.214,0.05926,0.12986,0,0
1,GO LYMPHANGIOGENESIS,0.60692,0.059247,0.084039,0,0
1,GO INTERFERON BETA PRODUCTION,0.50109,0.059171,0.097996,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.1306,0.059159,0.12618,0,0
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.16602,0.05914,0.10915,0,0
1,GO ACID SECRETION,0.28529,0.058951,0.077793,0,0
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.51122,0.058861,0.080565,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.13467,0.058836,0.098722,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.18102,0.058828,0.12338,0,0
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.062884,0.058714,0.097326,0,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.21989,0.058616,0.10366,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.21989,0.058378,0.12803,0,0
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.30724,0.058345,0.11987,0,0
1,GO CARDIAC SEPTUM DEVELOPMENT,0.27126,0.058283,0.15061,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.20256,0.05815,0.10652,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.098083,0.058114,0.11778,0,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.19156,0.058114,0.1096,0,0
1,GO GOLGI VESICLE BUDDING,0.072385,0.057936,0.12483,0,0
1,GO NOTCH SIGNALING PATHWAY,0.08881,0.057904,0.1399,0,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.214,0.057831,0.09044,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.58498,0.057668,0.063878,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.19156,0.057586,0.13537,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.30724,0.057562,0.13148,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.10811,0.057553,0.11814,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.47137,0.057451,0.1286,0,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.50109,0.057431,0.064346,0,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.36271,0.057421,0.12334,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.18102,0.057303,0.14261,0,0
1,GO RESPONSE TO TESTOSTERONE,0.33821,0.057196,0.088617,0,0
1,GO GLUTAMATE SECRETION,0.1475,0.057195,0.16727,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.55277,0.057,0.079514,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10811,0.05685,0.13841,0,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.19156,0.056785,0.14895,0,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.24463,0.05667,0.10327,0,0
1,GO REGULATION OF PROTEIN BINDING,0.20256,0.056625,0.12992,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.40594,0.056503,0.10898,0,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.50109,0.056316,0.063133,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.11524,0.056284,0.069115,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.098083,0.056175,0.1003,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.40594,0.055705,0.076385,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.23203,0.055692,0.086296,0,0
1,GO PEROXISOMAL TRANSPORT,0.11163,0.055616,0.084222,0,0
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.10811,0.055503,0.17183,0,0
1,GO REGULATION OF PHOSPHORYLATION,0.23827,0.055409,0.12863,0,0
1,GO REGULATION OF PEPTIDE SECRETION,0.41494,0.055161,0.10044,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,1,0.054978,0.0013571,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.20822,0.054977,0.10114,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.054439,0.054775,0.16986,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.20256,0.054763,0.093549,0,0
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.44264,0.054757,0.11747,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.16123,0.054726,0.097626,0,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.48117,0.054704,0.077119,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.15197,0.054629,0.13185,0,0
1,GO RESPONSE TO GROWTH FACTOR,0.19156,0.054628,0.13963,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.074935,0.054488,0.093106,0,0
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.27821,0.054417,0.10658,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.27126,0.054396,0.121,0,0
1,GO STRIATED MUSCLE CONTRACTION,0.14312,0.054353,0.10862,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.50109,0.054245,0.084523,0,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.37964,0.054149,0.13097,0,0
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.18102,0.0541,0.15697,0,0
1,GO KETONE BIOSYNTHETIC PROCESS,0.15655,0.054027,0.10711,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.7336,0.053994,0.077176,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.47137,0.053935,0.071505,0,0
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.21989,0.053789,0.09286,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.23203,0.053771,0.11999,0,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.10811,0.053704,0.11942,0,0
1,GO OPSONIZATION,0.90549,0.053634,-0.037393,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.79394,0.053618,0.033961,0,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.15655,0.053434,0.11434,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.33029,0.053302,0.095807,0,0
1,GO EMBRYONIC EYE MORPHOGENESIS,0.19156,0.053285,0.14897,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.094909,0.053154,0.10162,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.27126,0.053137,0.13866,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.12662,0.053086,0.15641,0,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.065157,0.053049,0.10924,0,0
1,GO PONS DEVELOPMENT,0.42405,0.052938,0.21566,0,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.16602,0.052869,0.11286,0,0
1,GO RESPONSE TO PEPTIDE,0.23203,0.052734,0.11884,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.2577,0.052722,0.13612,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.30724,0.0527,0.14538,0,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.38829,0.052655,0.090081,0,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.61803,0.052562,0.105,0,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.32248,0.052502,0.097934,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.25111,0.052406,0.10642,0,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.78176,0.052379,0.054991,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.26442,0.052359,0.11388,0,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.20822,0.052327,0.1024,0,0
1,GO VASCULOGENESIS,0.37111,0.052293,0.1308,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.23827,0.052288,0.111,0,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.15655,0.052173,0.084665,0,0
1,GO BASEMENT MEMBRANE ASSEMBLY,0.3148,0.052057,0.1408,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.30724,0.05195,0.073294,0,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.37964,0.051908,0.10077,0,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48117,0.051894,0.13978,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.37111,0.051785,0.088693,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.10134,0.05178,0.10843,0,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.44264,0.051763,0.078317,0,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.18102,0.051753,0.13085,0,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.27126,0.051662,0.090887,0,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.60692,0.051629,0.06202,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.14312,0.051623,0.13924,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.23203,0.051599,0.11757,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.46168,0.051578,0.089061,0,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.15655,0.051524,0.10703,0,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.76963,0.05148,0.002525,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.214,0.051375,0.12062,0,0
1,GO NUCLEOSIDE METABOLIC PROCESS,0.098083,0.051372,0.076043,0,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.38829,0.051301,0.12314,0,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.41494,0.051299,0.099738,0,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.20256,0.05129,0.13995,0,0
1,GO AMINE CATABOLIC PROCESS,0.48117,0.051182,0.055038,0,0
1,GO RESPONSE TO ACIDIC PH,0.43329,0.051155,0.097574,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.36271,0.051153,0.065894,0,0
1,GO TOOTH MINERALIZATION,0.33821,0.0511,0.15383,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.28529,0.051052,0.1113,0,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.48117,0.051046,0.059786,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.42405,0.050767,0.084925,0,0
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.24463,0.050762,0.13663,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.37964,0.050744,0.10091,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.21989,0.05056,0.11365,0,0
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.21989,0.050513,0.11191,0,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.19156,0.050417,0.13108,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.50109,0.050372,0.10389,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.74555,0.050191,0.052766,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.2259,0.050166,0.10609,0,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.11894,0.050144,0.14354,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.13467,0.050058,0.12012,0,0
1,GO LIPID CATABOLIC PROCESS,0.51122,0.049967,0.075699,0,0
1,GO BODY MORPHOGENESIS,0.36271,0.049845,0.13774,0,0
1,GO CHONDROCYTE DEVELOPMENT,0.35442,0.049778,0.1201,0,0
1,GO CELLULAR KETONE METABOLIC PROCESS,0.15655,0.049709,0.080663,0,0
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.37964,0.049699,0.074547,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.20822,0.049555,0.11087,0,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.51122,0.049493,0.036784,0,0
1,GO STEROL TRANSPORT,0.43329,0.049218,0.093158,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.214,0.049216,0.1182,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.3148,0.049204,0.096481,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.26442,0.049153,0.10925,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.54223,0.049071,0.068009,0,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.32248,0.04906,0.10872,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.28529,0.048629,0.14892,0,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.15655,0.048617,0.16227,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.37964,0.048516,0.080474,0,0
1,GO STEROID HORMONE SECRETION,0.94321,0.048429,0.035649,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.2998,0.04842,0.09276,0,0
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.10134,0.048405,0.068485,0,0
1,GO VESICLE BUDDING FROM MEMBRANE,0.44264,0.048338,0.08058,0,0
1,GO O GLYCAN PROCESSING,0.89296,0.048265,0.0056489,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.37111,0.048225,0.049044,0,0
1,GO WATER HOMEOSTASIS,0.214,0.048201,0.13345,0,0
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.197,0.047994,0.14221,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.83078,0.047953,0.040026,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.53179,0.047617,0.085053,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.50109,0.047607,0.075477,0,0
1,GO VACUOLE ORGANIZATION,0.24463,0.04759,0.115,0,0
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.094909,0.047563,0.1953,0,0
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.26442,0.047376,0.1095,0,0
1,GO TRANSCYTOSIS,0.79394,0.047328,0.042461,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.17591,0.047311,0.096197,0,0
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.37964,0.047233,0.077854,0,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.64051,0.047158,0.095869,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49108,0.047152,0.092756,0,0
1,GO REGULATION OF ISOTYPE SWITCHING,0.48117,0.047123,0.10584,0,0
1,GO ORGAN INDUCTION,0.43329,0.047059,0.067144,0,0
1,GO POSITIVE REGULATION OF VIRAL PROCESS,0.35442,0.047018,0.082519,0,0
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.25111,0.046953,0.13265,0,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.57414,0.046895,0.063943,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.81845,0.046871,0.037853,0,0
1,GO MIDBODY ABSCISSION,0.13885,0.046786,0.087498,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.15197,0.046628,0.15038,0,0
1,GO RESPONSE TO ACID CHEMICAL,0.23203,0.046611,0.098488,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.21989,0.046435,0.11166,0,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.25111,0.046413,0.14583,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.65188,0.046384,-0.024855,0,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.40594,0.046373,0.030661,0,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.29248,0.046327,0.11918,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.2577,0.046312,0.15465,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.64051,0.046283,0.075432,0,0
1,GO INORGANIC ANION TRANSPORT,0.214,0.04626,0.1016,0,0
1,GO PEPTIDE SECRETION,0.29248,0.046134,0.10562,0,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.48117,0.046099,0.097504,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.37111,0.045941,0.11169,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.33029,0.045842,0.09312,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.21989,0.045835,0.18578,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.2998,0.045637,0.086285,0,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.44264,0.045576,0.11065,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.23827,0.045551,0.054024,0,0
1,GO REGULATION OF EXOSOMAL SECRETION,0.37111,0.045494,0.10604,0,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.37111,0.045475,0.079024,0,0
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.2577,0.045377,0.13606,0,0
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.64051,0.045373,0.093398,0,0
1,GO ARTERY DEVELOPMENT,0.62923,0.045319,0.09416,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.43329,0.045311,0.13377,0,0
1,GO SARCOMERE ORGANIZATION,0.11894,0.045278,0.11311,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.20822,0.045264,0.08158,0,0
1,GO MUSCLE ADAPTATION,0.42405,0.045201,0.108,0,0
1,GO ORGAN GROWTH,0.2577,0.04493,0.12091,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.24463,0.044872,0.072481,0,0
1,GO REGULATION OF LIPID STORAGE,0.2998,0.044582,0.12918,0,0
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.15655,0.044568,0.088576,0,0
1,GO MEMBRANE FUSION,0.4521,0.044556,0.077439,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.79394,0.044506,0.063283,0,0
1,GO RESPONSE TO HORMONE,0.41494,0.044435,0.10333,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.95582,0.044409,0.020845,0,0
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.2577,0.044218,0.096147,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.197,0.044171,0.10041,0,0
1,GO HEART VALVE DEVELOPMENT,0.68646,0.044042,0.11686,0,0
1,GO MUSCLE CELL MIGRATION,0.33029,0.044018,0.12583,0,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47137,0.04394,0.091351,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.43329,0.043923,0.14233,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.49108,0.043743,0.1078,0,0
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.26442,0.043721,0.058912,0,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.89296,0.043703,0.057371,0,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.98106,0.043654,0.011358,0,0
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.95582,0.043611,0.01948,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.28529,0.043522,0.11596,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.46168,0.043469,0.087477,0,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.67486,0.043397,0.05224,0,0
1,GO RESPONSE TO ANGIOTENSIN,0.90549,0.043251,0.034867,0,0
1,GO REGULATION OF VESICLE FUSION,0.23827,0.043237,0.13878,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.2577,0.043158,0.12129,0,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.94321,0.04309,-0.011643,0,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.49108,0.043066,0.057165,0,0
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.1475,0.043012,0.087705,0,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.35442,0.042956,0.058373,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.2577,0.042921,0.076579,0,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.18102,0.042867,0.1234,0,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.197,0.042804,0.096171,0,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,0.28529,0.042747,0.11497,0,0
1,GO JNK CASCADE,0.34626,0.04266,0.11741,0,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.2998,0.042515,0.13758,0,0
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.58498,0.042496,0.057585,0,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.41494,0.04242,0.10646,0,0
1,GO MUSCLE SYSTEM PROCESS,0.27126,0.042406,0.1019,0,0
1,GO DENDRITE SELF AVOIDANCE,0.42405,0.042389,0.093626,0,0
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.44264,0.042253,0.074041,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.58498,0.041998,0.082261,0,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.19156,0.041932,0.099244,0,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.41494,0.041804,0.1256,0,0
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.16123,0.04172,0.072976,0,0
1,GO MEMBRANE REPOLARIZATION,0.80618,0.041659,0.052758,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.98106,0.04165,0.0025953,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.39705,0.041642,0.085139,0,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.37111,0.041635,0.11888,0,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.46168,0.041543,0.10009,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.23827,0.04129,0.12314,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,0.39705,0.041239,0.098595,0,0
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.054439,0.041204,0.1156,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.35442,0.041158,0.082853,0,0
1,GO ATP METABOLIC PROCESS,0.11894,0.041132,0.07305,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.34626,0.041052,0.11926,0,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.50109,0.040873,0.10508,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.55277,0.040864,0.058857,0,0
1,GO CHOLESTEROL STORAGE,0.4521,0.040437,0.11285,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.75756,0.040398,0.041722,0,0
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.51122,0.040293,0.068136,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.43329,0.04028,0.11336,0,0
1,GO IMMUNE SYSTEM DEVELOPMENT,0.79394,0.039951,0.056474,0,0
1,GO CYTOPLASMIC TRANSLATION,0.2998,0.03991,0.044709,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,1,0.039828,0.032137,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.49108,0.03964,0.095947,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.78176,0.039142,0.053137,0,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.75756,0.03907,0.060724,0,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.28529,0.038926,0.13125,0,0
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.33821,0.038919,0.076202,0,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.53179,0.038863,0.092236,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.2259,0.03882,0.065959,0,0
1,GO SULFATE TRANSPORT,0.16602,0.038804,0.13555,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.214,0.038751,0.098623,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.88046,0.038732,0.011791,0,0
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.89296,0.038716,-0.0020641,0,0
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.80618,0.038703,0.028764,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.47137,0.038692,0.097583,0,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.35442,0.038649,0.10285,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY,0.214,0.038546,0.089972,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.74555,0.038545,-0.00075787,0,0
1,GO APOPTOTIC PROCESS,0.33029,0.038537,0.099371,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.38829,0.038314,0.060689,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.79394,0.038272,-0.065459,0,0
1,GO MITOTIC CYTOKINETIC PROCESS,0.080256,0.038262,0.097698,0,0
1,GO HOMEOSTATIC PROCESS,0.33821,0.038257,0.093642,0,0
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.64051,0.038207,0.10957,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.61803,0.038165,0.05438,0,0
1,GO CHONDROCYTE DIFFERENTIATION,0.50109,0.03803,0.11373,0,0
1,GO ACTIN FILAMENT ORGANIZATION,0.46168,0.038027,0.11424,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.17091,0.037943,0.16506,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.2998,0.037803,0.12118,0,0
1,GO ORGANIC ACID METABOLIC PROCESS,0.23203,0.037559,0.087631,0,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.76963,0.03751,0.064848,0,0
1,GO PLASMA MEMBRANE ORGANIZATION,0.47137,0.037502,0.10274,0,0
1,GO FEVER GENERATION,0.86799,0.037458,0.01801,0,0
1,GO REGULATION OF ENDOCYTOSIS,0.30724,0.037458,0.1165,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.86799,0.037312,0.03083,0,0
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.20822,0.037303,0.14168,0,0
1,GO POSITIVE REGULATION OF SECRETION,0.65188,0.037231,0.072267,0,0
1,GO TUBE DEVELOPMENT,0.43329,0.037215,0.1173,0,0
1,GO ADAPTIVE THERMOGENESIS,0.46168,0.037198,0.092957,0,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.37964,0.03719,0.097108,0,0
1,GO PODOSOME ASSEMBLY,0.47137,0.037088,0.11439,0,0
1,GO ENDODERMAL CELL FATE COMMITMENT,0.62923,0.036934,0.062462,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.23827,0.036912,0.10095,0,0
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.58498,0.036911,0.052177,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.27821,0.036884,0.099444,0,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.37964,0.036837,0.10515,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.34626,0.0368,0.073999,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.90549,0.036775,0.043563,0,0
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.20256,0.036765,0.097456,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29248,0.036727,0.082853,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.64051,0.036584,0.04695,0,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.48117,0.036545,0.077023,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.15655,0.03636,0.14314,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.61803,0.036276,0.047779,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.50109,0.036072,0.085515,0,0
1,GO MYELOID CELL HOMEOSTASIS,0.41494,0.03607,0.096738,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.25111,0.035908,0.11922,0,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.27821,0.035824,0.11255,0,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.57414,0.035779,0.088617,0,0
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.68646,0.035734,0.048119,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.69814,0.035692,0.043722,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.23827,0.035654,0.057875,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.27126,0.035508,0.10601,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.32248,0.03537,0.13159,0,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.2577,0.035346,0.13734,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.86799,0.03525,0.022069,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.42405,0.03518,0.10911,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.86799,0.035142,0.046576,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.38829,0.03511,0.10456,0,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.56341,0.035101,0.077781,0,0
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.99368,0.035101,0.0031631,0,0
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.84314,0.03501,-0.00033698,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.25111,0.034891,0.10469,0,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.41494,0.034835,0.084332,0,0
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.70989,0.034824,0.044865,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.39705,0.034627,0.11134,0,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.99368,0.034562,0.044019,0,0
1,GO RENAL WATER HOMEOSTASIS,0.30724,0.034553,0.16266,0,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.2577,0.034417,0.066569,0,0
1,GO ANIMAL ORGAN FORMATION,0.36271,0.034386,0.095375,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.098083,0.034376,0.1634,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.88046,0.034292,0.030277,0,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.30724,0.034288,0.095633,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.79394,0.034188,0.049566,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.35442,0.03413,0.094749,0,0
1,GO ERAD PATHWAY,0.15655,0.034047,0.098845,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.48117,0.033995,0.071368,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.2259,0.033989,0.13167,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.95582,0.03397,-0.0046956,0,0
1,GO ORGANIC ACID TRANSPORT,0.1475,0.03395,0.11945,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.37111,0.033825,0.10654,0,0
1,GO RESPONSE TO STEROID HORMONE,0.34626,0.033654,0.10536,0,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.38829,0.033619,0.063452,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.19156,0.033586,0.10012,0,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.98106,0.033582,0.0043964,0,0
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.32248,0.033541,0.095371,0,0
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.26442,0.033524,0.077794,0,0
1,GO PROTEIN HOMOTETRAMERIZATION,0.41494,0.033487,0.06976,0,0
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.54223,0.033418,0.10733,0,0
1,GO PEPTIDE CATABOLIC PROCESS,0.86799,0.033377,0.014619,0,0
1,GO GLAND MORPHOGENESIS,0.37111,0.033093,0.13117,0,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.51122,0.033075,0.11062,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.27821,0.033033,0.11028,0,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.3148,0.032908,0.063667,0,0
1,GO STEROID METABOLIC PROCESS,0.36271,0.032852,0.075775,0,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.34626,0.032849,0.11558,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.19156,0.032657,0.10229,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.34626,0.032647,0.098499,0,0
1,GO TYPE I INTERFERON PRODUCTION,0.5959,0.032592,0.072215,0,0
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.34626,0.032592,0.081851,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.53179,0.032554,0.10131,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.44264,0.03241,0.10043,0,0
1,GO MUSCLE CONTRACTION,0.29248,0.032375,0.099237,0,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.41494,0.032358,0.068313,0,0
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.56341,0.032161,0.12676,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.65188,0.032049,0.050711,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.5959,0.032023,0.098471,0,0
1,GO CELLULAR RESPONSE TO DSRNA,0.51122,0.032001,0.097177,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.2998,0.031981,0.097667,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.62923,0.031972,0.068709,0,0
1,GO EPITHELIAL CELL PROLIFERATION,0.40594,0.031951,0.1096,0,0
1,GO SODIUM ION HOMEOSTASIS,0.35442,0.031914,0.11226,0,0
1,GO ANION TRANSPORT,0.15655,0.031855,0.12309,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.39705,0.031714,0.10046,0,0
1,GO SERTOLI CELL DIFFERENTIATION,0.37964,0.031602,0.11966,0,0
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.85555,0.031528,-0.027561,0,0
1,GO DRUG METABOLIC PROCESS,0.69814,0.031484,0.018206,0,0
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.98106,0.03147,0.038642,0,0
1,GO ALCOHOL METABOLIC PROCESS,0.19156,0.031406,0.10412,0,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.93062,0.031347,0.084841,0,0
1,GO REGULATION OF GLIOGENESIS,0.62923,0.031328,0.078078,0,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.43329,0.031325,0.1203,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.32248,0.031146,0.10533,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.38829,0.031145,0.093625,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.74555,0.030881,0.050629,0,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.42405,0.03084,0.10216,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.95582,0.030781,-0.024828,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.48117,0.030734,-0.11411,0,0
1,GO OSTEOBLAST DIFFERENTIATION,0.43329,0.030661,0.094202,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.2577,0.030624,0.095694,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.39705,0.030616,0.065547,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.197,0.030523,0.14177,0,0
1,GO RESPONSE TO DRUG,0.42405,0.030231,0.096336,0,0
1,GO SECONDARY METABOLIC PROCESS,0.39705,0.030006,0.080209,0,0
1,GO TUBE MORPHOGENESIS,0.56341,0.029947,0.11054,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.41494,0.02993,0.10509,0,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.20256,0.029878,0.14549,0,0
1,GO REGULATION OF CELL DEATH,0.52145,0.029779,0.090817,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.54223,0.029703,0.067206,0,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.37111,0.029644,0.093568,0,0
1,GO CARTILAGE MORPHOGENESIS,0.2998,0.029588,0.12495,0,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.99368,0.02954,0.056826,0,0
1,GO KERATINOCYTE PROLIFERATION,0.47137,0.029463,0.10539,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.94321,0.02946,0.040883,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.98106,0.029376,0.038848,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.67486,0.02937,0.055536,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.94321,0.029345,0.04961,0,0
1,GO POSITIVE REGULATION OF URINE VOLUME,0.95582,0.029325,0.024965,0,0
1,GO MICROVILLUS ORGANIZATION,0.58498,0.029293,0.06511,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.37111,0.029233,0.097052,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,1,0.029174,0.045042,0,0
1,GO SYMBIOTIC PROCESS,0.26442,0.029116,0.08047,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.2259,0.029101,0.10728,0,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.2577,0.029071,0.14533,0,0
1,GO REPLACEMENT OSSIFICATION,0.79394,0.029067,0.065204,0,0
1,GO ISOPRENOID METABOLIC PROCESS,0.27126,0.02904,0.074515,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.58498,0.029006,0.097083,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.43329,0.02888,0.086745,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.52145,0.028848,0.042873,0,0
1,GO NUCLEOTIDE SALVAGE,0.84314,0.028816,-0.0012757,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.85555,0.028764,0.022612,0,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.91805,0.028641,-0.0060736,0,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.80618,0.02848,0.051915,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.2998,0.028442,0.06742,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.48117,0.028427,0.066293,0,0
1,GO RNA 5 END PROCESSING,0.3148,0.028422,0.054647,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65188,0.028418,0.086876,0,0
1,GO PROTEOLYSIS,0.32248,0.028395,0.10364,0,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,0.23827,0.028377,0.089265,0,0
1,GO POSITIVE REGULATION OF ERAD PATHWAY,0.84314,0.02833,0.060726,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.40594,0.028318,0.10463,0,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.33821,0.028307,0.10941,0,0
1,GO RESPONSE TO PROGESTERONE,0.74555,0.028271,0.077548,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.54223,0.028219,0.098034,0,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.55277,0.028121,0.092093,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.62923,0.028075,0.073586,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.95582,0.028055,0.014277,0,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.44264,0.027971,0.12066,0,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.57414,0.027954,0.10581,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.57414,0.027676,0.094354,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.67486,0.027472,0.075925,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.68646,0.027462,0.06058,0,0
1,GO HEART FORMATION,0.61803,0.027406,0.065521,0,0
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.57414,0.027228,0.066797,0,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.61803,0.027219,0.097841,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.40594,0.027007,0.074825,0,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.62923,0.026963,0.086147,0,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.61803,0.026959,0.087589,0,0
1,GO OXIDATION REDUCTION PROCESS,0.32248,0.026843,0.065631,0,0
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.55277,0.026793,0.094579,0,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.32248,0.026783,0.13644,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.53179,0.026344,0.094436,0,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.42405,0.026256,0.10419,0,0
1,GO RESPONSE TO GAMMA RADIATION,0.33029,0.026237,0.077855,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.88046,0.026184,-0.032035,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.41494,0.026148,0.085084,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.40594,0.026148,0.082592,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.70989,0.026138,0.035659,0,0
1,GO BONE GROWTH,0.61803,0.026115,0.092866,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.40594,0.025985,0.053513,0,0
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.69814,0.025864,0.044536,0,0
1,GO QUINONE METABOLIC PROCESS,0.35442,0.025816,0.099925,0,0
1,GO RENAL SYSTEM PROCESS,0.42405,0.025709,0.12124,0,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.41494,0.025624,0.084343,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.49108,0.025524,0.084181,0,0
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.57414,0.025433,0.097227,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.7336,0.025365,0.04313,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.91805,0.02526,0.044218,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.62923,0.025223,0.071292,0,0
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.83078,0.025199,0.035405,0,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.68646,0.025171,0.080155,0,0
1,GO REGULATION OF RESPONSE TO STRESS,0.70989,0.025159,0.07457,0,0
1,GO PINOCYTOSIS,0.86799,0.025157,0.04948,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.32248,0.025084,0.081723,0,0
1,GO RIBOSOME ASSEMBLY,0.64051,0.025075,0.014672,0,0
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68646,0.024995,0.090057,0,0
1,GO SKIN DEVELOPMENT,0.38829,0.024971,0.087735,0,0
1,GO NEGATIVE REGULATION OF CELL DEATH,0.49108,0.024576,0.084971,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.88046,0.024557,0.039857,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.48117,0.024392,0.12727,0,0
1,GO MYOFIBRIL ASSEMBLY,0.44264,0.02429,0.087757,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.62923,0.024248,0.055267,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.57414,0.024221,0.063096,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.83078,0.024184,0.030462,0,0
1,GO KERATINOCYTE MIGRATION,0.88046,0.024174,0.061725,0,0
1,GO TETRAPYRROLE METABOLIC PROCESS,0.29248,0.024147,0.075109,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.72171,0.023974,0.07551,0,0
1,GO INTERFERON ALPHA PRODUCTION,0.78176,0.023961,0.029354,0,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.37111,0.023853,0.11533,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.88046,0.023808,0.031498,0,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.79394,0.023782,0.046392,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.69814,0.023758,0.065899,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.41494,0.023718,0.065572,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.37111,0.023674,0.13007,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.55277,0.02362,0.075924,0,0
1,GO LIPID EXPORT FROM CELL,1,0.023499,0.012913,0,0
1,GO MESODERMAL CELL DIFFERENTIATION,0.75756,0.023386,0.059156,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.80618,0.023193,0.058567,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.3148,0.023063,0.088836,0,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.51122,0.023043,0.080171,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.60692,0.022951,0.029452,0,0
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.76963,0.022921,0.073165,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.81845,0.022913,0.074974,0,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.80618,0.022758,0.047767,0,0
1,GO MYELOID CELL DIFFERENTIATION,0.83078,0.022421,0.067588,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.23203,0.022415,0.099369,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.66333,0.022351,0.060504,0,0
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.23827,0.022343,0.15716,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.42405,0.022289,0.11669,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.48117,0.0221,0.10385,0,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.40594,0.022003,0.11906,0,0
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.2998,0.021936,0.069011,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.64051,0.021771,0.056225,0,0
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.37964,0.021731,0.11541,0,0
1,GO HEMIDESMOSOME ASSEMBLY,0.93062,0.021224,0.02331,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.44264,0.02122,0.082194,0,0
1,GO REGULATION OF HEMOPOIESIS,0.86799,0.021173,0.044928,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.98106,0.021119,0.0072005,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.86799,0.021095,0.017357,0,0
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.66333,0.020997,0.061514,0,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.25111,0.020798,0.11833,0,0
1,GO LIPID GLYCOSYLATION,0.52145,0.020716,0.099677,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.93062,0.020697,0.056925,0,0
1,GO CELLULAR HOMEOSTASIS,0.75756,0.020612,0.064774,0,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,0.34626,0.020604,0.097889,0,0
1,GO MULTIVESICULAR BODY ORGANIZATION,0.30724,0.020543,0.061406,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.95582,0.020477,0.041355,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.80618,0.020453,0.071492,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.96843,0.020452,0.061225,0,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.44264,0.02045,0.11133,0,0
1,GO RESPONSE TO REDOX STATE,0.60692,0.020421,0.068563,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.2259,0.020421,0.079501,0,0
1,GO SPERM CAPACITATION,0.50109,0.020113,0.05621,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.3148,0.020008,0.064503,0,0
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.67486,0.019998,0.058272,0,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.43329,0.019855,0.051324,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.27126,0.019749,0.062448,0,0
1,GO CELL CELL ADHESION,0.81845,0.019637,0.077647,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.23827,0.019598,0.17705,0,0
1,GO VIRAL BUDDING,0.40594,0.019507,0.046904,0,0
1,GO ORGANIC ANION TRANSPORT,0.15197,0.019209,0.12436,0,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.36271,0.019152,0.096579,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.27821,0.019135,0.11057,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.61803,0.019127,0.097403,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.70989,0.019122,0.018252,0,0
1,GO PENTOSE METABOLIC PROCESS,0.18102,0.019074,0.094763,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.7336,0.019028,0.076883,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.81845,0.018953,-0.0049589,0,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.47137,0.018848,0.085383,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.79394,0.018785,0.01327,0,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.91805,0.018693,0.059817,0,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.78176,0.018662,-0.056654,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.65188,0.018574,0.043756,0,0
1,GO CHEMICAL HOMEOSTASIS,0.62923,0.018523,0.075164,0,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.52145,0.018509,0.11903,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.69814,0.018484,0.0068352,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.94321,0.018389,0.019003,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.43329,0.018318,0.083144,0,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.81845,0.018217,-0.0017455,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.46168,0.018168,0.099108,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.32248,0.018123,0.068526,0,0
1,GO P38MAPK CASCADE,0.99368,0.018119,0.069753,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.93062,0.018096,-0.0082802,0,0
1,GO AGING,0.36271,0.018092,0.10064,0,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1,0.018026,0.028037,0,0
1,GO TELOMERASE RNA LOCALIZATION,0.21989,0.017953,0.068038,0,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.93062,0.017897,0.014652,0,0
1,GO NATURAL KILLER CELL ACTIVATION,0.84314,0.017888,-0.031734,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.43329,0.017869,0.09814,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.55277,0.017858,0.07873,0,0
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.83078,0.017812,-0.042276,0,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.61803,0.017805,0.093246,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.69814,0.017781,0.059469,0,0
1,GO CELL FATE DETERMINATION,0.46168,0.017714,0.092881,0,0
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.47137,0.017709,0.11915,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.46168,0.017703,0.089514,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.41494,0.017636,0.096055,0,0
1,GO RESPONSE TO ETHANOL,0.56341,0.017542,0.083291,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.7336,0.017518,0.062893,0,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.68646,0.017422,0.073972,0,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.44264,0.017411,0.10086,0,0
1,GO ENDOTHELIAL CELL PROLIFERATION,0.78176,0.017357,0.082711,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.61803,0.017272,0.066784,0,0
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.62923,0.01719,0.072996,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.95582,0.017037,0.020558,0,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.56341,0.016927,0.087386,0,0
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.54223,0.016902,0.09611,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.37964,0.01688,0.068243,0,0
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.37964,0.016809,0.14916,0,0
1,GO REGULATION OF ANION TRANSPORT,0.40594,0.016796,0.091238,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.70989,0.016795,0.046821,0,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.64051,0.016753,0.04324,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.60692,0.016735,0.098457,0,0
1,GO RESPONSE TO DEXAMETHASONE,0.65188,0.016661,0.061821,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.57414,0.016617,0.047397,0,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.62923,0.016438,0.11948,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.58498,0.016351,0.086056,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.55277,0.01618,0.089044,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.56341,0.015928,0.061819,0,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.93062,0.015915,-0.010611,0,0
1,GO BASEMENT MEMBRANE ORGANIZATION,0.65188,0.01585,0.088891,0,0
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.85555,0.015734,0.0041424,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.60692,0.015532,0.098707,0,0
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.54223,0.015374,0.10457,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.90549,0.015368,0.04103,0,0
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.83078,0.015324,0.06201,0,0
1,GO T CELL HOMEOSTASIS,0.84314,0.015238,0.014202,0,0
1,GO B CELL DIFFERENTIATION,0.96843,0.015192,0.022646,0,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.70989,0.015063,0.064935,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.74555,0.015009,0.084865,0,0
1,GO PROTEIN N LINKED GLYCOSYLATION,0.5959,0.014905,0.066472,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.61803,0.014851,0.06765,0,0
1,GO RESPONSE TO DIETARY EXCESS,0.4521,0.01461,0.097489,0,0
1,GO VIRAL GENOME REPLICATION,0.54223,0.014562,0.081331,0,0
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.69814,0.014494,0.050631,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.60692,0.014443,-0.022866,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.57414,0.014313,0.05755,0,0
1,GO REGULATION OF HEART RATE,0.33821,0.014297,0.081828,0,0
1,GO DIET INDUCED THERMOGENESIS,0.46168,0.014163,0.089295,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.91805,0.014112,0.01583,0,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.95582,0.014053,0.019326,0,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.98106,0.01401,0.067825,0,0
1,GO MESODERM MORPHOGENESIS,0.3148,0.013954,0.12282,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.5959,0.01394,0.035659,0,0
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.90549,0.013931,0.034152,0,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.58498,0.013847,0.080249,0,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.39705,0.013688,0.071327,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.7336,0.013625,0.0447,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.69814,0.013501,0.077629,0,0
1,GO HEME METABOLIC PROCESS,0.74555,0.013374,0.049201,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.83078,0.013262,0.047948,0,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.75756,0.013169,0.080375,0,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS,0.66333,0.013153,0.073917,0,0
1,GO RESPONSE TO WATER,0.88046,0.013118,0.0095772,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.32248,0.013096,0.11144,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.88046,0.013005,0.047883,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.74555,0.012391,0.075512,0,0
1,GO REGULATION OF CELLULAR PH,0.66333,0.012379,0.065914,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.96843,0.012213,0.027186,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.60692,0.01212,0.06464,0,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.4521,0.012112,0.11616,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.66333,0.012085,0.086968,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.214,0.011948,0.12464,0,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.85555,0.011659,0.042985,0,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.67486,0.011646,0.055852,0,0
1,GO OSSIFICATION,0.7336,0.011634,0.078649,0,0
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.64051,0.011628,0.068326,0,0
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.7336,0.011588,0.074526,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.41494,0.011537,0.091733,0,0
1,GO ANION HOMEOSTASIS,0.37964,0.011486,0.11313,0,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.79394,0.011327,0.06146,0,0
1,GO LIPID METABOLIC PROCESS,0.28529,0.011326,0.092949,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.96843,0.011295,0.061208,0,0
1,GO GASTRIC ACID SECRETION,0.46168,0.011161,0.054068,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.95582,0.011134,0.01952,0,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.74555,0.011127,0.089843,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.42405,0.010951,0.080327,0,0
1,GO SECRETION,0.98106,0.01094,0.051492,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.91805,0.010832,0.019978,0,0
1,GO GASTRULATION,0.40594,0.010791,0.11627,0,0
1,GO REGENERATION,0.72171,0.010685,0.070675,0,0
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.86799,0.010593,-0.028903,0,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.60692,0.010539,0.069225,0,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.86799,0.010529,0.011483,0,0
1,GO ORGANELLE INHERITANCE,0.27126,0.01043,0.10184,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.7336,0.010363,0.071483,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.4521,0.010254,0.087794,0,0
1,GO SECRETION BY TISSUE,0.68646,0.010079,0.043941,0,0
1,GO RELAXATION OF MUSCLE,0.84314,0.010073,0.015589,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.54223,0.010001,0.074984,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.43329,0.0099602,0.12639,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.90549,0.009862,0.022687,0,0
1,GO TRANSLATIONAL ELONGATION,0.75756,0.0097887,0.013801,0,0
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.81845,0.0097615,0.018699,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.88046,0.009565,0.077703,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.70989,0.0094302,0.088891,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.88046,0.0093989,0.030967,0,0
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.98106,0.0093346,0.044721,0,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.4521,0.0091662,0.065567,0,0
1,GO RESPONSE TO ALCOHOL,0.72171,0.0090301,0.072892,0,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.42405,0.0090119,0.062073,0,0
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.88046,0.0089582,0.039458,0,0
1,GO PLACENTA DEVELOPMENT,0.27821,0.0089519,0.13141,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.84314,0.0089512,0.049048,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.75756,0.0088918,0.013704,0,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.74555,0.0086926,-0.059933,0,0
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.41494,0.0085759,0.10742,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.52145,0.00846,0.087865,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.70989,0.008292,-0.00048481,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.65188,0.0082625,0.06099,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.88046,0.0082235,0.045832,0,0
1,GO NEGATIVE REGULATION OF GROWTH,0.50109,0.0082038,0.091945,0,0
1,GO EPIDERMIS DEVELOPMENT,0.33029,0.0081295,0.090053,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.80618,0.0080591,-0.0017114,0,0
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.84314,0.0079407,0.014225,0,0
1,GO SKELETAL MUSCLE TISSUE REGENERATION,0.76963,0.0079198,0.026833,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.47137,0.0079055,0.078173,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.62923,0.0078873,0.086898,0,0
1,GO FATTY ACID METABOLIC PROCESS,0.56341,0.0078663,0.063323,0,0
1,GO RESPONSE TO ATP,0.98106,0.0078483,0.027199,0,0
1,GO RESPONSE TO OSMOTIC STRESS,0.49108,0.0077497,0.085578,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.84314,0.0076099,0.067612,0,0
1,GO RESPONSE TO METAL ION,0.65188,0.0075788,0.064515,0,0
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.70989,0.0075,0.039551,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.72171,0.0074632,0.068582,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.88046,0.0073918,0.053937,0,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.98106,0.0073834,0.048739,0,0
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.75756,0.0073262,0.042758,0,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.66333,0.0072864,0.086865,0,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.68646,0.0072787,0.064815,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.93062,0.0072139,0.020455,0,0
1,GO TISSUE HOMEOSTASIS,0.96843,0.0071673,0.058696,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.95582,0.0071555,0.0034404,0,0
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.65188,0.0070573,0.040512,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.61803,0.0070093,0.11699,0,0
1,GO LUTEINIZATION,0.65188,0.0069499,0.096139,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.96843,0.0069498,0.029326,0,0
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.79394,0.0068774,0.04708,0,0
1,GO TRANSFERRIN TRANSPORT,0.96843,0.0068361,0.042298,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.64051,0.0068264,0.077915,0,0
1,GO I KAPPAB PHOSPHORYLATION,0.86799,0.0068127,-0.0052638,0,0
1,GO GLYCINE TRANSPORT,0.68646,0.0067947,0.085024,0,0
1,GO LIPID STORAGE,0.47137,0.0067174,0.097861,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.67486,0.0065464,0.049306,0,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.39705,0.006416,0.084247,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.93062,0.0063897,0.035256,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.27126,0.0063602,0.086044,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.62923,0.0062247,0.09172,0,0
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.80618,0.0061308,0.022318,0,0
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.93062,0.0060723,0.039496,0,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.72171,0.0060329,0.078032,0,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,0.7336,0.0059036,0.08721,0,0
1,GO CELLULAR RESPONSE TO VIRUS,0.58498,0.0058338,0.082018,0,0
1,GO RETINOL METABOLIC PROCESS,0.93062,0.0057357,-0.014876,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.85555,0.0056973,0.036426,0,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.84314,0.0056773,-0.016555,0,0
1,GO AMINO SUGAR METABOLIC PROCESS,0.89296,0.0056378,0.039674,0,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.44264,0.0056216,0.073708,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.50109,0.005494,0.030371,0,0
1,GO CELLULAR RESPIRATION,0.94321,0.0053696,0.0079393,0,0
1,GO SLEEP,0.69814,0.0053209,0.022508,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62923,0.0053031,0.008202,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.37964,0.0052239,0.088964,0,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.88046,0.0051103,0.019211,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.90549,0.0049186,0.014312,0,0
1,GO ENDOCYTOSIS,0.69814,0.0048254,0.084534,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.41494,0.0048129,0.075665,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.81845,0.0047751,0.085317,0,0
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.48117,0.0046751,0.099816,0,0
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.83078,0.0046312,0.072003,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.48117,0.0044493,-0.032122,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.67486,0.0043819,0.073866,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.69814,0.004287,0.073448,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.96843,0.0042561,0.065579,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.56341,0.0042265,0.088711,0,0
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.96843,0.004173,0.036596,0,0
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.75756,0.004166,-0.020878,0,0
1,GO BONE DEVELOPMENT,0.62923,0.0041198,0.10284,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.93062,0.0041071,-0.0041715,0,0
1,GO RESPONSE TO MURAMYL DIPEPTIDE,0.88046,0.0039057,0.053601,0,0
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.65188,0.0037566,0.095281,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.70989,0.0036907,-1.8028e-06,0,0
1,GO SEROTONIN SECRETION,0.64051,0.0035109,0.047167,0,0
1,GO VIRAL LIFE CYCLE,0.88046,0.0034909,0.058798,0,0
1,GO TRANSITION METAL ION TRANSPORT,0.94321,0.0033614,0.022902,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.38829,0.003305,0.11304,0,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.33029,0.0032524,0.10924,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.53179,0.0032321,0.046147,0,0
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.94321,0.0032122,0.006418,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.88046,0.00315,0.051539,0,0
1,GO AMYLOID BETA FORMATION,0.3148,0.0031055,0.1257,0,0
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.84314,0.0030837,0.043342,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.54223,0.0028811,0.10234,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.83078,0.0028484,0.048917,0,0
1,GO CELLULAR RESPONSE TO ATP,0.83078,0.0027526,0.049349,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.95582,0.002713,0.028172,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.61803,0.002483,0.057042,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.96843,0.0023677,0.0096718,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.93062,0.0022662,0.024795,0,0
1,GO TRANSLATIONAL INITIATION,0.98106,0.002128,0.0078577,0,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.93062,0.0021063,-0.0034372,0,0
1,GO RESPONSE TO OXYGEN LEVELS,0.88046,0.0020797,0.053192,0,0
1,GO GLIAL CELL PROLIFERATION,0.96843,0.0020301,0.029168,0,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.49108,0.001841,0.06211,0,0
1,GO REGULATION OF VIRAL GENOME REPLICATION,0.72171,0.0015452,0.057844,0,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.7336,0.0015228,0.074654,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.69814,0.0011673,0.069198,0,0
1,GO LIPID LOCALIZATION,0.57414,0.0011383,0.072984,0,0
1,GO REGULATION OF RELAXATION OF MUSCLE,0.93062,0.0011378,-0.018253,0,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.62923,0.00099142,0.078251,0,0
1,GO TRNA 5 LEADER REMOVAL,0.69814,0.00097085,-0.016398,0,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.75756,0.00065158,0.043771,0,0
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.93062,0.0004946,0.014821,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.40594,0.00048317,0.071443,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.66333,0.0004234,0.050847,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.67486,0.00030733,-0.022191,0,0
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.74555,0.00016526,0.01663,0,0
1,GO CELLULAR RESPONSE TO ETHANOL,0.95582,2.7738e-05,0.010731,0,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.57414,-6.6278e-05,0.088783,0,0
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.81845,-0.0001796,0.017068,0,0
1,GO MYELOID CELL DEVELOPMENT,0.76963,-0.00020172,0.026035,0,0
1,GO RESPONSE TO TUMOR CELL,0.98106,-0.00021687,0.00045528,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.51122,-0.00028972,0.071665,0,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.88046,-0.00039505,0.041057,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.84314,-0.00049632,0.017481,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.96843,-0.0005382,0.034537,0,0
1,GO TERPENOID METABOLIC PROCESS,0.3148,-0.00056765,0.083391,0,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.66333,-0.00076404,0.057292,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.46168,-0.00083985,0.16773,0,0
1,GO REGULATION OF PH,0.64051,-0.00096098,0.062693,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.80618,-0.00096975,0.053354,0,0
1,GO LIVER MORPHOGENESIS,0.81845,-0.0010222,0.051103,0,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76963,-0.0010312,0.059227,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.2577,-0.0010394,0.10016,0,0
1,GO REGULATION OF GASTRULATION,1,-0.0011115,0.036229,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.98106,-0.0012014,0.07458,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.37964,-0.0012024,0.11183,0,0
1,GO ENDOCARDIAL CUSHION FORMATION,0.85555,-0.0012028,0.059305,0,0
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.86799,-0.001496,0.032206,0,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.70989,-0.0015045,0.067587,0,0
1,GO CELL MOTILITY,0.76963,-0.0015815,0.085181,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.72171,-0.0016733,0.047309,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.36271,-0.0016913,-0.041058,0,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.81845,-0.0016993,0.038977,0,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.94321,-0.0018317,0.024808,0,0
1,GO GLIAL CELL APOPTOTIC PROCESS,0.84314,-0.0018335,0.057424,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.74555,-0.0020274,0.058876,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.84314,-0.0020406,0.051694,0,0
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.74555,-0.0021035,-0.0066598,0,0
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.70989,-0.0021166,-0.079153,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.70989,-0.0023433,0.064013,0,0
1,GO ION HOMEOSTASIS,0.93062,-0.0028923,0.048056,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.86799,-0.0028978,0.046565,0,0
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.86799,-0.0031083,0.0080132,0,0
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.75756,-0.0031173,0.041253,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.86799,-0.0032173,0.00014891,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.93062,-0.0032245,0.051897,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.86799,-0.003331,0.069714,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.60692,-0.0034001,-0.021126,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.95582,-0.003412,-0.017989,0,0
1,GO ENDODERM DEVELOPMENT,0.7336,-0.0036031,0.087941,0,0
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.62923,-0.0037964,-0.093922,0,0
1,GO RESPONSE TO INTERLEUKIN 12,0.76963,-0.0038473,-0.0071125,0,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.99368,-0.0040184,0.032247,0,0
1,GO TRANSEPITHELIAL TRANSPORT,0.74555,-0.0041024,0.043192,0,0
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.66333,-0.0044022,-0.06429,0,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.88046,-0.0044696,0.061713,0,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.50109,-0.0045206,0.093392,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.44264,-0.0045731,-0.069819,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.91805,-0.0045997,0.024438,0,0
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.96843,-0.00465,0.074424,0,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.86799,-0.004682,0.07536,0,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.80618,-0.0046934,0.051019,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.62923,-0.0047782,0.0042334,0,0
1,GO DIGESTION,0.78176,-0.0048332,0.042213,0,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.72171,-0.0049872,0.083133,0,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.83078,-0.0051676,0.080623,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.42405,-0.0051895,0.12178,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.98106,-0.0052323,0.026522,0,0
1,GO B CELL ACTIVATION,0.78176,-0.0053216,-0.026842,0,0
1,GO LEUKOCYTE DIFFERENTIATION,0.90549,-0.005341,-0.0031957,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.86799,-0.0055589,0.06884,0,0
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.95582,-0.0060801,0.0031018,0,0
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.57414,-0.0060871,0.095941,0,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.95582,-0.006314,0.052253,0,0
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.70989,-0.0063753,0.03757,0,0
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.89296,-0.0065578,0.051335,0,0
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.61803,-0.0071457,0.065209,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.70989,-0.007454,0.010805,0,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.57414,-0.0074601,0.10181,0,0
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.49108,-0.0075136,0.054573,0,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.64051,-0.007552,0.068482,0,0
1,GO AORTA DEVELOPMENT,0.85555,-0.007596,0.08902,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.80618,-0.0076789,0.021471,0,0
1,GO REGULATION OF VACUOLE ORGANIZATION,0.58498,-0.0078967,0.089254,0,0
1,GO NADP METABOLIC PROCESS,0.81845,-0.0079124,0.039563,0,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.50109,-0.0079354,0.069893,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.69814,-0.0080994,0.0068535,0,0
1,GO RESPONSE TO FATTY ACID,0.95582,-0.008492,0.042463,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.86799,-0.0085008,0.021116,0,0
1,GO HEAD MORPHOGENESIS,0.93062,-0.0085138,0.055944,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.58498,-0.00862,0.04641,0,0
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.7336,-0.0086287,0.094371,0,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.95582,-0.0086407,0.056573,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.95582,-0.0086658,0.009928,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.88046,-0.0086938,-0.013083,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.48117,-0.0087448,0.094037,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.67486,-0.008971,0.06843,0,0
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.80618,-0.0089921,0.051204,0,0
1,GO SALIVARY GLAND DEVELOPMENT,0.5959,-0.0090299,0.10299,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.76963,-0.0090888,-0.032868,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.37964,-0.0091332,0.074909,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.72171,-0.0093139,0.022422,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.94321,-0.0093304,0.035226,0,0
1,GO SMOOTH MUSCLE CELL MIGRATION,0.88046,-0.0096194,0.077399,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.70989,-0.009654,0.070301,0,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.60692,-0.0099241,-0.059004,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.96843,-0.0099314,0.0086768,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.85555,-0.0099908,0.050706,0,0
1,GO RIG I SIGNALING PATHWAY,0.47137,-0.010009,0.081559,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.88046,-0.010106,0.008667,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.86799,-0.010208,0.064111,0,0
1,GO RETINAL METABOLIC PROCESS,0.83078,-0.010216,0.028328,0,0
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.61803,-0.010271,0.056359,0,0
1,GO CELLULAR RESPONSE TO SALT STRESS,0.95582,-0.010326,0.038991,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.68646,-0.010396,-0.011279,0,0
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.86799,-0.010397,0.065608,0,0
1,GO MODULATION BY HOST OF VIRAL PROCESS,0.96843,-0.010442,0.032143,0,0
1,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.80618,-0.010893,-0.032783,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.81845,-0.011056,0.084736,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.56341,-0.011085,0.096181,0,0
1,GO REGULATION OF MAPK CASCADE,0.84314,-0.011114,0.075653,0,0
1,GO HEART FIELD SPECIFICATION,0.99368,-0.01116,0.064564,0,0
1,GO REGULATION OF LIPID TRANSPORT,0.60692,-0.011251,0.059901,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.98106,-0.011301,0.016249,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.90549,-0.011317,-0.013774,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.96843,-0.011399,0.043059,0,0
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.65188,-0.011472,-0.087179,0,0
1,GO TISSUE REGENERATION,0.94321,-0.011488,0.035149,0,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.67486,-0.01161,-0.029439,0,0
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.98106,-0.011729,0.043258,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.80618,-0.011843,0.0035466,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.84314,-0.011869,0.0059429,0,0
1,GO AUTOPHAGIC CELL DEATH,0.75756,-0.011885,0.0045271,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.65188,-0.0121,0.083783,0,0
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.56341,-0.012291,-0.11595,0,0
1,GO T CELL DIFFERENTIATION,0.91805,-0.012308,-0.016944,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.57414,-0.012353,0.079733,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.79394,-0.012628,0.0031964,0,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1,-0.012646,0.048048,0,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.95582,-0.012698,0.060429,0,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.67486,-0.012854,0.035849,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.93062,-0.013028,0.014749,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.85555,-0.013112,0.013298,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.56341,-0.013183,0.093492,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.78176,-0.013314,0.04711,0,0
1,GO ZINC ION TRANSPORT,0.91805,-0.013594,0.028668,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.96843,-0.013601,0.044343,0,0
1,GO PROTEIN MATURATION,0.76963,-0.013618,0.053146,0,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.83078,-0.013629,-0.012001,0,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.91805,-0.013714,0.079036,0,0
1,GO THYMOCYTE APOPTOTIC PROCESS,0.89296,-0.01377,-0.0086902,0,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.57414,-0.013831,-0.013143,0,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.95582,-0.013856,0.062833,0,0
1,GO CHOLESTEROL EFFLUX,0.70989,-0.01387,0.05091,0,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.78176,-0.013922,0.070778,0,0
1,GO ENDOTHELIUM DEVELOPMENT,0.98106,-0.013979,0.061874,0,0
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.88046,-0.014024,0.037626,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.81845,-0.014091,-0.006869,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,1,-0.014212,0.025432,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.67486,-0.01422,0.091576,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.65188,-0.014387,-0.064182,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.90549,-0.014392,0.030502,0,0
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.93062,-0.0146,0.032138,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.88046,-0.014742,0.0531,0,0
1,GO TRNA 5 END PROCESSING,0.81845,-0.015005,0.0041428,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.78176,-0.015091,0.020845,0,0
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.84314,-0.015129,0.034748,0,0
1,GO EPIBOLY,0.89296,-0.015138,0.069481,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.95582,-0.0153,0.011331,0,0
1,GO DEFENSE RESPONSE TO VIRUS,0.95582,-0.015362,0.016525,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.80618,-0.015374,0.013701,0,0
1,GO REGULATION OF STEROL TRANSPORT,0.99368,-0.015456,0.017861,0,0
1,GO REGULATION OF OSSIFICATION,0.70989,-0.015665,0.080567,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.72171,-0.0158,0.046337,0,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.66333,-0.015997,0.045847,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.95582,-0.016008,0.039539,0,0
1,GO CARTILAGE DEVELOPMENT,0.74555,-0.016024,0.075473,0,0
1,GO BIOLOGICAL ADHESION,0.95582,-0.016061,0.067883,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.85555,-0.016101,-0.0023419,0,0
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.72171,-0.016175,0.07138,0,0
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.64051,-0.016242,0.080869,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.96843,-0.016607,0.034115,0,0
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.65188,-0.016702,-0.11976,0,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.64051,-0.016789,-0.0042254,0,0
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.81845,-0.016811,0.069602,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.39705,-0.016823,0.1634,0,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.91805,-0.017301,0.0061795,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.85555,-0.017378,0.039405,0,0
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.95582,-0.017433,0.082727,0,0
1,GO FC RECEPTOR SIGNALING PATHWAY,0.90549,-0.017464,0.020139,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.62923,-0.017551,0.064749,0,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.79394,-0.017687,0.07797,0,0
1,GO NIK NF KAPPAB SIGNALING,0.88046,-0.017732,0.026056,0,0
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.80618,-0.017747,0.040074,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.83078,-0.017763,0.052816,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.84314,-0.017887,0.075458,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.96843,-0.0181,0.007055,0,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.90549,-0.018182,0.017341,0,0
1,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.61803,-0.018184,-0.11904,0,0
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.66333,-0.018306,0.012821,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.94321,-0.018682,0.02268,0,0
1,GO GLIAL CELL MIGRATION,0.7336,-0.018712,0.02111,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.78176,-0.018839,0.0044272,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.78176,-0.018932,0.049552,0,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.84314,-0.018986,0.054152,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.91805,-0.019012,0.056649,0,0
1,GO MAINTENANCE OF LOCATION,0.93062,-0.019141,0.063614,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.5959,-0.019263,0.0016005,0,0
1,GO ASTROCYTE DIFFERENTIATION,0.89296,-0.019322,0.030263,0,0
1,GO CARBOHYDRATE TRANSPORT,0.38829,-0.019323,0.084359,0,0
1,GO PROTEIN KINASE B SIGNALING,0.96843,-0.019592,0.044671,0,0
1,GO MESENCHYME MORPHOGENESIS,0.64051,-0.019663,0.0010215,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.68646,-0.019712,0.10815,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.96843,-0.019731,0.059267,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.58498,-0.019751,0.062827,0,0
1,GO AEROBIC RESPIRATION,0.56341,-0.019833,-0.0022325,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.33821,-0.01991,0.056268,0,0
1,GO PLATELET MORPHOGENESIS,0.85555,-0.020269,0.056751,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.93062,-0.020462,0.029547,0,0
1,GO REGULATION OF CELL MATRIX ADHESION,0.74555,-0.020487,0.11101,0,0
1,GO CELLULAR RESPONSE TO LIPID,0.76963,-0.020602,0.070993,0,0
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.86799,-0.020735,0.023484,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.83078,-0.020829,0.030645,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.94321,-0.02089,0.040537,0,0
1,GO HYPOTONIC RESPONSE,0.86799,-0.020993,0.069051,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.93062,-0.021029,0.033054,0,0
1,GO HEART TRABECULA FORMATION,0.4521,-0.021043,-0.072628,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.65188,-0.021372,-0.064184,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.81845,-0.021383,0.021715,0,0
1,GO TRABECULA MORPHOGENESIS,0.99368,-0.021465,0.035851,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.99368,-0.021523,0.054283,0,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.95582,-0.02154,0.067089,0,0
1,GO REGULATION OF ANOIKIS,0.66333,-0.021595,0.092594,0,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.98106,-0.021784,0.0058698,0,0
1,GO DNA DEAMINATION,0.48117,-0.021869,-0.062735,0,0
1,GO VASCULATURE DEVELOPMENT,0.83078,-0.021957,0.052876,0,0
1,GO REGULATION OF SYMBIOTIC PROCESS,0.90549,-0.022051,0.031058,0,0
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.5959,-0.022065,-0.0095818,0,0
1,GO EXOCYTOSIS,0.65188,-0.0221,0.018805,0,0
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.75756,-0.022228,0.039713,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.67486,-0.02228,-0.012375,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,1,-0.022386,0.0086553,0,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.96843,-0.022501,0.044756,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.74555,-0.022641,-0.068957,0,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.94321,-0.022708,0.03851,0,0
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.85555,-0.022761,0.015371,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.96843,-0.022845,0.014221,0,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.68646,-0.022864,0.0049207,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.81845,-0.023252,0.00049234,0,0
1,GO HOMOTYPIC CELL CELL ADHESION,0.96843,-0.023311,0.049625,0,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.69814,-0.023444,0.070177,0,0
1,GO ACTIN NUCLEATION,0.95582,-0.023479,0.054651,0,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.96843,-0.023558,0.019392,0,0
1,GO REGULATION OF PROTEOLYSIS,0.88046,-0.023777,0.059107,0,0
1,GO CELL RECOGNITION,0.76963,-0.023923,0.027703,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.79394,-0.024093,0.055946,0,0
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.81845,-0.024101,0.047964,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.75756,-0.024178,0.1027,0,0
1,GO RESPONSE TO PAIN,0.52145,-0.024257,0.070113,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.7336,-0.024409,0.044627,0,0
1,GO VIRION ASSEMBLY,0.66333,-0.024626,0.013028,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.62923,-0.024772,0.0059879,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.91805,-0.024776,0.034442,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.99368,-0.024801,0.0040867,0,0
1,GO LYSOSOME LOCALIZATION,0.94321,-0.02491,0.022205,0,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.84314,-0.024943,0.04177,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.83078,-0.025054,-0.029692,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.88046,-0.025087,0.077207,0,0
1,GO INTERACTION WITH SYMBIONT,0.85555,-0.0251,0.0083004,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.78176,-0.025302,-0.02155,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.85555,-0.02561,0.040346,0,0
1,GO CELL SUBSTRATE ADHESION,0.94321,-0.025665,0.073309,0,0
1,GO REGULATION OF VIRAL LIFE CYCLE,0.88046,-0.025732,0.030952,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.79394,-0.02576,0.042273,0,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.76963,-0.025837,0.04652,0,0
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.74555,-0.026267,-0.059577,0,0
1,GO METAL ION HOMEOSTASIS,0.91805,-0.026277,0.031167,0,0
1,GO RESPONSE TO VIRUS,0.95582,-0.026606,0.009291,0,0
1,GO UTP METABOLIC PROCESS,1,-0.026664,0.0013236,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.76963,-0.02667,0.037585,0,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.68646,-0.026685,-0.020954,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.81845,-0.027074,0.016701,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.86799,-0.027119,-0.020977,0,0
1,GO FORMATION OF PRIMARY GERM LAYER,0.96843,-0.027221,0.059755,0,0
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.86799,-0.027331,0.070441,0,0
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.79394,-0.027462,0.035733,0,0
1,GO OVULATION,0.70989,-0.027515,-0.016519,0,0
1,GO REGULATION OF VASOCONSTRICTION,0.79394,-0.027759,0.092892,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.55277,-0.02796,0.093916,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.52145,-0.028011,-0.058913,0,0
1,GO REGULATION OF TUBE SIZE,0.5959,-0.028168,0.07206,0,0
1,GO RESPONSE TO KETONE,1,-0.028177,0.055962,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.62923,-0.028429,-0.027514,0,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.60692,-0.028695,0.065067,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.64051,-0.028703,-0.017163,0,0
1,GO RESPONSE TO ESTROGEN,0.94321,-0.028715,0.03662,0,0
1,GO FATTY ACID TRANSPORT,0.81845,-0.028755,0.04578,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.33029,-0.028789,-0.02282,0,0
1,GO MAINTENANCE OF LOCATION IN CELL,0.69814,-0.02887,0.020135,0,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.98106,-0.028999,0.027549,0,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.89296,-0.029294,0.064957,0,0
1,GO PROTEIN NITROSYLATION,0.44264,-0.029311,-0.069007,0,0
1,GO PHAGOCYTOSIS RECOGNITION,0.85555,-0.029425,-0.022525,0,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.68646,-0.029485,0.088662,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.61803,-0.02955,0.012762,0,0
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.96843,-0.029587,0.063265,0,0
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.75756,-0.029661,0.074795,0,0
1,GO INTERACTION WITH HOST,0.89296,-0.029682,0.05211,0,0
1,GO REGULATION OF LIPID LOCALIZATION,0.52145,-0.029766,0.076139,0,0
1,GO RESPONSE TO ANTIBIOTIC,0.86799,-0.029918,0.036826,0,0
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.47137,-0.029974,-0.0945,0,0
1,GO GLOMERULUS DEVELOPMENT,0.96843,-0.030086,0.045781,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.81845,-0.030177,-0.0030137,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.91805,-0.030297,0.021436,0,0
1,GO BLOOD VESSEL MORPHOGENESIS,0.72171,-0.030689,0.040846,0,0
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.74555,-0.030789,-0.012951,0,0
1,GO BLASTODERM SEGMENTATION,0.36271,-0.03088,0.096364,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.84314,-0.030949,0.050872,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.42405,-0.031169,-0.038104,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.75756,-0.031339,-0.017397,0,0
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.99368,-0.031546,0.054128,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.70989,-0.0316,-0.02892,0,0
1,GO LYMPHOCYTE ACTIVATION,0.74555,-0.031721,-0.033349,0,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.65188,-0.031749,-0.067096,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.96843,-0.031803,0.057101,0,0
1,GO TAXIS,0.90549,-0.031925,0.072953,0,0
1,GO VITAMIN METABOLIC PROCESS,0.90549,-0.032177,0.033989,0,0
1,GO ANIMAL ORGAN REGENERATION,1,-0.032182,0.038229,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.56341,-0.032309,0.15993,0,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.64051,-0.03257,0.011726,0,0
1,GO AMINOGLYCAN METABOLIC PROCESS,0.81845,-0.032755,0.059596,0,0
1,GO MACROPHAGE DIFFERENTIATION,0.79394,-0.032785,-0.02355,0,0
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.90549,-0.032795,0.013863,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.80618,-0.033093,0.023512,0,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.75756,-0.033174,0.016313,0,0
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.67486,-0.033216,0.047067,0,0
1,GO FIBROBLAST PROLIFERATION,0.88046,-0.033223,0.072147,0,0
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.54223,-0.033275,-0.05283,0,0
1,GO RESPONSE TO RETINOIC ACID,0.81845,-0.033281,0.065225,0,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.43329,-0.033388,-0.063786,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.81845,-0.033521,0.05105,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.86799,-0.03365,0.026345,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.72171,-0.033712,-0.00076966,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.91805,-0.033719,0.00092403,0,0
1,GO AMINE METABOLIC PROCESS,0.65188,-0.03378,0.0496,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.98106,-0.033995,0.029164,0,0
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.51122,-0.034057,-0.041722,0,0
1,GO REGULATION OF GLOMERULAR FILTRATION,0.86799,-0.034071,0.016963,0,0
1,GO SUPEROXIDE METABOLIC PROCESS,0.4521,-0.03443,-0.02505,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.94321,-0.034431,0.026607,0,0
1,GO OSTEOCLAST DIFFERENTIATION,0.79394,-0.034676,0.0012203,0,0
1,GO APOPTOTIC SIGNALING PATHWAY,0.95582,-0.0347,0.049537,0,0
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.81845,-0.034815,-0.0089141,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.78176,-0.034847,0.018539,0,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.95582,-0.03488,-0.00079964,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.88046,-0.035106,0.030435,0,0
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.61803,-0.035191,-0.089572,0,0
1,GO BONE MINERALIZATION,0.7336,-0.035384,0.028013,0,0
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.94321,-0.035484,0.012124,0,0
1,GO ATP BIOSYNTHETIC PROCESS,0.49108,-0.035695,-0.055534,0,0
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.46168,-0.035757,-0.044866,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.58498,-0.035986,-0.078971,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.84314,-0.035988,0.034545,0,0
1,GO BRONCHUS DEVELOPMENT,0.78176,-0.03617,0.087479,0,0
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.76963,-0.036216,0.0077608,0,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.57414,-0.03628,-0.032461,0,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.91805,-0.036355,0.064864,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.72171,-0.036431,0.028017,0,0
1,GO AMP METABOLIC PROCESS,0.52145,-0.036453,-0.032683,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.57414,-0.03648,0.099055,0,0
1,GO ARTERY MORPHOGENESIS,0.95582,-0.036706,0.050373,0,0
1,GO IRON ION TRANSPORT,0.7336,-0.036893,0.014297,0,0
1,GO DIGESTIVE SYSTEM PROCESS,0.86799,-0.036959,0.040244,0,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.74555,-0.037069,-0.033611,0,0
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.89296,-0.03707,0.038794,0,0
1,GO POSITIVE REGULATION OF LIPID STORAGE,0.65188,-0.037122,0.085828,0,0
1,GO SPERM EGG RECOGNITION,0.78176,-0.037341,-0.0057239,0,0
1,GO RESPONSE TO AMYLOID BETA,0.76963,-0.037368,0.03438,0,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.52145,-0.037373,-0.10801,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.72171,-0.037438,0.003722,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.67486,-0.037532,0.057934,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.75756,-0.037635,0.0014337,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.65188,-0.037881,-0.0074593,0,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.48117,-0.037888,-0.05866,0,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67486,-0.037941,0.022448,0,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.94321,-0.038039,0.05295,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.94321,-0.038373,0.034454,0,0
1,GO RESPONSE TO ISCHEMIA,0.81845,-0.038495,0.023976,0,0
1,GO RESPONSE TO THYROID HORMONE,0.85555,-0.038546,0.0063698,0,0
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.48117,-0.038629,-0.03338,0,0
1,GO IMMUNOGLOBULIN PRODUCTION,0.67486,-0.038651,-0.032129,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.72171,-0.038797,0.022183,0,0
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.62923,-0.038803,-0.090703,0,0
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.72171,-0.03881,0.043259,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.72171,-0.03885,-0.00089391,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.85555,-0.038874,0.079828,0,0
1,GO BIOMINERALIZATION,0.98106,-0.038884,0.05009,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.85555,-0.038939,0.039121,0,0
1,GO GAS TRANSPORT,0.50109,-0.038966,-0.063659,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.86799,-0.039199,0.054311,0,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.81845,-0.039234,0.010511,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.80618,-0.03929,0.035759,0,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.61803,-0.039376,-0.077224,0,0
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.89296,-0.039516,0.064779,0,0
1,GO ARGININE METABOLIC PROCESS,0.89296,-0.039572,0.020457,0,0
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.7336,-0.03958,0.032096,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.66333,-0.039589,0.049602,0,0
1,GO RESPONSE TO VITAMIN D,0.96843,-0.039917,0.022578,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.84314,-0.039945,0.073789,0,0
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.70989,-0.039956,0.0071034,0,0
1,GO TISSUE MIGRATION,0.80618,-0.040203,0.040809,0,0
1,GO REGULATION OF BODY FLUID LEVELS,0.95582,-0.040358,0.049856,0,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.94321,-0.04037,0.046805,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.98106,-0.040405,0.020349,0,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.7336,-0.0405,0.0064692,0,0
1,GO GLYCINE METABOLIC PROCESS,0.70989,-0.040855,-0.012968,0,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.57414,-0.041168,-0.01277,0,0
1,GO REGULATION OF CELL ADHESION,0.74555,-0.041168,0.014964,0,0
1,GO ALPHA BETA T CELL ACTIVATION,0.7336,-0.041316,-0.06784,0,0
1,GO PARAXIAL MESODERM DEVELOPMENT,0.66333,-0.041503,0.074048,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.86799,-0.041537,-0.002694,0,0
1,GO TRANSLATIONAL TERMINATION,0.41494,-0.041554,-0.022463,0,0
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.61803,-0.041654,-0.072533,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.61803,-0.041836,-0.0041542,0,0
1,GO OSTEOBLAST PROLIFERATION,0.79394,-0.041911,0.045786,0,0
1,GO STEROID ESTERIFICATION,0.57414,-0.042023,-0.038136,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29248,-0.04205,-0.030255,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.68646,-0.042181,-0.014078,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.81845,-0.04225,-0.016131,0,0
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.86799,-0.042301,0.051557,0,0
1,GO RESPONSE TO NUTRIENT,0.95582,-0.042367,0.045765,0,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.68646,-0.04242,0.013716,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.78176,-0.042477,-0.015684,0,0
1,GO RESPONSE TO LITHIUM ION,0.7336,-0.042637,0.054802,0,0
1,GO CERAMIDE CATABOLIC PROCESS,0.47137,-0.042846,0.0083663,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.70989,-0.042863,-0.0083073,0,0
1,GO CELL CELL JUNCTION MAINTENANCE,0.94321,-0.042999,0.064504,0,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.64051,-0.043087,0.011502,0,0
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.98106,-0.043121,0.035805,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.96843,-0.043336,0.036505,0,0
1,GO VACUOLAR ACIDIFICATION,0.34626,-0.043469,-0.01958,0,0
1,GO PH REDUCTION,0.69814,-0.043725,0.015692,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.85555,-0.044092,0.061215,0,0
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.61803,-0.044175,-0.0015147,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.86799,-0.044321,0.030478,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.56341,-0.044389,-0.0017776,0,0
1,GO L SERINE METABOLIC PROCESS,0.96843,-0.044448,0.01815,0,0
1,GO PEPTIDYL TYROSINE MODIFICATION,0.93062,-0.044524,0.062223,0,0
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.95582,-0.044639,0.036112,0,0
1,GO RESPONSE TO OXIDATIVE STRESS,0.80618,-0.044665,0.036655,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,0.89296,-0.044704,0.036814,0,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.66333,-0.044827,-0.072167,0,0
1,GO RESPONSE TO WOUNDING,0.88046,-0.045122,0.044946,0,0
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.81845,-0.045123,-0.0066765,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.75756,-0.045246,0.043705,0,0
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.93062,-0.045356,0.053088,0,0
1,GO REGULATION OF NECROTIC CELL DEATH,0.51122,-0.045656,-0.019404,0,0
1,GO RESPONSE TO DSRNA,0.88046,-0.04584,0.045301,0,0
1,GO RENAL ABSORPTION,0.89296,-0.04584,0.014924,0,0
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.70989,-0.04585,0.020306,0,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.65188,-0.045935,-0.037389,0,0
1,GO WOUND HEALING,0.81845,-0.046051,0.03338,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.66333,-0.046186,-0.030156,0,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.90549,-0.046207,-0.015291,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.88046,-0.046316,0.030462,0,0
1,GO IRON ION HOMEOSTASIS,0.7336,-0.046541,0.010506,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.75756,-0.047103,0.001439,0,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.5959,-0.047325,0.0014916,0,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.52145,-0.04736,0.0035505,0,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.7336,-0.047372,-0.010247,0,0
1,GO PROTEASOME ASSEMBLY,0.96843,-0.04768,0.018563,0,0
1,GO CELL ACTIVATION,0.58498,-0.047794,-0.039473,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.5959,-0.047814,-0.089057,0,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.61803,-0.047894,-0.049084,0,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.79394,-0.047936,0.022945,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.68646,-0.048023,0.06629,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.70989,-0.048037,0.00038325,0,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.51122,-0.048267,-0.011726,0,0
1,GO RESPONSE TO MINERALOCORTICOID,0.55277,-0.048297,-0.027205,0,0
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.81845,-0.048644,-0.0096776,0,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.74555,-0.048667,0.025177,0,0
1,GO RENAL FILTRATION,0.49108,-0.048858,0.15189,0,0
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.7336,-0.048969,-0.0060226,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.5959,-0.048977,0.078528,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.79394,-0.049228,0.029644,0,0
1,GO MEMBRANE PROTEIN PROTEOLYSIS,0.85555,-0.049277,0.03038,0,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.84314,-0.049347,0.019251,0,0
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.70989,-0.049838,-0.02125,0,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.28529,-0.049855,-0.046351,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.44264,-0.049915,-0.0084246,0,0
1,GO MULTI ORGANISM CELLULAR PROCESS,0.69814,-0.050007,0.0059914,0,0
1,GO COPPER ION TRANSPORT,0.72171,-0.050201,-0.015374,0,0
1,GO CELL MATRIX ADHESION,1,-0.050274,0.081876,0,0
1,GO FACE DEVELOPMENT,0.88046,-0.050473,0.05089,0,0
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.72171,-0.050474,-0.010701,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.17591,-0.050522,-0.040995,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.7336,-0.050635,0.013448,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.96843,-0.050828,0.083091,0,0
1,GO RESPONSE TO LIPID,0.93062,-0.050905,0.041825,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.86799,-0.050973,-0.0050234,0,0
1,GO TOXIN METABOLIC PROCESS,0.70989,-0.050979,-0.016973,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.55277,-0.051082,-0.025315,0,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.68646,-0.051085,0.0050328,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.75756,-0.051154,0.0057663,0,0
1,GO MUSCLE CELL FATE COMMITMENT,0.12273,-0.051403,-0.13443,0,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.80618,-0.051757,0.043789,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.33029,-0.051909,-0.038506,0,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.65188,-0.052169,-0.05526,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.95582,-0.052447,0.026873,0,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.56341,-0.053079,-0.10392,0,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.50109,-0.053198,0.026252,0,0
1,GO AMYLOID FIBRIL FORMATION,0.68646,-0.053321,-0.0048696,0,0
1,GO RESPONSE TO VITAMIN,0.81845,-0.053438,0.025613,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.78176,-0.053507,0.00099375,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.50109,-0.053579,0.0062974,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.81845,-0.053734,0.01985,0,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.57414,-0.05374,-0.062794,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.7336,-0.053969,0.012459,0,0
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.57414,-0.053988,-0.055833,0,0
1,GO ACTIN FILAMENT SEVERING,0.44264,-0.054167,-0.041527,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.37964,-0.054305,-0.028596,0,0
1,GO STEROID CATABOLIC PROCESS,0.35442,-0.054508,-0.082315,0,0
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.49108,-0.054684,-0.016415,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.5959,-0.054711,-0.083306,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1,-0.054935,0.058696,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.65188,-0.055224,-0.022041,0,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.54223,-0.055304,-0.021613,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.54223,-0.055321,-0.019901,0,0
1,GO GTP METABOLIC PROCESS,0.60692,-0.055617,0.0041151,0,0
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.1475,-0.055636,-0.050942,0,0
1,GO RESPONSE TO CYTOKINE,0.43329,-0.055738,-0.026327,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.53179,-0.055748,-0.017488,0,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.93062,-0.055817,0.025224,0,0
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.35442,-0.056029,-0.012961,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.43329,-0.056062,-0.073792,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.55277,-0.05613,-0.05977,0,0
1,GO RENAL SODIUM EXCRETION,0.84314,-0.056322,0.023117,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.5959,-0.056752,0.085082,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.60692,-0.0568,0.00067248,0,0
1,GO REGULATION OF EXCRETION,0.66333,-0.056818,-0.0090158,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.72171,-0.05684,-0.0014952,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.27126,-0.057127,-0.081446,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.74555,-0.05715,0.030116,0,0
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.89296,-0.05782,0.042312,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.80618,-0.057829,-0.0049543,0,0
1,GO REGULATION OF RECEPTOR BINDING,0.99368,-0.057952,0.041002,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.88046,-0.058005,0.057657,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.64051,-0.05803,0.035403,0,0
1,GO REGULATION OF DEFENSE RESPONSE,0.55277,-0.058131,-0.028494,0,0
1,GO STORE OPERATED CALCIUM ENTRY,0.67486,-0.058168,0.044059,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.48117,-0.058238,-0.12386,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.95582,-0.05828,0.041717,0,0
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.83078,-0.058331,0.07166,0,0
1,GO HYALURONAN METABOLIC PROCESS,0.7336,-0.058382,0.028851,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.70989,-0.058483,-0.026443,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.5959,-0.058653,0.0093236,0,0
1,GO MUSCLE CELL PROLIFERATION,0.64051,-0.058715,0.018903,0,0
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.61803,-0.058776,-0.059497,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.33821,-0.058903,-0.027808,0,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.57414,-0.05912,-0.0090702,0,0
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.76963,-0.059282,0.03531,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.42405,-0.059365,-0.11493,0,0
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.72171,-0.059412,0.030427,0,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.60692,-0.059572,0.0027863,0,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.54223,-0.059686,-0.04557,0,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.50109,-0.059728,-0.048477,0,0
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.58498,-0.059817,-0.0040895,0,0
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.23203,-0.060119,-0.061854,0,0
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.55277,-0.060139,-0.037478,0,0
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.89296,-0.060355,0.0082138,0,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.72171,-0.060386,-0.014197,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.70989,-0.06071,0.041771,0,0
1,GO PROTEIN HYDROXYLATION,0.85555,-0.06071,0.0098806,0,0
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.43329,-0.060719,0.0045723,0,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.57414,-0.060738,0.0038804,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.5959,-0.060891,-0.025856,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.95582,-0.061024,0.025545,0,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.57414,-0.061039,-0.012033,0,0
1,GO CELLULAR IRON ION HOMEOSTASIS,0.76963,-0.0612,0.0067352,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.80618,-0.061224,0.057228,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.74555,-0.061455,0.062368,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.81845,-0.061849,0.025636,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.74555,-0.061899,-0.0058278,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.78176,-0.061947,0.041022,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.55277,-0.061952,-0.0082092,0,0
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.38829,-0.061953,-0.096728,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.84314,-0.062048,0.018366,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.86799,-0.062058,0.011811,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.61803,-0.062191,-0.085836,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.94321,-0.062225,0.036186,0,0
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.93062,-0.062318,0.046883,0,0
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.80618,-0.062355,-0.051219,0,0
1,GO CYTOKINE PRODUCTION,0.52145,-0.062496,-0.048822,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.61803,-0.062545,0.024838,0,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.76963,-0.062546,0.0030279,0,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.85555,-0.062668,0.032329,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.42405,-0.062891,-0.047162,0,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.79394,-0.063049,0.021654,0,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.36271,-0.063071,0.11864,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.78176,-0.063124,-0.013558,0,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.24463,-0.063137,-0.040541,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.61803,-0.063172,0.0064151,0,0
1,GO T CELL ACTIVATION,0.72171,-0.063328,-0.058746,0,0
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.67486,-0.06343,-0.070271,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.76963,-0.063491,-0.034889,0,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.36271,-0.063694,-0.065223,0,0
1,GO GERMINAL CENTER FORMATION,0.39705,-0.06376,-0.12594,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.90549,-0.064061,0.059574,0,0
1,GO DEFENSE RESPONSE,0.51122,-0.064182,-0.048826,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.098083,-0.064449,-0.068276,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.33821,-0.064568,-0.044593,0,0
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.27126,-0.064752,-0.096713,0,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.58498,-0.065075,-0.026857,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.74555,-0.065082,-0.0031254,0,0
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.49108,-0.06513,-0.072767,0,0
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.57414,-0.06514,-0.022233,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.95582,-0.065166,0.055325,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.66333,-0.065568,-0.00024966,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.81845,-0.065684,0.043557,0,0
1,GO RESPONSE TO FLUID SHEAR STRESS,0.61803,-0.065886,0.016209,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.53179,-0.066041,-0.06596,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.17591,-0.0662,-0.061929,0,0
1,GO POLYAMINE METABOLIC PROCESS,0.25111,-0.066405,-0.018523,0,0
1,GO ENDOCRINE PROCESS,0.85555,-0.066514,0.014818,0,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.64051,-0.066712,-0.028672,0,0
1,GO T HELPER 1 CELL DIFFERENTIATION,0.44264,-0.066978,-0.14287,0,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.85555,-0.067075,0.048215,0,0
1,GO RESPONSE TO CADMIUM ION,0.37111,-0.067093,-0.030325,0,0
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.55277,-0.067218,-0.029126,0,0
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.85555,-0.067334,0.017702,0,0
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.37964,-0.067612,-0.12951,0,0
1,GO KERATINIZATION,0.42405,-0.067747,-0.070822,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.55277,-0.067747,0.014327,0,0
1,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.4521,-0.067793,-0.12134,0,0
1,GO B CELL HOMEOSTASIS,0.66333,-0.06805,-0.022893,0,0
1,GO PHAGOSOME ACIDIFICATION,0.35442,-0.068056,-0.0094127,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.83078,-0.068132,0.059912,0,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.85555,-0.068297,0.038083,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.32248,-0.068379,-0.018138,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.83078,-0.068533,0.018178,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.5959,-0.068556,0.06696,0,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.55277,-0.068667,-0.021339,0,0
1,GO T CELL APOPTOTIC PROCESS,0.39705,-0.068926,-0.1119,0,0
1,GO RESPONSE TO BIOTIC STIMULUS,0.48117,-0.068937,-0.050771,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.36271,-0.069109,-0.05245,0,0
1,GO RESPONSE TO HYPEROXIA,0.25111,-0.069124,-0.038213,0,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.90549,-0.069322,0.029146,0,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.47137,-0.069389,-0.0071835,0,0
1,GO RESPONSE TO INTERLEUKIN 2,0.68646,-0.069437,-0.03445,0,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.33821,-0.069575,-0.059486,0,0
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.37111,-0.069745,-0.091897,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.49108,-0.070026,-0.0087766,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.5959,-0.070026,-0.018728,0,0
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.68646,-0.070351,0.013912,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.4521,-0.070593,-0.019739,0,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.46168,-0.070602,-0.090432,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.55277,-0.070652,-0.056101,0,0
1,GO POLYOL TRANSPORT,0.72171,-0.070907,0.006835,0,0
1,GO RUFFLE ASSEMBLY,0.69814,-0.071145,0.028766,0,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.72171,-0.071245,0.024289,0,0
1,GO REGULATION OF CELL CELL ADHESION,0.70989,-0.071337,-0.036478,0,0
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.51122,-0.071456,-0.035574,0,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.39705,-0.071532,-0.038616,0,0
1,GO REGULATION OF CELL ACTIVATION,0.56341,-0.071676,-0.076023,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.43329,-0.071872,-0.072059,0,0
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.61803,-0.071956,-0.058996,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.2998,-0.072194,-0.040393,0,0
1,GO FIBROBLAST ACTIVATION,0.44264,-0.072212,-0.026514,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.64051,-0.072516,-0.022366,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.7336,-0.072946,0.032972,0,0
1,GO RESPONSE TO CORTICOSTEROID,0.90549,-0.072962,0.029769,0,0
1,GO REGULATION OF METANEPHROS DEVELOPMENT,0.81845,-0.073348,0.0052777,0,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.43329,-0.073383,-0.033043,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.48117,-0.073473,-0.015333,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.66333,-0.073526,-0.041532,0,0
1,GO GONADOTROPIN SECRETION,0.67486,-0.073625,0.013712,0,0
1,GO PROTEIN PROCESSING,0.4521,-0.073666,0.00083988,0,0
1,GO BONE CELL DEVELOPMENT,0.37111,-0.073728,-0.031625,0,0
1,GO IRON ION TRANSMEMBRANE TRANSPORT,0.2577,-0.074225,-0.084788,0,0
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.70989,-0.074251,-0.0054547,0,0
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.60692,-0.074442,-0.010173,0,0
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.70989,-0.074453,0.02837,0,0
1,GO REGULATION OF T CELL ACTIVATION,0.64051,-0.074474,-0.082403,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.83078,-0.074723,0.013583,0,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.75756,-0.075367,0.070116,0,0
1,GO PHAGOSOME MATURATION,0.2998,-0.075379,-0.015588,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.79394,-0.075588,0.0071268,0,0
1,GO COPPER ION HOMEOSTASIS,0.51122,-0.07563,-0.012828,0,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.65188,-0.075941,-0.01884,0,0
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.49108,-0.076148,0.00040981,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.93062,-0.076335,0.0083427,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.36271,-0.07634,-0.12636,0,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1,-0.077234,0.050517,0,0
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.4521,-0.077348,0.0044836,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.44264,-0.077554,0.011749,0,0
1,GO MEMBRANE RAFT ORGANIZATION,0.32248,-0.077593,-0.094434,0,0
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.33821,-0.077668,-0.040817,0,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.54223,-0.077722,-0.056525,0,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.69814,-0.077848,-0.0035988,0,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.49108,-0.077854,-0.081961,0,0
1,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.93062,-0.07803,0.019085,0,0
1,GO FOAM CELL DIFFERENTIATION,0.76963,-0.078175,0.0010127,0,0
1,GO CERAMIDE TRANSPORT,0.39705,-0.078239,-0.066909,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.35442,-0.078361,-0.17009,0,0
1,GO ETHANOL METABOLIC PROCESS,0.64051,-0.078415,-0.066745,0,0
1,GO MAST CELL ACTIVATION,0.60692,-0.078539,-0.059691,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.41494,-0.07857,-0.054082,0,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.43329,-0.078575,-0.007647,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.55277,-0.079338,0.012423,0,0
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.38829,-0.07934,-0.072812,0,0
1,GO RESPONSE TO MANGANESE ION,0.34626,-0.079381,-0.032438,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.52145,-0.079451,-0.036175,0,0
1,GO T CELL RECEPTOR SIGNALING PATHWAY,0.62923,-0.079647,-0.042833,0,0
1,GO PROGRAMMED NECROTIC CELL DEATH,0.54223,-0.079705,-0.014271,0,0
1,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.26442,-0.079719,-0.15406,0,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.53179,-0.079784,-0.035657,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.36271,-0.079943,-0.078789,0,0
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.56341,-0.080242,-0.011688,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.62923,-0.080299,-0.022647,0,0
1,GO KERATAN SULFATE METABOLIC PROCESS,0.33821,-0.080406,-0.040876,0,0
1,GO PROSTANOID METABOLIC PROCESS,0.10811,-0.080762,-0.16115,0,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.68646,-0.080795,0.021757,0,0
1,GO CELL REDOX HOMEOSTASIS,0.38829,-0.080896,-0.049637,0,0
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.94321,-0.08093,0.05887,0,0
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.95582,-0.080964,0.064164,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.75756,-0.081186,-0.0014227,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.42405,-0.08122,-0.028301,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.35442,-0.081266,-0.035991,0,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.99368,-0.081279,0.043193,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.65188,-0.081383,0.060925,0,0
1,GO PROTEIN DENEDDYLATION,0.18624,-0.081411,-0.057378,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.39705,-0.081612,-0.028507,0,0
1,GO MUSCLE FILAMENT SLIDING,0.47137,-0.081714,-0.027406,0,0
1,GO HYALURONAN CATABOLIC PROCESS,0.76963,-0.081793,-0.020369,0,0
1,GO REGULATION OF VASCULATURE DEVELOPMENT,0.58498,-0.081818,0.018808,0,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.40594,-0.082292,-0.018174,0,0
1,GO INNATE IMMUNE RESPONSE,0.42405,-0.082332,-0.085413,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.70989,-0.082657,-0.012832,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.69814,-0.082765,-0.0073991,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.52145,-0.082801,-0.036198,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.57414,-0.083113,0.0087023,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.53179,-0.083132,-0.010099,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.78176,-0.083255,0.011377,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.96843,-0.083742,0.033253,0,0
1,GO ACTIVATION OF IMMUNE RESPONSE,0.49108,-0.083956,-0.067744,0,0
1,GO ARACHIDONIC ACID SECRETION,0.70989,-0.084111,0.00097051,0,0
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.49108,-0.084292,-0.0088487,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.37111,-0.084297,-0.021387,0,0
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.38829,-0.084512,-0.010885,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.58498,-0.084734,-0.022501,0,0
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.11163,-0.084773,-0.04946,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.76963,-0.085117,-0.001839,0,0
1,GO RESPONSE TO INTERLEUKIN 4,0.47137,-0.08515,-0.046566,0,0
1,GO RESPONSE TO CAMP,0.62923,-0.085165,0.020394,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.81845,-0.085223,0.013376,0,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.44264,-0.085255,-0.036626,0,0
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.78176,-0.085603,-0.0078889,0,0
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.56341,-0.085734,-0.054917,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.42405,-0.086001,-0.12238,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.90549,-0.08608,0.0080666,0,0
1,GO MEMBRANE INVAGINATION,0.55277,-0.086239,-0.035614,0,0
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.5959,-0.086319,-0.050292,0,0
1,GO THYMIC T CELL SELECTION,0.52145,-0.086491,-0.13302,0,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.43329,-0.086807,-0.056686,0,0
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.1306,-0.086874,-0.064505,0,0
1,GO CGMP MEDIATED SIGNALING,0.20822,-0.086899,-0.092007,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67486,-0.086973,-0.025438,0,0
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.36271,-0.087028,-0.080333,0,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.40594,-0.087076,-0.013147,0,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.42405,-0.087126,-0.11388,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.96843,-0.087187,0.020919,0,0
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.46168,-0.087289,-0.074486,0,0
1,GO HEART INDUCTION,0.4521,-0.087314,-0.042602,0,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.58498,-0.087333,-0.0533,0,0
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.13885,-0.088036,-0.11615,0,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.37964,-0.088117,-0.053084,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.61803,-0.088161,-0.029189,0,0
1,GO IMMUNE EFFECTOR PROCESS,0.49108,-0.088235,-0.060627,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.28529,-0.088377,0.02874,0,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.20256,-0.088415,-0.22992,0,0
1,GO RESPONSE TO INTERLEUKIN 18,0.88046,-0.088447,0.013176,0,0
1,GO PHAGOCYTOSIS,0.37111,-0.088573,-0.06917,0,0
1,GO NECROTIC CELL DEATH,0.42405,-0.088712,-0.025579,0,0
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.57414,-0.088805,-0.033052,0,0
1,GO LIPID IMPORT INTO CELL,0.94321,-0.088899,0.061869,0,0
1,GO RESPONSE TO GONADOTROPIN,0.51122,-0.089101,-0.024961,0,0
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.54223,-0.0896,-0.12524,0,0
1,GO ENDOTHELIAL CELL MIGRATION,0.55277,-0.08962,0.012719,0,0
1,GO CELL ADHESION MOLECULE PRODUCTION,0.41494,-0.090049,-0.076238,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.60692,-0.090261,0.026037,0,0
1,GO PANCREATIC JUICE SECRETION,0.43329,-0.090264,-0.048661,0,0
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.43329,-0.090309,-0.078829,0,0
1,GO VASCULAR WOUND HEALING,0.43329,-0.09071,-0.02218,0,0
1,GO REGULATION OF BIOMINERALIZATION,0.62923,-0.090718,0.0050271,0,0
1,GO COAGULATION,0.58498,-0.090851,-0.0023643,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.89296,-0.091039,0.039774,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.46168,-0.091191,-0.038241,0,0
1,GO SMOOTH MUSCLE CELL PROLIFERATION,0.32248,-0.091255,-0.027727,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.48117,-0.091757,-0.10258,0,0
1,GO AORTA MORPHOGENESIS,0.67486,-0.091921,0.011055,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.34626,-0.092025,-0.071207,0,0
1,GO DETECTION OF OTHER ORGANISM,0.36271,-0.092053,-0.14891,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION,0.51122,-0.092151,-0.052384,0,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.80618,-0.092288,-0.012371,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.41494,-0.092296,-0.040101,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.81845,-0.092312,0.010158,0,0
1,GO REGULATION OF PROTEIN MATURATION,0.42405,-0.092575,-0.010599,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.74555,-0.092665,-0.069128,0,0
1,GO B CELL MEDIATED IMMUNITY,0.33821,-0.092694,-0.13739,0,0
1,GO BONE REMODELING,0.50109,-0.092735,0.0018045,0,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.60692,-0.093262,-0.011766,0,0
1,GO MOVEMENT IN HOST ENVIRONMENT,0.67486,-0.093438,0.0017434,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.7336,-0.093492,-0.0054595,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION,0.54223,-0.093722,-0.052428,0,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.40594,-0.093749,-0.020437,0,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.44264,-0.094137,-0.10884,0,0
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.76963,-0.09422,0.025795,0,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.37964,-0.09445,-0.020121,0,0
1,GO MYELOID CELL APOPTOTIC PROCESS,0.4521,-0.094475,-0.0515,0,0
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.80618,-0.094597,0.031484,0,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.14312,-0.094898,-0.13172,0,0
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.70989,-0.094954,0.0083076,0,0
1,GO ERK1 AND ERK2 CASCADE,0.69814,-0.09507,-0.010768,0,0
1,GO REGULATION OF WOUND HEALING,0.39705,-0.095407,-0.040025,0,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.18102,-0.09554,-0.034782,0,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,0.33029,-0.095594,-0.098572,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.3148,-0.095815,-0.073618,0,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.53179,-0.096094,-0.054538,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.25111,-0.09616,-0.12012,0,0
1,GO GLYCOLIPID CATABOLIC PROCESS,0.39705,-0.096196,-0.052606,0,0
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.42405,-0.096356,-0.089304,0,0
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.68646,-0.096369,-0.0023551,0,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.33821,-0.096449,-0.067091,0,0
1,GO CORNIFICATION,0.3148,-0.096456,-0.10049,0,0
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.76963,-0.096513,0.017446,0,0
1,GO REGULATION OF GLIAL CELL MIGRATION,0.36271,-0.096614,-0.11582,0,0
1,GO LEUKOCYTE APOPTOTIC PROCESS,0.32248,-0.096627,-0.13506,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.54223,-0.096856,-0.038183,0,0
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.29248,-0.097109,-0.078292,0,0
1,GO REGULATION OF IMMUNE RESPONSE,0.52145,-0.097214,-0.07573,0,0
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.70989,-0.097391,0.0014478,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.5959,-0.097439,-0.0060221,0,0
1,GO REGULATION OF B CELL ACTIVATION,0.42405,-0.097734,-0.12358,0,0
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.41494,-0.098187,-0.017288,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.48117,-0.098227,-0.024673,0,0
1,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.70989,-0.098426,-0.030769,0,0
1,GO PULMONARY VALVE MORPHOGENESIS,0.66333,-0.098489,0.0016359,0,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.55277,-0.098799,-0.069967,0,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.20256,-0.099053,-0.09613,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0080134,-0.099438,-0.1131,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.25111,-0.099785,-0.090959,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.11163,-0.099946,-0.10058,0,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.66333,-0.10016,0.0055948,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.38829,-0.10033,-0.04459,0,0
1,GO INFLAMMATORY RESPONSE,0.38829,-0.10044,-0.082476,0,0
1,GO ENDODERM FORMATION,0.56341,-0.10064,-0.010191,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.49108,-0.10099,-0.089035,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.19156,-0.101,-0.041719,0,0
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.69814,-0.10128,-0.018124,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.51122,-0.10131,-0.016639,0,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.44264,-0.10144,-0.078201,0,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.2577,-0.10145,-0.090773,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.64051,-0.10229,-0.01834,0,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.69814,-0.10241,0.018138,0,0
1,GO SYNCYTIUM FORMATION,0.48117,-0.1026,-0.03617,0,0
1,GO LEUKOCYTE PROLIFERATION,0.36271,-0.10262,-0.13408,0,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.86799,-0.10264,0.076856,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.39705,-0.10266,-0.074126,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.24463,-0.10271,-0.1507,0,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.46168,-0.10295,-0.027498,0,0
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.48117,-0.103,-0.057554,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.5959,-0.10316,-0.071733,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.32248,-0.10328,-0.037656,0,0
1,GO RESPONSE TO INTERLEUKIN 1,0.37964,-0.10328,-0.060567,0,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.46168,-0.10351,-0.020003,0,0
1,GO AORTIC VALVE DEVELOPMENT,0.64051,-0.10364,-0.0066918,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.37111,-0.10388,-0.09162,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.49108,-0.10388,-0.044551,0,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.36271,-0.10395,-0.12309,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.34626,-0.10415,-0.1038,0,0
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.64051,-0.10459,-0.030613,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.28529,-0.10471,-0.16178,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.62923,-0.10479,-0.018224,0,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.37111,-0.10499,-0.11156,0,0
1,GO ETHER METABOLIC PROCESS,0.10811,-0.10512,-0.063966,0,0
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.33029,-0.10517,-0.07474,0,0
1,GO NEURON REMODELING,0.23203,-0.10522,-0.11722,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.35442,-0.10528,-0.11971,0,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.51122,-0.10558,-0.032505,0,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.44264,-0.10572,-0.1179,0,0
1,GO RESPONSE TO INTERLEUKIN 6,0.52145,-0.10589,-0.01042,0,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.7336,-0.10639,-0.0088199,0,0
1,GO CHONDROCYTE PROLIFERATION,0.60692,-0.10642,-0.023775,0,0
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.49108,-0.10645,-0.074128,0,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.81845,-0.10655,0.032305,0,0
1,GO REGULATION OF ODONTOGENESIS,0.55277,-0.10689,-0.039054,0,0
1,GO RESPONSE TO LEPTIN,0.27126,-0.10699,-0.047313,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.39705,-0.10723,-0.11218,0,0
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.36271,-0.10727,-0.11174,0,0
1,GO MATERNAL PLACENTA DEVELOPMENT,0.79394,-0.10736,0.025452,0,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.43329,-0.10745,-0.012085,0,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.18102,-0.10799,-0.097117,0,0
1,GO CYTIDINE TO URIDINE EDITING,0.32248,-0.10822,-0.11378,0,0
1,GO PROGESTERONE METABOLIC PROCESS,0.51122,-0.10842,0.028795,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.4521,-0.10858,-0.0099748,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.35442,-0.10876,-0.071709,0,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.44264,-0.10891,-0.051059,0,0
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.47137,-0.10946,-0.0051807,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.40594,-0.10978,-0.10273,0,0
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.44264,-0.10994,-0.037431,0,0
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.39705,-0.11018,-0.023082,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.96843,-0.11018,0.066435,0,0
1,GO MYELOID LEUKOCYTE ACTIVATION,0.32248,-0.11049,-0.097307,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.54223,-0.11057,-0.10254,0,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.49108,-0.11058,-0.11456,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.3148,-0.1106,-0.04902,0,0
1,GO CARDIOBLAST DIFFERENTIATION,0.48117,-0.11084,-0.051893,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.37111,-0.1109,-0.046881,0,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.69814,-0.11092,-0.046378,0,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.50109,-0.1111,-0.10496,0,0
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.42405,-0.11113,-0.1038,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.37111,-0.11118,-0.07091,0,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.57414,-0.11131,-0.060348,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.24463,-0.11181,-0.1558,0,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.33029,-0.11195,-0.11485,0,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.76963,-0.112,0.01979,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.33029,-0.11211,-0.12881,0,0
1,GO T CELL SELECTION,0.62923,-0.1124,-0.11989,0,0
1,GO HEMOGLOBIN METABOLIC PROCESS,0.065157,-0.11259,-0.061404,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.95582,-0.11361,0.027809,0,0
1,GO REGULATION OF CALCIUM ION IMPORT,0.23827,-0.11397,-0.082026,0,0
1,GO B CELL PROLIFERATION,0.35442,-0.11398,-0.17492,0,0
1,GO POSITIVE CHEMOTAXIS,0.4521,-0.11403,-0.023824,0,0
1,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.4521,-0.11403,-0.057477,0,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.046961,-0.11404,-0.099481,0,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23203,-0.11415,-0.17249,0,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.43329,-0.11417,-0.10884,0,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.48117,-0.11446,-0.085991,0,0
1,GO RUFFLE ORGANIZATION,0.29248,-0.1146,-0.028543,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.27126,-0.11466,-0.092778,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.7336,-0.11467,0.026184,0,0
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.37111,-0.11469,-0.11284,0,0
1,GO LEUKOCYTE HOMEOSTASIS,0.61803,-0.11473,-0.042608,0,0
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.42405,-0.11526,-0.10861,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.2577,-0.11586,-0.075333,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.27126,-0.11588,-0.13279,0,0
1,GO PROTEIN OXIDATION,0.11524,-0.11597,-0.11464,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.50109,-0.11667,-0.024239,0,0
1,GO CELL CELL RECOGNITION,0.098083,-0.11704,-0.090573,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.90549,-0.1172,0.017447,0,0
1,GO PULMONARY VALVE DEVELOPMENT,0.64051,-0.11741,-0.0059502,0,0
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.34626,-0.11752,-0.13194,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.35442,-0.11786,-0.13631,0,0
1,GO REGULATION OF PHAGOCYTOSIS,0.47137,-0.11789,-0.078692,0,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.60692,-0.11808,-0.039558,0,0
1,GO PLATELET ACTIVATION,0.61803,-0.11827,-0.0055729,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.52145,-0.11836,-0.030475,0,0
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.32248,-0.11839,-0.03115,0,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.33029,-0.11847,-0.13888,0,0
1,GO PHOSPHATE ION TRANSPORT,0.54223,-0.11873,-0.026734,0,0
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.27821,-0.11892,-0.19738,0,0
1,GO MYOBLAST FUSION,0.49108,-0.11954,-0.047579,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.61803,-0.11989,-0.065656,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.37111,-0.12023,-0.058062,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.81845,-0.12075,0.063394,0,0
1,GO VITAMIN TRANSPORT,0.34626,-0.12101,-0.035186,0,0
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.33029,-0.12103,-0.11396,0,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.37964,-0.12114,-0.0835,0,0
1,GO TRANSITION METAL ION HOMEOSTASIS,0.15655,-0.12128,-0.052001,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.091819,-0.12142,-0.12807,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.41494,-0.12154,-0.050989,0,0
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.4521,-0.12169,-0.11298,0,0
1,GO T CELL LINEAGE COMMITMENT,0.51122,-0.1217,-0.076294,0,0
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.43329,-0.12171,-0.017841,0,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.56341,-0.12182,-0.021724,0,0
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.29248,-0.12193,-0.17249,0,0
1,GO RESPONSE TO EPINEPHRINE,0.40594,-0.12202,-0.051092,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.3148,-0.12211,-0.17166,0,0
1,GO ACUTE PHASE RESPONSE,0.11894,-0.12217,-0.15599,0,0
1,GO AMINOGLYCAN CATABOLIC PROCESS,0.34626,-0.12237,-0.035825,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.214,-0.12278,-0.15031,0,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.56341,-0.1236,-0.029595,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.61803,-0.12372,-0.003143,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.46168,-0.12414,-0.039799,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.85555,-0.12454,-0.015916,0,0
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.7336,-0.1246,0.0034789,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.23203,-0.12467,-0.10224,0,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.43329,-0.12488,-0.085288,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.32248,-0.12488,-0.12084,0,0
1,GO B CELL APOPTOTIC PROCESS,0.11524,-0.12493,-0.093889,0,0
1,GO DETOXIFICATION,0.12273,-0.12512,-0.067811,0,0
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.25111,-0.12524,-0.086737,0,0
1,GO ENTRY INTO HOST,0.61803,-0.12525,-0.017979,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0172,-0.1254,-0.11757,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.2577,-0.12565,-0.07183,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.24463,-0.12596,-0.19393,0,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.10134,-0.12612,-0.070923,0,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.2998,-0.12616,-0.094764,0,0
1,GO T CELL PROLIFERATION,0.32248,-0.12618,-0.14275,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.29248,-0.12631,-0.027701,0,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.26442,-0.12637,-0.17249,0,0
1,GO AMYLOID BETA CLEARANCE,0.90549,-0.12664,0.020304,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.36271,-0.12709,-0.026245,0,0
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.33029,-0.12737,-0.12741,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.27126,-0.12755,-0.10225,0,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.35442,-0.12779,-0.06693,0,0
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.53179,-0.12788,-0.031182,0,0
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.35442,-0.12796,-0.12019,0,0
1,GO REGULATION OF TISSUE REMODELING,0.37111,-0.12815,-0.030573,0,0
1,GO LYMPH NODE DEVELOPMENT,0.23203,-0.1282,-0.15006,0,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.39705,-0.12861,-0.065392,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.39705,-0.12922,-0.088854,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.26442,-0.12937,-0.17814,0,0
1,GO RESPIRATORY BURST,0.25111,-0.13024,-0.17179,0,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.40594,-0.13051,-0.050211,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.32248,-0.13092,-0.053506,0,0
1,GO CD40 SIGNALING PATHWAY,0.27821,-0.13131,-0.13488,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.24463,-0.13154,-0.069354,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.37111,-0.1316,-0.010319,0,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.33821,-0.13195,-0.052255,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.19156,-0.13211,-0.089904,0,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.43329,-0.13238,-0.11859,0,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.37964,-0.13262,-0.063004,0,0
1,GO NEUTROPHIL HOMEOSTASIS,0.34626,-0.13391,-0.087046,0,0
1,GO CELLULAR COPPER ION HOMEOSTASIS,0.13885,-0.13399,-0.088874,0,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34626,-0.13428,-0.099474,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.39705,-0.13454,-0.13593,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.55277,-0.13457,-0.10364,0,0
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.33029,-0.13457,-0.14284,0,0
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.55277,-0.1347,-0.078885,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.08588,-0.13482,-0.17054,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.64051,-0.13554,-0.020312,0,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.33821,-0.13573,-0.11497,0,0
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.39705,-0.13594,-0.13881,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.37964,-0.13595,-0.090808,0,0
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.38829,-0.13611,-0.060327,0,0
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.42405,-0.13649,-0.11126,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.72171,-0.13677,0.069874,0,0
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.27821,-0.13686,-0.065718,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.33821,-0.1371,-0.083868,0,0
1,GO REGULATION OF LIPASE ACTIVITY,0.30724,-0.13718,-0.064492,0,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.2577,-0.13721,-0.13508,0,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.3148,-0.13749,-0.082032,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.27821,-0.13763,-0.074806,0,0
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.2259,-0.13837,-0.19665,0,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.34626,-0.13882,-0.17441,0,0
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.39705,-0.14022,-0.049271,0,0
1,GO RESPONSE TO INTERLEUKIN 7,0.16123,-0.14023,-0.086986,0,0
1,GO GALACTOSE METABOLIC PROCESS,0.53179,-0.14053,-0.0063812,0,0
1,GO REGULATION OF CHEMOTAXIS,0.43329,-0.1412,-0.05087,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.10811,-0.14122,-0.13469,0,0
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.75756,-0.14133,0.0034633,0,0
1,GO PLATELET AGGREGATION,0.61803,-0.14194,-0.017027,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.47137,-0.14201,-0.031662,0,0
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.41494,-0.14206,-0.11635,0,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.41494,-0.14219,-0.13793,0,0
1,GO POSITIVE T CELL SELECTION,0.66333,-0.14237,-0.10897,0,0
1,GO MATURE B CELL DIFFERENTIATION,0.52145,-0.1425,-0.10636,0,0
1,GO TISSUE REMODELING,0.30724,-0.14255,-0.028134,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.28529,-0.14298,-0.17819,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.68646,-0.14321,-0.030613,0,0
1,GO LYMPHOCYTE MEDIATED IMMUNITY,0.39705,-0.14325,-0.13793,0,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.2259,-0.14356,-0.193,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.19156,-0.14401,-0.10971,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.17591,-0.14412,-0.10227,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.69814,-0.14417,-0.035827,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.37964,-0.14421,-0.054662,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.32248,-0.14445,-0.08468,0,0
1,GO T CELL CYTOKINE PRODUCTION,0.33029,-0.14479,-0.14721,0,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.40594,-0.14518,-0.026475,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.12273,-0.14551,-0.13836,0,0
1,GO ZYMOGEN INHIBITION,0.25111,-0.14556,-0.1171,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.28529,-0.14575,-0.058417,0,0
1,GO PROSTAGLANDIN SECRETION,0.64051,-0.14578,-0.048724,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.1306,-0.14662,-0.1553,0,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.35442,-0.14689,-0.13329,0,0
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.36271,-0.147,-0.12618,0,0
1,GO MUCUS SECRETION,0.19156,-0.1471,-0.18107,0,0
1,GO CYTOKINE SECRETION,0.30724,-0.14733,-0.11028,0,0
1,GO DETECTION OF BIOTIC STIMULUS,0.2998,-0.14734,-0.14529,0,0
1,GO CYTOKINE METABOLIC PROCESS,0.28529,-0.14736,-0.1415,0,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.23203,-0.14736,-0.17332,0,0
1,GO ADAPTIVE IMMUNE RESPONSE,0.38829,-0.14769,-0.16212,0,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.42405,-0.14818,-0.10887,0,0
1,GO ASTROCYTE DEVELOPMENT,0.55277,-0.14861,-0.037748,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.3148,-0.14882,-0.085966,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.3148,-0.14907,-0.096062,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.40594,-0.14926,-0.11101,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.14312,-0.14989,-0.17446,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.12662,-0.15049,-0.087831,0,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.49108,-0.15087,-0.028211,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.29248,-0.15151,-0.10807,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.098083,-0.15231,-0.12069,0,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.33029,-0.1524,-0.077548,0,0
1,GO LEUKOCYTE MIGRATION,0.3148,-0.15246,-0.10969,0,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.33029,-0.15304,-0.094242,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.32248,-0.15319,-0.071243,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.19156,-0.1537,-0.10245,0,0
1,GO T HELPER 2 CELL DIFFERENTIATION,0.39705,-0.15397,-0.14093,0,0
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.2259,-0.15401,-0.21655,0,0
1,GO ENDODERMAL CELL DIFFERENTIATION,0.3148,-0.15456,-0.07568,0,0
1,GO LEUKOCYTE CHEMOTAXIS,0.18102,-0.15459,-0.17413,0,0
1,GO GAP JUNCTION ASSEMBLY,0.2998,-0.15463,-0.10159,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.57414,-0.15473,-0.076279,0,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.66333,-0.15536,0.0075087,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.4521,-0.15609,-0.085037,0,0
1,GO IMMUNOGLOBULIN SECRETION,0.2577,-0.15623,-0.16759,0,0
1,GO MACROPHAGE ACTIVATION,0.33821,-0.15639,-0.14602,0,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.23827,-0.15658,-0.045944,0,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.098083,-0.15754,-0.19432,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.34626,-0.15788,-0.080373,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.15655,-0.1579,-0.11389,0,0
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.091819,-0.15807,-0.11988,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.23827,-0.15822,-0.11139,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.28529,-0.15837,-0.2245,0,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.43329,-0.1586,-0.12973,0,0
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.25111,-0.15881,-0.17597,0,0
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.27126,-0.15887,-0.1285,0,0
1,GO RESPONSE TO INTERFERON GAMMA,0.30724,-0.15894,-0.16635,0,0
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.23203,-0.15898,-0.18119,0,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.29248,-0.15933,-0.13214,0,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.11894,-0.15982,-0.17434,0,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.53179,-0.15984,-0.0097778,0,0
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.37111,-0.16031,-0.063915,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.13885,-0.16038,-0.081459,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.18102,-0.16052,-0.11417,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.19156,-0.16059,-0.15466,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.26442,-0.16066,-0.13266,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.3148,-0.16078,-0.12069,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.2998,-0.16108,-0.12469,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.32248,-0.16124,-0.070388,0,0
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.46168,-0.16129,-0.049157,0,0
1,GO T CELL MEDIATED IMMUNITY,0.20256,-0.16138,-0.18555,0,0
1,GO FLUID TRANSPORT,0.17591,-0.16138,-0.13584,0,0
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.3148,-0.16145,-0.098422,0,0
1,GO CELL CHEMOTAXIS,0.2577,-0.16149,-0.12433,0,0
1,GO POSITIVE REGULATION OF COAGULATION,0.094909,-0.1623,-0.14417,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.93062,-0.16239,0.051337,0,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.32248,-0.16305,-0.083466,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.17091,-0.16316,-0.14881,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.29248,-0.16368,-0.095187,0,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.33029,-0.16377,-0.10021,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.49108,-0.16402,-0.10541,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.214,-0.16406,-0.17048,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.42405,-0.16414,-0.106,0,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.28529,-0.16422,-0.21596,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.18102,-0.16452,-0.1069,0,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.28529,-0.16482,-0.12396,0,0
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.36271,-0.16489,-0.038188,0,0
1,GO VITAMIN D METABOLIC PROCESS,0.24463,-0.16501,-0.14016,0,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.214,-0.16548,-0.12879,0,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.16123,-0.16593,-0.11511,0,0
1,GO INTESTINAL ABSORPTION,0.72171,-0.16623,-0.038326,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.15655,-0.16637,-0.1112,0,0
1,GO INTERLEUKIN 2 PRODUCTION,0.25111,-0.16659,-0.17995,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.20822,-0.16663,-0.10989,0,0
1,GO BLEB ASSEMBLY,0.40594,-0.16694,-0.06051,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.33029,-0.16701,-0.07035,0,0
1,GO INTERLEUKIN 1 PRODUCTION,0.18624,-0.16705,-0.1855,0,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.14312,-0.16719,-0.18624,0,0
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.52145,-0.16743,-0.04516,0,0
1,GO CELLULAR EXTRAVASATION,0.33029,-0.16859,-0.12117,0,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.23203,-0.16863,-0.11581,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.37964,-0.16868,-0.089079,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.69814,-0.16878,-0.10502,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.098083,-0.16878,-0.12639,0,0
1,GO REGULATION OF BONE REMODELING,0.2998,-0.16879,-0.061161,0,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.38829,-0.16956,-0.029347,0,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.1306,-0.16959,-0.1675,0,0
1,GO GTP BIOSYNTHETIC PROCESS,0.16123,-0.17019,-0.11482,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.20256,-0.1709,-0.22934,0,0
1,GO NEUROINFLAMMATORY RESPONSE,0.25111,-0.17111,-0.17527,0,0
1,GO GLIAL CELL ACTIVATION,0.23203,-0.17117,-0.18051,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.2259,-0.1722,-0.063021,0,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.35442,-0.17275,-0.17376,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.214,-0.17352,-0.1464,0,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.197,-0.17477,-0.1012,0,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.32248,-0.17482,-0.081739,0,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.18624,-0.17515,-0.18152,0,0
1,GO TRABECULA FORMATION,0.20822,-0.17523,-0.1001,0,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.29248,-0.17562,-0.18443,0,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.44264,-0.17604,-0.1237,0,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.47137,-0.17616,-0.075317,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.30724,-0.17694,-0.1584,0,0
1,GO RESPONSE TO BACTERIUM,0.2998,-0.17756,-0.10651,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.2998,-0.17794,-0.084838,0,0
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.27821,-0.17796,-0.16378,0,0
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.094909,-0.178,-0.23481,0,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.25111,-0.17832,-0.13318,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.12273,-0.17887,-0.17111,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.27821,-0.17911,-0.15669,0,0
1,GO BONE TRABECULA MORPHOGENESIS,0.74555,-0.1795,-0.00852,0,0
1,GO BONE RESORPTION,0.23203,-0.17973,-0.084186,0,0
1,GO RESPONSE TO ZINC ION,0.043559,-0.18027,-0.14118,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.42405,-0.18049,-0.12167,0,0
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.2259,-0.18107,-0.12572,0,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.33821,-0.18179,-0.12929,0,0
1,GO LEUKOCYTE AGGREGATION,0.26442,-0.18233,-0.22598,0,0
1,GO GLYCOPROTEIN CATABOLIC PROCESS,0.15197,-0.18272,-0.078511,0,0
1,GO INTERLEUKIN 8 PRODUCTION,0.28529,-0.18368,-0.14001,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.11163,-0.18431,-0.20353,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.23827,-0.18459,-0.1722,0,0
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.16123,-0.18467,-0.20485,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.15655,-0.18497,-0.20907,0,0
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.2998,-0.1851,-0.17153,0,0
1,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.13885,-0.18521,-0.22577,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.197,-0.18524,-0.10258,0,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.17091,-0.18654,-0.18632,0,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,0.10134,-0.18673,-0.19151,0,0
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.76963,-0.18689,-0.0054964,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.08881,-0.18787,-0.099279,0,0
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.19156,-0.18895,-0.18484,0,0
1,GO MACROPHAGE MIGRATION,0.12273,-0.18921,-0.19252,0,0
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.094909,-0.18959,-0.16392,0,0
1,GO NEUTROPHIL EXTRAVASATION,0.33029,-0.19005,-0.12006,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.23827,-0.19072,-0.20367,0,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.23827,-0.19157,-0.15225,0,0
1,GO CELL KILLING,0.16602,-0.19184,-0.18926,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.094909,-0.19282,-0.27726,0,0
1,GO VASODILATION,0.1475,-0.19289,-0.11449,0,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.11163,-0.19397,-0.19522,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.48117,-0.19425,-0.085684,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.29248,-0.19479,-0.14963,0,0
1,GO RESPONSE TO TYPE I INTERFERON,0.47137,-0.1952,-0.089491,0,0
1,GO APOPTOTIC CELL CLEARANCE,0.3148,-0.19603,-0.12193,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.3148,-0.19611,-0.065473,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.18624,-0.19658,-0.14019,0,0
1,GO REGULATION OF MACROPHAGE MIGRATION,0.13467,-0.19909,-0.18348,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.33821,-0.20045,-0.086241,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.2259,-0.20056,-0.19132,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.48117,-0.20078,-0.040203,0,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.058535,-0.20179,-0.17399,0,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.25111,-0.20191,-0.19454,0,0
1,GO DENDRITIC CELL DIFFERENTIATION,0.24463,-0.20206,-0.22519,0,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.21989,-0.20271,-0.14706,0,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.17091,-0.20295,-0.14443,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.21989,-0.20302,-0.14381,0,0
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.33821,-0.20335,-0.11301,0,0
1,GO HISTAMINE TRANSPORT,0.47137,-0.20344,-0.063757,0,0
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.27126,-0.20363,-0.18376,0,0
1,GO ASTROCYTE ACTIVATION,0.26442,-0.20492,-0.13514,0,0
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.26442,-0.20498,-0.1625,0,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.42405,-0.20582,-0.14067,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.27821,-0.20587,-0.12518,0,0
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.23827,-0.20669,-0.132,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.28529,-0.20719,-0.1763,0,0
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.10811,-0.20721,-0.14476,0,0
1,GO REGULATION OF COAGULATION,0.072385,-0.20735,-0.17241,0,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.16602,-0.20747,-0.2585,0,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.26442,-0.20747,-0.14235,0,0
1,GO NEUTROPHIL MIGRATION,0.13467,-0.20754,-0.23819,0,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.1306,-0.2078,-0.20426,0,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.067497,-0.20781,-0.32012,0,0
1,GO OSTEOCLAST DEVELOPMENT,0.1306,-0.20819,-0.15587,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.1306,-0.20855,-0.16854,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.15655,-0.20858,-0.24622,0,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.214,-0.21024,-0.13269,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.11163,-0.21063,-0.21322,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.34626,-0.21066,-0.1148,0,0
1,GO RESPONSE TO PROTOZOAN,0.2259,-0.21106,-0.22556,0,0
1,GO TROPHOBLAST CELL MIGRATION,0.13467,-0.21129,-0.085372,0,0
1,GO EMBRYO IMPLANTATION,0.11894,-0.21131,-0.11179,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.14312,-0.2119,-0.21361,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.41494,-0.21291,-0.12652,0,0
1,GO PLATELET DEGRANULATION,0.20822,-0.21362,-0.099724,0,0
1,GO T CELL EXTRAVASATION,0.46168,-0.21384,-0.10887,0,0
1,GO PROTEIN TRIMERIZATION,0.1306,-0.214,-0.15149,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.13885,-0.2145,-0.19804,0,0
1,GO INTEGRIN ACTIVATION,0.10468,-0.21467,-0.21423,0,0
1,GO NEGATIVE T CELL SELECTION,0.38829,-0.21525,-0.20237,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.13885,-0.21528,-0.18715,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.14312,-0.21531,-0.20239,0,0
1,GO GRANULOCYTE MIGRATION,0.10134,-0.21546,-0.23296,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.046961,-0.21564,-0.21278,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.28529,-0.21649,-0.20652,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.46168,-0.21772,-0.082983,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.10811,-0.21802,-0.21363,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.016475,-0.21871,-0.27726,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.091819,-0.21874,-0.17263,0,0
1,GO RESPONSE TO INTERFERON ALPHA,0.21989,-0.21936,-0.15104,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.66333,-0.21973,-0.12671,0,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.38829,-0.22015,-0.18072,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.13467,-0.22068,-0.22345,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.17091,-0.22092,-0.10585,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.14312,-0.22185,-0.14091,0,0
1,GO ADRENAL GLAND DEVELOPMENT,0.38829,-0.22251,-0.040592,0,0
1,GO BLOOD VESSEL REMODELING,0.19156,-0.22282,-0.097867,0,0
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.16123,-0.22352,-0.12186,0,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.197,-0.22363,-0.19661,0,0
1,GO MACROPHAGE CHEMOTAXIS,0.098083,-0.2237,-0.18227,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.069906,-0.22407,-0.22555,0,0
1,GO LIPID DIGESTION,0.062884,-0.22418,-0.21757,0,0
1,GO RESPONSE TO INTERFERON BETA,0.14312,-0.22447,-0.18596,0,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.32248,-0.22496,-0.14936,0,0
1,GO LYMPHOCYTE COSTIMULATION,0.34626,-0.22531,-0.15753,0,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.15197,-0.22578,-0.1882,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.25111,-0.22633,-0.14149,0,0
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.2259,-0.22658,-0.094128,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.065157,-0.22701,-0.23924,0,0
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.17091,-0.22742,-0.22157,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.24463,-0.22836,-0.20185,0,0
1,GO REGULATION OF MYOBLAST FUSION,0.18624,-0.22847,-0.17863,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.19156,-0.2287,-0.18267,0,0
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.27821,-0.22893,-0.12533,0,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.10811,-0.22961,-0.19885,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.054439,-0.23077,-0.13566,0,0
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.29248,-0.23153,-0.23742,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.27126,-0.23167,-0.12836,0,0
1,GO RESPONSE TO COPPER ION,0.006955,-0.23227,-0.19361,0,0
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.23203,-0.23392,-0.11546,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.24463,-0.23404,-0.19852,0,0
1,GO GRANULOCYTE CHEMOTAXIS,0.08881,-0.23457,-0.23984,0,0
1,GO RESPONSE TO CHEMOKINE,0.1306,-0.23573,-0.25476,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.29248,-0.237,-0.14895,0,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.15197,-0.23772,-0.25034,0,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.16123,-0.2383,-0.18693,0,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.25111,-0.23849,-0.19961,0,0
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.11163,-0.23927,-0.27354,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.054439,-0.23965,-0.17292,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.14312,-0.23974,-0.27702,0,0
1,GO RESPONSE TO INTERLEUKIN 15,0.32248,-0.241,-0.16724,0,0
1,GO DECIDUALIZATION,0.43329,-0.24261,-0.07509,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.1306,-0.24287,-0.24998,0,0
1,GO CHEMOKINE PRODUCTION,0.20256,-0.24334,-0.13494,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10134,-0.2435,-0.27558,0,0
1,GO COLLAGEN METABOLIC PROCESS,0.080256,-0.24356,-0.14182,0,0
1,GO DENDRITIC CELL MIGRATION,0.20256,-0.24397,-0.255,0,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.197,-0.24413,-0.16981,0,0
1,GO NEUTROPHIL CHEMOTAXIS,0.10811,-0.24431,-0.25494,0,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.30724,-0.24433,-0.11986,0,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.098083,-0.24435,-0.28164,0,0
1,GO NEGATIVE REGULATION OF COAGULATION,0.08303,-0.24468,-0.18117,0,0
1,GO EPOXYGENASE P450 PATHWAY,0.23203,-0.24479,-0.12712,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.056456,-0.24594,-0.20561,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.1475,-0.24623,-0.21906,0,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.18624,-0.24641,-0.22456,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.10134,-0.24715,-0.26979,0,0
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.069906,-0.2475,-0.25503,0,0
1,GO ELASTIC FIBER ASSEMBLY,0.37964,-0.24925,-0.12989,0,0
1,GO HISTAMINE SECRETION,0.19156,-0.24959,-0.14261,0,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.26442,-0.2507,-0.22387,0,0
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.077559,-0.25146,-0.1983,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.10811,-0.25228,-0.27615,0,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.11524,-0.25253,-0.18512,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.17591,-0.2527,-0.16733,0,0
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.33821,-0.25323,-0.10478,0,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.16123,-0.25335,-0.24955,0,0
1,GO SUPEROXIDE ANION GENERATION,0.2577,-0.25499,-0.13626,0,0
1,GO NEGATIVE REGULATION OF CELL KILLING,0.1306,-0.25499,-0.27037,0,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.21989,-0.25607,-0.16769,0,0
1,GO REGULATION OF PLATELET ACTIVATION,0.11163,-0.25653,-0.2025,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.197,-0.25659,-0.22475,0,0
1,GO COLLAGEN BIOSYNTHETIC PROCESS,0.15197,-0.25686,-0.11703,0,0
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.38829,-0.25713,-0.12921,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.25111,-0.25729,-0.18991,0,0
1,GO LYMPHOCYTE MIGRATION,0.15655,-0.25764,-0.23524,0,0
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.25111,-0.25783,-0.23669,0,0
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.11163,-0.25823,-0.29727,0,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.18102,-0.25845,-0.29828,0,0
1,GO REGULATION OF BONE DEVELOPMENT,0.054439,-0.25859,-0.21515,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.14312,-0.26051,-0.13511,0,0
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.060677,-0.26234,-0.32192,0,0
1,GO HUMORAL IMMUNE RESPONSE,0.091819,-0.26331,-0.21057,0,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.11524,-0.26467,-0.18947,0,0
1,GO REGULATION OF CELL KILLING,0.16602,-0.26502,-0.20034,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.094909,-0.26619,-0.18792,0,0
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.08303,-0.26636,-0.29495,0,0
1,GO INTERFERON GAMMA PRODUCTION,0.13467,-0.26643,-0.22789,0,0
1,GO RESPONSE TO LIPOTEICHOIC ACID,0.13885,-0.26705,-0.21583,0,0
1,GO ZYMOGEN ACTIVATION,0.15197,-0.26916,-0.13368,0,0
1,GO T CELL MEDIATED CYTOTOXICITY,0.08881,-0.26939,-0.28234,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.098083,-0.27014,-0.23326,0,0
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0036751,-0.27251,-0.32551,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.077559,-0.27325,-0.18404,0,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.25111,-0.27591,-0.1891,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.11894,-0.27734,-0.23707,0,0
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.16602,-0.27817,-0.19436,0,0
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.1306,-0.27837,-0.25473,0,0
1,GO TYPE 2 IMMUNE RESPONSE,0.17091,-0.27843,-0.22622,0,0
1,GO INTERLEUKIN 4 PRODUCTION,0.067497,-0.28123,-0.27902,0,0
1,GO CHEMOKINE SECRETION,0.08588,-0.28218,-0.27321,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.067497,-0.28319,-0.26667,0,0
1,GO MACROPHAGE PROLIFERATION,0.13467,-0.28545,-0.22502,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.10811,-0.2856,-0.28804,0,0
1,GO COMPLEMENT ACTIVATION,0.072385,-0.28591,-0.29978,0,0
1,GO REGULATION OF T CELL MIGRATION,0.069906,-0.28595,-0.24939,0,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.1475,-0.28705,-0.21868,0,0
1,GO PROTEIN ACTIVATION CASCADE,0.15655,-0.28935,-0.16636,0,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.16123,-0.29093,-0.28575,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.060677,-0.29125,-0.39754,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.21989,-0.29187,-0.25978,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.08588,-0.29248,-0.29401,0,0
1,GO CELLULAR DEFENSE RESPONSE,0.15655,-0.29504,-0.26146,0,0
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.11894,-0.29705,-0.20872,0,0
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.16123,-0.29783,-0.24285,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.19156,-0.29804,-0.19847,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.18102,-0.29815,-0.14299,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.10811,-0.29856,-0.252,0,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.062884,-0.29868,-0.27889,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.13885,-0.29954,-0.32683,0,0
1,GO MONONUCLEAR CELL MIGRATION,0.054439,-0.29987,-0.30178,0,0
1,GO WATER TRANSPORT,0.11894,-0.30122,-0.20008,0,0
1,GO TOLERANCE INDUCTION,0.21989,-0.30227,-0.31035,0,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.074935,-0.30353,-0.1803,0,0
1,GO REGULATION OF NEUTROPHIL ACTIVATION,0.12662,-0.30502,-0.26989,0,0
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.08303,-0.3053,-0.23887,0,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.080256,-0.30721,-0.18573,0,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.1306,-0.30779,-0.19216,0,0
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.094909,-0.30863,-0.15479,0,0
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.26442,-0.31152,-0.14573,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.08303,-0.31165,-0.26667,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.077559,-0.31356,-0.29307,0,0
1,GO COLLAGEN FIBRIL ORGANIZATION,0.08881,-0.31397,-0.20962,0,0
1,GO T CELL MIGRATION,0.098083,-0.31491,-0.25369,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.37964,-0.317,-0.10991,0,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.25111,-0.3187,-0.27368,0,0
1,GO ETHANOL OXIDATION,0.1475,-0.32021,-0.22758,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.054439,-0.32326,-0.28665,0,0
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.20256,-0.32358,-0.14832,0,0
1,GO INFLAMMATORY RESPONSE TO WOUNDING,0.10811,-0.32445,-0.21815,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.18624,-0.32559,-0.25549,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.08881,-0.33215,-0.34319,0,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.1475,-0.33222,-0.23802,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10811,-0.33261,-0.24035,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.1475,-0.3357,-0.30691,0,0
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.080256,-0.33735,-0.38312,0,0
1,GO LYMPHOCYTE CHEMOTAXIS,0.08881,-0.33977,-0.30896,0,0
1,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.062884,-0.34047,-0.31539,0,0
1,GO T CELL CHEMOTAXIS,0.10134,-0.3425,-0.28482,0,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.065157,-0.34467,-0.2057,0,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.2998,-0.34758,-0.16142,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.11524,-0.34841,-0.20646,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.14312,-0.35216,-0.25078,0,0
1,GO REGULATION OF MEMBRANE INVAGINATION,0.41494,-0.35529,-0.11067,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.062884,-0.35548,-0.34482,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.11163,-0.36483,-0.2366,0,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.054439,-0.36639,-0.2882,0,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.08881,-0.36915,-0.26287,0,0
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.091819,-0.36932,-0.30897,0,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.1475,-0.37439,-0.2134,0,0
1,GO T CELL TOLERANCE INDUCTION,0.27126,-0.38262,-0.29832,0,0
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.080256,-0.38582,-0.28661,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.060677,-0.40263,-0.31162,0,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.10468,-0.40367,-0.23864,0,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.11163,-0.41845,-0.34207,0,0
1,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.26442,-0.42512,-0.31841,0,0
1,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.1306,-0.43624,-0.45619,0,0
1,GO CYTOLYSIS,0.098083,-0.4423,-0.32535,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.069906,-0.44266,-0.29991,0,0
1,GO CHRONIC INFLAMMATORY RESPONSE,0.069906,-0.44325,-0.38277,0,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.1475,-0.4501,-0.26615,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.069906,-0.47488,-0.41949,0,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.058535,-0.49568,-0.50842,0,0
1,GO EOSINOPHIL MIGRATION,0.019548,-0.53192,-0.48293,0,0
1,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.058535,-0.58471,-0.541,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.0172,-0.58527,-0.47715,0,0
1,GO NATURAL KILLER CELL CHEMOTAXIS,0.35442,-0.68183,-0.27273,0,0
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.0060238,1.0131,0.76432,1,1
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.0049572,0.96785,0.81503,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0044907,0.89025,0.78304,1,1
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.010101,0.87879,0.76163,1,1
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00332,0.8399,0.70966,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0029965,0.70061,0.63081,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,0.011063,0.69605,0.51528,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00045436,0.67591,0.66195,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00332,0.65722,0.63128,1,1
2,GO HYPERSENSITIVITY,0.0060238,0.65273,0.53112,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0034935,0.6471,0.60668,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.0031545,0.62322,0.48582,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00068502,0.61707,0.57731,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00020554,0.61552,0.6235,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0010798,0.61211,0.5695,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.0010798,0.60669,0.58112,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.0066311,0.60613,0.49767,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0013481,0.60467,0.56181,1,1
2,GO SYNAPSE PRUNING,0.010572,0.59603,0.56148,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0060238,0.57994,0.50455,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0042727,0.57899,0.52834,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0047188,0.57578,0.45042,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.010101,0.56242,0.49093,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0028457,0.5596,0.474,1,1
2,GO PLASMINOGEN ACTIVATION,0.00076864,0.55935,0.44736,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0015882,0.55648,0.59659,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0054671,0.55462,0.44,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00051151,0.55248,0.52935,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0025648,0.54269,0.44693,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0054671,0.54226,0.47551,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0015882,0.53933,0.4591,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00068502,0.53868,0.54576,1,1
2,GO FIBRINOLYSIS,0.0019699,0.53837,0.42742,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00091199,0.52634,0.5434,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0028457,0.52492,0.50695,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00332,0.52152,0.43149,1,1
2,GO NEUTROPHIL MIGRATION,0.0054671,0.51879,0.4344,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.0080134,0.51788,0.44391,1,1
2,GO LYMPHOCYTE MIGRATION,0.0052065,0.51705,0.43175,1,1
2,GO MONONUCLEAR CELL MIGRATION,0.0044907,0.51567,0.45388,1,1
2,GO NK T CELL DIFFERENTIATION,0.0096484,0.51346,0.41168,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0044907,0.51312,0.45361,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0021907,0.50699,0.49199,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00054254,0.50602,0.49721,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0027019,0.50156,0.48673,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0038653,0.5015,0.42747,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0034935,0.50003,0.44496,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0034935,0.4978,0.46296,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0044907,0.49597,0.43164,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00028019,0.4948,0.54122,1,1
2,GO DETECTION OF BIOTIC STIMULUS,0.0028457,0.49448,0.39733,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0012071,0.4938,0.46497,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.0031545,0.49351,0.45452,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0038653,0.49095,0.41007,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0060238,0.48991,0.42819,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0083971,0.48915,0.43677,1,1
2,GO T CELL MIGRATION,0.0052065,0.48563,0.44937,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0057394,0.48502,0.46686,1,1
2,GO GRANULOCYTE MIGRATION,0.0029965,0.48446,0.42605,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0031545,0.48281,0.44963,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0049572,0.48269,0.45074,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0016767,0.48091,0.48456,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0028457,0.48071,0.44451,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00332,0.47786,0.44629,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0038653,0.47601,0.3951,1,1
2,GO B CELL PROLIFERATION,0.0031545,0.47364,0.41503,1,1
2,GO RESPIRATORY BURST,0.0019699,0.47241,0.45434,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0034935,0.47212,0.45249,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0044907,0.47196,0.42935,1,1
2,GO GLYCINE TRANSPORT,0.034576,0.47162,0.29735,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.008797,0.47074,0.36422,1,1
2,GO CHEMOKINE SECRETION,0.0049572,0.47073,0.46568,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0003797,0.46946,0.49989,1,1
2,GO IMMUNOGLOBULIN SECRETION,0.0029965,0.46901,0.38598,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.0040644,0.46699,0.41677,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0017696,0.46644,0.43006,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0023095,0.46611,0.42577,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0036751,0.46552,0.40835,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.0057394,0.46371,0.39618,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0031545,0.46266,0.44874,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.008797,0.46221,0.39873,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00042807,0.4614,0.47567,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.0038653,0.46011,0.43536,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00086166,0.45901,0.43943,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0017696,0.45889,0.41739,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.0027019,0.45781,0.45829,1,1
2,GO CD40 SIGNALING PATHWAY,0.0047188,0.4556,0.3726,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0015041,0.45508,0.43538,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.00081392,0.45492,0.45392,1,1
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0034935,0.45475,0.39265,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0013481,0.45362,0.42901,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0027019,0.45347,0.38835,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.007293,0.45038,0.43883,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0012071,0.44752,0.46931,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0029965,0.44594,0.44895,1,1
2,GO INTERLEUKIN 2 PRODUCTION,0.011574,0.44572,0.35399,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0024341,0.44415,0.41764,1,1
2,GO REGULATION OF MYOBLAST FUSION,0.0015041,0.44407,0.48142,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,0.0018673,0.44246,0.39631,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0031545,0.44075,0.37984,1,1
2,GO NEGATIVE REGULATION OF ANOIKIS,0.0018673,0.43762,0.41236,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0028457,0.43671,0.40792,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0083971,0.43554,0.36376,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.0018673,0.43546,0.39419,1,1
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00018128,0.43518,0.49102,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0049572,0.43487,0.40095,1,1
2,GO REGULATION OF PHAGOCYTOSIS,0.0024341,0.43061,0.40686,1,1
2,GO LEUKOCYTE CHEMOTAXIS,0.0021907,0.42982,0.40117,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.012106,0.429,0.33583,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0027019,0.42831,0.39425,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0029965,0.42722,0.40959,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.0066311,0.42709,0.38966,1,1
2,GO HISTAMINE SECRETION,0.0049572,0.4268,0.3704,1,1
2,GO MACROPHAGE ACTIVATION,0.0036751,0.42584,0.422,1,1
2,GO MACROPHAGE MIGRATION,0.0023095,0.42276,0.38898,1,1
2,GO AMYLOID BETA CLEARANCE,0.0019699,0.42171,0.38721,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0076456,0.42094,0.51427,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0012071,0.41813,0.39213,1,1
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018736,0.41423,0.37038,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0057394,0.41397,0.3787,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.006955,0.41393,0.34619,1,1
2,GO CYTOKINE METABOLIC PROCESS,0.0054671,0.41277,0.34796,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0042727,0.41143,0.35399,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.0040644,0.41133,0.36449,1,1
2,GO RESPONSE TO FUNGUS,0.00057531,0.40936,0.37058,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.011063,0.40783,0.36726,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0018673,0.40519,0.41989,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0014241,0.4048,0.37042,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00068502,0.40384,0.42431,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,0.00332,0.40131,0.42098,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00020554,0.40061,0.45934,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0036751,0.39943,0.35548,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00072571,0.39863,0.38682,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.0024341,0.39813,0.3838,1,1
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0023095,0.39697,0.38287,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0040644,0.39565,0.36426,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0044907,0.3927,0.33857,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0096484,0.39199,0.32781,1,1
2,GO HUMORAL IMMUNE RESPONSE,0.0014241,0.38904,0.40318,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.0040644,0.38886,0.37637,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.013235,0.38862,0.45514,1,1
2,GO REGULATION OF T CELL MIGRATION,0.0027019,0.38779,0.39332,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0038653,0.38723,0.40489,1,1
2,GO REGULATION OF PLATELET AGGREGATION,0.0016767,0.38673,0.35993,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0034935,0.38575,0.35703,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0052065,0.38556,0.34672,1,1
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0024341,0.38448,0.34019,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00086166,0.3835,0.34893,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.0013481,0.38349,0.37103,1,1
2,GO INTERLEUKIN 6 PRODUCTION,0.0047188,0.3834,0.33523,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010101,0.38294,0.3208,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0017696,0.38278,0.34481,1,1
2,GO INTESTINAL ABSORPTION,0.00026348,0.38236,0.42558,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,0.00054254,0.38222,0.40685,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0034935,0.38165,0.32905,1,1
2,GO CELL CHEMOTAXIS,0.0013481,0.37621,0.37111,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031545,0.37485,0.36471,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0052065,0.37403,0.34902,1,1
2,GO PHAGOCYTOSIS,0.0021907,0.37293,0.35442,1,1
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00096503,0.37011,0.35581,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0010209,0.36972,0.36884,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042807,0.36919,0.38016,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0028457,0.36903,0.39637,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0014241,0.36878,0.3602,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0027019,0.36862,0.38014,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00332,0.36694,0.33746,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0013481,0.36611,0.32439,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0052065,0.366,0.36288,1,1
2,GO RESPONSE TO MAGNESIUM ION,0.00076864,0.36585,0.39209,1,1
2,GO INTESTINAL LIPID ABSORPTION,0.0021907,0.36502,0.34024,1,1
2,GO ZYMOGEN INHIBITION,0.0025648,0.36443,0.35571,1,1
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0060238,0.36398,0.32541,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0021907,0.36318,0.35997,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0015882,0.35967,0.35394,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0013481,0.35821,0.39953,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012071,0.3581,0.34968,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0029965,0.35761,0.31752,1,1
2,GO GAP JUNCTION ASSEMBLY,0.0049572,0.35702,0.41754,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00054254,0.35503,0.42114,1,1
2,GO CHEMOKINE PRODUCTION,0.0029965,0.35262,0.33588,1,1
2,GO VASCULAR WOUND HEALING,0.0012758,0.3519,0.38938,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0028457,0.35181,0.36795,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0015882,0.35118,0.34131,1,1
2,GO NEGATIVE REGULATION OF COAGULATION,0.0012758,0.35112,0.37431,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00096503,0.35021,0.48037,1,1
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0044907,0.34993,0.39376,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.34956,0.38776,1,1
2,GO LEUKOCYTE MIGRATION,0.0015041,0.34933,0.37667,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,0.0011418,0.34932,0.34172,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0020776,0.34858,0.36465,1,1
2,GO STEROID CATABOLIC PROCESS,0.00029789,0.34764,0.35153,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0016767,0.3462,0.3335,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0010209,0.34381,0.37652,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0040644,0.34378,0.32235,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0025648,0.34079,0.31972,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0020776,0.33985,0.34742,1,1
2,GO LUTEINIZATION,0.0034935,0.33972,0.3294,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0025648,0.33958,0.32366,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0024341,0.33958,0.32924,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00081392,0.33956,0.36494,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.020391,0.33942,0.26414,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.0027019,0.33825,0.31819,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0080134,0.33625,0.34366,1,1
2,GO BLEB ASSEMBLY,0.010101,0.33518,0.3376,1,1
2,GO MEMBRANE INVAGINATION,0.0049572,0.33508,0.33751,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0054671,0.33495,0.33412,1,1
2,GO REGULATION OF COAGULATION,0.00064645,0.33347,0.36492,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.33342,0.31435,1,1
2,GO ZYMOGEN ACTIVATION,0.00028019,0.33285,0.35488,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0020776,0.33226,0.34402,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.006955,0.33131,0.29933,1,1
2,GO FOAM CELL DIFFERENTIATION,0.0034935,0.33016,0.30918,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0012758,0.32955,0.30643,1,1
2,GO INFLAMMATORY RESPONSE,0.0024341,0.32939,0.32586,1,1
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0044907,0.32878,0.40349,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0031545,0.3287,0.31782,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00096503,0.3286,0.32366,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0042727,0.32769,0.27722,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015882,0.32723,0.31248,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0028457,0.32496,0.29143,1,1
2,GO HISTAMINE TRANSPORT,0.006955,0.32329,0.33829,1,1
2,GO PLATELET DEGRANULATION,0.0003797,0.32325,0.36341,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0080134,0.32223,0.30403,1,1
2,GO SUPEROXIDE ANION GENERATION,0.0028457,0.32208,0.34749,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0049572,0.32204,0.33236,1,1
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.0054671,0.32116,0.30233,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0011418,0.32109,0.35956,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.01266,0.32087,0.26082,1,1
2,GO REGULATION OF FIBRINOLYSIS,0.010572,0.32047,0.31506,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0036751,0.3197,0.32676,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0024341,0.31773,0.31901,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0027019,0.31722,0.34002,1,1
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.016475,0.31632,0.28954,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00096503,0.31619,0.37409,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0049572,0.3159,0.33156,1,1
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0054671,0.31569,0.35389,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0036751,0.3133,0.34544,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0047188,0.31297,0.31931,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0038653,0.31268,0.2939,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0038653,0.31237,0.29697,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0013481,0.31144,0.37321,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0016767,0.31144,0.3438,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0015041,0.31028,0.30919,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0028457,0.30829,0.28725,1,1
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0172,0.30802,0.24366,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.0017696,0.30802,0.31643,1,1
2,GO PLATELET AGGREGATION,0.0038653,0.30728,0.30506,1,1
2,GO O GLYCAN PROCESSING,0.0049572,0.30472,0.24315,1,1
2,GO ADRENAL GLAND DEVELOPMENT,0.0015041,0.30361,0.35922,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0015041,0.30218,0.36855,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.0028457,0.30189,0.31089,1,1
2,GO GALACTOSE METABOLIC PROCESS,0.00091199,0.30155,0.38942,1,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0017696,0.30116,0.34989,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.019548,0.301,0.2832,1,1
2,GO PLATELET ACTIVATION,0.0060238,0.29988,0.27962,1,1
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.025096,0.29969,0.24368,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00096503,0.29873,0.34124,1,1
2,GO RESPONSE TO THYROID HORMONE,0.00064645,0.29852,0.30559,1,1
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00332,0.2983,0.28653,1,1
2,GO ANDROGEN METABOLIC PROCESS,0.006955,0.29812,0.22709,1,1
2,GO LIPID DIGESTION,0.013834,0.29571,0.29583,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00060992,0.29532,0.32505,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.0024341,0.29528,0.30449,1,1
2,GO REGULATION OF CELL FATE SPECIFICATION,0.0016767,0.29481,0.31863,1,1
2,GO HEART INDUCTION,0.0017696,0.29415,0.33302,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0014241,0.29403,0.32374,1,1
2,GO CHOLESTEROL STORAGE,0.0038653,0.29386,0.32634,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00081392,0.29383,0.30362,1,1
2,GO ENTRY INTO HOST,0.0016767,0.29376,0.29921,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0066311,0.29335,0.32012,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0040644,0.29335,0.30932,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.013235,0.29289,0.28629,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.013235,0.29274,0.29345,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0014241,0.29268,0.34733,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.050584,0.29215,0.21179,1,1
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0044907,0.28849,0.27282,1,1
2,GO PROSTANOID METABOLIC PROCESS,0.0027019,0.28794,0.28145,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0028457,0.28788,0.27574,1,1
2,GO BLOOD VESSEL REMODELING,0.0060238,0.28774,0.32917,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00051151,0.28769,0.32373,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0017696,0.28761,0.27733,1,1
2,GO PHOSPHATE ION TRANSPORT,0.0018673,0.28758,0.27839,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0012758,0.28554,0.32239,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0028457,0.28527,0.27254,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0092139,0.28445,0.26369,1,1
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00086166,0.28328,0.30694,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.0063209,0.28297,0.27547,1,1
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.012106,0.28212,0.24255,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0036751,0.28052,0.26608,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.0012071,0.2804,0.30322,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0066311,0.27951,0.26671,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,0.01266,0.27878,0.25157,1,1
2,GO REGULATION OF ANOIKIS,0.0080134,0.27869,0.30413,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.00086166,0.27815,0.27505,1,1
2,GO LEYDIG CELL DIFFERENTIATION,0.01266,0.27791,0.36186,1,1
2,GO PHAGOLYSOSOME ASSEMBLY,0.00096503,0.27771,0.33426,1,1
2,GO REFLEX,0.014457,0.27705,0.29326,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.0019699,0.27634,0.29337,1,1
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.024086,0.27621,0.24008,1,1
2,GO MAST CELL MIGRATION,0.0080134,0.27615,0.27547,1,1
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00096503,0.27532,0.40992,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.017954,0.27485,0.20413,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00068502,0.27406,0.28878,1,1
2,GO SECONDARY HEART FIELD SPECIFICATION,0.0014241,0.27399,0.39227,1,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.034576,0.2727,0.25266,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0013481,0.27257,0.33132,1,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0011418,0.27229,0.28151,1,1
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0052065,0.27056,0.28728,1,1
2,GO BONE RESORPTION,0.0027019,0.27053,0.30829,1,1
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.0038653,0.26989,0.29074,1,1
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.048745,0.26889,0.24727,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0057394,0.26768,0.30758,1,1
2,GO OSTEOBLAST PROLIFERATION,0.0014241,0.26701,0.33102,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.010572,0.26648,0.26099,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.045233,0.26618,0.22093,1,1
2,GO HORMONE CATABOLIC PROCESS,0.0044907,0.26604,0.24817,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083971,0.26578,0.31795,1,1
2,GO STEROID ESTERIFICATION,0.0076456,0.26545,0.25408,1,1
2,GO RELAXATION OF CARDIAC MUSCLE,0.015776,0.26525,0.26328,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0054671,0.26493,0.33106,1,1
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00081392,0.26452,0.32359,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0019699,0.2643,0.26171,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00332,0.26406,0.43972,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0034935,0.26296,0.28164,1,1
2,GO MUCUS SECRETION,0.0020776,0.26141,0.31222,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0044907,0.26099,0.26138,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0017696,0.26071,0.31365,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0013481,0.2605,0.2687,1,1
2,GO NEPHRIC DUCT DEVELOPMENT,0.024086,0.26027,0.25189,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0003797,0.25909,0.34077,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0012071,0.25804,0.27824,1,1
2,GO PROTEIN HYDROXYLATION,0.008797,0.2579,0.27512,1,1
2,GO STEROL HOMEOSTASIS,0.0047188,0.25769,0.2289,1,1
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0034935,0.25741,0.25303,1,1
2,GO COPPER ION TRANSPORT,0.00057531,0.25638,0.30176,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.015104,0.25533,0.25508,1,1
2,GO COLLAGEN FIBRIL ORGANIZATION,0.016475,0.25406,0.39516,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0066311,0.25294,0.25947,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.020391,0.25179,0.23281,1,1
2,GO RESPONSE TO LITHIUM ION,0.00011593,0.25174,0.30421,1,1
2,GO RESPONSE TO IRON ION,0.0054671,0.24845,0.22692,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0025648,0.24843,0.26594,1,1
2,GO HYALURONAN CATABOLIC PROCESS,0.00332,0.2482,0.28332,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.010101,0.24657,0.23312,1,1
2,GO BICARBONATE TRANSPORT,0.052482,0.2463,0.16185,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.013235,0.24605,0.23189,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.0052065,0.24391,0.23539,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00076864,0.24372,0.29557,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0066311,0.24331,0.23753,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00332,0.24324,0.26838,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.019548,0.24299,0.29662,1,1
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0047188,0.24204,0.33281,1,1
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.007293,0.24197,0.27903,1,1
2,GO ARACHIDONIC ACID SECRETION,0.0023095,0.2417,0.24501,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.0016767,0.24054,0.26795,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.0054671,0.24016,0.24784,1,1
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0057394,0.2398,0.22861,1,1
2,GO REGULATION OF CELL FATE COMMITMENT,0.00332,0.23729,0.25072,1,1
2,GO PANCREATIC JUICE SECRETION,0.0096484,0.23684,0.24606,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0083971,0.23488,0.27853,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00332,0.23458,0.24763,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.048745,0.23355,0.18406,1,1
2,GO LUNG ALVEOLUS DEVELOPMENT,0.0015041,0.23322,0.31304,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0024341,0.23257,0.27735,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0027019,0.23236,0.24327,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.015776,0.23167,0.23951,1,1
2,GO CELL REDOX HOMEOSTASIS,0.0015041,0.23162,0.21284,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0172,0.23136,0.31018,1,1
2,GO SUBPALLIUM DEVELOPMENT,0.041938,0.23089,0.21208,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.010572,0.23089,0.23878,1,1
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0172,0.22885,0.25522,1,1
2,GO CELL MATRIX ADHESION,0.015104,0.22872,0.25879,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0063209,0.22746,0.22952,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0057394,0.22712,0.2664,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0080134,0.2271,0.2254,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0047188,0.22703,0.22662,1,1
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.014457,0.22678,0.22683,1,1
2,GO AMINE BIOSYNTHETIC PROCESS,0.0024341,0.22629,0.24344,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0047188,0.22536,0.26503,1,1
2,GO RUFFLE ORGANIZATION,0.0049572,0.22519,0.24723,1,1
2,GO EPIBOLY,0.0042727,0.22439,0.28942,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0066311,0.22378,0.29881,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0047188,0.22362,0.21623,1,1
2,GO DRUG METABOLIC PROCESS,0.026142,0.22349,0.14399,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0013481,0.22254,0.30179,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.010101,0.22211,0.23888,1,1
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0036751,0.22149,0.27265,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.0096484,0.22128,0.27172,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041938,0.22121,0.22887,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0080134,0.21876,0.31454,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0029965,0.21844,0.22732,1,1
2,GO REGULATION OF CELL MATRIX ADHESION,0.0076456,0.21834,0.2642,1,1
2,GO RELAXATION OF MUSCLE,0.018736,0.21711,0.18497,1,1
2,GO B CELL APOPTOTIC PROCESS,0.00332,0.21688,0.23362,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.010572,0.21596,0.25332,1,1
2,GO DOPAMINE METABOLIC PROCESS,0.010572,0.21521,0.22503,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.016475,0.21517,0.21117,1,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.0080134,0.21304,0.23674,1,1
2,GO ORGAN INDUCTION,0.0040644,0.21303,0.23432,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.011574,0.21238,0.25896,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.0044907,0.21181,0.24323,1,1
2,GO REGULATION OF VASCULOGENESIS,0.041938,0.21176,0.22634,1,1
2,GO LIVER MORPHOGENESIS,0.010572,0.20969,0.26763,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.022172,0.20968,0.20808,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.013834,0.20959,0.23719,1,1
2,GO PROTEIN KINASE C SIGNALING,0.018736,0.20933,0.24353,1,1
2,GO REGULATION OF NUCLEASE ACTIVITY,0.031957,0.20863,0.17105,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.037377,0.20842,0.28667,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0016767,0.20824,0.25987,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.015104,0.20781,0.2318,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015041,0.2078,0.29626,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0012758,0.20778,0.254,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.041938,0.20768,0.18086,1,1
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.021265,0.20758,0.21942,1,1
2,GO PROGESTERONE METABOLIC PROCESS,0.025096,0.20635,0.19808,1,1
2,GO STEROL TRANSPORT,0.014457,0.20581,0.20777,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0076456,0.20528,0.25127,1,1
2,GO HEART FIELD SPECIFICATION,0.007293,0.20494,0.28422,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.033245,0.20492,0.22026,1,1
2,GO AMINO ACID IMPORT,0.0080134,0.20431,0.20329,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.026142,0.20251,0.21902,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.01266,0.20248,0.20226,1,1
2,GO KERATINOCYTE DEVELOPMENT,0.031957,0.20209,0.27004,1,1
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0034935,0.20202,0.29729,1,1
2,GO LIPID IMPORT INTO CELL,0.0047188,0.20165,0.22009,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0014241,0.20125,0.25983,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.017954,0.20095,0.30058,1,1
2,GO RESPONSE TO FATTY ACID,0.013235,0.20071,0.19385,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.041938,0.20028,0.24447,1,1
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0083971,0.20002,0.19024,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00042807,0.19992,0.26035,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00042807,0.19963,0.24419,1,1
2,GO NADPH REGENERATION,0.0047188,0.19959,0.18305,1,1
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.010101,0.19959,0.20834,1,1
2,GO VASODILATION,0.0025648,0.19932,0.23957,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0063209,0.19854,0.23835,1,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0023095,0.19764,0.22929,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.006955,0.1975,0.28424,1,1
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.02951,0.19663,0.17446,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.013834,0.19645,0.24695,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.02951,0.19642,0.22223,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.040368,0.19634,0.27053,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.026142,0.19568,0.22478,1,1
2,GO TRACHEA MORPHOGENESIS,0.024086,0.1955,0.24984,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.01266,0.19511,0.22145,1,1
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.020391,0.19443,0.29664,1,1
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.008797,0.19436,0.20376,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015104,0.19364,0.22201,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.027226,0.19355,0.21532,1,1
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.0025648,0.19348,0.26306,1,1
2,GO STEROL METABOLIC PROCESS,0.006955,0.1934,0.17128,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.011063,0.19321,0.19339,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.02951,0.19307,0.27838,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0028457,0.19229,0.23929,1,1
2,GO DISACCHARIDE METABOLIC PROCESS,0.013235,0.19208,0.22167,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.038848,0.19197,0.23976,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0018673,0.19194,0.20461,1,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.033245,0.19155,0.22595,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.0096484,0.19122,0.20395,1,1
2,GO REGULATION OF EXOSOMAL SECRETION,0.00021879,0.19063,0.26479,1,1
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.018736,0.19031,0.19357,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.00072571,0.19006,0.21594,1,1
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0096484,0.19004,0.32732,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.021265,0.18914,0.18808,1,1
2,GO ENDOCRINE PROCESS,0.0066311,0.1889,0.22797,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.023112,0.18883,0.27817,1,1
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.035953,0.18847,0.20601,1,1
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.020391,0.18803,0.20554,1,1
2,GO RESPONSE TO REDOX STATE,0.0060238,0.18774,0.25511,1,1
2,GO MANGANESE ION TRANSPORT,0.023112,0.18772,0.18745,1,1
2,GO PROTEIN OXIDATION,0.0076456,0.1876,0.25308,1,1
2,GO RESPONSE TO MANGANESE ION,0.0080134,0.1865,0.21006,1,1
2,GO ATP BIOSYNTHETIC PROCESS,0.0052065,0.18619,0.20127,1,1
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.043559,0.18584,0.15556,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.026142,0.18554,0.14025,1,1
2,GO PLASMA MEMBRANE FUSION,0.012106,0.18502,0.2615,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.0044907,0.18423,0.22466,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.022172,0.18422,0.16829,1,1
2,GO DETECTION OF MECHANICAL STIMULUS,0.019548,0.18409,0.21393,1,1
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.024086,0.18334,0.19717,1,1
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.014457,0.18327,0.22296,1,1
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.027226,0.18021,0.22996,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0017696,0.17906,0.364,1,1
2,GO MESENCHYME MORPHOGENESIS,0.031957,0.17902,0.2343,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.015776,0.17863,0.21784,1,1
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0038653,0.17831,0.22552,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.012106,0.17827,0.25018,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.02951,0.17587,0.2013,1,1
2,GO INTERACTION WITH SYMBIONT,0.0057394,0.17445,0.18055,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0096484,0.17435,0.22519,1,1
2,GO TOXIN METABOLIC PROCESS,0.0057394,0.17433,0.23152,1,1
2,GO VACUOLAR ACIDIFICATION,0.0036751,0.17296,0.18296,1,1
2,GO LUNG CELL DIFFERENTIATION,0.0092139,0.17261,0.26538,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.019548,0.17244,0.23377,1,1
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0036751,0.17156,0.17184,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0083971,0.17097,0.25571,1,1
2,GO PHAGOSOME ACIDIFICATION,0.00060992,0.17096,0.21933,1,1
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.041938,0.17056,0.16294,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0034935,0.17017,0.19065,1,1
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.025096,0.17015,0.16969,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.020391,0.16964,0.21249,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.010101,0.16943,0.19387,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0017696,0.1692,0.21821,1,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00096503,0.16917,0.20829,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.024086,0.16893,0.15591,1,1
2,GO NADP METABOLIC PROCESS,0.0014241,0.16872,0.20584,1,1
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.007293,0.16862,0.2841,1,1
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.034576,0.1684,0.18871,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.027226,0.16793,0.24329,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.013834,0.16786,0.19663,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0028457,0.16785,0.21425,1,1
2,GO IRON ION HOMEOSTASIS,0.0020776,0.16762,0.20982,1,1
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.041938,0.16754,0.189,1,1
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0034935,0.16751,0.21811,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0020776,0.16737,0.18496,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.046961,0.16724,0.16654,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.038848,0.16716,0.15785,1,1
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.017954,0.16661,0.18453,1,1
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.026142,0.16639,0.22668,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,0.027226,0.16594,0.19089,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.023112,0.1659,0.16287,1,1
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.015776,0.16493,0.18179,1,1
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.016475,0.16314,0.2822,1,1
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.024086,0.16256,0.19358,1,1
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.043559,0.16153,0.16862,1,1
2,GO VITAMIN TRANSPORT,0.006955,0.16151,0.19712,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.014457,0.16135,0.27381,1,1
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0052065,0.16051,0.17598,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.023112,0.16045,0.21147,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.0060238,0.16011,0.20679,1,1
2,GO CATECHOLAMINE METABOLIC PROCESS,0.028348,0.1599,0.17482,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.040368,0.15914,0.15976,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.020391,0.15689,0.24076,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0034935,0.1558,0.19013,1,1
2,GO REGULATION OF ENDOCRINE PROCESS,0.021265,0.15508,0.19867,1,1
2,GO DETOXIFICATION,0.016475,0.15457,0.14339,1,1
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.022172,0.15279,0.24135,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.033245,0.15272,0.26829,1,1
2,GO MUSCLE ADAPTATION,0.028348,0.15204,0.17434,1,1
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.038848,0.15174,0.19235,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0029965,0.15125,0.2131,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.013834,0.15082,0.16486,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0049572,0.14995,0.19741,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0024341,0.14917,0.1461,1,1
2,GO CARBOHYDRATE TRANSPORT,0.01266,0.14895,0.16095,1,1
2,GO POSITIVE REGULATION OF CELL AGING,0.026142,0.14894,0.14474,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.015104,0.14891,0.15285,1,1
2,GO PLASMA MEMBRANE ORGANIZATION,0.024086,0.14817,0.19954,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.024086,0.14801,0.16075,1,1
2,GO IRON ION TRANSPORT,0.0015041,0.14701,0.19407,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.018736,0.14665,0.17508,1,1
2,GO NAD METABOLIC PROCESS,0.0031545,0.14595,0.22016,1,1
2,GO ER OVERLOAD RESPONSE,0.011574,0.14566,0.19725,1,1
2,GO MESONEPHROS DEVELOPMENT,0.046961,0.14557,0.16094,1,1
2,GO DEVELOPMENTAL INDUCTION,0.028348,0.1449,0.17774,1,1
2,GO ANIMAL ORGAN REGENERATION,0.0025648,0.14473,0.20833,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.026142,0.1442,0.18894,1,1
2,GO MUSCLE FILAMENT SLIDING,0.035953,0.14414,0.11019,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.026142,0.14389,0.13387,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.022172,0.14368,0.19672,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.027226,0.14353,0.17071,1,1
2,GO STEROID METABOLIC PROCESS,0.0047188,0.14288,0.16889,1,1
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.027226,0.14269,0.15511,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.019548,0.14255,0.14633,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0054671,0.14229,0.19171,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0024341,0.14209,0.20214,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0063209,0.14094,0.19425,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.018736,0.14091,0.17097,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0012071,0.14054,0.1852,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.045233,0.14044,0.16248,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0057394,0.13991,0.19603,1,1
2,GO REGULATION OF FIBROBLAST MIGRATION,0.050584,0.13986,0.17847,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.048745,0.13925,0.18033,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.021265,0.13908,0.15432,1,1
2,GO RESPONSE TO METAL ION,0.0057394,0.13772,0.16281,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0015041,0.13767,0.16813,1,1
2,GO REGULATION OF VASCULAR PERMEABILITY,0.0172,0.13698,0.22139,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.052482,0.13654,0.13608,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.018736,0.13563,0.15942,1,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.037377,0.13484,0.17929,1,1
2,GO RUFFLE ASSEMBLY,0.017954,0.13405,0.17089,1,1
2,GO REGULATION OF MUSCLE ADAPTATION,0.02951,0.13383,0.17818,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.052482,0.13348,0.14831,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0096484,0.13346,0.1763,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.008797,0.13338,0.17708,1,1
2,GO FIBROBLAST MIGRATION,0.037377,0.13335,0.17849,1,1
2,GO AMINE METABOLIC PROCESS,0.00076864,0.13298,0.16158,1,1
2,GO ANOIKIS,0.038848,0.13281,0.21552,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.012106,0.13258,0.1573,1,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.026142,0.1325,0.12805,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.033245,0.13245,0.13564,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.052482,0.13184,0.15155,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0066311,0.13124,0.15418,1,1
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.050584,0.13067,0.1585,1,1
2,GO COPPER ION HOMEOSTASIS,0.012106,0.1304,0.17153,1,1
2,GO RESPONSE TO HYPEROXIA,0.0172,0.12984,0.20262,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.010101,0.12878,0.17876,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0057394,0.12855,0.18551,1,1
2,GO AUTOPHAGIC CELL DEATH,0.01266,0.12799,0.19382,1,1
2,GO MAINTENANCE OF CELL POLARITY,0.040368,0.12758,0.19505,1,1
2,GO MIDBODY ABSCISSION,0.010101,0.12539,0.14063,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.007293,0.12451,0.15046,1,1
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0076456,0.12446,0.13556,1,1
2,GO ETHER METABOLIC PROCESS,0.038848,0.12442,0.14026,1,1
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.043559,0.12404,0.13543,1,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.007293,0.12341,0.14301,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.028348,0.12315,0.16324,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.034576,0.12298,0.14043,1,1
2,GO RESPONSE TO COLD,0.026142,0.12278,0.17552,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.045233,0.12269,0.10487,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0076456,0.12213,0.16312,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0049572,0.12148,0.16516,1,1
2,GO NUCLEOTIDE TRANSPORT,0.050584,0.12104,0.13948,1,1
2,GO CHONDROCYTE DEVELOPMENT,0.023112,0.12073,0.29892,1,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.0092139,0.11911,0.14694,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.017954,0.11884,0.15625,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.037377,0.11821,0.12921,1,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.028348,0.11708,0.18054,1,1
2,GO RESPONSE TO ETHANOL,0.0080134,0.11684,0.1549,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.011574,0.11681,0.18032,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.022172,0.1168,0.14173,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.050584,0.11601,0.16145,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0015882,0.11525,0.21356,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.018736,0.11525,0.16999,1,1
2,GO SPLEEN DEVELOPMENT,0.035953,0.11442,0.13511,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0012758,0.11286,0.16426,1,1
2,GO RESPONSE TO CADMIUM ION,0.038848,0.11181,0.14059,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.033245,0.11167,0.12842,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.013235,0.11136,0.16797,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.035953,0.11093,0.17586,1,1
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0172,0.11057,0.14018,1,1
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.043559,0.10949,0.14949,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.013834,0.10912,0.14509,1,1
2,GO SPHINGOLIPID METABOLIC PROCESS,0.045233,0.10807,0.14487,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.050584,0.10609,0.13863,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.02951,0.10593,0.12085,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.043559,0.1029,0.1764,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.034576,0.10284,0.14785,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0036751,0.10228,0.16213,1,1
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0172,0.10134,0.11049,1,1
2,GO MESODERM MORPHOGENESIS,0.030713,0.10118,0.18903,1,1
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.048745,0.10094,0.11402,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.026142,0.097227,0.14667,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.030713,0.09571,0.17488,1,1
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.030713,0.095114,0.10548,1,1
2,GO VESICLE TARGETING,0.040368,0.094208,0.13243,1,1
2,GO COPII COATED VESICLE BUDDING,0.043559,0.093829,0.13388,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.031957,0.093413,0.1296,1,1
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0076456,0.093205,0.11028,1,1
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.045233,0.0893,0.12884,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.01266,0.089233,0.10793,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012106,0.088761,0.14871,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.046961,0.087555,0.13416,1,1
2,GO VESICLE ORGANIZATION,0.027226,0.085925,0.14324,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.041938,0.083431,0.13256,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.033245,0.071949,0.11898,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.00091199,0.07098,0.10724,1,1
2,GO OXIDATION REDUCTION PROCESS,0.018736,0.06775,0.11199,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.023112,0.06742,0.12044,1,1
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.010101,0.78339,0.68224,1,0
2,GO T CELL TOLERANCE INDUCTION,0.015776,0.7165,0.59313,1,0
2,GO TOLERANCE INDUCTION,0.013235,0.68399,0.59964,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,0.008797,0.68096,0.62907,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0054671,0.67938,0.61984,1,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0018673,0.65222,0.60008,1,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0042727,0.63284,0.55861,1,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.040368,0.61874,0.445,1,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0029965,0.61807,0.51868,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.013834,0.61712,0.48729,1,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.016475,0.61431,0.48556,1,0
2,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.007293,0.60494,0.48154,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.012106,0.60364,0.51411,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0044907,0.59582,0.58712,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0040644,0.5957,0.52123,1,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.010572,0.59417,0.5382,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0049572,0.59012,0.4439,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0052065,0.58752,0.49408,1,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0025648,0.58614,0.53696,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.035953,0.58212,0.47108,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0083971,0.58084,0.51802,1,0
2,GO T CELL CHEMOTAXIS,0.010572,0.57798,0.48289,1,0
2,GO POSITIVE T CELL SELECTION,0.012106,0.57287,0.42215,1,0
2,GO MONOCYTE CHEMOTAXIS,0.0038653,0.57117,0.51193,1,0
2,GO ADHESION OF SYMBIONT TO HOST,0.0034935,0.56818,0.55144,1,0
2,GO CELLULAR DEFENSE RESPONSE,0.0034935,0.56389,0.51556,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0047188,0.5632,0.53371,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.0063209,0.55612,0.47236,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.027226,0.55543,0.42595,1,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.007293,0.55185,0.45347,1,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.006955,0.54979,0.5636,1,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0060238,0.54786,0.46461,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.012106,0.54598,0.4745,1,0
2,GO DENDRITIC CELL MIGRATION,0.0060238,0.54495,0.4755,1,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.010572,0.54382,0.40409,1,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.013834,0.54374,0.44365,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0025648,0.53677,0.44254,1,0
2,GO INTERLEUKIN 12 PRODUCTION,0.0044907,0.535,0.45885,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.007293,0.53263,0.45154,1,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0092139,0.5321,0.43087,1,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.0076456,0.53069,0.49474,1,0
2,GO RESPONSE TO PROTOZOAN,0.0092139,0.52329,0.44256,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0092139,0.52262,0.43218,1,0
2,GO LEUKOCYTE AGGREGATION,0.016475,0.5214,0.45628,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0027019,0.51917,0.46356,1,0
2,GO T CELL SELECTION,0.008797,0.51761,0.39902,1,0
2,GO GERMINAL CENTER FORMATION,0.0029965,0.51736,0.49714,1,0
2,GO NEUTROPHIL CHEMOTAXIS,0.0044907,0.51584,0.45163,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0063209,0.51454,0.46532,1,0
2,GO DETECTION OF OTHER ORGANISM,0.0044907,0.51418,0.44466,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0080134,0.51169,0.42067,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0172,0.50862,0.37131,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0063209,0.50834,0.51565,1,0
2,GO NEGATIVE T CELL SELECTION,0.013235,0.50546,0.46783,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0031545,0.5034,0.48914,1,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.019548,0.50321,0.45877,1,0
2,GO CYTOLYSIS,0.006955,0.50211,0.52739,1,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0057394,0.49928,0.44778,1,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.0025648,0.49786,0.45635,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0042727,0.49781,0.45391,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0080134,0.49683,0.44964,1,0
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.008797,0.49596,0.45987,1,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.0042727,0.49544,0.4262,1,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0080134,0.49281,0.45073,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0063209,0.4927,0.46545,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.008797,0.48929,0.45217,1,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.0076456,0.48538,0.44271,1,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.010572,0.48479,0.42232,1,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.010572,0.48364,0.39466,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0060238,0.48227,0.42974,1,0
2,GO RESPONSE TO INTERLEUKIN 15,0.0044907,0.48225,0.50162,1,0
2,GO TYPE 2 IMMUNE RESPONSE,0.0063209,0.48189,0.43443,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.012106,0.48096,0.42895,1,0
2,GO THYMIC T CELL SELECTION,0.01266,0.47837,0.39309,1,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.016475,0.47794,0.3561,1,0
2,GO COMPLEMENT ACTIVATION,0.0029965,0.47738,0.50027,1,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.017954,0.47654,0.3637,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0049572,0.47249,0.4222,1,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0080134,0.47207,0.41331,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0092139,0.47194,0.39659,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0080134,0.4692,0.43944,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.01266,0.46729,0.3407,1,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0015882,0.46588,0.49072,1,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0052065,0.46476,0.42623,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.007293,0.46425,0.45243,1,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0034935,0.46273,0.41092,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.015776,0.46255,0.36802,1,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.008797,0.46246,0.44373,1,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.0092139,0.46196,0.37718,1,0
2,GO RESPONSE TO CHEMOKINE,0.015104,0.4602,0.38771,1,0
2,GO RESPONSE TO TYPE I INTERFERON,0.0092139,0.45857,0.38466,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.026142,0.45668,0.37781,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.007293,0.45668,0.39789,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.015104,0.45655,0.41153,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0063209,0.456,0.39651,1,0
2,GO T CELL EXTRAVASATION,0.013235,0.45435,0.36499,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013834,0.45367,0.41322,1,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0036751,0.45131,0.43415,1,0
2,GO REGULATION OF CELL KILLING,0.0076456,0.45054,0.38386,1,0
2,GO RESPONSE TO INTERFERON BETA,0.0047188,0.44943,0.42234,1,0
2,GO NEUROINFLAMMATORY RESPONSE,0.008797,0.44902,0.40146,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024341,0.44703,0.4202,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.007293,0.44685,0.37584,1,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0052065,0.44527,0.38509,1,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.012106,0.44519,0.41848,1,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0057394,0.44487,0.38729,1,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00091199,0.44486,0.48069,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.006955,0.4447,0.39503,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.0092139,0.44136,0.4016,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0092139,0.43997,0.40632,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0054671,0.43987,0.41112,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.0052065,0.43825,0.43498,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0066311,0.43709,0.36205,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0060238,0.433,0.36871,1,0
2,GO GLIAL CELL ACTIVATION,0.011574,0.43293,0.41282,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.011063,0.43277,0.36434,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.011063,0.43267,0.35901,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0057394,0.43045,0.39178,1,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.010101,0.42937,0.41266,1,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.008797,0.42861,0.42147,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.006955,0.42602,0.37736,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0172,0.42437,0.34371,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.011063,0.42308,0.38592,1,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.0054671,0.42276,0.39702,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.013834,0.42168,0.35279,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.0054671,0.42163,0.34608,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0052065,0.42086,0.38504,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.0076456,0.42063,0.4003,1,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010572,0.42045,0.35548,1,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.010101,0.41812,0.39493,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0096484,0.41791,0.37258,1,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.008797,0.41735,0.3607,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.008797,0.41711,0.36398,1,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.011063,0.41553,0.37032,1,0
2,GO CELL KILLING,0.0076456,0.41477,0.36004,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0080134,0.41441,0.37541,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.019548,0.41436,0.34673,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.01266,0.41422,0.34407,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0172,0.414,0.37436,1,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0060238,0.41397,0.40924,1,0
2,GO T CELL MEDIATED IMMUNITY,0.006955,0.41377,0.3569,1,0
2,GO APOPTOTIC CELL CLEARANCE,0.0049572,0.41353,0.4036,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0080134,0.4135,0.37844,1,0
2,GO INTERLEUKIN 5 PRODUCTION,0.0092139,0.41349,0.34672,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0042727,0.41308,0.3752,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0096484,0.4123,0.36845,1,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0024341,0.41197,0.35787,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0096484,0.41148,0.37634,1,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.013834,0.41101,0.39616,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010572,0.41074,0.37539,1,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0076456,0.41025,0.40151,1,0
2,GO INTEGRIN ACTIVATION,0.0044907,0.40933,0.4071,1,0
2,GO ASTROCYTE ACTIVATION,0.0076456,0.40864,0.33381,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.010572,0.40822,0.38859,1,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.013235,0.40804,0.3592,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0054671,0.40754,0.35687,1,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0052065,0.40618,0.38064,1,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00332,0.40453,0.40037,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0063209,0.4044,0.34881,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.0031545,0.40404,0.38498,1,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.011574,0.40358,0.35758,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.015776,0.40338,0.34695,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0083971,0.40334,0.35648,1,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.010572,0.40322,0.3661,1,0
2,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.0172,0.40305,0.30768,1,0
2,GO LYMPHOCYTE COSTIMULATION,0.012106,0.40292,0.33494,1,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0019699,0.40265,0.37619,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0096484,0.40237,0.35446,1,0
2,GO ALPHA BETA T CELL ACTIVATION,0.010572,0.40092,0.34672,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0054671,0.40092,0.3789,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.006955,0.4008,0.39331,1,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0052065,0.39991,0.37664,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.007293,0.39829,0.39847,1,0
2,GO T CELL APOPTOTIC PROCESS,0.0066311,0.398,0.35329,1,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.006955,0.39486,0.31815,1,0
2,GO LYMPH NODE DEVELOPMENT,0.008797,0.39481,0.34468,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0018673,0.39465,0.40561,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0076456,0.39376,0.37193,1,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.014457,0.39304,0.36823,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0047188,0.39207,0.33603,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.0057394,0.39195,0.35635,1,0
2,GO INTERFERON GAMMA PRODUCTION,0.0083971,0.39168,0.39607,1,0
2,GO T CELL PROLIFERATION,0.0060238,0.39161,0.38253,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.011063,0.39145,0.33411,1,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0029965,0.39142,0.36306,1,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0016767,0.38979,0.37988,1,0
2,GO T CELL LINEAGE COMMITMENT,0.0054671,0.38931,0.34776,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.015776,0.38916,0.33007,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.01266,0.38845,0.35782,1,0
2,GO CELLULAR EXTRAVASATION,0.0034935,0.38844,0.36628,1,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.0044907,0.3872,0.36736,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0083971,0.38647,0.34397,1,0
2,GO LEUKOCYTE PROLIFERATION,0.0049572,0.38522,0.36762,1,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.020391,0.38478,0.36032,1,0
2,GO MACROPHAGE PROLIFERATION,0.012106,0.38457,0.43607,1,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0052065,0.38456,0.33392,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0076456,0.38447,0.31007,1,0
2,GO CYTOKINE SECRETION,0.0052065,0.38399,0.3262,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0047188,0.3838,0.36648,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0060238,0.38372,0.36358,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.0092139,0.38363,0.31076,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0044907,0.38343,0.35699,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.006955,0.38134,0.32913,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0054671,0.3796,0.35312,1,0
2,GO T CELL DIFFERENTIATION,0.0083971,0.37955,0.30303,1,0
2,GO RESPONSE TO INTERLEUKIN 2,0.006955,0.3795,0.39115,1,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0049572,0.37945,0.33863,1,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0052065,0.3794,0.34749,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.016475,0.37775,0.35696,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.0057394,0.37761,0.33928,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0047188,0.37742,0.31983,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.010572,0.37648,0.32156,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.008797,0.37622,0.3601,1,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.006955,0.37569,0.33585,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0038653,0.37522,0.36759,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0060238,0.37476,0.34774,1,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0040644,0.37193,0.35511,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.008797,0.37187,0.3421,1,0
2,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.0063209,0.37166,0.3853,1,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.0066311,0.37107,0.36059,1,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0063209,0.36994,0.33048,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.01266,0.36946,0.31604,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0080134,0.36738,0.35712,1,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0083971,0.36733,0.32335,1,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0054671,0.36726,0.39384,1,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0083971,0.36725,0.37821,1,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.017954,0.36664,0.36356,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0076456,0.36651,0.33984,1,0
2,GO NAD BIOSYNTHETIC PROCESS,0.0036751,0.36585,0.33806,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0049572,0.36488,0.35538,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.006955,0.36254,0.33751,1,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.014457,0.36211,0.38568,1,0
2,GO MAST CELL ACTIVATION,0.0025648,0.36151,0.36985,1,0
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.016475,0.36148,0.32892,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.011063,0.36142,0.31963,1,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.010572,0.36139,0.28793,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0060238,0.36102,0.33315,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0066311,0.36088,0.32265,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0066311,0.3606,0.33401,1,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.010101,0.36025,0.37478,1,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.014457,0.3601,0.33863,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0060238,0.35883,0.33396,1,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.011574,0.35781,0.33661,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0076456,0.35769,0.3262,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0047188,0.35691,0.34824,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0021907,0.35471,0.37652,1,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.011063,0.35467,0.35102,1,0
2,GO B CELL MEDIATED IMMUNITY,0.007293,0.3535,0.3778,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.006955,0.35346,0.35689,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0044907,0.35289,0.35304,1,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.015104,0.35184,0.3379,1,0
2,GO REGULATION OF CELL ACTIVATION,0.0052065,0.35151,0.32462,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.006955,0.35024,0.33375,1,0
2,GO RESPONSE TO INTERLEUKIN 18,0.0080134,0.34897,0.39805,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.007293,0.34748,0.32937,1,0
2,GO T CELL ACTIVATION,0.0060238,0.34729,0.31968,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.012106,0.34625,0.2926,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.0029965,0.34522,0.38604,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.01266,0.3452,0.30776,1,0
2,GO CELL JUNCTION DISASSEMBLY,0.006955,0.34498,0.39086,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0066311,0.3449,0.33614,1,0
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.012106,0.34246,0.35014,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0031545,0.34245,0.34878,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0066311,0.34108,0.34505,1,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.020391,0.34107,0.33004,1,0
2,GO ACTIVATED T CELL PROLIFERATION,0.0044907,0.34022,0.31309,1,0
2,GO NEUTROPHIL EXTRAVASATION,0.023112,0.33983,0.28651,1,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.013834,0.33946,0.31638,1,0
2,GO MAST CELL MEDIATED IMMUNITY,0.0029965,0.3382,0.36392,1,0
2,GO MACROPHAGE DIFFERENTIATION,0.0076456,0.33748,0.33594,1,0
2,GO PROTEIN ACTIVATION CASCADE,0.011574,0.33561,0.3243,1,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.010572,0.3351,0.39256,1,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.0040644,0.33503,0.35539,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0054671,0.33502,0.31692,1,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.011574,0.33499,0.34647,1,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0083971,0.33383,0.3059,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.010572,0.33358,0.32772,1,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0172,0.33291,0.33967,1,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.018736,0.33192,0.28978,1,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0063209,0.33126,0.32687,1,0
2,GO PHAGOCYTOSIS RECOGNITION,0.012106,0.33091,0.32995,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0034935,0.33038,0.30354,1,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.01266,0.32928,0.31927,1,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.007293,0.32878,0.34527,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0034935,0.32853,0.33084,1,0
2,GO NATURAL KILLER CELL ACTIVATION,0.0080134,0.3278,0.32249,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0040644,0.3277,0.31751,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0052065,0.32757,0.32433,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.018736,0.32734,0.32825,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.006955,0.32702,0.29901,1,0
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.0042727,0.32633,0.43444,1,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.00332,0.3261,0.32675,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.0034935,0.32609,0.32954,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.007293,0.32553,0.30914,1,0
2,GO LEUKOCYTE HOMEOSTASIS,0.0066311,0.32432,0.27714,1,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0054671,0.32374,0.30435,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.020391,0.32373,0.27961,1,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0096484,0.32317,0.38035,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0080134,0.3229,0.3104,1,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.015776,0.32181,0.2881,1,0
2,GO RESPONSE TO PROSTAGLANDIN,0.016475,0.32143,0.26041,1,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.0015882,0.32113,0.33941,1,0
2,GO REGULATION OF CELL CELL ADHESION,0.0034935,0.3211,0.31846,1,0
2,GO REGULATION OF BONE REMODELING,0.0023095,0.32078,0.33305,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0092139,0.32039,0.29905,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0083971,0.31925,0.32445,1,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.010101,0.31872,0.31329,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.0066311,0.31853,0.27813,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.0057394,0.31712,0.39352,1,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0076456,0.3163,0.2734,1,0
2,GO INNATE IMMUNE RESPONSE,0.0054671,0.31555,0.30631,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0049572,0.3154,0.3077,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0049572,0.31507,0.29444,1,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.011063,0.31479,0.36229,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0083971,0.31436,0.31947,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.028348,0.31387,0.29191,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0076456,0.31345,0.3397,1,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.018736,0.31296,0.30287,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.010101,0.31254,0.36604,1,0
2,GO PEPTIDE CROSS LINKING,0.0083971,0.3123,0.33821,1,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.007293,0.31199,0.29059,1,0
2,GO INTERFERON ALPHA PRODUCTION,0.022172,0.31163,0.26831,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0060238,0.31073,0.29145,1,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.0096484,0.31016,0.28682,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0024341,0.30967,0.35602,1,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.010572,0.30946,0.32109,1,0
2,GO CYTIDINE TO URIDINE EDITING,0.033245,0.30943,0.2718,1,0
2,GO RESPONSE TO BACTERIUM,0.0018673,0.30898,0.31405,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.028348,0.30812,0.27873,1,0
2,GO LYMPHOCYTE ACTIVATION,0.0080134,0.30755,0.28969,1,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.052482,0.30736,0.21976,1,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0076456,0.30728,0.26196,1,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0092139,0.30693,0.32194,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00332,0.30671,0.32534,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0092139,0.30561,0.30625,1,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.012106,0.30532,0.30362,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0036751,0.30441,0.33191,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0092139,0.30414,0.30861,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0044907,0.30349,0.29785,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.0038653,0.30286,0.29909,1,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.011063,0.30273,0.3227,1,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.007293,0.30267,0.26088,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.013834,0.30244,0.301,1,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.015776,0.30229,0.26138,1,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0054671,0.30219,0.29798,1,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.006955,0.30201,0.31606,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.013834,0.3014,0.27743,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.007293,0.30103,0.28227,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.033245,0.30067,0.29433,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0040644,0.30063,0.31008,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0038653,0.30014,0.31419,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0052065,0.29891,0.30629,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0034935,0.29882,0.29891,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0031545,0.2986,0.30882,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0076456,0.29655,0.27656,1,0
2,GO B CELL ACTIVATION,0.0049572,0.29616,0.29253,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.031957,0.29608,0.24852,1,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.018736,0.29608,0.28124,1,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0066311,0.29576,0.28105,1,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.02951,0.29551,0.28583,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.019548,0.2917,0.25461,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0060238,0.29077,0.28897,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.006955,0.29058,0.29671,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.037377,0.29039,0.24321,1,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.031957,0.28895,0.2864,1,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0054671,0.2888,0.31798,1,0
2,GO REGULATION OF TISSUE REMODELING,0.0019699,0.28654,0.33497,1,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.011063,0.28645,0.28519,1,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0040644,0.28455,0.35037,1,0
2,GO REGULATION OF CHEMOTAXIS,0.0029965,0.28389,0.31092,1,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0066311,0.28243,0.2959,1,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.015776,0.28097,0.26562,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0063209,0.28065,0.25301,1,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0080134,0.28057,0.3029,1,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0092139,0.28053,0.30526,1,0
2,GO RESPONSE TO INTERLEUKIN 6,0.0034935,0.2803,0.33744,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.008797,0.27944,0.26757,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.011063,0.27838,0.29795,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0020776,0.27824,0.30763,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0063209,0.27824,0.26708,1,0
2,GO SEROTONIN SECRETION,0.038848,0.27801,0.23562,1,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0063209,0.27787,0.30022,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.011063,0.27756,0.26766,1,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0047188,0.27754,0.31568,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0096484,0.27697,0.2767,1,0
2,GO MYOBLAST FUSION,0.0027019,0.27678,0.3405,1,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0052065,0.27667,0.29614,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.006955,0.27599,0.30343,1,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.017954,0.27584,0.31976,1,0
2,GO DEFENSE RESPONSE TO VIRUS,0.011574,0.27514,0.27075,1,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.013235,0.27507,0.25992,1,0
2,GO RESPONSE TO TUMOR CELL,0.013235,0.27492,0.2899,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0057394,0.27491,0.26893,1,0
2,GO DEFENSE RESPONSE,0.0040644,0.27445,0.28504,1,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0029965,0.27445,0.30309,1,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.011574,0.27355,0.2426,1,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0049572,0.27343,0.32954,1,0
2,GO CELL ACTIVATION,0.0040644,0.27342,0.28328,1,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0076456,0.27325,0.26909,1,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.013235,0.27298,0.27162,1,0
2,GO ERK1 AND ERK2 CASCADE,0.0092139,0.27225,0.26189,1,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.043559,0.27201,0.26249,1,0
2,GO LIPOXYGENASE PATHWAY,0.0080134,0.27184,0.32182,1,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.025096,0.27133,0.2492,1,0
2,GO CYTOKINE PRODUCTION,0.0054671,0.27076,0.27852,1,0
2,GO REGULATION OF WOUND HEALING,0.0018673,0.27019,0.29225,1,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0054671,0.27002,0.37666,1,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.013834,0.26949,0.26851,1,0
2,GO MYELOID CELL APOPTOTIC PROCESS,0.0054671,0.26853,0.28991,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.0040644,0.26852,0.27445,1,0
2,GO REGULATION OF DEFENSE RESPONSE,0.0052065,0.26848,0.253,1,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0044907,0.26799,0.23364,1,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.011063,0.2679,0.26841,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0172,0.26692,0.21097,1,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.048745,0.26615,0.2671,1,0
2,GO TRABECULA FORMATION,0.014457,0.26602,0.26939,1,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0096484,0.26575,0.27329,1,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.012106,0.26567,0.28392,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0031545,0.26537,0.28153,1,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.0092139,0.26461,0.25764,1,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.027226,0.26454,0.2592,1,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0052065,0.2639,0.27982,1,0
2,GO TRANSCYTOSIS,0.006955,0.26352,0.28684,1,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0049572,0.2633,0.29027,1,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.015104,0.26281,0.2719,1,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.020391,0.26221,0.28695,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.012106,0.26214,0.26656,1,0
2,GO T CELL HOMEOSTASIS,0.0172,0.26125,0.20881,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.007293,0.26097,0.29565,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.010572,0.25989,0.23667,1,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.011063,0.25984,0.31368,1,0
2,GO NEUTROPHIL HOMEOSTASIS,0.011574,0.25984,0.33786,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0066311,0.25968,0.26503,1,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.030713,0.25907,0.25004,1,0
2,GO ACUTE PHASE RESPONSE,0.0054671,0.25891,0.30495,1,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0080134,0.25863,0.22615,1,0
2,GO TISSUE REMODELING,0.0024341,0.25838,0.32166,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.038848,0.25824,0.23737,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.015776,0.25697,0.33788,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0031545,0.25657,0.31367,1,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.024086,0.25609,0.2847,1,0
2,GO SYNCYTIUM FORMATION,0.0042727,0.25463,0.29854,1,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.031957,0.25462,0.20867,1,0
2,GO CHOLESTEROL EFFLUX,0.016475,0.25398,0.22396,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.011063,0.2539,0.23711,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.0066311,0.25388,0.2669,1,0
2,GO COLLAGEN METABOLIC PROCESS,0.010572,0.2533,0.36016,1,0
2,GO PINOCYTOSIS,0.035953,0.25275,0.22743,1,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0080134,0.25201,0.28921,1,0
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.034576,0.25195,0.29659,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.021265,0.25095,0.2294,1,0
2,GO B CELL HOMEOSTASIS,0.01266,0.25094,0.24771,1,0
2,GO RESPONSE TO INTERLEUKIN 4,0.017954,0.24785,0.22619,1,0
2,GO REGULATION OF CELL ADHESION,0.0038653,0.24726,0.28504,1,0
2,GO REGULATION OF LIPASE ACTIVITY,0.019548,0.24673,0.20717,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0083971,0.24655,0.26402,1,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.022172,0.24629,0.25567,1,0
2,GO OSTEOCLAST DEVELOPMENT,0.0092139,0.24626,0.3279,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0080134,0.24617,0.24656,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.011574,0.2458,0.23627,1,0
2,GO RESPONSE TO INTERLEUKIN 7,0.0066311,0.24568,0.26923,1,0
2,GO RESPONSE TO VIRUS,0.014457,0.24511,0.24853,1,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.006955,0.24437,0.27191,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0028457,0.24432,0.25374,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.0040644,0.24411,0.28684,1,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0092139,0.24347,0.29453,1,0
2,GO SEQUESTERING OF METAL ION,0.024086,0.24192,0.18582,1,0
2,GO COLLAGEN CATABOLIC PROCESS,0.0096484,0.24168,0.38805,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.006955,0.24164,0.21868,1,0
2,GO COAGULATION,0.0083971,0.24117,0.24078,1,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.046961,0.24044,0.24147,1,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.014457,0.23971,0.22078,1,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.010572,0.23958,0.26602,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0052065,0.23956,0.26415,1,0
2,GO ASTROCYTE DEVELOPMENT,0.015776,0.23858,0.27193,1,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0066311,0.23836,0.34402,1,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.033245,0.23803,0.23345,1,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013834,0.23801,0.26269,1,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.011063,0.23656,0.26159,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0047188,0.23599,0.2571,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0044907,0.2357,0.26729,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.015776,0.23554,0.24561,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0018673,0.23544,0.29276,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0080134,0.23532,0.22622,1,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.011063,0.23479,0.24089,1,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.013235,0.23463,0.28097,1,0
2,GO BONE REMODELING,0.0029965,0.23449,0.29996,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.016475,0.23432,0.20045,1,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0096484,0.23304,0.26483,1,0
2,GO OSTEOCLAST DIFFERENTIATION,0.0076456,0.23219,0.27274,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.02951,0.23217,0.25439,1,0
2,GO I KAPPAB PHOSPHORYLATION,0.026142,0.23137,0.23091,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.011063,0.23107,0.2432,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0012071,0.23105,0.25256,1,0
2,GO RESPONSE TO CYTOKINE,0.0049572,0.23069,0.25725,1,0
2,GO ACTIN FILAMENT SEVERING,0.018736,0.23063,0.2631,1,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.030713,0.23046,0.21005,1,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.027226,0.23003,0.20204,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.011063,0.22942,0.2372,1,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.024086,0.22931,0.25542,1,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.013834,0.22897,0.29215,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.011063,0.22872,0.20569,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.006955,0.22817,0.27801,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.050584,0.22774,0.24194,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.007293,0.22768,0.22868,1,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.019548,0.22758,0.25128,1,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.010101,0.22699,0.26704,1,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0063209,0.22679,0.23602,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0025648,0.22659,0.21799,1,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0060238,0.22626,0.23594,1,0
2,GO P38MAPK CASCADE,0.015776,0.22621,0.25145,1,0
2,GO SERTOLI CELL DIFFERENTIATION,0.048745,0.22515,0.19243,1,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.022172,0.22511,0.26977,1,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.008797,0.2249,0.25281,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0096484,0.22473,0.27225,1,0
2,GO REGULATION OF BODY FLUID LEVELS,0.022172,0.22456,0.21151,1,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0038653,0.2242,0.29986,1,0
2,GO SEQUESTERING OF CALCIUM ION,0.0054671,0.22376,0.24094,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0066311,0.22305,0.24386,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0083971,0.22305,0.2649,1,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.034576,0.22266,0.22486,1,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.045233,0.22232,0.23826,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0080134,0.22201,0.23091,1,0
2,GO BILE ACID AND BILE SALT TRANSPORT,0.011574,0.22152,0.21966,1,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.027226,0.22111,0.21173,1,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.01266,0.22083,0.24715,1,0
2,GO BONE CELL DEVELOPMENT,0.018736,0.22064,0.24903,1,0
2,GO REGULATION OF LIPID STORAGE,0.015776,0.22033,0.23315,1,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.013834,0.22003,0.2504,1,0
2,GO WOUND HEALING,0.0083971,0.21957,0.24637,1,0
2,GO PULMONARY VALVE DEVELOPMENT,0.052482,0.2192,0.22749,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.017954,0.21875,0.22475,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.046961,0.21842,0.32892,1,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.023112,0.21828,0.22343,1,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.018736,0.21804,0.24318,1,0
2,GO TRABECULA MORPHOGENESIS,0.043559,0.21764,0.22507,1,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0047188,0.21728,0.27572,1,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.013834,0.21673,0.30771,1,0
2,GO REGULATION OF STEROL TRANSPORT,0.017954,0.21665,0.21092,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0083971,0.2165,0.25737,1,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.022172,0.21639,0.24921,1,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.019548,0.21533,0.1858,1,0
2,GO REGULATION OF RECEPTOR BINDING,0.022172,0.21517,0.25971,1,0
2,GO RESPONSE TO NITRIC OXIDE,0.0096484,0.21455,0.20473,1,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.011063,0.21411,0.20095,1,0
2,GO PROTEIN TRIMERIZATION,0.012106,0.21299,0.26321,1,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0076456,0.21276,0.25701,1,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.028348,0.21262,0.2474,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.046961,0.21231,0.22809,1,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0083971,0.21216,0.25269,1,0
2,GO PROSTAGLANDIN TRANSPORT,0.0080134,0.21189,0.24862,1,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.02951,0.21184,0.20798,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01266,0.21166,0.23587,1,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.043559,0.21128,0.18188,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.012106,0.21091,0.29357,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.037377,0.21087,0.23269,1,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.01266,0.21078,0.25527,1,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.034576,0.21041,0.19457,1,0
2,GO B CELL DIFFERENTIATION,0.0066311,0.20996,0.26172,1,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0172,0.20988,0.31162,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.025096,0.20949,0.22691,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.028348,0.20904,0.22751,1,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0172,0.20879,0.20769,1,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0096484,0.20875,0.25053,1,0
2,GO RESPONSE TO HYDROPEROXIDE,0.028348,0.20853,0.25569,1,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.008797,0.20831,0.22372,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0080134,0.20816,0.27195,1,0
2,GO VAGINA DEVELOPMENT,0.045233,0.2081,0.2224,1,0
2,GO PROTEIN NITROSYLATION,0.0054671,0.20803,0.2187,1,0
2,GO EXOCYTOSIS,0.0025648,0.20786,0.24055,1,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.007293,0.20646,0.23673,1,0
2,GO NECROTIC CELL DEATH,0.0057394,0.20583,0.21454,1,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.014457,0.20567,0.24917,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.025096,0.20544,0.27695,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.031957,0.20511,0.30227,1,0
2,GO DECIDUALIZATION,0.022172,0.20504,0.31804,1,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.023112,0.20502,0.16777,1,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.052482,0.20466,0.20691,1,0
2,GO RENAL ABSORPTION,0.026142,0.20434,0.26495,1,0
2,GO SECRETION BY TISSUE,0.014457,0.20422,0.18158,1,0
2,GO REGULATION OF BONE MINERALIZATION,0.019548,0.2042,0.23726,1,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.015104,0.20404,0.26502,1,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.028348,0.20337,0.20298,1,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.031957,0.20334,0.25243,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.028348,0.20274,0.2268,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.027226,0.20258,0.23115,1,0
2,GO NIK NF KAPPAB SIGNALING,0.013834,0.20257,0.1889,1,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.037377,0.20242,0.18202,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.030713,0.20218,0.23702,1,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.038848,0.20141,0.22191,1,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0076456,0.20077,0.1884,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.040368,0.20072,0.21798,1,0
2,GO RESPONSE TO AMYLOID BETA,0.028348,0.20064,0.25546,1,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.021265,0.20039,0.22144,1,0
2,GO PHOSPHOLIPID TRANSPORT,0.020391,0.20016,0.19843,1,0
2,GO GRANULOCYTE DIFFERENTIATION,0.02951,0.1998,0.22451,1,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.026142,0.19911,0.20058,1,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.015104,0.19892,0.21578,1,0
2,GO CELL SUBSTRATE ADHESION,0.019548,0.19819,0.24919,1,0
2,GO BIOMINERALIZATION,0.016475,0.19789,0.22274,1,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.031957,0.19769,0.24749,1,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.030713,0.1976,0.2305,1,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0080134,0.19756,0.26347,1,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.011574,0.19745,0.24295,1,0
2,GO RESPONSE TO WOUNDING,0.017954,0.19727,0.22453,1,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.014457,0.19721,0.23523,1,0
2,GO ETHANOL OXIDATION,0.040368,0.19681,0.24131,1,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.035953,0.19633,0.32656,1,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.015776,0.1963,0.20029,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.014457,0.1962,0.23272,1,0
2,GO CGMP MEDIATED SIGNALING,0.040368,0.19617,0.18633,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.0066311,0.19592,0.22432,1,0
2,GO TYPE I INTERFERON PRODUCTION,0.02951,0.19567,0.19421,1,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.006955,0.19564,0.20448,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.026142,0.19517,0.20793,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0096484,0.19437,0.22919,1,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.017954,0.19423,0.1882,1,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.018736,0.19383,0.2305,1,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0083971,0.19287,0.20412,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.016475,0.1924,0.21077,1,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.018736,0.19238,0.2213,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.0038653,0.19237,0.21809,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.043559,0.19203,0.22071,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.050584,0.19159,0.22068,1,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0080134,0.19143,0.23771,1,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.031957,0.19106,0.22484,1,0
2,GO RESPONSE TO DEXAMETHASONE,0.011574,0.19068,0.18449,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0063209,0.19063,0.2386,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.008797,0.19004,0.2105,1,0
2,GO TISSUE MIGRATION,0.025096,0.18941,0.21347,1,0
2,GO CELL CELL RECOGNITION,0.0034935,0.18915,0.20779,1,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0057394,0.18911,0.22997,1,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0083971,0.18905,0.20813,1,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0092139,0.189,0.22368,1,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.021265,0.18824,0.20983,1,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.038848,0.18793,0.22103,1,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.013235,0.18784,0.19528,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.026142,0.18752,0.22,1,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.015776,0.18663,0.27863,1,0
2,GO AMYLOID FIBRIL FORMATION,0.025096,0.18662,0.23947,1,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.013834,0.18653,0.19807,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.0076456,0.18586,0.18527,1,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.012106,0.18551,0.18588,1,0
2,GO PROTEIN KINASE B SIGNALING,0.018736,0.18543,0.20474,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0092139,0.18524,0.24712,1,0
2,GO CELL ADHESION MOLECULE PRODUCTION,0.026142,0.18513,0.28375,1,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016475,0.18497,0.2308,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.01266,0.18468,0.1996,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0083971,0.18461,0.21592,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.035953,0.18441,0.24532,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.014457,0.18434,0.20688,1,0
2,GO RESPONSE TO ISCHEMIA,0.013834,0.18371,0.2223,1,0
2,GO RESPONSE TO RETINOIC ACID,0.023112,0.1837,0.1987,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041938,0.18324,0.21436,1,0
2,GO CELLULAR RESPONSE TO DSRNA,0.023112,0.1829,0.22339,1,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.028348,0.18278,0.2311,1,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.025096,0.18243,0.24533,1,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.050584,0.18233,0.22795,1,0
2,GO MYOTUBE DIFFERENTIATION,0.031957,0.18193,0.19418,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.038848,0.18173,0.1785,1,0
2,GO DIET INDUCED THERMOGENESIS,0.045233,0.18164,0.151,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.012106,0.18164,0.19507,1,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.041938,0.18127,0.20979,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.010572,0.18125,0.20788,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.008797,0.18098,0.23915,1,0
2,GO REGULATION OF BIOMINERALIZATION,0.022172,0.18031,0.21747,1,0
2,GO REGULATION OF HEMOPOIESIS,0.011063,0.18021,0.212,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.015104,0.17925,0.23725,1,0
2,GO PHAGOSOME MATURATION,0.00096503,0.17924,0.22903,1,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.024086,0.17878,0.16622,1,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.025096,0.17812,0.21259,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.0044907,0.17805,0.19257,1,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0076456,0.17789,0.22967,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.026142,0.17786,0.21799,1,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0038653,0.17786,0.27755,1,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.027226,0.17762,0.23175,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0025648,0.17761,0.23886,1,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.030713,0.17743,0.21145,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.043559,0.1772,0.2114,1,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.050584,0.1771,0.2693,1,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.027226,0.17705,0.31001,1,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.034576,0.1765,0.29112,1,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.031957,0.1764,0.22626,1,0
2,GO PROTEIN PROCESSING,0.0021907,0.17634,0.21508,1,0
2,GO CELL CELL ADHESION,0.015776,0.1763,0.21737,1,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.014457,0.17612,0.23132,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0031545,0.17555,0.24594,1,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.052482,0.17485,0.2073,1,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.013834,0.17477,0.21998,1,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.034576,0.17456,0.20805,1,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0096484,0.17423,0.18141,1,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.026142,0.17414,0.17134,1,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.045233,0.17378,0.20532,1,0
2,GO CELLULAR ION HOMEOSTASIS,0.0092139,0.1737,0.18001,1,0
2,GO SECRETION,0.0066311,0.17337,0.20289,1,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0092139,0.17334,0.19183,1,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.013834,0.17309,0.24493,1,0
2,GO LIPID LOCALIZATION,0.011574,0.17266,0.18686,1,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.045233,0.17257,0.15641,1,0
2,GO INTERFERON BETA PRODUCTION,0.038848,0.17172,0.20382,1,0
2,GO HYALURONAN METABOLIC PROCESS,0.014457,0.17168,0.23234,1,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0080134,0.17131,0.21907,1,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.035953,0.17097,0.23746,1,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.046961,0.17089,0.20834,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0060238,0.17059,0.20929,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.018736,0.17036,0.19486,1,0
2,GO CELLULAR RESPONSE TO VIRUS,0.050584,0.17022,0.17264,1,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0029965,0.17012,0.21521,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.035953,0.16998,0.21173,1,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.020391,0.16992,0.29493,1,0
2,GO BIOLOGICAL ADHESION,0.024086,0.16921,0.21821,1,0
2,GO RESPONSE TO LIPID,0.015776,0.16894,0.19277,1,0
2,GO METAL ION HOMEOSTASIS,0.0083971,0.16839,0.18777,1,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.016475,0.16791,0.17066,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0172,0.16749,0.20401,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,0.0092139,0.16727,0.1953,1,0
2,GO INTERACTION WITH HOST,0.0052065,0.16716,0.21541,1,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.037377,0.16669,0.17107,1,0
2,GO PYROPTOSIS,0.048745,0.16653,0.18936,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.045233,0.16647,0.22279,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.008797,0.16636,0.20043,1,0
2,GO MYELOID CELL DEVELOPMENT,0.041938,0.16609,0.19811,1,0
2,GO FATTY ACID TRANSPORT,0.0057394,0.16587,0.1895,1,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.048745,0.1658,0.1869,1,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.052482,0.16574,0.20227,1,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011574,0.16555,0.20879,1,0
2,GO RESPONSE TO INTERLEUKIN 12,0.012106,0.16512,0.16545,1,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.045233,0.16505,0.19885,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.019548,0.16502,0.2105,1,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.026142,0.16488,0.21431,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.045233,0.16463,0.14309,1,0
2,GO LIPID CATABOLIC PROCESS,0.012106,0.16447,0.17399,1,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.023112,0.16408,0.19226,1,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.011063,0.164,0.17542,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.031957,0.164,0.21703,1,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.025096,0.16332,0.228,1,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.02951,0.16301,0.17848,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.014457,0.16296,0.21723,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.023112,0.16256,0.19526,1,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.048745,0.16249,0.15437,1,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0049572,0.16241,0.19794,1,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.037377,0.16173,0.18186,1,0
2,GO EMBRYO IMPLANTATION,0.0044907,0.16161,0.28657,1,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.038848,0.16118,0.21032,1,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.041938,0.1608,0.18249,1,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.035953,0.16063,0.21107,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.013235,0.16036,0.187,1,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0083971,0.16033,0.18797,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.033245,0.16031,0.20957,1,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.034576,0.16026,0.23796,1,0
2,GO REGULATION OF VASOCONSTRICTION,0.033245,0.16004,0.20897,1,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.040368,0.15976,0.21306,1,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.015104,0.15961,0.19855,1,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.043559,0.15957,0.20736,1,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.033245,0.15881,0.16347,1,0
2,GO LIPID TRANSLOCATION,0.043559,0.1581,0.20308,1,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.01266,0.1581,0.1983,1,0
2,GO TAXIS,0.045233,0.15793,0.19224,1,0
2,GO PEPTIDE SECRETION,0.010101,0.15792,0.18435,1,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.037377,0.15792,0.18433,1,0
2,GO ION HOMEOSTASIS,0.011574,0.15784,0.17452,1,0
2,GO ENDODERM FORMATION,0.050584,0.15777,0.25685,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.041938,0.15766,0.20018,1,0
2,GO REGULATION OF MAPK CASCADE,0.023112,0.1576,0.19712,1,0
2,GO MYELIN MAINTENANCE,0.052482,0.15758,0.21476,1,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.013235,0.15743,0.18655,1,0
2,GO REGULATION OF LIPID LOCALIZATION,0.013235,0.15736,0.19216,1,0
2,GO CALCIUM MEDIATED SIGNALING,0.019548,0.15725,0.17831,1,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.040368,0.15719,0.17662,1,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.011574,0.15665,0.25192,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.02951,0.15634,0.17365,1,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.034576,0.15623,0.19532,1,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.035953,0.15584,0.23662,1,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.045233,0.15537,0.18856,1,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.026142,0.15529,0.22934,1,0
2,GO REGULATION OF PROTEIN MATURATION,0.015104,0.15512,0.19146,1,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.038848,0.15502,0.15087,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.015776,0.1546,0.19075,1,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.023112,0.15459,0.18941,1,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.046961,0.15455,0.22434,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0083971,0.15372,0.17327,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.031957,0.15347,0.22964,1,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.014457,0.15341,0.19257,1,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.022172,0.15328,0.15943,1,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.033245,0.15281,0.20221,1,0
2,GO RESPONSE TO DSRNA,0.020391,0.15271,0.18746,1,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.043559,0.15271,0.18439,1,0
2,GO REGULATION OF LIPID TRANSPORT,0.0096484,0.15252,0.1871,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.015104,0.15174,0.19575,1,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.043559,0.15165,0.17936,1,0
2,GO RESPONSE TO VITAMIN,0.013235,0.15144,0.22419,1,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.02951,0.15141,0.20779,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.016475,0.15122,0.21402,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.027226,0.15117,0.19034,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0172,0.15114,0.11863,1,0
2,GO DIGESTION,0.0080134,0.15089,0.17337,1,0
2,GO MUSCLE CELL PROLIFERATION,0.0172,0.15086,0.21021,1,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.043559,0.15085,0.15616,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.016475,0.15073,0.18983,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.024086,0.15053,0.17664,1,0
2,GO ARGININE METABOLIC PROCESS,0.040368,0.15028,0.14314,1,0
2,GO LIPID STORAGE,0.01266,0.14972,0.20592,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.019548,0.14969,0.18865,1,0
2,GO VASCULATURE DEVELOPMENT,0.038848,0.14955,0.21606,1,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.052482,0.14937,0.19106,1,0
2,GO REGULATION OF CELL SHAPE,0.045233,0.1492,0.20146,1,0
2,GO PROTEIN MATURATION,0.0057394,0.14888,0.17146,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.034576,0.14876,0.23589,1,0
2,GO LIPID HOMEOSTASIS,0.034576,0.14861,0.1663,1,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.030713,0.14835,0.17799,1,0
2,GO REGULATION OF OSSIFICATION,0.0172,0.14701,0.21524,1,0
2,GO RESPONSE TO GROWTH HORMONE,0.02951,0.14677,0.16593,1,0
2,GO ENDOCYTOSIS,0.050584,0.14662,0.17908,1,0
2,GO PROTEIN AUTOPROCESSING,0.017954,0.14656,0.17759,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.021265,0.14641,0.15865,1,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.016475,0.14632,0.19033,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.019548,0.14524,0.17806,1,0
2,GO OSSIFICATION,0.019548,0.14493,0.20673,1,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045233,0.14489,0.19431,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.035953,0.14481,0.15738,1,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.026142,0.14479,0.18643,1,0
2,GO TISSUE HOMEOSTASIS,0.040368,0.14457,0.17577,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.0172,0.14448,0.19092,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.017954,0.14447,0.18121,1,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.046961,0.14419,0.182,1,0
2,GO VIRAL LIFE CYCLE,0.011574,0.14402,0.18769,1,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.045233,0.14379,0.14308,1,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.013235,0.14365,0.1574,1,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.028348,0.14306,0.21504,1,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.010101,0.14287,0.19001,1,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.050584,0.14237,0.2182,1,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.025096,0.14224,0.23658,1,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.037377,0.14219,0.16542,1,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.025096,0.14212,0.18545,1,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.015776,0.14202,0.15952,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.030713,0.14143,0.15725,1,0
2,GO MICROVILLUS ORGANIZATION,0.014457,0.14141,0.20848,1,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0034935,0.14061,0.18826,1,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.019548,0.14049,0.23128,1,0
2,GO REGULATION OF ANION TRANSPORT,0.019548,0.1404,0.1867,1,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.020391,0.14035,0.1648,1,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.050584,0.14002,0.13731,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.0172,0.13993,0.17448,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.046961,0.1393,0.13874,1,0
2,GO RESPONSE TO STEROL,0.045233,0.13899,0.21279,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.015776,0.13888,0.21211,1,0
2,GO RESPONSE TO LEPTIN,0.041938,0.13841,0.151,1,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.038848,0.13837,0.14492,1,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.046961,0.13829,0.16594,1,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.028348,0.13793,0.17617,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.028348,0.13691,0.23012,1,0
2,GO RESPONSE TO NUTRIENT,0.0096484,0.13648,0.21212,1,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.008797,0.13647,0.19382,1,0
2,GO VIRAL GENOME REPLICATION,0.035953,0.13645,0.16605,1,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.025096,0.13599,0.16994,1,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.028348,0.13554,0.18713,1,0
2,GO BILE ACID METABOLIC PROCESS,0.043559,0.13532,0.14311,1,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.024086,0.13475,0.23742,1,0
2,GO CELL MOTILITY,0.037377,0.13455,0.19146,1,0
2,GO JNK CASCADE,0.046961,0.13451,0.17487,1,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.037377,0.13446,0.14306,1,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.030713,0.1344,0.20486,1,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.033245,0.13411,0.18027,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.028348,0.13382,0.19797,1,0
2,GO RESPONSE TO CAMP,0.02951,0.13327,0.16846,1,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.033245,0.13315,0.21905,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.033245,0.13314,0.16053,1,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.013834,0.13285,0.15746,1,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.028348,0.13224,0.1875,1,0
2,GO FACE DEVELOPMENT,0.046961,0.13216,0.22823,1,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.037377,0.13202,0.1227,1,0
2,GO CHEMICAL HOMEOSTASIS,0.016475,0.13185,0.16623,1,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.027226,0.13146,0.16279,1,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.045233,0.13033,0.17795,1,0
2,GO MAINTENANCE OF LOCATION,0.013834,0.13013,0.17492,1,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.021265,0.12979,0.14381,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.033245,0.12967,0.14931,1,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.020391,0.12933,0.16649,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.008797,0.12919,0.18216,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.016475,0.12896,0.17471,1,0
2,GO REGULATION OF TUBE SIZE,0.034576,0.12855,0.17115,1,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.038848,0.12819,0.17535,1,0
2,GO REGULATION OF PROTEOLYSIS,0.016475,0.12798,0.16638,1,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.021265,0.12777,0.17893,1,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.041938,0.12731,0.13837,1,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.024086,0.12708,0.18083,1,0
2,GO VITAMIN METABOLIC PROCESS,0.0042727,0.1268,0.16583,1,0
2,GO FIBROBLAST PROLIFERATION,0.045233,0.12678,0.18217,1,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.052482,0.12669,0.14098,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.014457,0.12661,0.16859,1,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.024086,0.12608,0.17755,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.045233,0.12566,0.14114,1,0
2,GO CERAMIDE TRANSPORT,0.048745,0.12525,0.19317,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.031957,0.12472,0.14119,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.052482,0.12458,0.16225,1,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.040368,0.12451,0.14629,1,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.014457,0.12431,0.15705,1,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.027226,0.12423,0.1706,1,0
2,GO CELL RECOGNITION,0.038848,0.12418,0.15711,1,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.048745,0.12377,0.19655,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.025096,0.12374,0.1732,1,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.037377,0.12367,0.16509,1,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.045233,0.12365,0.14148,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.048745,0.12352,0.13987,1,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.0047188,0.12303,0.26108,1,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.046961,0.123,0.17271,1,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.018736,0.12288,0.16334,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.050584,0.12286,0.15065,1,0
2,GO ORGANELLE MEMBRANE FUSION,0.011574,0.1227,0.17261,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0096484,0.12267,0.17518,1,0
2,GO STRIATED MUSCLE CONTRACTION,0.052482,0.12229,0.13112,1,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.045233,0.12173,0.18559,1,0
2,GO HORMONE METABOLIC PROCESS,0.026142,0.12129,0.14269,1,0
2,GO MYELOID CELL HOMEOSTASIS,0.024086,0.1212,0.17166,1,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.026142,0.12067,0.16476,1,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.038848,0.12061,0.17925,1,0
2,GO MEMBRANE FUSION,0.0063209,0.12055,0.17399,1,0
2,GO RESPONSE TO CORTICOSTEROID,0.0172,0.12044,0.17266,1,0
2,GO POSITIVE REGULATION OF SIGNALING,0.035953,0.12042,0.16171,1,0
2,GO PH REDUCTION,0.012106,0.12036,0.15324,1,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.045233,0.11984,0.16707,1,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.050584,0.1193,0.15958,1,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0054671,0.11915,0.20158,1,0
2,GO RESPONSE TO ALCOHOL,0.037377,0.11899,0.16134,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.033245,0.11834,0.1558,1,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.052482,0.11824,0.16069,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.006955,0.1182,0.16928,1,0
2,GO REGULATION OF SECRETION,0.025096,0.11816,0.15419,1,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.035953,0.11768,0.17311,1,0
2,GO MUSCLE CELL MIGRATION,0.035953,0.11758,0.21604,1,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.045233,0.11614,0.25909,1,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.031957,0.11567,0.1586,1,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.031957,0.11556,0.1665,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.031957,0.11488,0.17123,1,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.024086,0.11466,0.15392,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.031957,0.11409,0.14366,1,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.020391,0.11393,0.16088,1,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.048745,0.11388,0.14118,1,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.050584,0.11381,0.17278,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0042727,0.11302,0.16386,1,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.037377,0.11293,0.1751,1,0
2,GO CELLULAR HOMEOSTASIS,0.020391,0.11264,0.15027,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031957,0.11152,0.13183,1,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.014457,0.11148,0.13305,1,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.037377,0.11096,0.15213,1,0
2,GO TROPHOBLAST CELL MIGRATION,0.050584,0.11036,0.22534,1,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.040368,0.10976,0.18572,1,0
2,GO CARTILAGE DEVELOPMENT,0.038848,0.10902,0.21375,1,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.050584,0.10889,0.16015,1,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.040368,0.10843,0.15293,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.046961,0.10841,0.13949,1,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.030713,0.10819,0.14782,1,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.043559,0.108,0.17952,1,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.048745,0.10758,0.13874,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0031545,0.10751,0.17316,1,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.031957,0.10741,0.1873,1,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.035953,0.10729,0.20929,1,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.027226,0.10722,0.14462,1,0
2,GO EPITHELIAL CELL PROLIFERATION,0.028348,0.10714,0.1863,1,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.035953,0.10693,0.16772,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.045233,0.10552,0.14653,1,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.02951,0.10544,0.20026,1,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.027226,0.1053,0.13965,1,0
2,GO REGULATION OF CELL DEATH,0.038848,0.10525,0.14713,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.052482,0.10454,0.13765,1,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.031957,0.10417,0.16154,1,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.016475,0.10357,0.15128,1,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.0172,0.10292,0.16948,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.033245,0.10141,0.16832,1,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.052482,0.1013,0.13078,1,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.046961,0.1007,0.19121,1,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.040368,0.10063,0.18142,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.026142,0.099206,0.17171,1,0
2,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.040368,0.098847,0.13797,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.034576,0.098163,0.17852,1,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.011063,0.097439,0.14901,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0096484,0.097354,0.16073,1,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.045233,0.097311,0.13748,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.050584,0.097156,0.12927,1,0
2,GO LIPID METABOLIC PROCESS,0.046961,0.096773,0.13451,1,0
2,GO REGULATION OF CELLULAR PH,0.023112,0.096567,0.1409,1,0
2,GO RESPONSE TO KETONE,0.038848,0.096097,0.15944,1,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0076456,0.095273,0.13451,1,0
2,GO ORGANIC ANION TRANSPORT,0.034576,0.094486,0.14299,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.022172,0.094334,0.16364,1,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.034576,0.094119,0.22022,1,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.037377,0.093936,0.13008,1,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.031957,0.093855,0.14466,1,0
2,GO MEMBRANE ORGANIZATION,0.031957,0.092398,0.14384,1,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.040368,0.091684,0.11893,1,0
2,GO APOPTOTIC PROCESS,0.045233,0.091326,0.14196,1,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0172,0.089714,0.15106,1,0
2,GO AGING,0.022172,0.089334,0.16155,1,0
2,GO RESPONSE TO OXYGEN LEVELS,0.0172,0.088663,0.16078,1,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.038848,0.085883,0.14288,1,0
2,GO SYMBIOTIC PROCESS,0.027226,0.085431,0.12105,1,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.052482,0.084814,0.11385,1,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.038848,0.083789,0.12557,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.021265,0.083649,0.17194,1,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.052482,0.083481,0.21305,1,0
2,GO CELLULAR RESPONSE TO DRUG,0.048745,0.082895,0.13686,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.050584,0.082547,0.11921,1,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.052482,0.082248,0.13017,1,0
2,GO DETECTION OF STIMULUS,0.040368,0.082006,0.098724,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.038848,0.081692,0.15622,1,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.031957,0.080816,0.13656,1,0
2,GO GOLGI VESICLE BUDDING,0.041938,0.080701,0.1353,1,0
2,GO REGULATION OF PH,0.034576,0.080695,0.12968,1,0
2,GO RESPONSE TO DRUG,0.052482,0.080436,0.14528,1,0
2,GO PROTEOLYSIS,0.046961,0.080353,0.13492,1,0
2,GO ORGANELLE FUSION,0.041938,0.079551,0.1367,1,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.024086,0.0789,0.12501,1,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.030713,0.078121,0.13175,1,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.035953,0.075935,0.12388,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.028348,0.074181,0.10912,1,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.021265,0.073739,0.13114,1,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.048745,0.0706,0.12697,1,0
2,GO ENDOSOME ORGANIZATION,0.037377,0.068373,0.1293,1,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.038848,0.068285,0.13731,1,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.034576,0.068267,0.15856,1,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.052482,0.063785,0.091872,1,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.022172,0.061682,0.13976,1,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.052482,0.058591,0.1087,1,0
2,GO PEROXISOMAL TRANSPORT,0.046961,0.054752,0.1009,1,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.050584,0.053657,0.15291,1,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.045233,-0.055339,-0.071395,1,0
2,GO TRNA 5 END PROCESSING,0.050584,-0.063538,-0.071331,1,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.048745,-0.08192,-0.11441,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.040368,-0.10739,-0.12928,1,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.050584,-0.10934,-0.12222,1,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.045233,-0.11439,-0.11088,1,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.052482,-0.12098,-0.14005,1,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0080134,-0.12346,-0.11356,1,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.034576,-0.124,-0.10755,1,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.023112,-0.13373,-0.10932,1,0
2,GO RNA INTERFERENCE,0.046961,-0.13484,-0.11321,1,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.037377,-0.13874,-0.1038,1,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.015104,-0.13886,-0.14585,1,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.050584,-0.14391,-0.11049,1,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.038848,-0.15682,-0.15154,1,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.028348,-0.18114,-0.15641,1,0
2,GO OTIC VESICLE DEVELOPMENT,0.015104,-0.20044,-0.21723,1,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.041938,-0.2083,-0.16337,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.031957,-0.22161,-0.2528,1,0
2,GO REGULATION OF RESPONSE TO FOOD,0.013834,-0.2665,-0.22594,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.037377,-0.29112,-0.25434,1,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.013834,-0.29837,-0.28846,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.015776,-0.30613,-0.23636,1,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.027226,-0.3441,-0.24418,1,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.028348,-0.34687,-0.25375,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0080134,-0.34867,-0.25781,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.017954,-0.34981,-0.36365,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.056456,0.29615,0.24746,0,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.069906,0.28108,0.20711,0,1
2,GO DNA DEAMINATION,0.062884,0.27998,0.17629,0,1
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.054439,0.26209,0.23171,0,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.062884,0.26019,0.2685,0,1
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.067497,0.23966,0.18782,0,1
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.062884,0.22774,0.19265,0,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.058535,0.22753,0.19327,0,1
2,GO EPITHELIAL CELL CELL ADHESION,0.1306,0.22742,0.19637,0,1
2,GO HEART TRABECULA FORMATION,0.11524,0.22211,0.17603,0,1
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.10468,0.22035,0.16549,0,1
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.065157,0.21902,0.20216,0,1
2,GO NEPHRIC DUCT MORPHOGENESIS,0.080256,0.21455,0.18756,0,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.13885,0.21357,0.19926,0,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.10468,0.20385,0.14384,0,1
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.10134,0.20335,0.19193,0,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.15197,0.19814,0.16114,0,1
2,GO GENITALIA DEVELOPMENT,0.060677,0.19722,0.16433,0,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.058535,0.19503,0.18888,0,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.098083,0.19461,0.19155,0,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.08588,0.19382,0.18109,0,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.054439,0.19047,0.16462,0,1
2,GO REPLICATIVE SENESCENCE,0.067497,0.18831,0.18454,0,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.072385,0.18769,0.19784,0,1
2,GO MULTICELLULAR ORGANISM AGING,0.065157,0.18686,0.14592,0,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.074935,0.18187,0.14634,0,1
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.067497,0.17967,0.19616,0,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.15197,0.17945,0.14792,0,1
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.077559,0.17925,0.21697,0,1
2,GO RETINAL METABOLIC PROCESS,0.058535,0.17909,0.18225,0,1
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.18102,0.17867,0.13038,0,1
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.10811,0.17492,0.17552,0,1
2,GO HEART TRABECULA MORPHOGENESIS,0.080256,0.17117,0.18522,0,1
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.060677,0.16501,0.1813,0,1
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.094909,0.16333,0.25893,0,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.058535,0.16311,0.18357,0,1
2,GO RESPONSE TO EPINEPHRINE,0.15655,0.16256,0.14645,0,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.074935,0.16194,0.21588,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.077559,0.16085,0.17402,0,1
2,GO ZINC ION HOMEOSTASIS,0.074935,0.15727,0.16399,0,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.056456,0.15611,0.18387,0,1
2,GO POSITIVE REGULATION OF HEART RATE,0.10811,0.15422,0.14999,0,1
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.067497,0.15233,0.16403,0,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.094909,0.15208,0.14137,0,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.062884,0.15203,0.14867,0,1
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.065157,0.15155,0.17076,0,1
2,GO CARDIAC CELL FATE COMMITMENT,0.42405,0.14998,0.051949,0,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.072385,0.14583,0.10773,0,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.23203,0.14411,0.10548,0,1
2,GO ETHER BIOSYNTHETIC PROCESS,0.11163,0.14308,0.13055,0,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.10811,0.14307,0.14996,0,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.054439,0.14257,0.15745,0,1
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.13467,0.1417,0.091834,0,1
2,GO LIPID OXIDATION,0.10134,0.14034,0.11311,0,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.08588,0.13941,0.16791,0,1
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.20822,0.13902,0.16153,0,1
2,GO STRIATUM DEVELOPMENT,0.069906,0.13632,0.16819,0,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.50109,0.13572,0.072605,0,1
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.067497,0.13549,0.16304,0,1
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.10811,0.13422,0.14177,0,1
2,GO GLUCOSE CATABOLIC PROCESS,0.060677,0.13376,0.17338,0,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.060677,0.13369,0.19015,0,1
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.17591,0.13332,0.15324,0,1
2,GO CELLULAR RESPONSE TO ZINC ION,0.34626,0.13289,0.1172,0,1
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.08881,0.13288,0.14004,0,1
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.18624,0.13233,0.11281,0,1
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.1306,0.13211,0.1244,0,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.16123,0.13069,0.12152,0,1
2,GO MUSCLE HYPERTROPHY,0.10134,0.12983,0.13519,0,1
2,GO ACTIN MEDIATED CELL CONTRACTION,0.054439,0.12974,0.14293,0,1
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.060677,0.12964,0.16809,0,1
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.062884,0.12817,0.16152,0,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.069906,0.12778,0.14048,0,1
2,GO L GLUTAMATE IMPORT,0.12662,0.12763,0.13986,0,1
2,GO NADH METABOLIC PROCESS,0.12273,0.12446,0.14273,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.34626,0.12145,0.092332,0,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.065157,0.12108,0.17386,0,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.11524,0.12072,0.13614,0,1
2,GO ANION HOMEOSTASIS,0.056456,0.11677,0.16379,0,1
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.094909,0.11676,0.15502,0,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.10811,0.11663,0.13573,0,1
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.074935,0.11661,0.14621,0,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.14312,0.116,0.11419,0,1
2,GO TRANSFERRIN TRANSPORT,0.060677,0.11526,0.13582,0,1
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.08588,0.11432,0.19422,0,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.11524,0.11411,0.13737,0,1
2,GO NUCLEOTIDE SALVAGE,0.12273,0.11359,0.09348,0,1
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.074935,0.11333,0.18255,0,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.26442,0.11188,0.1188,0,1
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.065157,0.11157,0.12894,0,1
2,GO MODIFIED AMINO ACID TRANSPORT,0.062884,0.10881,0.14775,0,1
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.10134,0.10879,0.1506,0,1
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.12662,0.10799,0.1349,0,1
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.2998,0.10544,0.083049,0,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.1306,0.10431,0.059592,0,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.060677,0.103,0.12905,0,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.074935,0.1029,0.12387,0,1
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.28529,0.10158,0.13256,0,1
2,GO RESPONSE TO ETHER,0.10468,0.1012,0.12791,0,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.074935,0.10074,0.12572,0,1
2,GO URONIC ACID METABOLIC PROCESS,0.19156,0.10028,0.10582,0,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.060677,0.099396,0.14343,0,1
2,GO FATTY ACID CATABOLIC PROCESS,0.098083,0.093959,0.11524,0,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.11163,0.093618,0.11081,0,1
2,GO LIPOPROTEIN METABOLIC PROCESS,0.080256,0.092459,0.11944,0,1
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.17591,0.092415,0.11859,0,1
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.15655,0.092274,0.13233,0,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.080256,0.091729,0.09451,0,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.08881,0.091525,0.14727,0,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.091819,0.091387,0.11557,0,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.12662,0.090304,0.090435,0,1
2,GO CARBOHYDRATE HOMEOSTASIS,0.1306,0.089611,0.10943,0,1
2,GO PURINE NUCLEOTIDE TRANSPORT,0.11894,0.089583,0.12751,0,1
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.069906,0.089549,0.14959,0,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.1306,0.089372,0.13531,0,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.1475,0.087831,0.068137,0,1
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.21989,0.087455,0.12899,0,1
2,GO SULFUR COMPOUND TRANSPORT,0.2259,0.08533,0.11564,0,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.26442,0.084945,0.076509,0,1
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.080256,0.084775,0.13717,0,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.054439,0.082463,0.10073,0,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.10811,0.082442,0.10951,0,1
2,GO REGULATION OF PROTEIN DEACETYLATION,0.098083,0.082387,0.1416,0,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.08588,0.082182,0.11793,0,1
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.11163,0.081273,0.093221,0,1
2,GO GLUCOSE METABOLIC PROCESS,0.16123,0.081207,0.10883,0,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.077559,0.080836,0.11236,0,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.065157,0.080361,0.10657,0,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.056456,0.079885,0.11764,0,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.20256,0.079216,0.094465,0,1
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.12273,0.079022,0.094938,0,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.214,0.078514,0.095429,0,1
2,GO PROTEIN DESTABILIZATION,0.054439,0.078455,0.13474,0,1
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.60692,0.078084,0.031292,0,1
2,GO ERAD PATHWAY,0.20256,0.078075,0.099282,0,1
2,GO PIGMENT METABOLIC PROCESS,0.18102,0.076574,0.082435,0,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.10811,0.076377,0.094251,0,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.11163,0.07528,0.10995,0,1
2,GO MITOTIC CYTOKINETIC PROCESS,0.060677,0.072078,0.10792,0,1
2,GO ONE CARBON METABOLIC PROCESS,0.26442,0.070899,0.081568,0,1
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.060677,0.070839,0.10381,0,1
2,GO AMP METABOLIC PROCESS,0.098083,0.070346,0.095143,0,1
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.20822,0.070047,0.087294,0,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.072385,0.069765,0.11755,0,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.214,0.069531,0.11536,0,1
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.33029,0.06879,0.0828,0,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.19156,0.067685,0.084406,0,1
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.27126,0.067482,0.089879,0,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.10811,0.067227,0.10686,0,1
2,GO ZINC ION TRANSPORT,0.060677,0.066684,0.087639,0,1
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.11163,0.065739,0.11517,0,1
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.30724,0.062609,0.081803,0,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.091819,0.061901,0.10004,0,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.10134,0.061588,0.13667,0,1
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.4521,0.056365,0.092375,0,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.32248,0.055393,0.056746,0,1
2,GO ATP METABOLIC PROCESS,0.12273,0.054739,0.074619,0,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.18102,0.035401,0.11943,0,1
2,GO EOSINOPHIL MIGRATION,0.0010209,0.77407,0.68118,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.0016767,0.70982,0.657,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.0047188,0.49381,0.46018,0,0
2,GO OPSONIZATION,0.0080134,0.48131,0.40731,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0023095,0.48021,0.44818,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0063209,0.41093,0.3602,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0012758,0.38441,0.39595,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.006955,0.32579,0.35653,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.021265,0.30301,0.25276,0,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.010101,0.30215,0.28398,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.0010209,0.30127,0.31405,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0019699,0.29816,0.38995,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00076864,0.28889,0.32021,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0036751,0.28301,0.36188,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0020776,0.28195,0.29126,0,0
2,GO LYSOSOME LOCALIZATION,0.0083971,0.2767,0.2476,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0020776,0.27294,0.34991,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.16602,0.27161,0.13589,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.058535,0.26954,0.24846,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.056456,0.26929,0.20936,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0083971,0.26824,0.30556,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.011063,0.26723,0.32866,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0054671,0.26703,0.3461,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0080134,0.26565,0.30855,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.058535,0.26406,0.26952,0,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.10468,0.26042,0.18929,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0036751,0.26017,0.29072,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.0031545,0.25865,0.3266,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.1475,0.25651,0.24125,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.013834,0.24921,0.25791,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.080256,0.24794,0.21684,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.08588,0.24523,0.19779,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.014457,0.24513,0.20638,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.023112,0.2443,0.3008,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.013235,0.24217,0.23645,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0044907,0.24196,0.29284,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.010572,0.24112,0.26874,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0076456,0.24027,0.22735,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0042727,0.23534,0.2812,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.10134,0.23258,0.17204,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.10134,0.23062,0.17906,0,0
2,GO POLYOL TRANSPORT,0.040368,0.22976,0.24443,0,0
2,GO POSITIVE CHEMOTAXIS,0.0015041,0.22904,0.29094,0,0
2,GO INNERVATION,0.13467,0.22887,0.24653,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.18624,0.2278,0.1478,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.0172,0.22711,0.24673,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.067497,0.2267,0.2165,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.15197,0.22636,0.2077,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.011574,0.22513,0.26008,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.02951,0.22364,0.28246,0,0
2,GO BONE MINERALIZATION,0.0060238,0.22308,0.24557,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.08588,0.21958,0.20495,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0029965,0.2193,0.23847,0,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.080256,0.21857,0.2757,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.054439,0.21824,0.25728,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.11163,0.21797,0.17942,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.11524,0.21584,0.16204,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.08588,0.21552,0.27751,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.065157,0.21461,0.19608,0,0
2,GO PROSTAGLANDIN SECRETION,0.0080134,0.2121,0.24088,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.24463,0.21197,0.20552,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.030713,0.2118,0.19428,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.031957,0.2114,0.22392,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.094909,0.20975,0.21228,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.077559,0.20945,0.23827,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.08588,0.20907,0.20919,0,0
2,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.058535,0.20838,0.1772,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.1306,0.2083,0.24146,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.077559,0.20725,0.15557,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.046961,0.20515,0.21313,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.0023095,0.20445,0.24892,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.08881,0.20375,0.21558,0,0
2,GO RENAL FILTRATION,0.026142,0.20348,0.30435,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.021265,0.20297,0.2167,0,0
2,GO REGULATION OF PINOCYTOSIS,0.072385,0.20256,0.19792,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.020391,0.20214,0.22512,0,0
2,GO AXIS ELONGATION,0.024086,0.20069,0.21918,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.28529,0.19988,0.11705,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.011063,0.19682,0.23848,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.10811,0.19665,0.205,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.077559,0.1959,0.16931,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.10811,0.1957,0.19268,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.11524,0.19556,0.22519,0,0
2,GO BRONCHUS DEVELOPMENT,0.077559,0.19544,0.24705,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.041938,0.19514,0.21332,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.037377,0.19505,0.18644,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.056456,0.19455,0.16836,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.014457,0.19394,0.22595,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.062884,0.19295,0.24263,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.2259,0.1916,0.17816,0,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.0034935,0.19096,0.24471,0,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.060677,0.19056,0.19923,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.080256,0.19045,0.17541,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.20822,0.18889,0.14531,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.080256,0.18829,0.18469,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.077559,0.18491,0.29915,0,0
2,GO SKIN MORPHOGENESIS,0.056456,0.18476,0.27217,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.006955,0.18474,0.27853,0,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.067497,0.18427,0.17141,0,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.091819,0.18421,0.19561,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.060677,0.1831,0.1958,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.069906,0.18274,0.16791,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.074935,0.1825,0.22019,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.056456,0.18228,0.2348,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.030713,0.18021,0.25137,0,0
2,GO PROTEIN LOCALIZATION TO AXON,0.30724,0.17979,0.16323,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.0040644,0.17918,0.23379,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0024341,0.17893,0.24418,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.23203,0.17823,0.15534,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.15655,0.178,0.20941,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.10468,0.17778,0.18449,0,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0021907,0.17749,0.19178,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.08303,0.17711,0.16999,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.060677,0.1769,0.15877,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.12273,0.17657,0.20693,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.013834,0.17611,0.22374,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.056456,0.17579,0.18038,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.14312,0.17571,0.17721,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.077559,0.17499,0.19252,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.027226,0.17464,0.22919,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.028348,0.17422,0.20113,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.02951,0.17419,0.23947,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.060677,0.17416,0.21947,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.08303,0.17407,0.1273,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.052482,0.1738,0.18131,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.0063209,0.17233,0.1955,0,0
2,GO LIPID EXPORT FROM CELL,0.0096484,0.17141,0.18886,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.18624,0.17051,0.17571,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.024086,0.17031,0.23382,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.0054671,0.16912,0.21716,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.08881,0.1683,0.1727,0,0
2,GO MICROVILLUS ASSEMBLY,0.028348,0.16823,0.17807,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.098083,0.16814,0.14597,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.10134,0.16785,0.16709,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.006955,0.16783,0.25887,0,0
2,GO REGULATION OF ODONTOGENESIS,0.069906,0.16751,0.18878,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.13885,0.167,0.16306,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.25111,0.16694,0.13412,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.08588,0.16693,0.20863,0,0
2,GO ALANINE TRANSPORT,0.077559,0.16659,0.21728,0,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.062884,0.16649,0.19376,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.44264,0.16642,0.10057,0,0
2,GO AMINE CATABOLIC PROCESS,0.12273,0.16623,0.13437,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.074935,0.16595,0.1298,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.25111,0.16592,0.13235,0,0
2,GO STEROID HORMONE SECRETION,0.069906,0.16571,0.15172,0,0
2,GO RESPONSE TO GONADOTROPIN,0.019548,0.1655,0.21326,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.067497,0.16472,0.26326,0,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.065157,0.16467,0.14958,0,0
2,GO ETHANOL METABOLIC PROCESS,0.058535,0.16462,0.18984,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.16602,0.16373,0.12629,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.025096,0.16356,0.20435,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.20256,0.16275,0.10762,0,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.11894,0.16258,0.13702,0,0
2,GO PROTEIN DEMANNOSYLATION,0.062884,0.16251,0.19182,0,0
2,GO METANEPHROS MORPHOGENESIS,0.077559,0.16237,0.18818,0,0
2,GO GLOMERULUS DEVELOPMENT,0.069906,0.16218,0.23787,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.048745,0.16215,0.21429,0,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.069906,0.16209,0.16597,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.41494,0.16196,0.10506,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.054439,0.16196,0.17819,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.08881,0.16166,0.18248,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.13467,0.16097,0.16091,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.23827,0.1608,0.14681,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.056456,0.16042,0.14602,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.08303,0.16029,0.18245,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.08303,0.15895,0.35072,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.011574,0.15853,0.21,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.067497,0.15755,0.16326,0,0
2,GO PROSTATIC BUD FORMATION,0.08881,0.15732,0.24351,0,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.091819,0.15721,0.1616,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.040368,0.15691,0.22884,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.045233,0.1569,0.18327,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.069906,0.15688,0.20913,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.17091,0.15685,0.14962,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.060677,0.15649,0.18394,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.32248,0.15642,0.070236,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.46168,0.15556,0.11183,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.08881,0.15511,0.16934,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.091819,0.1545,0.17066,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.015104,0.15435,0.20927,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.015776,0.15425,0.20638,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.054439,0.15387,0.19827,0,0
2,GO SEX DETERMINATION,0.60692,0.15349,0.057253,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.02951,0.15329,0.21908,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.33029,0.15278,0.11895,0,0
2,GO RENAL SYSTEM PROCESS,0.08588,0.15262,0.17719,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.13885,0.15248,0.13779,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.043559,0.15215,0.19497,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.098083,0.15215,0.1928,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18624,0.1517,0.14247,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.10811,0.15157,0.11422,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.08881,0.15144,0.19656,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.077559,0.15134,0.16885,0,0
2,GO GANGLION DEVELOPMENT,0.12662,0.15121,0.19682,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.16123,0.1511,0.17057,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.048745,0.15104,0.19521,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.25111,0.15096,0.14925,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.08881,0.15084,0.20877,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.11524,0.15063,0.19282,0,0
2,GO RESPONSE TO PROGESTERONE,0.060677,0.15041,0.20038,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.091819,0.15037,0.20972,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.13467,0.1501,0.12954,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.1475,0.14991,0.16091,0,0
2,GO GLAND MORPHOGENESIS,0.065157,0.14988,0.21015,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.072385,0.14888,0.14688,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.065157,0.14853,0.17111,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.43329,0.14815,0.062269,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.28529,0.14792,0.13897,0,0
2,GO KERATINOCYTE DIFFERENTIATION,0.056456,0.14768,0.14072,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.018736,0.14753,0.19949,0,0
2,GO RESPONSE TO ESTROGEN,0.065157,0.14733,0.15997,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.080256,0.14706,0.16524,0,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.080256,0.1469,0.21562,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.069906,0.14646,0.17152,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.10811,0.1464,0.17731,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.19156,0.14553,0.10946,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.0040644,0.14528,0.19439,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.16602,0.14489,0.13262,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.065157,0.14481,0.24096,0,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.11163,0.14444,0.13911,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.08303,0.14398,0.15021,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.072385,0.14366,0.18313,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.11524,0.14348,0.20646,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.060677,0.14315,0.14755,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.030713,0.14299,0.22433,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.34626,0.14292,0.15465,0,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.30724,0.14263,0.082473,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.28529,0.14261,0.12411,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.072385,0.14255,0.14686,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.14312,0.1425,0.15509,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.056456,0.14219,0.18843,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.19156,0.14179,0.1428,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.031957,0.14166,0.21115,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.23203,0.14138,0.098496,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.062884,0.14136,0.20033,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.1306,0.14062,0.18387,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.062884,0.14055,0.21907,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.3148,0.14038,0.12972,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.091819,0.14036,0.17264,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0049572,0.13996,0.23321,0,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.062884,0.1397,0.13233,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.10811,0.13947,0.19513,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.074935,0.13947,0.15258,0,0
2,GO TUBE MORPHOGENESIS,0.077559,0.13946,0.1857,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.024086,0.13943,0.16966,0,0
2,GO HYPOTONIC RESPONSE,0.13885,0.13931,0.12568,0,0
2,GO STEM CELL DIVISION,0.44264,0.13929,0.11399,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.10134,0.13925,0.15545,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.072385,0.1388,0.21391,0,0
2,GO RESPONSE TO COPPER ION,0.10468,0.13871,0.14074,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.035953,0.13867,0.24041,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.080256,0.13862,0.11928,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.50109,0.13859,0.081208,0,0
2,GO REGULATION OF VESICLE FUSION,0.23203,0.13855,0.16975,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.072385,0.13845,0.21921,0,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054439,0.13839,0.23194,0,0
2,GO NEURONAL ACTION POTENTIAL,0.077559,0.13826,0.15268,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.072385,0.13802,0.24608,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.08881,0.13801,0.17559,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.16602,0.13801,0.16747,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.17591,0.1379,0.13695,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.056456,0.13777,0.17291,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11524,0.13767,0.16645,0,0
2,GO CAMP METABOLIC PROCESS,0.3148,0.13748,0.13443,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.1306,0.13696,0.16015,0,0
2,GO RESPONSE TO FORSKOLIN,0.18624,0.13688,0.18087,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.19156,0.13682,0.10565,0,0
2,GO RESPONSE TO ACIDIC PH,0.069906,0.13678,0.20338,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.080256,0.13645,0.17104,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.2577,0.13639,0.24484,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.077559,0.13634,0.17706,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.2577,0.13623,0.1474,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.12273,0.13599,0.17388,0,0
2,GO RIG I SIGNALING PATHWAY,0.10468,0.1358,0.13601,0,0
2,GO EXPLORATION BEHAVIOR,0.2259,0.13556,0.10104,0,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.10811,0.13539,0.16675,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.098083,0.13534,0.22987,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.080256,0.13532,0.17776,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.08588,0.13524,0.21758,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.056456,0.13518,0.17544,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.10134,0.13502,0.15227,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.058535,0.13494,0.14771,0,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.10468,0.13475,0.16801,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.1475,0.13446,0.2174,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.067497,0.13438,0.20718,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.08303,0.13432,0.15263,0,0
2,GO OVULATION,0.072385,0.13391,0.17724,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.32248,0.1338,0.14671,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.10811,0.13372,0.14456,0,0
2,GO KERATINOCYTE PROLIFERATION,0.074935,0.13364,0.17931,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.050584,0.13341,0.17197,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.065157,0.13333,0.14762,0,0
2,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.054439,0.13297,0.12731,0,0
2,GO FEVER GENERATION,0.214,0.13293,0.10978,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.069906,0.13281,0.15796,0,0
2,GO REGULATION OF GASTRULATION,0.11163,0.1324,0.1584,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.027226,0.13237,0.17717,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.074935,0.13236,0.15568,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.058535,0.1322,0.23095,0,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.069906,0.13167,0.14801,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.28529,0.13128,0.13252,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.072385,0.131,0.18508,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.08303,0.13099,0.25901,0,0
2,GO PLATELET MORPHOGENESIS,0.13467,0.13089,0.15533,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.074935,0.13087,0.17277,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.37111,0.13087,0.14134,0,0
2,GO SEROTONIN TRANSPORT,0.33821,0.13072,0.10719,0,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.058535,0.13055,0.1659,0,0
2,GO MALE SEX DETERMINATION,0.64051,0.13018,0.036185,0,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.065157,0.13007,0.17787,0,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.058535,0.12977,0.17717,0,0
2,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.098083,0.1297,0.18751,0,0
2,GO ANIMAL ORGAN FORMATION,0.048745,0.1296,0.16207,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.025096,0.12943,0.17676,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.060677,0.12935,0.18432,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.34626,0.12921,0.094214,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.21989,0.12916,0.12579,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.16123,0.12916,0.14652,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.10134,0.1291,0.11947,0,0
2,GO MYOBLAST DIFFERENTIATION,0.060677,0.12888,0.1656,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.098083,0.12856,0.16624,0,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.12273,0.12851,0.17192,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.23827,0.12826,0.14523,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.022172,0.12818,0.25014,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.02951,0.12806,0.16913,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.53179,0.12786,0.12554,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.14312,0.12775,0.14424,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.17591,0.12772,0.14692,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.19156,0.12754,0.18324,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.072385,0.12754,0.16905,0,0
2,GO RESPONSE TO PAIN,0.060677,0.12752,0.14929,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.23827,0.12752,0.16436,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.13885,0.12723,0.12977,0,0
2,GO RECEPTOR RECYCLING,0.17591,0.12714,0.13435,0,0
2,GO MUSCLE CONTRACTION,0.074935,0.12709,0.137,0,0
2,GO CONVERGENT EXTENSION,0.022172,0.12699,0.27541,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.074935,0.12655,0.14602,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.08588,0.12654,0.14901,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.054439,0.12652,0.15319,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.025096,0.12617,0.18247,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.16123,0.1261,0.17049,0,0
2,GO FLUID TRANSPORT,0.16602,0.12588,0.15991,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.080256,0.12569,0.12764,0,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.060677,0.12559,0.16386,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.074935,0.12555,0.17968,0,0
2,GO MRNA TRANSCRIPTION,0.13885,0.12549,0.16353,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.094909,0.12545,0.14297,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.094909,0.12539,0.11133,0,0
2,GO REPLACEMENT OSSIFICATION,0.098083,0.12524,0.19992,0,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.065157,0.12509,0.16002,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.072385,0.12501,0.17445,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.36271,0.12495,0.12774,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.08588,0.12476,0.17485,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.46168,0.12452,0.12153,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.25111,0.12439,0.12938,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.10134,0.12422,0.1811,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.077559,0.124,0.14117,0,0
2,GO REGULATION OF EXCRETION,0.16123,0.12375,0.11004,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.08588,0.12351,0.18648,0,0
2,GO ERBB SIGNALING PATHWAY,0.10134,0.12338,0.15873,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.40594,0.12324,0.098905,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.1306,0.12313,0.10896,0,0
2,GO TOOTH MINERALIZATION,0.23203,0.12291,0.13348,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.197,0.12236,0.13607,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.062884,0.12217,0.18332,0,0
2,GO MUSCLE SYSTEM PROCESS,0.069906,0.12214,0.13781,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.056456,0.12202,0.17473,0,0
2,GO DRUG CATABOLIC PROCESS,0.1475,0.12202,0.063768,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.18102,0.122,0.12558,0,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.054439,0.12196,0.16685,0,0
2,GO TERPENOID METABOLIC PROCESS,0.10811,0.12195,0.12076,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.14312,0.12189,0.19819,0,0
2,GO RESPONSE TO VITAMIN D,0.050584,0.12189,0.21374,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.074935,0.12172,0.21573,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.08303,0.12151,0.13626,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.074935,0.12149,0.17516,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.44264,0.12123,0.088529,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.3148,0.12094,0.081411,0,0
2,GO HEPARIN METABOLIC PROCESS,0.15197,0.12083,0.12203,0,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.19156,0.12082,0.12184,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.11524,0.12068,0.16792,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.214,0.12054,0.13033,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.08588,0.11979,0.15231,0,0
2,GO SOMATIC STEM CELL DIVISION,0.30724,0.1197,0.15305,0,0
2,GO WATER HOMEOSTASIS,0.080256,0.11942,0.15896,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.17091,0.11941,0.12377,0,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.08303,0.11935,0.17177,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.054439,0.11932,0.13742,0,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.067497,0.11928,0.13809,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.1475,0.11898,0.14801,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.23827,0.11881,0.14487,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.054439,0.11821,0.15098,0,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.23827,0.11808,0.14292,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.08588,0.11804,0.11926,0,0
2,GO NERVE DEVELOPMENT,0.15197,0.118,0.16289,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.069906,0.11799,0.18957,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.054439,0.11791,0.14698,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.44264,0.11762,0.12685,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.14312,0.1176,0.14181,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.19156,0.11735,0.12389,0,0
2,GO RESPONSE TO X RAY,0.12273,0.11732,0.12966,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.034576,0.11725,0.20156,0,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.10468,0.11718,0.095002,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.14312,0.11712,0.14274,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.060677,0.11686,0.1663,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.27821,0.11683,0.13779,0,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.18624,0.11679,0.10677,0,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.054439,0.11674,0.15091,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.08881,0.11656,0.18258,0,0
2,GO TUBE DEVELOPMENT,0.072385,0.11638,0.18001,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.08588,0.11637,0.13498,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.13467,0.11609,0.12084,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.077559,0.11592,0.2143,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.10468,0.11584,0.11492,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.15197,0.1158,0.13326,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.26442,0.11575,0.085726,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16123,0.11563,0.25759,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.072385,0.11535,0.14803,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.054439,0.11532,0.14913,0,0
2,GO HEART VALVE DEVELOPMENT,0.20822,0.11532,0.16055,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.08588,0.11526,0.16955,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.08588,0.11505,0.14499,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.056456,0.11504,0.16572,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.10134,0.11496,0.090902,0,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.10134,0.11491,0.13138,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.098083,0.11488,0.18029,0,0
2,GO GLIAL CELL PROLIFERATION,0.38829,0.11449,0.10145,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.11524,0.11436,0.17517,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.11524,0.11433,0.1481,0,0
2,GO ACTIN FILAMENT ORGANIZATION,0.091819,0.11431,0.15273,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.18624,0.11408,0.10578,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.077559,0.11403,0.12616,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.1475,0.11397,0.15042,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.15655,0.11396,0.11014,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.18102,0.1139,0.21758,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.57414,0.11382,0.086306,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.024086,0.11357,0.14649,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.33029,0.1134,0.12171,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.13467,0.11339,0.16932,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.56341,0.11329,0.06421,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.12662,0.11324,0.17888,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.12662,0.11307,0.18792,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.214,0.11303,0.14374,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.037377,0.1129,0.22998,0,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.060677,0.11278,0.14297,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.32248,0.11263,0.10992,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.058535,0.11257,0.14994,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.056456,0.11256,0.14426,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.10134,0.11253,0.11232,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.13467,0.1124,0.1738,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.11894,0.11237,0.11984,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.1306,0.1123,0.15761,0,0
2,GO REGULATION OF RELAXATION OF MUSCLE,0.13885,0.11228,0.21097,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.098083,0.11222,0.13457,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.19156,0.11221,0.14986,0,0
2,GO REGULATION OF HEART RATE,0.14312,0.11162,0.099049,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.11524,0.11138,0.13032,0,0
2,GO REGULATION OF HORMONE LEVELS,0.08588,0.11135,0.11583,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.11524,0.1111,0.16614,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.091819,0.11108,0.1888,0,0
2,GO STRESS FIBER ASSEMBLY,0.1475,0.11089,0.15704,0,0
2,GO AMELOGENESIS,0.16123,0.11087,0.13265,0,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.08303,0.11081,0.12394,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.15197,0.11062,0.18203,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.197,0.11055,0.14016,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.074935,0.11053,0.16784,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.17091,0.1103,0.13412,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.18102,0.1102,0.12063,0,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.13885,0.11018,0.19129,0,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.10134,0.11011,0.13585,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.08303,0.11003,0.14814,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.197,0.10988,0.10662,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.16602,0.10985,0.14073,0,0
2,GO RESPONSE TO INACTIVITY,0.2577,0.10956,0.11818,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.072385,0.10933,0.15542,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.10811,0.10925,0.14164,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.077559,0.10914,0.1646,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.08881,0.10912,0.15418,0,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.11163,0.10893,0.12744,0,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.10468,0.10883,0.20556,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.060677,0.10872,0.13034,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.08881,0.10863,0.13964,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.197,0.10845,0.11246,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.08588,0.10837,0.12914,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.13467,0.10836,0.13722,0,0
2,GO RESPONSE TO CALCIUM ION,0.08303,0.10833,0.13129,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.53179,0.1083,0.095284,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.058535,0.10813,0.13072,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.040368,0.10811,0.10948,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.16602,0.10778,0.15215,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.1306,0.10769,0.13107,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.077559,0.10765,0.12049,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.33029,0.10759,0.12111,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.23827,0.10755,0.075999,0,0
2,GO HOMEOSTATIC PROCESS,0.056456,0.10753,0.14094,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.214,0.10735,0.1489,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.065157,0.10694,0.16554,0,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.34626,0.10692,0.13571,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.08881,0.10686,0.15561,0,0
2,GO BODY FLUID SECRETION,0.08881,0.10675,0.13748,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.2259,0.10671,0.11072,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.32248,0.10671,0.088927,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.11524,0.10656,0.14861,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.17091,0.10655,0.1036,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.214,0.10652,0.10736,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.13885,0.10607,0.15489,0,0
2,GO SKIN DEVELOPMENT,0.08881,0.10576,0.14358,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.64051,0.10568,0.10686,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.098083,0.10565,0.18089,0,0
2,GO REGULATION OF PROTEIN BINDING,0.17091,0.10564,0.12872,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.10811,0.10558,0.14102,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.12662,0.10546,0.13822,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.034576,0.10542,0.15794,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.52145,0.10506,0.12252,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.013834,0.10505,0.17333,0,0
2,GO INSEMINATION,0.2577,0.105,0.10283,0,0
2,GO ENDODERM DEVELOPMENT,0.13467,0.10488,0.2023,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.1475,0.10472,0.14771,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.15655,0.10468,0.16029,0,0
2,GO PROTEIN ADP RIBOSYLATION,0.27126,0.10464,0.0968,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.62923,0.1045,0.074917,0,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.072385,0.10445,0.23909,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.10811,0.10441,0.1922,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.29248,0.1043,0.12721,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.13467,0.10429,0.16714,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.058535,0.1042,0.18312,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.58498,0.10412,0.065181,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.08303,0.10412,0.16008,0,0
2,GO AMYLOID BETA FORMATION,0.094909,0.10387,0.16541,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.11894,0.10385,0.16048,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.080256,0.10379,0.16718,0,0
2,GO RESPONSE TO STEROID HORMONE,0.080256,0.10374,0.14769,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.17591,0.10373,0.12707,0,0
2,GO REGULATION OF PROTEIN IMPORT,0.11163,0.1037,0.12001,0,0
2,GO CORNIFICATION,0.18624,0.10349,0.12344,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.08881,0.10336,0.12919,0,0
2,GO REGULATION OF HEAT GENERATION,0.24463,0.10336,0.14149,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.11894,0.10334,0.098064,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.074935,0.10333,0.14758,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.094909,0.10311,0.12593,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.038848,0.10309,0.14297,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.1306,0.10292,0.16872,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.197,0.10272,0.14656,0,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.16602,0.10271,0.15015,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.23827,0.10256,0.097987,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.11894,0.1024,0.18004,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.19156,0.10238,0.11937,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.074935,0.1023,0.15513,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.27821,0.10225,0.090294,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.094909,0.10222,0.14301,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.074935,0.10201,0.17937,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.10134,0.102,0.14076,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.08881,0.10196,0.15942,0,0
2,GO HEART FORMATION,0.062884,0.10196,0.17063,0,0
2,GO SPROUTING ANGIOGENESIS,0.197,0.10193,0.14932,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.069906,0.10186,0.15483,0,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.08303,0.10182,0.12281,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.011574,0.10178,0.16392,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.19156,0.10176,0.13263,0,0
2,GO SIGNAL RELEASE,0.11524,0.1015,0.12757,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.058535,0.10148,0.16981,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.43329,0.10142,0.12822,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.27126,0.10142,0.13149,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.20822,0.10142,0.14431,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.25111,0.10141,0.098283,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.13467,0.10135,0.094265,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.48117,0.10126,0.079533,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.50109,0.10123,0.064282,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.25111,0.10122,0.1396,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.46168,0.1012,0.089087,0,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.069906,0.1009,0.141,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.14312,0.10089,0.14891,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.17091,0.10084,0.15224,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.065157,0.10078,0.14034,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.077559,0.1007,0.12267,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.12273,0.10055,0.14504,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.26442,0.10054,0.12036,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.094909,0.10054,0.12852,0,0
2,GO MEMBRANE REPOLARIZATION,0.21989,0.10047,0.10796,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.27821,0.10041,0.11048,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.17091,0.10039,0.11598,0,0
2,GO URETER DEVELOPMENT,0.53179,0.10033,0.057358,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.48117,0.10021,0.12469,0,0
2,GO LUNG MORPHOGENESIS,0.091819,0.10019,0.19857,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.056456,0.10018,0.1321,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.058535,0.10016,0.21086,0,0
2,GO NEPHRON DEVELOPMENT,0.14312,0.099814,0.1571,0,0
2,GO ANIMAL ORGAN MATURATION,0.30724,0.099655,0.13234,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.041938,0.099627,0.16571,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.48117,0.09957,0.076334,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.18624,0.099567,0.14118,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.056456,0.099539,0.13915,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.1475,0.09952,0.2249,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.065157,0.099414,0.12615,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.25111,0.099406,0.12707,0,0
2,GO NEURON DEATH,0.14312,0.099397,0.12431,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.64051,0.099366,0.10805,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.20822,0.099347,0.11267,0,0
2,GO REGULATION OF TRANSPORT,0.08303,0.099253,0.12218,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.24463,0.099157,0.13261,0,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.19156,0.099148,0.15621,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.13885,0.099016,0.13038,0,0
2,GO ORGANIC CATION TRANSPORT,0.20822,0.098994,0.12324,0,0
2,GO ADAPTIVE THERMOGENESIS,0.08588,0.098971,0.13679,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.27821,0.098934,0.13758,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.16123,0.098851,0.11624,0,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.11163,0.098728,0.20166,0,0
2,GO POSITIVE REGULATION OF BINDING,0.1475,0.098677,0.11238,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.14312,0.098583,0.1424,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.16123,0.098372,0.14435,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.26442,0.098354,0.15289,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.21989,0.098338,0.13416,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.080256,0.098315,0.14209,0,0
2,GO GLIAL CELL MIGRATION,0.1306,0.098262,0.1724,0,0
2,GO ACTION POTENTIAL,0.20822,0.098245,0.087239,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.28529,0.098076,0.087639,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.16123,0.098041,0.097903,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.08303,0.097969,0.14722,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.18102,0.097948,0.14277,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.098083,0.097836,0.14245,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.17591,0.097658,0.10815,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.30724,0.097621,0.11736,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.12273,0.097496,0.13144,0,0
2,GO CARTILAGE MORPHOGENESIS,0.15197,0.097485,0.15267,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17091,0.097365,0.17419,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.68646,0.097115,0.080891,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.10811,0.09707,0.15099,0,0
2,GO LIVER REGENERATION,0.098083,0.096962,0.12498,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.098083,0.096894,0.15121,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.08303,0.096732,0.23314,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.10468,0.09655,0.093769,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.14312,0.09622,0.13264,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.27821,0.096195,0.11264,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.17091,0.096094,0.13597,0,0
2,GO REGULATION OF DOPAMINE SECRETION,0.37964,0.095942,0.11643,0,0
2,GO DETECTION OF CALCIUM ION,0.20256,0.095895,0.11148,0,0
2,GO METANEPHROS DEVELOPMENT,0.14312,0.095658,0.15344,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.058535,0.09563,0.13411,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.050584,0.095527,0.17324,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.10468,0.095526,0.095583,0,0
2,GO NOTOCHORD DEVELOPMENT,0.214,0.09547,0.14762,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.08303,0.095438,0.14143,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.10811,0.095395,0.18802,0,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.13885,0.095334,0.13059,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.08881,0.095214,0.15036,0,0
2,GO ARTERY MORPHOGENESIS,0.12662,0.095179,0.2091,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.16123,0.095069,0.1768,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.197,0.095054,0.14628,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.1306,0.09478,0.13624,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.08303,0.094693,0.1424,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.25111,0.094337,0.10123,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.12273,0.094333,0.24279,0,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.045233,0.094118,0.21814,0,0
2,GO NEURON REMODELING,0.21989,0.094107,0.16823,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.57414,0.094099,0.073067,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.080256,0.094057,0.19602,0,0
2,GO ORGANIC ACID TRANSPORT,0.054439,0.094008,0.13693,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.197,0.093864,0.11,0,0
2,GO FATTY ACID BETA OXIDATION,0.25111,0.093713,0.085189,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.50109,0.093706,0.098153,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.08303,0.093605,0.15934,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.1306,0.093548,0.16139,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.33029,0.093494,0.10288,0,0
2,GO HEAD MORPHOGENESIS,0.10134,0.093149,0.21644,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.065157,0.093132,0.14696,0,0
2,GO RESPONSE TO UV B,0.10468,0.093088,0.16226,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.39705,0.093006,0.089646,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.39705,0.092907,0.12178,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.13467,0.092887,0.15263,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.094909,0.092698,0.12657,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.48117,0.092629,0.081425,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.18624,0.092594,0.1056,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.64051,0.092502,0.065166,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.214,0.092494,0.13027,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.18624,0.092467,0.14799,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.33029,0.092447,0.077095,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.058535,0.092373,0.16002,0,0
2,GO HISTONE H2B UBIQUITINATION,0.16123,0.092207,0.10561,0,0
2,GO VASCULOGENESIS,0.24463,0.092129,0.14319,0,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.30724,0.092122,0.10888,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.40594,0.092089,0.070441,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.61803,0.092062,0.034925,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.056456,0.092051,0.18583,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.08588,0.092014,0.20527,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.12273,0.092005,0.13462,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.11163,0.09192,0.11703,0,0
2,GO RESPONSE TO ATP,0.1475,0.091889,0.13401,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.060677,0.091579,0.11542,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.23203,0.091565,0.14645,0,0
2,GO XENOBIOTIC TRANSPORT,0.13885,0.091458,0.16075,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.57414,0.09135,0.061969,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.2998,0.091261,0.10548,0,0
2,GO FEAR RESPONSE,0.32248,0.09125,0.049527,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.12273,0.091087,0.10101,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.12273,0.091051,0.13159,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.069906,0.090723,0.13272,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.067497,0.090712,0.18516,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.24463,0.090582,0.12938,0,0
2,GO TRACHEA DEVELOPMENT,0.1306,0.09054,0.16561,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.060677,0.090524,0.11972,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.3148,0.090317,0.093553,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.15655,0.090256,0.11531,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.13885,0.0902,0.12645,0,0
2,GO RESPONSE TO HORMONE,0.08881,0.09018,0.13814,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.12662,0.090074,0.16448,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.1475,0.090042,0.12716,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.27821,0.089895,0.13572,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.21989,0.089864,0.11042,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.067497,0.089804,0.14957,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.098083,0.089721,0.12183,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.10468,0.089656,0.17251,0,0
2,GO MEMBRANE DEPOLARIZATION,0.32248,0.089591,0.072073,0,0
2,GO REGULATION OF ION TRANSPORT,0.197,0.089549,0.10733,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.074935,0.089503,0.17009,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.27821,0.089392,0.12304,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.062884,0.089179,0.17346,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.34626,0.089164,0.083744,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.069906,0.089145,0.11551,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.36271,0.089144,0.11533,0,0
2,GO KERATINOCYTE MIGRATION,0.067497,0.089113,0.20792,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.28529,0.089008,0.11939,0,0
2,GO KERATINIZATION,0.15655,0.088966,0.10972,0,0
2,GO BONE MATURATION,0.52145,0.08883,0.094017,0,0
2,GO RESPONSE TO PH,0.10468,0.088818,0.17234,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.17091,0.088776,0.096615,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.11163,0.08873,0.15172,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.32248,0.088594,0.098866,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.37111,0.088568,0.09363,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.15655,0.088517,0.13933,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.197,0.088383,0.13173,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.11163,0.088362,0.13634,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.08881,0.088347,0.17723,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.08881,0.088163,0.18933,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.54223,0.088039,0.098078,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.23827,0.087954,0.1206,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.19156,0.087953,0.11466,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.30724,0.08794,0.098061,0,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.25111,0.087833,0.1591,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.55277,0.087735,0.13493,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.33821,0.087482,0.093529,0,0
2,GO SODIUM ION HOMEOSTASIS,0.12662,0.087376,0.11971,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.08881,0.087367,0.14294,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.29248,0.087341,0.099134,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.1306,0.087314,0.1019,0,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.214,0.087294,0.13672,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.17591,0.087214,0.15171,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.12662,0.087146,0.11727,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.12662,0.087097,0.12971,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.17091,0.087077,0.10677,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.062884,0.086903,0.14801,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.13885,0.086682,0.079355,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.062884,0.086676,0.14558,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.96843,0.086673,0.015585,0,0
2,GO HEART PROCESS,0.2998,0.086654,0.085233,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.098083,0.08663,0.10589,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.17091,0.086624,0.11626,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.08881,0.086542,0.23709,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.069906,0.086496,0.14113,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.2259,0.086416,0.099678,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.11894,0.086228,0.22821,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.33029,0.086212,0.09198,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.2577,0.08612,0.1178,0,0
2,GO RESPONSE TO TESTOSTERONE,0.065157,0.086102,0.14213,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.21989,0.086086,0.16765,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.10134,0.085578,0.12389,0,0
2,GO INOSITOL METABOLIC PROCESS,0.60692,0.085452,0.077011,0,0
2,GO L AMINO ACID TRANSPORT,0.14312,0.085334,0.11914,0,0
2,GO FAT CELL DIFFERENTIATION,0.062884,0.085281,0.1674,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.074935,0.085159,0.15946,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.069906,0.085049,0.149,0,0
2,GO GLYCINE METABOLIC PROCESS,0.60692,0.085005,0.042418,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.33029,0.084979,0.078845,0,0
2,GO RESPONSE TO AMINE,0.37111,0.084739,0.076615,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.11524,0.084734,0.13996,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.58498,0.084709,0.08742,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.094909,0.084491,0.18017,0,0
2,GO RESPONSE TO ESTRADIOL,0.16602,0.084484,0.12295,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.23203,0.084407,0.11035,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.067497,0.084303,0.14711,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.056456,0.084261,0.12722,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.49108,0.084111,0.08311,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.20256,0.084079,0.23081,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.08588,0.084019,0.1434,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.077559,0.083979,0.14022,0,0
2,GO GLYCOSYLATION,0.08303,0.083912,0.12386,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.060677,0.083751,0.13294,0,0
2,GO SLEEP,0.1475,0.083741,0.098336,0,0
2,GO ION TRANSPORT,0.067497,0.08357,0.11649,0,0
2,GO GASTRULATION,0.072385,0.083569,0.18546,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.18624,0.083496,0.10185,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.33029,0.083461,0.13036,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.38829,0.083409,0.12308,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.4521,0.083351,0.10869,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.27126,0.083339,0.20303,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.13885,0.083249,0.12125,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.11163,0.083181,0.12497,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.072385,0.083165,0.14757,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.17591,0.083077,0.10453,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.27126,0.083077,0.13335,0,0
2,GO COPULATION,0.48117,0.082897,0.094686,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.08881,0.082889,0.14064,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.4521,0.082819,0.06518,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.39705,0.082675,0.10049,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.26442,0.082657,0.12753,0,0
2,GO FUCOSYLATION,0.30724,0.082647,0.076913,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.197,0.082566,0.09741,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.2259,0.082529,0.11695,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.21989,0.082503,0.10823,0,0
2,GO NEURON APOPTOTIC PROCESS,0.23203,0.08247,0.10492,0,0
2,GO PODOSOME ASSEMBLY,0.33029,0.082322,0.11916,0,0
2,GO FOREGUT MORPHOGENESIS,0.75756,0.082237,0.052379,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.13467,0.082216,0.15315,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.30724,0.082212,0.10681,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.60692,0.081919,0.080989,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.15655,0.081909,0.12393,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.056456,0.081894,0.14735,0,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.11894,0.081726,0.15187,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.28529,0.08169,0.064858,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.25111,0.081525,0.081269,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.4521,0.08143,0.10386,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.077559,0.081419,0.14136,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.11163,0.081383,0.11722,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.065157,0.081341,0.19811,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.13467,0.081332,0.15852,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.44264,0.081332,0.1353,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.17591,0.081161,0.14776,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.2577,0.081107,0.10866,0,0
2,GO IMPORT INTO CELL,0.16602,0.080916,0.11518,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.14312,0.080887,0.13066,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.23203,0.080879,0.16319,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.33821,0.080745,0.094677,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11894,0.080681,0.11162,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.20822,0.080582,0.14773,0,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.23203,0.080524,0.057354,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.42405,0.080513,0.12218,0,0
2,GO GLUTAMATE SECRETION,0.79394,0.080456,0.055808,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.23203,0.08044,0.14635,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.074935,0.080343,0.13034,0,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.19156,0.080302,0.14291,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.2577,0.080176,0.10341,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.12273,0.080164,0.081861,0,0
2,GO RESPONSE TO PEPTIDE,0.15655,0.080129,0.12432,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.23203,0.080035,0.15681,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.11524,0.079893,0.098566,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.12662,0.079792,0.14828,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.11524,0.079785,0.15028,0,0
2,GO BONE DEVELOPMENT,0.10468,0.07976,0.18418,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.35442,0.079686,0.042256,0,0
2,GO TISSUE REGENERATION,0.2998,0.079528,0.086964,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.08303,0.079412,0.14747,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.26442,0.079322,0.13802,0,0
2,GO INORGANIC ANION TRANSPORT,0.16123,0.079262,0.10154,0,0
2,GO BODY MORPHOGENESIS,0.16123,0.079202,0.18151,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.37964,0.079102,0.093623,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.58498,0.079072,0.0794,0,0
2,GO ANION TRANSPORT,0.074935,0.078834,0.12843,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.077559,0.078815,0.18185,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.065157,0.078772,0.14072,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.080256,0.07875,0.1324,0,0
2,GO RESPONSE TO GAMMA RADIATION,0.056456,0.078713,0.1143,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.10468,0.07865,0.13845,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.23203,0.078515,0.14359,0,0
2,GO HYPEROSMOTIC RESPONSE,0.29248,0.07849,0.12736,0,0
2,GO AUTOPHAGOSOME MATURATION,0.39705,0.078482,0.097524,0,0
2,GO REGULATION OF NEURON MATURATION,0.36271,0.07844,0.13263,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.16602,0.07844,0.14919,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.2998,0.078346,0.082198,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.12273,0.078276,0.12123,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.13467,0.078256,0.11837,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.35442,0.078229,0.074327,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.32248,0.078097,0.11082,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.10134,0.078052,0.13751,0,0
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.40594,0.078005,0.10132,0,0
2,GO GLUCOSE IMPORT,0.34626,0.078004,0.080233,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.094909,0.077837,0.13338,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.197,0.077727,0.10694,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.40594,0.077549,0.088736,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.10134,0.077477,0.15306,0,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.24463,0.077407,0.10409,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.29248,0.077344,0.083167,0,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.2577,0.077235,0.091626,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.39705,0.077176,0.081531,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.44264,0.077069,0.096556,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.08588,0.07706,0.12314,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.077559,0.077021,0.13965,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13885,0.076993,0.12965,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.072385,0.076982,0.17139,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.060677,0.076878,0.12561,0,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.27126,0.076826,0.076503,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.23827,0.076811,0.14659,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.38829,0.076761,0.10679,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.35442,0.076692,0.093993,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.26442,0.076636,0.10896,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.08881,0.076623,0.20468,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.18102,0.076608,0.085427,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.16602,0.076575,0.12111,0,0
2,GO LIPID MODIFICATION,0.24463,0.076531,0.10215,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.56341,0.07645,0.07095,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.33821,0.076437,0.091229,0,0
2,GO CELL GROWTH,0.27821,0.076379,0.11112,0,0
2,GO HEART GROWTH,0.2998,0.076152,0.10174,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.065157,0.076023,0.10684,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.214,0.075792,0.093359,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.27126,0.07557,0.093583,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.10811,0.075568,0.10565,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.197,0.075444,0.063167,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.069906,0.075426,0.16531,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.077559,0.075378,0.10392,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.39705,0.075364,0.10106,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.08588,0.075305,0.15691,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.16602,0.075277,0.070797,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.13885,0.075259,0.18294,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.094909,0.075143,0.17593,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.30724,0.075117,0.078207,0,0
2,GO RESPONSE TO BMP,0.11163,0.0751,0.18178,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.20256,0.075092,0.12814,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.19156,0.075014,0.13114,0,0
2,GO GENITALIA MORPHOGENESIS,0.47137,0.07499,0.080025,0,0
2,GO MYOBLAST MIGRATION,0.54223,0.074911,0.045578,0,0
2,GO REGULATION OF BINDING,0.23827,0.074838,0.10676,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.53179,0.074737,0.066266,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.12662,0.074722,0.11912,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.16123,0.074689,0.15304,0,0
2,GO LIPID DROPLET ORGANIZATION,0.16602,0.07468,0.097692,0,0
2,GO CALCIUM ION IMPORT,0.20822,0.074654,0.10692,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.098083,0.074572,0.18843,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.18624,0.074558,0.11469,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.36271,0.074347,0.088072,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.098083,0.074227,0.11549,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.11163,0.074076,0.11936,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.18624,0.074072,0.13234,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.34626,0.074005,0.054507,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.18624,0.073818,0.11116,0,0
2,GO MITOCHONDRIAL FISSION,0.015104,0.073754,0.16458,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.36271,0.073744,0.095858,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.37964,0.073639,0.05733,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.12273,0.073626,0.11232,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.29248,0.073572,0.12068,0,0
2,GO PIGMENT ACCUMULATION,0.48117,0.073507,0.11737,0,0
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.18102,0.073488,0.099278,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.11524,0.073368,0.13136,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.062884,0.073354,0.11615,0,0
2,GO COCHLEA DEVELOPMENT,0.3148,0.073073,0.091002,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.44264,0.072974,0.086979,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.1306,0.072962,0.13532,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.23827,0.07293,0.067791,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.20256,0.072917,0.18408,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.30724,0.072908,0.14004,0,0
2,GO CHONDROCYTE PROLIFERATION,0.4521,0.072897,0.12464,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.46168,0.072881,0.098453,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.64051,0.072668,0.089702,0,0
2,GO CATECHOLAMINE UPTAKE,0.3148,0.072653,0.14706,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.12662,0.072652,0.12595,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.20822,0.0726,0.087919,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.91805,0.072571,0.032151,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.26442,0.072537,0.1218,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.1475,0.072384,0.16038,0,0
2,GO RETINOL METABOLIC PROCESS,0.2998,0.072276,0.063076,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.13467,0.072209,0.14465,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.37111,0.072203,0.025776,0,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.08303,0.072194,0.20785,0,0
2,GO EPIDERMIS DEVELOPMENT,0.091819,0.072097,0.1315,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.08881,0.072062,0.18494,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.1475,0.072058,0.12275,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.3148,0.072058,0.11274,0,0
2,GO PLACENTA DEVELOPMENT,0.058535,0.071991,0.16833,0,0
2,GO MESENCHYME DEVELOPMENT,0.14312,0.071955,0.14256,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.08588,0.071944,0.1193,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.35442,0.071926,0.097829,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.3148,0.071779,0.10358,0,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.18624,0.071751,0.13555,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.10134,0.071727,0.14214,0,0
2,GO PROTEIN IMPORT,0.29248,0.071647,0.080303,0,0
2,GO GLIAL CELL DEVELOPMENT,0.20822,0.071611,0.12938,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.32248,0.071584,0.055356,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.16602,0.071581,0.12434,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.20822,0.071526,0.092159,0,0
2,GO REGULATION OF ACTIN NUCLEATION,0.098083,0.071491,0.12605,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.33821,0.071483,0.11822,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.10468,0.071464,0.13703,0,0
2,GO REGULATION OF MYELINATION,0.1475,0.071446,0.15301,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.13885,0.071354,0.12492,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.13467,0.071272,0.12687,0,0
2,GO HORMONE TRANSPORT,0.15655,0.071179,0.10353,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.197,0.071143,0.094074,0,0
2,GO CELLULAR RESPONSE TO ATP,0.25111,0.071124,0.11659,0,0
2,GO RESPONSE TO UV C,0.38829,0.071111,0.087793,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.2577,0.071104,0.082694,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.10134,0.071043,0.11531,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.23203,0.070977,0.11257,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.17091,0.070974,0.1004,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.074935,0.07093,0.095725,0,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.11163,0.070895,0.07112,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.36271,0.070888,0.087939,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.34626,0.070761,0.081809,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.36271,0.070667,0.087596,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.08588,0.070633,0.176,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.38829,0.070612,0.074982,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.27821,0.070524,0.077472,0,0
2,GO CELL MATURATION,0.18624,0.070402,0.11031,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.54223,0.070371,0.082476,0,0
2,GO GTP METABOLIC PROCESS,0.2577,0.070367,0.07619,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.10811,0.070193,0.12926,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.077559,0.070164,0.22898,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.197,0.070146,0.16653,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.098083,0.070082,0.16454,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.86799,0.070041,-0.0079584,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.27126,0.07002,0.10948,0,0
2,GO PERICARDIUM DEVELOPMENT,0.2998,0.069862,0.12749,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.2577,0.069826,0.11633,0,0
2,GO LACTATE METABOLIC PROCESS,0.18102,0.069748,0.086359,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.072385,0.069693,0.10959,0,0
2,GO CELL CELL SIGNALING,0.25111,0.069655,0.10185,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.08881,0.06965,0.13001,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.17091,0.069507,0.082892,0,0
2,GO VIRAL RELEASE FROM HOST CELL,0.13885,0.069265,0.099258,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.11524,0.069243,0.1851,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.08303,0.069215,0.17945,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12662,0.069191,0.12081,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.062884,0.06914,0.13728,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.08588,0.069081,0.1063,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.10134,0.06893,0.1341,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.3148,0.06889,0.10607,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.3148,0.068864,0.11178,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.15655,0.068844,0.09729,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.64051,0.068841,0.09365,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.19156,0.068836,0.14168,0,0
2,GO BONE GROWTH,0.20822,0.068795,0.1776,0,0
2,GO METAL ION TRANSPORT,0.11524,0.068653,0.11079,0,0
2,GO ERBB2 SIGNALING PATHWAY,0.5959,0.068627,0.067695,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.15655,0.068606,0.12677,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.060677,0.068592,0.23296,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.43329,0.068558,0.045181,0,0
2,GO VIRAL BUDDING,0.10134,0.068551,0.082568,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.18624,0.068531,0.10603,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.20256,0.068508,0.1019,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.42405,0.068175,0.085238,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.2259,0.068166,0.11295,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.067497,0.06814,0.20267,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.094909,0.067995,0.16929,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.10468,0.067881,0.12643,0,0
2,GO ENAMEL MINERALIZATION,0.36271,0.067811,0.12266,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.33821,0.067803,0.073762,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.2998,0.067802,0.093976,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.20822,0.067615,0.10892,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.16123,0.067543,0.14174,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.34626,0.067515,0.10128,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.41494,0.067391,0.11562,0,0
2,GO RESPONSE TO CAFFEINE,0.197,0.06739,0.10875,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.15655,0.067352,0.17047,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.23827,0.06734,0.10499,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.53179,0.067252,0.071031,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.30724,0.067229,0.099843,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.16602,0.067228,0.11733,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.52145,0.066921,0.09174,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10811,0.066854,0.12836,0,0
2,GO CATION TRANSPORT,0.10811,0.066833,0.10793,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.15655,0.066768,0.18034,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.17091,0.066748,0.15603,0,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.17591,0.066711,0.11011,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.08303,0.066705,0.18227,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.08881,0.066527,0.10581,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.091819,0.066351,0.15898,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.20822,0.066106,0.17679,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.13467,0.066069,0.09411,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.1475,0.065955,0.2214,0,0
2,GO DOPAMINE TRANSPORT,0.43329,0.065869,0.11457,0,0
2,GO ECTODERM DEVELOPMENT,0.94321,0.065634,0.034894,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.37964,0.06562,0.082195,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.16602,0.065496,0.148,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.20256,0.065445,0.13991,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.12662,0.065396,0.12272,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.2998,0.06539,0.11103,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.36271,0.065317,0.097446,0,0
2,GO CELL JUNCTION ORGANIZATION,0.64051,0.065275,0.083516,0,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.23203,0.06527,0.10597,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.19156,0.065262,0.1562,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.23203,0.065117,0.10579,0,0
2,GO ENSHEATHMENT OF NEURONS,0.24463,0.065106,0.12355,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.37964,0.065103,0.089201,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.23827,0.065074,0.14811,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.27821,0.065032,0.1062,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.13467,0.065002,0.16695,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.14312,0.064841,0.13531,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.86799,0.064836,0.047907,0,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.49108,0.064835,0.10072,0,0
2,GO BONE MORPHOGENESIS,0.12662,0.064819,0.17718,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.13467,0.064816,0.1131,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.33821,0.064592,0.0743,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.40594,0.064586,0.073641,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.10134,0.064453,0.18695,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.214,0.064303,0.13249,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.15655,0.064214,0.080338,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.34626,0.064213,0.075643,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.16123,0.064111,0.10077,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.25111,0.064087,0.15404,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.29248,0.064084,0.097147,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.11524,0.064066,0.11493,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.056456,0.063982,0.12897,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.37964,0.063941,0.083615,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.2998,0.063926,0.091346,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.11894,0.063918,0.12249,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.78176,0.063842,0.040441,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.13467,0.063822,0.11045,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.16123,0.063809,0.13315,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.20256,0.063801,0.069765,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.15197,0.063768,0.11492,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.17591,0.063665,0.086691,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.15655,0.063655,0.085865,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.40594,0.063655,0.1031,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.18624,0.063655,0.1222,0,0
2,GO REGULATION OF HORMONE SECRETION,0.20256,0.063649,0.098125,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.26442,0.063634,0.072241,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.23827,0.063634,0.095658,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.197,0.063631,0.12514,0,0
2,GO SELECTIVE AUTOPHAGY,0.3148,0.063604,0.10601,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.094909,0.063573,0.13253,0,0
2,GO MEMBRANE FISSION,0.24463,0.063551,0.11646,0,0
2,GO PROTEIN POLYMERIZATION,0.30724,0.063467,0.099224,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.28529,0.063448,0.11474,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18624,0.063439,0.17973,0,0
2,GO ARTERY DEVELOPMENT,0.23203,0.063382,0.16525,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.1475,0.063375,0.13006,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.33821,0.063362,0.090709,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.96843,0.063328,0.0082294,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.069906,0.063315,0.11915,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.16602,0.063304,0.15456,0,0
2,GO REGULATION OF EXOCYTOSIS,0.17591,0.063264,0.12368,0,0
2,GO FATTY ACID HOMEOSTASIS,0.25111,0.063223,0.099818,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.51122,0.063181,0.062988,0,0
2,GO HAIR CELL DIFFERENTIATION,0.41494,0.063171,0.066922,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.20256,0.063105,0.10605,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.36271,0.063026,0.081141,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.2259,0.062912,0.11616,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.18624,0.062836,0.086568,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.197,0.062796,0.10441,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.11894,0.062673,0.098881,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.5959,0.062655,0.081671,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.83078,0.062509,0.027165,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.26442,0.062504,0.09703,0,0
2,GO DEVELOPMENTAL MATURATION,0.44264,0.062499,0.09411,0,0
2,GO RESPONSE TO AMPHETAMINE,0.33029,0.06241,0.073244,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.47137,0.0624,0.080875,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.55277,0.062374,0.077506,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.83078,0.062175,0.038846,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.13885,0.062153,0.16685,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.72171,0.062081,0.052134,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.16602,0.061968,0.092182,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.30724,0.061958,0.13018,0,0
2,GO RECEPTOR CLUSTERING,0.55277,0.061917,0.087689,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.44264,0.061863,0.081166,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.17591,0.061823,0.16021,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.12273,0.061567,0.16943,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.37111,0.061394,0.077114,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33821,0.061349,0.095727,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.11163,0.061218,0.1271,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.53179,0.061122,0.067592,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.20822,0.06108,0.19077,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.24463,0.061073,0.12155,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.23827,0.061036,0.11326,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.18624,0.061009,0.13018,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.28529,0.061008,0.083884,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.037377,0.060848,0.1318,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.34626,0.060811,0.10499,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.78176,0.060713,0.057956,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.41494,0.060553,0.08262,0,0
2,GO HEAT GENERATION,0.2259,0.060486,0.12488,0,0
2,GO LOCOMOTOR RHYTHM,0.49108,0.060477,0.10052,0,0
2,GO MYOBLAST PROLIFERATION,0.72171,0.060439,0.018561,0,0
2,GO REGULATION OF DNA BINDING,0.36271,0.060328,0.078687,0,0
2,GO RESPONSE TO STARVATION,0.18624,0.060302,0.10087,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.23203,0.060284,0.11888,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.52145,0.060268,0.073993,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.37964,0.060231,0.080054,0,0
2,GO HEME METABOLIC PROCESS,0.08881,0.060161,0.10237,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.32248,0.060132,0.069826,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.10134,0.059994,0.14385,0,0
2,GO VACUOLE ORGANIZATION,0.065157,0.059913,0.13448,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.021265,0.059831,0.11114,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.53179,0.059807,0.095384,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.66333,0.059579,0.065281,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.18102,0.059502,0.101,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.18624,0.059499,0.13985,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.094909,0.059484,0.13633,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.2998,0.059448,0.11376,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.34626,0.059438,0.11641,0,0
2,GO RESPONSE TO LEAD ION,0.24463,0.059179,0.10266,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.10134,0.05912,0.10915,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.30724,0.059055,0.06621,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.54223,0.058928,0.099314,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.76963,0.058772,0.067145,0,0
2,GO EPOXYGENASE P450 PATHWAY,0.27821,0.05877,0.1029,0,0
2,GO KIDNEY MORPHOGENESIS,0.1475,0.058582,0.13661,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.1475,0.058532,0.10576,0,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.1475,0.058485,0.10434,0,0
2,GO CARDIAC CONDUCTION,0.52145,0.058437,0.056098,0,0
2,GO APPENDAGE DEVELOPMENT,0.43329,0.058384,0.090002,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.2259,0.058331,0.11732,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.13885,0.058299,0.16104,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.36271,0.058296,0.07805,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.61803,0.058275,0.060508,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.41494,0.05819,0.085126,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.11894,0.058178,0.13244,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.20256,0.05799,0.058207,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.33821,0.057983,0.10191,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.55277,0.057895,0.065446,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.37964,0.057864,0.10739,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.30724,0.057808,0.10609,0,0
2,GO SENSORY PERCEPTION OF TASTE,0.21989,0.057784,0.074342,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.19156,0.057712,0.11656,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.17591,0.057699,0.1004,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.47137,0.057687,0.068672,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.55277,0.057662,0.084938,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.077559,0.057652,0.13307,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.37964,0.057466,0.043394,0,0
2,GO LIPID GLYCOSYLATION,0.36271,0.057388,0.093628,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.18624,0.057318,0.091137,0,0
2,GO CHLORIDE TRANSPORT,0.43329,0.057264,0.069069,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.33821,0.057242,0.10437,0,0
2,GO CELL JUNCTION ASSEMBLY,0.40594,0.057231,0.095608,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.49108,0.057168,0.071285,0,0
2,GO WATER TRANSPORT,0.18102,0.057127,0.16992,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.197,0.057028,0.1391,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.18624,0.056953,0.075759,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.83078,0.056777,0.010771,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.16123,0.056568,0.11493,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.60692,0.056435,0.078338,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.41494,0.056423,0.080133,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.1475,0.056389,0.13168,0,0
2,GO RESPONSE TO COCAINE,0.94321,0.056386,0.01665,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.091819,0.056348,0.16879,0,0
2,GO MIDGUT DEVELOPMENT,0.43329,0.056316,0.09985,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.3148,0.056311,0.10614,0,0
2,GO RESPONSE TO INSECTICIDE,0.89296,0.056218,0.027348,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.20256,0.056171,0.089835,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.66333,0.056088,0.082601,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.24463,0.056024,0.13223,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.3148,0.056013,0.080211,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.26442,0.055932,0.13362,0,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.29248,0.055879,0.08087,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.23827,0.055874,0.1057,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.14312,0.055813,0.08121,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.23827,0.055756,0.12221,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.15655,0.055715,0.13041,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.54223,0.055708,0.084998,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.72171,0.055703,0.063945,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.56341,0.055596,0.098284,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.197,0.055377,0.12914,0,0
2,GO REGULATION OF TRANSPOSITION,0.55277,0.055338,0.053411,0,0
2,GO TOXIN TRANSPORT,0.30724,0.055295,0.096838,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.24463,0.055287,0.087309,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.15197,0.055209,0.12446,0,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.2998,0.055155,0.091184,0,0
2,GO RESPONSE TO POTASSIUM ION,0.84314,0.055097,-0.04154,0,0
2,GO POLYOL METABOLIC PROCESS,0.41494,0.055094,0.087109,0,0
2,GO RESPONSE TO SALT STRESS,0.32248,0.055046,0.1128,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.18102,0.05496,0.098328,0,0
2,GO UV PROTECTION,0.58498,0.054792,0.079885,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.28529,0.05477,0.10709,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.33821,0.054767,0.13977,0,0
2,GO NOTCH SIGNALING PATHWAY,0.23203,0.054739,0.11622,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.33821,0.054678,0.087774,0,0
2,GO RESPONSE TO DOPAMINE,0.72171,0.05462,0.05315,0,0
2,GO LYSOSOMAL TRANSPORT,0.61803,0.054485,0.095763,0,0
2,GO ENERGY HOMEOSTASIS,0.54223,0.05439,0.092539,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.33821,0.054389,0.072333,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.19156,0.054324,0.1039,0,0
2,GO RNA DECAPPING,0.69814,0.054323,0.074647,0,0
2,GO MYOFIBRIL ASSEMBLY,0.2998,0.054295,0.10285,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.20822,0.054263,0.1103,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.16602,0.054233,0.076808,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.29248,0.0542,0.13418,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.42405,0.054149,0.09635,0,0
2,GO CELL CELL SIGNALING BY WNT,0.17091,0.054119,0.12033,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.21989,0.053986,0.17947,0,0
2,GO RESPONSE TO OSMOTIC STRESS,0.091819,0.053927,0.14035,0,0
2,GO REGENERATION,0.1475,0.053925,0.13032,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.64051,0.053872,0.06975,0,0
2,GO RECEPTOR INTERNALIZATION,0.48117,0.053852,0.090207,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.098083,0.053848,0.10979,0,0
2,GO SALIVA SECRETION,0.83078,0.053731,0.043562,0,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.35442,0.053715,0.10111,0,0
2,GO MAGNESIUM ION TRANSPORT,0.25111,0.053701,0.11068,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.091819,0.05369,0.13654,0,0
2,GO ORGAN GROWTH,0.24463,0.053573,0.1088,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.18624,0.053541,0.12228,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.28529,0.053514,0.16136,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.098083,0.053467,0.11851,0,0
2,GO MYELIN ASSEMBLY,0.17591,0.053411,0.17887,0,0
2,GO COLLATERAL SPROUTING,0.67486,0.053329,-0.014379,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.42405,0.053232,0.073523,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.19156,0.053062,0.099106,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.36271,0.053039,0.11271,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.86799,0.052937,0.061493,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.5959,0.052921,0.078023,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.16123,0.05289,0.099534,0,0
2,GO AORTA MORPHOGENESIS,0.38829,0.052841,0.11872,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.66333,0.052831,0.059365,0,0
2,GO THIOESTER METABOLIC PROCESS,0.10468,0.052806,0.10281,0,0
2,GO COCHLEA MORPHOGENESIS,0.33821,0.052677,0.098909,0,0
2,GO POLYAMINE METABOLIC PROCESS,0.53179,0.052375,0.039085,0,0
2,GO NEGATIVE CHEMOTAXIS,0.72171,0.052362,0.077239,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.41494,0.052195,0.12573,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.11163,0.052176,0.1364,0,0
2,GO GDP METABOLIC PROCESS,0.40594,0.052061,0.097256,0,0
2,GO PEROXISOME ORGANIZATION,0.069906,0.052051,0.087409,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.18102,0.051975,0.080364,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.56341,0.051894,0.063715,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.40594,0.051864,0.080133,0,0
2,GO REGULATION OF TOR SIGNALING,0.80618,0.051835,0.055803,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.25111,0.051818,0.16192,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.15197,0.051596,0.11795,0,0
2,GO SECONDARY METABOLIC PROCESS,0.15197,0.051582,0.082126,0,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.2998,0.051487,0.11124,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.08303,0.051425,0.13263,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.54223,0.051403,0.05348,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.34626,0.051377,0.10944,0,0
2,GO FIBROBLAST ACTIVATION,0.37111,0.051322,0.11606,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.28529,0.05131,0.1019,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.5959,0.051282,0.031396,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.38829,0.051235,0.09399,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.24463,0.051154,0.090027,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.19156,0.051146,0.12313,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.46168,0.051063,0.090963,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.33821,0.051041,0.11071,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.36271,0.050856,0.09326,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.25111,0.050838,0.093409,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.33821,0.050828,0.12458,0,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.26442,0.050766,0.084052,0,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.60692,0.050637,0.067337,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.55277,0.050496,0.064525,0,0
2,GO RESPONSE TO INSULIN,0.20822,0.050375,0.11057,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.32248,0.050294,0.088863,0,0
2,GO DIOL METABOLIC PROCESS,0.20256,0.050264,0.11532,0,0
2,GO GLAND DEVELOPMENT,0.12662,0.050252,0.14304,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.33029,0.050032,0.090279,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.41494,0.050024,0.094197,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.2998,0.049905,0.065786,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.88046,0.049827,0.032149,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.62923,0.049808,0.059023,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.214,0.049757,0.11055,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.32248,0.049633,0.078653,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.17591,0.049599,0.090052,0,0
2,GO THYMUS DEVELOPMENT,0.61803,0.04954,0.055728,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.47137,0.049465,0.061581,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.30724,0.049405,0.092408,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.25111,0.049394,0.13541,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.42405,0.049324,0.062298,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.54223,0.049322,0.10319,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.7336,0.049315,0.064023,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.12273,0.049315,0.13034,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.19156,0.049288,0.15158,0,0
2,GO APPENDAGE MORPHOGENESIS,0.52145,0.049249,0.083698,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.58498,0.049229,0.084157,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.40594,0.049126,0.097768,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.2577,0.049125,0.11654,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.15655,0.049059,0.11397,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.5959,0.04898,0.045708,0,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.18624,0.048979,0.14983,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.26442,0.04877,0.078793,0,0
2,GO DNA CATABOLIC PROCESS,0.37111,0.048718,0.070717,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.13467,0.048652,0.088031,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.2259,0.048504,0.11771,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.41494,0.048488,0.083361,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.64051,0.04844,0.064366,0,0
2,GO PENTOSE METABOLIC PROCESS,0.34626,0.048428,0.04024,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.32248,0.048419,0.047321,0,0
2,GO RESPONSE TO ALKALOID,0.46168,0.048417,0.055264,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.37964,0.048406,0.070424,0,0
2,GO DNA DEMETHYLATION,0.75756,0.048233,0.055625,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.47137,0.048228,0.070218,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.37111,0.048215,0.054587,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.47137,0.048157,0.083944,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.26442,0.048148,0.11988,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.38829,0.04813,0.14687,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.93062,0.048015,-0.011133,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.20822,0.048014,0.12312,0,0
2,GO PROTEIN PALMITOYLATION,0.60692,0.047961,0.079869,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.58498,0.047945,0.034405,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.44264,0.047937,0.088183,0,0
2,GO EAR DEVELOPMENT,0.2577,0.047902,0.098562,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.52145,0.047671,0.060863,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.3148,0.047638,0.096953,0,0
2,GO REGULATION OF CELL DIVISION,0.74555,0.04748,0.058437,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.48117,0.04736,0.084763,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.96843,0.047262,0.028962,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.37111,0.047108,0.085983,0,0
2,GO REGULATION OF GLIOGENESIS,0.44264,0.047078,0.088517,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.49108,0.047063,0.070544,0,0
2,GO REGULATION OF MITOPHAGY,0.99368,0.047041,0.047804,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.50109,0.047019,0.090756,0,0
2,GO GLIOGENESIS,0.42405,0.046858,0.10662,0,0
2,GO VIRION ASSEMBLY,0.043559,0.046855,0.094442,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.27126,0.046793,0.090022,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.72171,0.046755,0.034743,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.37111,0.046717,0.067954,0,0
2,GO GONADOTROPIN SECRETION,0.20822,0.046715,0.12631,0,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.25111,0.046712,0.075772,0,0
2,GO IMPORT INTO NUCLEUS,0.52145,0.046674,0.063421,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.27126,0.046584,0.098455,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.47137,0.046215,0.12174,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.27126,0.046193,0.12678,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.30724,0.046155,0.11993,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.68646,0.046113,0.058174,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.72171,0.046107,0.047931,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.3148,0.046019,0.10404,0,0
2,GO PARENTAL BEHAVIOR,0.72171,0.045939,0.017905,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.098083,0.045934,0.10729,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.38829,0.045924,0.096349,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.15655,0.045902,0.1368,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.43329,0.045891,0.093588,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.47137,0.045857,0.07583,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.7336,0.045686,0.018648,0,0
2,GO ACTIN NUCLEATION,0.056456,0.045661,0.13255,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.48117,0.045469,0.052034,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.46168,0.045467,0.092607,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.3148,0.045464,0.091775,0,0
2,GO TUBULIN DEACETYLATION,0.70989,0.045117,0.082058,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.30724,0.045019,0.03449,0,0
2,GO REGULATION OF HAIR CYCLE,0.43329,0.044957,0.090465,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.38829,0.044902,0.10127,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.67486,0.044878,0.061566,0,0
2,GO NEURAL CREST FORMATION,0.67486,0.044808,0.051028,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.48117,0.04476,0.077008,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.16602,0.04476,0.097439,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.78176,0.044703,0.059855,0,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.197,0.044579,0.1382,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.21989,0.044472,0.12054,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.90549,0.044406,0.0042052,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.33029,0.044243,0.08942,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.074935,0.044229,0.11245,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.35442,0.044051,0.071212,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.58498,0.044005,0.068978,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.46168,0.044005,0.062042,0,0
2,GO NEURON MATURATION,0.67486,0.043922,0.072012,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.49108,0.043776,0.095238,0,0
2,GO REGULATION OF HEART GROWTH,0.2259,0.043754,0.10705,0,0
2,GO GOLGI LOCALIZATION,0.40594,0.043719,0.060912,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.27126,0.043688,0.11278,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.67486,0.043653,0.093356,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.79394,0.043545,0.022059,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.1475,0.043475,0.15923,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.99368,0.043469,0.02834,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.30724,0.043444,0.068653,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.48117,0.043439,0.096449,0,0
2,GO SPERM CAPACITATION,0.33821,0.043027,0.082604,0,0
2,GO EPITHELIUM DEVELOPMENT,0.14312,0.042942,0.12908,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.99368,0.042917,0.029943,0,0
2,GO DE NOVO PROTEIN FOLDING,0.48117,0.042841,0.053131,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.33029,0.042814,0.091656,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.56341,0.042802,0.014087,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.39705,0.042648,0.091434,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.18624,0.042555,0.088374,0,0
2,GO SODIUM ION TRANSPORT,0.57414,0.042518,0.052472,0,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.52145,0.042503,0.11807,0,0
2,GO OVULATION CYCLE PROCESS,0.68646,0.042435,0.069904,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.40594,0.042318,0.06465,0,0
2,GO REGULATION OF URINE VOLUME,0.33821,0.042289,0.1124,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.44264,0.042222,0.12344,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.26442,0.042195,0.092285,0,0
2,GO AMINO ACID TRANSPORT,0.41494,0.042148,0.085944,0,0
2,GO EAR MORPHOGENESIS,0.42405,0.042075,0.076221,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.40594,0.041952,0.096273,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.19156,0.041892,0.14189,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.83078,0.041785,0.036397,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.93062,0.041761,-0.072409,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.25111,0.041724,0.18307,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.41494,0.041706,0.071027,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.60692,0.04138,0.062186,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.95582,0.041295,0.01123,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.24463,0.041294,0.08485,0,0
2,GO VACUOLAR TRANSPORT,0.43329,0.041159,0.094175,0,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.37964,0.041138,0.091419,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.12273,0.041086,0.10123,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.89296,0.040974,0.050777,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.55277,0.040965,0.055585,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.28529,0.040874,0.096612,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.69814,0.040819,0.15603,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.43329,0.040787,0.081112,0,0
2,GO GROWTH HORMONE SECRETION,0.78176,0.040508,0.0271,0,0
2,GO PEPTIDE HORMONE SECRETION,0.52145,0.040481,0.08172,0,0
2,GO CELL FATE SPECIFICATION,0.60692,0.040432,0.05866,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.33029,0.040355,0.054985,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.62923,0.040212,0.061135,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.62923,0.040195,0.069102,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.13467,0.040113,0.074929,0,0
2,GO RESPONSE TO NICOTINE,0.72171,0.040112,0.036122,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.38829,0.040076,0.12762,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.4521,0.039969,0.064203,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.30724,0.039933,0.15873,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.13467,0.03991,0.10569,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.47137,0.039792,0.052354,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.40594,0.039788,0.10377,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.24463,0.039756,0.078045,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.78176,0.039751,0.029317,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.60692,0.039726,0.087568,0,0
2,GO HEART DEVELOPMENT,0.2998,0.03972,0.11386,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.17091,0.039697,0.1009,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.68646,0.039577,0.10502,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.90549,0.039533,0.037904,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.28529,0.039494,0.084297,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.56341,0.039458,-0.0024974,0,0
2,GO MESODERM DEVELOPMENT,0.15197,0.039437,0.13615,0,0
2,GO ENDOCYTIC RECYCLING,0.54223,0.039423,0.097487,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.46168,0.039369,0.072387,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.39705,0.039345,0.091122,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.49108,0.039251,0.076132,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.93062,0.039248,0.039262,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.23203,0.039227,0.07804,0,0
2,GO RESPONSE TO ZINC ION,0.25111,0.039147,0.098821,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.18102,0.039097,0.069335,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.30724,0.039027,0.067074,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.27126,0.038996,0.13026,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.34626,0.038937,0.1187,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.54223,0.038868,0.074233,0,0
2,GO MOTILE CILIUM ASSEMBLY,1,0.038804,-0.017376,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.197,0.03878,0.09881,0,0
2,GO REGULATION OF AUTOPHAGY,0.17091,0.038692,0.1196,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.32248,0.038632,0.11864,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.61803,0.038609,0.076886,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.80618,0.038586,0.05257,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.98106,0.038524,0.0053723,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.55277,0.038459,0.078812,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.56341,0.038436,0.065287,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.57414,0.038407,0.054171,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.23203,0.038384,0.07997,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.86799,0.038368,0.032137,0,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.34626,0.03789,0.073837,0,0
2,GO INSULIN SECRETION,0.46168,0.037766,0.079403,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.62923,0.037708,0.05335,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.39705,0.037636,0.081751,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.214,0.037543,0.11261,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.52145,0.037493,0.078512,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.33029,0.037473,0.092107,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.20256,0.037379,0.069842,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.69814,0.037378,0.025614,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.67486,0.037356,0.062633,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.23203,0.037329,0.10408,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.37111,0.037263,0.11565,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.36271,0.037203,0.081584,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.52145,0.037116,0.097941,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.23827,0.037073,0.10019,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.37964,0.036949,0.12151,0,0
2,GO CIRCADIAN RHYTHM,0.66333,0.036943,0.071415,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.86799,0.036879,0.011272,0,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.90549,0.036862,0.024729,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.40594,0.036794,0.068576,0,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.27821,0.036759,0.092604,0,0
2,GO GROWTH,0.44264,0.036643,0.099096,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.56341,0.036426,0.091836,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.76963,0.036367,0.092087,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.32248,0.036083,0.12462,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.48117,0.03594,0.071448,0,0
2,GO TOR SIGNALING,0.72171,0.035828,0.056889,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.32248,0.035638,0.059067,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.2259,0.035572,0.098496,0,0
2,GO CELLULAR PIGMENTATION,0.65188,0.035571,0.045824,0,0
2,GO SYNAPSE ORGANIZATION,0.93062,0.035553,0.022234,0,0
2,GO RENAL WATER HOMEOSTASIS,0.64051,0.035552,0.10247,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.56341,0.035551,0.095564,0,0
2,GO PONS DEVELOPMENT,0.76963,0.035474,0.14463,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.52145,0.035389,0.08343,0,0
2,GO AORTA DEVELOPMENT,0.46168,0.035368,0.11753,0,0
2,GO VESICLE LOCALIZATION,0.65188,0.035346,0.071182,0,0
2,GO RHYTHMIC BEHAVIOR,0.29248,0.035342,0.10661,0,0
2,GO RESPONSE TO GLUCAGON,0.67486,0.035307,0.035426,0,0
2,GO RESPONSE TO LEUCINE,0.83078,0.035286,0.064973,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.42405,0.035283,0.11533,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.81845,0.03524,0.052352,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.54223,0.03524,0.063735,0,0
2,GO CGMP METABOLIC PROCESS,0.79394,0.035184,0.043338,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.33029,0.035109,0.086526,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.55277,0.035077,0.10246,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.5959,0.034965,0.049366,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.53179,0.034938,0.064729,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.40594,0.034913,0.041105,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.88046,0.034832,0.050054,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.47137,0.034802,0.074411,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.23827,0.034777,0.10383,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.83078,0.034717,0.038385,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.72171,0.034684,0.067716,0,0
2,GO RENAL SODIUM EXCRETION,0.55277,0.034609,0.069463,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.11894,0.034576,0.11197,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.89296,0.034538,0.030271,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.58498,0.034507,0.037984,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.35442,0.034481,0.087741,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.80618,0.03447,0.0579,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.57414,0.034377,0.025983,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.197,0.034308,0.092701,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.1475,0.034274,0.19771,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.37111,0.034245,0.098466,0,0
2,GO BLASTOCYST FORMATION,0.70989,0.034173,0.042417,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.44264,0.034163,0.076359,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.214,0.034162,0.11154,0,0
2,GO EPITHELIAL CELL MATURATION,0.38829,0.034102,0.10393,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.50109,0.034069,0.10403,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.50109,0.034052,0.06976,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.33029,0.034047,0.084795,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.18624,0.034047,0.10348,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.28529,0.033802,0.15038,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.20256,0.033732,0.10195,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.2998,0.033692,0.079341,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.34626,0.03363,0.097537,0,0
2,GO ENDOSOMAL TRANSPORT,0.57414,0.03349,0.08151,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.7336,0.033351,0.09639,0,0
2,GO CYTOKINETIC PROCESS,0.16123,0.033326,0.1002,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.36271,0.033289,0.1165,0,0
2,GO REGULATION OF GTP BINDING,0.79394,0.033225,0.039704,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.1475,0.033185,0.10795,0,0
2,GO MEMBRANE BIOGENESIS,0.4521,0.033182,0.092658,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.34626,0.033167,0.11734,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.2577,0.033113,0.17475,0,0
2,GO ATP TRANSPORT,0.35442,0.03308,0.086505,0,0
2,GO MALE SEX DIFFERENTIATION,0.2259,0.033066,0.11368,0,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.1306,0.03305,0.098438,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.41494,0.032962,0.087509,0,0
2,GO CRISTAE FORMATION,0.99368,0.032959,0.023089,0,0
2,GO SPERM EGG RECOGNITION,0.33821,0.03292,0.039983,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.42405,0.032898,0.089693,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.96843,0.032705,0.030191,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.66333,0.032672,0.09734,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.68646,0.03259,0.023227,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.42405,0.032304,0.04672,0,0
2,GO NEURON CELL CELL ADHESION,0.68646,0.032251,0.053614,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.64051,0.032241,0.083155,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.98106,0.032195,0.036813,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.57414,0.032147,0.082429,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.56341,0.032047,0.052705,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.68646,0.032012,0.057016,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.64051,0.031898,0.091578,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.32248,0.031885,0.068673,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.38829,0.031866,0.09957,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.36271,0.031837,0.064122,0,0
2,GO DNA DEALKYLATION,0.52145,0.031618,0.069778,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.68646,0.031594,0.0063722,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.32248,0.03149,0.093046,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.5959,0.031467,0.076395,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.40594,0.031444,0.067061,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.48117,0.031425,0.039099,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.33029,0.031342,0.072069,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.37964,0.031292,0.091521,0,0
2,GO MIDBRAIN DEVELOPMENT,0.65188,0.031274,0.061672,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.50109,0.031256,0.10098,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.89296,0.031191,0.015204,0,0
2,GO EXOCYTIC PROCESS,0.32248,0.03119,0.12175,0,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.34626,0.031136,0.084584,0,0
2,GO STEM CELL DIFFERENTIATION,0.26442,0.031104,0.10027,0,0
2,GO FILOPODIUM ASSEMBLY,0.62923,0.030999,0.081919,0,0
2,GO FUCOSE METABOLIC PROCESS,0.46168,0.030981,0.065437,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.54223,0.030961,0.077966,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.60692,0.030866,0.075716,0,0
2,GO DEVELOPMENTAL GROWTH,0.70989,0.030783,0.073452,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.41494,0.030744,0.094292,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.37964,0.030347,0.087383,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.46168,0.030282,0.086836,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.89296,0.030151,0.03603,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.30724,0.030091,0.098425,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.2577,0.029982,0.10243,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.80618,0.029862,0.026546,0,0
2,GO AEROBIC RESPIRATION,0.2259,0.029796,0.05465,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.66333,0.02976,0.046542,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.94321,0.029759,-0.0065888,0,0
2,GO THYROID GLAND DEVELOPMENT,0.50109,0.029756,0.069736,0,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.72171,0.029749,0.048498,0,0
2,GO N GLYCAN PROCESSING,0.26442,0.029732,0.1695,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.3148,0.029716,0.05134,0,0
2,GO SULFATE TRANSPORT,0.66333,0.029708,0.058682,0,0
2,GO REGULATION OF INSULIN SECRETION,0.3148,0.029694,0.08493,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.94321,0.029653,0.041614,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.55277,0.029397,0.047891,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.69814,0.029386,0.03607,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.27126,0.029362,0.095297,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.2259,0.029327,0.090387,0,0
2,GO TRANSPOSITION,0.69814,0.029313,0.04118,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.21989,0.02928,0.09784,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.37111,0.029278,0.098707,0,0
2,GO MATING,1,0.029187,0.030211,0,0
2,GO EPITHELIAL TUBE FORMATION,0.54223,0.029177,0.083044,0,0
2,GO SEGMENT SPECIFICATION,0.72171,0.029027,0.055808,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.38829,0.028992,0.06498,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.46168,0.028968,0.10259,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.48117,0.028954,0.096685,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.67486,0.02894,0.034754,0,0
2,GO ORGANELLE INHERITANCE,0.40594,0.028921,0.087266,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.23203,0.028739,0.14443,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.67486,0.028643,-0.0503,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.68646,0.028619,0.063204,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.56341,0.028605,0.068898,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.70989,0.028568,0.03968,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.52145,0.028536,0.12547,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.40594,0.028523,0.10832,0,0
2,GO VIRAL RNA GENOME REPLICATION,0.5959,0.028506,0.066058,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.54223,0.028477,0.060649,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.47137,0.028441,0.080853,0,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.4521,0.028379,0.13035,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.62923,0.028357,0.016263,0,0
2,GO MEMBRANE DISASSEMBLY,0.99368,0.028282,0.03016,0,0
2,GO LACTATION,0.36271,0.028188,0.1083,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.3148,0.028176,0.095442,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.30724,0.028093,0.082061,0,0
2,GO CELLULAR RESPONSE TO UV,0.91805,0.028004,0.019701,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.27126,0.02797,0.15051,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.94321,0.027953,0.023073,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.55277,0.027918,0.047783,0,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.34626,0.027891,0.1057,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.16602,0.02787,0.16134,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.72171,0.027728,0.13238,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.60692,0.027621,0.074046,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.66333,0.027525,0.077183,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.68646,0.027422,0.043469,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.20822,0.027421,0.041945,0,0
2,GO REGULATION OF GROWTH,0.27821,0.027051,0.11287,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69814,0.026999,0.093453,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10468,0.026969,0.13143,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.36271,0.026877,0.11375,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.56341,0.026796,0.071365,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.98106,0.026651,0.045911,0,0
2,GO VESICLE CARGO LOADING,0.57414,0.026532,0.074904,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.95582,0.026478,0.016875,0,0
2,GO RRNA MODIFICATION,1,0.026465,0.017919,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.35442,0.026417,0.10101,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.7336,0.026363,0.053365,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.72171,0.026146,-0.099373,0,0
2,GO PROTEIN TETRAMERIZATION,0.33029,0.026022,0.083104,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.23827,0.025878,0.11911,0,0
2,GO NEPHRON MORPHOGENESIS,0.197,0.025865,0.12688,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.91805,0.025834,0.050175,0,0
2,GO INCLUSION BODY ASSEMBLY,0.48117,0.025815,0.10619,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.61803,0.025642,0.044648,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.4521,0.025623,0.071867,0,0
2,GO MOLTING CYCLE,0.36271,0.025542,0.10119,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.62923,0.025482,0.061057,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.23827,0.025469,0.03867,0,0
2,GO TISSUE MORPHOGENESIS,0.1475,0.025295,0.13982,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.53179,0.025263,0.037214,0,0
2,GO RESPONSE TO VITAMIN A,0.58498,0.025208,0.042271,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.34626,0.025172,0.090947,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.16123,0.025146,0.13369,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.54223,0.024947,0.083557,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.68646,0.024939,0.055257,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.88046,0.024899,0.060206,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.83078,0.02484,0.070252,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.3148,0.024802,0.095962,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.62923,0.02478,0.057622,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.76963,0.024757,-0.019141,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.60692,0.02467,0.062948,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.60692,0.02454,0.053001,0,0
2,GO TRNA CATABOLIC PROCESS,0.79394,0.024508,-0.019811,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.5959,0.024486,0.055263,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.61803,0.024338,0.053987,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.53179,0.024311,0.096568,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.86799,0.024237,0.054403,0,0
2,GO NEURON PROJECTION EXTENSION,0.81845,0.024228,0.028617,0,0
2,GO HEART MORPHOGENESIS,0.38829,0.024139,0.11285,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.69814,0.024045,0.034586,0,0
2,GO SENSORY PERCEPTION,0.55277,0.023998,0.052413,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.34626,0.023972,0.099954,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.33029,0.023957,0.074775,0,0
2,GO NEURAL TUBE FORMATION,0.47137,0.023952,0.093727,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.83078,0.023885,0.0090434,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.78176,0.023849,0.025605,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.69814,0.023791,0.049967,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.84314,0.023613,0.023827,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.64051,0.023608,0.08017,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.28529,0.02351,0.11138,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.4521,0.023479,0.02445,0,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.75756,0.023458,0.051343,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.80618,0.023342,0.040556,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.18624,0.023341,0.073622,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.57414,0.023339,0.053565,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.76963,0.022983,0.0058501,0,0
2,GO PROTEIN STABILIZATION,0.3148,0.022787,0.081194,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.57414,0.022651,0.062001,0,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.75756,0.022579,0.027826,0,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.3148,0.022569,0.11241,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.93062,0.022557,0.056242,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.62923,0.022538,0.017846,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.91805,0.02235,0.0010262,0,0
2,GO ACID SECRETION,0.55277,0.022344,0.041756,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.46168,0.022324,0.11259,0,0
2,GO CELL AGING,0.2259,0.022184,0.10154,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.49108,0.022123,0.077454,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.90549,0.022095,0.015042,0,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.69814,0.021955,0.061734,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.98106,0.021949,0.020819,0,0
2,GO CELL FATE DETERMINATION,0.27821,0.021931,0.12169,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.81845,0.021795,0.071488,0,0
2,GO CARNITINE METABOLIC PROCESS,0.68646,0.021785,0.057195,0,0
2,GO MITOPHAGY,0.79394,0.021613,0.062699,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.42405,0.021557,0.085661,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.26442,0.021538,0.06819,0,0
2,GO NUCLEOSIDE SALVAGE,0.2259,0.021468,0.077807,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.60692,0.021444,0.078286,0,0
2,GO EXCRETION,0.50109,0.021417,0.091053,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.76963,0.021389,0.053573,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.83078,0.021364,0.019607,0,0
2,GO NEPHRON TUBULE FORMATION,0.4521,0.021079,0.086751,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.10468,0.021018,0.19645,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.51122,0.021004,0.044585,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.95582,0.020857,0.018841,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.98106,0.020845,0.045104,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.27821,0.020837,0.11871,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.90549,0.020706,0.053176,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17591,0.020697,0.075159,0,0
2,GO DEPHOSPHORYLATION,0.57414,0.020686,0.071989,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.72171,0.02061,0.069618,0,0
2,GO HAIR FOLLICLE MATURATION,0.37964,0.02053,0.097471,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.54223,0.020479,0.070983,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.44264,0.02042,0.089698,0,0
2,GO PROTEIN POLYUBIQUITINATION,0.65188,0.020374,0.060842,0,0
2,GO REPRODUCTION,0.76963,0.020352,0.055421,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.48117,0.020264,0.08035,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.21989,0.020254,0.08376,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.43329,0.020245,0.10284,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.33029,0.020226,0.055839,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.70989,0.020202,0.070331,0,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.33029,0.020138,0.064459,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.58498,0.020003,0.059949,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.75756,0.019916,0.0074474,0,0
2,GO RHYTHMIC PROCESS,0.70989,0.019806,0.066218,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.25111,0.019672,0.06665,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.81845,0.019526,0.041588,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.47137,0.019457,0.16955,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.61803,0.019323,0.061329,0,0
2,GO ESTROUS CYCLE,0.76963,0.019266,0.061359,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.58498,0.019223,0.065973,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.41494,0.019212,0.056394,0,0
2,GO VISUAL BEHAVIOR,0.84314,0.01911,0.045268,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.86799,0.019106,0.03403,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.46168,0.018987,0.078865,0,0
2,GO SOMITOGENESIS,0.53179,0.018883,0.081635,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.56341,0.018649,0.043892,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.72171,0.018623,0.038034,0,0
2,GO SEX DIFFERENTIATION,0.70989,0.018577,0.063928,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.98106,0.018409,0.059986,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.48117,0.018324,0.089824,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.46168,0.018171,0.084568,0,0
2,GO HEPATOCYTE DIFFERENTIATION,0.86799,0.018046,0.017052,0,0
2,GO NERVOUS SYSTEM PROCESS,0.84314,0.017862,0.036592,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.7336,0.017816,0.052848,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.66333,0.017754,0.057662,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.74555,0.017662,0.064827,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.53179,0.017548,0.056534,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.54223,0.017544,0.056935,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.88046,0.01733,0.068171,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.65188,0.017288,0.035238,0,0
2,GO CELLULAR RESPIRATION,0.197,0.017282,0.052959,0,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.68646,0.017126,0.032854,0,0
2,GO POLYOL CATABOLIC PROCESS,0.60692,0.017044,0.055434,0,0
2,GO PSEUDOURIDINE SYNTHESIS,0.7336,0.016718,-0.012906,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.81845,0.016711,0.0046065,0,0
2,GO ORGANELLE DISASSEMBLY,0.32248,0.016622,0.086409,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.76963,0.016558,0.016662,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.78176,0.016406,0.052521,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.85555,0.01634,0.030711,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57414,0.016326,0.077014,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.84314,0.016245,-0.076401,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.21989,0.01624,0.10279,0,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.67486,0.016157,0.029988,0,0
2,GO REGULATION OF ORGAN GROWTH,0.34626,0.016157,0.097329,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.94321,0.016113,0.071903,0,0
2,GO CELLULAR SENESCENCE,0.20822,0.016111,0.096815,0,0
2,GO PROTEIN FOLDING,0.50109,0.016051,0.06498,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.85555,0.015756,0.051273,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.36271,0.015666,0.081998,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.57414,0.015624,0.067126,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.66333,0.015532,0.064468,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.75756,0.015412,0.062526,0,0
2,GO REGULATION OF CELL AGING,0.39705,0.015311,0.074422,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.65188,0.015194,0.025278,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.61803,0.015181,0.086273,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.57414,0.015176,0.080433,0,0
2,GO OVULATION CYCLE,0.67486,0.015143,0.074774,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.58498,0.014922,0.095267,0,0
2,GO TUBE FORMATION,0.53179,0.014908,0.083853,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.53179,0.014797,0.049481,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.86799,0.014797,0.022904,0,0
2,GO INNER EAR MORPHOGENESIS,0.56341,0.014759,0.061832,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.44264,0.014752,0.082676,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.98106,0.014532,0.025455,0,0
2,GO OXYGEN TRANSPORT,0.79394,0.014519,0.032734,0,0
2,GO REGULATION OF ERAD PATHWAY,0.35442,0.014508,0.090906,0,0
2,GO GOLGI VESICLE TRANSPORT,0.37964,0.014456,0.088457,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.94321,0.014433,0.039229,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.62923,0.014306,0.07479,0,0
2,GO PARTURITION,0.7336,0.014211,0.059305,0,0
2,GO PROTEIN TARGETING,0.2998,0.014175,0.039411,0,0
2,GO RESPONSE TO UV,0.93062,0.014169,0.020046,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.57414,0.014164,0.064003,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.72171,0.014118,0.054095,0,0
2,GO DNA RECOMBINATION,0.74555,0.014046,-0.0027439,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.98106,0.013961,0.034183,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.27126,0.013813,0.093085,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.66333,0.013809,0.065501,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.83078,0.013755,0.048053,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.52145,0.013681,0.048589,0,0
2,GO SOMITE DEVELOPMENT,0.51122,0.013638,0.083292,0,0
2,GO ORGANELLE LOCALIZATION,0.89296,0.013571,0.044343,0,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.42405,0.013541,0.061514,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.48117,0.013521,0.046499,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.81845,0.013374,0.039729,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.40594,0.0133,0.046951,0,0
2,GO PEPTIDE METABOLIC PROCESS,0.47137,0.013193,0.034691,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.42405,0.013169,0.067612,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.57414,0.013135,0.070916,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.96843,0.013111,0.02503,0,0
2,GO FORELIMB MORPHOGENESIS,0.88046,0.013071,0.021743,0,0
2,GO PHOTOTRANSDUCTION,0.80618,0.012929,0.0019683,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.96843,0.012908,0.052759,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.78176,0.012882,-0.034407,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.89296,0.012852,0.048351,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.85555,0.012838,0.049071,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.89296,0.01282,0.020714,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.43329,0.012748,0.081262,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.26442,0.012716,0.057872,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.42405,0.012662,0.10663,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.85555,0.012655,0.0042056,0,0
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.74555,0.012619,0.045369,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.93062,0.012494,0.065074,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.96843,0.012462,0.0029435,0,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.85555,0.012301,-0.015062,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.29248,0.012261,0.12987,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.53179,0.012244,0.058637,0,0
2,GO LOCOMOTORY BEHAVIOR,0.99368,0.012236,0.041019,0,0
2,GO ODONTOGENESIS,0.24463,0.012218,0.13667,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.89296,0.01218,0.014833,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.30724,0.012114,0.075553,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.3148,0.012103,0.053262,0,0
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.55277,0.011931,0.060024,0,0
2,GO RESPONSE TO HEAT,0.3148,0.011786,0.087797,0,0
2,GO RESPONSE TO ACTIVITY,0.27126,0.011658,0.089131,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.55277,0.011561,0.09853,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.29248,0.011448,0.11271,0,0
2,GO MITOCHONDRION ORGANIZATION,0.33821,0.01138,0.06161,0,0
2,GO BEHAVIOR,0.93062,0.011157,0.024572,0,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.86799,0.011061,0.011847,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.61803,0.010903,0.062337,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.57414,0.010896,0.092388,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.83078,0.010752,0.059293,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.67486,0.010745,0.04144,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.96843,0.010739,0.1052,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.42405,0.010688,0.10134,0,0
2,GO POTASSIUM ION TRANSPORT,0.65188,0.010651,0.049533,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.67486,0.010473,0.063361,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.80618,0.010402,0.029647,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.53179,0.010365,-0.027992,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.85555,0.010259,0.059957,0,0
2,GO TRANSLESION SYNTHESIS,0.95582,0.010249,0.023494,0,0
2,GO CYTOSKELETON ORGANIZATION,0.89296,0.010182,0.05949,0,0
2,GO QUINONE METABOLIC PROCESS,0.49108,0.010151,0.033178,0,0
2,GO LIPID PHOSPHORYLATION,0.42405,0.010102,0.112,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.86799,0.010096,0.053777,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1,0.01005,0.037909,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.64051,0.0099832,0.069461,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.86799,0.0099545,0.057758,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.66333,0.0099298,0.018222,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.78176,0.0099074,0.011179,0,0
2,GO CELL CYCLE ARREST,0.98106,0.0096855,0.04504,0,0
2,GO MONOAMINE TRANSPORT,0.61803,0.0096101,0.094422,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.91805,0.0095143,0.036761,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.94321,0.0094834,0.041472,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.58498,0.0094735,0.025665,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.7336,0.0093766,0.056197,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.79394,0.009295,0.016402,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.5959,0.0089567,0.072709,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.98106,0.0089038,0.052654,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.49108,0.0088832,0.09044,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.51122,0.0088688,0.072966,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,1,0.0088397,0.050626,0,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.81845,0.0087999,-0.014012,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.91805,0.0082277,0.03835,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.76963,0.0082204,0.014455,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.83078,0.0082074,0.070378,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.93062,0.0080866,0.035583,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.94321,0.0080366,0.036585,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.44264,0.0080286,0.092359,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.4521,0.0080113,0.074692,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.33821,0.0080016,0.098772,0,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.41494,0.0078437,0.09401,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.93062,0.0077561,0.037844,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.25111,0.0076687,0.092721,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.65188,0.0076312,0.08008,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.88046,0.0076254,0.045224,0,0
2,GO MITOTIC DNA REPLICATION,0.86799,0.0076198,0.028867,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.53179,0.0076137,0.17927,0,0
2,GO TRANSLATIONAL TERMINATION,0.99368,0.0075834,-0.0038358,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.68646,0.0075227,0.069702,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.86799,0.0074525,0.012669,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.88046,0.0073045,0.02706,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.96843,0.0072558,0.027052,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.72171,0.007129,0.038095,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.78176,0.0071097,0.065592,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.75756,0.0070791,0.058372,0,0
2,GO GOLGI ORGANIZATION,0.26442,0.007009,0.1022,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.76963,0.0069192,0.036952,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.56341,0.0068544,0.065262,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.99368,0.0068148,0.044812,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.91805,0.0067838,0.050221,0,0
2,GO NOSE DEVELOPMENT,0.89296,0.0066477,0.043313,0,0
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.43329,0.006623,0.074582,0,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.89296,0.0065438,0.031871,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.67486,0.0065064,0.05298,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.86799,0.0064975,0.025934,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.55277,0.0064697,0.064943,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.76963,0.0063988,0.045926,0,0
2,GO CYTOSOLIC TRANSPORT,0.53179,0.0063978,0.093632,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.69814,0.0063638,0.066456,0,0
2,GO CATECHOLAMINE SECRETION,0.98106,0.0063477,0.057259,0,0
2,GO ERYTHROCYTE MATURATION,0.58498,0.0063416,-0.026226,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.76963,0.006295,0.038887,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.64051,0.0060863,0.046754,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.76963,0.0060497,-0.017253,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.53179,0.0059349,0.071109,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.76963,0.0058845,0.044323,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.50109,0.0058039,0.061373,0,0
2,GO LYMPHANGIOGENESIS,0.68646,0.0057613,0.079596,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.76963,0.0057514,0.035551,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.66333,0.0057469,0.085359,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.49108,0.0057311,0.076004,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.84314,0.0056737,0.0058158,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.58498,0.0054826,0.089068,0,0
2,GO REGIONALIZATION,0.69814,0.0054398,0.064693,0,0
2,GO NCRNA CATABOLIC PROCESS,0.86799,0.0054095,0.018003,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,1,0.0053226,0.058691,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.51122,0.0053119,0.089506,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.75756,0.0052763,0.057545,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.85555,0.0052242,0.036054,0,0
2,GO SINGLE FERTILIZATION,0.91805,0.0051629,0.015077,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.88046,0.0051518,0.044979,0,0
2,GO BLASTOCYST DEVELOPMENT,0.86799,0.0050073,0.033653,0,0
2,GO RESPONSE TO RADIATION,0.94321,0.0049634,0.041487,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.81845,0.0049154,0.014582,0,0
2,GO NEURON DIFFERENTIATION,0.67486,0.0049114,0.020761,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.85555,0.0047356,0.058039,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.66333,0.0046451,0.086663,0,0
2,GO INTRACELLULAR TRANSPORT,0.74555,0.0045539,0.053216,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.88046,0.0045437,0.0547,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.96843,0.0045165,0.041487,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.38829,0.0044768,0.068091,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.61803,0.0044052,0.049918,0,0
2,GO METHIONINE METABOLIC PROCESS,0.67486,0.004391,-0.035313,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.83078,0.0043315,0.053242,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.41494,0.0043195,0.096662,0,0
2,GO SPERM AXONEME ASSEMBLY,0.47137,0.0042571,-0.053,0,0
2,GO PROTEIN KINASE A SIGNALING,0.7336,0.0042499,0.05091,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.28529,0.0041672,0.18716,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.94321,0.0041479,0.029625,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.95582,0.0039981,0.028223,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,1,0.0038633,0.058875,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.70989,0.0037864,0.040221,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.76963,0.0036943,-0.0021533,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.81845,0.0034138,0.044301,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.90549,0.0033206,-0.02389,0,0
2,GO PROTEIN REFOLDING,0.94321,0.0033142,-0.0076629,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.35442,0.0032658,0.12149,0,0
2,GO GMP METABOLIC PROCESS,0.66333,0.0032567,0.052954,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.7336,0.0031387,0.060335,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.98106,0.0031084,0.021319,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.88046,0.0030647,0.047746,0,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.55277,0.0030126,0.074592,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.85555,0.0029939,0.079105,0,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.85555,0.0029388,0.030309,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.43329,0.0028997,0.10726,0,0
2,GO PROTEASOME ASSEMBLY,0.80618,0.002412,-0.018976,0,0
2,GO SNORNA METABOLIC PROCESS,0.93062,0.0023975,0.016872,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,1,0.0023791,0.0037898,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.44264,0.0023292,0.054611,0,0
2,GO TONGUE MORPHOGENESIS,0.85555,0.0022064,0.04036,0,0
2,GO DNA LIGATION,0.86799,0.0022027,0.011443,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.96843,0.0020538,0.050104,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.80618,0.0018528,0.037713,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.64051,0.0017983,0.041525,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.69814,0.0017649,0.071538,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.49108,0.0016987,0.058938,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.91805,0.0016386,0.021674,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.50109,0.0015485,0.09303,0,0
2,GO CELL PART MORPHOGENESIS,0.65188,0.0014958,0.011129,0,0
2,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.65188,0.0014707,-0.013656,0,0
2,GO SARCOMERE ORGANIZATION,0.81845,0.0011189,0.032349,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.89296,0.0010224,0.047367,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.94321,0.00099554,0.035728,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.76963,0.00092,0.065977,0,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.96843,0.00086507,0.03319,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.33029,0.00082371,0.10886,0,0
2,GO EMBRYO DEVELOPMENT,0.58498,0.0008226,0.082295,0,0
2,GO RESPONSE TO WATER,0.66333,0.00050784,0.052734,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.66333,0.00045959,0.020743,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.75756,0.00043269,0.019207,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.67486,0.00041817,-0.01385,0,0
2,GO CELL PROJECTION ORGANIZATION,0.85555,0.00019301,0.034939,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.89296,0.00015381,0.060078,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.7336,7.9905e-05,-0.006688,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.81845,4.5849e-06,0.0082777,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.94321,-4.2805e-06,0.0028873,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.66333,-2.4339e-05,0.078201,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.46168,-5.021e-05,0.10691,0,0
2,GO FERTILIZATION,0.78176,-9.7672e-05,0.013026,0,0
2,GO HEAD DEVELOPMENT,0.78176,-0.00012826,0.030555,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.81845,-0.00024332,0.02316,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.80618,-0.00036398,0.045833,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.7336,-0.00039409,-0.010764,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.57414,-0.00040395,0.072968,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.53179,-0.00044218,0.071289,0,0
2,GO MITOCHONDRIAL TRANSCRIPTION,0.84314,-0.00046933,-0.0082601,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.64051,-0.00047307,0.069128,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.95582,-0.00047929,0.024153,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.94321,-0.00060569,0.0312,0,0
2,GO NEURON DEVELOPMENT,0.76963,-0.00065668,0.025988,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.2577,-0.00070872,0.10588,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.75756,-0.00085288,0.01569,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.81845,-0.00089409,0.06758,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.84314,-0.0011713,0.039282,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.55277,-0.0012378,0.099439,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.52145,-0.0013877,0.06505,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.91805,-0.0014412,0.057949,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.66333,-0.0014778,0.050061,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.98106,-0.0015224,0.026624,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.85555,-0.0016317,0.036011,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.66333,-0.0016887,0.051971,0,0
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.65188,-0.0019879,0.033647,0,0
2,GO CELL FATE COMMITMENT,0.51122,-0.0021211,0.087879,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.54223,-0.0021309,0.081927,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.56341,-0.0022231,0.07131,0,0
2,GO CELL MORPHOGENESIS,0.95582,-0.0022399,0.064491,0,0
2,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,1,-0.0023309,0.038132,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.74555,-0.0027044,0.059587,0,0
2,GO COGNITION,0.76963,-0.002773,0.012879,0,0
2,GO REGULATION OF BEHAVIOR,0.98106,-0.0028061,0.015902,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.55277,-0.0028745,0.0010538,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,1,-0.002877,0.043066,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.86799,-0.0028962,0.017112,0,0
2,GO ACROSOME REACTION,0.65188,-0.0029191,0.048407,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.74555,-0.0029806,0.046922,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.62923,-0.003096,-0.0015876,0,0
2,GO SYNAPTIC VESICLE MATURATION,0.91805,-0.003332,0.069778,0,0
2,GO RESPONSE TO AXON INJURY,0.61803,-0.003332,0.086232,0,0
2,GO REGULATION OF OOGENESIS,0.94321,-0.0033666,0.018792,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.88046,-0.0033704,0.030418,0,0
2,GO AMINE TRANSPORT,0.91805,-0.0033836,0.050973,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.62923,-0.0034045,0.075256,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.94321,-0.0034286,0.02767,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.37964,-0.0034723,0.0826,0,0
2,GO HISTONE H3 ACETYLATION,0.80618,-0.0035025,0.024183,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.91805,-0.0035359,0.03989,0,0
2,GO RESPONSE TO OXYGEN RADICAL,0.68646,-0.0035401,0.044847,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.68646,-0.0036113,-0.0078436,0,0
2,GO MULTI ORGANISM PROCESS,0.98106,-0.0036188,0.04096,0,0
2,GO REGULATION OF CELL MATURATION,0.98106,-0.0036416,0.033348,0,0
2,GO RRNA METHYLATION,0.75756,-0.0037196,0.029222,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.98106,-0.0037301,0.03469,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.72171,-0.0037368,0.001986,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.65188,-0.0037926,0.074196,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.43329,-0.0038613,0.092469,0,0
2,GO GROOMING BEHAVIOR,0.98106,-0.0040396,0.0019713,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.91805,-0.0040687,0.046593,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.51122,-0.0041499,0.04762,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.93062,-0.004301,0.06192,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.99368,-0.0044493,0.020349,0,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.64051,-0.0045703,0.0091591,0,0
2,GO MACROAUTOPHAGY,0.48117,-0.0045984,0.08282,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.62923,-0.004642,-0.063708,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.5959,-0.0046585,0.11522,0,0
2,GO RESPONSE TO SALT,0.53179,-0.0047997,-0.034306,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.89296,-0.0048573,0.062938,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.95582,-0.0049785,0.035889,0,0
2,GO MITOCHONDRIAL FUSION,0.99368,-0.0050352,0.03954,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.36271,-0.0051604,0.062337,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.79394,-0.0052273,0.035204,0,0
2,GO RNA DESTABILIZATION,0.85555,-0.005345,0.07052,0,0
2,GO RNA CATABOLIC PROCESS,0.74555,-0.0053707,0.0042735,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.79394,-0.0055428,0.023255,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.91805,-0.0055478,0.048265,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.84314,-0.0055792,0.028033,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.86799,-0.0056739,0.048133,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.95582,-0.0057899,0.032779,0,0
2,GO SEGMENTATION,0.70989,-0.0059359,0.066326,0,0
2,GO NEURAL TUBE DEVELOPMENT,0.68646,-0.0060221,0.076257,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.88046,-0.0060484,0.037664,0,0
2,GO BLASTOCYST GROWTH,0.81845,-0.0062697,0.032263,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.78176,-0.0062857,0.044151,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,1,-0.0064282,0.027299,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1,-0.0066029,0.010967,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.85555,-0.0066048,0.050026,0,0
2,GO UTERUS DEVELOPMENT,0.69814,-0.0066591,0.051544,0,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.88046,-0.0067576,0.028186,0,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.88046,-0.0067599,0.031931,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.68646,-0.0068582,0.05936,0,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.49108,-0.0069398,-0.024343,0,0
2,GO SYNAPTIC SIGNALING,0.80618,-0.0069739,0.0073531,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,1,-0.0070002,0.024083,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,1,-0.0070756,0.029963,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.5959,-0.0070944,0.076001,0,0
2,GO RNA CAPPING,0.83078,-0.0070978,0.016185,0,0
2,GO NEURON PROJECTION ARBORIZATION,1,-0.0070988,0.064561,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.99368,-0.007136,0.030483,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.69814,-0.0071493,0.074825,0,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.75756,-0.0072116,0.025651,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.88046,-0.007448,0.039698,0,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.68646,-0.0075242,0.00044893,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.94321,-0.007526,-0.0082301,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.68646,-0.0075307,0.090116,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.95582,-0.0075654,0.061645,0,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.81845,-0.007623,0.057003,0,0
2,GO VESICLE DOCKING,0.61803,-0.0076292,0.086516,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.91805,-0.0076599,0.029448,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.90549,-0.0077112,0.047546,0,0
2,GO HISTONE DEACETYLATION,0.89296,-0.0077576,0.029545,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.86799,-0.0077821,-0.026025,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.99368,-0.0079219,0.030422,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.84314,-0.0080665,0.056993,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.67486,-0.0080873,0.074553,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.84314,-0.0080903,0.076388,0,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.80618,-0.00836,0.018682,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.81845,-0.0084582,0.054703,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.90549,-0.0085247,0.044123,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.94321,-0.0086329,0.04679,0,0
2,GO STEM CELL PROLIFERATION,0.65188,-0.0086378,0.078637,0,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.90549,-0.008677,0.04599,0,0
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.39705,-0.008705,-0.033885,0,0
2,GO BLASTODERM SEGMENTATION,0.80618,-0.0088714,0.060568,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.68646,-0.0089169,0.043047,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.41494,-0.0089632,0.11699,0,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.81845,-0.0091116,-0.0057722,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.84314,-0.0091739,0.062492,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.85555,-0.0092078,-0.0019194,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1,-0.0092099,0.014619,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.75756,-0.0092986,0.034672,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.74555,-0.0093313,0.021213,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.88046,-0.0094504,0.04915,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.65188,-0.0095008,0.042015,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.95582,-0.009547,0.045371,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.84314,-0.0095561,-0.012399,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.64051,-0.0095785,0.071876,0,0
2,GO RETINA HOMEOSTASIS,0.90549,-0.0096622,0.0013203,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.83078,-0.009735,0.025599,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.89296,-0.0098286,0.032872,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.70989,-0.009865,0.013478,0,0
2,GO RNA SURVEILLANCE,0.98106,-0.0099089,0.026964,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.36271,-0.0099437,0.11283,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.67486,-0.010006,-0.010562,0,0
2,GO PIGMENTATION,0.89296,-0.010014,0.037131,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.90549,-0.010101,0.043955,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.98106,-0.010285,0.033607,0,0
2,GO MITOCHONDRIAL TRANSLATION,0.5959,-0.010332,-0.012698,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.65188,-0.010407,0.0055738,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.91805,-0.010428,0.012874,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.67486,-0.010465,0.060102,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.70989,-0.010503,0.019814,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.42405,-0.010523,0.055094,0,0
2,GO NEUROGENESIS,0.78176,-0.010601,0.03432,0,0
2,GO NEURON PROJECTION REGENERATION,0.83078,-0.010628,0.077318,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.86799,-0.010636,0.038645,0,0
2,GO PANCREAS DEVELOPMENT,0.94321,-0.010661,0.060939,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.69814,-0.010814,0.023811,0,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.35442,-0.010893,-0.035232,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.80618,-0.010991,0.061369,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.7336,-0.011046,0.04673,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.58498,-0.01114,-0.035005,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.57414,-0.011296,0.074155,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1,-0.011393,0.026385,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.99368,-0.011574,0.031365,0,0
2,GO AXON DEVELOPMENT,0.66333,-0.011647,0.010466,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.99368,-0.011832,0.039827,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.84314,-0.012052,0.051816,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.37111,-0.012066,-0.010544,0,0
2,GO CELL PROJECTION ASSEMBLY,0.85555,-0.012089,0.025282,0,0
2,GO V D J RECOMBINATION,0.85555,-0.012091,0.024805,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.70989,-0.012301,0.023045,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.85555,-0.012315,0.060621,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.7336,-0.012327,0.032275,0,0
2,GO TELENCEPHALON REGIONALIZATION,0.88046,-0.012518,-0.018547,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.96843,-0.012729,0.015439,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.66333,-0.012844,0.085455,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.72171,-0.012879,0.0014477,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.65188,-0.013086,0.062248,0,0
2,GO ASSOCIATIVE LEARNING,0.53179,-0.0131,-0.012305,0,0
2,GO HINDLIMB MORPHOGENESIS,0.95582,-0.013106,0.032084,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.91805,-0.013115,-0.053239,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.90549,-0.013148,0.055336,0,0
2,GO REGULATION OF DNA METHYLATION,0.93062,-0.013399,0.029618,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.89296,-0.013886,0.018648,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.64051,-0.013976,0.057533,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.75756,-0.013997,0.020685,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.55277,-0.014009,-0.029329,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.86799,-0.014065,0.037944,0,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.72171,-0.014091,0.0018288,0,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.84314,-0.0143,0.017575,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.70989,-0.014351,0.011255,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.90549,-0.014385,0.025725,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.74555,-0.014441,0.0020663,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.70989,-0.014453,-0.00088217,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.61803,-0.014571,-0.037643,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.48117,-0.014592,-0.056352,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.49108,-0.014906,-0.031219,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.83078,-0.014937,0.058506,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.51122,-0.014969,-0.015544,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.50109,-0.015019,0.085411,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.90549,-0.015182,0.024247,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.5959,-0.015191,0.016756,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.89296,-0.01524,0.062572,0,0
2,GO SULFATION,0.76963,-0.0153,0.074696,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.5959,-0.015355,-0.034255,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.85555,-0.015369,0.02424,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.75756,-0.015403,0.021121,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.84314,-0.015468,-0.006752,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.70989,-0.015707,-0.00020273,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.88046,-0.015763,0.021499,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.89296,-0.015805,0.03211,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.95582,-0.01593,0.045073,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.85555,-0.015967,0.058665,0,0
2,GO SYNAPSE ASSEMBLY,0.84314,-0.015972,-0.00082954,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.90549,-0.016039,0.042526,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.56341,-0.016046,-0.022743,0,0
2,GO REGULATION OF CELL CYCLE,0.80618,-0.016082,0.023444,0,0
2,GO RETINA LAYER FORMATION,0.60692,-0.016088,-0.030737,0,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.37964,-0.016096,-0.046702,0,0
2,GO CHROMOSOME LOCALIZATION,0.65188,-0.016101,0.0023993,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.78176,-0.01627,0.04916,0,0
2,GO VIRAL GENE EXPRESSION,0.62923,-0.016281,-0.0067203,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.79394,-0.016392,0.015575,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.79394,-0.016511,0.031909,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.94321,-0.016629,0.016208,0,0
2,GO PRESYNAPSE ORGANIZATION,0.99368,-0.016869,0.0077885,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.94321,-0.016897,0.036564,0,0
2,GO L SERINE METABOLIC PROCESS,0.68646,-0.016905,0.051395,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.33029,-0.017023,-0.088331,0,0
2,GO CELL JUNCTION MAINTENANCE,0.78176,-0.017096,0.015318,0,0
2,GO SNRNA METABOLIC PROCESS,0.52145,-0.017191,-0.0052901,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.76963,-0.017268,-0.010668,0,0
2,GO MICROTUBULE SEVERING,0.28529,-0.017334,-0.10893,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.58498,-0.017368,0.0050996,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.46168,-0.017377,-0.019556,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.83078,-0.01744,0.018946,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.96843,-0.01747,0.032299,0,0
2,GO VOCALIZATION BEHAVIOR,0.91805,-0.017489,-0.00085574,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.79394,-0.017589,0.03547,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.91805,-0.017717,0.05475,0,0
2,GO TELOMERE CAPPING,0.5959,-0.017947,0.0093607,0,0
2,GO REGULATION OF CELL SIZE,0.78176,-0.017964,0.045019,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.43329,-0.018007,0.11456,0,0
2,GO SNRNA PROCESSING,0.66333,-0.018139,-0.0097336,0,0
2,GO PORE COMPLEX ASSEMBLY,0.99368,-0.018254,0.03534,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.88046,-0.018262,-0.021716,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,1,-0.018353,0.072407,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.83078,-0.018405,0.052345,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.98106,-0.018432,0.035529,0,0
2,GO PRIMARY MIRNA PROCESSING,0.86799,-0.018638,0.0086905,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.81845,-0.018644,0.043557,0,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.48117,-0.018657,0.067064,0,0
2,GO SNRNA TRANSCRIPTION,0.46168,-0.018713,-0.011042,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.80618,-0.018952,0.062792,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.5959,-0.018962,0.02699,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.56341,-0.019047,0.055311,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.93062,-0.019054,0.031727,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.4521,-0.019057,0.063911,0,0
2,GO ACTIN CROSSLINK FORMATION,0.68646,-0.01909,0.07373,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.51122,-0.019201,-0.026246,0,0
2,GO CYTOPLASM ORGANIZATION,0.4521,-0.019273,0.10749,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.86799,-0.019573,0.042553,0,0
2,GO NOREPINEPHRINE SECRETION,0.68646,-0.019696,-0.024857,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.72171,-0.019702,0.013679,0,0
2,GO MITOTIC CYTOKINESIS,0.79394,-0.019734,0.02508,0,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.67486,-0.019739,-0.0030058,0,0
2,GO NCRNA TRANSCRIPTION,0.41494,-0.019785,-0.015657,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.74555,-0.019962,-0.019006,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.86799,-0.020008,0.015428,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.98106,-0.020027,0.018239,0,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.74555,-0.020147,-0.0035352,0,0
2,GO TORC1 SIGNALING,0.68646,-0.02021,0.015537,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.86799,-0.020348,0.020295,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.41494,-0.020362,-0.059762,0,0
2,GO BIOLOGICAL PHASE,0.83078,-0.020419,0.0030573,0,0
2,GO NEUROBLAST PROLIFERATION,0.96843,-0.02054,0.039862,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.4521,-0.020615,-0.094416,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.95582,-0.020642,0.050598,0,0
2,GO COENZYME A METABOLIC PROCESS,0.83078,-0.020741,0.037965,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.58498,-0.020757,0.069169,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.53179,-0.020794,-0.050838,0,0
2,GO PROTEIN ACETYLATION,0.69814,-0.020863,0.016748,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.91805,-0.021112,0.016836,0,0
2,GO DENDRITE DEVELOPMENT,0.55277,-0.021155,-0.013572,0,0
2,GO NUCLEUS LOCALIZATION,0.48117,-0.02116,-0.041716,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.78176,-0.021358,-0.01374,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.67486,-0.021385,-0.016941,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.83078,-0.021395,0.018916,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.72171,-0.021474,0.054135,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.48117,-0.021475,-0.032648,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.89296,-0.021678,0.031499,0,0
2,GO MEMORY,0.84314,-0.021767,0.016815,0,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.74555,-0.021792,-0.00092982,0,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.65188,-0.021953,-0.0088823,0,0
2,GO NEUROBLAST DIVISION,0.62923,-0.021972,-0.0035859,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.83078,-0.022003,-0.0028974,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.48117,-0.022206,-0.0093143,0,0
2,GO PHOTOPERIODISM,0.90549,-0.022358,0.031842,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.72171,-0.02243,0.016168,0,0
2,GO GAS TRANSPORT,0.96843,-0.022431,0.007151,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.84314,-0.022455,0.069719,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.65188,-0.022475,-0.018433,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.79394,-0.022597,0.036701,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.90549,-0.022714,0.030009,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.69814,-0.02276,0.079123,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.85555,-0.023027,0.019558,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.85555,-0.023059,0.042271,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.98106,-0.023211,0.038138,0,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.96843,-0.023311,0.022571,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.85555,-0.023369,-0.0053223,0,0
2,GO NEURON MIGRATION,0.58498,-0.023397,-0.01976,0,0
2,GO EATING BEHAVIOR,0.98106,-0.023398,0.025483,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.50109,-0.023674,0.10738,0,0
2,GO PROTEIN MANNOSYLATION,0.95582,-0.023686,0.016012,0,0
2,GO TRANSLATIONAL INITIATION,0.27126,-0.023757,-0.027262,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.53179,-0.023786,0.10982,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.66333,-0.023955,0.0049309,0,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.49108,-0.024104,-0.010455,0,0
2,GO CYTOPLASMIC TRANSLATION,0.16602,-0.02416,-0.044641,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.4521,-0.024185,-0.028748,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.68646,-0.024244,-0.040203,0,0
2,GO CYTOKINESIS,0.72171,-0.024257,0.016518,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.46168,-0.024344,-0.018113,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.58498,-0.024347,-0.0071625,0,0
2,GO REGULATION OF FERTILIZATION,0.89296,-0.02436,0.028949,0,0
2,GO FOREBRAIN CELL MIGRATION,0.69814,-0.02457,-0.0023177,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.7336,-0.024612,0.0068808,0,0
2,GO NUCLEAR TRANSPORT,0.67486,-0.024641,0.011734,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.60692,-0.024645,0.0098304,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.4521,-0.024771,-0.037438,0,0
2,GO SPINDLE LOCALIZATION,0.78176,-0.024816,0.027442,0,0
2,GO NUCLEUS ORGANIZATION,0.86799,-0.024948,0.025542,0,0
2,GO WALKING BEHAVIOR,0.44264,-0.025016,-0.035146,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.5959,-0.025317,0.0070147,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.36271,-0.025538,-0.020867,0,0
2,GO FOREBRAIN DEVELOPMENT,0.69814,-0.025575,0.023156,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.94321,-0.025619,-0.0064955,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.70989,-0.025632,-0.029377,0,0
2,GO AMINO ACID ACTIVATION,0.51122,-0.025744,-0.010729,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.86799,-0.02586,0.047489,0,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.91805,-0.025913,0.026709,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.66333,-0.025923,-0.038569,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.90549,-0.02594,0.092972,0,0
2,GO CELL DIVISION,0.7336,-0.02597,0.0084497,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.52145,-0.026295,-0.0012326,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.96843,-0.026465,0.044888,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.74555,-0.026479,0.03224,0,0
2,GO RNA MODIFICATION,0.43329,-0.026546,-0.019865,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.68646,-0.026624,-0.019677,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.79394,-0.026653,0.022522,0,0
2,GO METAPHASE PLATE CONGRESSION,0.62923,-0.026706,-0.0044721,0,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.43329,-0.026757,-0.020342,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.83078,-0.026761,0.020548,0,0
2,GO NUCLEAR MIGRATION,0.47137,-0.026808,-0.042818,0,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.90549,-0.026817,0.054695,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.96843,-0.026912,0.026625,0,0
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.53179,-0.026915,-0.0085497,0,0
2,GO AZOLE TRANSMEMBRANE TRANSPORT,0.58498,-0.026961,0.10525,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.51122,-0.027113,0.12199,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.89296,-0.027179,0.026443,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.89296,-0.027236,0.0097382,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.68646,-0.027349,-0.0022714,0,0
2,GO HISTONE PHOSPHORYLATION,0.99368,-0.027516,0.026237,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.42405,-0.02755,-0.048248,0,0
2,GO ALDITOL METABOLIC PROCESS,0.89296,-0.027615,0.0003451,0,0
2,GO DNA METABOLIC PROCESS,0.57414,-0.027658,0.0038869,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.74555,-0.027757,-0.0023743,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76963,-0.02792,0.022446,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.23203,-0.028044,-0.070234,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.62923,-0.028068,0.076906,0,0
2,GO RRNA METABOLIC PROCESS,0.25111,-0.028153,-0.029481,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.76963,-0.02821,0.016962,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.80618,-0.028297,0.065261,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.93062,-0.028559,0.034404,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.4521,-0.028607,-0.010337,0,0
2,GO RECOMBINATIONAL REPAIR,0.33821,-0.028744,-0.041978,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.7336,-0.0288,-0.0047156,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.95582,-0.028834,0.069375,0,0
2,GO ADULT BEHAVIOR,0.74555,-0.028865,0.0050446,0,0
2,GO PROTEIN DENEDDYLATION,1,-0.028905,0.015017,0,0
2,GO MATURATION OF 5 8S RRNA,0.54223,-0.028916,-0.011955,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.85555,-0.029122,0.032784,0,0
2,GO REGULATION OF GENE SILENCING,0.56341,-0.029124,0.0029194,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.40594,-0.029125,-0.0079092,0,0
2,GO RIBOSOME BIOGENESIS,0.26442,-0.029207,-0.031441,0,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.74555,-0.029327,-0.0080962,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.60692,-0.029337,0.0066202,0,0
2,GO NOREPINEPHRINE TRANSPORT,0.94321,-0.02938,0.037369,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.85555,-0.029506,-0.058153,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.76963,-0.029646,-0.012157,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.80618,-0.029661,0.015333,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.60692,-0.029922,0.085083,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.58498,-0.029927,-0.013757,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.83078,-0.030056,0.035308,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.5959,-0.030246,-0.0017247,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.69814,-0.030299,0.014011,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.68646,-0.030339,0.0067225,0,0
2,GO FEEDING BEHAVIOR,0.60692,-0.0304,-0.02677,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.85555,-0.030471,0.046958,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.46168,-0.030557,0.0046912,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.93062,-0.030576,-0.011028,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.67486,-0.03061,0.076938,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.79394,-0.030658,0.027893,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.49108,-0.03072,-0.036499,0,0
2,GO RIBOSOME ASSEMBLY,0.43329,-0.030779,-0.025854,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.39705,-0.030981,-0.08999,0,0
2,GO NEURAL CREST CELL MIGRATION,0.79394,-0.031002,0.071996,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.93062,-0.031096,0.015113,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.35442,-0.031208,-0.021491,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.83078,-0.031252,0.045942,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.4521,-0.031286,-0.0035539,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.72171,-0.031421,0.071615,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.94321,-0.031652,-0.00079833,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.72171,-0.031775,0.0014121,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.57414,-0.031811,0.0037652,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.37964,-0.032133,-0.02458,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.94321,-0.032453,0.032655,0,0
2,GO NEUROMUSCULAR PROCESS,0.93062,-0.032482,0.0096322,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.90549,-0.032515,0.03425,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.28529,-0.032661,-0.059679,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.47137,-0.033006,-0.01058,0,0
2,GO AXON EXTENSION,0.5959,-0.033182,0.0090667,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.7336,-0.03327,-0.0095168,0,0
2,GO SPINAL CORD PATTERNING,0.81845,-0.033341,-0.0018563,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.79394,-0.03346,-0.017372,0,0
2,GO MACROMOLECULE DEACYLATION,0.90549,-0.033475,0.036892,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.47137,-0.033481,-0.010999,0,0
2,GO NCRNA PROCESSING,0.20256,-0.033544,-0.038185,0,0
2,GO CELL CYCLE,0.67486,-0.033555,0.011644,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.61803,-0.033578,-0.055971,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.26442,-0.033718,-0.05728,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.78176,-0.033729,0.051792,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.91805,-0.03374,0.031606,0,0
2,GO TONGUE DEVELOPMENT,0.95582,-0.033743,0.019707,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.60692,-0.033747,0.0071535,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.35442,-0.03387,-0.030632,0,0
2,GO NEURON FATE COMMITMENT,0.89296,-0.033974,0.022898,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.56341,-0.034057,0.0068608,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.84314,-0.034374,-0.011236,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.80618,-0.034383,0.055571,0,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.40594,-0.034389,-0.010288,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.94321,-0.034425,0.034744,0,0
2,GO REGULATION OF ACROSOME REACTION,0.69814,-0.034589,0.055154,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.93062,-0.034605,0.034991,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.65188,-0.034696,-0.046735,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.48117,-0.03484,0.0089896,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.60692,-0.034852,0.027592,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.83078,-0.034894,0.021805,0,0
2,GO REGULATION OF CYTOKINESIS,0.56341,-0.034995,-0.0061381,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.76963,-0.035085,0.035118,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.56341,-0.035107,-0.020231,0,0
2,GO RRNA CATABOLIC PROCESS,0.65188,-0.035112,-0.0026574,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.88046,-0.035117,0.052755,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.66333,-0.035133,0.013802,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.98106,-0.035192,0.063012,0,0
2,GO POSTREPLICATION REPAIR,0.70989,-0.035211,0.0037586,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.58498,-0.035312,0.00060471,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.93062,-0.035391,0.023722,0,0
2,GO OOCYTE DIFFERENTIATION,0.30724,-0.035613,-0.035231,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.47137,-0.035649,-0.01105,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.27126,-0.035789,-0.03415,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.61803,-0.035978,0.0052728,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.51122,-0.036117,-0.006419,0,0
2,GO PENILE ERECTION,0.83078,-0.036144,-0.043993,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.54223,-0.036183,0.0011468,0,0
2,GO SEXUAL REPRODUCTION,0.56341,-0.036218,-0.0015266,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.64051,-0.036294,-0.0052011,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.56341,-0.036381,-0.020054,0,0
2,GO GENE SILENCING,0.37111,-0.036405,-0.015629,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.62923,-0.036884,0.0065776,0,0
2,GO PROTEIN ACYLATION,0.85555,-0.03694,0.025457,0,0
2,GO PROTEIN MONOUBIQUITINATION,0.62923,-0.036975,0.0029198,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.21989,-0.037089,-0.051486,0,0
2,GO SNORNA 3 END PROCESSING,0.61803,-0.037148,0.0011655,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.88046,-0.037215,0.018137,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.58498,-0.037318,-0.036215,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.68646,-0.037351,0.0020847,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.52145,-0.037369,0.0047585,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.40594,-0.037377,-0.025615,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.85555,-0.037397,0.060845,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.40594,-0.037412,-0.027255,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.54223,-0.037422,-0.0001911,0,0
2,GO MITOTIC CELL CYCLE,0.67486,-0.037641,0.01188,0,0
2,GO MATURATION OF LSU RRNA,0.54223,-0.037685,-0.025694,0,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.88046,-0.037751,0.03946,0,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.10811,-0.037849,-0.053296,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.36271,-0.037987,-0.076359,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.94321,-0.03799,0.016146,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.40594,-0.038033,-0.035939,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.33821,-0.038035,-0.054035,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.62923,-0.038102,-0.044809,0,0
2,GO REGULATION OF DNA REPLICATION,0.34626,-0.038252,-0.02366,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.90549,-0.038255,0.002559,0,0
2,GO AXONAL FASCICULATION,0.69814,-0.038276,-0.024384,0,0
2,GO MISMATCH REPAIR,0.37964,-0.038325,-0.041777,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.51122,-0.038537,-0.026962,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.95582,-0.038596,0.012367,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.43329,-0.038639,-0.0095979,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.86799,-0.038721,0.010126,0,0
2,GO EYE MORPHOGENESIS,0.78176,-0.038723,0.068136,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.67486,-0.038908,-0.0048486,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.96843,-0.039117,0.02959,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.54223,-0.039226,-0.015911,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.64051,-0.039353,0.0068251,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.38829,-0.039363,-0.037871,0,0
2,GO TRANSLATIONAL ELONGATION,0.40594,-0.039396,-0.024276,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.53179,-0.039412,-0.016486,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.70989,-0.039632,0.016802,0,0
2,GO RRNA 3 END PROCESSING,0.67486,-0.039638,-0.014921,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.70989,-0.039652,0.00018352,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.56341,-0.039765,-0.017266,0,0
2,GO PROSTATE GLAND GROWTH,0.4521,-0.039789,-0.061385,0,0
2,GO RRNA TRANSCRIPTION,0.49108,-0.040211,-0.009902,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.27126,-0.040234,-0.041588,0,0
2,GO METENCEPHALON DEVELOPMENT,0.50109,-0.04036,-0.019102,0,0
2,GO REGULATION OF MRNA BINDING,0.86799,-0.040396,0.015552,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.81845,-0.040401,0.023589,0,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.99368,-0.040405,0.024814,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.48117,-0.040483,-0.029355,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.52145,-0.040663,-0.048432,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.48117,-0.040695,-0.012026,0,0
2,GO MANNOSYLATION,0.89296,-0.04083,0.029157,0,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.17091,-0.040846,-0.045334,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.5959,-0.040849,-0.02061,0,0
2,GO SPERMATID DIFFERENTIATION,0.44264,-0.040882,-0.024837,0,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.91805,-0.041035,0.064484,0,0
2,GO CELL CYCLE PROCESS,0.61803,-0.041217,0.00251,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.29248,-0.041227,-0.12411,0,0
2,GO CHROMOSOME SEPARATION,0.32248,-0.041429,-0.029269,0,0
2,GO HISTONE MRNA METABOLIC PROCESS,0.50109,-0.041455,-0.0099096,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.55277,-0.04153,0.097802,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.78176,-0.041539,0.0074092,0,0
2,GO SIALYLATION,0.98106,-0.041632,0.056252,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.58498,-0.041861,-0.046555,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.37964,-0.041897,-0.0043957,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.56341,-0.041943,-0.06494,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.58498,-0.042008,0.021431,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.81845,-0.042272,-0.0088028,0,0
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.89296,-0.042301,-0.0055589,0,0
2,GO FOREBRAIN REGIONALIZATION,0.91805,-0.042336,-0.010189,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.43329,-0.042379,-0.022871,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.35442,-0.042411,-0.036213,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.91805,-0.042494,0.027817,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.46168,-0.042834,-0.0061582,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.88046,-0.042915,0.023507,0,0
2,GO LEARNING,0.33821,-0.042998,-0.060879,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.47137,-0.043244,-0.015166,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.76963,-0.043296,0.038384,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.2998,-0.043329,-0.031134,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.33029,-0.04341,-0.027876,0,0
2,GO PALLIUM DEVELOPMENT,0.54223,-0.043798,-0.00057593,0,0
2,GO SPECIFICATION OF SYMMETRY,0.74555,-0.043802,0.023225,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.79394,-0.044059,-0.010521,0,0
2,GO NEURON PROJECTION GUIDANCE,0.65188,-0.044177,0.012438,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.32248,-0.044279,-0.082828,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.90549,-0.044289,0.069764,0,0
2,GO MRNA METHYLATION,0.37111,-0.044389,-0.041809,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.65188,-0.044556,0.0048962,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.91805,-0.044563,0.038417,0,0
2,GO ORGANELLE ASSEMBLY,0.49108,-0.044716,-0.0046273,0,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.3148,-0.04484,-0.026312,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.46168,-0.044912,-0.020823,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.51122,-0.045182,-0.019459,0,0
2,GO DNA REPAIR,0.36271,-0.045215,-0.026196,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.94321,-0.045261,0.031838,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.90549,-0.045281,0.035917,0,0
2,GO TRNA TRANSPORT,0.2577,-0.045294,-0.028419,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.47137,-0.045414,-0.02175,0,0
2,GO HISTONE MONOUBIQUITINATION,0.69814,-0.045421,0.0037348,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.61803,-0.04581,-0.02684,0,0
2,GO NCRNA 3 END PROCESSING,0.49108,-0.046047,-0.013319,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.89296,-0.046053,0.049704,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.72171,-0.046297,0.021798,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,1,-0.046298,0.031204,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.49108,-0.046439,-0.023165,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10134,-0.046491,-0.098056,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.5959,-0.046529,-0.012077,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.41494,-0.046856,-0.01184,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.70989,-0.04686,0.013375,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.33029,-0.046872,-0.025978,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.57414,-0.046926,-0.035449,0,0
2,GO MEMBRANE DOCKING,0.60692,-0.047117,0.0059966,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.50109,-0.047199,-0.0049358,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.53179,-0.047225,-0.013309,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.51122,-0.047399,-0.0095239,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.88046,-0.047576,0.024704,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.49108,-0.047837,0.0063892,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.91805,-0.047862,0.047332,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.46168,-0.047891,-0.012037,0,0
2,GO NCRNA METABOLIC PROCESS,0.17591,-0.047909,-0.036773,0,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.23827,-0.047959,-0.028788,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.33029,-0.047999,-0.035984,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.58498,-0.048029,0.023206,0,0
2,GO ACROSOME ASSEMBLY,0.84314,-0.048058,0.0039185,0,0
2,GO MATING BEHAVIOR,0.54223,-0.048081,-0.05545,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.11163,-0.04814,-0.050185,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.94321,-0.048407,0.074329,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.47137,-0.048591,-0.0086049,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.69814,-0.048598,0.098278,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.39705,-0.048628,-0.011748,0,0
2,GO MIRNA METABOLIC PROCESS,0.28529,-0.048633,-0.041276,0,0
2,GO RNA PROCESSING,0.18102,-0.048725,-0.048289,0,0
2,GO SUCKLING BEHAVIOR,0.79394,-0.048937,7.8264e-05,0,0
2,GO GAMETE GENERATION,0.55277,-0.049108,-0.012359,0,0
2,GO TELOMERASE RNA LOCALIZATION,0.2577,-0.049108,-0.028204,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.44264,-0.049112,-0.010242,0,0
2,GO NEURON RECOGNITION,0.84314,-0.049388,0.0046148,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.46168,-0.04941,-0.0073365,0,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.2577,-0.049422,-0.028679,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.84314,-0.049463,0.001925,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.20822,-0.04947,-0.078574,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.75756,-0.049498,0.04103,0,0
2,GO SECRETORY GRANULE LOCALIZATION,0.95582,-0.049684,0.048894,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.35442,-0.049711,-0.021983,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.95582,-0.049833,0.023327,0,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.84314,-0.049972,0.03487,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.3148,-0.050068,-0.025141,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.67486,-0.050188,0.0036221,0,0
2,GO SISTER CHROMATID SEGREGATION,0.41494,-0.050219,-0.01557,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24463,-0.050369,-0.062074,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.91805,-0.050446,0.025065,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.50109,-0.050555,0.0048689,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.35442,-0.050646,-0.054009,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.51122,-0.050711,-0.022231,0,0
2,GO MRNA CLEAVAGE,0.18102,-0.050717,-0.050812,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.48117,-0.050735,-0.047334,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.62923,-0.050771,0.0034631,0,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.39705,-0.050773,-0.012496,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.34626,-0.050866,-0.017724,0,0
2,GO TRNA PROCESSING,0.14312,-0.050945,-0.06634,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.69814,-0.051046,0.0093534,0,0
2,GO AXIS SPECIFICATION,0.70989,-0.05125,0.017451,0,0
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.57414,-0.051309,0.049671,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.41494,-0.051573,-0.021617,0,0
2,GO HISTONE UBIQUITINATION,0.4521,-0.051684,-0.018135,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.64051,-0.051772,-0.019723,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.81845,-0.051789,-0.001607,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10134,-0.051814,-0.072009,0,0
2,GO HISTONE H2A UBIQUITINATION,0.37964,-0.051871,-0.030687,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.96843,-0.051939,0.033426,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.85555,-0.05198,-0.014322,0,0
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.08881,-0.052012,-0.075118,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.90549,-0.052015,0.01012,0,0
2,GO SHORT TERM MEMORY,0.35442,-0.052051,-0.067693,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.62923,-0.052106,-0.013549,0,0
2,GO LONG TERM MEMORY,0.66333,-0.052113,-0.0010542,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,1,-0.052137,0.047319,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.48117,-0.052197,-0.010737,0,0
2,GO NON RECOMBINATIONAL REPAIR,0.50109,-0.05244,-0.0039653,0,0
2,GO REGULATION OF DNA REPAIR,0.37111,-0.052676,-0.027939,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.26442,-0.052804,-0.056986,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.66333,-0.052833,0.011781,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.29248,-0.052972,-0.062221,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.50109,-0.053009,-0.0080262,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.93062,-0.053107,0.037008,0,0
2,GO MEIOTIC CELL CYCLE,0.32248,-0.053247,-0.040059,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.42405,-0.053299,-0.0093135,0,0
2,GO CELLULAR RESPONSE TO PH,0.93062,-0.053394,0.024635,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.38829,-0.053445,-0.013452,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.5959,-0.053513,0.014967,0,0
2,GO DNA REPLICATION,0.38829,-0.053599,-0.044169,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.62923,-0.053602,0.0046963,0,0
2,GO MICROTUBULE NUCLEATION,0.66333,-0.053604,0.011202,0,0
2,GO IMP BIOSYNTHETIC PROCESS,0.83078,-0.053957,0.022558,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.37964,-0.053961,-0.054689,0,0
2,GO GOLGI RIBBON FORMATION,0.75756,-0.054176,0.091291,0,0
2,GO TRNA 5 LEADER REMOVAL,0.16602,-0.054232,-0.070466,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.1306,-0.054263,-0.048037,0,0
2,GO MALE GAMETE GENERATION,0.34626,-0.0544,-0.022416,0,0
2,GO REGULATION OF RNA BINDING,0.76963,-0.054488,0.010221,0,0
2,GO REGULATION OF AXONOGENESIS,0.39705,-0.05458,-0.029651,0,0
2,GO THALAMUS DEVELOPMENT,0.91805,-0.054612,0.036201,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.37111,-0.054732,-0.032428,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.27821,-0.054799,-0.084642,0,0
2,GO TRNA METABOLIC PROCESS,0.13467,-0.054931,-0.057569,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.50109,-0.054959,-0.012734,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.13885,-0.054961,-0.070506,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.43329,-0.055155,-0.020961,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.44264,-0.055165,-0.058259,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.37964,-0.055292,-0.023761,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.37111,-0.055298,-0.016802,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.35442,-0.055442,-0.017712,0,0
2,GO DENDRITE EXTENSION,0.74555,-0.055493,0.07414,0,0
2,GO HINDBRAIN DEVELOPMENT,0.80618,-0.0557,0.020888,0,0
2,GO EXTRACELLULAR TRANSPORT,0.44264,-0.055847,-0.068923,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.20822,-0.055952,-0.050575,0,0
2,GO ORGANELLE FISSION,0.56341,-0.055968,0.0051695,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.32248,-0.056219,-0.069688,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.20822,-0.05622,-0.036893,0,0
2,GO MITOCHONDRION LOCALIZATION,0.38829,-0.056237,-0.033326,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52145,-0.056261,-0.011803,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.57414,-0.056272,-0.016673,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.88046,-0.056555,0.045356,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.49108,-0.056606,-0.020301,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.40594,-0.056615,-0.043276,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.83078,-0.056681,0.033052,0,0
2,GO CELL CYCLE CHECKPOINT,0.48117,-0.056783,-0.020388,0,0
2,GO TELOMERE ORGANIZATION,0.29248,-0.056787,-0.031311,0,0
2,GO CENTROSOME SEPARATION,0.35442,-0.057091,-0.028313,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.93062,-0.057135,0.048078,0,0
2,GO MRNA METABOLIC PROCESS,0.20256,-0.057171,-0.03784,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.56341,-0.057246,-0.022364,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.80618,-0.057309,0.011919,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.58498,-0.057332,-0.034404,0,0
2,GO CHROMOSOME SEGREGATION,0.39705,-0.057332,-0.031168,0,0
2,GO REGULATION OF HIPPO SIGNALING,1,-0.057432,0.014009,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.42405,-0.057829,-0.038797,0,0
2,GO FEMALE GAMETE GENERATION,0.37964,-0.058041,-0.017832,0,0
2,GO METHYLATION,0.2577,-0.058065,-0.040378,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.37964,-0.058298,-0.037835,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.49108,-0.058471,-0.1226,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.40594,-0.058491,0.0049498,0,0
2,GO PROTEIN SUMOYLATION,0.28529,-0.058554,-0.011447,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.32248,-0.058916,-0.034925,0,0
2,GO HISTONE H4 DEACETYLATION,0.37111,-0.058918,-0.037013,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.57414,-0.059429,-0.05914,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.3148,-0.059436,-0.021898,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.60692,-0.059453,-0.027024,0,0
2,GO RNA LOCALIZATION,0.27821,-0.059817,-0.022422,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.86799,-0.059829,-0.00044338,0,0
2,GO RNA METHYLATION,0.34626,-0.060233,-0.041222,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.33029,-0.060441,-0.04395,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.64051,-0.060703,-0.0046968,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.37111,-0.060817,-0.006671,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.5959,-0.061096,-0.0085438,0,0
2,GO AXONEME ASSEMBLY,0.43329,-0.061137,-0.085302,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.57414,-0.061172,0.0086136,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.85555,-0.061344,0.033306,0,0
2,GO DNA MODIFICATION,0.58498,-0.061346,-0.00090049,0,0
2,GO GERM CELL DEVELOPMENT,0.3148,-0.06154,-0.037401,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.36271,-0.061651,-0.057079,0,0
2,GO PRO B CELL DIFFERENTIATION,0.98106,-0.06168,0.037294,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.38829,-0.061745,-0.047751,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.61803,-0.061767,0.0019141,0,0
2,GO SPINDLE ORGANIZATION,0.42405,-0.062292,-0.01792,0,0
2,GO MRNA TRANSPORT,0.26442,-0.06237,-0.030702,0,0
2,GO EXIT FROM MITOSIS,0.33821,-0.062594,-0.019167,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.74555,-0.062625,0.0015851,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.52145,-0.06268,-0.019371,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.60692,-0.062728,0.010286,0,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.2577,-0.063016,-0.060228,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.24463,-0.063105,-0.064898,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.66333,-0.063108,0.0030027,0,0
2,GO DENDRITE SELF AVOIDANCE,0.72171,-0.063183,0.0034844,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.62923,-0.063772,0.10988,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.68646,-0.063913,0.0040256,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.52145,-0.063959,-0.011555,0,0
2,GO NUCLEAR EXPORT,0.30724,-0.064203,-0.019588,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.7336,-0.064256,0.014921,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.58498,-0.064273,-0.0032737,0,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.52145,-0.064318,-0.0037878,0,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.35442,-0.064356,-0.012862,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.26442,-0.064427,-0.071515,0,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.21989,-0.064494,-0.040736,0,0
2,GO RNA STABILIZATION,0.58498,-0.0645,-0.00084071,0,0
2,GO HISTONE H4 ACETYLATION,0.64051,-0.064666,0.010149,0,0
2,GO SPERM MOTILITY,0.35442,-0.06489,-0.057313,0,0
2,GO TRNA METHYLATION,0.094909,-0.06492,-0.079134,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.74555,-0.064942,0.025458,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.38829,-0.064951,-0.069778,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.2577,-0.064965,-0.056987,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.50109,-0.065204,-0.041081,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.48117,-0.065219,-0.016081,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.50109,-0.065313,-0.030205,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.28529,-0.065505,-0.062443,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.90549,-0.065513,0.016438,0,0
2,GO RESPONSE TO FOOD,0.20822,-0.065588,-0.10466,0,0
2,GO CHROMOSOME ORGANIZATION,0.2998,-0.065681,-0.023618,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.83078,-0.065784,0.043293,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.37964,-0.065907,-0.024218,0,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.29248,-0.065925,-0.06472,0,0
2,GO MICROTUBULE POLYMERIZATION,0.38829,-0.066038,-0.038404,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.19156,-0.06613,-0.045116,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.35442,-0.066285,-0.025031,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.44264,-0.06629,-0.019152,0,0
2,GO DENDRITE MORPHOGENESIS,0.39705,-0.066389,-0.043792,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.91805,-0.066486,0.051479,0,0
2,GO NEUROTRANSMITTER SECRETION,0.56341,-0.066976,0.0024217,0,0
2,GO CHROMOSOME CONDENSATION,0.57414,-0.067025,-0.021169,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.43329,-0.067028,-0.017179,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.46168,-0.067118,-0.030539,0,0
2,GO RESPONSE TO HYDROXYUREA,0.56341,-0.067182,-0.019623,0,0
2,GO IMP METABOLIC PROCESS,0.60692,-0.067212,0.002492,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.93062,-0.067368,0.040057,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.197,-0.067415,-0.11983,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.46168,-0.067428,-0.010111,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.37964,-0.067494,-0.10538,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.56341,-0.06772,-0.032221,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.2259,-0.067792,-0.090882,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.34626,-0.067933,-0.070526,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.40594,-0.067959,-0.054685,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.54223,-0.068065,-0.0073853,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.85555,-0.068188,-0.010083,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.64051,-0.068262,-0.0048595,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.7336,-0.068575,-0.0085417,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.08588,-0.06863,-0.069242,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.2998,-0.068797,-0.040555,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.30724,-0.068991,-0.058894,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.23827,-0.069289,-0.067727,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.74555,-0.069321,-0.018308,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.33029,-0.069374,-0.042175,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.25111,-0.069414,-0.060228,0,0
2,GO MITOTIC RECOMBINATION,0.3148,-0.069427,-0.074051,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.38829,-0.069566,-0.015285,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.33821,-0.069657,-0.082943,0,0
2,GO CENTROSOME DUPLICATION,0.51122,-0.069845,-0.021497,0,0
2,GO RNA 3 END PROCESSING,0.17091,-0.069971,-0.052887,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11163,-0.070081,-0.059627,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.64051,-0.070355,0.0092519,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.20256,-0.070714,-0.053326,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.23203,-0.070763,-0.042039,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.67486,-0.070935,0.0085112,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.47137,-0.071064,-0.037735,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.20822,-0.071546,-0.047,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.83078,-0.071643,0.087362,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.50109,-0.071657,-0.016924,0,0
2,GO OOGENESIS,0.15655,-0.071738,-0.06603,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.16602,-0.071786,-0.052258,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.27821,-0.071912,-0.055395,0,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.93062,-0.072004,0.022749,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.56341,-0.072253,0.0020877,0,0
2,GO DNA GEOMETRIC CHANGE,0.30724,-0.072273,-0.041296,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.36271,-0.072401,-0.069526,0,0
2,GO MATURATION OF SSU RRNA,0.44264,-0.0725,-0.025149,0,0
2,GO MICROTUBULE ANCHORING,0.39705,-0.072599,-0.050889,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.26442,-0.072681,-0.0362,0,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.54223,-0.072718,-0.0044833,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.2998,-0.073071,-0.10286,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.60692,-0.073153,-0.0040933,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.52145,-0.073327,-0.0049503,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.29248,-0.073662,-0.03878,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.53179,-0.073689,-0.023093,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.37964,-0.073802,-0.026648,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.25111,-0.073846,-0.05843,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.24463,-0.074429,-0.040433,0,0
2,GO DNA STRAND ELONGATION,0.16123,-0.074708,-0.096048,0,0
2,GO SPINDLE ASSEMBLY,0.44264,-0.075068,-0.011362,0,0
2,GO RNA 5 END PROCESSING,0.17091,-0.075162,-0.043899,0,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.15197,-0.075185,-0.056083,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.33821,-0.075408,-0.073045,0,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.66333,-0.075528,-0.0059687,0,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.23827,-0.07562,-0.033746,0,0
2,GO SISTER CHROMATID COHESION,0.49108,-0.075738,-0.018868,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.44264,-0.075765,-0.011911,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.094909,-0.076058,-0.057749,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.1475,-0.076415,-0.063975,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.5959,-0.076572,-0.0033404,0,0
2,GO CILIUM MOVEMENT,0.37964,-0.076706,-0.063087,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.46168,-0.076765,-0.036133,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.26442,-0.076869,-0.055463,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.56341,-0.077087,0.00048885,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.53179,-0.077196,0.013251,0,0
2,GO DIVALENT METAL ION EXPORT,0.53179,-0.07726,-0.042394,0,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.10811,-0.077334,-0.055444,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.7336,-0.077336,-0.0069729,0,0
2,GO ASYMMETRIC CELL DIVISION,0.53179,-0.077599,-0.03372,0,0
2,GO GENETIC IMPRINTING,0.33029,-0.07768,-0.057926,0,0
2,GO MICROTUBULE BASED PROCESS,0.26442,-0.077714,-0.045588,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.28529,-0.078262,-0.059804,0,0
2,GO STARTLE RESPONSE,0.54223,-0.07835,-0.039014,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.18102,-0.078418,-0.055112,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.58498,-0.078659,-0.049963,0,0
2,GO GTP BIOSYNTHETIC PROCESS,0.2998,-0.078833,-0.049939,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.19156,-0.078868,-0.062418,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.47137,-0.078988,-0.04682,0,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.18102,-0.079052,-0.081332,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.28529,-0.079111,-0.046492,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.39705,-0.07919,-0.033027,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.25111,-0.079435,-0.050342,0,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.091819,-0.07992,-0.077647,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.15197,-0.079955,-0.11419,0,0
2,GO DEMETHYLATION,0.4521,-0.080008,0.0085278,0,0
2,GO SYNAPTIC MEMBRANE ADHESION,0.57414,-0.080436,-0.083349,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.29248,-0.080541,-0.034831,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.37111,-0.08091,-0.006856,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.95582,-0.081068,0.049155,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.3148,-0.081112,-0.025736,0,0
2,GO HIPPO SIGNALING,0.98106,-0.081279,0.045021,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.19156,-0.081607,-0.062159,0,0
2,GO OOCYTE MATURATION,0.4521,-0.081692,-0.042457,0,0
2,GO MRNA MODIFICATION,0.15197,-0.082296,-0.073099,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.85555,-0.082307,0.0016499,0,0
2,GO DNA PACKAGING,0.197,-0.082345,-0.06384,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.78176,-0.082486,-0.017744,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.2259,-0.082509,-0.094291,0,0
2,GO FAT CELL PROLIFERATION,0.64051,-0.082698,-0.034781,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.46168,-0.082792,-0.045389,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.15655,-0.082832,-0.047625,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.12273,-0.082867,-0.089685,0,0
2,GO PROTEIN NEDDYLATION,0.26442,-0.083008,-0.069026,0,0
2,GO CENTRIOLE ASSEMBLY,0.39705,-0.083103,-0.04954,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.48117,-0.083541,-0.011664,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.48117,-0.083815,-0.022259,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.25111,-0.083891,-0.058724,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.29248,-0.083896,-0.106,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.26442,-0.084212,-0.013107,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.50109,-0.08429,-0.017043,0,0
2,GO SYNAPTIC VESICLE PRIMING,0.99368,-0.084369,0.032222,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.61803,-0.084397,-0.015618,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.25111,-0.084531,-0.05147,0,0
2,GO MRNA 3 END PROCESSING,0.18102,-0.084649,-0.061935,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.33029,-0.084943,-0.027497,0,0
2,GO REGULATION OF AXON GUIDANCE,0.93062,-0.085363,0.062373,0,0
2,GO RNA POLYADENYLATION,0.25111,-0.085597,-0.039215,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.98106,-0.085609,0.033923,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.2998,-0.085921,-0.042767,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.34626,-0.086025,-0.033982,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.49108,-0.086247,-0.0087783,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.47137,-0.087132,-0.022899,0,0
2,GO CELL CYCLE DNA REPLICATION,0.17591,-0.087198,-0.082361,0,0
2,GO CILIUM ORGANIZATION,0.35442,-0.087365,-0.05196,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.70989,-0.087393,-0.036223,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.49108,-0.087759,-0.062,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.56341,-0.087793,-0.015749,0,0
2,GO MICROTUBULE BUNDLE FORMATION,0.41494,-0.087914,-0.060931,0,0
2,GO BRAIN MORPHOGENESIS,0.13467,-0.087931,-0.095976,0,0
2,GO TRNA MODIFICATION,0.14312,-0.088007,-0.075239,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.48117,-0.088106,-0.034443,0,0
2,GO BASE EXCISION REPAIR,0.12273,-0.088535,-0.062303,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.18102,-0.088587,-0.055874,0,0
2,GO P BODY ASSEMBLY,0.44264,-0.088599,-0.0094195,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.36271,-0.088624,-0.018704,0,0
2,GO CHROMATIN ORGANIZATION,0.43329,-0.088979,-0.019032,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.34626,-0.089104,-0.053143,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.83078,-0.08915,0.041223,0,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.33029,-0.089616,-0.1022,0,0
2,GO NEURON FATE SPECIFICATION,0.46168,-0.089657,-0.028616,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.197,-0.089682,-0.11294,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.197,-0.08993,-0.063361,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.80618,-0.089953,0.015437,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.197,-0.090074,-0.046057,0,0
2,GO UTP METABOLIC PROCESS,0.23203,-0.090417,-0.072088,0,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.70989,-0.090693,0.0059472,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.1475,-0.090825,-0.056244,0,0
2,GO RNA SPLICING,0.15655,-0.091011,-0.069642,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.197,-0.091095,-0.10023,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.11524,-0.091119,-0.093904,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.15655,-0.091394,-0.071997,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.33029,-0.091461,-0.073758,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.25111,-0.091492,-0.049778,0,0
2,GO CARNITINE SHUTTLE,0.16602,-0.091523,-0.083501,0,0
2,GO VIRAL LATENCY,0.33821,-0.091524,-0.031005,0,0
2,GO MRNA PROCESSING,0.18102,-0.09187,-0.065654,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.62923,-0.091903,-0.013953,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.27126,-0.092164,-0.054891,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.12273,-0.092531,-0.060904,0,0
2,GO LYSINE METABOLIC PROCESS,0.84314,-0.092545,-0.0071216,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.58498,-0.092843,-0.030692,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.2577,-0.093176,-0.080792,0,0
2,GO DNA CONFORMATION CHANGE,0.24463,-0.093204,-0.055541,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.85555,-0.093441,0.0032672,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.80618,-0.09345,0.021047,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.68646,-0.093548,-0.014323,0,0
2,GO DNA METHYLATION,0.16123,-0.093622,-0.055391,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.52145,-0.09409,-0.020527,0,0
2,GO REPLICATION FORK PROCESSING,0.1475,-0.094186,-0.12745,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.37964,-0.094299,-0.032142,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.32248,-0.094488,-0.047992,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.21989,-0.094929,-0.048703,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.19156,-0.095262,-0.0935,0,0
2,GO PROTEIN DEMETHYLATION,0.27126,-0.095311,-0.032149,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.13467,-0.095753,-0.069748,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.88046,-0.095865,0.062443,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.18102,-0.095874,-0.065521,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.10468,-0.096106,-0.1083,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.12273,-0.096243,-0.083701,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.26442,-0.096794,-0.056865,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.46168,-0.096919,-0.01999,0,0
2,GO OXIDATIVE DEMETHYLATION,0.1306,-0.096991,-0.098229,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.62923,-0.097081,-0.014759,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.18624,-0.097316,-0.076272,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48117,-0.097581,-0.02968,0,0
2,GO CHROMATIN REMODELING,0.27126,-0.097748,-0.051564,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.51122,-0.098081,-0.054039,0,0
2,GO MALE MEIOSIS I,0.37111,-0.098149,-0.045087,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.38829,-0.098668,-0.042446,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.37111,-0.098766,-0.054343,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.2998,-0.098805,-0.10478,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.197,-0.098897,-0.085488,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.57414,-0.098906,-0.022454,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.12662,-0.099443,-0.083614,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.75756,-0.099458,-0.0037171,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.25111,-0.099465,-0.052553,0,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.10468,-0.099486,-0.12949,0,0
2,GO HISTONE H3 DEACETYLATION,0.23203,-0.099585,-0.051785,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.27126,-0.099854,-0.040139,0,0
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.098083,-0.09999,-0.081613,0,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.39705,-0.10034,-0.085646,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.2259,-0.1004,-0.066577,0,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.13467,-0.10052,-0.063656,0,0
2,GO DNA REPLICATION INITIATION,0.094909,-0.10056,-0.094496,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.98106,-0.10056,0.045684,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.13885,-0.10058,-0.10917,0,0
2,GO PROTEIN METHYLATION,0.16602,-0.10067,-0.060916,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.28529,-0.1008,-0.072085,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.37964,-0.10111,-0.073465,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.197,-0.10125,-0.094187,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.37964,-0.10129,-0.089113,0,0
2,GO HISTONE H3 K9 METHYLATION,0.2259,-0.10142,-0.073101,0,0
2,GO HISTONE H3 K36 METHYLATION,0.26442,-0.10146,-0.085107,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.12662,-0.10168,-0.097745,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.49108,-0.10175,-0.059089,0,0
2,GO POSITIVE REGULATION OF ACROSOME REACTION,0.2259,-0.10194,-0.081077,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.11163,-0.10216,-0.080984,0,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.094909,-0.10236,-0.066242,0,0
2,GO G0 TO G1 TRANSITION,0.12662,-0.10266,-0.091721,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.55277,-0.10291,0.0025122,0,0
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.28529,-0.10351,-0.059836,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.2577,-0.1038,-0.053511,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.49108,-0.10391,-0.037302,0,0
2,GO NUCLEAR PORE ORGANIZATION,0.2259,-0.10415,-0.065644,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.1475,-0.10422,-0.06809,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.40594,-0.10424,-0.067652,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.11163,-0.10437,-0.077406,0,0
2,GO HISTONE METHYLATION,0.17091,-0.10443,-0.067687,0,0
2,GO LOOP OF HENLE DEVELOPMENT,0.64051,-0.10449,-0.065238,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.39705,-0.10452,-0.081178,0,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.11163,-0.10475,-0.082673,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.40594,-0.10487,-0.037114,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.34626,-0.10503,-0.040463,0,0
2,GO CHROMATIN SILENCING,0.13467,-0.10513,-0.0926,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.40594,-0.10519,-0.033977,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.20256,-0.10531,-0.051645,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.25111,-0.10594,-0.03577,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.3148,-0.10601,-0.039664,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.23827,-0.10651,-0.056651,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.99368,-0.10663,0.061387,0,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.13467,-0.10684,-0.085382,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.2577,-0.10694,-0.10872,0,0
2,GO DOSAGE COMPENSATION,0.35442,-0.10728,-0.052047,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.11524,-0.1073,-0.061208,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.18624,-0.10743,-0.069885,0,0
2,GO NEURAL TUBE PATTERNING,0.5959,-0.1076,-0.023484,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.15197,-0.10769,-0.092396,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.42405,-0.10772,-0.039051,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.13885,-0.10854,-0.082341,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.34626,-0.10884,-0.033269,0,0
2,GO HISTONE H3 K4 METHYLATION,0.18102,-0.10901,-0.081691,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.28529,-0.10938,-0.051034,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.30724,-0.11011,-0.034264,0,0
2,GO KINETOCHORE ASSEMBLY,0.32248,-0.1102,-0.069332,0,0
2,GO NUCLEOSOME ASSEMBLY,0.17591,-0.11028,-0.077358,0,0
2,GO REGULATION OF MRNA PROCESSING,0.13885,-0.1103,-0.076904,0,0
2,GO VIRAL TRANSLATION,0.15197,-0.11062,-0.063443,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.25111,-0.11064,-0.053064,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.21989,-0.11076,-0.069494,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.12273,-0.11086,-0.13037,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.16602,-0.11144,-0.1004,0,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.52145,-0.11203,-0.01042,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.36271,-0.11264,-0.042883,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.29248,-0.11287,-0.039528,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.214,-0.1136,-0.085506,0,0
2,GO CELL AGGREGATION,0.75756,-0.11371,-0.0069732,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.12273,-0.11416,-0.10052,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.13467,-0.11442,-0.10267,0,0
2,GO GASTRIC ACID SECRETION,0.20822,-0.11458,-0.070477,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.40594,-0.11469,-0.024148,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.43329,-0.11507,-0.024308,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.1306,-0.11518,-0.15707,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.3148,-0.11539,-0.052207,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.25111,-0.11572,-0.085306,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.19156,-0.11592,-0.12611,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.23203,-0.11621,-0.073715,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.38829,-0.11635,-0.05143,0,0
2,GO PIRNA METABOLIC PROCESS,0.1475,-0.11658,-0.10181,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.12662,-0.11729,-0.079892,0,0
2,GO CHROMATIN DISASSEMBLY,0.19156,-0.11737,-0.082484,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.65188,-0.11746,-0.037408,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.23827,-0.11807,-0.069076,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.20256,-0.11828,-0.091637,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.13885,-0.11847,-0.07152,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.49108,-0.11898,-0.074464,0,0
2,GO CARDIAC CHAMBER FORMATION,0.08881,-0.11904,-0.22795,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.68646,-0.11961,-0.025635,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.67486,-0.1201,0.0086882,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.33029,-0.12048,-0.064926,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.08881,-0.12086,-0.077874,0,0
2,GO DNA REPLICATION CHECKPOINT,0.094909,-0.12095,-0.13565,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.065157,-0.12114,-0.08991,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.26442,-0.12127,-0.061665,0,0
2,GO SYNAPSE MATURATION,0.39705,-0.12212,-0.11768,0,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.68646,-0.12278,0.01365,0,0
2,GO HISTONE DEUBIQUITINATION,0.214,-0.12278,-0.066465,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.29248,-0.12289,-0.091041,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.23203,-0.12309,-0.08654,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.41494,-0.12331,-0.11669,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.95582,-0.12407,0.040702,0,0
2,GO REGULATION OF RNA SPLICING,0.18624,-0.12438,-0.068653,0,0
2,GO KINETOCHORE ORGANIZATION,0.24463,-0.12448,-0.087517,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.17591,-0.12466,-0.080827,0,0
2,GO NUCLEOSOME ORGANIZATION,0.11163,-0.12516,-0.081814,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.88046,-0.12528,0.030063,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.37964,-0.12571,-0.042965,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.17591,-0.12634,-0.06455,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.069906,-0.12672,-0.12185,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.10468,-0.12677,-0.087699,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.18102,-0.12749,-0.041403,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.27821,-0.12841,-0.049695,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.57414,-0.12864,-0.034984,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.16123,-0.12882,-0.081057,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.098083,-0.12892,-0.095724,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.08588,-0.12933,-0.11253,0,0
2,GO HISTONE EXCHANGE,0.08881,-0.12947,-0.11512,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.25111,-0.12986,-0.062337,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.3148,-0.13054,-0.093087,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.056456,-0.13097,-0.10646,0,0
2,GO HISTONE H2A ACETYLATION,0.18624,-0.13123,-0.072831,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.33821,-0.13175,-0.12388,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.32248,-0.13253,-0.067096,0,0
2,GO AXO DENDRITIC TRANSPORT,0.23203,-0.13294,-0.055512,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.3148,-0.13295,-0.099037,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.17591,-0.13406,-0.067624,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.15655,-0.13469,-0.061076,0,0
2,GO DENSE CORE GRANULE TRANSPORT,0.62923,-0.1355,0.0043753,0,0
2,GO REGULATION OF APPETITE,0.16123,-0.13571,-0.12661,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.40594,-0.13572,-0.033653,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.18624,-0.13577,-0.082694,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.44264,-0.13591,-0.041039,0,0
2,GO INTRACILIARY TRANSPORT,0.2259,-0.13634,-0.10401,0,0
2,GO AXONAL TRANSPORT,0.17091,-0.1364,-0.06239,0,0
2,GO NODAL SIGNALING PATHWAY,0.2577,-0.13798,-0.082412,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.93062,-0.138,0.007691,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.20256,-0.13918,-0.06914,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.35442,-0.13948,-0.07221,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.20256,-0.13972,-0.064463,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.23827,-0.13977,-0.10536,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.2998,-0.14003,-0.034874,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.13467,-0.14169,-0.092494,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.13885,-0.14212,-0.090551,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.1306,-0.14227,-0.083168,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.18624,-0.14236,-0.14605,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.19156,-0.14237,-0.069131,0,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.16602,-0.14275,-0.10936,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.35442,-0.14419,-0.046469,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.098083,-0.14463,-0.082732,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.27821,-0.14492,-0.096812,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.08588,-0.14557,-0.11025,0,0
2,GO STRESS GRANULE ASSEMBLY,0.15655,-0.1464,-0.051878,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.29248,-0.14777,-0.058255,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.28529,-0.14815,-0.084706,0,0
2,GO PROTEIN POLYGLUTAMYLATION,0.08303,-0.14886,-0.13505,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.23827,-0.14997,-0.12749,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.16602,-0.15063,-0.11327,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.10134,-0.15109,-0.10246,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.074935,-0.15146,-0.13065,0,0
2,GO SPINAL CORD DEVELOPMENT,0.18102,-0.15316,-0.091644,0,0
2,GO REGULATION OF SYNAPSE MATURATION,0.27821,-0.15346,-0.14407,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.10811,-0.15387,-0.15561,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.13885,-0.15458,-0.092065,0,0
2,GO LIMB BUD FORMATION,0.23827,-0.15586,-0.14821,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.33821,-0.15637,-0.14198,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.08881,-0.15959,-0.12955,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.11163,-0.16012,-0.13835,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.20822,-0.16091,-0.074288,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.17591,-0.16253,-0.10277,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.062884,-0.16538,-0.13179,0,0
2,GO RESPONSE TO L GLUTAMATE,0.058535,-0.16686,-0.14885,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.13467,-0.16799,-0.098247,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.43329,-0.16877,-0.066746,0,0
2,GO REGULATION OF NEURON MIGRATION,0.15197,-0.16937,-0.12482,0,0
2,GO MRNA SPLICE SITE SELECTION,0.069906,-0.16963,-0.17861,0,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.13467,-0.16984,-0.10949,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.4521,-0.17074,-0.11725,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.214,-0.1719,-0.12607,0,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.065157,-0.17298,-0.17209,0,0
2,GO PREPULSE INHIBITION,0.25111,-0.1758,-0.16106,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.20822,-0.1768,-0.096199,0,0
2,GO DENDRITIC TRANSPORT,0.48117,-0.17823,-0.063132,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.49108,-0.17859,-0.077078,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.11524,-0.18882,-0.10177,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.08588,-0.18913,-0.17313,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.26442,-0.18934,-0.12019,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.10134,-0.18999,-0.12752,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.14312,-0.19104,-0.10839,0,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.197,-0.19144,-0.075049,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.18624,-0.19175,-0.11224,0,0
2,GO HEART VALVE FORMATION,0.26442,-0.19208,-0.10043,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.094909,-0.19512,-0.12493,0,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.13467,-0.19579,-0.17889,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.15197,-0.1989,-0.089853,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.28529,-0.19981,-0.10283,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.37964,-0.20012,-0.076914,0,0
2,GO HISTONE H3 K27 METHYLATION,0.091819,-0.20096,-0.14591,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.52145,-0.2027,-0.076298,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.080256,-0.20469,-0.1864,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.08881,-0.21308,-0.11984,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.1306,-0.21344,-0.19943,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.10468,-0.21437,-0.11242,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.08881,-0.21751,-0.15652,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.041938,-0.22964,-0.28071,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.34626,-0.24102,-0.092959,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.17591,-0.24229,-0.18065,0,0
2,GO POSTSYNAPSE ASSEMBLY,0.197,-0.2528,-0.1874,0,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.08588,-0.2607,-0.19702,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.094909,-0.26598,-0.17879,0,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.12273,-0.31032,-0.22241,0,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.006955,-0.46719,-0.42691,0,0
3,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.00020554,1.3009,1.1461,1,1
3,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.00028019,1.2291,1.0878,1,1
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00018128,1.1883,1.067,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00033648,1.1765,1.0109,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00010866,1.0674,0.98911,1,1
3,GO CHRONIC INFLAMMATORY RESPONSE,2.2907e-05,1.0497,0.94345,1,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00031664,1.049,0.81087,1,1
3,GO NATURAL KILLER CELL CHEMOTAXIS,0.00051151,1.0422,0.99377,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,5.6086e-05,1.016,0.94284,1,1
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.636e-05,1.0138,0.9719,1,1
3,GO TOLERANCE INDUCTION,0.00040321,1.0037,0.84859,1,1
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00035748,0.98571,0.97826,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00054254,0.97908,0.82954,1,1
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.7249e-05,0.97026,0.96774,1,1
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00054254,0.95327,0.72046,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.00068502,0.95134,0.8008,1,1
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.4805e-05,0.94918,0.81399,1,1
3,GO T CELL TOLERANCE INDUCTION,0.00029789,0.94674,0.89537,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,7.3279e-05,0.94146,0.85868,1,1
3,GO HYPERSENSITIVITY,0.00029789,0.94002,0.84112,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00020554,0.93508,0.85164,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,6.4139e-05,0.93178,0.91268,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00017019,0.93037,0.80125,1,1
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,5.9985e-05,0.91974,0.75288,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00023283,0.91928,0.81633,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00023283,0.91016,0.78209,1,1
3,GO T CELL CHEMOTAXIS,0.00010866,0.90146,0.76269,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00015974,0.89706,0.84616,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.8267e-05,0.89653,0.89859,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,3.7287e-05,0.89535,0.80607,1,1
3,GO T HELPER 1 CELL DIFFERENTIATION,3.0304e-05,0.89161,0.81485,1,1
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00017019,0.88717,0.83172,1,1
3,GO NEGATIVE T CELL SELECTION,0.00024771,0.88464,0.83842,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00015974,0.88211,0.71567,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00011593,0.87696,0.84139,1,1
3,GO DENDRITIC CELL MIGRATION,0.00019306,0.87431,0.77272,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,8.3641e-05,0.87039,0.77821,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.00021879,0.87034,0.78389,1,1
3,GO DETECTION OF OTHER ORGANISM,0.00014062,0.86494,0.73009,1,1
3,GO INTERLEUKIN 10 PRODUCTION,7.8298e-05,0.86308,0.7015,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00029789,0.86034,0.77963,1,1
3,GO SYNAPSE PRUNING,0.00026348,0.85822,0.90576,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.248e-05,0.85721,0.78346,1,1
3,GO RESPONSE TO PROTOZOAN,7.8298e-05,0.8531,0.7416,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00010181,0.85268,0.85954,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,7.8298e-05,0.84866,0.75973,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.8267e-05,0.84421,0.7585,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,4.2763e-05,0.83775,0.75614,1,1
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00091199,0.83715,0.71213,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,1.9888e-05,0.83496,0.79132,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,8.3641e-05,0.83281,0.79309,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00014062,0.82739,0.73412,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,8.9327e-05,0.82737,0.78027,1,1
3,GO T HELPER 2 CELL DIFFERENTIATION,3.7287e-05,0.82689,0.76679,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00021879,0.82552,0.70755,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0003797,0.82298,0.70471,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,8.9327e-05,0.8221,0.76501,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,9.5377e-05,0.82061,0.65961,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.81459,0.69962,1,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.0010798,0.81335,0.69665,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.9985e-05,0.80976,0.6725,1,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.00015974,0.80686,0.79635,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,7.8298e-05,0.80677,0.73353,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,7.3279e-05,0.80454,0.76648,1,1
3,GO CYTOLYSIS,0.00014989,0.80082,0.81026,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,0.00020554,0.80074,0.7231,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.00051151,0.79535,0.64558,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00014989,0.79531,0.66767,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00010181,0.7939,0.71584,1,1
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,6.8565e-05,0.79218,0.82334,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.00014989,0.79218,0.66731,1,1
3,GO INTERLEUKIN 2 PRODUCTION,2.8267e-05,0.78939,0.70779,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00020554,0.78425,0.74041,1,1
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00023283,0.78321,0.76425,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00026348,0.78252,0.65755,1,1
3,GO DETECTION OF BIOTIC STIMULUS,7.8298e-05,0.78214,0.64415,1,1
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00076864,0.78121,0.8635,1,1
3,GO POSITIVE T CELL SELECTION,0.00029789,0.78111,0.67866,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.7287e-05,0.77915,0.76133,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.00013188,0.77876,0.72752,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00018128,0.77595,0.69215,1,1
3,GO MONOCYTE CHEMOTAXIS,3.4805e-05,0.7753,0.77923,1,1
3,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00042807,0.775,0.72656,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,8.3641e-05,0.77482,0.67819,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.77356,0.6748,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,7.3279e-05,0.77253,0.71699,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9985e-05,0.77151,0.75518,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.4139e-05,0.77139,0.67178,1,1
3,GO INFLAMMATORY RESPONSE TO WOUNDING,7.8298e-05,0.76988,0.6791,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00028019,0.76914,0.68875,1,1
3,GO THYMIC T CELL SELECTION,0.00091199,0.76795,0.62367,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.636e-05,0.76616,0.75688,1,1
3,GO T CELL MIGRATION,0.00017019,0.7645,0.68484,1,1
3,GO CELLULAR DEFENSE RESPONSE,0.00019306,0.76434,0.68687,1,1
3,GO INTERLEUKIN 13 PRODUCTION,9.5377e-05,0.76378,0.7212,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.9936e-05,0.76364,0.73751,1,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00028019,0.76341,0.61585,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.00017019,0.76263,0.65105,1,1
3,GO REGULATION OF T CELL CHEMOTAXIS,5.6086e-05,0.76106,0.69785,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.8565e-05,0.75938,0.70033,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.5779e-05,0.75901,0.70091,1,1
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00026348,0.75836,0.70455,1,1
3,GO RESPONSE TO CHEMOKINE,3.0304e-05,0.75816,0.73071,1,1
3,GO CYCLOOXYGENASE PATHWAY,5.2428e-05,0.75757,0.77294,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.9936e-05,0.75752,0.75532,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00013188,0.75679,0.67066,1,1
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00014062,0.7533,0.70033,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.00024771,0.75161,0.64512,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014062,0.75104,0.7207,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00020554,0.74938,0.68959,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,7.8298e-05,0.74799,0.68385,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,4.5779e-05,0.7477,0.69366,1,1
3,GO LEUKOCYTE AGGREGATION,7.8298e-05,0.7466,0.80474,1,1
3,GO RESPONSE TO INTERLEUKIN 15,7.8298e-05,0.74655,0.72307,1,1
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00045436,0.74591,0.61311,1,1
3,GO T CELL EXTRAVASATION,7.8298e-05,0.74508,0.65639,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00012367,0.74167,0.69216,1,1
3,GO T CELL CYTOKINE PRODUCTION,4.5779e-05,0.73949,0.65627,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00015974,0.73901,0.66224,1,1
3,GO INTERLEUKIN 12 PRODUCTION,0.00040321,0.7387,0.62479,1,1
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00023283,0.73601,0.70438,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.4139e-05,0.73368,0.68532,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00015974,0.73256,0.73105,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.00021879,0.73249,0.68364,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,8.9327e-05,0.73193,0.62995,1,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,9.5377e-05,0.73166,0.77309,1,1
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.0304e-05,0.7313,0.738,1,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,7.3279e-05,0.72914,0.67392,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012367,0.72817,0.66465,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,4.8997e-05,0.72721,0.67941,1,1
3,GO LYMPHOCYTE MIGRATION,0.00017019,0.72683,0.66909,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.9327e-05,0.72588,0.67688,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.00045436,0.72447,0.73787,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,4.8997e-05,0.72309,0.72271,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00011593,0.72274,0.64913,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,8.3641e-05,0.72237,0.63363,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.2539e-06,0.72219,0.82207,1,1
3,GO T CELL MEDIATED IMMUNITY,4.5779e-05,0.71945,0.62824,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,8.3641e-05,0.71889,0.65454,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,7.3279e-05,0.71835,0.65082,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,4.2763e-05,0.71784,0.65019,1,1
3,GO TYPE 2 IMMUNE RESPONSE,4.2763e-05,0.71754,0.7093,1,1
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.248e-05,0.71699,0.71385,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.4805e-05,0.71686,0.65354,1,1
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0012071,0.71632,0.57104,1,1
3,GO CHEMOKINE SECRETION,0.00024771,0.7162,0.70431,1,1
3,GO ETHANOL OXIDATION,1.2939e-05,0.71519,0.9026,1,1
3,GO REGULATION OF GLIAL CELL MIGRATION,0.00029789,0.71401,0.59863,1,1
3,GO NEUTROPHIL MIGRATION,6.4139e-05,0.71387,0.64917,1,1
3,GO HEMIDESMOSOME ASSEMBLY,0.010572,0.71281,0.53373,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00018128,0.71269,0.59748,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.6086e-05,0.71197,0.64985,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.3641e-05,0.7113,0.59567,1,1
3,GO RESPONSE TO INTERFERON GAMMA,9.5377e-05,0.71121,0.64111,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.00015974,0.71046,0.62991,1,1
3,GO MONONUCLEAR CELL MIGRATION,2.8267e-05,0.70982,0.71177,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.7287e-05,0.70973,0.70659,1,1
3,GO T CELL SELECTION,0.00033648,0.70952,0.62966,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00021879,0.70929,0.60107,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,0.00045436,0.70791,0.60377,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.00018128,0.70787,0.63969,1,1
3,GO INTERLEUKIN 8 PRODUCTION,2.1347e-05,0.70617,0.6263,1,1
3,GO GLIAL CELL ACTIVATION,0.00019306,0.70601,0.66749,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,0.0015041,0.70599,0.52958,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00081392,0.70555,0.58794,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,9.5377e-05,0.70503,0.6278,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00033648,0.70489,0.66386,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.6086e-05,0.70483,0.61351,1,1
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,8.9327e-05,0.70278,0.69727,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.00068502,0.70194,0.54341,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,9.5377e-05,0.70101,0.67591,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.00010866,0.69947,0.676,1,1
3,GO GERMINAL CENTER FORMATION,0.00054254,0.69922,0.64486,1,1
3,GO B CELL PROLIFERATION,0.00019306,0.6991,0.65755,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,0.00018128,0.69717,0.64708,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00012367,0.697,0.59916,1,1
3,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00086166,0.6968,0.6407,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.00019306,0.69358,0.6343,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00018128,0.6927,0.62812,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.7287e-05,0.6906,0.63154,1,1
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,5.2428e-05,0.68967,0.69264,1,1
3,GO INTERLEUKIN 1 PRODUCTION,5.9985e-05,0.68926,0.65024,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00014989,0.68882,0.70822,1,1
3,GO REGULATION OF CELL KILLING,0.00010866,0.68822,0.63865,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00020554,0.68728,0.63942,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,8.3641e-05,0.68624,0.61156,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00014062,0.68532,0.6393,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00013188,0.68497,0.59792,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,6.8565e-05,0.68372,0.63605,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00040321,0.68259,0.62488,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00019306,0.67899,0.58222,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00029789,0.6787,0.6218,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00020554,0.67491,0.55497,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00019306,0.67432,0.55564,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.3279e-05,0.67388,0.64034,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.8298e-05,0.67353,0.59717,1,1
3,GO GRANULOCYTE MIGRATION,5.9985e-05,0.67295,0.61838,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00011593,0.67213,0.60709,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00014989,0.67127,0.60291,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019306,0.67077,0.58242,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00060992,0.67041,0.70391,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,8.9327e-05,0.66708,0.63313,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00013188,0.66683,0.57621,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.8298e-05,0.66668,0.58769,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00024771,0.66665,0.71765,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,4.8997e-05,0.66615,0.68786,1,1
3,GO INTERLEUKIN 17 PRODUCTION,9.5377e-05,0.66408,0.6232,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00014062,0.66306,0.60376,1,1
3,GO B CELL MEDIATED IMMUNITY,0.00014062,0.66279,0.60989,1,1
3,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.00040321,0.66259,0.6785,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00011593,0.66169,0.57387,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00060992,0.66044,0.58266,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00014989,0.66009,0.60277,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,7.3279e-05,0.65938,0.63967,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.0015882,0.65937,0.55348,1,1
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00014989,0.65914,0.76661,1,1
3,GO CELLULAR RESPONSE TO ETHANOL,0.00018128,0.6588,0.55264,1,1
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00064645,0.65812,0.59916,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00015974,0.65791,0.57708,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00096503,0.65738,0.54862,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00014062,0.65639,0.57553,1,1
3,GO COMPLEMENT ACTIVATION,0.00015974,0.65556,0.75405,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00010181,0.65532,0.59251,1,1
3,GO GRANULOCYTE CHEMOTAXIS,5.9985e-05,0.65487,0.6384,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00015974,0.65423,0.55798,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0015882,0.65352,0.55458,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0010798,0.65276,0.51686,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00051151,0.65186,0.55979,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,9.5377e-05,0.65166,0.56179,1,1
3,GO RESPONSE TO INTERFERON BETA,0.00014989,0.65095,0.57172,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00057531,0.65089,0.5804,1,1
3,GO RESPONSE TO LIPOTEICHOIC ACID,0.00015974,0.64947,0.63145,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00081392,0.64907,0.55885,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00013188,0.64789,0.57902,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00076864,0.64731,0.58215,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00010866,0.64711,0.62744,1,1
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00017019,0.6469,0.60957,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00096503,0.64651,0.53435,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00021879,0.64611,0.57038,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00048214,0.64574,0.54315,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00057531,0.64543,0.64225,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,3.4805e-05,0.64478,0.67808,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.3279e-05,0.64411,0.60425,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00014062,0.64344,0.61629,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00024771,0.64053,0.72591,1,1
3,GO MATURE B CELL DIFFERENTIATION,0.00013188,0.64046,0.63506,1,1
3,GO NEUROINFLAMMATORY RESPONSE,0.00033648,0.64033,0.5944,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.7249e-05,0.63901,0.65795,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00018128,0.63596,0.55112,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.00018128,0.63344,0.5996,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.00045436,0.63142,0.57182,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00051151,0.62924,0.69187,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,9.5377e-05,0.62849,0.57566,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00020554,0.62753,0.59795,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00017019,0.62699,0.53995,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00020554,0.62676,0.57109,1,1
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00017019,0.6259,0.69192,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.00060992,0.62559,0.55405,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00028019,0.6251,0.54766,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00014989,0.62328,0.54595,1,1
3,GO FIBRINOLYSIS,0.00015974,0.62275,0.58643,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00010181,0.62247,0.53462,1,1
3,GO CYTOKINE METABOLIC PROCESS,6.4139e-05,0.61983,0.57842,1,1
3,GO REGULATION OF PHAGOCYTOSIS,0.00014062,0.61914,0.57387,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,8.9327e-05,0.6184,0.55117,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00017019,0.61836,0.54925,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0003797,0.61682,0.52831,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00011593,0.61663,0.54073,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.9327e-05,0.61505,0.54041,1,1
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010181,0.61407,0.62806,1,1
3,GO RESPONSE TO TYPE I INTERFERON,0.00040321,0.61285,0.52943,1,1
3,GO REGULATION OF MEMBRANE INVAGINATION,0.00072571,0.61282,0.59466,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,6.8565e-05,0.61252,0.61739,1,1
3,GO REGULATION OF MYOBLAST FUSION,0.00091199,0.61248,0.58261,1,1
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00040321,0.6123,0.61956,1,1
3,GO MACROPHAGE MIGRATION,6.4139e-05,0.61161,0.59464,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00019306,0.611,0.5338,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00020554,0.61069,0.60607,1,1
3,GO T CELL APOPTOTIC PROCESS,6.8565e-05,0.60975,0.55275,1,1
3,GO ETHANOL METABOLIC PROCESS,2.636e-05,0.6083,0.68427,1,1
3,GO AMYLOID BETA CLEARANCE,0.00018128,0.608,0.53649,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00020554,0.60736,0.50599,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012367,0.60636,0.55234,1,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00031664,0.60578,0.51647,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,7.3279e-05,0.60572,0.66159,1,1
3,GO T CELL PROLIFERATION,0.00021879,0.60554,0.55208,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00019306,0.60425,0.5303,1,1
3,GO REGULATION OF T CELL MIGRATION,0.00015974,0.60421,0.57141,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00018128,0.60359,0.54426,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.00011593,0.60346,0.58618,1,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00017019,0.60323,0.59914,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.00014062,0.60308,0.5396,1,1
3,GO I KAPPAB PHOSPHORYLATION,6.8565e-05,0.60299,0.54276,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00010866,0.60277,0.52839,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.6086e-05,0.60239,0.59064,1,1
3,GO ASTROCYTE ACTIVATION,0.00013188,0.60233,0.5252,1,1
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,3.7287e-05,0.60133,0.59237,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00023283,0.60093,0.54222,1,1
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,8.3641e-05,0.60058,0.61301,1,1
3,GO MACROPHAGE ACTIVATION,0.00017019,0.59976,0.5903,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.8298e-05,0.59973,0.59715,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0012071,0.59945,0.48524,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,5.6086e-05,0.59926,0.62029,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00028019,0.5986,0.52359,1,1
3,GO NEUTROPHIL EXTRAVASATION,0.00019306,0.59815,0.58129,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,4.2763e-05,0.59809,0.61992,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00019306,0.59766,0.52406,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,5.9985e-05,0.597,0.56306,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00026348,0.59683,0.63502,1,1
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00045436,0.59664,0.56567,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00015974,0.59648,0.57376,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.5377e-05,0.596,0.5441,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,8.3641e-05,0.59212,0.56782,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010181,0.59196,0.56953,1,1
3,GO PHAGOCYTOSIS RECOGNITION,0.00012367,0.59109,0.60962,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.00019306,0.59084,0.52045,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00028019,0.59005,0.56784,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.9327e-05,0.5891,0.54502,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.9327e-05,0.58884,0.54768,1,1
3,GO LEUKOCYTE PROLIFERATION,0.00023283,0.58708,0.54166,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00014062,0.58705,0.53573,1,1
3,GO MACROPHAGE CHEMOTAXIS,6.4139e-05,0.58676,0.56691,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.5377e-05,0.5856,0.52731,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015041,0.58516,0.51919,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,8.3641e-05,0.58501,0.52913,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00020554,0.58457,0.53773,1,1
3,GO PLASMINOGEN ACTIVATION,0.00040321,0.58387,0.51295,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,2.2907e-05,0.58386,0.55953,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.00029789,0.58385,0.55943,1,1
3,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,3.7287e-05,0.58293,0.61753,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00019306,0.58261,0.511,1,1
3,GO BLEB ASSEMBLY,0.00064645,0.58221,0.55495,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014989,0.58165,0.54226,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0066311,0.58066,0.4703,1,1
3,GO CELLULAR EXTRAVASATION,0.00033648,0.58055,0.55431,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.58043,0.5245,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,4.2763e-05,0.57804,0.51728,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,6.8565e-05,0.57804,0.62939,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00011593,0.5777,0.52622,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.00081392,0.57734,0.53121,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00026348,0.57673,0.62654,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00018128,0.57523,0.49986,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00023283,0.57462,0.49553,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00012367,0.57423,0.52378,1,1
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.00018128,0.57358,0.60009,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00013188,0.57269,0.5719,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00033648,0.57191,0.4845,1,1
3,GO CELL KILLING,0.00017019,0.57121,0.52625,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00024771,0.5711,0.59117,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00051151,0.57069,0.53688,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.8267e-05,0.56982,0.57854,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00045436,0.5698,0.52658,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00020554,0.56842,0.53467,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00011593,0.56719,0.55328,1,1
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00060992,0.56605,0.47335,1,1
3,GO T CELL DIFFERENTIATION,0.00023283,0.5651,0.50377,1,1
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00024771,0.56499,0.61685,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00028019,0.56493,0.47619,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,8.9327e-05,0.56483,0.54721,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00091199,0.56355,0.51194,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00014989,0.56289,0.54564,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0012071,0.56255,0.49248,1,1
3,GO T CELL ACTIVATION,0.00021879,0.56184,0.50683,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00024771,0.5614,0.50592,1,1
3,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00081392,0.5613,0.61915,1,1
3,GO BONE TRABECULA MORPHOGENESIS,0.0052065,0.55955,0.45874,1,1
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,6.4139e-05,0.55916,0.60873,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00011593,0.55882,0.57681,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0010209,0.55858,0.5093,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00026348,0.5585,0.50153,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,0.00012367,0.55815,0.53839,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00054254,0.55776,0.53488,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00024771,0.55727,0.48844,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.8565e-05,0.55649,0.60868,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,6.8565e-05,0.5564,0.53305,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,6.4139e-05,0.55637,0.60256,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.8298e-05,0.55601,0.58273,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.9327e-05,0.55559,0.53965,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,8.9327e-05,0.55518,0.50563,1,1
3,GO CD40 SIGNALING PATHWAY,0.00015974,0.55458,0.50763,1,1
3,GO MACROPHAGE PROLIFERATION,0.0012071,0.55386,0.64269,1,1
3,GO MACROPHAGE DIFFERENTIATION,0.00021879,0.55342,0.50354,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00014989,0.55302,0.51906,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,4.2763e-05,0.55301,0.59742,1,1
3,GO NEUTROPHIL HOMEOSTASIS,3.9936e-05,0.55299,0.5621,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.5377e-05,0.55176,0.53273,1,1
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00023283,0.55169,0.52882,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00026348,0.54961,0.49689,1,1
3,GO INTEGRIN ACTIVATION,0.00026348,0.54824,0.57874,1,1
3,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.0015882,0.54799,0.46495,1,1
3,GO INTERLEUKIN 6 PRODUCTION,0.00023283,0.5477,0.48731,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,5.2428e-05,0.54734,0.54601,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00068502,0.54659,0.49468,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0003797,0.54435,0.5649,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,8.9327e-05,0.54391,0.57875,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00042807,0.54272,0.48626,1,1
3,GO IMMUNE RESPONSE TO TUMOR CELL,3.7287e-05,0.54199,0.56364,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,8.3641e-05,0.54184,0.54232,1,1
3,GO LEUKOCYTE CHEMOTAXIS,0.00014062,0.54162,0.55211,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.8524e-05,0.54156,0.55129,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.8565e-05,0.54133,0.50338,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00042807,0.54106,0.46583,1,1
3,GO REGULATION OF B CELL ACTIVATION,0.00029789,0.54064,0.54886,1,1
3,GO CYTOKINE SECRETION,0.00010866,0.53883,0.49479,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,8.9327e-05,0.53815,0.57247,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.00026348,0.53777,0.50056,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00014989,0.53737,0.5595,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.00033648,0.53459,0.58758,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.00018128,0.53391,0.45825,1,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00011593,0.53324,0.60375,1,1
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0003797,0.53121,0.54559,1,1
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,2.636e-05,0.5306,0.47544,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0010209,0.53011,0.43905,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00014062,0.52945,0.53701,1,1
3,GO RESPIRATORY BURST,0.0010209,0.52929,0.46979,1,1
3,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.0010798,0.52863,0.57475,1,1
3,GO CYTIDINE TO URIDINE EDITING,0.00029789,0.52856,0.50583,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.3279e-05,0.52851,0.48844,1,1
3,GO RESPONSE TO MURAMYL DIPEPTIDE,7.8298e-05,0.52787,0.51886,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.8997e-05,0.52709,0.58131,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.5779e-05,0.52688,0.53317,1,1
3,GO PHAGOCYTOSIS,0.00015974,0.52662,0.48376,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,3.7287e-05,0.5265,0.5177,1,1
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0021907,0.52179,0.48658,1,1
3,GO ACUTE PHASE RESPONSE,2.636e-05,0.52157,0.54544,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,7.8298e-05,0.52079,0.54425,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00014062,0.52056,0.46901,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.00017019,0.52005,0.44291,1,1
3,GO NAD BIOSYNTHETIC PROCESS,2.8267e-05,0.51974,0.49127,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,6.4139e-05,0.51935,0.50657,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00010866,0.51928,0.4393,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.00021879,0.51879,0.47923,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00054254,0.51822,0.53416,1,1
3,GO MEMBRANE RAFT ORGANIZATION,0.00072571,0.5181,0.48313,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00060992,0.51752,0.50231,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00024771,0.51687,0.45394,1,1
3,GO INNATE IMMUNE RESPONSE,0.00010866,0.51676,0.46177,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010866,0.51662,0.49672,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.00042807,0.51467,0.43314,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00010181,0.51355,0.51055,1,1
3,GO LYMPH NODE DEVELOPMENT,0.0044907,0.5135,0.41309,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00024771,0.51205,0.52719,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.00011593,0.51181,0.52784,1,1
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0016767,0.51176,0.47257,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00028019,0.51158,0.49612,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00028019,0.51151,0.42266,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00026348,0.51137,0.47133,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00020554,0.5106,0.4652,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00012367,0.51013,0.48615,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00064645,0.50982,0.44905,1,1
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00060992,0.50977,0.52468,1,1
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.2907e-05,0.50968,0.61459,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00023283,0.50907,0.48255,1,1
3,GO HUMORAL IMMUNE RESPONSE,0.00014062,0.50903,0.57765,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,4.8997e-05,0.50873,0.5216,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00033648,0.50762,0.47162,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.9327e-05,0.50734,0.46705,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00011593,0.50662,0.46617,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00013188,0.50593,0.5316,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00014989,0.50566,0.49139,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00057531,0.50515,0.58965,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00033648,0.50512,0.48188,1,1
3,GO PROTEIN ACTIVATION CASCADE,0.00021879,0.50491,0.59346,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,5.6086e-05,0.50383,0.56492,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00014989,0.50374,0.44737,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00033648,0.50315,0.43742,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,5.9985e-05,0.50298,0.49534,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00010181,0.50266,0.49384,1,1
3,GO REGULATION OF BONE DEVELOPMENT,7.8298e-05,0.50195,0.55765,1,1
3,GO ZYMOGEN INHIBITION,0.00020554,0.50123,0.49967,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00028019,0.50068,0.41531,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00023283,0.50056,0.45926,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.3641e-05,0.50038,0.5377,1,1
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00015974,0.50017,0.47937,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00028019,0.4995,0.45238,1,1
3,GO PEPTIDE CROSS LINKING,0.00035748,0.49936,0.50598,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00010181,0.49841,0.44393,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00015974,0.49769,0.43765,1,1
3,GO B CELL HOMEOSTASIS,0.0010209,0.49723,0.41496,1,1
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.248e-05,0.49631,0.59487,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00023283,0.49619,0.46377,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0023095,0.49519,0.46702,1,1
3,GO CHEMOKINE PRODUCTION,7.8298e-05,0.49475,0.50537,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.00028019,0.49438,0.46286,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00010181,0.49369,0.4599,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.8267e-05,0.49343,0.50187,1,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00040321,0.49307,0.41994,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0011418,0.493,0.46863,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.0014241,0.49262,0.5288,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.49156,0.502,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014989,0.48994,0.47242,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00029789,0.4897,0.45771,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.00048214,0.48837,0.53495,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,8.9327e-05,0.48797,0.60511,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00012367,0.48777,0.43615,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00035748,0.48758,0.58433,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00014989,0.48748,0.44417,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00019306,0.48575,0.45448,1,1
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0083971,0.48533,0.45172,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0018673,0.48471,0.40769,1,1
3,GO RESPONSE TO HYDROPEROXIDE,0.00054254,0.48447,0.47744,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0042727,0.48421,0.40983,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,6.4139e-05,0.48417,0.49659,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,3.4805e-05,0.48379,0.47443,1,1
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00054254,0.48179,0.5239,1,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,2.4576e-05,0.48154,0.48453,1,1
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00031664,0.48143,0.50596,1,1
3,GO CELL CHEMOTAXIS,0.00020554,0.48087,0.48922,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00014062,0.48031,0.4254,1,1
3,GO REGULATION OF PLATELET ACTIVATION,0.0010209,0.47964,0.51375,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00023283,0.47933,0.4887,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0038653,0.47916,0.43991,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00045436,0.47893,0.49157,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00057531,0.4775,0.47532,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023283,0.47674,0.45849,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0024341,0.47659,0.44399,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00013188,0.47596,0.4335,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.47587,0.41928,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00040321,0.47579,0.43832,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00064645,0.47557,0.44617,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,6.4139e-05,0.47525,0.47168,1,1
3,GO MULTI ORGANISM CELLULAR PROCESS,0.00031664,0.475,0.50362,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,6.8565e-05,0.47363,0.49587,1,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0014241,0.47264,0.47491,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00011593,0.47238,0.4321,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.00072571,0.47219,0.40697,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.2907e-05,0.47205,0.48325,1,1
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00017019,0.47196,0.46329,1,1
3,GO IMMUNE EFFECTOR PROCESS,0.00014062,0.47134,0.4206,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00014989,0.4703,0.48021,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00029789,0.46996,0.43107,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,8.3641e-05,0.46812,0.44996,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00019306,0.46807,0.46559,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.3279e-05,0.46775,0.4947,1,1
3,GO T CELL DIFFERENTIATION IN THYMUS,0.00060992,0.46759,0.4198,1,1
3,GO CYTOKINE PRODUCTION,0.00013188,0.46663,0.43181,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019306,0.46586,0.46047,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00017019,0.46561,0.43361,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00019306,0.46372,0.50483,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00024771,0.46312,0.39275,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00014989,0.46224,0.47521,1,1
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00048214,0.46215,0.47436,1,1
3,GO MITRAL VALVE DEVELOPMENT,0.0036751,0.46206,0.36854,1,1
3,GO VITAMIN D METABOLIC PROCESS,0.00028019,0.46189,0.45551,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00015974,0.4612,0.40586,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00020554,0.46094,0.48613,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00014989,0.46044,0.46905,1,1
3,GO INFLAMMATORY RESPONSE,0.00015974,0.45986,0.46155,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00031664,0.45792,0.51599,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.5377e-05,0.45752,0.45416,1,1
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,6.8565e-05,0.45733,0.4992,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00051151,0.45702,0.52352,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00081392,0.45683,0.43966,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,8.9327e-05,0.45675,0.44029,1,1
3,GO MYELOID CELL APOPTOTIC PROCESS,1.7249e-05,0.45658,0.45659,1,1
3,GO T CELL LINEAGE COMMITMENT,0.00040321,0.45555,0.4837,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,0.00019306,0.45539,0.41642,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.00017019,0.45536,0.45763,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00026348,0.45527,0.46943,1,1
3,GO SUPEROXIDE ANION GENERATION,0.00045436,0.45474,0.43152,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00020554,0.4543,0.44627,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00011593,0.45414,0.48787,1,1
3,GO MEMBRANE INVAGINATION,0.00091199,0.45401,0.41936,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0003797,0.45391,0.38379,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.00086166,0.45379,0.57744,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,6.8565e-05,0.45297,0.52946,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,2.8267e-05,0.45277,0.55663,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0036751,0.45257,0.50202,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015041,0.45245,0.4215,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.00021879,0.45216,0.41885,1,1
3,GO OSTEOCLAST DIFFERENTIATION,0.00028019,0.45194,0.40652,1,1
3,GO FEVER GENERATION,0.00018128,0.45184,0.4241,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00035748,0.45138,0.42673,1,1
3,GO OSTEOCLAST DEVELOPMENT,0.00017019,0.45102,0.55582,1,1
3,GO LEUKOCYTE MIGRATION,0.00026348,0.45057,0.46798,1,1
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00020554,0.45042,0.53017,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0015882,0.45028,0.39699,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00019306,0.44951,0.43787,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.00012367,0.44937,0.42239,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00017019,0.44921,0.48163,1,1
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00024771,0.44899,0.44499,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00014989,0.44806,0.43509,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.8267e-05,0.44524,0.47559,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00020554,0.44421,0.43934,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.44395,0.44644,1,1
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00051151,0.44368,0.44294,1,1
3,GO AMINE CATABOLIC PROCESS,0.00015974,0.44274,0.39398,1,1
3,GO B CELL ACTIVATION,0.00024771,0.44232,0.46618,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00048214,0.4418,0.51343,1,1
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00028019,0.44016,0.63618,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00028019,0.43965,0.41615,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00020554,0.43948,0.42136,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00014989,0.43943,0.46177,1,1
3,GO RESPONSE TO INTERLEUKIN 2,0.0028457,0.43866,0.47752,1,1
3,GO RESPONSE TO BACTERIUM,0.00010181,0.4384,0.46703,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,0.00010866,0.43771,0.40351,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.00011593,0.43724,0.45871,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00045436,0.43612,0.44692,1,1
3,GO DEFENSE RESPONSE,0.00013188,0.43559,0.40516,1,1
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00068502,0.43505,0.39353,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00072571,0.4338,0.45034,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.00018128,0.43317,0.47212,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00020554,0.43299,0.46758,1,1
3,GO SOMATIC STEM CELL DIVISION,0.0042727,0.4317,0.41642,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.00096503,0.43151,0.37987,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.636e-05,0.43107,0.44268,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00057531,0.43045,0.34542,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00051151,0.42952,0.39671,1,1
3,GO ACTIN FILAMENT SEVERING,0.00045436,0.42772,0.46361,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00031664,0.4275,0.3929,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,9.5377e-05,0.42692,0.46312,1,1
3,GO RETINAL METABOLIC PROCESS,5.6086e-05,0.42681,0.50365,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.9888e-05,0.42672,0.43391,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00020554,0.42655,0.38213,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00048214,0.42641,0.41705,1,1
3,GO RESPONSE TO TUMOR CELL,0.00028019,0.42621,0.45232,1,1
3,GO CHOLESTEROL STORAGE,0.00031664,0.42593,0.45429,1,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00048214,0.4254,0.45249,1,1
3,GO MYOBLAST FUSION,0.00040321,0.42525,0.44474,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.00021879,0.42523,0.55391,1,1
3,GO CELL ACTIVATION,0.00024771,0.4252,0.39037,1,1
3,GO REGULATION OF STEM CELL DIVISION,0.0016767,0.42492,0.45859,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.0010798,0.42407,0.35488,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.7287e-05,0.42395,0.40662,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0019699,0.42358,0.40932,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.2035e-05,0.42302,0.44041,1,1
3,GO SKIN MORPHOGENESIS,0.0049572,0.42246,0.38872,1,1
3,GO ENTRY INTO HOST,0.00018128,0.42232,0.40968,1,1
3,GO PROSTANOID METABOLIC PROCESS,6.8565e-05,0.42193,0.42539,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00035748,0.42192,0.40702,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0028457,0.42192,0.3729,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00012367,0.42174,0.44132,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0012071,0.42155,0.4439,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00048214,0.42102,0.44168,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00029789,0.42065,0.4886,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0031545,0.41939,0.44256,1,1
3,GO FLUID TRANSPORT,0.00081392,0.41935,0.43087,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.0304e-05,0.41869,0.44147,1,1
3,GO HYPOTONIC RESPONSE,0.0011418,0.41862,0.37653,1,1
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00035748,0.41862,0.45679,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0012758,0.41803,0.38885,1,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00015974,0.41779,0.42298,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00011593,0.41765,0.55349,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00015974,0.41714,0.44333,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,0.00096503,0.41706,0.4337,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0003797,0.41656,0.54926,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00011593,0.41617,0.4205,1,1
3,GO RESPONSE TO VIRUS,0.00014989,0.41608,0.39819,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.00086166,0.41556,0.40172,1,1
3,GO FOAM CELL DIFFERENTIATION,0.00060992,0.41534,0.42389,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0040644,0.41531,0.40563,1,1
3,GO WATER TRANSPORT,0.0023095,0.41385,0.42403,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.0003797,0.41369,0.35668,1,1
3,GO ASTROCYTE DEVELOPMENT,0.00017019,0.41297,0.44583,1,1
3,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0013481,0.41251,0.39137,1,1
3,GO BONE RESORPTION,0.0015882,0.41212,0.38555,1,1
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,7.8298e-05,0.41146,0.53979,1,1
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00042807,0.41101,0.47934,1,1
3,GO MACROPHAGE APOPTOTIC PROCESS,0.0016767,0.41083,0.42016,1,1
3,GO RETINOL METABOLIC PROCESS,7.1973e-06,0.41023,0.4325,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00057531,0.41003,0.44579,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00086166,0.4091,0.34004,1,1
3,GO RESPONSE TO INTERLEUKIN 1,3.248e-05,0.40885,0.37722,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.0036751,0.40841,0.40996,1,1
3,GO COLLAGEN CATABOLIC PROCESS,0.00072571,0.40786,0.4439,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,7.8298e-05,0.4072,0.46757,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029965,0.40715,0.40734,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,7.8298e-05,0.4066,0.69543,1,1
3,GO REGULATION OF DEFENSE RESPONSE,0.00014989,0.40659,0.36767,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.00011593,0.40637,0.40586,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00021879,0.40566,0.38458,1,1
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0083971,0.40523,0.34012,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00029789,0.40498,0.40959,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0003797,0.40475,0.35126,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00035748,0.40456,0.42167,1,1
3,GO TRANSCYTOSIS,0.0025648,0.40449,0.40145,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0018673,0.40382,0.34541,1,1
3,GO PINOCYTOSIS,0.00072571,0.40306,0.3876,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.9985e-05,0.40294,0.43348,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00028019,0.40281,0.4002,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00015974,0.40244,0.38089,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.5377e-05,0.40179,0.38525,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00029789,0.40165,0.44156,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,6.4139e-05,0.40153,0.51201,1,1
3,GO BONE CELL DEVELOPMENT,0.00045436,0.40102,0.41498,1,1
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00051151,0.40028,0.37514,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.00011593,0.39994,0.44362,1,1
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0016767,0.39968,0.40897,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00028019,0.39929,0.37351,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00068502,0.39899,0.37336,1,1
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0019699,0.39895,0.33445,1,1
3,GO ETHANOL CATABOLIC PROCESS,0.00014062,0.39894,0.42168,1,1
3,GO SYNCYTIUM FORMATION,0.00020554,0.39817,0.43104,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.3973,0.45413,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00011593,0.39625,0.47499,1,1
3,GO ERK1 AND ERK2 CASCADE,0.00031664,0.39586,0.38213,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00010866,0.39527,0.36958,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00064645,0.39491,0.42418,1,1
3,GO MUCUS SECRETION,0.00015974,0.39365,0.43619,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,5.6086e-05,0.39336,0.47119,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,7.8298e-05,0.39323,0.33656,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00018128,0.39289,0.42913,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00048214,0.39281,0.35113,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00042807,0.39158,0.39015,1,1
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0020776,0.39121,0.34259,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00026348,0.39108,0.51055,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00035748,0.39051,0.4406,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00011593,0.39015,0.35949,1,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.00023283,0.38998,0.43611,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,4.5779e-05,0.38993,0.42951,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.9985e-05,0.3891,0.39176,1,1
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.00081392,0.38807,0.41067,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.00040321,0.38802,0.36533,1,1
3,GO HYALURONAN CATABOLIC PROCESS,0.00010181,0.38772,0.47498,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00054254,0.38768,0.39359,1,1
3,GO ETHER BIOSYNTHETIC PROCESS,0.00024771,0.38694,0.38018,1,1
3,GO B CELL DIFFERENTIATION,0.00021879,0.3864,0.45887,1,1
3,GO RESPONSE TO CYTOKINE,0.00012367,0.38489,0.36881,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,9.5377e-05,0.38478,0.43842,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00057531,0.38465,0.42227,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.00060992,0.38455,0.42053,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,9.5377e-05,0.38404,0.40167,1,1
3,GO PODOSOME ASSEMBLY,0.00057531,0.38377,0.42879,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00033648,0.38372,0.36441,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00014989,0.38303,0.34707,1,1
3,GO SEQUESTERING OF METAL ION,0.00057531,0.38235,0.42787,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0057394,0.38122,0.29036,1,1
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00051151,0.38093,0.39902,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0011418,0.38083,0.39532,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0020776,0.38074,0.32825,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.00028019,0.38056,0.38172,1,1
3,GO STEROL HOMEOSTASIS,8.3641e-05,0.3805,0.37674,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00035748,0.38022,0.44791,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00091199,0.38002,0.28403,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0023095,0.37973,0.35597,1,1
3,GO CELL ADHESION MOLECULE PRODUCTION,0.0012758,0.37903,0.44467,1,1
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00014989,0.37901,0.42574,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00057531,0.37879,0.37244,1,1
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00068502,0.37869,0.44487,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00010181,0.37863,0.40272,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00014062,0.37841,0.41828,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00021879,0.3783,0.36704,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00023283,0.37791,0.38216,1,1
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00054254,0.37766,0.44998,1,1
3,GO SKELETAL MUSCLE TISSUE REGENERATION,5.6086e-05,0.37676,0.37004,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0011418,0.37608,0.3578,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0020776,0.37571,0.46776,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.248e-05,0.37545,0.41898,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0025648,0.37485,0.35836,1,1
3,GO T CELL HOMEOSTASIS,0.0014241,0.37484,0.33041,1,1
3,GO NIK NF KAPPAB SIGNALING,8.9327e-05,0.37439,0.33251,1,1
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00057531,0.37381,0.42651,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.0023095,0.37372,0.30848,1,1
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.0016767,0.37328,0.36045,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0020776,0.37319,0.41103,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.0014241,0.37315,0.35439,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00076864,0.3728,0.3058,1,1
3,GO REGULATION OF LIPASE ACTIVITY,5.9985e-05,0.37253,0.39164,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,7.3279e-05,0.37237,0.38824,1,1
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0010209,0.37219,0.42305,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00091199,0.37217,0.38261,1,1
3,GO PROTEIN TRIMERIZATION,0.00033648,0.37202,0.45139,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00019306,0.37198,0.35645,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0015882,0.37151,0.41089,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,5.9985e-05,0.37035,0.46266,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,8.3641e-05,0.37002,0.41518,1,1
3,GO PROTEIN NITROSYLATION,0.00026348,0.36994,0.36197,1,1
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0036751,0.36978,0.37065,1,1
3,GO VAGINA DEVELOPMENT,0.010101,0.36953,0.32016,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0003797,0.36891,0.4275,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00035748,0.36829,0.37879,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.8267e-05,0.36804,0.42352,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00076864,0.36776,0.3454,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022172,0.36742,0.28925,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,8.9327e-05,0.36706,0.49417,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.019548,0.36645,0.25817,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8524e-05,0.36601,0.40652,1,1
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.0019699,0.36529,0.52962,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,5.9985e-05,0.36523,0.38959,1,1
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,5.6086e-05,0.36514,0.39902,1,1
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0015882,0.36509,0.35119,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.00018128,0.36477,0.36919,1,1
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.010572,0.36473,0.30624,1,1
3,GO PYROPTOSIS,0.00091199,0.36451,0.40629,1,1
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.7287e-05,0.3645,0.37455,1,1
3,GO DIET INDUCED THERMOGENESIS,0.0029965,0.36443,0.32821,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,8.3641e-05,0.36379,0.40098,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0015882,0.36342,0.3259,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00035748,0.36329,0.43388,1,1
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0015882,0.36273,0.34868,1,1
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0015041,0.36269,0.55526,1,1
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0042727,0.36266,0.35895,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0015882,0.36249,0.38078,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.0010209,0.36174,0.40818,1,1
3,GO REGULATION OF CHEMOTAXIS,0.00035748,0.36171,0.3882,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0012071,0.36123,0.41113,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0040644,0.36089,0.36006,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.00017019,0.35982,0.35482,1,1
3,GO RENAL ABSORPTION,0.0003797,0.35979,0.47315,1,1
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00023283,0.35974,0.3869,1,1
3,GO INTERFERON BETA PRODUCTION,0.00072571,0.35928,0.35766,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,4.2763e-05,0.35903,0.43008,1,1
3,GO MAST CELL ACTIVATION,0.0096484,0.35893,0.33439,1,1
3,GO RESPONSE TO FUNGUS,0.0027019,0.35837,0.36829,1,1
3,GO REGULATION OF BONE REMODELING,0.006955,0.35763,0.30523,1,1
3,GO ZYMOGEN ACTIVATION,0.00033648,0.35752,0.40854,1,1
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.0021907,0.35637,0.35785,1,1
3,GO GAP JUNCTION ASSEMBLY,0.0018673,0.3563,0.45793,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026348,0.35628,0.34051,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.0015041,0.35583,0.30973,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.012106,0.35537,0.31791,1,1
3,GO INTERACTION WITH SYMBIONT,1.7249e-05,0.35537,0.36881,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00091199,0.35371,0.42675,1,1
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00033648,0.3533,0.3582,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00060992,0.35325,0.43098,1,1
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00029789,0.35308,0.44708,1,1
3,GO LYMPHANGIOGENESIS,0.0013481,0.35256,0.42336,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0027019,0.35202,0.33261,1,1
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0060238,0.35159,0.4075,1,1
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00072571,0.35067,0.41681,1,1
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00012367,0.34953,0.48396,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.00018128,0.34947,0.34746,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.00028019,0.3489,0.43301,1,1
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0017696,0.34831,0.37698,1,1
3,GO COLLAGEN FIBRIL ORGANIZATION,0.0052065,0.3481,0.45821,1,1
3,GO PROSTATE GLAND GROWTH,0.00045436,0.34791,0.38977,1,1
3,GO GAS TRANSPORT,0.014457,0.34783,0.34082,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00010866,0.34769,0.3483,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00096503,0.34766,0.45502,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00021879,0.34737,0.36372,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00012367,0.34728,0.3619,1,1
3,GO LIPOXYGENASE PATHWAY,0.018736,0.34547,0.33548,1,1
3,GO TRABECULA FORMATION,0.0096484,0.34436,0.31615,1,1
3,GO DNA DEAMINATION,0.0016767,0.34299,0.35915,1,1
3,GO ENDODERMAL CELL DIFFERENTIATION,0.0025648,0.34286,0.41844,1,1
3,GO MYELOID CELL DEVELOPMENT,0.00029789,0.34276,0.36482,1,1
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0017696,0.34275,0.35547,1,1
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0038653,0.34268,0.37657,1,1
3,GO BONE REMODELING,0.0024341,0.34227,0.33189,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.00042807,0.34224,0.31554,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00054254,0.34214,0.35177,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00026348,0.34171,0.36335,1,1
3,GO REGULATION OF CELL ADHESION,0.00045436,0.34156,0.37459,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0012071,0.34085,0.33655,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0038653,0.33998,0.31729,1,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00010866,0.33977,0.43126,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0016767,0.3393,0.36281,1,1
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00010866,0.33911,0.37345,1,1
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00023283,0.33896,0.38742,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00033648,0.33869,0.32286,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,4.8997e-05,0.33842,0.35121,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00096503,0.33814,0.33691,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00035748,0.33773,0.44488,1,1
3,GO RESPONSE TO MANGANESE ION,0.00023283,0.33755,0.33528,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072571,0.33674,0.37542,1,1
3,GO MODULATION BY HOST OF VIRAL PROCESS,7.3279e-05,0.33639,0.34204,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.00029789,0.33593,0.34668,1,1
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.8565e-05,0.3359,0.42281,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.0049572,0.33538,0.35033,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00024771,0.33536,0.35977,1,1
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0013481,0.33529,0.32926,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,0.0028457,0.33489,0.39377,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00033648,0.33482,0.34945,1,1
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00091199,0.33447,0.39788,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00057531,0.33412,0.32468,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00010866,0.33402,0.40519,1,1
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00086166,0.33341,0.36592,1,1
3,GO LIVER MORPHOGENESIS,0.00018128,0.33333,0.36866,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.0018673,0.33324,0.37083,1,1
3,GO DRUG CATABOLIC PROCESS,0.006955,0.33242,0.24982,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00045436,0.33169,0.32167,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00045436,0.33137,0.31538,1,1
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0016767,0.33052,0.35767,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0014241,0.33039,0.35863,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.016475,0.33032,0.22335,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00048214,0.33031,0.40077,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.0017696,0.32996,0.3494,1,1
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00017019,0.32965,0.34933,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00014062,0.32945,0.37557,1,1
3,GO SERTOLI CELL DEVELOPMENT,0.00091199,0.32941,0.32884,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00040321,0.32864,0.36022,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00057531,0.32864,0.30572,1,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.015104,0.32812,0.27875,1,1
3,GO TRANSEPITHELIAL TRANSPORT,0.0024341,0.32791,0.32212,1,1
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0012758,0.32788,0.39259,1,1
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00033648,0.32706,0.39134,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,6.8565e-05,0.32699,0.41117,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0018673,0.32665,0.36346,1,1
3,GO LYMPH VESSEL DEVELOPMENT,0.0029965,0.32567,0.40659,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,3.4805e-05,0.32553,0.35846,1,1
3,GO CHONDROCYTE PROLIFERATION,0.0057394,0.3255,0.33781,1,1
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00060992,0.32536,0.3514,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.00072571,0.32516,0.33631,1,1
3,GO P38MAPK CASCADE,0.00013188,0.32463,0.3814,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00042807,0.32388,0.32493,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00015974,0.32376,0.34278,1,1
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.015776,0.32373,0.34254,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0025648,0.32366,0.37191,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0017696,0.3232,0.27384,1,1
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0015041,0.32279,0.40984,1,1
3,GO CORNIFICATION,0.013235,0.32239,0.26155,1,1
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00091199,0.32225,0.29363,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0010209,0.32199,0.31444,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00015974,0.32181,0.41164,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00042807,0.32173,0.39206,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.00051151,0.3213,0.32591,1,1
3,GO STEROID ESTERIFICATION,0.0010798,0.32114,0.29437,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0052065,0.32073,0.31138,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0018673,0.32065,0.37565,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00014989,0.32049,0.31885,1,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.00054254,0.32033,0.3454,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00042807,0.32016,0.40728,1,1
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.011063,0.32004,0.28072,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00045436,0.31984,0.31238,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0011418,0.31978,0.33991,1,1
3,GO CHOLESTEROL EFFLUX,0.0029965,0.31977,0.28399,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00072571,0.31943,0.31202,1,1
3,GO PLATELET ACTIVATION,0.010101,0.31881,0.30908,1,1
3,GO SEROTONIN SECRETION,0.023112,0.31821,0.31744,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.014457,0.31775,0.26655,1,1
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0025648,0.31691,0.29849,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00010866,0.31658,0.30448,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00096503,0.31631,0.38133,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00068502,0.31576,0.39389,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0010209,0.31562,0.34305,1,1
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,8.3641e-05,0.31553,0.43629,1,1
3,GO REGULATION OF PLATELET AGGREGATION,0.007293,0.31511,0.33899,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0014241,0.31505,0.35456,1,1
3,GO RESPONSE TO DSRNA,0.00045436,0.31472,0.30166,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00023283,0.31456,0.3512,1,1
3,GO DECIDUALIZATION,0.0014241,0.31422,0.3506,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00096503,0.31411,0.38702,1,1
3,GO EPIDERMIS MORPHOGENESIS,0.0047188,0.31402,0.32028,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.00072571,0.31399,0.34967,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0011418,0.31392,0.31328,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00035748,0.31338,0.31935,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.0003797,0.31313,0.33515,1,1
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00091199,0.31261,0.40289,1,1
3,GO REGULATION OF CALCIUM ION IMPORT,0.0010798,0.31143,0.338,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00091199,0.31137,0.36364,1,1
3,GO REGULATION OF LIPID STORAGE,0.00091199,0.31113,0.3162,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00060992,0.31106,0.33426,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0012758,0.31095,0.34258,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00020554,0.31027,0.35922,1,1
3,GO FIBROBLAST ACTIVATION,0.0029965,0.31024,0.29971,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0034935,0.31013,0.34212,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.008797,0.30971,0.29538,1,1
3,GO REGULATION OF TISSUE REMODELING,0.0047188,0.30921,0.31556,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0034935,0.30911,0.25987,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.01266,0.30909,0.31127,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0040644,0.30862,0.34069,1,1
3,GO AMYLOID FIBRIL FORMATION,0.0018673,0.30797,0.34285,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.0010209,0.30779,0.35431,1,1
3,GO NOTOCHORD DEVELOPMENT,0.0172,0.30773,0.25306,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00068502,0.30733,0.33204,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0012758,0.30713,0.28873,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.3279e-05,0.30629,0.34046,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00064645,0.30619,0.35094,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0025648,0.30546,0.33728,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.0010798,0.30524,0.36754,1,1
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0023095,0.30478,0.27009,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00064645,0.30477,0.26394,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00031664,0.3046,0.36409,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.0013481,0.30436,0.30703,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0057394,0.30424,0.3559,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,8.3641e-05,0.30384,0.3484,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.0010209,0.3029,0.30869,1,1
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00031664,0.30275,0.3622,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00026348,0.3024,0.37115,1,1
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.0014241,0.30231,0.3277,1,1
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0017696,0.30195,0.4673,1,1
3,GO CERAMIDE TRANSPORT,0.016475,0.30061,0.24532,1,1
3,GO RIG I SIGNALING PATHWAY,0.00064645,0.3,0.28541,1,1
3,GO PLATELET DEGRANULATION,0.0013481,0.29996,0.39736,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00091199,0.29889,0.29064,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0018673,0.29845,0.28056,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.0003797,0.29841,0.26437,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.0031545,0.29835,0.27716,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00031664,0.29835,0.31797,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0034935,0.29812,0.34684,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0060238,0.29805,0.3153,1,1
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.00042807,0.29802,0.37141,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00057531,0.29763,0.39146,1,1
3,GO REGULATION OF PINOCYTOSIS,0.011574,0.29755,0.26028,1,1
3,GO RESPONSE TO THYROID HORMONE,0.008797,0.29703,0.257,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0019699,0.29701,0.23586,1,1
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00028019,0.29666,0.38418,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00042807,0.29656,0.36448,1,1
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00332,0.29632,0.29134,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00013188,0.29631,0.34137,1,1
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00051151,0.29615,0.36978,1,1
3,GO NECROTIC CELL DEATH,0.00072571,0.29506,0.29659,1,1
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0019699,0.29506,0.37539,1,1
3,GO TISSUE REMODELING,0.0017696,0.29487,0.35577,1,1
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.0063209,0.29487,0.32089,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0012071,0.29427,0.30515,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0021907,0.29427,0.32661,1,1
3,GO CALCIUM MEDIATED SIGNALING,0.0017696,0.29415,0.29907,1,1
3,GO KERATINOCYTE PROLIFERATION,0.0025648,0.29407,0.29929,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00068502,0.29405,0.25387,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.015776,0.29399,0.26267,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00020554,0.29389,0.30929,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00051151,0.29377,0.34324,1,1
3,GO STEM CELL DIVISION,0.010101,0.29336,0.26802,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0049572,0.29335,0.335,1,1
3,GO INTERACTION WITH HOST,0.00019306,0.29302,0.29024,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0034935,0.2926,0.21327,1,1
3,GO MAMMARY GLAND MORPHOGENESIS,0.0012071,0.29259,0.35688,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00024771,0.29253,0.29871,1,1
3,GO CELLULAR RESPONSE TO DSRNA,0.0016767,0.29226,0.3342,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00045436,0.29181,0.31789,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0010798,0.29175,0.3228,1,1
3,GO THYROID HORMONE METABOLIC PROCESS,0.0080134,0.29124,0.25246,1,1
3,GO RESPONSE TO INACTIVITY,0.014457,0.29121,0.23353,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.0003797,0.29106,0.29864,1,1
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.010572,0.29104,0.32445,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0047188,0.29085,0.32815,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.018736,0.29076,0.27632,1,1
3,GO RESPONSE TO AMYLOID BETA,0.014457,0.29072,0.27754,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0017696,0.28977,0.34823,1,1
3,GO ARTERY MORPHOGENESIS,0.0012758,0.28959,0.34862,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00026348,0.28933,0.36562,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,6.8565e-05,0.28928,0.29339,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.00023283,0.28913,0.35003,1,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00028019,0.28905,0.34613,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.00035748,0.28852,0.31574,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0015041,0.28843,0.31798,1,1
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.011063,0.28835,0.26284,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0057394,0.28826,0.21384,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00086166,0.28795,0.37451,1,1
3,GO LUNG MORPHOGENESIS,0.00332,0.28787,0.30396,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0016767,0.28738,0.32429,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0014241,0.28735,0.26512,1,1
3,GO URETER DEVELOPMENT,0.027226,0.28734,0.21415,1,1
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.00033648,0.28624,0.33551,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.013235,0.28586,0.33146,1,1
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00332,0.28536,0.28173,1,1
3,GO TERPENOID METABOLIC PROCESS,4.2763e-05,0.28499,0.28924,1,1
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0057394,0.28477,0.32817,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00029789,0.28461,0.35123,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.0003797,0.28446,0.3271,1,1
3,GO MUSCLE CELL FATE COMMITMENT,0.00076864,0.28446,0.31924,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0036751,0.28408,0.34869,1,1
3,GO COPPER ION TRANSPORT,0.0014241,0.28383,0.30026,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0010209,0.28377,0.2995,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0063209,0.28366,0.33217,1,1
3,GO RESPONSE TO GROWTH HORMONE,0.00020554,0.28301,0.29421,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012367,0.28285,0.30411,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0018673,0.28261,0.33444,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0049572,0.28258,0.28026,1,1
3,GO MYOBLAST MIGRATION,0.035953,0.28252,0.22564,1,1
3,GO GLIAL CELL PROLIFERATION,0.0012758,0.28227,0.31577,1,1
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0025648,0.28207,0.28758,1,1
3,GO RESPONSE TO FLUID SHEAR STRESS,0.00072571,0.28178,0.41631,1,1
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0015041,0.28166,0.33278,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.023112,0.28163,0.27375,1,1
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0027019,0.28134,0.29764,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0003797,0.28101,0.29317,1,1
3,GO RUFFLE ORGANIZATION,0.00096503,0.28096,0.3034,1,1
3,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0044907,0.28072,0.26211,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00031664,0.28031,0.3182,1,1
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.0172,0.28001,0.23783,1,1
3,GO RESPONSE TO STEROL,0.0015041,0.27939,0.29282,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00057531,0.27928,0.32891,1,1
3,GO B CELL APOPTOTIC PROCESS,0.00068502,0.27924,0.32371,1,1
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0057394,0.27914,0.25266,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.026142,0.27912,0.26619,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0013481,0.27906,0.36032,1,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00091199,0.27868,0.30681,1,1
3,GO RESPONSE TO INTERLEUKIN 12,0.00072571,0.27853,0.26881,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0017696,0.27849,0.2912,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0016767,0.27839,0.24948,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0096484,0.27834,0.26954,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0017696,0.27826,0.29343,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0029965,0.27816,0.34248,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0057394,0.27805,0.25865,1,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00026348,0.27797,0.3778,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00091199,0.27758,0.37231,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0025648,0.2775,0.31394,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00096503,0.27748,0.28042,1,1
3,GO ARGININE METABOLIC PROCESS,0.00086166,0.2772,0.29176,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.0015882,0.27686,0.30675,1,1
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.010101,0.27668,0.30716,1,1
3,GO HEPATOCYTE DIFFERENTIATION,0.033245,0.27655,0.20686,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0015882,0.27637,0.31732,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,0.0019699,0.27617,0.32381,1,1
3,GO PLATELET AGGREGATION,0.0066311,0.27527,0.34116,1,1
3,GO SALIVA SECRETION,0.0066311,0.27499,0.28941,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.0018673,0.27488,0.29318,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0016767,0.27471,0.28093,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0038653,0.27422,0.28052,1,1
3,GO GLOMERULUS DEVELOPMENT,0.0049572,0.27405,0.35165,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.014457,0.27403,0.24145,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00014989,0.27398,0.30905,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.010101,0.27395,0.2512,1,1
3,GO ENDODERM FORMATION,0.0012758,0.27352,0.39585,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.040368,0.27335,0.19833,1,1
3,GO HEAT GENERATION,0.0034935,0.2733,0.27207,1,1
3,GO ARACHIDONIC ACID SECRETION,0.00332,0.27327,0.25231,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00012367,0.27287,0.26722,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0018673,0.27273,0.30717,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0020776,0.27273,0.26032,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.025096,0.27162,0.23861,1,1
3,GO TRABECULA MORPHOGENESIS,0.018736,0.27155,0.27539,1,1
3,GO OVULATION,0.0010798,0.27118,0.32482,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00040321,0.27088,0.29727,1,1
3,GO COAGULATION,0.0052065,0.27072,0.28687,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0021907,0.2707,0.32037,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00086166,0.27066,0.29926,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.011574,0.26953,0.22112,1,1
3,GO REGULATION OF PROTEIN MATURATION,0.00020554,0.26938,0.32357,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.028348,0.26914,0.21322,1,1
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0010209,0.26834,0.35832,1,1
3,GO DRUG METABOLIC PROCESS,0.0012758,0.26815,0.28821,1,1
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0044907,0.26771,0.29894,1,1
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.006955,0.2677,0.23225,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0025648,0.26766,0.33773,1,1
3,GO TRACHEA DEVELOPMENT,0.0016767,0.26758,0.34758,1,1
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.007293,0.26752,0.39994,1,1
3,GO ENDODERM DEVELOPMENT,0.007293,0.26752,0.2929,1,1
3,GO LYMPH VESSEL MORPHOGENESIS,0.0052065,0.26728,0.37285,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00072571,0.26637,0.29115,1,1
3,GO ISOPRENOID METABOLIC PROCESS,3.0304e-05,0.26631,0.25674,1,1
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00086166,0.26615,0.39551,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,8.9327e-05,0.26586,0.30181,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.0060238,0.26563,0.27609,1,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00096503,0.26528,0.29852,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.006955,0.26481,0.25327,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00068502,0.26466,0.32207,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0029965,0.26466,0.33105,1,1
3,GO PULMONARY VALVE DEVELOPMENT,0.0092139,0.26398,0.35494,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00023283,0.26382,0.33596,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00064645,0.26379,0.32544,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00019306,0.26375,0.29097,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0038653,0.2636,0.28701,1,1
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0083971,0.26358,0.3027,1,1
3,GO RESPONSE TO ATP,0.0003797,0.26332,0.30347,1,1
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00048214,0.26322,0.32396,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0047188,0.26321,0.37711,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0013481,0.26318,0.27409,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0010798,0.26286,0.28295,1,1
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00029789,0.26267,0.2729,1,1
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0025648,0.26251,0.39573,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0063209,0.26208,0.25144,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00072571,0.26206,0.24836,1,1
3,GO PRIMARY MIRNA PROCESSING,0.0023095,0.26204,0.36674,1,1
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0063209,0.26201,0.27958,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00068502,0.26183,0.27366,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.007293,0.26176,0.31274,1,1
3,GO PEPTIDE CATABOLIC PROCESS,0.0024341,0.26174,0.3242,1,1
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00081392,0.26126,0.32808,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0023095,0.2612,0.29706,1,1
3,GO REPLACEMENT OSSIFICATION,0.0047188,0.26099,0.30567,1,1
3,GO WOUND HEALING,0.0027019,0.26097,0.29502,1,1
3,GO ARTERY DEVELOPMENT,0.0016767,0.2608,0.34014,1,1
3,GO REGULATION OF WOUND HEALING,0.0013481,0.2607,0.3407,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014989,0.26056,0.28401,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0010209,0.26034,0.34292,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0013481,0.26018,0.28548,1,1
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0172,0.26007,0.29566,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0024341,0.25995,0.26502,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.0047188,0.25915,0.24708,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010101,0.25912,0.30405,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0003797,0.25844,0.35336,1,1
3,GO AMINO SUGAR METABOLIC PROCESS,0.00035748,0.25796,0.32519,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.0015041,0.25784,0.28574,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.027226,0.25751,0.24412,1,1
3,GO SULFATION,0.014457,0.25742,0.25223,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0024341,0.25705,0.32255,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.015776,0.25658,0.2415,1,1
3,GO CELL CELL RECOGNITION,0.00019306,0.25656,0.27843,1,1
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0060238,0.25505,0.27001,1,1
3,GO AMELOGENESIS,0.00072571,0.255,0.32653,1,1
3,GO VIRAL GENOME REPLICATION,0.0017696,0.25487,0.27529,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0003797,0.25477,0.25841,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0052065,0.25474,0.30256,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0021907,0.25468,0.32422,1,1
3,GO O GLYCAN PROCESSING,0.020391,0.2546,0.2125,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083971,0.25438,0.35659,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00011593,0.25407,0.32351,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.013834,0.25401,0.22833,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0017696,0.2539,0.26287,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.0063209,0.25381,0.31242,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.041938,0.2537,0.28866,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00057531,0.25337,0.30261,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00060992,0.25336,0.29718,1,1
3,GO VIRAL LIFE CYCLE,0.00045436,0.25326,0.2711,1,1
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.023112,0.25324,0.27058,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.014457,0.25263,0.24374,1,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.00019306,0.25257,0.26276,1,1
3,GO REGULATION OF CELL SHAPE,0.0011418,0.25189,0.30315,1,1
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0012071,0.25188,0.32263,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.0031545,0.25162,0.23944,1,1
3,GO MATERNAL PLACENTA DEVELOPMENT,0.0020776,0.25153,0.28665,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.0012071,0.25148,0.30528,1,1
3,GO FOREGUT MORPHOGENESIS,0.0080134,0.25128,0.30419,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00081392,0.25115,0.28501,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0021907,0.25109,0.26656,1,1
3,GO MRNA TRANSCRIPTION,0.0019699,0.251,0.30136,1,1
3,GO TISSUE MIGRATION,0.0023095,0.251,0.30064,1,1
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.008797,0.25089,0.2528,1,1
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.010572,0.25051,0.33269,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.015104,0.25044,0.2704,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,6.4139e-05,0.25024,0.29061,1,1
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0076456,0.2502,0.31455,1,1
3,GO FACE DEVELOPMENT,0.031957,0.25005,0.24096,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0047188,0.25002,0.26537,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0018673,0.24999,0.2857,1,1
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0052065,0.24946,0.31158,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0025648,0.24942,0.35303,1,1
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.025096,0.2493,0.25044,1,1
3,GO GLAND MORPHOGENESIS,0.0054671,0.2484,0.30085,1,1
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0060238,0.24793,0.28901,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0080134,0.24774,0.27536,1,1
3,GO ENAMEL MINERALIZATION,0.00081392,0.24734,0.3806,1,1
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.015104,0.24728,0.25096,1,1
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0047188,0.24694,0.22576,1,1
3,GO PROTEIN KINASE B SIGNALING,0.00091199,0.24689,0.29064,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.022172,0.24687,0.21645,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0042727,0.24686,0.20218,1,1
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0066311,0.2466,0.34641,1,1
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.022172,0.24655,0.24195,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.012106,0.2465,0.30542,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.050584,0.24633,0.20532,1,1
3,GO ODONTOGENESIS,0.0024341,0.24606,0.26125,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.0010209,0.24601,0.297,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00076864,0.24592,0.2837,1,1
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0060238,0.24576,0.34421,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.00068502,0.2457,0.30465,1,1
3,GO MUSCLE CELL PROLIFERATION,0.00068502,0.24556,0.31242,1,1
3,GO MANGANESE ION TRANSPORT,0.0031545,0.24556,0.24157,1,1
3,GO EPIBOLY,0.0018673,0.2455,0.30716,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00091199,0.24522,0.25199,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0021907,0.24507,0.25952,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0036751,0.24497,0.27324,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.048745,0.24493,0.28621,1,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00091199,0.24422,0.273,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,7.3279e-05,0.24416,0.26854,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.00096503,0.24414,0.28809,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00072571,0.24395,0.3607,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00045436,0.24373,0.28834,1,1
3,GO CELL MATRIX ADHESION,0.0063209,0.24367,0.31066,1,1
3,GO CELL SUBSTRATE ADHESION,0.0063209,0.24362,0.31533,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.027226,0.24359,0.23733,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0031545,0.24359,0.23738,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0024341,0.24355,0.3084,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013834,0.24354,0.23464,1,1
3,GO REGULATION OF GASTRULATION,0.0012071,0.24288,0.28898,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.00057531,0.24287,0.26752,1,1
3,GO CELL REDOX HOMEOSTASIS,0.0010209,0.24258,0.26314,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.006955,0.24256,0.2883,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.048745,0.24231,0.19919,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0017696,0.2423,0.32857,1,1
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0010798,0.24203,0.24172,1,1
3,GO CELL VOLUME HOMEOSTASIS,0.0017696,0.24152,0.28621,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0042727,0.24093,0.26475,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0003797,0.24069,0.26092,1,1
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.031957,0.2405,0.21347,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.017954,0.24042,0.23215,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.0052065,0.24039,0.22653,1,1
3,GO PROSTATE GLAND DEVELOPMENT,0.0083971,0.24026,0.26955,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0029965,0.24022,0.27254,1,1
3,GO HYALURONAN METABOLIC PROCESS,0.0034935,0.24012,0.33142,1,1
3,GO RESPONSE TO FATTY ACID,0.0010209,0.23988,0.24544,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.0038653,0.23963,0.29717,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.015776,0.23936,0.19021,1,1
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0027019,0.23889,0.36543,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00021879,0.23847,0.30364,1,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.0034935,0.23823,0.24355,1,1
3,GO BLOOD VESSEL MORPHOGENESIS,0.0016767,0.23794,0.33763,1,1
3,GO FEMALE GENITALIA DEVELOPMENT,0.0092139,0.23781,0.20295,1,1
3,GO KERATINOCYTE MIGRATION,0.0080134,0.23728,0.26948,1,1
3,GO TOOTH MINERALIZATION,0.0080134,0.23695,0.30565,1,1
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.037377,0.23655,0.27415,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0076456,0.23639,0.28088,1,1
3,GO PLASMA MEMBRANE FUSION,0.008797,0.23613,0.26304,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00091199,0.23564,0.37491,1,1
3,GO SECRETION BY TISSUE,0.0021907,0.23563,0.22444,1,1
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0066311,0.23519,0.2257,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0066311,0.23513,0.23543,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.00068502,0.2351,0.26044,1,1
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.00332,0.23502,0.24529,1,1
3,GO AORTA DEVELOPMENT,0.0020776,0.23499,0.31642,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0015041,0.23438,0.26769,1,1
3,GO VASCULATURE DEVELOPMENT,0.0011418,0.23435,0.32848,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.011063,0.23407,0.291,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0049572,0.23401,0.2492,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.0034935,0.23379,0.25265,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00026348,0.23352,0.2534,1,1
3,GO REGULATION OF BONE MINERALIZATION,0.011063,0.23302,0.2808,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.019548,0.23282,0.23996,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.0083971,0.23252,0.25655,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0049572,0.23237,0.26445,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.013834,0.23222,0.27172,1,1
3,GO TISSUE REGENERATION,0.0017696,0.2322,0.22872,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0013481,0.23175,0.29479,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.015104,0.2317,0.20167,1,1
3,GO PANCREATIC JUICE SECRETION,0.018736,0.23165,0.2438,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0047188,0.23146,0.29721,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0027019,0.23133,0.27218,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0036751,0.23128,0.23783,1,1
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.033245,0.23123,0.20862,1,1
3,GO GLIAL CELL MIGRATION,0.026142,0.23113,0.23555,1,1
3,GO STEROL TRANSPORT,0.0010798,0.23077,0.26936,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00332,0.23072,0.33371,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0096484,0.23057,0.29137,1,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00086166,0.2304,0.28885,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0021907,0.23034,0.26987,1,1
3,GO RESPONSE TO LIPID,0.0010798,0.23019,0.25176,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0054671,0.22992,0.28742,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00042807,0.22941,0.27669,1,1
3,GO AMYLOID BETA FORMATION,0.0027019,0.22913,0.25054,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0017696,0.22823,0.22345,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00026348,0.22727,0.25711,1,1
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.010572,0.2272,0.2252,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.043559,0.22711,0.20632,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0012758,0.2271,0.25321,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.22701,0.20094,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.00068502,0.227,0.23121,1,1
3,GO TROPHOBLAST CELL MIGRATION,0.0015041,0.22659,0.28737,1,1
3,GO RESPONSE TO RETINOIC ACID,0.0024341,0.22653,0.25717,1,1
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0036751,0.22646,0.25864,1,1
3,GO MIDGUT DEVELOPMENT,0.02951,0.22638,0.2452,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00086166,0.22612,0.2614,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.0011418,0.22608,0.28097,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0010798,0.22607,0.24541,1,1
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.023112,0.22595,0.19183,1,1
3,GO CELL CELL ADHESION,0.0052065,0.22586,0.25216,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0028457,0.22583,0.29339,1,1
3,GO BONE DEVELOPMENT,0.0023095,0.22567,0.27656,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.012106,0.22512,0.27094,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.00086166,0.22498,0.22807,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.038848,0.22486,0.22868,1,1
3,GO RESPONSE TO WOUNDING,0.0060238,0.22485,0.2594,1,1
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00010181,0.22464,0.26127,1,1
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0020776,0.22457,0.19276,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0025648,0.22456,0.2541,1,1
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0017696,0.22448,0.26293,1,1
3,GO DETOXIFICATION,0.00048214,0.22331,0.22344,1,1
3,GO FATTY ACID TRANSPORT,0.00048214,0.22311,0.25969,1,1
3,GO RESPONSE TO ISCHEMIA,0.0047188,0.22302,0.26519,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.0021907,0.22254,0.24029,1,1
3,GO LIPID HOMEOSTASIS,0.00040321,0.22219,0.25576,1,1
3,GO EXOCYTOSIS,0.0054671,0.22218,0.22407,1,1
3,GO EMBRYO IMPLANTATION,0.0013481,0.22215,0.30939,1,1
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.0040644,0.22194,0.23972,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.018736,0.22194,0.30292,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0012758,0.22155,0.24051,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00051151,0.22114,0.23981,1,1
3,GO RESPONSE TO GAMMA RADIATION,0.0015882,0.22101,0.24343,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00091199,0.22095,0.24665,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0012071,0.22065,0.25343,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,0.006955,0.22057,0.29153,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019699,0.22042,0.27643,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00086166,0.22001,0.23194,1,1
3,GO RESPONSE TO ESTROGEN,0.0021907,0.21959,0.25682,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.015104,0.21916,0.2444,1,1
3,GO GENITALIA DEVELOPMENT,0.024086,0.21878,0.1964,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.034576,0.21828,0.28942,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0015882,0.21816,0.30929,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.01266,0.21786,0.18258,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0014241,0.21781,0.25302,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0066311,0.21742,0.29155,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0025648,0.21686,0.32556,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00091199,0.21682,0.24937,1,1
3,GO CELLULAR RESPONSE TO ATP,0.0016767,0.21678,0.26835,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0016767,0.21667,0.24197,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.015104,0.21649,0.23717,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00054254,0.21631,0.2618,1,1
3,GO LIPID STORAGE,0.0038653,0.21606,0.24264,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.037377,0.21604,0.19504,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00064645,0.216,0.23623,1,1
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.013235,0.21593,0.22862,1,1
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0060238,0.2158,0.23353,1,1
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0020776,0.21561,0.2666,1,1
3,GO CELL CELL JUNCTION MAINTENANCE,0.014457,0.21558,0.27221,1,1
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0012071,0.21526,0.26904,1,1
3,GO AORTA MORPHOGENESIS,0.0092139,0.21522,0.30455,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0027019,0.21458,0.28355,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.008797,0.21447,0.23435,1,1
3,GO PULMONARY VALVE MORPHOGENESIS,0.025096,0.21395,0.32052,1,1
3,GO NEPHRON TUBULE FORMATION,0.006955,0.21384,0.29977,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00332,0.21365,0.19366,1,1
3,GO BILE ACID METABOLIC PROCESS,0.00064645,0.21358,0.22367,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.01266,0.21351,0.23114,1,1
3,GO REGULATION OF BIOMINERALIZATION,0.019548,0.21336,0.25382,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0038653,0.21318,0.33805,1,1
3,GO HEPARIN METABOLIC PROCESS,0.008797,0.21292,0.27882,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00064645,0.21272,0.24035,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.011574,0.21249,0.22608,1,1
3,GO REGULATION OF DNA METHYLATION,0.031957,0.2124,0.16897,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.022172,0.21201,0.11988,1,1
3,GO RESPONSE TO X RAY,0.015104,0.21198,0.21696,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0019699,0.21192,0.25015,1,1
3,GO BICARBONATE TRANSPORT,0.040368,0.21173,0.17816,1,1
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0017696,0.21173,0.24678,1,1
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0063209,0.21151,0.30133,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010572,0.211,0.26378,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.018736,0.21078,0.21678,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0066311,0.21056,0.24946,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0038653,0.21042,0.29495,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.010572,0.21023,0.30874,1,1
3,GO TISSUE HOMEOSTASIS,0.00072571,0.21011,0.24844,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0054671,0.21008,0.25039,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0014241,0.21001,0.24499,1,1
3,GO REGULATION OF MAPK CASCADE,0.0034935,0.2098,0.24262,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.025096,0.2094,0.22275,1,1
3,GO ESTROUS CYCLE,0.046961,0.20934,0.21904,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0025648,0.2091,0.31152,1,1
3,GO RESPONSE TO SALT STRESS,0.038848,0.20906,0.17945,1,1
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.006955,0.20895,0.28288,1,1
3,GO ERBB SIGNALING PATHWAY,0.0011418,0.20877,0.2452,1,1
3,GO REGULATION OF LIPID LOCALIZATION,0.0024341,0.20852,0.23971,1,1
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0034935,0.20843,0.23864,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0015041,0.20842,0.23695,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.00081392,0.20803,0.24378,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.0029965,0.20802,0.24347,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0015041,0.20785,0.26193,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.025096,0.20736,0.22619,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013834,0.207,0.22495,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.0027019,0.20675,0.2203,1,1
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0015882,0.20673,0.25024,1,1
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.011574,0.2067,0.21283,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.024086,0.20659,0.24486,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0018673,0.20635,0.20021,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.01266,0.20607,0.24416,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00091199,0.20586,0.30698,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.037377,0.20585,0.19635,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00010866,0.20576,0.24183,1,1
3,GO PLATELET MORPHOGENESIS,0.0066311,0.20573,0.27712,1,1
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.046961,0.20573,0.20235,1,1
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0052065,0.2053,0.20358,1,1
3,GO BIOLOGICAL ADHESION,0.0066311,0.20525,0.25635,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.00081392,0.20517,0.26677,1,1
3,GO MYOTUBE DIFFERENTIATION,0.0049572,0.2051,0.24662,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.0025648,0.20489,0.21836,1,1
3,GO RNA DECAPPING,0.0080134,0.20478,0.21455,1,1
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0076456,0.20478,0.22625,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0016767,0.20475,0.25954,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.0014241,0.20456,0.26914,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.0012758,0.20438,0.2202,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0012758,0.20424,0.23069,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.011063,0.20408,0.27507,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.01266,0.2039,0.27579,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.0076456,0.20388,0.25654,1,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0044907,0.20377,0.2301,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.045233,0.20291,0.30305,1,1
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.006955,0.2029,0.21598,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,0.0025648,0.20261,0.18347,1,1
3,GO RESPONSE TO VITAMIN,0.011063,0.20209,0.21611,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.016475,0.20195,0.24194,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.010572,0.20169,0.25574,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00332,0.20159,0.22824,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.0019699,0.20103,0.24479,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00086166,0.20072,0.22877,1,1
3,GO RECEPTOR RECYCLING,0.020391,0.20065,0.17991,1,1
3,GO TUBE MORPHOGENESIS,0.0040644,0.20055,0.26119,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0042727,0.2003,0.23795,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.016475,0.20016,0.19424,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00031664,0.20005,0.24695,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0034935,0.19997,0.22946,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0054671,0.19958,0.29203,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.023112,0.19944,0.15082,1,1
3,GO FIBROBLAST PROLIFERATION,0.00096503,0.1994,0.26723,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0083971,0.19922,0.24514,1,1
3,GO IRON ION HOMEOSTASIS,0.0010798,0.1991,0.25424,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0063209,0.19906,0.27785,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0060238,0.19902,0.19046,1,1
3,GO BIOMINERALIZATION,0.019548,0.19901,0.21914,1,1
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0080134,0.19891,0.21197,1,1
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.027226,0.1989,0.24692,1,1
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.037377,0.19889,0.22309,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0036751,0.19883,0.22548,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.0016767,0.19857,0.23298,1,1
3,GO PROTEIN DEMANNOSYLATION,0.017954,0.19835,0.24787,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,0.010101,0.19814,0.21319,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.008797,0.19791,0.21434,1,1
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.016475,0.19749,0.21789,1,1
3,GO LAMELLIPODIUM ORGANIZATION,0.0012758,0.19739,0.24093,1,1
3,GO LIVER REGENERATION,0.00051151,0.19725,0.24236,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0028457,0.19713,0.26673,1,1
3,GO COPPER ION HOMEOSTASIS,0.007293,0.1968,0.19622,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.0076456,0.19679,0.20613,1,1
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.023112,0.19679,0.19371,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0057394,0.19669,0.25911,1,1
3,GO ANIMAL ORGAN REGENERATION,0.00064645,0.1963,0.23664,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.0027019,0.19622,0.23922,1,1
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0023095,0.19621,0.21174,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.021265,0.19599,0.22002,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.014457,0.19572,0.22893,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.018736,0.19543,0.16957,1,1
3,GO MALE GENITALIA DEVELOPMENT,0.026142,0.19535,0.22406,1,1
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.0023095,0.19471,0.26575,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.022172,0.19463,0.20757,1,1
3,GO CELLULAR IRON ION HOMEOSTASIS,0.0038653,0.19426,0.21101,1,1
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.013834,0.19424,0.27126,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.011063,0.19409,0.23801,1,1
3,GO TAXIS,0.010101,0.19406,0.23548,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0066311,0.19387,0.24895,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.037377,0.19387,0.17211,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0014241,0.19363,0.20738,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.015776,0.19312,0.28233,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0083971,0.19304,0.21713,1,1
3,GO NUCLEOTIDE SALVAGE,0.0038653,0.19288,0.20628,1,1
3,GO CELLULAR RESPONSE TO CAMP,0.0040644,0.19252,0.2187,1,1
3,GO TONGUE DEVELOPMENT,0.045233,0.19226,0.17811,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.027226,0.19184,0.20063,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0052065,0.1916,0.20597,1,1
3,GO ERYTHROCYTE MATURATION,0.015104,0.19123,0.24618,1,1
3,GO REGULATION OF PROTEIN IMPORT,0.00040321,0.19118,0.22936,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.013834,0.19112,0.21821,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0092139,0.19107,0.21368,1,1
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.046961,0.19104,0.23537,1,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.028348,0.19104,0.18003,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0015041,0.19098,0.21273,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.00081392,0.19077,0.21203,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0044907,0.19077,0.22523,1,1
3,GO HEART VALVE DEVELOPMENT,0.022172,0.19075,0.28807,1,1
3,GO METAL ION HOMEOSTASIS,0.018736,0.1907,0.19159,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.006955,0.19061,0.25749,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0066311,0.19022,0.20791,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0012071,0.19012,0.28298,1,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.013235,0.19002,0.19398,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00086166,0.18977,0.18455,1,1
3,GO MUSCLE CELL MIGRATION,0.0063209,0.18968,0.25851,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0092139,0.18946,0.19434,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.00081392,0.18941,0.19419,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.024086,0.18938,0.20677,1,1
3,GO ETHER METABOLIC PROCESS,0.0020776,0.18915,0.21897,1,1
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0023095,0.18912,0.21706,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0083971,0.18905,0.24939,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.007293,0.18897,0.20608,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00072571,0.18889,0.23591,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.0025648,0.18879,0.17758,1,1
3,GO RESPONSE TO IONIZING RADIATION,0.010101,0.18852,0.18097,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034935,0.18801,0.19947,1,1
3,GO SKIN DEVELOPMENT,0.01266,0.188,0.19227,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.00054254,0.18799,0.20702,1,1
3,GO RESPONSE TO NUTRIENT,0.0047188,0.18794,0.21219,1,1
3,GO STEROL METABOLIC PROCESS,0.00057531,0.18792,0.22412,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0011418,0.18773,0.21774,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0080134,0.18733,0.23539,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0027019,0.1873,0.20673,1,1
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0092139,0.18727,0.24445,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.017954,0.18725,0.21081,1,1
3,GO FOCAL ADHESION ASSEMBLY,0.018736,0.1872,0.25754,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.011063,0.18698,0.19489,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.013834,0.18694,0.20268,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.00068502,0.18649,0.20921,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0083971,0.18649,0.2674,1,1
3,GO ZINC ION HOMEOSTASIS,0.020391,0.18634,0.21463,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0096484,0.18614,0.21746,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.010572,0.18548,0.20588,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00054254,0.18542,0.227,1,1
3,GO RNA DESTABILIZATION,0.033245,0.18529,0.21453,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013235,0.1852,0.23002,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0012758,0.18512,0.26829,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0057394,0.18492,0.21334,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0076456,0.18482,0.21533,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.007293,0.18478,0.22017,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.011574,0.18477,0.20461,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.021265,0.18472,0.19668,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.022172,0.18417,0.16657,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.030713,0.18416,0.17991,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0040644,0.18402,0.1832,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0031545,0.18367,0.2418,1,1
3,GO MYOBLAST PROLIFERATION,0.0063209,0.18345,0.28703,1,1
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.031957,0.18344,0.1703,1,1
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.011574,0.18315,0.21185,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.035953,0.18296,0.18029,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0080134,0.18295,0.19446,1,1
3,GO RESPONSE TO CAMP,0.011574,0.18293,0.21116,1,1
3,GO HEME METABOLIC PROCESS,0.00031664,0.18278,0.20911,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0052065,0.18198,0.21241,1,1
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.021265,0.1819,0.2694,1,1
3,GO AUTOPHAGOSOME MATURATION,0.0031545,0.18165,0.18041,1,1
3,GO PROTEIN PROCESSING,0.0034935,0.18152,0.23004,1,1
3,GO IMP BIOSYNTHETIC PROCESS,0.040368,0.18124,0.12305,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0042727,0.18116,0.23295,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.046961,0.18104,0.19954,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.010101,0.18091,0.25963,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.01266,0.1809,0.20793,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.00023283,0.18085,0.23235,1,1
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0034935,0.18072,0.21154,1,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00332,0.1807,0.31038,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0013481,0.18055,0.21719,1,1
3,GO FORMATION OF PRIMARY GERM LAYER,0.0066311,0.18053,0.2726,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0092139,0.18045,0.21994,1,1
3,GO PLACENTA DEVELOPMENT,0.0076456,0.18006,0.20558,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.00072571,0.17994,0.22883,1,1
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.010572,0.17966,0.23998,1,1
3,GO EMBRYONIC HEMOPOIESIS,0.010572,0.17959,0.25213,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0036751,0.17908,0.2122,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.0015041,0.17902,0.22161,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0024341,0.17875,0.20482,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.011063,0.17874,0.18618,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0080134,0.17866,0.16797,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0003797,0.17863,0.2397,1,1
3,GO LIPID CATABOLIC PROCESS,0.0024341,0.17832,0.19382,1,1
3,GO RESPONSE TO UV B,0.008797,0.17801,0.20673,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0083971,0.17777,0.19173,1,1
3,GO CELL MOTILITY,0.010572,0.1776,0.21826,1,1
3,GO MIDDLE EAR MORPHOGENESIS,0.030713,0.17751,0.14347,1,1
3,GO MAINTENANCE OF LOCATION,0.0080134,0.17731,0.19639,1,1
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.01266,0.17708,0.20094,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.020391,0.17703,0.25211,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0092139,0.1769,0.23403,1,1
3,GO PORE COMPLEX ASSEMBLY,0.025096,0.17667,0.16303,1,1
3,GO ENDOCYTOSIS,0.0172,0.1766,0.20072,1,1
3,GO RESPONSE TO KETONE,0.0076456,0.17654,0.19941,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,0.0042727,0.17632,0.17788,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.018736,0.17628,0.16435,1,1
3,GO REGULATION OF HEAT GENERATION,0.02951,0.17625,0.2136,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.020391,0.17596,0.19346,1,1
3,GO EPIDERMIS DEVELOPMENT,0.013834,0.17579,0.183,1,1
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.041938,0.17574,0.17269,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00086166,0.17561,0.21341,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.010572,0.17559,0.20663,1,1
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.025096,0.17553,0.20245,1,1
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.17542,0.28807,1,1
3,GO LIPID IMPORT INTO CELL,0.015104,0.17525,0.19861,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.013235,0.17525,0.12323,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0016767,0.17524,0.1849,1,1
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.028348,0.17513,0.14424,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00332,0.17494,0.22404,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0063209,0.17493,0.20643,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0049572,0.17444,0.216,1,1
3,GO LIPID OXIDATION,0.014457,0.17438,0.14713,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.02951,0.17421,0.18614,1,1
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.046961,0.17413,0.15152,1,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.027226,0.17408,0.18781,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0017696,0.17372,0.23709,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.013235,0.17288,0.19842,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0023095,0.17274,0.19668,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.021265,0.17257,0.17738,1,1
3,GO REGULATION OF PROTEOLYSIS,0.0013481,0.17256,0.20997,1,1
3,GO SYMBIOTIC PROCESS,0.00091199,0.17237,0.1846,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.015776,0.1722,0.18664,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0021907,0.17164,0.20008,1,1
3,GO BONE MORPHOGENESIS,0.013235,0.17115,0.24613,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0015041,0.17113,0.20203,1,1
3,GO STEROID METABOLIC PROCESS,0.00076864,0.17075,0.1929,1,1
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0025648,0.17027,0.18066,1,1
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.017954,0.16991,0.14904,1,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.016475,0.1699,0.14702,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.019548,0.16981,0.1892,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.013834,0.1694,0.20596,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0028457,0.16933,0.21533,1,1
3,GO ION HOMEOSTASIS,0.018736,0.16912,0.17672,1,1
3,GO REGULATION OF LIPID TRANSPORT,0.0042727,0.16906,0.217,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.011063,0.1689,0.23343,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0076456,0.16875,0.23137,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0076456,0.16832,0.23614,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0080134,0.16816,0.1879,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.0172,0.16815,0.19517,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.024086,0.16801,0.19853,1,1
3,GO PERICARDIUM DEVELOPMENT,0.007293,0.16708,0.28021,1,1
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.011063,0.16706,0.20631,1,1
3,GO RUFFLE ASSEMBLY,0.0092139,0.16699,0.20525,1,1
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.01266,0.16678,0.17066,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.006955,0.16677,0.17955,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.021265,0.16654,0.18087,1,1
3,GO CORONARY VASCULATURE DEVELOPMENT,0.018736,0.16622,0.2665,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0049572,0.16601,0.21599,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.018736,0.16576,0.23976,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00332,0.16562,0.22303,1,1
3,GO JNK CASCADE,0.0060238,0.16557,0.21727,1,1
3,GO BLASTOCYST FORMATION,0.00068502,0.16551,0.19863,1,1
3,GO LAMELLIPODIUM ASSEMBLY,0.0092139,0.1654,0.19984,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.011574,0.16532,0.17939,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.0042727,0.16499,0.18943,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0063209,0.16497,0.1777,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0066311,0.16468,0.23455,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0010209,0.16437,0.20518,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.0023095,0.1642,0.22243,1,1
3,GO LIPID LOCALIZATION,0.0057394,0.16416,0.21004,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.011063,0.16415,0.19581,1,1
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.0096484,0.16409,0.18115,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.02951,0.16391,0.20671,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00096503,0.16362,0.22955,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.019548,0.16352,0.17966,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0096484,0.16333,0.16788,1,1
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.016475,0.16317,0.15768,1,1
3,GO INTESTINAL ABSORPTION,0.035953,0.16315,0.24364,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.046961,0.16307,0.16195,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0010798,0.16304,0.19711,1,1
3,GO ACTIVATION OF MAPKK ACTIVITY,0.052482,0.16299,0.17733,1,1
3,GO FAT CELL DIFFERENTIATION,0.007293,0.16285,0.22509,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0040644,0.16281,0.22274,1,1
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.038848,0.16273,0.15453,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.025096,0.16268,0.18212,1,1
3,GO REGULATION OF OSSIFICATION,0.022172,0.16221,0.22467,1,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0096484,0.16214,0.22567,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.0024341,0.16185,0.17464,1,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.027226,0.16177,0.21387,1,1
3,GO VITAMIN METABOLIC PROCESS,0.00054254,0.16167,0.19667,1,1
3,GO ANION HOMEOSTASIS,0.0040644,0.16156,0.22291,1,1
3,GO GASTRIC ACID SECRETION,0.040368,0.16144,0.16906,1,1
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.010572,0.16125,0.2366,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.00091199,0.16111,0.20363,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.01266,0.16081,0.17844,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.014457,0.16026,0.1841,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0052065,0.16022,0.18399,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0031545,0.1598,0.20887,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.010101,0.1598,0.15851,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.019548,0.1595,0.16415,1,1
3,GO RRNA MODIFICATION,0.038848,0.15911,0.09175,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0063209,0.1589,0.17579,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00332,0.15823,0.21507,1,1
3,GO GASTRULATION,0.0092139,0.1582,0.22576,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.011574,0.15815,0.1797,1,1
3,GO RESPONSE TO STEROID HORMONE,0.016475,0.15802,0.17793,1,1
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.006955,0.15786,0.20775,1,1
3,GO SECRETION,0.025096,0.1577,0.17376,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0076456,0.15752,0.1731,1,1
3,GO RESPONSE TO STEROL DEPLETION,0.043559,0.15746,0.19685,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.018736,0.15728,0.16754,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0034935,0.15726,0.19744,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0096484,0.15695,0.16175,1,1
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.028348,0.15672,0.21046,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.019548,0.15666,0.20773,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.021265,0.15622,0.20038,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.017954,0.15622,0.2143,1,1
3,GO OSTEOBLAST DIFFERENTIATION,0.015776,0.15616,0.19565,1,1
3,GO EPITHELIAL CELL PROLIFERATION,0.019548,0.15601,0.20523,1,1
3,GO GTP METABOLIC PROCESS,0.0017696,0.15589,0.1758,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0057394,0.15559,0.16371,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.015104,0.15557,0.17773,1,1
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.007293,0.1555,0.1845,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.021265,0.15513,0.17866,1,1
3,GO BLASTODERM SEGMENTATION,0.0036751,0.15502,0.23464,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.015104,0.15479,0.19306,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.028348,0.15454,0.21663,1,1
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.034576,0.15447,0.18603,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0024341,0.15423,0.20589,1,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.014457,0.15407,0.20627,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00045436,0.15395,0.19354,1,1
3,GO TUBE DEVELOPMENT,0.015776,0.15362,0.21617,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0015041,0.15355,0.3357,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.028348,0.15336,0.16193,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.028348,0.15317,0.20429,1,1
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.022172,0.15304,0.13668,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.010572,0.15302,0.15798,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0019699,0.15265,0.19741,1,1
3,GO VESICLE CARGO LOADING,0.027226,0.15258,0.15339,1,1
3,GO REGENERATION,0.0052065,0.15213,0.19241,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.011063,0.15171,0.1946,1,1
3,GO THIOESTER METABOLIC PROCESS,0.010101,0.15159,0.16307,1,1
3,GO VACUOLAR ACIDIFICATION,0.0096484,0.15157,0.18179,1,1
3,GO PROTEIN AUTOPROCESSING,0.046961,0.15157,0.15903,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0012071,0.15131,0.22715,1,1
3,GO NADP METABOLIC PROCESS,0.014457,0.15094,0.15825,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.020391,0.1509,0.21575,1,1
3,GO TOXIN TRANSPORT,0.041938,0.15083,0.14913,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.052482,0.15064,0.24323,1,1
3,GO LIPID METABOLIC PROCESS,0.0031545,0.15051,0.1742,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00076864,0.15021,0.20333,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.011574,0.15016,0.21452,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.016475,0.14984,0.20622,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0066311,0.14947,0.187,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.006955,0.14947,0.199,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.010572,0.14933,0.14552,1,1
3,GO VITAMIN TRANSPORT,0.013235,0.14924,0.19271,1,1
3,GO BODY FLUID SECRETION,0.035953,0.14922,0.14443,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.031957,0.149,0.21375,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.048745,0.1485,0.22548,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0038653,0.1483,0.1741,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.016475,0.14813,0.17472,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.045233,0.14788,0.17083,1,1
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02951,0.14775,0.15341,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.020391,0.14764,0.23866,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0049572,0.14748,0.21767,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.052482,0.14695,0.19809,1,1
3,GO CARTILAGE DEVELOPMENT,0.014457,0.14655,0.22798,1,1
3,GO PROTEIN MATURATION,0.007293,0.14645,0.17842,1,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0092139,0.14627,0.19447,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.024086,0.14625,0.20417,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.050584,0.14622,0.16389,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.025096,0.14615,0.17096,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0096484,0.14611,0.29837,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0024341,0.14603,0.2014,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.015104,0.14597,0.17579,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.013834,0.14584,0.1709,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0029965,0.14559,0.18865,1,1
3,GO DIGESTION,0.021265,0.1451,0.17009,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.027226,0.14506,0.1402,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.0172,0.14498,0.21648,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.037377,0.14493,0.21812,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.012106,0.14487,0.17039,1,1
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0172,0.14479,0.20192,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.011574,0.14467,0.20119,1,1
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.050584,0.1446,0.15859,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.01266,0.14457,0.17461,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.013235,0.1442,0.16774,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0083971,0.14358,0.15939,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.015104,0.14342,0.26328,1,1
3,GO SELECTIVE AUTOPHAGY,0.017954,0.14337,0.16242,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.034576,0.14334,0.14396,1,1
3,GO REGULATION OF CELL DEATH,0.0024341,0.14332,0.18784,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0076456,0.14309,0.18682,1,1
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00081392,0.14284,0.1608,1,1
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0012758,0.14255,0.17195,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00332,0.14255,0.18844,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0019699,0.14205,0.15619,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.024086,0.14201,0.16219,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.028348,0.14182,0.18942,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.020391,0.14175,0.16746,1,1
3,GO VIRAL RELEASE FROM HOST CELL,0.020391,0.14116,0.13827,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.024086,0.14078,0.095329,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.026142,0.1407,0.21113,1,1
3,GO RESPONSE TO ALCOHOL,0.019548,0.14042,0.17465,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.011063,0.14028,0.16722,1,1
3,GO MUSCLE ADAPTATION,0.033245,0.13932,0.17376,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.022172,0.13919,0.19598,1,1
3,GO CELLULAR PIGMENTATION,0.011063,0.13902,0.17084,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.014457,0.13874,0.16686,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.015104,0.13862,0.1731,1,1
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.006955,0.13861,0.19465,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0031545,0.13784,0.159,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.0036751,0.13759,0.17679,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.010572,0.13674,0.14243,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.043559,0.13672,0.1185,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.033245,0.13612,0.18827,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.0020776,0.13544,0.16533,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.045233,0.1353,0.13294,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.02951,0.13503,0.20202,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.028348,0.1344,0.19418,1,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.017954,0.13434,0.14765,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.021265,0.134,0.19352,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.015776,0.13393,0.17473,1,1
3,GO CHEMICAL HOMEOSTASIS,0.043559,0.13388,0.1535,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.02951,0.13377,0.15938,1,1
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0083971,0.13369,0.1684,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.010101,0.13361,0.1711,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.021265,0.13358,0.18543,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.030713,0.13322,0.19933,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.027226,0.13282,0.22692,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.048745,0.13249,0.24998,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0172,0.13235,0.15546,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.01266,0.13153,0.1447,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.048745,0.13134,0.14837,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.034576,0.13122,0.1758,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.020391,0.13105,0.15734,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0172,0.13099,0.2142,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.028348,0.13091,0.16343,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0044907,0.13052,0.20195,1,1
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.01266,0.13049,0.23757,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.017954,0.13049,0.17148,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.0047188,0.13043,0.15702,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.025096,0.13033,0.16341,1,1
3,GO MICROVILLUS ORGANIZATION,0.031957,0.12989,0.15643,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.037377,0.12946,0.17144,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.045233,0.129,0.17043,1,1
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.043559,0.12855,0.1666,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0096484,0.12853,0.24651,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.012106,0.12788,0.16321,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.035953,0.12767,0.17482,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.026142,0.12761,0.1555,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.020391,0.12759,0.18346,1,1
3,GO SKELETAL SYSTEM DEVELOPMENT,0.021265,0.12752,0.19691,1,1
3,GO CELLULAR HOMEOSTASIS,0.027226,0.12728,0.1437,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0018673,0.12708,0.21219,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.016475,0.12702,0.14868,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.025096,0.12699,0.13855,1,1
3,GO RESPONSE TO VITAMIN A,0.041938,0.12693,0.17484,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.016475,0.12666,0.12651,1,1
3,GO RESPONSE TO HORMONE,0.022172,0.12641,0.1628,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.043559,0.12604,0.14118,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.015776,0.12545,0.16148,1,1
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.037377,0.12525,0.12429,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00048214,0.12509,0.18766,1,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.025096,0.12498,0.2044,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00332,0.12471,0.15728,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.019548,0.12455,0.16381,1,1
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.031957,0.12443,0.16559,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0063209,0.12433,0.2085,1,1
3,GO FIBROBLAST MIGRATION,0.038848,0.12425,0.19796,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.041938,0.12414,0.17709,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0096484,0.12364,0.1942,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0029965,0.12312,0.19259,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.010101,0.1229,0.14735,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0044907,0.12262,0.18705,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.021265,0.12256,0.15916,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.020391,0.12198,0.16923,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.0025648,0.12188,0.14443,1,1
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0029965,0.12187,0.14143,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.037377,0.12179,0.13168,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0049572,0.12109,0.16706,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.010101,0.12095,0.1719,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,0.0016767,0.12092,0.15886,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00332,0.12067,0.1649,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.008797,0.12066,0.18278,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.010101,0.12047,0.17045,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.043559,0.12044,0.1285,1,1
3,GO STEM CELL DIFFERENTIATION,0.02951,0.12042,0.14615,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.030713,0.12039,0.14003,1,1
3,GO PROTEIN TETRAMERIZATION,0.0092139,0.11985,0.1749,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0028457,0.11958,0.15217,1,1
3,GO LIPID MODIFICATION,0.034576,0.11934,0.14035,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.023112,0.11817,0.11662,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0076456,0.11813,0.18408,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018736,0.11803,0.15926,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.020391,0.11791,0.17101,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0096484,0.11773,0.1638,1,1
3,GO ACTIN NUCLEATION,0.011574,0.11631,0.16385,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.046961,0.11622,0.1044,1,1
3,GO APOPTOTIC PROCESS,0.0066311,0.11595,0.16486,1,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.048745,0.11561,0.13747,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.011063,0.11558,0.17676,1,1
3,GO AMP METABOLIC PROCESS,0.014457,0.11544,0.15188,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.040368,0.11509,0.16573,1,1
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0096484,0.11507,0.20498,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.02951,0.1143,0.14362,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.037377,0.11382,0.17194,1,1
3,GO HOMEOSTATIC PROCESS,0.020391,0.11363,0.15536,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.050584,0.1135,0.15393,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.027226,0.11335,0.13787,1,1
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.031957,0.11327,0.19138,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.038848,0.11321,0.17614,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0080134,0.11305,0.16633,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.013834,0.11282,0.15997,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0034935,0.11263,0.16452,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.045233,0.11157,0.14314,1,1
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.046961,0.11119,0.1359,1,1
3,GO CELL RECOGNITION,0.048745,0.11086,0.1596,1,1
3,GO REGULATION OF ORGAN GROWTH,0.013235,0.11053,0.19225,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.008797,0.10961,0.16214,1,1
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.028348,0.10941,0.19975,1,1
3,GO REGULATION OF METAL ION TRANSPORT,0.040368,0.10935,0.15228,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.026142,0.10888,0.14217,1,1
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.012106,0.10856,0.12579,1,1
3,GO IRON ION TRANSPORT,0.023112,0.10807,0.16188,1,1
3,GO RESPONSE TO PEPTIDE,0.035953,0.10793,0.15454,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.043559,0.10769,0.12997,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.048745,0.10748,0.14147,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.025096,0.10693,0.13701,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.037377,0.10678,0.14876,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.014457,0.10677,0.13907,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.031957,0.10661,0.15553,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.052482,0.10577,0.15163,1,1
3,GO RECEPTOR METABOLIC PROCESS,0.052482,0.10564,0.14209,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.035953,0.10452,0.14864,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.017954,0.10428,0.17126,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.016475,0.10373,0.1559,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.045233,0.10341,0.14056,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0096484,0.10337,0.14786,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.040368,0.10294,0.1214,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.016475,0.10156,0.12013,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0024341,0.10059,0.14256,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.026142,0.10034,0.15616,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015776,0.10004,0.16617,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.025096,0.10002,0.12919,1,1
3,GO COPII COATED VESICLE BUDDING,0.050584,0.09964,0.13019,1,1
3,GO ANDROGEN METABOLIC PROCESS,0.030713,0.09963,0.12484,1,1
3,GO CALCINEURIN MEDIATED SIGNALING,0.050584,0.09953,0.16257,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.011574,0.097126,0.16303,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.0066311,0.09626,0.1349,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.010572,0.096213,0.14202,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0083971,0.096003,0.16101,1,1
3,GO PROTEOLYSIS,0.020391,0.095978,0.14381,1,1
3,GO PROTEIN DESTABILIZATION,0.037377,0.094451,0.14751,1,1
3,GO GOLGI VESICLE BUDDING,0.050584,0.092516,0.13099,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.052482,0.091883,0.14233,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.091417,0.10075,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.048745,0.090049,0.15036,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.0096484,0.089033,0.14458,1,1
3,GO AGING,0.016475,0.089012,0.16294,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.031957,0.088968,0.16065,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.035953,0.088826,0.11636,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.037377,0.087785,0.14587,1,1
3,GO RESPONSE TO DRUG,0.037377,0.087432,0.14655,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.027226,0.087328,0.12594,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0172,0.085219,0.14178,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.041938,0.084754,0.12325,1,1
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.050584,0.084015,0.16764,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.037377,0.083835,0.078252,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.02951,0.083534,0.13922,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.016475,0.08326,0.12438,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.010101,0.082071,0.13417,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.01266,0.08197,0.13311,1,1
3,GO OXIDATION REDUCTION PROCESS,0.021265,0.080901,0.10864,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.046961,0.079578,0.14157,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.02951,0.078243,0.15106,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.043559,0.072567,0.13229,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.034576,0.072002,0.079137,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00068502,0.62696,0.637,1,0
3,GO ADHESION OF SYMBIONT TO HOST,0.0025648,0.57401,0.53337,1,0
3,GO NK T CELL DIFFERENTIATION,0.018736,0.39513,0.36865,1,0
3,GO ELASTIC FIBER ASSEMBLY,0.0025648,0.3763,0.66579,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0049572,0.37604,0.50266,1,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0023095,0.33592,0.44407,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.012106,0.32254,0.37664,1,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.0015041,0.32224,0.43257,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0052065,0.31379,0.34272,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0047188,0.30796,0.4417,1,0
3,GO CELL AGGREGATION,0.022172,0.29473,0.2543,1,0
3,GO REGULATION OF COAGULATION,0.0012758,0.28384,0.40163,1,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0020776,0.28254,0.34474,1,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.016475,0.27938,0.24109,1,0
3,GO VASCULAR WOUND HEALING,0.0036751,0.27562,0.38179,1,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.012106,0.27272,0.28935,1,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.0092139,0.2725,0.29953,1,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.025096,0.27099,0.35707,1,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.008797,0.27072,0.35618,1,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.033245,0.26863,0.30438,1,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.0012071,0.26503,0.36624,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.026142,0.26354,0.27268,1,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0020776,0.26281,0.31223,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0018673,0.26147,0.29551,1,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.020391,0.25275,0.31843,1,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.0063209,0.25031,0.27638,1,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0019699,0.25008,0.3526,1,0
3,GO BRONCHUS DEVELOPMENT,0.011574,0.24894,0.32463,1,0
3,GO STEROID CATABOLIC PROCESS,0.024086,0.24713,0.21666,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.019548,0.24079,0.28579,1,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0049572,0.24045,0.2573,1,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00332,0.23898,0.2953,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.037377,0.23664,0.20549,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.048745,0.2356,0.28674,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.028348,0.23535,0.30621,1,0
3,GO AORTIC VALVE DEVELOPMENT,0.019548,0.23273,0.34165,1,0
3,GO PIGMENT ACCUMULATION,0.041938,0.23001,0.27715,1,0
3,GO BLOOD VESSEL REMODELING,0.0063209,0.22706,0.36959,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.027226,0.22705,0.25192,1,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.010572,0.22455,0.29326,1,0
3,GO BONE MATURATION,0.021265,0.21575,0.24655,1,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0044907,0.21232,0.33808,1,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.031957,0.20184,0.20727,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.013834,0.19774,0.274,1,0
3,GO OSTEOBLAST PROLIFERATION,0.023112,0.19497,0.25037,1,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.018736,0.192,0.1857,1,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00332,0.18821,0.28644,1,0
3,GO RESPONSE TO HYPEROXIA,0.0017696,0.18734,0.2805,1,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.020391,0.18644,0.2048,1,0
3,GO ANIMAL ORGAN MATURATION,0.026142,0.18024,0.21552,1,0
3,GO PHOSPHATE ION TRANSPORT,0.0052065,0.1796,0.27716,1,0
3,GO RENAL VESICLE DEVELOPMENT,0.034576,0.17946,0.21495,1,0
3,GO REGULATION OF ANOIKIS,0.038848,0.17872,0.22287,1,0
3,GO GENITALIA MORPHOGENESIS,0.040368,0.17757,0.23616,1,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.033245,0.17641,0.1887,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.033245,0.17491,0.21943,1,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.028348,0.17139,0.2004,1,0
3,GO CHONDROCYTE DEVELOPMENT,0.046961,0.16988,0.25175,1,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.025096,0.16804,0.24675,1,0
3,GO TRACHEA MORPHOGENESIS,0.050584,0.16199,0.29267,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.012106,0.15895,0.26917,1,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.048745,0.15789,0.25745,1,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.02951,0.15756,0.21644,1,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.025096,0.15591,0.29601,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.045233,0.15575,0.14862,1,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.015776,0.15274,0.2969,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.035953,0.15262,0.23471,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.040368,0.15221,0.21953,1,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0076456,0.15089,0.2459,1,0
3,GO REGULATION OF HAIR CYCLE,0.033245,0.14957,0.21105,1,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.034576,0.14933,0.26657,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.019548,0.14789,0.27314,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.02951,0.14379,0.22403,1,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.038848,0.14226,0.18288,1,0
3,GO COBALAMIN METABOLIC PROCESS,0.038848,0.14209,0.18003,1,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046961,0.13764,0.2069,1,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.028348,0.1369,0.2323,1,0
3,GO ENDOCRINE PROCESS,0.0172,0.1362,0.22145,1,0
3,GO OSSIFICATION,0.037377,0.13619,0.19332,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.028348,0.13584,0.20238,1,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.040368,0.13298,0.16418,1,0
3,GO RESPONSE TO CADMIUM ION,0.018736,0.13223,0.1776,1,0
3,GO PIGMENT GRANULE ORGANIZATION,0.011574,0.13147,0.22814,1,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.040368,0.1283,0.24943,1,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.023112,0.12408,0.19913,1,0
3,GO AUTOPHAGIC CELL DEATH,0.011574,0.12137,0.17864,1,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.041938,0.12066,0.1382,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.028348,0.1204,0.18451,1,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0038653,0.11884,0.1975,1,0
3,GO NEPHRON DEVELOPMENT,0.043559,0.11514,0.19718,1,0
3,GO HORMONE METABOLIC PROCESS,0.024086,0.11444,0.15293,1,0
3,GO ALCOHOL CATABOLIC PROCESS,0.037377,0.11196,0.13865,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017954,0.10858,0.24432,1,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.050584,0.10511,0.18692,1,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.040368,0.10402,0.17683,1,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.041938,0.099397,0.21516,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.035953,0.098637,0.15561,1,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.015104,0.088537,0.14519,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.045233,0.086399,0.14254,1,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.041938,0.083064,0.12073,1,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.052482,0.080137,0.16583,1,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.048745,-0.075192,-0.052667,1,0
3,GO OXIDATIVE PHOSPHORYLATION,0.020391,-0.078822,-0.092115,1,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.014457,-0.086558,-0.094029,1,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0172,-0.088829,-0.11519,1,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.043559,-0.096076,-0.25403,1,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.033245,-0.099637,-0.093228,1,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.041938,-0.10145,-0.089429,1,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.037377,-0.10379,-0.078535,1,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.018736,-0.10425,-0.26686,1,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0054671,-0.10693,-0.13301,1,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.020391,-0.10975,-0.13045,1,0
3,GO WALKING BEHAVIOR,0.052482,-0.11038,-0.13995,1,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.052482,-0.11618,-0.19214,1,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.050584,-0.11955,-0.11858,1,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.045233,-0.11977,-0.089336,1,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.043559,-0.12236,-0.13955,1,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.030713,-0.1234,-0.1452,1,0
3,GO RESPONSE TO CATECHOLAMINE,0.022172,-0.12539,-0.11018,1,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.045233,-0.12603,-0.15634,1,0
3,GO MEMBRANE DOCKING,0.023112,-0.12983,-0.14359,1,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017954,-0.13142,-0.14731,1,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.033245,-0.13346,-0.10415,1,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.033245,-0.13718,-0.17014,1,0
3,GO FEAR RESPONSE,0.025096,-0.1376,-0.14854,1,0
3,GO POSTSYNAPSE ORGANIZATION,0.052482,-0.13777,-0.12414,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.048745,-0.13785,-0.1549,1,0
3,GO EPITHELIAL CELL MATURATION,0.046961,-0.13973,-0.20235,1,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.019548,-0.14106,-0.14541,1,0
3,GO RESPONSE TO FOOD,0.035953,-0.14125,-0.1647,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.0083971,-0.14167,-0.19034,1,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.041938,-0.14251,-0.21123,1,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.040368,-0.14312,-0.10565,1,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.015776,-0.14465,-0.17752,1,0
3,GO MITOCHONDRION LOCALIZATION,0.028348,-0.14471,-0.15768,1,0
3,GO TRANSPORT ALONG MICROTUBULE,0.035953,-0.14482,-0.15259,1,0
3,GO TUBULIN DEACETYLATION,0.046961,-0.14521,-0.13132,1,0
3,GO HISTONE EXCHANGE,0.027226,-0.14974,-0.25699,1,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.023112,-0.15096,-0.14219,1,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.043559,-0.15121,-0.30038,1,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.027226,-0.15255,-0.12399,1,0
3,GO NUCLEOSOME ASSEMBLY,0.048745,-0.1545,-0.20821,1,0
3,GO RESPONSE TO DOPAMINE,0.013834,-0.155,-0.13187,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.048745,-0.15529,-0.11878,1,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.052482,-0.15662,-0.12771,1,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.028348,-0.15808,-0.29287,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.048745,-0.15868,-0.19943,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.037377,-0.15981,-0.12972,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.046961,-0.16057,-0.19326,1,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.048745,-0.16085,-0.11809,1,0
3,GO METENCEPHALON DEVELOPMENT,0.037377,-0.16154,-0.15789,1,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.034576,-0.16181,-0.14369,1,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.01266,-0.16223,-0.19441,1,0
3,GO CELL FATE SPECIFICATION,0.050584,-0.16235,-0.14615,1,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.041938,-0.1635,-0.13739,1,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0172,-0.16771,-0.2874,1,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.022172,-0.1681,-0.24773,1,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.045233,-0.16816,-0.14028,1,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.014457,-0.16933,-0.14066,1,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.041938,-0.16999,-0.18389,1,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.050584,-0.17011,-0.17957,1,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.030713,-0.17168,-0.2149,1,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.016475,-0.17176,-0.145,1,0
3,GO CEREBELLAR CORTEX FORMATION,0.045233,-0.17227,-0.16236,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.026142,-0.17327,-0.16925,1,0
3,GO CHROMOSOME CONDENSATION,0.035953,-0.17327,-0.27483,1,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.013834,-0.17601,-0.18812,1,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.033245,-0.17944,-0.16605,1,0
3,GO AXONEME ASSEMBLY,0.028348,-0.17989,-0.23172,1,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.027226,-0.18224,-0.23561,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.015104,-0.18285,-0.19299,1,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.040368,-0.18395,-0.11096,1,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0172,-0.18517,-0.16729,1,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.052482,-0.18631,-0.12704,1,0
3,GO SYNAPSE ORGANIZATION,0.031957,-0.18685,-0.1395,1,0
3,GO RESPONSE TO POTASSIUM ION,0.040368,-0.18701,-0.25832,1,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.031957,-0.18897,-0.24584,1,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.046961,-0.19025,-0.12204,1,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.018736,-0.19037,-0.22204,1,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.011574,-0.19039,-0.22556,1,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.027226,-0.19058,-0.23204,1,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.031957,-0.19064,-0.24056,1,0
3,GO FEEDING BEHAVIOR,0.0040644,-0.19106,-0.18159,1,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.035953,-0.19162,-0.11842,1,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0066311,-0.19263,-0.21179,1,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.010101,-0.19277,-0.2047,1,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.026142,-0.19333,-0.16534,1,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.026142,-0.19492,-0.18895,1,0
3,GO NEURON MATURATION,0.046961,-0.1979,-0.13871,1,0
3,GO PEPTIDE HORMONE SECRETION,0.018736,-0.19804,-0.12889,1,0
3,GO NEURON MIGRATION,0.040368,-0.19825,-0.16576,1,0
3,GO NEURAL RETINA DEVELOPMENT,0.027226,-0.20102,-0.18562,1,0
3,GO INSULIN SECRETION,0.040368,-0.20103,-0.10814,1,0
3,GO AXO DENDRITIC TRANSPORT,0.011574,-0.20118,-0.20408,1,0
3,GO MAINTENANCE OF CELL POLARITY,0.027226,-0.2014,-0.1769,1,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.023112,-0.20254,-0.25589,1,0
3,GO KINETOCHORE ORGANIZATION,0.026142,-0.20255,-0.38506,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.023112,-0.2031,-0.12619,1,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.026142,-0.20339,-0.17545,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.038848,-0.20486,-0.18553,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.025096,-0.20507,-0.2773,1,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.040368,-0.20586,-0.15337,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.010572,-0.20644,-0.1495,1,0
3,GO REGULATION OF SYNAPSE MATURATION,0.019548,-0.20658,-0.3102,1,0
3,GO NOTCH RECEPTOR PROCESSING,0.027226,-0.20853,-0.19067,1,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.0063209,-0.2115,-0.3515,1,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.023112,-0.21224,-0.18331,1,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.021265,-0.2128,-0.20956,1,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0172,-0.21339,-0.20424,1,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.013235,-0.21341,-0.18375,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0066311,-0.21383,-0.24003,1,0
3,GO MICROTUBULE POLYMERIZATION,0.008797,-0.21519,-0.2094,1,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.017954,-0.21551,-0.26085,1,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.015104,-0.21574,-0.15064,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.019548,-0.21589,-0.14214,1,0
3,GO AXONAL TRANSPORT,0.0096484,-0.21718,-0.21115,1,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.011574,-0.21732,-0.1901,1,0
3,GO CELL JUNCTION MAINTENANCE,0.022172,-0.21782,-0.20394,1,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.013834,-0.21886,-0.20202,1,0
3,GO LOCOMOTORY BEHAVIOR,0.020391,-0.22119,-0.1663,1,0
3,GO SPINAL CORD DEVELOPMENT,0.043559,-0.22132,-0.17943,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.041938,-0.2217,-0.17772,1,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.035953,-0.22191,-0.13426,1,0
3,GO NEUROMUSCULAR PROCESS,0.017954,-0.22388,-0.17963,1,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0029965,-0.22616,-0.20023,1,0
3,GO REGULATION OF RESPONSE TO FOOD,0.021265,-0.22671,-0.23846,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.037377,-0.22799,-0.15133,1,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.007293,-0.22896,-0.21139,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0040644,-0.22936,-0.291,1,0
3,GO NERVE DEVELOPMENT,0.048745,-0.22996,-0.17109,1,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.023112,-0.23064,-0.22667,1,0
3,GO MICROTUBULE BUNDLE FORMATION,0.023112,-0.23393,-0.2083,1,0
3,GO SYNAPTIC VESICLE RECYCLING,0.0052065,-0.23474,-0.18368,1,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0017696,-0.23522,-0.2916,1,0
3,GO RESPONSE TO COCAINE,0.011063,-0.23536,-0.21253,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.040368,-0.23572,-0.18546,1,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00091199,-0.23629,-0.2673,1,0
3,GO VESICLE DOCKING,0.01266,-0.23706,-0.14683,1,0
3,GO SYNAPTIC SIGNALING,0.0066311,-0.23728,-0.19878,1,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0096484,-0.23729,-0.2144,1,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.0036751,-0.23751,-0.2096,1,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.035953,-0.23869,-0.18219,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0020776,-0.23879,-0.23366,1,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.052482,-0.23897,-0.1446,1,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.046961,-0.23992,-0.22789,1,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0080134,-0.24078,-0.21346,1,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0040644,-0.24097,-0.23456,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0017696,-0.24105,-0.25799,1,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.050584,-0.24319,-0.14366,1,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0040644,-0.24462,-0.24537,1,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0054671,-0.24629,-0.26802,1,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.007293,-0.24666,-0.21406,1,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0028457,-0.24702,-0.262,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0049572,-0.24888,-0.25919,1,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.019548,-0.25018,-0.27444,1,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.017954,-0.25142,-0.23568,1,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.0066311,-0.25156,-0.1917,1,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.040368,-0.25286,-0.18919,1,0
3,GO PRESYNAPSE ORGANIZATION,0.006955,-0.25459,-0.2223,1,0
3,GO REPRODUCTIVE BEHAVIOR,0.016475,-0.25522,-0.21627,1,0
3,GO OPTIC NERVE DEVELOPMENT,0.041938,-0.25645,-0.27112,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.037377,-0.25662,-0.31049,1,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0010798,-0.25678,-0.28322,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0018673,-0.25768,-0.26185,1,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0054671,-0.25779,-0.24981,1,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.018736,-0.25821,-0.2611,1,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.035953,-0.26087,-0.19384,1,0
3,GO DOPAMINE METABOLIC PROCESS,0.019548,-0.26414,-0.17541,1,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0063209,-0.26416,-0.23456,1,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.0040644,-0.2643,-0.33109,1,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.027226,-0.26582,-0.19283,1,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.0044907,-0.26629,-0.20526,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.026142,-0.26652,-0.2117,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.013834,-0.26813,-0.20631,1,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.030713,-0.26999,-0.17419,1,0
3,GO PROTEIN PALMITOYLATION,0.013834,-0.27071,-0.22388,1,0
3,GO INTRACILIARY TRANSPORT,0.025096,-0.27097,-0.22643,1,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0054671,-0.27124,-0.25574,1,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0036751,-0.27183,-0.26901,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0066311,-0.27186,-0.23677,1,0
3,GO SUCKLING BEHAVIOR,0.0042727,-0.27202,-0.30294,1,0
3,GO EXOCYTIC PROCESS,0.0092139,-0.27325,-0.19013,1,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.0029965,-0.27337,-0.21848,1,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0076456,-0.27435,-0.2295,1,0
3,GO EATING BEHAVIOR,0.0038653,-0.27518,-0.22543,1,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0060238,-0.27671,-0.25121,1,0
3,GO NEURONAL ACTION POTENTIAL,0.0042727,-0.27679,-0.24379,1,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.024086,-0.27793,-0.23422,1,0
3,GO DETECTION OF CALCIUM ION,0.007293,-0.27884,-0.22678,1,0
3,GO SYNAPSE ASSEMBLY,0.0092139,-0.27901,-0.2359,1,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.019548,-0.28295,-0.21247,1,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0028457,-0.28509,-0.31598,1,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0044907,-0.28527,-0.2634,1,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0023095,-0.28594,-0.27268,1,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.022172,-0.28956,-0.32618,1,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.035953,-0.29223,-0.17896,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.0013481,-0.29251,-0.27358,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.018736,-0.29469,-0.27676,1,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0057394,-0.29763,-0.24595,1,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.024086,-0.2998,-0.25393,1,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.0029965,-0.30268,-0.24498,1,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0092139,-0.30527,-0.36132,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.015104,-0.30543,-0.26198,1,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0012758,-0.31177,-0.29297,1,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00072571,-0.31246,-0.32926,1,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.030713,-0.31606,-0.19595,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0025648,-0.31701,-0.29165,1,0
3,GO SECRETORY GRANULE LOCALIZATION,0.006955,-0.31939,-0.28833,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.011574,-0.32121,-0.2917,1,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.024086,-0.32137,-0.25539,1,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0060238,-0.32256,-0.28224,1,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.007293,-0.32396,-0.3258,1,0
3,GO PARENTAL BEHAVIOR,0.0066311,-0.32448,-0.39221,1,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0038653,-0.32636,-0.35213,1,0
3,GO THALAMUS DEVELOPMENT,0.0020776,-0.32748,-0.33555,1,0
3,GO FOREBRAIN REGIONALIZATION,0.0092139,-0.32817,-0.28007,1,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0038653,-0.32917,-0.22341,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0063209,-0.33262,-0.26864,1,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00086166,-0.33264,-0.28912,1,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0083971,-0.33364,-0.33936,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0092139,-0.33401,-0.31839,1,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0049572,-0.33472,-0.28716,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.013834,-0.34055,-0.24787,1,0
3,GO GLUTAMATE SECRETION,0.0014241,-0.34118,-0.30817,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0060238,-0.34178,-0.2769,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.011063,-0.34216,-0.32722,1,0
3,GO REGULATION OF VESICLE FUSION,0.00048214,-0.34453,-0.34631,1,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.00076864,-0.34717,-0.29754,1,0
3,GO DIENCEPHALON DEVELOPMENT,0.0054671,-0.34752,-0.2489,1,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.026142,-0.34805,-0.3362,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0013481,-0.35138,-0.30247,1,0
3,GO RESPONSE TO ACETYLCHOLINE,0.0047188,-0.35195,-0.30235,1,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0028457,-0.3526,-0.30461,1,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.014457,-0.35536,-0.28533,1,0
3,GO NOREPINEPHRINE TRANSPORT,0.038848,-0.35764,-0.22738,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00096503,-0.35778,-0.31153,1,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.0060238,-0.36022,-0.28652,1,0
3,GO REFLEX,0.0083971,-0.36059,-0.28535,1,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.0018673,-0.36065,-0.2947,1,0
3,GO ADULT BEHAVIOR,0.0012758,-0.36242,-0.2749,1,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0023095,-0.36382,-0.31882,1,0
3,GO CGMP METABOLIC PROCESS,0.007293,-0.36907,-0.30228,1,0
3,GO VOCALIZATION BEHAVIOR,0.012106,-0.37521,-0.31174,1,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.007293,-0.37629,-0.31266,1,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.0047188,-0.37813,-0.35521,1,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00029789,-0.3853,-0.32002,1,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00091199,-0.38693,-0.36621,1,0
3,GO REGULATION OF MICROTUBULE BINDING,0.0010798,-0.38777,-0.32613,1,0
3,GO TELENCEPHALON REGIONALIZATION,0.0047188,-0.38825,-0.34699,1,0
3,GO NEURON FATE COMMITMENT,0.0021907,-0.38837,-0.32836,1,0
3,GO DENDRITIC TRANSPORT,0.0012758,-0.38882,-0.43246,1,0
3,GO PROTEIN POLYGLUTAMYLATION,0.0016767,-0.38907,-0.32672,1,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0015882,-0.39032,-0.2788,1,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0024341,-0.39034,-0.33682,1,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0014241,-0.39039,-0.36059,1,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0034935,-0.39266,-0.39158,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.034576,-0.39556,-0.2501,1,0
3,GO SYNAPSE MATURATION,0.010572,-0.39566,-0.34206,1,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0042727,-0.39602,-0.31161,1,0
3,GO SPINAL CORD PATTERNING,0.0021907,-0.3962,-0.37006,1,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00086166,-0.39745,-0.32261,1,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.022172,-0.39899,-0.29202,1,0
3,GO NEUROTRANSMITTER TRANSPORT,0.00072571,-0.40177,-0.31694,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.0012071,-0.40723,-0.38006,1,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.01266,-0.415,-0.40292,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.0027019,-0.41825,-0.37041,1,0
3,GO DENDRITE EXTENSION,0.00086166,-0.4184,-0.36647,1,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00048214,-0.41885,-0.369,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00076864,-0.423,-0.3882,1,0
3,GO CATECHOLAMINE UPTAKE,0.0023095,-0.42375,-0.3586,1,0
3,GO MONOAMINE TRANSPORT,0.0025648,-0.42616,-0.29975,1,0
3,GO AMINE TRANSPORT,0.0003797,-0.42779,-0.34875,1,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.041938,-0.42915,-0.27909,1,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00048214,-0.42977,-0.37672,1,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00051151,-0.43737,-0.37992,1,0
3,GO RESPONSE TO INSECTICIDE,5.2428e-05,-0.43762,-0.42353,1,0
3,GO PITUITARY GLAND DEVELOPMENT,0.0029965,-0.43904,-0.33534,1,0
3,GO NEUROTRANSMITTER SECRETION,0.0003797,-0.44065,-0.36596,1,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00048214,-0.44392,-0.39558,1,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.0060238,-0.44787,-0.29881,1,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0057394,-0.44966,-0.38537,1,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0027019,-0.4618,-0.40595,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00076864,-0.46203,-0.45449,1,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0019699,-0.46936,-0.46087,1,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.010572,-0.47635,-0.32328,1,0
3,GO GANGLION DEVELOPMENT,0.0023095,-0.47697,-0.40411,1,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.014457,-0.48842,-0.37138,1,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.00045436,-0.48981,-0.47103,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0011418,-0.49481,-0.46358,1,0
3,GO STARTLE RESPONSE,0.00045436,-0.49649,-0.43559,1,0
3,GO SYNAPTIC VESICLE PRIMING,0.0003797,-0.49959,-0.4174,1,0
3,GO GROWTH HORMONE SECRETION,0.0021907,-0.50062,-0.39332,1,0
3,GO PROTEIN LOCALIZATION TO AXON,0.0028457,-0.50146,-0.4129,1,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00332,-0.50383,-0.40456,1,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00060992,-0.50428,-0.43663,1,0
3,GO REGULATION OF DENDRITE EXTENSION,0.00060992,-0.50716,-0.42906,1,0
3,GO GLIAL CELL FATE COMMITMENT,0.0027019,-0.50743,-0.43796,1,0
3,GO DOPAMINE TRANSPORT,0.00017019,-0.51151,-0.45759,1,0
3,GO REGULATION OF DOPAMINE SECRETION,0.00011593,-0.52238,-0.50177,1,0
3,GO NEURON CELL CELL ADHESION,0.00023283,-0.53295,-0.5128,1,0
3,GO INNERVATION,0.0014241,-0.5383,-0.4611,1,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00057531,-0.5464,-0.50604,1,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00060992,-0.54951,-0.45997,1,0
3,GO PREPULSE INHIBITION,0.0012758,-0.56419,-0.45465,1,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00042807,-0.56425,-0.43585,1,0
3,GO CATECHOLAMINE SECRETION,0.00020554,-0.56476,-0.43769,1,0
3,GO NOSE DEVELOPMENT,0.0080134,-0.56905,-0.43758,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00068502,-0.56964,-0.49039,1,0
3,GO DENSE CORE GRANULE TRANSPORT,0.00024771,-0.57035,-0.60243,1,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00051151,-0.57075,-0.50529,1,0
3,GO MECHANOSENSORY BEHAVIOR,0.0020776,-0.57298,-0.42015,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0024341,-0.5801,-0.488,1,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00028019,-0.58025,-0.50331,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00026348,-0.59,-0.4844,1,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0003797,-0.59413,-0.48724,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00086166,-0.61133,-0.53147,1,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.00096503,-0.61231,-0.55823,1,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00064645,-0.61427,-0.56583,1,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00019306,-0.61804,-0.56279,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00076864,-0.62183,-0.4981,1,0
3,GO NEURON FATE SPECIFICATION,0.00023283,-0.63169,-0.557,1,0
3,GO SYNAPTIC VESICLE DOCKING,0.00021879,-0.63695,-0.61213,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00031664,-0.64604,-0.49728,1,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00028019,-0.65772,-0.57049,1,0
3,GO SYNAPTIC VESICLE MATURATION,8.3641e-05,-0.67194,-0.60626,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,9.5377e-05,-0.68102,-0.68309,1,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00033648,-0.70184,-0.59722,1,0
3,GO PONS DEVELOPMENT,0.0013481,-0.78513,-0.70734,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00020554,-0.79519,-0.66885,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,6.4139e-05,-0.84381,-0.76486,1,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,8.3641e-05,-0.87588,-0.74408,1,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00012367,-1.057,-0.86802,1,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.054439,0.30852,0.28104,0,1
3,GO RESPONSE TO CORTICOSTERONE,0.062884,0.29944,0.21788,0,1
3,GO POLYOL TRANSPORT,0.08588,0.26509,0.18558,0,1
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.08303,0.25922,0.19992,0,1
3,GO CYTOPLASM ORGANIZATION,0.14312,0.25734,0.23468,0,1
3,GO REGULATION OF TRANSPOSITION,0.10811,0.24021,0.14984,0,1
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.077559,0.24021,0.22601,0,1
3,GO PROTEIN O LINKED GLYCOSYLATION,0.058535,0.23778,0.14676,0,1
3,GO HEAD MORPHOGENESIS,0.080256,0.23606,0.207,0,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.13467,0.23516,0.15865,0,1
3,GO HIPPO SIGNALING,0.060677,0.22549,0.20687,0,1
3,GO ENDODERMAL CELL FATE COMMITMENT,0.060677,0.22127,0.17768,0,1
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.058535,0.22057,0.20857,0,1
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.062884,0.21836,0.23214,0,1
3,GO TRANSPOSITION,0.11894,0.21754,0.13602,0,1
3,GO KERATINIZATION,0.062884,0.21429,0.15046,0,1
3,GO L SERINE METABOLIC PROCESS,0.24463,0.20987,0.062006,0,1
3,GO HISTONE H3 K4 TRIMETHYLATION,0.2259,0.2077,0.1644,0,1
3,GO ECTODERM DEVELOPMENT,0.14312,0.20478,0.10027,0,1
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.091819,0.20339,0.15907,0,1
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.28529,0.20276,0.09964,0,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.080256,0.2019,0.13867,0,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.197,0.20103,0.11443,0,1
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.091819,0.19847,0.17384,0,1
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.074935,0.19654,0.16372,0,1
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.067497,0.19582,0.17954,0,1
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.080256,0.19526,0.17752,0,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.056456,0.19449,0.2159,0,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.058535,0.1934,0.24581,0,1
3,GO LYSOSOME LOCALIZATION,0.10811,0.19178,0.16554,0,1
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.10468,0.18733,0.21559,0,1
3,GO SEGMENT SPECIFICATION,0.12273,0.18568,0.16916,0,1
3,GO RESPONSE TO UV C,0.062884,0.18351,0.1704,0,1
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.72171,0.1835,-0.0040163,0,1
3,GO NCRNA CATABOLIC PROCESS,0.11163,0.18269,0.11912,0,1
3,GO XENOBIOTIC TRANSPORT,0.080256,0.18119,0.17107,0,1
3,GO REGULATION OF WATER LOSS VIA SKIN,0.11163,0.18038,0.10837,0,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.072385,0.17979,0.16205,0,1
3,GO REGULATION OF HIPPO SIGNALING,0.17091,0.17671,0.14949,0,1
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.058535,0.17607,0.19323,0,1
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.43329,0.17471,0.090452,0,1
3,GO SPINDLE MIDZONE ASSEMBLY,0.40594,0.17257,-0.0086509,0,1
3,GO DNA METHYLATION,0.18102,0.17244,0.083333,0,1
3,GO BASEMENT MEMBRANE ASSEMBLY,0.098083,0.17149,0.24327,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.20256,0.16887,0.12763,0,1
3,GO NADPH REGENERATION,0.056456,0.16844,0.1359,0,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.14312,0.16742,0.13939,0,1
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.058535,0.16546,0.17593,0,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.17091,0.16474,0.054178,0,1
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.10134,0.16463,0.10658,0,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.091819,0.1645,0.18906,0,1
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.094909,0.1638,0.10906,0,1
3,GO BODY MORPHOGENESIS,0.13885,0.16034,0.15625,0,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.060677,0.15962,0.19595,0,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.21989,0.15862,0.073467,0,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.11524,0.15815,0.097409,0,1
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.062884,0.15759,0.1705,0,1
3,GO REGULATION OF URINE VOLUME,0.058535,0.15686,0.21195,0,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.074935,0.15627,0.13221,0,1
3,GO REGULATION OF CELLULAR PH,0.080256,0.1543,0.12084,0,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.062884,0.15429,0.14931,0,1
3,GO LIPID DIGESTION,0.12662,0.15353,0.16795,0,1
3,GO GLUTAMINE METABOLIC PROCESS,0.10468,0.15264,0.104,0,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.10134,0.15263,0.13809,0,1
3,GO DEFINITIVE HEMOPOIESIS,0.074935,0.15239,0.21704,0,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.10134,0.1507,0.14591,0,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.11894,0.15035,0.13352,0,1
3,GO PARTURITION,0.08881,0.1502,0.1676,0,1
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.08588,0.15011,0.16304,0,1
3,GO PROTEIN TARGETING TO LYSOSOME,0.14312,0.14883,0.1376,0,1
3,GO ENDOCYTIC RECYCLING,0.094909,0.14857,0.16012,0,1
3,GO TRNA CATABOLIC PROCESS,0.44264,0.14785,0.091911,0,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11524,0.14781,0.12298,0,1
3,GO MYOFIBRIL ASSEMBLY,0.060677,0.14773,0.17983,0,1
3,GO RESPONSE TO PARATHYROID HORMONE,0.17091,0.14762,0.13901,0,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.094909,0.14694,0.11145,0,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.067497,0.14688,0.18357,0,1
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.067497,0.1466,0.158,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.12662,0.14619,0.12172,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.11163,0.14483,0.099358,0,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.067497,0.1445,0.11063,0,1
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.1306,0.14331,0.1417,0,1
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.13467,0.14299,0.14648,0,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.13885,0.14281,0.13898,0,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.11894,0.1424,0.056773,0,1
3,GO CARDIAC SEPTUM DEVELOPMENT,0.065157,0.14205,0.191,0,1
3,GO STEROL BIOSYNTHETIC PROCESS,0.10811,0.14205,0.12672,0,1
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.10134,0.14176,0.1317,0,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.10811,0.14162,0.16476,0,1
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.11894,0.14162,0.11058,0,1
3,GO NEUROBLAST DIVISION,0.074935,0.13876,0.16924,0,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.058535,0.13772,0.14538,0,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.20256,0.137,0.10358,0,1
3,GO CHONDROCYTE DIFFERENTIATION,0.058535,0.13653,0.21034,0,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.060677,0.13643,0.10852,0,1
3,GO DNA MODIFICATION,0.15197,0.13637,0.085959,0,1
3,GO MIRNA METABOLIC PROCESS,0.23203,0.13607,0.10718,0,1
3,GO RESPONSE TO MECHANICAL STIMULUS,0.08588,0.13551,0.16179,0,1
3,GO SARCOMERE ORGANIZATION,0.072385,0.13457,0.14682,0,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10134,0.13443,0.092176,0,1
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.19156,0.13428,0.13102,0,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.067497,0.13378,0.22133,0,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.3148,0.13378,0.1172,0,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.29248,0.1336,0.06894,0,1
3,GO SEGMENTATION,0.1306,0.13275,0.13483,0,1
3,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.067497,0.13263,0.13516,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.10134,0.13259,0.10421,0,1
3,GO RRNA METHYLATION,0.091819,0.13241,0.095389,0,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.10134,0.13238,0.10216,0,1
3,GO REGULATION OF VASCULOGENESIS,0.094909,0.13177,0.23667,0,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.08881,0.13138,0.14585,0,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.16602,0.1309,0.12037,0,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.056456,0.13035,0.16344,0,1
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.058535,0.12862,0.17052,0,1
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065157,0.12647,0.13744,0,1
3,GO GALACTOSE METABOLIC PROCESS,0.056456,0.12525,0.17745,0,1
3,GO CELLULAR RESPONSE TO UV,0.080256,0.12513,0.12229,0,1
3,GO HISTONE H2B UBIQUITINATION,0.35442,0.12512,0.071137,0,1
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.094909,0.12457,0.12202,0,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.19156,0.12423,0.11867,0,1
3,GO ALDITOL METABOLIC PROCESS,0.17591,0.12357,0.052741,0,1
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.10811,0.12228,0.14332,0,1
3,GO COPII COATED VESICLE CARGO LOADING,0.074935,0.12202,0.1377,0,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.058535,0.12124,0.13895,0,1
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.067497,0.12123,0.13013,0,1
3,GO HEART MORPHOGENESIS,0.08303,0.12079,0.16862,0,1
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.10811,0.12064,0.089296,0,1
3,GO VIRAL RNA GENOME REPLICATION,0.197,0.12053,0.09506,0,1
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.065157,0.12032,0.13681,0,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.091819,0.12018,0.12733,0,1
3,GO QUINONE METABOLIC PROCESS,0.056456,0.11966,0.083377,0,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.34626,0.11939,0.04763,0,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.197,0.11896,0.041079,0,1
3,GO DENDRITIC SPINE MAINTENANCE,0.08881,0.11838,0.17802,0,1
3,GO V D J RECOMBINATION,0.214,0.11828,0.10806,0,1
3,GO REGULATION OF PROTEIN BINDING,0.12273,0.11821,0.13473,0,1
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.49108,0.11755,0.081804,0,1
3,GO REGULATION OF ENDOCYTOSIS,0.08303,0.1173,0.14622,0,1
3,GO DNA DEMETHYLATION,0.14312,0.11714,0.13008,0,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.072385,0.11638,0.092232,0,1
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.26442,0.11626,0.083258,0,1
3,GO AUTOPHAGY OF NUCLEUS,0.098083,0.11595,0.13534,0,1
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.11524,0.11562,0.11828,0,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.08588,0.11517,0.12661,0,1
3,GO REGULATION OF TELOMERASE ACTIVITY,0.10468,0.11515,0.08548,0,1
3,GO HISTONE H3 ACETYLATION,0.30724,0.11484,0.087071,0,1
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.11163,0.11454,0.077722,0,1
3,GO RNA MODIFICATION,0.077559,0.114,0.10335,0,1
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.19156,0.11384,0.14648,0,1
3,GO LYTIC VACUOLE ORGANIZATION,0.1475,0.11382,0.12785,0,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.21989,0.1137,0.084964,0,1
3,GO REPLICATIVE SENESCENCE,0.18624,0.11303,0.11815,0,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.11524,0.11293,0.16292,0,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.12662,0.11292,0.10427,0,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.15197,0.11241,0.15115,0,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.069906,0.1118,0.13648,0,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.11894,0.11175,0.1247,0,1
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.214,0.11152,0.12927,0,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.08588,0.11137,0.13307,0,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.069906,0.11118,0.13806,0,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.34626,0.11116,0.048628,0,1
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.11894,0.11094,0.10886,0,1
3,GO RNA METHYLATION,0.214,0.11088,0.085807,0,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.1475,0.11084,0.12801,0,1
3,GO REGULATION OF PH,0.10468,0.11058,0.10646,0,1
3,GO ADAPTIVE THERMOGENESIS,0.10811,0.11049,0.12968,0,1
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.37111,0.11039,0.068879,0,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.08303,0.11026,0.15339,0,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.094909,0.10988,0.15566,0,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.094909,0.10964,0.126,0,1
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.10811,0.10928,0.16885,0,1
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.11894,0.10915,0.1364,0,1
3,GO SNORNA METABOLIC PROCESS,0.24463,0.10847,0.027993,0,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.23203,0.10807,0.12591,0,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.072385,0.10775,0.14736,0,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.058535,0.10756,0.15395,0,1
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.17591,0.10741,0.11206,0,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12273,0.10725,0.086404,0,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.12662,0.10689,0.087297,0,1
3,GO APICAL JUNCTION ASSEMBLY,0.214,0.10681,0.11528,0,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.077559,0.10668,0.18921,0,1
3,GO LIPID PHOSPHORYLATION,0.077559,0.10643,0.15817,0,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.062884,0.10531,0.18427,0,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.7336,0.10526,0.063545,0,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.08303,0.10502,0.16783,0,1
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.067497,0.10486,0.13872,0,1
3,GO PROTEIN IMPORT,0.15655,0.10444,0.09812,0,1
3,GO HISTONE DEACETYLATION,0.43329,0.10442,0.067227,0,1
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.062884,0.1044,0.15052,0,1
3,GO REGULATION OF GENE SILENCING,0.16602,0.10422,0.097894,0,1
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.065157,0.10392,0.16082,0,1
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.42405,0.10352,0.04248,0,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.072385,0.1035,0.14499,0,1
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.094909,0.10331,0.089159,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.34626,0.10287,0.066622,0,1
3,GO BLASTOCYST GROWTH,0.38829,0.10216,0.061103,0,1
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.32248,0.10182,0.080522,0,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.20822,0.10136,0.097413,0,1
3,GO TRNA 5 LEADER REMOVAL,0.33821,0.10112,0.028861,0,1
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.32248,0.10088,0.096862,0,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.12662,0.10082,0.10828,0,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.065157,0.10075,0.11007,0,1
3,GO TEMPERATURE HOMEOSTASIS,0.062884,0.10048,0.14383,0,1
3,GO RESPONSE TO WATER,0.16602,0.10013,0.14735,0,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.080256,0.099965,0.14525,0,1
3,GO MAMMARY GLAND DEVELOPMENT,0.098083,0.099774,0.16649,0,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.17091,0.09962,0.11033,0,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.27126,0.099604,0.062298,0,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.3148,0.099508,0.045989,0,1
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.81845,0.099255,0.046636,0,1
3,GO MULTI ORGANISM LOCALIZATION,0.12273,0.099228,0.074909,0,1
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.1475,0.098948,0.13592,0,1
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.12273,0.098747,0.13004,0,1
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.42405,0.098615,0.11292,0,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.23203,0.098387,0.067263,0,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.065157,0.098158,0.089602,0,1
3,GO GDP METABOLIC PROCESS,0.074935,0.097024,0.17487,0,1
3,GO RETINA HOMEOSTASIS,0.08303,0.096973,0.093179,0,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.27126,0.096616,0.10231,0,1
3,GO METHYLATION,0.52145,0.09655,0.042996,0,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.12273,0.096517,0.11009,0,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.091819,0.09645,0.14903,0,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.40594,0.096131,0.043029,0,1
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.074935,0.096062,0.17506,0,1
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.18102,0.09598,0.14045,0,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.054439,0.095692,0.10789,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.29248,0.095457,0.038418,0,1
3,GO SPERM EGG RECOGNITION,0.077559,0.095431,0.11333,0,1
3,GO NEURAL TUBE FORMATION,0.3148,0.095334,0.096868,0,1
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.077559,0.095323,0.13459,0,1
3,GO MODIFIED AMINO ACID TRANSPORT,0.072385,0.095201,0.15172,0,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.2259,0.095089,0.081389,0,1
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.10134,0.094789,0.13837,0,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.27821,0.094114,0.056618,0,1
3,GO CARBOHYDRATE TRANSPORT,0.13467,0.093841,0.12022,0,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.1306,0.09378,0.11746,0,1
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.12273,0.093046,0.13005,0,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.40594,0.092498,0.090648,0,1
3,GO DNA DEALKYLATION,0.20256,0.092076,0.11293,0,1
3,GO PROTEIN POLYUBIQUITINATION,0.41494,0.09202,0.065105,0,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.10134,0.091999,0.10117,0,1
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.1475,0.091581,0.082704,0,1
3,GO IMPORT INTO NUCLEUS,0.214,0.091485,0.084056,0,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.197,0.090491,0.084032,0,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.062884,0.090229,0.13296,0,1
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.37964,0.089981,0.054083,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.56341,0.089749,0.020317,0,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.065157,0.089673,0.13602,0,1
3,GO GENE SILENCING,0.33821,0.088897,0.062191,0,1
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.094909,0.08875,0.11999,0,1
3,GO RNA INTERFERENCE,0.37964,0.08852,0.06882,0,1
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.40594,0.088483,0.061775,0,1
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.10134,0.088481,0.1005,0,1
3,GO TISSUE MORPHOGENESIS,0.094909,0.088142,0.14102,0,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.072385,0.087991,0.11503,0,1
3,GO CELLULAR RESPONSE TO RADIATION,0.10468,0.087788,0.10724,0,1
3,GO INTRACELLULAR MRNA LOCALIZATION,0.056456,0.08774,0.15907,0,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.53179,0.087725,0.066697,0,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.056456,0.087546,0.16696,0,1
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.091819,0.087498,0.15162,0,1
3,GO MALE SEX DIFFERENTIATION,0.12273,0.087185,0.12276,0,1
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.058535,0.086843,0.1243,0,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.074935,0.086291,0.1412,0,1
3,GO RESPONSE TO ACTIVITY,0.10811,0.086259,0.12175,0,1
3,GO REGULATION OF GLUCOSE IMPORT,0.37964,0.086218,0.070093,0,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.11163,0.086114,0.12573,0,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.18624,0.086001,0.11587,0,1
3,GO GOLGI RIBBON FORMATION,0.23203,0.085985,0.12716,0,1
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.069906,0.085968,0.11737,0,1
3,GO REGULATION OF DNA RECOMBINATION,0.3148,0.085695,0.075874,0,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.15655,0.085689,0.11693,0,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.08303,0.085644,0.13379,0,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.60692,0.085462,0.057313,0,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.197,0.085324,0.1124,0,1
3,GO PIRNA METABOLIC PROCESS,0.65188,0.085194,0.036813,0,1
3,GO REGULATION OF CATABOLIC PROCESS,0.072385,0.084908,0.11222,0,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.32248,0.084901,0.085199,0,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.072385,0.084851,0.1561,0,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.27821,0.084791,0.088126,0,1
3,GO EPITHELIAL TUBE FORMATION,0.2998,0.084312,0.097427,0,1
3,GO TUBE FORMATION,0.2259,0.084176,0.10733,0,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.08588,0.083926,0.13854,0,1
3,GO SPLEEN DEVELOPMENT,0.098083,0.083877,0.12667,0,1
3,GO RNA STABILIZATION,0.15197,0.082947,0.085627,0,1
3,GO RESPONSE TO UV,0.38829,0.08287,0.074067,0,1
3,GO THYMUS DEVELOPMENT,0.080256,0.081347,0.1262,0,1
3,GO MRNA CLEAVAGE,0.34626,0.081298,0.0693,0,1
3,GO REGULATION OF PROTEIN STABILITY,0.12273,0.081251,0.096534,0,1
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.44264,0.081117,0.048551,0,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.094909,0.080904,0.10567,0,1
3,GO PLASMA MEMBRANE TUBULATION,0.214,0.080709,0.14987,0,1
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.30724,0.080424,0.10139,0,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.23827,0.079979,0.079126,0,1
3,GO PROTEIN KINASE A SIGNALING,0.23827,0.079488,0.1027,0,1
3,GO REGULATION OF CELL DIFFERENTIATION,0.15655,0.079463,0.12471,0,1
3,GO SULFUR COMPOUND TRANSPORT,0.26442,0.079294,0.089577,0,1
3,GO L GLUTAMATE IMPORT,0.27126,0.079199,0.10583,0,1
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.25111,0.079161,0.11567,0,1
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.08303,0.078987,0.11616,0,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.12662,0.078538,0.11608,0,1
3,GO VIRAL GENE EXPRESSION,0.11894,0.07842,0.060022,0,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.99368,0.078352,0.018201,0,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.14312,0.077943,0.070217,0,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.062884,0.077561,0.15553,0,1
3,GO VACUOLE ORGANIZATION,0.077559,0.077297,0.12317,0,1
3,GO CELL AGING,0.16602,0.076823,0.10809,0,1
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.33821,0.07639,0.086118,0,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.08881,0.076202,0.16982,0,1
3,GO CHROMATIN DISASSEMBLY,0.50109,0.076128,0.06203,0,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.16602,0.076044,0.12041,0,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.12273,0.075832,0.098213,0,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.61803,0.075778,0.047015,0,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.23203,0.075534,0.09028,0,1
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.17591,0.075353,0.11905,0,1
3,GO EPITHELIUM DEVELOPMENT,0.12662,0.074977,0.11655,0,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.074935,0.074924,0.13314,0,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.21989,0.074596,0.080229,0,1
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.10811,0.074273,0.12462,0,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.1475,0.074249,0.10955,0,1
3,GO RESPONSE TO INSULIN,0.11163,0.074209,0.12493,0,1
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.36271,0.07409,0.040217,0,1
3,GO RESPONSE TO RADIATION,0.38829,0.07381,0.07152,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.4521,0.073695,0.054285,0,1
3,GO PH REDUCTION,0.62923,0.073632,0.040865,0,1
3,GO GLUCOSE IMPORT,0.33029,0.073365,0.080695,0,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.065157,0.073278,0.099921,0,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.55277,0.073266,0.049278,0,1
3,GO MAINTENANCE OF CELL NUMBER,0.27821,0.072476,0.11078,0,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.44264,0.072247,0.049584,0,1
3,GO MACROMOLECULE CATABOLIC PROCESS,0.17091,0.072158,0.089388,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.20256,0.072033,0.10448,0,1
3,GO REGULATION OF CELL AGING,0.40594,0.071906,0.041307,0,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.12662,0.071506,0.12381,0,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.23203,0.071493,0.10976,0,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.2577,0.071321,0.10032,0,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.12273,0.071253,0.13612,0,1
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.197,0.070747,0.10193,0,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.15655,0.070674,0.13615,0,1
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.24463,0.070613,0.097334,0,1
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.214,0.070539,0.097189,0,1
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.52145,0.070454,0.055012,0,1
3,GO RESPONSE TO HEAT,0.23203,0.070404,0.082778,0,1
3,GO VIRAL TRANSLATION,0.10811,0.070069,0.099315,0,1
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.08881,0.070045,0.13497,0,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.08881,0.070018,0.11974,0,1
3,GO MACROMOLECULE DEACYLATION,0.60692,0.069677,0.053371,0,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.20256,0.069124,0.13624,0,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.14312,0.069121,0.084516,0,1
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.46168,0.069046,0.06864,0,1
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.27126,0.068882,0.085602,0,1
3,GO RNA 5 END PROCESSING,0.17591,0.068311,0.053907,0,1
3,GO MATURATION OF SSU RRNA,0.1306,0.068193,0.061738,0,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.197,0.06818,0.11338,0,1
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.41494,0.06808,0.050555,0,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.54223,0.067579,0.048759,0,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.214,0.067503,0.1161,0,1
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.57414,0.067463,0.029737,0,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.61803,0.067436,0.068848,0,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.2998,0.067227,0.093763,0,1
3,GO CELLULAR SENESCENCE,0.26442,0.066946,0.084319,0,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.25111,0.066565,0.099697,0,1
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.19156,0.066302,0.098779,0,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.12662,0.065874,0.12505,0,1
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.26442,0.06554,0.11257,0,1
3,GO ENDOSOMAL TRANSPORT,0.30724,0.065538,0.083144,0,1
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.46168,0.065394,0.062619,0,1
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.17091,0.065388,0.095139,0,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.10134,0.065241,0.13381,0,1
3,GO CANONICAL WNT SIGNALING PATHWAY,0.41494,0.065218,0.099212,0,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.13467,0.065102,0.11936,0,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.1306,0.065075,0.1177,0,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33029,0.064255,0.091854,0,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.058535,0.06394,0.13709,0,1
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.43329,0.063231,0.10718,0,1
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24463,0.063078,0.082286,0,1
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.094909,0.062905,0.1142,0,1
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.16123,0.06282,0.13646,0,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.32248,0.062662,0.088745,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.70989,0.062582,0.024785,0,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.25111,0.062166,0.10273,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.18624,0.062096,0.10352,0,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.197,0.061825,0.096635,0,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.2998,0.06146,0.044539,0,1
3,GO ANIMAL ORGAN MORPHOGENESIS,0.26442,0.061457,0.11484,0,1
3,GO RRNA TRANSCRIPTION,0.57414,0.06144,0.03004,0,1
3,GO REGULATION OF AUTOPHAGY,0.17591,0.060944,0.10212,0,1
3,GO GTP BIOSYNTHETIC PROCESS,0.27126,0.060529,0.068287,0,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.28529,0.060249,0.068879,0,1
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.43329,0.060176,0.075484,0,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.13467,0.060146,0.10344,0,1
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.37964,0.059884,0.046449,0,1
3,GO SNRNA PROCESSING,0.47137,0.059748,0.027398,0,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.23203,0.059621,0.096385,0,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.23827,0.059568,0.089307,0,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.16123,0.059562,0.099157,0,1
3,GO PIGMENT METABOLIC PROCESS,0.197,0.059306,0.085189,0,1
3,GO INNER CELL MASS CELL PROLIFERATION,0.58498,0.059225,-0.0099608,0,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.30724,0.058932,0.10311,0,1
3,GO NUCLEAR TRANSPORT,0.47137,0.057678,0.047194,0,1
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.10468,0.057187,0.13651,0,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.10468,0.056736,0.12244,0,1
3,GO GOLGI VESICLE TRANSPORT,0.38829,0.056735,0.068538,0,1
3,GO PROTEIN STABILIZATION,0.27126,0.056643,0.079687,0,1
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.30724,0.056616,0.066428,0,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.33029,0.056472,0.031542,0,1
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.56341,0.056222,0.066662,0,1
3,GO LYSOSOMAL TRANSPORT,0.37964,0.055041,0.093677,0,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.33029,0.054898,0.047755,0,1
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.11163,0.054772,0.1023,0,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.27821,0.054636,0.034487,0,1
3,GO PROTEIN CATABOLIC PROCESS,0.33821,0.054353,0.08,0,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.43329,0.054196,0.011114,0,1
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.17591,0.054084,0.093117,0,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20822,0.054028,0.11852,0,1
3,GO RNA CATABOLIC PROCESS,0.091819,0.053803,0.062579,0,1
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.34626,0.053747,0.074127,0,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.18102,0.053149,0.067102,0,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.42405,0.052687,0.065831,0,1
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.37964,0.052201,0.083743,0,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.26442,0.052106,0.09692,0,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.10811,0.050671,0.11288,0,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.15655,0.050415,0.087182,0,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.69814,0.049528,0.051606,0,1
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.3148,0.049488,0.11328,0,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.32248,0.049488,0.089616,0,1
3,GO CYTOKINETIC PROCESS,0.80618,0.049284,-0.016049,0,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.069906,0.0492,0.074659,0,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.42405,0.048803,0.068784,0,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.17591,0.048627,0.087967,0,1
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.2577,0.048436,0.083594,0,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.29248,0.047508,0.056736,0,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.60692,0.047446,0.048974,0,1
3,GO RIBOSOME BIOGENESIS,0.20822,0.047249,0.049128,0,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.18102,0.046444,0.094277,0,1
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.81845,0.046348,0.0402,0,1
3,GO MACROAUTOPHAGY,0.27821,0.042856,0.072889,0,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.3148,0.042412,0.087399,0,1
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.56341,0.042386,0.064534,0,1
3,GO ENDOSOME ORGANIZATION,0.20822,0.042372,0.084883,0,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.16602,0.041971,0.071806,0,1
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.3148,0.041616,0.09496,0,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.35442,0.041288,0.069905,0,1
3,GO VIRION ASSEMBLY,0.15197,0.041191,0.072204,0,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.2259,0.039731,0.1067,0,1
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.57414,0.039641,0.042153,0,1
3,GO EMBRYONIC MORPHOGENESIS,0.37111,0.037082,0.10329,0,1
3,GO REGULATION OF MACROAUTOPHAGY,0.37111,0.036982,0.071592,0,1
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.19156,0.03692,0.10113,0,1
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.214,0.035751,0.062799,0,1
3,GO REGULATION OF DNA METABOLIC PROCESS,0.64051,0.035735,0.039939,0,1
3,GO MEMBRANE ORGANIZATION,0.46168,0.035533,0.077304,0,1
3,GO VACUOLAR TRANSPORT,0.37111,0.035057,0.080935,0,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.35442,0.034521,0.072672,0,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.26442,0.033245,0.041217,0,1
3,GO DEPHOSPHORYLATION,0.46168,0.032336,0.070915,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.4521,0.03089,0.090536,0,1
3,GO PEPTIDYL SERINE MODIFICATION,0.79394,0.030803,0.061978,0,1
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.85555,0.030479,0.0015252,0,1
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.33821,0.030147,0.079436,0,1
3,GO TRANSLATIONAL INITIATION,0.4521,0.026802,0.031909,0,1
3,GO CYTOSKELETON ORGANIZATION,0.93062,0.026296,0.049902,0,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.83078,0.024774,0.034357,0,1
3,GO EOSINOPHIL MIGRATION,0.0011418,0.77242,0.72978,0,0
3,GO EOSINOPHIL CHEMOTAXIS,0.00091199,0.72974,0.70523,0,0
3,GO OPSONIZATION,0.0015041,0.64657,0.57786,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.00060992,0.61267,0.58259,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0011418,0.49122,0.53804,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.024086,0.41883,0.30606,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.0031545,0.37516,0.34597,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.017954,0.32894,0.30067,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0038653,0.30459,0.39358,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.025096,0.30328,0.32525,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0080134,0.29421,0.34922,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.013235,0.27944,0.28864,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.01266,0.2753,0.27584,0,0
3,GO RESPONSE TO VITAMIN D,0.0066311,0.26528,0.27592,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.020391,0.26473,0.22516,0,0
3,GO ENDOTHELIAL CELL MIGRATION,0.0028457,0.26203,0.31993,0,0
3,GO EPITHELIAL CELL CELL ADHESION,0.062884,0.25608,0.22997,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.011063,0.25094,0.28297,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00091199,0.25056,0.39609,0,0
3,GO VASCULOGENESIS,0.0076456,0.25015,0.31162,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0014241,0.24954,0.42097,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.045233,0.24738,0.31807,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0024341,0.2456,0.37523,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.010572,0.24542,0.38347,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0054671,0.24541,0.30793,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.031957,0.24219,0.20085,0,0
3,GO BIOLOGICAL PHASE,0.035953,0.24185,0.28206,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.23203,0.24024,0.20921,0,0
3,GO REGULATION OF RESPIRATORY BURST,0.10468,0.23975,0.16227,0,0
3,GO OXYGEN TRANSPORT,0.214,0.23866,0.15844,0,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.10134,0.23822,0.26602,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0057394,0.2333,0.38849,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.013235,0.23229,0.29827,0,0
3,GO RESPONSE TO PROGESTERONE,0.0057394,0.23197,0.26729,0,0
3,GO PROSTAGLANDIN SECRETION,0.028348,0.23186,0.2571,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.0031545,0.22954,0.27304,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.08303,0.22891,0.24403,0,0
3,GO POSITIVE CHEMOTAXIS,0.0015882,0.2289,0.3392,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.027226,0.22845,0.28164,0,0
3,GO MYOBLAST DIFFERENTIATION,0.0017696,0.22815,0.26461,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.006955,0.22631,0.23803,0,0
3,GO SPROUTING ANGIOGENESIS,0.0020776,0.22389,0.33397,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.014457,0.22379,0.36924,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.028348,0.22108,0.22255,0,0
3,GO REGULATION OF ODONTOGENESIS,0.0092139,0.21776,0.30227,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0021907,0.21595,0.29216,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.60692,0.21506,0.069932,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.043559,0.21477,0.25473,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.0025648,0.2137,0.28696,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.037377,0.21272,0.22032,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.1306,0.2125,0.17595,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.077559,0.2065,0.20551,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.2259,0.20462,0.1251,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.031957,0.20127,0.23417,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.019548,0.2007,0.28931,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0080134,0.20062,0.21833,0,0
3,GO NEGATIVE REGULATION OF ANOIKIS,0.098083,0.1991,0.22211,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.035953,0.19761,0.23201,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.033245,0.19485,0.29802,0,0
3,GO PROSTATIC BUD FORMATION,0.023112,0.19475,0.3128,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.08881,0.19356,0.19114,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.11894,0.19206,0.16575,0,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.027226,0.18884,0.19167,0,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.010101,0.18841,0.25592,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.034576,0.18641,0.26056,0,0
3,GO HISTAMINE SECRETION,0.2998,0.18294,0.13442,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.10468,0.18267,0.21701,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.030713,0.18112,0.22628,0,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.17091,0.18097,0.12659,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.08881,0.17718,0.31807,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.054439,0.17572,0.26204,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.015104,0.17434,0.25013,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.038848,0.17408,0.21926,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.018736,0.17382,0.20457,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.017954,0.17342,0.29239,0,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.025096,0.17237,0.26542,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.024086,0.1713,0.17971,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.10134,0.17039,0.17062,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.15655,0.17019,0.2199,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.12273,0.16982,0.17188,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.080256,0.16799,0.12775,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.17091,0.16618,0.18657,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.069906,0.16556,0.19989,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.14312,0.16552,0.18915,0,0
3,GO MITOCHONDRIAL RNA PROCESSING,0.32248,0.16538,0.081752,0,0
3,GO RESPONSE TO SALT,0.021265,0.16535,0.14616,0,0
3,GO GLYCINE METABOLIC PROCESS,0.12273,0.16453,0.11559,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.11894,0.16429,0.17775,0,0
3,GO BONE MINERALIZATION,0.050584,0.16312,0.21566,0,0
3,GO NEURON REMODELING,0.094909,0.16304,0.21395,0,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.214,0.16067,0.18199,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.056456,0.16063,0.2385,0,0
3,GO IMP METABOLIC PROCESS,0.045233,0.15854,0.1231,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.08303,0.15822,0.27003,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.10134,0.15529,0.22147,0,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.16602,0.155,0.20375,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0047188,0.15488,0.22213,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.011063,0.1542,0.26179,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.37964,0.15378,0.10557,0,0
3,GO METANEPHROS DEVELOPMENT,0.0172,0.1532,0.21982,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.077559,0.15096,0.15878,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.065157,0.15042,0.13658,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.017954,0.15012,0.25701,0,0
3,GO INTESTINAL LIPID ABSORPTION,0.12662,0.14964,0.17401,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.028348,0.14887,0.15893,0,0
3,GO SMOOTH MUSCLE CELL MIGRATION,0.011574,0.14856,0.26508,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.12273,0.14841,0.17631,0,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.037377,0.14837,0.18679,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.023112,0.14831,0.18771,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.080256,0.14699,0.15492,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.08881,0.14693,0.16597,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.12273,0.1468,0.13158,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.23827,0.14538,0.14043,0,0
3,GO AZOLE TRANSMEMBRANE TRANSPORT,0.38829,0.14503,0.11254,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.080256,0.14467,0.15122,0,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.21989,0.14402,0.11021,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.033245,0.14388,0.22287,0,0
3,GO REGULATION OF MYELINATION,0.077559,0.14354,0.16688,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.041938,0.14116,0.19226,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11894,0.14073,0.16127,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.23203,0.14053,0.18024,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.08303,0.14052,0.17534,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.091819,0.14046,0.21085,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.38829,0.14042,0.071291,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.08881,0.1403,0.23774,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.058535,0.13973,0.23671,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.10811,0.13859,0.1407,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.37964,0.1383,0.1092,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.030713,0.13774,0.20708,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.072385,0.13692,0.17812,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.18102,0.13631,0.12504,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.13467,0.13589,0.22079,0,0
3,GO MESENCHYME MORPHOGENESIS,0.072385,0.13522,0.22022,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.10811,0.13454,0.15618,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.040368,0.13427,0.21748,0,0
3,GO RENAL FILTRATION,0.11163,0.134,0.25941,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.11894,0.13339,0.1563,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.08303,0.13261,0.21655,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.052482,0.132,0.20906,0,0
3,GO REGULATION OF AXON GUIDANCE,0.25111,0.13185,0.13417,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.080256,0.13173,0.13334,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.12662,0.13084,0.17163,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.40594,0.13057,0.10485,0,0
3,GO LIPID EXPORT FROM CELL,0.02951,0.13034,0.17408,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.08588,0.13022,0.2062,0,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.11524,0.13014,0.17119,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.043559,0.13005,0.18054,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.08303,0.12954,0.23132,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.08881,0.12823,0.23858,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.19156,0.12776,0.17755,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.010101,0.12732,0.17731,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.16123,0.12714,0.14302,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.11894,0.12713,0.16209,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.065157,0.12677,0.11698,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.14312,0.12671,0.16534,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.10134,0.12579,0.15202,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.062884,0.12577,0.15809,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.054439,0.12373,0.17386,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.34626,0.12368,0.092954,0,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.12273,0.12361,0.17565,0,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.02951,0.12339,0.16597,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.24463,0.12275,0.11775,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23827,0.12262,0.14487,0,0
3,GO WATER HOMEOSTASIS,0.18102,0.12248,0.11855,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.056456,0.12224,0.12916,0,0
3,GO COCHLEA MORPHOGENESIS,0.10134,0.12178,0.14721,0,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.13885,0.12153,0.16957,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.85555,0.12055,-9.698e-05,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.2577,0.12052,0.1511,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.041938,0.12026,0.24949,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.062884,0.12012,0.19843,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.12662,0.12004,0.16604,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.094909,0.11887,0.16189,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.074935,0.11827,0.11646,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.11894,0.11814,0.17527,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.36271,0.11744,0.10832,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.11524,0.11689,0.12611,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.2259,0.11678,0.16072,0,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.041938,0.11677,0.16614,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.197,0.11576,0.13718,0,0
3,GO FILOPODIUM ASSEMBLY,0.13467,0.11561,0.14149,0,0
3,GO HAIR FOLLICLE MATURATION,0.11894,0.11541,0.15018,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.08588,0.1153,0.20844,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.16602,0.11528,0.18688,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.197,0.11524,0.13657,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.5959,0.11506,0.061652,0,0
3,GO ANIMAL ORGAN FORMATION,0.098083,0.11471,0.16819,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.33029,0.11419,-0.0039268,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.077559,0.11382,0.17549,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.13467,0.11303,0.13419,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.16123,0.11301,0.19472,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.51122,0.11284,0.085363,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.14312,0.11279,0.14004,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.080256,0.1127,0.14518,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.13467,0.11263,0.1236,0,0
3,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.38829,0.11261,0.068281,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.062884,0.11252,0.19035,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.20256,0.11249,0.18798,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.29248,0.11194,0.14832,0,0
3,GO MUSCLE HYPERTROPHY,0.21989,0.11141,0.12404,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.043559,0.11101,0.19645,0,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.37111,0.11082,0.12334,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.12662,0.11074,0.085115,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.13885,0.11058,0.12722,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.060677,0.11019,0.25287,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.27126,0.11014,0.12084,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.018736,0.10961,0.15926,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.08588,0.10945,0.14728,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.26442,0.10925,0.078854,0,0
3,GO P BODY ASSEMBLY,0.46168,0.10925,0.073017,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.046961,0.109,0.20542,0,0
3,GO PHAGOSOME MATURATION,0.16602,0.10828,0.1313,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.18102,0.10809,0.12013,0,0
3,GO RESPONSE TO COPPER ION,0.25111,0.10792,0.1051,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.18102,0.10779,0.18327,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.14312,0.10741,0.18873,0,0
3,GO HORMONE CATABOLIC PROCESS,0.15655,0.10732,0.12615,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.1306,0.10726,0.16924,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.15197,0.10701,0.19644,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0092139,0.10654,0.15067,0,0
3,GO AMINO ACID IMPORT,0.2259,0.10635,0.13099,0,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.10811,0.10627,0.20231,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.33029,0.10627,0.12938,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.18624,0.10608,0.22816,0,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.098083,0.10592,0.14333,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.53179,0.10575,0.020542,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17591,0.10565,0.18892,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.11894,0.10491,0.22387,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.069906,0.10473,0.24401,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.08881,0.10465,0.1882,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.95582,0.10437,0.030038,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.18102,0.1043,0.16467,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.08588,0.10385,0.19184,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.20256,0.10366,0.14375,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.25111,0.10361,0.17051,0,0
3,GO MICROVILLUS ASSEMBLY,0.24463,0.103,0.10489,0,0
3,GO FATTY ACID BETA OXIDATION,0.2259,0.10289,0.093407,0,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.10811,0.10276,0.15791,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.37111,0.10265,0.075104,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.37964,0.10248,0.095625,0,0
3,GO REGULATION OF PEPTIDE SECRETION,0.15655,0.10234,0.12391,0,0
3,GO MRNA MODIFICATION,0.19156,0.10188,0.11556,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.197,0.10187,0.11289,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.069906,0.1017,0.21321,0,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.33029,0.10129,0.091853,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.12273,0.10104,0.16437,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.077559,0.10099,0.144,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.15197,0.10088,0.15667,0,0
3,GO AXIS ELONGATION,0.062884,0.10063,0.2013,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.37964,0.10056,0.083196,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.1306,0.10038,0.11594,0,0
3,GO RESPONSE TO ZINC ION,0.091819,0.10006,0.12295,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.050584,0.10002,0.1732,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.30724,0.098872,0.08262,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.027226,0.098625,0.20708,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.18102,0.09861,0.13055,0,0
3,GO PRO B CELL DIFFERENTIATION,0.44264,0.098528,0.091455,0,0
3,GO PROTEIN OXIDATION,0.23203,0.098509,0.088805,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.056456,0.098073,0.14742,0,0
3,GO OVULATION CYCLE,0.19156,0.097392,0.14138,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.61803,0.097271,0.00034519,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.72171,0.097182,0.01308,0,0
3,GO CARNITINE SHUTTLE,0.2259,0.097058,0.10779,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.074935,0.097049,0.24258,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.53179,0.097009,0.061396,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.091819,0.096908,0.23266,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.90549,0.09668,-0.051295,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.067497,0.09667,0.16589,0,0
3,GO REGULATION OF ICOSANOID SECRETION,0.2259,0.096302,0.12276,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.44264,0.096278,0.081934,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.89296,0.095946,-0.026605,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.091819,0.095673,0.16601,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.15655,0.095474,0.10623,0,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.11163,0.095374,0.21218,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.55277,0.095275,0.05237,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.08881,0.094311,0.175,0,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18624,0.09429,0.12562,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.70989,0.094021,0.038496,0,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.1306,0.093752,0.12505,0,0
3,GO STRESS FIBER ASSEMBLY,0.08588,0.093678,0.18563,0,0
3,GO ASYMMETRIC CELL DIVISION,0.16123,0.093409,0.11161,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.17591,0.093048,0.12552,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.12662,0.093039,0.094885,0,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.18102,0.092683,0.16114,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.12273,0.092414,0.15232,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.058535,0.092312,0.15929,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.27126,0.0921,0.14371,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.7336,0.092078,0.052574,0,0
3,GO TRNA PROCESSING,0.2577,0.092048,0.061634,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.040368,0.091941,0.12796,0,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.062884,0.091921,0.12426,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.18102,0.091893,0.18268,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.1306,0.091487,0.10926,0,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.077559,0.09146,0.12964,0,0
3,GO TRNA MODIFICATION,0.21989,0.091452,0.076605,0,0
3,GO CELL CELL JUNCTION ORGANIZATION,0.40594,0.091386,0.11406,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.26442,0.091312,0.1091,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.074935,0.091257,0.21659,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.058535,0.090984,0.14233,0,0
3,GO RESPONSE TO GONADOTROPIN,0.12273,0.090849,0.13781,0,0
3,GO RESPONSE TO EPINEPHRINE,0.16602,0.090805,0.15505,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.10811,0.090382,0.20332,0,0
3,GO MOLTING CYCLE,0.1306,0.090331,0.13388,0,0
3,GO MESENCHYME DEVELOPMENT,0.15197,0.090268,0.14943,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.69814,0.090178,0.040603,0,0
3,GO CELL CELL JUNCTION ASSEMBLY,0.33029,0.090156,0.11093,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.020391,0.090084,0.15071,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.08881,0.089873,0.16634,0,0
3,GO HINDLIMB MORPHOGENESIS,0.47137,0.089687,0.095219,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.20256,0.089529,0.12246,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.51122,0.089189,0.041568,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.23203,0.089186,0.18541,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.23827,0.088911,0.072475,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.61803,0.088903,0.076849,0,0
3,GO SNORNA 3 END PROCESSING,0.34626,0.088834,0.011852,0,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.12662,0.088742,0.22064,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.15197,0.08842,0.17541,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.26442,0.088279,0.16291,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.16602,0.088263,0.11571,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.32248,0.088159,0.1121,0,0
3,GO PENTOSE METABOLIC PROCESS,0.050584,0.08806,0.15027,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.44264,0.087674,0.11634,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.12273,0.087632,0.13283,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.56341,0.087621,0.032408,0,0
3,GO OVULATION CYCLE PROCESS,0.30724,0.087586,0.11575,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.33029,0.086964,0.082605,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.21989,0.086842,0.13277,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.20822,0.086482,0.13391,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.074935,0.086222,0.094792,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.091819,0.086206,0.14117,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.065157,0.08597,0.14485,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.14312,0.085731,0.065577,0,0
3,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.23827,0.085396,0.1648,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.08881,0.085051,0.13565,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.55277,0.084728,0.087008,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.027226,0.084614,0.15436,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.42405,0.084514,0.095673,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.39705,0.084448,0.062358,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.19156,0.08429,0.13631,0,0
3,GO ANOIKIS,0.11163,0.084287,0.16254,0,0
3,GO HISTONE H4 DEACETYLATION,0.58498,0.084019,0.037349,0,0
3,GO GLYCINE TRANSPORT,0.79394,0.083813,0.028558,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.18102,0.083558,0.14167,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.11894,0.083455,0.18428,0,0
3,GO STEROID HORMONE SECRETION,0.51122,0.083419,0.082595,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.46168,0.083397,0.072487,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.062884,0.083335,0.19279,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.074935,0.083242,0.15485,0,0
3,GO RESPONSE TO ESTRADIOL,0.074935,0.08324,0.14723,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.13467,0.083153,0.10067,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.25111,0.083141,0.11942,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.13467,0.082984,0.18252,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.33821,0.082912,0.089792,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.64051,0.082697,0.068257,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.44264,0.082561,0.076539,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.11524,0.082255,0.13801,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.098083,0.082014,0.11456,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.43329,0.081957,0.089567,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.7336,0.081876,0.055531,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.12273,0.081817,0.16729,0,0
3,GO MESODERM MORPHOGENESIS,0.056456,0.081341,0.17561,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.20822,0.081116,0.10723,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.35442,0.081014,0.10568,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.11894,0.080719,0.21179,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.12273,0.080396,0.15553,0,0
3,GO RESPONSE TO TESTOSTERONE,0.32248,0.080357,0.079549,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.55277,0.080352,0.14423,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.20256,0.080153,0.077998,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.30724,0.080054,0.10693,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.64051,0.079985,0.11349,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.091819,0.079916,0.10852,0,0
3,GO NCRNA METABOLIC PROCESS,0.24463,0.079795,0.055943,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.072385,0.079787,0.14732,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.30724,0.079378,0.14712,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.15197,0.079377,0.1315,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.25111,0.07894,0.12163,0,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.074935,0.078747,0.12665,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.66333,0.078612,0.042588,0,0
3,GO HISTONE DEUBIQUITINATION,0.55277,0.078143,0.066076,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.34626,0.078102,0.069871,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.51122,0.077783,0.040354,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.69814,0.077714,0.073451,0,0
3,GO DNA RECOMBINATION,0.7336,0.077545,-0.011621,0,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.33821,0.077507,0.071241,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.11894,0.077232,0.12719,0,0
3,GO UV PROTECTION,0.14312,0.077138,0.15908,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.64051,0.076834,0.041189,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.23827,0.076774,0.1379,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.42405,0.076768,0.12494,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.10811,0.076756,0.10477,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.53179,0.0766,0.06226,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.214,0.076352,0.14053,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.11163,0.076294,0.20283,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.30724,0.076228,0.13691,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.25111,0.076183,0.10656,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.67486,0.076123,0.044218,0,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.33029,0.076077,0.094791,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.28529,0.07606,0.20151,0,0
3,GO REGULATION OF HEART GROWTH,0.058535,0.075879,0.15635,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.17091,0.075817,0.17043,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.46168,0.075687,0.090672,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.091819,0.075588,0.1557,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.4521,0.075503,0.096722,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.53179,0.07496,0.017647,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.16602,0.074582,0.12818,0,0
3,GO CONVERGENT EXTENSION,0.44264,0.074493,0.10363,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.18102,0.074394,0.12762,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.23203,0.074337,0.083073,0,0
3,GO GLIAL CELL DEVELOPMENT,0.29248,0.074328,0.10905,0,0
3,GO NEPHRON MORPHOGENESIS,0.077559,0.074254,0.15272,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.072385,0.074136,0.18126,0,0
3,GO RESPONSE TO ETHANOL,0.18624,0.074087,0.094949,0,0
3,GO BONE GROWTH,0.12273,0.074046,0.19292,0,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.14312,0.0739,0.12537,0,0
3,GO NCRNA PROCESSING,0.16123,0.073809,0.065393,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.28529,0.073763,0.068844,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.19156,0.073448,0.11948,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.043559,0.073444,0.12563,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12662,0.073189,0.15704,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.30724,0.073076,0.14062,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.11163,0.073041,0.12876,0,0
3,GO MYELIN MAINTENANCE,0.37111,0.072947,0.12436,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.10811,0.072739,0.12129,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.050584,0.0725,0.15459,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.5959,0.07233,0.069991,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.60692,0.072308,0.085529,0,0
3,GO HISTAMINE TRANSPORT,0.54223,0.072209,0.083755,0,0
3,GO RNA SURVEILLANCE,0.36271,0.071992,0.032277,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.14312,0.071817,0.078408,0,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.094909,0.071702,0.12711,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.57414,0.071695,0.050249,0,0
3,GO GLIOGENESIS,0.42405,0.071683,0.092875,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.21989,0.071538,0.09718,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.21989,0.071203,0.12381,0,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.21989,0.071182,0.1412,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.56341,0.071101,0.092052,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.25111,0.070937,0.10784,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.57414,0.070914,0.051448,0,0
3,GO PIGMENTATION,0.20256,0.07091,0.08539,0,0
3,GO REGULATION OF GLIOGENESIS,0.069906,0.070882,0.14304,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.64051,0.070852,0.040806,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.47137,0.070835,0.10274,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.18102,0.070827,0.12505,0,0
3,GO TRNA METHYLATION,0.21989,0.070766,0.090911,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.197,0.070613,0.17132,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.51122,0.070525,0.046146,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.32248,0.070396,0.10222,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.072385,0.07013,0.12638,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.10134,0.070008,0.13427,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.23203,0.07,0.15675,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.20822,0.06998,0.13732,0,0
3,GO ORGAN GROWTH,0.065157,0.069669,0.16607,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.10811,0.069619,0.14206,0,0
3,GO SLEEP,0.094909,0.069466,0.1229,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.12273,0.069393,0.13227,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.18624,0.069254,0.12218,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.23203,0.068693,0.12866,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.11894,0.068416,0.13635,0,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.13885,0.068358,0.12344,0,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.23827,0.06799,0.10431,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.27126,0.067985,0.13216,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.85555,0.067815,0.04073,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.46168,0.067726,0.089673,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.5959,0.067712,0.062222,0,0
3,GO RENAL SYSTEM PROCESS,0.12662,0.067657,0.169,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.62923,0.067407,0.012951,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.46168,0.06738,0.061344,0,0
3,GO TRNA 5 END PROCESSING,0.47137,0.067047,0.0040328,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.20256,0.067032,0.11074,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.24463,0.067001,0.097902,0,0
3,GO ER OVERLOAD RESPONSE,0.32248,0.066747,0.089372,0,0
3,GO TRNA METABOLIC PROCESS,0.35442,0.066731,0.046667,0,0
3,GO RRNA CATABOLIC PROCESS,0.69814,0.06657,0.023184,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.62923,0.066349,0.034512,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.27126,0.066309,0.1351,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35442,0.06619,0.16652,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.15197,0.066142,0.15827,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.1306,0.066117,0.13719,0,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.27821,0.06602,0.12144,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.33821,0.065946,0.069928,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.50109,0.065857,0.054029,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.11163,0.065849,0.12672,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.24463,0.065374,0.097378,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.08881,0.065371,0.14794,0,0
3,GO REGULATION OF TRANSPORT,0.55277,0.065256,0.080499,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.43329,0.065212,0.10441,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.17091,0.065151,0.15003,0,0
3,GO GMP METABOLIC PROCESS,0.32248,0.065102,0.085886,0,0
3,GO MATURATION OF 5 8S RRNA,0.34626,0.06506,0.039307,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.214,0.064868,0.14741,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.28529,0.064635,0.077169,0,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.69814,0.064447,0.0061338,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.74555,0.064288,0.035933,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.15197,0.064253,0.11819,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.40594,0.064179,0.028229,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.74555,0.064096,-0.035777,0,0
3,GO MATURATION OF LSU RRNA,0.32248,0.06381,0.050158,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.65188,0.063642,0.060926,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.21989,0.063632,0.15642,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.52145,0.063532,0.077751,0,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.19156,0.063519,0.06815,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.40594,0.06349,0.059744,0,0
3,GO PROTEIN HYDROXYLATION,0.197,0.063486,0.11451,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.52145,0.063474,0.063371,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.85555,0.06346,0.036153,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.18624,0.063388,0.18011,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.10468,0.06336,0.12144,0,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.46168,0.063358,0.065216,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.16123,0.063274,0.13961,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.10811,0.063128,0.12111,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.214,0.063108,0.084006,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.57414,0.062964,0.077563,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.077559,0.062931,0.11554,0,0
3,GO GOLGI ORGANIZATION,0.46168,0.062791,0.080195,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.61803,0.06279,0.061189,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.30724,0.062583,0.10292,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.42405,0.06251,0.076772,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.17091,0.061985,0.11228,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.81845,0.061974,0.0083301,0,0
3,GO REGULATION OF EXOSOMAL SECRETION,0.42405,0.061934,0.068798,0,0
3,GO NEURAL CREST CELL MIGRATION,0.35442,0.061842,0.096215,0,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.24463,0.061789,0.12241,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.197,0.061703,0.12055,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.53179,0.061546,0.0705,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.88046,0.061541,0.016018,0,0
3,GO RESPONSE TO IRON ION,0.75756,0.061076,0.066235,0,0
3,GO LACTATE METABOLIC PROCESS,0.5959,0.060918,0.047365,0,0
3,GO RECEPTOR INTERNALIZATION,0.43329,0.060874,0.099481,0,0
3,GO DE NOVO PROTEIN FOLDING,0.90549,0.060662,0.02057,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.11894,0.060601,0.1146,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.077559,0.060551,0.10947,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.42405,0.060482,0.029982,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.43329,0.060295,0.10526,0,0
3,GO RELAXATION OF MUSCLE,0.57414,0.059984,0.063598,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.30724,0.059955,0.16494,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.33821,0.059891,0.064623,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.08588,0.059833,0.16069,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.23827,0.059749,0.08304,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.29248,0.059681,0.13167,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.53179,0.059607,0.075713,0,0
3,GO REGULATION OF CELL DIVISION,0.88046,0.059481,0.042606,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.065157,0.059352,0.15648,0,0
3,GO VESICLE TARGETING,0.24463,0.059332,0.094264,0,0
3,GO MESODERM DEVELOPMENT,0.24463,0.059258,0.10342,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.25111,0.058774,0.11483,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.091819,0.058632,0.11907,0,0
3,GO RESPONSE TO BMP,0.33821,0.058542,0.12827,0,0
3,GO DEMETHYLATION,0.46168,0.058495,0.067026,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.57414,0.058452,0.10254,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.44264,0.05841,0.083137,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.077559,0.058303,0.13801,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.46168,0.058167,0.08462,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.27821,0.058144,0.10224,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.48117,0.058028,0.06984,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.2998,0.057967,0.11012,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.56341,0.057869,0.079997,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.12273,0.057704,0.13626,0,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.47137,0.057649,0.089915,0,0
3,GO MESONEPHROS DEVELOPMENT,0.2998,0.057602,0.10271,0,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.2259,0.057517,0.10614,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.48117,0.057433,0.069004,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.35442,0.05739,0.087872,0,0
3,GO HEART DEVELOPMENT,0.13885,0.057311,0.13842,0,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.32248,0.057281,0.085238,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.66333,0.056855,0.048851,0,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.51122,0.056758,0.04074,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.2998,0.056671,0.1287,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.85555,0.056671,0.00052175,0,0
3,GO NAD METABOLIC PROCESS,0.2998,0.056546,0.097208,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.69814,0.056397,0.059998,0,0
3,GO REGULATION OF BINDING,0.42405,0.056293,0.086062,0,0
3,GO INORGANIC ANION TRANSPORT,0.34626,0.056259,0.079666,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.29248,0.056124,0.13316,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.23827,0.05596,0.093,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.5959,0.055925,0.080068,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12662,0.055793,0.11932,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.60692,0.055619,0.029597,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.53179,0.055512,0.090733,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.53179,0.055398,0.17116,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.43329,0.055351,0.1305,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.37964,0.055073,0.11616,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.93062,0.054994,-0.030983,0,0
3,GO SIGNAL PEPTIDE PROCESSING,0.46168,0.054851,0.08265,0,0
3,GO MAST CELL MIGRATION,0.56341,0.05472,0.086915,0,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.52145,0.054534,0.038341,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.43329,0.054451,0.099828,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.23827,0.054421,0.085856,0,0
3,GO RESPONSE TO CAFFEINE,0.68646,0.054057,0.031738,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.17091,0.054021,0.17251,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.43329,0.053997,0.089651,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.57414,0.053996,0.068267,0,0
3,GO ORGANIC ANION TRANSPORT,0.2577,0.053752,0.10024,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.13467,0.053387,0.079629,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.98106,0.05333,-0.0099903,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.70989,0.053318,0.042379,0,0
3,GO KIDNEY MORPHOGENESIS,0.20256,0.053201,0.1211,0,0
3,GO MUSCLE FILAMENT SLIDING,0.21989,0.053094,0.12171,0,0
3,GO SOMITOGENESIS,0.52145,0.053071,0.067798,0,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.214,0.053019,0.15149,0,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.17091,0.052994,0.10686,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.54223,0.052978,0.011078,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.55277,0.052807,0.069879,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.7336,0.05255,0.032439,0,0
3,GO OXIDATIVE DEMETHYLATION,0.79394,0.052491,0.045705,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.28529,0.052477,0.095562,0,0
3,GO PROTEIN SUMOYLATION,0.41494,0.052389,0.055814,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.55277,0.05228,0.075252,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.58498,0.052245,0.045011,0,0
3,GO MANNOSYLATION,0.83078,0.052208,0.01348,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.19156,0.052016,0.12207,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.28529,0.051672,0.10304,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.69814,0.051653,0.025547,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.62923,0.051623,-0.02251,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1,0.05161,0.017686,0,0
3,GO RESPONSE TO ETHER,0.29248,0.051603,0.098909,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40594,0.05147,0.081835,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.57414,0.05144,0.11279,0,0
3,GO MITOPHAGY,0.56341,0.051093,0.067996,0,0
3,GO ORGAN INDUCTION,0.52145,0.051062,0.092806,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.74555,0.05093,0.063864,0,0
3,GO PYRUVATE METABOLIC PROCESS,0.79394,0.050898,0.038931,0,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.30724,0.050784,0.17064,0,0
3,GO PEROXISOME ORGANIZATION,0.072385,0.05077,0.090107,0,0
3,GO PEPTIDE SECRETION,0.37111,0.050716,0.09328,0,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.42405,0.050602,0.071533,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.72171,0.050147,0.050271,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.20256,0.049978,0.10977,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.90549,0.049825,0.05056,0,0
3,GO TELOMERE ORGANIZATION,0.89296,0.049752,-0.019497,0,0
3,GO RENAL WATER HOMEOSTASIS,0.38829,0.049709,0.12451,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.29248,0.049542,0.14012,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.58498,0.049256,0.031988,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.38829,0.049146,0.043508,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.21989,0.049137,0.083876,0,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.36271,0.049126,0.048273,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.34626,0.04908,0.057646,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.29248,0.049051,0.18342,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.34626,0.048957,0.092184,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.26442,0.048944,0.10273,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.33029,0.048846,0.091045,0,0
3,GO TONGUE MORPHOGENESIS,0.62923,0.048688,0.049122,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.58498,0.04848,0.070491,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.2998,0.048475,0.1014,0,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.2577,0.048333,0.072316,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.56341,0.047977,0.065092,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.39705,0.047795,0.11038,0,0
3,GO POSITIVE REGULATION OF SECRETION,0.38829,0.047753,0.082704,0,0
3,GO LACTATION,0.80618,0.047622,0.061922,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.34626,0.047611,0.094876,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.197,0.047574,0.078123,0,0
3,GO ANION TRANSPORT,0.27126,0.047435,0.091558,0,0
3,GO REGULATION OF ERAD PATHWAY,0.11894,0.047398,0.13284,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.35442,0.047327,0.079418,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.33821,0.047274,0.086448,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.25111,0.04719,0.089259,0,0
3,GO GOLGI LOCALIZATION,0.2998,0.047189,0.065751,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.43329,0.047008,0.066283,0,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.56341,0.046931,0.084205,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.85555,0.046868,0.023701,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.95582,0.046709,0.0047774,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.38829,0.046311,0.077967,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.60692,0.046274,0.095446,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.2998,0.046167,0.09417,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.35442,0.046075,0.097931,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.48117,0.046035,0.075588,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.40594,0.04593,0.1091,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.17091,0.045872,0.11016,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.93062,0.04585,0.023465,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.46168,0.045703,0.068796,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.3148,0.045701,0.1569,0,0
3,GO REGULATION OF FERTILIZATION,0.28529,0.04563,0.058345,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.66333,0.045533,0.066923,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.28529,0.045438,0.16215,0,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.33821,0.045416,0.16647,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.23827,0.045139,0.096494,0,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.58498,0.045075,0.051556,0,0
3,GO ALANINE TRANSPORT,0.70989,0.045,0.088268,0,0
3,GO NUCLEOSIDE SALVAGE,0.214,0.044847,0.063524,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.76963,0.044846,0.056903,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.27126,0.04478,0.054074,0,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.67486,0.044485,0.031841,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.47137,0.044436,0.078725,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.43329,0.044376,0.075183,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.76963,0.044245,0.058409,0,0
3,GO RESPONSE TO METAL ION,0.49108,0.044097,0.078113,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.53179,0.04407,0.092198,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.27126,0.044063,0.094769,0,0
3,GO NCRNA 3 END PROCESSING,0.81845,0.043922,-0.012136,0,0
3,GO VITAMIN CATABOLIC PROCESS,0.81845,0.043895,0.028003,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.51122,0.043877,0.071381,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.35442,0.043649,0.082891,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.20822,0.043566,0.13464,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.56341,0.043538,0.062223,0,0
3,GO LOCOMOTOR RHYTHM,0.57414,0.043439,0.078815,0,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.47137,0.043396,0.076597,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.23827,0.043131,0.16459,0,0
3,GO RRNA METABOLIC PROCESS,0.25111,0.043101,0.047139,0,0
3,GO HISTONE H3 K4 METHYLATION,0.88046,0.042985,-0.0022451,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.64051,0.042909,0.054388,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.94321,0.042898,0.025712,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.37111,0.042812,0.11408,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.23827,0.042812,0.15094,0,0
3,GO PROTEASOME ASSEMBLY,0.52145,0.042702,0.015776,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.36271,0.042573,0.044855,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.88046,0.04257,0.0098071,0,0
3,GO PHOTOPERIODISM,0.57414,0.042529,0.042084,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.27126,0.042418,0.058116,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.72171,0.0424,0.070913,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.33821,0.042334,0.10603,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.66333,0.042195,0.054125,0,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.83078,0.04219,0.011142,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.50109,0.042165,0.030108,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.44264,0.042158,0.074811,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.39705,0.042147,0.094668,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.1306,0.041772,0.14026,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.24463,0.04176,0.12131,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.76963,0.041674,-0.065616,0,0
3,GO EPITHELIAL CELL DEVELOPMENT,0.29248,0.041674,0.12503,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.85555,0.041628,0.045771,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.19156,0.041425,0.093924,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.99368,0.041267,0.0082253,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.41494,0.041163,0.096695,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.38829,0.041055,0.086841,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.55277,0.040995,0.10262,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.11524,0.040881,0.11962,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.90549,0.04086,0.018764,0,0
3,GO CELL CELL SIGNALING BY WNT,0.65188,0.040649,0.076929,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.98106,0.040427,-0.0081111,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.40594,0.040191,0.085626,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.24463,0.040123,0.083793,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.69814,0.040021,0.043272,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.27821,0.039927,0.13271,0,0
3,GO RENAL TUBULE DEVELOPMENT,0.17091,0.039858,0.14125,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.68646,0.039608,0.039283,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.90549,0.039487,0.013584,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.39705,0.039307,0.11598,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.36271,0.039298,0.083093,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.7336,0.039243,0.021232,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.4521,0.03912,0.077062,0,0
3,GO HEART GROWTH,0.19156,0.039092,0.1247,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.98106,0.039035,0.012598,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.17591,0.038849,0.087339,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.96843,0.038535,0.011221,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.68646,0.038527,0.048884,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.3148,0.038308,0.10127,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.47137,0.0382,0.071012,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.32248,0.038022,0.029289,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.90549,0.037891,0.032955,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.24463,0.037551,0.077984,0,0
3,GO BLASTOCYST DEVELOPMENT,0.67486,0.037466,0.018587,0,0
3,GO NEGATIVE CHEMOTAXIS,0.42405,0.037332,0.11653,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.69814,0.037196,0.02284,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.50109,0.037099,-0.0018381,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.32248,0.03708,0.10281,0,0
3,GO MAGNESIUM ION TRANSPORT,0.69814,0.037035,0.012285,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.60692,0.03678,0.057048,0,0
3,GO SECONDARY METABOLIC PROCESS,0.83078,0.036569,0.026433,0,0
3,GO CALCIUM ION IMPORT,0.36271,0.036525,0.084996,0,0
3,GO AMINO ACID ACTIVATION,0.55277,0.036498,0.026474,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.18624,0.036402,0.10111,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55277,0.036282,0.042903,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.33821,0.036216,0.076617,0,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.72171,0.036171,0.041822,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.95582,0.036043,-0.084039,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.66333,0.035787,0.059548,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.29248,0.035736,0.082359,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.72171,0.035509,0.027914,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.38829,0.035482,0.10676,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.4521,0.03545,0.099472,0,0
3,GO UTP METABOLIC PROCESS,0.70989,0.035321,0.031921,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.81845,0.035087,0.023426,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.37111,0.035032,0.10513,0,0
3,GO REGULATION OF NEURON MATURATION,0.99368,0.034964,0.061182,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.99368,0.03492,-0.055917,0,0
3,GO RESPONSE TO CALCIUM ION,0.37964,0.03482,0.081704,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.41494,0.034501,0.075356,0,0
3,GO METAL ION TRANSPORT,0.58498,0.034227,0.066978,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.81845,0.034223,0.074624,0,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.29248,0.034103,0.050753,0,0
3,GO HISTONE PHOSPHORYLATION,0.96843,0.033963,-0.0058197,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.54223,0.033872,0.026962,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.25111,0.033792,0.19294,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.68646,0.033728,0.040912,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.88046,0.033679,0.052324,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.3148,0.033537,0.083638,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.2259,0.033394,0.044349,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.16602,0.033326,0.090967,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.54223,0.033038,0.076327,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.91805,0.033019,0.0094411,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.96843,0.033001,-0.0058507,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.93062,0.032992,0.048411,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.27821,0.032959,0.14044,0,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.88046,0.032858,-0.0236,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.83078,0.032783,0.035185,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.54223,0.032558,0.075733,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.89296,0.032522,-0.023586,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.80618,0.032496,0.031355,0,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.37964,0.032476,0.084451,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.37111,0.032422,0.09371,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.60692,0.032411,0.048141,0,0
3,GO PROTEIN AUTOUBIQUITINATION,0.98106,0.032353,0.011792,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.44264,0.032316,0.10851,0,0
3,GO DETECTION OF STIMULUS,0.54223,0.032199,0.052426,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.7336,0.03211,0.028386,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.197,0.032068,0.19057,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.94321,0.032032,0.001867,0,0
3,GO PEROXISOMAL TRANSPORT,0.12273,0.032002,0.083873,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.36271,0.03199,0.11454,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.55277,0.031793,0.088653,0,0
3,GO PROTEIN POLYMERIZATION,0.62923,0.031737,0.069945,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.42405,0.03163,0.019071,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.61803,0.031623,0.079266,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.18102,0.031614,0.10802,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.46168,0.031471,0.056829,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.64051,0.031444,0.041429,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.93062,0.031412,-0.0023695,0,0
3,GO LIPID DROPLET ORGANIZATION,0.85555,0.03126,0.02075,0,0
3,GO GLUCOSE METABOLIC PROCESS,0.78176,0.030996,0.053396,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.47137,0.030869,0.056306,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.67486,0.030869,-0.09518,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.67486,0.030852,0.029552,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.85555,0.030825,0.024765,0,0
3,GO TRNA TRANSPORT,0.54223,0.030699,0.0011424,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.89296,0.030688,-0.07072,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.72171,0.030451,0.0086293,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.69814,0.030366,0.037967,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.81845,0.03036,0.059666,0,0
3,GO PHAGOSOME ACIDIFICATION,0.55277,0.03027,0.048006,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,1,0.030126,-0.023157,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.86799,0.030118,0.043436,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.50109,0.030055,0.073818,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.47137,0.030017,0.046543,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.33821,0.030002,0.082009,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.94321,0.029788,0.02949,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.91805,0.029699,-0.014814,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.69814,0.0295,0.059555,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.62923,0.029486,0.058989,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.86799,0.029334,0.029728,0,0
3,GO MUSCLE SYSTEM PROCESS,0.33029,0.029333,0.10389,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.91805,0.029324,0.0072536,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.85555,0.029291,0.0025763,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.40594,0.029132,0.072252,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.96843,0.029071,-0.010331,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.53179,0.028917,0.093941,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.68646,0.028771,0.034952,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.5959,0.028703,0.063054,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.84314,0.028698,0.042836,0,0
3,GO SPECIFICATION OF SYMMETRY,0.83078,0.028623,0.04069,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.74555,0.028623,0.032207,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.67486,0.028592,0.029647,0,0
3,GO CELLULAR RESPONSE TO PH,0.78176,0.028582,0.039627,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.30724,0.028387,0.079653,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.60692,0.028381,0.057857,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.83078,0.028359,-0.032519,0,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.80618,0.028351,0.044182,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.72171,0.028338,0.061095,0,0
3,GO SEX DIFFERENTIATION,0.60692,0.02826,0.066259,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.64051,0.02824,0.063453,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.80618,0.028233,0.078955,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.64051,0.027998,0.048626,0,0
3,GO ENSHEATHMENT OF NEURONS,0.52145,0.027962,0.084652,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.90549,0.027938,0.010326,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.75756,0.027828,-0.033163,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.41494,0.027545,0.076192,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.37111,0.027492,0.12843,0,0
3,GO REGULATION OF GTP BINDING,0.80618,0.027297,0.034285,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.57414,0.027135,0.061352,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.50109,0.027069,0.068704,0,0
3,GO REGULATION OF TUBE SIZE,0.38829,0.026898,0.11922,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.94321,0.026869,-0.0065717,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.62923,0.026697,0.033876,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.91805,0.026658,-0.038223,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.56341,0.026516,0.071108,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.70989,0.026409,0.04167,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.37964,0.026279,0.058617,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.42405,0.026241,0.092587,0,0
3,GO ERAD PATHWAY,0.27821,0.026197,0.10041,0,0
3,GO GROWTH,0.83078,0.026184,0.073294,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.5959,0.026137,0.077235,0,0
3,GO POSITIVE REGULATION OF BINDING,0.83078,0.025969,0.05955,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.62923,0.025949,0.062627,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.10468,0.025734,0.13793,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.86799,0.025733,0.020061,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.15655,0.025563,0.057417,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.72171,0.02555,0.057036,0,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.29248,0.025482,0.10026,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.60692,0.025182,0.075788,0,0
3,GO SENSORY PERCEPTION,0.91805,0.025136,0.031125,0,0
3,GO RESPONSE TO LIGHT STIMULUS,1,0.0251,0.02263,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.2577,0.025069,0.14576,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.20256,0.024899,0.12187,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.4521,0.024894,0.093421,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.76963,0.024869,0.055737,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.91805,0.024857,0.01059,0,0
3,GO RESPONSE TO LEPTIN,0.88046,0.024802,0.041149,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.41494,0.024768,0.090249,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.99368,0.024723,0.036044,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.61803,0.024568,0.016987,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.94321,0.02456,0.046854,0,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.30724,0.024505,0.10685,0,0
3,GO RIBOSOME ASSEMBLY,0.56341,0.024462,0.020417,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1,0.024345,0.014569,0,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.80618,0.024232,0.0037434,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.79394,0.024216,-0.018255,0,0
3,GO FUCOSE METABOLIC PROCESS,0.90549,0.024191,0.02013,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.95582,0.024054,-0.013683,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.46168,0.024048,0.079768,0,0
3,GO MRNA TRANSPORT,0.89296,0.023925,0.0035873,0,0
3,GO DNA METABOLIC PROCESS,0.95582,0.023857,-0.014834,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.51122,0.023849,0.074468,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.86799,0.023686,0.02791,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.93062,0.02368,-0.0050337,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.93062,0.023671,-0.08362,0,0
3,GO PROTEIN DEMETHYLATION,0.78176,0.023548,0.0070697,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.76963,0.023524,-0.014883,0,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.3148,0.023523,0.073664,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.33821,0.023326,0.13747,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.38829,0.023276,0.13763,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.96843,0.023195,0.021136,0,0
3,GO INSEMINATION,0.72171,0.023194,0.053171,0,0
3,GO EXCRETION,0.81845,0.023141,0.04669,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.37964,0.0231,0.082288,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.72171,0.023047,0.05868,0,0
3,GO MRNA METHYLATION,0.70989,0.023033,0.038569,0,0
3,GO TOR SIGNALING,0.74555,0.022992,0.049856,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.93062,0.022749,-0.0088652,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.2259,0.022622,0.11256,0,0
3,GO REPRODUCTION,0.96843,0.022585,0.032379,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.95582,0.022176,0.0011111,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.65188,0.022112,0.056137,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.86799,0.02175,0.027931,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.32248,0.021492,0.096011,0,0
3,GO SNRNA METABOLIC PROCESS,0.86799,0.021447,-6.1207e-05,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.70989,0.021437,0.054682,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.37111,0.021409,0.14918,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.50109,0.021304,-0.031883,0,0
3,GO NUCLEAR EXPORT,0.7336,0.021287,0.021466,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.27126,0.021264,0.11895,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.66333,0.020966,0.061734,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.54223,0.020923,0.068308,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.95582,0.02091,-0.018674,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.50109,0.020804,0.066874,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.85555,0.020727,-0.0028051,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.36271,0.020669,0.1447,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.42405,0.020548,-0.10466,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.46168,0.020376,0.085878,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.37964,0.020294,0.11449,0,0
3,GO NOTCH SIGNALING PATHWAY,0.93062,0.020066,0.040512,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.80618,0.020006,0.020337,0,0
3,GO RESPONSE TO ACIDIC PH,0.68646,0.019791,0.075764,0,0
3,GO ORGANELLE DISASSEMBLY,0.76963,0.019644,0.036402,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.84314,0.019614,0.047627,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.50109,0.019523,0.07301,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.49108,0.01949,0.084549,0,0
3,GO NEURON DEATH,0.53179,0.019463,0.079482,0,0
3,GO REGULATION OF LYASE ACTIVITY,0.88046,0.019442,0.010902,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.19156,0.019316,0.10309,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.94321,0.019297,0.045629,0,0
3,GO INNER EAR MORPHOGENESIS,0.91805,0.019203,0.011908,0,0
3,GO REGULATION OF TOR SIGNALING,0.90549,0.019199,0.041886,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.58498,0.019016,0.061579,0,0
3,GO ION TRANSPORT,0.72171,0.019014,0.059422,0,0
3,GO RNA LOCALIZATION,0.75756,0.019008,0.015027,0,0
3,GO NCRNA TRANSCRIPTION,0.93062,0.018954,-0.01067,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.58498,0.018954,0.064239,0,0
3,GO RNA 3 END PROCESSING,0.99368,0.01895,-0.014911,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.44264,0.018861,0.093439,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.72171,0.018769,0.070586,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.54223,0.018642,0.082336,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.57414,0.018474,0.076779,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.5959,0.018461,0.052105,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,1,0.018425,0.0062984,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.5959,0.018289,0.035647,0,0
3,GO EAR MORPHOGENESIS,0.89296,0.018198,0.020095,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.75756,0.018194,0.02036,0,0
3,GO REGULATION OF SECRETION,0.83078,0.018178,0.05282,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.99368,0.018063,0.02687,0,0
3,GO POLYOL METABOLIC PROCESS,0.57414,0.018036,0.065924,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.76963,0.017894,0.052075,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.26442,0.017873,0.11007,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.56341,0.017841,0.071128,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.96843,0.017762,-0.014173,0,0
3,GO UTERUS DEVELOPMENT,0.7336,0.017622,0.024164,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.91805,0.017574,0.03381,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.67486,0.017458,0.047988,0,0
3,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.50109,0.017374,0.071648,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.76963,0.017268,-0.053315,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.81845,0.017241,0.063817,0,0
3,GO G0 TO G1 TRANSITION,0.88046,0.017127,-0.040746,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.78176,0.016996,0.041679,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.46168,0.016965,0.0729,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.78176,0.0168,0.049032,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,1,0.016725,0.016571,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.53179,0.016718,0.059777,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1,0.016614,0.014192,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.61803,0.016545,0.075432,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.47137,0.01651,0.05851,0,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.48117,0.016319,-0.03757,0,0
3,GO RNA PROCESSING,0.83078,0.016237,0.016693,0,0
3,GO LYSINE METABOLIC PROCESS,0.83078,0.015989,-0.028053,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.99368,0.015897,0.056423,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.96843,0.01588,0.016132,0,0
3,GO CELL CYCLE ARREST,0.98106,0.015872,0.019276,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.85555,0.015791,0.025668,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.55277,0.015732,0.023246,0,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.64051,0.015644,-0.0049515,0,0
3,GO NUCLEUS LOCALIZATION,0.5959,0.015611,-0.018499,0,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.89296,0.015573,0.026187,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.98106,0.01552,0.053458,0,0
3,GO MEMBRANE DISASSEMBLY,0.66333,0.015509,-0.059565,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.42405,0.015297,0.16173,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.90549,0.015244,-0.023078,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.90549,0.015212,-0.062437,0,0
3,GO SODIUM ION HOMEOSTASIS,0.64051,0.015193,0.066512,0,0
3,GO FEMALE GAMETE GENERATION,0.80618,0.015072,-0.013244,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.79394,0.014877,-0.071168,0,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.75756,0.014845,0.0077496,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.96843,0.014577,0.013433,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.93062,0.014313,-0.064728,0,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.94321,0.014173,0.0026958,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.96843,0.01414,-0.022724,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.72171,0.013736,0.02264,0,0
3,GO LIPID TRANSLOCATION,0.78176,0.01371,0.072899,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.85555,0.013679,0.059692,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.95582,0.013417,0.036189,0,0
3,GO REPLICATION FORK PROCESSING,0.84314,0.013397,-0.064604,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.76963,0.013366,0.071567,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.79394,0.01334,0.054814,0,0
3,GO ORGANIC ACID TRANSPORT,0.60692,0.013301,0.071864,0,0
3,GO GLYCOSYLATION,0.57414,0.013138,0.06776,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.66333,0.013106,0.024016,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.95582,0.013045,0.017252,0,0
3,GO REGULATION OF GROWTH,0.7336,0.012997,0.077464,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.55277,0.012982,0.032169,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.49108,0.012968,0.098826,0,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.61803,0.012863,-0.0053494,0,0
3,GO FATTY ACID HOMEOSTASIS,0.36271,0.012752,0.082123,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.83078,0.012682,-0.045222,0,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.99368,0.012582,0.032445,0,0
3,GO MITOCHONDRION ORGANIZATION,0.98106,0.012565,0.019823,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.72171,0.012562,0.013654,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.55277,0.012432,0.078512,0,0
3,GO AMINE METABOLIC PROCESS,0.49108,0.012422,0.053436,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.93062,0.012422,0.01291,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47137,0.012401,0.063892,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.37111,0.012193,0.15587,0,0
3,GO SNRNA TRANSCRIPTION,0.96843,0.011999,-0.00056377,0,0
3,GO NODAL SIGNALING PATHWAY,0.54223,0.011814,0.041138,0,0
3,GO CYTOPLASMIC TRANSLATION,0.94321,0.011777,-0.0044662,0,0
3,GO MIDBODY ABSCISSION,0.76963,0.011503,-0.030331,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.80618,0.011376,0.047647,0,0
3,GO REGULATION OF ION TRANSPORT,0.81845,0.011304,0.045467,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.86799,0.011297,-0.013839,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.54223,0.011128,0.0853,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.57414,0.011019,-0.044501,0,0
3,GO REGULATION OF BEHAVIOR,0.99368,0.011012,0.015588,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.38829,0.010808,0.096387,0,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.56341,0.010727,-0.0027478,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.70989,0.010687,0.014856,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.89296,0.010576,0.045962,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1,0.01056,-0.0032398,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.85555,0.010366,0.049663,0,0
3,GO MULTI ORGANISM PROCESS,0.84314,0.010323,0.014917,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.57414,0.010255,0.037423,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.7336,0.010136,-0.022386,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.72171,0.010127,0.051735,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.95582,0.010094,0.05599,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.88046,0.0099355,0.030001,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.99368,0.009771,0.016518,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.90549,0.0097428,0.043135,0,0
3,GO EMBRYO DEVELOPMENT,0.49108,0.009728,0.084068,0,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.89296,0.0095872,0.0052215,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.75756,0.0095132,0.047215,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.76963,0.0095054,0.090042,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.61803,0.0094441,0.075515,0,0
3,GO HEART TRABECULA FORMATION,0.50109,0.0094327,0.11285,0,0
3,GO FORELIMB MORPHOGENESIS,0.85555,0.009363,-0.00046155,0,0
3,GO APPENDAGE MORPHOGENESIS,0.67486,0.0093228,0.07317,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.52145,0.0093146,0.06143,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.83078,0.0092669,0.023163,0,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.61803,0.0091377,0.026983,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.85555,0.009082,0.0068175,0,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.70989,0.0090133,0.054034,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.72171,0.0089168,0.075592,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.5959,0.0088975,0.08185,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.85555,0.0088686,0.012062,0,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.93062,0.0088342,0.02543,0,0
3,GO GLAND DEVELOPMENT,0.51122,0.0087407,0.098482,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.78176,0.0087198,0.046408,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.79394,0.0086156,0.03837,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.99368,0.0085595,0.023872,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.50109,0.0084655,-0.03967,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.95582,0.0084237,-0.013503,0,0
3,GO REGULATION OF CELL CYCLE,0.75756,0.0083991,-0.012227,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.64051,0.0083684,0.026997,0,0
3,GO AEROBIC RESPIRATION,0.35442,0.0083219,-0.030939,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.38829,0.0082787,0.13374,0,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.65188,0.0080904,0.018239,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.78176,0.0080189,-0.0027033,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.64051,0.0079809,0.027719,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.55277,0.0079036,0.088273,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.95582,0.0078901,0.032361,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.4521,0.0078203,0.065153,0,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.81845,0.0078167,0.027071,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.70989,0.0077682,0.00034135,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.67486,0.0077359,0.05926,0,0
3,GO RESPONSE TO COLD,0.94321,0.0077301,0.033189,0,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.85555,0.0077189,-0.018523,0,0
3,GO EAR DEVELOPMENT,0.99368,0.0076241,0.022819,0,0
3,GO PROTEIN METHYLATION,0.65188,0.0075744,-0.036006,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.65188,0.007497,0.057147,0,0
3,GO INTRACELLULAR TRANSPORT,0.94321,0.0074802,0.031918,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.76963,0.0074504,-0.063515,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.94321,0.0072864,-0.022361,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.79394,0.0072128,-0.023122,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.5959,0.0072005,0.073726,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.66333,0.0071104,0.051262,0,0
3,GO VESICLE ORGANIZATION,0.78176,0.007099,0.052587,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.68646,0.0070929,0.059693,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.69814,0.006976,0.068407,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.7336,0.0069053,0.073073,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.90549,0.0067772,0.029913,0,0
3,GO HYPEROSMOTIC RESPONSE,0.95582,0.0067053,0.037262,0,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.78176,0.0066853,0.055908,0,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.25111,0.0066852,0.12589,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.95582,0.0066602,0.015651,0,0
3,GO HISTONE H3 K27 METHYLATION,0.48117,0.0065078,-0.083313,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.94321,0.0062909,0.0057399,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.89296,0.0062806,-0.024845,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.67486,0.0062702,0.061468,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.57414,0.006206,0.07077,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.5959,0.0059628,-0.018905,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.57414,0.0058715,0.06895,0,0
3,GO HISTONE H3 DEACETYLATION,0.89296,0.0057957,0.0054098,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.86799,0.0057676,-0.021886,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.53179,0.0056449,-0.067469,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.94321,0.0055354,0.01845,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.83078,0.0055164,-0.00080597,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.90549,0.0054192,0.0034968,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.95582,0.0052309,-0.013036,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.70989,0.0051402,0.010034,0,0
3,GO CATION TRANSPORT,0.96843,0.0050694,0.041034,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.94321,0.0050361,0.039314,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.90549,0.004881,0.045436,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.37964,0.0048793,0.12687,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.70989,0.0048736,0.06431,0,0
3,GO VESICLE LOCALIZATION,0.81845,0.0048565,0.023641,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.88046,0.0046087,-0.021547,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.86799,0.0044743,0.034157,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.35442,0.0044503,0.063982,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.65188,0.0044424,-0.018866,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.95582,0.0043573,0.021264,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.94321,0.0041496,0.032171,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.93062,0.0040594,-0.032606,0,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.53179,0.0040198,0.073033,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.57414,0.003955,0.071197,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.83078,0.0038802,0.051388,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.55277,0.0036781,0.085067,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.78176,0.0036348,0.060119,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.83078,0.0036193,0.044231,0,0
3,GO REGULATION OF DNA BINDING,0.98106,0.0035282,0.010056,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.64051,0.003379,-0.01227,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.90549,0.0033372,0.01475,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.78176,0.0032593,0.044444,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.74555,0.0031919,0.0097405,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.99368,0.003168,0.043796,0,0
3,GO BRAIN MORPHOGENESIS,0.55277,0.0031503,-0.045854,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.81845,0.0028002,0.015034,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.52145,0.0027886,-0.025281,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.94321,0.0026155,0.039239,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.75756,0.0025105,0.010846,0,0
3,GO TRANSLATIONAL TERMINATION,0.75756,0.002345,-0.033796,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.86799,0.0022586,0.034941,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.98106,0.0022368,0.011231,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.70989,0.0022017,0.049731,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.60692,0.0021931,0.079544,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.98106,0.0016753,0.048506,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.83078,0.0014663,0.040873,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.88046,0.001462,-0.018327,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.42405,0.0012332,0.098934,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.43329,0.001165,-0.084599,0,0
3,GO CELL CYCLE CHECKPOINT,0.79394,0.00090799,-0.054698,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.84314,0.00086649,-0.0070819,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.72171,0.00086607,-0.018954,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.3148,0.00081676,0.18467,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.48117,0.00081351,-0.044115,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.98106,0.00065985,-0.0074879,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.7336,0.00058161,-0.0092724,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.34626,0.00048886,0.08992,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.70989,0.00022868,0.008007,0,0
3,GO REGULATION OF MITOPHAGY,0.93062,0.00022192,0.036424,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.66333,0.00019469,0.065021,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.69814,0.00016253,0.062796,0,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.72171,0.00010713,0.083786,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.83078,7.0153e-05,0.031658,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.98106,-4.4744e-05,-0.0034922,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.76963,-0.00026484,0.051945,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.89296,-0.00030681,0.012206,0,0
3,GO REGULATION OF CELL MATURATION,0.76963,-0.00034774,0.020848,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.52145,-0.00037557,-0.050589,0,0
3,GO REGULATION OF ANION TRANSPORT,0.4521,-0.00056186,0.081409,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.67486,-0.00059604,0.062616,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.68646,-0.00063684,-0.030481,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.93062,-0.0006638,0.025727,0,0
3,GO NUCLEUS ORGANIZATION,0.58498,-0.0007884,-0.030428,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,1,-0.00089194,0.051919,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.55277,-0.00089923,-0.048907,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.88046,-0.0012268,0.012943,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.80618,-0.001262,0.052583,0,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.85555,-0.0013532,0.057808,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.51122,-0.0014551,0.081958,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.75756,-0.0015099,0.045675,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.89296,-0.0016451,-0.012268,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.89296,-0.002007,0.04511,0,0
3,GO NEURON APOPTOTIC PROCESS,0.86799,-0.0020509,0.041952,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.86799,-0.0021435,-0.063474,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.91805,-0.0021948,0.029185,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.75756,-0.0023426,0.061327,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.75756,-0.0024418,0.061248,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.85555,-0.0025348,-0.04081,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.58498,-0.0025563,0.051481,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.68646,-0.002587,-0.0078483,0,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.61803,-0.0029634,-0.018383,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.88046,-0.0030333,0.044924,0,0
3,GO DENDRITE SELF AVOIDANCE,0.50109,-0.0030481,0.07834,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.84314,-0.0030848,-0.01152,0,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.79394,-0.0030981,0.060457,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.98106,-0.0031277,0.013732,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.80618,-0.0031967,0.036981,0,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.56341,-0.0032752,0.003107,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.84314,-0.0032849,0.044354,0,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.86799,-0.0032979,-0.0023378,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.57414,-0.0033106,0.017127,0,0
3,GO TRANSLATIONAL ELONGATION,0.28529,-0.0033852,-0.05697,0,0
3,GO VIRAL BUDDING,0.72171,-0.0034358,-0.0031643,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.96843,-0.0034597,0.034434,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.99368,-0.0035674,0.024986,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.95582,-0.0036707,-0.033073,0,0
3,GO RESPONSE TO PH,0.4521,-0.0037753,0.1055,0,0
3,GO HEART VALVE FORMATION,0.67486,-0.0038639,0.073527,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.5959,-0.0038671,-0.029852,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.76963,-0.0039412,-0.021568,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.83078,-0.0039544,0.013008,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.96843,-0.0040233,0.035711,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.54223,-0.004105,-0.022733,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.40594,-0.0043273,0.14675,0,0
3,GO SPERM CAPACITATION,0.88046,-0.0045132,-0.0071283,0,0
3,GO HISTONE MONOUBIQUITINATION,0.91805,-0.004542,-0.014397,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.94321,-0.004563,0.042232,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.78176,-0.004673,-0.029384,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.49108,-0.0047297,0.088878,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.65188,-0.0047848,0.0089919,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.76963,-0.0048533,0.066151,0,0
3,GO STEM CELL PROLIFERATION,0.72171,-0.0048779,0.018852,0,0
3,GO APPENDAGE DEVELOPMENT,0.75756,-0.0049919,0.065999,0,0
3,GO EXECUTION PHASE OF APOPTOSIS,0.98106,-0.0050215,0.030557,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.70989,-0.0052281,0.066837,0,0
3,GO MRNA METABOLIC PROCESS,0.88046,-0.0052471,0.0080162,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.75756,-0.0052721,0.017033,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,1,-0.0053017,0.019982,0,0
3,GO POSITIVE REGULATION OF CELL MATURATION,0.64051,-0.0053436,0.092418,0,0
3,GO LONG TERM MEMORY,0.64051,-0.0053941,-0.016411,0,0
3,GO TORC1 SIGNALING,0.95582,-0.0054722,0.022981,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.83078,-0.0055556,0.022497,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.80618,-0.005596,0.0051007,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.96843,-0.0056075,0.017325,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.67486,-0.0056441,0.068286,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.7336,-0.0058473,0.00048034,0,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.68646,-0.006064,0.0020335,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.7336,-0.00612,-0.034491,0,0
3,GO NEURAL TUBE PATTERNING,0.74555,-0.0062949,0.037198,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.98106,-0.0063947,-0.059227,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.19156,-0.0065319,-0.19573,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.98106,-0.0066567,-0.013434,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.42405,-0.006753,-0.082031,0,0
3,GO SEROTONIN TRANSPORT,0.57414,-0.0067757,0.09118,0,0
3,GO CELL FATE COMMITMENT,0.85555,-0.0069095,0.036058,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.79394,-0.0069191,0.055002,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.96843,-0.0070219,0.024188,0,0
3,GO METANEPHROS MORPHOGENESIS,0.70989,-0.0072068,0.024945,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.55277,-0.0073124,-0.024212,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.72171,-0.007366,0.064341,0,0
3,GO RNA POLYADENYLATION,0.98106,-0.0074086,0.016816,0,0
3,GO CELL CYCLE,0.5959,-0.0074385,-0.027035,0,0
3,GO RESPONSE TO AXON INJURY,0.80618,-0.0074385,0.025461,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.81845,-0.0077937,0.0061758,0,0
3,GO MEMBRANE FUSION,0.83078,-0.0078121,0.029424,0,0
3,GO CYTOSOLIC TRANSPORT,0.89296,-0.0078328,0.037633,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.69814,-0.0078938,-0.045421,0,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.79394,-0.0079393,-0.03249,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.91805,-0.0079633,-0.047,0,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.58498,-0.0079724,-0.058266,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.85555,-0.0080936,-0.010226,0,0
3,GO MRNA 3 END PROCESSING,0.84314,-0.0081525,-0.021032,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.98106,-0.0081769,0.014089,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.81845,-0.0084071,-0.021897,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.86799,-0.0084563,0.025141,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.79394,-0.0085339,0.022402,0,0
3,GO CELL CYCLE PROCESS,0.53179,-0.0093285,-0.04136,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.81845,-0.0096748,0.009621,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.83078,-0.0098195,0.066576,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.5959,-0.0099918,0.0044055,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.4521,-0.010121,-0.004984,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.86799,-0.010193,0.048204,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.96843,-0.010256,0.019323,0,0
3,GO HISTONE H3 K9 METHYLATION,0.86799,-0.010406,-0.0091811,0,0
3,GO GENETIC IMPRINTING,0.88046,-0.01049,7.2153e-05,0,0
3,GO GONADOTROPIN SECRETION,0.86799,-0.010583,0.023871,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.91805,-0.010729,-0.013635,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.43329,-0.010906,-0.081791,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.80618,-0.010912,0.0073454,0,0
3,GO RESPONSE TO STARVATION,0.93062,-0.010918,0.032969,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.42405,-0.01093,0.0056257,0,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.60692,-0.011102,-0.042189,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.81845,-0.011609,0.027574,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.93062,-0.011706,0.028323,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.70989,-0.011831,-0.020009,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.85555,-0.011877,0.0041195,0,0
3,GO REGULATION OF ACROSOME REACTION,0.85555,-0.012035,-0.0031708,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.80618,-0.012089,0.035065,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.95582,-0.012172,0.015651,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.99368,-0.012316,0.059544,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.58498,-0.012344,-0.038174,0,0
3,GO EPITHELIAL CELL MORPHOGENESIS,0.79394,-0.012413,0.031331,0,0
3,GO CHROMATIN ORGANIZATION,0.61803,-0.01246,-0.034452,0,0
3,GO TELOMERASE RNA LOCALIZATION,0.76963,-0.01247,-0.059444,0,0
3,GO PROTEIN TARGETING,0.84314,-0.012744,0.010897,0,0
3,GO ACID SECRETION,0.99368,-0.012854,0.013805,0,0
3,GO MITOTIC RECOMBINATION,0.85555,-0.013366,-0.014282,0,0
3,GO FERTILIZATION,0.38829,-0.0136,-0.035914,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.46168,-0.013648,-0.030718,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.74555,-0.01365,-0.028758,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.72171,-0.013682,0.023698,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.69814,-0.01377,-0.011576,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.4521,-0.013998,-0.10041,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.70989,-0.01403,-0.0060843,0,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.76963,-0.01409,0.023086,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.91805,-0.014145,-0.0076424,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.5959,-0.014183,0.00043154,0,0
3,GO REGULATION OF HORMONE LEVELS,0.68646,-0.014221,0.014572,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.4521,-0.014407,-0.081789,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.68646,-0.014895,-0.011302,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.99368,-0.015188,0.043637,0,0
3,GO RENAL SODIUM EXCRETION,0.62923,-0.01525,0.067845,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.62923,-0.015266,0.0054337,0,0
3,GO HISTONE H2A UBIQUITINATION,0.68646,-0.015454,-0.030807,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.81845,-0.015461,-0.01576,0,0
3,GO METHIONINE METABOLIC PROCESS,0.57414,-0.015527,0.049377,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.50109,-0.015545,-0.014185,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.5959,-0.015632,-0.058503,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.91805,-0.015706,-0.00012001,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.98106,-0.015794,0.02384,0,0
3,GO MITOTIC CELL CYCLE,0.48117,-0.015973,-0.047805,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.79394,-0.016009,0.036484,0,0
3,GO EXPLORATION BEHAVIOR,0.94321,-0.0162,0.0056467,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.94321,-0.016316,0.03716,0,0
3,GO PHOTOTRANSDUCTION,0.91805,-0.016397,0.004525,0,0
3,GO ACTIN CROSSLINK FORMATION,0.61803,-0.016702,-0.011228,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.61803,-0.016785,0.0037848,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.88046,-0.016823,-0.013516,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.4521,-0.016828,-0.013102,0,0
3,GO DEVELOPMENTAL GROWTH,0.84314,-0.017019,0.040615,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.54223,-0.017167,0.094728,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.94321,-0.017362,0.023039,0,0
3,GO REGULATION OF EXCRETION,0.60692,-0.017369,0.063871,0,0
3,GO VASODILATION,0.52145,-0.01746,0.068838,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.81845,-0.017935,-0.0023752,0,0
3,GO EYE MORPHOGENESIS,0.94321,-0.017956,0.057344,0,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.88046,-0.017958,0.064407,0,0
3,GO SIALYLATION,0.56341,-0.018038,0.08088,0,0
3,GO MALE GAMETE GENERATION,0.39705,-0.018215,-0.051663,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.36271,-0.018344,-0.10659,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.89296,-0.018483,0.034611,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.54223,-0.018541,-0.086922,0,0
3,GO CELL MATURATION,0.79394,-0.018553,0.030025,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.69814,-0.018648,-0.0038323,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.94321,-0.018697,0.014814,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.89296,-0.018731,0.050171,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.76963,-0.018803,-0.018871,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.7336,-0.018828,-0.01089,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.93062,-0.018906,0.028491,0,0
3,GO CHROMATIN REMODELING,0.61803,-0.018999,-0.060317,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.3148,-0.019059,0.14314,0,0
3,GO TELOMERE CAPPING,0.66333,-0.019062,-0.028614,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.78176,-0.019064,-0.0053321,0,0
3,GO CELL GROWTH,0.88046,-0.019076,0.045015,0,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.67486,-0.019087,-0.060095,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.51122,-0.019166,-0.030763,0,0
3,GO HISTONE UBIQUITINATION,0.75756,-0.019256,-0.035682,0,0
3,GO FUCOSYLATION,0.75756,-0.019383,-0.0091282,0,0
3,GO CHROMOSOME ORGANIZATION,0.50109,-0.019498,-0.057866,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.93062,-0.019517,-0.019908,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.74555,-0.019525,0.010871,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.61803,-0.019528,0.12201,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.76963,-0.019575,0.071156,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.85555,-0.019587,0.026257,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.58498,-0.01963,-0.010001,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.83078,-0.019671,0.026249,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.86799,-0.019735,0.032666,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.62923,-0.019758,-0.034798,0,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.80618,-0.019864,0.023777,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.49108,-0.019881,-0.033937,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.99368,-0.020028,-0.0011804,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.75756,-0.020047,0.0037565,0,0
3,GO LOOP OF HENLE DEVELOPMENT,0.79394,-0.020141,0.037441,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.72171,-0.020152,-0.029528,0,0
3,GO DNA REPAIR,0.47137,-0.020184,-0.071227,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.79394,-0.020301,-0.018612,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.62923,-0.020537,0.016991,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.65188,-0.020629,-0.037813,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.61803,-0.02071,0.016579,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.5959,-0.021011,0.026312,0,0
3,GO THYROID GLAND DEVELOPMENT,0.5959,-0.021138,-0.004351,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.76963,-0.021171,-0.019549,0,0
3,GO HISTONE METHYLATION,0.64051,-0.021186,-0.037393,0,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.91805,-0.021402,0.015909,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.93062,-0.021402,0.018961,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.78176,-0.021678,0.028759,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.96843,-0.021963,0.033059,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.67486,-0.021978,0.080327,0,0
3,GO SOMITE DEVELOPMENT,0.99368,-0.022058,0.025549,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.5959,-0.022087,-0.029631,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.98106,-0.022148,0.040653,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.75756,-0.022227,-0.041009,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.84314,-0.022252,0.054783,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.74555,-0.022364,0.018584,0,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.67486,-0.022665,-0.011772,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.70989,-0.022765,-0.034585,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.25111,-0.022827,-0.08532,0,0
3,GO PROTEIN MANNOSYLATION,0.51122,-0.022878,-0.051668,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.81845,-0.023112,0.037559,0,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.38829,-0.02322,-0.14769,0,0
3,GO GAMETE GENERATION,0.36271,-0.023271,-0.043031,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.79394,-0.023413,0.060581,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.93062,-0.023447,-0.0045414,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.89296,-0.023452,-0.0043762,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.52145,-0.023508,0.0093182,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.4521,-0.023657,-0.12089,0,0
3,GO NEURON PROJECTION REGENERATION,0.96843,-0.02378,0.04608,0,0
3,GO SPERM MOTILITY,0.76963,-0.023998,-0.027937,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.53179,-0.024184,-0.029081,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.96843,-0.024355,0.041099,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.83078,-0.024547,0.035948,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.83078,-0.024603,0.093231,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.88046,-0.024718,0.039856,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.88046,-0.024871,0.0095136,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.62923,-0.024978,-0.047073,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.47137,-0.025651,-0.047515,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.43329,-0.025665,-0.01432,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.67486,-0.025837,-0.022273,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.37111,-0.026095,-0.058386,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.55277,-0.026316,-0.077969,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.52145,-0.026316,-0.0029296,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.89296,-0.026427,-0.023647,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.96843,-0.026527,0.023094,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.80618,-0.026651,-0.030922,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.32248,-0.026656,-0.023469,0,0
3,GO MUSCLE CONTRACTION,0.58498,-0.026799,0.078319,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.80618,-0.026861,0.052835,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.95582,-0.026896,-0.00054853,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.70989,-0.026983,-0.042025,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.41494,-0.026988,-0.095866,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.98106,-0.027211,0.097759,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.67486,-0.027499,0.02579,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.39705,-0.027571,-0.071562,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.40594,-0.027606,-0.024674,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.60692,-0.027682,-0.032264,0,0
3,GO RECOMBINATIONAL REPAIR,0.43329,-0.027773,-0.099147,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.39705,-0.027811,-0.0271,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.55277,-0.027959,-0.054207,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.58498,-0.028028,0.069375,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.41494,-0.028067,-0.072541,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.58498,-0.028515,-0.022503,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.84314,-0.028706,0.095395,0,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.50109,-0.028723,-0.057436,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.94321,-0.028752,0.020648,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.62923,-0.028893,-0.087224,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.58498,-0.028924,0.013814,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.94321,-0.028982,0.022994,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.56341,-0.028989,-0.015404,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.65188,-0.029075,0.002968,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.41494,-0.029333,-0.089925,0,0
3,GO REGULATION OF HEART RATE,0.95582,-0.029628,0.01839,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.90549,-0.029662,0.036507,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.2259,-0.02968,-0.088151,0,0
3,GO RHYTHMIC BEHAVIOR,0.95582,-0.029846,0.028347,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.90549,-0.029917,0.0068768,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.96843,-0.029925,0.021533,0,0
3,GO PENILE ERECTION,0.74555,-0.029986,-0.087957,0,0
3,GO RESPONSE TO HYDROXYUREA,0.38829,-0.030016,-0.090642,0,0
3,GO DNA CATABOLIC PROCESS,0.67486,-0.030077,0.012818,0,0
3,GO ORGANIC CATION TRANSPORT,1,-0.030134,0.031795,0,0
3,GO CHLORIDE TRANSPORT,0.96843,-0.03023,0.020184,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.47137,-0.030261,0.0083251,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.98106,-0.030319,0.031372,0,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.67486,-0.030609,0.00013683,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.81845,-0.030699,0.019813,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.50109,-0.030711,-0.077633,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.52145,-0.030732,0.061962,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.38829,-0.030793,-0.041544,0,0
3,GO CAMP METABOLIC PROCESS,0.98106,-0.030883,0.04762,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.69814,-0.030946,0.0019475,0,0
3,GO CELLULAR RESPIRATION,0.15197,-0.031145,-0.041443,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.38829,-0.03159,-0.026133,0,0
3,GO LUTEINIZATION,0.64051,-0.031809,0.077308,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.47137,-0.031868,0.009083,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.37964,-0.032008,-0.042019,0,0
3,GO RNA CAPPING,0.40594,-0.032103,-0.050175,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.52145,-0.032152,-0.0083476,0,0
3,GO SEXUAL REPRODUCTION,0.32248,-0.03225,-0.039016,0,0
3,GO RHYTHMIC PROCESS,0.78176,-0.032251,0.027352,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.37964,-0.032319,-0.055911,0,0
3,GO ATP METABOLIC PROCESS,0.37111,-0.032379,-0.022386,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.40594,-0.032554,-0.049281,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.68646,-0.032664,-0.024354,0,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.95582,-0.03268,0.0054622,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.53179,-0.032879,-0.033983,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.2998,-0.032929,-0.041089,0,0
3,GO SINGLE FERTILIZATION,0.197,-0.033128,-0.048466,0,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.18102,-0.033141,-0.056209,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.55277,-0.033149,-0.036839,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.32248,-0.033253,-0.040825,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.33029,-0.033581,-0.050531,0,0
3,GO MYELIN ASSEMBLY,0.40594,-0.033713,-0.016577,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.84314,-0.033739,0.047824,0,0
3,GO PROTEIN REFOLDING,0.88046,-0.033882,-0.014046,0,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.23203,-0.034148,-0.02134,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.72171,-0.034443,0.028903,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.49108,-0.034457,-0.057939,0,0
3,GO CELL JUNCTION ASSEMBLY,0.70989,-0.034769,0.024951,0,0
3,GO EXIT FROM MITOSIS,0.18624,-0.034785,-0.13518,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.81845,-0.034914,0.024028,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.44264,-0.034976,-0.027336,0,0
3,GO ZINC ION TRANSPORT,0.85555,-0.035017,0.023917,0,0
3,GO MITOTIC CYTOKINESIS,0.37111,-0.035121,-0.076354,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.40594,-0.035274,-0.075756,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.93062,-0.035284,0.041311,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.66333,-0.03534,0.027961,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.55277,-0.035382,-0.0080265,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.5959,-0.035574,-0.009464,0,0
3,GO ENERGY HOMEOSTASIS,0.58498,-0.03571,-0.0013989,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.56341,-0.036041,-0.052698,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.89296,-0.036162,-0.0024848,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.42405,-0.036169,-0.088352,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.47137,-0.036232,-0.022121,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.56341,-0.036245,0.0039454,0,0
3,GO REGULATION OF CELL SIZE,0.90549,-0.036271,0.052922,0,0
3,GO NUCLEAR MIGRATION,0.44264,-0.036338,-0.03403,0,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.42405,-0.036382,-0.0719,0,0
3,GO OOCYTE DIFFERENTIATION,0.21989,-0.036761,-0.082988,0,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.58498,-0.03688,0.0080754,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.86799,-0.037068,0.024534,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.67486,-0.037141,-0.031184,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.66333,-0.03724,0.01527,0,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.85555,-0.037536,0.069345,0,0
3,GO CELL CELL SIGNALING,0.44264,-0.037639,0.0019811,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.44264,-0.037702,-0.037244,0,0
3,GO DOSAGE COMPENSATION,0.53179,-0.037725,-0.05321,0,0
3,GO BASE EXCISION REPAIR,0.53179,-0.037827,-0.084078,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.42405,-0.038157,-0.037355,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.58498,-0.038199,-0.0035684,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.37111,-0.038264,-0.019576,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.57414,-0.038281,-0.034372,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.58498,-0.038327,0.050301,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.39705,-0.038444,-0.11917,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.72171,-0.038543,0.012364,0,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.53179,-0.039,-0.0015928,0,0
3,GO CHROMATIN SILENCING,0.34626,-0.039024,-0.080662,0,0
3,GO CELL MORPHOGENESIS,0.58498,-0.03904,0.019363,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.55277,-0.039095,0.0085714,0,0
3,GO MIDBRAIN DEVELOPMENT,0.57414,-0.039246,0.0079827,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.83078,-0.039259,0.0063561,0,0
3,GO REGIONALIZATION,0.4521,-0.039495,-0.01166,0,0
3,GO POLYOL CATABOLIC PROCESS,0.23203,-0.039649,-0.07449,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.53179,-0.039715,0.0023981,0,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.44264,-0.03983,-0.087137,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.5959,-0.040156,-0.011411,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.64051,-0.040366,-0.03372,0,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.2259,-0.040415,-0.062609,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.27821,-0.040448,-0.050308,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.66333,-0.040614,-0.018752,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.37111,-0.040654,-0.008656,0,0
3,GO PROTEIN ACETYLATION,0.43329,-0.040828,-0.031022,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.64051,-0.041071,-0.017997,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.2259,-0.041073,-0.10195,0,0
3,GO IMPORT INTO CELL,0.86799,-0.041108,0.025907,0,0
3,GO COGNITION,0.42405,-0.041305,-0.032131,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.11524,-0.041354,-0.14627,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.56341,-0.041509,0.018753,0,0
3,GO MEMBRANE REPOLARIZATION,0.76963,-0.041657,0.020389,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.51122,-0.041835,0.018641,0,0
3,GO DNA GEOMETRIC CHANGE,0.52145,-0.041941,-0.086117,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.70989,-0.042031,-0.026821,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.98106,-0.042053,0.036876,0,0
3,GO FAT CELL PROLIFERATION,0.37964,-0.04251,-0.050146,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.57414,-0.042565,0.017076,0,0
3,GO LUNG CELL DIFFERENTIATION,0.41494,-0.04267,-0.081877,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.20822,-0.042677,-0.076856,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.80618,-0.042764,0.031993,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.62923,-0.042884,-0.030459,0,0
3,GO DIOL METABOLIC PROCESS,0.39705,-0.04294,-0.04649,0,0
3,GO N GLYCAN PROCESSING,0.72171,-0.042988,0.067789,0,0
3,GO MISMATCH REPAIR,0.20822,-0.04315,-0.10113,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.54223,-0.043337,0.01332,0,0
3,GO PROTEIN FOLDING,0.20822,-0.043431,-0.023304,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.4521,-0.043542,-0.046655,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.15197,-0.043558,-0.1069,0,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.98106,-0.043573,0.03418,0,0
3,GO DNA REPLICATION,0.4521,-0.043597,-0.094544,0,0
3,GO LIPID GLYCOSYLATION,0.44264,-0.043775,-0.038848,0,0
3,GO MITOCHONDRIAL FISSION,0.79394,-0.043965,0.03752,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.61803,-0.044399,-0.018489,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.37111,-0.044459,-0.045414,0,0
3,GO NADH METABOLIC PROCESS,0.49108,-0.044473,-0.028587,0,0
3,GO CARTILAGE MORPHOGENESIS,0.91805,-0.044494,0.051704,0,0
3,GO POSITIVE REGULATION OF ACROSOME REACTION,0.66333,-0.044808,-0.031964,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.41494,-0.044872,-0.10643,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.52145,-0.044889,-0.022205,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.24463,-0.045187,-0.13994,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.2577,-0.045212,-0.069306,0,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.26442,-0.045238,-0.11486,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.56341,-0.045257,-0.098975,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.52145,-0.045454,-0.017384,0,0
3,GO ORGANELLE LOCALIZATION,0.214,-0.045726,-0.053096,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.74555,-0.045812,-0.021674,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.94321,-0.045838,0.027779,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.51122,-0.045985,-0.069434,0,0
3,GO COPULATION,0.93062,-0.046054,0.022407,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.18624,-0.046154,-0.18929,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.80618,-0.046196,0.0048744,0,0
3,GO OOGENESIS,0.28529,-0.046404,-0.079401,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.95582,-0.04646,0.023846,0,0
3,GO CORPUS CALLOSUM DEVELOPMENT,0.89296,-0.046719,0.062571,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.86799,-0.046811,0.040439,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.83078,-0.047327,0.027368,0,0
3,GO VIRAL LATENCY,0.98106,-0.047393,-0.030124,0,0
3,GO RESPONSE TO LITHIUM ION,0.81845,-0.047453,0.016327,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.29248,-0.047688,-0.07321,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.70989,-0.047693,0.033297,0,0
3,GO SODIUM ION TRANSPORT,0.50109,-0.04774,-0.014346,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.78176,-0.047833,0.0050248,0,0
3,GO HISTONE H4 ACETYLATION,0.3148,-0.047924,-0.055338,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.39705,-0.048053,-0.07714,0,0
3,GO ORGANELLE INHERITANCE,0.79394,-0.048807,-0.0020722,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.72171,-0.049354,-0.0071143,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.2577,-0.049466,-0.079016,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27126,-0.049489,-0.099915,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.35442,-0.049795,-0.16958,0,0
3,GO MEMORY,0.2998,-0.049923,-0.046806,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.50109,-0.049937,0.0080021,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.84314,-0.049944,0.044614,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.83078,-0.050023,0.01907,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.2577,-0.050293,-0.059601,0,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.95582,-0.050373,0.017042,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.3148,-0.050484,-0.018561,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,1,-0.050831,0.02776,0,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.23203,-0.050924,-0.057636,0,0
3,GO CRISTAE FORMATION,0.33821,-0.050958,-0.037013,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.74555,-0.05118,-0.00083358,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.86799,-0.051234,0.0042765,0,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.17091,-0.051235,-0.074424,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.51122,-0.051363,-0.03251,0,0
3,GO ATP TRANSPORT,0.39705,-0.051394,-0.018811,0,0
3,GO CELL JUNCTION ORGANIZATION,0.49108,-0.051509,-0.0019987,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.96843,-0.051563,0.036867,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.49108,-0.051774,-0.015855,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.44264,-0.051921,-0.01224,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.36271,-0.052018,-0.082634,0,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.89296,-0.052054,0.030596,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.20822,-0.052099,-0.01533,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.18102,-0.052119,-0.14322,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.64051,-0.052278,-0.013017,0,0
3,GO DNA LIGATION,0.41494,-0.052433,-0.093033,0,0
3,GO GERM CELL DEVELOPMENT,0.2577,-0.052498,-0.070888,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.80618,-0.052572,0.049919,0,0
3,GO TRANSFERRIN TRANSPORT,0.52145,-0.052949,-0.013922,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.52145,-0.053003,-0.028697,0,0
3,GO SPERMATID DIFFERENTIATION,0.41494,-0.053324,-0.055668,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.38829,-0.053333,-0.0075243,0,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.38829,-0.053368,-0.033426,0,0
3,GO CELL DIVISION,0.37964,-0.053416,-0.069302,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.67486,-0.053426,-0.013331,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.47137,-0.053537,-0.077005,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.26442,-0.053573,-0.12712,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.26442,-0.05397,-0.071719,0,0
3,GO CILIUM MOVEMENT,0.53179,-0.054051,-0.065902,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.55277,-0.054509,-0.10582,0,0
3,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.46168,-0.055026,-0.048856,0,0
3,GO REGULATION OF NEURON MIGRATION,0.37964,-0.055219,-0.080853,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.56341,-0.055399,-0.0046913,0,0
3,GO DEVELOPMENTAL INDUCTION,0.65188,-0.055706,-0.018644,0,0
3,GO REGULATION OF DNA REPLICATION,0.37964,-0.055804,-0.082041,0,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.40594,-0.055862,-0.043729,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.54223,-0.055906,-0.013051,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.49108,-0.055937,-0.011534,0,0
3,GO AXONAL FASCICULATION,0.39705,-0.05613,-0.080444,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.28529,-0.056262,-0.083124,0,0
3,GO EXTRACELLULAR TRANSPORT,0.93062,-0.056329,-0.0026026,0,0
3,GO SHORT TERM MEMORY,0.41494,-0.056415,-0.067619,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.52145,-0.056557,0.010186,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.67486,-0.056878,-0.03953,0,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.28529,-0.056908,-0.015053,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.74555,-0.056914,0.12939,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.5959,-0.056915,-0.024579,0,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.48117,-0.056968,-0.035907,0,0
3,GO HISTONE H3 K36 METHYLATION,0.4521,-0.057141,-0.070595,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.41494,-0.057668,-0.094062,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.4521,-0.057707,-0.03886,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.65188,-0.057718,-0.024825,0,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.30724,-0.057739,-0.078613,0,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.96843,-0.057861,0.019981,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.60692,-0.058079,-0.033009,0,0
3,GO DNA CONFORMATION CHANGE,0.34626,-0.058358,-0.10697,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.88046,-0.058436,0.0244,0,0
3,GO REGULATION OF MRNA BINDING,0.28529,-0.058664,-0.052626,0,0
3,GO PROTEIN ACYLATION,0.27821,-0.058749,-0.055787,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.53179,-0.058806,-0.049494,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.88046,-0.058844,0.027974,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.30724,-0.058845,-0.074857,0,0
3,GO CELL PROJECTION ASSEMBLY,0.62923,-0.058974,0.0023005,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.26442,-0.058976,-0.1117,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.36271,-0.059198,-0.051901,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.33821,-0.059348,-0.045479,0,0
3,GO MEIOTIC CELL CYCLE,0.10134,-0.059375,-0.15928,0,0
3,GO CIRCADIAN RHYTHM,0.43329,-0.059543,-0.0079585,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.52145,-0.059643,-0.024397,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.65188,-0.059674,-0.049855,0,0
3,GO REGULATION OF APPETITE,0.25111,-0.059769,-0.09534,0,0
3,GO AXON EXTENSION,0.36271,-0.060098,-0.025341,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.29248,-0.060152,-0.16298,0,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.53179,-0.060228,-0.023368,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.84314,-0.060276,0.023686,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.48117,-0.060489,-0.039602,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.32248,-0.060506,-0.072358,0,0
3,GO RESPONSE TO LEAD ION,0.56341,-0.060572,-0.0030793,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.33821,-0.061046,-0.14249,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.65188,-0.06129,-0.044309,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.69814,-0.06135,-0.071605,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.214,-0.061428,-0.099338,0,0
3,GO HISTONE H2A ACETYLATION,0.17091,-0.061468,-0.11607,0,0
3,GO PROTEIN NEDDYLATION,0.27126,-0.061517,-0.046914,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.21989,-0.061632,-0.080501,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.38829,-0.061737,-0.025876,0,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.42405,-0.061752,-0.0044591,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.37111,-0.062092,-0.053111,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.24463,-0.06227,-0.043745,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.66333,-0.062364,-0.065955,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.27126,-0.062406,-0.070288,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.21989,-0.062516,-0.033228,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.43329,-0.062658,0.0071674,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.34626,-0.062675,-0.032479,0,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.27821,-0.062945,-0.023633,0,0
3,GO REGULATION OF DNA REPAIR,0.30724,-0.062971,-0.069719,0,0
3,GO CENTROSOME SEPARATION,0.32248,-0.063381,-0.15914,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.85555,-0.063539,0.044654,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.32248,-0.063881,-0.061103,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.214,-0.063895,-0.16636,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.62923,-0.06435,0.013984,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.44264,-0.064373,-0.07113,0,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.65188,-0.064444,-0.090454,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.37111,-0.064614,-0.15097,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.41494,-0.064616,-0.0084746,0,0
3,GO NEURAL CREST FORMATION,0.74555,-0.06474,0.069385,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.78176,-0.06479,0.016184,0,0
3,GO MRNA PROCESSING,0.55277,-0.064812,-0.039927,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.65188,-0.064967,0.012998,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.33029,-0.064982,-0.027317,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.20256,-0.06502,-0.1158,0,0
3,GO HAIR CELL DIFFERENTIATION,0.39705,-0.065046,-0.031291,0,0
3,GO NEURON PROJECTION GUIDANCE,0.27821,-0.065118,-0.037809,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.56341,-0.065537,-0.028231,0,0
3,GO SULFATE TRANSPORT,0.29248,-0.065554,-0.084336,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.62923,-0.065632,0.023604,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.35442,-0.065722,-0.022694,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.91805,-0.065725,0.023654,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.5959,-0.065879,0.079621,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.67486,-0.066032,0.00021101,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.28529,-0.066076,-0.084116,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.57414,-0.066145,0.0021399,0,0
3,GO REGULATION OF RNA SPLICING,0.4521,-0.066222,-0.039899,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.197,-0.066385,-0.019511,0,0
3,GO HEART PROCESS,0.85555,-0.066551,0.016631,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.98106,-0.066663,-0.0068125,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.47137,-0.066817,-0.11698,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.23827,-0.066831,-0.16819,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.25111,-0.067137,-0.076139,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.48117,-0.067359,-0.11337,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.3148,-0.067437,-0.10938,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.2998,-0.067509,-0.10094,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.37964,-0.067572,-0.093237,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.44264,-0.067706,-0.067862,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.24463,-0.068073,-0.071624,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.40594,-0.068133,-0.051219,0,0
3,GO CHROMOSOME SEGREGATION,0.197,-0.068265,-0.15715,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.30724,-0.068432,-0.019542,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.19156,-0.068478,-0.20612,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.42405,-0.068838,-0.004343,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.91805,-0.069131,0.066645,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.15655,-0.069887,-0.18608,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.38829,-0.070231,-0.010566,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.56341,-0.070238,-0.063729,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.74555,-0.07035,0.020063,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.2259,-0.071167,-0.05724,0,0
3,GO CENTRIOLE ASSEMBLY,0.30724,-0.071195,-0.11158,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.7336,-0.071239,-0.014264,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.054439,-0.071647,-0.13449,0,0
3,GO ORGANELLE ASSEMBLY,0.2998,-0.071686,-0.041512,0,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.5959,-0.071786,-0.010176,0,0
3,GO RNA SPLICING,0.53179,-0.071986,-0.042215,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.52145,-0.072006,-0.050838,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.54223,-0.072153,-0.028715,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.50109,-0.072636,-0.12142,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.86799,-0.072662,0.038207,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.99368,-0.072763,0.034349,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.32248,-0.072767,-0.087407,0,0
3,GO CYTOKINESIS,0.15197,-0.072793,-0.10189,0,0
3,GO L AMINO ACID TRANSPORT,0.99368,-0.07286,0.039646,0,0
3,GO SPINDLE ASSEMBLY,0.19156,-0.072932,-0.1427,0,0
3,GO REGULATION OF RNA BINDING,0.33029,-0.073012,-0.071283,0,0
3,GO STRESS GRANULE ASSEMBLY,0.48117,-0.073186,-0.030011,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.40594,-0.073264,-0.036076,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.44264,-0.073451,-0.0059621,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.55277,-0.073665,-0.049152,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.046961,-0.073707,-0.055733,0,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.21989,-0.073746,-0.090322,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.10468,-0.073864,-0.079491,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.12662,-0.073947,-0.15499,0,0
3,GO CHROMOSOME SEPARATION,0.23827,-0.073983,-0.16239,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.39705,-0.074146,-0.018165,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.12662,-0.074212,-0.077918,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.40594,-0.074222,-0.011604,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.28529,-0.074261,-0.1377,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.2259,-0.074279,-0.10894,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.21989,-0.074412,-0.16007,0,0
3,GO RESPONSE TO AMINE,0.25111,-0.074454,-0.058948,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.44264,-0.07496,-0.043544,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.37964,-0.075023,-0.043927,0,0
3,GO ORGANELLE FISSION,0.1475,-0.075385,-0.12226,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.33821,-0.07566,-0.068066,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.52145,-0.075669,-0.018568,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.34626,-0.075841,-0.029576,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.30724,-0.076177,-0.083788,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.2998,-0.076184,-0.13273,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.12662,-0.076258,-0.12275,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.2998,-0.076297,-0.065419,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.60692,-0.076341,0.024034,0,0
3,GO NUCLEOTIDE TRANSPORT,0.51122,-0.076479,-0.0039923,0,0
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.29248,-0.076618,-0.038223,0,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.27821,-0.076618,-0.042139,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.56341,-0.076795,-0.00026458,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.20822,-0.076891,-0.06343,0,0
3,GO TRANSLESION SYNTHESIS,0.33821,-0.077179,-0.068975,0,0
3,GO RESPONSE TO ALKALOID,0.11524,-0.077336,-0.050567,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.13885,-0.077467,-0.099617,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.95582,-0.077706,0.044989,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.20256,-0.07776,-0.16608,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.35442,-0.077786,-0.074193,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.13467,-0.077813,-0.24985,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.24463,-0.078306,-0.086356,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.2998,-0.078645,-0.028622,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.072385,-0.078853,-0.061821,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.21989,-0.079351,-0.081225,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.4521,-0.07937,-0.050431,0,0
3,GO RESPONSE TO PAIN,0.53179,-0.079402,-0.030166,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.23203,-0.079679,-0.055835,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.7336,-0.07985,-0.0014315,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.18624,-0.080021,-0.08852,0,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.62923,-0.080026,0.024263,0,0
3,GO CARDIAC CHAMBER FORMATION,0.42405,-0.080092,-0.091501,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.46168,-0.080202,-0.007026,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.32248,-0.080425,-0.044122,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.83078,-0.080563,0.0018366,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.57414,-0.080689,-0.040961,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.80618,-0.080728,0.028427,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.1475,-0.080948,-0.075107,0,0
3,GO CHROMOSOME LOCALIZATION,0.10134,-0.081088,-0.16275,0,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.40594,-0.081328,-0.0641,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.38829,-0.081396,-0.047625,0,0
3,GO NERVOUS SYSTEM PROCESS,0.29248,-0.08145,-0.022273,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.214,-0.081482,-0.064713,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.13885,-0.081588,-0.034791,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.27821,-0.081824,-0.056081,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.28529,-0.081839,-0.086829,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.4521,-0.081873,-0.02799,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.13885,-0.08198,-0.12718,0,0
3,GO POSTREPLICATION REPAIR,0.33821,-0.082114,-0.068083,0,0
3,GO CENTROSOME DUPLICATION,0.214,-0.0823,-0.12922,0,0
3,GO ASSOCIATIVE LEARNING,0.13885,-0.08258,-0.076375,0,0
3,GO MITOCHONDRIAL FUSION,0.17091,-0.082601,-0.04821,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.2998,-0.082607,-0.07127,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.70989,-0.08323,-0.019441,0,0
3,GO CARNITINE METABOLIC PROCESS,0.5959,-0.083696,-0.0026946,0,0
3,GO REGULATION OF CYTOKINESIS,0.21989,-0.083825,-0.11078,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.214,-0.084166,-0.095768,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.16123,-0.084731,-0.10311,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.33821,-0.084898,-0.041043,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.18102,-0.085239,-0.1138,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.065157,-0.085317,-0.1831,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.38829,-0.085576,-0.050694,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.2998,-0.085707,-0.077636,0,0
3,GO OOCYTE MATURATION,0.27126,-0.085972,-0.10633,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.2259,-0.086265,-0.048152,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.048745,-0.086471,-0.15439,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.16602,-0.08686,-0.044871,0,0
3,GO SEX DETERMINATION,0.43329,-0.087132,-0.070094,0,0
3,GO DIVALENT METAL ION EXPORT,0.26442,-0.087135,-0.094447,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.4521,-0.087694,-0.015751,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.1475,-0.087917,-0.17043,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.51122,-0.088114,-0.030485,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.80618,-0.088136,0.0029798,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.17091,-0.088263,-0.1051,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.2998,-0.088748,-0.077708,0,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.39705,-0.089531,-0.068806,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.074935,-0.090016,-0.23013,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.062884,-0.090496,-0.13745,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.75756,-0.090598,-0.015265,0,0
3,GO MEMBRANE DEPOLARIZATION,0.21989,-0.09071,-0.063293,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.53179,-0.091615,-0.01342,0,0
3,GO NEUROGENESIS,0.214,-0.091649,-0.031847,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.18624,-0.091856,-0.11946,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.25111,-0.091867,-0.15008,0,0
3,GO HEART FORMATION,0.40594,-0.091891,-0.025588,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.27126,-0.091945,-0.07107,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.79394,-0.091981,0.0080159,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.38829,-0.091991,-0.068813,0,0
3,GO CELL PROJECTION ORGANIZATION,0.27821,-0.092312,-0.03035,0,0
3,GO AXIS SPECIFICATION,0.26442,-0.092396,-0.057668,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37964,-0.092467,-0.012689,0,0
3,GO RRNA 3 END PROCESSING,0.25111,-0.09284,-0.096501,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.20256,-0.093038,-0.11509,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.10134,-0.093188,-0.090678,0,0
3,GO MALE SEX DETERMINATION,0.32248,-0.09347,-0.11864,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.34626,-0.093487,-0.019914,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.08303,-0.093861,-0.10323,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.13467,-0.094065,-0.16768,0,0
3,GO SIGNAL RELEASE,0.214,-0.094107,-0.033649,0,0
3,GO SISTER CHROMATID SEGREGATION,0.15655,-0.09453,-0.17754,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.16123,-0.094965,-0.084369,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.39705,-0.095028,-0.091586,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.40594,-0.095192,-0.068527,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.060677,-0.095275,-0.24502,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.51122,-0.095473,-0.068354,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.40594,-0.096127,-0.015033,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.056456,-0.096276,-0.21055,0,0
3,GO SISTER CHROMATID COHESION,0.20256,-0.096334,-0.16798,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.058535,-0.096352,-0.10294,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.32248,-0.096408,-0.038128,0,0
3,GO RESPONSE TO GLUCAGON,0.21989,-0.096565,-0.073631,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.72171,-0.09685,-0.0069047,0,0
3,GO SPINDLE LOCALIZATION,0.17591,-0.097321,-0.11154,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.25111,-0.097502,-0.050196,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.18102,-0.097538,-0.051162,0,0
3,GO COENZYME A METABOLIC PROCESS,0.1475,-0.097573,-0.062666,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.28529,-0.09761,-0.053662,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.16123,-0.097966,-0.051317,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.3148,-0.098401,-0.10652,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.098083,-0.098889,-0.13764,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.2998,-0.098925,-0.1119,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.058535,-0.099206,-0.092019,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.29248,-0.099341,-0.11516,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.16602,-0.099599,-0.061516,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.37964,-0.099786,-0.026768,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.18102,-0.099818,-0.089875,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.14312,-0.1001,-0.10257,0,0
3,GO INOSITOL METABOLIC PROCESS,0.094909,-0.1001,-0.13639,0,0
3,GO RESPONSE TO AMPHETAMINE,0.27821,-0.10013,-0.066531,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.33821,-0.10019,-0.033199,0,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.19156,-0.10096,-0.0515,0,0
3,GO ACTION POTENTIAL,0.1475,-0.10114,-0.060317,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.85555,-0.10128,0.013843,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.17091,-0.10146,-0.070555,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.60692,-0.10151,-0.022222,0,0
3,GO MATING,0.37111,-0.10157,-0.041368,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.25111,-0.10171,-0.071479,0,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.2998,-0.1021,-0.077808,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.091819,-0.10224,-0.071286,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.20822,-0.10242,-0.066126,0,0
3,GO NEURON PROJECTION ORGANIZATION,0.20822,-0.10255,-0.063569,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.30724,-0.10273,-0.070672,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.21989,-0.10284,-0.065752,0,0
3,GO DNA PACKAGING,0.18624,-0.10422,-0.15165,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.36271,-0.10447,-0.026786,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.60692,-0.10469,-0.03498,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.11894,-0.1049,-0.10348,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.13885,-0.10534,-0.13916,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.062884,-0.10546,-0.070656,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.16602,-0.10572,-0.11633,0,0
3,GO RESPONSE TO LEUCINE,0.12273,-0.106,-0.14916,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.19156,-0.10608,-0.058812,0,0
3,GO DEVELOPMENTAL MATURATION,0.25111,-0.10611,-0.033713,0,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.11163,-0.10644,-0.11284,0,0
3,GO REGULATION OF MRNA PROCESSING,0.2259,-0.10667,-0.077331,0,0
3,GO ORGANELLE FUSION,0.074935,-0.10702,-0.045341,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.13467,-0.10717,-0.097593,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.23827,-0.10763,-0.063642,0,0
3,GO METAPHASE PLATE CONGRESSION,0.1306,-0.10784,-0.1722,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.55277,-0.10789,-0.04181,0,0
3,GO AXON DEVELOPMENT,0.20256,-0.10806,-0.057563,0,0
3,GO CELL CYCLE DNA REPLICATION,0.24463,-0.10814,-0.17705,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.50109,-0.10823,-0.028598,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.15197,-0.10853,-0.29056,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.098083,-0.1089,-0.13558,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.33821,-0.10927,-0.056206,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.17091,-0.10942,-0.11382,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.1475,-0.11023,-0.061266,0,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.3148,-0.11029,-0.066632,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.2259,-0.1109,-0.063519,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.10468,-0.11094,-0.098937,0,0
3,GO VISUAL BEHAVIOR,0.20256,-0.11132,-0.067461,0,0
3,GO LIMB BUD FORMATION,0.46168,-0.11147,0.16212,0,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.18102,-0.11153,-0.063576,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.38829,-0.11175,-0.012296,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.067497,-0.11205,-0.06691,0,0
3,GO LEARNING,0.069906,-0.11218,-0.1328,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.39705,-0.1125,-0.045973,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.25111,-0.11271,-0.12268,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.49108,-0.11326,-0.068313,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.33029,-0.11344,-0.074083,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.065157,-0.11345,-0.12694,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.12662,-0.11348,-0.063479,0,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.39705,-0.11375,-0.063588,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.027226,-0.11391,-0.13101,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.12273,-0.11398,-0.080879,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.069906,-0.11458,-0.13931,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.34626,-0.11486,-0.038929,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.24463,-0.11502,-0.048185,0,0
3,GO DNA STRAND ELONGATION,0.16602,-0.11511,-0.22333,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.44264,-0.11516,-0.045896,0,0
3,GO DENDRITE DEVELOPMENT,0.094909,-0.11527,-0.10763,0,0
3,GO ACROSOME REACTION,0.077559,-0.11528,-0.096134,0,0
3,GO BEHAVIOR,0.08881,-0.1159,-0.088245,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.094909,-0.11616,-0.23459,0,0
3,GO NUCLEOSOME ORGANIZATION,0.15655,-0.11624,-0.14132,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.18102,-0.1164,-0.11784,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.15655,-0.11646,-0.085109,0,0
3,GO MEMBRANE BIOGENESIS,0.20256,-0.11647,-0.074599,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.060677,-0.11664,-0.10634,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.1475,-0.11666,-0.063973,0,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.17091,-0.11667,-0.093901,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.3148,-0.11672,-0.088102,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.10811,-0.11703,-0.18444,0,0
3,GO REGULATION OF HORMONE SECRETION,0.1306,-0.11794,-0.05917,0,0
3,GO KINETOCHORE ASSEMBLY,0.094909,-0.11828,-0.29378,0,0
3,GO NEURON DIFFERENTIATION,0.1475,-0.11833,-0.060961,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.27821,-0.11868,-0.093837,0,0
3,GO LEYDIG CELL DIFFERENTIATION,0.68646,-0.11888,-0.028999,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.12273,-0.11889,-0.1236,0,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.19156,-0.11946,-0.09058,0,0
3,GO HEAD DEVELOPMENT,0.12273,-0.11958,-0.07226,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.51122,-0.11976,-0.061772,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.11894,-0.11997,-0.1145,0,0
3,GO CELL PART MORPHOGENESIS,0.10134,-0.12026,-0.082502,0,0
3,GO REGULATION OF EXOCYTOSIS,0.11163,-0.12032,-0.073035,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.37964,-0.12036,-0.071628,0,0
3,GO MEMBRANE FISSION,0.11894,-0.1219,-0.088662,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.17091,-0.1219,-0.13735,0,0
3,GO STRIATUM DEVELOPMENT,0.67486,-0.12269,-0.0062761,0,0
3,GO FOREBRAIN CELL MIGRATION,0.23203,-0.12271,-0.076253,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.15655,-0.12281,-0.073055,0,0
3,GO CGMP MEDIATED SIGNALING,0.49108,-0.12285,-0.044263,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16602,-0.12296,-0.086848,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.065157,-0.12304,-0.16703,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.1475,-0.12314,-0.060735,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.25111,-0.12346,-0.093997,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.2577,-0.12384,-0.077212,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10811,-0.1239,-0.11601,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.46168,-0.12423,-0.011967,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.62923,-0.1245,-0.033796,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.08881,-0.12459,-0.17586,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.077559,-0.12469,-0.13623,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.32248,-0.12483,-0.14269,0,0
3,GO SPERM AXONEME ASSEMBLY,0.36271,-0.12521,-0.078244,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.12273,-0.12541,-0.18723,0,0
3,GO NEURON DEVELOPMENT,0.094909,-0.12543,-0.071286,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.094909,-0.12546,-0.13614,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.11524,-0.12565,-0.068155,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75756,-0.12587,0.013277,0,0
3,GO MICROTUBULE ANCHORING,0.2259,-0.12682,-0.092299,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.11894,-0.12731,-0.12942,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.20822,-0.12789,-0.066695,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.26442,-0.12792,-0.10549,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.1306,-0.12797,-0.12439,0,0
3,GO MICROTUBULE BASED PROCESS,0.080256,-0.12813,-0.13308,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.37111,-0.12845,-0.042222,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.20256,-0.12881,-0.059948,0,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.24463,-0.12882,-0.080049,0,0
3,GO MALE MEIOSIS I,0.080256,-0.12972,-0.15532,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.094909,-0.1305,-0.074799,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.46168,-0.13059,-0.037497,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.060677,-0.13075,-0.16041,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.08588,-0.13137,-0.13721,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.17091,-0.13138,-0.16904,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0031545,-0.13272,-0.14472,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.2998,-0.13273,-0.17556,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.1306,-0.13274,-0.082089,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.022172,-0.13286,-0.17974,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.44264,-0.13289,-0.041885,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.091819,-0.13299,-0.084085,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.074935,-0.13299,-0.14309,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.18102,-0.13329,-0.074403,0,0
3,GO MICROTUBULE NUCLEATION,0.10468,-0.13341,-0.11726,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.42405,-0.13348,-0.057069,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.10468,-0.13349,-0.085918,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.37964,-0.13365,-0.040621,0,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.24463,-0.13366,-0.092459,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.091819,-0.13412,-0.18409,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.034576,-0.13488,-0.12926,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.16123,-0.13507,-0.12757,0,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.25111,-0.13512,-0.10787,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.13467,-0.13522,-0.070259,0,0
3,GO PROTEIN DENEDDYLATION,0.027226,-0.13523,-0.10102,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.24463,-0.13534,-0.093832,0,0
3,GO REGULATION OF INSULIN SECRETION,0.11163,-0.13554,-0.067956,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.13885,-0.13574,-0.099089,0,0
3,GO DNA REPLICATION CHECKPOINT,0.21989,-0.137,-0.20871,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.18102,-0.13775,-0.11903,0,0
3,GO ACROSOME ASSEMBLY,0.18102,-0.13833,-0.14346,0,0
3,GO MICROTUBULE SEVERING,0.08303,-0.13856,-0.15429,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.33029,-0.13906,-0.20135,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.10811,-0.13928,-0.17963,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.43329,-0.13941,-0.029563,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.072385,-0.13975,-0.19878,0,0
3,GO HORMONE TRANSPORT,0.074935,-0.13983,-0.074077,0,0
3,GO RESPONSE TO REDOX STATE,0.13885,-0.14025,-0.093865,0,0
3,GO COCHLEA DEVELOPMENT,0.11163,-0.14043,-0.10018,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.10468,-0.14044,-0.12385,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.14312,-0.14052,-0.12196,0,0
3,GO REGULATION OF AXONOGENESIS,0.23203,-0.14079,-0.070081,0,0
3,GO NEUROBLAST PROLIFERATION,0.094909,-0.14166,-0.12703,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.062884,-0.14179,-0.13224,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.24463,-0.14251,-0.11901,0,0
3,GO PROTEIN KINASE C SIGNALING,0.51122,-0.14256,0.00023499,0,0
3,GO DENDRITE MORPHOGENESIS,0.067497,-0.14275,-0.13938,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.13885,-0.14282,-0.22031,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.094909,-0.14288,-0.11264,0,0
3,GO SPINDLE ORGANIZATION,0.077559,-0.14326,-0.17112,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.062884,-0.14331,-0.13863,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.13885,-0.14351,-0.071147,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.017954,-0.14362,-0.17029,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.080256,-0.14417,-0.13679,0,0
3,GO INCLUSION BODY ASSEMBLY,0.065157,-0.1444,-0.048134,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.091819,-0.1455,-0.12989,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.11894,-0.14591,-0.13425,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.27821,-0.14619,-0.10799,0,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.29248,-0.14668,-0.031221,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.11524,-0.1479,-0.080918,0,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.080256,-0.1487,-0.16393,0,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.058535,-0.14884,-0.10488,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.11524,-0.14913,-0.071939,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.1306,-0.14965,-0.097059,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.11163,-0.15039,-0.086503,0,0
3,GO TOXIN METABOLIC PROCESS,0.65188,-0.15088,-0.034299,0,0
3,GO RESPONSE TO L GLUTAMATE,0.2259,-0.15144,-0.097598,0,0
3,GO CELL FATE DETERMINATION,0.44264,-0.15171,-0.043694,0,0
3,GO MITOTIC DNA REPLICATION,0.28529,-0.15236,-0.19381,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.23203,-0.15273,-0.06439,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.30724,-0.15324,-0.097726,0,0
3,GO NEURON PROJECTION EXTENSION,0.10811,-0.1536,-0.087342,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.065157,-0.1539,-0.1311,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.27126,-0.15435,-0.089992,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.15197,-0.15447,-0.080725,0,0
3,GO CARDIAC CONDUCTION,0.16602,-0.15497,-0.069655,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.197,-0.15525,-0.084068,0,0
3,GO CARDIAC VENTRICLE FORMATION,0.24463,-0.15587,-0.15472,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.13885,-0.15607,-0.08876,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.13885,-0.15674,-0.053515,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.29248,-0.15702,-0.065516,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.069906,-0.15738,-0.13389,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.054439,-0.15765,-0.12576,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.27126,-0.15849,-0.22133,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.64051,-0.15888,-0.058106,0,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.11524,-0.15919,-0.14331,0,0
3,GO PALLIUM DEVELOPMENT,0.060677,-0.15941,-0.12129,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.013834,-0.15994,-0.20692,0,0
3,GO HINDBRAIN DEVELOPMENT,0.13467,-0.16005,-0.086416,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.11524,-0.16114,-0.16945,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.16123,-0.16138,-0.19954,0,0
3,GO REGULATION OF OOGENESIS,0.077559,-0.16207,-0.10754,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.34626,-0.16251,-0.090796,0,0
3,GO POTASSIUM ION TRANSPORT,0.054439,-0.16297,-0.11008,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.077559,-0.16397,-0.14144,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.08588,-0.16459,-0.17819,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.16602,-0.16609,-0.080801,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.32248,-0.16699,-0.08224,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.1475,-0.16718,-0.12021,0,0
3,GO RECEPTOR CLUSTERING,0.19156,-0.16729,-0.082357,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.056456,-0.16745,-0.14704,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.060677,-0.16776,-0.12035,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.197,-0.16883,-0.071131,0,0
3,GO DNA REPLICATION INITIATION,0.17091,-0.16951,-0.20971,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.197,-0.17006,-0.070863,0,0
3,GO FOREBRAIN DEVELOPMENT,0.074935,-0.17042,-0.10085,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.54223,-0.17089,-0.05701,0,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.060677,-0.17094,-0.12117,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.16602,-0.171,-0.11676,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.32248,-0.17172,-0.019324,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.091819,-0.17264,-0.091822,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.29248,-0.17336,-0.094193,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.13885,-0.17342,-0.13759,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.23827,-0.17385,-0.089701,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.214,-0.17459,-0.13895,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11524,-0.1751,-0.14405,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.55277,-0.17538,-0.05094,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0172,-0.17566,-0.20155,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.069906,-0.17584,-0.12112,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.067497,-0.17673,-0.11757,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.060677,-0.17858,-0.17557,0,0
3,GO AMINO ACID TRANSPORT,0.056456,-0.17883,-0.086595,0,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.094909,-0.17937,-0.10305,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0066311,-0.17977,-0.19872,0,0
3,GO CILIUM ORGANIZATION,0.080256,-0.18115,-0.13606,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.10134,-0.18287,-0.2503,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.35442,-0.18388,-0.04768,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.08303,-0.18535,-0.16044,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.43329,-0.1858,-0.063433,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.33029,-0.18678,-0.17283,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.16123,-0.18739,-0.13715,0,0
3,GO PANCREAS DEVELOPMENT,0.060677,-0.18764,-0.11089,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.020391,-0.18802,-0.19919,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.11894,-0.18838,-0.1321,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.056456,-0.18922,-0.13495,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.098083,-0.18963,-0.14429,0,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.072385,-0.18987,-0.15671,0,0
3,GO HEART INDUCTION,0.21989,-0.18998,-0.073553,0,0
3,GO RESPONSE TO NICOTINE,0.08881,-0.19121,-0.13427,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.072385,-0.19422,-0.30554,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.067497,-0.1964,-0.17408,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.094909,-0.19832,-0.16082,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.077559,-0.19964,-0.10056,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.10468,-0.19981,-0.15878,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.12662,-0.20041,-0.1594,0,0
3,GO MITOCHONDRION DISTRIBUTION,0.098083,-0.20126,-0.097851,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.23827,-0.20137,-0.10358,0,0
3,GO MRNA SPLICE SITE SELECTION,0.072385,-0.20389,-0.19776,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.24463,-0.20543,-0.11923,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.065157,-0.20924,-0.18325,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.30724,-0.21035,-0.16217,0,0
3,GO NEURON RECOGNITION,0.067497,-0.21308,-0.14652,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.074935,-0.21311,-0.14098,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.08588,-0.21561,-0.17436,0,0
3,GO COLLATERAL SPROUTING,0.10811,-0.22046,-0.13386,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.21989,-0.22369,-0.070825,0,0
3,GO REGULATION OF RELAXATION OF MUSCLE,0.18102,-0.224,-0.19451,0,0
3,GO RETINA LAYER FORMATION,0.060677,-0.22455,-0.23453,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.08303,-0.22516,-0.19604,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.15197,-0.22916,-0.093471,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.1306,-0.23094,-0.11862,0,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.077559,-0.23319,-0.13662,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.056456,-0.23397,-0.13888,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.098083,-0.23457,-0.17184,0,0
3,GO ADRENAL GLAND DEVELOPMENT,0.080256,-0.23476,-0.15011,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.056456,-0.23525,-0.17395,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.054439,-0.24138,-0.15525,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.060677,-0.24327,-0.20497,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.0028457,-0.24584,-0.24517,0,0
3,GO MATING BEHAVIOR,0.037377,-0.24659,-0.1892,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0054671,-0.25123,-0.26055,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.074935,-0.25348,-0.19935,0,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.022172,-0.25727,-0.26685,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.37964,-0.25776,-0.092245,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.08881,-0.25934,-0.1989,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.010101,-0.25975,-0.21279,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.065157,-0.26163,-0.16783,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.058535,-0.26189,-0.34429,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.08588,-0.26483,-0.16914,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.072385,-0.27856,-0.15918,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0057394,-0.28195,-0.25994,0,0
3,GO NOREPINEPHRINE SECRETION,0.080256,-0.28348,-0.17626,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11163,-0.28968,-0.18553,0,0
3,GO GROOMING BEHAVIOR,0.00054254,-0.30175,-0.34978,0,0
3,GO HEART FIELD SPECIFICATION,0.067497,-0.30658,-0.20764,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.094909,-0.32019,-0.18306,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.067497,-0.33433,-0.2287,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.023112,-0.34125,-0.26461,0,0
3,GO RESPONSE TO FORSKOLIN,0.030713,-0.37534,-0.22778,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0016767,-0.40185,-0.35689,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.08303,-0.43374,-0.21156,0,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0013481,-0.43627,-0.38464,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0012758,-0.53981,-0.50059,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00024771,-0.55732,-0.4563,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00033648,-0.57532,-0.45208,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00024771,-0.61348,-0.5688,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.0012071,-0.69161,-0.54802,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.017954,-0.7669,-0.46649,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.00060992,-0.85385,-0.75911,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00040321,0.75503,0.5886,1,1
4,GO REGULATION OF SYNAPSE MATURATION,0.0012071,0.73274,0.51397,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00076864,0.64165,0.5586,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0011418,0.62234,0.54627,1,1
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00033648,0.62181,0.53982,1,1
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0019699,0.58129,0.46849,1,1
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00015974,0.57125,0.52227,1,1
4,GO PREPULSE INHIBITION,0.00020554,0.56354,0.57469,1,1
4,GO SYNAPSE MATURATION,0.00031664,0.54335,0.51967,1,1
4,GO VOCALIZATION BEHAVIOR,6.8565e-05,0.54202,0.54746,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0010798,0.52212,0.45089,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00072571,0.51415,0.44856,1,1
4,GO DISTAL TUBULE DEVELOPMENT,0.027226,0.51251,0.35695,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0020776,0.50601,0.54175,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.046961,0.49449,0.33029,1,1
4,GO INNER DYNEIN ARM ASSEMBLY,0.037377,0.49293,0.33686,1,1
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00014062,0.4905,0.44221,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00045436,0.48708,0.54035,1,1
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00051151,0.48469,0.45028,1,1
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00018128,0.48313,0.46615,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.015104,0.48015,0.39507,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.023112,0.47879,0.3415,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0057394,0.47867,0.35944,1,1
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00096503,0.47283,0.42888,1,1
4,GO LONG TERM SYNAPTIC DEPRESSION,0.00021879,0.47222,0.40378,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00031664,0.47129,0.49947,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0020776,0.46915,0.39772,1,1
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017696,0.46468,0.44741,1,1
4,GO MICROTUBULE DEPOLYMERIZATION,0.00072571,0.45979,0.43282,1,1
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00033648,0.45704,0.4336,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0010209,0.45429,0.39469,1,1
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0020776,0.45139,0.40134,1,1
4,GO DENDRITIC TRANSPORT,0.0025648,0.44865,0.41961,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.010101,0.4467,0.40382,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00081392,0.44615,0.61719,1,1
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0042727,0.44354,0.47077,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00048214,0.44316,0.44058,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00060992,0.44255,0.37635,1,1
4,GO PROTEIN LOCALIZATION TO AXON,0.0031545,0.44179,0.41618,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0092139,0.43875,0.43839,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.0011418,0.43767,0.39276,1,1
4,GO SPINAL CORD PATTERNING,0.0031545,0.43739,0.37033,1,1
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0027019,0.43697,0.45781,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00013188,0.4351,0.41112,1,1
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0066311,0.43409,0.43496,1,1
4,GO AROMATIC AMINO ACID TRANSPORT,9.5377e-05,0.43159,0.46625,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.00072571,0.43022,0.46699,1,1
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0013481,0.43005,0.34569,1,1
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00018128,0.42906,0.39931,1,1
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,5.2428e-05,0.4286,0.44842,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00081392,0.42704,0.38538,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.0010798,0.427,0.44572,1,1
4,GO TELENCEPHALON GLIAL CELL MIGRATION,6.4139e-05,0.426,0.4324,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0015041,0.42421,0.39501,1,1
4,GO HEART VALVE FORMATION,8.9327e-05,0.423,0.50594,1,1
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00018128,0.42255,0.42099,1,1
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.0036751,0.42235,0.38302,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00012367,0.41979,0.40627,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00033648,0.4197,0.55747,1,1
4,GO CARDIAC CHAMBER FORMATION,0.00064645,0.41951,0.45728,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00029789,0.41896,0.44224,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00068502,0.41889,0.41852,1,1
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010866,0.41481,0.47977,1,1
4,GO REGULATION OF GLUTAMATE SECRETION,0.0015882,0.41339,0.43866,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00091199,0.41091,0.40766,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0011418,0.40891,0.37531,1,1
4,GO SYNAPTIC VESICLE BUDDING,0.00091199,0.4071,0.37208,1,1
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00054254,0.40596,0.39188,1,1
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0066311,0.40245,0.3598,1,1
4,GO RESPONSE TO POTASSIUM ION,0.0092139,0.40233,0.32154,1,1
4,GO REGULATION OF NEURON MIGRATION,0.0038653,0.40204,0.38396,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0040644,0.40188,0.34904,1,1
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.027226,0.40185,0.33462,1,1
4,GO FACIAL NERVE MORPHOGENESIS,0.033245,0.4018,0.30951,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00076864,0.40167,0.34156,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00057531,0.3977,0.3916,1,1
4,GO ANATOMICAL STRUCTURE REGRESSION,0.0049572,0.3958,0.35815,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.027226,0.39526,0.29838,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00031664,0.39462,0.38629,1,1
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0027019,0.39387,0.31538,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00057531,0.39267,0.41322,1,1
4,GO SYNAPTIC VESICLE DOCKING,0.035953,0.39212,0.32259,1,1
4,GO TELENCEPHALON REGIONALIZATION,0.011063,0.38974,0.34774,1,1
4,GO NEURON CELLULAR HOMEOSTASIS,0.00042807,0.38937,0.3978,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00072571,0.38633,0.35739,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00015974,0.38594,0.37892,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,8.3641e-05,0.38554,0.42173,1,1
4,GO DIVALENT METAL ION EXPORT,0.00010181,0.38444,0.46523,1,1
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00057531,0.38133,0.36063,1,1
4,GO RECEPTOR CLUSTERING,0.0027019,0.3812,0.34008,1,1
4,GO REGULATION OF CYCLASE ACTIVITY,3.9936e-05,0.38043,0.36934,1,1
4,GO COLLATERAL SPROUTING,0.00054254,0.38022,0.38136,1,1
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00076864,0.37979,0.40471,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0015041,0.37925,0.4032,1,1
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0013481,0.37852,0.44296,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0080134,0.3783,0.29604,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0024341,0.37719,0.43128,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.00045436,0.37648,0.46466,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00096503,0.376,0.37122,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.025096,0.37315,0.34321,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00033648,0.37264,0.36069,1,1
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.035953,0.37238,0.312,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00011593,0.37153,0.42036,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00096503,0.37126,0.36409,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0027019,0.36918,0.35359,1,1
4,GO MITRAL VALVE DEVELOPMENT,0.027226,0.36826,0.25709,1,1
4,GO PARENTAL BEHAVIOR,0.024086,0.3677,0.34695,1,1
4,GO NOREPINEPHRINE SECRETION,0.00081392,0.36733,0.39873,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00019306,0.36613,0.38862,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00054254,0.3649,0.36633,1,1
4,GO NEUROMUSCULAR PROCESS,6.8565e-05,0.36432,0.39015,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0015882,0.36369,0.33141,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0036751,0.36276,0.3591,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00028019,0.36062,0.4014,1,1
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0012758,0.35961,0.34468,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0083971,0.35958,0.33867,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0010209,0.35955,0.40637,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.0021907,0.3591,0.34568,1,1
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00026348,0.35826,0.397,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0036751,0.35765,0.31488,1,1
4,GO REGULATION OF LYASE ACTIVITY,4.5779e-05,0.35754,0.34785,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.0080134,0.35745,0.26552,1,1
4,GO ALANINE TRANSPORT,0.00042807,0.35568,0.398,1,1
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0096484,0.35565,0.28302,1,1
4,GO OLFACTORY LOBE DEVELOPMENT,0.006955,0.35496,0.28773,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.011574,0.3545,0.24705,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0096484,0.35431,0.28598,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.010101,0.35315,0.28206,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00035748,0.35261,0.33535,1,1
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.030713,0.35209,0.30361,1,1
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0010798,0.3516,0.3408,1,1
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0021907,0.34922,0.30643,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00031664,0.34841,0.3534,1,1
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0042727,0.3469,0.39774,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00332,0.34639,0.35418,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00014062,0.34518,0.33147,1,1
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.035953,0.34498,0.28682,1,1
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.010101,0.34476,0.3341,1,1
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0020776,0.3446,0.34978,1,1
4,GO LIPID GLYCOSYLATION,0.0016767,0.3445,0.33194,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.0047188,0.34415,0.3739,1,1
4,GO RETROGRADE AXONAL TRANSPORT,0.0018673,0.34338,0.38225,1,1
4,GO RESPONSE TO ACETYLCHOLINE,0.00019306,0.3425,0.42091,1,1
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,4.5779e-05,0.34215,0.44378,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00072571,0.34159,0.43146,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0020776,0.34108,0.32926,1,1
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.00015974,0.33953,0.38469,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0034935,0.33952,0.42648,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00014062,0.3393,0.34511,1,1
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0040644,0.33873,0.34391,1,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.024086,0.33872,0.37988,1,1
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00086166,0.33861,0.36285,1,1
4,GO THALAMUS DEVELOPMENT,0.011574,0.3384,0.31293,1,1
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.02951,0.33792,0.27901,1,1
4,GO CRANIAL NERVE MORPHOGENESIS,0.013834,0.33787,0.26939,1,1
4,GO MALE SEX DETERMINATION,0.026142,0.33773,0.28652,1,1
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.0057394,0.33733,0.39975,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00086166,0.33717,0.34493,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00072571,0.33637,0.35816,1,1
4,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.023112,0.33628,0.33147,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0080134,0.33591,0.30231,1,1
4,GO RETINA LAYER FORMATION,0.0057394,0.33578,0.30007,1,1
4,GO LIMB BUD FORMATION,0.024086,0.33567,0.30744,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.041938,0.33374,0.24288,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00091199,0.3329,0.34276,1,1
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0018673,0.33101,0.35693,1,1
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00012367,0.33062,0.35706,1,1
4,GO AZOLE TRANSMEMBRANE TRANSPORT,0.0017696,0.33021,0.35142,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0066311,0.32964,0.28806,1,1
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00068502,0.32901,0.33082,1,1
4,GO HISTONE H3 K27 METHYLATION,0.01266,0.32766,0.29558,1,1
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0018673,0.3272,0.32473,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0076456,0.32618,0.26725,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00068502,0.32589,0.33586,1,1
4,GO STARTLE RESPONSE,0.00081392,0.3252,0.4136,1,1
4,GO LOCALIZATION WITHIN MEMBRANE,0.00332,0.32502,0.28387,1,1
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.00017019,0.3234,0.36677,1,1
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00054254,0.32278,0.42688,1,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0092139,0.32101,0.28014,1,1
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0029965,0.32077,0.32682,1,1
4,GO AORTIC VALVE DEVELOPMENT,0.015776,0.32063,0.26263,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00072571,0.32027,0.28657,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00035748,0.32024,0.29641,1,1
4,GO FUCOSYLATION,0.00033648,0.32001,0.3019,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.045233,0.31994,0.21263,1,1
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.00045436,0.31989,0.37229,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0096484,0.31967,0.30938,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0015882,0.31966,0.40027,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.00042807,0.31948,0.32634,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00064645,0.31825,0.39591,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0052065,0.31757,0.31681,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.00081392,0.31743,0.31649,1,1
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0023095,0.31718,0.33423,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00054254,0.31679,0.3117,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0057394,0.31649,0.32919,1,1
4,GO RESPONSE TO LEUCINE,0.0016767,0.31571,0.3676,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.0015882,0.3154,0.34974,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.022172,0.31538,0.21587,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.017954,0.31503,0.2753,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0057394,0.31493,0.31451,1,1
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.00051151,0.31483,0.35777,1,1
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.006955,0.31442,0.25672,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0080134,0.31312,0.28523,1,1
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00031664,0.31198,0.3599,1,1
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.010572,0.31187,0.30761,1,1
4,GO CGMP METABOLIC PROCESS,0.0016767,0.31174,0.33356,1,1
4,GO GLUTAMATE SECRETION,0.0013481,0.31159,0.33084,1,1
4,GO PIGMENT ACCUMULATION,0.0057394,0.31138,0.32968,1,1
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0092139,0.31131,0.37449,1,1
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00081392,0.3113,0.32834,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.0036751,0.31055,0.44087,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.010101,0.30974,0.31098,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00042807,0.30961,0.30224,1,1
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0044907,0.30948,0.26937,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00029789,0.30947,0.35671,1,1
4,GO REGULATION OF VESICLE FUSION,0.0038653,0.30914,0.30093,1,1
4,GO EPITHELIAL CELL MATURATION,0.007293,0.30874,0.31732,1,1
4,GO SYNAPTIC VESICLE MATURATION,0.0040644,0.3087,0.40955,1,1
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.00048214,0.30867,0.30971,1,1
4,GO NEURON MATURATION,0.0063209,0.30852,0.26306,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.021265,0.30777,0.21777,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00068502,0.3076,0.35246,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.0092139,0.30755,0.2906,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0036751,0.3074,0.29997,1,1
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00064645,0.30726,0.32349,1,1
4,GO CELL JUNCTION MAINTENANCE,0.0013481,0.30715,0.35078,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.045233,0.30655,0.24376,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.015104,0.30648,0.25368,1,1
4,GO NEURONAL ION CHANNEL CLUSTERING,0.0054671,0.30594,0.3506,1,1
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00091199,0.30572,0.29736,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.02951,0.30547,0.2708,1,1
4,GO SYNAPTIC VESICLE LOCALIZATION,0.0042727,0.30529,0.29402,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0066311,0.30483,0.25851,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.025096,0.30444,0.27163,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.00051151,0.30444,0.35342,1,1
4,GO CELL FATE SPECIFICATION,0.0016767,0.30414,0.26348,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.015104,0.30411,0.36502,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00054254,0.30389,0.34535,1,1
4,GO RESPONSE TO INSECTICIDE,0.0054671,0.30362,0.29707,1,1
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0057394,0.30335,0.29262,1,1
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00064645,0.30236,0.30707,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00024771,0.30202,0.3969,1,1
4,GO LEARNING,0.0023095,0.30185,0.29633,1,1
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00081392,0.30131,0.29539,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.0027019,0.30115,0.33052,1,1
4,GO NEURON FATE SPECIFICATION,0.0034935,0.30086,0.34459,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0010798,0.30053,0.31836,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00060992,0.30028,0.31568,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0029965,0.29997,0.28311,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0011418,0.29973,0.33448,1,1
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00064645,0.29961,0.32755,1,1
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.048745,0.29924,0.24759,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0017696,0.2991,0.34169,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0023095,0.29907,0.31156,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.00091199,0.29897,0.32629,1,1
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.0013481,0.29893,0.28979,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0066311,0.29855,0.35228,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.00072571,0.29822,0.3177,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.007293,0.29821,0.26673,1,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0017696,0.29792,0.29438,1,1
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00091199,0.29759,0.33145,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.0049572,0.2974,0.31371,1,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011063,0.29641,0.29126,1,1
4,GO RESPONSE TO GLUCAGON,0.0012758,0.29564,0.31068,1,1
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.027226,0.29504,0.2413,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0080134,0.29491,0.33664,1,1
4,GO LONG TERM SYNAPTIC POTENTIATION,0.0013481,0.29476,0.30741,1,1
4,GO NEURON FATE COMMITMENT,0.0038653,0.29455,0.28701,1,1
4,GO REGULATION OF MICROTUBULE BINDING,0.0011418,0.29427,0.38949,1,1
4,GO CELL PROLIFERATION IN FOREBRAIN,0.0054671,0.29423,0.32941,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0015041,0.2942,0.33788,1,1
4,GO HISTONE H3 K36 METHYLATION,0.023112,0.29398,0.2717,1,1
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0172,0.29388,0.23363,1,1
4,GO NEURON PROJECTION GUIDANCE,0.00091199,0.29364,0.33178,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0057394,0.29276,0.27291,1,1
4,GO CHEMOSENSORY BEHAVIOR,0.0012071,0.29267,0.2821,1,1
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0027019,0.29236,0.28026,1,1
4,GO LONG TERM MEMORY,0.00064645,0.2922,0.32486,1,1
4,GO CORPUS CALLOSUM DEVELOPMENT,0.00014062,0.29218,0.39477,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.011574,0.29195,0.28355,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00072571,0.29184,0.30951,1,1
4,GO NEUROTRANSMITTER SECRETION,0.0010798,0.29171,0.31743,1,1
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.040368,0.29154,0.27878,1,1
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0080134,0.29136,0.34436,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.00057531,0.29092,0.30976,1,1
4,GO AXON EXTENSION,0.00035748,0.29077,0.342,1,1
4,GO NEURAL CREST FORMATION,0.013235,0.2907,0.32762,1,1
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0092139,0.29045,0.29087,1,1
4,GO GROWTH HORMONE SECRETION,0.0023095,0.29041,0.36988,1,1
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0052065,0.29017,0.31832,1,1
4,GO FORELIMB MORPHOGENESIS,0.0018673,0.29003,0.30327,1,1
4,GO SPINAL CORD DEVELOPMENT,0.00081392,0.29003,0.30562,1,1
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00086166,0.28995,0.33784,1,1
4,GO ADAPTATION OF SIGNALING PATHWAY,0.00060992,0.28995,0.3705,1,1
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.0012071,0.28909,0.38058,1,1
4,GO REGULATION OF AXONOGENESIS,0.00045436,0.28902,0.35711,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.28902,0.24076,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.028348,0.28869,0.25322,1,1
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00054254,0.28865,0.32145,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0031545,0.28858,0.2886,1,1
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0012758,0.28851,0.34634,1,1
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0029965,0.2877,0.32984,1,1
4,GO NEURON MIGRATION,0.0015041,0.2874,0.31735,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0172,0.28715,0.21522,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0066311,0.28665,0.31739,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00028019,0.28655,0.31389,1,1
4,GO SYNAPTIC SIGNALING,0.00081392,0.28645,0.2946,1,1
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.045233,0.2863,0.24734,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.013834,0.28598,0.29583,1,1
4,GO ACTIN FILAMENT BASED TRANSPORT,0.0047188,0.28572,0.2937,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.0010209,0.2857,0.40459,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0017696,0.28539,0.33959,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0012071,0.28517,0.32055,1,1
4,GO NUCLEAR MIGRATION,0.0063209,0.28507,0.33861,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0015882,0.28491,0.26963,1,1
4,GO DENDRITE MORPHOGENESIS,0.0052065,0.2843,0.29292,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.00068502,0.28417,0.27494,1,1
4,GO TORC1 SIGNALING,0.00057531,0.28363,0.33055,1,1
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00048214,0.28352,0.28506,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.052482,0.28331,0.25566,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0038653,0.28303,0.30379,1,1
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,8.3641e-05,0.28293,0.34059,1,1
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0019699,0.28267,0.30566,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0015882,0.28249,0.34388,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.0031545,0.28128,0.30484,1,1
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.0042727,0.28105,0.39346,1,1
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.022172,0.28097,0.26611,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00081392,0.28074,0.29574,1,1
4,GO NUCLEUS LOCALIZATION,0.0042727,0.28061,0.34799,1,1
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.018736,0.27983,0.28245,1,1
4,GO CARDIAC ATRIUM DEVELOPMENT,0.041938,0.27981,0.22552,1,1
4,GO NEUROBLAST PROLIFERATION,0.00081392,0.27978,0.30027,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.010572,0.27945,0.29877,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.020391,0.2792,0.20117,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0011418,0.2791,0.33285,1,1
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.022172,0.2787,0.22851,1,1
4,GO MUSCLE FIBER DEVELOPMENT,0.0052065,0.27835,0.24533,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.0036751,0.27794,0.28393,1,1
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0066311,0.27741,0.23752,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.00081392,0.27709,0.3229,1,1
4,GO VITAMIN CATABOLIC PROCESS,0.017954,0.27691,0.23681,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.020391,0.27671,0.26517,1,1
4,GO MICROTUBULE POLYMERIZATION,0.0020776,0.27649,0.30104,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.006955,0.27599,0.31126,1,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0076456,0.2755,0.31168,1,1
4,GO FOREGUT MORPHOGENESIS,0.0049572,0.27549,0.2731,1,1
4,GO NEURON CELL CELL ADHESION,0.008797,0.27508,0.43765,1,1
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.007293,0.27482,0.28509,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0052065,0.27461,0.27599,1,1
4,GO NEURAL TUBE PATTERNING,0.018736,0.27423,0.22382,1,1
4,GO WALKING BEHAVIOR,0.00048214,0.27411,0.31494,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00048214,0.27408,0.28983,1,1
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0024341,0.27337,0.34114,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.00096503,0.27308,0.30379,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0029965,0.27305,0.30326,1,1
4,GO SYNAPSE ORGANIZATION,0.0018673,0.27281,0.29411,1,1
4,GO DENDRITE DEVELOPMENT,0.0021907,0.2724,0.29443,1,1
4,GO MYOTUBE CELL DEVELOPMENT,0.013834,0.27185,0.21255,1,1
4,GO NEURON RECOGNITION,0.0029965,0.2707,0.29752,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011063,0.27038,0.26603,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.00076864,0.26992,0.31183,1,1
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.022172,0.2699,0.26855,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.012106,0.2696,0.23196,1,1
4,GO NEURON PROJECTION EXTENSION,0.00054254,0.2689,0.31424,1,1
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.013235,0.26888,0.39383,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0015882,0.26866,0.29845,1,1
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00045436,0.26846,0.30466,1,1
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00057531,0.26844,0.31296,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00020554,0.26815,0.35066,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0034935,0.26805,0.26763,1,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00035748,0.268,0.33706,1,1
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021907,0.26771,0.26893,1,1
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0024341,0.26735,0.37117,1,1
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0092139,0.26697,0.25643,1,1
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0080134,0.26653,0.28177,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.007293,0.26647,0.31172,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00076864,0.26629,0.26709,1,1
4,GO REGULATION OF AXON GUIDANCE,0.0057394,0.26595,0.29261,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0023095,0.26591,0.29472,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0049572,0.26589,0.23595,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.011063,0.26517,0.2745,1,1
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00057531,0.26513,0.27375,1,1
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.0018673,0.26456,0.27807,1,1
4,GO EMBRYONIC EYE MORPHOGENESIS,0.0060238,0.26455,0.28854,1,1
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00051151,0.26447,0.31347,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.013235,0.26429,0.28012,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0038653,0.2641,0.26946,1,1
4,GO EXPLORATION BEHAVIOR,0.027226,0.26407,0.22576,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.033245,0.26365,0.23883,1,1
4,GO AXONAL FASCICULATION,0.011063,0.26355,0.30761,1,1
4,GO ADULT BEHAVIOR,0.0016767,0.26355,0.29826,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.007293,0.26351,0.31069,1,1
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0027019,0.26334,0.27904,1,1
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0076456,0.26293,0.26725,1,1
4,GO CGMP MEDIATED SIGNALING,0.010572,0.26291,0.23436,1,1
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.016475,0.26276,0.22129,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0019699,0.26257,0.25259,1,1
4,GO EATING BEHAVIOR,0.00031664,0.26246,0.32851,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0018673,0.26244,0.31128,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0015041,0.26144,0.28524,1,1
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.021265,0.26143,0.21013,1,1
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.0018673,0.26069,0.27494,1,1
4,GO LATERAL VENTRICLE DEVELOPMENT,0.0029965,0.26064,0.33881,1,1
4,GO CELL PART MORPHOGENESIS,0.0018673,0.26045,0.28721,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.021265,0.25989,0.28057,1,1
4,GO MICROTUBULE SEVERING,0.045233,0.25984,0.19597,1,1
4,GO RESPONSE TO NICOTINE,0.021265,0.25968,0.23142,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031957,0.25953,0.2079,1,1
4,GO NEURAL RETINA DEVELOPMENT,0.00091199,0.25924,0.32206,1,1
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.011574,0.25898,0.28388,1,1
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0040644,0.25874,0.23358,1,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.019548,0.25848,0.28098,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.007293,0.25835,0.3132,1,1
4,GO CARBOHYDRATE PHOSPHORYLATION,0.00068502,0.25824,0.27406,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.033245,0.25809,0.27819,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.011063,0.25753,0.27315,1,1
4,GO REPRODUCTIVE BEHAVIOR,0.025096,0.25747,0.24229,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.025096,0.25719,0.21265,1,1
4,GO PROTEIN KINASE C SIGNALING,0.011063,0.25687,0.28331,1,1
4,GO CALCINEURIN MEDIATED SIGNALING,0.0049572,0.25645,0.24148,1,1
4,GO MICROTUBULE NUCLEATION,0.0066311,0.2564,0.26735,1,1
4,GO LIPID TRANSLOCATION,0.013235,0.25633,0.27214,1,1
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0013481,0.25613,0.251,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.0017696,0.25525,0.29569,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0057394,0.25497,0.2082,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.010101,0.25493,0.24827,1,1
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00064645,0.25428,0.35274,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.0066311,0.25413,0.23839,1,1
4,GO MEMBRANE DEPOLARIZATION,0.017954,0.25388,0.20783,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00045436,0.25372,0.29527,1,1
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00035748,0.25351,0.29639,1,1
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.0029965,0.25321,0.22819,1,1
4,GO GLIAL CELL MIGRATION,0.0038653,0.25308,0.28579,1,1
4,GO RESPONSE TO INACTIVITY,0.033245,0.25291,0.19829,1,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.026142,0.25245,0.23759,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0011418,0.25229,0.27006,1,1
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.026142,0.25185,0.30473,1,1
4,GO REGULATION OF MRNA BINDING,0.00332,0.25167,0.22369,1,1
4,GO FEAR RESPONSE,0.035953,0.25161,0.18436,1,1
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0060238,0.25151,0.25881,1,1
4,GO CELL MIGRATION IN HINDBRAIN,0.0052065,0.2512,0.33479,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0057394,0.25102,0.29911,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0096484,0.25049,0.20322,1,1
4,GO BEHAVIOR,0.0029965,0.25025,0.2477,1,1
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0010798,0.25011,0.26132,1,1
4,GO AXON DEVELOPMENT,0.0020776,0.25007,0.29162,1,1
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0036751,0.24986,0.29311,1,1
4,GO HISTONE METHYLATION,0.007293,0.24985,0.237,1,1
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0023095,0.24939,0.25733,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.011574,0.24935,0.22815,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.008797,0.24904,0.33722,1,1
4,GO NERVE DEVELOPMENT,0.013235,0.24894,0.2583,1,1
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018673,0.24877,0.31106,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.01266,0.24871,0.23781,1,1
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0013481,0.24828,0.29523,1,1
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0047188,0.24779,0.30634,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.026142,0.24758,0.2123,1,1
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.021265,0.24751,0.26758,1,1
4,GO FOREBRAIN CELL MIGRATION,0.0054671,0.24741,0.27042,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0036751,0.24739,0.31711,1,1
4,GO GDP METABOLIC PROCESS,0.0024341,0.24731,0.28327,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0038653,0.24729,0.27236,1,1
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00019306,0.24705,0.26853,1,1
4,GO COLLECTING DUCT DEVELOPMENT,0.027226,0.24701,0.34162,1,1
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.015776,0.24668,0.23841,1,1
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.0042727,0.24654,0.27137,1,1
4,GO TUBULIN DEACETYLATION,0.0029965,0.24648,0.29251,1,1
4,GO LOCOMOTORY BEHAVIOR,0.0025648,0.24645,0.28077,1,1
4,GO REGULATION OF GOLGI ORGANIZATION,0.00042807,0.24629,0.27857,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.0054671,0.24615,0.28849,1,1
4,GO RESPONSE TO ISCHEMIA,0.013834,0.24589,0.23013,1,1
4,GO REGULATION OF BEHAVIOR,0.012106,0.24509,0.19881,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.007293,0.24497,0.26008,1,1
4,GO SPINDLE MIDZONE ASSEMBLY,0.010572,0.24472,0.28582,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0036751,0.24467,0.23711,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.016475,0.2446,0.32524,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0013481,0.24402,0.27904,1,1
4,GO RESPONSE TO VITAMIN A,0.011574,0.24399,0.19323,1,1
4,GO FILOPODIUM ASSEMBLY,0.022172,0.24329,0.2123,1,1
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00091199,0.24312,0.28095,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00057531,0.24295,0.27734,1,1
4,GO ORGANIC CATION TRANSPORT,0.0172,0.24274,0.23187,1,1
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.014457,0.24266,0.19075,1,1
4,GO HISTONE H3 K9 METHYLATION,0.010572,0.24235,0.2582,1,1
4,GO AXO DENDRITIC TRANSPORT,0.0063209,0.24232,0.26283,1,1
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0029965,0.2423,0.20803,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,0.0172,0.24221,0.28565,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.010572,0.24216,0.21551,1,1
4,GO NEURAL CREST CELL MIGRATION,0.0047188,0.24203,0.27101,1,1
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0029965,0.24203,0.2298,1,1
4,GO GLUCOSE CATABOLIC PROCESS,0.00042807,0.2419,0.27972,1,1
4,GO SYNAPTIC VESICLE RECYCLING,0.0015041,0.24162,0.2794,1,1
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.011574,0.24157,0.25594,1,1
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.00076864,0.24126,0.27631,1,1
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0076456,0.24107,0.25405,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0029965,0.24099,0.30372,1,1
4,GO CELLULAR COMPONENT MAINTENANCE,0.0025648,0.24093,0.28895,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.015776,0.24071,0.18097,1,1
4,GO CHROMATIN DISASSEMBLY,0.0029965,0.24041,0.27396,1,1
4,GO ASSOCIATIVE LEARNING,0.0038653,0.24023,0.26828,1,1
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.046961,0.23993,0.20404,1,1
4,GO PROTEIN DEPOLYMERIZATION,0.0018673,0.23987,0.28126,1,1
4,GO PEPTIDE HORMONE SECRETION,0.0015882,0.23949,0.24426,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0038653,0.23892,0.24639,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.031957,0.23841,0.21364,1,1
4,GO PROTEIN KINASE A SIGNALING,0.007293,0.23793,0.22372,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0027019,0.23791,0.32183,1,1
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.0029965,0.23787,0.24913,1,1
4,GO FEEDING BEHAVIOR,0.00091199,0.23786,0.25803,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0038653,0.2377,0.26806,1,1
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00019306,0.23733,0.26764,1,1
4,GO NEURON DEVELOPMENT,0.0016767,0.23655,0.26635,1,1
4,GO CEREBRAL CORTEX DEVELOPMENT,0.0015882,0.23653,0.28743,1,1
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.0066311,0.23647,0.27919,1,1
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.015776,0.23646,0.27731,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.0017696,0.23644,0.24507,1,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.0015882,0.2364,0.32484,1,1
4,GO GANGLION DEVELOPMENT,0.031957,0.23634,0.24392,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0020776,0.23613,0.27646,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0021907,0.23611,0.22895,1,1
4,GO METENCEPHALON DEVELOPMENT,0.0020776,0.236,0.26205,1,1
4,GO RHYTHMIC BEHAVIOR,0.0016767,0.23593,0.27201,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0020776,0.23591,0.24865,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.013235,0.23571,0.22616,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0019699,0.23559,0.28307,1,1
4,GO CEREBELLAR CORTEX FORMATION,0.010572,0.23558,0.24371,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.011063,0.23547,0.23483,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0063209,0.23508,0.29196,1,1
4,GO CATECHOLAMINE UPTAKE,0.0018673,0.23494,0.34192,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.043559,0.23489,0.24641,1,1
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.021265,0.23463,0.21394,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.2338,0.26974,1,1
4,GO DEVELOPMENTAL CELL GROWTH,0.0016767,0.23337,0.27994,1,1
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.0080134,0.23336,0.21051,1,1
4,GO ATRIAL SEPTUM DEVELOPMENT,0.023112,0.23294,0.25909,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0036751,0.23284,0.23258,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.038848,0.23256,0.25656,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0028457,0.23235,0.26032,1,1
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.012106,0.23221,0.23291,1,1
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0024341,0.2317,0.28212,1,1
4,GO RESPONSE TO NITRIC OXIDE,0.012106,0.23166,0.23102,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0014241,0.23159,0.25991,1,1
4,GO CELLULAR RESPONSE TO PH,0.0016767,0.23125,0.30091,1,1
4,GO HEART VALVE DEVELOPMENT,0.015776,0.23124,0.25446,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.011574,0.23108,0.23859,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0054671,0.23108,0.27455,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00035748,0.231,0.26939,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0023095,0.23092,0.31966,1,1
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0096484,0.23055,0.26361,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.013235,0.23051,0.24039,1,1
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0024341,0.23047,0.23365,1,1
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0034935,0.23046,0.29137,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.008797,0.23045,0.21498,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.021265,0.23019,0.208,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0023095,0.23017,0.34249,1,1
4,GO DENDRITE SELF AVOIDANCE,0.02951,0.23003,0.23118,1,1
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00035748,0.22966,0.25802,1,1
4,GO INSULIN SECRETION,0.00091199,0.22942,0.26467,1,1
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0029965,0.22907,0.27013,1,1
4,GO DENDRITIC SPINE DEVELOPMENT,0.0023095,0.22907,0.29845,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0011418,0.22873,0.25891,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0025648,0.22863,0.25376,1,1
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0096484,0.22839,0.2473,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.048745,0.22831,0.22963,1,1
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0060238,0.22811,0.21744,1,1
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.043559,0.2281,0.19005,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0015882,0.22793,0.27402,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0010798,0.2279,0.34588,1,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0010209,0.22789,0.23687,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0015882,0.22787,0.28817,1,1
4,GO NEURON DIFFERENTIATION,0.0015041,0.22786,0.26007,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.023112,0.22785,0.19711,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0049572,0.22724,0.23534,1,1
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0060238,0.22693,0.21976,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00042807,0.22641,0.26651,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.046961,0.22603,0.24852,1,1
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.012106,0.22579,0.1989,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.041938,0.22559,0.16796,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.023112,0.2249,0.22038,1,1
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.012106,0.22473,0.27317,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.015104,0.22472,0.19645,1,1
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0014241,0.22415,0.29598,1,1
4,GO REGULATION OF CELL SIZE,0.0016767,0.2241,0.27877,1,1
4,GO REGULATION OF EXOCYTOSIS,0.0027019,0.22398,0.23625,1,1
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00033648,0.22389,0.2592,1,1
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0052065,0.22377,0.26998,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.0017696,0.22376,0.26327,1,1
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0015882,0.22369,0.25032,1,1
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.0066311,0.22369,0.25292,1,1
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0057394,0.22354,0.30365,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.017954,0.22311,0.27377,1,1
4,GO PROTEIN DEMETHYLATION,0.012106,0.22277,0.2614,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0172,0.22272,0.19538,1,1
4,GO NEURONAL ACTION POTENTIAL,0.031957,0.22265,0.17536,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0020776,0.22237,0.27144,1,1
4,GO LEFT RIGHT PATTERN FORMATION,0.026142,0.22226,0.19528,1,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.048745,0.22224,0.20133,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.018736,0.22218,0.22204,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0018673,0.22206,0.27352,1,1
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0019699,0.22197,0.24916,1,1
4,GO RESPONSE TO HYDROXYUREA,0.0092139,0.22053,0.23406,1,1
4,GO CAMP METABOLIC PROCESS,0.035953,0.22005,0.22186,1,1
4,GO POTASSIUM ION TRANSPORT,0.00060992,0.22001,0.27483,1,1
4,GO CARDIAC CONDUCTION,0.0027019,0.21983,0.23751,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0042727,0.21979,0.34589,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0015882,0.21975,0.22967,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00060992,0.21974,0.3163,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.0024341,0.21972,0.26853,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.018736,0.21942,0.14855,1,1
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00096503,0.21922,0.30074,1,1
4,GO HINDBRAIN MORPHOGENESIS,0.0047188,0.21915,0.22497,1,1
4,GO REGULATION OF STEM CELL PROLIFERATION,0.0027019,0.21903,0.23759,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.020391,0.21868,0.19604,1,1
4,GO REGULATION OF OOGENESIS,0.0015882,0.21851,0.22349,1,1
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0047188,0.21843,0.18705,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0027019,0.21818,0.24002,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0031545,0.21785,0.28855,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.028348,0.21722,0.22603,1,1
4,GO NEURON APOPTOTIC PROCESS,0.0096484,0.21722,0.19145,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0011418,0.21718,0.23076,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.0096484,0.21711,0.27154,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0018673,0.2169,0.29391,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0012071,0.21669,0.26734,1,1
4,GO RESPONSE TO DOPAMINE,0.00064645,0.21639,0.25308,1,1
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0038653,0.21635,0.23615,1,1
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0042727,0.21633,0.27187,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.015104,0.2163,0.18572,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.021265,0.21626,0.18656,1,1
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0015882,0.21598,0.31922,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.0036751,0.2151,0.24406,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0049572,0.21496,0.22766,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0052065,0.21466,0.23077,1,1
4,GO L AMINO ACID TRANSPORT,0.0036751,0.21411,0.21595,1,1
4,GO ENDOCYTIC RECYCLING,0.020391,0.2141,0.20998,1,1
4,GO RESPONSE TO ACIDIC PH,0.0057394,0.214,0.32042,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0024341,0.21392,0.25542,1,1
4,GO FOREBRAIN GENERATION OF NEURONS,0.018736,0.21376,0.17713,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.011574,0.21363,0.17318,1,1
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0040644,0.21342,0.25799,1,1
4,GO NEURAL CREST CELL DIFFERENTIATION,0.020391,0.21329,0.21412,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.00040321,0.21309,0.23724,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.018736,0.21254,0.25657,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0038653,0.21245,0.24487,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0096484,0.21238,0.19587,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0015882,0.21234,0.25537,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0080134,0.21202,0.25562,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.037377,0.21173,0.19005,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.052482,0.21164,0.23229,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.008797,0.21161,0.22496,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.010101,0.21137,0.23221,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.040368,0.21128,0.23208,1,1
4,GO ACTIN CROSSLINK FORMATION,0.027226,0.21121,0.22791,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.045233,0.21116,0.22193,1,1
4,GO MEMORY,0.0049572,0.21107,0.23416,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0049572,0.21079,0.24594,1,1
4,GO REGULATION OF PROTON TRANSPORT,0.00086166,0.21073,0.21808,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.0014241,0.21066,0.30429,1,1
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.012106,0.21064,0.21439,1,1
4,GO SYNAPSE ASSEMBLY,0.010101,0.21056,0.26638,1,1
4,GO REGULATION OF ION TRANSPORT,0.0057394,0.21043,0.20856,1,1
4,GO CALCIUM ION IMPORT,0.0063209,0.21012,0.20991,1,1
4,GO REGULATION OF MITOPHAGY,0.0027019,0.21004,0.30059,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.037377,0.20987,0.20787,1,1
4,GO IMPORT INTO CELL,0.0011418,0.20951,0.23423,1,1
4,GO PONS DEVELOPMENT,0.033245,0.20943,0.35072,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0018673,0.20941,0.26161,1,1
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.028348,0.20939,0.2324,1,1
4,GO POSITIVE REGULATION OF RNA SPLICING,0.0063209,0.20932,0.20549,1,1
4,GO MITOCHONDRION LOCALIZATION,0.0042727,0.20929,0.24274,1,1
4,GO RECEPTOR INTERNALIZATION,0.0010798,0.2092,0.23975,1,1
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.040368,0.20916,0.23403,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.015776,0.20909,0.20775,1,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.010101,0.20898,0.22051,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.010101,0.20875,0.2667,1,1
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019548,0.20833,0.28403,1,1
4,GO PLATELET MORPHOGENESIS,0.0024341,0.20816,0.30947,1,1
4,GO REGULATION OF RNA BINDING,0.011063,0.20807,0.18433,1,1
4,GO CARNITINE SHUTTLE,0.022172,0.20765,0.21424,1,1
4,GO LACTATION,0.018736,0.20748,0.18501,1,1
4,GO SCHWANN CELL DEVELOPMENT,0.0060238,0.20746,0.26857,1,1
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.043559,0.20735,0.22746,1,1
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0031545,0.20734,0.24453,1,1
4,GO SIALYLATION,0.021265,0.20729,0.25717,1,1
4,GO NEUROGENESIS,0.0016767,0.20717,0.25008,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.010572,0.20712,0.19347,1,1
4,GO MOTOR NEURON AXON GUIDANCE,0.011574,0.20704,0.25392,1,1
4,GO HINDLIMB MORPHOGENESIS,0.0080134,0.20694,0.24492,1,1
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0049572,0.20656,0.23482,1,1
4,GO PALLIUM DEVELOPMENT,0.0042727,0.20645,0.23362,1,1
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.012106,0.20628,0.23894,1,1
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0063209,0.2055,0.2335,1,1
4,GO NEURON DEATH,0.010572,0.2053,0.19063,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0018673,0.20523,0.23257,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.020391,0.20503,0.21327,1,1
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022172,0.20502,0.2093,1,1
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.00013188,0.20473,0.28839,1,1
4,GO PODOSOME ASSEMBLY,0.043559,0.20459,0.24803,1,1
4,GO LOCOMOTOR RHYTHM,0.015104,0.20447,0.27431,1,1
4,GO CELL FATE COMMITMENT,0.00332,0.20442,0.20984,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.008797,0.20426,0.24929,1,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.0066311,0.20409,0.24378,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.031957,0.20393,0.20755,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0096484,0.2039,0.21425,1,1
4,GO CELL MORPHOGENESIS,0.00332,0.2036,0.25054,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.02951,0.20323,0.19789,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0042727,0.20317,0.22201,1,1
4,GO REGULATION OF HORMONE SECRETION,0.0057394,0.20308,0.20488,1,1
4,GO NEGATIVE CHEMOTAXIS,0.030713,0.20299,0.23186,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.014457,0.2027,0.20016,1,1
4,GO HINDBRAIN DEVELOPMENT,0.008797,0.20262,0.21613,1,1
4,GO REGULATION OF CELL MORPHOGENESIS,0.00332,0.2026,0.25967,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.010101,0.2023,0.17952,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.020391,0.20229,0.20315,1,1
4,GO DOPAMINE TRANSPORT,0.041938,0.20226,0.23017,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING,0.013235,0.20221,0.1792,1,1
4,GO PROTEIN METHYLATION,0.0172,0.20188,0.19947,1,1
4,GO HEAD DEVELOPMENT,0.0038653,0.20157,0.23063,1,1
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0038653,0.20113,0.22549,1,1
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0020776,0.20072,0.23285,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.035953,0.20066,0.17165,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0049572,0.20063,0.2073,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.0014241,0.20033,0.24637,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.0049572,0.20028,0.22383,1,1
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.01266,0.20025,0.2111,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.019548,0.20011,0.21516,1,1
4,GO DEVELOPMENTAL MATURATION,0.0096484,0.20007,0.21602,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00019306,0.19999,0.25051,1,1
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.043559,0.19972,0.17305,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.027226,0.19941,0.22713,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0014241,0.19927,0.2218,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.031957,0.19897,0.16384,1,1
4,GO CELL JUNCTION ASSEMBLY,0.02951,0.19883,0.19982,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.0023095,0.19872,0.3426,1,1
4,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.015776,0.19858,0.2423,1,1
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024341,0.1984,0.24061,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.045233,0.19831,0.18025,1,1
4,GO CERAMIDE TRANSPORT,0.013834,0.19826,0.23817,1,1
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.0083971,0.19753,0.22065,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.01266,0.19753,0.22205,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.011574,0.19731,0.20876,1,1
4,GO FOREBRAIN DEVELOPMENT,0.0014241,0.19721,0.25139,1,1
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0052065,0.19706,0.23118,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.031957,0.19697,0.21874,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0038653,0.19691,0.22627,1,1
4,GO PLASMA MEMBRANE TUBULATION,0.0010209,0.19669,0.28917,1,1
4,GO PROTEIN TRIMERIZATION,0.027226,0.19647,0.25353,1,1
4,GO TELENCEPHALON DEVELOPMENT,0.0029965,0.19633,0.23911,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0031545,0.1963,0.22216,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.00057531,0.196,0.22215,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.0172,0.19565,0.23313,1,1
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0060238,0.19554,0.26771,1,1
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.030713,0.19547,0.27277,1,1
4,GO RESPIRATORY SYSTEM PROCESS,0.011063,0.19527,0.2754,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0076456,0.19523,0.23905,1,1
4,GO PULMONARY VALVE MORPHOGENESIS,0.031957,0.19519,0.24977,1,1
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.038848,0.19507,0.26076,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00035748,0.19505,0.23463,1,1
4,GO ACIDIC AMINO ACID TRANSPORT,0.00091199,0.19434,0.2791,1,1
4,GO MONOAMINE TRANSPORT,0.0036751,0.19406,0.28521,1,1
4,GO RESPONSE TO COCAINE,0.023112,0.19391,0.19743,1,1
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0080134,0.19334,0.1931,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.021265,0.19319,0.22901,1,1
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0031545,0.19298,0.23546,1,1
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0015882,0.19261,0.25369,1,1
4,GO SIGNAL RELEASE,0.008797,0.19257,0.19865,1,1
4,GO COGNITION,0.0044907,0.19253,0.22896,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0017696,0.19217,0.31425,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0049572,0.19191,0.23254,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.015776,0.19181,0.23301,1,1
4,GO NERVOUS SYSTEM PROCESS,0.00040321,0.19178,0.23404,1,1
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.011063,0.19163,0.17096,1,1
4,GO REGULATION OF TUBULIN DEACETYLATION,0.013235,0.19158,0.2208,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0080134,0.19136,0.20604,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0083971,0.19131,0.19632,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0021907,0.19125,0.25779,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0083971,0.19112,0.21675,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.008797,0.19099,0.20333,1,1
4,GO SENSORY PERCEPTION,0.00040321,0.19097,0.20291,1,1
4,GO STEM CELL PROLIFERATION,0.0028457,0.19087,0.23737,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0040644,0.19081,0.22614,1,1
4,GO HORMONE TRANSPORT,0.0042727,0.19072,0.21311,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.040368,0.19048,0.17025,1,1
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00076864,0.19028,0.27316,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.015776,0.19023,0.16905,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0054671,0.19013,0.24965,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.013235,0.18997,0.24806,1,1
4,GO PITUITARY GLAND DEVELOPMENT,0.015104,0.18966,0.17827,1,1
4,GO VISUAL BEHAVIOR,0.0038653,0.18956,0.22312,1,1
4,GO RESPONSE TO PH,0.0060238,0.18951,0.28394,1,1
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.010572,0.18938,0.28278,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0015041,0.18933,0.24405,1,1
4,GO OVULATION CYCLE PROCESS,0.020391,0.18918,0.18,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.006955,0.18883,0.20313,1,1
4,GO NEUROTRANSMITTER UPTAKE,0.0034935,0.18874,0.22483,1,1
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0049572,0.1887,0.22208,1,1
4,GO MRNA TRANSCRIPTION,0.034576,0.1883,0.20961,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.0019699,0.18821,0.31832,1,1
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.012106,0.18815,0.21776,1,1
4,GO PANCREAS DEVELOPMENT,0.020391,0.18814,0.17172,1,1
4,GO DORSAL VENTRAL PATTERN FORMATION,0.0092139,0.18797,0.20908,1,1
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.012106,0.18773,0.16624,1,1
4,GO ERYTHROCYTE MATURATION,0.040368,0.18763,0.20327,1,1
4,GO CELLULAR RESPONSE TO ATP,0.0066311,0.18742,0.2233,1,1
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.017954,0.18726,0.18726,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.016475,0.18718,0.1795,1,1
4,GO OUTFLOW TRACT MORPHOGENESIS,0.046961,0.18713,0.19254,1,1
4,GO AMINO ACID TRANSPORT,0.0017696,0.18706,0.23061,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.019548,0.18703,0.28306,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.031957,0.18695,0.17383,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.021265,0.18679,0.18108,1,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0034935,0.18658,0.21442,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.026142,0.18658,0.20498,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.0038653,0.18652,0.22003,1,1
4,GO CELL JUNCTION ORGANIZATION,0.0066311,0.18631,0.24085,1,1
4,GO HISTONE H3 K4 METHYLATION,0.037377,0.18621,0.18805,1,1
4,GO NADH METABOLIC PROCESS,0.0010209,0.18607,0.23208,1,1
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0096484,0.18586,0.25712,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.0040644,0.18583,0.22231,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0027019,0.18575,0.20502,1,1
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.043559,0.18557,0.17007,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.019548,0.18534,0.24083,1,1
4,GO CELL PROJECTION ORGANIZATION,0.0052065,0.18487,0.22258,1,1
4,GO PRESYNAPSE ORGANIZATION,0.037377,0.18485,0.2071,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.048745,0.18484,0.2062,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.016475,0.18474,0.20426,1,1
4,GO MULTICELLULAR ORGANISM GROWTH,0.0036751,0.18471,0.24213,1,1
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.0027019,0.18466,0.2275,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0024341,0.18462,0.23281,1,1
4,GO DNA DEMETHYLATION,0.017954,0.18462,0.1922,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0096484,0.18457,0.2474,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00086166,0.18453,0.23717,1,1
4,GO CELL CELL SIGNALING,0.0066311,0.18444,0.20639,1,1
4,GO NAD METABOLIC PROCESS,0.00057531,0.1844,0.22022,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0031545,0.18421,0.23648,1,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0049572,0.18396,0.19771,1,1
4,GO DENDRITE EXTENSION,0.011063,0.18388,0.22523,1,1
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.011574,0.18365,0.19875,1,1
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0038653,0.18352,0.24638,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0020776,0.18309,0.2017,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.028348,0.18308,0.19542,1,1
4,GO SPECIFICATION OF SYMMETRY,0.021265,0.18272,0.18512,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.012106,0.18259,0.1938,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.011063,0.18255,0.22216,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.010101,0.18252,0.22204,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.0038653,0.18234,0.18371,1,1
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.048745,0.18221,0.18723,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.02951,0.18216,0.17103,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.020391,0.18196,0.20631,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.02951,0.18196,0.20881,1,1
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0047188,0.18193,0.23141,1,1
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0034935,0.18169,0.21958,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.015776,0.18149,0.17281,1,1
4,GO EMBRYONIC HEMOPOIESIS,0.034576,0.18139,0.18967,1,1
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.012106,0.18098,0.21415,1,1
4,GO INCLUSION BODY ASSEMBLY,0.0036751,0.18098,0.25319,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0024341,0.1809,0.20084,1,1
4,GO CRISTAE FORMATION,0.025096,0.18067,0.17838,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.01266,0.18036,0.21294,1,1
4,GO ARGININE METABOLIC PROCESS,0.024086,0.17999,0.17008,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0027019,0.17993,0.23722,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0012758,0.1799,0.21123,1,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0076456,0.17968,0.25494,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0096484,0.1796,0.22957,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.028348,0.17956,0.16709,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.014457,0.17941,0.24085,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.010572,0.17932,0.19517,1,1
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022172,0.17925,0.21591,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.017954,0.1789,0.15033,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.012106,0.17874,0.23799,1,1
4,GO EXOCYTIC PROCESS,0.0060238,0.17868,0.2025,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.00033648,0.17864,0.26798,1,1
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.017954,0.17861,0.16255,1,1
4,GO NEGATIVE REGULATION OF CELL AGING,0.023112,0.17855,0.16441,1,1
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.031957,0.17844,0.21812,1,1
4,GO MEMBRANE REPOLARIZATION,0.025096,0.17819,0.18416,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.011574,0.17817,0.20517,1,1
4,GO FATTY ACID HOMEOSTASIS,0.011063,0.17817,0.24003,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.025096,0.17803,0.20053,1,1
4,GO XENOBIOTIC TRANSPORT,0.043559,0.17778,0.19897,1,1
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.0010209,0.1777,0.22014,1,1
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0052065,0.17751,0.26478,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0013481,0.17745,0.18992,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.028348,0.17745,0.22692,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0076456,0.17739,0.21304,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.01266,0.17703,0.20758,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0038653,0.17694,0.20569,1,1
4,GO HISTONE H3 DEACETYLATION,0.008797,0.17675,0.21848,1,1
4,GO HISTONE DEUBIQUITINATION,0.030713,0.17671,0.21062,1,1
4,GO SENSORY SYSTEM DEVELOPMENT,0.0024341,0.1764,0.23992,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0042727,0.17623,0.2061,1,1
4,GO REGULATION OF TOR SIGNALING,0.026142,0.17587,0.18444,1,1
4,GO REGULATION OF CELL DEVELOPMENT,0.00332,0.17587,0.22486,1,1
4,GO REGULATION OF HORMONE LEVELS,0.010572,0.17578,0.17036,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.0066311,0.17578,0.19034,1,1
4,GO REGULATION OF GONAD DEVELOPMENT,0.0027019,0.1756,0.23153,1,1
4,GO MEMBRANE FISSION,0.037377,0.17556,0.19237,1,1
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.0036751,0.17519,0.24057,1,1
4,GO RECEPTOR RECYCLING,0.050584,0.17511,0.14732,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027226,0.17511,0.20331,1,1
4,GO DNA DEALKYLATION,0.0080134,0.17499,0.1882,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.037377,0.17489,0.20286,1,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.048745,0.17478,0.21008,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0023095,0.17452,0.25214,1,1
4,GO MALE MEIOSIS I,0.0172,0.17411,0.1937,1,1
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013235,0.17396,0.21763,1,1
4,GO REGULATION OF MRNA PROCESSING,0.038848,0.17378,0.1585,1,1
4,GO DICARBOXYLIC ACID TRANSPORT,0.0031545,0.17363,0.22492,1,1
4,GO PATTERN SPECIFICATION PROCESS,0.008797,0.1736,0.19151,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00076864,0.17325,0.2073,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.017954,0.1732,0.16984,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.019548,0.17312,0.25526,1,1
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0096484,0.17299,0.18147,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.031957,0.17298,0.17702,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.015776,0.17295,0.19631,1,1
4,GO LIPID PHOSPHORYLATION,0.024086,0.17288,0.1952,1,1
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.022172,0.17287,0.18319,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.030713,0.17281,0.25798,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.015776,0.17274,0.228,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.014457,0.17274,0.23137,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0042727,0.17273,0.19592,1,1
4,GO POSITIVE REGULATION OF DNA BINDING,0.016475,0.1724,0.16631,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.017954,0.17218,0.2094,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,0.0015882,0.17202,0.20082,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0063209,0.17189,0.17813,1,1
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.033245,0.17188,0.16668,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.011063,0.17151,0.20594,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.017954,0.17148,0.22372,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0036751,0.17145,0.18477,1,1
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.031957,0.17127,0.16204,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.031957,0.1707,0.21558,1,1
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0023095,0.17065,0.20228,1,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0092139,0.17061,0.1988,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0083971,0.17042,0.23901,1,1
4,GO RESPONSE TO FOOD,0.030713,0.16956,0.15906,1,1
4,GO DEMETHYLATION,0.0092139,0.16952,0.20346,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0027019,0.16948,0.29404,1,1
4,GO EYE MORPHOGENESIS,0.0049572,0.16946,0.23816,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0066311,0.16946,0.22804,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0172,0.16934,0.20889,1,1
4,GO REGULATION OF GLIOGENESIS,0.037377,0.16922,0.15552,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.015776,0.16895,0.17733,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0052065,0.16886,0.19318,1,1
4,GO CARDIAC SEPTUM DEVELOPMENT,0.050584,0.16879,0.20002,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.038848,0.16876,0.15828,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.035953,0.16868,0.17615,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.017954,0.16857,0.19147,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.021265,0.16837,0.16197,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.010101,0.16788,0.16375,1,1
4,GO FATTY ACID BETA OXIDATION,0.043559,0.16774,0.14018,1,1
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0049572,0.1675,0.2289,1,1
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.035953,0.16731,0.18233,1,1
4,GO CAMERA TYPE EYE DEVELOPMENT,0.0017696,0.16719,0.24508,1,1
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.008797,0.16689,0.23498,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.043559,0.16674,0.18699,1,1
4,GO HISTONE H4 ACETYLATION,0.016475,0.16667,0.21005,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0172,0.16654,0.22536,1,1
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0021907,0.16637,0.2393,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0063209,0.16635,0.22535,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.010101,0.16633,0.19987,1,1
4,GO G0 TO G1 TRANSITION,0.035953,0.16631,0.17664,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.0025648,0.16626,0.32207,1,1
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.033245,0.16625,0.17058,1,1
4,GO VESICLE DOCKING,0.017954,0.16612,0.17906,1,1
4,GO PEPTIDYL ARGININE METHYLATION,0.007293,0.16591,0.20101,1,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.021265,0.16587,0.17645,1,1
4,GO CIRCADIAN RHYTHM,0.0092139,0.16586,0.183,1,1
4,GO APPENDAGE MORPHOGENESIS,0.016475,0.16568,0.21041,1,1
4,GO NEURAL TUBE DEVELOPMENT,0.037377,0.16531,0.19287,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.033245,0.16519,0.19044,1,1
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.011574,0.16492,0.18675,1,1
4,GO CELLULAR RESPONSE TO CAMP,0.045233,0.16477,0.15418,1,1
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0096484,0.16468,0.21608,1,1
4,GO ACID SECRETION,0.0027019,0.16467,0.19944,1,1
4,GO MUSCLE CONTRACTION,0.0092139,0.1644,0.18121,1,1
4,GO OOCYTE DIFFERENTIATION,0.031957,0.16436,0.14056,1,1
4,GO MIRNA METABOLIC PROCESS,0.0031545,0.16432,0.20905,1,1
4,GO REGULATION OF MYELINATION,0.046961,0.1643,0.18271,1,1
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0057394,0.16408,0.22807,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0024341,0.16403,0.22108,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.0044907,0.16399,0.20159,1,1
4,GO NOTCH SIGNALING PATHWAY,0.034576,0.16392,0.16719,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.018736,0.1638,0.19184,1,1
4,GO METAL ION TRANSPORT,0.0066311,0.1637,0.19011,1,1
4,GO CATION TRANSPORT,0.0052065,0.16356,0.19327,1,1
4,GO ACTION POTENTIAL,0.0036751,0.16304,0.20806,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.012106,0.16303,0.28403,1,1
4,GO RESPONSE TO BMP,0.048745,0.1629,0.18946,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.015776,0.16269,0.19285,1,1
4,GO UV PROTECTION,0.016475,0.16268,0.24083,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.035953,0.16248,0.16962,1,1
4,GO SOMITE DEVELOPMENT,0.045233,0.16247,0.16624,1,1
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.045233,0.16239,0.16118,1,1
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.0080134,0.16227,0.22183,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.018736,0.16219,0.17328,1,1
4,GO CATECHOLAMINE SECRETION,0.010101,0.16204,0.27627,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0080134,0.16197,0.18808,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015104,0.16194,0.18478,1,1
4,GO LIPOPROTEIN LOCALIZATION,0.040368,0.16192,0.20695,1,1
4,GO PROTEIN AUTOPHOSPHORYLATION,0.021265,0.16186,0.20986,1,1
4,GO COBALAMIN METABOLIC PROCESS,0.023112,0.16181,0.19708,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.007293,0.16143,0.21729,1,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0049572,0.1614,0.24034,1,1
4,GO CELL MATURATION,0.040368,0.16138,0.15165,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.012106,0.16136,0.20884,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.0054671,0.16116,0.17867,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0020776,0.16077,0.24364,1,1
4,GO REGULATION OF TRANSPOSITION,0.046961,0.1607,0.17809,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.045233,0.16069,0.16082,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.011574,0.16021,0.20678,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.026142,0.16019,0.19464,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.00332,0.16015,0.21314,1,1
4,GO DENDRITIC SPINE MAINTENANCE,0.02951,0.16011,0.22863,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.031957,0.16004,0.25077,1,1
4,GO POST EMBRYONIC DEVELOPMENT,0.024086,0.16,0.20941,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.006955,0.15999,0.20631,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.022172,0.15946,0.18566,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.050584,0.15925,0.22933,1,1
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.020391,0.15914,0.22402,1,1
4,GO ORGANELLE LOCALIZATION,0.025096,0.15912,0.16496,1,1
4,GO PROTEIN POLYMERIZATION,0.0034935,0.15893,0.21155,1,1
4,GO SENSORY ORGAN DEVELOPMENT,0.0049572,0.15887,0.21913,1,1
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0063209,0.15869,0.2515,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.011574,0.15847,0.2018,1,1
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.041938,0.15822,0.16955,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.017954,0.15819,0.18252,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0013481,0.15808,0.21002,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.027226,0.15796,0.18781,1,1
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0049572,0.15793,0.20288,1,1
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.018736,0.15792,0.1507,1,1
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.023112,0.15785,0.15777,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00054254,0.15752,0.19066,1,1
4,GO MEMBRANE BIOGENESIS,0.023112,0.1573,0.18891,1,1
4,GO DEVELOPMENTAL GROWTH,0.010572,0.15694,0.19833,1,1
4,GO TOR SIGNALING,0.016475,0.15684,0.18833,1,1
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0063209,0.15683,0.22024,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.019548,0.15683,0.19623,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0010798,0.15678,0.17632,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0092139,0.15677,0.19393,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.013834,0.15674,0.1901,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.01266,0.15663,0.20412,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0066311,0.15631,0.17125,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.031957,0.15631,0.17087,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.013235,0.15617,0.2678,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0096484,0.15614,0.16564,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0060238,0.15613,0.18709,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.038848,0.15549,0.16177,1,1
4,GO REGULATION OF RNA SPLICING,0.046961,0.15539,0.14183,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.020391,0.15527,0.18225,1,1
4,GO MEMBRANE DOCKING,0.034576,0.15512,0.17456,1,1
4,GO MYOFIBRIL ASSEMBLY,0.027226,0.15494,0.18461,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.010572,0.15481,0.26734,1,1
4,GO REGULATION OF TRANSPORT,0.021265,0.15479,0.17147,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.025096,0.15441,0.24383,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.041938,0.15435,0.19275,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.052482,0.15434,0.19328,1,1
4,GO CHROMATIN REMODELING,0.033245,0.1542,0.16883,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.050584,0.15416,0.16437,1,1
4,GO RESPONSE TO WATER,0.048745,0.15384,0.14381,1,1
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.027226,0.15368,0.15866,1,1
4,GO MEMBRANE DISASSEMBLY,0.019548,0.15367,0.22255,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.022172,0.15353,0.25525,1,1
4,GO CELL RECOGNITION,0.041938,0.1535,0.17155,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.011063,0.15308,0.22074,1,1
4,GO LIMBIC SYSTEM DEVELOPMENT,0.013235,0.15305,0.18646,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.033245,0.15301,0.17976,1,1
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.006955,0.15245,0.21072,1,1
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.043559,0.15237,0.18115,1,1
4,GO SODIUM ION TRANSPORT,0.0054671,0.15232,0.19566,1,1
4,GO REGIONALIZATION,0.011574,0.15231,0.17374,1,1
4,GO MULTICELLULAR ORGANISM AGING,0.031957,0.15211,0.16329,1,1
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.017954,0.15208,0.18876,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.0034935,0.15196,0.1833,1,1
4,GO SNORNA METABOLIC PROCESS,0.01266,0.15147,0.16358,1,1
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0016767,0.15144,0.24529,1,1
4,GO EAR MORPHOGENESIS,0.022172,0.15092,0.16769,1,1
4,GO MITOPHAGY,0.018736,0.15071,0.21315,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0076456,0.15048,0.25043,1,1
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.024086,0.15019,0.19902,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.0092139,0.15014,0.16452,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.033245,0.15007,0.1873,1,1
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.01266,0.14994,0.21448,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.050584,0.14983,0.1685,1,1
4,GO RETINAL CONE CELL DIFFERENTIATION,0.025096,0.14951,0.35099,1,1
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0034935,0.1495,0.21505,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.023112,0.14936,0.18379,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.043559,0.14922,0.15289,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.0029965,0.14921,0.18891,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.048745,0.149,0.18589,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.0060238,0.1488,0.1836,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.015776,0.14862,0.1845,1,1
4,GO ORGANIC ACID TRANSPORT,0.027226,0.1485,0.14466,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0083971,0.14846,0.19203,1,1
4,GO PHAGOSOME MATURATION,0.043559,0.14845,0.15345,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.027226,0.14845,0.17561,1,1
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.021265,0.14811,0.16622,1,1
4,GO DIENCEPHALON DEVELOPMENT,0.016475,0.1481,0.19274,1,1
4,GO CHROMATIN ORGANIZATION,0.023112,0.14808,0.18175,1,1
4,GO HEART PROCESS,0.022172,0.14794,0.16362,1,1
4,GO ROOF OF MOUTH DEVELOPMENT,0.052482,0.14787,0.16463,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.020391,0.14761,0.20116,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.030713,0.14748,0.1688,1,1
4,GO MUSCLE SYSTEM PROCESS,0.021265,0.14689,0.16833,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.010572,0.14686,0.31568,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.021265,0.14682,0.17256,1,1
4,GO REGULATION OF FIBROBLAST MIGRATION,0.021265,0.14663,0.20688,1,1
4,GO POLYOL METABOLIC PROCESS,0.0047188,0.14631,0.18622,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0040644,0.14624,0.19363,1,1
4,GO MACROMOLECULE DEACYLATION,0.028348,0.14593,0.16929,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0024341,0.1458,0.18614,1,1
4,GO REGULATION OF GTPASE ACTIVITY,0.02951,0.14556,0.2098,1,1
4,GO HIPPOCAMPUS DEVELOPMENT,0.018736,0.14546,0.18126,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.008797,0.14544,0.21561,1,1
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.043559,0.14539,0.13887,1,1
4,GO GLIOGENESIS,0.02951,0.14485,0.1791,1,1
4,GO AMINE TRANSPORT,0.0066311,0.14477,0.25088,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.013235,0.14469,0.17217,1,1
4,GO METHYLATION,0.041938,0.14466,0.13998,1,1
4,GO SENSORY ORGAN MORPHOGENESIS,0.011063,0.14459,0.20186,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.023112,0.14438,0.18805,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.006955,0.14434,0.17614,1,1
4,GO REGULATION OF SECRETION,0.026142,0.14422,0.17798,1,1
4,GO SULFATE TRANSPORT,0.050584,0.14389,0.18338,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.023112,0.14388,0.14141,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.017954,0.14375,0.13444,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0057394,0.14352,0.22694,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.028348,0.14331,0.16534,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.040368,0.14291,0.18763,1,1
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.035953,0.14289,0.18549,1,1
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.048745,0.14284,0.20184,1,1
4,GO HISTONE DEACETYLATION,0.026142,0.14277,0.18199,1,1
4,GO REGULATION OF DNA REPAIR,0.028348,0.14273,0.16443,1,1
4,GO RRNA TRANSCRIPTION,0.0063209,0.14272,0.17335,1,1
4,GO ION TRANSPORT,0.0092139,0.14235,0.17132,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0038653,0.14229,0.33629,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.033245,0.14222,0.13008,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.025096,0.14222,0.18555,1,1
4,GO GENETIC IMPRINTING,0.033245,0.14218,0.21346,1,1
4,GO CELL PROJECTION ASSEMBLY,0.045233,0.14214,0.17081,1,1
4,GO APPENDAGE DEVELOPMENT,0.014457,0.14198,0.20711,1,1
4,GO OOGENESIS,0.040368,0.14194,0.13617,1,1
4,GO TRANSFERRIN TRANSPORT,0.020391,0.14149,0.14504,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.030713,0.14144,0.21307,1,1
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.024086,0.14113,0.1734,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.046961,0.14107,0.15863,1,1
4,GO LYSOSOMAL TRANSPORT,0.041938,0.14087,0.18456,1,1
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.046961,0.14075,0.18004,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.016475,0.14038,0.20651,1,1
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.043559,0.14026,0.18972,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.0172,0.14007,0.16847,1,1
4,GO INNER EAR MORPHOGENESIS,0.023112,0.13983,0.16046,1,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.046961,0.13976,0.15094,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.010101,0.13976,0.16962,1,1
4,GO SPLEEN DEVELOPMENT,0.012106,0.13958,0.21035,1,1
4,GO REGULATION OF CELL CYCLE ARREST,0.014457,0.13956,0.16386,1,1
4,GO ACTIN FILAMENT BASED PROCESS,0.020391,0.13919,0.19201,1,1
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.046961,0.13915,0.16435,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.028348,0.13907,0.19838,1,1
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.022172,0.13887,0.18059,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.050584,0.13884,0.14697,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.045233,0.1387,0.16957,1,1
4,GO RHYTHMIC PROCESS,0.0172,0.13866,0.17106,1,1
4,GO GLIAL CELL DIFFERENTIATION,0.033245,0.13866,0.17132,1,1
4,GO REGULATION OF PROTEIN BINDING,0.018736,0.13844,0.18033,1,1
4,GO PROTEIN ACYLATION,0.040368,0.13844,0.17147,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.038848,0.13842,0.1759,1,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.043559,0.13826,0.19906,1,1
4,GO TRANSPOSITION,0.034576,0.13822,0.17578,1,1
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.030713,0.13818,0.16791,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.013834,0.13813,0.17615,1,1
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.052482,0.13799,0.16294,1,1
4,GO RESPONSE TO ALKALOID,0.045233,0.13785,0.13281,1,1
4,GO ENSHEATHMENT OF NEURONS,0.037377,0.13771,0.15731,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.014457,0.13755,0.19648,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.023112,0.13702,0.18938,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.027226,0.13648,0.15385,1,1
4,GO LIPID MODIFICATION,0.045233,0.13642,0.13477,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.015104,0.13642,0.18383,1,1
4,GO RESPONSE TO ATP,0.030713,0.13639,0.18798,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.018736,0.13638,0.14883,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031957,0.13629,0.16228,1,1
4,GO CYTOSKELETON ORGANIZATION,0.010572,0.13577,0.19404,1,1
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.048745,0.13512,0.1699,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.011063,0.13477,0.15957,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.018736,0.13447,0.20006,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.008797,0.13398,0.18613,1,1
4,GO INTERMEMBRANE LIPID TRANSFER,0.030713,0.13395,0.1928,1,1
4,GO RRNA CATABOLIC PROCESS,0.011574,0.1338,0.1699,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.038848,0.13372,0.15471,1,1
4,GO CLATHRIN COAT ASSEMBLY,0.046961,0.13336,0.15176,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0172,0.13315,0.1931,1,1
4,GO CANONICAL WNT SIGNALING PATHWAY,0.025096,0.13307,0.16471,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.017954,0.13298,0.17873,1,1
4,GO HISTONE H2A ACETYLATION,0.02951,0.13296,0.16674,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.006955,0.13287,0.19159,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0031545,0.13256,0.20065,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.015776,0.13237,0.17726,1,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.019548,0.13222,0.19836,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.037377,0.13211,0.14233,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.017954,0.13211,0.18838,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.028348,0.13201,0.12156,1,1
4,GO CARDIAC MUSCLE CONTRACTION,0.026142,0.1315,0.15471,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.040368,0.13146,0.13921,1,1
4,GO CELL GROWTH,0.014457,0.13144,0.19416,1,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.030713,0.1313,0.17479,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.007293,0.13127,0.16093,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.043559,0.131,0.20253,1,1
4,GO GLIAL CELL DEVELOPMENT,0.035953,0.13075,0.17945,1,1
4,GO EAR DEVELOPMENT,0.035953,0.13049,0.16504,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.0076456,0.13029,0.16296,1,1
4,GO FIBROBLAST MIGRATION,0.025096,0.13022,0.20622,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.050584,0.12999,0.18176,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.024086,0.12914,0.17153,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.033245,0.12897,0.17944,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.050584,0.12896,0.17545,1,1
4,GO LAMELLIPODIUM ASSEMBLY,0.050584,0.1289,0.16533,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.050584,0.12883,0.16474,1,1
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.050584,0.12874,0.12743,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.0042727,0.12856,0.14289,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.025096,0.12849,0.11996,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.028348,0.12847,0.12301,1,1
4,GO REGULATION OF HISTONE MODIFICATION,0.018736,0.12835,0.17487,1,1
4,GO SCHWANN CELL DIFFERENTIATION,0.021265,0.12821,0.20291,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.016475,0.12802,0.15985,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.040368,0.12792,0.17975,1,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.034576,0.12771,0.19519,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,0.017954,0.12769,0.24716,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.02951,0.12768,0.16836,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.027226,0.12727,0.16333,1,1
4,GO HEART MORPHOGENESIS,0.052482,0.1272,0.17538,1,1
4,GO PROTEIN ACETYLATION,0.028348,0.12696,0.17152,1,1
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.017954,0.12692,0.17931,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.016475,0.12684,0.1703,1,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.022172,0.12683,0.17822,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0052065,0.12675,0.18069,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.027226,0.12636,0.18209,1,1
4,GO REGULATION OF DNA BINDING,0.014457,0.12624,0.16291,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.048745,0.12618,0.1032,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0096484,0.12617,0.1957,1,1
4,GO CHROMOSOME ORGANIZATION,0.048745,0.12602,0.14934,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.048745,0.12594,0.14959,1,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.034576,0.12562,0.17846,1,1
4,GO RESPONSE TO AMINO ACID STARVATION,0.013235,0.12555,0.18133,1,1
4,GO REGULATION OF CELL MATURATION,0.025096,0.12543,0.14902,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0040644,0.12527,0.13741,1,1
4,GO GMP METABOLIC PROCESS,0.011574,0.12506,0.16827,1,1
4,GO REGULATION OF CYTOKINESIS,0.038848,0.12486,0.16862,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.021265,0.1247,0.12797,1,1
4,GO POSITIVE REGULATION OF GROWTH,0.026142,0.12468,0.18219,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.019548,0.12453,0.20254,1,1
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.01266,0.12448,0.17727,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.033245,0.12427,0.10742,1,1
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.027226,0.12419,0.22327,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.023112,0.12407,0.12359,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.018736,0.12398,0.17956,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.026142,0.12357,0.18119,1,1
4,GO GLUCOSE METABOLIC PROCESS,0.014457,0.12342,0.16106,1,1
4,GO REGULATION OF HISTONE UBIQUITINATION,0.014457,0.12329,0.17751,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.027226,0.12325,0.12539,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.045233,0.12323,0.12025,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.026142,0.12315,0.18456,1,1
4,GO PROTEIN INSERTION INTO MEMBRANE,0.034576,0.12306,0.10637,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.038848,0.12284,0.15255,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.052482,0.12263,0.12775,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.046961,0.12222,0.11507,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.02951,0.12171,0.15593,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.034576,0.12137,0.14081,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.014457,0.12118,0.14156,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.028348,0.12099,0.16951,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.050584,0.12083,0.1504,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.041938,0.12083,0.14129,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.011574,0.12064,0.14995,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.027226,0.12058,0.15165,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.037377,0.12031,0.16081,1,1
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.038848,0.12,0.14078,1,1
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.025096,0.11982,0.18453,1,1
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0047188,0.11963,0.15655,1,1
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.020391,0.11933,0.12236,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.021265,0.11932,0.1777,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.016475,0.1193,0.20171,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.041938,0.11924,0.12628,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.006955,0.11906,0.173,1,1
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.045233,0.11904,0.11537,1,1
4,GO CELL CELL SIGNALING BY WNT,0.016475,0.11886,0.16732,1,1
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.014457,0.11872,0.19058,1,1
4,GO AXIS SPECIFICATION,0.052482,0.11867,0.13003,1,1
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.033245,0.11854,0.15568,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.035953,0.11847,0.1471,1,1
4,GO MEMBRANE ORGANIZATION,0.030713,0.11815,0.14622,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.043559,0.11786,0.13977,1,1
4,GO PHOTOTRANSDUCTION,0.007293,0.1176,0.30466,1,1
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.017954,0.11705,0.11603,1,1
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.048745,0.1166,0.15251,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.031957,0.11642,0.15926,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.02951,0.11633,0.21874,1,1
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.052482,0.1161,0.10813,1,1
4,GO VACUOLAR TRANSPORT,0.048745,0.11608,0.15607,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.027226,0.11585,0.18015,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.041938,0.11566,0.13078,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.023112,0.11562,0.17259,1,1
4,GO DNA METHYLATION,0.040368,0.11557,0.14795,1,1
4,GO REGULATION OF DEPHOSPHORYLATION,0.026142,0.11534,0.16145,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.020391,0.1152,0.11973,1,1
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0096484,0.11494,0.17316,1,1
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.050584,0.11494,0.16903,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.024086,0.11492,0.16424,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.031957,0.11435,0.14919,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.011574,0.11423,0.15618,1,1
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.048745,0.1139,0.14438,1,1
4,GO MUSCLE FILAMENT SLIDING,0.026142,0.11379,0.17948,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.02951,0.11338,0.14197,1,1
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.046961,0.11299,0.17162,1,1
4,GO CELL CYCLE ARREST,0.041938,0.11276,0.1409,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.019548,0.1124,0.1792,1,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.02951,0.1122,0.11984,1,1
4,GO RESPONSE TO STARVATION,0.040368,0.11198,0.13502,1,1
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.034576,0.11183,0.13769,1,1
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.034576,0.11183,0.14311,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.033245,0.1116,0.1379,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.035953,0.11118,0.1701,1,1
4,GO NCRNA CATABOLIC PROCESS,0.046961,0.11114,0.11883,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0172,0.11107,0.1605,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.019548,0.11057,0.13449,1,1
4,GO EMBRYONIC PATTERN SPECIFICATION,0.035953,0.1101,0.1223,1,1
4,GO POSITIVE REGULATION OF BINDING,0.011574,0.10946,0.15441,1,1
4,GO EMBRYONIC MORPHOGENESIS,0.02951,0.10888,0.1737,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.045233,0.10866,0.14047,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.015776,0.10844,0.17525,1,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.025096,0.10837,0.15451,1,1
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0080134,0.10804,0.24147,1,1
4,GO VESICLE LOCALIZATION,0.028348,0.10756,0.15661,1,1
4,GO DNA METHYLATION OR DEMETHYLATION,0.021265,0.10752,0.15233,1,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.025096,0.1075,0.15776,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.026142,0.10745,0.15678,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.020391,0.10726,0.17068,1,1
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.048745,0.10636,0.14879,1,1
4,GO DETECTION OF STIMULUS,0.0096484,0.10628,0.13895,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.030713,0.10532,0.15528,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.019548,0.10523,0.1669,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0172,0.10502,0.13528,1,1
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.034576,0.10497,0.17359,1,1
4,GO EMBRYO DEVELOPMENT,0.020391,0.10475,0.16967,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.038848,0.10434,0.1331,1,1
4,GO SEXUAL REPRODUCTION,0.048745,0.10362,0.12424,1,1
4,GO GROWTH,0.022172,0.10343,0.16587,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0172,0.10271,0.19203,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.041938,0.10202,0.1404,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.028348,0.10187,0.1316,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.025096,0.10149,0.11257,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.02951,0.1011,0.16454,1,1
4,GO NEGATIVE REGULATION OF BINDING,0.048745,0.10108,0.15151,1,1
4,GO MULTI ORGANISM PROCESS,0.052482,0.10105,0.11979,1,1
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.017954,0.10099,0.16859,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.025096,0.099913,0.098284,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.033245,0.099703,0.15251,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.031957,0.099474,0.098018,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.050584,0.099373,0.13179,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.052482,0.09936,0.16062,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.025096,0.098574,0.19801,1,1
4,GO DEPHOSPHORYLATION,0.033245,0.098138,0.13368,1,1
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.048745,0.098063,0.17206,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.046961,0.097631,0.14953,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.030713,0.097283,0.17513,1,1
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.034576,0.096823,0.15502,1,1
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.030713,0.096282,0.17509,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035953,0.096018,0.13407,1,1
4,GO RESPONSE TO LIGHT STIMULUS,0.010572,0.095936,0.16254,1,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.019548,0.095634,0.16763,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.043559,0.095484,0.13395,1,1
4,GO REGULATION OF BINDING,0.031957,0.095,0.15847,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.025096,0.094895,0.12132,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION,0.048745,0.09425,0.12282,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.048745,0.093992,0.17541,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.041938,0.093712,0.15448,1,1
4,GO DNA MODIFICATION,0.024086,0.093456,0.14312,1,1
4,GO GASTRIC ACID SECRETION,0.046961,0.091733,0.13808,1,1
4,GO ORGANELLE ASSEMBLY,0.052482,0.09151,0.14232,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.019548,0.09133,0.19992,1,1
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.037377,0.090816,0.14802,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.034576,0.088924,0.10168,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.015104,0.088664,0.18729,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.025096,0.08792,0.10541,1,1
4,GO CYTOSOLIC TRANSPORT,0.045233,0.087743,0.17391,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.033245,0.087555,0.14703,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.050584,0.087504,0.1112,1,1
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.040368,0.087439,0.11037,1,1
4,GO PHOTOPERIODISM,0.019548,0.087221,0.16342,1,1
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.043559,0.086982,0.13794,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.041938,0.085959,0.16121,1,1
4,GO ATP METABOLIC PROCESS,0.0057394,0.085258,0.105,1,1
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.046961,0.08477,0.14635,1,1
4,GO PIGMENT METABOLIC PROCESS,0.037377,0.08428,0.1063,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.033245,0.084015,0.15424,1,1
4,GO SECONDARY METABOLIC PROCESS,0.043559,0.083612,0.1166,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.052482,0.082934,0.12621,1,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.041938,0.082343,0.14498,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.040368,0.081221,0.15307,1,1
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.027226,0.080261,0.10317,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.028348,0.079601,0.090608,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.043559,0.079415,0.13415,1,1
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.046961,0.079372,0.14315,1,1
4,GO RESPONSE TO RADIATION,0.041938,0.07821,0.12992,1,1
4,GO PROTEIN DEPHOSPHORYLATION,0.035953,0.074937,0.13374,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.034576,0.073322,0.11778,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.037377,0.072036,0.092214,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.046961,0.071529,0.10676,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.020391,0.07126,0.11988,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.041938,0.067726,0.12141,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.046961,0.066848,0.084863,1,1
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.052482,0.065445,0.10274,1,1
4,GO FOREBRAIN REGIONALIZATION,0.034576,0.3258,0.22328,1,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0060238,0.30503,0.30916,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.010101,0.30204,0.30167,1,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.010572,0.2872,0.33765,1,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0080134,0.28299,0.31965,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00332,0.27968,0.26705,1,0
4,GO INNERVATION,0.027226,0.27659,0.31906,1,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.018736,0.26874,0.33041,1,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.018736,0.26758,0.24818,1,0
4,GO DENSE CORE GRANULE TRANSPORT,0.046961,0.26165,0.29609,1,0
4,GO MICROTUBULE BUNDLE FORMATION,0.0172,0.25706,0.23277,1,0
4,GO SEX DETERMINATION,0.028348,0.2566,0.20459,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.019548,0.25613,0.25392,1,0
4,GO RESPONSE TO L GLUTAMATE,0.0083971,0.25151,0.22514,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.0018673,0.25136,0.2901,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0023095,0.2499,0.39985,1,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.022172,0.24921,0.24086,1,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0063209,0.23472,0.28589,1,0
4,GO NEURON REMODELING,0.023112,0.23134,0.31361,1,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.019548,0.22883,0.22464,1,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.027226,0.21955,0.27993,1,0
4,GO AXONAL TRANSPORT,0.010572,0.21913,0.25839,1,0
4,GO SYNAPTIC VESICLE PRIMING,0.026142,0.21802,0.27943,1,0
4,GO MICROTUBULE ANCHORING,0.027226,0.21573,0.22315,1,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.046961,0.21074,0.19885,1,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.016475,0.21057,0.21519,1,0
4,GO TRANSPORT ALONG MICROTUBULE,0.015104,0.20933,0.20329,1,0
4,GO SKELETAL MUSCLE ADAPTATION,0.013235,0.20629,0.21835,1,0
4,GO NOSE DEVELOPMENT,0.050584,0.20021,0.24989,1,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0063209,0.19994,0.24002,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.052482,0.1998,0.2444,1,0
4,GO INOSITOL METABOLIC PROCESS,0.017954,0.19826,0.25924,1,0
4,GO RESPONSE TO PAIN,0.037377,0.19749,0.20911,1,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.038848,0.19337,0.2006,1,0
4,GO THYROID GLAND DEVELOPMENT,0.045233,0.18139,0.17503,1,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.034576,0.17813,0.22825,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.050584,0.17781,0.2365,1,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.018736,0.17337,0.28033,1,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.028348,0.17242,0.25568,1,0
4,GO MICROTUBULE BASED TRANSPORT,0.028348,0.17117,0.19409,1,0
4,GO PROTEIN PALMITOYLATION,0.048745,0.16959,0.18793,1,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.021265,0.16872,0.18966,1,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.027226,0.16637,0.17196,1,0
4,GO OXIDATIVE DEMETHYLATION,0.031957,0.16417,0.1452,1,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.016475,0.16232,0.20367,1,0
4,GO MICROTUBULE BASED MOVEMENT,0.034576,0.16166,0.17953,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.027226,0.16024,0.19009,1,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.040368,0.16012,0.20448,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.030713,0.15888,0.16745,1,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.034576,0.15786,0.19732,1,0
4,GO SECONDARY PALATE DEVELOPMENT,0.046961,0.15577,0.22759,1,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.019548,0.15562,0.23907,1,0
4,GO BRAIN MORPHOGENESIS,0.034576,0.15297,0.16682,1,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.022172,0.15194,0.18456,1,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.024086,0.15105,0.19389,1,0
4,GO HISTONE H3 K14 ACETYLATION,0.045233,0.14951,0.18093,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0029965,0.14836,0.2002,1,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.008797,0.14635,0.26613,1,0
4,GO CHOLESTEROL EFFLUX,0.037377,0.14573,0.20405,1,0
4,GO NUCLEAR BODY ORGANIZATION,0.007293,0.14566,0.19227,1,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.025096,0.14374,0.24127,1,0
4,GO AMMONIUM ION METABOLIC PROCESS,0.022172,0.14336,0.22195,1,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.041938,0.1433,0.18044,1,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.026142,0.14244,0.20514,1,0
4,GO REGULATION OF BLOOD CIRCULATION,0.021265,0.14235,0.176,1,0
4,GO MICROTUBULE BASED PROCESS,0.035953,0.14224,0.1756,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.026142,0.14041,0.20016,1,0
4,GO ACTIVATION OF MAPK ACTIVITY,0.050584,0.13985,0.1769,1,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.025096,0.13534,0.15215,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.027226,0.13467,0.16275,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.030713,0.13394,0.13466,1,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.025096,0.13277,0.18606,1,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.052482,0.12956,0.18721,1,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0080134,0.12804,0.22224,1,0
4,GO REGULATION OF SENSORY PERCEPTION,0.016475,0.12764,0.21391,1,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.02951,0.12548,0.17795,1,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.045233,0.12017,0.15221,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.048745,0.12009,0.18181,1,0
4,GO ATP TRANSPORT,0.037377,0.11965,0.14039,1,0
4,GO ANION HOMEOSTASIS,0.01266,0.11873,0.19582,1,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.048745,0.11858,0.1451,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.030713,0.11824,0.25464,1,0
4,GO MAMMARY GLAND DEVELOPMENT,0.038848,0.1174,0.18226,1,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.037377,0.1172,0.16591,1,0
4,GO PEPTIDE SECRETION,0.043559,0.11715,0.17018,1,0
4,GO COPPER ION HOMEOSTASIS,0.038848,0.11589,0.16409,1,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.052482,0.11583,0.16233,1,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.022172,0.11273,0.13463,1,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.034576,0.11225,0.16271,1,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.046961,0.11058,0.12719,1,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.024086,0.10995,0.13466,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.050584,0.10828,0.14512,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.046961,0.10785,0.14628,1,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.027226,0.10691,0.17541,1,0
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.052482,0.10666,0.16653,1,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.052482,0.10532,0.14942,1,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.033245,0.1017,0.11435,1,0
4,GO CELLULAR HOMEOSTASIS,0.043559,0.098073,0.14588,1,0
4,GO GLAND DEVELOPMENT,0.045233,0.096884,0.14776,1,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.040368,0.095544,0.16159,1,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.045233,0.095026,0.11097,1,0
4,GO ANION TRANSPORT,0.050584,0.091526,0.13224,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.052482,0.091138,0.13606,1,0
4,GO MIDBRAIN DEVELOPMENT,0.034576,0.089115,0.15012,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.034576,0.085456,0.18425,1,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.050584,0.075752,0.14501,1,0
4,GO SULFUR COMPOUND TRANSPORT,0.052482,0.07544,0.16788,1,0
4,GO REGULATION OF GROWTH,0.033245,0.073224,0.16031,1,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.043559,0.059462,0.14642,1,0
4,GO MITOCHONDRIAL TRANSLATION,0.046961,-0.062244,-0.071613,1,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.022172,-0.11415,-0.10051,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.026142,-0.1244,-0.14427,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.038848,-0.14753,-0.14486,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.034576,-0.14842,-0.088533,1,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.025096,-0.14911,-0.13046,1,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.052482,-0.17152,-0.18648,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0092139,-0.17588,-0.15784,1,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.011574,-0.19315,-0.14337,1,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0019699,-0.22586,-0.18245,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0028457,-0.25032,-0.22709,1,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.022172,-0.2538,-0.24512,1,0
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.034576,-0.25551,-0.29668,1,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.034576,-0.26,-0.35574,1,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0031545,-0.26178,-0.25635,1,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.011063,-0.33338,-0.38074,1,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.043559,-0.34379,-0.24028,1,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0063209,-0.38382,-0.42578,1,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.080256,0.46832,0.41065,0,1
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.28529,0.40695,0.19189,0,1
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.08588,0.36696,0.25938,0,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.094909,0.36328,0.26365,0,1
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.10134,0.35808,0.20747,0,1
4,GO OUTER DYNEIN ARM ASSEMBLY,0.060677,0.35173,0.24415,0,1
4,GO ADRENAL GLAND DEVELOPMENT,0.062884,0.34398,0.20111,0,1
4,GO PENILE ERECTION,0.14312,0.3208,0.2016,0,1
4,GO REGULATION OF RECEPTOR CLUSTERING,0.054439,0.32044,0.26187,0,1
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.197,0.31155,0.24942,0,1
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.058535,0.30735,0.21981,0,1
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.054439,0.30474,0.21521,0,1
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.056456,0.29977,0.24437,0,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.10134,0.29574,0.27682,0,1
4,GO AXONEME ASSEMBLY,0.054439,0.29377,0.1989,0,1
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.13467,0.28896,0.17255,0,1
4,GO LYMPHANGIOGENESIS,0.23827,0.28807,0.13811,0,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.08303,0.28798,0.21997,0,1
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.091819,0.28545,0.20541,0,1
4,GO BONE TRABECULA MORPHOGENESIS,0.12662,0.28497,0.27523,0,1
4,GO RESPONSE TO INTERLEUKIN 2,0.15655,0.28091,0.26901,0,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.077559,0.27707,0.24528,0,1
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.094909,0.27588,0.15922,0,1
4,GO PULMONARY VALVE DEVELOPMENT,0.062884,0.2679,0.23667,0,1
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.11524,0.26533,0.1561,0,1
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.056456,0.26308,0.27784,0,1
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.094909,0.25634,0.16176,0,1
4,GO COPULATION,0.12273,0.25615,0.15973,0,1
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.060677,0.25411,0.21042,0,1
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.34626,0.25384,0.21787,0,1
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.060677,0.25312,0.22252,0,1
4,GO SULFATION,0.11163,0.25274,0.14701,0,1
4,GO MOTILE CILIUM ASSEMBLY,0.11163,0.25248,0.2097,0,1
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.065157,0.24945,0.17269,0,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.1475,0.24833,0.18434,0,1
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.077559,0.24711,0.20735,0,1
4,GO CYTIDINE TO URIDINE EDITING,0.25111,0.24655,0.19462,0,1
4,GO DOSAGE COMPENSATION,0.067497,0.24634,0.19655,0,1
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.065157,0.24619,0.20318,0,1
4,GO PHAGOCYTOSIS RECOGNITION,0.15655,0.24386,0.18572,0,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.11894,0.24355,0.15475,0,1
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.080256,0.2431,0.18923,0,1
4,GO LYMPH VESSEL DEVELOPMENT,0.15197,0.24048,0.18459,0,1
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.069906,0.24041,0.31562,0,1
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.12273,0.24001,0.17007,0,1
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.065157,0.23945,0.19578,0,1
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.062884,0.23847,0.25202,0,1
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.13467,0.23793,0.1552,0,1
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.17091,0.23671,0.14812,0,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.13467,0.23587,0.2039,0,1
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.077559,0.23394,0.23989,0,1
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.11894,0.23366,0.23206,0,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.077559,0.23219,0.25493,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.08303,0.23201,0.18252,0,1
4,GO SOMATIC STEM CELL DIVISION,0.27821,0.22514,0.13059,0,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.10134,0.22501,0.14508,0,1
4,GO AORTA MORPHOGENESIS,0.13467,0.22337,0.14796,0,1
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.077559,0.2214,0.27301,0,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.10468,0.2212,0.16265,0,1
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.074935,0.22086,0.23917,0,1
4,GO CARDIOBLAST DIFFERENTIATION,0.067497,0.22013,0.17991,0,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.17091,0.2186,0.18724,0,1
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.1306,0.21839,0.2002,0,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.21989,0.21783,0.13722,0,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.072385,0.21739,0.2186,0,1
4,GO STEM CELL DIVISION,0.23203,0.21665,0.13512,0,1
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.19156,0.21455,0.14541,0,1
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.062884,0.21205,0.22735,0,1
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.16602,0.21196,0.17338,0,1
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.18102,0.21132,0.086049,0,1
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.056456,0.21063,0.16625,0,1
4,GO STORE OPERATED CALCIUM ENTRY,0.13467,0.2102,0.16833,0,1
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.11163,0.20849,0.27975,0,1
4,GO LYMPH VESSEL MORPHOGENESIS,0.25111,0.20808,0.12876,0,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.11524,0.20722,0.18071,0,1
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.077559,0.20697,0.1858,0,1
4,GO OTIC VESICLE DEVELOPMENT,0.30724,0.20679,0.038113,0,1
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.1306,0.20495,0.14916,0,1
4,GO DNA DEAMINATION,0.11163,0.20362,0.17293,0,1
4,GO SERTOLI CELL DIFFERENTIATION,0.08303,0.20102,0.16945,0,1
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.16123,0.20034,0.17484,0,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.197,0.20016,0.11756,0,1
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.12662,0.19982,0.14967,0,1
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.091819,0.19976,0.14218,0,1
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.11524,0.19895,0.19792,0,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.08588,0.1969,0.17653,0,1
4,GO REPLICATION FORK PROCESSING,0.36271,0.19669,0.10854,0,1
4,GO MATING BEHAVIOR,0.062884,0.19652,0.18309,0,1
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.15197,0.19607,0.16227,0,1
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.077559,0.1958,0.21982,0,1
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.15655,0.19423,0.16181,0,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.40594,0.1938,0.08842,0,1
4,GO ENDOTHELIUM DEVELOPMENT,0.060677,0.19348,0.17414,0,1
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10134,0.19321,0.1303,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11894,0.1931,0.17051,0,1
4,GO REPLACEMENT OSSIFICATION,0.15655,0.19273,0.11924,0,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.23827,0.19273,0.15703,0,1
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.18624,0.19269,0.16635,0,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.091819,0.19269,0.21312,0,1
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.08303,0.19143,0.19793,0,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.098083,0.19044,0.23121,0,1
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.074935,0.19023,0.11698,0,1
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.094909,0.19023,0.16443,0,1
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.214,0.18984,0.14948,0,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.062884,0.18921,0.1942,0,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.062884,0.18909,0.22184,0,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.069906,0.18871,0.1658,0,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.077559,0.18782,0.17895,0,1
4,GO LEFT RIGHT AXIS SPECIFICATION,0.197,0.18767,0.11691,0,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.12662,0.18721,0.14939,0,1
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.08303,0.18696,0.22051,0,1
4,GO P BODY ASSEMBLY,0.11894,0.18523,0.16257,0,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.058535,0.18523,0.20033,0,1
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.10134,0.18523,0.21804,0,1
4,GO REGULATION OF NEURON MATURATION,0.054439,0.1851,0.1966,0,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.054439,0.18456,0.20358,0,1
4,GO CHONDROCYTE PROLIFERATION,0.214,0.18435,0.1495,0,1
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.098083,0.18371,0.20624,0,1
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.10468,0.18154,0.15813,0,1
4,GO REGULATION OF PINOCYTOSIS,0.23203,0.18086,0.14226,0,1
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.072385,0.18078,0.16568,0,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.32248,0.18012,0.14941,0,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.091819,0.17996,0.17825,0,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.11163,0.17987,0.14425,0,1
4,GO RESPONSE TO UV B,0.08881,0.17932,0.082672,0,1
4,GO PRO B CELL DIFFERENTIATION,0.12273,0.17918,0.16565,0,1
4,GO SHORT TERM MEMORY,0.060677,0.17911,0.25815,0,1
4,GO SERTOLI CELL DEVELOPMENT,0.17091,0.17896,0.14423,0,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.065157,0.17838,0.20107,0,1
4,GO GLOMERULUS DEVELOPMENT,0.27126,0.17836,0.13827,0,1
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.08588,0.17834,0.17731,0,1
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.14312,0.17775,0.15713,0,1
4,GO SPERM MOTILITY,0.098083,0.17762,0.11827,0,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.15197,0.17741,0.10553,0,1
4,GO EPIDERMIS MORPHOGENESIS,0.2998,0.17726,0.11137,0,1
4,GO GRANULOCYTE DIFFERENTIATION,0.080256,0.17679,0.21937,0,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.10134,0.17609,0.21074,0,1
4,GO CELLULAR RESPONSE TO SALT STRESS,0.08588,0.17536,0.14955,0,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.20822,0.17446,0.14872,0,1
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.20822,0.1744,0.15284,0,1
4,GO TELOMERE CAPPING,0.065157,0.17376,0.16251,0,1
4,GO REGULATION OF TELOMERE CAPPING,0.08588,0.17357,0.16936,0,1
4,GO OSTEOBLAST DEVELOPMENT,0.16602,0.17213,0.13576,0,1
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10468,0.17176,0.098826,0,1
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.08881,0.17168,0.16826,0,1
4,GO COLLAGEN FIBRIL ORGANIZATION,0.29248,0.17153,0.16766,0,1
4,GO SPINDLE LOCALIZATION,0.091819,0.17073,0.16111,0,1
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.08881,0.1707,0.22137,0,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.16602,0.1696,0.10717,0,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.197,0.16925,0.15635,0,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.065157,0.16795,0.16219,0,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.062884,0.16773,0.16513,0,1
4,GO MATING,0.056456,0.167,0.16395,0,1
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.094909,0.16695,0.21779,0,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.17091,0.16686,0.11922,0,1
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.067497,0.16638,0.14428,0,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.15655,0.16544,0.17961,0,1
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.19156,0.16468,0.1506,0,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.065157,0.16417,0.21507,0,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.30724,0.16389,0.11167,0,1
4,GO SPROUTING ANGIOGENESIS,0.20256,0.16308,0.1378,0,1
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.08881,0.16303,0.14148,0,1
4,GO REGULATION OF HAIR CYCLE,0.20256,0.163,0.082617,0,1
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.24463,0.16293,0.10438,0,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.11163,0.16292,0.13247,0,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.056456,0.16225,0.14793,0,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.08588,0.16219,0.14116,0,1
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.056456,0.16175,0.138,0,1
4,GO ACTIVATION OF MAPKK ACTIVITY,0.060677,0.16152,0.20344,0,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.056456,0.16047,0.18666,0,1
4,GO RENAL WATER HOMEOSTASIS,0.069906,0.1598,0.21899,0,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.077559,0.1587,0.12443,0,1
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.20822,0.15861,0.19359,0,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.08588,0.15771,0.14806,0,1
4,GO REGULATION OF GASTRULATION,0.16602,0.1576,0.13073,0,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.091819,0.15744,0.1364,0,1
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.080256,0.15722,0.19788,0,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.18102,0.15694,0.14399,0,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.18102,0.15681,0.1043,0,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.14312,0.15646,0.17429,0,1
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.14312,0.15623,0.13391,0,1
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.074935,0.15615,0.191,0,1
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.08303,0.15602,0.12605,0,1
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.065157,0.15601,0.14909,0,1
4,GO CRANIAL NERVE DEVELOPMENT,0.10811,0.1557,0.16728,0,1
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.16602,0.15557,0.14892,0,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.15655,0.15489,0.13091,0,1
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.18624,0.15405,0.099042,0,1
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.1306,0.15281,0.14786,0,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.060677,0.15279,0.16524,0,1
4,GO ECTODERM DEVELOPMENT,0.27126,0.15248,0.0925,0,1
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.15197,0.15226,0.18339,0,1
4,GO BLOOD VESSEL REMODELING,0.11524,0.15217,0.19431,0,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.056456,0.15215,0.15703,0,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.1306,0.15196,0.18629,0,1
4,GO SEQUESTERING OF CALCIUM ION,0.077559,0.15166,0.18847,0,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.13885,0.15155,0.16039,0,1
4,GO DEVELOPMENTAL INDUCTION,0.065157,0.15062,0.11804,0,1
4,GO ACROSOME ASSEMBLY,0.15655,0.15062,0.12812,0,1
4,GO PANCREATIC JUICE SECRETION,0.10134,0.15043,0.188,0,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.065157,0.1504,0.17991,0,1
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.069906,0.15031,0.1573,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.060677,0.15017,0.12982,0,1
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.056456,0.15013,0.18466,0,1
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.08881,0.15012,0.13848,0,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.28529,0.14986,0.10347,0,1
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.10811,0.14971,0.16269,0,1
4,GO REGULATION OF PROTEIN SUMOYLATION,0.091819,0.1489,0.13776,0,1
4,GO RESPONSE TO LEPTIN,0.10811,0.1484,0.10443,0,1
4,GO CHROMOSOME CONDENSATION,0.10468,0.14839,0.15224,0,1
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.20822,0.1483,0.14062,0,1
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.11524,0.14812,0.12605,0,1
4,GO AORTA DEVELOPMENT,0.10134,0.1481,0.19824,0,1
4,GO ARTERY MORPHOGENESIS,0.20822,0.14801,0.13781,0,1
4,GO REGULATION OF HEART MORPHOGENESIS,0.098083,0.14725,0.15124,0,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.12662,0.14699,0.14419,0,1
4,GO RECEPTOR CATABOLIC PROCESS,0.11524,0.14669,0.14099,0,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.074935,0.14665,0.179,0,1
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.14312,0.14653,0.19187,0,1
4,GO DEFINITIVE HEMOPOIESIS,0.072385,0.14627,0.21508,0,1
4,GO RESPONSE TO SALT,0.08303,0.14624,0.12753,0,1
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.20256,0.14571,0.10112,0,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.058535,0.14557,0.19371,0,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.10134,0.14516,0.19333,0,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.074935,0.14409,0.17165,0,1
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.062884,0.14373,0.16281,0,1
4,GO POSITIVE REGULATION OF CELL AGING,0.11163,0.14341,0.11338,0,1
4,GO FOCAL ADHESION ASSEMBLY,0.11894,0.14337,0.18066,0,1
4,GO NEPHRON DEVELOPMENT,0.23827,0.14322,0.11928,0,1
4,GO COCHLEA DEVELOPMENT,0.054439,0.143,0.18737,0,1
4,GO INSEMINATION,0.21989,0.14293,0.1309,0,1
4,GO RESPONSE TO CAMP,0.08303,0.14226,0.14562,0,1
4,GO SPINDLE ASSEMBLY,0.077559,0.14192,0.13273,0,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.056456,0.1417,0.15036,0,1
4,GO REGULATION OF CHROMATIN BINDING,0.11894,0.14149,0.13857,0,1
4,GO CHROMATIN SILENCING,0.074935,0.14128,0.1436,0,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.28529,0.14116,0.10855,0,1
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.067497,0.14108,0.15517,0,1
4,GO HIPPO SIGNALING,0.18102,0.14086,0.1676,0,1
4,GO NODAL SIGNALING PATHWAY,0.094909,0.14015,0.1391,0,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.08303,0.1396,0.11185,0,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.1306,0.13912,0.12324,0,1
4,GO NOTOCHORD DEVELOPMENT,0.36271,0.13903,0.098656,0,1
4,GO LIPID OXIDATION,0.20256,0.13892,0.091904,0,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.25111,0.13879,0.11111,0,1
4,GO HAIR CELL DIFFERENTIATION,0.065157,0.13859,0.18748,0,1
4,GO MUSCLE HYPERTROPHY,0.11524,0.13849,0.13012,0,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.21989,0.13845,0.13965,0,1
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.13885,0.13835,0.17169,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.074935,0.13798,0.13394,0,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.18624,0.13776,0.14027,0,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.069906,0.13768,0.14965,0,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.10134,0.13761,0.14479,0,1
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.065157,0.13739,0.12424,0,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.19156,0.13729,0.1489,0,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.065157,0.13723,0.18114,0,1
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.054439,0.13702,0.13547,0,1
4,GO TUBE FORMATION,0.094909,0.13694,0.14048,0,1
4,GO RNA DESTABILIZATION,0.062884,0.13675,0.18419,0,1
4,GO CARNITINE METABOLIC PROCESS,0.094909,0.13638,0.1333,0,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.080256,0.13619,0.13879,0,1
4,GO SENSORY PERCEPTION OF TASTE,0.2998,0.13604,0.054827,0,1
4,GO GERM CELL DEVELOPMENT,0.058535,0.13551,0.12654,0,1
4,GO REGULATION OF CELL AGING,0.069906,0.1353,0.10247,0,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.16123,0.13524,0.14704,0,1
4,GO DNA PACKAGING,0.060677,0.13518,0.15237,0,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.072385,0.13509,0.19323,0,1
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.32248,0.13488,0.112,0,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.14312,0.13463,0.082628,0,1
4,GO RESPONSE TO AMINE,0.060677,0.13442,0.11585,0,1
4,GO LATERAL MESODERM DEVELOPMENT,0.15655,0.13439,0.12853,0,1
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.13885,0.13408,0.17117,0,1
4,GO MESENCHYME MORPHOGENESIS,0.11524,0.13394,0.15988,0,1
4,GO REGULATION OF FEEDING BEHAVIOR,0.12273,0.13369,0.089453,0,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.062884,0.13346,0.17488,0,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.26442,0.13345,0.1215,0,1
4,GO HISTONE H4 K16 ACETYLATION,0.21989,0.13334,0.11964,0,1
4,GO EPITHELIAL TUBE FORMATION,0.091819,0.13331,0.13837,0,1
4,GO MUSCLE ADAPTATION,0.1475,0.13322,0.12772,0,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.056456,0.13309,0.14895,0,1
4,GO CORONARY VASCULATURE DEVELOPMENT,0.067497,0.13271,0.20072,0,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.13885,0.13212,0.1312,0,1
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.18102,0.13206,0.14024,0,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.08588,0.13203,0.16531,0,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.08881,0.13178,0.16169,0,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.058535,0.13154,0.14115,0,1
4,GO CELL VOLUME HOMEOSTASIS,0.080256,0.13148,0.16675,0,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.074935,0.13121,0.16934,0,1
4,GO STEROL TRANSPORT,0.23203,0.13102,0.11612,0,1
4,GO SPINDLE ORGANIZATION,0.08588,0.131,0.13975,0,1
4,GO ENDOCARDIUM DEVELOPMENT,0.17591,0.13099,0.097449,0,1
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.2259,0.13077,0.12507,0,1
4,GO ARTERY DEVELOPMENT,0.12273,0.13057,0.17413,0,1
4,GO NEURAL TUBE FORMATION,0.080256,0.1305,0.16322,0,1
4,GO HOMOLOGOUS RECOMBINATION,0.40594,0.13015,0.064779,0,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.24463,0.13008,0.10097,0,1
4,GO PROTEIN HOMOTETRAMERIZATION,0.072385,0.12993,0.11946,0,1
4,GO HISTONE H4 DEACETYLATION,0.12273,0.12962,0.12916,0,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.10811,0.12932,0.12628,0,1
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.08881,0.1293,0.15402,0,1
4,GO DIGESTION,0.1306,0.12897,0.11356,0,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.14312,0.12814,0.15331,0,1
4,GO CARDIAC CHAMBER DEVELOPMENT,0.08303,0.12745,0.16435,0,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.080256,0.12735,0.20843,0,1
4,GO SNARE COMPLEX ASSEMBLY,0.17091,0.1273,0.091132,0,1
4,GO THYMUS DEVELOPMENT,0.077559,0.12689,0.1282,0,1
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.065157,0.12683,0.19589,0,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.069906,0.12589,0.18456,0,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.060677,0.12571,0.11427,0,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.060677,0.12559,0.15556,0,1
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.15197,0.12541,0.18023,0,1
4,GO REGULATION OF TELOMERE MAINTENANCE,0.098083,0.12534,0.13585,0,1
4,GO BASEMENT MEMBRANE ASSEMBLY,0.12273,0.12529,0.18526,0,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.34626,0.12512,0.083484,0,1
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.10468,0.12507,0.15242,0,1
4,GO HISTONE PHOSPHORYLATION,0.062884,0.12439,0.1372,0,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.080256,0.12406,0.13668,0,1
4,GO DNA RECOMBINATION,0.15197,0.1239,0.11479,0,1
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.30724,0.12388,0.10813,0,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.21989,0.12383,0.10856,0,1
4,GO DOUBLE STRAND BREAK REPAIR,0.067497,0.12368,0.14219,0,1
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.065157,0.1235,0.1665,0,1
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.077559,0.1235,0.13515,0,1
4,GO RNA SPLICING,0.18102,0.12331,0.093296,0,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.10468,0.12325,0.13245,0,1
4,GO GONADOTROPIN SECRETION,0.20256,0.12289,0.082014,0,1
4,GO MRNA PROCESSING,0.18624,0.12274,0.10072,0,1
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.069906,0.12232,0.14404,0,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.069906,0.12211,0.13431,0,1
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.11524,0.12159,0.15971,0,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.11163,0.12141,0.15733,0,1
4,GO COLLAGEN METABOLIC PROCESS,0.30724,0.12064,0.16733,0,1
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.15655,0.11961,0.10873,0,1
4,GO HYPEROSMOTIC RESPONSE,0.054439,0.11952,0.22065,0,1
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.14312,0.11944,0.16177,0,1
4,GO NON RECOMBINATIONAL REPAIR,0.098083,0.11927,0.13419,0,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.094909,0.11913,0.12854,0,1
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.26442,0.11895,0.094642,0,1
4,GO MEIOTIC CELL CYCLE,0.1475,0.11887,0.11533,0,1
4,GO SEGMENTATION,0.12273,0.11864,0.13668,0,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.091819,0.11842,0.11469,0,1
4,GO PROTEIN TARGETING TO VACUOLE,0.054439,0.11832,0.17355,0,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.15655,0.11821,0.12121,0,1
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.054439,0.11804,0.12129,0,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.16123,0.11775,0.10482,0,1
4,GO T CELL HOMEOSTASIS,0.15197,0.11754,0.16459,0,1
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.10468,0.11744,0.15484,0,1
4,GO CALCIUM MEDIATED SIGNALING,0.11163,0.11733,0.1583,0,1
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.056456,0.11712,0.16251,0,1
4,GO GOLGI RIBBON FORMATION,0.32248,0.11677,0.10799,0,1
4,GO TELOMERE ORGANIZATION,0.1306,0.11676,0.10757,0,1
4,GO MALE GAMETE GENERATION,0.056456,0.11665,0.1251,0,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.15655,0.11644,0.091183,0,1
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.074935,0.11644,0.15227,0,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.072385,0.1162,0.13307,0,1
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072385,0.11605,0.16108,0,1
4,GO RESPONSE TO ALCOHOL,0.10134,0.11601,0.13223,0,1
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.091819,0.11596,0.16033,0,1
4,GO ENDOCYTOSIS,0.065157,0.11577,0.16725,0,1
4,GO SNORNA 3 END PROCESSING,0.058535,0.11565,0.12576,0,1
4,GO REGULATION OF GLUCONEOGENESIS,0.062884,0.11557,0.14577,0,1
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.16123,0.11552,0.14443,0,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.26442,0.11551,0.067361,0,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.08303,0.11537,0.18895,0,1
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.067497,0.11511,0.1306,0,1
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.10468,0.11479,0.11186,0,1
4,GO SOMITOGENESIS,0.058535,0.1147,0.15685,0,1
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.10468,0.1146,0.15119,0,1
4,GO MEMBRANE FUSION,0.10811,0.11422,0.12484,0,1
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.16602,0.11416,0.094967,0,1
4,GO NEUROBLAST DIVISION,0.074935,0.11385,0.19294,0,1
4,GO SEX DIFFERENTIATION,0.065157,0.11375,0.12638,0,1
4,GO POSITIVE REGULATION OF URINE VOLUME,0.33821,0.11374,0.11407,0,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.10811,0.11367,0.13836,0,1
4,GO TONGUE MORPHOGENESIS,0.38829,0.11356,0.052429,0,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.10468,0.11331,0.12587,0,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.19156,0.11327,0.094114,0,1
4,GO RESPONSE TO ESTRADIOL,0.065157,0.11324,0.14454,0,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.062884,0.11311,0.13581,0,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.074935,0.11268,0.18652,0,1
4,GO GAMETE GENERATION,0.067497,0.11264,0.12555,0,1
4,GO MISMATCH REPAIR,0.077559,0.11244,0.13309,0,1
4,GO RESPONSE TO GONADOTROPIN,0.27821,0.11183,0.10987,0,1
4,GO ORGANELLE FISSION,0.12662,0.11164,0.11562,0,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.18624,0.11131,0.10581,0,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.074935,0.11117,0.10919,0,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.094909,0.11097,0.1529,0,1
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.10134,0.11094,0.12914,0,1
4,GO REGULATION OF CELL CYCLE,0.08588,0.11094,0.12835,0,1
4,GO VIRAL RNA GENOME REPLICATION,0.074935,0.11088,0.15175,0,1
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.24463,0.1106,0.11472,0,1
4,GO ORGANELLE MEMBRANE FUSION,0.072385,0.11049,0.14262,0,1
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.08881,0.11044,0.17678,0,1
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.20256,0.11043,0.092714,0,1
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.08303,0.1103,0.11151,0,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.39705,0.11017,0.061874,0,1
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.08881,0.11009,0.16348,0,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.08303,0.10992,0.14385,0,1
4,GO MATURATION OF 5 8S RRNA,0.34626,0.10927,0.058512,0,1
4,GO MEIOTIC CELL CYCLE PROCESS,0.11524,0.10916,0.11278,0,1
4,GO CARDIOCYTE DIFFERENTIATION,0.10468,0.10911,0.12472,0,1
4,GO PHAGOSOME ACIDIFICATION,0.15655,0.10901,0.093814,0,1
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.19156,0.10882,0.11554,0,1
4,GO G2 DNA DAMAGE CHECKPOINT,0.37111,0.10874,0.098022,0,1
4,GO POSITIVE REGULATION OF CELL CYCLE,0.069906,0.10817,0.13387,0,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.098083,0.10809,0.15708,0,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.20256,0.10783,0.12202,0,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.14312,0.10764,0.12547,0,1
4,GO LYTIC VACUOLE ORGANIZATION,0.10134,0.10751,0.1376,0,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.18102,0.10748,0.13187,0,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.067497,0.10739,0.11241,0,1
4,GO RESPONSE TO CALCIUM ION,0.12662,0.10738,0.11263,0,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.072385,0.10727,0.09057,0,1
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.08588,0.10721,0.11646,0,1
4,GO CYTOKINESIS,0.062884,0.10702,0.1397,0,1
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.2577,0.10699,0.13844,0,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.098083,0.10686,0.11886,0,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.060677,0.10669,0.1095,0,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.33029,0.10647,0.11439,0,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.056456,0.10631,0.12234,0,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.069906,0.10623,0.14531,0,1
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.11163,0.10611,0.13665,0,1
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16123,0.10601,0.15355,0,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.10468,0.10561,0.11116,0,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.08881,0.10537,0.11705,0,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.062884,0.10505,0.13937,0,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.08881,0.10487,0.1015,0,1
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.14312,0.10472,0.13665,0,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.08588,0.10468,0.1157,0,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.094909,0.10459,0.082714,0,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.054439,0.10449,0.14147,0,1
4,GO REGULATION OF CELL CYCLE PROCESS,0.069906,0.10443,0.12738,0,1
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.080256,0.10403,0.11497,0,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.08881,0.10391,0.12435,0,1
4,GO PROTEIN TETRAMERIZATION,0.069906,0.10365,0.12211,0,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.1475,0.10361,0.11824,0,1
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.18102,0.10322,0.14761,0,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.14312,0.10291,0.098312,0,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.44264,0.1029,0.039443,0,1
4,GO SKELETAL SYSTEM DEVELOPMENT,0.094909,0.10288,0.15586,0,1
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.08588,0.1027,0.13969,0,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.13885,0.10248,0.13849,0,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.08303,0.10245,0.13236,0,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.094909,0.10226,0.12128,0,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.077559,0.10222,0.11947,0,1
4,GO FATTY ACID CATABOLIC PROCESS,0.1306,0.10202,0.10688,0,1
4,GO REGULATION OF CELL DIVISION,0.15655,0.10147,0.12501,0,1
4,GO CELL CYCLE PROCESS,0.094909,0.10111,0.12167,0,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.11524,0.10085,0.12688,0,1
4,GO CELL CYCLE,0.10468,0.10081,0.12271,0,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.1475,0.10038,0.17622,0,1
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.10811,0.10026,0.14957,0,1
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.11524,0.099868,0.12474,0,1
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.11524,0.099768,0.15217,0,1
4,GO DNA INTEGRITY CHECKPOINT,0.24463,0.099444,0.10351,0,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.47137,0.098755,0.090224,0,1
4,GO GENE SILENCING,0.08588,0.098407,0.13272,0,1
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.18102,0.098207,0.095377,0,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.20256,0.097913,0.085842,0,1
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.40594,0.097591,0.043657,0,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.214,0.097376,0.088304,0,1
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.214,0.097346,0.10437,0,1
4,GO PARTURITION,0.21989,0.097279,0.12095,0,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.060677,0.097061,0.12099,0,1
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.24463,0.096589,0.083621,0,1
4,GO PORE COMPLEX ASSEMBLY,0.10811,0.09652,0.10945,0,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.10468,0.096501,0.15842,0,1
4,GO PROTEIN AUTOUBIQUITINATION,0.24463,0.096472,0.095544,0,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.067497,0.096308,0.12823,0,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.098083,0.096138,0.163,0,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.10134,0.096081,0.15795,0,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.094909,0.095981,0.086429,0,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.16123,0.095981,0.17632,0,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.1306,0.095846,0.14101,0,1
4,GO SMOOTH MUSCLE CONTRACTION,0.072385,0.095673,0.16054,0,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.23203,0.095578,0.17655,0,1
4,GO RESPONSE TO INSULIN,0.058535,0.095453,0.13283,0,1
4,GO REGULATION OF MITOTIC CELL CYCLE,0.11163,0.095321,0.11836,0,1
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.074935,0.095132,0.12164,0,1
4,GO DNA REPAIR,0.080256,0.094867,0.12053,0,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.069906,0.094804,0.12207,0,1
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.10134,0.094603,0.085545,0,1
4,GO PH REDUCTION,0.091819,0.094542,0.11315,0,1
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.23203,0.094185,0.092775,0,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.37111,0.094168,0.076534,0,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.20256,0.093843,0.15012,0,1
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29248,0.093742,0.11176,0,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.056456,0.093726,0.15831,0,1
4,GO DNA METABOLIC PROCESS,0.08881,0.092946,0.1189,0,1
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.197,0.09294,0.081465,0,1
4,GO MRNA TRANSPORT,0.27821,0.092786,0.09563,0,1
4,GO MITOTIC CELL CYCLE,0.11894,0.092687,0.11375,0,1
4,GO REGULATION OF GENE SILENCING,0.058535,0.092472,0.13633,0,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.43329,0.092381,0.07546,0,1
4,GO REPRODUCTION,0.062884,0.0919,0.12524,0,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.13885,0.091592,0.14175,0,1
4,GO ENDOSOMAL TRANSPORT,0.062884,0.091574,0.13887,0,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.058535,0.091246,0.13814,0,1
4,GO CELL DIVISION,0.16123,0.091158,0.10818,0,1
4,GO RESPONSE TO COLD,0.17091,0.090878,0.087066,0,1
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.11524,0.090603,0.11742,0,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.08588,0.09046,0.11542,0,1
4,GO FEMALE GAMETE GENERATION,0.16602,0.090232,0.091424,0,1
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.15655,0.089717,0.099998,0,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.058535,0.089562,0.16476,0,1
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.072385,0.089555,0.12352,0,1
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.197,0.089502,0.075556,0,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.16123,0.089485,0.10309,0,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.2577,0.089424,0.07826,0,1
4,GO NUCLEUS ORGANIZATION,0.20822,0.089396,0.096611,0,1
4,GO REGULATION OF AUTOPHAGY,0.069906,0.089396,0.1288,0,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.21989,0.089356,0.078715,0,1
4,GO ERYTHROCYTE DEVELOPMENT,0.18624,0.088996,0.13015,0,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.23203,0.088968,0.082844,0,1
4,GO MAINTENANCE OF CELL NUMBER,0.080256,0.088954,0.13875,0,1
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.27821,0.088668,0.071626,0,1
4,GO NUCLEAR EXPORT,0.23827,0.088052,0.094892,0,1
4,GO VACUOLE ORGANIZATION,0.12662,0.087971,0.1217,0,1
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.27126,0.087859,0.1127,0,1
4,GO PROTEIN POLYUBIQUITINATION,0.08881,0.087114,0.12262,0,1
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.077559,0.086752,0.11882,0,1
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.19156,0.086685,0.086756,0,1
4,GO BLASTOCYST DEVELOPMENT,0.08881,0.086681,0.097525,0,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.056456,0.086528,0.11767,0,1
4,GO CELLULAR RESPONSE TO STARVATION,0.091819,0.086159,0.11996,0,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.14312,0.086094,0.11145,0,1
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.065157,0.08608,0.098949,0,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.13467,0.085845,0.093863,0,1
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.11894,0.085233,0.10896,0,1
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.072385,0.084834,0.16116,0,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.069906,0.084781,0.13793,0,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.08588,0.084634,0.16422,0,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.080256,0.084607,0.11741,0,1
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.49108,0.084277,0.059278,0,1
4,GO DNA CATABOLIC PROCESS,0.067497,0.084251,0.12405,0,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.24463,0.08402,0.1143,0,1
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.060677,0.083891,0.11253,0,1
4,GO BLASTOCYST FORMATION,0.072385,0.083846,0.09802,0,1
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.197,0.083067,0.094452,0,1
4,GO CELL CYCLE PHASE TRANSITION,0.197,0.082723,0.093927,0,1
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.067497,0.082452,0.11818,0,1
4,GO NCRNA TRANSCRIPTION,0.15197,0.082129,0.10085,0,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.054439,0.08192,0.10727,0,1
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.062884,0.081753,0.14042,0,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.08588,0.08136,0.11262,0,1
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.10134,0.081223,0.12531,0,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.098083,0.080982,0.079889,0,1
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.25111,0.080891,0.11992,0,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.19156,0.080454,0.068076,0,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.12662,0.080354,0.14743,0,1
4,GO RETINOIC ACID METABOLIC PROCESS,0.37964,0.079687,0.060694,0,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.14312,0.079579,0.11579,0,1
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.19156,0.079371,0.053388,0,1
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.2259,0.079001,0.076068,0,1
4,GO ONE CARBON METABOLIC PROCESS,0.072385,0.078888,0.11187,0,1
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.18624,0.078559,0.10919,0,1
4,GO REGULATION OF NUCLEAR DIVISION,0.12662,0.078534,0.10649,0,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.074935,0.078361,0.1213,0,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.11894,0.078355,0.08317,0,1
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.18102,0.077959,0.059355,0,1
4,GO NUCLEAR TRANSPORT,0.23203,0.077797,0.085529,0,1
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.13467,0.077549,0.11075,0,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.13885,0.077463,0.098261,0,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.20822,0.077346,0.094659,0,1
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.18624,0.077281,0.11028,0,1
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.094909,0.076248,0.12235,0,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.2998,0.0751,0.078356,0,1
4,GO INTRACELLULAR TRANSPORT,0.10134,0.075042,0.10153,0,1
4,GO REGULATION OF MACROAUTOPHAGY,0.12273,0.074954,0.11699,0,1
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.23203,0.074879,0.070019,0,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.16123,0.074757,0.10347,0,1
4,GO AUTOPHAGY OF NUCLEUS,0.197,0.074535,0.10124,0,1
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.14312,0.07446,0.10459,0,1
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.15197,0.07441,0.1096,0,1
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.23203,0.073867,0.10295,0,1
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.2259,0.073816,0.08249,0,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.11524,0.073693,0.11089,0,1
4,GO REGULATION OF PROTEIN FOLDING,0.197,0.073098,0.10139,0,1
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.2577,0.072946,0.08275,0,1
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.1475,0.072916,0.10785,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.27126,0.072836,0.09126,0,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.2259,0.072545,0.086348,0,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.18102,0.07249,0.097888,0,1
4,GO PIGMENTATION,0.13467,0.072325,0.10705,0,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.13467,0.071651,0.11042,0,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.20822,0.071626,0.073414,0,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.098083,0.071251,0.1244,0,1
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.36271,0.071243,0.074825,0,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.13467,0.071224,0.10607,0,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.10811,0.070745,0.089789,0,1
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.091819,0.070601,0.14397,0,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.08881,0.070186,0.1074,0,1
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.11894,0.07017,0.11851,0,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.214,0.069808,0.10317,0,1
4,GO RESPONSE TO HEAT,0.23203,0.069694,0.098098,0,1
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.3148,0.06961,0.091504,0,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.11163,0.069404,0.18352,0,1
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15197,0.068918,0.076976,0,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.12662,0.068855,0.14303,0,1
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.10134,0.068206,0.13593,0,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.17591,0.06814,0.09231,0,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10134,0.068101,0.095415,0,1
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.214,0.067815,0.060252,0,1
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.11163,0.067724,0.10956,0,1
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.13467,0.067696,0.10203,0,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.17591,0.067385,0.1249,0,1
4,GO AUTOPHAGOSOME MATURATION,0.53179,0.067342,0.068074,0,1
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.12662,0.067254,0.10308,0,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.3148,0.066817,0.098798,0,1
4,GO MACROAUTOPHAGY,0.2577,0.065887,0.092097,0,1
4,GO CELLULAR RESPONSE TO UV,0.67486,0.064369,0.049421,0,1
4,GO DNA BIOSYNTHETIC PROCESS,0.12273,0.063828,0.098093,0,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.17591,0.062864,0.11325,0,1
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.17091,0.062794,0.11015,0,1
4,GO BASE EXCISION REPAIR,0.077559,0.062264,0.1256,0,1
4,GO GOLGI VESICLE TRANSPORT,0.15655,0.062158,0.1073,0,1
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.33821,0.061765,0.10387,0,1
4,GO REGULATION OF DNA METABOLIC PROCESS,0.13467,0.061259,0.11301,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.21989,0.061001,0.08826,0,1
4,GO CELLULAR RESPONSE TO DRUG,0.13885,0.060832,0.10777,0,1
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.13885,0.060327,0.077315,0,1
4,GO REGULATION OF CATABOLIC PROCESS,0.16602,0.060265,0.10493,0,1
4,GO RNA STABILIZATION,0.28529,0.060237,0.089026,0,1
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.214,0.059319,0.082971,0,1
4,GO MRNA METABOLIC PROCESS,0.34626,0.059101,0.055031,0,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.17091,0.059051,0.10119,0,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.19156,0.057646,0.13196,0,1
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.080256,0.05564,0.092037,0,1
4,GO PROTEIN CATABOLIC PROCESS,0.13885,0.055058,0.11174,0,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.15197,0.054697,0.11016,0,1
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.091819,0.054405,0.11968,0,1
4,GO RETINA HOMEOSTASIS,0.16602,0.054118,0.069852,0,1
4,GO PROTEIN STABILIZATION,0.10811,0.054034,0.10355,0,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.16123,0.053805,0.082763,0,1
4,GO RESPONSE TO UV,0.4521,0.053778,0.071326,0,1
4,GO VIRAL TRANSLATION,0.34626,0.05242,0.05254,0,1
4,GO SARCOMERE ORGANIZATION,0.2998,0.051162,0.069699,0,1
4,GO NUCLEOSIDE METABOLIC PROCESS,0.1475,0.046765,0.074483,0,1
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.20822,0.043781,0.12545,0,1
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.11894,0.041661,0.11435,0,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.16602,0.039135,0.10192,0,1
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.54223,0.037397,0.046461,0,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.30724,0.031076,0.10908,0,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.25111,0.030672,0.069718,0,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0025648,0.46112,0.41523,0,0
4,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.11894,0.45352,0.44494,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.00076864,0.40632,0.47502,0,0
4,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.18624,0.39513,0.28006,0,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0038653,0.37526,0.5134,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.2577,0.34132,0.25332,0,0
4,GO T CELL TOLERANCE INDUCTION,0.15197,0.33889,0.37578,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.019548,0.33265,0.34821,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.058535,0.31295,0.22846,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.077559,0.29118,0.20246,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.054439,0.29017,0.25766,0,0
4,GO NK T CELL DIFFERENTIATION,0.069906,0.28824,0.35621,0,0
4,GO REGULATION OF TOLERANCE INDUCTION,0.2259,0.28682,0.28419,0,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.21989,0.26785,0.26947,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.18102,0.26655,0.16143,0,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.2259,0.26421,0.30517,0,0
4,GO MRNA SPLICE SITE SELECTION,0.10468,0.26266,0.16724,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.2577,0.25989,0.15605,0,0
4,GO LOOP OF HENLE DEVELOPMENT,0.197,0.25958,0.15656,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.08303,0.25545,0.19255,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.15655,0.25215,0.17132,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.23203,0.25007,0.13805,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.072385,0.24983,0.21649,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.1475,0.24787,0.26587,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.058535,0.24511,0.21457,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.08881,0.24321,0.24325,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.017954,0.2411,0.24422,0,0
4,GO POSITIVE T CELL SELECTION,0.16123,0.23813,0.27698,0,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0172,0.2338,0.29099,0,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.39705,0.23205,0.16756,0,0
4,GO MACROPHAGE PROLIFERATION,0.18624,0.23156,0.25687,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.094909,0.23155,0.1883,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.052482,0.2285,0.22281,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.10134,0.22773,0.25621,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.017954,0.22767,0.22605,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.27126,0.22666,0.23558,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.25111,0.22431,0.24576,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.031957,0.22104,0.26377,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.008797,0.21738,0.25297,0,0
4,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.214,0.21555,0.19741,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.01266,0.21451,0.22431,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.37111,0.21427,0.11162,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.16602,0.21387,0.25744,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.20256,0.21312,0.23151,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.08881,0.21123,0.2046,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.24463,0.21085,0.16637,0,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.072385,0.21064,0.19938,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.062884,0.21023,0.2095,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.17091,0.20943,0.14475,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.2259,0.20939,0.20311,0,0
4,GO THYMIC T CELL SELECTION,0.19156,0.20853,0.24764,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.067497,0.20775,0.18671,0,0
4,GO TRABECULA MORPHOGENESIS,0.098083,0.20652,0.19175,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.18102,0.20635,0.16579,0,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.28529,0.20468,0.19113,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.056456,0.20426,0.15168,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.19156,0.20397,0.15518,0,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.013834,0.20386,0.29656,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.13885,0.20369,0.18117,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.058535,0.20364,0.20193,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.094909,0.20331,0.22717,0,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.14312,0.2032,0.16917,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.36271,0.20304,0.13405,0,0
4,GO MIDGUT DEVELOPMENT,0.080256,0.203,0.18675,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.018736,0.20282,0.23787,0,0
4,GO L SERINE METABOLIC PROCESS,0.015104,0.20212,0.29904,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.18624,0.20126,0.16801,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.11894,0.20107,0.16213,0,0
4,GO TOLERANCE INDUCTION,0.36271,0.20061,0.22827,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.23827,0.19972,0.18441,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.26442,0.19966,0.11747,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.214,0.19955,0.19659,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.080256,0.19767,0.15955,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.1306,0.1968,0.20008,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.1475,0.19651,0.2784,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.080256,0.19506,0.15908,0,0
4,GO RESPONSE TO TYPE I INTERFERON,0.38829,0.19417,0.15565,0,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.43329,0.19336,0.16161,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.15197,0.19316,0.15822,0,0
4,GO RESPONSE TO IRON ION,0.080256,0.19069,0.1327,0,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.060677,0.19026,0.14762,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.054439,0.19016,0.21076,0,0
4,GO RESPONSE TO MAGNESIUM ION,0.094909,0.18883,0.19754,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.056456,0.18774,0.20522,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.041938,0.1877,0.26469,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.32248,0.18742,0.19864,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.094909,0.1874,0.2738,0,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.10468,0.18733,0.16346,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.15655,0.18712,0.21063,0,0
4,GO GLYCINE TRANSPORT,0.14312,0.18668,0.16609,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.15655,0.18662,0.12957,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.30724,0.18645,0.11771,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.035953,0.18605,0.2013,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.70989,0.18551,0.068215,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.2259,0.18531,0.28544,0,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.23203,0.18436,0.14942,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.060677,0.18387,0.22643,0,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.25111,0.18377,0.15658,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.13885,0.18356,0.28499,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.091819,0.18352,0.22327,0,0
4,GO REGULATION OF DOPAMINE SECRETION,0.08881,0.18306,0.19281,0,0
4,GO URETER DEVELOPMENT,0.3148,0.18296,0.053475,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,0.21989,0.18288,0.23156,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.16123,0.18275,0.22258,0,0
4,GO RESPONSE TO VITAMIN,0.12662,0.18209,0.1404,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.34626,0.18099,0.11988,0,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.050584,0.18088,0.18324,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.34626,0.18083,0.098887,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.37964,0.18057,0.092592,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.08588,0.17945,0.18712,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.2259,0.17944,0.14218,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.12273,0.17869,0.17052,0,0
4,GO CILIUM MOVEMENT,0.094909,0.17795,0.12487,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.67486,0.17793,0.066958,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.13885,0.17778,0.14887,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.23827,0.17729,0.12546,0,0
4,GO PROSTATIC BUD FORMATION,0.08881,0.17655,0.19952,0,0
4,GO RESPONSE TO VITAMIN D,0.14312,0.1763,0.14584,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.40594,0.17569,0.031823,0,0
4,GO MYELIN MAINTENANCE,0.080256,0.17561,0.21601,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.072385,0.17519,0.14093,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.046961,0.17391,0.19402,0,0
4,GO STEROID ESTERIFICATION,0.20822,0.17386,0.1379,0,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.072385,0.17378,0.19312,0,0
4,GO T CELL SELECTION,0.17091,0.17369,0.26246,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.11524,0.17211,0.23409,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.18624,0.17193,0.17018,0,0
4,GO DOPAMINE METABOLIC PROCESS,0.13885,0.17192,0.15259,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.056456,0.1718,0.18175,0,0
4,GO TRABECULA FORMATION,0.28529,0.17115,0.13138,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.094909,0.17113,0.16214,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.33029,0.17079,0.13338,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.86799,0.17059,-0.0035928,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.17091,0.17045,0.17445,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.3148,0.17037,0.25885,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.12662,0.17034,0.16675,0,0
4,GO PHOSPHOLIPID TRANSPORT,0.060677,0.17007,0.17461,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.21989,0.16977,0.22632,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.15197,0.16906,0.12398,0,0
4,GO SUCKLING BEHAVIOR,0.062884,0.16888,0.19512,0,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.20822,0.16878,0.11454,0,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.21989,0.1687,0.20113,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.13885,0.16843,0.13037,0,0
4,GO PINOCYTOSIS,0.15197,0.16843,0.17977,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.098083,0.16805,0.15765,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.077559,0.16798,0.17549,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.23203,0.16772,0.10384,0,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.043559,0.16758,0.20879,0,0
4,GO REGULATION OF RECEPTOR BINDING,0.1475,0.16696,0.19865,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.28529,0.16669,0.13494,0,0
4,GO MAST CELL MIGRATION,0.16123,0.16663,0.19757,0,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.15655,0.1661,0.2058,0,0
4,GO AMINO ACID IMPORT,0.072385,0.16577,0.15518,0,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.18102,0.16554,0.22084,0,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.25111,0.16548,0.10755,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.043559,0.16492,0.23361,0,0
4,GO SEROTONIN SECRETION,0.16123,0.1645,0.18344,0,0
4,GO T CELL LINEAGE COMMITMENT,0.1306,0.1643,0.23227,0,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.38829,0.16357,0.21332,0,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.060677,0.16353,0.17112,0,0
4,GO METANEPHROS MORPHOGENESIS,0.098083,0.16342,0.14956,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.058535,0.16296,0.21222,0,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.21989,0.16285,0.12029,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.16123,0.16229,0.25558,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.16123,0.16225,0.14689,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.1306,0.16193,0.23325,0,0
4,GO LYSOSOME LOCALIZATION,0.062884,0.16183,0.2079,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.12273,0.1615,0.18334,0,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.4521,0.16105,0.15461,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.10134,0.16092,0.27527,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.067497,0.16086,0.22731,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.27821,0.1606,0.041966,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.2259,0.16006,0.13788,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.10134,0.1597,0.18579,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.010572,0.1597,0.20492,0,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.33029,0.15938,0.20936,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.054439,0.15938,0.2715,0,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.17091,0.1587,0.14423,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.091819,0.15801,0.17763,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.33821,0.15773,0.10244,0,0
4,GO GLIAL CELL PROLIFERATION,0.197,0.15708,0.12823,0,0
4,GO CILIUM ORGANIZATION,0.054439,0.15684,0.17956,0,0
4,GO OOCYTE MATURATION,0.062884,0.15684,0.13213,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.25111,0.15643,0.13323,0,0
4,GO SEROTONIN TRANSPORT,0.021265,0.15627,0.23404,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.11524,0.1562,0.21269,0,0
4,GO DENDRITIC CELL MIGRATION,0.46168,0.15596,0.14387,0,0
4,GO ENERGY HOMEOSTASIS,0.094909,0.15561,0.14406,0,0
4,GO INTRACILIARY TRANSPORT,0.18102,0.15554,0.13722,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.10134,0.1555,0.19868,0,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10134,0.15538,0.15273,0,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.16123,0.15528,0.1161,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.37964,0.15516,0.16381,0,0
4,GO RENAL FILTRATION,0.11894,0.15499,0.2295,0,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.11524,0.15409,0.27136,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.043559,0.15271,0.15635,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.27821,0.15271,0.11643,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.033245,0.1524,0.14603,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.30724,0.15206,0.14706,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.16602,0.15202,0.16266,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.96843,0.15185,0.031803,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.050584,0.15152,0.19983,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.080256,0.15123,0.21632,0,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.056456,0.15119,0.17893,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.23827,0.15091,0.1058,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.15197,0.15089,0.14836,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.02951,0.15082,0.23653,0,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.29248,0.15075,0.080797,0,0
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.46168,0.15007,0.10337,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.37111,0.14975,0.15054,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.197,0.14956,0.13153,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.045233,0.14945,0.20703,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.23203,0.14932,0.12975,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.23827,0.1492,0.14952,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.66333,0.14904,0.020005,0,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.44264,0.14896,0.1557,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.42405,0.14881,0.0952,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.21989,0.14878,0.18155,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.072385,0.14857,0.18707,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.08588,0.14847,0.21167,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.48117,0.14847,0.10261,0,0
4,GO REGULATION OF RESPIRATORY BURST,0.12662,0.14846,0.19315,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.11894,0.1483,0.16595,0,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.074935,0.14799,0.21644,0,0
4,GO RESPONSE TO DIETARY EXCESS,0.24463,0.14751,0.097566,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.20822,0.14739,0.14328,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.17591,0.14736,0.13862,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.18624,0.14709,0.14294,0,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.054439,0.14682,0.18105,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.10134,0.14654,0.17744,0,0
4,GO CHROMOSOME SEPARATION,0.2259,0.14636,0.10768,0,0
4,GO ALPHA BETA T CELL ACTIVATION,0.23827,0.14618,0.18658,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.15655,0.14607,0.17542,0,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.29248,0.14561,0.096196,0,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.91805,0.14529,-0.0086563,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.13885,0.14522,0.17799,0,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.15197,0.14412,0.14189,0,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.214,0.14381,0.15758,0,0
4,GO METANEPHROS DEVELOPMENT,0.197,0.14373,0.11466,0,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.46168,0.14361,0.059975,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.062884,0.14333,0.15668,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.53179,0.14319,0.092053,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.44264,0.14318,0.12996,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.16123,0.14312,0.10569,0,0
4,GO COCHLEA MORPHOGENESIS,0.20822,0.14304,0.14594,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.2259,0.14282,0.12502,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.27821,0.14275,0.16599,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.20822,0.14269,0.122,0,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.197,0.14261,0.17824,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.13885,0.14233,0.1538,0,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.37111,0.14221,0.084284,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.067497,0.1419,0.14726,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.060677,0.14189,0.18837,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.36271,0.14177,0.081309,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.13885,0.14144,0.16157,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.33029,0.14141,0.20841,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.13467,0.14126,0.15449,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.094909,0.14122,0.21054,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.2577,0.14112,0.14905,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.37111,0.14108,0.15478,0,0
4,GO RECOMBINATIONAL REPAIR,0.11894,0.14088,0.13413,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.38829,0.14082,0.13071,0,0
4,GO TONGUE DEVELOPMENT,0.37111,0.1407,0.070962,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.34626,0.14056,0.089478,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.13885,0.14016,0.18691,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.11524,0.13998,0.23861,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.1306,0.1395,0.11565,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12662,0.13946,0.16376,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.28529,0.13913,0.1023,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.11163,0.13834,0.081383,0,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.1475,0.1383,0.11843,0,0
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.060677,0.13815,0.15748,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.069906,0.13811,0.17604,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.18624,0.13786,0.20622,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16123,0.13783,0.21948,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.2259,0.13747,0.29667,0,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.10134,0.13734,0.17788,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.16123,0.13728,0.13508,0,0
4,GO GENITALIA MORPHOGENESIS,0.10468,0.13709,0.17931,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.077559,0.13685,0.17011,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.08303,0.13675,0.16312,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.080256,0.13675,0.23533,0,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.077559,0.1364,0.1618,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.25111,0.13616,0.15844,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.15655,0.1357,0.098902,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.32248,0.13568,0.16495,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.26442,0.13556,0.14432,0,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.33029,0.13544,0.17073,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.17591,0.13522,0.14967,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.08303,0.135,0.1522,0,0
4,GO EXIT FROM MITOSIS,0.067497,0.1349,0.13188,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.61803,0.13483,0.14544,0,0
4,GO STEROID HORMONE SECRETION,0.12662,0.1346,0.14736,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.20822,0.13455,0.16139,0,0
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.23203,0.13432,0.13484,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.15655,0.13429,0.12111,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.037377,0.134,0.18515,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.13885,0.13398,0.22175,0,0
4,GO DNA REPLICATION CHECKPOINT,0.2577,0.13372,0.10519,0,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.17591,0.13357,0.15634,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.14312,0.13346,0.10654,0,0
4,GO N GLYCAN PROCESSING,0.094909,0.13313,0.20328,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.14312,0.13287,0.15539,0,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.11894,0.13275,0.18026,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.40594,0.13274,0.098995,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.16602,0.13262,0.16294,0,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.1475,0.13249,0.13065,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.214,0.13223,0.14087,0,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.11524,0.13211,0.15378,0,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.32248,0.13199,0.19674,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.37964,0.13186,0.14471,0,0
4,GO MESENCHYME DEVELOPMENT,0.091819,0.13186,0.15532,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.098083,0.13165,0.14924,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.2259,0.13141,0.13337,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.52145,0.13141,0.066278,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.10468,0.13132,0.13414,0,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.11163,0.13113,0.1609,0,0
4,GO MAST CELL ACTIVATION,0.214,0.1311,0.17119,0,0
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.080256,0.131,0.11997,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.15197,0.13096,0.15809,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.33029,0.13096,0.16207,0,0
4,GO CELLULAR RESPONSE TO KETONE,0.14312,0.1309,0.12675,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.17591,0.13088,0.12344,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.23827,0.13085,0.080579,0,0
4,GO RIG I SIGNALING PATHWAY,0.35442,0.13077,0.088438,0,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.33821,0.13073,0.11659,0,0
4,GO RESPONSE TO AMPHETAMINE,0.1475,0.13066,0.10404,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.065157,0.13064,0.15525,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.067497,0.13057,0.13918,0,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.077559,0.13054,0.15157,0,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.046961,0.13041,0.21271,0,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.12273,0.13039,0.19991,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.44264,0.13039,0.079359,0,0
4,GO INTERFERON BETA PRODUCTION,0.2259,0.13036,0.14886,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.037377,0.13036,0.22146,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.52145,0.13034,0.076232,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.08588,0.13017,0.136,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.38829,0.13016,0.14239,0,0
4,GO HEAD MORPHOGENESIS,0.32248,0.13014,0.14273,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.18624,0.12987,0.10435,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.13467,0.1296,0.18477,0,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.056456,0.12941,0.15351,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.34626,0.1293,0.098362,0,0
4,GO REGULATION OF BONE REMODELING,0.23203,0.12927,0.16204,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.27126,0.12927,0.10747,0,0
4,GO CIRCULATORY SYSTEM PROCESS,0.069906,0.12895,0.14497,0,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.034576,0.12894,0.16466,0,0
4,GO ADAPTIVE THERMOGENESIS,0.062884,0.12894,0.14259,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.080256,0.12856,0.16925,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.031957,0.12833,0.16878,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.033245,0.1282,0.22702,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.10468,0.12812,0.122,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.15197,0.12797,0.10479,0,0
4,GO OPTIC NERVE DEVELOPMENT,0.16602,0.12796,0.20604,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.3148,0.1279,0.1095,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.16602,0.12782,0.17031,0,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.28529,0.12779,0.16896,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.23203,0.12773,0.09796,0,0
4,GO GROOMING BEHAVIOR,0.15655,0.12768,0.12846,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15655,0.12767,0.1724,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.52145,0.12764,0.07009,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.27126,0.12741,0.1399,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.11524,0.12737,0.16314,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.11163,0.12732,0.1186,0,0
4,GO RESPONSE TO NUTRIENT,0.13467,0.12726,0.13208,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.080256,0.12719,0.20317,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.11894,0.12714,0.24748,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.4521,0.12706,0.10075,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.20256,0.12692,0.13628,0,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.11524,0.1268,0.13846,0,0
4,GO LUTEINIZATION,0.098083,0.12651,0.21786,0,0
4,GO NEPHRON TUBULE FORMATION,0.56341,0.12618,-0.013122,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.11524,0.12617,0.18783,0,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.14312,0.12617,0.18288,0,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.067497,0.12606,0.16669,0,0
4,GO INTERLEUKIN 12 PRODUCTION,0.40594,0.12598,0.15228,0,0
4,GO BIOMINERALIZATION,0.33821,0.12582,0.10224,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.12273,0.12571,0.15178,0,0
4,GO RESPONSE TO TESTOSTERONE,0.12662,0.1257,0.11191,0,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.072385,0.12557,0.13856,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.30724,0.12552,0.10522,0,0
4,GO SECRETORY GRANULE ORGANIZATION,0.1475,0.1254,0.14532,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.052482,0.12512,0.15968,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.098083,0.12511,0.21998,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.37964,0.12506,0.18834,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.10134,0.12504,0.19019,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.24463,0.12503,0.12559,0,0
4,GO NATURAL KILLER CELL ACTIVATION,0.26442,0.12501,0.16429,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.14312,0.12494,0.14585,0,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.214,0.12492,0.13405,0,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.47137,0.12491,0.09386,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.54223,0.1247,0.055455,0,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.08303,0.12449,0.16993,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13467,0.12449,0.15657,0,0
4,GO REGULATION OF TISSUE REMODELING,0.29248,0.12425,0.15692,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.85555,0.12424,0.026892,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.29248,0.12417,0.15975,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.197,0.12377,0.11083,0,0
4,GO STRESS FIBER ASSEMBLY,0.069906,0.12368,0.18261,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.20822,0.12345,0.11502,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.27821,0.12312,0.1669,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.080256,0.1231,0.17454,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.14312,0.12287,0.14594,0,0
4,GO CYTOPLASM ORGANIZATION,0.57414,0.12257,0.043822,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.33029,0.12254,0.070817,0,0
4,GO TYPE I INTERFERON PRODUCTION,0.17591,0.12227,0.14854,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.38829,0.12224,0.086994,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.29248,0.12224,0.095003,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.17091,0.1222,0.13858,0,0
4,GO ODONTOGENESIS,0.13885,0.1221,0.15381,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.091819,0.12202,0.19529,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.11894,0.12197,0.19661,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.16123,0.12183,0.12293,0,0
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.077559,0.12168,0.14698,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.37964,0.12151,0.11284,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.24463,0.1214,0.13345,0,0
4,GO BONE GROWTH,0.11894,0.12139,0.17819,0,0
4,GO CELLULAR EXTRAVASATION,0.30724,0.12124,0.16083,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.12273,0.12123,0.12492,0,0
4,GO FAT CELL PROLIFERATION,0.27126,0.12122,0.1296,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.36271,0.1212,0.077639,0,0
4,GO REGULATION OF TUBE SIZE,0.14312,0.12106,0.1331,0,0
4,GO REGULATION OF AMYLOID BETA FORMATION,0.18624,0.12101,0.1344,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.14312,0.12101,0.14041,0,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.37111,0.12098,0.12285,0,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.13467,0.12077,0.13763,0,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.214,0.12073,0.11342,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.1475,0.1207,0.16288,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.15197,0.12068,0.17035,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.197,0.12063,0.15658,0,0
4,GO PLATELET AGGREGATION,0.11524,0.12062,0.19345,0,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.20822,0.12051,0.12016,0,0
4,GO RESPONSE TO AXON INJURY,0.035953,0.12049,0.19272,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.056456,0.12031,0.19254,0,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.44264,0.12026,0.11465,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.2259,0.12003,0.11388,0,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.21989,0.12002,0.14483,0,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.08588,0.11999,0.16035,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.33821,0.11998,0.19681,0,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.27821,0.11993,0.15521,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.17091,0.11988,0.098637,0,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.065157,0.11981,0.15483,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.10468,0.11971,0.2022,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.046961,0.11966,0.16595,0,0
4,GO VITAMIN METABOLIC PROCESS,0.072385,0.11954,0.10747,0,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.4521,0.1195,0.073247,0,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.19156,0.1194,0.18665,0,0
4,GO VASCULOGENESIS,0.28529,0.11916,0.14237,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.32248,0.11895,0.085993,0,0
4,GO RETINOL METABOLIC PROCESS,0.55277,0.11887,0.032954,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.1475,0.1188,0.14793,0,0
4,GO ANIMAL ORGAN FORMATION,0.27821,0.11876,0.095888,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.069906,0.11866,0.12436,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.098083,0.1185,0.1274,0,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.39705,0.11824,0.13713,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.16123,0.11812,0.16817,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.067497,0.11808,0.16513,0,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10468,0.11797,0.1544,0,0
4,GO RESPONSE TO FATTY ACID,0.35442,0.1179,0.093975,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.080256,0.11782,0.18008,0,0
4,GO REGULATION OF PEPTIDE SECRETION,0.067497,0.11771,0.16039,0,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.23203,0.11749,0.15029,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.42405,0.11746,0.12065,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.17591,0.11739,0.13357,0,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.41494,0.11729,0.10361,0,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.27126,0.11706,0.074772,0,0
4,GO MAST CELL MEDIATED IMMUNITY,0.197,0.11689,0.17612,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.11524,0.11685,0.14949,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.15655,0.11684,0.11968,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.28529,0.11682,0.14535,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.12662,0.11652,0.24411,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.11163,0.11647,0.11676,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.12662,0.11642,0.14458,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.08881,0.11635,0.14785,0,0
4,GO REGULATION OF CELL SHAPE,0.10134,0.11624,0.1867,0,0
4,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.41494,0.11622,0.10602,0,0
4,GO PROTEIN KINASE B SIGNALING,0.10468,0.11604,0.15709,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.11524,0.11571,0.19312,0,0
4,GO EXTRACELLULAR TRANSPORT,0.2577,0.11568,0.12888,0,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.53179,0.11556,0.14889,0,0
4,GO KINETOCHORE ORGANIZATION,0.55277,0.11552,0.053166,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.57414,0.11541,0.033478,0,0
4,GO RESPONSE TO RETINOIC ACID,0.12662,0.11527,0.1496,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.17591,0.11527,0.1546,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.4521,0.11524,0.085739,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.42405,0.11522,0.13791,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.077559,0.11514,0.15751,0,0
4,GO NEGATIVE T CELL SELECTION,0.34626,0.11498,0.23439,0,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.94321,0.11488,0.022725,0,0
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.88046,0.11485,0.00048031,0,0
4,GO TERPENOID METABOLIC PROCESS,0.25111,0.11483,0.082167,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16602,0.11478,0.17575,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.2998,0.11478,0.16411,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.15197,0.11476,0.11531,0,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.12662,0.11465,0.24047,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.40594,0.11463,0.07655,0,0
4,GO POSITIVE REGULATION OF SECRETION,0.10134,0.11459,0.13875,0,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.21989,0.11452,0.098834,0,0
4,GO B CELL HOMEOSTASIS,0.24463,0.11407,0.17643,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.18102,0.114,0.10555,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.069906,0.11378,0.16466,0,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.41494,0.11377,0.059505,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.39705,0.11377,0.15041,0,0
4,GO LIPID IMPORT INTO CELL,0.17591,0.11376,0.12714,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.10811,0.11375,0.078077,0,0
4,GO CELLULAR DEFENSE RESPONSE,0.56341,0.11365,0.11226,0,0
4,GO RENAL SYSTEM PROCESS,0.1306,0.11338,0.16768,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.85555,0.11335,0.027433,0,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.38829,0.11331,0.083386,0,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.13467,0.113,0.13847,0,0
4,GO RESPONSE TO HORMONE,0.08588,0.11295,0.12921,0,0
4,GO GLYCINE METABOLIC PROCESS,0.050584,0.11291,0.17958,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.11524,0.11282,0.14089,0,0
4,GO PLATELET ACTIVATION,0.10134,0.11282,0.21163,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.12662,0.1128,0.14913,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.23827,0.11269,0.12745,0,0
4,GO RESPONSE TO STEROID HORMONE,0.18624,0.11267,0.12001,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.16602,0.1126,0.13448,0,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.37964,0.11253,0.065373,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.5959,0.11246,0.054987,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.23827,0.11244,0.10077,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.51122,0.11239,0.09487,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.57414,0.11227,0.064117,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.16123,0.11225,0.14484,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.35442,0.11215,0.08793,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.24463,0.11185,0.13788,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.23827,0.11176,0.09842,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.67486,0.1115,0.043074,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.50109,0.1115,0.13004,0,0
4,GO MITOTIC RECOMBINATION,0.23827,0.11142,0.089579,0,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.28529,0.11124,0.074565,0,0
4,GO MYELIN ASSEMBLY,0.072385,0.11123,0.19612,0,0
4,GO INTEGRIN ACTIVATION,0.29248,0.11122,0.15914,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.091819,0.11112,0.16201,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.16123,0.11112,0.16383,0,0
4,GO MOLTING CYCLE,0.17091,0.11108,0.10601,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.08303,0.11102,0.20131,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.26442,0.11068,0.15917,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.24463,0.11065,0.14349,0,0
4,GO CARTILAGE MORPHOGENESIS,0.056456,0.11042,0.1925,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.16123,0.11037,0.14861,0,0
4,GO VASCULAR WOUND HEALING,0.41494,0.11034,0.12179,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.23827,0.11034,0.10257,0,0
4,GO PLACENTA DEVELOPMENT,0.19156,0.11032,0.11916,0,0
4,GO CELL FATE DETERMINATION,0.11163,0.11031,0.12065,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.214,0.11017,0.083654,0,0
4,GO ENDODERM DEVELOPMENT,0.11163,0.1101,0.1997,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.069906,0.11008,0.15856,0,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.080256,0.10998,0.14783,0,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10134,0.10997,0.11407,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.32248,0.10982,0.17046,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.29248,0.1098,0.073505,0,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.062884,0.10979,0.16011,0,0
4,GO STEROID CATABOLIC PROCESS,0.18102,0.10969,0.14322,0,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.069906,0.10936,0.13447,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.13467,0.10936,0.14169,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.15197,0.10924,0.13254,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.214,0.10921,0.14607,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.33821,0.10918,0.096369,0,0
4,GO LIPID CATABOLIC PROCESS,0.16602,0.10908,0.10953,0,0
4,GO REGULATION OF EXCRETION,0.13467,0.10901,0.14592,0,0
4,GO MYOBLAST PROLIFERATION,0.060677,0.10889,0.15234,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.054439,0.10888,0.15832,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.30724,0.10887,0.20256,0,0
4,GO DNA CONFORMATION CHANGE,0.11524,0.10884,0.12629,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.1306,0.10881,0.1376,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.08881,0.10871,0.13679,0,0
4,GO KERATINOCYTE MIGRATION,0.30724,0.1087,0.11158,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.62923,0.10857,0.03896,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.08303,0.10856,0.16197,0,0
4,GO REGULATION OF ACTIN NUCLEATION,0.27821,0.1082,0.10084,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.66333,0.10817,0.048913,0,0
4,GO REGULATION OF STEROL TRANSPORT,0.16123,0.10802,0.12934,0,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.065157,0.10795,0.13805,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.062884,0.10786,0.1287,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.062884,0.10783,0.19786,0,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.27126,0.10778,0.12874,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.34626,0.10764,0.087626,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.08588,0.10761,0.15599,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.067497,0.10745,0.13956,0,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.21989,0.10744,0.1201,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.098083,0.10738,0.13654,0,0
4,GO CELL MATRIX ADHESION,0.18624,0.10734,0.16431,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.39705,0.10731,0.11493,0,0
4,GO REGULATION OF T CELL ACTIVATION,0.29248,0.10715,0.15264,0,0
4,GO SISTER CHROMATID COHESION,0.19156,0.10714,0.10952,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.18624,0.10712,0.12794,0,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.048745,0.10712,0.13852,0,0
4,GO SKIN MORPHOGENESIS,0.38829,0.10709,0.14967,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.2577,0.10707,0.084924,0,0
4,GO RESPONSE TO FORSKOLIN,0.20822,0.107,0.16377,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.10134,0.10695,0.13364,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.214,0.10693,0.097913,0,0
4,GO CELL CELL ADHESION,0.091819,0.1068,0.17615,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.17591,0.10657,0.2164,0,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.47137,0.10641,0.12575,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.42405,0.10633,0.081789,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.2577,0.10616,0.08517,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.214,0.10613,0.20634,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.47137,0.10607,0.086323,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.37111,0.10607,0.12489,0,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.4521,0.10594,0.073653,0,0
4,GO MITOTIC DNA REPLICATION,0.2998,0.1059,0.11569,0,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.15655,0.10567,0.11387,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.10134,0.10558,0.13258,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.12273,0.10551,0.13861,0,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.13885,0.10546,0.21651,0,0
4,GO T CELL DIFFERENTIATION,0.2259,0.10534,0.1791,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.37964,0.10521,0.080492,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.2577,0.10518,0.1815,0,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.091819,0.10507,0.18644,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.33821,0.10502,0.08363,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.41494,0.10495,0.048472,0,0
4,GO ORGANIC ANION TRANSPORT,0.072385,0.10475,0.12696,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.2259,0.10467,0.085366,0,0
4,GO MYOTUBE DIFFERENTIATION,0.18624,0.10459,0.12315,0,0
4,GO CENTROSOME DUPLICATION,0.35442,0.1044,0.085064,0,0
4,GO CELL SUBSTRATE ADHESION,0.1475,0.1043,0.17449,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.08303,0.10411,0.13291,0,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.27821,0.10405,0.12346,0,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.11524,0.10402,0.1408,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.11163,0.10396,0.14644,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.11894,0.10392,0.11873,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.12662,0.10378,0.16717,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.20822,0.10371,0.18153,0,0
4,GO NEUTROPHIL EXTRAVASATION,0.23827,0.10365,0.19013,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.25111,0.10365,0.085715,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.043559,0.10357,0.11204,0,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.40594,0.10356,0.17086,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.2998,0.10355,0.099407,0,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.08881,0.10344,0.138,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.41494,0.10341,0.07558,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.32248,0.10332,0.071395,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.99368,0.10327,-0.060012,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.21989,0.10304,0.10895,0,0
4,GO RNA SURVEILLANCE,0.37111,0.10297,0.067847,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.38829,0.10286,0.12334,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.065157,0.10286,0.14579,0,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.27821,0.10276,0.12155,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.10468,0.10276,0.13843,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.49108,0.10268,0.063421,0,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.23203,0.10267,0.16859,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.056456,0.1026,0.16472,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.16602,0.10259,0.11674,0,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.054439,0.10258,0.14104,0,0
4,GO CYCLOOXYGENASE PATHWAY,0.90549,0.10256,-0.0024969,0,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.35442,0.10246,0.12969,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.46168,0.10243,0.092617,0,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.19156,0.10243,0.15378,0,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.058535,0.1024,0.15171,0,0
4,GO BONE MORPHOGENESIS,0.24463,0.10236,0.14895,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.16123,0.10235,0.17677,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.17591,0.10234,0.13859,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.23827,0.10231,0.085956,0,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.24463,0.10227,0.080103,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.2259,0.10219,0.16107,0,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.23203,0.10203,0.16026,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.08588,0.10188,0.17541,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.15655,0.10183,0.12841,0,0
4,GO RESPONSE TO MINERALOCORTICOID,0.64051,0.1018,0.054215,0,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.15197,0.10177,0.15939,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.17591,0.10173,0.15426,0,0
4,GO OSSIFICATION,0.27126,0.10157,0.10946,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.072385,0.10152,0.20428,0,0
4,GO TAXIS,0.11163,0.10147,0.16688,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.2259,0.10145,0.098613,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.094909,0.10126,0.18175,0,0
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.16123,0.10113,0.11797,0,0
4,GO ISOPRENOID METABOLIC PROCESS,0.43329,0.10094,0.062568,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.18102,0.10093,0.12225,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.197,0.10091,0.13303,0,0
4,GO HISTONE UBIQUITINATION,0.20256,0.10088,0.11419,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.20822,0.10087,0.087184,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.197,0.10077,0.11903,0,0
4,GO BODY MORPHOGENESIS,0.2577,0.10073,0.15417,0,0
4,GO AMINOGLYCAN METABOLIC PROCESS,0.214,0.10068,0.12951,0,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.08588,0.10064,0.12689,0,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.26442,0.10061,0.14067,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.13467,0.10055,0.12954,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.42405,0.10035,0.089301,0,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.067497,0.10032,0.17596,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.7336,0.10026,0.051578,0,0
4,GO REGULATION OF NEUTROPHIL ACTIVATION,0.16602,0.10024,0.27541,0,0
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.36271,0.10019,0.13949,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.2259,0.10017,0.1148,0,0
4,GO TUBE DEVELOPMENT,0.16123,0.10014,0.13841,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.53179,0.10012,0.095569,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.42405,0.10008,0.15134,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.33029,0.099902,0.12578,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.34626,0.099894,0.11897,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.080256,0.099876,0.15873,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.37964,0.099805,0.10991,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.17591,0.099681,0.075692,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.25111,0.099677,0.078781,0,0
4,GO ACTIN NUCLEATION,0.21989,0.099645,0.092341,0,0
4,GO DIGESTIVE SYSTEM PROCESS,0.14312,0.099557,0.10928,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.27126,0.099505,0.12672,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.2577,0.099446,0.10577,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.15655,0.099424,0.13281,0,0
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.19156,0.099303,0.15155,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.214,0.09928,0.14657,0,0
4,GO REGULATION OF MAP KINASE ACTIVITY,0.08303,0.099235,0.16292,0,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.20256,0.099232,0.16302,0,0
4,GO RESPONSE TO METAL ION,0.15655,0.099175,0.10059,0,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.058535,0.09904,0.14434,0,0
4,GO RESPONSE TO INTERLEUKIN 15,0.49108,0.099005,0.15263,0,0
4,GO LYMPHOCYTE COSTIMULATION,0.20256,0.09895,0.21972,0,0
4,GO CARTILAGE DEVELOPMENT,0.23203,0.098928,0.1248,0,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.52145,0.098861,0.062807,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.13467,0.098825,0.10618,0,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.55277,0.098753,0.1336,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.197,0.098694,0.094277,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.17091,0.098656,0.17082,0,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.40594,0.098604,0.10734,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.32248,0.098542,0.1085,0,0
4,GO FACE DEVELOPMENT,0.35442,0.098502,0.12104,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.11163,0.098432,0.10567,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.65188,0.098313,0.040266,0,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.074935,0.09831,0.14742,0,0
4,GO HEME METABOLIC PROCESS,0.47137,0.098256,0.050105,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.37964,0.0982,0.087257,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.4521,0.098191,0.11462,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.29248,0.098188,0.15068,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.11163,0.098101,0.12946,0,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.28529,0.097989,0.070412,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.11894,0.097955,0.19153,0,0
4,GO RESPONSE TO PEPTIDE,0.065157,0.097702,0.14563,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.47137,0.097516,0.11513,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.060677,0.097458,0.12435,0,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.26442,0.097431,0.093039,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.67486,0.097394,0.051713,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.44264,0.097362,0.11024,0,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.39705,0.097347,0.082585,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.062884,0.097284,0.14288,0,0
4,GO BIOLOGICAL ADHESION,0.098083,0.097283,0.17696,0,0
4,GO STEM CELL DIFFERENTIATION,0.11894,0.097278,0.11525,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.13467,0.097242,0.10513,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.33821,0.097228,0.092663,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.214,0.097143,0.1345,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.48117,0.097136,0.063017,0,0
4,GO CELLULAR RESPONSE TO STEROL,0.32248,0.097122,0.13675,0,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.214,0.097108,0.15115,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.34626,0.097097,0.092704,0,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.20822,0.096973,0.11947,0,0
4,GO CELL CYCLE DNA REPLICATION,0.2577,0.096958,0.10168,0,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.33029,0.096929,0.065595,0,0
4,GO NUCLEOSOME ORGANIZATION,0.10468,0.096925,0.12984,0,0
4,GO METAL ION HOMEOSTASIS,0.11163,0.096895,0.14089,0,0
4,GO BONE MINERALIZATION,0.49108,0.09688,0.079903,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.40594,0.096786,0.12675,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.37964,0.096784,0.21328,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.17091,0.096766,0.093849,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.077559,0.096738,0.078872,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.27126,0.096715,0.10643,0,0
4,GO CHROMOSOME LOCALIZATION,0.26442,0.09671,0.088504,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.2259,0.096705,0.11699,0,0
4,GO OVULATION CYCLE,0.13885,0.096677,0.13829,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.2259,0.096675,0.097088,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.25111,0.096628,0.17166,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25111,0.09661,0.082052,0,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.79394,0.096556,0.043254,0,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.19156,0.09652,0.12343,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.18102,0.096518,0.081194,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.056456,0.096349,0.10126,0,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.23203,0.096274,0.10206,0,0
4,GO CELLULAR RESPONSE TO ALKALOID,0.23827,0.096259,0.086959,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.37111,0.096228,0.10141,0,0
4,GO REGULATION OF VASCULAR PERMEABILITY,0.074935,0.096114,0.19083,0,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.75756,0.096084,-0.025688,0,0
4,GO BODY FLUID SECRETION,0.15197,0.096077,0.11761,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.96843,0.096025,-0.030717,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.20256,0.095942,0.12543,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.29248,0.095816,0.14804,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.64051,0.09581,0.072419,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.76963,0.095794,0.00015345,0,0
4,GO GLAND MORPHOGENESIS,0.21989,0.095551,0.13927,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.29248,0.095371,0.10207,0,0
4,GO NCRNA 3 END PROCESSING,0.23203,0.095285,0.05903,0,0
4,GO RESPONSE TO KETONE,0.17091,0.095282,0.12061,0,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.10811,0.095263,0.10508,0,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.15655,0.095236,0.1436,0,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.10134,0.095197,0.12764,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.074935,0.095092,0.15115,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.21989,0.095058,0.13385,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.065157,0.095038,0.13002,0,0
4,GO LYMPHOCYTE ACTIVATION,0.20256,0.094982,0.16922,0,0
4,GO CHLORIDE TRANSPORT,0.060677,0.094841,0.13393,0,0
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.074935,0.094766,0.1367,0,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.23203,0.094748,0.1851,0,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.12273,0.094604,0.1383,0,0
4,GO LEUKOCYTE AGGREGATION,0.78176,0.094519,0.0588,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.37964,0.09451,0.065285,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.25111,0.094433,0.11146,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.1475,0.094326,0.17172,0,0
4,GO CONVERGENT EXTENSION,0.18624,0.094278,0.16742,0,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.4521,0.094185,0.10007,0,0
4,GO B CELL PROLIFERATION,0.33821,0.094105,0.18783,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.54223,0.093992,0.054098,0,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.1306,0.093919,0.12167,0,0
4,GO NUCLEOTIDE SALVAGE,0.10811,0.093914,0.13594,0,0
4,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.13885,0.093879,0.14301,0,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.2259,0.093736,0.13333,0,0
4,GO T CELL ACTIVATION,0.26442,0.093701,0.15448,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.060677,0.093691,0.16183,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.38829,0.093683,0.078712,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.17591,0.093663,0.10792,0,0
4,GO CELLULAR ION HOMEOSTASIS,0.098083,0.093619,0.14061,0,0
4,GO CD40 SIGNALING PATHWAY,0.27126,0.093611,0.157,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.32248,0.093598,0.11955,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.13885,0.09353,0.10982,0,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.40594,0.093445,0.10354,0,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.17091,0.093411,0.10953,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.048745,0.093331,0.19889,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.23827,0.093273,0.11903,0,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.33821,0.093244,0.10493,0,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.08303,0.093205,0.14036,0,0
4,GO POSITIVE REGULATION OF SIGNALING,0.054439,0.093201,0.14761,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.69814,0.092983,0.057108,0,0
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.27821,0.092798,0.18042,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.062884,0.092792,0.1459,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.13467,0.092706,0.14993,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.08881,0.092662,0.14092,0,0
4,GO DNA REPLICATION INITIATION,0.15197,0.092631,0.12579,0,0
4,GO LYMPH NODE DEVELOPMENT,0.29248,0.092605,0.17368,0,0
4,GO SISTER CHROMATID SEGREGATION,0.19156,0.092605,0.10056,0,0
4,GO HISTONE H3 ACETYLATION,0.072385,0.092603,0.14786,0,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.43329,0.0925,0.090309,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.1475,0.092335,0.11119,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.21989,0.092325,0.17396,0,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.19156,0.092287,0.28983,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.26442,0.09227,0.11556,0,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.067497,0.09204,0.14126,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.60692,0.091908,0.079917,0,0
4,GO CHEMICAL HOMEOSTASIS,0.069906,0.091781,0.1394,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.15197,0.091781,0.11408,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.17091,0.091754,0.13164,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.39705,0.091708,0.10235,0,0
4,GO NEGATIVE REGULATION OF SECRETION,0.098083,0.091553,0.14323,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.17091,0.091523,0.12962,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.50109,0.091398,0.072519,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.38829,0.091319,0.084616,0,0
4,GO RELAXATION OF MUSCLE,0.76963,0.091189,0.041466,0,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.37111,0.091158,0.11554,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.15197,0.091083,0.12596,0,0
4,GO REGULATION OF ANION TRANSPORT,0.10468,0.091048,0.14231,0,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.1475,0.091009,0.13423,0,0
4,GO SUPEROXIDE METABOLIC PROCESS,0.18624,0.091003,0.14076,0,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.30724,0.090952,0.11694,0,0
4,GO DNA REPLICATION,0.23203,0.090872,0.093056,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.25111,0.090868,0.11063,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.17091,0.090633,0.11159,0,0
4,GO CENTRIOLE ASSEMBLY,0.47137,0.090617,0.075269,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.054439,0.090567,0.15372,0,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.20256,0.090505,0.11675,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.197,0.090376,0.12352,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.35442,0.090315,0.13871,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.46168,0.090265,0.16036,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.26442,0.09017,0.12015,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.61803,0.090158,-0.083012,0,0
4,GO SPHINGOLIPID METABOLIC PROCESS,0.12662,0.090016,0.11804,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.70989,0.089985,0.055219,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30724,0.089886,0.1171,0,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.32248,0.089842,0.19939,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.83078,0.089802,0.027922,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.13885,0.089727,0.12064,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.64051,0.089703,0.048847,0,0
4,GO KINETOCHORE ASSEMBLY,0.64051,0.089657,0.042174,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.17091,0.089601,0.10326,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.08303,0.089571,0.12425,0,0
4,GO REGULATION OF OSSIFICATION,0.20822,0.089516,0.12817,0,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.28529,0.089499,0.12436,0,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.056456,0.08949,0.14311,0,0
4,GO CHROMOSOME SEGREGATION,0.27126,0.089481,0.092726,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.1475,0.089379,0.12472,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.33821,0.089311,0.14729,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.16123,0.089307,0.14606,0,0
4,GO TEMPERATURE HOMEOSTASIS,0.094909,0.089295,0.12529,0,0
4,GO POLYOL CATABOLIC PROCESS,0.23203,0.089206,0.091291,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.58498,0.088972,0.042363,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.27126,0.088871,0.17117,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.17591,0.088793,0.15508,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.42405,0.08873,0.11841,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.40594,0.088725,0.094188,0,0
4,GO HORMONE METABOLIC PROCESS,0.18624,0.08864,0.094997,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.2577,0.088569,0.10977,0,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.48117,0.088555,0.07688,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.79394,0.088484,-0.011979,0,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.49108,0.088391,0.11104,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.094909,0.088309,0.093998,0,0
4,GO VIRAL GENOME REPLICATION,0.49108,0.088229,0.052448,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.33821,0.088198,0.10727,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.23827,0.088048,0.12122,0,0
4,GO ION HOMEOSTASIS,0.094909,0.088017,0.13847,0,0
4,GO RESPONSE TO ACTIVITY,0.23203,0.087949,0.083029,0,0
4,GO REGULATION OF BODY FLUID LEVELS,0.15197,0.087919,0.13622,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.27821,0.08785,0.10712,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.62923,0.087807,0.047307,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.67486,0.087788,0.043715,0,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.2259,0.087696,0.11728,0,0
4,GO AGING,0.17591,0.08762,0.10811,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.25111,0.087575,0.11693,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.17091,0.087571,0.12135,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.33029,0.087542,0.097391,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.23203,0.087476,0.10553,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.27821,0.087442,0.1007,0,0
4,GO BONE RESORPTION,0.30724,0.087405,0.14189,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.28529,0.087402,0.058975,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.197,0.087396,0.18051,0,0
4,GO RESPONSE TO WOUNDING,0.214,0.087312,0.13464,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.24463,0.087306,0.10805,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.56341,0.087304,0.092607,0,0
4,GO LIPOPROTEIN METABOLIC PROCESS,0.23203,0.087265,0.078281,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.30724,0.087223,0.10853,0,0
4,GO MRNA METHYLATION,0.44264,0.08716,0.074581,0,0
4,GO HEART FIELD SPECIFICATION,0.57414,0.087153,0.056125,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.50109,0.087148,0.0478,0,0
4,GO HEART DEVELOPMENT,0.11163,0.087071,0.14217,0,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.16602,0.08704,0.10247,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.47137,0.087001,0.064423,0,0
4,GO REGULATION OF MUSCLE ADAPTATION,0.18102,0.086899,0.12491,0,0
4,GO SALIVA SECRETION,0.17591,0.086766,0.16308,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.20822,0.086737,0.15048,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.1306,0.086613,0.10962,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.25111,0.086606,0.18706,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.15197,0.086595,0.1881,0,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.4521,0.086505,0.1097,0,0
4,GO ENDOCRINE HORMONE SECRETION,0.2259,0.086457,0.090665,0,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.30724,0.086407,0.10149,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.17091,0.086397,0.13028,0,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.3148,0.086249,0.13982,0,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.3148,0.086185,0.12932,0,0
4,GO APOPTOTIC PROCESS,0.091819,0.086175,0.12187,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.13885,0.086169,0.11155,0,0
4,GO RRNA MODIFICATION,0.65188,0.086165,0.044524,0,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35442,0.08616,0.10989,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.3148,0.086148,0.085174,0,0
4,GO ENDOTHELIAL CELL MIGRATION,0.41494,0.086097,0.11083,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.14312,0.08605,0.11527,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.2998,0.085839,0.11048,0,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.37964,0.085823,0.078197,0,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.34626,0.085783,0.15055,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.54223,0.085751,0.011635,0,0
4,GO RNA 3 END PROCESSING,0.26442,0.085751,0.07719,0,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.38829,0.085729,0.068825,0,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.23203,0.085684,0.154,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.37964,0.085499,0.10151,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.36271,0.085479,0.084157,0,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.17591,0.085473,0.14086,0,0
4,GO B CELL ACTIVATION,0.23203,0.085456,0.18131,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.10468,0.085371,0.12972,0,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.42405,0.085324,0.11298,0,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.16602,0.085321,0.17775,0,0
4,GO SPERMATID DIFFERENTIATION,0.20822,0.08532,0.081432,0,0
4,GO LUNG ALVEOLUS DEVELOPMENT,0.7336,0.085293,0.076377,0,0
4,GO ANIMAL ORGAN MATURATION,0.25111,0.08514,0.12708,0,0
4,GO TETRAPYRROLE METABOLIC PROCESS,0.10811,0.085134,0.094462,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.062884,0.085015,0.13446,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.069906,0.084956,0.14644,0,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.41494,0.084949,0.086501,0,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.10468,0.084834,0.11067,0,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.11163,0.084754,0.11352,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.2577,0.084728,0.15553,0,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.16602,0.084689,0.13969,0,0
4,GO AMYLOID FIBRIL FORMATION,0.46168,0.084684,0.099153,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.3148,0.084663,0.16307,0,0
4,GO CERAMIDE CATABOLIC PROCESS,0.24463,0.084555,0.14536,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.72171,0.084385,0.086033,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.96843,0.08413,0.003681,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.23827,0.084114,0.091167,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.077559,0.08406,0.15758,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.68646,0.084041,0.064566,0,0
4,GO REGULATION OF HEMOPOIESIS,0.20256,0.08398,0.1329,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.21989,0.083903,0.10677,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.15655,0.083884,0.088333,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.214,0.083835,0.11332,0,0
4,GO TOXIN TRANSPORT,0.2259,0.083783,0.10919,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.4521,0.083771,0.13898,0,0
4,GO UTP METABOLIC PROCESS,0.51122,0.083759,0.022903,0,0
4,GO TISSUE MIGRATION,0.35442,0.083684,0.11614,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.29248,0.08367,0.10205,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.32248,0.083632,0.16284,0,0
4,GO HOMEOSTATIC PROCESS,0.072385,0.083604,0.13146,0,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.66333,0.083559,0.026506,0,0
4,GO NADP METABOLIC PROCESS,0.49108,0.083508,0.059841,0,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.08881,0.083429,0.1302,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.52145,0.083412,0.09055,0,0
4,GO REGULATION OF PHOSPHORYLATION,0.077559,0.083342,0.13997,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.17591,0.083289,0.093699,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.1306,0.083259,0.13203,0,0
4,GO POSITIVE REGULATION OF CELL DEATH,0.069906,0.083059,0.13673,0,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.13467,0.082983,0.14145,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.094909,0.082827,0.22942,0,0
4,GO MRNA 3 END PROCESSING,0.3148,0.082792,0.086728,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.10811,0.082716,0.17615,0,0
4,GO MESONEPHROS DEVELOPMENT,0.2259,0.082664,0.10028,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.23203,0.082464,0.10606,0,0
4,GO GLUCOSE IMPORT,0.12662,0.082441,0.11193,0,0
4,GO VITAMIN TRANSPORT,0.11163,0.082441,0.15116,0,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.17091,0.082381,0.099846,0,0
4,GO RNA PROCESSING,0.32248,0.08221,0.067184,0,0
4,GO REGULATION OF B CELL ACTIVATION,0.23203,0.082192,0.19486,0,0
4,GO STRESS GRANULE ASSEMBLY,0.21989,0.082148,0.11957,0,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.37964,0.082032,0.085573,0,0
4,GO ERBB SIGNALING PATHWAY,0.37964,0.082013,0.10126,0,0
4,GO HYPOTONIC RESPONSE,0.28529,0.082005,0.10383,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.080256,0.081938,0.15375,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.15197,0.081598,0.15326,0,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.11894,0.081594,0.135,0,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.26442,0.08153,0.11746,0,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.29248,0.081461,0.14217,0,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.46168,0.08127,0.1044,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.28529,0.081126,0.10235,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.40594,0.081115,0.11161,0,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.077559,0.081091,0.14643,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.32248,0.080825,0.13452,0,0
4,GO HAIR FOLLICLE MATURATION,0.214,0.080759,0.12139,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.2998,0.080751,0.11594,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.29248,0.080736,0.086985,0,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.060677,0.0806,0.12841,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.26442,0.080531,0.060431,0,0
4,GO ALCOHOL CATABOLIC PROCESS,0.091819,0.080451,0.12686,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.66333,0.080429,0.02867,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.40594,0.08041,0.14418,0,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.21989,0.080359,0.16191,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.15197,0.080339,0.10784,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.16123,0.080283,0.13829,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.94321,0.080278,-0.007507,0,0
4,GO REGULATION OF IMMUNE RESPONSE,0.39705,0.080196,0.10367,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.13885,0.080187,0.14753,0,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.28529,0.08004,0.16864,0,0
4,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.7336,0.079913,0.097469,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.39705,0.079816,0.088712,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.080256,0.079813,0.1308,0,0
4,GO TISSUE REGENERATION,0.80618,0.079774,0.038103,0,0
4,GO CELL ADHESION MOLECULE PRODUCTION,0.40594,0.079735,0.10797,0,0
4,GO CELL MOTILITY,0.11163,0.079641,0.14768,0,0
4,GO REGULATION OF CELLULAR PH,0.25111,0.079565,0.10051,0,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.23203,0.079564,0.1157,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.30724,0.07951,0.086022,0,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.10468,0.07949,0.12258,0,0
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.17591,0.079415,0.10824,0,0
4,GO NEURON PROJECTION REGENERATION,0.054439,0.079354,0.21481,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.08588,0.079071,0.1159,0,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.33821,0.078984,0.093195,0,0
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.26442,0.078958,0.093082,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.2259,0.07895,0.14546,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.20822,0.078804,0.12616,0,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.47137,0.078787,0.070991,0,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.08881,0.078771,0.14515,0,0
4,GO NUCLEOTIDE TRANSPORT,0.065157,0.078688,0.13208,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.36271,0.078672,0.10119,0,0
4,GO ORGAN GROWTH,0.20256,0.078627,0.11612,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.15655,0.078558,0.099859,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.38829,0.078465,0.19868,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.17591,0.078392,0.086774,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.55277,0.078332,0.060417,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.94321,0.078315,0.019004,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.35442,0.078293,0.093177,0,0
4,GO RESPONSE TO DRUG,0.13885,0.078213,0.1088,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.10468,0.078161,0.13484,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.14312,0.078149,0.15465,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.20822,0.078057,0.17315,0,0
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.18624,0.078001,0.096326,0,0
4,GO CELL CYCLE CHECKPOINT,0.21989,0.077889,0.10259,0,0
4,GO TUBE MORPHOGENESIS,0.197,0.077868,0.14133,0,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.12662,0.077775,0.15559,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.16602,0.077701,0.12737,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.37111,0.077689,0.21059,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.38829,0.07754,0.079736,0,0
4,GO LEUKOCYTE PROLIFERATION,0.33821,0.077524,0.14621,0,0
4,GO AXIS ELONGATION,0.44264,0.077484,0.088515,0,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.50109,0.077397,0.11255,0,0
4,GO MUSCLE CELL PROLIFERATION,0.55277,0.077344,0.069125,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.81845,0.077295,-0.013471,0,0
4,GO HORMONE CATABOLIC PROCESS,0.37964,0.077224,0.081924,0,0
4,GO JNK CASCADE,0.08881,0.077164,0.16664,0,0
4,GO MEMBRANE RAFT ORGANIZATION,0.47137,0.07712,0.095942,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.36271,0.077078,0.089366,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.20256,0.077039,0.13078,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.23827,0.076955,0.14105,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.098083,0.076811,0.13793,0,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.56341,0.076776,0.045051,0,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.25111,0.076714,0.072558,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.66333,0.076704,0.043675,0,0
4,GO LEUKOCYTE DIFFERENTIATION,0.21989,0.076638,0.15983,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.21989,0.076596,0.23988,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.58498,0.076554,0.08072,0,0
4,GO VESICLE BUDDING FROM MEMBRANE,0.214,0.076539,0.097258,0,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.27821,0.076513,0.10888,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.17091,0.076506,0.11265,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.072385,0.07647,0.11104,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.41494,0.076466,0.10838,0,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.43329,0.076464,0.10487,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.077559,0.076411,0.15813,0,0
4,GO REGULATION OF CELL ADHESION,0.19156,0.0763,0.16497,0,0
4,GO SNRNA PROCESSING,0.3148,0.076208,0.061878,0,0
4,GO HISTONE H2A UBIQUITINATION,0.23827,0.07609,0.11236,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.3148,0.076004,0.12605,0,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.30724,0.075941,0.098316,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.077559,0.075886,0.13946,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.38829,0.075831,0.10881,0,0
4,GO VESICLE ORGANIZATION,0.065157,0.075806,0.12849,0,0
4,GO REGULATION OF PH,0.1475,0.075746,0.11241,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.43329,0.075721,0.059057,0,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.21989,0.075683,0.18693,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.1306,0.075648,0.17182,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.077559,0.075621,0.13789,0,0
4,GO TOOTH MINERALIZATION,0.41494,0.075521,0.14209,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.37111,0.075482,0.091392,0,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.38829,0.075462,0.054819,0,0
4,GO PIRNA METABOLIC PROCESS,0.27821,0.075437,0.075034,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.10811,0.07539,0.14785,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.12662,0.075315,0.11118,0,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.39705,0.075239,0.087096,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.27126,0.07514,0.13721,0,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.19156,0.075091,0.1007,0,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.29248,0.075001,0.11739,0,0
4,GO RNA POLYADENYLATION,0.13467,0.074875,0.12901,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.60692,0.074825,0.035698,0,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.10134,0.074789,0.12672,0,0
4,GO HEART GROWTH,0.3148,0.074731,0.088837,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.15655,0.074704,0.17133,0,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.40594,0.074504,0.13759,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.49108,0.074478,0.089965,0,0
4,GO POSITIVE REGULATION OF FERTILIZATION,0.12273,0.07434,0.13686,0,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.11894,0.074269,0.1123,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.29248,0.074201,0.13792,0,0
4,GO ORGANELLE FUSION,0.080256,0.074115,0.13247,0,0
4,GO SECRETION,0.14312,0.073768,0.12412,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.44264,0.07375,0.06883,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.197,0.073566,0.2028,0,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.10468,0.073428,0.14476,0,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.3148,0.073418,0.15499,0,0
4,GO ORGANIC ACID METABOLIC PROCESS,0.20256,0.073384,0.081615,0,0
4,GO REGULATION OF LIPID TRANSPORT,0.14312,0.073187,0.12853,0,0
4,GO SPHINGOID METABOLIC PROCESS,0.2259,0.073134,0.14571,0,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.14312,0.073133,0.15276,0,0
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.2577,0.073097,0.098001,0,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.12662,0.073081,0.15268,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.61803,0.07296,0.043691,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.44264,0.072891,0.0929,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.20256,0.072884,0.15673,0,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.3148,0.072866,0.064277,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.33029,0.0728,0.1201,0,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.20256,0.072741,0.13638,0,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.12273,0.072733,0.13616,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.41494,0.072582,0.061652,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.47137,0.072576,0.1386,0,0
4,GO VASCULATURE DEVELOPMENT,0.25111,0.072403,0.14285,0,0
4,GO RESPONSE TO GROWTH HORMONE,0.47137,0.072258,0.088783,0,0
4,GO LIPID HOMEOSTASIS,0.13885,0.072163,0.11777,0,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.60692,0.072136,0.06095,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.25111,0.071983,0.11951,0,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.34626,0.071955,0.16239,0,0
4,GO CARBOHYDRATE TRANSPORT,0.37111,0.07195,0.088407,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.38829,0.071947,0.11104,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.34626,0.071941,0.082137,0,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.045233,0.071933,0.17625,0,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.37964,0.071913,0.12375,0,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.15197,0.071896,0.096989,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.27126,0.071885,0.10012,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.47137,0.071684,0.12006,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.34626,0.071655,0.086458,0,0
4,GO AMYLOID BETA FORMATION,0.26442,0.071549,0.11531,0,0
4,GO NUCLEOSIDE SALVAGE,0.16602,0.071548,0.067006,0,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.26442,0.071394,0.11555,0,0
4,GO T CELL PROLIFERATION,0.3148,0.071362,0.14701,0,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.16602,0.071321,0.11829,0,0
4,GO BONE DEVELOPMENT,0.17091,0.071273,0.14952,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.84314,0.071249,0.0095738,0,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.13885,0.071163,0.12688,0,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.11894,0.071144,0.11898,0,0
4,GO INORGANIC ANION TRANSPORT,0.18624,0.07102,0.10752,0,0
4,GO REGULATION OF CELL CELL ADHESION,0.24463,0.071003,0.14751,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27126,0.070991,0.099918,0,0
4,GO DNA GEOMETRIC CHANGE,0.25111,0.070907,0.095819,0,0
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.091819,0.070784,0.10022,0,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.26442,0.070743,0.14844,0,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.48117,0.070727,0.077507,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.10468,0.070699,0.12496,0,0
4,GO EPITHELIUM DEVELOPMENT,0.1475,0.070659,0.11286,0,0
4,GO REGULATION OF LIPID LOCALIZATION,0.214,0.070566,0.12293,0,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.2577,0.070561,0.13088,0,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.12662,0.070436,0.13532,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.28529,0.070402,0.084078,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.40594,0.070386,0.089141,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.44264,0.070375,0.10437,0,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.67486,0.070266,0.035113,0,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.41494,0.070204,0.1212,0,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.55277,0.070192,0.069531,0,0
4,GO EXCRETION,0.069906,0.070185,0.16667,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.43329,0.070163,0.091006,0,0
4,GO RESPONSE TO INTERLEUKIN 6,0.48117,0.070113,0.098819,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.96843,0.070076,-0.023746,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.34626,0.07007,0.15946,0,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.27821,0.069999,0.073136,0,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.13467,0.069975,0.13956,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.16123,0.069949,0.12881,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.20822,0.069939,0.11472,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.47137,0.069877,0.062587,0,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.13467,0.069855,0.10494,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.2998,0.069841,0.12062,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.42405,0.06983,0.14021,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.14312,0.069811,0.11748,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.11163,0.069801,0.15255,0,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.23203,0.069587,0.13549,0,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.78176,0.069578,0.060184,0,0
4,GO REGULATION OF CELL DEATH,0.17091,0.069526,0.10999,0,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.20822,0.069524,0.090318,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.37964,0.069458,0.10101,0,0
4,GO PEPTIDE CATABOLIC PROCESS,0.20256,0.069341,0.15035,0,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.37964,0.06934,0.10356,0,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.1306,0.069332,0.15473,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.3148,0.069246,0.1152,0,0
4,GO GENITALIA DEVELOPMENT,0.72171,0.069239,0.063889,0,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.18102,0.069221,0.13872,0,0
4,GO ERAD PATHWAY,0.10134,0.069159,0.11995,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.24463,0.069136,0.20353,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.28529,0.069085,0.1048,0,0
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.60692,0.06907,0.051833,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.56341,0.069028,0.063609,0,0
4,GO RESPONSE TO ABIOTIC STIMULUS,0.08881,0.068976,0.11644,0,0
4,GO MYELOID CELL HOMEOSTASIS,0.23827,0.068934,0.096539,0,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.15655,0.068918,0.10309,0,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.25111,0.068916,0.14187,0,0
4,GO RESPONSE TO LIPID,0.28529,0.068901,0.10392,0,0
4,GO SPERM AXONEME ASSEMBLY,0.7336,0.068712,-0.0013143,0,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.41494,0.068677,0.074247,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.39705,0.068611,0.091703,0,0
4,GO GASTRULATION,0.13885,0.06851,0.15687,0,0
4,GO RESPONSE TO OXYGEN LEVELS,0.214,0.068404,0.08953,0,0
4,GO MAINTENANCE OF LOCATION,0.12273,0.068367,0.13745,0,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.21989,0.06835,0.082321,0,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.27821,0.068311,0.097372,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.32248,0.068297,0.11096,0,0
4,GO RESPONSE TO PROTOZOAN,0.38829,0.068282,0.16235,0,0
4,GO PERICARDIUM DEVELOPMENT,0.19156,0.06827,0.15572,0,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.094909,0.068266,0.10901,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.50109,0.068251,0.058366,0,0
4,GO MRNA MODIFICATION,0.74555,0.068171,0.030025,0,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.16602,0.068157,0.143,0,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.27126,0.068151,0.14155,0,0
4,GO SUPEROXIDE ANION GENERATION,0.33029,0.068145,0.14417,0,0
4,GO NEPHRON MORPHOGENESIS,0.2998,0.068114,0.092397,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.32248,0.067962,0.10619,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.33029,0.067888,0.070946,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.47137,0.06785,0.092358,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.33821,0.067793,0.081377,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.08588,0.067776,0.1098,0,0
4,GO REGULATION OF CELL ACTIVATION,0.27126,0.067722,0.15514,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.41494,0.06765,0.093355,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.19156,0.067559,0.11202,0,0
4,GO STRIATUM DEVELOPMENT,0.34626,0.067505,0.097342,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.10468,0.067467,0.10907,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.33029,0.067458,0.13461,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.51122,0.067408,0.071123,0,0
4,GO AMINE METABOLIC PROCESS,0.12273,0.067405,0.079848,0,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.24463,0.067269,0.10668,0,0
4,GO CELLULAR LIPID METABOLIC PROCESS,0.214,0.067113,0.095574,0,0
4,GO MRNA CLEAVAGE,0.080256,0.067045,0.12787,0,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.16602,0.066961,0.15639,0,0
4,GO BONE MATURATION,0.38829,0.066926,0.11307,0,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.28529,0.066926,0.084892,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.57414,0.066875,0.095813,0,0
4,GO GOLGI ORGANIZATION,0.2998,0.066805,0.098568,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.24463,0.066795,0.18109,0,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.29248,0.06674,0.10686,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.27821,0.066715,0.10621,0,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.48117,0.066644,0.061474,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.3148,0.066639,0.11041,0,0
4,GO ACROSOME REACTION,0.14312,0.066512,0.1458,0,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.10468,0.066476,0.15315,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.27821,0.066459,0.083457,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.1475,0.066446,0.099505,0,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.41494,0.066426,0.065869,0,0
4,GO SELECTIVE AUTOPHAGY,0.15197,0.066418,0.1376,0,0
4,GO MYELOID CELL DIFFERENTIATION,0.20256,0.066394,0.13575,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.21989,0.066355,0.12899,0,0
4,GO POSITIVE REGULATION OF ACROSOME REACTION,0.197,0.066288,0.14551,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.12662,0.066262,0.14151,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.66333,0.066223,0.081813,0,0
4,GO FAT CELL DIFFERENTIATION,0.48117,0.066186,0.083137,0,0
4,GO LIPID LOCALIZATION,0.25111,0.066118,0.10501,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.55277,0.066077,0.071236,0,0
4,GO ARACHIDONIC ACID SECRETION,0.47137,0.066038,0.065098,0,0
4,GO MESODERM DEVELOPMENT,0.10468,0.066015,0.12902,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.2998,0.06592,0.099334,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.15197,0.065911,0.17008,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.20822,0.065762,0.10051,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.18102,0.065737,0.085928,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.39705,0.065617,0.07092,0,0
4,GO EMBRYO IMPLANTATION,0.46168,0.065604,0.10025,0,0
4,GO BLASTODERM SEGMENTATION,0.2577,0.065589,0.10836,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.4521,0.065578,0.072466,0,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.49108,0.065388,0.094174,0,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.1306,0.065345,0.11645,0,0
4,GO RESPONSE TO ETHANOL,0.18624,0.065281,0.093146,0,0
4,GO FERTILIZATION,0.072385,0.065118,0.10724,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.16123,0.065012,0.11173,0,0
4,GO REGULATION OF HYDROLASE ACTIVITY,0.1306,0.064877,0.12574,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.32248,0.06477,0.085252,0,0
4,GO RESPONSE TO STEROL,0.1306,0.064705,0.18254,0,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.42405,0.064643,0.10657,0,0
4,GO OXIDATION REDUCTION PROCESS,0.17591,0.06458,0.060908,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.58498,0.064531,0.081222,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.18102,0.064518,0.10765,0,0
4,GO LEUKOCYTE HOMEOSTASIS,0.41494,0.064502,0.12015,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.35442,0.064428,0.078219,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.85555,0.064308,0.031886,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.17591,0.064286,0.1306,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.84314,0.064196,0.050321,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.37111,0.064184,0.069799,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.28529,0.064161,0.094903,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.1475,0.064046,0.139,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.41494,0.063866,0.071562,0,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.49108,0.06386,0.06555,0,0
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.36271,0.063808,0.079355,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.214,0.063801,0.082434,0,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.4521,0.063695,0.10112,0,0
4,GO CELL CELL RECOGNITION,0.38829,0.063647,0.068278,0,0
4,GO CELLULAR RESPONSE TO LIPID,0.2998,0.063573,0.10631,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.40594,0.06356,0.092788,0,0
4,GO RUFFLE ORGANIZATION,0.44264,0.063543,0.098012,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION,0.27821,0.063539,0.13887,0,0
4,GO MYOBLAST DIFFERENTIATION,0.43329,0.06338,0.072066,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.47137,0.063302,0.12006,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.80618,0.063256,0.022375,0,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.11524,0.063226,0.1217,0,0
4,GO TISSUE MORPHOGENESIS,0.18102,0.063124,0.13452,0,0
4,GO KIDNEY MORPHOGENESIS,0.33821,0.063098,0.088346,0,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.23203,0.063087,0.10147,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.37964,0.063082,0.068969,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.56341,0.062934,0.061923,0,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.19156,0.062841,0.18708,0,0
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.10468,0.062768,0.13487,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.091819,0.06275,0.11964,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.29248,0.062735,0.063868,0,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.55277,0.062725,0.099709,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.78176,0.062725,0.052751,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.33029,0.062701,0.13047,0,0
4,GO VESICLE TARGETING,0.29248,0.062628,0.082911,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.39705,0.062592,0.078801,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.37111,0.062584,0.059302,0,0
4,GO COAGULATION,0.17091,0.062572,0.1399,0,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.19156,0.062539,0.097259,0,0
4,GO MITOCHONDRIAL FISSION,0.2577,0.062535,0.087088,0,0
4,GO METAPHASE PLATE CONGRESSION,0.32248,0.062423,0.080718,0,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.46168,0.062388,0.10843,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.49108,0.062374,0.1173,0,0
4,GO LIPID METABOLIC PROCESS,0.23827,0.062227,0.094129,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.44264,0.062023,0.087719,0,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.1475,0.061893,0.13605,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.93062,0.061875,0.0016669,0,0
4,GO REGULATION OF DNA REPLICATION,0.51122,0.06179,0.061637,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.28529,0.061746,0.080219,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.35442,0.061484,0.12423,0,0
4,GO TRANSLESION SYNTHESIS,0.35442,0.061457,0.068826,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33029,0.061373,0.10368,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.61803,0.061364,0.058611,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.89296,0.061302,-0.024618,0,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.14312,0.061276,0.17714,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.214,0.061125,0.097483,0,0
4,GO MUSCLE CELL FATE COMMITMENT,0.74555,0.060913,-0.0034725,0,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.2577,0.060797,0.10169,0,0
4,GO FATTY ACID METABOLIC PROCESS,0.60692,0.060768,0.047622,0,0
4,GO REGULATION OF MAPK CASCADE,0.11524,0.060681,0.14371,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.27821,0.060425,0.14776,0,0
4,GO REGULATION OF CHEMOTAXIS,0.46168,0.060413,0.09832,0,0
4,GO RENAL SODIUM EXCRETION,0.214,0.060343,0.13405,0,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.15197,0.060033,0.097492,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.42405,0.059976,0.061687,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.37111,0.059919,0.09455,0,0
4,GO RESPONSE TO CAFFEINE,0.12662,0.059909,0.1282,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.99368,0.059854,0.033453,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.25111,0.059851,0.13569,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.36271,0.059833,0.043935,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.96843,0.05978,0.010422,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.2577,0.059764,0.13438,0,0
4,GO ACTIN FILAMENT SEVERING,0.84314,0.059752,0.0512,0,0
4,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.79394,0.059693,0.048908,0,0
4,GO TRNA TRANSPORT,0.35442,0.05968,0.08402,0,0
4,GO GLYCEROLIPID METABOLIC PROCESS,0.17591,0.059585,0.10906,0,0
4,GO RESPONSE TO LEAD ION,0.39705,0.059585,0.089303,0,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.19156,0.059554,0.065496,0,0
4,GO ALCOHOL METABOLIC PROCESS,0.20256,0.059393,0.092184,0,0
4,GO CELLULAR SENESCENCE,0.16602,0.059279,0.079209,0,0
4,GO EPIDERMAL CELL DIFFERENTIATION,0.84314,0.059278,0.014301,0,0
4,GO AMINO SUGAR CATABOLIC PROCESS,0.86799,0.059247,0.027787,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.67486,0.059178,0.050682,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.55277,0.059151,0.10833,0,0
4,GO MESODERM MORPHOGENESIS,0.20256,0.059148,0.13958,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.18102,0.059144,0.18836,0,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.58498,0.059058,0.046756,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4521,0.059017,0.14683,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.3148,0.058934,0.093484,0,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.13885,0.058855,0.14563,0,0
4,GO SKIN DEVELOPMENT,0.53179,0.058811,0.049621,0,0
4,GO BONE CELL DEVELOPMENT,0.17591,0.058809,0.18173,0,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.93062,0.058771,-0.041379,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.2998,0.058744,0.12879,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.36271,0.058736,0.078607,0,0
4,GO GLYCOSYLATION,0.17091,0.058686,0.097856,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.13467,0.05867,0.088441,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.50109,0.058549,0.061957,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.34626,0.058515,0.08471,0,0
4,GO RNA LOCALIZATION,0.33821,0.058446,0.074137,0,0
4,GO MATURATION OF SSU RRNA,0.57414,0.058388,0.038399,0,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.29248,0.058324,0.13349,0,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.18102,0.058324,0.10779,0,0
4,GO THIOESTER METABOLIC PROCESS,0.61803,0.05831,0.03095,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.214,0.058293,0.10174,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.37111,0.05827,0.10636,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.21989,0.058263,0.12858,0,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.18102,0.058237,0.15169,0,0
4,GO STEROL METABOLIC PROCESS,0.43329,0.058221,0.067659,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.40594,0.058204,0.043482,0,0
4,GO PEPTIDE CROSS LINKING,0.41494,0.058191,0.11297,0,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.70989,0.058078,0.03735,0,0
4,GO REGULATION OF ORGAN GROWTH,0.34626,0.058002,0.090251,0,0
4,GO VACUOLAR ACIDIFICATION,0.79394,0.05796,0.037707,0,0
4,GO REGULATION OF B CELL PROLIFERATION,0.27126,0.057923,0.20167,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.50109,0.057908,0.11696,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.27821,0.057877,0.1489,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.85555,0.057784,0.024111,0,0
4,GO HEART FORMATION,0.43329,0.05777,0.079626,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.21989,0.057694,0.10474,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.40594,0.05764,0.1216,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.33821,0.057613,0.089499,0,0
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.23203,0.057522,0.10792,0,0
4,GO CHEMOKINE SECRETION,0.96843,0.057509,-0.021065,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11163,0.057495,0.10281,0,0
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.08303,0.057469,0.19754,0,0
4,GO REGULATION OF ODONTOGENESIS,0.65188,0.057464,0.05817,0,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.44264,0.057337,0.046395,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.34626,0.057315,0.090385,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.20822,0.057271,0.088835,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.197,0.057209,0.11456,0,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.2577,0.05716,0.087251,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.2577,0.057123,0.10578,0,0
4,GO TRANSITION METAL ION TRANSPORT,0.41494,0.057095,0.063823,0,0
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.27126,0.057089,0.082056,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.33821,0.057035,0.15818,0,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.35442,0.056939,0.12809,0,0
4,GO REGENERATION,0.36271,0.056837,0.083119,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.37111,0.056783,0.08306,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.1306,0.056619,0.13522,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.44264,0.056607,0.095986,0,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.19156,0.056602,0.15095,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.35442,0.056505,0.11451,0,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.29248,0.056496,0.14585,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.1306,0.056488,0.1192,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.17091,0.05642,0.1114,0,0
4,GO RRNA METHYLATION,0.42405,0.056417,0.047648,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.17591,0.056235,0.15893,0,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.20256,0.056226,0.11081,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.47137,0.056197,0.086345,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.30724,0.056163,0.12813,0,0
4,GO RESPONSE TO CORTICOSTEROID,0.37964,0.056144,0.081202,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.34626,0.056083,0.084523,0,0
4,GO STEROID METABOLIC PROCESS,0.65188,0.056023,0.041898,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.35442,0.056022,0.14938,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.28529,0.05598,0.13642,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.33029,0.055963,0.064246,0,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.48117,0.055911,0.10542,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.27126,0.055799,0.095058,0,0
4,GO BONE REMODELING,0.2577,0.055778,0.15644,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.35442,0.055774,0.078916,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.34626,0.055533,0.10256,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2259,0.055528,0.097192,0,0
4,GO RNA METHYLATION,0.51122,0.055442,0.05012,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.2998,0.05535,0.16247,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.27126,0.055342,0.080729,0,0
4,GO MUSCLE CELL MIGRATION,0.34626,0.055322,0.11863,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.46168,0.055304,0.12068,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.69814,0.055292,0.060085,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.43329,0.055285,0.099865,0,0
4,GO HISTONE MONOUBIQUITINATION,0.42405,0.055264,0.084175,0,0
4,GO ALDITOL METABOLIC PROCESS,0.39705,0.055154,0.073103,0,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.60692,0.055121,0.047011,0,0
4,GO INTERFERON ALPHA PRODUCTION,0.50109,0.054966,0.093305,0,0
4,GO MITOCHONDRIAL TRANSPORT,0.17091,0.054951,0.07453,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.90549,0.054941,0.036744,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.60692,0.05492,0.065612,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.89296,0.054848,0.0059154,0,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.40594,0.054811,0.06238,0,0
4,GO T CELL EXTRAVASATION,0.43329,0.0548,0.13802,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.54223,0.054735,0.079381,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.49108,0.054722,0.077222,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.33821,0.054702,0.12321,0,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.80618,0.054681,0.037656,0,0
4,GO RESPONSE TO CORTICOSTERONE,0.5959,0.054654,0.076794,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.214,0.054611,0.13678,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.4521,0.054505,0.080196,0,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.93062,0.05447,0.033186,0,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.56341,0.054397,0.054787,0,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.33029,0.054396,0.11502,0,0
4,GO MANNOSYLATION,0.34626,0.054361,0.084256,0,0
4,GO MITOTIC CYTOKINESIS,0.39705,0.054314,0.082697,0,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.1475,0.054306,0.12023,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.89296,0.054306,-0.021464,0,0
4,GO LYSINE METABOLIC PROCESS,0.67486,0.054245,0.033945,0,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.50109,0.054217,0.058473,0,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.44264,0.05415,0.11185,0,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.23827,0.054124,0.12214,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.35442,0.05412,0.13332,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.4521,0.054114,0.16789,0,0
4,GO REGULATION OF BLOOD PRESSURE,0.44264,0.054073,0.082611,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.52145,0.054048,0.045875,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.20256,0.053981,0.13769,0,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.34626,0.053931,0.12456,0,0
4,GO NUCLEOSOME ASSEMBLY,0.42405,0.053924,0.078953,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.33821,0.053891,0.086153,0,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.28529,0.053763,0.11148,0,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.15655,0.053659,0.12397,0,0
4,GO TISSUE REMODELING,0.28529,0.053622,0.14443,0,0
4,GO RESPONSE TO VIRUS,0.5959,0.053451,0.067279,0,0
4,GO EPIBOLY,0.55277,0.053411,0.11482,0,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.21989,0.05341,0.11269,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.39705,0.053388,0.052825,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.38829,0.05319,0.041725,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.214,0.053172,0.15296,0,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.23203,0.053154,0.16231,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.88046,0.053129,0.039494,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.78176,0.053033,0.023132,0,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.33821,0.052976,0.12099,0,0
4,GO RESPONSE TO EPINEPHRINE,0.79394,0.052968,0.014149,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.24463,0.052958,0.098322,0,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.64051,0.052893,0.036606,0,0
4,GO GTP BIOSYNTHETIC PROCESS,0.43329,0.052829,0.022926,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.46168,0.052765,0.12365,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.28529,0.052746,0.076465,0,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.32248,0.052728,0.13897,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.26442,0.052713,0.079577,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.50109,0.052705,0.058691,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.42405,0.052679,0.085833,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.47137,0.0525,0.07321,0,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.51122,0.052455,0.060965,0,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.27126,0.052425,0.15181,0,0
4,GO COPII COATED VESICLE BUDDING,0.37111,0.052336,0.074398,0,0
4,GO DIOL METABOLIC PROCESS,0.33821,0.052301,0.07656,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.61803,0.052289,0.022993,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.27126,0.05216,0.11827,0,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.94321,0.052155,-0.0017664,0,0
4,GO STEROL HOMEOSTASIS,0.67486,0.051997,0.051447,0,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.44264,0.051958,0.066699,0,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.08881,0.051946,0.064943,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.33821,0.051922,0.088107,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.2259,0.051872,0.14785,0,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.25111,0.05162,0.12652,0,0
4,GO TISSUE HOMEOSTASIS,0.33029,0.051463,0.103,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.23203,0.051427,0.17032,0,0
4,GO MALE SEX DIFFERENTIATION,0.32248,0.051397,0.091955,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.38829,0.051397,0.080762,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.54223,0.05132,0.061008,0,0
4,GO TRNA METHYLATION,0.96843,0.051303,0.0065456,0,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.19156,0.051301,0.092874,0,0
4,GO NIK NF KAPPAB SIGNALING,0.4521,0.051248,0.072506,0,0
4,GO ZINC ION TRANSPORT,0.035953,0.051237,0.13482,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.60692,0.051216,0.052728,0,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.33029,0.051177,0.067387,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.26442,0.051096,0.12595,0,0
4,GO ASYMMETRIC CELL DIVISION,0.32248,0.050978,0.10279,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.76963,0.050954,-0.029693,0,0
4,GO REGULATION OF DNA METHYLATION,0.35442,0.050905,0.076695,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.42405,0.050896,0.072255,0,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.28529,0.050886,0.096796,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.58498,0.050748,0.1127,0,0
4,GO MITOCHONDRION ORGANIZATION,0.077559,0.050741,0.091662,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.38829,0.050708,0.11635,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.4521,0.050706,0.10156,0,0
4,GO REGULATION OF URINE VOLUME,0.48117,0.050666,0.091661,0,0
4,GO WOUND HEALING,0.2259,0.050594,0.13057,0,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.16123,0.050489,0.10197,0,0
4,GO RESPONSE TO OSMOTIC STRESS,0.4521,0.050451,0.083695,0,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.30724,0.050377,0.1024,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.37964,0.050302,0.10955,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.57414,0.050286,0.04081,0,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.56341,0.05024,0.062813,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.58498,0.050151,0.067737,0,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.21989,0.049762,0.14185,0,0
4,GO PENTOSE METABOLIC PROCESS,0.25111,0.049755,0.10382,0,0
4,GO PROTEIN N LINKED GLYCOSYLATION,0.49108,0.049713,0.05549,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.64051,0.049552,0.10183,0,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.54223,0.04948,0.043752,0,0
4,GO TRNA CATABOLIC PROCESS,0.56341,0.049453,0.043518,0,0
4,GO REGULATION OF HEART RATE,0.46168,0.049287,0.062124,0,0
4,GO VAGINA DEVELOPMENT,0.51122,0.049167,0.073784,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.25111,0.04916,0.054007,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.33821,0.04905,0.071164,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.32248,0.048968,0.10942,0,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.42405,0.048921,0.064988,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.41494,0.048875,0.093152,0,0
4,GO EXOCYTOSIS,0.28529,0.048821,0.10255,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.39705,0.048767,0.16184,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.28529,0.048628,0.078725,0,0
4,GO AMINE CATABOLIC PROCESS,0.53179,0.048625,0.082175,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.53179,0.048515,0.054263,0,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.28529,0.048514,0.12105,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.2998,0.048449,0.081425,0,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.26442,0.048444,0.087647,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.12273,0.048382,0.15815,0,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.48117,0.04836,0.10448,0,0
4,GO ERK1 AND ERK2 CASCADE,0.26442,0.048332,0.13284,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.61803,0.048287,0.066318,0,0
4,GO MYELOID CELL DEVELOPMENT,0.27126,0.048273,0.13669,0,0
4,GO LIPID BIOSYNTHETIC PROCESS,0.38829,0.048273,0.071883,0,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.75756,0.04824,0.042325,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.34626,0.04815,0.1285,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.51122,0.048146,0.10101,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.54223,0.048101,0.071141,0,0
4,GO FIBROBLAST PROLIFERATION,0.37111,0.047999,0.10737,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.88046,0.047931,0.030094,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.48117,0.047907,0.099913,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.51122,0.047846,0.053892,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.35442,0.047838,0.12887,0,0
4,GO NCRNA PROCESSING,0.90549,0.047803,0.018317,0,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.27821,0.047782,0.16344,0,0
4,GO REGULATION OF VASCULOGENESIS,0.74555,0.047764,0.033607,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.2577,0.047721,0.15886,0,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.55277,0.047703,0.05869,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.11163,0.047677,0.14378,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.16123,0.047659,0.072564,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.43329,0.047653,0.06507,0,0
4,GO GOLGI VESICLE BUDDING,0.42405,0.04764,0.073646,0,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.48117,0.047633,0.043155,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.51122,0.04761,0.077447,0,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.32248,0.047594,0.056616,0,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.1306,0.047569,0.13556,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.49108,0.047555,0.10547,0,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.37964,0.047519,0.10719,0,0
4,GO PROTEIN SUMOYLATION,0.21989,0.047356,0.10918,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.33029,0.047323,0.092829,0,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.25111,0.047233,0.084714,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.4521,0.047189,0.092699,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.66333,0.04713,0.050941,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.83078,0.047129,0.035076,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.2577,0.047092,0.12568,0,0
4,GO CELLULAR PIGMENTATION,0.58498,0.047068,0.055001,0,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.37111,0.047057,0.14537,0,0
4,GO ORGANELLE DISASSEMBLY,0.20822,0.046972,0.09268,0,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.88046,0.04686,0.017225,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.2998,0.046823,0.12325,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.35442,0.046749,0.097102,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.34626,0.046721,0.085268,0,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.85555,0.046666,0.021494,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.55277,0.046604,0.086444,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.75756,0.046525,0.059136,0,0
4,GO RNA MODIFICATION,0.33821,0.046522,0.065387,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.42405,0.046508,0.054016,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.49108,0.046493,0.086094,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.54223,0.046263,0.15889,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.86799,0.046169,0.033642,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.3148,0.046163,0.05768,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.2998,0.04611,0.10796,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.32248,0.04609,0.096102,0,0
4,GO PROTEIN DEGLYCOSYLATION,0.44264,0.04604,0.099037,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.29248,0.046028,0.19337,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.1306,0.045896,0.16653,0,0
4,GO DIET INDUCED THERMOGENESIS,0.90549,0.045832,-0.00084783,0,0
4,GO TRACHEA MORPHOGENESIS,0.50109,0.045816,0.1033,0,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.51122,0.04568,0.061622,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.35442,0.045465,0.088426,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.44264,0.045441,0.081628,0,0
4,GO RESPONSE TO LITHIUM ION,0.90549,0.04526,0.028231,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.15655,0.045135,0.1067,0,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.67486,0.045134,0.08135,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.40594,0.045131,0.12316,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.70989,0.04506,0.046572,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.49108,0.045041,0.075434,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.38829,0.045008,0.081588,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.42405,0.044965,0.10658,0,0
4,GO DNA STRAND ELONGATION,0.51122,0.044911,0.062149,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.43329,0.044868,0.061503,0,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.26442,0.04473,0.11962,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.33029,0.044638,0.080372,0,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.16602,0.044557,0.11928,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.39705,0.044544,0.15198,0,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.76963,0.044503,0.0077926,0,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.23827,0.044466,0.08344,0,0
4,GO RESPONSE TO AMYLOID BETA,0.11894,0.044366,0.21315,0,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.69814,0.044335,0.055173,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.40594,0.044293,0.084982,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.55277,0.04422,0.071021,0,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.33029,0.044154,0.11417,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.5959,0.044047,0.055058,0,0
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.30724,0.044022,0.098802,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.43329,0.04392,0.062687,0,0
4,GO DIOL BIOSYNTHETIC PROCESS,0.52145,0.04366,0.053349,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.33029,0.043454,0.10886,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.75756,0.043393,0.037406,0,0
4,GO GALACTOSE METABOLIC PROCESS,0.78176,0.043338,0.034011,0,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.62923,0.043328,0.061192,0,0
4,GO NCRNA METABOLIC PROCESS,0.74555,0.043265,0.028036,0,0
4,GO HEPARIN METABOLIC PROCESS,0.69814,0.043246,0.037698,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.23203,0.043162,0.083482,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.4521,0.043118,0.065597,0,0
4,GO CELL AGING,0.17591,0.042904,0.084289,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.58498,0.042866,0.035701,0,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.5959,0.042854,0.069259,0,0
4,GO SNRNA METABOLIC PROCESS,0.68646,0.042801,0.036879,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.16123,0.042777,0.10798,0,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.33029,0.042726,0.091242,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.51122,0.042554,0.11906,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.84314,0.042553,-0.0086945,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.40594,0.042536,0.092914,0,0
4,GO POSITIVE CHEMOTAXIS,0.50109,0.042523,0.074123,0,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.46168,0.042478,0.17277,0,0
4,GO TRACHEA DEVELOPMENT,0.57414,0.042428,0.07589,0,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.56341,0.042403,0.053938,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.50109,0.042384,0.086969,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.44264,0.042274,0.068243,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.43329,0.042225,0.11922,0,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.95582,0.042164,0.020744,0,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.52145,0.042152,0.088491,0,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.25111,0.042062,0.0725,0,0
4,GO ORGANELLE INHERITANCE,0.23203,0.042044,0.099244,0,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.51122,0.041924,0.11193,0,0
4,GO RESPONSE TO ESTROGEN,0.33029,0.041843,0.10299,0,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.5959,0.041841,0.045763,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.85555,0.041562,0.036796,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.17091,0.041556,0.093787,0,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.47137,0.041507,0.099302,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.56341,0.041502,0.040923,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.43329,0.041381,0.14091,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.80618,0.041325,0.031389,0,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.91805,0.041317,0.026496,0,0
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.47137,0.041309,0.066454,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.3148,0.041145,0.052571,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.86799,0.041134,0.038687,0,0
4,GO RESPONSE TO OXIDATIVE STRESS,0.46168,0.041115,0.076404,0,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.57414,0.041103,0.082894,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.67486,0.04103,0.041978,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.18624,0.040994,0.090651,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.72171,0.040898,0.048324,0,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.42405,0.040765,0.062671,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.58498,0.040717,0.032292,0,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.88046,0.040518,0.0021871,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.3148,0.040505,0.12045,0,0
4,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.47137,0.040492,0.20521,0,0
4,GO REGULATION OF RESPONSE TO STRESS,0.28529,0.040478,0.0941,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.53179,0.040426,0.07259,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.47137,0.040275,0.071424,0,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.79394,0.040273,0.039999,0,0
4,GO AMINE BIOSYNTHETIC PROCESS,0.33029,0.040251,0.099524,0,0
4,GO EPITHELIAL CELL PROLIFERATION,0.4521,0.040141,0.083777,0,0
4,GO P38MAPK CASCADE,0.38829,0.040089,0.12201,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.50109,0.040076,0.072294,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.74555,0.040073,0.030225,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.17091,0.040055,0.12778,0,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.27821,0.04,0.14274,0,0
4,GO RUFFLE ASSEMBLY,0.70989,0.039917,0.071687,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.94321,0.039796,0.0082205,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.37111,0.039791,0.14485,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.26442,0.039777,0.080093,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.27126,0.039706,0.072722,0,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.72171,0.039625,0.054792,0,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.39705,0.039555,0.12659,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.66333,0.039546,0.021967,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.51122,0.039501,0.07977,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.75756,0.039399,0.034667,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.98106,0.039393,-0.026968,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.27126,0.039386,0.1019,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.18102,0.039359,0.09483,0,0
4,GO SNRNA TRANSCRIPTION,0.54223,0.039281,0.055743,0,0
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.55277,0.039281,0.077674,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.33821,0.039266,0.085886,0,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.78176,0.03916,0.037229,0,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.12273,0.039132,0.14318,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.20256,0.039096,0.18371,0,0
4,GO FATTY ACID TRANSPORT,0.53179,0.039034,0.062782,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.61803,0.038935,0.041703,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.33029,0.038909,0.12739,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.93062,0.038873,0.033147,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.43329,0.0388,0.11554,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.91805,0.038752,0.02881,0,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.47137,0.038642,0.098704,0,0
4,GO DEFENSE RESPONSE TO VIRUS,0.61803,0.038638,0.074584,0,0
4,GO TRNA MODIFICATION,0.90549,0.038487,0.002718,0,0
4,GO RRNA METABOLIC PROCESS,0.89296,0.038485,0.02061,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.214,0.038465,0.087508,0,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.69814,0.038449,0.031623,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.18624,0.038394,0.11183,0,0
4,GO ENDOSOME ORGANIZATION,0.43329,0.03832,0.069208,0,0
4,GO IMPORT INTO NUCLEUS,0.4521,0.038297,0.066787,0,0
4,GO PROTEIN MATURATION,0.52145,0.038201,0.058941,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.42405,0.038182,0.097477,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.29248,0.038159,0.026285,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.35442,0.038002,0.079069,0,0
4,GO RESPONSE TO ZINC ION,0.24463,0.037859,0.1094,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.68646,0.037829,0.05626,0,0
4,GO MICROVILLUS ASSEMBLY,0.30724,0.037695,0.09383,0,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.90549,0.037671,0.006884,0,0
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.55277,0.037576,0.079888,0,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.50109,0.037496,0.068418,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.51122,0.037475,0.1215,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.47137,0.037437,0.077224,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.69814,0.03737,0.060816,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.46168,0.037294,0.18321,0,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.62923,0.037272,0.050558,0,0
4,GO B CELL MEDIATED IMMUNITY,0.43329,0.037183,0.14204,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.197,0.037171,0.10287,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.74555,0.037152,0.091014,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.89296,0.037102,-8.5829e-05,0,0
4,GO PROTEOLYSIS,0.25111,0.037094,0.09265,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.23203,0.037079,0.11362,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.46168,0.036946,0.13525,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.42405,0.036933,0.12774,0,0
4,GO UTERUS DEVELOPMENT,0.23203,0.036902,0.15319,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.43329,0.03684,0.038058,0,0
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.44264,0.036701,0.078309,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.51122,0.036695,0.09929,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.49108,0.036671,0.097781,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.76963,0.036658,0.01815,0,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.33821,0.036658,0.089333,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.50109,0.036634,0.044186,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.32248,0.03661,0.12321,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.50109,0.036587,0.052334,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.76963,0.036533,0.041882,0,0
4,GO PEROXISOME ORGANIZATION,0.62923,0.036504,0.021794,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.80618,0.036441,0.046544,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.33029,0.036439,0.12523,0,0
4,GO BILE ACID AND BILE SALT TRANSPORT,0.53179,0.036372,0.078791,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.55277,0.036316,0.093054,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.34626,0.036163,0.16409,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.80618,0.036148,0.043812,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.54223,0.036117,0.041896,0,0
4,GO RNA CAPPING,0.17091,0.036063,0.08108,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.57414,0.036045,0.042522,0,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.2998,0.035898,0.08965,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.46168,0.035873,0.079942,0,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.5959,0.035857,0.088997,0,0
4,GO WATER HOMEOSTASIS,0.55277,0.035843,0.070694,0,0
4,GO INNATE IMMUNE RESPONSE,0.55277,0.035784,0.063169,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.53179,0.035738,0.129,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.96843,0.03562,0.038618,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.61803,0.03556,0.039095,0,0
4,GO PROTEIN FOLDING,0.44264,0.035548,0.054222,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.35442,0.035522,0.16963,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.50109,0.035469,0.11546,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.36271,0.035317,0.067075,0,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.62923,0.03531,0.0075003,0,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.10134,0.035298,0.13267,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.72171,0.035217,0.042206,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.42405,0.035177,0.12061,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.43329,0.035091,0.074548,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.26442,0.03509,0.12094,0,0
4,GO POSTREPLICATION REPAIR,0.79394,0.034923,0.03471,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.3148,0.034836,0.096223,0,0
4,GO REGULATION OF CELL KILLING,0.65188,0.03476,0.082621,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.43329,0.034756,0.075044,0,0
4,GO MYOBLAST FUSION,0.24463,0.0347,0.14708,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.35442,0.034472,0.08048,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.52145,0.034251,0.11356,0,0
4,GO IMMUNE EFFECTOR PROCESS,0.52145,0.034246,0.076469,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.58498,0.034153,0.081656,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.38829,0.034149,0.081602,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.214,0.034081,0.14287,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.4521,0.033982,0.073569,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.51122,0.033979,0.063337,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.61803,0.033794,0.090282,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.95582,0.033749,0.017078,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.38829,0.033692,0.1204,0,0
4,GO REGULATION OF ACROSOME REACTION,0.34626,0.033688,0.10169,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.81845,0.033681,0.046023,0,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.48117,0.033672,0.11494,0,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.37964,0.033574,0.049614,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.44264,0.033554,0.065474,0,0
4,GO TYPE 2 IMMUNE RESPONSE,0.86799,0.033478,0.034614,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.84314,0.03329,0.022946,0,0
4,GO PHOSPHATE ION TRANSPORT,0.64051,0.033285,0.070233,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.50109,0.033281,0.091914,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.55277,0.033148,0.025275,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.28529,0.033121,0.099454,0,0
4,GO VASODILATION,0.84314,0.033094,0.015849,0,0
4,GO FLUID TRANSPORT,0.7336,0.033062,0.030998,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.79394,0.033039,0.0065061,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.58498,0.032977,0.04128,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.67486,0.03284,0.06125,0,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.80618,0.032828,0.043425,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.42405,0.032822,0.12336,0,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.47137,0.03282,0.12197,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.65188,0.032754,0.048717,0,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.23203,0.032746,0.097059,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.47137,0.032677,0.052638,0,0
4,GO SODIUM ION HOMEOSTASIS,0.214,0.032668,0.11827,0,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.37111,0.032585,0.11929,0,0
4,GO PLASMA MEMBRANE FUSION,0.78176,0.032504,0.020343,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.66333,0.032493,-0.058266,0,0
4,GO PHAGOCYTOSIS,0.37964,0.0323,0.12918,0,0
4,GO VIRAL LATENCY,0.96843,0.032094,0.014827,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.93062,0.032071,0.032247,0,0
4,GO PEROXISOMAL TRANSPORT,0.68646,0.032003,0.019666,0,0
4,GO RESPONSE TO REDOX STATE,0.66333,0.031934,0.032567,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42405,0.031901,0.057481,0,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.86799,0.031835,0.022537,0,0
4,GO ETHANOL METABOLIC PROCESS,0.66333,0.031754,-0.11659,0,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.65188,0.031681,0.09227,0,0
4,GO RESPIRATORY BURST,0.57414,0.031618,0.11559,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.42405,0.031538,0.069248,0,0
4,GO MITOCHONDRIAL DEPOLARIZATION,0.28529,0.031532,0.14621,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.80618,0.031523,0.040863,0,0
4,GO B CELL APOPTOTIC PROCESS,0.27126,0.031503,0.12988,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.17591,0.031473,0.086019,0,0
4,GO PROTEIN MANNOSYLATION,0.27821,0.031457,0.1106,0,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.66333,0.031419,0.052772,0,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.26442,0.031358,0.12569,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.83078,0.03131,0.028181,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.25111,0.031306,0.099076,0,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.65188,0.031251,0.041636,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.50109,0.031231,0.083669,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.48117,0.031065,0.15583,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10468,0.031065,0.12434,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.54223,0.03084,0.042857,0,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.42405,0.030787,0.14086,0,0
4,GO GOLGI LOCALIZATION,0.89296,0.030787,0.016239,0,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.86799,0.030761,0.0048551,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.35442,0.030638,0.14987,0,0
4,GO REGULATION OF PROTEIN STABILITY,0.25111,0.030582,0.086451,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.98106,0.030519,0.009841,0,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.62923,0.030418,0.056655,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.65188,0.030354,-0.027812,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.5959,0.030353,0.060701,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.28529,0.030269,0.082048,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.61803,0.030167,0.05528,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.51122,0.030161,0.079004,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.2259,0.030151,0.085148,0,0
4,GO LIPID DROPLET ORGANIZATION,0.2577,0.030144,0.096334,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.36271,0.029789,0.14897,0,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.68646,0.029712,0.071746,0,0
4,GO CELL ACTIVATION,0.34626,0.029319,0.11578,0,0
4,GO RESPONSE TO ANTIBIOTIC,1,0.029243,0.024498,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.38829,0.029201,0.065301,0,0
4,GO RESPONSE TO ANGIOTENSIN,0.72171,0.029164,0.071313,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.95582,0.029144,0.0098681,0,0
4,GO TRNA PROCESSING,0.98106,0.029115,0.0073734,0,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.50109,0.02911,0.06778,0,0
4,GO HYALURONAN METABOLIC PROCESS,0.78176,0.029022,0.04491,0,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.42405,0.028843,0.063807,0,0
4,GO REGULATION OF FERTILIZATION,0.36271,0.028664,0.064916,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.49108,0.028639,0.090158,0,0
4,GO PROTEIN IMPORT,0.52145,0.028638,0.062894,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.37111,0.028622,0.14696,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.79394,0.028621,0.0532,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.81845,0.028579,0.023352,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.51122,0.028421,0.074511,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.30724,0.028323,0.09911,0,0
4,GO NADPH REGENERATION,0.38829,0.028235,0.060038,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.43329,0.02816,0.12154,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.72171,0.028026,0.052461,0,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.76963,0.027991,0.063621,0,0
4,GO PROTEIN PROCESSING,0.80618,0.027914,0.04503,0,0
4,GO SINGLE FERTILIZATION,0.15655,0.027814,0.10066,0,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.68646,0.027808,0.042377,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.36271,0.027799,0.081345,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.76963,0.027714,-0.040862,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.55277,0.027645,0.05023,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.85555,0.027595,-0.014311,0,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.2577,0.027491,0.084044,0,0
4,GO RNA INTERFERENCE,0.95582,0.02748,0.0059615,0,0
4,GO PROTEIN DESTABILIZATION,0.38829,0.027354,0.099651,0,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.72171,0.027247,0.053659,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.55277,0.027193,0.071112,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.99368,0.027148,0.0011897,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.66333,0.027091,0.050407,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.50109,0.027053,0.086513,0,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.80618,0.026968,0.021453,0,0
4,GO SLEEP,0.34626,0.026933,0.10636,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.47137,0.026811,0.14059,0,0
4,GO REGULATION OF APPETITE,0.75756,0.026715,0.015837,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.33821,0.026715,0.081334,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.33821,0.026693,0.068892,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.57414,0.026642,0.054083,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.85555,0.026634,0.012391,0,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.40594,0.026577,0.10832,0,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.65188,0.026519,0.051238,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.33821,0.026509,0.13415,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.44264,0.026506,0.052907,0,0
4,GO VIRAL LIFE CYCLE,0.58498,0.026488,0.059926,0,0
4,GO FIBROBLAST ACTIVATION,0.52145,0.026198,0.080016,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.40594,0.0261,0.059861,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.61803,0.026077,0.076575,0,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.4521,0.025991,0.14743,0,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.43329,0.025962,0.073612,0,0
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.49108,0.025955,0.086688,0,0
4,GO AUTOPHAGIC CELL DEATH,0.7336,0.025897,0.022911,0,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.38829,0.025867,0.10408,0,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.61803,0.025857,0.05768,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.58498,0.025856,0.060314,0,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.58498,0.025854,0.061985,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.86799,0.025835,-0.0039317,0,0
4,GO L GLUTAMATE IMPORT,0.35442,0.025691,0.088977,0,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.5959,0.02569,0.062726,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.52145,0.025576,0.094846,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.33029,0.02557,0.13333,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.81845,0.025171,0.016946,0,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.64051,0.024839,0.090925,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.38829,0.024821,0.095435,0,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.55277,0.024815,0.098128,0,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.69814,0.024809,0.065858,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.89296,0.02479,0.017793,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.66333,0.024671,0.024363,0,0
4,GO RESPONSE TO INTERLEUKIN 18,0.74555,0.024625,-0.062873,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.56341,0.024606,0.098219,0,0
4,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.56341,0.024474,0.049363,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.47137,0.024453,0.042597,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.33029,0.024416,0.15643,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.49108,0.024397,0.066378,0,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.5959,0.024297,0.099371,0,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.25111,0.024212,0.10197,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.79394,0.02414,0.040287,0,0
4,GO RESPONSE TO INTERFERON GAMMA,0.68646,0.024069,0.072711,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.54223,0.023995,0.060875,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.78176,0.023982,0.048035,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.32248,0.023948,0.1309,0,0
4,GO PROTEIN O LINKED GLYCOSYLATION,0.5959,0.023947,0.050562,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.65188,0.023922,0.055521,0,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.39705,0.023836,0.10279,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.28529,0.023758,0.084867,0,0
4,GO PROTEIN OXIDATION,0.47137,0.023655,0.064439,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.197,0.023547,0.042593,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.68646,0.023474,0.050012,0,0
4,GO DNA LIGATION,0.94321,0.023416,0.0096892,0,0
4,GO KERATINOCYTE PROLIFERATION,0.74555,0.023394,0.038563,0,0
4,GO B CELL DIFFERENTIATION,0.21989,0.02325,0.1823,0,0
4,GO GERMINAL CENTER FORMATION,0.49108,0.023014,0.1527,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.99368,0.023001,0.0035124,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.67486,0.022912,0.054532,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.35442,0.022855,0.053922,0,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.51122,0.022717,0.10576,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.2259,0.022701,0.10901,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.78176,0.022635,0.016828,0,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.62923,0.022476,0.071513,0,0
4,GO REGULATION OF DEFENSE RESPONSE,0.4521,0.022351,0.073997,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.34626,0.022347,0.096244,0,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.50109,0.022287,0.060057,0,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.20256,0.022206,0.12085,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.38829,0.022157,0.1288,0,0
4,GO REGULATION OF GTP BINDING,0.95582,0.022037,0.025407,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.58498,0.021867,0.061796,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.077559,0.021837,0.1701,0,0
4,GO COENZYME A METABOLIC PROCESS,0.44264,0.021781,0.054358,0,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,1,0.021758,-0.0052072,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.53179,0.021421,0.066343,0,0
4,GO SEGMENT SPECIFICATION,0.89296,0.021378,-0.0072524,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.68646,0.02136,0.061041,0,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.38829,0.021337,0.12109,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.44264,0.02129,0.1275,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.40594,0.021125,0.16556,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.99368,0.021096,0.00049101,0,0
4,GO REGULATION OF ERAD PATHWAY,0.66333,0.021092,0.06644,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.81845,0.021083,0.068808,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.95582,0.02097,-0.019554,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.27821,0.020827,0.078868,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.41494,0.020562,0.062665,0,0
4,GO SYMBIOTIC PROCESS,0.54223,0.020501,0.052033,0,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.64051,0.020414,0.034294,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.88046,0.020406,0.010997,0,0
4,GO RESPONSE TO SALT STRESS,0.51122,0.020295,0.075089,0,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.74555,0.020253,-0.020172,0,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.43329,0.020191,0.11884,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.74555,0.020136,0.03051,0,0
4,GO SECRETION BY TISSUE,0.4521,0.02005,0.064906,0,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.75756,0.020029,0.047744,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.46168,0.019833,0.069389,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.84314,0.019826,-0.013256,0,0
4,GO CELL KILLING,0.70989,0.019635,0.059576,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.28529,0.019595,0.17349,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.62923,0.019584,0.06832,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.67486,0.019566,0.064766,0,0
4,GO KERATINOCYTE DIFFERENTIATION,0.94321,0.019358,-0.029229,0,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.93062,0.019276,0.00037776,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.53179,0.019101,0.085222,0,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.49108,0.019025,0.088424,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.4521,0.018686,0.077565,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.54223,0.0186,0.059813,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.2259,0.018593,0.1083,0,0
4,GO VIRION ASSEMBLY,0.47137,0.018428,0.043129,0,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.42405,0.018376,0.17313,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.68646,0.018258,0.054628,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.96843,0.018253,0.022933,0,0
4,GO CELLULAR RESPONSE TO DSRNA,0.75756,0.018103,-0.011024,0,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.48117,0.017936,0.086198,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.55277,0.017911,0.097756,0,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.74555,0.017754,0.038254,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.90549,0.017728,0.0040428,0,0
4,GO RENAL ABSORPTION,0.96843,0.017709,0.016046,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.61803,0.017543,0.033209,0,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.79394,0.017475,0.048679,0,0
4,GO BLASTOCYST GROWTH,0.96843,0.017417,0.020614,0,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.33029,0.017405,0.085349,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.70989,0.01737,0.025412,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.56341,0.017294,0.079823,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.93062,0.017222,0.026249,0,0
4,GO T CELL CHEMOTAXIS,0.55277,0.017193,0.10497,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.58498,0.017075,0.039192,0,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.60692,0.017062,0.072126,0,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.66333,0.01704,0.058245,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.62923,0.017006,0.037735,0,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.4521,0.017005,0.13012,0,0
4,GO EPIDERMIS DEVELOPMENT,0.51122,0.016952,0.052157,0,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.61803,0.016888,0.057643,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.50109,0.016813,0.10323,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.28529,0.016736,0.10521,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.98106,0.016694,0.01897,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.86799,0.016647,0.031694,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.52145,0.016506,0.054288,0,0
4,GO RIBOSOME BIOGENESIS,0.72171,0.016474,-0.016536,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.51122,0.016397,0.13181,0,0
4,GO DECIDUALIZATION,0.58498,0.016163,0.081163,0,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.5959,0.016079,0.06487,0,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.49108,0.016041,0.10988,0,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.69814,0.016032,0.038008,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.50109,0.016005,0.053569,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.5959,0.015885,0.081126,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.90549,0.015847,0.012519,0,0
4,GO MYOBLAST MIGRATION,0.99368,0.015841,-0.017445,0,0
4,GO OLIGOPEPTIDE TRANSPORT,0.46168,0.015813,0.1003,0,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.58498,0.0158,0.11727,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.25111,0.01569,0.13124,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.74555,0.015509,-0.055318,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.89296,0.015479,-0.014388,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.93062,0.015412,0.017967,0,0
4,GO V D J RECOMBINATION,0.60692,0.015164,0.054689,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.70989,0.01514,0.015694,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.99368,0.015106,0.017677,0,0
4,GO PROSTANOID METABOLIC PROCESS,0.53179,0.015011,-0.064252,0,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.33029,0.014927,0.098749,0,0
4,GO PRIMARY MIRNA PROCESSING,0.93062,0.014842,-0.013664,0,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.81845,0.014796,0.042011,0,0
4,GO ENDODERM FORMATION,0.36271,0.014795,0.166,0,0
4,GO PROTEIN TARGETING,0.80618,0.01476,0.020857,0,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.52145,0.014711,0.059604,0,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.54223,0.014711,0.055588,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.46168,0.014684,0.057074,0,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.66333,0.014677,0.085219,0,0
4,GO CYTOLYSIS,0.80618,0.014668,0.036539,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.54223,0.014658,0.074954,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.67486,0.014562,0.041395,0,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.37111,0.014491,0.13008,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.5959,0.014488,0.076667,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.99368,0.014474,-0.0039716,0,0
4,GO POSITIVE REGULATION OF WOUND HEALING,0.89296,0.014316,0.042947,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.57414,0.014255,0.05875,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.70989,0.014066,0.052462,0,0
4,GO REGULATION OF LIGASE ACTIVITY,0.2998,0.014064,0.091797,0,0
4,GO PROGRAMMED NECROTIC CELL DEATH,0.53179,0.013955,0.080484,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.96843,0.013841,0.037898,0,0
4,GO ENDOCRINE PROCESS,0.89296,0.013225,0.039725,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.69814,0.013221,-0.036652,0,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.85555,0.013034,-0.028375,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.85555,0.013028,0.023055,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.74555,0.012902,0.040429,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.95582,0.01281,-0.014319,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.51122,0.012628,0.048086,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.38829,0.012477,0.13261,0,0
4,GO QUINONE METABOLIC PROCESS,0.95582,0.01219,0.054529,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.79394,0.012178,0.019862,0,0
4,GO REGULATION OF PROTEOLYSIS,0.4521,0.012085,0.073105,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66333,0.011915,0.054739,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.74555,0.011883,0.05712,0,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.93062,0.011639,0.018835,0,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.91805,0.011507,0.015328,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.53179,0.011396,0.090077,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.58498,0.011346,0.054563,0,0
4,GO SYNCYTIUM FORMATION,0.2259,0.011312,0.15029,0,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.76963,0.0113,0.013583,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.35442,0.011277,0.11255,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.86799,0.011143,0.0099765,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.99368,0.011076,0.028551,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.70989,0.010923,0.030946,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.4521,0.01087,0.11254,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.7336,0.01085,0.053762,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.17591,0.010841,0.10784,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.89296,0.010834,-0.00732,0,0
4,GO RESPONSE TO CYTOKINE,0.48117,0.010746,0.082613,0,0
4,GO WATER TRANSPORT,0.5959,0.010635,0.088555,0,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.53179,0.010606,0.068761,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.75756,0.010081,0.028321,0,0
4,GO LUNG CELL DIFFERENTIATION,0.7336,0.010022,-0.0037204,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.51122,0.0099857,0.071946,0,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.94321,0.0099854,0.019705,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.78176,0.0099722,0.055807,0,0
4,GO REGULATION OF MYOBLAST FUSION,0.60692,0.0098867,0.088808,0,0
4,GO METHIONINE METABOLIC PROCESS,0.60692,0.0097839,0.065103,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.86799,0.0095019,0.027006,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.37111,0.0094643,0.15168,0,0
4,GO TRNA METABOLIC PROCESS,0.86799,0.009355,-0.00060041,0,0
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.88046,0.0092779,0.03944,0,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.93062,0.0092569,0.042079,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.93062,0.0092187,0.013059,0,0
4,GO REGULATION OF RELAXATION OF MUSCLE,0.89296,0.009167,0.049924,0,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.61803,0.0091247,0.077152,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.86799,0.0089448,-0.0065041,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.57414,0.0087323,0.070188,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.56341,0.0087161,0.11647,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.52145,0.0087023,0.084405,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.81845,0.0086792,0.029698,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.39705,0.0085281,0.14242,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.48117,0.0084131,0.083298,0,0
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.33029,0.008315,0.060871,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.64051,0.0082392,0.042557,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.81845,0.0082022,0.021612,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.5959,0.008096,0.064685,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.41494,0.0079963,0.055936,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.84314,0.0079446,0.015284,0,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.76963,0.0077796,0.066346,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.62923,0.0077692,0.11321,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.41494,0.0075596,0.075804,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.46168,0.0075017,0.1398,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.5959,0.0073984,0.10381,0,0
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.35442,0.0073383,0.10278,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.85555,0.0073318,0.042475,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.67486,0.0073226,0.043175,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62923,0.0072095,-0.022692,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.75756,0.0070412,0.040525,0,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.39705,0.0064859,0.10727,0,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.79394,0.0064835,0.042521,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.50109,0.0064793,0.12723,0,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.64051,0.0064566,-0.014839,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.4521,0.0063422,0.092555,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.83078,0.0060774,0.043332,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72171,0.0060579,0.0057591,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.83078,0.0060139,0.048576,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.89296,0.0059068,0.022736,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.70989,0.0058197,0.053285,0,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.70989,0.0057747,-0.012126,0,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.39705,0.0057214,0.13972,0,0
4,GO MEMBRANE INVAGINATION,0.30724,0.0056011,0.15765,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.42405,0.0054561,0.10779,0,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.4521,0.005343,0.22222,0,0
4,GO REGULATION OF HEART GROWTH,0.89296,0.005034,0.040083,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.58498,0.0049745,0.063057,0,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.65188,0.0048187,0.067052,0,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.55277,0.0046054,0.10565,0,0
4,GO CYTOKINETIC PROCESS,0.86799,0.0045824,0.046744,0,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.86799,0.0045633,0.033217,0,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.58498,0.0045213,0.098872,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.61803,0.0045029,0.1029,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.83078,0.0044743,0.052892,0,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.27821,0.0043573,0.074737,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.41494,0.0043535,0.078107,0,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.91805,0.0042648,0.03946,0,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.56341,0.0040428,0.077043,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.88046,0.003886,0.027584,0,0
4,GO RESPONSE TO X RAY,0.90549,0.0038828,0.026233,0,0
4,GO LUNG MORPHOGENESIS,0.74555,0.0037184,0.042342,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.61803,0.003661,0.055282,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.40594,0.0036071,-0.02282,0,0
4,GO CYTOKINE PRODUCTION,0.44264,0.0035828,0.094079,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.29248,0.0033377,0.19322,0,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.54223,0.0032045,0.072375,0,0
4,GO RESPONSE TO ETHER,0.99368,0.0030267,0.017896,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.38829,0.0029641,0.074302,0,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.36271,0.0028728,0.13807,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5959,0.0028556,-0.01887,0,0
4,GO UBIQUINONE METABOLIC PROCESS,0.86799,0.0027247,-0.002406,0,0
4,GO NATURAL KILLER CELL CHEMOTAXIS,0.85555,0.0025518,-0.040685,0,0
4,GO CELL AGGREGATION,0.95582,0.0025363,-0.039569,0,0
4,GO KETONE BIOSYNTHETIC PROCESS,0.86799,0.0024985,-0.0098085,0,0
4,GO ENAMEL MINERALIZATION,0.79394,0.0023519,0.08221,0,0
4,GO PROTEIN HYDROXYLATION,0.95582,0.0022577,0.034557,0,0
4,GO AMP METABOLIC PROCESS,0.99368,0.0022205,0.031426,0,0
4,GO PROTEIN DENEDDYLATION,0.85555,0.0019979,0.020866,0,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.62923,0.0019296,0.07641,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.89296,0.0019143,0.032247,0,0
4,GO VIRAL BUDDING,0.94321,0.0018747,0.017734,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.62923,0.0017479,0.074957,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.96843,0.0017433,0.037866,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.37111,0.0016686,0.077651,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.36271,0.0016526,0.16951,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.62923,0.0016311,0.071863,0,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.46168,0.0015973,0.10038,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.89296,0.001345,0.032251,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.61803,0.0013019,0.030355,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.61803,0.001195,-0.018805,0,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.74555,0.0011699,0.051372,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.26442,0.0010251,0.10085,0,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.47137,0.00098751,0.084627,0,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.80618,0.00095591,0.015082,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.53179,0.00090133,0.11006,0,0
4,GO CELL REDOX HOMEOSTASIS,0.88046,0.0008681,-0.015315,0,0
4,GO CELLULAR RESPIRATION,0.68646,0.00073815,0.024548,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.80618,0.00071918,0.048726,0,0
4,GO AMELOGENESIS,0.85555,0.00056865,0.064851,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.86799,0.00048715,0.017019,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.67486,0.00043069,0.052071,0,0
4,GO LEUKOCYTE MIGRATION,0.62923,0.00036118,0.06668,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.98106,0.00035729,-0.00053717,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.51122,0.00034423,0.099862,0,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.66333,0.00033033,-0.060695,0,0
4,GO STEROID BIOSYNTHETIC PROCESS,0.58498,0.00021839,-0.0016806,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.95582,0.00010636,-0.010906,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.44264,0.00010038,0.039779,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.48117,5.0898e-05,-0.087975,0,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.74555,-0.00019157,-0.0090985,0,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.72171,-0.00019587,-0.0061718,0,0
4,GO RESPONSE TO UV C,0.95582,-0.0002403,0.00052636,0,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.78176,-0.00026046,0.033395,0,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.7336,-0.00031662,0.036147,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.79394,-0.0003426,0.023568,0,0
4,GO ANOIKIS,0.83078,-0.0004477,0.036188,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.86799,-0.00046197,0.026904,0,0
4,GO MITOCHONDRIAL FUSION,0.61803,-0.00052322,0.067449,0,0
4,GO RESPONSE TO PROGESTERONE,0.99368,-0.00054394,0.017323,0,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.39705,-0.00061393,0.10047,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.52145,-0.00073287,0.073148,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.52145,-0.00074573,0.14698,0,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.41494,-0.00075569,0.078591,0,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.57414,-0.0008305,0.058967,0,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.54223,-0.00088058,0.091289,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.55277,-0.00095802,-0.016251,0,0
4,GO RESPONSE TO STEROL DEPLETION,0.66333,-0.0010767,0.07605,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.54223,-0.0011809,-0.022025,0,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.54223,-0.0012817,0.087815,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.75756,-0.0013473,0.039476,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.91805,-0.0013588,0.015045,0,0
4,GO HEART TRABECULA FORMATION,0.75756,-0.0014646,0.050383,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.25111,-0.0015842,0.16713,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.85555,-0.0016252,0.0064695,0,0
4,GO LIPID EXPORT FROM CELL,0.64051,-0.0017346,0.057974,0,0
4,GO DEFENSE RESPONSE,0.54223,-0.0018434,0.073134,0,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.5959,-0.0018858,0.078869,0,0
4,GO REGULATION OF WATER LOSS VIA SKIN,0.57414,-0.0019578,-0.037973,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.58498,-0.0022806,0.093286,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.93062,-0.0024006,0.030708,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.91805,-0.002431,0.017141,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.78176,-0.0024314,0.025499,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.40594,-0.0025496,-0.022014,0,0
4,GO INTESTINAL LIPID ABSORPTION,0.86799,-0.0027539,-0.0087383,0,0
4,GO REGULATION OF FIBRINOLYSIS,0.76963,-0.0028556,-0.030013,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.69814,-0.0030649,0.075035,0,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.37111,-0.0030908,0.13188,0,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.7336,-0.0030919,0.06001,0,0
4,GO T CELL APOPTOTIC PROCESS,0.68646,-0.0030923,0.060166,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.70989,-0.0031653,0.028157,0,0
4,GO HISTONE EXCHANGE,0.94321,-0.0031797,0.001843,0,0
4,GO RESPONSE TO TUMOR CELL,0.99368,-0.0032132,0.011192,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.65188,-0.0033679,0.050032,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.85555,-0.0034098,0.024667,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.79394,-0.0034375,0.033952,0,0
4,GO T CELL MIGRATION,0.52145,-0.0034694,0.11699,0,0
4,GO PLATELET DEGRANULATION,0.55277,-0.003537,0.084195,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.84314,-0.0035608,0.0066192,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.94321,-0.0035829,0.029301,0,0
4,GO MYELOID LEUKOCYTE ACTIVATION,0.69814,-0.0035979,0.047202,0,0
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.80618,-0.0036226,-0.0077378,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.32248,-0.0036391,0.15572,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.61803,-0.003689,0.086873,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.94321,-0.0037731,0.028028,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.39705,-0.0037864,0.098746,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.64051,-0.0038955,0.10253,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.93062,-0.0040133,0.042077,0,0
4,GO RRNA 3 END PROCESSING,0.91805,-0.0043869,0.002396,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.38829,-0.0045815,0.11344,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.78176,-0.0045909,0.036219,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.3148,-0.0047562,0.17126,0,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.96843,-0.0048313,0.0092566,0,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.47137,-0.0048583,0.12172,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.64051,-0.0049625,0.053842,0,0
4,GO KERATINIZATION,0.78176,-0.0049717,-0.041744,0,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.40594,-0.00503,0.14395,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.51122,-0.0050719,-0.019496,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.41494,-0.0050843,0.044359,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.41494,-0.0052414,0.07378,0,0
4,GO RNA 5 END PROCESSING,0.91805,-0.0057243,0.0079759,0,0
4,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.53179,-0.0057729,0.13539,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.99368,-0.0059133,0.0013869,0,0
4,GO INTERACTION WITH HOST,0.61803,-0.0061052,0.069282,0,0
4,GO CYTOKINE SECRETION,0.65188,-0.0062573,0.054425,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.89296,-0.006258,-0.0035986,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.55277,-0.0063176,-0.030714,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.88046,-0.0064676,0.030033,0,0
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1,-0.0064679,0.028125,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.96843,-0.006506,-0.001451,0,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.5959,-0.0066211,0.074513,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.76963,-0.0066447,0.068529,0,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.75756,-0.006743,-0.011242,0,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.84314,-0.0068157,0.036058,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.76963,-0.0071189,0.034851,0,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62923,-0.0071374,0.091226,0,0
4,GO REGULATION OF ICOSANOID SECRETION,0.76963,-0.0072139,0.055625,0,0
4,GO ORGAN INDUCTION,0.98106,-0.0072984,-0.014301,0,0
4,GO OVULATION,0.67486,-0.0074225,-0.053701,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.86799,-0.0075924,-0.006366,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.5959,-0.0077133,-0.01504,0,0
4,GO PROSTATE GLAND GROWTH,0.90549,-0.0077889,-0.011488,0,0
4,GO RESPONSE TO BIOTIC STIMULUS,0.61803,-0.0078519,0.053907,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.39705,-0.0078535,0.12179,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.74555,-0.0080728,0.072182,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.70989,-0.0081447,0.048869,0,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.38829,-0.0083933,0.12164,0,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.69814,-0.0084476,-0.0020939,0,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.62923,-0.0085808,0.089747,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.90549,-0.0086471,0.029518,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.90549,-0.0087273,0.032562,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.50109,-0.0087979,0.095352,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.83078,-0.0088376,0.030317,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.65188,-0.008876,0.062868,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.91805,-0.0088884,0.041427,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.75756,-0.0088887,0.057023,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.74555,-0.0095432,0.048811,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.41494,-0.0095862,0.13981,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.95582,-0.0096253,0.015556,0,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.5959,-0.0096322,0.095716,0,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.49108,-0.0099203,0.10355,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.84314,-0.010044,-0.0055765,0,0
4,GO VIRAL RELEASE FROM HOST CELL,0.47137,-0.01026,0.064993,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.95582,-0.010266,0.003787,0,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.57414,-0.010355,0.081654,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.55277,-0.010382,-0.10438,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.58498,-0.010405,-0.0014023,0,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.57414,-0.010432,0.072816,0,0
4,GO RNA CATABOLIC PROCESS,0.61803,-0.010849,-0.0021726,0,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.76963,-0.010899,0.00013321,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.78176,-0.01098,-0.016005,0,0
4,GO ICOSANOID METABOLIC PROCESS,0.79394,-0.011194,-0.011196,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.80618,-0.011247,0.0055986,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.38829,-0.011249,-0.046808,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.93062,-0.011354,0.016254,0,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.50109,-0.011429,-0.03465,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.68646,-0.011464,-0.026824,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.7336,-0.011511,0.026643,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.89296,-0.011538,0.0085546,0,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.79394,-0.011814,-0.006202,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.68646,-0.011862,0.019738,0,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.46168,-0.01197,0.10968,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.76963,-0.012135,0.011227,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.81845,-0.012394,0.046917,0,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.76963,-0.012434,0.039655,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.39705,-0.01247,0.067094,0,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.66333,-0.012513,0.0074623,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.62923,-0.012695,-0.031212,0,0
4,GO SPERM CAPACITATION,0.98106,-0.0127,0.010563,0,0
4,GO T CELL MEDIATED IMMUNITY,0.67486,-0.013199,0.057791,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.55277,-0.013547,-0.0053932,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.86799,-0.013602,0.0027886,0,0
4,GO PROGESTERONE METABOLIC PROCESS,0.83078,-0.013667,0.0086842,0,0
4,GO NECROTIC CELL DEATH,0.65188,-0.013674,0.057481,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.81845,-0.013746,-0.044549,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.91805,-0.01377,0.039655,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.85555,-0.013853,-0.030691,0,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.44264,-0.013952,0.11254,0,0
4,GO DETOXIFICATION,0.62923,-0.013987,-0.014923,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.85555,-0.014036,0.025377,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.86799,-0.014095,0.020665,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.76963,-0.014224,0.067668,0,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.67486,-0.01429,-0.032107,0,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.57414,-0.014771,-0.069507,0,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.83078,-0.015178,0.0078834,0,0
4,GO CENTROSOME SEPARATION,0.81845,-0.015356,0.044044,0,0
4,GO MANGANESE ION TRANSPORT,0.85555,-0.015359,0.0073381,0,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.90549,-0.015542,0.0067153,0,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.61803,-0.015605,0.061168,0,0
4,GO RESPONSE TO CADMIUM ION,0.85555,-0.015678,0.04166,0,0
4,GO REGULATION OF WOUND HEALING,0.75756,-0.015716,0.050481,0,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.99368,-0.015945,-0.00096864,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.4521,-0.016091,-0.046525,0,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.56341,-0.016151,0.06313,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.46168,-0.016226,0.10137,0,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.3148,-0.016392,0.20804,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.69814,-0.016395,0.061412,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.94321,-0.016456,0.02792,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.64051,-0.016601,-0.0062047,0,0
4,GO RESPONSE TO HYPEROXIA,0.96843,-0.016804,0.038748,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.76963,-0.016805,0.0039735,0,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.44264,-0.016949,0.14936,0,0
4,GO DETECTION OF OTHER ORGANISM,0.78176,-0.017006,0.068373,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.54223,-0.017204,-0.028822,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.96843,-0.017354,0.041398,0,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.94321,-0.017368,0.022524,0,0
4,GO MICROVILLUS ORGANIZATION,0.68646,-0.017378,-0.0074702,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.89296,-0.017408,0.030216,0,0
4,GO BIOLOGICAL PHASE,0.68646,-0.017615,-0.041396,0,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.99368,-0.018094,0.005528,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.74555,-0.018279,-0.015754,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.86799,-0.018323,-0.0080596,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.55277,-0.018333,-0.02036,0,0
4,GO IRON ION TRANSPORT,1,-0.018403,0.037296,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.94321,-0.018471,0.025958,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.57414,-0.018558,-0.0435,0,0
4,GO PROTEIN DEMANNOSYLATION,0.84314,-0.018564,0.069387,0,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.50109,-0.018738,0.099201,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.67486,-0.01893,0.02894,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.65188,-0.019057,0.072854,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.83078,-0.019142,0.038769,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.72171,-0.019421,0.061004,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.43329,-0.0195,-0.028612,0,0
4,GO RETINAL METABOLIC PROCESS,0.66333,-0.019504,-0.038873,0,0
4,GO FRUCTOSE METABOLIC PROCESS,0.65188,-0.019522,0.060078,0,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.95582,-0.019732,0.039212,0,0
4,GO LYMPHOCYTE MIGRATION,0.57414,-0.019763,0.088278,0,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.67486,-0.019781,0.002409,0,0
4,GO INFLAMMATORY RESPONSE,0.65188,-0.019851,0.066543,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.93062,-0.019904,0.002785,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.66333,-0.020044,-0.008557,0,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.49108,-0.020081,0.1154,0,0
4,GO CELL CHEMOTAXIS,0.88046,-0.020916,0.033152,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.81845,-0.020938,0.069739,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.61803,-0.021044,-0.012137,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.7336,-0.021165,-0.0064888,0,0
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.34626,-0.021199,-0.063115,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.78176,-0.02154,0.073895,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.46168,-0.021864,0.11964,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.47137,-0.022039,-0.021109,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.69814,-0.02207,0.044621,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.74555,-0.022252,0.068233,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.53179,-0.022549,0.10299,0,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.99368,-0.022592,0.027722,0,0
4,GO TRANSCYTOSIS,0.64051,-0.022696,-0.024101,0,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.93062,-0.022892,0.038402,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.89296,-0.023137,0.042812,0,0
4,GO SPERM EGG RECOGNITION,0.84314,-0.023315,-0.0053894,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.76963,-0.023455,0.06618,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.74555,-0.023591,0.014388,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.90549,-0.023673,0.034173,0,0
4,GO AEROBIC RESPIRATION,0.75756,-0.023886,0.012921,0,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.61803,-0.024254,0.0052105,0,0
4,GO MAGNESIUM ION TRANSPORT,0.55277,-0.024256,-0.011734,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.93062,-0.024588,0.045313,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.91805,-0.024589,0.022793,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.33029,-0.02475,-0.053343,0,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.67486,-0.024869,0.0075206,0,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.84314,-0.024879,0.027961,0,0
4,GO PYROPTOSIS,0.83078,-0.024931,0.050927,0,0
4,GO ZYMOGEN ACTIVATION,0.74555,-0.025071,-0.014737,0,0
4,GO FOAM CELL DIFFERENTIATION,0.76963,-0.025099,0.04485,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.55277,-0.025158,-0.084568,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.81845,-0.025533,0.045426,0,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.65188,-0.025728,-0.035907,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.89296,-0.025732,0.027205,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.65188,-0.02598,-0.011946,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.88046,-0.026067,-0.008363,0,0
4,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.62923,-0.026238,0.082961,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.46168,-0.026371,0.00025161,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.64051,-0.026372,0.011638,0,0
4,GO ESTROGEN METABOLIC PROCESS,0.51122,-0.026408,-0.037331,0,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.90549,-0.026568,-0.010508,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.98106,-0.026627,0.012907,0,0
4,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.48117,-0.026698,-0.053636,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.43329,-0.026746,0.13782,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.66333,-0.026817,0.071966,0,0
4,GO REGULATION OF T CELL MIGRATION,0.70989,-0.026983,0.057701,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.85555,-0.026984,0.049056,0,0
4,GO RESPONSE TO DEXAMETHASONE,0.74555,-0.027006,-0.0010809,0,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.57414,-0.027128,0.074631,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.80618,-0.027215,-0.030676,0,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.30724,-0.027286,0.14963,0,0
4,GO INTESTINAL ABSORPTION,0.74555,-0.027598,-0.010283,0,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.60692,-0.028148,0.10217,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.56341,-0.028295,-0.015384,0,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.67486,-0.028464,0.048831,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.37111,-0.028495,0.15053,0,0
4,GO VESICLE CARGO LOADING,0.52145,-0.028544,0.002569,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.69814,-0.029149,-0.0064068,0,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.93062,-0.029411,0.028445,0,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.68646,-0.029654,0.048004,0,0
4,GO LACTATE METABOLIC PROCESS,0.85555,-0.029714,0.033268,0,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.94321,-0.029795,0.030972,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.58498,-0.029814,-0.018539,0,0
4,GO RESPONSE TO COPPER ION,0.83078,-0.029856,0.060669,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.89296,-0.030366,0.046154,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.58498,-0.0304,-0.0025519,0,0
4,GO LIPID DIGESTION,0.85555,-0.030501,-0.040937,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.58498,-0.030656,-0.03853,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.4521,-0.030804,0.11874,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.74555,-0.030926,-0.013897,0,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.69814,-0.031239,0.074403,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.7336,-0.031304,0.01046,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1,-0.031552,0.017431,0,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.69814,-0.03161,-0.014033,0,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.61803,-0.031666,0.072618,0,0
4,GO PROTEIN REFOLDING,0.83078,-0.03203,0.0054631,0,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.79394,-0.032477,0.032598,0,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.5959,-0.03258,0.096625,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.76963,-0.03278,-0.022046,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.72171,-0.032951,0.01588,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.51122,-0.032977,-0.068589,0,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.38829,-0.032982,-0.039304,0,0
4,GO VITAMIN D METABOLIC PROCESS,0.94321,-0.03307,0.0025092,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.94321,-0.033303,0.0043451,0,0
4,GO RNA DECAPPING,0.81845,-0.033339,0.053981,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.75756,-0.033348,0.066714,0,0
4,GO REGULATION OF COAGULATION,1,-0.03338,0.0092847,0,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.91805,-0.033456,0.019253,0,0
4,GO DE NOVO PROTEIN FOLDING,0.81845,-0.033532,0.020745,0,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.61803,-0.033668,0.08423,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.65188,-0.034164,-0.032897,0,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.89296,-0.03435,0.033698,0,0
4,GO KERATAN SULFATE METABOLIC PROCESS,0.98106,-0.034428,0.035892,0,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.89296,-0.03443,0.060361,0,0
4,GO RESPONSE TO DSRNA,0.75756,-0.034629,-0.0020747,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.67486,-0.034642,0.060339,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.78176,-0.034955,0.052432,0,0
4,GO ASTROCYTE DEVELOPMENT,0.67486,-0.035011,0.085141,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.62923,-0.035274,0.074626,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.52145,-0.03534,0.11483,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.83078,-0.035741,-0.022866,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.78176,-0.036028,0.024259,0,0
4,GO T CELL CYTOKINE PRODUCTION,0.75756,-0.036226,0.055108,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.41494,-0.036484,0.12455,0,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.67486,-0.036818,0.062101,0,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.37111,-0.036914,-0.026224,0,0
4,GO TOXIN METABOLIC PROCESS,0.95582,-0.037031,0.019934,0,0
4,GO ANIMAL ORGAN REGENERATION,0.76963,-0.037465,0.018895,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.91805,-0.037721,0.0084372,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.56341,-0.03782,-0.059144,0,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.86799,-0.03791,-0.0071422,0,0
4,GO POLYOL TRANSPORT,0.7336,-0.038157,-0.011564,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.85555,-0.038173,0.055878,0,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.66333,-0.038246,0.0020201,0,0
4,GO REPLICATIVE SENESCENCE,0.93062,-0.03849,0.027941,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.66333,-0.038544,-0.0033868,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.80618,-0.03857,0.041226,0,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.37964,-0.038883,-0.017685,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.93062,-0.038895,0.020126,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.89296,-0.039191,0.042231,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.61803,-0.039205,-0.018882,0,0
4,GO OSTEOBLAST PROLIFERATION,0.84314,-0.039366,2.3523e-05,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.69814,-0.039429,0.058799,0,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.56341,-0.039491,-0.039152,0,0
4,GO GAP JUNCTION ASSEMBLY,0.94321,-0.039526,0.01462,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.53179,-0.039633,-0.026756,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.69814,-0.039783,-0.023157,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78176,-0.039882,0.038167,0,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.51122,-0.039934,-0.087693,0,0
4,GO GLIAL CELL ACTIVATION,0.62923,-0.039941,0.076991,0,0
4,GO AMINO ACID ACTIVATION,0.34626,-0.040431,-0.027061,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.65188,-0.040479,-0.010686,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.61803,-0.040481,0.062661,0,0
4,GO HYPERSENSITIVITY,0.65188,-0.041081,0.11844,0,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.80618,-0.041264,0.064133,0,0
4,GO ZINC ION HOMEOSTASIS,0.7336,-0.041507,0.067082,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.35442,-0.04155,-0.0097443,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.74555,-0.041679,-0.017744,0,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.55277,-0.041868,-0.047519,0,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.40594,-0.041916,-0.077523,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.56341,-0.042008,-0.043691,0,0
4,GO RESPONSE TO INTERFERON BETA,0.68646,-0.042044,0.060809,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.70989,-0.04232,0.020282,0,0
4,GO TRANSLATIONAL ELONGATION,0.2259,-0.042455,-0.033265,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.62923,-0.0425,-0.073972,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.67486,-0.042783,-0.038858,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.56341,-0.042787,-0.0089038,0,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.85555,-0.042882,-0.011882,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.91805,-0.042982,0.021901,0,0
4,GO RESPONSE TO INTERLEUKIN 1,0.80618,-0.043187,-0.01456,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.52145,-0.043594,-0.026184,0,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.78176,-0.043735,-0.00095118,0,0
4,GO IMMUNOGLOBULIN SECRETION,0.64051,-0.043781,0.05667,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.37111,-0.043803,-0.039629,0,0
4,GO REGULATION OF ANOIKIS,0.39705,-0.043858,-0.075305,0,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.74555,-0.043971,-0.018111,0,0
4,GO RESPONSE TO INTERFERON ALPHA,0.62923,-0.044174,0.10206,0,0
4,GO CYTOPLASMIC TRANSLATION,0.28529,-0.044194,-0.042489,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.91805,-0.044521,0.043603,0,0
4,GO MATURATION OF LSU RRNA,0.32248,-0.044529,-0.074279,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.50109,-0.044836,-0.030937,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.16602,-0.045093,-0.038716,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.7336,-0.045603,-0.03687,0,0
4,GO HISTONE H2B UBIQUITINATION,0.47137,-0.045741,-0.025948,0,0
4,GO LIPID STORAGE,0.52145,-0.045815,0.088559,0,0
4,GO MACROPHAGE ACTIVATION,0.60692,-0.04585,0.087189,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.76963,-0.046244,0.046917,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.41494,-0.046294,0.11777,0,0
4,GO EPOXYGENASE P450 PATHWAY,0.49108,-0.046657,-0.090295,0,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.91805,-0.04682,-0.034121,0,0
4,GO CHOLESTEROL STORAGE,0.95582,-0.046832,0.060964,0,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.57414,-0.046898,-0.060678,0,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.84314,-0.046938,0.053076,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.20256,-0.047126,-0.049233,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.35442,-0.047191,-0.051802,0,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.72171,-0.047352,-0.0076417,0,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.89296,-0.047654,0.016413,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.3148,-0.047697,-0.022584,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.21989,-0.047718,-0.056179,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.79394,-0.047801,0.042622,0,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.79394,-0.048297,-0.0043098,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.79394,-0.048564,-0.00031178,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.78176,-0.048682,0.029222,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.74555,-0.049089,0.045099,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.55277,-0.049116,-0.014157,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.89296,-0.049189,0.047493,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.64051,-0.0492,0.069337,0,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.89296,-0.049206,-0.0020064,0,0
4,GO ETHER METABOLIC PROCESS,0.74555,-0.049257,-0.01842,0,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.88046,-0.049306,0.051737,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.76963,-0.049974,0.047544,0,0
4,GO BILE ACID METABOLIC PROCESS,0.43329,-0.050217,-0.044225,0,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.62923,-0.050387,0.087964,0,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.69814,-0.050434,0.048915,0,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.84314,-0.050603,-0.019856,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.5959,-0.050775,-0.063776,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.96843,-0.051289,0.015934,0,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.54223,-0.051576,0.12358,0,0
4,GO TRNA 5 END PROCESSING,0.36271,-0.051825,-0.034765,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.84314,-0.051891,-0.004126,0,0
4,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.65188,-0.051993,0.11447,0,0
4,GO REGULATION OF LIPID STORAGE,0.58498,-0.052078,0.095723,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.50109,-0.052199,-0.039669,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.041938,-0.052567,-0.067703,0,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.79394,-0.052579,0.015118,0,0
4,GO CYTOKINE METABOLIC PROCESS,0.72171,-0.052832,0.05842,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.27821,-0.053046,-0.12814,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.89296,-0.053048,0.030025,0,0
4,GO REGULATION OF CELLULAR RESPIRATION,0.43329,-0.053626,-0.010201,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.33029,-0.053715,-0.07555,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.80618,-0.053743,0.00054957,0,0
4,GO SYNAPSE PRUNING,0.57414,-0.053789,0.13363,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99368,-0.05396,0.0018028,0,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.80618,-0.054074,0.043549,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.5959,-0.054163,-0.031008,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.93062,-0.054205,0.03009,0,0
4,GO HEAT GENERATION,0.46168,-0.054607,-0.097167,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.24463,-0.054618,-0.040151,0,0
4,GO IMP METABOLIC PROCESS,0.65188,-0.055306,0.0072365,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.57414,-0.055617,-0.039763,0,0
4,GO MIDBODY ABSCISSION,0.23203,-0.055763,-0.060032,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.95582,-0.055801,0.014802,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.42405,-0.055929,-0.082265,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.65188,-0.056031,-0.022319,0,0
4,GO INTERACTION WITH SYMBIONT,0.65188,-0.056072,-0.028805,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.99368,-0.056565,0.034839,0,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.72171,-0.056664,-0.020124,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.53179,-0.056725,0.10964,0,0
4,GO REGULATION OF PLATELET ACTIVATION,0.57414,-0.056732,0.10334,0,0
4,GO REFLEX,0.55277,-0.056745,-0.043394,0,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.98106,-0.05679,0.0041838,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.29248,-0.056941,-0.039898,0,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.69814,-0.057089,0.012686,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.72171,-0.057609,-0.016474,0,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.30724,-0.057612,0.15381,0,0
4,GO MOVEMENT IN HOST ENVIRONMENT,0.76963,-0.057796,0.047512,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.41494,-0.057799,-0.052668,0,0
4,GO DETECTION OF CALCIUM ION,0.86799,-0.058063,0.040977,0,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.48117,-0.058071,-0.067413,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.80618,-0.058105,0.068107,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.84314,-0.058502,0.029887,0,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.37111,-0.05868,-0.053646,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.93062,-0.058893,0.0021597,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.7336,-0.059379,0.067735,0,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.3148,-0.059515,-0.11727,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.94321,-0.059515,0.0086615,0,0
4,GO VIRAL GENE EXPRESSION,0.069906,-0.059631,-0.061181,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.44264,-0.059936,0.14743,0,0
4,GO LIVER MORPHOGENESIS,0.40594,-0.060157,-0.051269,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.16602,-0.060186,-0.061564,0,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.88046,-0.060262,-0.0081379,0,0
4,GO RESPONSE TO MANGANESE ION,0.7336,-0.061046,0.0018164,0,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.80618,-0.061104,-0.00010861,0,0
4,GO TRNA 5 LEADER REMOVAL,0.062884,-0.06135,-0.10067,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.37111,-0.061771,-0.042786,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.39705,-0.061839,-0.042793,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.4521,-0.061866,-0.02354,0,0
4,GO INTERLEUKIN 13 PRODUCTION,0.96843,-0.062757,-0.032818,0,0
4,GO DETECTION OF BIOTIC STIMULUS,0.80618,-0.063405,0.054199,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.26442,-0.06345,-0.056153,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.16123,-0.063538,-0.058488,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.90549,-0.064033,0.040274,0,0
4,GO O GLYCAN PROCESSING,0.80618,-0.064267,-0.026516,0,0
4,GO CORNIFICATION,0.42405,-0.064397,-0.098292,0,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.61803,-0.064473,-0.01621,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.94321,-0.064482,0.033143,0,0
4,GO ER OVERLOAD RESPONSE,0.44264,-0.064769,-0.0045625,0,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.85555,-0.064854,0.036747,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.95582,-0.065253,0.013178,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.90549,-0.065281,0.032482,0,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.83078,-0.065439,0.036775,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.7336,-0.065663,0.019301,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.53179,-0.06606,-0.078754,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.49108,-0.066366,-0.019957,0,0
4,GO LEUKOCYTE CHEMOTAXIS,0.98106,-0.066379,0.0042076,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.15655,-0.066704,-0.062846,0,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.80618,-0.066705,0.052875,0,0
4,GO IMP BIOSYNTHETIC PROCESS,0.75756,-0.067418,0.0062089,0,0
4,GO BICARBONATE TRANSPORT,0.37111,-0.067956,-0.054042,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.035953,-0.068306,-0.12483,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.55277,-0.068519,-0.02843,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.91805,-0.068625,0.058057,0,0
4,GO RIBOSOME ASSEMBLY,0.24463,-0.06887,-0.044195,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.52145,-0.069049,-0.13057,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.55277,-0.069343,-0.02462,0,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.3148,-0.069756,-0.052086,0,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.34626,-0.070003,-0.084293,0,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.85555,-0.070212,0.042879,0,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.93062,-0.070467,-0.0094028,0,0
4,GO MACROPHAGE MIGRATION,0.84314,-0.070575,-0.0031583,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.70989,-0.070865,0.11649,0,0
4,GO ASTROCYTE ACTIVATION,0.49108,-0.071459,0.10286,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.90549,-0.071854,0.033664,0,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.40594,-0.072101,-0.088156,0,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.90549,-0.072558,0.02842,0,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.95582,-0.072953,0.014296,0,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.95582,-0.073258,0.029436,0,0
4,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.70989,-0.073831,0.065973,0,0
4,GO PROTEIN AUTOPROCESSING,0.37111,-0.075088,-0.065061,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.55277,-0.075596,0.086584,0,0
4,GO POSITIVE REGULATION OF COAGULATION,0.54223,-0.076489,-0.034153,0,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.79394,-0.076654,0.047514,0,0
4,GO LIVER REGENERATION,0.51122,-0.076773,-0.011048,0,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.52145,-0.077178,-0.045495,0,0
4,GO RESPONSE TO FUNGUS,0.83078,-0.077238,-0.016888,0,0
4,GO HISTAMINE TRANSPORT,0.64051,-0.077529,-0.053505,0,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1,-0.077784,0.0017439,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.51122,-0.077842,-0.002658,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.67486,-0.078178,-0.0051377,0,0
4,GO PROSTAGLANDIN TRANSPORT,0.61803,-0.078512,-0.0046261,0,0
4,GO TRANSLATIONAL TERMINATION,0.056456,-0.07856,-0.076595,0,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.23203,-0.079105,-0.018359,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.40594,-0.079302,-0.085109,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.79394,-0.079618,-0.0037857,0,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.47137,-0.079733,-0.057615,0,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.33821,-0.079905,-0.072631,0,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.55277,-0.079918,-0.045322,0,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.88046,-0.080939,0.021839,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.21989,-0.081421,-0.056309,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.38829,-0.081458,-0.025328,0,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.62923,-0.081494,0.086934,0,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.57414,-0.082355,-0.069399,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.90549,-0.082557,0.021667,0,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.84314,-0.082659,0.013164,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.08588,-0.082853,-0.073797,0,0
4,GO RESPONSE TO THYROID HORMONE,0.72171,-0.082912,-0.017583,0,0
4,GO GTP METABOLIC PROCESS,0.23203,-0.082946,-0.05518,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.027226,-0.083157,-0.12171,0,0
4,GO REGULATION OF HEAT GENERATION,0.46168,-0.084613,-0.12365,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.27126,-0.084666,-0.058695,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.84314,-0.085099,-0.030064,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.29248,-0.085115,-0.040284,0,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.56341,-0.085465,-0.088061,0,0
4,GO INTERLEUKIN 1 PRODUCTION,0.99368,-0.085632,0.017961,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.10811,-0.086271,-0.078006,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.43329,-0.086748,-0.11082,0,0
4,GO PROTEIN NITROSYLATION,0.38829,-0.087283,-0.069159,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.50109,-0.08749,-0.01784,0,0
4,GO INTERLEUKIN 10 PRODUCTION,0.84314,-0.087572,0.043392,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.046961,-0.088417,-0.069156,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.96843,-0.08842,0.03097,0,0
4,GO PROTEASOME ASSEMBLY,0.074935,-0.088597,-0.093501,0,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.26442,-0.088646,-0.053893,0,0
4,GO RESPONSE TO BACTERIUM,0.99368,-0.089035,-0.0044223,0,0
4,GO PLASMINOGEN ACTIVATION,0.2259,-0.08908,-0.1344,0,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.7336,-0.089818,-0.025154,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.79394,-0.089921,0.068203,0,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.78176,-0.090111,-0.041934,0,0
4,GO ACUTE PHASE RESPONSE,0.32248,-0.091409,-0.10893,0,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.91805,-0.0916,0.010477,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.197,-0.0917,-0.043694,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.40594,-0.091711,-0.010956,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60692,-0.091776,-0.062141,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.7336,-0.092171,-0.038618,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.65188,-0.092207,0.079043,0,0
4,GO ENTRY INTO HOST,0.78176,-0.09228,0.043079,0,0
4,GO FEVER GENERATION,0.29248,-0.092872,-0.1413,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.68646,-0.093169,0.1003,0,0
4,GO NEUTROPHIL MIGRATION,0.84314,-0.094103,-0.01746,0,0
4,GO ACUTE INFLAMMATORY RESPONSE,0.89296,-0.094153,-0.019732,0,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.79394,-0.09428,-0.026524,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.37964,-0.094568,-0.081661,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.33821,-0.094757,-0.029483,0,0
4,GO CHEMOKINE PRODUCTION,0.99368,-0.094921,0.0053817,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.28529,-0.095012,-0.11846,0,0
4,GO DRUG METABOLIC PROCESS,0.18624,-0.095244,-0.097428,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.10468,-0.095271,-0.084343,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.95582,-0.095593,0.0052882,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.37111,-0.095729,-0.16258,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.08303,-0.09625,-0.068924,0,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.5959,-0.096483,-0.066303,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.26442,-0.096534,-0.04267,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.98106,-0.096573,0.015415,0,0
4,GO GAS TRANSPORT,0.75756,-0.096611,-0.029867,0,0
4,GO HEART INDUCTION,0.79394,-0.097352,-0.020143,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.12662,-0.097683,-0.092621,0,0
4,GO MATURE B CELL DIFFERENTIATION,0.40594,-0.09874,0.12469,0,0
4,GO PROTEIN NEDDYLATION,0.038848,-0.098839,-0.097027,0,0
4,GO IRON ION HOMEOSTASIS,0.33821,-0.098889,-0.04369,0,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.1475,-0.099131,-0.083739,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1,-0.099346,-0.0031707,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.66333,-0.10018,-0.020112,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.84314,-0.10076,0.029463,0,0
4,GO MYELOID LEUKOCYTE MIGRATION,0.85555,-0.1008,-0.0198,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.70989,-0.10104,0.060861,0,0
4,GO NEUTROPHIL CHEMOTAXIS,0.7336,-0.10145,-0.038977,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.67486,-0.10239,0.11268,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.33821,-0.10321,-0.072589,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.21989,-0.10374,-0.060871,0,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.94321,-0.10395,0.017693,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.47137,-0.10417,-0.034827,0,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.66333,-0.10599,-0.04068,0,0
4,GO ESTROUS CYCLE,0.51122,-0.10728,-0.060834,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.14312,-0.10849,-0.10188,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.89296,-0.10922,0.022806,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.67486,-0.11078,-0.028858,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1,-0.11381,0.0066481,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.15655,-0.11449,-0.10713,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.48117,-0.11479,-0.05026,0,0
4,GO AMYLOID BETA CLEARANCE,0.86799,-0.11484,0.057601,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.030713,-0.11487,-0.098869,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.56341,-0.11487,-0.058944,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.16123,-0.11522,-0.11419,0,0
4,GO ZYMOGEN INHIBITION,0.76963,-0.11544,-0.030238,0,0
4,GO COMPLEMENT ACTIVATION,0.91805,-0.11602,0.019836,0,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.48117,-0.11665,-0.082997,0,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.7336,-0.1205,-0.021164,0,0
4,GO GRANULOCYTE MIGRATION,0.86799,-0.12098,-0.020457,0,0
4,GO POSITIVE REGULATION OF HEART RATE,0.20256,-0.12101,-0.11747,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.27821,-0.12204,-0.072848,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.90549,-0.12209,-0.021355,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.077559,-0.12468,-0.12981,0,0
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.65188,-0.12547,0.055058,0,0
4,GO ADHESION OF SYMBIONT TO HOST,0.47137,-0.12592,-0.12876,0,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.78176,-0.12616,0.06873,0,0
4,GO RESPONSE TO CHEMOKINE,0.93062,-0.12669,0.0098309,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.12662,-0.12806,-0.091768,0,0
4,GO TRANSLATIONAL INITIATION,0.0047188,-0.13072,-0.11286,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.58498,-0.13152,-0.063283,0,0
4,GO COPPER ION TRANSPORT,0.20822,-0.1325,-0.096977,0,0
4,GO SEQUESTERING OF METAL ION,0.40594,-0.13281,-0.097822,0,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.89296,-0.13394,0.021277,0,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.57414,-0.13402,-0.032739,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.34626,-0.13437,-0.014138,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.84314,-0.13535,0.044654,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.2998,-0.13607,-0.10611,0,0
4,GO LIPOXYGENASE PATHWAY,0.37964,-0.13686,-0.12283,0,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.33821,-0.13697,-0.054525,0,0
4,GO INTERLEUKIN 8 PRODUCTION,0.90549,-0.13722,0.0067616,0,0
4,GO GRANULOCYTE CHEMOTAXIS,0.69814,-0.1373,-0.044272,0,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.52145,-0.14069,-0.029075,0,0
4,GO BRONCHUS DEVELOPMENT,0.91805,-0.14124,-0.0016637,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.96843,-0.14431,-0.0038215,0,0
4,GO DRUG CATABOLIC PROCESS,0.098083,-0.14653,-0.13441,0,0
4,GO ETHANOL OXIDATION,0.23203,-0.1466,-0.20253,0,0
4,GO BLEB ASSEMBLY,0.54223,-0.1469,-0.075595,0,0
4,GO RESPONSE TO LIPOTEICHOIC ACID,0.83078,-0.14738,-0.0056279,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.37964,-0.14785,-0.11529,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.91805,-0.14815,0.0080998,0,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.95582,-0.14941,-0.0013877,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.28529,-0.14994,-0.073646,0,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.89296,-0.15018,-0.010544,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.08881,-0.15216,-0.10157,0,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.99368,-0.1554,0.02506,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.54223,-0.15596,-0.044232,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.197,-0.15914,-0.12942,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.88046,-0.15925,-0.010619,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.33029,-0.16102,-0.15211,0,0
4,GO FIBRINOLYSIS,0.42405,-0.16291,-0.099079,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.56341,-0.16786,-0.063268,0,0
4,GO PROSTAGLANDIN SECRETION,0.76963,-0.16946,-0.020848,0,0
4,GO ANDROGEN METABOLIC PROCESS,0.062884,-0.17019,-0.11033,0,0
4,GO OXYGEN TRANSPORT,0.38829,-0.17027,-0.11991,0,0
4,GO HUMORAL IMMUNE RESPONSE,0.81845,-0.17051,-0.050935,0,0
4,GO SIGNAL PEPTIDE PROCESSING,0.067497,-0.17102,-0.13035,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.19156,-0.17489,-0.097597,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.074935,-0.17513,-0.11823,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.1306,-0.17831,-0.1321,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.197,-0.18012,-0.084011,0,0
4,GO DEFENSE RESPONSE TO BACTERIUM,0.67486,-0.18315,-0.050425,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.074935,-0.18357,-0.1683,0,0
4,GO HISTAMINE SECRETION,0.32248,-0.18453,-0.12531,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1,-0.18723,-0.0082683,0,0
4,GO MONONUCLEAR CELL MIGRATION,0.50109,-0.19072,-0.091259,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.10468,-0.1965,-0.17879,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.86799,-0.19831,-0.027555,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.18624,-0.19931,-0.15431,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.75756,-0.19964,-0.012024,0,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.37111,-0.2007,-0.13747,0,0
4,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.2577,-0.20214,-0.17737,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.58498,-0.20329,-0.084286,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.67486,-0.20711,-0.082096,0,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.098083,-0.20721,-0.21733,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.065157,-0.20857,-0.1494,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.75756,-0.22374,-0.055804,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.2998,-0.22843,-0.12397,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.40594,-0.23512,-0.14813,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.89296,-0.24441,-0.027947,0,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.33029,-0.24658,-0.15424,0,0
4,GO MUCUS SECRETION,0.08588,-0.25237,-0.22144,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.24463,-0.283,-0.19359,0,0
4,GO MONOCYTE CHEMOTAXIS,0.33029,-0.28649,-0.15332,0,0
4,GO OPSONIZATION,0.014457,-0.32036,-0.39374,0,0
4,GO EOSINOPHIL MIGRATION,0.61803,-0.32465,-0.062857,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.37964,-0.33203,-0.18755,0,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.58498,-0.34309,-0.12253,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.17091,-0.3577,-0.21335,0,0
4,GO EOSINOPHIL CHEMOTAXIS,0.41494,-0.38545,-0.14526,0,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.017954,0.35245,0.24592,1,1
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.034576,0.23926,0.29829,1,1
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0036751,0.20328,0.22418,1,1
5,GO PROTEIN REFOLDING,0.035953,0.17981,0.15833,1,1
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.041938,0.16756,0.14419,1,1
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.011063,0.16299,0.1218,1,1
5,GO URONIC ACID METABOLIC PROCESS,0.020391,0.16254,0.11697,1,1
5,GO TRNA 5 LEADER REMOVAL,0.018736,0.15802,0.11636,1,1
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.050584,0.14838,0.15074,1,1
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.026142,0.14751,0.15569,1,1
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0057394,0.14689,0.12695,1,1
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0027019,0.14242,0.14621,1,1
5,GO MITOCHONDRIAL TRANSLATION,0.027226,0.13271,0.10053,1,1
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.027226,0.1271,0.16092,1,1
5,GO TRANSLATIONAL TERMINATION,0.027226,0.12139,0.096923,1,1
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.022172,0.12046,0.1414,1,1
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.034576,0.11016,0.1217,1,1
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.011063,0.10854,0.14857,1,1
5,GO TRANSLATIONAL ELONGATION,0.010101,0.10441,0.10061,1,1
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0042727,0.10299,0.12276,1,1
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.014457,0.097621,0.11629,1,1
5,GO TRNA 5 END PROCESSING,0.037377,0.095309,0.093766,1,1
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.010101,0.086006,0.10723,1,1
5,GO OXIDATIVE PHOSPHORYLATION,0.015776,0.070081,0.097966,1,1
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.030713,0.066632,0.1154,1,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.050584,-0.076383,-0.051783,1,0
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.024086,-0.081322,-0.063408,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.041938,-0.082199,-0.062482,1,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.028348,-0.084529,-0.083338,1,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.024086,-0.084849,-0.089743,1,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.052482,-0.084957,-0.096978,1,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.025096,-0.086245,-0.05522,1,0
5,GO DETECTION OF VISIBLE LIGHT,0.052482,-0.086496,-0.10389,1,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.043559,-0.086549,-0.053279,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.026142,-0.088385,-0.091774,1,0
5,GO REGULATION OF ATP METABOLIC PROCESS,0.048745,-0.088932,-0.0665,1,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.010101,-0.089708,-0.073203,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.048745,-0.090216,-0.051048,1,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.016475,-0.090704,-0.071517,1,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.037377,-0.091435,-0.042293,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.024086,-0.091624,-0.062798,1,0
5,GO VIRAL RELEASE FROM HOST CELL,0.018736,-0.092954,-0.083233,1,0
5,GO REGULATION OF CELL CYCLE,0.048745,-0.093187,-0.065889,1,0
5,GO REGULATION OF CELL AGING,0.026142,-0.09372,-0.085555,1,0
5,GO ORGANELLE LOCALIZATION,0.052482,-0.094565,-0.06852,1,0
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.018736,-0.094901,-0.067845,1,0
5,GO REGULATION OF ERAD PATHWAY,0.033245,-0.094933,-0.070063,1,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.048745,-0.09546,-0.085882,1,0
5,GO PEROXISOME ORGANIZATION,0.041938,-0.095568,-0.056434,1,0
5,GO PEROXISOMAL TRANSPORT,0.046961,-0.095575,-0.05009,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.014457,-0.095644,-0.077452,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.034576,-0.095669,-0.081535,1,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.043559,-0.095851,-0.11524,1,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.015104,-0.096242,-0.10682,1,0
5,GO MACROAUTOPHAGY,0.034576,-0.096795,-0.066317,1,0
5,GO OXIDATION REDUCTION PROCESS,0.041938,-0.09693,-0.047534,1,0
5,GO INTRACELLULAR TRANSPORT,0.027226,-0.097858,-0.057419,1,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.02951,-0.098409,-0.069215,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.020391,-0.098798,-0.081764,1,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.025096,-0.099676,-0.10317,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.026142,-0.099703,-0.074492,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.045233,-0.099965,-0.071598,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.018736,-0.10025,-0.08895,1,0
5,GO OOGENESIS,0.043559,-0.1011,-0.094171,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.046961,-0.10133,-0.049455,1,0
5,GO CARBOHYDRATE METABOLIC PROCESS,0.030713,-0.10223,-0.057057,1,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.048745,-0.10229,-0.077843,1,0
5,GO DETOXIFICATION,0.02951,-0.1025,-0.16835,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.016475,-0.10294,-0.08448,1,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.017954,-0.10401,-0.1458,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.034576,-0.10417,-0.080415,1,0
5,GO CELLULAR RESPONSE TO STARVATION,0.025096,-0.10484,-0.077048,1,0
5,GO TETRAPYRROLE METABOLIC PROCESS,0.033245,-0.10499,-0.067296,1,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.02951,-0.10555,-0.073629,1,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.022172,-0.1057,-0.071709,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.045233,-0.10667,-0.077019,1,0
5,GO CELLULAR SENESCENCE,0.023112,-0.1068,-0.094547,1,0
5,GO REGULATION OF HORMONE LEVELS,0.046961,-0.1068,-0.074161,1,0
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.048745,-0.1072,-0.060314,1,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.021265,-0.10726,-0.07771,1,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.008797,-0.10751,-0.093252,1,0
5,GO CELLULAR KETONE METABOLIC PROCESS,0.034576,-0.10785,-0.057418,1,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.02951,-0.1086,-0.13533,1,0
5,GO REGULATION OF HISTONE MODIFICATION,0.041938,-0.10889,-0.081138,1,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.025096,-0.10914,-0.06773,1,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.010101,-0.10956,-0.1054,1,0
5,GO DETECTION OF ABIOTIC STIMULUS,0.034576,-0.10966,-0.097752,1,0
5,GO CHLORIDE TRANSPORT,0.040368,-0.10991,-0.10471,1,0
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.050584,-0.11024,-0.079951,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.020391,-0.11102,-0.084142,1,0
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.037377,-0.11128,-0.11362,1,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.022172,-0.11175,-0.096345,1,0
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.043559,-0.11188,-0.11062,1,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.033245,-0.11265,-0.09177,1,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0172,-0.11315,-0.14556,1,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.035953,-0.1135,-0.064826,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY,0.026142,-0.11359,-0.071813,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.017954,-0.11451,-0.068303,1,0
5,GO DETECTION OF LIGHT STIMULUS,0.010572,-0.11456,-0.115,1,0
5,GO ORGANIC ACID CATABOLIC PROCESS,0.037377,-0.1146,-0.073463,1,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.010101,-0.11544,-0.082667,1,0
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.013834,-0.11562,-0.10147,1,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.040368,-0.11605,-0.10564,1,0
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.027226,-0.1165,-0.070858,1,0
5,GO STRIATED MUSCLE CONTRACTION,0.045233,-0.11656,-0.076061,1,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.043559,-0.11697,-0.054959,1,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.048745,-0.11708,-0.080677,1,0
5,GO NOTCH SIGNALING PATHWAY,0.041938,-0.1171,-0.06519,1,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.02951,-0.11716,-0.10313,1,0
5,GO SEXUAL REPRODUCTION,0.050584,-0.11735,-0.074078,1,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.02951,-0.11747,-0.098881,1,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.022172,-0.11804,-0.087586,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.041938,-0.11867,-0.064654,1,0
5,GO SPHINGOLIPID METABOLIC PROCESS,0.043559,-0.11876,-0.057422,1,0
5,GO FERTILIZATION,0.045233,-0.11891,-0.076013,1,0
5,GO PHOTOTRANSDUCTION,0.0029965,-0.11904,-0.12281,1,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.052482,-0.11916,-0.052666,1,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.040368,-0.11922,-0.091778,1,0
5,GO REGULATION OF MACROAUTOPHAGY,0.033245,-0.11931,-0.07677,1,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.016475,-0.11936,-0.097679,1,0
5,GO REGULATION OF LYASE ACTIVITY,0.037377,-0.11936,-0.13703,1,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.030713,-0.11949,-0.10181,1,0
5,GO FEMALE GAMETE GENERATION,0.018736,-0.11982,-0.11159,1,0
5,GO FEAR RESPONSE,0.024086,-0.11983,-0.1566,1,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.038848,-0.11993,-0.087175,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.038848,-0.12015,-0.092252,1,0
5,GO CARDIAC MUSCLE CONTRACTION,0.048745,-0.12045,-0.082793,1,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.041938,-0.12052,-0.079212,1,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.031957,-0.12058,-0.070229,1,0
5,GO BLASTOCYST FORMATION,0.00332,-0.12062,-0.11327,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.027226,-0.12078,-0.068227,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0172,-0.12114,-0.094445,1,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.025096,-0.12129,-0.068557,1,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.022172,-0.12134,-0.10943,1,0
5,GO CELL AGING,0.0172,-0.12163,-0.097366,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.024086,-0.12179,-0.10403,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.019548,-0.12181,-0.11861,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0172,-0.12181,-0.10155,1,0
5,GO RESPONSE TO MINERALOCORTICOID,0.043559,-0.12193,-0.12828,1,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.052482,-0.12196,-0.049143,1,0
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.037377,-0.12207,-0.094416,1,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.014457,-0.12221,-0.10246,1,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.012106,-0.12226,-0.092459,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.038848,-0.12227,-0.098912,1,0
5,GO RESPONSE TO CARBOHYDRATE,0.037377,-0.12359,-0.071375,1,0
5,GO EXECUTION PHASE OF APOPTOSIS,0.0172,-0.12376,-0.081318,1,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.052482,-0.12399,-0.10578,1,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.017954,-0.12404,-0.084072,1,0
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.034576,-0.12429,-0.082211,1,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.023112,-0.12432,-0.10695,1,0
5,GO GAMETE GENERATION,0.048745,-0.12439,-0.073305,1,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.028348,-0.12471,-0.12369,1,0
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.025096,-0.12494,-0.12222,1,0
5,GO TOR SIGNALING,0.046961,-0.12497,-0.081374,1,0
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.043559,-0.12512,-0.06019,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.013834,-0.12528,-0.11115,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.025096,-0.12567,-0.091652,1,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.018736,-0.12568,-0.085771,1,0
5,GO IMPORT INTO NUCLEUS,0.019548,-0.12601,-0.096483,1,0
5,GO PORE COMPLEX ASSEMBLY,0.026142,-0.12617,-0.094953,1,0
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.01266,-0.1262,-0.082771,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.030713,-0.12665,-0.11231,1,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.034576,-0.12686,-0.12891,1,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.020391,-0.12719,-0.072055,1,0
5,GO GLYCOSYLATION,0.052482,-0.12738,-0.070298,1,0
5,GO HISTONE H3 ACETYLATION,0.043559,-0.12745,-0.10088,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.048745,-0.12749,-0.069892,1,0
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.046961,-0.12769,-0.096731,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0172,-0.12775,-0.067272,1,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.040368,-0.12808,-0.12651,1,0
5,GO HEME METABOLIC PROCESS,0.027226,-0.12865,-0.087356,1,0
5,GO HISTONE H2B UBIQUITINATION,0.034576,-0.12868,-0.10115,1,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.041938,-0.12919,-0.10318,1,0
5,GO GOLGI VESICLE TRANSPORT,0.013235,-0.12942,-0.094848,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,0.014457,-0.12964,-0.073093,1,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.041938,-0.12986,-0.10169,1,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.021265,-0.12992,-0.12022,1,0
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.017954,-0.1301,-0.098649,1,0
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0096484,-0.13019,-0.098892,1,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.024086,-0.13065,-0.068106,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,0.02951,-0.1309,-0.091801,1,0
5,GO PROTEIN POLYUBIQUITINATION,0.025096,-0.13123,-0.083065,1,0
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.045233,-0.13123,-0.098036,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.012106,-0.13164,-0.082256,1,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.040368,-0.13169,-0.16059,1,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.025096,-0.13182,-0.083307,1,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.031957,-0.13216,-0.090157,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.048745,-0.13245,-0.059972,1,0
5,GO ORGANIC ACID TRANSPORT,0.024086,-0.13267,-0.085406,1,0
5,GO RESPONSE TO UV,0.025096,-0.13275,-0.099281,1,0
5,GO RESPONSE TO LIGHT STIMULUS,0.025096,-0.13317,-0.08492,1,0
5,GO ENDOSOME ORGANIZATION,0.0172,-0.13318,-0.07695,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.012106,-0.13356,-0.087314,1,0
5,GO PROTEIN DESTABILIZATION,0.052482,-0.13358,-0.053038,1,0
5,GO MULTI ORGANISM PROCESS,0.011574,-0.13371,-0.099034,1,0
5,GO MEMBRANE FUSION,0.015104,-0.13387,-0.091104,1,0
5,GO CELLULAR RESPONSE TO UV,0.030713,-0.13403,-0.10622,1,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.028348,-0.13459,-0.089169,1,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.024086,-0.13472,-0.1348,1,0
5,GO TRANSMEMBRANE TRANSPORT,0.013235,-0.13529,-0.088656,1,0
5,GO MYOFIBRIL ASSEMBLY,0.043559,-0.13608,-0.12291,1,0
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.016475,-0.13622,-0.12273,1,0
5,GO REGULATION OF AUTOPHAGY,0.013834,-0.13626,-0.09061,1,0
5,GO ERYTHROCYTE DEVELOPMENT,0.022172,-0.13643,-0.12402,1,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0076456,-0.13662,-0.13949,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.02951,-0.13681,-0.061861,1,0
5,GO ANION TRANSMEMBRANE TRANSPORT,0.022172,-0.13731,-0.091424,1,0
5,GO VACUOLAR TRANSPORT,0.016475,-0.13742,-0.11242,1,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.02951,-0.13763,-0.1409,1,0
5,GO ARACHIDONIC ACID SECRETION,0.023112,-0.13764,-0.15133,1,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.020391,-0.13764,-0.086907,1,0
5,GO PROTEIN CATABOLIC PROCESS,0.014457,-0.13788,-0.079613,1,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.011574,-0.13788,-0.11118,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.013834,-0.13799,-0.091781,1,0
5,GO REGIONALIZATION,0.040368,-0.138,-0.096866,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.026142,-0.13817,-0.11412,1,0
5,GO DIET INDUCED THERMOGENESIS,0.0172,-0.13836,-0.2321,1,0
5,GO CELLULAR RESPONSE TO RADIATION,0.0063209,-0.13839,-0.11501,1,0
5,GO PROTEIN IMPORT,0.019548,-0.1384,-0.087078,1,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.033245,-0.13842,-0.13112,1,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.021265,-0.13864,-0.11156,1,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0060238,-0.13865,-0.12003,1,0
5,GO CELL CYCLE ARREST,0.014457,-0.13865,-0.10057,1,0
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.030713,-0.13896,-0.091528,1,0
5,GO RESPONSE TO RADIATION,0.0080134,-0.13906,-0.10757,1,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.026142,-0.13983,-0.10206,1,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.052482,-0.13989,-0.13368,1,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.037377,-0.13992,-0.060072,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.031957,-0.14002,-0.090631,1,0
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.024086,-0.14028,-0.092074,1,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.006955,-0.14042,-0.11981,1,0
5,GO SENSORY PERCEPTION OF TASTE,0.01266,-0.14054,-0.1941,1,0
5,GO HISTONE PHOSPHORYLATION,0.050584,-0.14117,-0.089023,1,0
5,GO GLUCOSE IMPORT,0.031957,-0.14137,-0.092487,1,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.031957,-0.14142,-0.09924,1,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.040368,-0.14178,-0.11619,1,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0096484,-0.14222,-0.097157,1,0
5,GO LIPID BIOSYNTHETIC PROCESS,0.015104,-0.14285,-0.080349,1,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.040368,-0.14293,-0.11813,1,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.023112,-0.14301,-0.073774,1,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.025096,-0.14304,-0.11945,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.015776,-0.14331,-0.09393,1,0
5,GO REGULATION OF BLOOD CIRCULATION,0.022172,-0.14367,-0.11743,1,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.045233,-0.14381,-0.10165,1,0
5,GO ION TRANSMEMBRANE TRANSPORT,0.021265,-0.14387,-0.09537,1,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.02951,-0.144,-0.11327,1,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.037377,-0.1441,-0.10673,1,0
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.012106,-0.14416,-0.12299,1,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.010572,-0.14418,-0.13769,1,0
5,GO GMP METABOLIC PROCESS,0.018736,-0.14454,-0.10971,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0096484,-0.14472,-0.14355,1,0
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.024086,-0.14481,-0.11859,1,0
5,GO HEART PROCESS,0.018736,-0.14507,-0.1088,1,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.017954,-0.14535,-0.1241,1,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.025096,-0.14597,-0.10853,1,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.017954,-0.14603,-0.1162,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.007293,-0.14617,-0.087964,1,0
5,GO MUSCLE CELL DEVELOPMENT,0.034576,-0.14643,-0.091208,1,0
5,GO VESICLE LOCALIZATION,0.0092139,-0.14676,-0.10582,1,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0080134,-0.14689,-0.10812,1,0
5,GO CHLORIDE ION HOMEOSTASIS,0.023112,-0.14693,-0.17173,1,0
5,GO NEGATIVE REGULATION OF GROWTH,0.010572,-0.14706,-0.13781,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.028348,-0.14731,-0.11634,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0172,-0.14735,-0.10176,1,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.043559,-0.14743,-0.084494,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.018736,-0.14762,-0.1848,1,0
5,GO REGULATION OF CATABOLIC PROCESS,0.01266,-0.14765,-0.088923,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.007293,-0.1483,-0.096963,1,0
5,GO RRNA CATABOLIC PROCESS,0.024086,-0.14857,-0.11285,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.013235,-0.14857,-0.11543,1,0
5,GO REGULATION OF CELLULAR LOCALIZATION,0.0076456,-0.14893,-0.11448,1,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0023095,-0.14898,-0.11836,1,0
5,GO LACTATION,0.02951,-0.14898,-0.114,1,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.011574,-0.14913,-0.2162,1,0
5,GO REGULATION OF PROTEIN TARGETING,0.0080134,-0.14939,-0.10362,1,0
5,GO EPIDERMIS DEVELOPMENT,0.028348,-0.14941,-0.13843,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.012106,-0.14946,-0.094482,1,0
5,GO DEVELOPMENTAL INDUCTION,0.040368,-0.14964,-0.076662,1,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.0047188,-0.1498,-0.19317,1,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.038848,-0.15001,-0.11273,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.028348,-0.15017,-0.15999,1,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.031957,-0.1503,-0.1108,1,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.037377,-0.15047,-0.12785,1,0
5,GO ACYLGLYCEROL HOMEOSTASIS,0.026142,-0.15062,-0.15824,1,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.030713,-0.15083,-0.11238,1,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.045233,-0.15103,-0.17784,1,0
5,GO GOLGI VESICLE BUDDING,0.006955,-0.15109,-0.11363,1,0
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.037377,-0.15115,-0.073305,1,0
5,GO RHYTHMIC PROCESS,0.017954,-0.15117,-0.10026,1,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.048745,-0.15122,-0.13646,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.040368,-0.15144,-0.17361,1,0
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.038848,-0.15145,-0.09921,1,0
5,GO CATION TRANSPORT,0.011574,-0.15166,-0.10902,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.013834,-0.15172,-0.13615,1,0
5,GO NEURON PROJECTION EXTENSION,0.040368,-0.15183,-0.13616,1,0
5,GO IMPORT INTO CELL,0.019548,-0.15192,-0.10763,1,0
5,GO VESICLE ORGANIZATION,0.0076456,-0.15197,-0.10346,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0080134,-0.15201,-0.12062,1,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0096484,-0.15209,-0.14351,1,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.018736,-0.15236,-0.12164,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.028348,-0.15248,-0.10009,1,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.048745,-0.15249,-0.095056,1,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.019548,-0.15277,-0.10525,1,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.026142,-0.15285,-0.14699,1,0
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.01266,-0.15285,-0.12956,1,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.01266,-0.15287,-0.18597,1,0
5,GO EPITHELIAL TUBE FORMATION,0.020391,-0.15295,-0.12605,1,0
5,GO SODIUM ION TRANSPORT,0.024086,-0.15309,-0.11116,1,0
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0054671,-0.15313,-0.1557,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0066311,-0.15331,-0.10794,1,0
5,GO MIDBRAIN DEVELOPMENT,0.0040644,-0.15345,-0.13247,1,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.02951,-0.15363,-0.12089,1,0
5,GO HEAD DEVELOPMENT,0.046961,-0.15372,-0.1059,1,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.037377,-0.15375,-0.14289,1,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.033245,-0.15375,-0.17025,1,0
5,GO BILE ACID METABOLIC PROCESS,0.033245,-0.15378,-0.10858,1,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.026142,-0.15379,-0.14652,1,0
5,GO SENSORY PERCEPTION,0.0052065,-0.15381,-0.12575,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.050584,-0.15397,-0.14028,1,0
5,GO REGULATION OF EXOCYTOSIS,0.046961,-0.15397,-0.088336,1,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0076456,-0.15398,-0.10593,1,0
5,GO CATION TRANSMEMBRANE TRANSPORT,0.019548,-0.15415,-0.1016,1,0
5,GO PATTERN SPECIFICATION PROCESS,0.022172,-0.15433,-0.11688,1,0
5,GO DETECTION OF STIMULUS,0.0027019,-0.15437,-0.1212,1,0
5,GO ENDOSOMAL TRANSPORT,0.016475,-0.1544,-0.091297,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.010572,-0.1546,-0.090619,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.030713,-0.15496,-0.20115,1,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.013834,-0.15514,-0.11968,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0083971,-0.1556,-0.11801,1,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0038653,-0.15564,-0.14161,1,0
5,GO CERAMIDE METABOLIC PROCESS,0.033245,-0.15572,-0.065864,1,0
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.017954,-0.15607,-0.092562,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.019548,-0.15628,-0.12373,1,0
5,GO CARBOHYDRATE TRANSPORT,0.023112,-0.15646,-0.089703,1,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.013834,-0.15663,-0.091426,1,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.050584,-0.15702,-0.094342,1,0
5,GO RESPONSE TO ABIOTIC STIMULUS,0.007293,-0.15706,-0.10199,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.013235,-0.15739,-0.10206,1,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.0172,-0.15755,-0.18858,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.006955,-0.15763,-0.096942,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.027226,-0.15784,-0.10461,1,0
5,GO TRANSITION METAL ION TRANSPORT,0.037377,-0.15789,-0.080982,1,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.0063209,-0.15796,-0.16017,1,0
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.014457,-0.15806,-0.11017,1,0
5,GO FOLIC ACID METABOLIC PROCESS,0.024086,-0.1582,-0.099527,1,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.014457,-0.15822,-0.11998,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.041938,-0.15852,-0.15571,1,0
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.019548,-0.1588,-0.094151,1,0
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0076456,-0.1588,-0.10484,1,0
5,GO NEGATIVE REGULATION OF DNA BINDING,0.020391,-0.15897,-0.13618,1,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.043559,-0.15909,-0.11646,1,0
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.013834,-0.15912,-0.11762,1,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.02951,-0.15914,-0.10675,1,0
5,GO PROTEIN TARGETING TO VACUOLE,0.018736,-0.15923,-0.13079,1,0
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.007293,-0.15927,-0.13475,1,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.019548,-0.15946,-0.12381,1,0
5,GO TRNA CATABOLIC PROCESS,0.031957,-0.15952,-0.15874,1,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.023112,-0.15961,-0.1038,1,0
5,GO REGULATION OF PEPTIDE TRANSPORT,0.0076456,-0.15975,-0.12778,1,0
5,GO RETINA HOMEOSTASIS,0.0096484,-0.15976,-0.1431,1,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0172,-0.15978,-0.14221,1,0
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.025096,-0.15983,-0.094761,1,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.022172,-0.15994,-0.12175,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00332,-0.16003,-0.17027,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.035953,-0.16018,-0.13212,1,0
5,GO REGULATION OF CELL DIVISION,0.0076456,-0.1602,-0.13346,1,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.025096,-0.16023,-0.089596,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0080134,-0.16024,-0.15954,1,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0049572,-0.16035,-0.18457,1,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.011063,-0.16036,-0.12711,1,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.012106,-0.16068,-0.11134,1,0
5,GO INNER EAR MORPHOGENESIS,0.019548,-0.16072,-0.14325,1,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.013834,-0.16084,-0.11872,1,0
5,GO AMINE METABOLIC PROCESS,0.014457,-0.16101,-0.10203,1,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0042727,-0.1613,-0.13154,1,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.017954,-0.16147,-0.21166,1,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.024086,-0.16178,-0.12416,1,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.031957,-0.16199,-0.14813,1,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.041938,-0.16235,-0.14784,1,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.046961,-0.16287,-0.16679,1,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.015776,-0.16291,-0.11293,1,0
5,GO POLYOL BIOSYNTHETIC PROCESS,0.011574,-0.16292,-0.1158,1,0
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.041938,-0.16294,-0.10988,1,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.023112,-0.16318,-0.12762,1,0
5,GO DEPHOSPHORYLATION,0.011063,-0.16333,-0.10193,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.010572,-0.16333,-0.12118,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION,0.021265,-0.16336,-0.12077,1,0
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.023112,-0.16352,-0.1148,1,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.011574,-0.16365,-0.12265,1,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.041938,-0.16395,-0.1126,1,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.013834,-0.164,-0.094722,1,0
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0083971,-0.16413,-0.11211,1,0
5,GO MEMBRANE ORGANIZATION,0.006955,-0.16417,-0.11414,1,0
5,GO ORGANIC ACID METABOLIC PROCESS,0.010101,-0.16452,-0.097736,1,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.028348,-0.16457,-0.1112,1,0
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.014457,-0.1646,-0.11392,1,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.012106,-0.16492,-0.19742,1,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.031957,-0.16534,-0.15597,1,0
5,GO THYROID HORMONE METABOLIC PROCESS,0.043559,-0.16542,-0.24754,1,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.011574,-0.16558,-0.12935,1,0
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.030713,-0.16563,-0.1034,1,0
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.021265,-0.16586,-0.12396,1,0
5,GO REPRODUCTION,0.01266,-0.16588,-0.11049,1,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.008797,-0.16599,-0.22712,1,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0049572,-0.16626,-0.22444,1,0
5,GO PROTEIN AUTOUBIQUITINATION,0.050584,-0.16656,-0.085593,1,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.046961,-0.16658,-0.16559,1,0
5,GO EAR MORPHOGENESIS,0.021265,-0.1666,-0.13322,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0025648,-0.16661,-0.18059,1,0
5,GO REGULATION OF BEHAVIOR,0.0076456,-0.16663,-0.16161,1,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.017954,-0.16664,-0.11853,1,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0092139,-0.16677,-0.12378,1,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.038848,-0.16679,-0.11272,1,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0092139,-0.16689,-0.13388,1,0
5,GO CELLULAR PIGMENTATION,0.020391,-0.16692,-0.12144,1,0
5,GO PROTEIN HOMOOLIGOMERIZATION,0.0096484,-0.16702,-0.11414,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.022172,-0.1672,-0.15387,1,0
5,GO ERYTHROCYTE MATURATION,0.027226,-0.16727,-0.1638,1,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.033245,-0.1673,-0.12394,1,0
5,GO SULFATION,0.035953,-0.16744,-0.21082,1,0
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.015104,-0.16749,-0.10781,1,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.020391,-0.16766,-0.11391,1,0
5,GO SYMBIOTIC PROCESS,0.0031545,-0.1677,-0.12987,1,0
5,GO CELLULAR RESPONSE TO STEROL,0.02951,-0.16774,-0.15237,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.035953,-0.16812,-0.11638,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0042727,-0.16822,-0.14185,1,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.013235,-0.16823,-0.12836,1,0
5,GO LIPID OXIDATION,0.017954,-0.16832,-0.11919,1,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.025096,-0.16838,-0.13197,1,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.019548,-0.16844,-0.13985,1,0
5,GO SKIN DEVELOPMENT,0.030713,-0.16852,-0.14404,1,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.015776,-0.16853,-0.15651,1,0
5,GO LIPOPROTEIN METABOLIC PROCESS,0.019548,-0.16869,-0.099248,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,0.017954,-0.16876,-0.11988,1,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.043559,-0.16898,-0.075809,1,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.015104,-0.16911,-0.15298,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.01266,-0.16914,-0.1888,1,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0063209,-0.16916,-0.13583,1,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0028457,-0.16921,-0.21096,1,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.033245,-0.16936,-0.1189,1,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.038848,-0.1694,-0.10259,1,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.008797,-0.16981,-0.1825,1,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.0080134,-0.17002,-0.14517,1,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.050584,-0.17003,-0.1111,1,0
5,GO COPII COATED VESICLE BUDDING,0.0042727,-0.17019,-0.13088,1,0
5,GO VESICLE TARGETING,0.0066311,-0.17024,-0.12248,1,0
5,GO INORGANIC ANION TRANSPORT,0.015776,-0.17028,-0.1097,1,0
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.013834,-0.17033,-0.16506,1,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0083971,-0.17039,-0.11408,1,0
5,GO MUSCLE SYSTEM PROCESS,0.011063,-0.17043,-0.13494,1,0
5,GO PROTEIN DEPHOSPHORYLATION,0.011063,-0.1705,-0.097636,1,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0172,-0.17063,-0.10781,1,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0066311,-0.17073,-0.12357,1,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.01266,-0.17117,-0.096468,1,0
5,GO NADP METABOLIC PROCESS,0.0076456,-0.17131,-0.11838,1,0
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.017954,-0.17157,-0.099103,1,0
5,GO REGULATION OF MUSCLE CONTRACTION,0.020391,-0.17172,-0.11805,1,0
5,GO FATTY ACID METABOLIC PROCESS,0.012106,-0.17182,-0.11851,1,0
5,GO RUFFLE ASSEMBLY,0.035953,-0.17219,-0.1048,1,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.012106,-0.17229,-0.11043,1,0
5,GO LIPID HOMEOSTASIS,0.012106,-0.17244,-0.14692,1,0
5,GO MUSCLE CONTRACTION,0.015776,-0.17266,-0.12901,1,0
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.026142,-0.17277,-0.12131,1,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0172,-0.17285,-0.15504,1,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.041938,-0.17305,-0.10312,1,0
5,GO RECEPTOR CATABOLIC PROCESS,0.02951,-0.1731,-0.10681,1,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.025096,-0.17322,-0.13826,1,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.0063209,-0.17324,-0.10734,1,0
5,GO NEGATIVE REGULATION OF BINDING,0.0044907,-0.17328,-0.14259,1,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.014457,-0.17359,-0.12714,1,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.011574,-0.17367,-0.13274,1,0
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.007293,-0.17368,-0.13117,1,0
5,GO SIGNAL RELEASE,0.025096,-0.17375,-0.10224,1,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.041938,-0.17378,-0.13014,1,0
5,GO ION TRANSPORT,0.010101,-0.17379,-0.10901,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0076456,-0.17384,-0.15808,1,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0092139,-0.17418,-0.16029,1,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.033245,-0.1743,-0.10295,1,0
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.013834,-0.17445,-0.12218,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION,0.0060238,-0.17447,-0.13043,1,0
5,GO ORGANIC ANION TRANSPORT,0.011574,-0.17491,-0.1014,1,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.008797,-0.17514,-0.12293,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0047188,-0.17543,-0.12437,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.007293,-0.17544,-0.17578,1,0
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.008797,-0.17547,-0.12206,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.017954,-0.17554,-0.13461,1,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.030713,-0.17571,-0.1218,1,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.020391,-0.17572,-0.16415,1,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.014457,-0.17586,-0.13193,1,0
5,GO RESPONSE TO INTERLEUKIN 12,0.0076456,-0.1759,-0.16513,1,0
5,GO GLYCEROLIPID METABOLIC PROCESS,0.010572,-0.17591,-0.10943,1,0
5,GO METAL ION TRANSPORT,0.0076456,-0.17592,-0.12487,1,0
5,GO NERVOUS SYSTEM PROCESS,0.011063,-0.17595,-0.12131,1,0
5,GO PROTEIN TETRAMERIZATION,0.015776,-0.1763,-0.11061,1,0
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.010101,-0.17631,-0.12424,1,0
5,GO MEMORY,0.040368,-0.17633,-0.1319,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0049572,-0.17645,-0.14426,1,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0057394,-0.17661,-0.18749,1,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.010572,-0.17668,-0.12118,1,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0027019,-0.17678,-0.14109,1,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0080134,-0.1768,-0.18539,1,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.015104,-0.17693,-0.12332,1,0
5,GO REGULATION OF HISTONE DEACETYLATION,0.052482,-0.17718,-0.12033,1,0
5,GO CELL CELL JUNCTION ASSEMBLY,0.048745,-0.17721,-0.1002,1,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.030713,-0.17729,-0.16616,1,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.0044907,-0.1773,-0.19222,1,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0060238,-0.17733,-0.24256,1,0
5,GO PROTEIN MATURATION,0.011574,-0.17735,-0.11412,1,0
5,GO ANION TRANSPORT,0.011063,-0.17739,-0.10735,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.027226,-0.17746,-0.14341,1,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.015104,-0.17756,-0.14103,1,0
5,GO VESICLE BUDDING FROM MEMBRANE,0.0063209,-0.17784,-0.11748,1,0
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.013235,-0.17813,-0.15448,1,0
5,GO BEHAVIOR,0.035953,-0.17819,-0.13256,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0066311,-0.17821,-0.16275,1,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.0010209,-0.17827,-0.14458,1,0
5,GO VITAMIN METABOLIC PROCESS,0.028348,-0.17838,-0.10345,1,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.050584,-0.17839,-0.10234,1,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.046961,-0.1784,-0.16266,1,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.02951,-0.17856,-0.10667,1,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.043559,-0.17879,-0.14366,1,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.016475,-0.17904,-0.098682,1,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.012106,-0.17935,-0.13682,1,0
5,GO NEURAL TUBE FORMATION,0.028348,-0.17937,-0.12699,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.037377,-0.17968,-0.13745,1,0
5,GO LIPID METABOLIC PROCESS,0.007293,-0.17981,-0.1135,1,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.010101,-0.18002,-0.16609,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0049572,-0.18011,-0.12044,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.023112,-0.18013,-0.11932,1,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0057394,-0.18019,-0.1301,1,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.020391,-0.1802,-0.21037,1,0
5,GO IRON ION TRANSPORT,0.045233,-0.18022,-0.097039,1,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.01266,-0.18031,-0.13813,1,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.0060238,-0.18049,-0.14086,1,0
5,GO EMBRYO DEVELOPMENT,0.0080134,-0.18054,-0.14458,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.030713,-0.18054,-0.11684,1,0
5,GO REGULATION OF SYSTEM PROCESS,0.012106,-0.18061,-0.13227,1,0
5,GO RESPIRATORY SYSTEM PROCESS,0.028348,-0.18065,-0.16706,1,0
5,GO SEGMENT SPECIFICATION,0.048745,-0.18069,-0.1698,1,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.033245,-0.18083,-0.12052,1,0
5,GO CELL MATURATION,0.013235,-0.18088,-0.12112,1,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.035953,-0.18089,-0.11693,1,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0034935,-0.18094,-0.12701,1,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.016475,-0.1812,-0.13036,1,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0042727,-0.18127,-0.16535,1,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.014457,-0.18134,-0.13841,1,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.026142,-0.18138,-0.1542,1,0
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.052482,-0.18159,-0.15263,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0092139,-0.18166,-0.13127,1,0
5,GO RESPONSE TO IONIZING RADIATION,0.006955,-0.18166,-0.14611,1,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0042727,-0.18171,-0.14997,1,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.01266,-0.18181,-0.11897,1,0
5,GO RESPONSE TO OXYGEN RADICAL,0.021265,-0.18187,-0.12322,1,0
5,GO PLASMA MEMBRANE TUBULATION,0.01266,-0.18187,-0.14093,1,0
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0083971,-0.18191,-0.12506,1,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0052065,-0.18206,-0.17726,1,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0028457,-0.1821,-0.17734,1,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.020391,-0.18214,-0.17633,1,0
5,GO REGULATION OF VASCULOGENESIS,0.052482,-0.1822,-0.13007,1,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.031957,-0.18225,-0.11866,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.007293,-0.18229,-0.12792,1,0
5,GO REGULATION OF PROTEIN DEACETYLATION,0.033245,-0.18232,-0.10994,1,0
5,GO LENS FIBER CELL DIFFERENTIATION,0.0172,-0.18268,-0.1551,1,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.008797,-0.18271,-0.18897,1,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.043559,-0.18289,-0.18556,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.016475,-0.18291,-0.15918,1,0
5,GO EPITHELIUM DEVELOPMENT,0.0096484,-0.18334,-0.13316,1,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0080134,-0.1835,-0.16166,1,0
5,GO PEPTIDYL SERINE MODIFICATION,0.0083971,-0.18352,-0.1207,1,0
5,GO SYNAPTIC VESICLE BUDDING,0.037377,-0.18357,-0.15799,1,0
5,GO REGULATION OF GROWTH,0.0083971,-0.18377,-0.13614,1,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.024086,-0.18399,-0.25538,1,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0023095,-0.18419,-0.20152,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.013235,-0.18428,-0.1194,1,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0028457,-0.18442,-0.14043,1,0
5,GO RESPONSE TO INACTIVITY,0.034576,-0.18442,-0.14498,1,0
5,GO ISOPRENOID METABOLIC PROCESS,0.011574,-0.18446,-0.13759,1,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.008797,-0.1849,-0.14889,1,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.034576,-0.18492,-0.19011,1,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.018736,-0.18513,-0.17706,1,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.035953,-0.18525,-0.23249,1,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.010572,-0.1853,-0.11481,1,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.038848,-0.18531,-0.14489,1,0
5,GO REGULATION OF TRANSPORT,0.0052065,-0.1854,-0.13203,1,0
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.013834,-0.18552,-0.17596,1,0
5,GO DIVALENT METAL ION EXPORT,0.013834,-0.1856,-0.23936,1,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0034935,-0.18564,-0.13678,1,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.020391,-0.1857,-0.17166,1,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.014457,-0.18571,-0.15643,1,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0044907,-0.18588,-0.16851,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0052065,-0.18604,-0.13555,1,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.035953,-0.18607,-0.16527,1,0
5,GO CELLULAR RESPONSE TO KETONE,0.0019699,-0.18609,-0.19694,1,0
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0042727,-0.18615,-0.13743,1,0
5,GO RESPONSE TO GAMMA RADIATION,0.0080134,-0.18615,-0.14283,1,0
5,GO POSITIVE REGULATION OF CELL GROWTH,0.0044907,-0.18642,-0.15589,1,0
5,GO ALCOHOL METABOLIC PROCESS,0.015104,-0.18658,-0.10252,1,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0080134,-0.18662,-0.17316,1,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.040368,-0.1867,-0.14585,1,0
5,GO RESPONSE TO FATTY ACID,0.020391,-0.1868,-0.17062,1,0
5,GO CELL GROWTH,0.0066311,-0.18682,-0.13843,1,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011574,-0.18685,-0.12605,1,0
5,GO MOLTING CYCLE,0.02951,-0.18691,-0.13749,1,0
5,GO POSITIVE REGULATION OF BINDING,0.0042727,-0.18693,-0.13285,1,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.013235,-0.18709,-0.11753,1,0
5,GO CELLULAR LIPID METABOLIC PROCESS,0.0066311,-0.18714,-0.12043,1,0
5,GO LUNG CELL DIFFERENTIATION,0.022172,-0.18748,-0.10346,1,0
5,GO POLYOL METABOLIC PROCESS,0.013235,-0.18749,-0.10401,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.018736,-0.18759,-0.11979,1,0
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.037377,-0.18796,-0.12441,1,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0044907,-0.18796,-0.17851,1,0
5,GO CELLULAR HOMEOSTASIS,0.0040644,-0.18801,-0.14707,1,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.038848,-0.18807,-0.12235,1,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.0040644,-0.18816,-0.21906,1,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.008797,-0.18817,-0.15095,1,0
5,GO REGULATION OF DEPHOSPHORYLATION,0.0047188,-0.18817,-0.13575,1,0
5,GO CYTOSKELETON ORGANIZATION,0.01266,-0.18818,-0.127,1,0
5,GO NEURON DEATH,0.0060238,-0.18836,-0.13489,1,0
5,GO LIPID CATABOLIC PROCESS,0.0092139,-0.18856,-0.12877,1,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00332,-0.18858,-0.1581,1,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0027019,-0.1886,-0.14876,1,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.038848,-0.1887,-0.1683,1,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0040644,-0.18882,-0.14173,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.022172,-0.1889,-0.13404,1,0
5,GO STEROL TRANSPORT,0.010101,-0.18904,-0.16763,1,0
5,GO NEURON APOPTOTIC PROCESS,0.011063,-0.18919,-0.11032,1,0
5,GO CELL CELL SIGNALING,0.008797,-0.18935,-0.13319,1,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.015776,-0.18942,-0.19538,1,0
5,GO L AMINO ACID TRANSPORT,0.021265,-0.18962,-0.10302,1,0
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.017954,-0.18963,-0.14186,1,0
5,GO DRUG METABOLIC PROCESS,0.0042727,-0.18967,-0.20771,1,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0096484,-0.18968,-0.1287,1,0
5,GO REGULATION OF DNA BINDING,0.012106,-0.18973,-0.1239,1,0
5,GO HORMONE METABOLIC PROCESS,0.027226,-0.18979,-0.11969,1,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0096484,-0.18982,-0.16321,1,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0083971,-0.19029,-0.17153,1,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0036751,-0.19031,-0.14835,1,0
5,GO REGULATION OF MUSCLE ADAPTATION,0.052482,-0.19052,-0.09774,1,0
5,GO RESPONSE TO OXYGEN LEVELS,0.015776,-0.19073,-0.10043,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00332,-0.19081,-0.15411,1,0
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.013235,-0.19081,-0.11376,1,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.026142,-0.19099,-0.12387,1,0
5,GO LYSOSOMAL TRANSPORT,0.01266,-0.19118,-0.14459,1,0
5,GO RESPONSE TO DSRNA,0.024086,-0.19127,-0.13607,1,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0047188,-0.19128,-0.1678,1,0
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0052065,-0.19134,-0.13683,1,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.031957,-0.19143,-0.13084,1,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0049572,-0.19146,-0.14915,1,0
5,GO PLATELET MORPHOGENESIS,0.040368,-0.19167,-0.14212,1,0
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.031957,-0.1917,-0.12008,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.015776,-0.19173,-0.14236,1,0
5,GO POSTSYNAPSE ORGANIZATION,0.030713,-0.19191,-0.16192,1,0
5,GO CELLULAR RESPONSE TO DRUG,0.019548,-0.19207,-0.11589,1,0
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.011574,-0.19218,-0.10494,1,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.014457,-0.19225,-0.1206,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0054671,-0.19229,-0.15159,1,0
5,GO CELL CELL JUNCTION ORGANIZATION,0.027226,-0.19236,-0.12581,1,0
5,GO ORGAN INDUCTION,0.026142,-0.19236,-0.13023,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0054671,-0.19245,-0.14938,1,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.026142,-0.19277,-0.14328,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00096503,-0.19278,-0.19873,1,0
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0063209,-0.19298,-0.14444,1,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0052065,-0.19302,-0.15868,1,0
5,GO RECEPTOR RECYCLING,0.014457,-0.19317,-0.14075,1,0
5,GO APICAL PROTEIN LOCALIZATION,0.024086,-0.19326,-0.14047,1,0
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0172,-0.19338,-0.13618,1,0
5,GO REGULATION OF FIBROBLAST MIGRATION,0.011063,-0.19338,-0.16614,1,0
5,GO NEURON DEVELOPMENT,0.028348,-0.19342,-0.13129,1,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0096484,-0.19345,-0.13816,1,0
5,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.050584,-0.19347,-0.13413,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057394,-0.19365,-0.20373,1,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.02951,-0.19379,-0.13019,1,0
5,GO SOMITE DEVELOPMENT,0.014457,-0.1938,-0.16408,1,0
5,GO NEURON DIFFERENTIATION,0.027226,-0.19384,-0.12691,1,0
5,GO THYMUS DEVELOPMENT,0.033245,-0.194,-0.091842,1,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0080134,-0.19416,-0.11014,1,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0042727,-0.19424,-0.12903,1,0
5,GO MUSCLE ADAPTATION,0.021265,-0.19443,-0.12368,1,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.023112,-0.19454,-0.11716,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0054671,-0.19455,-0.19699,1,0
5,GO ETHER METABOLIC PROCESS,0.030713,-0.19472,-0.11869,1,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0049572,-0.1948,-0.14704,1,0
5,GO COCHLEA DEVELOPMENT,0.0096484,-0.19492,-0.18894,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024086,-0.1952,-0.11696,1,0
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0096484,-0.19528,-0.11885,1,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.013834,-0.1955,-0.1863,1,0
5,GO NEPHRON MORPHOGENESIS,0.0080134,-0.19554,-0.16058,1,0
5,GO CELL PART MORPHOGENESIS,0.035953,-0.19557,-0.13974,1,0
5,GO DNA DEAMINATION,0.050584,-0.1956,-0.1768,1,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0076456,-0.1957,-0.19867,1,0
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.0080134,-0.19582,-0.14872,1,0
5,GO REGULATION OF ION TRANSPORT,0.0083971,-0.19584,-0.13611,1,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.019548,-0.19593,-0.16865,1,0
5,GO CARNITINE METABOLIC PROCESS,0.037377,-0.19594,-0.16598,1,0
5,GO LIPID TRANSLOCATION,0.035953,-0.19596,-0.1659,1,0
5,GO FATTY ACID TRANSPORT,0.0080134,-0.19599,-0.14701,1,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.013235,-0.19616,-0.14204,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.023112,-0.19617,-0.19226,1,0
5,GO INTRACELLULAR LIPID TRANSPORT,0.030713,-0.19623,-0.13344,1,0
5,GO ENDOCYTIC RECYCLING,0.017954,-0.19632,-0.13067,1,0
5,GO CALCIUM ION IMPORT,0.025096,-0.1965,-0.13133,1,0
5,GO PROTEIN NITROSYLATION,0.028348,-0.19659,-0.16953,1,0
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0044907,-0.19673,-0.16066,1,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0066311,-0.19682,-0.14629,1,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.016475,-0.19686,-0.20046,1,0
5,GO PROTEOLYSIS,0.0047188,-0.1969,-0.12597,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0044907,-0.19704,-0.12704,1,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.0057394,-0.1971,-0.13881,1,0
5,GO PHOSPHOLIPID TRANSPORT,0.008797,-0.19724,-0.16127,1,0
5,GO HOMEOSTATIC PROCESS,0.0036751,-0.19738,-0.14954,1,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.006955,-0.19739,-0.15172,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.018736,-0.19744,-0.13781,1,0
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.028348,-0.19746,-0.11508,1,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.007293,-0.19747,-0.11558,1,0
5,GO PIGMENTATION,0.015104,-0.19748,-0.13089,1,0
5,GO HEART DEVELOPMENT,0.008797,-0.19751,-0.1579,1,0
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0017696,-0.19756,-0.18477,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.0054671,-0.19757,-0.22594,1,0
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.0063209,-0.19759,-0.15381,1,0
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.010101,-0.19769,-0.17072,1,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.0083971,-0.19781,-0.18538,1,0
5,GO SENSORY PERCEPTION OF PAIN,0.0042727,-0.19789,-0.1785,1,0
5,GO AUTOPHAGIC CELL DEATH,0.0066311,-0.19791,-0.19273,1,0
5,GO REGULATION OF PROTEIN IMPORT,0.0027019,-0.19794,-0.17011,1,0
5,GO SMOOTHENED SIGNALING PATHWAY,0.025096,-0.19819,-0.14712,1,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.026142,-0.19846,-0.15302,1,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.014457,-0.19857,-0.14843,1,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.028348,-0.19878,-0.20397,1,0
5,GO STEROL HOMEOSTASIS,0.011574,-0.19879,-0.17868,1,0
5,GO APOPTOTIC SIGNALING PATHWAY,0.0042727,-0.19886,-0.13765,1,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.016475,-0.19887,-0.14821,1,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0063209,-0.19892,-0.13909,1,0
5,GO RESPONSE TO METAL ION,0.018736,-0.19895,-0.092222,1,0
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0057394,-0.19895,-0.15441,1,0
5,GO CELL JUNCTION ASSEMBLY,0.027226,-0.19911,-0.14249,1,0
5,GO RESPONSE TO GLUCAGON,0.0063209,-0.19913,-0.19183,1,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.046961,-0.1992,-0.1651,1,0
5,GO SEX DIFFERENTIATION,0.0080134,-0.19922,-0.14847,1,0
5,GO RESPONSE TO NITROGEN COMPOUND,0.0044907,-0.19924,-0.13091,1,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.028348,-0.19924,-0.17703,1,0
5,GO NECROTIC CELL DEATH,0.037377,-0.19926,-0.14731,1,0
5,GO ANATOMICAL STRUCTURE MATURATION,0.006955,-0.19953,-0.14861,1,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.007293,-0.19958,-0.16345,1,0
5,GO DEVELOPMENTAL CELL GROWTH,0.031957,-0.1996,-0.13209,1,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.0038653,-0.19961,-0.13952,1,0
5,GO RETINAL METABOLIC PROCESS,0.031957,-0.19968,-0.24963,1,0
5,GO MAINTENANCE OF CELL NUMBER,0.0057394,-0.1997,-0.17708,1,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.010572,-0.19974,-0.1566,1,0
5,GO MUSCLE TISSUE DEVELOPMENT,0.008797,-0.20036,-0.14738,1,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00064645,-0.2005,-0.1831,1,0
5,GO ADAPTIVE THERMOGENESIS,0.011063,-0.20057,-0.12567,1,0
5,GO CELL JUNCTION ORGANIZATION,0.015776,-0.20074,-0.14823,1,0
5,GO RESPONSE TO INSULIN,0.014457,-0.20087,-0.10081,1,0
5,GO CELL PROJECTION ASSEMBLY,0.019548,-0.20092,-0.12756,1,0
5,GO MESODERM DEVELOPMENT,0.0063209,-0.20103,-0.13711,1,0
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0042727,-0.20105,-0.14536,1,0
5,GO APOPTOTIC PROCESS,0.0036751,-0.20109,-0.15402,1,0
5,GO NEUROBLAST DIVISION,0.018736,-0.20116,-0.2086,1,0
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0028457,-0.20138,-0.1618,1,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.030713,-0.20139,-0.13456,1,0
5,GO INSEMINATION,0.023112,-0.20146,-0.27178,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.033245,-0.20182,-0.11877,1,0
5,GO REGULATION OF NEURON DIFFERENTIATION,0.030713,-0.20187,-0.12742,1,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.027226,-0.20205,-0.13647,1,0
5,GO GROWTH,0.007293,-0.20227,-0.13968,1,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.007293,-0.20229,-0.23385,1,0
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.0052065,-0.20232,-0.17074,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.046961,-0.20242,-0.18865,1,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011063,-0.20254,-0.23514,1,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.017954,-0.2026,-0.13876,1,0
5,GO SENSORY ORGAN DEVELOPMENT,0.0054671,-0.2027,-0.16569,1,0
5,GO RESPONSE TO UV B,0.02951,-0.20284,-0.17691,1,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.045233,-0.20284,-0.13688,1,0
5,GO MESONEPHROS DEVELOPMENT,0.0083971,-0.20289,-0.15128,1,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.040368,-0.20292,-0.10259,1,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.008797,-0.20298,-0.24525,1,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0172,-0.20306,-0.20709,1,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0083971,-0.20307,-0.17667,1,0
5,GO ERYTHROCYTE HOMEOSTASIS,0.0096484,-0.20307,-0.12391,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0063209,-0.20315,-0.14915,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02951,-0.20338,-0.12359,1,0
5,GO TOXIN TRANSPORT,0.020391,-0.20345,-0.14129,1,0
5,GO MUSCLE HYPERTROPHY,0.030713,-0.20364,-0.11343,1,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.023112,-0.2037,-0.12402,1,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.02951,-0.20372,-0.16114,1,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.037377,-0.20373,-0.18785,1,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00332,-0.20378,-0.1735,1,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.012106,-0.20379,-0.14426,1,0
5,GO ANION HOMEOSTASIS,0.0052065,-0.20382,-0.18124,1,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0052065,-0.20401,-0.1482,1,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0096484,-0.2041,-0.14199,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.025096,-0.20431,-0.19096,1,0
5,GO MUSCLE ORGAN DEVELOPMENT,0.0054671,-0.20444,-0.15658,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.025096,-0.20445,-0.13663,1,0
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.008797,-0.20446,-0.14674,1,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.0080134,-0.20454,-0.12835,1,0
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0052065,-0.2046,-0.1572,1,0
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0054671,-0.2047,-0.15975,1,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.010101,-0.20481,-0.20322,1,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0036751,-0.20512,-0.15454,1,0
5,GO REGULATION OF SODIUM ION TRANSPORT,0.013235,-0.20527,-0.12539,1,0
5,GO GLAND DEVELOPMENT,0.010101,-0.20534,-0.14155,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.011063,-0.20546,-0.14654,1,0
5,GO NEUROGENESIS,0.0172,-0.2056,-0.13403,1,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.030713,-0.20567,-0.13767,1,0
5,GO NEURAL TUBE DEVELOPMENT,0.0092139,-0.20574,-0.17326,1,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.020391,-0.20577,-0.1761,1,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.007293,-0.20579,-0.14154,1,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.028348,-0.20581,-0.138,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.040368,-0.20585,-0.14769,1,0
5,GO ODONTOGENESIS,0.0042727,-0.20587,-0.23164,1,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0076456,-0.20591,-0.12167,1,0
5,GO NEUROBLAST PROLIFERATION,0.038848,-0.20591,-0.14937,1,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.011063,-0.20594,-0.14755,1,0
5,GO RESPONSE TO ANTIBIOTIC,0.0066311,-0.20602,-0.17164,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.010572,-0.20616,-0.17161,1,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0047188,-0.20643,-0.19565,1,0
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.012106,-0.20649,-0.14212,1,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.043559,-0.2066,-0.21783,1,0
5,GO NEGATIVE REGULATION OF CELL DEATH,0.0036751,-0.20661,-0.15932,1,0
5,GO RESPONSE TO CALCIUM ION,0.0172,-0.20662,-0.098933,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,0.0015882,-0.20663,-0.19604,1,0
5,GO ACTIN MEDIATED CELL CONTRACTION,0.033245,-0.2067,-0.1127,1,0
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.018736,-0.20671,-0.12202,1,0
5,GO REGULATION OF PROTEIN BINDING,0.0052065,-0.20674,-0.15176,1,0
5,GO SENSORY ORGAN MORPHOGENESIS,0.0092139,-0.207,-0.1638,1,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.028348,-0.20717,-0.14096,1,0
5,GO TISSUE MORPHOGENESIS,0.0057394,-0.20726,-0.16423,1,0
5,GO REGULATION OF HAIR CYCLE,0.0076456,-0.20744,-0.19862,1,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.022172,-0.20748,-0.27794,1,0
5,GO REGULATION OF BINDING,0.0060238,-0.20758,-0.13426,1,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.019548,-0.20772,-0.18474,1,0
5,GO LINOLEIC ACID METABOLIC PROCESS,0.035953,-0.20775,-0.16829,1,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0063209,-0.20778,-0.13316,1,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.010101,-0.20791,-0.16462,1,0
5,GO PROTEIN POLYMERIZATION,0.0047188,-0.20794,-0.1323,1,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0172,-0.20796,-0.19946,1,0
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.014457,-0.20812,-0.10307,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0063209,-0.20838,-0.14104,1,0
5,GO NEURON PROJECTION ORGANIZATION,0.046961,-0.20842,-0.13919,1,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.011574,-0.20842,-0.13217,1,0
5,GO CELL CELL SIGNALING BY WNT,0.0060238,-0.20843,-0.14833,1,0
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0036751,-0.20844,-0.14861,1,0
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.02951,-0.20845,-0.21791,1,0
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.033245,-0.2085,-0.12341,1,0
5,GO ETHANOL CATABOLIC PROCESS,0.043559,-0.20858,-0.22092,1,0
5,GO MYELOID CELL HOMEOSTASIS,0.0080134,-0.20865,-0.14394,1,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.021265,-0.2087,-0.11057,1,0
5,GO REGULATION OF DNA RECOMBINATION,0.025096,-0.20883,-0.13478,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.013235,-0.20884,-0.13409,1,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0049572,-0.20898,-0.14196,1,0
5,GO PLACENTA DEVELOPMENT,0.0060238,-0.20905,-0.16643,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.040368,-0.20906,-0.15976,1,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.031957,-0.20919,-0.12301,1,0
5,GO RESPONSE TO OXIDATIVE STRESS,0.006955,-0.20952,-0.14328,1,0
5,GO COGNITION,0.010572,-0.20956,-0.14932,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0042727,-0.20965,-0.14014,1,0
5,GO CELL PROJECTION ORGANIZATION,0.014457,-0.20969,-0.13647,1,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.012106,-0.20974,-0.14481,1,0
5,GO EMBRYONIC MORPHOGENESIS,0.0057394,-0.20986,-0.17277,1,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0052065,-0.20988,-0.142,1,0
5,GO DRUG CATABOLIC PROCESS,0.00332,-0.20989,-0.2209,1,0
5,GO LIPID MODIFICATION,0.0096484,-0.20993,-0.12807,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.011574,-0.20997,-0.193,1,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.028348,-0.21008,-0.20935,1,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.010572,-0.21023,-0.13522,1,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.022172,-0.21028,-0.28076,1,0
5,GO COPPER ION TRANSPORT,0.015776,-0.21041,-0.19966,1,0
5,GO RESPONSE TO ACID CHEMICAL,0.0014241,-0.21048,-0.16351,1,0
5,GO DISTAL TUBULE DEVELOPMENT,0.040368,-0.2105,-0.32293,1,0
5,GO AGING,0.0049572,-0.21058,-0.15408,1,0
5,GO RIG I SIGNALING PATHWAY,0.0052065,-0.21073,-0.18728,1,0
5,GO EAR DEVELOPMENT,0.010101,-0.2108,-0.14208,1,0
5,GO ERBB2 SIGNALING PATHWAY,0.012106,-0.21088,-0.15889,1,0
5,GO TRANSPOSITION,0.0066311,-0.21103,-0.18681,1,0
5,GO RESPONSE TO GROWTH HORMONE,0.027226,-0.21125,-0.13032,1,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.021265,-0.2114,-0.18245,1,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0092139,-0.21172,-0.12134,1,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.008797,-0.21192,-0.17353,1,0
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.0057394,-0.21194,-0.18397,1,0
5,GO CELL FATE COMMITMENT,0.010572,-0.21196,-0.15735,1,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.012106,-0.21206,-0.1902,1,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.014457,-0.21207,-0.16604,1,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0044907,-0.21209,-0.13678,1,0
5,GO REGULATION OF CELL DEATH,0.0029965,-0.21219,-0.16818,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0052065,-0.21231,-0.15939,1,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.01266,-0.21236,-0.15787,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0092139,-0.21238,-0.17371,1,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.016475,-0.21243,-0.17922,1,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0092139,-0.21258,-0.16698,1,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0031545,-0.21291,-0.18018,1,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.052482,-0.21298,-0.20081,1,0
5,GO RESPONSE TO DEXAMETHASONE,0.0096484,-0.21321,-0.20341,1,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.031957,-0.21321,-0.13196,1,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0083971,-0.21325,-0.14158,1,0
5,GO REGULATION OF ENDOCYTOSIS,0.0031545,-0.21331,-0.17392,1,0
5,GO AUTOPHAGOSOME MATURATION,0.019548,-0.21334,-0.13384,1,0
5,GO POSITIVE REGULATION OF TRANSPORT,0.0047188,-0.21336,-0.1595,1,0
5,GO COPPER ION HOMEOSTASIS,0.0027019,-0.2134,-0.17533,1,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.048745,-0.21361,-0.18145,1,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0054671,-0.21362,-0.18325,1,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0029965,-0.2137,-0.16271,1,0
5,GO COLLECTING DUCT DEVELOPMENT,0.026142,-0.21371,-0.28822,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.020391,-0.21425,-0.14677,1,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0063209,-0.21442,-0.15154,1,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.048745,-0.21452,-0.16788,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0076456,-0.21466,-0.17896,1,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0031545,-0.21468,-0.1544,1,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.031957,-0.21468,-0.14164,1,0
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.0054671,-0.21471,-0.14313,1,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.043559,-0.21474,-0.16417,1,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0040644,-0.21479,-0.13836,1,0
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.019548,-0.2148,-0.15427,1,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.020391,-0.21505,-0.1651,1,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.011574,-0.21512,-0.18077,1,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.01266,-0.21535,-0.15082,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.031957,-0.21542,-0.15506,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0066311,-0.21543,-0.21197,1,0
5,GO SKIN EPIDERMIS DEVELOPMENT,0.020391,-0.21553,-0.15365,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.0052065,-0.21556,-0.16,1,0
5,GO PROTEIN PROCESSING,0.012106,-0.21558,-0.15421,1,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.016475,-0.21559,-0.1979,1,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0040644,-0.21561,-0.14864,1,0
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0025648,-0.21577,-0.16997,1,0
5,GO SECONDARY PALATE DEVELOPMENT,0.027226,-0.21597,-0.18204,1,0
5,GO RESPONSE TO ACIDIC PH,0.041938,-0.21605,-0.17917,1,0
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0047188,-0.21641,-0.15982,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.011063,-0.21643,-0.12696,1,0
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0036751,-0.21649,-0.15596,1,0
5,GO CELL AGGREGATION,0.019548,-0.21649,-0.23503,1,0
5,GO RESPONSE TO THYROID HORMONE,0.008797,-0.21677,-0.17422,1,0
5,GO REGULATION OF SECRETION,0.0080134,-0.21681,-0.13673,1,0
5,GO DEVELOPMENTAL GROWTH,0.0092139,-0.21707,-0.15247,1,0
5,GO EMBRYONIC BODY MORPHOGENESIS,0.035953,-0.21728,-0.18939,1,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.035953,-0.21744,-0.14524,1,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.006955,-0.21749,-0.1665,1,0
5,GO RENAL TUBULE DEVELOPMENT,0.01266,-0.21775,-0.16218,1,0
5,GO RESPONSE TO PEPTIDE HORMONE,0.007293,-0.21779,-0.12844,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.008797,-0.21779,-0.17186,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.007293,-0.21787,-0.19228,1,0
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0023095,-0.21795,-0.20195,1,0
5,GO CARDIOCYTE DIFFERENTIATION,0.01266,-0.21822,-0.14155,1,0
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.01266,-0.21825,-0.20569,1,0
5,GO RESPONSE TO STEROID HORMONE,0.0052065,-0.21847,-0.17895,1,0
5,GO PROTEIN DEMANNOSYLATION,0.01266,-0.21859,-0.15904,1,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.030713,-0.21865,-0.12253,1,0
5,GO FUCOSE METABOLIC PROCESS,0.0172,-0.2187,-0.16604,1,0
5,GO PEPTIDE SECRETION,0.0076456,-0.21877,-0.14729,1,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.033245,-0.2188,-0.13509,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.02951,-0.21903,-0.14513,1,0
5,GO GLIAL CELL DEVELOPMENT,0.0060238,-0.21905,-0.1622,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.028348,-0.21907,-0.13966,1,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.018736,-0.21911,-0.22976,1,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0038653,-0.21948,-0.18132,1,0
5,GO REGULATION OF CELL DEVELOPMENT,0.010101,-0.21954,-0.14656,1,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00091199,-0.21965,-0.18925,1,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0080134,-0.21974,-0.16998,1,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0083971,-0.21979,-0.17646,1,0
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0044907,-0.21983,-0.17081,1,0
5,GO ACTIN CROSSLINK FORMATION,0.024086,-0.21996,-0.16669,1,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.018736,-0.21996,-0.24526,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0063209,-0.22003,-0.15568,1,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0025648,-0.22026,-0.18005,1,0
5,GO CIRCULATORY SYSTEM PROCESS,0.0054671,-0.22032,-0.16523,1,0
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0057394,-0.22045,-0.13757,1,0
5,GO PARTURITION,0.020391,-0.22061,-0.21073,1,0
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0029965,-0.22064,-0.15713,1,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0083971,-0.22073,-0.16911,1,0
5,GO EPITHELIAL CELL DEVELOPMENT,0.013834,-0.2208,-0.14958,1,0
5,GO RESPONSE TO ETHANOL,0.0052065,-0.22097,-0.15903,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.011574,-0.22098,-0.18765,1,0
5,GO REGULATION OF PINOCYTOSIS,0.037377,-0.22106,-0.17795,1,0
5,GO AXON EXTENSION,0.020391,-0.22107,-0.18397,1,0
5,GO RESPONSE TO VITAMIN A,0.0052065,-0.22113,-0.19368,1,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0092139,-0.22118,-0.15951,1,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.008797,-0.22127,-0.149,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.010572,-0.22138,-0.16084,1,0
5,GO SOMITOGENESIS,0.0060238,-0.22144,-0.18418,1,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.011063,-0.22145,-0.23299,1,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0092139,-0.22161,-0.16748,1,0
5,GO ACTIN FILAMENT BASED MOVEMENT,0.013235,-0.22166,-0.14978,1,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.011063,-0.22167,-0.20379,1,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.007293,-0.22169,-0.15235,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0060238,-0.22183,-0.135,1,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0060238,-0.22197,-0.15879,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.02951,-0.222,-0.1333,1,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.024086,-0.22218,-0.17951,1,0
5,GO NEGATIVE REGULATION OF SIGNALING,0.00332,-0.22221,-0.16129,1,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.0038653,-0.22225,-0.22749,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0042727,-0.2223,-0.22477,1,0
5,GO AMELOGENESIS,0.013235,-0.2223,-0.18307,1,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.010101,-0.22242,-0.15825,1,0
5,GO EXPLORATION BEHAVIOR,0.0080134,-0.22257,-0.24757,1,0
5,GO OSTEOBLAST DIFFERENTIATION,0.0038653,-0.22258,-0.2053,1,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0036751,-0.22259,-0.15872,1,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0031545,-0.22267,-0.18915,1,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.0060238,-0.22278,-0.17533,1,0
5,GO SECRETION BY TISSUE,0.0036751,-0.22295,-0.21923,1,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.011574,-0.22296,-0.17262,1,0
5,GO DORSAL AORTA DEVELOPMENT,0.048745,-0.22308,-0.15082,1,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.007293,-0.22319,-0.23466,1,0
5,GO POSITIVE REGULATION OF GROWTH,0.007293,-0.22328,-0.16694,1,0
5,GO V D J RECOMBINATION,0.023112,-0.22333,-0.21706,1,0
5,GO WATER HOMEOSTASIS,0.019548,-0.22335,-0.17459,1,0
5,GO LIPID PHOSPHORYLATION,0.0052065,-0.22344,-0.16926,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.007293,-0.22349,-0.22619,1,0
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0096484,-0.22355,-0.14499,1,0
5,GO ECTODERM DEVELOPMENT,0.020391,-0.22365,-0.1467,1,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.0018673,-0.22367,-0.18279,1,0
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.020391,-0.22369,-0.16223,1,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.017954,-0.22383,-0.17641,1,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.019548,-0.22394,-0.14102,1,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.031957,-0.22397,-0.15759,1,0
5,GO SPLEEN DEVELOPMENT,0.020391,-0.22402,-0.12604,1,0
5,GO ARGININE METABOLIC PROCESS,0.0063209,-0.22418,-0.19965,1,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0172,-0.2242,-0.18929,1,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.043559,-0.22427,-0.14208,1,0
5,GO DEVELOPMENTAL MATURATION,0.017954,-0.22463,-0.12648,1,0
5,GO PLASMA MEMBRANE ORGANIZATION,0.025096,-0.22476,-0.12611,1,0
5,GO CHEMICAL HOMEOSTASIS,0.0038653,-0.22504,-0.16205,1,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0029965,-0.22563,-0.17289,1,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.038848,-0.22567,-0.18743,1,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0063209,-0.22571,-0.15352,1,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.011574,-0.22576,-0.20871,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0054671,-0.22582,-0.1523,1,0
5,GO MESODERM MORPHOGENESIS,0.0054671,-0.22591,-0.1831,1,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.0092139,-0.22595,-0.26489,1,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.007293,-0.22611,-0.1955,1,0
5,GO DIGESTION,0.024086,-0.22617,-0.15428,1,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.019548,-0.22623,-0.16166,1,0
5,GO REGULATION OF TRANSPOSITION,0.0042727,-0.22623,-0.21255,1,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0027019,-0.2264,-0.17026,1,0
5,GO PROTEIN DEGLYCOSYLATION,0.0080134,-0.22656,-0.18477,1,0
5,GO PARAXIAL MESODERM DEVELOPMENT,0.011574,-0.22667,-0.18585,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.050584,-0.22677,-0.14173,1,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.012106,-0.22681,-0.21498,1,0
5,GO FIBROBLAST MIGRATION,0.010572,-0.22692,-0.17163,1,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0025648,-0.22698,-0.17553,1,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.050584,-0.22705,-0.13029,1,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.015104,-0.22708,-0.17438,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0028457,-0.22709,-0.16439,1,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.025096,-0.22712,-0.16462,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0017696,-0.22715,-0.25246,1,0
5,GO CAMERA TYPE EYE DEVELOPMENT,0.006955,-0.22717,-0.18205,1,0
5,GO REGULATION OF BLOOD PRESSURE,0.0044907,-0.22737,-0.18287,1,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0049572,-0.22751,-0.14866,1,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0044907,-0.22752,-0.15905,1,0
5,GO MUSCLE CELL DIFFERENTIATION,0.011063,-0.22753,-0.13351,1,0
5,GO RESPONSE TO DRUG,0.0042727,-0.22757,-0.16339,1,0
5,GO FEMALE SEX DIFFERENTIATION,0.0031545,-0.22757,-0.20429,1,0
5,GO RESPONSE TO GROWTH FACTOR,0.0025648,-0.22768,-0.18972,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0076456,-0.22788,-0.12825,1,0
5,GO POSITIVE REGULATION OF SECRETION,0.013235,-0.2279,-0.1389,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.0057394,-0.22796,-0.15716,1,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.024086,-0.22801,-0.1498,1,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.050584,-0.22804,-0.10638,1,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.0076456,-0.22816,-0.2262,1,0
5,GO MULTICELLULAR ORGANISM GROWTH,0.041938,-0.22819,-0.11134,1,0
5,GO TEMPERATURE HOMEOSTASIS,0.006955,-0.22838,-0.13841,1,0
5,GO LOCALIZATION WITHIN MEMBRANE,0.0036751,-0.22843,-0.21605,1,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.0023095,-0.22846,-0.19115,1,0
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0060238,-0.22846,-0.17533,1,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.013834,-0.22862,-0.18685,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.019548,-0.22903,-0.15201,1,0
5,GO SPECIFICATION OF SYMMETRY,0.010572,-0.22918,-0.16517,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0031545,-0.2293,-0.1649,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.025096,-0.22932,-0.15092,1,0
5,GO RESPONSE TO KETONE,0.0057394,-0.22937,-0.20322,1,0
5,GO LONG TERM SYNAPTIC POTENTIATION,0.031957,-0.22951,-0.1669,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0060238,-0.22958,-0.17561,1,0
5,GO RESPONSE TO HORMONE,0.0060238,-0.22961,-0.15377,1,0
5,GO LEFT RIGHT PATTERN FORMATION,0.037377,-0.22966,-0.13542,1,0
5,GO APPENDAGE DEVELOPMENT,0.0076456,-0.2298,-0.20156,1,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0052065,-0.22981,-0.1412,1,0
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0018673,-0.22983,-0.30334,1,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.018736,-0.22993,-0.16166,1,0
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.007293,-0.22997,-0.16449,1,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.050584,-0.23003,-0.20982,1,0
5,GO APPENDAGE MORPHOGENESIS,0.0080134,-0.23057,-0.22014,1,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0083971,-0.23089,-0.17577,1,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013235,-0.2311,-0.16678,1,0
5,GO PANCREATIC JUICE SECRETION,0.035953,-0.23118,-0.19326,1,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.01266,-0.23151,-0.15187,1,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.027226,-0.23156,-0.20342,1,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0017696,-0.23156,-0.19644,1,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.007293,-0.23161,-0.21965,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0044907,-0.2317,-0.16851,1,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0042727,-0.23173,-0.15662,1,0
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0036751,-0.23184,-0.17084,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0057394,-0.23184,-0.14594,1,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.025096,-0.23196,-0.16846,1,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0052065,-0.23212,-0.17738,1,0
5,GO CAMP METABOLIC PROCESS,0.015776,-0.23213,-0.22449,1,0
5,GO RESPONSE TO PEPTIDE,0.0057394,-0.23224,-0.14714,1,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.018736,-0.23237,-0.20741,1,0
5,GO REGULATION OF GASTRULATION,0.0060238,-0.23238,-0.20848,1,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.011063,-0.23245,-0.19201,1,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.006955,-0.23245,-0.18094,1,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.0063209,-0.23252,-0.15502,1,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.016475,-0.23263,-0.23412,1,0
5,GO RECEPTOR METABOLIC PROCESS,0.0021907,-0.23278,-0.1751,1,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.035953,-0.23285,-0.14419,1,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0096484,-0.23288,-0.15371,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.010101,-0.23292,-0.26125,1,0
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.0038653,-0.23304,-0.18459,1,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0096484,-0.2334,-0.19321,1,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0049572,-0.2335,-0.18615,1,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.013834,-0.2336,-0.20599,1,0
5,GO CALCINEURIN MEDIATED SIGNALING,0.020391,-0.23362,-0.16953,1,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00076864,-0.23379,-0.19363,1,0
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0044907,-0.23401,-0.15877,1,0
5,GO REGULATION OF METAL ION TRANSPORT,0.0040644,-0.23403,-0.17614,1,0
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.011574,-0.23408,-0.18103,1,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.046961,-0.23413,-0.16864,1,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.038848,-0.23422,-0.12162,1,0
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0031545,-0.23429,-0.1546,1,0
5,GO RESPONSE TO ALCOHOL,0.0038653,-0.23431,-0.19779,1,0
5,GO REGULATION OF RESPONSE TO STRESS,0.0036751,-0.23442,-0.18249,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00332,-0.23446,-0.16302,1,0
5,GO CANONICAL WNT SIGNALING PATHWAY,0.0038653,-0.23455,-0.17614,1,0
5,GO CARDIAC SEPTUM DEVELOPMENT,0.008797,-0.23455,-0.20913,1,0
5,GO STEROID ESTERIFICATION,0.023112,-0.23456,-0.1881,1,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00051151,-0.23464,-0.20356,1,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0044907,-0.23476,-0.19927,1,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.034576,-0.23492,-0.16695,1,0
5,GO KIDNEY MORPHOGENESIS,0.006955,-0.23497,-0.18122,1,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0047188,-0.23506,-0.17311,1,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0047188,-0.23511,-0.23146,1,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036751,-0.2352,-0.21714,1,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0034935,-0.23529,-0.17986,1,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.008797,-0.23538,-0.1557,1,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.016475,-0.23539,-0.18149,1,0
5,GO LIPID LOCALIZATION,0.0076456,-0.2354,-0.15523,1,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.035953,-0.23548,-0.13537,1,0
5,GO TRANSCYTOSIS,0.0172,-0.23553,-0.22133,1,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.041938,-0.23562,-0.27083,1,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.0047188,-0.23575,-0.20014,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.0063209,-0.2358,-0.17251,1,0
5,GO FEMALE GENITALIA DEVELOPMENT,0.0080134,-0.23628,-0.19811,1,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.052482,-0.23647,-0.16598,1,0
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.010572,-0.23661,-0.15507,1,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.0052065,-0.23692,-0.16537,1,0
5,GO REGULATION OF SYMBIOTIC PROCESS,0.0024341,-0.23692,-0.21109,1,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.00028019,-0.23696,-0.24526,1,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0076456,-0.23699,-0.15303,1,0
5,GO RESPONSE TO AUDITORY STIMULUS,0.02951,-0.23701,-0.18927,1,0
5,GO HEART GROWTH,0.007293,-0.23705,-0.15477,1,0
5,GO ANIMAL ORGAN MORPHOGENESIS,0.0038653,-0.23709,-0.1845,1,0
5,GO RESPONSE TO OSMOTIC STRESS,0.0054671,-0.23719,-0.17401,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0047188,-0.23738,-0.18123,1,0
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0038653,-0.23746,-0.15752,1,0
5,GO RESPONSE TO ISCHEMIA,0.027226,-0.23757,-0.13984,1,0
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0063209,-0.23768,-0.14857,1,0
5,GO ESTABLISHMENT OF CELL POLARITY,0.0066311,-0.23768,-0.16202,1,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0027019,-0.23771,-0.1719,1,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0027019,-0.23778,-0.18451,1,0
5,GO RESPONSE TO ESTRADIOL,0.0024341,-0.23798,-0.19735,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0038653,-0.23809,-0.1545,1,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0054671,-0.23814,-0.16286,1,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.006955,-0.23817,-0.19799,1,0
5,GO MESENCHYMAL CELL PROLIFERATION,0.008797,-0.23817,-0.25617,1,0
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.026142,-0.23818,-0.16112,1,0
5,GO ENDOTHELIUM DEVELOPMENT,0.0076456,-0.23821,-0.20814,1,0
5,GO GLIAL CELL DIFFERENTIATION,0.007293,-0.23829,-0.16228,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0047188,-0.23842,-0.18015,1,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.015776,-0.23854,-0.21946,1,0
5,GO NEURAL TUBE PATTERNING,0.0096484,-0.23863,-0.22515,1,0
5,GO MESENCHYME MORPHOGENESIS,0.016475,-0.23866,-0.20477,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0060238,-0.23877,-0.1625,1,0
5,GO CELLULAR ION HOMEOSTASIS,0.0034935,-0.23878,-0.18999,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.015776,-0.239,-0.16648,1,0
5,GO AXON DEVELOPMENT,0.016475,-0.2391,-0.1734,1,0
5,GO REGULATION OF GLIOGENESIS,0.0024341,-0.2393,-0.19578,1,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.0057394,-0.23952,-0.1774,1,0
5,GO ION HOMEOSTASIS,0.0028457,-0.23974,-0.18944,1,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.0052065,-0.23985,-0.20464,1,0
5,GO PRO B CELL DIFFERENTIATION,0.013235,-0.23994,-0.24802,1,0
5,GO REGULATION OF PROTEOLYSIS,0.0038653,-0.24006,-0.16478,1,0
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0034935,-0.2401,-0.16272,1,0
5,GO MAINTENANCE OF LOCATION,0.0047188,-0.24013,-0.17352,1,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.017954,-0.24025,-0.17674,1,0
5,GO NIK NF KAPPAB SIGNALING,0.0011418,-0.24027,-0.22906,1,0
5,GO REGULATION OF HYDROLASE ACTIVITY,0.0021907,-0.24033,-0.18444,1,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.011574,-0.2405,-0.18187,1,0
5,GO REGULATION OF PHOSPHORYLATION,0.0029965,-0.24059,-0.17523,1,0
5,GO STEM CELL PROLIFERATION,0.0083971,-0.24065,-0.18095,1,0
5,GO ATRIAL SEPTUM DEVELOPMENT,0.011063,-0.24067,-0.2255,1,0
5,GO NEURON PROJECTION GUIDANCE,0.019548,-0.24068,-0.20568,1,0
5,GO HINDLIMB MORPHOGENESIS,0.016475,-0.24079,-0.21983,1,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0052065,-0.24083,-0.23561,1,0
5,GO TONGUE DEVELOPMENT,0.0060238,-0.24095,-0.22463,1,0
5,GO REGULATION OF CELL SIZE,0.007293,-0.24098,-0.19619,1,0
5,GO CELL MORPHOGENESIS,0.0076456,-0.24099,-0.1709,1,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0042727,-0.24107,-0.14964,1,0
5,GO DIGESTIVE SYSTEM PROCESS,0.020391,-0.2411,-0.15549,1,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0096484,-0.24111,-0.14804,1,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0047188,-0.24112,-0.1909,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.018736,-0.24114,-0.19951,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0044907,-0.24133,-0.14673,1,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.011574,-0.24148,-0.17326,1,0
5,GO AMYLOID BETA METABOLIC PROCESS,0.0080134,-0.24169,-0.17339,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00332,-0.24173,-0.19915,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0040644,-0.24188,-0.18455,1,0
5,GO AORTA MORPHOGENESIS,0.021265,-0.24192,-0.22196,1,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0057394,-0.24205,-0.18997,1,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0024341,-0.24214,-0.19162,1,0
5,GO REGULATION OF AXONOGENESIS,0.031957,-0.24214,-0.17749,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0083971,-0.24215,-0.13085,1,0
5,GO BODY FLUID SECRETION,0.0080134,-0.24217,-0.16123,1,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0034935,-0.24234,-0.19808,1,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.025096,-0.24239,-0.24312,1,0
5,GO GASTRULATION,0.0034935,-0.24248,-0.22503,1,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0066311,-0.24252,-0.18581,1,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0034935,-0.24252,-0.16824,1,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.027226,-0.24274,-0.2183,1,0
5,GO CELL CELL RECOGNITION,0.0019699,-0.24292,-0.23742,1,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.040368,-0.24355,-0.14386,1,0
5,GO SEGMENTATION,0.0020776,-0.24356,-0.21615,1,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.010572,-0.24371,-0.18297,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.015776,-0.24372,-0.16596,1,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.008797,-0.24374,-0.24585,1,0
5,GO REGULATION OF ORGAN GROWTH,0.0028457,-0.24385,-0.17961,1,0
5,GO SECRETION,0.0049572,-0.2439,-0.17555,1,0
5,GO CELL VOLUME HOMEOSTASIS,0.0092139,-0.24399,-0.19892,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0028457,-0.24407,-0.17631,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0076456,-0.24424,-0.2001,1,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.028348,-0.24427,-0.19382,1,0
5,GO HEART TRABECULA MORPHOGENESIS,0.031957,-0.24429,-0.19748,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0027019,-0.24443,-0.26016,1,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.011063,-0.2445,-0.18186,1,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.015776,-0.24452,-0.16529,1,0
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.0047188,-0.2446,-0.17086,1,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.006955,-0.24472,-0.18396,1,0
5,GO POSITIVE REGULATION OF SIGNALING,0.00332,-0.24502,-0.17729,1,0
5,GO VIRAL LIFE CYCLE,0.0036751,-0.24512,-0.19355,1,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0027019,-0.24524,-0.20984,1,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.048745,-0.2454,-0.20668,1,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0052065,-0.24541,-0.17718,1,0
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0029965,-0.24558,-0.16938,1,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0020776,-0.24571,-0.21571,1,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014457,-0.24573,-0.17108,1,0
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,-0.24594,-0.1911,1,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0029965,-0.24604,-0.32368,1,0
5,GO STEM CELL DIFFERENTIATION,0.0013481,-0.24615,-0.20123,1,0
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0057394,-0.24665,-0.20835,1,0
5,GO PROTEIN ADP RIBOSYLATION,0.0024341,-0.24683,-0.20272,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.011063,-0.24686,-0.25434,1,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0042727,-0.24693,-0.23817,1,0
5,GO REGULATION OF LIPID TRANSPORT,0.0052065,-0.24695,-0.19987,1,0
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0028457,-0.2471,-0.18162,1,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0047188,-0.24742,-0.21717,1,0
5,GO HIPPO SIGNALING,0.007293,-0.24753,-0.23774,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE,0.0052065,-0.24782,-0.14701,1,0
5,GO MYOTUBE DIFFERENTIATION,0.0066311,-0.24789,-0.20465,1,0
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00332,-0.2479,-0.16954,1,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.052482,-0.24793,-0.15768,1,0
5,GO SENSORY SYSTEM DEVELOPMENT,0.0044907,-0.24797,-0.19632,1,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.013834,-0.24801,-0.25525,1,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.0014241,-0.24807,-0.21788,1,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.006955,-0.2484,-0.22574,1,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.025096,-0.24857,-0.16316,1,0
5,GO RESPONSE TO INTERLEUKIN 7,0.030713,-0.24872,-0.19235,1,0
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0057394,-0.24883,-0.1767,1,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.008797,-0.24885,-0.17809,1,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.052482,-0.24899,-0.17361,1,0
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0047188,-0.24926,-0.19751,1,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.010572,-0.24936,-0.15346,1,0
5,GO KERATINOCYTE PROLIFERATION,0.0080134,-0.2494,-0.24118,1,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0024341,-0.24962,-0.20699,1,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0172,-0.24965,-0.17735,1,0
5,GO EPITHELIAL CELL PROLIFERATION,0.00332,-0.24965,-0.21885,1,0
5,GO GANGLIOSIDE METABOLIC PROCESS,0.0096484,-0.24973,-0.16305,1,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0025648,-0.24981,-0.20272,1,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0042727,-0.24984,-0.17431,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.015776,-0.24987,-0.18695,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0028457,-0.24989,-0.2469,1,0
5,GO NEGATIVE REGULATION OF TRANSPORT,0.0021907,-0.25002,-0.16963,1,0
5,GO FAT CELL DIFFERENTIATION,0.007293,-0.25008,-0.17318,1,0
5,GO ACTIVATION OF JNKK ACTIVITY,0.0066311,-0.25027,-0.2132,1,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.018736,-0.25033,-0.19607,1,0
5,GO VIRAL GENOME REPLICATION,0.0042727,-0.25034,-0.20324,1,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0028457,-0.25071,-0.23075,1,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.02951,-0.25073,-0.15669,1,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.0080134,-0.25081,-0.17332,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0023095,-0.25081,-0.19157,1,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.020391,-0.25082,-0.20124,1,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0015041,-0.25092,-0.2892,1,0
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0172,-0.25119,-0.22192,1,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.013834,-0.25128,-0.24951,1,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.008797,-0.25147,-0.17215,1,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.0060238,-0.25161,-0.18521,1,0
5,GO CHOLESTEROL EFFLUX,0.025096,-0.25176,-0.1798,1,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016475,-0.25182,-0.16283,1,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0038653,-0.25192,-0.22732,1,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0031545,-0.25195,-0.19691,1,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0080134,-0.25216,-0.1947,1,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0038653,-0.2522,-0.22254,1,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0083971,-0.25229,-0.20139,1,0
5,GO RECEPTOR INTERNALIZATION,0.0012758,-0.2525,-0.21101,1,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0049572,-0.25252,-0.17526,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0024341,-0.25254,-0.18344,1,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.0038653,-0.25259,-0.18802,1,0
5,GO PROSTAGLANDIN TRANSPORT,0.038848,-0.25268,-0.18721,1,0
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0031545,-0.25282,-0.18017,1,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.030713,-0.25283,-0.19681,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.007293,-0.25284,-0.16997,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0017696,-0.25288,-0.20326,1,0
5,GO BODY MORPHOGENESIS,0.0054671,-0.25291,-0.25588,1,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0024341,-0.25306,-0.27124,1,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0044907,-0.25322,-0.18169,1,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0011418,-0.25333,-0.22831,1,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.025096,-0.25341,-0.23602,1,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0034935,-0.25351,-0.24068,1,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0015882,-0.25368,-0.24033,1,0
5,GO PROTEIN TARGETING TO LYSOSOME,0.025096,-0.25389,-0.16958,1,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.030713,-0.25394,-0.1819,1,0
5,GO NEURON RECOGNITION,0.0092139,-0.25401,-0.22813,1,0
5,GO ACTIN FILAMENT ORGANIZATION,0.00332,-0.25409,-0.18582,1,0
5,GO ORGANIC CATION TRANSPORT,0.015104,-0.25409,-0.18734,1,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.021265,-0.25423,-0.18662,1,0
5,GO ENDOCRINE PROCESS,0.035953,-0.25442,-0.1551,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.0172,-0.2545,-0.17572,1,0
5,GO POST EMBRYONIC DEVELOPMENT,0.0172,-0.25457,-0.16556,1,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.010572,-0.25487,-0.23503,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013834,-0.25488,-0.20729,1,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.033245,-0.25494,-0.21533,1,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.0036751,-0.25496,-0.25176,1,0
5,GO TERPENOID METABOLIC PROCESS,0.0040644,-0.25507,-0.18682,1,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.00332,-0.25507,-0.19792,1,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.0029965,-0.25514,-0.2184,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.010101,-0.25528,-0.2072,1,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.043559,-0.2553,-0.14833,1,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0028457,-0.25538,-0.24162,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.006955,-0.2555,-0.20118,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.034576,-0.25561,-0.20909,1,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.034576,-0.25562,-0.17418,1,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.015776,-0.25568,-0.15942,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.025096,-0.25572,-0.17697,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0080134,-0.25577,-0.21701,1,0
5,GO HYPOTONIC RESPONSE,0.0049572,-0.25607,-0.25802,1,0
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0021907,-0.25611,-0.20755,1,0
5,GO METANEPHROS MORPHOGENESIS,0.0047188,-0.25613,-0.24301,1,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0012758,-0.25624,-0.2112,1,0
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.011574,-0.25626,-0.13033,1,0
5,GO REGULATION OF TUBE SIZE,0.0063209,-0.25643,-0.19449,1,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.015776,-0.25665,-0.18646,1,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0049572,-0.25686,-0.19835,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.006955,-0.25686,-0.17637,1,0
5,GO RNA DESTABILIZATION,0.033245,-0.25698,-0.17133,1,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.011063,-0.25706,-0.21565,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0034935,-0.25707,-0.19083,1,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.034576,-0.25733,-0.18519,1,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.0076456,-0.25734,-0.2222,1,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0049572,-0.25737,-0.22598,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0029965,-0.25769,-0.18596,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0038653,-0.2579,-0.19918,1,0
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0034935,-0.25794,-0.20133,1,0
5,GO RETINOL METABOLIC PROCESS,0.0027019,-0.25799,-0.24672,1,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.013834,-0.258,-0.15169,1,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.016475,-0.25808,-0.22444,1,0
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0036751,-0.25823,-0.17997,1,0
5,GO NERVE DEVELOPMENT,0.034576,-0.25823,-0.17448,1,0
5,GO BIOMINERALIZATION,0.0083971,-0.25832,-0.19324,1,0
5,GO POSITIVE REGULATION OF CELL DEATH,0.0023095,-0.25847,-0.20556,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0027019,-0.25855,-0.29687,1,0
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0042727,-0.25885,-0.29485,1,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.021265,-0.25896,-0.24571,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00068502,-0.25917,-0.2686,1,0
5,GO RESPONSE TO NUTRIENT,0.0040644,-0.2592,-0.21328,1,0
5,GO CELLULAR RESPONSE TO DSRNA,0.015104,-0.25926,-0.22288,1,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0013481,-0.25928,-0.19369,1,0
5,GO WHITE FAT CELL DIFFERENTIATION,0.0057394,-0.25932,-0.21596,1,0
5,GO PROTEIN KINASE A SIGNALING,0.0015882,-0.25942,-0.22921,1,0
5,GO REGULATION OF CELL MORPHOGENESIS,0.0049572,-0.2599,-0.18943,1,0
5,GO MATING,0.025096,-0.2599,-0.19104,1,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.0036751,-0.25993,-0.21764,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0044907,-0.26009,-0.1746,1,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0083971,-0.26012,-0.22943,1,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.015776,-0.26018,-0.21236,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0019699,-0.26026,-0.2349,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0031545,-0.26053,-0.2054,1,0
5,GO CELL MOTILITY,0.0021907,-0.2607,-0.23605,1,0
5,GO NEPHRON DEVELOPMENT,0.007293,-0.26088,-0.19508,1,0
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0080134,-0.2609,-0.20744,1,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0029965,-0.26092,-0.17559,1,0
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0049572,-0.26101,-0.18628,1,0
5,GO CRANIAL NERVE DEVELOPMENT,0.015776,-0.26116,-0.21191,1,0
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.01266,-0.26122,-0.16759,1,0
5,GO REGULATION OF PLATELET AGGREGATION,0.0034935,-0.26129,-0.31841,1,0
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0029965,-0.26129,-0.21168,1,0
5,GO MESENCHYME DEVELOPMENT,0.0027019,-0.26138,-0.21533,1,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.019548,-0.2614,-0.23404,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0028457,-0.26152,-0.24401,1,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.007293,-0.26172,-0.27587,1,0
5,GO RESPONSE TO ATP,0.0027019,-0.26179,-0.21208,1,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0172,-0.26187,-0.19065,1,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0024341,-0.26207,-0.1994,1,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.0054671,-0.26236,-0.25498,1,0
5,GO RESPONSE TO NICOTINE,0.020391,-0.2625,-0.18976,1,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.0172,-0.26251,-0.22609,1,0
5,GO REGULATION OF VIRAL LIFE CYCLE,0.0029965,-0.2626,-0.23368,1,0
5,GO METAL ION HOMEOSTASIS,0.0029965,-0.26278,-0.20549,1,0
5,GO ENDOCYTOSIS,0.0027019,-0.26283,-0.20274,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0028457,-0.26287,-0.22145,1,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.0014241,-0.26298,-0.23825,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0096484,-0.26303,-0.18317,1,0
5,GO ACTIN FILAMENT BASED PROCESS,0.0040644,-0.26307,-0.18152,1,0
5,GO ENSHEATHMENT OF NEURONS,0.0044907,-0.26311,-0.18916,1,0
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0019699,-0.26313,-0.21003,1,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.0047188,-0.26316,-0.20791,1,0
5,GO REGULATION OF LIPID LOCALIZATION,0.0036751,-0.26321,-0.216,1,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0036751,-0.26322,-0.20186,1,0
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0020776,-0.26331,-0.223,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.019548,-0.26337,-0.18897,1,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0092139,-0.26338,-0.20567,1,0
5,GO GLIOGENESIS,0.0049572,-0.26338,-0.18696,1,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0031545,-0.26341,-0.19854,1,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0015882,-0.26345,-0.25682,1,0
5,GO REGULATION OF CELL DIFFERENTIATION,0.00332,-0.2637,-0.18371,1,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.031957,-0.26383,-0.35765,1,0
5,GO FACE DEVELOPMENT,0.0049572,-0.26405,-0.25658,1,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0049572,-0.26412,-0.25292,1,0
5,GO PROTEIN OXIDATION,0.023112,-0.26422,-0.17917,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00332,-0.26436,-0.19276,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0044907,-0.26437,-0.20136,1,0
5,GO EXOCYTOSIS,0.0049572,-0.26444,-0.19427,1,0
5,GO JNK CASCADE,0.0023095,-0.2645,-0.21731,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0025648,-0.26468,-0.20813,1,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.013235,-0.26476,-0.24293,1,0
5,GO HEART MORPHOGENESIS,0.00332,-0.26515,-0.2131,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0054671,-0.26539,-0.20319,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0031545,-0.26544,-0.24259,1,0
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0021907,-0.26546,-0.22929,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0016767,-0.26549,-0.23402,1,0
5,GO MUSCLE ORGAN MORPHOGENESIS,0.0031545,-0.26563,-0.20648,1,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0052065,-0.26565,-0.19143,1,0
5,GO GENITALIA DEVELOPMENT,0.0080134,-0.26583,-0.20351,1,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0042727,-0.26591,-0.22037,1,0
5,GO REGULATION OF MAP KINASE ACTIVITY,0.0036751,-0.266,-0.18938,1,0
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0038653,-0.26602,-0.21371,1,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.0049572,-0.26609,-0.21202,1,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.02951,-0.26619,-0.17316,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.013235,-0.26635,-0.18803,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0080134,-0.26636,-0.19676,1,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0092139,-0.26645,-0.17622,1,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.0012758,-0.26654,-0.24602,1,0
5,GO PEPTIDE CATABOLIC PROCESS,0.010572,-0.26657,-0.19877,1,0
5,GO OSSIFICATION,0.0034935,-0.26661,-0.2078,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.024086,-0.26671,-0.18231,1,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0028457,-0.26674,-0.19124,1,0
5,GO STEROID CATABOLIC PROCESS,0.037377,-0.26677,-0.17218,1,0
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0027019,-0.26677,-0.22434,1,0
5,GO ERBB SIGNALING PATHWAY,0.0031545,-0.26688,-0.202,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.0010798,-0.2669,-0.27618,1,0
5,GO REGULATION OF CALCIUM ION IMPORT,0.010572,-0.26694,-0.2306,1,0
5,GO REGULATION OF ANION TRANSPORT,0.0076456,-0.267,-0.17127,1,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.035953,-0.26705,-0.22503,1,0
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0076456,-0.26717,-0.18419,1,0
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0027019,-0.2673,-0.20649,1,0
5,GO CELLULAR RESPONSE TO LIPID,0.0021907,-0.26744,-0.22517,1,0
5,GO CERAMIDE TRANSPORT,0.045233,-0.26777,-0.16286,1,0
5,GO NEURON PROJECTION REGENERATION,0.010101,-0.26793,-0.21969,1,0
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0047188,-0.26798,-0.21098,1,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.034576,-0.26798,-0.1583,1,0
5,GO MALE SEX DIFFERENTIATION,0.0057394,-0.26798,-0.17335,1,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.022172,-0.26802,-0.20738,1,0
5,GO REGULATION OF GONAD DEVELOPMENT,0.011574,-0.26838,-0.18884,1,0
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00332,-0.26843,-0.22316,1,0
5,GO PROTEIN KINASE C SIGNALING,0.030713,-0.26844,-0.17859,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.01266,-0.26846,-0.20055,1,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0034935,-0.2686,-0.18217,1,0
5,GO MYELOID CELL DEVELOPMENT,0.008797,-0.26861,-0.2052,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.033245,-0.26867,-0.16082,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0044907,-0.26875,-0.1969,1,0
5,GO FILOPODIUM ASSEMBLY,0.0014241,-0.2689,-0.21759,1,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0096484,-0.26939,-0.23039,1,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0023095,-0.26941,-0.24673,1,0
5,GO REGENERATION,0.0044907,-0.26952,-0.18517,1,0
5,GO CD40 SIGNALING PATHWAY,0.0063209,-0.26959,-0.30632,1,0
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0019699,-0.26961,-0.1966,1,0
5,GO NEURON REMODELING,0.011063,-0.27004,-0.29163,1,0
5,GO RESPONSE TO HYPEROXIA,0.0025648,-0.2701,-0.2547,1,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.0036751,-0.27013,-0.23073,1,0
5,GO LIVER REGENERATION,0.0042727,-0.27023,-0.20387,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0060238,-0.27024,-0.20969,1,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.031957,-0.27037,-0.2115,1,0
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.010572,-0.27045,-0.20769,1,0
5,GO REGULATION OF MAST CELL ACTIVATION,0.013834,-0.27045,-0.28585,1,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0036751,-0.27051,-0.32751,1,0
5,GO EPIDERMIS MORPHOGENESIS,0.010101,-0.27054,-0.28025,1,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0031545,-0.27056,-0.23516,1,0
5,GO INTERACTION WITH HOST,0.0038653,-0.27059,-0.20406,1,0
5,GO RESPONSE TO VIRUS,0.0016767,-0.27077,-0.28647,1,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0057394,-0.27115,-0.19677,1,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0028457,-0.27116,-0.22905,1,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.037377,-0.27123,-0.18808,1,0
5,GO RESPONSE TO NITRIC OXIDE,0.0025648,-0.27137,-0.26392,1,0
5,GO REGULATION OF MAPK CASCADE,0.0020776,-0.27143,-0.23075,1,0
5,GO MEMBRANE BIOGENESIS,0.011574,-0.27144,-0.17868,1,0
5,GO RESPONSE TO STEROL,0.0036751,-0.27145,-0.23942,1,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.011574,-0.27153,-0.25081,1,0
5,GO DEVELOPMENTAL PIGMENTATION,0.0060238,-0.27153,-0.20425,1,0
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00332,-0.27153,-0.20046,1,0
5,GO INTERACTION WITH SYMBIONT,0.0016767,-0.27154,-0.21999,1,0
5,GO REGULATION OF COLLATERAL SPROUTING,0.012106,-0.2721,-0.25995,1,0
5,GO CELLULAR RESPONSE TO CAMP,0.0040644,-0.27211,-0.19292,1,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.006955,-0.27218,-0.2124,1,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.035953,-0.27229,-0.17203,1,0
5,GO CELLULAR RESPONSE TO ATP,0.0016767,-0.27234,-0.24591,1,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0052065,-0.27247,-0.16601,1,0
5,GO MYELOID CELL DIFFERENTIATION,0.0027019,-0.27251,-0.22446,1,0
5,GO RESPONSE TO WOUNDING,0.0047188,-0.27258,-0.23217,1,0
5,GO ANIMAL ORGAN REGENERATION,0.011574,-0.2726,-0.16333,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0027019,-0.27272,-0.20458,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.014457,-0.27274,-0.2552,1,0
5,GO ZYMOGEN ACTIVATION,0.040368,-0.27276,-0.20618,1,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.045233,-0.27284,-0.19836,1,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0020776,-0.27295,-0.32569,1,0
5,GO AMINE CATABOLIC PROCESS,0.0015882,-0.27301,-0.31675,1,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.00332,-0.27305,-0.23647,1,0
5,GO MAMMARY GLAND DEVELOPMENT,0.008797,-0.27306,-0.1792,1,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0060238,-0.27325,-0.30358,1,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.0034935,-0.27367,-0.31708,1,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.013834,-0.27382,-0.21525,1,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.038848,-0.27384,-0.21156,1,0
5,GO CALCIUM MEDIATED SIGNALING,0.0034935,-0.27386,-0.22936,1,0
5,GO PLASMA MEMBRANE FUSION,0.0096484,-0.27405,-0.26229,1,0
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.007293,-0.27418,-0.24673,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.010572,-0.27429,-0.24935,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.006955,-0.27443,-0.31298,1,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.011574,-0.27445,-0.20167,1,0
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0027019,-0.27456,-0.21328,1,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.013235,-0.27458,-0.19362,1,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0019699,-0.27458,-0.25031,1,0
5,GO MELANOCYTE DIFFERENTIATION,0.038848,-0.2748,-0.19128,1,0
5,GO HYALURONAN METABOLIC PROCESS,0.040368,-0.27489,-0.17424,1,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0054671,-0.27489,-0.2225,1,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0076456,-0.27515,-0.20824,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0029965,-0.2755,-0.22229,1,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.011574,-0.27558,-0.19472,1,0
5,GO REGULATION OF FATTY ACID OXIDATION,0.050584,-0.2757,-0.14412,1,0
5,GO PROSTATE GLAND GROWTH,0.0003797,-0.27599,-0.31899,1,0
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0031545,-0.27606,-0.23784,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0025648,-0.27612,-0.21611,1,0
5,GO ALANINE TRANSPORT,0.015104,-0.27614,-0.1942,1,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.050584,-0.27666,-0.21847,1,0
5,GO EPIBOLY,0.020391,-0.2767,-0.20823,1,0
5,GO URETER DEVELOPMENT,0.0031545,-0.27677,-0.30457,1,0
5,GO REGULATION OF SENSORY PERCEPTION,0.0096484,-0.27714,-0.21626,1,0
5,GO RESPONSE TO VITAMIN,0.0036751,-0.27718,-0.23802,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016767,-0.27719,-0.22701,1,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.028348,-0.2773,-0.15541,1,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0096484,-0.27731,-0.26122,1,0
5,GO DENDRITIC SPINE MAINTENANCE,0.0172,-0.27774,-0.22385,1,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.041938,-0.27778,-0.18668,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0080134,-0.2778,-0.18144,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0017696,-0.27806,-0.22443,1,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.023112,-0.27818,-0.28159,1,0
5,GO AORTA DEVELOPMENT,0.0076456,-0.27829,-0.23069,1,0
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0024341,-0.27833,-0.21683,1,0
5,GO ORGAN GROWTH,0.0036751,-0.27835,-0.18722,1,0
5,GO RESPONSE TO INTERLEUKIN 1,0.0031545,-0.27867,-0.24326,1,0
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0034935,-0.27888,-0.1788,1,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0052065,-0.27896,-0.18494,1,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0016767,-0.27936,-0.22638,1,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.0052065,-0.27952,-0.24333,1,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.030713,-0.27953,-0.19377,1,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0076456,-0.27961,-0.26333,1,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.021265,-0.27969,-0.17602,1,0
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0076456,-0.2797,-0.18798,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0042727,-0.27971,-0.24594,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0021907,-0.28002,-0.24512,1,0
5,GO RESPONSE TO CORTICOSTEROID,0.0076456,-0.28012,-0.20534,1,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0049572,-0.28014,-0.19483,1,0
5,GO TYPE I INTERFERON PRODUCTION,0.0049572,-0.28017,-0.22724,1,0
5,GO AMINOGLYCAN METABOLIC PROCESS,0.006955,-0.28019,-0.19955,1,0
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0092139,-0.28044,-0.16731,1,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0083971,-0.28058,-0.23608,1,0
5,GO CYTIDINE TO URIDINE EDITING,0.01266,-0.2806,-0.29658,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0020776,-0.28074,-0.21381,1,0
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0029965,-0.28087,-0.22054,1,0
5,GO POSTSYNAPSE ASSEMBLY,0.048745,-0.28088,-0.25564,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.023112,-0.28092,-0.23988,1,0
5,GO RESPONSE TO MANGANESE ION,0.0029965,-0.28096,-0.20925,1,0
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0063209,-0.2813,-0.21159,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.022172,-0.28145,-0.29472,1,0
5,GO TUBE DEVELOPMENT,0.00332,-0.28153,-0.2201,1,0
5,GO RESPONSE TO CAMP,0.010572,-0.28157,-0.17904,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.035953,-0.28165,-0.17543,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.010572,-0.28169,-0.28464,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0172,-0.28184,-0.15801,1,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0017696,-0.28202,-0.28408,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.016475,-0.28233,-0.21059,1,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.020391,-0.28248,-0.1973,1,0
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0063209,-0.28248,-0.16406,1,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0013481,-0.2825,-0.25875,1,0
5,GO NEPHRON TUBULE FORMATION,0.0036751,-0.28263,-0.25971,1,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0076456,-0.28266,-0.20327,1,0
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0018673,-0.28281,-0.2658,1,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.021265,-0.28286,-0.27681,1,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.040368,-0.28286,-0.18835,1,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.0083971,-0.28294,-0.17991,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0021907,-0.28298,-0.21778,1,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0014241,-0.28306,-0.25577,1,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0049572,-0.28307,-0.22956,1,0
5,GO REGULATION OF BODY FLUID LEVELS,0.0038653,-0.28324,-0.21864,1,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0029965,-0.28335,-0.23425,1,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.0044907,-0.28336,-0.1954,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0015882,-0.28342,-0.2498,1,0
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.010572,-0.28345,-0.20194,1,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0015041,-0.28346,-0.33259,1,0
5,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.040368,-0.28355,-0.21778,1,0
5,GO RESPONSE TO LIPID,0.0029965,-0.28356,-0.21501,1,0
5,GO HEAD MORPHOGENESIS,0.0031545,-0.28382,-0.30126,1,0
5,GO RECEPTOR CLUSTERING,0.007293,-0.28395,-0.23316,1,0
5,GO RESPONSE TO IRON ION,0.00332,-0.28397,-0.23065,1,0
5,GO MUSCLE CELL PROLIFERATION,0.0036751,-0.2841,-0.2388,1,0
5,GO ACTIVATED T CELL PROLIFERATION,0.00332,-0.28417,-0.29672,1,0
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0044907,-0.28422,-0.20476,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0063209,-0.2845,-0.19041,1,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0015882,-0.28455,-0.26303,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0024341,-0.28455,-0.20267,1,0
5,GO REGULATION OF NEURON MIGRATION,0.01266,-0.28458,-0.26812,1,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0016767,-0.28484,-0.25618,1,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0066311,-0.28517,-0.22228,1,0
5,GO COAGULATION,0.0040644,-0.28524,-0.23974,1,0
5,GO REGULATION OF AMYLOID BETA FORMATION,0.0049572,-0.28527,-0.24577,1,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0076456,-0.28528,-0.23146,1,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.020391,-0.28543,-0.16834,1,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.028348,-0.28545,-0.25167,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0023095,-0.28559,-0.19761,1,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.027226,-0.28561,-0.23767,1,0
5,GO TROPHOBLAST CELL MIGRATION,0.021265,-0.28584,-0.22237,1,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.010101,-0.28585,-0.25819,1,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0096484,-0.2859,-0.21587,1,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0060238,-0.286,-0.25992,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020391,-0.28601,-0.308,1,0
5,GO IRON ION HOMEOSTASIS,0.0025648,-0.28608,-0.21487,1,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.023112,-0.2862,-0.27044,1,0
5,GO HAIR FOLLICLE MATURATION,0.0036751,-0.28631,-0.24075,1,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0040644,-0.28633,-0.20497,1,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00332,-0.28635,-0.23173,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0017696,-0.28652,-0.23191,1,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.007293,-0.28653,-0.25339,1,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0063209,-0.28654,-0.23605,1,0
5,GO HOMOTYPIC CELL CELL ADHESION,0.007293,-0.28654,-0.23962,1,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0052065,-0.28658,-0.28549,1,0
5,GO RESPONSE TO X RAY,0.00064645,-0.28659,-0.28645,1,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0024341,-0.28673,-0.25185,1,0
5,GO SKELETAL SYSTEM DEVELOPMENT,0.0023095,-0.28684,-0.22779,1,0
5,GO FIBROBLAST PROLIFERATION,0.0010798,-0.28708,-0.27519,1,0
5,GO FORELIMB MORPHOGENESIS,0.010101,-0.2871,-0.27569,1,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0015041,-0.28718,-0.25172,1,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0034935,-0.28732,-0.31599,1,0
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0040644,-0.28734,-0.22772,1,0
5,GO CELLULAR RESPONSE TO ALCOHOL,0.0027019,-0.28738,-0.24332,1,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0066311,-0.28742,-0.23372,1,0
5,GO WOUND HEALING,0.0040644,-0.28771,-0.24132,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.007293,-0.28782,-0.26127,1,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0060238,-0.28789,-0.20216,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0172,-0.28791,-0.30057,1,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0049572,-0.28794,-0.25013,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.027226,-0.28805,-0.25457,1,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0057394,-0.28807,-0.22147,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0034935,-0.28809,-0.27098,1,0
5,GO LUTEINIZATION,0.019548,-0.28811,-0.22263,1,0
5,GO KERATINOCYTE MIGRATION,0.011063,-0.28841,-0.20194,1,0
5,GO PIGMENT GRANULE ORGANIZATION,0.0025648,-0.28842,-0.22311,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0047188,-0.28846,-0.29907,1,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.030713,-0.28848,-0.29233,1,0
5,GO PHOSPHATE ION TRANSPORT,0.019548,-0.28852,-0.18837,1,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0024341,-0.28883,-0.23975,1,0
5,GO LUNG MORPHOGENESIS,0.0063209,-0.28888,-0.25664,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0024341,-0.28897,-0.3037,1,0
5,GO RESPONSE TO ESTROGEN,0.0015041,-0.28927,-0.23299,1,0
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0066311,-0.28944,-0.2064,1,0
5,GO FOCAL ADHESION ASSEMBLY,0.0042727,-0.28944,-0.25189,1,0
5,GO LIVER MORPHOGENESIS,0.026142,-0.28945,-0.2224,1,0
5,GO REGULATION OF VASCULAR PERMEABILITY,0.027226,-0.28964,-0.15217,1,0
5,GO ETHANOL METABOLIC PROCESS,0.0012758,-0.28968,-0.37778,1,0
5,GO IMMUNE SYSTEM DEVELOPMENT,0.0023095,-0.28978,-0.24375,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0047188,-0.28978,-0.21114,1,0
5,GO AMYLOID BETA FORMATION,0.0044907,-0.2906,-0.22508,1,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0029965,-0.29064,-0.23938,1,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.008797,-0.2907,-0.22175,1,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.013235,-0.29076,-0.26909,1,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.010101,-0.29077,-0.27676,1,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0012758,-0.29122,-0.23991,1,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0172,-0.29123,-0.21681,1,0
5,GO REGULATORY T CELL DIFFERENTIATION,0.010101,-0.29132,-0.38722,1,0
5,GO TISSUE MIGRATION,0.0040644,-0.29141,-0.25203,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0080134,-0.29147,-0.16444,1,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0083971,-0.29169,-0.23849,1,0
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0021907,-0.29181,-0.21002,1,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0096484,-0.29193,-0.21972,1,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00028019,-0.29203,-0.28329,1,0
5,GO LAMELLIPODIUM ASSEMBLY,0.0021907,-0.29224,-0.20084,1,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0057394,-0.29226,-0.23662,1,0
5,GO TUBE MORPHOGENESIS,0.0028457,-0.29236,-0.2468,1,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.045233,-0.29238,-0.20716,1,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0015041,-0.2929,-0.26637,1,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.00332,-0.29303,-0.21128,1,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0052065,-0.29308,-0.20765,1,0
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0027019,-0.2932,-0.19303,1,0
5,GO NEGATIVE REGULATION OF SECRETION,0.0016767,-0.29326,-0.21953,1,0
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0031545,-0.29326,-0.19533,1,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0027019,-0.29329,-0.26394,1,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0047188,-0.29336,-0.19454,1,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0013481,-0.29366,-0.32887,1,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0066311,-0.29384,-0.23134,1,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.0047188,-0.29402,-0.28137,1,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0066311,-0.29404,-0.20449,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0044907,-0.29409,-0.25436,1,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0029965,-0.29417,-0.23416,1,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.043559,-0.29433,-0.22066,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0018673,-0.29433,-0.24621,1,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0083971,-0.29449,-0.19874,1,0
5,GO RESPONSE TO ANGIOTENSIN,0.0057394,-0.29462,-0.21709,1,0
5,GO LONG TERM MEMORY,0.040368,-0.29475,-0.17692,1,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.013834,-0.29477,-0.23705,1,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.034576,-0.29482,-0.22704,1,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.011063,-0.29492,-0.1847,1,0
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00332,-0.29522,-0.2052,1,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.0011418,-0.29525,-0.27991,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.008797,-0.2953,-0.24754,1,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0052065,-0.29536,-0.2516,1,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0063209,-0.29536,-0.26087,1,0
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0042727,-0.29546,-0.19986,1,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0036751,-0.29549,-0.20026,1,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.0076456,-0.29568,-0.25793,1,0
5,GO CELL RECOGNITION,0.00072571,-0.2957,-0.2673,1,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0020776,-0.29576,-0.23243,1,0
5,GO STRESS FIBER ASSEMBLY,0.0049572,-0.29581,-0.2176,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.022172,-0.2959,-0.2066,1,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.011063,-0.29608,-0.23981,1,0
5,GO SUPEROXIDE METABOLIC PROCESS,0.0013481,-0.29648,-0.27044,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0057394,-0.2965,-0.22942,1,0
5,GO GERMINAL CENTER FORMATION,0.026142,-0.29653,-0.36723,1,0
5,GO DEFENSE RESPONSE TO VIRUS,0.0020776,-0.29656,-0.29876,1,0
5,GO CERAMIDE CATABOLIC PROCESS,0.043559,-0.29657,-0.16252,1,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.048745,-0.29671,-0.22562,1,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0029965,-0.29692,-0.21813,1,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.01266,-0.29708,-0.26731,1,0
5,GO SEQUESTERING OF METAL ION,0.0021907,-0.29736,-0.31751,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0019699,-0.29737,-0.28778,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0060238,-0.29739,-0.25115,1,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0018673,-0.29752,-0.31431,1,0
5,GO ACTIVATION OF GTPASE ACTIVITY,0.0076456,-0.29767,-0.19288,1,0
5,GO RESPONSE TO CYTOKINE,0.0024341,-0.29776,-0.25666,1,0
5,GO PINOCYTOSIS,0.0063209,-0.29785,-0.25018,1,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.008797,-0.29814,-0.24155,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0021907,-0.29821,-0.25806,1,0
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0047188,-0.2983,-0.22571,1,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037377,-0.29842,-0.24922,1,0
5,GO RUFFLE ORGANIZATION,0.014457,-0.29847,-0.18654,1,0
5,GO LAMELLIPODIUM ORGANIZATION,0.0031545,-0.29855,-0.20624,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0020776,-0.2987,-0.2617,1,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0040644,-0.29882,-0.28018,1,0
5,GO GDP METABOLIC PROCESS,0.0021907,-0.29898,-0.24371,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.030713,-0.29924,-0.15798,1,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.015104,-0.29932,-0.31269,1,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.027226,-0.29943,-0.26633,1,0
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0080134,-0.29947,-0.23466,1,0
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00332,-0.2995,-0.19725,1,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0029965,-0.29977,-0.28572,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028457,-0.29987,-0.20339,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0031545,-0.29993,-0.25792,1,0
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0024341,-0.30014,-0.24591,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0012758,-0.30014,-0.22169,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0044907,-0.30015,-0.26397,1,0
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0034935,-0.30017,-0.19518,1,0
5,GO RESPONSE TO BMP,0.0047188,-0.30041,-0.22451,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0083971,-0.30063,-0.27752,1,0
5,GO TISSUE HOMEOSTASIS,0.0017696,-0.30065,-0.22994,1,0
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0076456,-0.30081,-0.20207,1,0
5,GO REGULATION OF DEFENSE RESPONSE,0.0023095,-0.30086,-0.26431,1,0
5,GO RESPONSE TO INTERLEUKIN 4,0.0036751,-0.30102,-0.27039,1,0
5,GO REGULATION OF VASOCONSTRICTION,0.0080134,-0.30106,-0.24698,1,0
5,GO DISACCHARIDE METABOLIC PROCESS,0.021265,-0.30108,-0.21744,1,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0019699,-0.30126,-0.25611,1,0
5,GO ICOSANOID METABOLIC PROCESS,0.008797,-0.30192,-0.22193,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0092139,-0.30206,-0.29312,1,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.0047188,-0.30206,-0.18811,1,0
5,GO ACTIVATION OF MAPKK ACTIVITY,0.00332,-0.30216,-0.21039,1,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0027019,-0.30243,-0.31403,1,0
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.011063,-0.30247,-0.24694,1,0
5,GO CARTILAGE DEVELOPMENT,0.00332,-0.30257,-0.23148,1,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0019699,-0.30292,-0.25951,1,0
5,GO MUSCLE CELL MIGRATION,0.0052065,-0.30328,-0.25345,1,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0042727,-0.30328,-0.23881,1,0
5,GO PODOSOME ASSEMBLY,0.00081392,-0.3033,-0.33026,1,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0027019,-0.30366,-0.25487,1,0
5,GO BONE CELL DEVELOPMENT,0.015776,-0.30369,-0.21764,1,0
5,GO EPOXYGENASE P450 PATHWAY,0.0024341,-0.30369,-0.2797,1,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0049572,-0.30404,-0.24942,1,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0096484,-0.30484,-0.22178,1,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0028457,-0.3049,-0.29455,1,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0096484,-0.30501,-0.26466,1,0
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0029965,-0.30519,-0.27391,1,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0066311,-0.30557,-0.24163,1,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0010798,-0.30573,-0.3326,1,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.006955,-0.30582,-0.25232,1,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.0042727,-0.30591,-0.24627,1,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0063209,-0.30617,-0.23586,1,0
5,GO REGULATION OF RESPONSE TO WOUNDING,0.0092139,-0.30625,-0.22026,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.0015882,-0.30651,-0.28333,1,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0044907,-0.30656,-0.32165,1,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0080134,-0.3067,-0.29757,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0012758,-0.30671,-0.39841,1,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0027019,-0.30672,-0.2716,1,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0028457,-0.30702,-0.25109,1,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.013834,-0.30722,-0.24378,1,0
5,GO TISSUE REGENERATION,0.0040644,-0.30751,-0.22093,1,0
5,GO B CELL HOMEOSTASIS,0.0054671,-0.30795,-0.27864,1,0
5,GO MYOBLAST MIGRATION,0.020391,-0.30831,-0.23154,1,0
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0019699,-0.30843,-0.24935,1,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00332,-0.30853,-0.26029,1,0
5,GO LIPID STORAGE,0.0038653,-0.30862,-0.21922,1,0
5,GO MIDGUT DEVELOPMENT,0.0052065,-0.30872,-0.28299,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0034935,-0.30884,-0.25879,1,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.034576,-0.30898,-0.17812,1,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0034935,-0.30914,-0.29259,1,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.0031545,-0.30917,-0.26754,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0057394,-0.30922,-0.1961,1,0
5,GO PROSTATE GLAND DEVELOPMENT,0.00042807,-0.30925,-0.36055,1,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.0029965,-0.30994,-0.27532,1,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0020776,-0.31027,-0.23721,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0034935,-0.31049,-0.37384,1,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0029965,-0.31054,-0.27947,1,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0025648,-0.31076,-0.30774,1,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.008797,-0.31086,-0.24065,1,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0080134,-0.31121,-0.27619,1,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0028457,-0.31135,-0.31251,1,0
5,GO VASCULATURE DEVELOPMENT,0.0021907,-0.31166,-0.28165,1,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0040644,-0.31182,-0.27535,1,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0023095,-0.312,-0.27638,1,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.016475,-0.3122,-0.24777,1,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0010798,-0.31222,-0.28594,1,0
5,GO STORE OPERATED CALCIUM ENTRY,0.0024341,-0.31222,-0.27345,1,0
5,GO REPLACEMENT OSSIFICATION,0.0083971,-0.31232,-0.24179,1,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0028457,-0.3124,-0.30727,1,0
5,GO BONE DEVELOPMENT,0.0015882,-0.31265,-0.2699,1,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0057394,-0.31271,-0.23387,1,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0011418,-0.3128,-0.37568,1,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.0016767,-0.31324,-0.33,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0024341,-0.3133,-0.28955,1,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0057394,-0.31342,-0.25051,1,0
5,GO NEUTROPHIL HOMEOSTASIS,0.0096484,-0.31363,-0.30256,1,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.022172,-0.31368,-0.25428,1,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.017954,-0.31397,-0.26446,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0080134,-0.31399,-0.29467,1,0
5,GO CARDIAC CHAMBER FORMATION,0.011063,-0.31405,-0.30524,1,0
5,GO AMYLOID FIBRIL FORMATION,0.015776,-0.3141,-0.2411,1,0
5,GO REGULATION OF HEMOPOIESIS,0.0013481,-0.31414,-0.27238,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.031957,-0.31422,-0.28571,1,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.00332,-0.31442,-0.28131,1,0
5,GO REGULATION OF LIPID STORAGE,0.0034935,-0.31444,-0.25686,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0031545,-0.3145,-0.29026,1,0
5,GO POSITIVE REGULATION OF WOUND HEALING,0.033245,-0.31455,-0.19639,1,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0092139,-0.31477,-0.25625,1,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0021907,-0.31503,-0.28915,1,0
5,GO PIGMENT ACCUMULATION,0.0047188,-0.31512,-0.32026,1,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0020776,-0.31519,-0.27807,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0018673,-0.31523,-0.3236,1,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.014457,-0.31528,-0.22401,1,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00332,-0.31534,-0.25212,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.015104,-0.3155,-0.19516,1,0
5,GO CELLULAR RESPONSE TO VIRUS,0.0016767,-0.3155,-0.27766,1,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.010101,-0.31561,-0.28527,1,0
5,GO EYE MORPHOGENESIS,0.0047188,-0.31589,-0.21743,1,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00064645,-0.3159,-0.30896,1,0
5,GO NEURAL CREST CELL MIGRATION,0.0015882,-0.316,-0.29368,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0023095,-0.31613,-0.2781,1,0
5,GO TRACHEA MORPHOGENESIS,0.0054671,-0.31613,-0.26663,1,0
5,GO GLAND MORPHOGENESIS,0.0015041,-0.31632,-0.33037,1,0
5,GO RESPONSE TO BIOTIC STIMULUS,0.0018673,-0.31652,-0.28984,1,0
5,GO EMBRYONIC HEMOPOIESIS,0.007293,-0.31669,-0.19779,1,0
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0057394,-0.31673,-0.25674,1,0
5,GO RESPONSE TO RETINOIC ACID,0.00332,-0.31684,-0.23834,1,0
5,GO TRABECULA MORPHOGENESIS,0.0036751,-0.31709,-0.30823,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0092139,-0.31733,-0.29289,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0024341,-0.31738,-0.23113,1,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0076456,-0.31744,-0.24697,1,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0083971,-0.31756,-0.21107,1,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.011063,-0.31761,-0.2433,1,0
5,GO RESPIRATORY BURST,0.010572,-0.31787,-0.34652,1,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036751,-0.31789,-0.29726,1,0
5,GO RESPONSE TO PH,0.0063209,-0.3179,-0.2066,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0054671,-0.3179,-0.28322,1,0
5,GO FOREGUT MORPHOGENESIS,0.0020776,-0.31813,-0.33448,1,0
5,GO EPITHELIAL CELL CELL ADHESION,0.0025648,-0.31817,-0.32335,1,0
5,GO CELL MATRIX ADHESION,0.0028457,-0.31826,-0.29354,1,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0060238,-0.31865,-0.26597,1,0
5,GO PLATELET AGGREGATION,0.0034935,-0.3188,-0.29455,1,0
5,GO CHOLESTEROL STORAGE,0.012106,-0.31884,-0.27692,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.016475,-0.31889,-0.24323,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0031545,-0.31898,-0.22273,1,0
5,GO GLIAL CELL MIGRATION,0.0031545,-0.31907,-0.25823,1,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00045436,-0.31921,-0.29258,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0066311,-0.31928,-0.20227,1,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0029965,-0.3194,-0.27719,1,0
5,GO NEURON PROJECTION ARBORIZATION,0.0092139,-0.31947,-0.24195,1,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.023112,-0.31953,-0.27641,1,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0029965,-0.31972,-0.31793,1,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0066311,-0.31993,-0.30583,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.0042727,-0.32051,-0.23759,1,0
5,GO ENGULFMENT OF APOPTOTIC CELL,0.0054671,-0.32059,-0.27277,1,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0092139,-0.32064,-0.26352,1,0
5,GO T CELL APOPTOTIC PROCESS,0.0012071,-0.32123,-0.37906,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.030713,-0.32125,-0.23523,1,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.016475,-0.32127,-0.26492,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.007293,-0.32142,-0.26031,1,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0029965,-0.32147,-0.26734,1,0
5,GO MYOBLAST PROLIFERATION,0.0024341,-0.32154,-0.2867,1,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0057394,-0.32204,-0.28047,1,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.022172,-0.32211,-0.23924,1,0
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0020776,-0.32249,-0.22725,1,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.0016767,-0.32258,-0.2843,1,0
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.0018673,-0.32266,-0.26363,1,0
5,GO INTERLEUKIN 5 PRODUCTION,0.033245,-0.32275,-0.29956,1,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00332,-0.32303,-0.28337,1,0
5,GO MYELOID LEUKOCYTE ACTIVATION,0.0028457,-0.32365,-0.28763,1,0
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0016767,-0.32373,-0.28987,1,0
5,GO ACTIVATION OF MAPK ACTIVITY,0.0023095,-0.32386,-0.20652,1,0
5,GO REGULATION OF BIOMINERALIZATION,0.0028457,-0.3241,-0.26488,1,0
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0057394,-0.32438,-0.23487,1,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.014457,-0.32454,-0.24006,1,0
5,GO SEQUESTERING OF CALCIUM ION,0.011063,-0.32467,-0.22064,1,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0076456,-0.3247,-0.24597,1,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0049572,-0.32485,-0.26364,1,0
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.052482,-0.32528,-0.29653,1,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0049572,-0.3257,-0.21714,1,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.00057531,-0.32578,-0.3519,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0012071,-0.32583,-0.27362,1,0
5,GO RESPONSE TO SALT STRESS,0.0042727,-0.32589,-0.27259,1,0
5,GO SEROTONIN SECRETION,0.015776,-0.32606,-0.29292,1,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.020391,-0.32627,-0.33738,1,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00021879,-0.32636,-0.40378,1,0
5,GO SERTOLI CELL DIFFERENTIATION,0.015776,-0.32647,-0.23396,1,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0040644,-0.32662,-0.29275,1,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0057394,-0.32685,-0.24827,1,0
5,GO OSTEOBLAST DEVELOPMENT,0.011063,-0.32685,-0.2574,1,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.013235,-0.32691,-0.28052,1,0
5,GO REGULATION OF PROTEIN MATURATION,0.0029965,-0.32707,-0.23155,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0017696,-0.32707,-0.2906,1,0
5,GO SEQUESTERING OF TRIGLYCERIDE,0.0060238,-0.32735,-0.26231,1,0
5,GO CELL SUBSTRATE ADHESION,0.0027019,-0.32736,-0.30208,1,0
5,GO TRANSEPITHELIAL TRANSPORT,0.0031545,-0.32746,-0.27934,1,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.0014241,-0.32764,-0.28337,1,0
5,GO REGULATION OF RECEPTOR BINDING,0.007293,-0.32783,-0.30869,1,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.025096,-0.32797,-0.23389,1,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0092139,-0.32842,-0.35039,1,0
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0017696,-0.32845,-0.28792,1,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0049572,-0.32855,-0.33579,1,0
5,GO OVULATION CYCLE PROCESS,0.0014241,-0.32869,-0.25742,1,0
5,GO PYROPTOSIS,0.031957,-0.32891,-0.23999,1,0
5,GO P38MAPK CASCADE,0.012106,-0.32906,-0.23393,1,0
5,GO REGULATION OF OSSIFICATION,0.0017696,-0.32916,-0.25517,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016767,-0.32918,-0.2449,1,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0028457,-0.32931,-0.35725,1,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0014241,-0.32933,-0.29317,1,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0080134,-0.32938,-0.25998,1,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0028457,-0.32979,-0.38257,1,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0015882,-0.33,-0.28923,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0012071,-0.33016,-0.41384,1,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0044907,-0.33024,-0.31338,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0015041,-0.33052,-0.28085,1,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0019699,-0.33053,-0.26802,1,0
5,GO BIOLOGICAL ADHESION,0.0023095,-0.33058,-0.28151,1,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.010572,-0.33103,-0.2614,1,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0063209,-0.33112,-0.31948,1,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00072571,-0.3312,-0.299,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0060238,-0.33122,-0.22785,1,0
5,GO DEFINITIVE HEMOPOIESIS,0.043559,-0.33123,-0.18352,1,0
5,GO ANIMAL ORGAN MATURATION,0.0054671,-0.33129,-0.23857,1,0
5,GO CRANIAL NERVE MORPHOGENESIS,0.0016767,-0.33152,-0.32838,1,0
5,GO CELL ACTIVATION,0.0019699,-0.33181,-0.2961,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0038653,-0.33214,-0.26491,1,0
5,GO AXONAL FASCICULATION,0.0023095,-0.3322,-0.33238,1,0
5,GO IMMUNE EFFECTOR PROCESS,0.0015882,-0.33223,-0.3024,1,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0080134,-0.33234,-0.27758,1,0
5,GO VOCALIZATION BEHAVIOR,0.021265,-0.33242,-0.29236,1,0
5,GO NEGATIVE CHEMOTAXIS,0.0029965,-0.3325,-0.30447,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0054671,-0.33253,-0.22111,1,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00072571,-0.33269,-0.32884,1,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.0018673,-0.33277,-0.32305,1,0
5,GO DENDRITE SELF AVOIDANCE,0.0012758,-0.33312,-0.37194,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0096484,-0.33335,-0.2682,1,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.0023095,-0.33336,-0.29629,1,0
5,GO MAMMARY GLAND MORPHOGENESIS,0.0019699,-0.33343,-0.33142,1,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0024341,-0.33351,-0.28262,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0023095,-0.33359,-0.30293,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0018673,-0.33367,-0.26039,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.021265,-0.33374,-0.2107,1,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0014241,-0.33376,-0.35755,1,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0015882,-0.33427,-0.3326,1,0
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0042727,-0.33434,-0.26459,1,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.0054671,-0.33459,-0.24613,1,0
5,GO DEFENSE RESPONSE,0.0019699,-0.3346,-0.29816,1,0
5,GO EMBRYO IMPLANTATION,0.0044907,-0.33463,-0.27277,1,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0013481,-0.33466,-0.31649,1,0
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0036751,-0.33474,-0.22499,1,0
5,GO PLATELET ACTIVATION,0.0031545,-0.33532,-0.29455,1,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0031545,-0.33558,-0.30669,1,0
5,GO NK T CELL DIFFERENTIATION,0.018736,-0.33569,-0.33464,1,0
5,GO PIGMENT CELL DIFFERENTIATION,0.007293,-0.33571,-0.24106,1,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00060992,-0.33574,-0.30352,1,0
5,GO POSITIVE REGULATION OF JNK CASCADE,0.0021907,-0.33574,-0.2698,1,0
5,GO NAD BIOSYNTHETIC PROCESS,0.0025648,-0.33615,-0.3458,1,0
5,GO REGULATION OF CELL MATRIX ADHESION,0.0031545,-0.33618,-0.28781,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0029965,-0.33622,-0.25215,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00081392,-0.33635,-0.3393,1,0
5,GO RENAL SYSTEM PROCESS,0.0034935,-0.33642,-0.24214,1,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0027019,-0.33647,-0.26812,1,0
5,GO PROTEIN KINASE B SIGNALING,0.0011418,-0.33664,-0.2801,1,0
5,GO ASTROCYTE DEVELOPMENT,0.00332,-0.33678,-0.31725,1,0
5,GO GLOMERULUS DEVELOPMENT,0.012106,-0.33682,-0.26426,1,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.0060238,-0.33693,-0.27366,1,0
5,GO WATER TRANSPORT,0.008797,-0.33701,-0.37339,1,0
5,GO REGULATION OF JUN KINASE ACTIVITY,0.0052065,-0.33729,-0.23207,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0028457,-0.33734,-0.34595,1,0
5,GO POSITIVE REGULATION OF COAGULATION,0.013235,-0.33758,-0.2576,1,0
5,GO T CELL HOMEOSTASIS,0.0017696,-0.33763,-0.28605,1,0
5,GO MEMBRANE RAFT ORGANIZATION,0.013834,-0.33784,-0.30023,1,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0027019,-0.33794,-0.33834,1,0
5,GO TUMOR NECROSIS FACTOR SECRETION,0.00076864,-0.33798,-0.35349,1,0
5,GO LATERAL MESODERM DEVELOPMENT,0.0049572,-0.3381,-0.25217,1,0
5,GO MAST CELL MIGRATION,0.0057394,-0.33827,-0.31999,1,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.0029965,-0.33828,-0.25892,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.014457,-0.33871,-0.24102,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0052065,-0.33892,-0.28269,1,0
5,GO BLASTODERM SEGMENTATION,0.0016767,-0.33925,-0.27549,1,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.007293,-0.33935,-0.31559,1,0
5,GO INTERFERON BETA PRODUCTION,0.0019699,-0.33961,-0.2925,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0060238,-0.33969,-0.28987,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0044907,-0.3397,-0.25538,1,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.019548,-0.33978,-0.26461,1,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.00096503,-0.33985,-0.31352,1,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.028348,-0.34018,-0.37079,1,0
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.01266,-0.34038,-0.26233,1,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0012071,-0.34041,-0.38334,1,0
5,GO RESPONSE TO BACTERIUM,0.0023095,-0.3409,-0.31737,1,0
5,GO ADHESION OF SYMBIONT TO HOST,0.038848,-0.34092,-0.35614,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0014241,-0.34094,-0.28294,1,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.023112,-0.34095,-0.29914,1,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0015882,-0.34117,-0.35816,1,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0172,-0.34124,-0.2764,1,0
5,GO RESPONSE TO INTERFERON BETA,0.0096484,-0.34133,-0.36738,1,0
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0040644,-0.34133,-0.24272,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0040644,-0.34145,-0.2851,1,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.006955,-0.34145,-0.35156,1,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.006955,-0.34151,-0.31238,1,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.045233,-0.34161,-0.20738,1,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00064645,-0.34178,-0.32578,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0023095,-0.34202,-0.24464,1,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0015041,-0.34203,-0.30555,1,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.008797,-0.34221,-0.35023,1,0
5,GO RESPONSE TO INTERLEUKIN 6,0.015104,-0.34279,-0.24542,1,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00332,-0.34279,-0.27989,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0049572,-0.34306,-0.31915,1,0
5,GO RETINOIC ACID METABOLIC PROCESS,7.3279e-05,-0.34306,-0.37441,1,0
5,GO PHOSPHOLIPID HOMEOSTASIS,0.00076864,-0.34315,-0.31466,1,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0027019,-0.34338,-0.2886,1,0
5,GO VAGINA DEVELOPMENT,0.0020776,-0.34371,-0.32574,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.006955,-0.34385,-0.2739,1,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0027019,-0.34389,-0.3021,1,0
5,GO ARTERY DEVELOPMENT,0.0024341,-0.34415,-0.28009,1,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.034576,-0.34441,-0.22346,1,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.033245,-0.34444,-0.28246,1,0
5,GO REGULATION OF CELL SHAPE,0.0013481,-0.34454,-0.28754,1,0
5,GO FEVER GENERATION,0.0029965,-0.34468,-0.30474,1,0
5,GO INTEGRIN ACTIVATION,0.010101,-0.34475,-0.35356,1,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.01266,-0.34484,-0.2587,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0018673,-0.34485,-0.25917,1,0
5,GO CELL CELL ADHESION,0.0017696,-0.34505,-0.28084,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0013481,-0.34522,-0.41258,1,0
5,GO TAXIS,0.00096503,-0.34528,-0.29068,1,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0014241,-0.34533,-0.33734,1,0
5,GO REGULATION OF WOUND HEALING,0.0172,-0.34534,-0.21328,1,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0027019,-0.34535,-0.30209,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0016767,-0.34565,-0.28197,1,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0042727,-0.34588,-0.21137,1,0
5,GO SKIN MORPHOGENESIS,0.0042727,-0.34592,-0.3493,1,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010101,-0.34618,-0.26903,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0027019,-0.34626,-0.32626,1,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0023095,-0.34627,-0.34706,1,0
5,GO FLUID TRANSPORT,0.00332,-0.34628,-0.335,1,0
5,GO REGULATION OF BONE REMODELING,0.0042727,-0.3464,-0.28334,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0015041,-0.3467,-0.33735,1,0
5,GO UV PROTECTION,0.0016767,-0.34681,-0.2813,1,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.00064645,-0.34704,-0.37914,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00332,-0.34755,-0.26067,1,0
5,GO UTERUS DEVELOPMENT,0.0057394,-0.34766,-0.2699,1,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.027226,-0.34793,-0.31087,1,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0034935,-0.34811,-0.32079,1,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.010101,-0.34836,-0.28538,1,0
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.013235,-0.34836,-0.23553,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0019699,-0.34849,-0.28001,1,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0080134,-0.34871,-0.24124,1,0
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.007293,-0.34889,-0.22914,1,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0017696,-0.34896,-0.3031,1,0
5,GO LYMPHANGIOGENESIS,0.0063209,-0.34917,-0.31267,1,0
5,GO HEAT GENERATION,0.00091199,-0.34928,-0.29507,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0015882,-0.34935,-0.3046,1,0
5,GO REGULATION OF GTPASE ACTIVITY,0.0031545,-0.34952,-0.21858,1,0
5,GO LYMPHOCYTE HOMEOSTASIS,0.0027019,-0.34983,-0.31043,1,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00076864,-0.34997,-0.34805,1,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0024341,-0.35021,-0.32799,1,0
5,GO BLOOD VESSEL MORPHOGENESIS,0.0024341,-0.35053,-0.29479,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.038848,-0.35083,-0.22559,1,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00068502,-0.35115,-0.37499,1,0
5,GO EXCRETION,0.017954,-0.35124,-0.20658,1,0
5,GO RESPONSE TO FUNGUS,0.010101,-0.35141,-0.29455,1,0
5,GO PROTEIN TRIMERIZATION,0.0019699,-0.35145,-0.34692,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.0080134,-0.35189,-0.26516,1,0
5,GO REGULATION OF AXON GUIDANCE,0.0036751,-0.35207,-0.27794,1,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0060238,-0.35218,-0.26335,1,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0031545,-0.3528,-0.2742,1,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.024086,-0.35287,-0.32844,1,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0025648,-0.35311,-0.34762,1,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0015882,-0.35313,-0.31664,1,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.0052065,-0.35323,-0.26548,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0023095,-0.35382,-0.30346,1,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0024341,-0.35411,-0.29148,1,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.0066311,-0.35416,-0.23753,1,0
5,GO ARTERY MORPHOGENESIS,0.0028457,-0.3542,-0.28636,1,0
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0047188,-0.35444,-0.23257,1,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0038653,-0.35452,-0.31543,1,0
5,GO BONE MORPHOGENESIS,0.0013481,-0.35456,-0.3073,1,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0052065,-0.35468,-0.26501,1,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0015041,-0.3547,-0.31114,1,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0028457,-0.35484,-0.28851,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.026142,-0.35515,-0.34084,1,0
5,GO REGULATION OF HEAT GENERATION,0.0024341,-0.3553,-0.27764,1,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.0016767,-0.35547,-0.34889,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0060238,-0.3556,-0.32184,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00332,-0.35578,-0.25965,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0049572,-0.35581,-0.27433,1,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00076864,-0.35607,-0.31063,1,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.0012758,-0.35642,-0.45598,1,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00026348,-0.35647,-0.33894,1,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.015104,-0.35668,-0.28507,1,0
5,GO STEM CELL DIVISION,0.00091199,-0.35694,-0.32757,1,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0044907,-0.35697,-0.33909,1,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.0015041,-0.35698,-0.28258,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.0034935,-0.35698,-0.29888,1,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0028457,-0.35708,-0.22691,1,0
5,GO RENAL VESICLE DEVELOPMENT,0.00064645,-0.35709,-0.35277,1,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0047188,-0.3571,-0.31415,1,0
5,GO RENAL ABSORPTION,0.0054671,-0.35734,-0.31376,1,0
5,GO OSTEOCLAST DEVELOPMENT,0.027226,-0.35749,-0.26124,1,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0029965,-0.35788,-0.2725,1,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0063209,-0.35811,-0.30164,1,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0052065,-0.35821,-0.25855,1,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0011418,-0.35826,-0.32775,1,0
5,GO INNATE IMMUNE RESPONSE,0.0012071,-0.35838,-0.33585,1,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0029965,-0.35862,-0.32771,1,0
5,GO OVULATION,0.01266,-0.35885,-0.28591,1,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0024341,-0.35911,-0.29024,1,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0057394,-0.35923,-0.3067,1,0
5,GO NATURAL KILLER CELL ACTIVATION,0.0038653,-0.3598,-0.33926,1,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0015041,-0.35985,-0.3253,1,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0023095,-0.35987,-0.27879,1,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0020776,-0.3599,-0.32014,1,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0031545,-0.35991,-0.2835,1,0
5,GO HYALURONAN CATABOLIC PROCESS,0.019548,-0.35998,-0.22346,1,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0031545,-0.36046,-0.44645,1,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0023095,-0.36057,-0.39916,1,0
5,GO GAP JUNCTION ASSEMBLY,0.0080134,-0.36071,-0.34949,1,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0044907,-0.36073,-0.35651,1,0
5,GO OSTEOCLAST DIFFERENTIATION,0.0027019,-0.36088,-0.30004,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0057394,-0.36103,-0.23653,1,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0042727,-0.36107,-0.26605,1,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01266,-0.36116,-0.27754,1,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.008797,-0.3613,-0.27873,1,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.0038653,-0.36166,-0.29068,1,0
5,GO PROSTANOID METABOLIC PROCESS,0.0052065,-0.36193,-0.28926,1,0
5,GO REGULATION OF COAGULATION,0.011574,-0.36197,-0.26058,1,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.0010798,-0.36217,-0.29691,1,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0014241,-0.36222,-0.29934,1,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.035953,-0.36257,-0.21728,1,0
5,GO LYMPHOCYTE ACTIVATION,0.00096503,-0.36257,-0.35659,1,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.022172,-0.36277,-0.31367,1,0
5,GO IMMUNOGLOBULIN SECRETION,0.008797,-0.36295,-0.38154,1,0
5,GO LEUKOCYTE HOMEOSTASIS,0.0025648,-0.36299,-0.32186,1,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.008797,-0.36313,-0.32378,1,0
5,GO BONE RESORPTION,0.0040644,-0.36328,-0.29889,1,0
5,GO ENTRY INTO HOST,0.0052065,-0.3634,-0.26789,1,0
5,GO OVULATION CYCLE,0.0018673,-0.36349,-0.27109,1,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0092139,-0.3636,-0.32315,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.0012758,-0.36362,-0.27764,1,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.0024341,-0.36404,-0.40017,1,0
5,GO ESTROUS CYCLE,0.013834,-0.36429,-0.27213,1,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0023095,-0.36442,-0.39094,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.023112,-0.3649,-0.20037,1,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0024341,-0.36511,-0.29359,1,0
5,GO GRANULOCYTE DIFFERENTIATION,0.0013481,-0.3652,-0.33811,1,0
5,GO NOTOCHORD DEVELOPMENT,0.0028457,-0.3652,-0.31821,1,0
5,GO REGULATION OF BONE MINERALIZATION,0.0021907,-0.36523,-0.29118,1,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00076864,-0.36526,-0.35121,1,0
5,GO PERICARDIUM DEVELOPMENT,0.0054671,-0.36545,-0.28565,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00048214,-0.36593,-0.38557,1,0
5,GO BONE MATURATION,0.0036751,-0.36607,-0.28023,1,0
5,GO REGULATION OF B CELL PROLIFERATION,0.0080134,-0.3662,-0.37438,1,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0029965,-0.36622,-0.36936,1,0
5,GO PEPTIDYL TYROSINE MODIFICATION,0.0021907,-0.3664,-0.28347,1,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0017696,-0.36669,-0.28811,1,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0018673,-0.36679,-0.33141,1,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.027226,-0.36686,-0.33636,1,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.010572,-0.367,-0.26009,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.024086,-0.36709,-0.23912,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0012071,-0.36714,-0.39813,1,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0024341,-0.36745,-0.28386,1,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0012758,-0.36757,-0.4012,1,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0044907,-0.36811,-0.32477,1,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0011418,-0.36822,-0.32598,1,0
5,GO LEUKOCYTE DIFFERENTIATION,0.0014241,-0.36826,-0.3358,1,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.0054671,-0.36827,-0.28664,1,0
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0011418,-0.36836,-0.30222,1,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00072571,-0.36856,-0.38526,1,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0036751,-0.36859,-0.32279,1,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00021879,-0.36883,-0.35238,1,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0020776,-0.3691,-0.29854,1,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0076456,-0.36959,-0.30458,1,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.0047188,-0.36965,-0.29906,1,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0012758,-0.36981,-0.35985,1,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00076864,-0.37002,-0.3196,1,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0031545,-0.37005,-0.30994,1,0
5,GO RENAL WATER HOMEOSTASIS,0.0080134,-0.3704,-0.24805,1,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.0028457,-0.37042,-0.35854,1,0
5,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.0025648,-0.37047,-0.39919,1,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.014457,-0.3707,-0.24926,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0049572,-0.37096,-0.32928,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0023095,-0.37123,-0.29988,1,0
5,GO INTERLEUKIN 17 PRODUCTION,0.0066311,-0.37129,-0.36091,1,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.015776,-0.37134,-0.42478,1,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.027226,-0.3716,-0.23417,1,0
5,GO MAST CELL MEDIATED IMMUNITY,0.006955,-0.3716,-0.31196,1,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.0013481,-0.37187,-0.33796,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028457,-0.37198,-0.41275,1,0
5,GO EMBRYONIC EYE MORPHOGENESIS,0.0029965,-0.37223,-0.3019,1,0
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00091199,-0.37251,-0.3352,1,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0028457,-0.37256,-0.26466,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0020776,-0.37262,-0.35832,1,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.011574,-0.37285,-0.34739,1,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00072571,-0.37302,-0.30793,1,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.007293,-0.37316,-0.35664,1,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0092139,-0.37323,-0.3847,1,0
5,GO RESPONSE TO INTERFERON ALPHA,0.0092139,-0.37367,-0.37882,1,0
5,GO ACUTE INFLAMMATORY RESPONSE,0.0049572,-0.37383,-0.3292,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0096484,-0.37395,-0.33519,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.02951,-0.37406,-0.31304,1,0
5,GO COCHLEA MORPHOGENESIS,0.00096503,-0.37416,-0.30563,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0018673,-0.37418,-0.46422,1,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0083971,-0.37427,-0.30416,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00072571,-0.37428,-0.30426,1,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.0052065,-0.3744,-0.47609,1,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0040644,-0.37451,-0.32122,1,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0042727,-0.37461,-0.24543,1,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.0016767,-0.37464,-0.32821,1,0
5,GO ENDODERM DEVELOPMENT,0.0016767,-0.37493,-0.34308,1,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0014241,-0.37512,-0.38852,1,0
5,GO CYTOKINE PRODUCTION,0.0012071,-0.37559,-0.32249,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0052065,-0.37563,-0.35627,1,0
5,GO PULMONARY VALVE DEVELOPMENT,0.0060238,-0.37594,-0.32587,1,0
5,GO GAS TRANSPORT,0.0036751,-0.37612,-0.37463,1,0
5,GO GLIAL CELL PROLIFERATION,0.00021879,-0.37651,-0.39095,1,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0012071,-0.37678,-0.34655,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00096503,-0.37686,-0.31392,1,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0015041,-0.37728,-0.36322,1,0
5,GO T CELL LINEAGE COMMITMENT,0.0044907,-0.37731,-0.35324,1,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00332,-0.37736,-0.33166,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0083971,-0.37737,-0.32788,1,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.0016767,-0.37749,-0.38643,1,0
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.00076864,-0.37751,-0.31599,1,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0017696,-0.37758,-0.33691,1,0
5,GO BASEMENT MEMBRANE ORGANIZATION,0.017954,-0.37779,-0.2482,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0019699,-0.37807,-0.33561,1,0
5,GO HEART VALVE FORMATION,0.0027019,-0.37814,-0.41923,1,0
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.030713,-0.3782,-0.22496,1,0
5,GO MAST CELL ACTIVATION,0.0042727,-0.37839,-0.32598,1,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0066311,-0.37843,-0.29561,1,0
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0096484,-0.37869,-0.3061,1,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0021907,-0.37877,-0.33923,1,0
5,GO T CELL DIFFERENTIATION IN THYMUS,0.0015041,-0.37915,-0.35884,1,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.013834,-0.37918,-0.45643,1,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0060238,-0.37927,-0.39657,1,0
5,GO REGULATION OF LIPASE ACTIVITY,0.0012758,-0.37943,-0.29906,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0047188,-0.37958,-0.37063,1,0
5,GO REGULATION OF MYELINATION,0.00086166,-0.37981,-0.31788,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0014241,-0.3802,-0.33688,1,0
5,GO INTERFERON ALPHA PRODUCTION,0.00060992,-0.38021,-0.37755,1,0
5,GO ENAMEL MINERALIZATION,0.0052065,-0.3805,-0.27467,1,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0010209,-0.38079,-0.33178,1,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.013834,-0.3808,-0.29651,1,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.0021907,-0.38096,-0.29383,1,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0015882,-0.38111,-0.33695,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0057394,-0.38136,-0.52653,1,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00076864,-0.3814,-0.32338,1,0
5,GO REGULATION OF IMMUNE RESPONSE,0.00081392,-0.38228,-0.34146,1,0
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0092139,-0.38248,-0.28425,1,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0017696,-0.38251,-0.39768,1,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.0054671,-0.3826,-0.39721,1,0
5,GO MYELOID LEUKOCYTE MIGRATION,0.0036751,-0.38263,-0.39227,1,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0034935,-0.38277,-0.32419,1,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0011418,-0.38289,-0.31928,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.016475,-0.38303,-0.30304,1,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0018673,-0.38343,-0.36966,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0029965,-0.38347,-0.3934,1,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00068502,-0.38359,-0.3856,1,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0057394,-0.38413,-0.28495,1,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0021907,-0.38424,-0.39237,1,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0038653,-0.38446,-0.29836,1,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0016767,-0.38453,-0.33046,1,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0063209,-0.38462,-0.30563,1,0
5,GO CYTOKINE METABOLIC PROCESS,0.0031545,-0.38472,-0.35804,1,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0060238,-0.38477,-0.31192,1,0
5,GO SYNCYTIUM FORMATION,0.0015882,-0.38512,-0.33481,1,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00064645,-0.38531,-0.41725,1,0
5,GO CELLULAR RESPONSE TO VITAMIN D,0.00068502,-0.38545,-0.38767,1,0
5,GO DEFENSE RESPONSE TO BACTERIUM,0.0027019,-0.38553,-0.32609,1,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.006955,-0.38628,-0.30366,1,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.0016767,-0.38689,-0.32556,1,0
5,GO ASTROCYTE ACTIVATION,0.007293,-0.38696,-0.3247,1,0
5,GO LEUKOTRIENE METABOLIC PROCESS,0.0012758,-0.38703,-0.34322,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011418,-0.38705,-0.33088,1,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0047188,-0.38754,-0.29236,1,0
5,GO RESPONSE TO AMYLOID BETA,0.0027019,-0.38754,-0.30333,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00060992,-0.38791,-0.38039,1,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.0029965,-0.38799,-0.36369,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0036751,-0.38805,-0.44831,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00068502,-0.38807,-0.39274,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0024341,-0.38827,-0.33755,1,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.015776,-0.38833,-0.22907,1,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0060238,-0.38839,-0.34906,1,0
5,GO TRABECULA FORMATION,0.0018673,-0.38872,-0.37066,1,0
5,GO FOAM CELL DIFFERENTIATION,0.006955,-0.38879,-0.29006,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0012071,-0.38885,-0.34243,1,0
5,GO LYMPH NODE DEVELOPMENT,0.013235,-0.3889,-0.31814,1,0
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0018673,-0.38903,-0.30823,1,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0024341,-0.38939,-0.37513,1,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023112,-0.38942,-0.3421,1,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0034935,-0.38943,-0.2815,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0054671,-0.38977,-0.34092,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00096503,-0.39074,-0.39428,1,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0047188,-0.39103,-0.36289,1,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0015041,-0.39104,-0.35634,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0038653,-0.39105,-0.2851,1,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00076864,-0.39111,-0.38014,1,0
5,GO REGULATION OF CELL ADHESION,0.0017696,-0.39207,-0.3199,1,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00048214,-0.39212,-0.31887,1,0
5,GO REGULATION OF BONE DEVELOPMENT,0.016475,-0.39224,-0.29275,1,0
5,GO MYOBLAST FUSION,0.0015041,-0.39238,-0.35065,1,0
5,GO REGULATION OF CELL ACTIVATION,0.00096503,-0.39239,-0.3703,1,0
5,GO INFLAMMATORY RESPONSE,0.0023095,-0.39247,-0.33663,1,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.023112,-0.39311,-0.26406,1,0
5,GO ANATOMICAL STRUCTURE REGRESSION,0.0025648,-0.39321,-0.35586,1,0
5,GO HEART VALVE DEVELOPMENT,0.0021907,-0.39394,-0.33543,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0038653,-0.39398,-0.32504,1,0
5,GO KERATAN SULFATE METABOLIC PROCESS,0.00332,-0.39424,-0.28079,1,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00091199,-0.39446,-0.31926,1,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0013481,-0.39513,-0.32939,1,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0027019,-0.39537,-0.31817,1,0
5,GO LYMPH VESSEL DEVELOPMENT,0.0080134,-0.39611,-0.30547,1,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.017954,-0.39633,-0.3002,1,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00096503,-0.39661,-0.41156,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.014457,-0.3967,-0.27981,1,0
5,GO TRACHEA DEVELOPMENT,0.0016767,-0.39676,-0.33871,1,0
5,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.00010181,-0.39708,-0.41002,1,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.0015041,-0.39708,-0.31576,1,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0017696,-0.39711,-0.40718,1,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00076864,-0.39716,-0.32657,1,0
5,GO ACUTE PHASE RESPONSE,0.0083971,-0.39717,-0.3177,1,0
5,GO I KAPPAB PHOSPHORYLATION,0.00051151,-0.39739,-0.38004,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0057394,-0.39742,-0.3075,1,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0015041,-0.39754,-0.33009,1,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0015882,-0.39757,-0.32772,1,0
5,GO REGULATION OF B CELL ACTIVATION,0.0034935,-0.39761,-0.37558,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0015882,-0.39775,-0.33911,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0011418,-0.39794,-0.39142,1,0
5,GO B CELL DIFFERENTIATION,0.00068502,-0.39812,-0.35294,1,0
5,GO CELL KILLING,0.0024341,-0.39818,-0.37718,1,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0020776,-0.39832,-0.31752,1,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0036751,-0.39833,-0.33828,1,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0027019,-0.39855,-0.33581,1,0
5,GO TOOTH MINERALIZATION,0.0036751,-0.39871,-0.30896,1,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00072571,-0.39875,-0.39255,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0018673,-0.3991,-0.37979,1,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0028457,-0.39974,-0.42691,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0019699,-0.39976,-0.3015,1,0
5,GO HYPEROSMOTIC RESPONSE,0.0034935,-0.40006,-0.30146,1,0
5,GO AMYLOID BETA CLEARANCE,0.0031545,-0.40012,-0.36544,1,0
5,GO BLOOD VESSEL REMODELING,0.0083971,-0.40049,-0.2853,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0042727,-0.40053,-0.34327,1,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0057394,-0.40054,-0.39026,1,0
5,GO INTERLEUKIN 2 PRODUCTION,0.00076864,-0.40063,-0.46176,1,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0025648,-0.40064,-0.39744,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.0025648,-0.40077,-0.38465,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0044907,-0.40084,-0.31115,1,0
5,GO REVERSE CHOLESTEROL TRANSPORT,0.011063,-0.4009,-0.34041,1,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0063209,-0.40135,-0.32357,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00332,-0.40242,-0.34763,1,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0011418,-0.40244,-0.31474,1,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.006955,-0.40292,-0.30537,1,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0040644,-0.40294,-0.32977,1,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00068502,-0.40304,-0.39478,1,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00332,-0.40309,-0.33884,1,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00068502,-0.40309,-0.40243,1,0
5,GO T CELL DIFFERENTIATION,0.00081392,-0.40336,-0.39698,1,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0012758,-0.40349,-0.43965,1,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015882,-0.40353,-0.32796,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00057531,-0.4041,-0.39101,1,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0031545,-0.40425,-0.29615,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00045436,-0.40428,-0.42609,1,0
5,GO AORTIC VALVE DEVELOPMENT,0.0024341,-0.40458,-0.33831,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00076864,-0.40465,-0.41655,1,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0010209,-0.40494,-0.36166,1,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0010798,-0.40528,-0.34103,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0014241,-0.40581,-0.45434,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0029965,-0.40585,-0.41129,1,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0010798,-0.40588,-0.37952,1,0
5,GO LYMPHOCYTE DIFFERENTIATION,0.00068502,-0.40589,-0.3822,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0028457,-0.40652,-0.34748,1,0
5,GO SIALYLATION,0.00332,-0.40663,-0.33948,1,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0172,-0.40667,-0.31779,1,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0012758,-0.40671,-0.37699,1,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0010209,-0.40697,-0.35879,1,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0034935,-0.40788,-0.40028,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0031545,-0.40822,-0.45633,1,0
5,GO RESPONSE TO TYPE I INTERFERON,0.0080134,-0.40842,-0.36156,1,0
5,GO REGULATION OF CHEMOTAXIS,0.0021907,-0.4086,-0.33152,1,0
5,GO REGULATION OF CELL CELL ADHESION,0.0011418,-0.40868,-0.35455,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.00332,-0.4087,-0.34218,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0172,-0.40876,-0.30153,1,0
5,GO REGULATION OF T CELL DIFFERENTIATION,0.00091199,-0.40896,-0.40217,1,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015882,-0.40956,-0.3584,1,0
5,GO PEPTIDE CROSS LINKING,0.016475,-0.40966,-0.36168,1,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0014241,-0.41003,-0.39858,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0063209,-0.41015,-0.36014,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0017696,-0.41029,-0.32918,1,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0012758,-0.41031,-0.37508,1,0
5,GO MACROPHAGE DIFFERENTIATION,0.0024341,-0.41048,-0.35942,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0020776,-0.41055,-0.29564,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00042807,-0.41058,-0.33883,1,0
5,GO REGULATION OF TISSUE REMODELING,0.0027019,-0.41061,-0.31138,1,0
5,GO T CELL MEDIATED IMMUNITY,0.0011418,-0.41069,-0.41691,1,0
5,GO BLEB ASSEMBLY,0.0063209,-0.41094,-0.36061,1,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0023095,-0.41097,-0.30584,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.015776,-0.41133,-0.30846,1,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00081392,-0.4117,-0.43104,1,0
5,GO CHONDROCYTE PROLIFERATION,0.0054671,-0.41188,-0.33373,1,0
5,GO ERK1 AND ERK2 CASCADE,0.00068502,-0.41189,-0.35428,1,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0013481,-0.41215,-0.32149,1,0
5,GO REGULATION OF CELL KILLING,0.0024341,-0.41297,-0.42715,1,0
5,GO LIPOPROTEIN LOCALIZATION,0.00086166,-0.4134,-0.33991,1,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0031545,-0.41415,-0.35191,1,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00054254,-0.41423,-0.41648,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0010209,-0.41457,-0.39031,1,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.011063,-0.41479,-0.35545,1,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00332,-0.41505,-0.31711,1,0
5,GO MACROPHAGE APOPTOTIC PROCESS,0.0038653,-0.41507,-0.40114,1,0
5,GO T CELL ACTIVATION,0.00081392,-0.41522,-0.38174,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0031545,-0.41532,-0.47204,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0020776,-0.4154,-0.27754,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0057394,-0.4155,-0.37043,1,0
5,GO MEMBRANE INVAGINATION,0.0019699,-0.41616,-0.3551,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0016767,-0.41629,-0.37882,1,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0044907,-0.41671,-0.38103,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0023095,-0.41683,-0.34175,1,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034935,-0.41684,-0.41331,1,0
5,GO CYTOKINE SECRETION,0.00081392,-0.41687,-0.39102,1,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00072571,-0.41687,-0.3647,1,0
5,GO DECIDUALIZATION,0.022172,-0.41754,-0.26399,1,0
5,GO GRANULOCYTE MIGRATION,0.0021907,-0.41794,-0.45367,1,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.008797,-0.41806,-0.31808,1,0
5,GO B CELL ACTIVATION,0.0012758,-0.41807,-0.34812,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0029965,-0.41895,-0.34732,1,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0013481,-0.41911,-0.42227,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0023095,-0.41912,-0.41663,1,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0038653,-0.4194,-0.39739,1,0
5,GO LEUKOCYTE MIGRATION,0.0028457,-0.4197,-0.34959,1,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0023095,-0.41979,-0.30662,1,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00051151,-0.41991,-0.43061,1,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0014241,-0.42034,-0.37761,1,0
5,GO B CELL PROLIFERATION,0.0047188,-0.42047,-0.41354,1,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0034935,-0.42054,-0.48182,1,0
5,GO REGULATION OF T CELL MIGRATION,0.0027019,-0.42085,-0.41016,1,0
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.0011418,-0.42107,-0.34,1,0
5,GO LIMB BUD FORMATION,0.0060238,-0.42128,-0.40196,1,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.028348,-0.42134,-0.45664,1,0
5,GO PHAGOCYTOSIS,0.0016767,-0.42177,-0.35954,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00091199,-0.42239,-0.37084,1,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00068502,-0.42242,-0.35767,1,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0029965,-0.42259,-0.3468,1,0
5,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0047188,-0.42261,-0.4942,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0020776,-0.42284,-0.39631,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0029965,-0.42287,-0.38251,1,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.0028457,-0.42318,-0.33593,1,0
5,GO FACIAL NERVE MORPHOGENESIS,0.0018673,-0.42319,-0.40175,1,0
5,GO REGULATION OF T CELL ACTIVATION,0.00068502,-0.42323,-0.39631,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0015041,-0.4236,-0.38215,1,0
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0029965,-0.42423,-0.41083,1,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00064645,-0.4243,-0.3648,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0049572,-0.42501,-0.44405,1,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.011063,-0.42535,-0.47036,1,0
5,GO MONONUCLEAR CELL MIGRATION,0.0031545,-0.42578,-0.48986,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0012071,-0.42609,-0.35793,1,0
5,GO OSTEOBLAST PROLIFERATION,0.006955,-0.4262,-0.29062,1,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00081392,-0.42628,-0.35762,1,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00023283,-0.42679,-0.45513,1,0
5,GO MOTOR NEURON AXON GUIDANCE,0.0011418,-0.42703,-0.33102,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00081392,-0.42738,-0.37865,1,0
5,GO PROSTATE GLAND MORPHOGENESIS,0.00072571,-0.42774,-0.43817,1,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00024771,-0.42776,-0.3784,1,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0012758,-0.42778,-0.39298,1,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0012071,-0.4283,-0.42962,1,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.010101,-0.4283,-0.47325,1,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0021907,-0.42842,-0.34744,1,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00096503,-0.42925,-0.3973,1,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0049572,-0.42939,-0.45764,1,0
5,GO INTERLEUKIN 6 PRODUCTION,0.0014241,-0.4294,-0.36694,1,0
5,GO COLLAGEN METABOLIC PROCESS,0.0044907,-0.42953,-0.37181,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0044907,-0.42969,-0.3096,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.0057394,-0.42974,-0.32212,1,0
5,GO RESPONSE TO HYDROPEROXIDE,0.00072571,-0.42982,-0.41069,1,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.00096503,-0.42994,-0.38914,1,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0029965,-0.43044,-0.4723,1,0
5,GO LEUKOCYTE CHEMOTAXIS,0.0019699,-0.43074,-0.41902,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00068502,-0.43076,-0.3867,1,0
5,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.0021907,-0.43099,-0.45511,1,0
5,GO LEUKOCYTE PROLIFERATION,0.0012071,-0.43101,-0.41291,1,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00332,-0.43131,-0.41735,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0010798,-0.43135,-0.36292,1,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.0013481,-0.43137,-0.39671,1,0
5,GO TISSUE REMODELING,0.00332,-0.4314,-0.31893,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0027019,-0.43202,-0.43438,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0028457,-0.43231,-0.36916,1,0
5,GO ALPHA BETA T CELL ACTIVATION,0.00064645,-0.43246,-0.45073,1,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00068502,-0.43282,-0.38029,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0017696,-0.43284,-0.43918,1,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0021907,-0.43324,-0.34626,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0012758,-0.43341,-0.41908,1,0
5,GO T CELL PROLIFERATION,0.0012758,-0.43464,-0.42418,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0034935,-0.43539,-0.38683,1,0
5,GO REGULATION OF MYOBLAST FUSION,0.0052065,-0.43599,-0.42226,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0029965,-0.43624,-0.43589,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00064645,-0.43635,-0.36488,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00086166,-0.43647,-0.41756,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00060992,-0.43651,-0.42517,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0015882,-0.43655,-0.41442,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0017696,-0.43685,-0.36703,1,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.006955,-0.43742,-0.29957,1,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.028348,-0.43748,-0.33164,1,0
5,GO LEUKOCYTE CELL CELL ADHESION,0.00086166,-0.43761,-0.4089,1,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00064645,-0.43789,-0.36976,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0012758,-0.43797,-0.39539,1,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0018673,-0.43806,-0.52849,1,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00081392,-0.43836,-0.40829,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0038653,-0.4389,-0.46686,1,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0013481,-0.43934,-0.34162,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0012071,-0.4394,-0.38252,1,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0028457,-0.43945,-0.42368,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0066311,-0.43958,-0.388,1,0
5,GO RESPONSE TO INTERFERON GAMMA,0.0020776,-0.44018,-0.45742,1,0
5,GO GAMMA DELTA T CELL ACTIVATION,0.0060238,-0.4403,-0.39039,1,0
5,GO PSEUDOPODIUM ORGANIZATION,0.00091199,-0.44051,-0.38005,1,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0052065,-0.44056,-0.4298,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0015882,-0.44096,-0.38877,1,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0021907,-0.44107,-0.41991,1,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00057531,-0.44111,-0.40802,1,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0057394,-0.44154,-0.39339,1,0
5,GO RESPONSE TO TUMOR CELL,0.0011418,-0.44177,-0.39059,1,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0013481,-0.44258,-0.39844,1,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0010798,-0.44281,-0.37683,1,0
5,GO CELL CHEMOTAXIS,0.0017696,-0.44285,-0.3948,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00072571,-0.44313,-0.41196,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00076864,-0.44337,-0.4518,1,0
5,GO NEUTROPHIL MIGRATION,0.0013481,-0.44342,-0.49351,1,0
5,GO FIBRINOLYSIS,0.010101,-0.44404,-0.36121,1,0
5,GO T CELL CYTOKINE PRODUCTION,0.00054254,-0.44425,-0.47896,1,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0034935,-0.44441,-0.47098,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0018673,-0.44494,-0.3308,1,0
5,GO COLLAGEN CATABOLIC PROCESS,0.0057394,-0.445,-0.38518,1,0
5,GO INTERLEUKIN 4 PRODUCTION,0.0034935,-0.4451,-0.45192,1,0
5,GO CELLULAR DEFENSE RESPONSE,0.0054671,-0.44519,-0.45625,1,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0054671,-0.44536,-0.34994,1,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00064645,-0.44551,-0.37507,1,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0031545,-0.44588,-0.3865,1,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00042807,-0.4459,-0.46781,1,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0016767,-0.44667,-0.38317,1,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0063209,-0.44703,-0.50701,1,0
5,GO POSITIVE REGULATION OF CELL KILLING,0.0034935,-0.44708,-0.43358,1,0
5,GO HUMORAL IMMUNE RESPONSE,0.0014241,-0.44725,-0.45372,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0029965,-0.4478,-0.4257,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00029789,-0.44783,-0.54476,1,0
5,GO PLATELET DEGRANULATION,0.0057394,-0.44806,-0.30551,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.011574,-0.44876,-0.39361,1,0
5,GO REGULATION OF FIBRINOLYSIS,0.024086,-0.44878,-0.29895,1,0
5,GO INTERLEUKIN 10 PRODUCTION,0.0066311,-0.45046,-0.43379,1,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0052065,-0.45065,-0.48422,1,0
5,GO REGULATION OF B CELL DIFFERENTIATION,0.00091199,-0.45116,-0.45871,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015041,-0.45124,-0.45432,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.018736,-0.45203,-0.38882,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0047188,-0.45207,-0.42088,1,0
5,GO T CELL SELECTION,0.0017696,-0.45235,-0.46836,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0028457,-0.45242,-0.45698,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010209,-0.45312,-0.42444,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0027019,-0.45348,-0.4794,1,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.015104,-0.4537,-0.41841,1,0
5,GO SUPEROXIDE ANION GENERATION,0.0020776,-0.4543,-0.35261,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION,0.0013481,-0.45431,-0.35608,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0096484,-0.45449,-0.39181,1,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00057531,-0.45452,-0.39101,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0024341,-0.45503,-0.47169,1,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0025648,-0.45504,-0.47956,1,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00068502,-0.45505,-0.45714,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00091199,-0.45518,-0.4544,1,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0060238,-0.4552,-0.37903,1,0
5,GO GRANULOCYTE CHEMOTAXIS,0.0020776,-0.45538,-0.47928,1,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0018673,-0.45549,-0.5124,1,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00096503,-0.45554,-0.40747,1,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0015041,-0.45578,-0.43228,1,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0023095,-0.45589,-0.41896,1,0
5,GO RESPONSE TO PROSTAGLANDIN,0.00076864,-0.45676,-0.39931,1,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0018673,-0.45788,-0.45767,1,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0023095,-0.45798,-0.40662,1,0
5,GO SERTOLI CELL DEVELOPMENT,0.0014241,-0.45912,-0.33889,1,0
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0066311,-0.45935,-0.39099,1,0
5,GO INTERLEUKIN 8 PRODUCTION,0.00091199,-0.45949,-0.4075,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0038653,-0.45971,-0.43681,1,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0018673,-0.45991,-0.43664,1,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027019,-0.46022,-0.39513,1,0
5,GO LYMPHOCYTE COSTIMULATION,0.0011418,-0.46025,-0.4317,1,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0027019,-0.46036,-0.40743,1,0
5,GO MONOCYTE CHEMOTAXIS,0.0066311,-0.46061,-0.52878,1,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0057394,-0.46089,-0.35164,1,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0027019,-0.461,-0.35022,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00064645,-0.46108,-0.43909,1,0
5,GO SALIVA SECRETION,0.00029789,-0.46187,-0.43417,1,0
5,GO REGULATION OF PLATELET ACTIVATION,0.0049572,-0.46213,-0.37621,1,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00096503,-0.46228,-0.4422,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.014457,-0.46229,-0.5255,1,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.00081392,-0.46235,-0.44931,1,0
5,GO CHONDROCYTE DEVELOPMENT,0.00091199,-0.46274,-0.36348,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0020776,-0.4628,-0.43263,1,0
5,GO INTERFERON GAMMA PRODUCTION,0.0010798,-0.46308,-0.4762,1,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0012071,-0.46318,-0.34269,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0034935,-0.46334,-0.40963,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072571,-0.46348,-0.47768,1,0
5,GO ZYMOGEN INHIBITION,0.0083971,-0.4635,-0.34407,1,0
5,GO RESPONSE TO CHEMOKINE,0.0012758,-0.46359,-0.50455,1,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0096484,-0.46407,-0.38239,1,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00026348,-0.46478,-0.46774,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.022172,-0.46515,-0.43642,1,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0083971,-0.46552,-0.42555,1,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00051151,-0.46579,-0.51778,1,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0080134,-0.4659,-0.42155,1,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.011574,-0.46628,-0.51425,1,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0025648,-0.46658,-0.34526,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0010209,-0.46741,-0.39901,1,0
5,GO MACROPHAGE MIGRATION,0.0027019,-0.46819,-0.41089,1,0
5,GO TYPE 2 IMMUNE RESPONSE,0.0021907,-0.46844,-0.47818,1,0
5,GO BONE REMODELING,0.0020776,-0.4687,-0.32548,1,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015041,-0.46949,-0.46068,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0076456,-0.46949,-0.4529,1,0
5,GO REGULATION OF GLIAL CELL MIGRATION,0.0013481,-0.4701,-0.42451,1,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00064645,-0.47055,-0.41529,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00086166,-0.47093,-0.42824,1,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0020776,-0.47131,-0.48631,1,0
5,GO LEUKOCYTE AGGREGATION,0.0042727,-0.47193,-0.56381,1,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00076864,-0.47312,-0.35126,1,0
5,GO GENITALIA MORPHOGENESIS,0.00033648,-0.47315,-0.44337,1,0
5,GO MACROPHAGE CHEMOTAXIS,0.0034935,-0.47339,-0.41978,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.006955,-0.47359,-0.38424,1,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00076864,-0.47439,-0.43495,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0017696,-0.47456,-0.40492,1,0
5,GO MITRAL VALVE DEVELOPMENT,0.0010209,-0.47545,-0.40403,1,0
5,GO TOLERANCE INDUCTION,0.0047188,-0.47579,-0.6268,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.026142,-0.476,-0.37025,1,0
5,GO CHEMOKINE PRODUCTION,0.0020776,-0.47679,-0.37221,1,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00091199,-0.47778,-0.40896,1,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0023095,-0.47783,-0.48302,1,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00048214,-0.47784,-0.46737,1,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.0003797,-0.47799,-0.52004,1,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0018673,-0.4789,-0.39176,1,0
5,GO INTERLEUKIN 13 PRODUCTION,0.0027019,-0.47895,-0.46535,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00072571,-0.47908,-0.49475,1,0
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0013481,-0.47938,-0.60368,1,0
5,GO DENDRITIC CELL DIFFERENTIATION,0.0018673,-0.47943,-0.51156,1,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0029965,-0.47945,-0.36119,1,0
5,GO T CELL MIGRATION,0.0015041,-0.47966,-0.51574,1,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0023095,-0.47993,-0.45853,1,0
5,GO CELL ADHESION MOLECULE PRODUCTION,0.0018673,-0.48035,-0.40363,1,0
5,GO NEUTROPHIL CHEMOTAXIS,0.0012071,-0.48076,-0.52466,1,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00081392,-0.48116,-0.43846,1,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.0018673,-0.48148,-0.4569,1,0
5,GO THYMIC T CELL SELECTION,0.0040644,-0.48155,-0.48045,1,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0023095,-0.483,-0.52558,1,0
5,GO RESPONSE TO PROTOZOAN,0.0015882,-0.48323,-0.52253,1,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.0019699,-0.48326,-0.40862,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.014457,-0.48333,-0.42659,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00091199,-0.48353,-0.36822,1,0
5,GO LYMPHOCYTE MIGRATION,0.0019699,-0.48366,-0.48937,1,0
5,GO NEURAL CREST FORMATION,0.0016767,-0.48405,-0.41893,1,0
5,GO ENDODERM FORMATION,0.0024341,-0.48415,-0.40473,1,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00072571,-0.48437,-0.5297,1,0
5,GO RESPONSE TO PEPTIDOGLYCAN,0.013235,-0.48466,-0.39185,1,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00040321,-0.48505,-0.53567,1,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.0013481,-0.48529,-0.44172,1,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0021907,-0.48586,-0.38583,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0018673,-0.48598,-0.44246,1,0
5,GO MACROPHAGE ACTIVATION,0.0016767,-0.4861,-0.42321,1,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0038653,-0.48624,-0.45423,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00096503,-0.4869,-0.5253,1,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00068502,-0.48707,-0.43422,1,0
5,GO NEUROINFLAMMATORY RESPONSE,0.0012071,-0.48711,-0.46657,1,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.012106,-0.48752,-0.48097,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00332,-0.48776,-0.3674,1,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.00332,-0.48778,-0.41132,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0012071,-0.48918,-0.51131,1,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0018673,-0.48937,-0.50048,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0092139,-0.49001,-0.40474,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.010101,-0.49022,-0.35355,1,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0012071,-0.49139,-0.47221,1,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.006955,-0.49188,-0.46896,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0015041,-0.49215,-0.47815,1,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0027019,-0.49291,-0.51333,1,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0023095,-0.49306,-0.39808,1,0
5,GO SOMATIC STEM CELL DIVISION,0.00033648,-0.49311,-0.51223,1,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0052065,-0.4937,-0.39718,1,0
5,GO INTERLEUKIN 1 PRODUCTION,0.0012758,-0.49386,-0.46077,1,0
5,GO REGULATION OF PHAGOCYTOSIS,0.0013481,-0.49404,-0.42883,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013481,-0.49456,-0.48613,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00081392,-0.49476,-0.46517,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0012071,-0.49496,-0.49048,1,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0080134,-0.49716,-0.55048,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0019699,-0.49723,-0.4312,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0010209,-0.49752,-0.45608,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0036751,-0.49831,-0.459,1,0
5,GO REGULATION OF MACROPHAGE MIGRATION,0.0020776,-0.49851,-0.41542,1,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00040321,-0.50009,-0.51987,1,0
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.01266,-0.5002,-0.35461,1,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072571,-0.50128,-0.4968,1,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.00045436,-0.50143,-0.45416,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.0020776,-0.50171,-0.49618,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0024341,-0.50202,-0.56637,1,0
5,GO PHAGOCYTOSIS RECOGNITION,0.0010798,-0.50297,-0.43044,1,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0049572,-0.50312,-0.40205,1,0
5,GO ALPHA BETA T CELL PROLIFERATION,0.0015882,-0.50327,-0.51725,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00068502,-0.50342,-0.45466,1,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00057531,-0.50411,-0.47185,1,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00072571,-0.50534,-0.57913,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00081392,-0.50551,-0.44278,1,0
5,GO BRONCHUS DEVELOPMENT,0.0042727,-0.50562,-0.3905,1,0
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.007293,-0.50684,-0.39796,1,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00072571,-0.50699,-0.4428,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0019699,-0.50731,-0.57001,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0018673,-0.50754,-0.34599,1,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0012071,-0.50759,-0.35678,1,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0018673,-0.50764,-0.45583,1,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0021907,-0.50774,-0.42879,1,0
5,GO ETHANOL OXIDATION,0.00042807,-0.50808,-0.48734,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0083971,-0.50813,-0.51715,1,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00091199,-0.51024,-0.43887,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0028457,-0.5103,-0.39214,1,0
5,GO PROTEIN ACTIVATION CASCADE,0.0040644,-0.51037,-0.37252,1,0
5,GO CELLULAR EXTRAVASATION,0.00064645,-0.51093,-0.47905,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00051151,-0.51298,-0.46822,1,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0010209,-0.51396,-0.5255,1,0
5,GO REGULATION OF STEM CELL DIVISION,0.00096503,-0.51445,-0.45755,1,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0020776,-0.51465,-0.41092,1,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.0057394,-0.51554,-0.61415,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0036751,-0.51575,-0.47304,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.020391,-0.51585,-0.52699,1,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0020776,-0.51608,-0.49573,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0011418,-0.51689,-0.5755,1,0
5,GO BONE TRABECULA MORPHOGENESIS,0.0017696,-0.51787,-0.5221,1,0
5,GO RESPONSE TO INTERLEUKIN 15,0.0042727,-0.51789,-0.49255,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00054254,-0.51796,-0.63287,1,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00091199,-0.51836,-0.45128,1,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0021907,-0.51941,-0.51383,1,0
5,GO RESPONSE TO LIPOTEICHOIC ACID,0.0028457,-0.51962,-0.4439,1,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.007293,-0.51975,-0.37322,1,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00057531,-0.51996,-0.47523,1,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0044907,-0.52008,-0.42225,1,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0013481,-0.52024,-0.41222,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00048214,-0.52159,-0.46026,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0063209,-0.52161,-0.51458,1,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0024341,-0.52256,-0.44131,1,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0015882,-0.52277,-0.457,1,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0023095,-0.52306,-0.41946,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0013481,-0.52313,-0.4468,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00076864,-0.52349,-0.49769,1,0
5,GO INTERLEUKIN 12 PRODUCTION,0.00332,-0.52414,-0.46465,1,0
5,GO HYPERSENSITIVITY,0.0015041,-0.5242,-0.65751,1,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.00014062,-0.52557,-0.6767,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00054254,-0.52741,-0.50253,1,0
5,GO ADAPTIVE IMMUNE RESPONSE,0.00076864,-0.52791,-0.49067,1,0
5,GO NEUTROPHIL EXTRAVASATION,0.00045436,-0.52842,-0.50313,1,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0017696,-0.52949,-0.51011,1,0
5,GO CHEMOKINE SECRETION,0.0012758,-0.52981,-0.56179,1,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0020776,-0.53039,-0.48263,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.01266,-0.53236,-0.38235,1,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.0010798,-0.53431,-0.54499,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.014457,-0.53602,-0.34731,1,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0013481,-0.53704,-0.41827,1,0
5,GO REGULATION OF TOLERANCE INDUCTION,0.00332,-0.53806,-0.65265,1,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.0018673,-0.53829,-0.4856,1,0
5,GO GLIAL CELL ACTIVATION,0.0012071,-0.53844,-0.49572,1,0
5,GO POSITIVE T CELL SELECTION,0.0024341,-0.53945,-0.51373,1,0
5,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00048214,-0.54001,-0.50127,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0012071,-0.54054,-0.51811,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0015882,-0.54063,-0.50758,1,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00081392,-0.54168,-0.45461,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00096503,-0.54232,-0.46685,1,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00086166,-0.54295,-0.51386,1,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0024341,-0.54445,-0.45211,1,0
5,GO MATURE B CELL DIFFERENTIATION,0.0015882,-0.54475,-0.44077,1,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00045436,-0.54558,-0.53582,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0036751,-0.54569,-0.50794,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0012758,-0.54722,-0.4908,1,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00019306,-0.5475,-0.50237,1,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0027019,-0.54872,-0.47961,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00060992,-0.5493,-0.41892,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0047188,-0.55,-0.56777,1,0
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.00081392,-0.55188,-0.463,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.00054254,-0.55194,-0.53855,1,0
5,GO T CELL EXTRAVASATION,0.0021907,-0.55302,-0.46064,1,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.00031664,-0.55415,-0.47798,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00033648,-0.55527,-0.54884,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00033648,-0.55534,-0.50867,1,0
5,GO DETECTION OF BIOTIC STIMULUS,0.0003797,-0.55582,-0.52606,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00015974,-0.55646,-0.66291,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00076864,-0.55851,-0.54189,1,0
5,GO LYMPHOCYTE CHEMOTAXIS,0.0027019,-0.55918,-0.56216,1,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00031664,-0.56032,-0.5664,1,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0019699,-0.56215,-0.49156,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00096503,-0.56238,-0.48751,1,0
5,GO RESPONSE TO INTERLEUKIN 2,0.0015041,-0.56291,-0.49283,1,0
5,GO DETECTION OF OTHER ORGANISM,0.00076864,-0.56299,-0.55024,1,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.0036751,-0.56568,-0.5093,1,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0018673,-0.56598,-0.46114,1,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0027019,-0.56701,-0.4943,1,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0031545,-0.56942,-0.45595,1,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.0042727,-0.56989,-0.46537,1,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0080134,-0.56994,-0.51947,1,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0018673,-0.57142,-0.48104,1,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0010798,-0.57192,-0.50846,1,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00086166,-0.5736,-0.43519,1,0
5,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.0023095,-0.57496,-0.56736,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0023095,-0.576,-0.46613,1,0
5,GO REGULATION OF NEUTROPHIL ACTIVATION,0.016475,-0.57616,-0.42509,1,0
5,GO T CELL CHEMOTAXIS,0.0015882,-0.57634,-0.56733,1,0
5,GO APOPTOTIC CELL CLEARANCE,0.0010209,-0.57655,-0.46352,1,0
5,GO B CELL MEDIATED IMMUNITY,0.00064645,-0.57795,-0.49804,1,0
5,GO CELL JUNCTION DISASSEMBLY,0.0013481,-0.57887,-0.49718,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0011418,-0.5794,-0.53393,1,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00048214,-0.58178,-0.52448,1,0
5,GO POSITIVE THYMIC T CELL SELECTION,0.0042727,-0.58223,-0.56968,1,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0003797,-0.5827,-0.55799,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0029965,-0.58632,-0.43676,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00054254,-0.59119,-0.46863,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00028019,-0.59176,-0.6148,1,0
5,GO CYCLOOXYGENASE PATHWAY,0.0066311,-0.59493,-0.44858,1,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.0017696,-0.5976,-0.47236,1,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.0003797,-0.59793,-0.5456,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00042807,-0.60331,-0.62541,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00042807,-0.60336,-0.59053,1,0
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0016767,-0.60425,-0.52942,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.0060238,-0.60595,-0.40841,1,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00015974,-0.60809,-0.61266,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0017696,-0.61028,-0.43879,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0019699,-0.61339,-0.65819,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.0024341,-0.61866,-0.44369,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0017696,-0.61956,-0.49951,1,0
5,GO RESPONSE TO INTERLEUKIN 18,0.0025648,-0.62463,-0.48844,1,0
5,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.00076864,-0.62738,-0.61779,1,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.0019699,-0.6274,-0.47694,1,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,9.5377e-05,-0.62847,-0.64373,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00091199,-0.63313,-0.58929,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0021907,-0.63349,-0.59113,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0044907,-0.63367,-0.48269,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00051151,-0.63467,-0.50951,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00068502,-0.63685,-0.69267,1,0
5,GO T CELL TOLERANCE INDUCTION,0.0015882,-0.64019,-0.73801,1,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00029789,-0.64169,-0.58553,1,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00081392,-0.64244,-0.65444,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0010209,-0.64765,-0.5562,1,0
5,GO COMPLEMENT ACTIVATION,0.00072571,-0.65645,-0.61006,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.0010209,-0.65689,-0.53571,1,0
5,GO CYTOLYSIS,0.0036751,-0.66566,-0.60883,1,0
5,GO DENDRITIC CELL MIGRATION,0.00048214,-0.67871,-0.64098,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0027019,-0.68193,-0.76084,1,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00081392,-0.68492,-0.69316,1,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0012758,-0.6926,-0.67792,1,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.00072571,-0.69334,-0.64382,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0096484,-0.70349,-0.43242,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0023095,-0.70764,-0.51189,1,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0012071,-0.70965,-0.6935,1,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00060992,-0.71232,-0.66447,1,0
5,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.0013481,-0.71357,-0.80659,1,0
5,GO MACROPHAGE PROLIFERATION,0.0010798,-0.71514,-0.61688,1,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0014241,-0.72687,-0.77645,1,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0019699,-0.76203,-0.69962,1,0
5,GO SYNAPSE PRUNING,0.0015882,-0.77478,-0.72371,1,0
5,GO ELASTIC FIBER ASSEMBLY,0.0016767,-0.78988,-0.61044,1,0
5,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.0019699,-0.80568,-0.89195,1,0
5,GO NEGATIVE T CELL SELECTION,0.00033648,-0.8266,-0.76452,1,0
5,GO NATURAL KILLER CELL CHEMOTAXIS,0.0076456,-0.86202,-0.72373,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0014241,-0.92899,-0.82028,1,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00057531,-0.94362,-0.85625,1,0
5,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.0015882,-0.96704,-0.8633,1,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00024771,-1.0061,-0.76833,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.08881,0.2464,0.16367,0,1
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.067497,0.23461,0.22252,0,1
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.15197,0.1732,0.11251,0,1
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.077559,0.1618,0.11853,0,1
5,GO CRISTAE FORMATION,0.13885,0.1617,0.13848,0,1
5,GO NUCLEOTIDE SALVAGE,0.44264,0.15967,0.032216,0,1
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10468,0.15218,0.082144,0,1
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.24463,0.14718,0.12202,0,1
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.074935,0.14442,0.11556,0,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.20256,0.14313,0.12387,0,1
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.12662,0.14169,0.10792,0,1
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.30724,0.13841,0.057954,0,1
5,GO GTP BIOSYNTHETIC PROCESS,0.24463,0.13798,0.06538,0,1
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.062884,0.13566,0.15573,0,1
5,GO PENTOSE METABOLIC PROCESS,0.094909,0.12787,0.085092,0,1
5,GO ALDEHYDE CATABOLIC PROCESS,0.069906,0.12246,0.095158,0,1
5,GO PROTEASOME ASSEMBLY,0.056456,0.11396,0.11249,0,1
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.37964,0.10663,0.035717,0,1
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.43329,0.10103,0.048476,0,1
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.074935,0.10074,0.10603,0,1
5,GO MITOCHONDRIAL GENE EXPRESSION,0.058535,0.099675,0.093236,0,1
5,GO MITOCHONDRIAL FUSION,0.091819,0.096733,0.10779,0,1
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.14312,0.094124,0.075335,0,1
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.16602,0.09145,0.095828,0,1
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.20822,0.075244,0.09401,0,1
5,GO DE NOVO PROTEIN FOLDING,0.26442,0.074371,0.079598,0,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.30724,0.071878,0.058462,0,1
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.21989,0.058747,0.065978,0,1
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.43329,0.056099,0.054841,0,1
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.12662,0.055035,0.12339,0,1
5,GO TRANSLATIONAL INITIATION,0.37964,0.026408,0.043975,0,1
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.08881,0.29145,0.30453,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.010572,0.26636,0.36718,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.058535,0.20689,0.27666,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.26442,0.20007,0.12635,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.17091,0.19907,0.17991,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.38829,0.18154,0.15354,0,0
5,GO PONS DEVELOPMENT,0.091819,0.17461,0.29327,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.84314,0.16548,-0.09598,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.29248,0.16254,0.23197,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.4521,0.15645,0.10761,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.10134,0.14221,0.24781,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.37111,0.14126,0.13439,0,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.18624,0.14123,0.11117,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.2998,0.13972,0.088775,0,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.81845,0.13473,-0.085028,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.27126,0.13399,0.13138,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.20256,0.13288,0.1386,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.67486,0.12788,0.090118,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1306,0.11937,0.090747,0,0
5,GO L SERINE METABOLIC PROCESS,0.69814,0.11741,0.05097,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.36271,0.11563,0.072457,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.62923,0.11498,0.092282,0,0
5,GO PROGESTERONE METABOLIC PROCESS,0.38829,0.11457,0.10744,0,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.37111,0.1144,0.10021,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.62923,0.10955,0.087174,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.1475,0.10937,0.12672,0,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.11163,0.10915,0.15227,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.14312,0.10833,0.092416,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.08881,0.10785,0.12281,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.069906,0.10741,0.10048,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.10468,0.10538,0.13879,0,0
5,GO KINETOCHORE ORGANIZATION,0.44264,0.1046,0.096498,0,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.197,0.10399,0.086525,0,0
5,GO IMP BIOSYNTHETIC PROCESS,0.40594,0.10373,0.13198,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.006955,0.10276,0.17974,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.24463,0.10244,0.14293,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.64051,0.098268,0.026982,0,0
5,GO SIGNAL PEPTIDE PROCESSING,0.37111,0.096563,0.090098,0,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.72171,0.095872,0.022588,0,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.2577,0.09508,0.14069,0,0
5,GO DENDRITE EXTENSION,0.43329,0.091976,0.11786,0,0
5,GO PROTEIN DENEDDYLATION,0.1306,0.091029,0.096568,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.61803,0.090172,0.11722,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.32248,0.089908,0.10174,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.43329,0.088373,0.1329,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.25111,0.086828,0.066232,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.76963,0.085027,0.098404,0,0
5,GO HISTONE EXCHANGE,0.17591,0.084402,0.10659,0,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.33029,0.084226,0.099333,0,0
5,GO LACTATE METABOLIC PROCESS,0.36271,0.083543,0.059372,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.65188,0.083518,0.078208,0,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.61803,0.083514,0.052172,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.021265,0.083447,0.10906,0,0
5,GO REGULATION OF MICROTUBULE BINDING,0.66333,0.083204,0.088274,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.75756,0.082089,0.012188,0,0
5,GO DETECTION OF CALCIUM ION,0.19156,0.081511,0.11605,0,0
5,GO CELL CYCLE DNA REPLICATION,0.33821,0.081056,0.085801,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.72171,0.080331,0.035869,0,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.49108,0.078728,0.063335,0,0
5,GO IMP METABOLIC PROCESS,0.46168,0.078591,0.1023,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.43329,0.077526,0.091961,0,0
5,GO AMP METABOLIC PROCESS,0.37111,0.076521,0.048134,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.75756,0.076262,-0.0096987,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.85555,0.07604,0.019339,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.2577,0.07592,0.059521,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.48117,0.075878,0.11492,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.48117,0.075548,0.058544,0,0
5,GO UTP METABOLIC PROCESS,0.48117,0.075206,0.038709,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.072385,0.074647,0.12691,0,0
5,GO DNA REPLICATION CHECKPOINT,0.40594,0.073827,0.096449,0,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.36271,0.073638,0.1167,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.10811,0.071164,0.089752,0,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.2998,0.070889,0.099602,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.4521,0.070606,0.081378,0,0
5,GO NUCLEOSOME ASSEMBLY,0.34626,0.070546,0.094763,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.58498,0.069904,0.076036,0,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.69814,0.069279,0.04335,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.19156,0.068805,0.080807,0,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.18624,0.066745,0.10447,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.81845,0.066041,0.070297,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.38829,0.065741,0.08342,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.33821,0.065175,0.075832,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.74555,0.064294,0.051485,0,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.41494,0.064253,0.052331,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.21989,0.064002,0.065312,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.30724,0.06301,0.10031,0,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.21989,0.06234,0.087397,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.69814,0.062205,0.055028,0,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.81845,0.062018,0.03995,0,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.46168,0.061306,0.047773,0,0
5,GO RESPONSE TO POTASSIUM ION,0.94321,0.061265,0.012772,0,0
5,GO RESPONSE TO REDOX STATE,0.62923,0.060863,0.050515,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.18102,0.060747,0.069051,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.1306,0.060623,0.068357,0,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.32248,0.060386,0.13063,0,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.10811,0.059359,0.093901,0,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.81845,0.057724,0.055815,0,0
5,GO REGULATION OF DENDRITE EXTENSION,0.3148,0.05757,0.12971,0,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.64051,0.057315,0.09964,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.99368,0.056379,0.0057972,0,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.32248,0.056342,0.077043,0,0
5,GO GROWTH HORMONE SECRETION,0.75756,0.055769,0.068379,0,0
5,GO METHIONINE METABOLIC PROCESS,0.61803,0.055663,0.045531,0,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.50109,0.05504,0.11573,0,0
5,GO KINETOCHORE ASSEMBLY,0.64051,0.054982,0.054804,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.80618,0.054727,0.040731,0,0
5,GO PROTEIN POLYGLUTAMYLATION,0.76963,0.054534,0.041732,0,0
5,GO RESPONSE TO COPPER ION,0.66333,0.054475,-0.077698,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.065157,0.053442,0.15228,0,0
5,GO TRANSFERRIN TRANSPORT,0.5959,0.053152,0.054954,0,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.32248,0.052844,0.058999,0,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.50109,0.05247,0.14338,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.96843,0.052213,-0.0098582,0,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.54223,0.050062,0.056575,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.57414,0.047857,0.033762,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.36271,0.047598,0.099664,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.32248,0.04748,0.089382,0,0
5,GO POSITIVE REGULATION OF ACROSOME REACTION,0.99368,0.047297,0.004913,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.7336,0.047133,0.0049663,0,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.93062,0.046893,0.0044997,0,0
5,GO MICROTUBULE NUCLEATION,0.5959,0.046601,0.088898,0,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.95582,0.046466,0.018902,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.25111,0.045793,0.070975,0,0
5,GO NADH METABOLIC PROCESS,0.61803,0.045626,0.069311,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.51122,0.045099,0.040079,0,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.48117,0.044884,0.052691,0,0
5,GO AEROBIC RESPIRATION,0.11163,0.044465,0.059307,0,0
5,GO QUINONE METABOLIC PROCESS,0.197,0.04382,0.05865,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.27126,0.043388,0.087201,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.44264,0.04273,0.1572,0,0
5,GO DIOL METABOLIC PROCESS,0.46168,0.042377,0.073797,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.75756,0.041724,-0.032215,0,0
5,GO DNA REPLICATION INITIATION,0.37111,0.04161,0.09593,0,0
5,GO BASE EXCISION REPAIR,0.2998,0.041593,0.082886,0,0
5,GO NEURON FATE SPECIFICATION,0.54223,0.041507,0.12866,0,0
5,GO OXIDATIVE DEMETHYLATION,0.99368,0.041306,0.0014009,0,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.62923,0.0412,0.025747,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.30724,0.041109,0.063273,0,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.68646,0.040618,0.029612,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.86799,0.040507,0.033311,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.96843,0.040199,0.0075537,0,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.90549,0.040133,-0.0024036,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.57414,0.040123,0.085241,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.84314,0.040108,0.017515,0,0
5,GO ANDROGEN METABOLIC PROCESS,0.44264,0.039898,0.065129,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.86799,0.03934,0.016727,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,1,0.039216,0.0083766,0,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.48117,0.03875,0.058828,0,0
5,GO RNA 5 END PROCESSING,0.21989,0.038254,0.071082,0,0
5,GO COENZYME A METABOLIC PROCESS,0.2998,0.037777,0.075951,0,0
5,GO ALDITOL METABOLIC PROCESS,0.37964,0.037515,0.068562,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.81845,0.037377,0.058569,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.95582,0.037134,0.03601,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.75756,0.036393,0.026029,0,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.23203,0.035403,0.063301,0,0
5,GO CELLULAR RESPIRATION,0.041938,0.035391,0.071355,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.95582,0.035072,-0.0062956,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.72171,0.034794,0.034316,0,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.88046,0.034624,-0.02491,0,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.43329,0.034257,-0.13295,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.55277,0.034178,0.040772,0,0
5,GO CYTOPLASMIC TRANSLATION,0.53179,0.034016,0.032306,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.3148,0.033969,0.087876,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.90549,0.033767,0.016883,0,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.78176,0.033588,0.045133,0,0
5,GO PROTEIN NEDDYLATION,0.10134,0.033099,0.10755,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.38829,0.03265,0.046258,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.65188,0.032226,0.036787,0,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.90549,0.032127,-0.024618,0,0
5,GO MATURATION OF 5 8S RRNA,0.67486,0.031693,0.051438,0,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.94321,0.031593,0.024845,0,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.33029,0.031546,0.049745,0,0
5,GO GROOMING BEHAVIOR,0.56341,0.031384,0.059979,0,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.66333,0.031115,0.051872,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.50109,0.030885,0.080528,0,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.91805,0.030813,-0.01869,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.79394,0.030695,0.050844,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.55277,0.030314,0.072361,0,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.40594,0.030265,0.040698,0,0
5,GO RESPONSE TO MUSCLE STRETCH,0.37111,0.030152,0.11496,0,0
5,GO RESPONSE TO DIETARY EXCESS,0.93062,0.029541,0.023781,0,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.39705,0.029266,0.062111,0,0
5,GO RIBOSOME ASSEMBLY,0.40594,0.028713,0.049336,0,0
5,GO RRNA 3 END PROCESSING,0.55277,0.028701,0.045924,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.96843,0.028405,0.036566,0,0
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.54223,0.028304,0.059287,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.78176,0.027991,0.007069,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.56341,0.027544,0.068412,0,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.84314,0.027484,0.0013624,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.70989,0.026736,-0.081076,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.70989,0.026486,0.035763,0,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.99368,0.026235,0.020461,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.69814,0.026169,-0.0080829,0,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.55277,0.025938,0.048982,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.84314,0.025661,0.03762,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.35442,0.025489,0.11028,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.52145,0.025375,0.069048,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.75756,0.025074,0.044344,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.88046,0.024741,0.016681,0,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.79394,0.024572,0.0060641,0,0
5,GO SYNAPTIC VESICLE MATURATION,0.62923,0.024408,0.11297,0,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.35442,0.0243,0.078318,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.56341,0.024207,0.1499,0,0
5,GO PIRNA METABOLIC PROCESS,0.91805,0.023966,-0.0084727,0,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.80618,0.023634,0.022187,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.67486,0.023335,-0.040947,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.52145,0.023068,0.045969,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.76963,0.023067,0.0553,0,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.89296,0.023016,0.018632,0,0
5,GO LOOP OF HENLE DEVELOPMENT,0.64051,0.022933,-0.054771,0,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.85555,0.022687,0.027794,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.89296,0.022621,0.03252,0,0
5,GO TRNA PROCESSING,0.60692,0.022506,0.045343,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.52145,0.022417,0.050101,0,0
5,GO NODAL SIGNALING PATHWAY,0.94321,0.02234,-0.011092,0,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.68646,0.02219,-0.01445,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.69814,0.021869,0.035685,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.68646,0.021388,0.075917,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.4521,0.021234,0.042781,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.62923,0.021188,0.050254,0,0
5,GO SNORNA METABOLIC PROCESS,0.96843,0.021011,0.014206,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.5959,0.020835,0.074434,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.43329,0.020723,0.077263,0,0
5,GO DNA STRAND ELONGATION,0.52145,0.020696,0.083918,0,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,1,0.019683,0.025528,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.95582,0.019573,0.014945,0,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.80618,0.018915,-0.017699,0,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.91805,0.018505,0.033228,0,0
5,GO CHROMOSOME CONDENSATION,0.60692,0.018397,0.081979,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.68646,0.018356,0.044063,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1,0.018335,0.016516,0,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.65188,0.018291,0.043766,0,0
5,GO SNARE COMPLEX ASSEMBLY,0.74555,0.018064,-0.031735,0,0
5,GO REGULATION OF VESICLE FUSION,0.88046,0.017607,0.046428,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.42405,0.017399,0.11371,0,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.60692,0.01731,0.091026,0,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.91805,0.017147,0.018681,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.64051,0.016852,0.064952,0,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.75756,0.01656,0.051594,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.93062,0.016478,0.0041747,0,0
5,GO REGULATION OF RELAXATION OF MUSCLE,0.64051,0.016442,-0.098912,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.81845,0.016432,0.028864,0,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.4521,0.016409,0.050975,0,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.74555,0.016125,0.027412,0,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.99368,0.0158,0.018387,0,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.70989,0.015088,-0.012991,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.88046,0.014887,0.045995,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.53179,0.014809,0.072683,0,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.95582,0.014769,0.014997,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.43329,0.014641,0.058083,0,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.96843,0.014344,0.051773,0,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.91805,0.013813,0.011444,0,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.85555,0.013676,0.022518,0,0
5,GO FATTY ACID HOMEOSTASIS,0.98106,0.013646,0.013541,0,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.94321,0.013351,0.00105,0,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.61803,0.013088,0.085186,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.91805,0.012904,0.013961,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.79394,0.011934,0.019859,0,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.99368,0.011767,0.022296,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.64051,0.011168,0.071054,0,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.89296,0.011067,0.028128,0,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.80618,0.011058,0.047138,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.69814,0.011051,0.057779,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.95582,0.010922,0.037096,0,0
5,GO NEURON FATE COMMITMENT,0.7336,0.010823,0.070885,0,0
5,GO DOPAMINE TRANSPORT,0.91805,0.010773,0.065986,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.96843,0.010524,0.04403,0,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.67486,0.010171,0.05292,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.84314,0.0099356,0.036683,0,0
5,GO FAT CELL PROLIFERATION,0.85555,0.0098959,0.026057,0,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.88046,0.0098951,0.034047,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.88046,0.0098868,-0.0056975,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.83078,0.0098866,0.0083747,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.60692,0.0098506,0.038768,0,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.85555,0.0095746,0.0038964,0,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.95582,0.0093802,0.030869,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.96843,0.0091247,0.036094,0,0
5,GO RESPONSE TO FOOD,0.91805,0.0089246,0.0076767,0,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.90549,0.0088048,0.024317,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.57414,0.0079726,0.062455,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.64051,0.0079101,-0.026588,0,0
5,GO RNA 3 END PROCESSING,0.68646,0.0073154,0.00098965,0,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.94321,0.0070562,0.0098581,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.99368,0.0069833,0.028523,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.89296,0.0067064,0.007993,0,0
5,GO HEART INDUCTION,0.90549,0.0065467,0.047123,0,0
5,GO NUCLEOSOME ORGANIZATION,0.75756,0.0064653,0.048586,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.90549,0.0062146,0.032802,0,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.91805,0.0061245,0.038764,0,0
5,GO DNA DEPENDENT DNA REPLICATION,0.66333,0.0057593,0.047642,0,0
5,GO TRNA MODIFICATION,0.86799,0.0056178,0.028523,0,0
5,GO RESPONSE TO HYDROXYUREA,0.66333,0.0055441,-0.011258,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.75756,0.0053395,0.053185,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.69814,0.0053322,-0.016255,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.47137,0.00506,-0.022588,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.94321,0.0049864,0.033273,0,0
5,GO NOTCH RECEPTOR PROCESSING,0.78176,0.0047144,0.057531,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.96843,0.0045963,0.040046,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.66333,0.00447,0.028272,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.86799,0.0042714,0.026215,0,0
5,GO INCLUSION BODY ASSEMBLY,0.78176,0.0034221,0.01161,0,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.76963,0.0034059,-0.0024047,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.67486,0.0032376,0.085906,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.70989,0.0030759,0.057894,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.74555,0.0028178,0.012014,0,0
5,GO NEURONAL ACTION POTENTIAL,0.99368,0.0027438,0.025856,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.96843,0.0022971,-0.0026761,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.62923,0.0021177,0.057988,0,0
5,GO MICROVILLUS ORGANIZATION,0.69814,0.0020008,0.054135,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.50109,0.0019419,0.049708,0,0
5,GO MEMBRANE REPOLARIZATION,0.50109,0.0018236,-0.026968,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.85555,0.0017402,0.022226,0,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.61803,0.001627,0.058824,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.80618,0.001445,0.0014916,0,0
5,GO MRNA 3 END PROCESSING,0.64051,0.0013026,-0.0072661,0,0
5,GO SNORNA 3 END PROCESSING,0.76963,0.0012779,0.0026488,0,0
5,GO SISTER CHROMATID COHESION,0.88046,0.0012645,0.052573,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.79394,0.0012529,0.054596,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96843,0.001162,0.018499,0,0
5,GO PSEUDOURIDINE SYNTHESIS,0.70989,0.0010606,0.053359,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.91805,0.00086991,0.028742,0,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.83078,0.00074368,0.026142,0,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.86799,0.00063566,0.042833,0,0
5,GO MATURATION OF LSU RRNA,0.78176,0.00060241,0.035529,0,0
5,GO LIPID DIGESTION,0.75756,0.0001391,0.079027,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.90549,-0.00013354,-0.0025696,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.72171,-0.00027041,0.056908,0,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.7336,-0.00064294,0.011711,0,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.84314,-0.0007892,0.045807,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.85555,-0.001208,0.039243,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.66333,-0.0012586,-0.006634,0,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.65188,-0.0013995,0.046187,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.95582,-0.0016367,0.004347,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.91805,-0.0017301,0.032378,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.40594,-0.0017426,-0.045603,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.78176,-0.0020947,-0.01007,0,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.89296,-0.0021418,0.014346,0,0
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.83078,-0.0021455,0.017487,0,0
5,GO MITOTIC DNA REPLICATION,0.79394,-0.0026315,0.067649,0,0
5,GO VESICLE DOCKING,0.72171,-0.0026484,0.0084265,0,0
5,GO DNA PACKAGING,0.81845,-0.0027427,0.043925,0,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.99368,-0.0033191,0.018903,0,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.78176,-0.0033315,-0.0012558,0,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.69814,-0.0034639,-0.003906,0,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,1,-0.0036469,0.026289,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.75756,-0.0037121,0.043457,0,0
5,GO POLYOL CATABOLIC PROCESS,0.78176,-0.003811,0.010774,0,0
5,GO ATP METABOLIC PROCESS,0.88046,-0.0038385,0.030645,0,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.72171,-0.0039942,-0.01618,0,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.60692,-0.0041463,0.066373,0,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.72171,-0.0043828,-0.0041353,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.96843,-0.0045224,0.025033,0,0
5,GO MEIOTIC CELL CYCLE,0.99368,-0.0047064,0.03086,0,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.67486,-0.0047939,0.040192,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.54223,-0.0049838,0.054184,0,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.99368,-0.0051098,0.030511,0,0
5,GO SKELETAL MUSCLE ADAPTATION,0.85555,-0.0051599,0.025183,0,0
5,GO CENTROSOME DUPLICATION,0.54223,-0.0051819,-0.016622,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42405,-0.0052738,-0.0079145,0,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.74555,-0.0055341,-0.020229,0,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.66333,-0.0055387,-0.028481,0,0
5,GO VIRAL GENE EXPRESSION,0.96843,-0.0057667,-0.0069544,0,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.83078,-0.0058134,0.021223,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.81845,-0.0059273,0.00063806,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.7336,-0.006112,0.01155,0,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.95582,-0.0063593,0.018775,0,0
5,GO RESPONSE TO LITHIUM ION,0.69814,-0.0064353,0.026052,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.74555,-0.0064891,0.062366,0,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.88046,-0.0066092,0.031851,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.51122,-0.0066805,-0.026999,0,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.68646,-0.0067226,0.057655,0,0
5,GO GLUTAMATE METABOLIC PROCESS,0.67486,-0.006764,-0.01199,0,0
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.7336,-0.0069256,-0.022156,0,0
5,GO CGMP METABOLIC PROCESS,0.70989,-0.0070725,-0.009016,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.72171,-0.0070881,-0.10078,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.65188,-0.0075418,-0.010755,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.67486,-0.0075487,-0.023117,0,0
5,GO MITOCHONDRIAL TRANSPORT,0.78176,-0.0075762,0.020239,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.93062,-0.0079211,0.022244,0,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.49108,-0.0080093,0.07882,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.89296,-0.0082914,0.018772,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.57414,-0.0083145,-0.056668,0,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.93062,-0.008526,0.006744,0,0
5,GO PROTEIN FOLDING,0.99368,-0.0085959,0.037139,0,0
5,GO HISTONE H4 K16 ACETYLATION,1,-0.0086469,0.030645,0,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.86799,-0.0089489,0.031414,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.44264,-0.0089704,0.093413,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.46168,-0.0091095,-0.0096605,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.54223,-0.009139,-0.0032498,0,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.83078,-0.0093774,-0.0025398,0,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.56341,-0.0098038,0.058332,0,0
5,GO AMINO ACID ACTIVATION,0.33821,-0.009905,0.11768,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.49108,-0.010422,-0.0035076,0,0
5,GO CHROMATIN SILENCING,0.60692,-0.010572,-0.01777,0,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.93062,-0.010579,0.019125,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.68646,-0.010617,-0.0021818,0,0
5,GO MAGNESIUM ION TRANSPORT,0.94321,-0.01071,0.031646,0,0
5,GO ACROSOME REACTION,0.4521,-0.010726,-0.036636,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.72171,-0.010823,0.054111,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.81845,-0.011026,0.040573,0,0
5,GO INOSITOL METABOLIC PROCESS,0.7336,-0.011054,-0.0078796,0,0
5,GO RECOMBINATIONAL REPAIR,0.72171,-0.011546,-0.0070674,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.70989,-0.011594,-0.026996,0,0
5,GO TELOMERE ORGANIZATION,0.89296,-0.011629,0.023351,0,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.66333,-0.011801,-0.0055379,0,0
5,GO RESPONSE TO INSECTICIDE,0.90549,-0.01186,0.0021784,0,0
5,GO CORTICOSTEROID HORMONE SECRETION,0.4521,-0.012194,-0.091262,0,0
5,GO CYTOPLASM ORGANIZATION,0.3148,-0.012409,-0.10683,0,0
5,GO ORGANELLE INHERITANCE,0.96843,-0.012571,0.048866,0,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.94321,-0.012617,0.017559,0,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.78176,-0.012666,0.047104,0,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.52145,-0.012726,-0.023615,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.58498,-0.012821,-0.037794,0,0
5,GO DNA GEOMETRIC CHANGE,0.76963,-0.01302,-0.00046559,0,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.53179,-0.013056,-0.029058,0,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4521,-0.013104,-0.014302,0,0
5,GO SPINDLE ASSEMBLY,0.66333,-0.013162,0.00099003,0,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.95582,-0.013426,0.011975,0,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.74555,-0.013473,0.0035451,0,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.89296,-0.01363,0.041003,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.4521,-0.013634,-0.030063,0,0
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1,-0.013723,0.048486,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.69814,-0.013818,0.051763,0,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.33821,-0.013834,-0.060621,0,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.93062,-0.01403,0.024055,0,0
5,GO TRNA METHYLATION,0.90549,-0.014038,0.011411,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.90549,-0.014239,0.028602,0,0
5,GO REPLICATION FORK PROCESSING,0.78176,-0.014352,-0.022871,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.62923,-0.014375,-0.0073396,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.76963,-0.01439,0.0059285,0,0
5,GO GLUCOSE METABOLIC PROCESS,0.48117,-0.014394,0.012319,0,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.58498,-0.014634,0.00056801,0,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.74555,-0.014663,0.028386,0,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.98106,-0.014781,0.015233,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.56341,-0.014782,-0.015369,0,0
5,GO POSITIVE REGULATION OF HEART RATE,0.95582,-0.014784,0.027308,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.46168,-0.014823,0.10589,0,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.91805,-0.014954,0.0090489,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.91805,-0.015105,0.019307,0,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.72171,-0.015202,-0.0173,0,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.53179,-0.015208,0.014614,0,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.90549,-0.015224,0.014849,0,0
5,GO PYRUVATE METABOLIC PROCESS,0.51122,-0.015258,-0.0020863,0,0
5,GO HEXOSE CATABOLIC PROCESS,0.70989,-0.015498,0.015808,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.69814,-0.01601,0.015808,0,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.83078,-0.016019,0.0073353,0,0
5,GO MRNA CLEAVAGE,0.37111,-0.016079,-0.026012,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.84314,-0.016096,0.021219,0,0
5,GO REGULATION OF DOPAMINE SECRETION,0.80618,-0.016206,0.080307,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.78176,-0.016322,0.027934,0,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.65188,-0.016325,0.0098196,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.76963,-0.016451,0.0085175,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.80618,-0.016507,-0.0019546,0,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.89296,-0.016706,0.06075,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.68646,-0.016792,-0.029701,0,0
5,GO DNA REPLICATION,0.78176,-0.016802,0.015585,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.94321,-0.017101,0.015448,0,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.94321,-0.017261,0.012236,0,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.79394,-0.017551,0.067625,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.51122,-0.017591,-0.01569,0,0
5,GO PROTEIN HYDROXYLATION,0.65188,-0.017635,0.081415,0,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.47137,-0.017843,-0.00060465,0,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.40594,-0.017871,0.12927,0,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.56341,-0.018214,0.073153,0,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.90549,-0.018236,0.038296,0,0
5,GO TRNA METABOLIC PROCESS,0.65188,-0.018262,0.044892,0,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.69814,-0.018268,0.0093315,0,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.55277,-0.018272,-0.017966,0,0
5,GO MITOCHONDRIAL FISSION,0.41494,-0.018348,-0.0091456,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.81845,-0.018721,0.0020066,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.80618,-0.018729,-0.014758,0,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.62923,-0.019158,-0.040629,0,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.39705,-0.01923,-0.089209,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.5959,-0.019781,-0.0094746,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.49108,-0.020066,-0.036254,0,0
5,GO MRNA SPLICE SITE SELECTION,0.90549,-0.020077,-0.0042265,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE,0.47137,-0.020177,-0.029532,0,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.98106,-0.020281,0.013641,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.99368,-0.020571,0.015662,0,0
5,GO RESPONSE TO COLD,0.75756,-0.020777,0.030881,0,0
5,GO DNA CONFORMATION CHANGE,0.93062,-0.02082,0.019317,0,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.86799,-0.020852,0.011735,0,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.81845,-0.02097,-0.010655,0,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.99368,-0.021093,0.041629,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.61803,-0.021314,-0.0090715,0,0
5,GO CHROMOSOME LOCALIZATION,0.85555,-0.021695,0.022992,0,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.76963,-0.022027,0.042158,0,0
5,GO TRANSLESION SYNTHESIS,0.91805,-0.022073,0.032525,0,0
5,GO RNA SPLICING,0.72171,-0.022301,-0.0010728,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.74555,-0.022353,0.018234,0,0
5,GO RRNA TRANSCRIPTION,0.55277,-0.022392,-0.011629,0,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.56341,-0.022585,0.054864,0,0
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.37964,-0.022641,-0.039732,0,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.84314,-0.022758,0.020852,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.76963,-0.02299,0.0039181,0,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.86799,-0.023123,0.024028,0,0
5,GO METAPHASE PLATE CONGRESSION,0.98106,-0.023298,0.040725,0,0
5,GO TUBULIN DEACETYLATION,0.79394,-0.023332,0.0024875,0,0
5,GO STEROID BIOSYNTHETIC PROCESS,0.62923,-0.023486,0.017893,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.62923,-0.023563,0.015578,0,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.86799,-0.023672,-0.00049735,0,0
5,GO EXIT FROM MITOSIS,0.46168,-0.023898,-0.0071673,0,0
5,GO ENERGY RESERVE METABOLIC PROCESS,0.28529,-0.023966,-0.015611,0,0
5,GO REGULATION OF MRNA PROCESSING,0.56341,-0.024013,-0.02536,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.53179,-0.024032,-0.0065798,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.78176,-0.02408,0.0021114,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.79394,-0.024265,0.011778,0,0
5,GO MRNA PROCESSING,0.65188,-0.024266,-0.010002,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.35442,-0.024309,-0.0078983,0,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.33029,-0.024348,-0.0013547,0,0
5,GO MRNA METABOLIC PROCESS,0.51122,-0.024481,-0.017237,0,0
5,GO MISMATCH REPAIR,0.78176,-0.024731,0.002635,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.84314,-0.02481,0.013888,0,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.7336,-0.02511,-0.022434,0,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.95582,-0.025121,0.0082841,0,0
5,GO MITOCHONDRION LOCALIZATION,0.40594,-0.025245,-0.035957,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.62923,-0.025274,-0.024395,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.42405,-0.025776,-0.020311,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.65188,-0.026088,0.00025569,0,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.60692,-0.026133,-0.024873,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.4521,-0.026302,-0.029582,0,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.98106,-0.026352,0.031318,0,0
5,GO NUCLEOTIDE PHOSPHORYLATION,0.46168,-0.026495,-0.0047735,0,0
5,GO HISTONE H2A ACETYLATION,0.38829,-0.026633,-0.040507,0,0
5,GO ZINC ION TRANSPORT,0.5959,-0.026776,-0.0020888,0,0
5,GO ER OVERLOAD RESPONSE,0.99368,-0.026822,0.026267,0,0
5,GO REGULATION OF ACROSOME REACTION,0.44264,-0.026924,-0.030844,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.54223,-0.027121,-0.035991,0,0
5,GO PHAGOSOME ACIDIFICATION,0.61803,-0.027607,0.0037635,0,0
5,GO TELOMERE CAPPING,0.5959,-0.027621,-0.0060646,0,0
5,GO REGULATION OF TUBULIN DEACETYLATION,1,-0.027649,0.021315,0,0
5,GO ORGANELLE DISASSEMBLY,0.64051,-0.027697,0.0040885,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.61803,-0.027738,0.048507,0,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.98106,-0.027752,0.044194,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,1,-0.027777,0.039146,0,0
5,GO NUCLEOSIDE SALVAGE,0.55277,-0.028312,-0.027136,0,0
5,GO TRICARBOXYLIC ACID CYCLE,0.89296,-0.028343,0.020957,0,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.54223,-0.028437,-0.025074,0,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.68646,-0.02871,-0.009298,0,0
5,GO REGULATION OF DNA REPLICATION,0.70989,-0.028905,0.013151,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.56341,-0.028939,-0.010695,0,0
5,GO RESPONSE TO CAFFEINE,0.88046,-0.028969,0.017082,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.81845,-0.028972,0.017016,0,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.7336,-0.029004,-0.015203,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.79394,-0.029161,0.067436,0,0
5,GO GONADOTROPIN SECRETION,0.70989,-0.0292,0.0087952,0,0
5,GO ORGANELLE FUSION,0.28529,-0.029615,-0.012786,0,0
5,GO GOLGI LOCALIZATION,0.88046,-0.029661,0.073684,0,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.89296,-0.029663,0.044336,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.55277,-0.029666,-0.024646,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.85555,-0.030395,0.015273,0,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.27821,-0.030468,-0.072061,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.58498,-0.030829,-0.020472,0,0
5,GO CENTRIOLE ASSEMBLY,0.54223,-0.030963,-0.030322,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.26442,-0.031094,-0.015282,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.48117,-0.031098,-0.0021942,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.95582,-0.031126,0.039292,0,0
5,GO HISTONE DEUBIQUITINATION,0.4521,-0.031155,-0.047048,0,0
5,GO SULFATE TRANSPORT,0.72171,-0.031336,0.068085,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.84314,-0.031352,0.038924,0,0
5,GO EXOCYTIC PROCESS,0.47137,-0.031544,-0.0010318,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47137,-0.032123,0.0028283,0,0
5,GO LOCOMOTOR RHYTHM,0.54223,-0.032307,-0.0080505,0,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.2259,-0.032316,-0.011507,0,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.55277,-0.032429,0.0095097,0,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.5959,-0.032452,-0.021142,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.90549,-0.032546,0.024541,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.96843,-0.032635,0.028506,0,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.46168,-0.032682,-0.0059427,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.20256,-0.032728,-0.057111,0,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.74555,-0.032773,0.0077871,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.57414,-0.032793,-0.006051,0,0
5,GO MITOTIC RECOMBINATION,0.4521,-0.032915,-0.050618,0,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.96843,-0.032931,0.0401,0,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.49108,-0.033034,-0.028367,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.83078,-0.033173,0.020797,0,0
5,GO POSTREPLICATION REPAIR,0.99368,-0.033396,0.02762,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.33029,-0.033577,-0.058172,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.84314,-0.033614,0.013932,0,0
5,GO RNA PROCESSING,0.67486,-0.033636,-0.0055457,0,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.38829,-0.033973,-0.028595,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.214,-0.03398,-0.028951,0,0
5,GO RNA POLYADENYLATION,0.54223,-0.034131,-0.021448,0,0
5,GO RESPONSE TO LEPTIN,0.83078,-0.034182,0.0088985,0,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.52145,-0.034197,-0.021013,0,0
5,GO THYROID GLAND DEVELOPMENT,0.57414,-0.034359,-0.013938,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.43329,-0.034359,-0.021214,0,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.99368,-0.034409,0.050106,0,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.5959,-0.03456,-0.053984,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.26442,-0.034658,-0.020859,0,0
5,GO SPINDLE ORGANIZATION,0.80618,-0.034782,0.018017,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.18102,-0.034902,-0.046559,0,0
5,GO POTASSIUM ION HOMEOSTASIS,0.43329,-0.035005,-0.040222,0,0
5,GO NUCLEOTIDE TRANSPORT,0.49108,-0.03505,-0.0096139,0,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.48117,-0.035291,-0.022847,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.66333,-0.035351,0.013153,0,0
5,GO MALE MEIOSIS I,0.75756,-0.035412,0.007987,0,0
5,GO NADPH REGENERATION,0.3148,-0.035486,-0.047544,0,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.18624,-0.03582,-0.15198,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.5959,-0.035857,-0.0089695,0,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.85555,-0.036074,0.01418,0,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.89296,-0.036386,0.029435,0,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.75756,-0.036399,-0.0045175,0,0
5,GO ADULT LOCOMOTORY BEHAVIOR,0.50109,-0.036722,-0.0050211,0,0
5,GO MICROTUBULE SEVERING,0.76963,-0.036831,-0.0099259,0,0
5,GO HISTONE H4 K5 ACETYLATION,0.74555,-0.036845,0.0089776,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.65188,-0.036852,0.0081194,0,0
5,GO VITAMIN CATABOLIC PROCESS,0.89296,-0.036862,0.00046303,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.90549,-0.036867,0.016569,0,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.80618,-0.036927,-0.029919,0,0
5,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.86799,-0.037003,0.053247,0,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.90549,-0.0372,0.013706,0,0
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.36271,-0.037293,-0.0099313,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.15655,-0.037298,-0.031394,0,0
5,GO MICROTUBULE POLYMERIZATION,0.53179,-0.037503,-0.0073282,0,0
5,GO PH REDUCTION,0.47137,-0.037558,-0.024012,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.37111,-0.037592,-0.048732,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.64051,-0.037597,-0.010006,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.48117,-0.037657,-0.027408,0,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.66333,-0.037917,-0.0032987,0,0
5,GO GLUTAMATE SECRETION,0.76963,-0.037925,0.0083438,0,0
5,GO GALACTOSE METABOLIC PROCESS,0.89296,-0.03796,0.008388,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.98106,-0.038301,0.023033,0,0
5,GO NCRNA TRANSCRIPTION,0.44264,-0.038359,-0.013564,0,0
5,GO REGULATION OF CHROMATIN BINDING,0.34626,-0.038745,-0.049534,0,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.72171,-0.038805,0.00053636,0,0
5,GO CHROMOSOME SEGREGATION,0.94321,-0.038807,0.022557,0,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.62923,-0.038813,-0.01693,0,0
5,GO RNA EXPORT FROM NUCLEUS,0.72171,-0.038828,0.0028322,0,0
5,GO VIRAL TRANSLATION,0.57414,-0.038977,-0.015455,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.44264,-0.039088,-0.044905,0,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.75756,-0.039115,-0.013657,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.58498,-0.039364,0.023941,0,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,1,-0.039488,0.019587,0,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.79394,-0.039576,-0.0039091,0,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.39705,-0.039935,0.0088424,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.80618,-0.039972,-0.020116,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.95582,-0.040496,0.026118,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.38829,-0.040533,-0.017491,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.32248,-0.040614,-0.020806,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.47137,-0.04072,-0.0059195,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.74555,-0.040856,0.017279,0,0
5,GO REGULATION OF RNA SPLICING,0.48117,-0.040895,-0.028996,0,0
5,GO RNA STABILIZATION,0.2577,-0.040957,-0.052819,0,0
5,GO RNA CATABOLIC PROCESS,0.29248,-0.041176,-0.025681,0,0
5,GO KETONE BIOSYNTHETIC PROCESS,0.61803,-0.041194,0.00055422,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.091819,-0.041287,-0.12464,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.7336,-0.041435,0.019572,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.56341,-0.041832,-0.014315,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.37111,-0.041873,-0.015933,0,0
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.2577,-0.041932,-0.021097,0,0
5,GO REFLEX,0.76963,-0.041935,0.059174,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.55277,-0.042237,-0.0097207,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.25111,-0.042359,-0.072108,0,0
5,GO NCRNA PROCESSING,0.94321,-0.042471,0.018349,0,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.66333,-0.042485,-0.019312,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.83078,-0.042562,-0.00084715,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.65188,-0.042751,-0.014191,0,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.38829,-0.043035,-0.056493,0,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.65188,-0.043096,-0.0092163,0,0
5,GO NCRNA 3 END PROCESSING,1,-0.043223,0.0091648,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.2577,-0.043382,-0.035542,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.93062,-0.043396,0.046694,0,0
5,GO ONE CARBON METABOLIC PROCESS,0.52145,-0.043569,-0.026497,0,0
5,GO MITOCHONDRION ORGANIZATION,0.38829,-0.043654,-0.0006741,0,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.79394,-0.04368,0.026169,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.53179,-0.043686,-0.045104,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.66333,-0.043741,-0.0057062,0,0
5,GO RIBOSOME BIOGENESIS,1,-0.043848,0.024466,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.41494,-0.043853,-0.038671,0,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.90549,-0.043933,0.015479,0,0
5,GO CELL JUNCTION MAINTENANCE,0.57414,-0.043986,-0.041572,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.40594,-0.044339,-0.016313,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.72171,-0.044393,-0.0036198,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.18102,-0.044601,-0.049503,0,0
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.51122,-0.044632,-0.041217,0,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.1306,-0.045072,-0.054882,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.17591,-0.045131,-0.036196,0,0
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.42405,-0.045204,-0.020132,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88046,-0.045339,0.029342,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.12662,-0.045406,-0.065554,0,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.58498,-0.045494,-0.017937,0,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.58498,-0.0456,-0.01663,0,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.33029,-0.045641,-0.057756,0,0
5,GO RETINA LAYER FORMATION,0.51122,-0.045723,-0.060362,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.30724,-0.04591,-0.038146,0,0
5,GO RELAXATION OF MUSCLE,0.37964,-0.045924,-0.075966,0,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.66333,-0.046089,0.011802,0,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.47137,-0.046198,-0.037917,0,0
5,GO OOCYTE DIFFERENTIATION,0.43329,-0.046337,-0.022662,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.28529,-0.046398,-0.017774,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.16602,-0.04653,-0.1352,0,0
5,GO VIRAL LATENCY,0.76963,-0.046678,0.010899,0,0
5,GO SNRNA TRANSCRIPTION,0.44264,-0.046846,-0.01889,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.2259,-0.046866,-0.030978,0,0
5,GO MRNA EXPORT FROM NUCLEUS,0.62923,-0.047061,-0.0078018,0,0
5,GO MEMBRANE DISASSEMBLY,0.38829,-0.047165,-0.038222,0,0
5,GO DNA REPAIR,0.52145,-0.0472,-0.0066387,0,0
5,GO ORGANELLE FISSION,0.74555,-0.047281,0.012047,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.76963,-0.047319,0.019684,0,0
5,GO GLUTAMINE METABOLIC PROCESS,0.50109,-0.04732,-0.0122,0,0
5,GO RESPONSE TO WATER,0.61803,-0.047453,-0.024646,0,0
5,GO RNA SURVEILLANCE,0.89296,-0.047471,0.013645,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.66333,-0.047492,-0.031938,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.94321,-0.04755,0.014558,0,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.94321,-0.047647,0.022907,0,0
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.2259,-0.047665,-0.029461,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.46168,-0.04771,-0.04593,0,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.35442,-0.047713,-0.0088493,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.34626,-0.047737,-0.035513,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.42405,-0.047862,-0.034479,0,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.74555,-0.04792,0.02822,0,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.23827,-0.048248,-0.083474,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.66333,-0.048361,0.033029,0,0
5,GO REGULATION OF MRNA BINDING,0.27821,-0.048487,-0.049997,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.32248,-0.048927,-0.028968,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.46168,-0.049034,-0.045663,0,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.1475,-0.049171,-0.077146,0,0
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.32248,-0.049305,-0.023387,0,0
5,GO RRNA METABOLIC PROCESS,0.89296,-0.049335,0.014194,0,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.57414,-0.04941,-0.039058,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.2998,-0.049432,-0.062264,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.88046,-0.049691,0.077871,0,0
5,GO MRNA TRANSPORT,0.51122,-0.049887,-0.018759,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.89296,-0.050068,0.021292,0,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.50109,-0.050328,-0.025071,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.66333,-0.050365,-0.01285,0,0
5,GO MRNA MODIFICATION,0.64051,-0.050444,-0.031168,0,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.96843,-0.050778,0.059826,0,0
5,GO RNA CAPPING,0.58498,-0.05111,0.00060936,0,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.44264,-0.051141,-0.0037444,0,0
5,GO REGULATION OF RNA BINDING,0.18102,-0.051329,-0.048289,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.54223,-0.051513,-0.05913,0,0
5,GO NEURAL NUCLEUS DEVELOPMENT,0.56341,-0.051559,0.0039165,0,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.50109,-0.05217,-0.011306,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.2259,-0.052288,-0.078415,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.72171,-0.052301,0.007232,0,0
5,GO REGULATION OF HEART RATE,0.33821,-0.052373,-0.042395,0,0
5,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.41494,-0.052401,-0.043921,0,0
5,GO HAIR CELL DIFFERENTIATION,0.2998,-0.052416,-0.03995,0,0
5,GO RESPONSE TO DOPAMINE,0.33029,-0.052465,-0.016954,0,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.29248,-0.052477,-0.053223,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.33821,-0.052599,-0.072666,0,0
5,GO MEMBRANE DOCKING,0.29248,-0.052801,-0.030093,0,0
5,GO MYELIN ASSEMBLY,0.2259,-0.052838,-0.044955,0,0
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.35442,-0.052895,-0.01467,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.49108,-0.0529,-0.029904,0,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.80618,-0.052946,0.0059418,0,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.34626,-0.05301,-0.09459,0,0
5,GO DNA INTEGRITY CHECKPOINT,0.214,-0.053053,-0.04979,0,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.33821,-0.053086,-0.091722,0,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.62923,-0.053514,-0.0058945,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.43329,-0.05379,-0.020941,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.2577,-0.053865,-0.0077796,0,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.75756,-0.053912,0.002872,0,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.67486,-0.054056,0.014907,0,0
5,GO PROTEIN TARGETING,0.077559,-0.054076,-0.017582,0,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.08881,-0.054123,-0.05818,0,0
5,GO NEUROTRANSMITTER SECRETION,0.76963,-0.054229,0.014151,0,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.4521,-0.054322,-0.022764,0,0
5,GO REGULATION OF CELLULAR PH,0.13885,-0.054333,-0.065775,0,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.38829,-0.054403,-0.045976,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.65188,-0.054612,0.0084362,0,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.55277,-0.054814,-0.0094455,0,0
5,GO AXONEME ASSEMBLY,0.30724,-0.054855,-0.13381,0,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.23203,-0.054977,-0.024028,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.12662,-0.055014,-0.051764,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.49108,-0.055064,-0.030536,0,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.54223,-0.055255,-0.017771,0,0
5,GO MANNOSYLATION,0.68646,-0.055295,0.012679,0,0
5,GO ATP TRANSPORT,0.33029,-0.055376,-0.033414,0,0
5,GO THIOESTER METABOLIC PROCESS,0.062884,-0.055421,-0.054388,0,0
5,GO RESPONSE TO COCAINE,0.52145,-0.055523,-0.032987,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.18102,-0.055763,-0.075533,0,0
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.44264,-0.05577,-0.0018889,0,0
5,GO KERATINIZATION,0.51122,-0.055833,-0.036352,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.72171,-0.055866,0.017532,0,0
5,GO GLYCINE METABOLIC PROCESS,0.98106,-0.055942,0.012204,0,0
5,GO DOPAMINE METABOLIC PROCESS,0.23827,-0.056254,-0.067468,0,0
5,GO RESPONSE TO CATECHOLAMINE,0.33821,-0.056403,-0.021134,0,0
5,GO NOSE DEVELOPMENT,0.66333,-0.056446,-0.023584,0,0
5,GO SNRNA PROCESSING,0.52145,-0.056581,-0.012153,0,0
5,GO RESPONSE TO ALKALOID,0.2259,-0.056659,-0.026057,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.70989,-0.05673,-0.0031549,0,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.35442,-0.056879,-0.02313,0,0
5,GO REGULATION OF ATPASE ACTIVITY,0.42405,-0.056995,-0.008862,0,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.27821,-0.057047,-0.044565,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.46168,-0.057155,-0.022804,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.32248,-0.057212,-0.026301,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.28529,-0.057423,-0.038435,0,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.95582,-0.057451,0.018419,0,0
5,GO CHROMOSOME SEPARATION,0.79394,-0.057503,0.019806,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.24463,-0.057576,-0.071007,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.21989,-0.057597,-0.065242,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.7336,-0.05761,0.02079,0,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.2577,-0.057654,-0.035982,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.66333,-0.057738,0.011022,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.53179,-0.057762,-0.026328,0,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.24463,-0.057811,-0.030597,0,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.23827,-0.057869,-0.048875,0,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.43329,-0.057909,-0.0064839,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13467,-0.058115,-0.048649,0,0
5,GO NAD METABOLIC PROCESS,0.35442,-0.058126,-0.016319,0,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.44264,-0.058142,-0.024799,0,0
5,GO MALE SEX DETERMINATION,0.52145,-0.05832,-0.067922,0,0
5,GO CORNIFICATION,0.50109,-0.058619,-0.066616,0,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.37111,-0.058652,0.00025723,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.68646,-0.058654,0.00021048,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.66333,-0.058806,0.0021286,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.35442,-0.058816,-0.03209,0,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.62923,-0.058992,-0.0044787,0,0
5,GO HORMONE BIOSYNTHETIC PROCESS,0.57414,-0.059025,0.005947,0,0
5,GO RESPONSE TO MUSCLE ACTIVITY,0.37964,-0.059045,-0.067567,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.20256,-0.05913,-0.042333,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18624,-0.05921,-0.041917,0,0
5,GO REGULATION OF CILIUM MOVEMENT,0.5959,-0.059216,-0.035575,0,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25111,-0.059267,-0.052855,0,0
5,GO PIGMENT METABOLIC PROCESS,0.20256,-0.059311,-0.015831,0,0
5,GO PIGMENT GRANULE LOCALIZATION,0.32248,-0.059488,-0.050702,0,0
5,GO NCRNA METABOLIC PROCESS,0.94321,-0.059519,0.01788,0,0
5,GO REGULATION OF DNA REPAIR,0.34626,-0.059527,-0.033156,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.35442,-0.059597,-0.044937,0,0
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.10811,-0.059629,-0.034137,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.79394,-0.059681,0.0068412,0,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.41494,-0.059714,-0.0080262,0,0
5,GO MATURATION OF SSU RRNA,0.81845,-0.059799,0.0075268,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.37111,-0.059857,-0.046537,0,0
5,GO RNA LOCALIZATION,0.57414,-0.060057,-0.0059904,0,0
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.13467,-0.060168,-0.069099,0,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.56341,-0.060354,-0.068875,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.46168,-0.060414,-0.088079,0,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.2998,-0.060426,-0.053138,0,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.37964,-0.060479,-0.053962,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.33821,-0.060534,-0.05716,0,0
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.17091,-0.060656,-0.086593,0,0
5,GO CELL CYCLE CHECKPOINT,0.27126,-0.060686,-0.039687,0,0
5,GO RNA MODIFICATION,0.37964,-0.060785,-0.028763,0,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.50109,-0.060845,-0.033183,0,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.15655,-0.061147,-0.10194,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.51122,-0.061171,-0.020867,0,0
5,GO SLEEP,0.21989,-0.061274,-0.063415,0,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.40594,-0.061738,-0.012911,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.23827,-0.061773,-0.038032,0,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.32248,-0.0619,-0.0089795,0,0
5,GO ORGANELLE MEMBRANE FUSION,0.094909,-0.061915,-0.053683,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.70989,-0.061923,0.0015261,0,0
5,GO CHEMOSENSORY BEHAVIOR,0.80618,-0.062017,-0.018714,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.3148,-0.062057,-0.032323,0,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.077559,-0.062133,-0.0396,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.39705,-0.062156,-0.023744,0,0
5,GO NUCLEAR EXPORT,0.36271,-0.062185,-0.027459,0,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.56341,-0.062389,0.0092993,0,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.76963,-0.062408,0.0091842,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.4521,-0.062739,-0.04433,0,0
5,GO SNRNA METABOLIC PROCESS,0.62923,-0.062838,-0.008675,0,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.23827,-0.062872,-0.05915,0,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.27126,-0.062901,-0.042441,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.23203,-0.062946,-0.025829,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.2259,-0.063161,-0.086862,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.78176,-0.063192,0.0029107,0,0
5,GO DNA MODIFICATION,0.18624,-0.063283,-0.037446,0,0
5,GO HEART FIELD SPECIFICATION,0.42405,-0.063301,0.0044365,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.10468,-0.063583,-0.051964,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.4521,-0.063599,-0.038206,0,0
5,GO CATECHOLAMINE SECRETION,0.47137,-0.063652,0.013377,0,0
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.28529,-0.06368,-0.0052242,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.3148,-0.063697,-0.042539,0,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.14312,-0.063768,-0.043695,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.214,-0.063772,-0.065109,0,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.78176,-0.063822,-0.0065711,0,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.19156,-0.063936,-0.030826,0,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.81845,-0.063952,-0.025956,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.2259,-0.063964,-0.033495,0,0
5,GO GOLGI ORGANIZATION,0.094909,-0.064193,-0.062583,0,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.23203,-0.064328,-0.066569,0,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.26442,-0.064355,-0.0095818,0,0
5,GO PROTEIN METHYLATION,0.33821,-0.064367,-0.055496,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.36271,-0.064534,-0.033625,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.27821,-0.064583,-0.098997,0,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.62923,-0.064758,-0.0095514,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.30724,-0.064813,-0.037698,0,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.75756,-0.064913,-0.005525,0,0
5,GO ACROSOME ASSEMBLY,0.27821,-0.06499,-0.074159,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.2998,-0.065008,-0.037841,0,0
5,GO BLASTOCYST DEVELOPMENT,0.094909,-0.06552,-0.036355,0,0
5,GO VACUOLAR ACIDIFICATION,0.44264,-0.065555,-0.011866,0,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.23827,-0.065709,-0.014912,0,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.96843,-0.065902,0.032258,0,0
5,GO REGULATION OF CYTOKINESIS,0.41494,-0.065907,-0.0051516,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.86799,-0.065961,0.024724,0,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.10468,-0.065973,-0.078268,0,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.93062,-0.066141,0.039088,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.16602,-0.066162,-0.073309,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.48117,-0.066231,-0.0032602,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.065157,-0.066367,-0.059645,0,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.16123,-0.06639,-0.044314,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.90549,-0.066409,0.020013,0,0
5,GO NUCLEUS ORGANIZATION,0.23203,-0.066571,-0.021416,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.35442,-0.066617,-0.1016,0,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.34626,-0.066659,-0.15271,0,0
5,GO SISTER CHROMATID SEGREGATION,0.95582,-0.066924,0.037987,0,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.56341,-0.06694,0.0092907,0,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.44264,-0.06696,-0.04264,0,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.53179,-0.066963,-0.013067,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.68646,-0.067135,-0.044518,0,0
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.214,-0.067235,-0.026089,0,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.49108,-0.067472,-0.04709,0,0
5,GO REGULATION OF FERTILIZATION,0.42405,-0.067511,-0.027032,0,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.3148,-0.067531,-0.032545,0,0
5,GO REGULATION OF PH,0.08303,-0.067693,-0.071813,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.27126,-0.067772,-0.05781,0,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.75756,-0.067792,0.023957,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.17091,-0.067973,-0.040123,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.3148,-0.068051,-0.028044,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.33029,-0.068056,-0.068613,0,0
5,GO MEMBRANE DEPOLARIZATION,0.2577,-0.068193,-0.060073,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.33821,-0.06834,-0.036647,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.094909,-0.068549,-0.065822,0,0
5,GO RESPONSE TO TESTOSTERONE,0.37111,-0.068689,-0.028976,0,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.1306,-0.068741,-0.060537,0,0
5,GO SPERM EGG RECOGNITION,0.16602,-0.068822,-0.052785,0,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.47137,-0.068839,-0.01271,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.48117,-0.069016,-0.018351,0,0
5,GO RRNA MODIFICATION,0.42405,-0.069031,-0.018545,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.3148,-0.069061,-0.024492,0,0
5,GO SENSORY PERCEPTION OF SMELL,0.4521,-0.069139,-0.03372,0,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.27126,-0.069184,-0.0046216,0,0
5,GO MITOTIC CELL CYCLE,0.19156,-0.069283,-0.033376,0,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.3148,-0.069376,-0.031315,0,0
5,GO ZINC ION HOMEOSTASIS,0.25111,-0.0694,-0.14469,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.61803,-0.069401,-0.009739,0,0
5,GO PEPTIDYL ARGININE METHYLATION,0.93062,-0.069441,0.012787,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.26442,-0.069632,-0.026245,0,0
5,GO ADRENAL GLAND DEVELOPMENT,0.75756,-0.069691,0.025489,0,0
5,GO PROTEIN MANNOSYLATION,0.5959,-0.069973,-0.0041512,0,0
5,GO MICROTUBULE BASED PROCESS,0.2577,-0.070257,-0.044775,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.28529,-0.070262,-0.033326,0,0
5,GO PROTEIN STABILIZATION,0.12273,-0.070421,-0.042553,0,0
5,GO CHROMOSOME ORGANIZATION,0.4521,-0.070514,-0.021646,0,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.27126,-0.070709,-0.040548,0,0
5,GO TONGUE MORPHOGENESIS,0.60692,-0.070858,-0.027752,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.4521,-0.070903,-0.010673,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.2577,-0.07119,-0.036684,0,0
5,GO RESPONSE TO EPINEPHRINE,0.37111,-0.071261,-0.071344,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.39705,-0.071274,-0.050555,0,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.20256,-0.071277,-0.044006,0,0
5,GO AMINO ACID TRANSPORT,0.10134,-0.071443,-0.049755,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.17591,-0.071657,-0.042041,0,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.10811,-0.07173,-0.04819,0,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.33029,-0.071829,-0.032583,0,0
5,GO MEMBRANE FISSION,0.15197,-0.071848,-0.060953,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.08588,-0.071929,-0.0286,0,0
5,GO MICROVILLUS ASSEMBLY,0.29248,-0.071946,-0.026172,0,0
5,GO DNA LIGATION,0.23827,-0.071968,-0.035537,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.2577,-0.072043,-0.092567,0,0
5,GO PHOTOPERIODISM,0.49108,-0.072219,-0.045073,0,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.39705,-0.072366,-0.030106,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.2998,-0.072529,-0.033424,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.15197,-0.072719,-0.030927,0,0
5,GO HEART TRABECULA FORMATION,0.32248,-0.072737,-0.090631,0,0
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.067497,-0.072795,-0.074362,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.14312,-0.072809,-0.038163,0,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.13885,-0.072942,-0.076166,0,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.24463,-0.072959,-0.059813,0,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.33821,-0.073029,-0.078227,0,0
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.37964,-0.073211,-0.012636,0,0
5,GO CYTOKINETIC PROCESS,0.11163,-0.07328,-0.022572,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.54223,-0.073286,-0.031591,0,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.32248,-0.073454,-0.076257,0,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.094909,-0.073622,-0.13771,0,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.61803,-0.073638,0.0076223,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.19156,-0.073712,-0.043471,0,0
5,GO POLYAMINE METABOLIC PROCESS,0.29248,-0.073943,-0.020725,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.24463,-0.07399,-0.080575,0,0
5,GO WALKING BEHAVIOR,0.20822,-0.074147,-0.077452,0,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.13467,-0.074274,-0.049873,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.10134,-0.074468,-0.056428,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.2998,-0.074568,-0.0031959,0,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.39705,-0.074718,-0.030039,0,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.077559,-0.074878,-0.045406,0,0
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.38829,-0.074922,-0.028495,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.094909,-0.074948,-0.083835,0,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.32248,-0.07495,-0.024416,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.2998,-0.075041,-0.037237,0,0
5,GO FEEDING BEHAVIOR,0.058535,-0.075327,-0.1082,0,0
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.056456,-0.075341,-0.05386,0,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.062884,-0.075424,-0.04774,0,0
5,GO CELL CYCLE PROCESS,0.13885,-0.075429,-0.045483,0,0
5,GO RNA METHYLATION,0.3148,-0.075449,-0.039907,0,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.048745,-0.07547,-0.046723,0,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.17591,-0.075473,-0.04399,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.12273,-0.075579,-0.037365,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.067497,-0.075636,-0.044785,0,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.1475,-0.075706,-0.057958,0,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.53179,-0.07571,-0.034918,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.43329,-0.075729,-0.02978,0,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.17591,-0.075754,-0.032125,0,0
5,GO RESPONSE TO AMINE,0.16123,-0.075912,-0.072334,0,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.33029,-0.075941,-0.010171,0,0
5,GO HISTONE H3 K27 METHYLATION,0.79394,-0.076126,-0.011346,0,0
5,GO REGULATION OF DNA METHYLATION,0.38829,-0.076401,-0.019339,0,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.99368,-0.076425,0.024968,0,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.36271,-0.076573,-0.033105,0,0
5,GO PROTEIN SUMOYLATION,0.15655,-0.076582,-0.053719,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.1306,-0.076651,-0.086272,0,0
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.12273,-0.076665,-0.023713,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.42405,-0.076704,-0.071544,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.85555,-0.076821,0.026983,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.3148,-0.076853,-0.17809,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.62923,-0.076893,-0.038093,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.33821,-0.076904,-0.060336,0,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.14312,-0.076987,-0.048574,0,0
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.23827,-0.077046,-0.027543,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.83078,-0.077104,-0.022383,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.13885,-0.077256,-0.09877,0,0
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.27126,-0.077407,-0.040618,0,0
5,GO REGULATION OF PROTEIN STABILITY,0.062884,-0.07743,-0.04173,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.19156,-0.077617,-0.084526,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.08881,-0.077736,-0.051033,0,0
5,GO VIRAL BUDDING,0.08588,-0.077799,-0.050795,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.26442,-0.077948,-0.043595,0,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.67486,-0.078273,-0.035844,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.27126,-0.078385,-0.036696,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.072385,-0.078436,-0.056907,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.69814,-0.078458,0.0007635,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.37964,-0.078597,-0.051626,0,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.10811,-0.078636,-0.059541,0,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.13467,-0.078671,-0.046464,0,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.34626,-0.078768,-0.060067,0,0
5,GO ACTION POTENTIAL,0.15655,-0.079205,-0.057811,0,0
5,GO DNA RECOMBINATION,0.18624,-0.079285,-0.051711,0,0
5,GO STRESS GRANULE ASSEMBLY,0.62923,-0.079334,-0.008884,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.067497,-0.079409,-0.097162,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.060677,-0.07946,-0.10665,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.37964,-0.079494,-0.043314,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.1306,-0.079497,-0.044933,0,0
5,GO SPERM CAPACITATION,0.56341,-0.079524,-0.066613,0,0
5,GO REGULATION OF EXOSOMAL SECRETION,0.18102,-0.07957,-0.05018,0,0
5,GO REGULATION OF OOGENESIS,0.1475,-0.079633,-0.0973,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.67486,-0.079643,-0.044448,0,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.20256,-0.079736,-0.055409,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.35442,-0.079779,-0.054147,0,0
5,GO PEPTIDE METABOLIC PROCESS,0.25111,-0.080523,-0.013278,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.40594,-0.080766,-0.014691,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.077559,-0.080842,-0.059074,0,0
5,GO REPLICATIVE SENESCENCE,0.17591,-0.080908,-0.11536,0,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.28529,-0.081286,-0.066719,0,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.41494,-0.081404,-0.050827,0,0
5,GO DNA METABOLIC PROCESS,0.23827,-0.081421,-0.03243,0,0
5,GO CYTOKINESIS,0.214,-0.081587,-0.024474,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.3148,-0.081776,-0.014015,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.058535,-0.081856,-0.074905,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.33029,-0.081928,-0.098283,0,0
5,GO SARCOMERE ORGANIZATION,0.13467,-0.081929,-0.077907,0,0
5,GO SPERM AXONEME ASSEMBLY,0.214,-0.081948,-0.070873,0,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.067497,-0.08202,-0.086367,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.47137,-0.082101,-0.030141,0,0
5,GO CELL CYCLE,0.10468,-0.082146,-0.048711,0,0
5,GO EATING BEHAVIOR,0.11163,-0.082156,-0.12022,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.12273,-0.082212,-0.065201,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.13885,-0.08227,-0.068557,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.11524,-0.082289,-0.064379,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.080256,-0.082622,-0.050193,0,0
5,GO DNA DEMETHYLATION,0.17591,-0.082672,-0.053203,0,0
5,GO GTP METABOLIC PROCESS,0.17091,-0.082751,-0.076197,0,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.20822,-0.082752,-0.10304,0,0
5,GO EPITHELIAL CELL MORPHOGENESIS,0.27126,-0.082988,-0.045159,0,0
5,GO CENTROSOME SEPARATION,0.89296,-0.08308,0.03184,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.20822,-0.083376,-0.11867,0,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.08303,-0.083396,-0.080086,0,0
5,GO ERAD PATHWAY,0.08303,-0.083435,-0.042444,0,0
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.10468,-0.083651,-0.037661,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.91805,-0.083687,0.028776,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.072385,-0.083801,-0.06139,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.214,-0.08385,-0.048532,0,0
5,GO REGULATION OF RESPONSE TO FOOD,0.75756,-0.083863,-0.041155,0,0
5,GO FATTY ACID CATABOLIC PROCESS,0.11894,-0.083863,-0.05574,0,0
5,GO STEROL METABOLIC PROCESS,0.080256,-0.084186,-0.058611,0,0
5,GO GASTRIC ACID SECRETION,0.24463,-0.08424,-0.07728,0,0
5,GO RESPONSE TO STARVATION,0.058535,-0.084318,-0.046836,0,0
5,GO METHYLATION,0.16123,-0.084398,-0.057652,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.16602,-0.084435,-0.076517,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.067497,-0.084553,-0.061669,0,0
5,GO AUTOPHAGY OF NUCLEUS,0.57414,-0.08457,-0.01869,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.094909,-0.084599,-0.045979,0,0
5,GO STEROID HORMONE SECRETION,0.10468,-0.084752,-0.16396,0,0
5,GO CHROMATIN REMODELING,0.32248,-0.084804,-0.040155,0,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.214,-0.084817,-0.06595,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.19156,-0.085066,-0.056783,0,0
5,GO TRNA TRANSPORT,0.60692,-0.085216,0.0012065,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.48117,-0.085284,0.0035425,0,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.16123,-0.085319,-0.10291,0,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.054439,-0.085324,-0.044931,0,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.072385,-0.085421,-0.048371,0,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.91805,-0.085458,0.0030105,0,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.30724,-0.085497,-0.06179,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.53179,-0.085673,-0.012169,0,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.18624,-0.085721,-0.025639,0,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.14312,-0.08582,-0.052225,0,0
5,GO HEPATOCYTE DIFFERENTIATION,0.21989,-0.085854,-0.092203,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.094909,-0.085877,-0.051349,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.33821,-0.085942,0.0067081,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.35442,-0.086061,-0.057921,0,0
5,GO CELL REDOX HOMEOSTASIS,0.094909,-0.086186,-0.10865,0,0
5,GO SUCKLING BEHAVIOR,0.32248,-0.086195,-0.074483,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.18624,-0.086487,-0.039501,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17091,-0.086614,-0.064464,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.54223,-0.086625,-0.0066639,0,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.080256,-0.086701,-0.045285,0,0
5,GO MANGANESE ION TRANSPORT,0.23203,-0.086785,-0.081344,0,0
5,GO AXONAL TRANSPORT,0.42405,-0.086866,-0.02914,0,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.14312,-0.086915,-0.031013,0,0
5,GO LYSINE METABOLIC PROCESS,0.15197,-0.086942,-0.11535,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.24463,-0.087034,-0.037626,0,0
5,GO DOSAGE COMPENSATION,0.61803,-0.087146,-0.022634,0,0
5,GO LIPID GLYCOSYLATION,0.091819,-0.087158,-0.1034,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.4521,-0.087167,-0.036466,0,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.19156,-0.087407,-0.093597,0,0
5,GO AXO DENDRITIC TRANSPORT,0.43329,-0.087493,-0.023814,0,0
5,GO CHROMATIN ORGANIZATION,0.2577,-0.087695,-0.049326,0,0
5,GO CELL DIVISION,0.12662,-0.087781,-0.052538,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.1475,-0.087788,-0.053241,0,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.46168,-0.087837,-0.028143,0,0
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.26442,-0.087919,-0.036416,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.20256,-0.088018,-0.036053,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.17091,-0.088172,-0.1724,0,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.24463,-0.088254,-0.028381,0,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.47137,-0.088285,-0.013034,0,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.11894,-0.088287,-0.08286,0,0
5,GO RESPONSE TO STEROL DEPLETION,0.2998,-0.088374,-0.0058043,0,0
5,GO RESPONSE TO SALT,0.18624,-0.088533,-0.082711,0,0
5,GO OLIGOPEPTIDE TRANSPORT,0.50109,-0.08904,-0.03082,0,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.32248,-0.089191,-0.03725,0,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.10811,-0.0892,-0.028728,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.12662,-0.089551,-0.07052,0,0
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.11524,-0.089614,-0.041495,0,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.11163,-0.089851,-0.050263,0,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.3148,-0.090048,-0.057495,0,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.90549,-0.090181,0.016682,0,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.3148,-0.09019,-0.085719,0,0
5,GO HISTONE H3 K36 METHYLATION,0.20256,-0.090202,-0.11123,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.36271,-0.090211,-0.078376,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.57414,-0.090345,-0.05139,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.44264,-0.090457,-0.0020387,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.12273,-0.090551,-0.069926,0,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.08881,-0.090579,-0.039914,0,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.16602,-0.090911,-0.11067,0,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.23203,-0.090938,-0.032899,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.2998,-0.090993,-0.060434,0,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.069906,-0.091185,-0.029566,0,0
5,GO BLASTOCYST GROWTH,0.34626,-0.09133,-0.045332,0,0
5,GO MIDBODY ABSCISSION,0.25111,-0.09156,-0.035911,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.98106,-0.091584,0.058249,0,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.065157,-0.091736,-0.0499,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.074935,-0.091746,-0.059136,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.30724,-0.091777,-0.053912,0,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.11524,-0.091877,-0.078549,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.39705,-0.092097,-0.051592,0,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.68646,-0.092161,-0.021624,0,0
5,GO BICARBONATE TRANSPORT,0.065157,-0.092303,-0.14054,0,0
5,GO RESPONSE TO ETHER,0.21989,-0.092488,-0.065843,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.23827,-0.092625,-0.092387,0,0
5,GO DNA CATABOLIC PROCESS,0.10134,-0.092701,-0.050508,0,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.41494,-0.092711,-0.037887,0,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.38829,-0.092718,-0.034883,0,0
5,GO CARBOHYDRATE HOMEOSTASIS,0.067497,-0.092889,-0.039677,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.49108,-0.093067,-0.028377,0,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.41494,-0.093074,-0.049623,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.091819,-0.093167,-0.071332,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.2577,-0.093203,-0.047327,0,0
5,GO HISTONE H4 ACETYLATION,0.197,-0.093241,-0.059607,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.27126,-0.093398,-0.092931,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.39705,-0.093399,-0.03917,0,0
5,GO ESTROGEN METABOLIC PROCESS,0.197,-0.093822,-0.079242,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.077559,-0.093879,-0.065898,0,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.66333,-0.093906,-0.014305,0,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.33029,-0.093929,-0.047799,0,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.55277,-0.093947,-0.014628,0,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.37111,-0.093995,-0.065473,0,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.23827,-0.094057,-0.090016,0,0
5,GO LIPID DROPLET ORGANIZATION,0.2577,-0.094158,-0.030882,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.19156,-0.09423,-0.043602,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.069906,-0.094248,-0.057552,0,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.19156,-0.094392,-0.029596,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.20822,-0.094515,-0.068795,0,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.20822,-0.094565,-0.081686,0,0
5,GO LIPID IMPORT INTO CELL,0.18624,-0.094661,-0.070788,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.21989,-0.095041,-0.071346,0,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.08303,-0.095197,-0.032951,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.16602,-0.095197,-0.071758,0,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.091819,-0.095247,-0.084553,0,0
5,GO INTESTINAL ABSORPTION,0.75756,-0.095271,-0.021923,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.060677,-0.095356,-0.064108,0,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.29248,-0.095641,-0.059692,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.08588,-0.095813,-0.06569,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.10134,-0.095837,-0.11556,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.11894,-0.095895,-0.044483,0,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.14312,-0.095993,-0.058348,0,0
5,GO REGULATION OF MITOPHAGY,0.50109,-0.09617,-0.023659,0,0
5,GO DEMETHYLATION,0.080256,-0.096187,-0.075147,0,0
5,GO VIRION ASSEMBLY,0.02951,-0.096455,-0.062866,0,0
5,GO PROTEIN O LINKED GLYCOSYLATION,0.12662,-0.096523,-0.087378,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.44264,-0.096659,-0.035964,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.2259,-0.096979,-0.049681,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.2259,-0.096999,-0.033425,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.66333,-0.097001,0.011791,0,0
5,GO PROTEIN ACETYLATION,0.12662,-0.09718,-0.064423,0,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.16602,-0.097182,-0.063276,0,0
5,GO SPERM MOTILITY,0.30724,-0.097271,-0.076272,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.44264,-0.097299,-0.012106,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.2259,-0.097381,-0.10231,0,0
5,GO RESPONSE TO CADMIUM ION,0.11894,-0.097407,-0.12317,0,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.30724,-0.097603,-0.064528,0,0
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.077559,-0.097614,-0.047055,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.214,-0.09784,-0.039344,0,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.46168,-0.098095,-0.032094,0,0
5,GO REGULATION OF MEMBRANE POTENTIAL,0.35442,-0.098152,-0.037146,0,0
5,GO HISTONE METHYLATION,0.24463,-0.098242,-0.072126,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.38829,-0.098259,-0.018633,0,0
5,GO TRANSPORT ALONG MICROTUBULE,0.29248,-0.098315,-0.038694,0,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.33821,-0.098394,-0.029056,0,0
5,GO PEPTIDYL LYSINE MODIFICATION,0.15655,-0.098668,-0.059813,0,0
5,GO SCHWANN CELL DEVELOPMENT,0.27821,-0.098713,-0.063959,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.214,-0.098975,-0.051435,0,0
5,GO RRNA METHYLATION,0.094909,-0.099229,-0.067131,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.23203,-0.099562,-0.059498,0,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.062884,-0.099585,-0.060469,0,0
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.42405,-0.099693,-0.017819,0,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.054439,-0.099724,-0.04026,0,0
5,GO PEPTIDE HORMONE SECRETION,0.2577,-0.099784,-0.03648,0,0
5,GO OOCYTE MATURATION,0.26442,-0.099817,-0.06953,0,0
5,GO PROTEIN AUTOPROCESSING,0.48117,-0.099911,-0.052757,0,0
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.091819,-0.10034,-0.055599,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.067497,-0.10043,-0.037774,0,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.072385,-0.1005,-0.094502,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.34626,-0.10076,-0.022294,0,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.058535,-0.10077,-0.069441,0,0
5,GO ACETYL COA METABOLIC PROCESS,0.36271,-0.1009,-0.028879,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.20256,-0.10127,-0.03271,0,0
5,GO RESPONSE TO ACTIVITY,0.08303,-0.10128,-0.091085,0,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.16123,-0.10147,-0.059033,0,0
5,GO HISTONE H3 DEACETYLATION,0.40594,-0.10159,-0.033939,0,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.19156,-0.10162,-0.050131,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.13467,-0.10167,-0.04905,0,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.046961,-0.10174,-0.065849,0,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.2998,-0.10175,-0.08866,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.11163,-0.10195,-0.038712,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.33029,-0.10202,-0.051583,0,0
5,GO RESPONSE TO MONOSACCHARIDE,0.10811,-0.10202,-0.042609,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.46168,-0.10212,-0.011382,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.062884,-0.1022,-0.061264,0,0
5,GO MICROTUBULE BASED MOVEMENT,0.2577,-0.10234,-0.061793,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.12662,-0.10261,-0.044247,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.50109,-0.10262,-0.032864,0,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.1306,-0.10269,-0.020449,0,0
5,GO P BODY ASSEMBLY,0.214,-0.1027,-0.090847,0,0
5,GO NUCLEAR TRANSPORT,0.10468,-0.10289,-0.05792,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.37111,-0.10293,-0.1737,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.098083,-0.10301,-0.090697,0,0
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.08881,-0.10301,-0.046252,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.15655,-0.10318,-0.059148,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.19156,-0.10344,-0.043996,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.25111,-0.10366,-0.048587,0,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.2577,-0.10378,-0.044193,0,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.18102,-0.10411,-0.066124,0,0
5,GO SINGLE FERTILIZATION,0.10468,-0.10413,-0.061633,0,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.26442,-0.10418,-0.079204,0,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.214,-0.10426,-0.048111,0,0
5,GO MUSCLE CELL FATE COMMITMENT,0.197,-0.1043,-0.13123,0,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.094909,-0.10432,-0.080436,0,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.056456,-0.10434,-0.071154,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.23203,-0.10435,-0.086047,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.062884,-0.10447,-0.045045,0,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.3148,-0.10448,-0.045464,0,0
5,GO PROTEIN ACYLATION,0.15197,-0.1045,-0.061706,0,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.23203,-0.10462,-0.073983,0,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.13467,-0.10469,-0.12296,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.12273,-0.1049,-0.092917,0,0
5,GO DNA METHYLATION,0.27821,-0.10493,-0.038894,0,0
5,GO SEX DETERMINATION,0.53179,-0.10502,-0.039193,0,0
5,GO PROTEIN MONOUBIQUITINATION,0.1306,-0.10509,-0.061689,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.18624,-0.10512,-0.12094,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.2259,-0.10523,-0.044276,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.34626,-0.10533,-0.086529,0,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.47137,-0.1054,-0.044716,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.13885,-0.10546,-0.072103,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.11894,-0.10547,-0.074272,0,0
5,GO AMINE TRANSPORT,0.41494,-0.1055,-0.024083,0,0
5,GO PROTEIN N LINKED GLYCOSYLATION,0.214,-0.10551,-0.026784,0,0
5,GO ENERGY HOMEOSTASIS,0.61803,-0.10567,-0.0056538,0,0
5,GO MONOAMINE TRANSPORT,0.2577,-0.10574,-0.03166,0,0
5,GO VISUAL BEHAVIOR,0.094909,-0.10576,-0.078146,0,0
5,GO CARDIAC CONDUCTION,0.10134,-0.10579,-0.079052,0,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.13885,-0.10585,-0.099859,0,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.094909,-0.10594,-0.10418,0,0
5,GO SYNAPTIC SIGNALING,0.18624,-0.1061,-0.0785,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.27126,-0.1061,-0.09925,0,0
5,GO DNA DEALKYLATION,0.11163,-0.10614,-0.062792,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.15197,-0.1062,-0.072024,0,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.08588,-0.10656,-0.043673,0,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.10811,-0.10657,-0.049491,0,0
5,GO REGULATION OF CELL MATURATION,0.062884,-0.10682,-0.070928,0,0
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11524,-0.10697,-0.063731,0,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.13467,-0.10697,-0.10726,0,0
5,GO MITOTIC CYTOKINESIS,0.10134,-0.1071,-0.040302,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.24463,-0.1071,-0.052517,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.08588,-0.10714,-0.060468,0,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.18102,-0.10722,-0.077745,0,0
5,GO RESPONSE TO LEUCINE,0.28529,-0.10725,-0.10046,0,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.61803,-0.10744,-0.010961,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.17591,-0.10751,-0.091051,0,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.64051,-0.10757,-0.063808,0,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.10811,-0.10761,-0.05444,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.1475,-0.10764,-0.13788,0,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.24463,-0.10768,-0.095636,0,0
5,GO DETECTION OF MECHANICAL STIMULUS,0.2259,-0.10776,-0.063816,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.062884,-0.10778,-0.10775,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.29248,-0.10785,-0.084676,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.11163,-0.10811,-0.12833,0,0
5,GO GENE SILENCING,0.13467,-0.10829,-0.059134,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.18624,-0.10845,-0.044587,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.08303,-0.10847,-0.044749,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.098083,-0.10862,-0.095379,0,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.29248,-0.10863,-0.03785,0,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.18624,-0.10894,-0.074677,0,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.29248,-0.10894,-0.069012,0,0
5,GO HISTONE MONOUBIQUITINATION,0.17591,-0.10897,-0.076332,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.15197,-0.10904,-0.069065,0,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.39705,-0.10907,-0.027195,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.2259,-0.10914,-0.059132,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.08588,-0.10927,-0.072161,0,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.074935,-0.10927,-0.13569,0,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.13467,-0.10943,-0.094577,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.10134,-0.10944,-0.06139,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.054439,-0.10963,-0.079455,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.072385,-0.10971,-0.07459,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.16123,-0.10998,-0.055462,0,0
5,GO NOREPINEPHRINE SECRETION,0.15197,-0.11012,-0.12884,0,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.27126,-0.1103,-0.054219,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.062884,-0.11033,-0.099231,0,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.40594,-0.11036,-0.096255,0,0
5,GO MICROTUBULE BUNDLE FORMATION,0.24463,-0.1104,-0.10278,0,0
5,GO MITOPHAGY,0.33029,-0.11042,-0.038014,0,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.060677,-0.11056,-0.072638,0,0
5,GO FIBROBLAST ACTIVATION,0.2577,-0.11069,-0.093141,0,0
5,GO HISTONE H3 K9 ACETYLATION,0.08303,-0.11078,-0.083499,0,0
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.1306,-0.11082,-0.048106,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.069906,-0.11091,-0.08436,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.074935,-0.11123,-0.083501,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.16602,-0.11124,-0.13854,0,0
5,GO CHROMATIN DISASSEMBLY,0.3148,-0.11132,-0.040508,0,0
5,GO REGULATION OF APPETITE,0.1306,-0.11133,-0.1311,0,0
5,GO SKELETAL MUSCLE CONTRACTION,0.11894,-0.11135,-0.085232,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.077559,-0.11141,-0.1745,0,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.23203,-0.11145,-0.14688,0,0
5,GO MRNA METHYLATION,0.16123,-0.11159,-0.091765,0,0
5,GO HISTONE DEACETYLATION,0.14312,-0.11184,-0.068093,0,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.080256,-0.1119,-0.14001,0,0
5,GO LYTIC VACUOLE ORGANIZATION,0.031957,-0.11197,-0.093006,0,0
5,GO POTASSIUM ION TRANSPORT,0.34626,-0.11207,-0.051648,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.14312,-0.11213,-0.088148,0,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.025096,-0.11217,-0.10308,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.27821,-0.11218,-0.071757,0,0
5,GO SELECTIVE AUTOPHAGY,0.065157,-0.11231,-0.083884,0,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.21989,-0.11251,-0.034432,0,0
5,GO SECRETORY GRANULE LOCALIZATION,0.2259,-0.11265,-0.092195,0,0
5,GO RESPONSE TO AMPHETAMINE,0.35442,-0.11271,-0.043653,0,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.065157,-0.11275,-0.10104,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.067497,-0.11285,-0.090292,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.214,-0.1129,-0.054256,0,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.091819,-0.11295,-0.091273,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.062884,-0.11304,-0.0839,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.49108,-0.11308,-0.054986,0,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.074935,-0.11337,-0.081293,0,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.17591,-0.1134,-0.070508,0,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.13885,-0.11341,-0.065059,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.17091,-0.11349,-0.064983,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.46168,-0.11367,-0.075085,0,0
5,GO SYNAPSE ASSEMBLY,0.20256,-0.11374,-0.097229,0,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.12662,-0.11378,-0.085604,0,0
5,GO LIMBIC SYSTEM DEVELOPMENT,0.10134,-0.11384,-0.07052,0,0
5,GO ORGANELLE ASSEMBLY,0.074935,-0.11389,-0.071787,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.17591,-0.11433,-0.1913,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.80618,-0.11436,0.050219,0,0
5,GO REGULATION OF PROTEIN ACETYLATION,0.062884,-0.11436,-0.070445,0,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.1306,-0.11441,-0.1486,0,0
5,GO REGULATION OF GLUCONEOGENESIS,0.37964,-0.11441,-0.038141,0,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.12662,-0.11476,-0.051925,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.098083,-0.11494,-0.11123,0,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.11894,-0.11495,-0.057991,0,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.24463,-0.115,-0.064537,0,0
5,GO SPINAL CORD PATTERNING,0.79394,-0.11506,0.0077781,0,0
5,GO RESPONSE TO CORTICOSTERONE,0.32248,-0.11521,-0.072968,0,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.072385,-0.11523,-0.093346,0,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.14312,-0.11546,-0.067746,0,0
5,GO CELL FATE DETERMINATION,0.37111,-0.11552,-0.028169,0,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.10134,-0.11553,-0.04301,0,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.30724,-0.11559,-0.079522,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.060677,-0.1157,-0.097686,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.17591,-0.11585,-0.065375,0,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.2998,-0.1159,-0.088116,0,0
5,GO G0 TO G1 TRANSITION,0.14312,-0.11603,-0.10572,0,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.3148,-0.11643,-0.043834,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.065157,-0.1165,-0.095165,0,0
5,GO MUSCLE FILAMENT SLIDING,0.33029,-0.11677,-0.081303,0,0
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.43329,-0.11707,-0.030876,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.11163,-0.11707,-0.064264,0,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.058535,-0.11713,-0.17126,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.074935,-0.11723,-0.065778,0,0
5,GO GLIAL CELL FATE COMMITMENT,0.5959,-0.11723,0.028038,0,0
5,GO GLYCINE TRANSPORT,0.38829,-0.1173,-0.11086,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.038848,-0.11731,-0.09635,0,0
5,GO GERM CELL DEVELOPMENT,0.060677,-0.11741,-0.089095,0,0
5,GO AZOLE TRANSMEMBRANE TRANSPORT,0.16602,-0.11773,-0.12096,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.51122,-0.11776,-0.043135,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.1475,-0.11792,-0.10963,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.21989,-0.11801,-0.069811,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.10134,-0.11821,-0.084415,0,0
5,GO ASSOCIATIVE LEARNING,0.1475,-0.11831,-0.080393,0,0
5,GO PROTEIN PALMITOYLATION,0.1475,-0.11836,-0.083962,0,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.214,-0.11837,-0.049921,0,0
5,GO RNA INTERFERENCE,0.18624,-0.11853,-0.066488,0,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.18102,-0.11854,-0.090479,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.2259,-0.11869,-0.082394,0,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.51122,-0.1187,-0.04893,0,0
5,GO CILIUM MOVEMENT,0.20256,-0.1188,-0.11593,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.056456,-0.11882,-0.13276,0,0
5,GO REGULATION OF RUFFLE ASSEMBLY,0.074935,-0.11886,-0.090851,0,0
5,GO MALE GAMETE GENERATION,0.10811,-0.11886,-0.058281,0,0
5,GO HISTONE H3 K4 METHYLATION,0.2998,-0.11949,-0.059659,0,0
5,GO ENDOCRINE HORMONE SECRETION,0.072385,-0.11956,-0.097284,0,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.060677,-0.11958,-0.10221,0,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.08303,-0.11971,-0.085447,0,0
5,GO STEROID METABOLIC PROCESS,0.08303,-0.11995,-0.057784,0,0
5,GO REGULATION OF CIRCADIAN RHYTHM,0.24463,-0.1203,-0.028926,0,0
5,GO SPINDLE LOCALIZATION,0.23203,-0.12057,-0.040347,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.35442,-0.12066,-0.07433,0,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.08588,-0.12085,-0.049619,0,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.067497,-0.12102,-0.071901,0,0
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.21989,-0.12106,-0.094786,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.54223,-0.12113,-0.0060889,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.030713,-0.12113,-0.11309,0,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.065157,-0.12124,-0.11986,0,0
5,GO INSULIN SECRETION,0.16123,-0.1213,-0.054778,0,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.11163,-0.12151,-0.10525,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.55277,-0.12164,-0.0236,0,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.24463,-0.12166,-0.10182,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.30724,-0.12169,-0.071502,0,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.10134,-0.12181,-0.07265,0,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.16602,-0.12183,-0.047827,0,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.19156,-0.12189,-0.06981,0,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.13885,-0.12192,-0.035688,0,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.39705,-0.12195,-0.050875,0,0
5,GO MIRNA METABOLIC PROCESS,0.14312,-0.12205,-0.061051,0,0
5,GO SULFUR COMPOUND TRANSPORT,0.098083,-0.12213,-0.029491,0,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.34626,-0.12217,-0.023083,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.18624,-0.12218,-0.074247,0,0
5,GO REGULATION OF CARDIAC CONDUCTION,0.10134,-0.1222,-0.08711,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.12273,-0.12225,-0.039849,0,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.072385,-0.12231,-0.076626,0,0
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.26442,-0.12231,-0.044608,0,0
5,GO RESPONSE TO ZINC ION,0.1475,-0.12236,-0.12679,0,0
5,GO CELLULAR RESPONSE TO ALKALOID,0.15197,-0.12249,-0.066119,0,0
5,GO PALLIUM DEVELOPMENT,0.214,-0.12254,-0.050952,0,0
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.072385,-0.1226,-0.054851,0,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.19156,-0.12262,-0.079512,0,0
5,GO STARTLE RESPONSE,0.47137,-0.12264,-0.065339,0,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.2998,-0.12309,-0.051602,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.49108,-0.12316,-0.035833,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.12273,-0.12318,-0.10526,0,0
5,GO INTRACILIARY TRANSPORT,0.54223,-0.12319,-0.052889,0,0
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.14312,-0.12325,-0.077807,0,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.060677,-0.1233,-0.10177,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.10811,-0.12335,-0.086734,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.11524,-0.12353,-0.11989,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.08881,-0.12356,-0.077748,0,0
5,GO HISTONE H2A MONOUBIQUITINATION,0.19156,-0.12358,-0.093066,0,0
5,GO STRIATED MUSCLE ADAPTATION,0.17591,-0.12358,-0.050801,0,0
5,GO AXIS SPECIFICATION,0.18624,-0.12377,-0.043212,0,0
5,GO CATECHOLAMINE UPTAKE,0.46168,-0.12378,-0.049908,0,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.18624,-0.12386,-0.06378,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.197,-0.12388,-0.091734,0,0
5,GO FUCOSYLATION,0.074935,-0.12394,-0.098548,0,0
5,GO RESPONSE TO LEAD ION,0.16123,-0.12401,-0.057203,0,0
5,GO DIENCEPHALON DEVELOPMENT,0.23827,-0.12405,-0.046028,0,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.30724,-0.1241,-0.096431,0,0
5,GO CYTOSOLIC TRANSPORT,0.054439,-0.12412,-0.073374,0,0
5,GO PEPTIDYL LYSINE ACETYLATION,0.11163,-0.12413,-0.070458,0,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.37964,-0.1242,-0.058026,0,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.33029,-0.1243,-0.063508,0,0
5,GO EPITHELIAL CELL MATURATION,0.17591,-0.12433,-0.076249,0,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.074935,-0.12461,-0.10292,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.74555,-0.12473,0.0045452,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.069906,-0.12488,-0.079079,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.10468,-0.12494,-0.03547,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.060677,-0.12498,-0.1057,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.18624,-0.12504,-0.090355,0,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.94321,-0.12509,0.035859,0,0
5,GO RNA DECAPPING,0.069906,-0.12515,-0.12366,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.1306,-0.12554,-0.095204,0,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.10134,-0.1256,-0.08962,0,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.13467,-0.12587,-0.061274,0,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.077559,-0.12594,-0.076893,0,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.18624,-0.12597,-0.098464,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.035953,-0.126,-0.10016,0,0
5,GO EPIDERMAL CELL DIFFERENTIATION,0.094909,-0.12609,-0.097956,0,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.077559,-0.12618,-0.20618,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.065157,-0.12656,-0.068383,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.072385,-0.12674,-0.075376,0,0
5,GO RESPONSE TO HEAT,0.056456,-0.12679,-0.06669,0,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.056456,-0.12682,-0.065175,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.18624,-0.12685,-0.031732,0,0
5,GO ADIPOSE TISSUE DEVELOPMENT,0.16602,-0.12699,-0.051766,0,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.054439,-0.12726,-0.08307,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.10811,-0.1273,-0.11037,0,0
5,GO B CELL APOPTOTIC PROCESS,0.2577,-0.12737,-0.066787,0,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.11894,-0.12783,-0.19357,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.10811,-0.12821,-0.044179,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.074935,-0.12821,-0.068836,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.17091,-0.12834,-0.091316,0,0
5,GO MYELIN MAINTENANCE,0.080256,-0.12842,-0.14575,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.27126,-0.12845,-0.11033,0,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.38829,-0.12845,-0.071525,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.08303,-0.12858,-0.1197,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.27126,-0.12874,-0.06031,0,0
5,GO HORMONE TRANSPORT,0.14312,-0.12897,-0.056756,0,0
5,GO SECONDARY METABOLIC PROCESS,0.08303,-0.12908,-0.075857,0,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.33821,-0.12955,-0.080429,0,0
5,GO MECHANORECEPTOR DIFFERENTIATION,0.20822,-0.12956,-0.066145,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.197,-0.13,-0.043963,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.11524,-0.13009,-0.097583,0,0
5,GO MACROMOLECULE DEACYLATION,0.13885,-0.13023,-0.053575,0,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.14312,-0.13041,-0.057838,0,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.1475,-0.13041,-0.07585,0,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.13467,-0.1306,-0.11953,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.40594,-0.13067,-0.069511,0,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.11894,-0.13118,-0.070144,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.08588,-0.13119,-0.11422,0,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.17591,-0.13126,-0.065654,0,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.13885,-0.13126,-0.12415,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.25111,-0.13132,-0.036277,0,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.15655,-0.13132,-0.12447,0,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.08881,-0.13137,-0.10233,0,0
5,GO REGULATION OF GENE SILENCING,0.11163,-0.13162,-0.063859,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.12662,-0.13167,-0.096923,0,0
5,GO REGULATION OF TOR SIGNALING,0.054439,-0.1318,-0.084797,0,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.11163,-0.13192,-0.080211,0,0
5,GO ACTIN NUCLEATION,0.056456,-0.13199,-0.083082,0,0
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.32248,-0.13216,-0.040402,0,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.17091,-0.13219,-0.18362,0,0
5,GO REGULATION OF GLUCOSE IMPORT,0.060677,-0.13224,-0.079759,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.091819,-0.13231,-0.058233,0,0
5,GO LENS FIBER CELL DEVELOPMENT,0.08881,-0.13244,-0.11089,0,0
5,GO CIRCADIAN RHYTHM,0.1475,-0.13271,-0.04743,0,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.7336,-0.1331,-0.020193,0,0
5,GO ENDOCARDIUM DEVELOPMENT,0.062884,-0.13318,-0.10596,0,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.1475,-0.13351,-0.11005,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.3148,-0.13357,-0.058116,0,0
5,GO SEROTONIN TRANSPORT,0.027226,-0.13372,-0.20664,0,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.15655,-0.13378,-0.057385,0,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.054439,-0.13417,-0.087626,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.056456,-0.13438,-0.053261,0,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.19156,-0.13438,-0.12156,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.062884,-0.13439,-0.12548,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.098083,-0.13447,-0.16379,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.052482,-0.13472,-0.10271,0,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.16602,-0.1348,-0.15107,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.10468,-0.13483,-0.13073,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.098083,-0.13485,-0.10621,0,0
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.060677,-0.13486,-0.083608,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.13467,-0.13487,-0.089675,0,0
5,GO COVALENT CHROMATIN MODIFICATION,0.11894,-0.13502,-0.07546,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.46168,-0.13503,-0.047752,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.3148,-0.13503,-0.12993,0,0
5,GO NCRNA CATABOLIC PROCESS,0.062884,-0.13528,-0.077578,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.056456,-0.13532,-0.06919,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.08588,-0.13583,-0.10701,0,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.25111,-0.13585,-0.0582,0,0
5,GO MICROTUBULE BASED TRANSPORT,0.23827,-0.13588,-0.065463,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.25111,-0.13607,-0.057244,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.37964,-0.13634,-0.08125,0,0
5,GO SPERMATID DIFFERENTIATION,0.072385,-0.1368,-0.084024,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.14312,-0.13682,-0.091321,0,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.077559,-0.13698,-0.048894,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.058535,-0.13704,-0.092678,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.13467,-0.13705,-0.096415,0,0
5,GO HISTONE H3 K9 METHYLATION,0.098083,-0.13706,-0.12988,0,0
5,GO LEYDIG CELL DIFFERENTIATION,0.26442,-0.13708,-0.062388,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.12273,-0.13745,-0.12774,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.2998,-0.13747,-0.049608,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.14312,-0.13752,-0.10171,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.40594,-0.13755,-0.04574,0,0
5,GO HISTONE UBIQUITINATION,0.13885,-0.13768,-0.079558,0,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.27126,-0.13797,-0.14251,0,0
5,GO ADULT BEHAVIOR,0.47137,-0.13812,-0.037686,0,0
5,GO CARTILAGE MORPHOGENESIS,0.046961,-0.13834,-0.2028,0,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.13885,-0.13839,-0.10113,0,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.11163,-0.13882,-0.12515,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.21989,-0.13884,-0.077499,0,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.80618,-0.13897,0.0028138,0,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.054439,-0.13925,-0.073116,0,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.072385,-0.13926,-0.070889,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.19156,-0.13937,-0.060942,0,0
5,GO ADHERENS JUNCTION ASSEMBLY,0.10468,-0.13941,-0.09255,0,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.27126,-0.13954,-0.036316,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.062884,-0.13965,-0.091627,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.062884,-0.13968,-0.11128,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.10811,-0.13978,-0.061641,0,0
5,GO ACID SECRETION,0.08881,-0.13988,-0.085695,0,0
5,GO REGULATION OF INSULIN SECRETION,0.11894,-0.14029,-0.062988,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.27821,-0.14041,-0.13564,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.21989,-0.14062,-0.062853,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.18624,-0.14075,-0.10119,0,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.011574,-0.14079,-0.09002,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.54223,-0.14079,0.019119,0,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.1475,-0.14083,-0.1088,0,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.056456,-0.14092,-0.10235,0,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.20822,-0.14099,-0.12792,0,0
5,GO NEUROTRANSMITTER UPTAKE,0.077559,-0.14125,-0.078472,0,0
5,GO EPITHELIAL CELL FATE COMMITMENT,0.54223,-0.14127,-0.050173,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.11524,-0.14138,-0.099473,0,0
5,GO APICAL JUNCTION ASSEMBLY,0.12273,-0.14166,-0.05933,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.080256,-0.14169,-0.24569,0,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.091819,-0.1418,-0.093057,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.069906,-0.14185,-0.065055,0,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.098083,-0.14185,-0.09821,0,0
5,GO FOREBRAIN DEVELOPMENT,0.074935,-0.14186,-0.092524,0,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.12273,-0.14194,-0.12275,0,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.42405,-0.14205,-0.035861,0,0
5,GO PANCREAS DEVELOPMENT,0.10134,-0.14215,-0.097475,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.072385,-0.14222,-0.095667,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25111,-0.14232,-0.082521,0,0
5,GO VIRAL RNA GENOME REPLICATION,0.037377,-0.14241,-0.1052,0,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.28529,-0.14249,-0.051518,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.10811,-0.14283,-0.061767,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.077559,-0.14284,-0.15355,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.12273,-0.1432,-0.10511,0,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.27126,-0.1434,-0.059257,0,0
5,GO ANOIKIS,0.10134,-0.1436,-0.091249,0,0
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.26442,-0.14361,-0.054606,0,0
5,GO REGULATION OF HORMONE SECRETION,0.11524,-0.14382,-0.065849,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.16602,-0.14386,-0.10732,0,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.14312,-0.14391,-0.16183,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.056456,-0.14393,-0.10639,0,0
5,GO REGULATION OF NEURON MATURATION,0.23203,-0.14427,-0.060889,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15655,-0.14434,-0.097346,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.18102,-0.14434,-0.11469,0,0
5,GO MYOTUBE CELL DEVELOPMENT,0.058535,-0.14496,-0.12302,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.072385,-0.14513,-0.11034,0,0
5,GO GANGLION DEVELOPMENT,0.2998,-0.14516,-0.010985,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.25111,-0.14537,-0.10766,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.016475,-0.14547,-0.11396,0,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.11163,-0.14553,-0.10298,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.37111,-0.14554,-0.062273,0,0
5,GO TRANSMISSION OF NERVE IMPULSE,0.33821,-0.14584,-0.049396,0,0
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.19156,-0.14598,-0.13292,0,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.094909,-0.14599,-0.093257,0,0
5,GO PREPULSE INHIBITION,0.4521,-0.14602,-0.10246,0,0
5,GO TELENCEPHALON DEVELOPMENT,0.058535,-0.14626,-0.09742,0,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.33029,-0.14639,-0.081175,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.069906,-0.14657,-0.12658,0,0
5,GO METENCEPHALON DEVELOPMENT,0.10134,-0.14657,-0.10765,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.056456,-0.14679,-0.14027,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.29248,-0.14681,-0.084802,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.08881,-0.14685,-0.096295,0,0
5,GO KERATINOCYTE DIFFERENTIATION,0.12662,-0.14698,-0.11227,0,0
5,GO GOLGI RIBBON FORMATION,0.08881,-0.14718,-0.10806,0,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.1475,-0.14751,-0.07184,0,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.10811,-0.14764,-0.086145,0,0
5,GO VESICLE CARGO LOADING,0.091819,-0.14808,-0.098877,0,0
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.11894,-0.14817,-0.087202,0,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.12662,-0.14828,-0.10747,0,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.054439,-0.1483,-0.11102,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.080256,-0.14869,-0.11614,0,0
5,GO EXTRACELLULAR TRANSPORT,0.072385,-0.14871,-0.21152,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.094909,-0.14875,-0.10341,0,0
5,GO CELLULAR RESPONSE TO PH,0.18624,-0.14939,-0.067193,0,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.40594,-0.14943,-0.058546,0,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.21989,-0.14993,-0.072811,0,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12662,-0.14999,-0.076283,0,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.062884,-0.15005,-0.12554,0,0
5,GO LEARNING,0.08588,-0.1501,-0.12674,0,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.10811,-0.1503,-0.14357,0,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.13885,-0.15032,-0.074816,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.08303,-0.15051,-0.17535,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.16602,-0.1506,-0.11094,0,0
5,GO HISTONE H2A UBIQUITINATION,0.1475,-0.15064,-0.097976,0,0
5,GO BROWN FAT CELL DIFFERENTIATION,0.20256,-0.15088,-0.10044,0,0
5,GO CILIUM ORGANIZATION,0.197,-0.1509,-0.082913,0,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.11894,-0.1509,-0.095987,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.20822,-0.15093,-0.061776,0,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.16602,-0.15128,-0.11343,0,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.16602,-0.15137,-0.11014,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.08881,-0.1516,-0.12761,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.058535,-0.15197,-0.085656,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.214,-0.15203,-0.12021,0,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.18624,-0.15212,-0.099959,0,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.88046,-0.15226,0.0030961,0,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.21989,-0.1523,-0.07965,0,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.033245,-0.15241,-0.12291,0,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.015776,-0.15267,-0.13279,0,0
5,GO VACUOLE ORGANIZATION,0.0172,-0.15276,-0.096173,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.11524,-0.15301,-0.080356,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.11163,-0.15312,-0.10165,0,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.37964,-0.15314,-0.039578,0,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.098083,-0.15332,-0.088788,0,0
5,GO SYNAPSE ORGANIZATION,0.056456,-0.15339,-0.13328,0,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.197,-0.1534,-0.064446,0,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.10468,-0.15357,-0.091539,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.10811,-0.1537,-0.1145,0,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.25111,-0.15386,-0.090372,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0066311,-0.15398,-0.13968,0,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.11894,-0.15404,-0.18561,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.062884,-0.15406,-0.13983,0,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.074935,-0.15441,-0.07882,0,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.29248,-0.1545,-0.11342,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.2259,-0.15471,-0.074818,0,0
5,GO POSITIVE REGULATION OF CELL MATURATION,0.08303,-0.15484,-0.11422,0,0
5,GO REGULATION OF ACTION POTENTIAL,0.077559,-0.15499,-0.1131,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.1306,-0.15542,-0.15552,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.13467,-0.15546,-0.098317,0,0
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.12273,-0.1555,-0.048334,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.056456,-0.15551,-0.20547,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.32248,-0.15617,-0.0497,0,0
5,GO PHAGOSOME MATURATION,0.058535,-0.15623,-0.10065,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.056456,-0.15646,-0.15097,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.08588,-0.15674,-0.077067,0,0
5,GO CELLULAR RESPONSE TO FATTY ACID,0.091819,-0.15677,-0.11198,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.022172,-0.15704,-0.1077,0,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.094909,-0.15726,-0.16576,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.11163,-0.15737,-0.11435,0,0
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.094909,-0.15774,-0.16061,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.78176,-0.15778,-0.052517,0,0
5,GO HEART FORMATION,0.026142,-0.15789,-0.12531,0,0
5,GO SYNAPTIC MEMBRANE ADHESION,0.19156,-0.15797,-0.17117,0,0
5,GO BRAIN MORPHOGENESIS,0.15655,-0.15821,-0.1109,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.077559,-0.15832,-0.07428,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.14312,-0.15839,-0.09209,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.058535,-0.15839,-0.12369,0,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.36271,-0.15904,-0.065261,0,0
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0063209,-0.15906,-0.1378,0,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.1306,-0.15908,-0.12506,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.058535,-0.15908,-0.10474,0,0
5,GO SYNAPSE MATURATION,0.33029,-0.15909,-0.10764,0,0
5,GO RHYTHMIC BEHAVIOR,0.08588,-0.1593,-0.082878,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.20256,-0.1593,-0.12811,0,0
5,GO MULTI ORGANISM LOCALIZATION,0.08303,-0.1594,-0.064126,0,0
5,GO AMINO ACID IMPORT,0.074935,-0.15976,-0.084531,0,0
5,GO ALCOHOL CATABOLIC PROCESS,0.077559,-0.16041,-0.08308,0,0
5,GO TORC1 SIGNALING,0.11894,-0.16055,-0.10621,0,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.20256,-0.16082,-0.1118,0,0
5,GO HORMONE CATABOLIC PROCESS,0.19156,-0.16096,-0.10263,0,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.074935,-0.16106,-0.19182,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.10811,-0.16146,-0.087635,0,0
5,GO GENETIC IMPRINTING,0.12273,-0.16204,-0.091096,0,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.067497,-0.16223,-0.093615,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.018736,-0.16226,-0.11525,0,0
5,GO HISTONE H4 DEACETYLATION,0.058535,-0.16233,-0.098849,0,0
5,GO MICROTUBULE ANCHORING,0.13885,-0.16281,-0.098216,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.15197,-0.16296,-0.088691,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.30724,-0.16303,-0.071522,0,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.15197,-0.16306,-0.092467,0,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.10134,-0.16309,-0.12586,0,0
5,GO REGULATION OF RESPIRATORY BURST,0.045233,-0.16321,-0.14405,0,0
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.33821,-0.16332,-0.081028,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.067497,-0.16354,-0.10014,0,0
5,GO DENDRITE MORPHOGENESIS,0.091819,-0.16405,-0.11918,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.08303,-0.16408,-0.15038,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.214,-0.16415,-0.086689,0,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.080256,-0.1642,-0.1337,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.056456,-0.16431,-0.10591,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.031957,-0.16445,-0.14971,0,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.29248,-0.16454,-0.086023,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.098083,-0.16498,-0.18307,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.058535,-0.16513,-0.086026,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.39705,-0.16518,-0.096042,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.098083,-0.16538,-0.1016,0,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.098083,-0.16556,-0.11709,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.21989,-0.16576,-0.066411,0,0
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.10811,-0.16582,-0.12758,0,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.072385,-0.16587,-0.1085,0,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.074935,-0.16618,-0.15531,0,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.34626,-0.16625,-0.11635,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.056456,-0.16638,-0.11397,0,0
5,GO OLIGODENDROCYTE DEVELOPMENT,0.098083,-0.16658,-0.078414,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.26442,-0.1666,-0.10723,0,0
5,GO MUSCLE FIBER DEVELOPMENT,0.054439,-0.16664,-0.12265,0,0
5,GO HINDBRAIN MORPHOGENESIS,0.11524,-0.16675,-0.1067,0,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.067497,-0.1671,-0.087744,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.13467,-0.16715,-0.13601,0,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.056456,-0.16722,-0.14879,0,0
5,GO BASIC AMINO ACID TRANSPORT,0.080256,-0.16756,-0.14683,0,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.27821,-0.16756,-0.071167,0,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.091819,-0.16757,-0.15072,0,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.094909,-0.16764,-0.10185,0,0
5,GO TUBE FORMATION,0.013834,-0.16765,-0.14559,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.58498,-0.16765,-0.067571,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.041938,-0.1677,-0.13832,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.060677,-0.16774,-0.12449,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.074935,-0.16804,-0.11398,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0049572,-0.16806,-0.11897,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0060238,-0.16826,-0.14601,0,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.091819,-0.16835,-0.11698,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.1306,-0.1685,-0.10222,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.094909,-0.16856,-0.11985,0,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.2259,-0.16883,-0.097715,0,0
5,GO CARDIAC CELL DEVELOPMENT,0.062884,-0.16905,-0.079269,0,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.28529,-0.16923,-0.092384,0,0
5,GO MATING BEHAVIOR,0.15197,-0.16953,-0.13487,0,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.214,-0.16973,-0.10916,0,0
5,GO DENDRITIC SPINE DEVELOPMENT,0.056456,-0.16981,-0.14063,0,0
5,GO PRESYNAPSE ORGANIZATION,0.15197,-0.16988,-0.12426,0,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.25111,-0.16998,-0.078145,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.062884,-0.17052,-0.19775,0,0
5,GO FATTY ACID BETA OXIDATION,0.080256,-0.17074,-0.072157,0,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.12662,-0.17083,-0.12364,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.069906,-0.17095,-0.12473,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.033245,-0.17126,-0.11705,0,0
5,GO CELL FATE SPECIFICATION,0.077559,-0.17136,-0.12027,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.01266,-0.17151,-0.16292,0,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.028348,-0.17188,-0.15614,0,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.37111,-0.17221,-0.061856,0,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.054439,-0.17226,-0.10023,0,0
5,GO POLYOL TRANSPORT,0.069906,-0.17235,-0.18796,0,0
5,GO HISTAMINE SECRETION,0.51122,-0.17263,-0.10039,0,0
5,GO CENTRIOLE CENTRIOLE COHESION,0.15655,-0.17265,-0.15538,0,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.02951,-0.1727,-0.14035,0,0
5,GO COPII COATED VESICLE CARGO LOADING,0.080256,-0.17342,-0.099465,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.24463,-0.17352,-0.080726,0,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.15197,-0.17363,-0.060653,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.098083,-0.17382,-0.092348,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.072385,-0.17383,-0.084038,0,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.19156,-0.17393,-0.17396,0,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.017954,-0.17394,-0.12267,0,0
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0049572,-0.17402,-0.13211,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.17091,-0.17421,-0.1138,0,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.1475,-0.1745,-0.16432,0,0
5,GO HINDBRAIN DEVELOPMENT,0.065157,-0.17485,-0.11065,0,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.077559,-0.17512,-0.143,0,0
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.077559,-0.17514,-0.1252,0,0
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.074935,-0.17528,-0.127,0,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.10134,-0.17588,-0.10935,0,0
5,GO LOCOMOTORY BEHAVIOR,0.11894,-0.17627,-0.10972,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.18624,-0.17725,-0.11326,0,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.077559,-0.17727,-0.11302,0,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.08881,-0.17733,-0.12779,0,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.074935,-0.17777,-0.15239,0,0
5,GO MRNA TRANSCRIPTION,0.062884,-0.17782,-0.12578,0,0
5,GO RESPONSE TO PAIN,0.17591,-0.17854,-0.097335,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.34626,-0.17865,-0.079884,0,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.13885,-0.17912,-0.094521,0,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.025096,-0.17925,-0.1059,0,0
5,GO RESPONSE TO L GLUTAMATE,0.12273,-0.18012,-0.12586,0,0
5,GO O GLYCAN PROCESSING,0.08588,-0.18106,-0.12534,0,0
5,GO SPHINGOID METABOLIC PROCESS,0.24463,-0.18117,-0.067954,0,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.15197,-0.18117,-0.12678,0,0
5,GO ASYMMETRIC CELL DIVISION,0.062884,-0.18125,-0.12587,0,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.069906,-0.18172,-0.15594,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0083971,-0.18209,-0.18714,0,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.054439,-0.18224,-0.099251,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.50109,-0.18251,-0.034148,0,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.17591,-0.18279,-0.11548,0,0
5,GO REGULATION OF ANOIKIS,0.16123,-0.18299,-0.10427,0,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.39705,-0.18318,-0.088227,0,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.39705,-0.18331,-0.07424,0,0
5,GO PROTEIN LOCALIZATION TO AXON,0.37964,-0.18375,-0.067115,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.08303,-0.18418,-0.12253,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.12273,-0.18428,-0.10008,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.17591,-0.18433,-0.095611,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.058535,-0.18438,-0.11571,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.11894,-0.18452,-0.16943,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.15197,-0.18456,-0.15625,0,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.23203,-0.18504,-0.1029,0,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.065157,-0.18519,-0.10205,0,0
5,GO RESPONSE TO UV C,0.069906,-0.18553,-0.12295,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.065157,-0.18557,-0.13286,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0083971,-0.18567,-0.26826,0,0
5,GO MULTICELLULAR ORGANISM AGING,0.060677,-0.18572,-0.10424,0,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.026142,-0.18613,-0.14066,0,0
5,GO NUCLEAR PORE ORGANIZATION,0.25111,-0.18679,-0.078176,0,0
5,GO SPINAL CORD DEVELOPMENT,0.30724,-0.18702,-0.079766,0,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.023112,-0.1872,-0.13517,0,0
5,GO PROTEIN DEMETHYLATION,0.14312,-0.18808,-0.11642,0,0
5,GO MALE GENITALIA DEVELOPMENT,0.067497,-0.18816,-0.13699,0,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.13467,-0.18871,-0.095535,0,0
5,GO CGMP MEDIATED SIGNALING,0.058535,-0.18914,-0.15542,0,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.058535,-0.18928,-0.16161,0,0
5,GO NEUROMUSCULAR PROCESS,0.10468,-0.19005,-0.11589,0,0
5,GO CARNITINE SHUTTLE,0.32248,-0.19014,-0.062324,0,0
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.054439,-0.19041,-0.093695,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.067497,-0.19053,-0.15512,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.10134,-0.19085,-0.11316,0,0
5,GO REGULATION OF RECEPTOR CLUSTERING,0.11524,-0.19109,-0.22052,0,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.08881,-0.19118,-0.17257,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.098083,-0.19148,-0.11901,0,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.069906,-0.19155,-0.15155,0,0
5,GO RETROGRADE AXONAL TRANSPORT,0.15655,-0.19182,-0.13293,0,0
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.10468,-0.19189,-0.15089,0,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.054439,-0.19207,-0.10138,0,0
5,GO NEURON MIGRATION,0.058535,-0.19244,-0.15349,0,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20822,-0.19302,-0.085855,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.33029,-0.19379,-0.070255,0,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.034576,-0.19434,-0.14849,0,0
5,GO FOREBRAIN CELL MIGRATION,0.069906,-0.19457,-0.14292,0,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.17091,-0.19537,-0.11223,0,0
5,GO NEURON MATURATION,0.13467,-0.19567,-0.096492,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.098083,-0.19578,-0.10562,0,0
5,GO REPRODUCTIVE BEHAVIOR,0.17091,-0.19585,-0.11476,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0036751,-0.19625,-0.16058,0,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.10811,-0.19663,-0.089866,0,0
5,GO REGULATION OF SYNAPSE MATURATION,0.23203,-0.19664,-0.13515,0,0
5,GO SCHWANN CELL DIFFERENTIATION,0.11524,-0.19705,-0.10564,0,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.025096,-0.19755,-0.13197,0,0
5,GO VITAMIN TRANSPORT,0.080256,-0.19815,-0.092493,0,0
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.080256,-0.19853,-0.12068,0,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.26442,-0.19878,-0.042628,0,0
5,GO PRIMARY MIRNA PROCESSING,0.15655,-0.19884,-0.078874,0,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.067497,-0.19903,-0.14614,0,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.077559,-0.19904,-0.13213,0,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.08588,-0.19909,-0.18126,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.12273,-0.19955,-0.10972,0,0
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.17091,-0.20014,-0.2364,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.058535,-0.20153,-0.18514,0,0
5,GO DENDRITE DEVELOPMENT,0.072385,-0.20169,-0.13166,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.19156,-0.20169,-0.11885,0,0
5,GO L GLUTAMATE IMPORT,0.033245,-0.20196,-0.16349,0,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.065157,-0.20218,-0.14267,0,0
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.13885,-0.20271,-0.12352,0,0
5,GO DENDRITIC TRANSPORT,0.52145,-0.20306,-0.045612,0,0
5,GO RESPONSE TO GONADOTROPIN,0.10134,-0.20383,-0.12516,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.060677,-0.20389,-0.17756,0,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13885,-0.20416,-0.10897,0,0
5,GO REGULATION OF ENDOCRINE PROCESS,0.062884,-0.20419,-0.12201,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.034576,-0.2043,-0.16047,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.12273,-0.20453,-0.18938,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.08881,-0.20455,-0.086944,0,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.080256,-0.20498,-0.10067,0,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.054439,-0.20542,-0.15462,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.017954,-0.20607,-0.11524,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.022172,-0.20613,-0.17723,0,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0019699,-0.20691,-0.1871,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,0.038848,-0.20697,-0.13389,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.077559,-0.20717,-0.17332,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0040644,-0.20721,-0.18798,0,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.12662,-0.20724,-0.14149,0,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.33821,-0.20752,-0.041648,0,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.072385,-0.20854,-0.14596,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.28529,-0.20906,-0.18696,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.010101,-0.20909,-0.17259,0,0
5,GO SODIUM ION HOMEOSTASIS,0.02951,-0.20949,-0.15743,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.072385,-0.21028,-0.16165,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.024086,-0.21029,-0.21811,0,0
5,GO REGULATION OF HEART GROWTH,0.0063209,-0.21075,-0.16266,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0076456,-0.21084,-0.17583,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.048745,-0.21131,-0.13477,0,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.091819,-0.2119,-0.15498,0,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.11524,-0.21198,-0.21198,0,0
5,GO HEPARIN METABOLIC PROCESS,0.12662,-0.21254,-0.1383,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.11894,-0.21274,-0.14737,0,0
5,GO MITOCHONDRION DISTRIBUTION,0.054439,-0.21296,-0.121,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.069906,-0.2131,-0.18323,0,0
5,GO NEGATIVE REGULATION OF ANOIKIS,0.20822,-0.21333,-0.12915,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0049572,-0.21352,-0.13588,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.30724,-0.21387,-0.093884,0,0
5,GO LIPID EXPORT FROM CELL,0.008797,-0.21431,-0.18298,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.17091,-0.2146,-0.10771,0,0
5,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.01266,-0.2149,-0.21706,0,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.15197,-0.21548,-0.11865,0,0
5,GO RESPONSE TO MAGNESIUM ION,0.21989,-0.21579,-0.096084,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.018736,-0.21581,-0.1723,0,0
5,GO HISTAMINE TRANSPORT,0.43329,-0.21592,-0.087506,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.02951,-0.21629,-0.12079,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.13885,-0.21681,-0.13319,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.53179,-0.21739,-0.05661,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.020391,-0.21756,-0.33501,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.037377,-0.21796,-0.11791,0,0
5,GO REGULATION OF PEPTIDE SECRETION,0.0083971,-0.21809,-0.15329,0,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.017954,-0.21845,-0.14316,0,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.050584,-0.21857,-0.15024,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.077559,-0.21882,-0.13816,0,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.031957,-0.21886,-0.17221,0,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.058535,-0.21898,-0.20626,0,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0096484,-0.21982,-0.20233,0,0
5,GO POSITIVE REGULATION OF CELL DIVISION,0.0057394,-0.22042,-0.17394,0,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.52145,-0.22055,-0.075122,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.10468,-0.22081,-0.14749,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0028457,-0.22117,-0.2397,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.27126,-0.22185,-0.13275,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.074935,-0.22201,-0.14545,0,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.0040644,-0.22208,-0.14659,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.067497,-0.22234,-0.15795,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.08881,-0.22243,-0.14929,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0034935,-0.22285,-0.17967,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.012106,-0.22365,-0.16079,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.14312,-0.22504,-0.14192,0,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0052065,-0.22534,-0.1377,0,0
5,GO ANIMAL ORGAN FORMATION,0.0015041,-0.2254,-0.21971,0,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.007293,-0.22591,-0.23733,0,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0080134,-0.22752,-0.17256,0,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.056456,-0.22783,-0.13193,0,0
5,GO XENOBIOTIC TRANSPORT,0.058535,-0.22798,-0.12876,0,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.2998,-0.22805,-0.097139,0,0
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.006955,-0.22828,-0.18168,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.098083,-0.22857,-0.17961,0,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.054439,-0.22885,-0.20488,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.074935,-0.22924,-0.16724,0,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.035953,-0.22941,-0.16944,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0013481,-0.22958,-0.21734,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.040368,-0.23057,-0.28762,0,0
5,GO MUCUS SECRETION,0.23827,-0.23075,-0.11968,0,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.072385,-0.23103,-0.053213,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.08303,-0.23188,-0.15908,0,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.054439,-0.23284,-0.10197,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0092139,-0.23328,-0.22812,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.040368,-0.23399,-0.20889,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.077559,-0.23429,-0.19755,0,0
5,GO VASODILATION,0.098083,-0.23452,-0.11419,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.008797,-0.23496,-0.17713,0,0
5,GO VITAMIN D METABOLIC PROCESS,0.056456,-0.23513,-0.20915,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.058535,-0.23573,-0.13468,0,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.10811,-0.23668,-0.16359,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.4521,-0.237,-0.086937,0,0
5,GO PLASMINOGEN ACTIVATION,0.11894,-0.23741,-0.20381,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.010101,-0.23742,-0.23038,0,0
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0042727,-0.23749,-0.15672,0,0
5,GO FOREBRAIN REGIONALIZATION,0.11524,-0.23947,-0.1784,0,0
5,GO MITOCHONDRIAL DEPOLARIZATION,0.0038653,-0.24021,-0.23399,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.052482,-0.24081,-0.16786,0,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0047188,-0.24101,-0.27101,0,0
5,GO NUCLEAR MIGRATION,0.30724,-0.24102,-0.094164,0,0
5,GO NUCLEUS LOCALIZATION,0.28529,-0.24122,-0.10074,0,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.067497,-0.24127,-0.1768,0,0
5,GO REGULATION OF GTP BINDING,0.024086,-0.24183,-0.22031,0,0
5,GO ACTIN FILAMENT SEVERING,0.098083,-0.24186,-0.16607,0,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.1475,-0.24197,-0.1761,0,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.060677,-0.24225,-0.26856,0,0
5,GO RESPONSE TO AXON INJURY,0.007293,-0.24256,-0.18246,0,0
5,GO LUNG ALVEOLUS DEVELOPMENT,0.056456,-0.24276,-0.11911,0,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.012106,-0.24317,-0.18065,0,0
5,GO COLLATERAL SPROUTING,0.054439,-0.24336,-0.17471,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.062884,-0.2444,-0.18225,0,0
5,GO REGULATION OF EXCRETION,0.045233,-0.24693,-0.1869,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.0036751,-0.24752,-0.25105,0,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.20256,-0.24826,-0.13082,0,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0040644,-0.24835,-0.1751,0,0
5,GO RESPONSE TO MECHANICAL STIMULUS,0.007293,-0.24912,-0.17824,0,0
5,GO PARENTAL BEHAVIOR,0.23203,-0.24918,-0.17594,0,0
5,GO RESPONSE TO ACETYLCHOLINE,0.11894,-0.2492,-0.16424,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.0019699,-0.25104,-0.29211,0,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.013834,-0.2517,-0.17964,0,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.072385,-0.25229,-0.15117,0,0
5,GO THALAMUS DEVELOPMENT,0.10811,-0.25269,-0.14646,0,0
5,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.067497,-0.25278,-0.18728,0,0
5,GO REGULATION OF ODONTOGENESIS,0.0044907,-0.25351,-0.27155,0,0
5,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.091819,-0.25378,-0.28565,0,0
5,GO PROSTATIC BUD FORMATION,0.0054671,-0.25425,-0.34736,0,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0031545,-0.25437,-0.1642,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.060677,-0.25496,-0.14885,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.098083,-0.25505,-0.18864,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.024086,-0.25509,-0.28177,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0047188,-0.25556,-0.20079,0,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.11524,-0.25654,-0.13694,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.11163,-0.25687,-0.17079,0,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.010572,-0.25694,-0.17561,0,0
5,GO RESPONSE TO FORSKOLIN,0.034576,-0.25769,-0.23627,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.32248,-0.25873,-0.10261,0,0
5,GO MYOBLAST DIFFERENTIATION,0.0028457,-0.25892,-0.22776,0,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.00332,-0.25965,-0.1991,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.056456,-0.26023,-0.18542,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.091819,-0.26084,-0.14724,0,0
5,GO METANEPHROS DEVELOPMENT,0.0038653,-0.26101,-0.22455,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.01266,-0.26138,-0.26664,0,0
5,GO TOXIN METABOLIC PROCESS,0.08303,-0.26278,-0.18256,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.24463,-0.26581,-0.13016,0,0
5,GO CELL MIGRATION IN HINDBRAIN,0.23203,-0.26582,-0.082023,0,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.067497,-0.26672,-0.18248,0,0
5,GO MECHANOSENSORY BEHAVIOR,0.16123,-0.26675,-0.14597,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.214,-0.26711,-0.11751,0,0
5,GO STRIATUM DEVELOPMENT,0.065157,-0.26757,-0.14059,0,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.080256,-0.2676,-0.15652,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.098083,-0.2683,-0.15802,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.080256,-0.26916,-0.20242,0,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.060677,-0.2699,-0.1712,0,0
5,GO BONE MINERALIZATION,0.013235,-0.27018,-0.19765,0,0
5,GO SHORT TERM MEMORY,0.17591,-0.27108,-0.16633,0,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.12662,-0.27128,-0.21096,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.01266,-0.27237,-0.28012,0,0
5,GO POSITIVE REGULATION OF NEURON DEATH,0.0027019,-0.27243,-0.19313,0,0
5,GO REGULATION OF ICOSANOID SECRETION,0.015104,-0.27265,-0.19153,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0096484,-0.27422,-0.18843,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.010572,-0.27433,-0.22774,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0017696,-0.27439,-0.31826,0,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.072385,-0.275,-0.25023,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0080134,-0.2766,-0.25295,0,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0066311,-0.27712,-0.23487,0,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0019699,-0.27759,-0.23144,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0057394,-0.27782,-0.21437,0,0
5,GO RENAL SODIUM EXCRETION,0.052482,-0.27872,-0.18372,0,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.10468,-0.27921,-0.14261,0,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.15655,-0.27925,-0.12085,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.19156,-0.27946,-0.14613,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.0044907,-0.28009,-0.23854,0,0
5,GO ASTROCYTE DIFFERENTIATION,0.0036751,-0.28189,-0.25097,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0028457,-0.2821,-0.31977,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.13467,-0.28214,-0.12821,0,0
5,GO LYSOSOME LOCALIZATION,0.0052065,-0.28219,-0.21422,0,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.058535,-0.28285,-0.28055,0,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.11894,-0.28313,-0.16999,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0049572,-0.2833,-0.24517,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.054439,-0.28363,-0.1686,0,0
5,GO BONE GROWTH,0.0066311,-0.28401,-0.26494,0,0
5,GO OPTIC NERVE DEVELOPMENT,0.060677,-0.28564,-0.24743,0,0
5,GO REGULATION OF FATTY ACID TRANSPORT,0.0060238,-0.28573,-0.20244,0,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.034576,-0.28677,-0.19945,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.007293,-0.28707,-0.24908,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.056456,-0.2871,-0.19194,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.0044907,-0.28793,-0.23548,0,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0060238,-0.2885,-0.22334,0,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0021907,-0.28873,-0.21634,0,0
5,GO INNERVATION,0.18102,-0.28874,-0.14537,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0019699,-0.28957,-0.25881,0,0
5,GO SMOOTH MUSCLE CONTRACTION,0.00332,-0.29081,-0.21461,0,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.3148,-0.29128,-0.18042,0,0
5,GO LIPOXYGENASE PATHWAY,0.067497,-0.29225,-0.23484,0,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.023112,-0.29249,-0.21314,0,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0036751,-0.29465,-0.31068,0,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.052482,-0.29541,-0.19021,0,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.0080134,-0.29598,-0.25801,0,0
5,GO MITOTIC CELL CYCLE ARREST,0.0083971,-0.29686,-0.23286,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0034935,-0.29852,-0.27387,0,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.00064645,-0.29909,-0.3002,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0036751,-0.30058,-0.2444,0,0
5,GO VASCULAR WOUND HEALING,0.062884,-0.30061,-0.17892,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.10811,-0.30496,-0.15899,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.020391,-0.30532,-0.2148,0,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0044907,-0.3077,-0.24416,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.035953,-0.30888,-0.17782,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.0080134,-0.30976,-0.2978,0,0
5,GO VASCULOGENESIS,0.0031545,-0.3107,-0.28826,0,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.08303,-0.31117,-0.19392,0,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0052065,-0.31121,-0.27226,0,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0040644,-0.31329,-0.24701,0,0
5,GO NEURON CELL CELL ADHESION,0.062884,-0.31382,-0.22925,0,0
5,GO CARDIOBLAST DIFFERENTIATION,0.0014241,-0.31409,-0.32506,0,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.028348,-0.31581,-0.25634,0,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.072385,-0.31591,-0.23007,0,0
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0023095,-0.31602,-0.24271,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0080134,-0.3162,-0.25049,0,0
5,GO CELLULAR RESPONSE TO NUTRIENT,0.00332,-0.31745,-0.31277,0,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.15197,-0.31761,-0.22388,0,0
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0015041,-0.32021,-0.28036,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0014241,-0.32187,-0.36755,0,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0044907,-0.32187,-0.3169,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.017954,-0.32736,-0.2587,0,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.028348,-0.32762,-0.24716,0,0
5,GO POSITIVE REGULATION OF MYELINATION,0.01266,-0.32827,-0.25788,0,0
5,GO RESPONSE TO VITAMIN D,0.0023095,-0.32852,-0.32675,0,0
5,GO PROSTAGLANDIN SECRETION,0.038848,-0.32891,-0.18805,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.011063,-0.33215,-0.19369,0,0
5,GO ENDOTHELIAL CELL MIGRATION,0.00332,-0.33354,-0.26494,0,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.0083971,-0.33393,-0.27016,0,0
5,GO CARDIAC VENTRICLE FORMATION,0.010572,-0.33641,-0.32419,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.0023095,-0.33734,-0.28078,0,0
5,GO AXIS ELONGATION,0.00332,-0.33807,-0.29314,0,0
5,GO CHONDROCYTE DIFFERENTIATION,0.0017696,-0.33817,-0.27442,0,0
5,GO ENDOTHELIAL CELL PROLIFERATION,0.0036751,-0.34035,-0.24236,0,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.034576,-0.34155,-0.24184,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0054671,-0.34198,-0.22316,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.048745,-0.34394,-0.19452,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0092139,-0.34722,-0.26935,0,0
5,GO COPULATION,0.015104,-0.34722,-0.30397,0,0
5,GO SALIVARY GLAND DEVELOPMENT,0.0057394,-0.34746,-0.29482,0,0
5,GO PENILE ERECTION,0.048745,-0.34858,-0.27161,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0054671,-0.34896,-0.3322,0,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.006955,-0.3509,-0.29547,0,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.056456,-0.35583,-0.2242,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0028457,-0.35689,-0.4034,0,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0023095,-0.3574,-0.28613,0,0
5,GO SMOOTH MUSCLE CELL MIGRATION,0.0076456,-0.35865,-0.25783,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.010101,-0.36096,-0.24275,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.058535,-0.36159,-0.27822,0,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.0027019,-0.36229,-0.28389,0,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.010572,-0.36293,-0.31308,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.007293,-0.36503,-0.33261,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.0016767,-0.36599,-0.33283,0,0
5,GO HEMIDESMOSOME ASSEMBLY,0.069906,-0.36625,-0.31806,0,0
5,GO REGULATION OF URINE VOLUME,0.010101,-0.36646,-0.25886,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0047188,-0.36948,-0.29811,0,0
5,GO OXYGEN TRANSPORT,0.016475,-0.37123,-0.31521,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.0047188,-0.37182,-0.26784,0,0
5,GO POSITIVE CHEMOTAXIS,0.0021907,-0.37232,-0.31208,0,0
5,GO CELLULAR RESPONSE TO IRON ION,0.0019699,-0.3729,-0.35638,0,0
5,GO SPROUTING ANGIOGENESIS,0.0015882,-0.38162,-0.311,0,0
5,GO N GLYCAN PROCESSING,0.025096,-0.3825,-0.19534,0,0
5,GO RESPONSE TO PROGESTERONE,0.0047188,-0.38502,-0.28585,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.030713,-0.38986,-0.28205,0,0
5,GO CONVERGENT EXTENSION,0.023112,-0.39038,-0.23621,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0076456,-0.39514,-0.32294,0,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.0012071,-0.39587,-0.38846,0,0
5,GO RENAL FILTRATION,0.0052065,-0.41038,-0.36637,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0038653,-0.41576,-0.35497,0,0
5,GO BIOLOGICAL PHASE,0.00045436,-0.41605,-0.40412,0,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0096484,-0.41654,-0.31514,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0029965,-0.42279,-0.30126,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.028348,-0.43484,-0.30918,0,0
5,GO OPSONIZATION,0.0096484,-0.43598,-0.4126,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.00060992,-0.43911,-0.42546,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0010798,-0.44194,-0.36382,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00035748,-0.44427,-0.47601,0,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.040368,-0.44744,-0.31516,0,0
5,GO CELLULAR RESPONSE TO VITAMIN,0.00076864,-0.45145,-0.42663,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0021907,-0.47892,-0.43207,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0024341,-0.48123,-0.40721,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.015776,-0.48134,-0.40405,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.0031545,-0.48245,-0.41154,0,0
5,GO EOSINOPHIL CHEMOTAXIS,0.0172,-0.50657,-0.53344,0,0
5,GO EOSINOPHIL MIGRATION,0.014457,-0.52998,-0.55332,0,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0040644,-0.61401,-0.45894,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00332,-0.61835,-0.43843,0,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0049572,-0.68324,-0.52679,0,0
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1.3909e-05,0.37482,0.40681,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,1.8524e-05,0.26399,0.31207,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00057531,0.23345,0.21034,1,1
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.024086,0.14255,0.13196,1,1
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.045233,0.12388,0.1132,1,1
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00054254,0.11832,0.14949,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.048745,-0.097372,-0.22949,1,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0063209,-0.10476,-0.1747,1,0
6,GO RRNA 3 END PROCESSING,0.045233,-0.10841,-0.14736,1,0
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.025096,-0.10996,-0.25663,1,0
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.02951,-0.11088,-0.21844,1,0
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0054671,-0.11584,-0.1684,1,0
6,GO UTP METABOLIC PROCESS,0.02951,-0.1279,-0.18303,1,0
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0040644,-0.12958,-0.19682,1,0
6,GO ELECTRON TRANSPORT CHAIN,0.0025648,-0.13578,-0.15876,1,0
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0015882,-0.13676,-0.21268,1,0
6,GO HISTONE EXCHANGE,0.0080134,-0.13825,-0.21128,1,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.025096,-0.13866,-0.18552,1,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.006955,-0.13914,-0.23201,1,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.018736,-0.15453,-0.19229,1,0
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0038653,-0.15524,-0.15994,1,0
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0018673,-0.15616,-0.19579,1,0
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0040644,-0.15882,-0.29141,1,0
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00057531,-0.15934,-0.25506,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,1.7249e-05,-0.1594,-0.19544,1,0
6,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.0057394,-0.16102,-0.22409,1,0
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.00040321,-0.16833,-0.29337,1,0
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00072571,-0.1719,-0.26442,1,0
6,GO OTIC VESICLE DEVELOPMENT,0.028348,-0.17519,-0.21665,1,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0019699,-0.1769,-0.21831,1,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.037377,-0.17733,-0.18052,1,0
6,GO REGULATION OF GLUTAMATE SECRETION,0.02951,-0.18332,-0.38733,1,0
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0013481,-0.18366,-0.24893,1,0
6,GO ESCRT COMPLEX DISASSEMBLY,0.0018673,-0.1845,-0.25172,1,0
6,GO RETINOL METABOLIC PROCESS,0.0010798,-0.18583,-0.28154,1,0
6,GO ERROR PRONE TRANSLESION SYNTHESIS,0.006955,-0.18717,-0.21956,1,0
6,GO PROTEIN TARGETING,3.0304e-05,-0.18841,-0.23047,1,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,1.6059e-05,-0.18868,-0.23714,1,0
6,GO RIBOSOME BIOGENESIS,0.00020554,-0.19109,-0.24044,1,0
6,GO CENTROMERE COMPLEX ASSEMBLY,0.0031545,-0.19171,-0.27567,1,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.00017019,-0.19225,-0.2422,1,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,1.4947e-05,-0.19504,-0.28718,1,0
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00021879,-0.1982,-0.2779,1,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.0016767,-0.20071,-0.28676,1,0
6,GO MITOCHONDRIAL TRANSCRIPTION,0.00048214,-0.2008,-0.25503,1,0
6,GO RETINAL ROD CELL DIFFERENTIATION,0.0034935,-0.20247,-0.27746,1,0
6,GO QUINONE METABOLIC PROCESS,0.00011593,-0.20274,-0.24957,1,0
6,GO SPERM EGG RECOGNITION,0.0057394,-0.20301,-0.19652,1,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,9.5377e-05,-0.2046,-0.27427,1,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.0011418,-0.20567,-0.24955,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00015974,-0.20633,-0.29756,1,0
6,GO RRNA METHYLATION,0.00060992,-0.21055,-0.29188,1,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00096503,-0.21202,-0.21669,1,0
6,GO TRNA METABOLIC PROCESS,5.9985e-05,-0.21298,-0.30708,1,0
6,GO DEFENSE RESPONSE TO FUNGUS,0.018736,-0.21354,-0.27866,1,0
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0017696,-0.21379,-0.28416,1,0
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,8.3641e-05,-0.21528,-0.26765,1,0
6,GO RNA CATABOLIC PROCESS,2.2907e-05,-0.21624,-0.2354,1,0
6,GO DNA LIGATION,0.00072571,-0.21787,-0.28345,1,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.0010798,-0.21816,-0.23405,1,0
6,GO TRNA PROCESSING,7.3279e-05,-0.21964,-0.30206,1,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,5.9985e-05,-0.2211,-0.2738,1,0
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00081392,-0.22116,-0.27486,1,0
6,GO MEIOSIS I CELL CYCLE PROCESS,0.00068502,-0.22305,-0.33206,1,0
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00014989,-0.22378,-0.27137,1,0
6,GO RRNA METABOLIC PROCESS,5.6086e-05,-0.22392,-0.2833,1,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.020391,-0.22571,-0.2741,1,0
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00040321,-0.22653,-0.27193,1,0
6,GO MALE MEIOSIS I,0.0066311,-0.22698,-0.35192,1,0
6,GO MIDBODY ABSCISSION,0.00068502,-0.22814,-0.30459,1,0
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0012758,-0.22955,-0.25444,1,0
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.024086,-0.22992,-0.28937,1,0
6,GO TRNA WOBBLE BASE MODIFICATION,0.00010866,-0.23007,-0.33297,1,0
6,GO TRNA MODIFICATION,8.9327e-05,-0.2309,-0.3233,1,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00014062,-0.2322,-0.28185,1,0
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.027226,-0.23255,-0.23248,1,0
6,GO NCRNA 3 END PROCESSING,0.00021879,-0.2331,-0.27566,1,0
6,GO SPERM AXONEME ASSEMBLY,0.048745,-0.23396,-0.18642,1,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00010866,-0.23421,-0.30418,1,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,5.2428e-05,-0.2344,-0.28323,1,0
6,GO RRNA MODIFICATION,0.00021879,-0.23443,-0.30545,1,0
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.7249e-05,-0.23482,-0.30408,1,0
6,GO MEIOTIC CHROMOSOME SEGREGATION,0.00035748,-0.23491,-0.36181,1,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,7.8298e-05,-0.23605,-0.3535,1,0
6,GO DRUG CATABOLIC PROCESS,0.0023095,-0.23725,-0.28105,1,0
6,GO AMIDE BIOSYNTHETIC PROCESS,6.6813e-06,-0.2382,-0.28578,1,0
6,GO VIRAL BUDDING,5.9985e-05,-0.23837,-0.32983,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,1.6059e-05,-0.23981,-0.30166,1,0
6,GO PSEUDOURIDINE SYNTHESIS,0.0010209,-0.24034,-0.28117,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3909e-05,-0.24058,-0.29865,1,0
6,GO RETINOIC ACID METABOLIC PROCESS,0.0054671,-0.24067,-0.26402,1,0
6,GO SNORNA 3 END PROCESSING,0.00332,-0.24114,-0.26682,1,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.636e-05,-0.24159,-0.3222,1,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,8.9327e-05,-0.24253,-0.29781,1,0
6,GO PEPTIDYL ASPARAGINE MODIFICATION,3.0304e-05,-0.24262,-0.32914,1,0
6,GO RNA CAPPING,0.00048214,-0.24302,-0.28155,1,0
6,GO SENSORY PERCEPTION OF TASTE,0.00048214,-0.24312,-0.31581,1,0
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,6.8565e-05,-0.24417,-0.29455,1,0
6,GO PEPTIDE METABOLIC PROCESS,7.7514e-06,-0.24428,-0.27903,1,0
6,GO HISTONE MRNA METABOLIC PROCESS,0.00020554,-0.24587,-0.28148,1,0
6,GO REGULATION OF FERTILIZATION,0.00072571,-0.24644,-0.28005,1,0
6,GO NCRNA PROCESSING,4.8997e-05,-0.24708,-0.30511,1,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0044907,-0.24762,-0.25993,1,0
6,GO UBIQUINONE METABOLIC PROCESS,0.00018128,-0.24836,-0.30133,1,0
6,GO KINETOCHORE ORGANIZATION,0.0010798,-0.24856,-0.35317,1,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00010866,-0.24859,-0.29582,1,0
6,GO SENSORY PERCEPTION OF SMELL,5.9985e-05,-0.24954,-0.26048,1,0
6,GO T CELL CYTOKINE PRODUCTION,0.0027019,-0.24975,-0.4913,1,0
6,GO T CELL CHEMOTAXIS,0.038848,-0.24988,-0.48699,1,0
6,GO MITOCHONDRIAL RNA PROCESSING,0.00035748,-0.24989,-0.3974,1,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.636e-05,-0.2505,-0.30771,1,0
6,GO PROTEIN INSERTION INTO MEMBRANE,2.2907e-05,-0.2508,-0.32178,1,0
6,GO REGULATION OF CILIUM MOVEMENT,0.010101,-0.25115,-0.20261,1,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,3.0304e-05,-0.25142,-0.31415,1,0
6,GO URONIC ACID METABOLIC PROCESS,0.00029789,-0.25175,-0.22176,1,0
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0047188,-0.25188,-0.46267,1,0
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.0015882,-0.25192,-0.26836,1,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.006955,-0.25294,-0.3132,1,0
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00011593,-0.25308,-0.32119,1,0
6,GO V D J RECOMBINATION,0.00057531,-0.25487,-0.33368,1,0
6,GO MACROMOLECULE DEPALMITOYLATION,1.6059e-05,-0.25502,-0.33197,1,0
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0083971,-0.25601,-0.4986,1,0
6,GO NCRNA METABOLIC PROCESS,2.2907e-05,-0.25646,-0.32058,1,0
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0028457,-0.25683,-0.32335,1,0
6,GO LACTATE METABOLIC PROCESS,0.00014989,-0.25851,-0.31093,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.2035e-05,-0.2588,-0.33663,1,0
6,GO VITAMIN CATABOLIC PROCESS,0.007293,-0.2591,-0.28149,1,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00086166,-0.25941,-0.30306,1,0
6,GO HYPERSENSITIVITY,0.02951,-0.25945,-0.53609,1,0
6,GO VIRAL LATENCY,7.8298e-05,-0.25972,-0.33896,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.018736,-0.26038,-0.37902,1,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.0025648,-0.26166,-0.31637,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,5.7533e-06,-0.26236,-0.30938,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.035953,-0.26266,-0.42959,1,0
6,GO PROTEIN NITROSYLATION,0.00086166,-0.26277,-0.33071,1,0
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00012367,-0.26344,-0.37219,1,0
6,GO RNA SURVEILLANCE,0.00010181,-0.26376,-0.32444,1,0
6,GO GASTRIC ACID SECRETION,0.00012367,-0.26469,-0.30234,1,0
6,GO MULTIVESICULAR BODY ORGANIZATION,1.9888e-05,-0.26504,-0.34977,1,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.048745,-0.26558,-0.18483,1,0
6,GO DRUG METABOLIC PROCESS,3.7287e-05,-0.26679,-0.33045,1,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,6.6813e-06,-0.2688,-0.29043,1,0
6,GO MITOTIC METAPHASE PLATE CONGRESSION,8.9327e-05,-0.26882,-0.36171,1,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0047188,-0.26886,-0.26045,1,0
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,1.2035e-05,-0.26951,-0.2994,1,0
6,GO RESPONSE TO FOOD,0.011063,-0.26994,-0.25164,1,0
6,GO T CELL MEDIATED IMMUNITY,0.0036751,-0.27043,-0.45716,1,0
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00024771,-0.27045,-0.35227,1,0
6,GO FOREBRAIN REGIONALIZATION,0.011063,-0.27068,-0.37087,1,0
6,GO ZINC ION HOMEOSTASIS,0.0016767,-0.27122,-0.32428,1,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0029965,-0.2732,-0.38644,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,0.035953,-0.27325,-0.40584,1,0
6,GO POSITIVE REGULATION OF ACROSOME REACTION,0.0012758,-0.27395,-0.30307,1,0
6,GO TRNA METHYLATION,0.00011593,-0.27402,-0.34694,1,0
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.012106,-0.27493,-0.24998,1,0
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0010209,-0.27562,-0.35192,1,0
6,GO OUTER DYNEIN ARM ASSEMBLY,0.01266,-0.27573,-0.34053,1,0
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.008797,-0.27645,-0.29586,1,0
6,GO POSTREPLICATION REPAIR,2.8267e-05,-0.27671,-0.35295,1,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,5.337e-06,-0.27756,-0.30199,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.020391,-0.27766,-0.43623,1,0
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.0016767,-0.27854,-0.28063,1,0
6,GO AMP METABOLIC PROCESS,3.7287e-05,-0.27856,-0.31007,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0060238,-0.27882,-0.45372,1,0
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.007293,-0.27958,-0.27381,1,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,2.8267e-05,-0.28004,-0.40228,1,0
6,GO RESPONSE TO INSECTICIDE,0.008797,-0.28084,-0.34529,1,0
6,GO POSITIVE REGULATION OF T CELL MIGRATION,0.012106,-0.2811,-0.48062,1,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,2.4576e-05,-0.2813,-0.31861,1,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,3.9936e-05,-0.28131,-0.31336,1,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,2.8267e-05,-0.28148,-0.31389,1,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00014989,-0.28193,-0.3661,1,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00031664,-0.28223,-0.27146,1,0
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,3.9936e-05,-0.28338,-0.36273,1,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00028019,-0.28408,-0.39078,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,8.3461e-06,-0.28566,-0.33909,1,0
6,GO KETONE BODY METABOLIC PROCESS,0.00042807,-0.28579,-0.25581,1,0
6,GO MONOCYTE CHEMOTAXIS,0.052482,-0.28733,-0.40874,1,0
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0029965,-0.28774,-0.28757,1,0
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,4.2763e-05,-0.28796,-0.41158,1,0
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,5.6086e-05,-0.28822,-0.349,1,0
6,GO CELL REDOX HOMEOSTASIS,3.0304e-05,-0.28955,-0.36749,1,0
6,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00076864,-0.2905,-0.40582,1,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,7.3279e-05,-0.29091,-0.42313,1,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,0.0015882,-0.29092,-0.37073,1,0
6,GO INTERLEUKIN 17 PRODUCTION,0.0036751,-0.29109,-0.50916,1,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,3.7287e-05,-0.29135,-0.35032,1,0
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00011593,-0.29241,-0.31223,1,0
6,GO TONGUE DEVELOPMENT,0.00017019,-0.29303,-0.36115,1,0
6,GO MITOTIC CYTOKINETIC PROCESS,4.2763e-05,-0.29409,-0.38305,1,0
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00017019,-0.29424,-0.29541,1,0
6,GO DETOXIFICATION,0.00051151,-0.29428,-0.27511,1,0
6,GO LIPOXYGENASE PATHWAY,0.0172,-0.29435,-0.2752,1,0
6,GO OOCYTE DIFFERENTIATION,0.00015974,-0.29436,-0.36965,1,0
6,GO RETINA HOMEOSTASIS,4.2763e-05,-0.2944,-0.3166,1,0
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,1.4947e-05,-0.29466,-0.3766,1,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.00010181,-0.29469,-0.34125,1,0
6,GO RESPONSE TO CHEMOKINE,0.025096,-0.29486,-0.42343,1,0
6,GO RNA MODIFICATION,1.2939e-05,-0.29523,-0.36553,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.008797,-0.2953,-0.30458,1,0
6,GO HISTONE SERINE PHOSPHORYLATION,0.00010181,-0.29579,-0.35998,1,0
6,GO TRANSLESION SYNTHESIS,2.1347e-05,-0.2963,-0.36919,1,0
6,GO AMINO ACID ACTIVATION,3.248e-05,-0.2964,-0.35739,1,0
6,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.052482,-0.29641,-0.60317,1,0
6,GO PROSTANOID METABOLIC PROCESS,0.0003797,-0.29644,-0.40482,1,0
6,GO PROTEIN TARGETING TO MITOCHONDRION,1.0403e-05,-0.29659,-0.3318,1,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,2.4576e-05,-0.29787,-0.3201,1,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.2907e-05,-0.29842,-0.39283,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,5.337e-06,-0.29862,-0.33393,1,0
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00033648,-0.29919,-0.33628,1,0
6,GO REGULATION OF FEEDING BEHAVIOR,0.00031664,-0.29922,-0.30715,1,0
6,GO T CELL APOPTOTIC PROCESS,0.0027019,-0.29982,-0.45621,1,0
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,6.4139e-05,-0.29991,-0.3458,1,0
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.00068502,-0.30027,-0.29517,1,0
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,2.1347e-05,-0.30088,-0.38276,1,0
6,GO PHOTOTRANSDUCTION,4.9495e-06,-0.30095,-0.3702,1,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.00014062,-0.30106,-0.3126,1,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.0403e-05,-0.30132,-0.36168,1,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,8.3641e-05,-0.30142,-0.40427,1,0
6,GO GTP METABOLIC PROCESS,1.4947e-05,-0.30158,-0.35878,1,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,1.3909e-05,-0.30164,-0.34387,1,0
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,3.7287e-05,-0.30205,-0.4117,1,0
6,GO STARTLE RESPONSE,0.0038653,-0.30212,-0.40892,1,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.8267e-05,-0.30271,-0.37177,1,0
6,GO OOGENESIS,8.3641e-05,-0.30284,-0.36251,1,0
6,GO FEAR RESPONSE,4.5779e-05,-0.30286,-0.38182,1,0
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.050584,-0.30321,-0.22596,1,0
6,GO RNA INTERFERENCE,0.00014062,-0.30352,-0.37481,1,0
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0020776,-0.30361,-0.2567,1,0
6,GO NUCLEOSOME ASSEMBLY,0.00024771,-0.30362,-0.34464,1,0
6,GO MATURATION OF SSU RRNA,8.3641e-05,-0.30378,-0.30485,1,0
6,GO POSITIVE REGULATION OF CELL AGING,0.00086166,-0.30406,-0.26737,1,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.0012758,-0.30484,-0.33792,1,0
6,GO KINETOCHORE ASSEMBLY,0.0003797,-0.30487,-0.388,1,0
6,GO SIGNAL PEPTIDE PROCESSING,0.0012071,-0.30489,-0.3091,1,0
6,GO HEPATOCYTE DIFFERENTIATION,0.0017696,-0.30641,-0.32242,1,0
6,GO NUCLEOSIDE METABOLIC PROCESS,8.9843e-06,-0.3065,-0.33675,1,0
6,GO SNRNA PROCESSING,8.3641e-05,-0.30675,-0.35173,1,0
6,GO SNORNA METABOLIC PROCESS,0.00026348,-0.30682,-0.31871,1,0
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.0049572,-0.30717,-0.43028,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00020554,-0.30724,-0.35802,1,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,4.5891e-06,-0.30725,-0.32935,1,0
6,GO TRNA CATABOLIC PROCESS,0.00029789,-0.30727,-0.42163,1,0
6,GO HOMOLOGOUS RECOMBINATION,8.3641e-05,-0.30762,-0.40848,1,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.00081392,-0.30874,-0.32868,1,0
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.0038653,-0.30894,-0.45646,1,0
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,1.1191e-05,-0.30901,-0.40519,1,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,6.2007e-06,-0.30908,-0.3668,1,0
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0003797,-0.30918,-0.36492,1,0
6,GO PLASMA MEMBRANE FUSION,0.0016767,-0.3094,-0.3231,1,0
6,GO RNA METHYLATION,5.2428e-05,-0.30984,-0.3855,1,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,8.9843e-06,-0.30993,-0.35513,1,0
6,GO EMBRYONIC AXIS SPECIFICATION,1.2035e-05,-0.31032,-0.38668,1,0
6,GO TRIPARTITE REGIONAL SUBDIVISION,6.4139e-05,-0.31152,-0.36791,1,0
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.007293,-0.31157,-0.48181,1,0
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.31162,-0.37356,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00010866,-0.31229,-0.33461,1,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00012367,-0.31233,-0.39276,1,0
6,GO NUCLEOTIDE EXCISION REPAIR,2.4576e-05,-0.31241,-0.36964,1,0
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.012106,-0.31243,-0.24363,1,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.0011418,-0.31247,-0.37281,1,0
6,GO PROTEIN ADP RIBOSYLATION,5.6086e-05,-0.31257,-0.46619,1,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.00026348,-0.31272,-0.28938,1,0
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0054671,-0.31275,-0.29176,1,0
6,GO DNA REPLICATION INITIATION,0.00017019,-0.3131,-0.34658,1,0
6,GO ETHANOL METABOLIC PROCESS,0.00057531,-0.31345,-0.42917,1,0
6,GO MRNA METABOLIC PROCESS,2.1347e-05,-0.31354,-0.33089,1,0
6,GO METHIONINE METABOLIC PROCESS,0.00010181,-0.31362,-0.35137,1,0
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,8.9843e-06,-0.31393,-0.35809,1,0
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00068502,-0.31424,-0.38302,1,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,1.2035e-05,-0.31439,-0.39472,1,0
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.038848,-0.31512,-0.40784,1,0
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00012367,-0.31518,-0.28731,1,0
6,GO DORSAL SPINAL CORD DEVELOPMENT,0.00048214,-0.31534,-0.44354,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0047188,-0.31548,-0.31529,1,0
6,GO PEROXISOME ORGANIZATION,2.4576e-05,-0.31553,-0.34911,1,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,7.1973e-06,-0.3156,-0.33907,1,0
6,GO GLYCOSIDE METABOLIC PROCESS,5.2428e-05,-0.31565,-0.35384,1,0
6,GO SNRNA METABOLIC PROCESS,3.4805e-05,-0.31566,-0.34739,1,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.6059e-05,-0.3157,-0.36787,1,0
6,GO MUSCLE FILAMENT SLIDING,0.00012367,-0.31606,-0.32048,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0057394,-0.31628,-0.27105,1,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0044907,-0.31633,-0.25603,1,0
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00035748,-0.31646,-0.39254,1,0
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00017019,-0.31686,-0.36775,1,0
6,GO EATING BEHAVIOR,0.0036751,-0.31701,-0.32736,1,0
6,GO POLYAMINE METABOLIC PROCESS,0.00012367,-0.31713,-0.33733,1,0
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,5.7533e-06,-0.31715,-0.37098,1,0
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,8.3641e-05,-0.31729,-0.40912,1,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.248e-05,-0.31746,-0.41961,1,0
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0076456,-0.31779,-0.29501,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.9985e-05,-0.31781,-0.39252,1,0
6,GO SALIVA SECRETION,0.011063,-0.31843,-0.2692,1,0
6,GO MEIOTIC CELL CYCLE PROCESS,6.4139e-05,-0.31915,-0.40509,1,0
6,GO RESPONSE TO NITROSATIVE STRESS,0.00014062,-0.31918,-0.28678,1,0
6,GO CELL CELL RECOGNITION,0.00048214,-0.31938,-0.31698,1,0
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,5.2428e-05,-0.31946,-0.3581,1,0
6,GO ETHANOL OXIDATION,0.0083971,-0.31974,-0.4388,1,0
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00040321,-0.3199,-0.36207,1,0
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0021907,-0.32046,-0.30207,1,0
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,2.4576e-05,-0.32072,-0.3812,1,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.00035748,-0.32149,-0.38207,1,0
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00068502,-0.32207,-0.32686,1,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.00031664,-0.32238,-0.33565,1,0
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00332,-0.32242,-0.39167,1,0
6,GO REGULATION OF CHROMOSOME SEPARATION,3.0304e-05,-0.32247,-0.42575,1,0
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.7249e-05,-0.32269,-0.41157,1,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.015104,-0.32339,-0.45812,1,0
6,GO CELLULAR OXIDANT DETOXIFICATION,0.00029789,-0.32349,-0.29717,1,0
6,GO RESPONSE TO INTERLEUKIN 12,1.8524e-05,-0.32392,-0.38587,1,0
6,GO ATP METABOLIC PROCESS,5.7533e-06,-0.32418,-0.34384,1,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00081392,-0.32421,-0.36379,1,0
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00020554,-0.32421,-0.26559,1,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00011593,-0.32438,-0.38899,1,0
6,GO REGULATION OF SPINDLE CHECKPOINT,0.00015974,-0.32475,-0.3847,1,0
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.1347e-05,-0.32486,-0.39871,1,0
6,GO SECRETION BY TISSUE,0.00011593,-0.32556,-0.33272,1,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,9.5377e-05,-0.32586,-0.40336,1,0
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,1.9888e-05,-0.32619,-0.37826,1,0
6,GO ACROSOME REACTION,0.00076864,-0.32626,-0.39143,1,0
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,7.8298e-05,-0.32747,-0.42109,1,0
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.9888e-05,-0.32756,-0.37639,1,0
6,GO RRNA CATABOLIC PROCESS,3.9936e-05,-0.32763,-0.43345,1,0
6,GO NADPH REGENERATION,5.2428e-05,-0.32784,-0.40508,1,0
6,GO ESTROGEN METABOLIC PROCESS,2.2907e-05,-0.32821,-0.33628,1,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,8.9843e-06,-0.32884,-0.3411,1,0
6,GO DNA STRAND ELONGATION,0.00012367,-0.32921,-0.3799,1,0
6,GO REGULATION OF PROTON TRANSPORT,5.6086e-05,-0.32978,-0.38335,1,0
6,GO INTRACILIARY RETROGRADE TRANSPORT,0.0014241,-0.32997,-0.39631,1,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.33003,-0.35718,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0076456,-0.33009,-0.34658,1,0
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.00076864,-0.33045,-0.38251,1,0
6,GO MONONUCLEAR CELL MIGRATION,0.0083971,-0.33113,-0.47752,1,0
6,GO DNA DEAMINATION,0.017954,-0.33138,-0.33625,1,0
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,2.636e-05,-0.33149,-0.37596,1,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,9.6689e-06,-0.33215,-0.35023,1,0
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.1347e-05,-0.3324,-0.4095,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0003797,-0.33242,-0.30527,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00086166,-0.33247,-0.45383,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.01266,-0.33281,-0.38671,1,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,1.6059e-05,-0.33284,-0.38723,1,0
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00020554,-0.33317,-0.38732,1,0
6,GO CELL KILLING,0.0080134,-0.33332,-0.39812,1,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,3.4805e-05,-0.33385,-0.34793,1,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.00033648,-0.33387,-0.31003,1,0
6,GO REGULATION OF HELICASE ACTIVITY,0.00051151,-0.33387,-0.32802,1,0
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,7.8298e-05,-0.33389,-0.38881,1,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00026348,-0.3344,-0.37359,1,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,5.7533e-06,-0.33445,-0.37119,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00091199,-0.33446,-0.51279,1,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00031664,-0.33449,-0.36843,1,0
6,GO MATURATION OF 5 8S RRNA,0.00019306,-0.33459,-0.32392,1,0
6,GO CIRCADIAN SLEEP WAKE CYCLE,9.5377e-05,-0.33465,-0.3842,1,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,7.7514e-06,-0.33481,-0.38712,1,0
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,3.4805e-05,-0.33485,-0.3575,1,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.9495e-06,-0.33502,-0.43392,1,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.00048214,-0.33558,-0.38033,1,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00068502,-0.33559,-0.51799,1,0
6,GO PEROXISOMAL TRANSPORT,2.2907e-05,-0.33576,-0.35007,1,0
6,GO MITOCHONDRION ORGANIZATION,4.9495e-06,-0.3359,-0.38473,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,4.2539e-06,-0.33595,-0.37079,1,0
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00068502,-0.33602,-0.352,1,0
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0020776,-0.33629,-0.37747,1,0
6,GO MITOCHONDRIAL TRANSPORT,8.3461e-06,-0.3365,-0.38646,1,0
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00011593,-0.33691,-0.2921,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.636e-05,-0.33714,-0.40669,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00020554,-0.33716,-0.51111,1,0
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.1191e-05,-0.33739,-0.45763,1,0
6,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00035748,-0.33751,-0.35272,1,0
6,GO RETINAL METABOLIC PROCESS,0.0096484,-0.33756,-0.3494,1,0
6,GO GERM CELL DEVELOPMENT,4.8997e-05,-0.33791,-0.37663,1,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,8.3641e-05,-0.33797,-0.32564,1,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00011593,-0.3384,-0.32598,1,0
6,GO REGULATION OF TRANSLATIONAL FIDELITY,5.9985e-05,-0.33852,-0.34823,1,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00064645,-0.33884,-0.34624,1,0
6,GO MIDDLE EAR MORPHOGENESIS,0.00068502,-0.33896,-0.34694,1,0
6,GO EPOXYGENASE P450 PATHWAY,0.030713,-0.33897,-0.20773,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.33944,-0.37227,1,0
6,GO PROTEIN HETEROTETRAMERIZATION,1.4947e-05,-0.33978,-0.43786,1,0
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0015882,-0.33991,-0.34752,1,0
6,GO INTERSTRAND CROSS LINK REPAIR,0.00010866,-0.33992,-0.38758,1,0
6,GO NEUTROPHIL MIGRATION,0.010101,-0.34012,-0.46194,1,0
6,GO FEEDING BEHAVIOR,0.00076864,-0.34036,-0.3686,1,0
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,1.7249e-05,-0.34037,-0.42596,1,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012071,-0.34045,-0.47311,1,0
6,GO POSITIVE REGULATION OF CELL KILLING,0.017954,-0.34054,-0.42348,1,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,4.5779e-05,-0.34072,-0.38857,1,0
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0003797,-0.34089,-0.37777,1,0
6,GO MYOBLAST MIGRATION,0.0028457,-0.34108,-0.35214,1,0
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.011063,-0.34136,-0.35706,1,0
6,GO DETECTION OF LIGHT STIMULUS,4.5891e-06,-0.34171,-0.38014,1,0
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00076864,-0.34178,-0.3904,1,0
6,GO MEIOTIC CELL CYCLE,2.636e-05,-0.34184,-0.43314,1,0
6,GO SPERMATID DIFFERENTIATION,0.00010866,-0.34197,-0.35586,1,0
6,GO POSITIVE REGULATION OF FERTILIZATION,8.3641e-05,-0.34243,-0.3752,1,0
6,GO SNRNA TRANSCRIPTION,4.8997e-05,-0.3425,-0.39622,1,0
6,GO METAPHASE PLATE CONGRESSION,3.248e-05,-0.34306,-0.4322,1,0
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00096503,-0.34307,-0.38345,1,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,2.2907e-05,-0.34324,-0.37601,1,0
6,GO MITOCHONDRIAL DNA REPLICATION,6.6813e-06,-0.34338,-0.42324,1,0
6,GO RESPONSE TO UV C,1.9888e-05,-0.34412,-0.48606,1,0
6,GO BASE EXCISION REPAIR,2.636e-05,-0.34433,-0.38582,1,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,4.2763e-05,-0.34458,-0.34448,1,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.007293,-0.34517,-0.33526,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0066311,-0.34533,-0.46993,1,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0014241,-0.34539,-0.27463,1,0
6,GO BICARBONATE TRANSPORT,0.00011593,-0.34548,-0.37536,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1.8524e-05,-0.34583,-0.35269,1,0
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,2.1347e-05,-0.3459,-0.4498,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0011418,-0.34597,-0.42197,1,0
6,GO DNA DOUBLE STRAND BREAK PROCESSING,3.248e-05,-0.34611,-0.45299,1,0
6,GO PHOTORECEPTOR CELL DEVELOPMENT,3.0304e-05,-0.34643,-0.3935,1,0
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.050584,-0.34664,-0.46741,1,0
6,GO PEPTIDYL ARGININE METHYLATION,3.4805e-05,-0.34668,-0.40191,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1.3909e-05,-0.34668,-0.35731,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,9.5377e-05,-0.3475,-0.3678,1,0
6,GO PH REDUCTION,9.6689e-06,-0.34752,-0.41698,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,4.2763e-05,-0.348,-0.44849,1,0
6,GO DENDRITIC CELL CHEMOTAXIS,0.020391,-0.34823,-0.5174,1,0
6,GO MULTIVESICULAR BODY SORTING PATHWAY,1.1191e-05,-0.34863,-0.40119,1,0
6,GO LIPID DIGESTION,0.041938,-0.34867,-0.27874,1,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00026348,-0.34877,-0.40277,1,0
6,GO NUCLEAR CHROMOSOME SEGREGATION,2.636e-05,-0.3489,-0.42777,1,0
6,GO TERPENOID METABOLIC PROCESS,2.8267e-05,-0.349,-0.37423,1,0
6,GO NODAL SIGNALING PATHWAY,2.8267e-05,-0.34953,-0.34765,1,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,1.9888e-05,-0.34982,-0.43703,1,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,1.3909e-05,-0.35063,-0.39594,1,0
6,GO DETECTION OF VISIBLE LIGHT,6.2007e-06,-0.35065,-0.36916,1,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0080134,-0.35096,-0.43815,1,0
6,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0054671,-0.35106,-0.35607,1,0
6,GO SPERM CAPACITATION,0.0025648,-0.35112,-0.25841,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.013235,-0.35114,-0.48089,1,0
6,GO REGULATION OF BEHAVIOR,3.4805e-05,-0.35166,-0.40603,1,0
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0049572,-0.35207,-0.52589,1,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0029965,-0.35239,-0.40001,1,0
6,GO GLUTATHIONE METABOLIC PROCESS,4.8997e-05,-0.35247,-0.33403,1,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.013834,-0.35259,-0.39317,1,0
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00010181,-0.35259,-0.34807,1,0
6,GO NEUTROPHIL CHEMOTAXIS,0.014457,-0.35271,-0.45844,1,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0003797,-0.35287,-0.35028,1,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,9.5377e-05,-0.35345,-0.38125,1,0
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,5.9985e-05,-0.3535,-0.39997,1,0
6,GO LYMPHOCYTE CHEMOTAXIS,0.028348,-0.35353,-0.4617,1,0
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,4.2763e-05,-0.35384,-0.48404,1,0
6,GO MUSCLE CELL FATE COMMITMENT,6.4139e-05,-0.35432,-0.40998,1,0
6,GO ALPHA BETA T CELL PROLIFERATION,0.010101,-0.35432,-0.5428,1,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0018673,-0.35439,-0.40273,1,0
6,GO CHROMATIN SILENCING AT TELOMERE,0.00086166,-0.35441,-0.35211,1,0
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,4.8997e-05,-0.35449,-0.37728,1,0
6,GO OOCYTE MATURATION,7.3279e-05,-0.3546,-0.40335,1,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00033648,-0.35466,-0.50617,1,0
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00042807,-0.35468,-0.36825,1,0
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00015974,-0.35472,-0.48817,1,0
6,GO MYELOID LEUKOCYTE MIGRATION,0.00068502,-0.35472,-0.50577,1,0
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0021907,-0.35478,-0.62195,1,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.6086e-05,-0.35492,-0.50522,1,0
6,GO ISOPRENOID METABOLIC PROCESS,2.1347e-05,-0.35519,-0.36491,1,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.2035e-05,-0.35564,-0.4292,1,0
6,GO RNA PROCESSING,1.7249e-05,-0.35576,-0.37954,1,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,1.2939e-05,-0.35587,-0.40473,1,0
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,1.2035e-05,-0.35629,-0.35649,1,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00096503,-0.35643,-0.32238,1,0
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00031664,-0.35649,-0.44992,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.030713,-0.35718,-0.43434,1,0
6,GO INTERFERON GAMMA PRODUCTION,0.0047188,-0.35735,-0.51641,1,0
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,9.5377e-05,-0.35735,-0.38149,1,0
6,GO AMINE METABOLIC PROCESS,2.636e-05,-0.3574,-0.33991,1,0
6,GO CHROMOSOME SEGREGATION,2.636e-05,-0.35757,-0.42631,1,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,6.6813e-06,-0.35766,-0.41198,1,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00015974,-0.35783,-0.45505,1,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00011593,-0.35811,-0.50083,1,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,2.4576e-05,-0.35813,-0.43735,1,0
6,GO TOLERANCE INDUCTION,0.019548,-0.35815,-0.61423,1,0
6,GO CELL CYCLE G2 M PHASE TRANSITION,1.2939e-05,-0.35856,-0.42335,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0092139,-0.35891,-0.48546,1,0
6,GO REGULATION OF MRNA BINDING,0.00012367,-0.35901,-0.38142,1,0
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,2.2907e-05,-0.35921,-0.41946,1,0
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,7.3279e-05,-0.35923,-0.36825,1,0
6,GO NUCLEOTIDE SALVAGE,0.00029789,-0.35981,-0.33128,1,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015882,-0.35982,-0.57098,1,0
6,GO KERATINOCYTE DIFFERENTIATION,0.00035748,-0.35984,-0.35245,1,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0021907,-0.36,-0.41737,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0016767,-0.3601,-0.30934,1,0
6,GO ONE CARBON METABOLIC PROCESS,7.1973e-06,-0.36028,-0.38591,1,0
6,GO GLUTAMATE METABOLIC PROCESS,3.248e-05,-0.36043,-0.42198,1,0
6,GO TRANSCRIPTION BY RNA POLYMERASE III,9.6689e-06,-0.36051,-0.40599,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.36129,-0.42646,1,0
6,GO PROSTATE GLAND GROWTH,0.00068502,-0.36147,-0.30953,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.01266,-0.3616,-0.49084,1,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.36168,-0.57525,1,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,7.3279e-05,-0.36169,-0.42029,1,0
6,GO NEGATIVE REGULATION OF DNA BINDING,2.636e-05,-0.36183,-0.41554,1,0
6,GO INTERLEUKIN 10 PRODUCTION,0.006955,-0.36193,-0.53173,1,0
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.337e-06,-0.36206,-0.38131,1,0
6,GO EXPLORATION BEHAVIOR,0.00035748,-0.36227,-0.43786,1,0
6,GO ACUTE PHASE RESPONSE,0.0010798,-0.36303,-0.43046,1,0
6,GO REGULATION OF CELLULAR RESPIRATION,8.3461e-06,-0.36327,-0.41591,1,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00076864,-0.36336,-0.45099,1,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0083971,-0.36363,-0.52821,1,0
6,GO DNA PACKAGING,2.8267e-05,-0.36371,-0.44189,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017954,-0.36426,-0.48419,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,7.7514e-06,-0.36438,-0.42728,1,0
6,GO AMINE CATABOLIC PROCESS,0.00057531,-0.36449,-0.39889,1,0
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,3.9422e-06,-0.36485,-0.40731,1,0
6,GO REGULATION OF CENTROSOME DUPLICATION,2.2907e-05,-0.36508,-0.45639,1,0
6,GO RESPONSE TO NITRIC OXIDE,0.00014062,-0.36528,-0.43965,1,0
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00010866,-0.36529,-0.33635,1,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00081392,-0.36579,-0.53045,1,0
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0024341,-0.36596,-0.48033,1,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.6086e-05,-0.36607,-0.44304,1,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0019699,-0.36609,-0.53796,1,0
6,GO ARACHIDONIC ACID METABOLIC PROCESS,6.4139e-05,-0.36628,-0.43032,1,0
6,GO REGULATION OF TRANSLATIONAL INITIATION,1.2939e-05,-0.36665,-0.42687,1,0
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,4.8997e-05,-0.36674,-0.42179,1,0
6,GO PROTEIN LOCALIZATION TO ORGANELLE,6.2007e-06,-0.36711,-0.40698,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.4947e-05,-0.36722,-0.42535,1,0
6,GO REGULATION OF NUCLEASE ACTIVITY,0.00042807,-0.36738,-0.38016,1,0
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0036751,-0.3674,-0.37836,1,0
6,GO NEURAL NUCLEUS DEVELOPMENT,7.3279e-05,-0.36749,-0.477,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.019548,-0.36757,-0.55125,1,0
6,GO ICOSANOID METABOLIC PROCESS,7.8298e-05,-0.36757,-0.40586,1,0
6,GO NEPHRON TUBULE FORMATION,0.00072571,-0.36787,-0.31783,1,0
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00081392,-0.36809,-0.36097,1,0
6,GO CHROMOSOME LOCALIZATION,1.8524e-05,-0.3681,-0.44975,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00028019,-0.36828,-0.45609,1,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,3.9422e-06,-0.36837,-0.38885,1,0
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.028348,-0.36845,-0.43626,1,0
6,GO CELLULAR KETONE METABOLIC PROCESS,4.2539e-06,-0.36891,-0.40988,1,0
6,GO REGULATION OF RNA BINDING,0.00012367,-0.369,-0.39766,1,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,5.7533e-06,-0.369,-0.40003,1,0
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00017019,-0.36902,-0.39076,1,0
6,GO EXIT FROM MITOSIS,1.4947e-05,-0.36911,-0.46919,1,0
6,GO INNATE IMMUNE RESPONSE,0.00020554,-0.36913,-0.50779,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010798,-0.36938,-0.54945,1,0
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,1.9888e-05,-0.36943,-0.444,1,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.00013188,-0.36947,-0.38108,1,0
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,8.3461e-06,-0.37024,-0.40056,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.0304e-05,-0.37035,-0.4078,1,0
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,8.9843e-06,-0.37036,-0.40773,1,0
6,GO RNA 3 END PROCESSING,3.4805e-05,-0.37036,-0.38832,1,0
6,GO SINGLE FERTILIZATION,7.3279e-05,-0.37039,-0.34791,1,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.37058,-0.40179,1,0
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0023095,-0.37098,-0.43032,1,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,1.0403e-05,-0.37105,-0.34596,1,0
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0096484,-0.37121,-0.43227,1,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.8565e-05,-0.37147,-0.42133,1,0
6,GO RESPONSE TO L GLUTAMATE,2.1347e-05,-0.3717,-0.43623,1,0
6,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00020554,-0.37188,-0.41389,1,0
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.010101,-0.37188,-0.27237,1,0
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.013834,-0.37197,-0.46695,1,0
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,8.3461e-06,-0.37205,-0.43885,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0047188,-0.37231,-0.43319,1,0
6,GO GRANULOCYTE MIGRATION,0.0047188,-0.37245,-0.48407,1,0
6,GO CILIUM MOVEMENT,0.00021879,-0.37262,-0.35986,1,0
6,GO TISSUE REGENERATION,0.00010181,-0.37289,-0.41018,1,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00018128,-0.37297,-0.40528,1,0
6,GO REGULATION OF EXIT FROM MITOSIS,2.8267e-05,-0.37305,-0.42883,1,0
6,GO INTRACILIARY TRANSPORT,0.00040321,-0.37307,-0.36266,1,0
6,GO RESPONSE TO INTERFERON GAMMA,0.0029965,-0.37321,-0.55364,1,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,5.337e-06,-0.37346,-0.38604,1,0
6,GO SPERM MOTILITY,0.00010181,-0.3735,-0.35177,1,0
6,GO MITOCHONDRION MORPHOGENESIS,1.7249e-05,-0.37353,-0.39697,1,0
6,GO REGULATION OF T CELL MIGRATION,0.0021907,-0.37384,-0.50657,1,0
6,GO NUCLEOSOME ORGANIZATION,3.7287e-05,-0.37405,-0.4074,1,0
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00010866,-0.37466,-0.39817,1,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00096503,-0.37488,-0.54455,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,3.248e-05,-0.37498,-0.36871,1,0
6,GO SKELETAL MUSCLE CELL PROLIFERATION,3.9936e-05,-0.37512,-0.40889,1,0
6,GO DENDRITIC CELL MIGRATION,0.015104,-0.37514,-0.53244,1,0
6,GO REGULATION OF ATPASE ACTIVITY,0.00012367,-0.37547,-0.3487,1,0
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00021879,-0.37568,-0.39357,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0012071,-0.37576,-0.51198,1,0
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.248e-05,-0.3758,-0.40585,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.8298e-05,-0.37592,-0.36827,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00010866,-0.37602,-0.44245,1,0
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,4.5779e-05,-0.37617,-0.38914,1,0
6,GO REGULATION OF TOLERANCE INDUCTION,0.024086,-0.37623,-0.59222,1,0
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.7249e-05,-0.37645,-0.40974,1,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,4.2763e-05,-0.37658,-0.39347,1,0
6,GO RESPONSE TO BACTERIUM,0.00011593,-0.3767,-0.48423,1,0
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.013834,-0.37683,-0.53954,1,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,1.4947e-05,-0.37684,-0.39451,1,0
6,GO RESPONSE TO TOXIC SUBSTANCE,1.3909e-05,-0.37694,-0.37933,1,0
6,GO DEFENSE RESPONSE TO BACTERIUM,0.0019699,-0.37699,-0.3976,1,0
6,GO SISTER CHROMATID SEGREGATION,2.8267e-05,-0.37704,-0.447,1,0
6,GO DNA CATABOLIC PROCESS,5.7533e-06,-0.37743,-0.4401,1,0
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.7249e-05,-0.3776,-0.40103,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00028019,-0.3777,-0.32634,1,0
6,GO COENZYME A METABOLIC PROCESS,1.0403e-05,-0.37781,-0.43278,1,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00024771,-0.37786,-0.53999,1,0
6,GO RESPONSE TO FUNGUS,0.0010798,-0.378,-0.38313,1,0
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,3.248e-05,-0.37801,-0.38561,1,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0011418,-0.37807,-0.5618,1,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.9495e-06,-0.37816,-0.42549,1,0
6,GO REGULATION OF OOGENESIS,3.4805e-05,-0.37819,-0.42183,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.0027019,-0.37821,-0.49057,1,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00072571,-0.37822,-0.53736,1,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,3.9936e-05,-0.37836,-0.45728,1,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.6813e-06,-0.37844,-0.4719,1,0
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0057394,-0.37851,-0.45531,1,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.0003797,-0.37858,-0.38769,1,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,1.6059e-05,-0.37863,-0.43134,1,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,9.5377e-05,-0.37873,-0.39993,1,0
6,GO SECONDARY METABOLIC PROCESS,1.4947e-05,-0.37874,-0.38083,1,0
6,GO PROTEIN AUTOPROCESSING,2.4576e-05,-0.37876,-0.40049,1,0
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00072571,-0.37887,-0.53441,1,0
6,GO MITOTIC SISTER CHROMATID SEGREGATION,3.7287e-05,-0.37897,-0.44216,1,0
6,GO MALE GAMETE GENERATION,2.636e-05,-0.37905,-0.39669,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0044907,-0.37918,-0.43221,1,0
6,GO HISTONE H3 K9 ACETYLATION,5.7533e-06,-0.37936,-0.46888,1,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00024771,-0.37939,-0.40965,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0083971,-0.37966,-0.53306,1,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072571,-0.37996,-0.35594,1,0
6,GO OXIDATIVE DEMETHYLATION,8.9327e-05,-0.38015,-0.41389,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,3.0304e-05,-0.38016,-0.40962,1,0
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.38017,-0.46127,1,0
6,GO HEART FIELD SPECIFICATION,0.00014989,-0.38026,-0.51254,1,0
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,4.5779e-05,-0.38033,-0.43274,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014241,-0.3806,-0.39532,1,0
6,GO DIGESTION,3.9936e-05,-0.38095,-0.35238,1,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.00010866,-0.38102,-0.42783,1,0
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.0025648,-0.38132,-0.31854,1,0
6,GO NCRNA TRANSCRIPTION,2.636e-05,-0.38155,-0.42728,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0013481,-0.38157,-0.50823,1,0
6,GO EXTRACELLULAR VESICLE BIOGENESIS,1.6059e-05,-0.38174,-0.48627,1,0
6,GO FERTILIZATION,3.7287e-05,-0.38175,-0.36146,1,0
6,GO NON MOTILE CILIUM ASSEMBLY,3.4805e-05,-0.38216,-0.45574,1,0
6,GO PROTEIN LOCALIZATION TO MEMBRANE,6.2007e-06,-0.38234,-0.39343,1,0
6,GO DETECTION OF STIMULUS,5.7533e-06,-0.38237,-0.38498,1,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,2.636e-05,-0.3825,-0.46356,1,0
6,GO OXIDATION REDUCTION PROCESS,4.5891e-06,-0.38258,-0.39295,1,0
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,3.4805e-05,-0.38293,-0.37207,1,0
6,GO RESPONSE TO MINERALOCORTICOID,8.9327e-05,-0.38305,-0.45904,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.4139e-05,-0.38324,-0.45555,1,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,5.7533e-06,-0.38326,-0.40882,1,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.7514e-06,-0.38341,-0.4222,1,0
6,GO TETRAPYRROLE METABOLIC PROCESS,8.3461e-06,-0.38355,-0.42099,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00091199,-0.38362,-0.51193,1,0
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,1.3909e-05,-0.38376,-0.41587,1,0
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,1.8524e-05,-0.38397,-0.4623,1,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,1.4947e-05,-0.38426,-0.39471,1,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0054671,-0.38452,-0.46275,1,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00026348,-0.38479,-0.32954,1,0
6,GO HISTONE PHOSPHORYLATION,8.3461e-06,-0.38519,-0.48934,1,0
6,GO REGULATION OF CELL KILLING,0.0060238,-0.38537,-0.49413,1,0
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00014989,-0.38539,-0.42231,1,0
6,GO CHEMOSENSORY BEHAVIOR,1.8524e-05,-0.38658,-0.42598,1,0
6,GO CYTIDINE TO URIDINE EDITING,0.043559,-0.38661,-0.40066,1,0
6,GO REGULATION OF CENTROSOME CYCLE,1.2035e-05,-0.38695,-0.46051,1,0
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00012367,-0.38697,-0.37492,1,0
6,GO FEMALE GAMETE GENERATION,1.2035e-05,-0.38713,-0.42986,1,0
6,GO REGULATION OF DOPAMINE SECRETION,0.0013481,-0.38725,-0.45589,1,0
6,GO NAD BIOSYNTHETIC PROCESS,0.00057531,-0.3874,-0.45215,1,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00020554,-0.38742,-0.44232,1,0
6,GO APOPTOTIC DNA FRAGMENTATION,1.0403e-05,-0.38763,-0.40213,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00031664,-0.3879,-0.45277,1,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,5.337e-06,-0.3881,-0.42292,1,0
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0047188,-0.38825,-0.40377,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.2428e-05,-0.38825,-0.44489,1,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00015974,-0.38837,-0.44509,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0076456,-0.38839,-0.51679,1,0
6,GO ATP TRANSPORT,7.8298e-05,-0.3884,-0.45159,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.0403e-05,-0.38849,-0.44327,1,0
6,GO PHOTORECEPTOR CELL MAINTENANCE,0.00014989,-0.38868,-0.33582,1,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0052065,-0.38892,-0.50179,1,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,2.4576e-05,-0.38895,-0.41123,1,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0019699,-0.38905,-0.49879,1,0
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,3.9936e-05,-0.38933,-0.43747,1,0
6,GO DNA DEPENDENT DNA REPLICATION,2.1347e-05,-0.38937,-0.44012,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.337e-06,-0.38947,-0.44175,1,0
6,GO INSEMINATION,0.00031664,-0.38957,-0.41525,1,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00081392,-0.38961,-0.52316,1,0
6,GO ACID SECRETION,5.6086e-05,-0.38965,-0.3727,1,0
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.248e-05,-0.38967,-0.45665,1,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,8.3641e-05,-0.38969,-0.56313,1,0
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,8.3641e-05,-0.38969,-0.42585,1,0
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00010181,-0.38973,-0.37531,1,0
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012071,-0.39009,-0.46183,1,0
6,GO POSTSYNAPSE ASSEMBLY,0.0031545,-0.3901,-0.49545,1,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,4.5891e-06,-0.3902,-0.41065,1,0
6,GO NEURON FATE COMMITMENT,0.0010798,-0.39051,-0.45358,1,0
6,GO ATP DEPENDENT CHROMATIN REMODELING,2.4576e-05,-0.39066,-0.41896,1,0
6,GO CHROMOSOME SEPARATION,1.9888e-05,-0.39079,-0.47626,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024771,-0.39089,-0.56189,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,1.7249e-05,-0.39102,-0.42562,1,0
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0027019,-0.39104,-0.40011,1,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0010798,-0.39116,-0.54357,1,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,7.3279e-05,-0.39127,-0.38781,1,0
6,GO HEME METABOLIC PROCESS,1.0403e-05,-0.39133,-0.42504,1,0
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,1.7249e-05,-0.39148,-0.41478,1,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,1.0403e-05,-0.39152,-0.45049,1,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,1.1191e-05,-0.39155,-0.4699,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0040644,-0.39158,-0.57797,1,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,4.2763e-05,-0.39166,-0.46179,1,0
6,GO MRNA SPLICE SITE SELECTION,0.00021879,-0.39167,-0.47342,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00060992,-0.39178,-0.628,1,0
6,GO FUCOSE METABOLIC PROCESS,1.6059e-05,-0.39184,-0.40961,1,0
6,GO LEUKOCYTE CHEMOTAXIS,0.00054254,-0.39184,-0.51377,1,0
6,GO STEROID ESTERIFICATION,0.00051151,-0.39199,-0.43203,1,0
6,GO LYSINE METABOLIC PROCESS,0.00045436,-0.39229,-0.37125,1,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,5.6086e-05,-0.39229,-0.47497,1,0
6,GO ALDITOL METABOLIC PROCESS,0.00010866,-0.3924,-0.37473,1,0
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00015974,-0.39252,-0.40504,1,0
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.012106,-0.3926,-0.43563,1,0
6,GO REGULATION OF HISTONE H4 ACETYLATION,9.6689e-06,-0.39285,-0.49905,1,0
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00031664,-0.39286,-0.39072,1,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.00011593,-0.39296,-0.41803,1,0
6,GO CARDIOLIPIN METABOLIC PROCESS,1.9888e-05,-0.39308,-0.41215,1,0
6,GO INTRACELLULAR PROTEIN TRANSPORT,6.2007e-06,-0.3931,-0.41772,1,0
6,GO RESPONSE TO BIOTIC STIMULUS,4.8997e-05,-0.39337,-0.49888,1,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0083971,-0.39343,-0.47927,1,0
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,6.8565e-05,-0.39351,-0.41524,1,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0012071,-0.39355,-0.5258,1,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00010866,-0.39396,-0.52557,1,0
6,GO INTERLEUKIN 5 PRODUCTION,0.0066311,-0.39466,-0.43226,1,0
6,GO MANNOSYLATION,2.8267e-05,-0.39483,-0.44344,1,0
6,GO GENITALIA MORPHOGENESIS,0.00031664,-0.39488,-0.41565,1,0
6,GO HUMORAL IMMUNE RESPONSE,0.0060238,-0.3949,-0.41735,1,0
6,GO RNA SPLICING,3.248e-05,-0.395,-0.39643,1,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,4.5779e-05,-0.39507,-0.46803,1,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,5.6086e-05,-0.39529,-0.39952,1,0
6,GO DNA REPLICATION CHECKPOINT,0.00021879,-0.39531,-0.4159,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,3.9422e-06,-0.3955,-0.43025,1,0
6,GO RESPONSE TO AMPHETAMINE,0.00018128,-0.39553,-0.36745,1,0
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00011593,-0.3958,-0.47659,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00042807,-0.39598,-0.54297,1,0
6,GO GLUTAMATE SECRETION,0.00057531,-0.39599,-0.49347,1,0
6,GO ETHANOL CATABOLIC PROCESS,0.00024771,-0.39609,-0.4178,1,0
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,6.6813e-06,-0.39613,-0.42648,1,0
6,GO REGULATION OF DNA BINDING,7.1973e-06,-0.39617,-0.4661,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0031545,-0.39641,-0.5527,1,0
6,GO CHROMATIN SILENCING,3.0304e-05,-0.39648,-0.44404,1,0
6,GO ESTABLISHMENT OF TISSUE POLARITY,4.5891e-06,-0.39664,-0.46594,1,0
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,3.9936e-05,-0.39719,-0.42582,1,0
6,GO CHROMOSOME CONDENSATION,5.6086e-05,-0.39725,-0.49215,1,0
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.050584,-0.39764,-0.38332,1,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,1.8524e-05,-0.39766,-0.411,1,0
6,GO LIPOPROTEIN METABOLIC PROCESS,7.7514e-06,-0.39766,-0.45765,1,0
6,GO HISTONE H2B UBIQUITINATION,4.5779e-05,-0.39798,-0.4595,1,0
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,7.1973e-06,-0.39812,-0.43322,1,0
6,GO TRIGLYCERIDE METABOLIC PROCESS,4.5891e-06,-0.39844,-0.46483,1,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0016767,-0.39932,-0.39661,1,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,0.00024771,-0.39943,-0.55217,1,0
6,GO REGULATION OF TRANSPOSITION,4.2763e-05,-0.39964,-0.45735,1,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,5.337e-06,-0.39975,-0.40422,1,0
6,GO T CELL MIGRATION,0.0021907,-0.39995,-0.57994,1,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,4.5779e-05,-0.39996,-0.56679,1,0
6,GO COBALAMIN METABOLIC PROCESS,3.248e-05,-0.40001,-0.43903,1,0
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.4805e-05,-0.40063,-0.44243,1,0
6,GO RESPONSE TO CADMIUM ION,2.636e-05,-0.40071,-0.43694,1,0
6,GO REGULATION OF CHROMOSOME SEGREGATION,2.1347e-05,-0.40108,-0.47214,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.6086e-05,-0.40131,-0.48937,1,0
6,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0042727,-0.40139,-0.5897,1,0
6,GO REGULATION OF MEMBRANE PERMEABILITY,1.2939e-05,-0.40145,-0.42119,1,0
6,GO THYROID GLAND DEVELOPMENT,3.0304e-05,-0.40151,-0.55393,1,0
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,2.4576e-05,-0.40152,-0.42464,1,0
6,GO SYMBIOTIC PROCESS,4.9495e-06,-0.40154,-0.42973,1,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00096503,-0.40155,-0.56585,1,0
6,GO CELL CYCLE DNA REPLICATION,5.2428e-05,-0.40171,-0.41882,1,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00051151,-0.40177,-0.30894,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.3461e-06,-0.40189,-0.45938,1,0
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.018736,-0.40196,-0.49616,1,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.2939e-05,-0.40196,-0.44179,1,0
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.021265,-0.40207,-0.6015,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.337e-06,-0.40249,-0.42381,1,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00051151,-0.40267,-0.55499,1,0
6,GO MEIOTIC CHROMOSOME SEPARATION,0.00010181,-0.40267,-0.50752,1,0
6,GO RESPONSE TO INTERLEUKIN 1,7.8298e-05,-0.40277,-0.43087,1,0
6,GO RESPONSE TO VITAMIN A,1.2035e-05,-0.40287,-0.39946,1,0
6,GO CYSTEINE METABOLIC PROCESS,0.00015974,-0.40316,-0.41319,1,0
6,GO CELLULAR RESPONSE TO ALKALOID,1.7249e-05,-0.40317,-0.42548,1,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,2.1347e-05,-0.4032,-0.45556,1,0
6,GO HORMONE CATABOLIC PROCESS,0.00026348,-0.40324,-0.38137,1,0
6,GO GRANULOCYTE CHEMOTAXIS,0.0052065,-0.40358,-0.47744,1,0
6,GO VITAMIN METABOLIC PROCESS,5.7533e-06,-0.40368,-0.42557,1,0
6,GO AMMONIUM ION METABOLIC PROCESS,0.00086166,-0.40371,-0.40724,1,0
6,GO NEURAL RETINA DEVELOPMENT,4.2763e-05,-0.40393,-0.45625,1,0
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0010798,-0.40394,-0.35701,1,0
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.0010209,-0.4041,-0.58958,1,0
6,GO ADHESION OF SYMBIONT TO HOST,0.0031545,-0.40427,-0.62663,1,0
6,GO GAMETE GENERATION,1.4947e-05,-0.40429,-0.42199,1,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,2.4576e-05,-0.4043,-0.55532,1,0
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,2.2907e-05,-0.40438,-0.42873,1,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00081392,-0.40468,-0.36064,1,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00057531,-0.40471,-0.41142,1,0
6,GO MRNA PROCESSING,2.4576e-05,-0.40478,-0.41585,1,0
6,GO ETHER METABOLIC PROCESS,1.0403e-05,-0.40481,-0.47645,1,0
6,GO DNA REPAIR,1.0403e-05,-0.40487,-0.4499,1,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,1.0403e-05,-0.40491,-0.43987,1,0
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,7.1973e-06,-0.40537,-0.45474,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.010101,-0.40538,-0.46228,1,0
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.9495e-06,-0.40549,-0.44921,1,0
6,GO TRANSPOSITION,3.7287e-05,-0.40551,-0.43402,1,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.6059e-05,-0.40578,-0.46908,1,0
6,GO MITOTIC RECOMBINATION,8.9327e-05,-0.40585,-0.45523,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00051151,-0.40585,-0.57292,1,0
6,GO NECROTIC CELL DEATH,2.1347e-05,-0.40589,-0.47858,1,0
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,3.9936e-05,-0.40595,-0.48798,1,0
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0013481,-0.406,-0.58016,1,0
6,GO INTERLEUKIN 2 PRODUCTION,0.00068502,-0.40613,-0.59325,1,0
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,8.3461e-06,-0.40623,-0.45037,1,0
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00020554,-0.40632,-0.45312,1,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.4064,-0.46605,1,0
6,GO INTERLEUKIN 4 PRODUCTION,0.0060238,-0.40659,-0.51435,1,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.8298e-05,-0.40665,-0.52828,1,0
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00017019,-0.4067,-0.33982,1,0
6,GO PHAGOSOME ACIDIFICATION,2.2907e-05,-0.40674,-0.43215,1,0
6,GO MRNA MODIFICATION,0.00024771,-0.40709,-0.38767,1,0
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0038653,-0.4071,-0.44965,1,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,-0.40712,-0.52927,1,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00012367,-0.4072,-0.57565,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00033648,-0.40728,-0.53467,1,0
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0052065,-0.40728,-0.49074,1,0
6,GO DENDRITE SELF AVOIDANCE,5.9985e-05,-0.40737,-0.49264,1,0
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,3.248e-05,-0.40743,-0.49948,1,0
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00068502,-0.40764,-0.42461,1,0
6,GO FATTY ACID METABOLIC PROCESS,5.337e-06,-0.40772,-0.43434,1,0
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,4.5779e-05,-0.40781,-0.39008,1,0
6,GO DEFENSE RESPONSE,3.7287e-05,-0.40784,-0.52069,1,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00332,-0.40818,-0.3883,1,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0010209,-0.40831,-0.42175,1,0
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,4.5891e-06,-0.40838,-0.43471,1,0
6,GO REGULATION OF T CELL ACTIVATION,0.00023283,-0.40856,-0.55894,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.3279e-05,-0.40892,-0.55275,1,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,5.6086e-05,-0.40892,-0.37207,1,0
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.5779e-05,-0.40909,-0.4579,1,0
6,GO REGULATION OF DENDRITE EXTENSION,0.00035748,-0.40929,-0.51057,1,0
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00020554,-0.4094,-0.41406,1,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,8.3461e-06,-0.40955,-0.43376,1,0
6,GO REGULATION OF HISTONE UBIQUITINATION,1.0403e-05,-0.40962,-0.48465,1,0
6,GO PROTEIN MANNOSYLATION,2.2907e-05,-0.40974,-0.47415,1,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,9.6689e-06,-0.40982,-0.43411,1,0
6,GO DNA RECOMBINATION,8.9843e-06,-0.40992,-0.46333,1,0
6,GO FAT CELL PROLIFERATION,2.2907e-05,-0.41,-0.4945,1,0
6,GO SENSORY PERCEPTION,5.7533e-06,-0.41008,-0.40895,1,0
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,6.8565e-05,-0.41013,-0.45289,1,0
6,GO TRANSITION METAL ION HOMEOSTASIS,2.2907e-05,-0.41014,-0.41448,1,0
6,GO CELLULAR DEFENSE RESPONSE,0.01266,-0.41016,-0.48165,1,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,7.1973e-06,-0.41019,-0.42981,1,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,1.7249e-05,-0.41022,-0.46908,1,0
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.00091199,-0.41026,-0.39022,1,0
6,GO ANDROGEN METABOLIC PROCESS,6.8565e-05,-0.41027,-0.36218,1,0
6,GO INTERLEUKIN 1 PRODUCTION,0.00068502,-0.41044,-0.54547,1,0
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0019699,-0.41066,-0.46955,1,0
6,GO DNA CONFORMATION CHANGE,1.3909e-05,-0.41072,-0.47132,1,0
6,GO BLASTOCYST DEVELOPMENT,4.9495e-06,-0.41082,-0.42055,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,9.6689e-06,-0.41088,-0.44419,1,0
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00023283,-0.41088,-0.4278,1,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00012367,-0.4111,-0.5522,1,0
6,GO NIK NF KAPPAB SIGNALING,2.1347e-05,-0.41134,-0.46739,1,0
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,1.8524e-05,-0.41134,-0.5346,1,0
6,GO T CELL PROLIFERATION,0.00057531,-0.41138,-0.55245,1,0
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.00014989,-0.41156,-0.36068,1,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,1.4947e-05,-0.41165,-0.44847,1,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,9.6689e-06,-0.41169,-0.47948,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.41195,-0.43737,1,0
6,GO POSITIVE REGULATION OF TRANSLATION,8.9843e-06,-0.41207,-0.41739,1,0
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0015041,-0.41222,-0.56033,1,0
6,GO PROTEIN FOLDING,3.9936e-05,-0.41225,-0.4154,1,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,3.248e-05,-0.41241,-0.46538,1,0
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0003797,-0.41248,-0.43714,1,0
6,GO HISTONE H2A UBIQUITINATION,1.9888e-05,-0.41256,-0.48465,1,0
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00018128,-0.41266,-0.34692,1,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,4.5779e-05,-0.41276,-0.46051,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0012758,-0.41279,-0.55537,1,0
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,8.3461e-06,-0.41283,-0.43688,1,0
6,GO PROTEIN MONOUBIQUITINATION,1.3909e-05,-0.41287,-0.48985,1,0
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.4947e-05,-0.41296,-0.42438,1,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00072571,-0.41307,-0.56386,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0020776,-0.41316,-0.56877,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00019306,-0.41361,-0.56772,1,0
6,GO ORGANELLE FISSION,1.0403e-05,-0.41361,-0.46918,1,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,3.4805e-05,-0.41368,-0.41719,1,0
6,GO AXONEME ASSEMBLY,0.0044907,-0.41377,-0.33854,1,0
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.030713,-0.41406,-0.38587,1,0
6,GO HEART INDUCTION,0.0020776,-0.4141,-0.42921,1,0
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00024771,-0.41412,-0.56835,1,0
6,GO RESPONSE TO AMINE,3.9936e-05,-0.41431,-0.40101,1,0
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,2.1347e-05,-0.41437,-0.45822,1,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,2.1347e-05,-0.41448,-0.48969,1,0
6,GO MISMATCH REPAIR,1.2035e-05,-0.41448,-0.46638,1,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,3.248e-05,-0.41467,-0.41028,1,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.9327e-05,-0.41479,-0.43806,1,0
6,GO PHOTOPERIODISM,0.00026348,-0.4148,-0.39882,1,0
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,7.1973e-06,-0.41514,-0.45217,1,0
6,GO CELL CYCLE PHASE TRANSITION,8.3461e-06,-0.41524,-0.45127,1,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.0403e-05,-0.41526,-0.41211,1,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,1.2939e-05,-0.4153,-0.40746,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.2763e-05,-0.41534,-0.54476,1,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0016767,-0.41584,-0.42009,1,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0052065,-0.41596,-0.49519,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00015974,-0.41613,-0.57994,1,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,4.5891e-06,-0.41614,-0.45117,1,0
6,GO NEURON FATE SPECIFICATION,0.0042727,-0.41622,-0.46288,1,0
6,GO ORGANIC ACID CATABOLIC PROCESS,5.7533e-06,-0.41652,-0.43716,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.8524e-05,-0.41655,-0.43931,1,0
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,5.9985e-05,-0.41666,-0.49375,1,0
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.9495e-06,-0.41688,-0.43665,1,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.8997e-05,-0.41704,-0.5404,1,0
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,5.6086e-05,-0.41755,-0.44066,1,0
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0029965,-0.41758,-0.39901,1,0
6,GO REGULATION OF IMMUNE RESPONSE,7.3279e-05,-0.41758,-0.54507,1,0
6,GO REGULATION OF GONAD DEVELOPMENT,1.2035e-05,-0.41771,-0.44496,1,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.0003797,-0.41778,-0.36504,1,0
6,GO NEGATIVE REGULATION OF GLIOGENESIS,4.2763e-05,-0.4178,-0.394,1,0
6,GO TRANSITION METAL ION TRANSPORT,7.7514e-06,-0.41783,-0.4325,1,0
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,1.7249e-05,-0.4179,-0.4784,1,0
6,GO SEXUAL REPRODUCTION,1.3909e-05,-0.41792,-0.42021,1,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0010209,-0.418,-0.55022,1,0
6,GO ACUTE INFLAMMATORY RESPONSE,0.00029789,-0.41801,-0.46633,1,0
6,GO METHYLATION,7.1973e-06,-0.4181,-0.46186,1,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,7.8298e-05,-0.4182,-0.53561,1,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00018128,-0.41822,-0.57279,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0066311,-0.41837,-0.5198,1,0
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00020554,-0.41839,-0.4174,1,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.038848,-0.41849,-0.48587,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.024086,-0.41855,-0.57656,1,0
6,GO ORGAN INDUCTION,6.8565e-05,-0.41868,-0.3883,1,0
6,GO RESPONSE TO PROTOZOAN,0.0066311,-0.41879,-0.53597,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014062,-0.41889,-0.57312,1,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,0.0021907,-0.41892,-0.47961,1,0
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.00014062,-0.41909,-0.47952,1,0
6,GO LEUKOCYTE CELL CELL ADHESION,0.00015974,-0.41914,-0.57381,1,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.4576e-05,-0.41917,-0.54468,1,0
6,GO RESPONSE TO DEXAMETHASONE,7.8298e-05,-0.41917,-0.42204,1,0
6,GO PROTEIN HETEROOLIGOMERIZATION,1.3909e-05,-0.41938,-0.47955,1,0
6,GO EPIDERMAL CELL DIFFERENTIATION,6.4139e-05,-0.41944,-0.40653,1,0
6,GO SMALL MOLECULE CATABOLIC PROCESS,6.2007e-06,-0.41946,-0.44259,1,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,1.1191e-05,-0.41947,-0.443,1,0
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00081392,-0.41955,-0.37427,1,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.3909e-05,-0.41965,-0.47972,1,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,5.337e-06,-0.4197,-0.44109,1,0
6,GO HISTONE H2A ACETYLATION,8.9327e-05,-0.41975,-0.4213,1,0
6,GO RECOMBINATIONAL REPAIR,2.2907e-05,-0.41986,-0.49161,1,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,8.3461e-06,-0.42032,-0.43114,1,0
6,GO THIOESTER METABOLIC PROCESS,4.5891e-06,-0.4204,-0.4325,1,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.013235,-0.42046,-0.33361,1,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00015974,-0.42052,-0.56344,1,0
6,GO ADAPTIVE IMMUNE RESPONSE,0.0016767,-0.42056,-0.57869,1,0
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,3.9936e-05,-0.4207,-0.4827,1,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0010798,-0.42084,-0.50434,1,0
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00017019,-0.42091,-0.3951,1,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0040644,-0.42107,-0.46827,1,0
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.9495e-06,-0.42134,-0.44592,1,0
6,GO EPIDERMIS DEVELOPMENT,2.1347e-05,-0.42138,-0.44678,1,0
6,GO MONOSACCHARIDE CATABOLIC PROCESS,1.3909e-05,-0.42144,-0.47043,1,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.00026348,-0.42161,-0.4281,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00018128,-0.42161,-0.57613,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,2.2907e-05,-0.42173,-0.48633,1,0
6,GO MYELOID LEUKOCYTE ACTIVATION,2.4576e-05,-0.4219,-0.53897,1,0
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00011593,-0.42211,-0.40508,1,0
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00045436,-0.42226,-0.45533,1,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,6.4139e-05,-0.42233,-0.47596,1,0
6,GO LINOLEIC ACID METABOLIC PROCESS,3.9936e-05,-0.42252,-0.48862,1,0
6,GO POTASSIUM ION HOMEOSTASIS,1.6059e-05,-0.42269,-0.48602,1,0
6,GO REGULATION OF MRNA METABOLIC PROCESS,1.4947e-05,-0.4231,-0.44287,1,0
6,GO PANCREATIC JUICE SECRETION,0.00029789,-0.42319,-0.45435,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00023283,-0.42334,-0.53979,1,0
6,GO HORMONE METABOLIC PROCESS,1.7249e-05,-0.42335,-0.39934,1,0
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00040321,-0.42362,-0.56543,1,0
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0016767,-0.42368,-0.47325,1,0
6,GO SYNAPTIC VESICLE TRANSPORT,4.2763e-05,-0.42371,-0.54049,1,0
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,2.1347e-05,-0.42395,-0.44648,1,0
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,7.7514e-06,-0.42399,-0.5088,1,0
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.1347e-05,-0.42417,-0.48196,1,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0092139,-0.42419,-0.48411,1,0
6,GO AUTOPHAGIC CELL DEATH,3.0304e-05,-0.42434,-0.45017,1,0
6,GO REGULATION OF DEFENSE RESPONSE,1.4947e-05,-0.42437,-0.51208,1,0
6,GO DOPAMINE METABOLIC PROCESS,9.5377e-05,-0.42473,-0.46367,1,0
6,GO RESPONSE TO INTERLEUKIN 18,0.0029965,-0.42494,-0.58906,1,0
6,GO EMBRYONIC PATTERN SPECIFICATION,8.3461e-06,-0.42498,-0.45184,1,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.2907e-05,-0.42502,-0.47177,1,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.7249e-05,-0.42504,-0.46809,1,0
6,GO BRAIN MORPHOGENESIS,1.1191e-05,-0.42534,-0.51711,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.337e-06,-0.42535,-0.47078,1,0
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00031664,-0.42563,-0.41741,1,0
6,GO ALPHA BETA T CELL ACTIVATION,0.00042807,-0.42582,-0.58086,1,0
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,5.337e-06,-0.42588,-0.52347,1,0
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00042807,-0.42594,-0.46628,1,0
6,GO T CELL ACTIVATION,0.00011593,-0.42604,-0.56811,1,0
6,GO MYOTUBE CELL DEVELOPMENT,1.2035e-05,-0.42614,-0.43333,1,0
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.248e-05,-0.42618,-0.45305,1,0
6,GO TONGUE MORPHOGENESIS,0.00068502,-0.42631,-0.3672,1,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.5891e-06,-0.42656,-0.45808,1,0
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,1.7249e-05,-0.4266,-0.52768,1,0
6,GO PROTEIN REFOLDING,0.00054254,-0.42669,-0.35761,1,0
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,7.8298e-05,-0.42679,-0.44475,1,0
6,GO PIGMENT METABOLIC PROCESS,6.2007e-06,-0.4269,-0.43868,1,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.0011418,-0.42699,-0.45194,1,0
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00023283,-0.427,-0.43163,1,0
6,GO SUPEROXIDE METABOLIC PROCESS,2.636e-05,-0.42702,-0.51707,1,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,8.9843e-06,-0.42714,-0.43142,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00017019,-0.42731,-0.57605,1,0
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00029789,-0.42738,-0.44071,1,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.4274,-0.48403,1,0
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,4.5891e-06,-0.42766,-0.45672,1,0
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.2539e-06,-0.42769,-0.51051,1,0
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,4.5891e-06,-0.4277,-0.48381,1,0
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,1.8524e-05,-0.42775,-0.44396,1,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,4.9495e-06,-0.42803,-0.44292,1,0
6,GO INTERLEUKIN 12 PRODUCTION,0.0049572,-0.42804,-0.52954,1,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,1.2035e-05,-0.4282,-0.42692,1,0
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,3.0304e-05,-0.4282,-0.44644,1,0
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,4.5891e-06,-0.42821,-0.44963,1,0
6,GO CYTOKINETIC PROCESS,9.6689e-06,-0.42845,-0.49546,1,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,8.9843e-06,-0.42877,-0.47806,1,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00064645,-0.42883,-0.57775,1,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.6059e-05,-0.42889,-0.41689,1,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.9985e-05,-0.42898,-0.37443,1,0
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00013188,-0.42907,-0.4455,1,0
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0013481,-0.42915,-0.36204,1,0
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,3.248e-05,-0.42917,-0.4746,1,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00015974,-0.42922,-0.56967,1,0
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00026348,-0.42927,-0.43331,1,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,8.3461e-06,-0.42935,-0.4243,1,0
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,2.8267e-05,-0.4294,-0.45038,1,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00020554,-0.42949,-0.40481,1,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00010866,-0.4297,-0.57398,1,0
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0019699,-0.42975,-0.45018,1,0
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,1.2939e-05,-0.4299,-0.50756,1,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.00048214,-0.43007,-0.4159,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00026348,-0.43027,-0.56243,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,7.7514e-06,-0.43036,-0.46108,1,0
6,GO LIVER REGENERATION,2.2907e-05,-0.43039,-0.42427,1,0
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,9.6689e-06,-0.43051,-0.4976,1,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.7287e-05,-0.43058,-0.49334,1,0
6,GO PYROPTOSIS,0.00028019,-0.4307,-0.42296,1,0
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.337e-06,-0.43082,-0.56043,1,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00017019,-0.43082,-0.52295,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.00019306,-0.43088,-0.41593,1,0
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,2.636e-05,-0.4309,-0.46763,1,0
6,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0019699,-0.43105,-0.57335,1,0
6,GO REGULATION OF EXOSOMAL SECRETION,1.8524e-05,-0.43115,-0.52067,1,0
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,9.6689e-06,-0.43122,-0.40658,1,0
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,5.6086e-05,-0.43128,-0.4622,1,0
6,GO PARENTAL BEHAVIOR,0.0063209,-0.43129,-0.45077,1,0
6,GO REGULATION OF MRNA PROCESSING,2.8267e-05,-0.43137,-0.47544,1,0
6,GO PIGMENT GRANULE LOCALIZATION,0.00010181,-0.43141,-0.421,1,0
6,GO CELLULAR LIPID CATABOLIC PROCESS,4.5891e-06,-0.43142,-0.49728,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00010866,-0.43143,-0.57454,1,0
6,GO EXTRACELLULAR TRANSPORT,0.00048214,-0.43151,-0.41723,1,0
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,4.2763e-05,-0.43156,-0.48725,1,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,4.8997e-05,-0.4316,-0.52897,1,0
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0012071,-0.43164,-0.53328,1,0
6,GO ACROSOME ASSEMBLY,0.00068502,-0.43167,-0.41293,1,0
6,GO CYTOKINE PRODUCTION,2.8267e-05,-0.43203,-0.55127,1,0
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00014989,-0.43206,-0.59115,1,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,5.6086e-05,-0.43207,-0.4721,1,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,0.00045436,-0.43219,-0.57366,1,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.5779e-05,-0.43238,-0.54723,1,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.9843e-06,-0.43244,-0.46705,1,0
6,GO REGULATION OF RNA SPLICING,1.6059e-05,-0.4325,-0.4614,1,0
6,GO REGULATION OF PH,5.7533e-06,-0.43266,-0.47923,1,0
6,GO DOPAMINE TRANSPORT,0.00091199,-0.43268,-0.45868,1,0
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0031545,-0.43272,-0.41384,1,0
6,GO ACETYL COA METABOLIC PROCESS,6.6813e-06,-0.43274,-0.515,1,0
6,GO CATECHOLAMINE METABOLIC PROCESS,5.9985e-05,-0.43274,-0.4576,1,0
6,GO DNA METABOLIC PROCESS,8.9843e-06,-0.43277,-0.45621,1,0
6,GO REGULATION OF SYNAPSE ASSEMBLY,9.6689e-06,-0.43283,-0.54574,1,0
6,GO SISTER CHROMATID COHESION,2.1347e-05,-0.43299,-0.49959,1,0
6,GO CENTROSOME SEPARATION,2.8267e-05,-0.43312,-0.48524,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.43314,-0.44855,1,0
6,GO DNA DEALKYLATION,9.6689e-06,-0.43356,-0.45818,1,0
6,GO REGULATION OF CELL ACTIVATION,6.8565e-05,-0.4336,-0.58437,1,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.9422e-06,-0.43365,-0.46167,1,0
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.4947e-05,-0.43372,-0.46071,1,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00014989,-0.4338,-0.40341,1,0
6,GO SYNAPTIC SIGNALING,1.9888e-05,-0.43388,-0.52531,1,0
6,GO CRISTAE FORMATION,2.636e-05,-0.434,-0.53138,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.9985e-05,-0.43402,-0.59948,1,0
6,GO RNA LOCALIZATION,2.4576e-05,-0.43407,-0.44373,1,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,-0.4341,-0.59197,1,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00029789,-0.43425,-0.4389,1,0
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00020554,-0.43427,-0.41622,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00054254,-0.4344,-0.50682,1,0
6,GO DNA MODIFICATION,6.2007e-06,-0.4344,-0.44794,1,0
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.4576e-05,-0.4345,-0.52052,1,0
6,GO POSITIVE REGULATION OF RNA SPLICING,3.9936e-05,-0.43453,-0.46126,1,0
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00019306,-0.43455,-0.45384,1,0
6,GO DETECTION OF BIOTIC STIMULUS,0.0018673,-0.43477,-0.51928,1,0
6,GO BLASTOCYST GROWTH,4.9495e-06,-0.43527,-0.49235,1,0
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,7.1973e-06,-0.4353,-0.45313,1,0
6,GO ACTIVATION OF IMMUNE RESPONSE,3.9936e-05,-0.43536,-0.54867,1,0
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0052065,-0.43542,-0.3878,1,0
6,GO POSITIVE REGULATION OF HORMONE SECRETION,1.6059e-05,-0.43546,-0.44693,1,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00011593,-0.43547,-0.55605,1,0
6,GO INFLAMMATORY RESPONSE,4.5779e-05,-0.43549,-0.55489,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00019306,-0.43559,-0.58406,1,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,4.2539e-06,-0.43575,-0.46159,1,0
6,GO VIRAL RELEASE FROM HOST CELL,1.0403e-05,-0.43586,-0.44824,1,0
6,GO MRNA 3 END PROCESSING,4.2763e-05,-0.43601,-0.43913,1,0
6,GO HISTONE UBIQUITINATION,1.8524e-05,-0.43604,-0.48527,1,0
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,2.4576e-05,-0.43607,-0.45629,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,2.636e-05,-0.43623,-0.48474,1,0
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.016475,-0.43655,-0.50044,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.2007e-06,-0.43667,-0.48087,1,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.7249e-05,-0.43686,-0.45372,1,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,3.7287e-05,-0.43701,-0.43323,1,0
6,GO ECTODERMAL PLACODE DEVELOPMENT,4.5779e-05,-0.43706,-0.41127,1,0
6,GO RNA EXPORT FROM NUCLEUS,2.4576e-05,-0.43732,-0.45291,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0023095,-0.43773,-0.58668,1,0
6,GO PROTEIN OXIDATION,5.6086e-05,-0.43791,-0.45434,1,0
6,GO COPPER ION TRANSPORT,8.3641e-05,-0.43792,-0.43182,1,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00012367,-0.43808,-0.60084,1,0
6,GO IMMUNE EFFECTOR PROCESS,2.8267e-05,-0.43823,-0.54853,1,0
6,GO RESPONSE TO VIRUS,8.3641e-05,-0.43823,-0.5153,1,0
6,GO GMP METABOLIC PROCESS,8.3461e-06,-0.43826,-0.44317,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.0403e-05,-0.43828,-0.43885,1,0
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,4.9495e-06,-0.43828,-0.44716,1,0
6,GO LYMPHOCYTE ACTIVATION,4.5779e-05,-0.43828,-0.57604,1,0
6,GO LEARNING,1.3909e-05,-0.4383,-0.51066,1,0
6,GO CYTOKINE METABOLIC PROCESS,7.8298e-05,-0.4383,-0.56127,1,0
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.337e-06,-0.43841,-0.49485,1,0
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,5.337e-06,-0.43871,-0.49956,1,0
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,5.337e-06,-0.43892,-0.45165,1,0
6,GO INTRACELLULAR TRANSPORT,6.2007e-06,-0.43894,-0.45808,1,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,0.00019306,-0.43896,-0.5609,1,0
6,GO MALE SEX DETERMINATION,4.8997e-05,-0.43896,-0.49101,1,0
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,8.3461e-06,-0.43898,-0.45939,1,0
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.018736,-0.43898,-0.52671,1,0
6,GO PROTEIN N LINKED GLYCOSYLATION,1.4947e-05,-0.43901,-0.43262,1,0
6,GO SENSORY PERCEPTION OF PAIN,7.1973e-06,-0.43908,-0.48766,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,6.2007e-06,-0.43927,-0.4796,1,0
6,GO NATURAL KILLER CELL ACTIVATION,0.00019306,-0.43929,-0.56603,1,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00015974,-0.43946,-0.5597,1,0
6,GO TOXIN METABOLIC PROCESS,5.6086e-05,-0.43947,-0.417,1,0
6,GO NEUROTRANSMITTER SECRETION,0.00029789,-0.43952,-0.54422,1,0
6,GO RESPONSE TO OXYGEN RADICAL,1.9888e-05,-0.43953,-0.42566,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,7.1973e-06,-0.43968,-0.49601,1,0
6,GO RRNA TRANSCRIPTION,9.6689e-06,-0.44004,-0.49115,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,3.248e-05,-0.44005,-0.49384,1,0
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,5.7533e-06,-0.44015,-0.48438,1,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,5.7533e-06,-0.4402,-0.5156,1,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,6.6813e-06,-0.44021,-0.49589,1,0
6,GO CELL CHEMOTAXIS,0.00017019,-0.44026,-0.54024,1,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,5.7533e-06,-0.44031,-0.44201,1,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.636e-05,-0.44031,-0.46798,1,0
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,1.0403e-05,-0.44032,-0.49157,1,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,5.7533e-06,-0.44032,-0.50274,1,0
6,GO IMMUNOGLOBULIN SECRETION,0.00086166,-0.44046,-0.48879,1,0
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,3.0304e-05,-0.4407,-0.45951,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,9.6689e-06,-0.44079,-0.45444,1,0
6,GO LEUKOCYTE PROLIFERATION,0.00024771,-0.44087,-0.56448,1,0
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00031664,-0.44095,-0.56197,1,0
6,GO CELL FATE SPECIFICATION,8.9843e-06,-0.44102,-0.49517,1,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014062,-0.44116,-0.45447,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0027019,-0.4412,-0.48127,1,0
6,GO RESPONSE TO ALKALOID,1.0403e-05,-0.4413,-0.46687,1,0
6,GO CELLULAR IRON ION HOMEOSTASIS,3.0304e-05,-0.44134,-0.42033,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE,2.2907e-05,-0.44176,-0.54559,1,0
6,GO NON CANONICAL WNT SIGNALING PATHWAY,4.5891e-06,-0.44176,-0.50534,1,0
6,GO IMP BIOSYNTHETIC PROCESS,0.007293,-0.44189,-0.36246,1,0
6,GO PRESYNAPSE ORGANIZATION,4.8997e-05,-0.44202,-0.51691,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024771,-0.44225,-0.51429,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE,6.6813e-06,-0.44235,-0.48176,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,1.2035e-05,-0.44241,-0.5114,1,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.8565e-05,-0.44252,-0.56964,1,0
6,GO NUCLEAR PORE ORGANIZATION,0.00029789,-0.44258,-0.47922,1,0
6,GO NEUTRAL LIPID METABOLIC PROCESS,4.5891e-06,-0.4426,-0.50898,1,0
6,GO REGULATION OF SENSORY PERCEPTION,1.9888e-05,-0.44263,-0.41388,1,0
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00028019,-0.44277,-0.50141,1,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,7.1973e-06,-0.44296,-0.45718,1,0
6,GO AXIS SPECIFICATION,8.9843e-06,-0.44307,-0.44776,1,0
6,GO LYMPHOCYTE MIGRATION,0.0023095,-0.44308,-0.54622,1,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,5.337e-06,-0.4431,-0.54257,1,0
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.7287e-05,-0.44314,-0.40526,1,0
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00045436,-0.4437,-0.47154,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,8.9327e-05,-0.4437,-0.55376,1,0
6,GO REGULATION OF ANIMAL ORGAN FORMATION,3.248e-05,-0.44379,-0.45502,1,0
6,GO PEPTIDYL CYSTEINE MODIFICATION,6.4139e-05,-0.4441,-0.43528,1,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,7.1973e-06,-0.44417,-0.4592,1,0
6,GO PROTEIN K48 LINKED UBIQUITINATION,7.1973e-06,-0.4442,-0.48465,1,0
6,GO TELOMERE ORGANIZATION,1.1191e-05,-0.44423,-0.4587,1,0
6,GO T CELL DIFFERENTIATION,6.4139e-05,-0.44423,-0.58701,1,0
6,GO CELLULAR RESPONSE TO UV,5.7533e-06,-0.44423,-0.47113,1,0
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,5.337e-06,-0.4444,-0.44919,1,0
6,GO DIGESTIVE SYSTEM PROCESS,2.2907e-05,-0.44443,-0.38708,1,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.00018128,-0.44443,-0.43577,1,0
6,GO CHEMOKINE PRODUCTION,0.00012367,-0.44444,-0.53623,1,0
6,GO CARNITINE METABOLIC PROCESS,0.00029789,-0.44455,-0.38619,1,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.7249e-05,-0.4447,-0.4293,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,2.2907e-05,-0.4447,-0.41187,1,0
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.7287e-05,-0.44489,-0.44381,1,0
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00014989,-0.4451,-0.37526,1,0
6,GO INTERACTION WITH SYMBIONT,3.9936e-05,-0.44515,-0.43797,1,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,5.9985e-05,-0.44522,-0.50719,1,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00091199,-0.44532,-0.39759,1,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.017954,-0.44543,-0.48637,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.6689e-06,-0.44553,-0.45474,1,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0038653,-0.44554,-0.49387,1,0
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.7249e-05,-0.4456,-0.47029,1,0
6,GO NEGATIVE REGULATION OF CELL KILLING,0.0083971,-0.44562,-0.63177,1,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00091199,-0.44597,-0.52283,1,0
6,GO URETER DEVELOPMENT,3.7287e-05,-0.4461,-0.48805,1,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,4.2539e-06,-0.44615,-0.49867,1,0
6,GO BILE ACID BIOSYNTHETIC PROCESS,1.1191e-05,-0.44617,-0.4428,1,0
6,GO MICROTUBULE SEVERING,0.00017019,-0.44624,-0.48067,1,0
6,GO CELL DIFFERENTIATION IN SPINAL CORD,1.9888e-05,-0.4463,-0.50556,1,0
6,GO DNA DEMETHYLATION,1.0403e-05,-0.44635,-0.48547,1,0
6,GO ORGANIC ACID METABOLIC PROCESS,4.9495e-06,-0.44635,-0.44867,1,0
6,GO VENTRAL SPINAL CORD DEVELOPMENT,1.8524e-05,-0.44645,-0.51121,1,0
6,GO CENTROSOME DUPLICATION,2.636e-05,-0.44653,-0.521,1,0
6,GO RESPONSE TO LEAD ION,6.2007e-06,-0.44654,-0.52848,1,0
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,2.1347e-05,-0.44663,-0.48415,1,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,0.00040321,-0.44666,-0.45747,1,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9936e-05,-0.44668,-0.43996,1,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,4.9495e-06,-0.44669,-0.46216,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0012758,-0.44677,-0.49991,1,0
6,GO REGULATION OF NUCLEAR DIVISION,8.9843e-06,-0.44681,-0.47132,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0017696,-0.44731,-0.52275,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,8.3461e-06,-0.4474,-0.59283,1,0
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,3.7287e-05,-0.44741,-0.43001,1,0
6,GO DORSAL VENTRAL PATTERN FORMATION,3.9936e-05,-0.44754,-0.46927,1,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.4476,-0.45655,1,0
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,1.4947e-05,-0.44781,-0.56651,1,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00060992,-0.44796,-0.44543,1,0
6,GO DIOL BIOSYNTHETIC PROCESS,8.9843e-06,-0.448,-0.51816,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.2007e-06,-0.44801,-0.49412,1,0
6,GO REGULATION OF CILIUM ASSEMBLY,2.636e-05,-0.4481,-0.4863,1,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,8.3461e-06,-0.44813,-0.41364,1,0
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0013481,-0.44814,-0.4865,1,0
6,GO REGULATION OF MITOTIC CELL CYCLE,7.1973e-06,-0.44846,-0.48367,1,0
6,GO G0 TO G1 TRANSITION,3.9936e-05,-0.44847,-0.47683,1,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00010866,-0.44847,-0.5543,1,0
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00033648,-0.44852,-0.51467,1,0
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,8.3461e-06,-0.44866,-0.47361,1,0
6,GO REGULATION OF LIPID TRANSPORT,9.6689e-06,-0.44869,-0.47386,1,0
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,7.3279e-05,-0.4487,-0.45143,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,2.4576e-05,-0.4487,-0.47251,1,0
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.337e-06,-0.44878,-0.492,1,0
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0017696,-0.44886,-0.44707,1,0
6,GO PROSTATE GLAND DEVELOPMENT,1.9888e-05,-0.44888,-0.50363,1,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,4.2539e-06,-0.44888,-0.4794,1,0
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,2.8267e-05,-0.44893,-0.55882,1,0
6,GO ZYMOGEN INHIBITION,0.0011418,-0.44895,-0.48062,1,0
6,GO SHORT TERM MEMORY,0.0003797,-0.44896,-0.47975,1,0
6,GO LIPID OXIDATION,4.5891e-06,-0.44898,-0.45889,1,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00013188,-0.44905,-0.48125,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION,9.5377e-05,-0.44919,-0.58837,1,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.6813e-06,-0.44933,-0.49114,1,0
6,GO REGULATION OF CELL CYCLE PROCESS,7.7514e-06,-0.44941,-0.48125,1,0
6,GO REFLEX,0.0031545,-0.44945,-0.45815,1,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00026348,-0.44948,-0.50692,1,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.44955,-0.51575,1,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00057531,-0.44972,-0.58751,1,0
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,7.1973e-06,-0.44982,-0.49203,1,0
6,GO MONOVALENT INORGANIC CATION TRANSPORT,8.3461e-06,-0.44986,-0.4588,1,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00017019,-0.44988,-0.56762,1,0
6,GO LEUKOCYTE TETHERING OR ROLLING,0.00020554,-0.45012,-0.54705,1,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,6.2007e-06,-0.45014,-0.48139,1,0
6,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0003797,-0.45017,-0.51066,1,0
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00048214,-0.45018,-0.45127,1,0
6,GO WALKING BEHAVIOR,9.6689e-06,-0.4503,-0.53615,1,0
6,GO AMINE TRANSPORT,0.00040321,-0.45043,-0.43727,1,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,1.1191e-05,-0.4507,-0.4493,1,0
6,GO UV DAMAGE EXCISION REPAIR,5.7533e-06,-0.45071,-0.52536,1,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,5.9985e-05,-0.45082,-0.65835,1,0
6,GO MACROMOLECULE CATABOLIC PROCESS,4.9495e-06,-0.45086,-0.46614,1,0
6,GO DETECTION OF ABIOTIC STIMULUS,5.7533e-06,-0.45092,-0.45781,1,0
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00010181,-0.45099,-0.55954,1,0
6,GO ZYMOGEN ACTIVATION,3.7287e-05,-0.45106,-0.55457,1,0
6,GO HISTONE MONOUBIQUITINATION,2.636e-05,-0.45116,-0.49952,1,0
6,GO REGULATION OF LYASE ACTIVITY,6.2007e-06,-0.45127,-0.47537,1,0
6,GO NEURAL TUBE PATTERNING,0.00011593,-0.4513,-0.45027,1,0
6,GO STEROL BIOSYNTHETIC PROCESS,5.7533e-06,-0.45144,-0.47011,1,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,5.337e-06,-0.45178,-0.49425,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,6.6813e-06,-0.4519,-0.47423,1,0
6,GO RESPONSE TO CORTICOSTEROID,1.7249e-05,-0.45192,-0.48407,1,0
6,GO POSITIVE REGULATION OF DNA BINDING,1.0403e-05,-0.45202,-0.4712,1,0
6,GO MYOBLAST PROLIFERATION,6.8565e-05,-0.45204,-0.45582,1,0
6,GO DNA REPLICATION,1.7249e-05,-0.4521,-0.47365,1,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.7514e-06,-0.45215,-0.45436,1,0
6,GO DOUBLE STRAND BREAK REPAIR,9.6689e-06,-0.45227,-0.50138,1,0
6,GO SUPEROXIDE ANION GENERATION,0.00018128,-0.45229,-0.53381,1,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.0403e-05,-0.45249,-0.53345,1,0
6,GO COCHLEA DEVELOPMENT,1.4947e-05,-0.45271,-0.50803,1,0
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,8.9843e-06,-0.45272,-0.51097,1,0
6,GO VACUOLAR ACIDIFICATION,7.1973e-06,-0.45272,-0.47772,1,0
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.4947e-05,-0.45277,-0.52936,1,0
6,GO CELL CYCLE PROCESS,8.3461e-06,-0.45289,-0.48798,1,0
6,GO STEROID METABOLIC PROCESS,5.337e-06,-0.45292,-0.46742,1,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,1.4947e-05,-0.45299,-0.46787,1,0
6,GO CELL DIVISION,1.0403e-05,-0.45299,-0.48294,1,0
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0031545,-0.45301,-0.5457,1,0
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00013188,-0.45323,-0.43676,1,0
6,GO HISTAMINE SECRETION,0.0038653,-0.45325,-0.37322,1,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,4.2539e-06,-0.45331,-0.44853,1,0
6,GO MITOTIC CELL CYCLE,8.9843e-06,-0.4534,-0.48615,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.8524e-05,-0.4534,-0.42021,1,0
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.3279e-05,-0.4534,-0.4954,1,0
6,GO BILE ACID METABOLIC PROCESS,1.3909e-05,-0.4534,-0.44053,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00029789,-0.45357,-0.59937,1,0
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,6.2007e-06,-0.45361,-0.49077,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00064645,-0.45362,-0.41044,1,0
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0020776,-0.45375,-0.60511,1,0
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0010798,-0.45387,-0.39979,1,0
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,7.7514e-06,-0.45393,-0.4598,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00035748,-0.45421,-0.53496,1,0
6,GO NEUROTRANSMITTER TRANSPORT,8.9327e-05,-0.45429,-0.53794,1,0
6,GO BLASTOCYST FORMATION,6.2007e-06,-0.45444,-0.46235,1,0
6,GO REGULATION OF CELL MATURATION,6.6813e-06,-0.45453,-0.46121,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00096503,-0.45463,-0.57128,1,0
6,GO RENAL ABSORPTION,0.00029789,-0.45464,-0.52379,1,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,7.3279e-05,-0.45467,-0.4416,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,1.0403e-05,-0.45491,-0.39959,1,0
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,2.636e-05,-0.45491,-0.49433,1,0
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,3.9422e-06,-0.45491,-0.51692,1,0
6,GO SYNAPTIC MEMBRANE ADHESION,6.4139e-05,-0.45493,-0.60775,1,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.5779e-05,-0.45497,-0.62256,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00010181,-0.45497,-0.45903,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00010181,-0.455,-0.55491,1,0
6,GO MACROPHAGE APOPTOTIC PROCESS,0.0052065,-0.45505,-0.36217,1,0
6,GO IRON ION TRANSPORT,1.2035e-05,-0.45511,-0.47074,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,7.8298e-05,-0.45514,-0.51568,1,0
6,GO PROTEIN O LINKED MANNOSYLATION,1.0403e-05,-0.45516,-0.51315,1,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,5.7533e-06,-0.45528,-0.47038,1,0
6,GO REGULATION OF STEROL TRANSPORT,9.6689e-06,-0.45532,-0.52873,1,0
6,GO REGULATION OF CELL AGING,6.6813e-06,-0.45534,-0.46785,1,0
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,2.2907e-05,-0.45548,-0.4401,1,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.9888e-05,-0.45553,-0.45264,1,0
6,GO CELLULAR MACROMOLECULE LOCALIZATION,6.2007e-06,-0.45558,-0.47901,1,0
6,GO NADH METABOLIC PROCESS,1.4947e-05,-0.45565,-0.52806,1,0
6,GO MITOTIC SISTER CHROMATID COHESION,3.7287e-05,-0.45569,-0.48411,1,0
6,GO MRNA CLEAVAGE,3.7287e-05,-0.4557,-0.47672,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00023283,-0.45577,-0.63604,1,0
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.8267e-05,-0.45583,-0.49747,1,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,2.636e-05,-0.45596,-0.47372,1,0
6,GO NERVOUS SYSTEM PROCESS,7.1973e-06,-0.45599,-0.46913,1,0
6,GO MULTI ORGANISM PROCESS,9.6689e-06,-0.4561,-0.44858,1,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.7287e-05,-0.45613,-0.44159,1,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7287e-05,-0.45629,-0.58428,1,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00019306,-0.45631,-0.5368,1,0
6,GO PROTEIN TRIMERIZATION,2.636e-05,-0.45633,-0.54814,1,0
6,GO MULTI ORGANISM LOCALIZATION,5.7533e-06,-0.45638,-0.49006,1,0
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.1191e-05,-0.45642,-0.44229,1,0
6,GO MULTICELLULAR ORGANISM REPRODUCTION,1.0403e-05,-0.45645,-0.44647,1,0
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,1.4947e-05,-0.45649,-0.48678,1,0
6,GO EMBRYONIC BRAIN DEVELOPMENT,0.00051151,-0.45655,-0.40136,1,0
6,GO INTERLEUKIN 8 PRODUCTION,0.00024771,-0.45656,-0.57107,1,0
6,GO MRNA EXPORT FROM NUCLEUS,2.636e-05,-0.4568,-0.47699,1,0
6,GO MICROTUBULE BASED MOVEMENT,3.7287e-05,-0.45686,-0.46623,1,0
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,4.5891e-06,-0.45694,-0.50232,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0054671,-0.45694,-0.48496,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.636e-05,-0.45703,-0.53331,1,0
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,1.9888e-05,-0.45704,-0.47556,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,7.7514e-06,-0.45708,-0.49722,1,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2428e-05,-0.45708,-0.59232,1,0
6,GO PEROXISOMAL MEMBRANE TRANSPORT,6.2007e-06,-0.45715,-0.49789,1,0
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,6.2007e-06,-0.45727,-0.49502,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0010798,-0.45747,-0.59171,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,4.8997e-05,-0.45766,-0.50637,1,0
6,GO TRANSCRIPTION BY RNA POLYMERASE I,5.7533e-06,-0.45771,-0.49543,1,0
6,GO DIET INDUCED THERMOGENESIS,6.8565e-05,-0.45784,-0.44862,1,0
6,GO REGULATION OF CENTRIOLE REPLICATION,2.2907e-05,-0.458,-0.50959,1,0
6,GO ESTABLISHMENT OF RNA LOCALIZATION,2.2907e-05,-0.45808,-0.47214,1,0
6,GO MATING,1.7249e-05,-0.45808,-0.47218,1,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,1.2035e-05,-0.45815,-0.51854,1,0
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.6059e-05,-0.45817,-0.46136,1,0
6,GO ACTIVATED T CELL PROLIFERATION,0.00013188,-0.45819,-0.53953,1,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.3909e-05,-0.45849,-0.5541,1,0
6,GO NUCLEUS ORGANIZATION,8.3461e-06,-0.45859,-0.49605,1,0
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.7533e-06,-0.4586,-0.48568,1,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00023283,-0.45874,-0.45147,1,0
6,GO RESPONSE TO ETHANOL,7.1973e-06,-0.45883,-0.43583,1,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,4.2763e-05,-0.45883,-0.52337,1,0
6,GO DE NOVO PROTEIN FOLDING,0.00054254,-0.45891,-0.41431,1,0
6,GO FLUID TRANSPORT,0.00013188,-0.459,-0.49124,1,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00031664,-0.45923,-0.57139,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,9.5377e-05,-0.45926,-0.39777,1,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,6.6813e-06,-0.45929,-0.47392,1,0
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.45933,-0.52643,1,0
6,GO PROTEIN MATURATION,4.9495e-06,-0.45951,-0.48211,1,0
6,GO FUCOSYLATION,5.7533e-06,-0.45955,-0.52817,1,0
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.5891e-06,-0.45975,-0.46165,1,0
6,GO PLASMINOGEN ACTIVATION,0.00021879,-0.45978,-0.56378,1,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,4.5891e-06,-0.45988,-0.55723,1,0
6,GO FATTY ACID CATABOLIC PROCESS,9.6689e-06,-0.45993,-0.45871,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.6059e-05,-0.46021,-0.55263,1,0
6,GO HEXOSE CATABOLIC PROCESS,9.6689e-06,-0.46022,-0.51831,1,0
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,3.4805e-05,-0.46028,-0.53839,1,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,1.9888e-05,-0.46031,-0.48909,1,0
6,GO DNA GEOMETRIC CHANGE,1.3909e-05,-0.46052,-0.48685,1,0
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,1.6059e-05,-0.46055,-0.50813,1,0
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0024341,-0.46055,-0.49543,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,5.9985e-05,-0.46068,-0.48693,1,0
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.2035e-05,-0.46073,-0.51653,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.1347e-05,-0.46095,-0.45096,1,0
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,6.2007e-06,-0.4612,-0.47586,1,0
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,1.2035e-05,-0.46121,-0.44722,1,0
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,4.2763e-05,-0.46132,-0.45201,1,0
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0019699,-0.46137,-0.57878,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0020776,-0.46138,-0.54938,1,0
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,4.9495e-06,-0.46176,-0.4897,1,0
6,GO RESPONSE TO LITHIUM ION,0.00026348,-0.46181,-0.42974,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,1.3909e-05,-0.46189,-0.47278,1,0
6,GO REGULATION OF CELL CYCLE ARREST,7.1973e-06,-0.46189,-0.49042,1,0
6,GO ACTIN NUCLEATION,6.2007e-06,-0.46193,-0.50225,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00033648,-0.46198,-0.56203,1,0
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.2035e-05,-0.4624,-0.49705,1,0
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,1.7249e-05,-0.4624,-0.44456,1,0
6,GO KETONE BIOSYNTHETIC PROCESS,1.4947e-05,-0.4624,-0.47116,1,0
6,GO MITOTIC NUCLEAR DIVISION,1.0403e-05,-0.46241,-0.49818,1,0
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00010181,-0.46249,-0.56597,1,0
6,GO METENCEPHALON DEVELOPMENT,7.7514e-06,-0.46257,-0.53134,1,0
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.6813e-06,-0.4626,-0.48129,1,0
6,GO TRIGLYCERIDE CATABOLIC PROCESS,3.4805e-05,-0.46266,-0.38975,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,5.7533e-06,-0.46282,-0.49212,1,0
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00026348,-0.46289,-0.50068,1,0
6,GO ARGININE METABOLIC PROCESS,1.0403e-05,-0.46296,-0.49414,1,0
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.00014989,-0.46315,-0.49382,1,0
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00086166,-0.46318,-0.52326,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00023283,-0.46326,-0.47323,1,0
6,GO HYPOTHALAMUS DEVELOPMENT,1.2939e-05,-0.46332,-0.48923,1,0
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,9.5377e-05,-0.46336,-0.51553,1,0
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,9.6689e-06,-0.46337,-0.51782,1,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,8.9843e-06,-0.46343,-0.45288,1,0
6,GO COPPER ION HOMEOSTASIS,9.6689e-06,-0.46359,-0.49533,1,0
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00026348,-0.464,-0.40348,1,0
6,GO DENDRITE EXTENSION,0.00014989,-0.46405,-0.51589,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0012758,-0.46405,-0.61368,1,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00011593,-0.46432,-0.56301,1,0
6,GO DETECTION OF OTHER ORGANISM,0.0020776,-0.46432,-0.56646,1,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00019306,-0.46436,-0.61108,1,0
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,6.8565e-05,-0.46436,-0.61328,1,0
6,GO RESPONSE TO NICOTINE,3.4805e-05,-0.46439,-0.4562,1,0
6,GO DICARBOXYLIC ACID TRANSPORT,3.248e-05,-0.46452,-0.48767,1,0
6,GO CELLULAR RESPONSE TO VIRUS,2.2907e-05,-0.46478,-0.52349,1,0
6,GO COCHLEA MORPHOGENESIS,1.0403e-05,-0.46512,-0.4706,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00014989,-0.46515,-0.48051,1,0
6,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00014062,-0.46525,-0.58603,1,0
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0076456,-0.46536,-0.45634,1,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,7.7514e-06,-0.46551,-0.49193,1,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.636e-05,-0.46553,-0.60745,1,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,6.6813e-06,-0.46562,-0.5539,1,0
6,GO REGULATION OF POTASSIUM ION TRANSPORT,1.3909e-05,-0.46563,-0.48854,1,0
6,GO CELL CYCLE,6.6813e-06,-0.46569,-0.49069,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,5.7533e-06,-0.4657,-0.50493,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0023095,-0.46571,-0.60126,1,0
6,GO ARACHIDONIC ACID SECRETION,1.6059e-05,-0.46572,-0.47972,1,0
6,GO CELLULAR RESPONSE TO RADIATION,5.7533e-06,-0.4659,-0.45361,1,0
6,GO POTASSIUM ION TRANSPORT,1.2939e-05,-0.46592,-0.4944,1,0
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.4576e-05,-0.46598,-0.58334,1,0
6,GO SKIN DEVELOPMENT,2.4576e-05,-0.46601,-0.46982,1,0
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.1347e-05,-0.46605,-0.56838,1,0
6,GO NCRNA CATABOLIC PROCESS,1.4947e-05,-0.4661,-0.46035,1,0
6,GO REGULATION OF CELL CELL ADHESION,3.4805e-05,-0.46631,-0.58765,1,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,8.9327e-05,-0.46637,-0.56062,1,0
6,GO FIBROBLAST APOPTOTIC PROCESS,3.4805e-05,-0.46646,-0.51212,1,0
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00060992,-0.46646,-0.51898,1,0
6,GO FEVER GENERATION,2.4576e-05,-0.46649,-0.47927,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,1.3909e-05,-0.46664,-0.48742,1,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.46665,-0.49903,1,0
6,GO FOLIC ACID METABOLIC PROCESS,1.2939e-05,-0.46673,-0.46448,1,0
6,GO STEROID CATABOLIC PROCESS,0.00064645,-0.46675,-0.43729,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.8565e-05,-0.46679,-0.5469,1,0
6,GO DETECTION OF CALCIUM ION,0.00017019,-0.46713,-0.444,1,0
6,GO RESPONSE TO UV,4.9495e-06,-0.46716,-0.50068,1,0
6,GO TYPE 2 IMMUNE RESPONSE,0.0015041,-0.46717,-0.54496,1,0
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0016767,-0.46723,-0.52024,1,0
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00048214,-0.46724,-0.40257,1,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,4.5891e-06,-0.46737,-0.47815,1,0
6,GO RESPONSE TO CAFFEINE,0.00013188,-0.46739,-0.44969,1,0
6,GO CHLORIDE TRANSPORT,6.2007e-06,-0.46743,-0.48758,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE,6.6813e-06,-0.46746,-0.51347,1,0
6,GO REGULATION OF PROTEIN ACETYLATION,3.9422e-06,-0.46752,-0.52202,1,0
6,GO CHROMATIN REMODELING,1.0403e-05,-0.4677,-0.50457,1,0
6,GO MITOTIC SPINDLE ASSEMBLY,6.8565e-05,-0.46773,-0.47227,1,0
6,GO CELLULAR PIGMENTATION,1.3909e-05,-0.46776,-0.42521,1,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,4.5891e-06,-0.46777,-0.53102,1,0
6,GO ALCOHOL CATABOLIC PROCESS,1.9888e-05,-0.46781,-0.46305,1,0
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,9.6689e-06,-0.46788,-0.48784,1,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.6059e-05,-0.46789,-0.55737,1,0
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,9.6689e-06,-0.46807,-0.445,1,0
6,GO MACROPHAGE MIGRATION,0.00051151,-0.46819,-0.54734,1,0
6,GO RESPONSE TO ELECTRICAL STIMULUS,1.9888e-05,-0.46822,-0.46185,1,0
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.3641e-05,-0.46826,-0.48264,1,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,4.5891e-06,-0.46829,-0.5065,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.9888e-05,-0.46832,-0.53924,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.7514e-06,-0.46835,-0.44477,1,0
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,2.1347e-05,-0.46837,-0.51392,1,0
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0036751,-0.46843,-0.52868,1,0
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00026348,-0.46844,-0.53085,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.7514e-06,-0.46845,-0.44555,1,0
6,GO IMMUNOGLOBULIN PRODUCTION,2.2907e-05,-0.46852,-0.55766,1,0
6,GO MITOTIC CYTOKINESIS,9.6689e-06,-0.46867,-0.51783,1,0
6,GO IRON ION HOMEOSTASIS,2.8267e-05,-0.46882,-0.45113,1,0
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00010181,-0.46886,-0.49697,1,0
6,GO STEROID BIOSYNTHETIC PROCESS,5.7533e-06,-0.46907,-0.45762,1,0
6,GO REGULATION OF HORMONE LEVELS,8.9843e-06,-0.46909,-0.46148,1,0
6,GO ORGANELLE ASSEMBLY,9.6689e-06,-0.46914,-0.48155,1,0
6,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.00010181,-0.46915,-0.435,1,0
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00014062,-0.46929,-0.48125,1,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,1.4947e-05,-0.46938,-0.50733,1,0
6,GO ALCOHOL METABOLIC PROCESS,4.5891e-06,-0.46948,-0.50012,1,0
6,GO ORGANELLE DISASSEMBLY,6.6813e-06,-0.46948,-0.50917,1,0
6,GO RESPONSE TO INTERLEUKIN 4,3.4805e-05,-0.46951,-0.52731,1,0
6,GO AMINE BIOSYNTHETIC PROCESS,0.00028019,-0.46954,-0.39505,1,0
6,GO REGULATION OF DNA REPAIR,1.2035e-05,-0.46963,-0.50072,1,0
6,GO C4 DICARBOXYLATE TRANSPORT,6.6813e-06,-0.4697,-0.49517,1,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,8.3461e-06,-0.46977,-0.50387,1,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.8997e-05,-0.46988,-0.52683,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.2939e-05,-0.46994,-0.57042,1,0
6,GO REGULATION OF MICROTUBULE BASED PROCESS,1.2035e-05,-0.46995,-0.51441,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00040321,-0.46997,-0.54011,1,0
6,GO RESPONSE TO X RAY,9.6689e-06,-0.47,-0.5376,1,0
6,GO MRNA TRANSPORT,2.4576e-05,-0.47004,-0.48368,1,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.337e-06,-0.47013,-0.4952,1,0
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,3.9936e-05,-0.47016,-0.54449,1,0
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.9936e-05,-0.47018,-0.52919,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0034935,-0.47041,-0.57712,1,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.3909e-05,-0.47043,-0.51191,1,0
6,GO LIPID CATABOLIC PROCESS,4.5891e-06,-0.47045,-0.49589,1,0
6,GO SINGLE STRAND BREAK REPAIR,1.0403e-05,-0.4705,-0.49603,1,0
6,GO PROTEIN TETRAMERIZATION,4.5891e-06,-0.47061,-0.48381,1,0
6,GO CELL CYCLE CHECKPOINT,1.0403e-05,-0.47062,-0.50175,1,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.00010866,-0.47071,-0.52043,1,0
6,GO MITOCHONDRIAL FUSION,0.00010181,-0.47097,-0.49356,1,0
6,GO IMPORT INTO NUCLEUS,4.5891e-06,-0.47098,-0.49159,1,0
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.2007e-06,-0.47101,-0.4788,1,0
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,9.6689e-06,-0.47108,-0.46761,1,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0019699,-0.47111,-0.5415,1,0
6,GO FEMALE GENITALIA DEVELOPMENT,2.1347e-05,-0.47133,-0.45796,1,0
6,GO HISTONE H3 K4 METHYLATION,1.3909e-05,-0.47136,-0.51621,1,0
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.00048214,-0.47141,-0.45308,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.7287e-05,-0.47141,-0.60393,1,0
6,GO REGULATION OF NEUROBLAST PROLIFERATION,3.248e-05,-0.47142,-0.48324,1,0
6,GO SUCKLING BEHAVIOR,5.9985e-05,-0.47146,-0.59247,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00024771,-0.47158,-0.75122,1,0
6,GO NUCLEAR TRANSPORT,5.7533e-06,-0.47167,-0.47893,1,0
6,GO ANIMAL ORGAN REGENERATION,1.3909e-05,-0.47169,-0.48222,1,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.00020554,-0.47188,-0.48261,1,0
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00011593,-0.47193,-0.47471,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.2035e-05,-0.47213,-0.47694,1,0
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,4.5891e-06,-0.47221,-0.48186,1,0
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00029789,-0.47225,-0.55695,1,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,2.2907e-05,-0.4723,-0.54792,1,0
6,GO HEAT GENERATION,8.3641e-05,-0.47236,-0.46033,1,0
6,GO PROGRAMMED NECROTIC CELL DEATH,2.4576e-05,-0.47239,-0.5311,1,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.7287e-05,-0.4724,-0.5201,1,0
6,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.026142,-0.47249,-0.72831,1,0
6,GO INNER DYNEIN ARM ASSEMBLY,0.0010209,-0.47273,-0.49061,1,0
6,GO TRANSPORT ALONG MICROTUBULE,2.8267e-05,-0.47277,-0.51407,1,0
6,GO CELL ACTIVATION,1.2035e-05,-0.47295,-0.56145,1,0
6,GO DEVELOPMENTAL INDUCTION,1.8524e-05,-0.47299,-0.48161,1,0
6,GO PROTEIN POLYUBIQUITINATION,4.9495e-06,-0.473,-0.50115,1,0
6,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,-0.473,-0.44041,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,3.0304e-05,-0.47302,-0.49279,1,0
6,GO DEFENSE RESPONSE TO VIRUS,0.00011593,-0.47306,-0.55633,1,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.0038653,-0.47333,-0.55668,1,0
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.47346,-0.5202,1,0
6,GO LENS FIBER CELL DEVELOPMENT,1.7249e-05,-0.47353,-0.53034,1,0
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.010572,-0.47354,-0.46597,1,0
6,GO REGULATION OF CELL CYCLE,5.7533e-06,-0.47369,-0.49873,1,0
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,5.337e-06,-0.47369,-0.49718,1,0
6,GO NADP METABOLIC PROCESS,1.2939e-05,-0.47372,-0.45478,1,0
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,8.3461e-06,-0.47401,-0.4989,1,0
6,GO PARTURITION,2.2907e-05,-0.47404,-0.46519,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0060238,-0.47408,-0.55722,1,0
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,4.5779e-05,-0.4741,-0.48864,1,0
6,GO REGULATION OF AMINO ACID TRANSPORT,8.3641e-05,-0.47437,-0.51039,1,0
6,GO DNA BIOSYNTHETIC PROCESS,5.7533e-06,-0.47438,-0.47337,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0042727,-0.47453,-0.52701,1,0
6,GO CELLULAR LIPID METABOLIC PROCESS,4.5891e-06,-0.47457,-0.49504,1,0
6,GO THALAMUS DEVELOPMENT,0.0011418,-0.47464,-0.43727,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.7533e-06,-0.47467,-0.50293,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.3461e-06,-0.47467,-0.51322,1,0
6,GO PITUITARY GLAND DEVELOPMENT,0.00026348,-0.4748,-0.48702,1,0
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,7.7514e-06,-0.47493,-0.47837,1,0
6,GO LYMPHOCYTE DIFFERENTIATION,2.8267e-05,-0.47493,-0.59711,1,0
6,GO SYNAPSE MATURATION,0.00010181,-0.47506,-0.59379,1,0
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.8524e-05,-0.47514,-0.48703,1,0
6,GO RESPONSE TO LIGHT STIMULUS,5.337e-06,-0.4753,-0.47159,1,0
6,GO POSITIVE REGULATION OF DNA REPAIR,1.2939e-05,-0.47534,-0.52541,1,0
6,GO NAD METABOLIC PROCESS,9.6689e-06,-0.47539,-0.54956,1,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,3.4805e-05,-0.47558,-0.49554,1,0
6,GO VAGINA DEVELOPMENT,0.00019306,-0.47569,-0.49698,1,0
6,GO ADULT LOCOMOTORY BEHAVIOR,1.6059e-05,-0.47586,-0.54484,1,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,3.9936e-05,-0.47591,-0.48116,1,0
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,8.3641e-05,-0.47595,-0.49362,1,0
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,8.9327e-05,-0.47598,-0.56554,1,0
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,8.9843e-06,-0.47601,-0.56357,1,0
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,6.6813e-06,-0.47605,-0.46547,1,0
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,3.4805e-05,-0.47614,-0.46208,1,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,2.8267e-05,-0.47614,-0.55819,1,0
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00031664,-0.47626,-0.56464,1,0
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.7287e-05,-0.47635,-0.48794,1,0
6,GO SYNAPTIC VESICLE BUDDING,0.00011593,-0.47643,-0.5349,1,0
6,GO PREPULSE INHIBITION,0.00068502,-0.47646,-0.55241,1,0
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.2907e-05,-0.47647,-0.45543,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.248e-05,-0.47647,-0.61352,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00096503,-0.4766,-0.54462,1,0
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,3.9936e-05,-0.47662,-0.44282,1,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,1.2035e-05,-0.47664,-0.49232,1,0
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,7.1973e-06,-0.47671,-0.4805,1,0
6,GO NOTOCHORD DEVELOPMENT,0.00054254,-0.47675,-0.47632,1,0
6,GO EXECUTION PHASE OF APOPTOSIS,8.3461e-06,-0.47678,-0.48204,1,0
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,9.6689e-06,-0.47679,-0.49238,1,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00048214,-0.47689,-0.64831,1,0
6,GO MIDBRAIN DEVELOPMENT,7.7514e-06,-0.47701,-0.4716,1,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00332,-0.47719,-0.62058,1,0
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,6.2007e-06,-0.47723,-0.48638,1,0
6,GO INNER CELL MASS CELL PROLIFERATION,7.1973e-06,-0.47728,-0.5629,1,0
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,5.7533e-06,-0.47732,-0.50776,1,0
6,GO POLYOL BIOSYNTHETIC PROCESS,4.9495e-06,-0.47736,-0.50239,1,0
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,2.636e-05,-0.47748,-0.52135,1,0
6,GO REPLICATION FORK PROCESSING,2.636e-05,-0.47753,-0.56946,1,0
6,GO REGULATION OF LIPID LOCALIZATION,7.1973e-06,-0.47756,-0.50201,1,0
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,7.1973e-06,-0.47768,-0.52015,1,0
6,GO PIGMENT GRANULE ORGANIZATION,1.4947e-05,-0.47769,-0.46863,1,0
6,GO APOPTOTIC SIGNALING PATHWAY,6.2007e-06,-0.47771,-0.50088,1,0
6,GO COGNITION,9.6689e-06,-0.47773,-0.50136,1,0
6,GO POSITIVE REGULATION OF CYTOKINESIS,1.4947e-05,-0.47774,-0.50128,1,0
6,GO LIPID IMPORT INTO CELL,7.7514e-06,-0.47776,-0.58819,1,0
6,GO PIGMENT ACCUMULATION,0.00057531,-0.47783,-0.53504,1,0
6,GO REGULATION OF CELLULAR PH,5.337e-06,-0.47786,-0.49826,1,0
6,GO WATER TRANSPORT,0.00010866,-0.47799,-0.52508,1,0
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,7.7514e-06,-0.47802,-0.47695,1,0
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.4139e-05,-0.47819,-0.5558,1,0
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.2763e-05,-0.47825,-0.57765,1,0
6,GO EXCITATORY SYNAPSE ASSEMBLY,0.0003797,-0.47831,-0.51224,1,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00013188,-0.47832,-0.52311,1,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,8.9843e-06,-0.47844,-0.50823,1,0
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,4.8997e-05,-0.47845,-0.53961,1,0
6,GO PROTEIN K63 LINKED UBIQUITINATION,3.9422e-06,-0.4785,-0.52133,1,0
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,3.4805e-05,-0.47857,-0.53021,1,0
6,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,6.2007e-06,-0.47877,-0.51429,1,0
6,GO MICROTUBULE BASED PROCESS,1.4947e-05,-0.47879,-0.50018,1,0
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0172,-0.47879,-0.49457,1,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0038653,-0.47881,-0.49551,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014989,-0.47882,-0.56989,1,0
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,2.636e-05,-0.47882,-0.53319,1,0
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,1.6059e-05,-0.47898,-0.47792,1,0
6,GO REGULATION OF SYMBIOTIC PROCESS,1.9888e-05,-0.47899,-0.51473,1,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.1973e-06,-0.47902,-0.55528,1,0
6,GO MECHANORECEPTOR DIFFERENTIATION,3.9422e-06,-0.4793,-0.52244,1,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,3.0304e-05,-0.47951,-0.43585,1,0
6,GO REGULATION OF DNA REPLICATION,1.6059e-05,-0.47955,-0.48471,1,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.9888e-05,-0.47974,-0.46855,1,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00024771,-0.47979,-0.51394,1,0
6,GO RESPONSE TO GAMMA RADIATION,7.7514e-06,-0.47982,-0.4834,1,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00076864,-0.48004,-0.60088,1,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,7.7514e-06,-0.48006,-0.51889,1,0
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.4803,-0.50977,1,0
6,GO HETEROTYPIC CELL CELL ADHESION,4.2763e-05,-0.48035,-0.56582,1,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,1.2939e-05,-0.48037,-0.58863,1,0
6,GO LIPID METABOLIC PROCESS,4.9495e-06,-0.48045,-0.49693,1,0
6,GO REGULATION OF MAST CELL ACTIVATION,1.8524e-05,-0.48051,-0.61666,1,0
6,GO NUCLEOTIDE PHOSPHORYLATION,4.5891e-06,-0.48052,-0.54047,1,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,1.7249e-05,-0.4806,-0.55533,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00011593,-0.48077,-0.58006,1,0
6,GO PORE COMPLEX ASSEMBLY,8.9843e-06,-0.48084,-0.50491,1,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,1.6059e-05,-0.48086,-0.4528,1,0
6,GO MESODERMAL CELL FATE COMMITMENT,3.7287e-05,-0.48089,-0.43283,1,0
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.2763e-05,-0.48094,-0.55807,1,0
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.6059e-05,-0.481,-0.56451,1,0
6,GO CHROMOSOME ORGANIZATION,8.9843e-06,-0.48103,-0.50772,1,0
6,GO LONG TERM SYNAPTIC DEPRESSION,5.6086e-05,-0.48103,-0.48869,1,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,2.1347e-05,-0.4811,-0.46304,1,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00010866,-0.48113,-0.60682,1,0
6,GO REGULATION OF LIPASE ACTIVITY,1.2035e-05,-0.48114,-0.51199,1,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0049572,-0.48119,-0.48576,1,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0012071,-0.48131,-0.58339,1,0
6,GO BROWN FAT CELL DIFFERENTIATION,1.6059e-05,-0.48131,-0.46154,1,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.7533e-06,-0.48136,-0.50266,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,1.1191e-05,-0.48141,-0.56027,1,0
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,8.9843e-06,-0.4816,-0.46426,1,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.48168,-0.51885,1,0
6,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,7.8298e-05,-0.48169,-0.53156,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.8267e-05,-0.48175,-0.48316,1,0
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,1.9888e-05,-0.48175,-0.47308,1,0
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00023283,-0.48177,-0.56591,1,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.2428e-05,-0.4818,-0.54566,1,0
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,9.6689e-06,-0.48186,-0.49808,1,0
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,6.6813e-06,-0.48192,-0.49476,1,0
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.00096503,-0.48205,-0.42785,1,0
6,GO NUCLEAR EXPORT,9.6689e-06,-0.48208,-0.49078,1,0
6,GO BILE ACID AND BILE SALT TRANSPORT,4.8997e-05,-0.48212,-0.47076,1,0
6,GO CHEMOKINE SECRETION,0.0028457,-0.48212,-0.57324,1,0
6,GO SYNAPSE ASSEMBLY,1.3909e-05,-0.48228,-0.57321,1,0
6,GO REGULATION OF SISTER CHROMATID COHESION,2.4576e-05,-0.48229,-0.53218,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,6.8565e-05,-0.48241,-0.56865,1,0
6,GO CEREBELLAR CORTEX DEVELOPMENT,1.9888e-05,-0.48242,-0.55068,1,0
6,GO LIPID DROPLET ORGANIZATION,4.9495e-06,-0.48251,-0.50281,1,0
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.00033648,-0.48263,-0.48163,1,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,1.2035e-05,-0.48267,-0.5131,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00023283,-0.48269,-0.59097,1,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,9.5377e-05,-0.48275,-0.53672,1,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,4.9495e-06,-0.48281,-0.53837,1,0
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.0403e-05,-0.48286,-0.54379,1,0
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,5.7533e-06,-0.48293,-0.51947,1,0
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,5.6086e-05,-0.48293,-0.50003,1,0
6,GO ALCOHOL BIOSYNTHETIC PROCESS,4.5891e-06,-0.48294,-0.51823,1,0
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,4.5891e-06,-0.48298,-0.486,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,1.7249e-05,-0.48315,-0.4624,1,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,1.4947e-05,-0.48316,-0.50321,1,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,6.2007e-06,-0.48318,-0.56996,1,0
6,GO ASYMMETRIC CELL DIVISION,4.5891e-06,-0.4832,-0.54401,1,0
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,6.4139e-05,-0.48321,-0.4696,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.7249e-05,-0.48331,-0.5666,1,0
6,GO NEUROMUSCULAR PROCESS,1.1191e-05,-0.48353,-0.555,1,0
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.0304e-05,-0.48356,-0.54793,1,0
6,GO MITOTIC SPINDLE ORGANIZATION,3.0304e-05,-0.48368,-0.49615,1,0
6,GO HYPOTONIC RESPONSE,3.0304e-05,-0.48378,-0.52573,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00026348,-0.48385,-0.61464,1,0
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,8.9843e-06,-0.48392,-0.56871,1,0
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.7533e-06,-0.48394,-0.49516,1,0
6,GO DIOL METABOLIC PROCESS,1.3909e-05,-0.48396,-0.53513,1,0
6,GO RESPONSE TO RADIATION,4.9495e-06,-0.48433,-0.477,1,0
6,GO FC RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.48434,-0.53913,1,0
6,GO CILIUM ORGANIZATION,4.2763e-05,-0.48438,-0.47867,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,4.5779e-05,-0.48468,-0.61822,1,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,4.5891e-06,-0.4849,-0.5555,1,0
6,GO NEGATIVE T CELL SELECTION,0.013235,-0.48512,-0.55093,1,0
6,GO CYTOKINE SECRETION,8.3641e-05,-0.48519,-0.54222,1,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,4.2763e-05,-0.48531,-0.43667,1,0
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,4.5891e-06,-0.48536,-0.48558,1,0
6,GO REGULATION OF MEMBRANE POTENTIAL,1.2035e-05,-0.48554,-0.51251,1,0
6,GO REGULATION OF ACTIN NUCLEATION,5.7533e-06,-0.48558,-0.5212,1,0
6,GO PEPTIDE HORMONE SECRETION,2.636e-05,-0.48568,-0.49507,1,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.2035e-05,-0.48585,-0.52307,1,0
6,GO B CELL MEDIATED IMMUNITY,0.00040321,-0.48594,-0.60754,1,0
6,GO CALCIUM MEDIATED SIGNALING,6.2007e-06,-0.48597,-0.50616,1,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.3909e-05,-0.48597,-0.56985,1,0
6,GO REGULATION OF SYNAPTIC PLASTICITY,1.8524e-05,-0.48623,-0.56114,1,0
6,GO REGULATION OF PHAGOCYTOSIS,0.00011593,-0.48623,-0.62887,1,0
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,7.7514e-06,-0.48628,-0.53102,1,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,1.4947e-05,-0.48642,-0.41679,1,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,5.7533e-06,-0.48644,-0.47125,1,0
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.7249e-05,-0.48645,-0.49796,1,0
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.48652,-0.48983,1,0
6,GO PURINE NUCLEOTIDE TRANSPORT,2.2907e-05,-0.48664,-0.47272,1,0
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00020554,-0.48678,-0.616,1,0
6,GO HISTONE H2A MONOUBIQUITINATION,8.3641e-05,-0.48682,-0.49211,1,0
6,GO HISTONE H4 DEACETYLATION,8.3641e-05,-0.487,-0.43385,1,0
6,GO RESPONSE TO CYTOKINE,1.2035e-05,-0.48704,-0.55393,1,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,5.337e-06,-0.48704,-0.52087,1,0
6,GO RESPONSE TO WATER,2.1347e-05,-0.48712,-0.5022,1,0
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00026348,-0.48734,-0.65611,1,0
6,GO CELL CYCLE G1 S PHASE TRANSITION,6.2007e-06,-0.48734,-0.4875,1,0
6,GO SKELETAL MUSCLE CONTRACTION,6.6813e-06,-0.48741,-0.49802,1,0
6,GO CATECHOLAMINE SECRETION,0.00081392,-0.48743,-0.47252,1,0
6,GO SPINDLE MIDZONE ASSEMBLY,2.2907e-05,-0.48755,-0.62913,1,0
6,GO LEUKOCYTE DIFFERENTIATION,1.2939e-05,-0.48758,-0.59754,1,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.4876,-0.49503,1,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,6.6813e-06,-0.48761,-0.48265,1,0
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,1.3909e-05,-0.48762,-0.55311,1,0
6,GO GLIAL CELL PROLIFERATION,2.8267e-05,-0.48763,-0.53024,1,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.8565e-05,-0.48767,-0.54754,1,0
6,GO TRNA TRANSPORT,1.7249e-05,-0.48767,-0.52021,1,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.9843e-06,-0.48787,-0.53607,1,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,1.0403e-05,-0.48795,-0.49048,1,0
6,GO MACROPHAGE CHEMOTAXIS,0.0010209,-0.48798,-0.52491,1,0
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.2939e-05,-0.48801,-0.489,1,0
6,GO EXOCYTIC PROCESS,4.2763e-05,-0.48809,-0.56266,1,0
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00023283,-0.48813,-0.57917,1,0
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,5.7533e-06,-0.48814,-0.51615,1,0
6,GO REGULATION OF MYELINATION,1.2035e-05,-0.48821,-0.5114,1,0
6,GO APOPTOTIC PROCESS,5.7533e-06,-0.48822,-0.51461,1,0
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,4.9495e-06,-0.48825,-0.53625,1,0
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.9495e-06,-0.48848,-0.52969,1,0
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.7249e-05,-0.48857,-0.50929,1,0
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,4.5779e-05,-0.48859,-0.54924,1,0
6,GO BEHAVIOR,1.2035e-05,-0.48864,-0.51688,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,4.5891e-06,-0.48865,-0.52556,1,0
6,GO NCRNA EXPORT FROM NUCLEUS,1.4947e-05,-0.48866,-0.53645,1,0
6,GO RESPONSE TO IMMOBILIZATION STRESS,5.9985e-05,-0.48873,-0.44326,1,0
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,1.2939e-05,-0.48875,-0.48343,1,0
6,GO OLIGODENDROCYTE DIFFERENTIATION,8.9843e-06,-0.48878,-0.48576,1,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0014241,-0.48901,-0.56499,1,0
6,GO CELLULAR COMPONENT DISASSEMBLY,4.9495e-06,-0.48904,-0.50278,1,0
6,GO ADULT BEHAVIOR,4.5779e-05,-0.48909,-0.52041,1,0
6,GO PROTEIN LOCALIZATION TO CHROMATIN,1.2035e-05,-0.48914,-0.52763,1,0
6,GO FATTY ACID TRANSPORT,4.2539e-06,-0.48935,-0.51853,1,0
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.0403e-05,-0.48942,-0.55017,1,0
6,GO PROTEIN AUTOUBIQUITINATION,5.337e-06,-0.48942,-0.49961,1,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.7249e-05,-0.48949,-0.59849,1,0
6,GO MODULATION BY HOST OF VIRAL PROCESS,1.6059e-05,-0.48964,-0.50676,1,0
6,GO STEROL METABOLIC PROCESS,6.2007e-06,-0.48968,-0.51254,1,0
6,GO RESPONSE TO OXIDATIVE STRESS,5.337e-06,-0.48975,-0.50335,1,0
6,GO RESPONSE TO PROSTAGLANDIN,5.9985e-05,-0.48975,-0.52935,1,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,4.8997e-05,-0.48979,-0.58685,1,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00028019,-0.48979,-0.60712,1,0
6,GO VASODILATION,3.7287e-05,-0.48999,-0.43988,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0023095,-0.49002,-0.57485,1,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.1973e-06,-0.4901,-0.5003,1,0
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,1.0403e-05,-0.4901,-0.51019,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00019306,-0.49011,-0.49677,1,0
6,GO TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.49021,-0.48063,1,0
6,GO PARAXIAL MESODERM DEVELOPMENT,6.8565e-05,-0.49022,-0.4626,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.49028,-0.47138,1,0
6,GO WATER HOMEOSTASIS,2.8267e-05,-0.49033,-0.48533,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00042807,-0.49038,-0.60723,1,0
6,GO PROTEIN HOMOOLIGOMERIZATION,6.6813e-06,-0.49042,-0.49863,1,0
6,GO RESPONSE TO FATTY ACID,7.1973e-06,-0.49042,-0.51437,1,0
6,GO EAR MORPHOGENESIS,1.3909e-05,-0.49056,-0.46807,1,0
6,GO STEM CELL DIFFERENTIATION,5.337e-06,-0.4906,-0.48612,1,0
6,GO SULFATION,3.248e-05,-0.49064,-0.49274,1,0
6,GO CELLULAR HOMEOSTASIS,5.337e-06,-0.49076,-0.5007,1,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.015776,-0.49079,-0.6202,1,0
6,GO MICROTUBULE BASED TRANSPORT,3.9936e-05,-0.49082,-0.50254,1,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,8.9843e-06,-0.49105,-0.51916,1,0
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,8.3461e-06,-0.49107,-0.52481,1,0
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00048214,-0.49113,-0.50197,1,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00018128,-0.49113,-0.5012,1,0
6,GO RIG I SIGNALING PATHWAY,1.3909e-05,-0.49119,-0.51434,1,0
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00010181,-0.49126,-0.5123,1,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,5.7533e-06,-0.49138,-0.51289,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7249e-05,-0.49159,-0.48396,1,0
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0010798,-0.49174,-0.44659,1,0
6,GO REPRODUCTION,7.7514e-06,-0.49174,-0.47485,1,0
6,GO DNA METHYLATION OR DEMETHYLATION,7.7514e-06,-0.49176,-0.48639,1,0
6,GO REGULATION OF DNA METABOLIC PROCESS,6.6813e-06,-0.49185,-0.50462,1,0
6,GO PROTEIN IMPORT,4.9495e-06,-0.49212,-0.4854,1,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,8.9843e-06,-0.49219,-0.49725,1,0
6,GO MAINTENANCE OF LOCATION IN CELL,4.9495e-06,-0.49222,-0.52663,1,0
6,GO ETHER BIOSYNTHETIC PROCESS,3.0304e-05,-0.49231,-0.52486,1,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.3461e-06,-0.49244,-0.53959,1,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,3.248e-05,-0.49248,-0.49727,1,0
6,GO PROTEIN LOCALIZATION TO CILIUM,0.00011593,-0.49254,-0.47203,1,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.9936e-05,-0.49263,-0.55439,1,0
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.337e-06,-0.49266,-0.51305,1,0
6,GO FATTY ACID HOMEOSTASIS,7.1973e-06,-0.49269,-0.55026,1,0
6,GO GLYCOSYLATION,6.6813e-06,-0.49276,-0.49563,1,0
6,GO PROTEIN COMPLEX OLIGOMERIZATION,6.2007e-06,-0.49278,-0.50985,1,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00014989,-0.49284,-0.59891,1,0
6,GO VITAMIN BIOSYNTHETIC PROCESS,1.2035e-05,-0.49285,-0.59392,1,0
6,GO WHITE FAT CELL DIFFERENTIATION,4.5891e-06,-0.49289,-0.53402,1,0
6,GO REGULATION OF PROTEIN FOLDING,0.00040321,-0.49294,-0.44907,1,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,4.2539e-06,-0.49295,-0.50876,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,1.1191e-05,-0.49296,-0.51835,1,0
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,6.2007e-06,-0.49298,-0.49803,1,0
6,GO PROTEIN PROCESSING,5.7533e-06,-0.49298,-0.52118,1,0
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,1.2035e-05,-0.49302,-0.53223,1,0
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,9.6689e-06,-0.49316,-0.56211,1,0
6,GO COPII COATED VESICLE BUDDING,1.2035e-05,-0.4932,-0.49081,1,0
6,GO ENDOCRINE PROCESS,6.2007e-06,-0.49326,-0.52106,1,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,7.7514e-06,-0.49339,-0.47829,1,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,3.7287e-05,-0.49349,-0.50961,1,0
6,GO FATTY ACID BETA OXIDATION,6.2007e-06,-0.49354,-0.48479,1,0
6,GO HORMONE TRANSPORT,1.4947e-05,-0.49356,-0.48571,1,0
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,5.6086e-05,-0.49362,-0.57321,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,4.2539e-06,-0.49379,-0.54109,1,0
6,GO NUCLEAR ENVELOPE ORGANIZATION,5.337e-06,-0.49396,-0.56682,1,0
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,8.9843e-06,-0.49403,-0.51067,1,0
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.2035e-05,-0.49408,-0.49495,1,0
6,GO NEUROINFLAMMATORY RESPONSE,0.00013188,-0.49429,-0.65988,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.9843e-06,-0.49456,-0.51484,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.49461,-0.61192,1,0
6,GO SPINDLE ASSEMBLY,1.9888e-05,-0.49466,-0.49765,1,0
6,GO NEURON CELL CELL ADHESION,0.007293,-0.49472,-0.41797,1,0
6,GO VESICLE BUDDING FROM MEMBRANE,9.6689e-06,-0.49488,-0.50115,1,0
6,GO HISTAMINE TRANSPORT,0.00048214,-0.49495,-0.445,1,0
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00026348,-0.49522,-0.41312,1,0
6,GO REGULATORY T CELL DIFFERENTIATION,0.00018128,-0.49522,-0.60519,1,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.248e-05,-0.49525,-0.59136,1,0
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.636e-05,-0.49531,-0.4919,1,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,1.1191e-05,-0.49547,-0.49301,1,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00015974,-0.49553,-0.54852,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.1191e-05,-0.49578,-0.50945,1,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,1.2939e-05,-0.49585,-0.55561,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.4959,-0.50425,1,0
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.2035e-05,-0.4959,-0.54847,1,0
6,GO REGULATION OF PEPTIDE TRANSPORT,5.337e-06,-0.49594,-0.53097,1,0
6,GO REGULATION OF CELL FATE SPECIFICATION,7.8298e-05,-0.49597,-0.52419,1,0
6,GO NEGATIVE REGULATION OF TRANSPORT,7.7514e-06,-0.49598,-0.48865,1,0
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,1.7249e-05,-0.49599,-0.69599,1,0
6,GO NEURON CELLULAR HOMEOSTASIS,0.00010181,-0.49613,-0.52047,1,0
6,GO CELLULAR SENESCENCE,6.2007e-06,-0.49632,-0.47568,1,0
6,GO CELL PROLIFERATION IN HINDBRAIN,1.8524e-05,-0.49632,-0.49945,1,0
6,GO AMINO SUGAR METABOLIC PROCESS,9.6689e-06,-0.49636,-0.52379,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,6.2007e-06,-0.49653,-0.52272,1,0
6,GO BLASTODERM SEGMENTATION,1.7249e-05,-0.49668,-0.47758,1,0
6,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00015974,-0.49671,-0.46479,1,0
6,GO ENDOSOME ORGANIZATION,5.7533e-06,-0.49685,-0.51008,1,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.6059e-05,-0.49685,-0.55208,1,0
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,5.337e-06,-0.49685,-0.51988,1,0
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.6813e-06,-0.49687,-0.51504,1,0
6,GO RESPONSE TO UV B,4.2763e-05,-0.49691,-0.49715,1,0
6,GO CELL RECOGNITION,1.9888e-05,-0.49694,-0.4718,1,0
6,GO LOCOMOTORY BEHAVIOR,1.7249e-05,-0.49697,-0.56096,1,0
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,2.2907e-05,-0.49698,-0.51964,1,0
6,GO REGULATION OF CATION CHANNEL ACTIVITY,7.7514e-06,-0.49702,-0.50305,1,0
6,GO GANGLION DEVELOPMENT,0.00086166,-0.49705,-0.51777,1,0
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0096484,-0.49707,-0.47146,1,0
6,GO REPRODUCTIVE BEHAVIOR,0.00012367,-0.49714,-0.48325,1,0
6,GO NUCLEAR BODY ORGANIZATION,9.5377e-05,-0.49716,-0.49808,1,0
6,GO NEGATIVE REGULATION OF CELL DEATH,5.337e-06,-0.49725,-0.50696,1,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0044907,-0.49726,-0.55663,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.2539e-06,-0.49729,-0.52613,1,0
6,GO CYCLOOXYGENASE PATHWAY,0.0036751,-0.49732,-0.51074,1,0
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,2.636e-05,-0.49736,-0.47986,1,0
6,GO CATION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49741,-0.49891,1,0
6,GO POSITIVE REGULATION OF ORGAN GROWTH,6.2007e-06,-0.49744,-0.54446,1,0
6,GO VIRAL GENOME REPLICATION,2.4576e-05,-0.49756,-0.53815,1,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.9843e-06,-0.49763,-0.51953,1,0
6,GO B CELL PROLIFERATION,0.00026348,-0.4977,-0.63485,1,0
6,GO RESPONSE TO ALCOHOL,5.7533e-06,-0.49776,-0.51883,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.5891e-06,-0.49781,-0.55385,1,0
6,GO INTERFERON ALPHA PRODUCTION,3.248e-05,-0.49784,-0.59974,1,0
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.1191e-05,-0.4979,-0.55757,1,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.2939e-05,-0.4979,-0.61496,1,0
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,1.2035e-05,-0.49801,-0.55925,1,0
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,8.3461e-06,-0.49811,-0.53014,1,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,7.1973e-06,-0.49823,-0.51666,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,7.1973e-06,-0.49826,-0.5865,1,0
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,1.7249e-05,-0.49831,-0.5205,1,0
6,GO RESPONSE TO TUMOR CELL,0.00060992,-0.49834,-0.49704,1,0
6,GO NEGATIVE REGULATION OF DNA REPLICATION,5.6086e-05,-0.4984,-0.46325,1,0
6,GO MITOTIC CELL CYCLE CHECKPOINT,1.0403e-05,-0.49845,-0.50802,1,0
6,GO REGULATION OF NECROTIC CELL DEATH,4.5779e-05,-0.49846,-0.49253,1,0
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,4.5891e-06,-0.49858,-0.50223,1,0
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0003797,-0.49859,-0.50503,1,0
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.0403e-05,-0.49864,-0.47122,1,0
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,8.9843e-06,-0.49876,-0.59555,1,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.9888e-05,-0.49876,-0.60989,1,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2035e-05,-0.49882,-0.56839,1,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,8.9843e-06,-0.49897,-0.49896,1,0
6,GO PHOSPHOLIPID HOMEOSTASIS,2.1347e-05,-0.49918,-0.52077,1,0
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,1.8524e-05,-0.49947,-0.52007,1,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,5.6086e-05,-0.49955,-0.57769,1,0
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,5.7533e-06,-0.4996,-0.53382,1,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,3.7287e-05,-0.49962,-0.51012,1,0
6,GO INORGANIC ANION TRANSPORT,4.9495e-06,-0.49973,-0.50267,1,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.7249e-05,-0.49974,-0.45145,1,0
6,GO MYOBLAST FUSION,3.7287e-05,-0.4998,-0.65015,1,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00023283,-0.49981,-0.48224,1,0
6,GO DIENCEPHALON DEVELOPMENT,5.9985e-05,-0.49984,-0.4973,1,0
6,GO REGULATION OF PROTEOLYSIS,5.337e-06,-0.49988,-0.51338,1,0
6,GO REGULATION OF RESPONSE TO STRESS,5.337e-06,-0.49991,-0.53025,1,0
6,GO PROTEIN KINASE A SIGNALING,8.3461e-06,-0.49995,-0.48352,1,0
6,GO CATION TRANSPORT,6.6813e-06,-0.5001,-0.49166,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00048214,-0.50011,-0.42822,1,0
6,GO NEUTRAL LIPID CATABOLIC PROCESS,6.6813e-06,-0.50017,-0.45239,1,0
6,GO REGULATION OF STEM CELL PROLIFERATION,1.1191e-05,-0.50024,-0.51336,1,0
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.8267e-05,-0.50025,-0.48526,1,0
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.8524e-05,-0.50026,-0.51089,1,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00024771,-0.50037,-0.52188,1,0
6,GO O GLYCAN PROCESSING,5.9985e-05,-0.5004,-0.46621,1,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,6.6813e-06,-0.50047,-0.54751,1,0
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.8997e-05,-0.50048,-0.54674,1,0
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.4947e-05,-0.50057,-0.53241,1,0
6,GO HORMONE MEDIATED SIGNALING PATHWAY,5.7533e-06,-0.50071,-0.5057,1,0
6,GO REGENERATION,8.9843e-06,-0.50079,-0.50592,1,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,6.6813e-06,-0.50082,-0.4969,1,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.8524e-05,-0.50085,-0.5633,1,0
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,2.4576e-05,-0.50094,-0.5211,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.9936e-05,-0.50121,-0.51917,1,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.4947e-05,-0.50134,-0.50573,1,0
6,GO ION TRANSMEMBRANE TRANSPORT,5.337e-06,-0.50136,-0.50237,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,7.3279e-05,-0.50138,-0.57826,1,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,3.7287e-05,-0.5014,-0.55319,1,0
6,GO HINDBRAIN MORPHOGENESIS,2.2907e-05,-0.50143,-0.53536,1,0
6,GO RELAXATION OF MUSCLE,2.8267e-05,-0.50161,-0.51231,1,0
6,GO TRANSFERRIN TRANSPORT,1.2035e-05,-0.50164,-0.48479,1,0
6,GO REGULATION OF TRANSPORTER ACTIVITY,8.3461e-06,-0.50165,-0.50378,1,0
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,5.337e-06,-0.50165,-0.55052,1,0
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,1.4947e-05,-0.50171,-0.54533,1,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,0.00020554,-0.50172,-0.60687,1,0
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.2007e-06,-0.50174,-0.49224,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,-0.50181,-0.58704,1,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.6689e-06,-0.50185,-0.52173,1,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00014062,-0.50188,-0.65002,1,0
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00017019,-0.50191,-0.63764,1,0
6,GO PROTEIN HOMOTETRAMERIZATION,5.337e-06,-0.50191,-0.4888,1,0
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,7.7514e-06,-0.50196,-0.49385,1,0
6,GO REGULATION OF GLIOGENESIS,7.7514e-06,-0.5021,-0.50313,1,0
6,GO NUCLEOTIDE TRANSPORT,1.2939e-05,-0.50212,-0.48848,1,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,2.1347e-05,-0.50219,-0.50877,1,0
6,GO PROTEOLYSIS,5.337e-06,-0.50221,-0.51279,1,0
6,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0021907,-0.50247,-0.49175,1,0
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,6.6813e-06,-0.50247,-0.51488,1,0
6,GO POSITIVE REGULATION OF BINDING,6.2007e-06,-0.50249,-0.52116,1,0
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,3.7287e-05,-0.50257,-0.56175,1,0
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.337e-06,-0.50279,-0.52648,1,0
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.3909e-05,-0.50292,-0.50923,1,0
6,GO HISTONE H3 K9 TRIMETHYLATION,8.9843e-06,-0.50297,-0.56723,1,0
6,GO STEROL HOMEOSTASIS,3.9422e-06,-0.503,-0.55621,1,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,2.636e-05,-0.50322,-0.50985,1,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.9888e-05,-0.50327,-0.60273,1,0
6,GO CARBOHYDRATE HOMEOSTASIS,6.6813e-06,-0.5033,-0.51951,1,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.9888e-05,-0.50344,-0.48632,1,0
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,1.0403e-05,-0.50346,-0.51488,1,0
6,GO CENTRIOLE ASSEMBLY,2.1347e-05,-0.50351,-0.55298,1,0
6,GO NEUTROPHIL EXTRAVASATION,7.8298e-05,-0.50388,-0.64642,1,0
6,GO T CELL SELECTION,0.00086166,-0.50388,-0.59915,1,0
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.5039,-0.52534,1,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,4.9495e-06,-0.50396,-0.50977,1,0
6,GO GOLGI VESICLE BUDDING,1.0403e-05,-0.50403,-0.51278,1,0
6,GO PEPTIDYL PROLINE HYDROXYLATION,9.5377e-05,-0.50405,-0.47122,1,0
6,GO CELLULAR ION HOMEOSTASIS,6.6813e-06,-0.50408,-0.50121,1,0
6,GO CARBOHYDRATE METABOLIC PROCESS,4.9495e-06,-0.5041,-0.51944,1,0
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00013188,-0.50431,-0.46069,1,0
6,GO METAL ION HOMEOSTASIS,6.6813e-06,-0.50431,-0.50383,1,0
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,6.2007e-06,-0.50435,-0.53088,1,0
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,5.337e-06,-0.5044,-0.53656,1,0
6,GO ADAPTATION OF SIGNALING PATHWAY,1.3909e-05,-0.5045,-0.55067,1,0
6,GO AMYLOID BETA FORMATION,5.337e-06,-0.50471,-0.56844,1,0
6,GO CYTOKINESIS,8.3461e-06,-0.50481,-0.5301,1,0
6,GO LEFT RIGHT AXIS SPECIFICATION,0.00028019,-0.50482,-0.51302,1,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.2007e-06,-0.50491,-0.52363,1,0
6,GO MACROPHAGE DIFFERENTIATION,3.9936e-05,-0.50495,-0.66777,1,0
6,GO PROTEIN METHYLATION,1.0403e-05,-0.50499,-0.52911,1,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,4.5779e-05,-0.50501,-0.55454,1,0
6,GO REGULATION OF HEMOPOIESIS,7.7514e-06,-0.50503,-0.55277,1,0
6,GO REGULATION OF CELL DEATH,5.337e-06,-0.50512,-0.51731,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.9843e-06,-0.50512,-0.50392,1,0
6,GO CARDIAC CHAMBER FORMATION,0.00020554,-0.50514,-0.52514,1,0
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,5.337e-06,-0.50516,-0.53713,1,0
6,GO RESPONSE TO NUTRIENT,8.9843e-06,-0.50527,-0.52638,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,5.9985e-05,-0.50528,-0.62158,1,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,8.3461e-06,-0.5053,-0.49255,1,0
6,GO SPINDLE ORGANIZATION,1.7249e-05,-0.50531,-0.51753,1,0
6,GO CARBOHYDRATE CATABOLIC PROCESS,4.9495e-06,-0.50533,-0.54801,1,0
6,GO CATECHOLAMINE UPTAKE,0.00042807,-0.50533,-0.48843,1,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00026348,-0.50539,-0.53498,1,0
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,3.4805e-05,-0.50541,-0.58676,1,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,5.7533e-06,-0.50543,-0.56742,1,0
6,GO REGULATION OF CAMP MEDIATED SIGNALING,5.7533e-06,-0.50546,-0.52683,1,0
6,GO PROTEIN LOCALIZATION TO SYNAPSE,5.6086e-05,-0.50547,-0.56326,1,0
6,GO MAST CELL ACTIVATION,1.4947e-05,-0.50548,-0.60916,1,0
6,GO INSULIN SECRETION,2.2907e-05,-0.50556,-0.50256,1,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.7249e-05,-0.50557,-0.58422,1,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,6.6813e-06,-0.50561,-0.53908,1,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,1.9888e-05,-0.50562,-0.49477,1,0
6,GO CELL MATURATION,8.9843e-06,-0.50567,-0.50734,1,0
6,GO LEUKOCYTE MIGRATION,3.9936e-05,-0.5057,-0.59014,1,0
6,GO CHOLESTEROL EFFLUX,5.337e-06,-0.50572,-0.56655,1,0
6,GO DNA INTEGRITY CHECKPOINT,1.1191e-05,-0.50575,-0.51225,1,0
6,GO RESPONSE TO HYDROPEROXIDE,7.3279e-05,-0.50579,-0.55883,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,2.636e-05,-0.50587,-0.4589,1,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.8524e-05,-0.5059,-0.58554,1,0
6,GO REGULATION OF INSULIN SECRETION,1.8524e-05,-0.50596,-0.5006,1,0
6,GO INNER EAR MORPHOGENESIS,1.2035e-05,-0.506,-0.47866,1,0
6,GO SYNAPTIC VESICLE LOCALIZATION,5.6086e-05,-0.506,-0.57627,1,0
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00042807,-0.50602,-0.53303,1,0
6,GO CELL CYCLE ARREST,4.9495e-06,-0.50603,-0.51505,1,0
6,GO STEROL TRANSPORT,4.5891e-06,-0.50603,-0.56671,1,0
6,GO REGULATION OF HORMONE SECRETION,1.2939e-05,-0.50604,-0.47915,1,0
6,GO RESPONSE TO ACTIVITY,5.337e-06,-0.50605,-0.47858,1,0
6,GO TUMOR NECROSIS FACTOR SECRETION,5.6086e-05,-0.50612,-0.52383,1,0
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,6.6813e-06,-0.50626,-0.53446,1,0
6,GO RESPONSE TO CATECHOLAMINE,1.3909e-05,-0.50632,-0.51596,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.2539e-06,-0.50634,-0.55516,1,0
6,GO REGULATION OF VIRAL LIFE CYCLE,2.636e-05,-0.50639,-0.5464,1,0
6,GO LIPID BIOSYNTHETIC PROCESS,4.5891e-06,-0.50646,-0.5053,1,0
6,GO CELLULAR RESPONSE TO VITAMIN D,0.00011593,-0.50654,-0.48437,1,0
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,1.2939e-05,-0.50655,-0.50176,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,0.0023095,-0.50668,-0.56157,1,0
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.3909e-05,-0.5067,-0.53454,1,0
6,GO CD40 SIGNALING PATHWAY,3.9936e-05,-0.50675,-0.61106,1,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0003797,-0.50684,-0.63896,1,0
6,GO NON RECOMBINATIONAL REPAIR,1.1191e-05,-0.50686,-0.50608,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.7533e-06,-0.50689,-0.52053,1,0
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,8.9843e-06,-0.50693,-0.50423,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,8.9843e-06,-0.50695,-0.47011,1,0
6,GO ERAD PATHWAY,7.7514e-06,-0.50698,-0.5551,1,0
6,GO MRNA METHYLATION,5.2428e-05,-0.50721,-0.5304,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,5.337e-06,-0.50734,-0.48284,1,0
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,2.2907e-05,-0.50743,-0.50672,1,0
6,GO T CELL LINEAGE COMMITMENT,0.00010181,-0.50754,-0.5694,1,0
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,9.6689e-06,-0.50756,-0.52092,1,0
6,GO GLYCEROLIPID CATABOLIC PROCESS,5.337e-06,-0.50757,-0.49891,1,0
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,4.5779e-05,-0.50764,-0.54192,1,0
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,4.9495e-06,-0.50765,-0.53716,1,0
6,GO NEURAL CREST FORMATION,0.0027019,-0.50788,-0.41248,1,0
6,GO PROGESTERONE METABOLIC PROCESS,0.00010866,-0.50789,-0.49199,1,0
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.1347e-05,-0.5079,-0.52102,1,0
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,5.337e-06,-0.50793,-0.55714,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0027019,-0.50794,-0.51242,1,0
6,GO POSITIVE REGULATION OF ANION TRANSPORT,5.2428e-05,-0.50807,-0.44721,1,0
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,3.4805e-05,-0.50813,-0.50707,1,0
6,GO PROTEIN STABILIZATION,8.3461e-06,-0.50828,-0.48307,1,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,1.2939e-05,-0.50832,-0.49838,1,0
6,GO MACROAUTOPHAGY,5.7533e-06,-0.50836,-0.52924,1,0
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,6.4139e-05,-0.50841,-0.53441,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,1.1191e-05,-0.50863,-0.52027,1,0
6,GO T CELL DIFFERENTIATION IN THYMUS,2.2907e-05,-0.50866,-0.58897,1,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,1.2035e-05,-0.50877,-0.51441,1,0
6,GO NEURONAL ACTION POTENTIAL,6.4139e-05,-0.50877,-0.4818,1,0
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.337e-06,-0.50882,-0.51573,1,0
6,GO FATTY ACYL COA METABOLIC PROCESS,4.2539e-06,-0.50885,-0.53386,1,0
6,GO NEGATIVE REGULATION OF ION TRANSPORT,9.6689e-06,-0.50886,-0.48964,1,0
6,GO TRANSMISSION OF NERVE IMPULSE,4.5779e-05,-0.50896,-0.49988,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,5.7533e-06,-0.50896,-0.54185,1,0
6,GO SIGNAL RELEASE,9.6689e-06,-0.50897,-0.51792,1,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,1.9888e-05,-0.50907,-0.63886,1,0
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00031664,-0.50913,-0.40518,1,0
6,GO RESPONSE TO IONIZING RADIATION,6.2007e-06,-0.50913,-0.50293,1,0
6,GO HOMEOSTATIC PROCESS,5.7533e-06,-0.50917,-0.51563,1,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,4.2539e-06,-0.50925,-0.56698,1,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016767,-0.50933,-0.55051,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00020554,-0.50934,-0.54856,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.50938,-0.51544,1,0
6,GO GLUCOSE METABOLIC PROCESS,6.6813e-06,-0.50971,-0.54589,1,0
6,GO ENGULFMENT OF APOPTOTIC CELL,8.9843e-06,-0.50974,-0.6251,1,0
6,GO REGULATION OF ATP METABOLIC PROCESS,3.9422e-06,-0.50981,-0.52454,1,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.50989,-0.48184,1,0
6,GO LIVER MORPHOGENESIS,7.3279e-05,-0.50991,-0.54959,1,0
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,5.7533e-06,-0.50994,-0.54097,1,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0029965,-0.51001,-0.5516,1,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00010181,-0.51011,-0.58682,1,0
6,GO VESICLE TARGETING,1.6059e-05,-0.51012,-0.50846,1,0
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.9888e-05,-0.51013,-0.49853,1,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.636e-05,-0.51016,-0.53599,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00020554,-0.51041,-0.57412,1,0
6,GO ORGANELLE LOCALIZATION,6.2007e-06,-0.51049,-0.54645,1,0
6,GO POSITIVE REGULATION OF TOR SIGNALING,4.9495e-06,-0.51054,-0.56636,1,0
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,6.6813e-06,-0.5106,-0.58683,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,6.6813e-06,-0.51068,-0.52487,1,0
6,GO FOREBRAIN CELL MIGRATION,6.2007e-06,-0.51073,-0.58387,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,6.6813e-06,-0.51079,-0.54265,1,0
6,GO REGULATION OF PROTEIN STABILITY,6.2007e-06,-0.5108,-0.49548,1,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,4.8997e-05,-0.51082,-0.55136,1,0
6,GO ACIDIC AMINO ACID TRANSPORT,3.7287e-05,-0.51087,-0.52562,1,0
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,9.6689e-06,-0.51088,-0.5327,1,0
6,GO TYPE I INTERFERON PRODUCTION,6.2007e-06,-0.51088,-0.58596,1,0
6,GO GENE SILENCING,7.7514e-06,-0.51091,-0.51281,1,0
6,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,-0.51101,-0.59182,1,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,3.9936e-05,-0.51106,-0.5128,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.248e-05,-0.51108,-0.55468,1,0
6,GO MULTICELLULAR ORGANISM AGING,7.1973e-06,-0.51118,-0.49782,1,0
6,GO ION HOMEOSTASIS,6.2007e-06,-0.51119,-0.50486,1,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,2.2907e-05,-0.51124,-0.49281,1,0
6,GO REGULATION OF GLUCOSE IMPORT,4.9495e-06,-0.51126,-0.51218,1,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.7249e-05,-0.51129,-0.59796,1,0
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.51131,-0.5287,1,0
6,GO SYNAPTIC VESICLE DOCKING,0.0015882,-0.51143,-0.64764,1,0
6,GO REGULATION OF HEART RATE,1.1191e-05,-0.51153,-0.51553,1,0
6,GO REGULATION OF CYCLASE ACTIVITY,5.337e-06,-0.51153,-0.50939,1,0
6,GO DENDRITIC CELL DIFFERENTIATION,0.0057394,-0.5116,-0.58503,1,0
6,GO MEMBRANE DOCKING,1.3909e-05,-0.51168,-0.5384,1,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,5.6086e-05,-0.51172,-0.54182,1,0
6,GO PROTEIN DEPHOSPHORYLATION,4.9495e-06,-0.51194,-0.54293,1,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,6.2007e-06,-0.512,-0.53196,1,0
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,8.9327e-05,-0.512,-0.46184,1,0
6,GO GLUCOSE CATABOLIC PROCESS,1.8524e-05,-0.51206,-0.57176,1,0
6,GO THYMUS DEVELOPMENT,1.2035e-05,-0.51208,-0.50495,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.248e-05,-0.51216,-0.6394,1,0
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,7.1973e-06,-0.51245,-0.55868,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,4.5891e-06,-0.51251,-0.54603,1,0
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,8.9327e-05,-0.51272,-0.60936,1,0
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.51275,-0.52231,1,0
6,GO EPITHELIAL CELL MATURATION,0.00017019,-0.51289,-0.49892,1,0
6,GO REGULATION OF BINDING,5.7533e-06,-0.51304,-0.52831,1,0
6,GO REGULATION OF CHROMOSOME ORGANIZATION,7.1973e-06,-0.51321,-0.5305,1,0
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.6059e-05,-0.51334,-0.58219,1,0
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.3279e-05,-0.51342,-0.61532,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.4576e-05,-0.51347,-0.68028,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION,5.7533e-06,-0.51348,-0.54308,1,0
6,GO RESPONSE TO INTERFERON BETA,0.0021907,-0.51352,-0.57509,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00010866,-0.51355,-0.55166,1,0
6,GO NEGATIVE REGULATION OF BINDING,7.1973e-06,-0.51363,-0.5138,1,0
6,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00033648,-0.5137,-0.56092,1,0
6,GO REGULATION OF AMYLOID BETA FORMATION,6.2007e-06,-0.51373,-0.59336,1,0
6,GO B CELL APOPTOTIC PROCESS,1.8524e-05,-0.51389,-0.54665,1,0
6,GO RESPONSE TO DRUG,4.9495e-06,-0.51389,-0.5172,1,0
6,GO ATP BIOSYNTHETIC PROCESS,4.5891e-06,-0.51394,-0.50932,1,0
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,6.2007e-06,-0.51404,-0.53615,1,0
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,7.7514e-06,-0.51405,-0.54899,1,0
6,GO SPLEEN DEVELOPMENT,6.6813e-06,-0.5141,-0.54016,1,0
6,GO SPINAL CORD DEVELOPMENT,5.7533e-06,-0.51419,-0.5738,1,0
6,GO RESPONSE TO ABIOTIC STIMULUS,5.7533e-06,-0.51423,-0.50347,1,0
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.51424,-0.47596,1,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,7.1973e-06,-0.51435,-0.5248,1,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,3.9422e-06,-0.5144,-0.56134,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.337e-06,-0.51442,-0.53115,1,0
6,GO HISTONE H4 K16 ACETYLATION,9.6689e-06,-0.5145,-0.58384,1,0
6,GO RESPONSE TO DOPAMINE,1.9888e-05,-0.5145,-0.5025,1,0
6,GO REGULATION OF PROTEIN TARGETING,4.9495e-06,-0.51453,-0.55796,1,0
6,GO REGULATION OF B CELL DIFFERENTIATION,6.8565e-05,-0.51459,-0.67587,1,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0044907,-0.51484,-0.53523,1,0
6,GO TOR SIGNALING,4.2539e-06,-0.51492,-0.58176,1,0
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,4.9495e-06,-0.51492,-0.56332,1,0
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,8.3461e-06,-0.51494,-0.56226,1,0
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.6059e-05,-0.51494,-0.46571,1,0
6,GO AUTOPHAGOSOME MATURATION,6.2007e-06,-0.51497,-0.54216,1,0
6,GO CELL ADHESION MOLECULE PRODUCTION,0.00023283,-0.51512,-0.57811,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.7249e-05,-0.51537,-0.58143,1,0
6,GO OSTEOBLAST DEVELOPMENT,3.248e-05,-0.51542,-0.50322,1,0
6,GO HISTONE H3 ACETYLATION,5.337e-06,-0.51548,-0.56107,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.011063,-0.5155,-0.65769,1,0
6,GO MAINTENANCE OF LOCATION,5.337e-06,-0.51552,-0.53988,1,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.2939e-05,-0.51564,-0.56383,1,0
6,GO THYROID HORMONE METABOLIC PROCESS,3.9936e-05,-0.51566,-0.47138,1,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,7.1973e-06,-0.51576,-0.51429,1,0
6,GO REGULATION OF DNA RECOMBINATION,6.6813e-06,-0.51584,-0.54785,1,0
6,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0015041,-0.516,-0.46373,1,0
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,6.8565e-05,-0.51606,-0.55065,1,0
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,1.9888e-05,-0.5161,-0.56654,1,0
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.6059e-05,-0.51614,-0.4963,1,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00014062,-0.51614,-0.6115,1,0
6,GO FOREGUT MORPHOGENESIS,7.3279e-05,-0.5164,-0.52842,1,0
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.6813e-06,-0.51645,-0.50459,1,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,3.9936e-05,-0.5165,-0.65993,1,0
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,1.3909e-05,-0.51652,-0.53625,1,0
6,GO RESPONSE TO INORGANIC SUBSTANCE,6.2007e-06,-0.51661,-0.49485,1,0
6,GO MEMBRANE INVAGINATION,2.4576e-05,-0.51663,-0.67023,1,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,4.9495e-06,-0.51669,-0.54503,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,3.248e-05,-0.5167,-0.59876,1,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.5377e-05,-0.51673,-0.56028,1,0
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,2.636e-05,-0.51684,-0.5218,1,0
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00057531,-0.51689,-0.51666,1,0
6,GO ION TRANSPORT,5.7533e-06,-0.517,-0.49537,1,0
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.5377e-05,-0.51707,-0.58955,1,0
6,GO MEMBRANE LIPID METABOLIC PROCESS,5.337e-06,-0.51708,-0.52705,1,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,6.6813e-06,-0.51716,-0.50982,1,0
6,GO PSEUDOPODIUM ORGANIZATION,0.00035748,-0.51732,-0.55444,1,0
6,GO SODIUM ION TRANSPORT,1.1191e-05,-0.51747,-0.49564,1,0
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.51748,-0.5739,1,0
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0025648,-0.5175,-0.53603,1,0
6,GO T CELL HOMEOSTASIS,1.1191e-05,-0.51788,-0.51225,1,0
6,GO SECRETION,5.7533e-06,-0.51808,-0.5339,1,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0027019,-0.51816,-0.57736,1,0
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,1.7249e-05,-0.51816,-0.47082,1,0
6,GO DEPHOSPHORYLATION,4.9495e-06,-0.5182,-0.54216,1,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,5.7533e-06,-0.51835,-0.54373,1,0
6,GO MANGANESE ION TRANSPORT,3.4805e-05,-0.51838,-0.46847,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION,6.2007e-06,-0.51843,-0.51117,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,5.6086e-05,-0.51847,-0.51846,1,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.51849,-0.54277,1,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00086166,-0.51849,-0.72173,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,8.3461e-06,-0.51853,-0.49125,1,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00017019,-0.51856,-0.54615,1,0
6,GO LYMPHOCYTE COSTIMULATION,0.00026348,-0.51864,-0.60795,1,0
6,GO EPIDERMIS MORPHOGENESIS,0.00045436,-0.51872,-0.49316,1,0
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.4576e-05,-0.51881,-0.54557,1,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.6059e-05,-0.51885,-0.5746,1,0
6,GO PROTEIN POLYGLUTAMYLATION,7.8298e-05,-0.51894,-0.48978,1,0
6,GO VITAMIN TRANSPORT,7.7514e-06,-0.51913,-0.4981,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,3.4805e-05,-0.5192,-0.59294,1,0
6,GO THIOESTER BIOSYNTHETIC PROCESS,4.5891e-06,-0.5192,-0.54228,1,0
6,GO PROTEIN CATABOLIC PROCESS,5.337e-06,-0.51922,-0.53425,1,0
6,GO LIMBIC SYSTEM DEVELOPMENT,8.9843e-06,-0.51931,-0.51447,1,0
6,GO POSTSYNAPSE ORGANIZATION,1.3909e-05,-0.51935,-0.55811,1,0
6,GO CHEMICAL HOMEOSTASIS,6.6813e-06,-0.51945,-0.5092,1,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.5377e-05,-0.51948,-0.63235,1,0
6,GO VIRAL LIFE CYCLE,4.5891e-06,-0.51955,-0.54557,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0021907,-0.5196,-0.60102,1,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,4.9495e-06,-0.51964,-0.52019,1,0
6,GO PROTEIN O LINKED GLYCOSYLATION,1.0403e-05,-0.51979,-0.50388,1,0
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.013834,-0.5198,-0.67106,1,0
6,GO SECOND MESSENGER MEDIATED SIGNALING,6.2007e-06,-0.51988,-0.50972,1,0
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,1.2939e-05,-0.51992,-0.56181,1,0
6,GO MALE GENITALIA DEVELOPMENT,4.2763e-05,-0.51996,-0.50936,1,0
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00054254,-0.52002,-0.48392,1,0
6,GO REGULATION OF CELL POPULATION PROLIFERATION,5.337e-06,-0.52002,-0.53972,1,0
6,GO RESPONSE TO ANTIBIOTIC,5.7533e-06,-0.52017,-0.49413,1,0
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.0304e-05,-0.52025,-0.50412,1,0
6,GO REGULATION OF COAGULATION,2.1347e-05,-0.52026,-0.60141,1,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,9.6689e-06,-0.52037,-0.56116,1,0
6,GO REGULATION OF CELL DIVISION,4.9495e-06,-0.52038,-0.54227,1,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,1.6059e-05,-0.5204,-0.58736,1,0
6,GO REGIONALIZATION,8.3461e-06,-0.52041,-0.51876,1,0
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,5.7533e-06,-0.52042,-0.54309,1,0
6,GO MECHANOSENSORY BEHAVIOR,0.0027019,-0.52044,-0.48057,1,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.0403e-05,-0.52044,-0.58694,1,0
6,GO RNA STABILIZATION,6.6813e-06,-0.5206,-0.50818,1,0
6,GO GENITALIA DEVELOPMENT,7.7514e-06,-0.52061,-0.52269,1,0
6,GO TOXIN TRANSPORT,8.3461e-06,-0.52073,-0.54313,1,0
6,GO LONG TERM SYNAPTIC POTENTIATION,2.2907e-05,-0.52083,-0.53314,1,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,4.2539e-06,-0.5209,-0.50542,1,0
6,GO REGULATION OF PLATELET AGGREGATION,2.8267e-05,-0.52093,-0.6159,1,0
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00028019,-0.52099,-0.54787,1,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,7.1973e-06,-0.52113,-0.54498,1,0
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,4.9495e-06,-0.52116,-0.52545,1,0
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,7.7514e-06,-0.52117,-0.5135,1,0
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,8.9843e-06,-0.52124,-0.52823,1,0
6,GO HORMONE BIOSYNTHETIC PROCESS,2.636e-05,-0.5214,-0.46131,1,0
6,GO PEPTIDE CROSS LINKING,0.00031664,-0.52143,-0.57015,1,0
6,GO CEREBELLAR CORTEX MORPHOGENESIS,1.9888e-05,-0.52144,-0.55932,1,0
6,GO POSITIVE REGULATION OF TRANSPORT,5.7533e-06,-0.52152,-0.54243,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.9843e-06,-0.52157,-0.5314,1,0
6,GO RESPONSE TO OSMOTIC STRESS,6.6813e-06,-0.52158,-0.52383,1,0
6,GO REGULATION OF INTRACELLULAR TRANSPORT,4.9495e-06,-0.52159,-0.54994,1,0
6,GO PATTERN SPECIFICATION PROCESS,8.9843e-06,-0.52161,-0.52468,1,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,8.9843e-06,-0.52162,-0.55201,1,0
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,1.6059e-05,-0.52164,-0.53413,1,0
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.1191e-05,-0.52165,-0.50517,1,0
6,GO PROTEIN ACYLATION,6.6813e-06,-0.52167,-0.55282,1,0
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,5.7533e-06,-0.52176,-0.5534,1,0
6,GO PROTEIN ACETYLATION,5.7533e-06,-0.52176,-0.55699,1,0
6,GO EAR DEVELOPMENT,8.3461e-06,-0.52176,-0.49654,1,0
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.4947e-05,-0.5218,-0.51094,1,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00028019,-0.52181,-0.55592,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.9495e-06,-0.52186,-0.55872,1,0
6,GO CEREBRAL CORTEX CELL MIGRATION,1.4947e-05,-0.52189,-0.61429,1,0
6,GO SEROTONIN SECRETION,3.7287e-05,-0.52193,-0.51869,1,0
6,GO ERK1 AND ERK2 CASCADE,1.4947e-05,-0.52199,-0.5884,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00015974,-0.52215,-0.55699,1,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,1.2035e-05,-0.52218,-0.51645,1,0
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.2428e-05,-0.52222,-0.54049,1,0
6,GO MITOTIC CHROMOSOME CONDENSATION,3.7287e-05,-0.52235,-0.60002,1,0
6,GO POSITIVE REGULATION OF EXOCYTOSIS,1.6059e-05,-0.52248,-0.55856,1,0
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,6.6813e-06,-0.52255,-0.51674,1,0
6,GO TISSUE HOMEOSTASIS,7.7514e-06,-0.52257,-0.53808,1,0
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.7249e-05,-0.52266,-0.5319,1,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,8.3461e-06,-0.52278,-0.55672,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00014062,-0.52283,-0.53222,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,5.337e-06,-0.52286,-0.55914,1,0
6,GO DNA METHYLATION,1.7249e-05,-0.52294,-0.50004,1,0
6,GO EXOCYTOSIS,5.337e-06,-0.52305,-0.5609,1,0
6,GO CELL CELL SIGNALING,6.6813e-06,-0.52311,-0.5211,1,0
6,GO GLYCEROLIPID METABOLIC PROCESS,4.2539e-06,-0.52312,-0.53884,1,0
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0024341,-0.52321,-0.58235,1,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.52322,-0.51477,1,0
6,GO RESPONSE TO GLUCAGON,0.00011593,-0.52323,-0.51176,1,0
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.7287e-05,-0.52323,-0.5235,1,0
6,GO REGULATION OF ORGANELLE ASSEMBLY,8.3461e-06,-0.52323,-0.54286,1,0
6,GO ENDOCRINE HORMONE SECRETION,7.7514e-06,-0.52338,-0.5096,1,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,8.9327e-05,-0.52351,-0.61677,1,0
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,4.9495e-06,-0.52354,-0.57516,1,0
6,GO POSITIVE REGULATION OF ION TRANSPORT,6.2007e-06,-0.52356,-0.50288,1,0
6,GO CEREBRAL CORTEX DEVELOPMENT,8.3461e-06,-0.52362,-0.6056,1,0
6,GO STRIATED MUSCLE CELL PROLIFERATION,7.7514e-06,-0.52375,-0.52663,1,0
6,GO METAL ION TRANSPORT,7.7514e-06,-0.52388,-0.50293,1,0
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52406,-0.58663,1,0
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,6.6813e-06,-0.52431,-0.49697,1,0
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,6.6813e-06,-0.52442,-0.51602,1,0
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,7.7514e-06,-0.52454,-0.5033,1,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.5246,-0.52257,1,0
6,GO SUBPALLIUM DEVELOPMENT,0.00048214,-0.52488,-0.5271,1,0
6,GO RESPONSE TO THYROID HORMONE,5.337e-06,-0.52498,-0.59348,1,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,4.8997e-05,-0.52511,-0.45066,1,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,4.9495e-06,-0.52511,-0.51443,1,0
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,1.9888e-05,-0.52527,-0.47017,1,0
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,3.0304e-05,-0.52533,-0.52346,1,0
6,GO MICROTUBULE BUNDLE FORMATION,0.00010181,-0.52544,-0.45779,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.5255,-0.53103,1,0
6,GO DIVALENT INORGANIC CATION TRANSPORT,6.2007e-06,-0.52554,-0.52997,1,0
6,GO GLYCOPROTEIN METABOLIC PROCESS,5.7533e-06,-0.52571,-0.53634,1,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4947e-05,-0.52575,-0.56754,1,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,7.1973e-06,-0.52578,-0.56508,1,0
6,GO HIPPOCAMPUS DEVELOPMENT,2.4576e-05,-0.52586,-0.49953,1,0
6,GO RESPONSE TO STARVATION,7.7514e-06,-0.52595,-0.52587,1,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,4.5891e-06,-0.52599,-0.57617,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,6.4139e-05,-0.52605,-0.47785,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,4.2539e-06,-0.52619,-0.56302,1,0
6,GO G2 DNA DAMAGE CHECKPOINT,1.6059e-05,-0.52632,-0.55319,1,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00031664,-0.52633,-0.58525,1,0
6,GO NEGATIVE REGULATION OF SECRETION,6.2007e-06,-0.52638,-0.49591,1,0
6,GO RESPONSE TO SALT STRESS,5.2428e-05,-0.52659,-0.46144,1,0
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,9.6689e-06,-0.52659,-0.51679,1,0
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,6.4139e-05,-0.52667,-0.50134,1,0
6,GO CRANIAL NERVE DEVELOPMENT,1.9888e-05,-0.52672,-0.58995,1,0
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00018128,-0.52675,-0.51725,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00096503,-0.52675,-0.69862,1,0
6,GO MITOTIC DNA REPLICATION,2.8267e-05,-0.52678,-0.50732,1,0
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,4.9495e-06,-0.52682,-0.54669,1,0
6,GO MITOCHONDRION LOCALIZATION,1.7249e-05,-0.52684,-0.57553,1,0
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00011593,-0.52699,-0.45008,1,0
6,GO HINDBRAIN DEVELOPMENT,8.3461e-06,-0.52706,-0.54166,1,0
6,GO LIMB BUD FORMATION,0.00042807,-0.52708,-0.53091,1,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,1.6059e-05,-0.52711,-0.57561,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.9985e-05,-0.52711,-0.59811,1,0
6,GO ER NUCLEUS SIGNALING PATHWAY,4.8997e-05,-0.52713,-0.50601,1,0
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.7249e-05,-0.52725,-0.57352,1,0
6,GO PYRUVATE METABOLIC PROCESS,5.337e-06,-0.52726,-0.54952,1,0
6,GO REGULATION OF ION TRANSPORT,6.6813e-06,-0.52731,-0.51133,1,0
6,GO PONS DEVELOPMENT,0.0021907,-0.52733,-0.56029,1,0
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.2035e-05,-0.52741,-0.53497,1,0
6,GO NEURON APOPTOTIC PROCESS,4.5891e-06,-0.52745,-0.53742,1,0
6,GO MYOTUBE DIFFERENTIATION,6.2007e-06,-0.52747,-0.57973,1,0
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,6.6813e-06,-0.52751,-0.55504,1,0
6,GO AMINO ACID TRANSPORT,9.6689e-06,-0.52753,-0.5381,1,0
6,GO REGULATION OF VESICLE FUSION,7.3279e-05,-0.52775,-0.6437,1,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,1.8524e-05,-0.52778,-0.52024,1,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.52783,-0.59197,1,0
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.52785,-0.53206,1,0
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.2007e-06,-0.52785,-0.58113,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00011593,-0.52786,-0.59567,1,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00040321,-0.52788,-0.61926,1,0
6,GO CELLULAR RESPONSE TO FATTY ACID,5.337e-06,-0.528,-0.52464,1,0
6,GO CHROMATIN ORGANIZATION,6.6813e-06,-0.52813,-0.55359,1,0
6,GO REGULATION OF SPINDLE ORGANIZATION,4.5779e-05,-0.52818,-0.49641,1,0
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,1.3909e-05,-0.52825,-0.50707,1,0
6,GO REGULATION OF PROTEIN IMPORT,4.9495e-06,-0.52841,-0.53367,1,0
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,5.337e-06,-0.52841,-0.53752,1,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.52844,-0.55215,1,0
6,GO REGULATION OF B CELL ACTIVATION,4.8997e-05,-0.52849,-0.64795,1,0
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.7514e-06,-0.52862,-0.51273,1,0
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.8524e-05,-0.52863,-0.45838,1,0
6,GO SEX DIFFERENTIATION,4.5891e-06,-0.52868,-0.5071,1,0
6,GO COMPLEMENT ACTIVATION,0.0029965,-0.52871,-0.60435,1,0
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,1.6059e-05,-0.52872,-0.57301,1,0
6,GO HISTONE METHYLATION,8.3461e-06,-0.52885,-0.56935,1,0
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.248e-05,-0.52887,-0.54772,1,0
6,GO RESPONSE TO AMINO ACID STARVATION,1.0403e-05,-0.52892,-0.54249,1,0
6,GO REGULATION OF PHOSPHATASE ACTIVITY,4.9495e-06,-0.52894,-0.57004,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,5.337e-06,-0.529,-0.54695,1,0
6,GO CGMP MEDIATED SIGNALING,1.1191e-05,-0.52908,-0.55236,1,0
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,7.7514e-06,-0.52909,-0.62375,1,0
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,4.9495e-06,-0.52922,-0.57897,1,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,7.1973e-06,-0.52925,-0.5699,1,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1.9888e-05,-0.52929,-0.57615,1,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.2035e-05,-0.52931,-0.59866,1,0
6,GO REGULATION OF CIRCADIAN RHYTHM,1.6059e-05,-0.52948,-0.53014,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.337e-06,-0.52959,-0.56764,1,0
6,GO ENDOCRINE SYSTEM DEVELOPMENT,2.1347e-05,-0.5296,-0.54315,1,0
6,GO REGULATION OF GENE SILENCING,7.7514e-06,-0.52985,-0.53083,1,0
6,GO ANION TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.52991,-0.52217,1,0
6,GO POSITIVE REGULATION OF SECRETION,6.6813e-06,-0.52996,-0.51528,1,0
6,GO HEART VALVE FORMATION,0.00013188,-0.53011,-0.56994,1,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,5.7533e-06,-0.53014,-0.60123,1,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00076864,-0.53046,-0.65075,1,0
6,GO RESPONSE TO OXYGEN LEVELS,5.337e-06,-0.5305,-0.50684,1,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,3.248e-05,-0.53052,-0.56039,1,0
6,GO PALLIUM DEVELOPMENT,1.6059e-05,-0.53052,-0.54789,1,0
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,7.1973e-06,-0.53052,-0.51859,1,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.00015974,-0.53057,-0.60402,1,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,1.0403e-05,-0.53058,-0.53015,1,0
6,GO T HELPER CELL LINEAGE COMMITMENT,0.0010209,-0.53063,-0.61226,1,0
6,GO REGULATION OF CHROMATIN BINDING,8.9843e-06,-0.53064,-0.59643,1,0
6,GO AXONAL FASCICULATION,1.8524e-05,-0.53065,-0.62544,1,0
6,GO SEX DETERMINATION,1.3909e-05,-0.53066,-0.50951,1,0
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,5.7533e-06,-0.53069,-0.5977,1,0
6,GO MONOAMINE TRANSPORT,0.00014989,-0.53076,-0.49778,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00020554,-0.53076,-0.61328,1,0
6,GO CALCINEURIN MEDIATED SIGNALING,5.7533e-06,-0.53079,-0.54664,1,0
6,GO AGING,4.9495e-06,-0.53084,-0.53357,1,0
6,GO REGULATION OF METAL ION TRANSPORT,6.6813e-06,-0.53092,-0.52083,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION,8.3461e-06,-0.53103,-0.50432,1,0
6,GO SYNAPTIC VESICLE MATURATION,0.0049572,-0.53113,-0.55129,1,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.9495e-06,-0.53133,-0.53446,1,0
6,GO RNA POLYADENYLATION,5.6086e-05,-0.53134,-0.53728,1,0
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,3.0304e-05,-0.53135,-0.50555,1,0
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,4.9495e-06,-0.53143,-0.54096,1,0
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,1.6059e-05,-0.53148,-0.57463,1,0
6,GO NOREPINEPHRINE TRANSPORT,0.00020554,-0.53153,-0.58231,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,9.5377e-05,-0.5316,-0.51037,1,0
6,GO MEMBRANE ORGANIZATION,5.337e-06,-0.53161,-0.55471,1,0
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,2.1347e-05,-0.53174,-0.53152,1,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,1.1191e-05,-0.5318,-0.54345,1,0
6,GO REGULATION OF STEROID METABOLIC PROCESS,4.5891e-06,-0.53193,-0.54409,1,0
6,GO REGULATION OF CYTOKINESIS,8.9843e-06,-0.53196,-0.55298,1,0
6,GO REGULATION OF B CELL PROLIFERATION,0.00013188,-0.53202,-0.66856,1,0
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,1.7249e-05,-0.5322,-0.52293,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.53235,-0.5807,1,0
6,GO LAYER FORMATION IN CEREBRAL CORTEX,9.6689e-06,-0.53245,-0.68878,1,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.7287e-05,-0.53246,-0.61383,1,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,7.3279e-05,-0.53259,-0.59451,1,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,4.2763e-05,-0.53265,-0.55867,1,0
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,3.7287e-05,-0.5327,-0.57433,1,0
6,GO REGULATION OF HISTONE PHOSPHORYLATION,3.4805e-05,-0.53278,-0.51548,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00045436,-0.53281,-0.6192,1,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017019,-0.53316,-0.56928,1,0
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,3.9936e-05,-0.5333,-0.52793,1,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0012071,-0.53336,-0.57681,1,0
6,GO RETINA LAYER FORMATION,0.00010181,-0.53336,-0.56704,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION,2.1347e-05,-0.5334,-0.62025,1,0
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,4.5891e-06,-0.53348,-0.50235,1,0
6,GO RESPONSE TO NITROGEN COMPOUND,5.7533e-06,-0.5335,-0.5418,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.1347e-05,-0.53384,-0.58645,1,0
6,GO PHAGOSOME MATURATION,5.7533e-06,-0.53389,-0.54575,1,0
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00018128,-0.5339,-0.58232,1,0
6,GO POSITIVE REGULATION OF DNA REPLICATION,1.0403e-05,-0.53396,-0.52458,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.53403,-0.64855,1,0
6,GO RESPONSE TO LIPID,5.7533e-06,-0.53405,-0.53563,1,0
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,5.7533e-06,-0.53414,-0.52335,1,0
6,GO MUSCLE FIBER DEVELOPMENT,1.1191e-05,-0.53421,-0.5349,1,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00019306,-0.53424,-0.5768,1,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,3.0304e-05,-0.53429,-0.53026,1,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,4.2539e-06,-0.53437,-0.55039,1,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,7.7514e-06,-0.53438,-0.63596,1,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.53452,-0.54376,1,0
6,GO POSITIVE REGULATION OF CELL DEATH,6.2007e-06,-0.53452,-0.54212,1,0
6,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0052065,-0.5347,-0.63639,1,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,4.5891e-06,-0.53496,-0.58003,1,0
6,GO REGULATION OF INTEGRIN ACTIVATION,0.00010866,-0.535,-0.57915,1,0
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.1191e-05,-0.53502,-0.51276,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.2939e-05,-0.5351,-0.49421,1,0
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00014989,-0.53515,-0.72535,1,0
6,GO MACROPHAGE ACTIVATION,6.4139e-05,-0.53516,-0.65837,1,0
6,GO AXO DENDRITIC TRANSPORT,3.7287e-05,-0.5352,-0.60642,1,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.1973e-06,-0.53525,-0.57268,1,0
6,GO TELENCEPHALON DEVELOPMENT,8.9843e-06,-0.53534,-0.55814,1,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.2428e-05,-0.53539,-0.64008,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,6.6813e-06,-0.53542,-0.50258,1,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.53547,-0.5979,1,0
6,GO GRANULOCYTE DIFFERENTIATION,1.4947e-05,-0.53554,-0.63555,1,0
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,6.8565e-05,-0.53556,-0.48512,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,5.7533e-06,-0.53563,-0.53487,1,0
6,GO SULFATE TRANSPORT,2.4576e-05,-0.53564,-0.50098,1,0
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00017019,-0.53572,-0.61126,1,0
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,1.2939e-05,-0.53572,-0.50093,1,0
6,GO LABYRINTHINE LAYER DEVELOPMENT,1.0403e-05,-0.53578,-0.58162,1,0
6,GO SERTOLI CELL DIFFERENTIATION,6.2007e-06,-0.53578,-0.62196,1,0
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,4.2539e-06,-0.53579,-0.54883,1,0
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,5.2428e-05,-0.53583,-0.51215,1,0
6,GO MEMORY,1.1191e-05,-0.53589,-0.52622,1,0
6,GO VITAMIN D METABOLIC PROCESS,1.9888e-05,-0.53616,-0.59858,1,0
6,GO SENSORY ORGAN MORPHOGENESIS,7.1973e-06,-0.5362,-0.5311,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.53623,-0.56393,1,0
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.2035e-05,-0.53631,-0.58367,1,0
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,1.2035e-05,-0.53632,-0.49527,1,0
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,7.3279e-05,-0.53636,-0.53754,1,0
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00014989,-0.5364,-0.53979,1,0
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,2.1347e-05,-0.5365,-0.5321,1,0
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,4.2539e-06,-0.53653,-0.52896,1,0
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.5779e-05,-0.53662,-0.57639,1,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,5.7533e-06,-0.53663,-0.54131,1,0
6,GO LYMPHOCYTE HOMEOSTASIS,1.1191e-05,-0.53667,-0.57262,1,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.53672,-0.59283,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.337e-06,-0.53689,-0.58718,1,0
6,GO RESPONSE TO HYDROGEN PEROXIDE,1.2939e-05,-0.53696,-0.48736,1,0
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00045436,-0.53699,-0.54899,1,0
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.8267e-05,-0.53709,-0.66848,1,0
6,GO MELANOCYTE DIFFERENTIATION,5.7533e-06,-0.53714,-0.54311,1,0
6,GO CELLULAR RESPONSE TO LIPID,4.9495e-06,-0.53721,-0.54839,1,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.7287e-05,-0.53723,-0.59223,1,0
6,GO REGULATION OF GLUCONEOGENESIS,5.337e-06,-0.53727,-0.59612,1,0
6,GO POLYOL METABOLIC PROCESS,4.9495e-06,-0.53729,-0.53466,1,0
6,GO RESPONSE TO PAIN,6.6813e-06,-0.5373,-0.55658,1,0
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,9.6689e-06,-0.5373,-0.55364,1,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.7249e-05,-0.53732,-0.60532,1,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00011593,-0.53739,-0.54168,1,0
6,GO AMELOGENESIS,1.7249e-05,-0.53742,-0.56819,1,0
6,GO PHOSPHOLIPID TRANSPORT,4.9495e-06,-0.53749,-0.58835,1,0
6,GO VISUAL BEHAVIOR,1.1191e-05,-0.53752,-0.525,1,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,3.0304e-05,-0.53774,-0.51685,1,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.0403e-05,-0.53777,-0.55535,1,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,9.5377e-05,-0.53782,-0.64972,1,0
6,GO POSITIVE REGULATION OF SIGNALING,5.337e-06,-0.53783,-0.54679,1,0
6,GO RESPONSE TO ESTRADIOL,7.1973e-06,-0.5379,-0.52886,1,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.9888e-05,-0.53807,-0.58089,1,0
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,5.9985e-05,-0.53807,-0.59277,1,0
6,GO CEREBELLAR CORTEX FORMATION,7.3279e-05,-0.53812,-0.5292,1,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,8.3461e-06,-0.53836,-0.61776,1,0
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.2007e-06,-0.53839,-0.53057,1,0
6,GO CELLULAR RESPONSE TO ATP,1.3909e-05,-0.53847,-0.51298,1,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.53851,-0.58274,1,0
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.9495e-06,-0.53858,-0.55776,1,0
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.2763e-05,-0.53865,-0.57964,1,0
6,GO AMYLOID FIBRIL FORMATION,1.2035e-05,-0.53876,-0.62657,1,0
6,GO RESPONSE TO STEROID HORMONE,5.337e-06,-0.53877,-0.5417,1,0
6,GO SYNCYTIUM FORMATION,1.7249e-05,-0.53877,-0.62783,1,0
6,GO THYMIC T CELL SELECTION,0.0017696,-0.53881,-0.58994,1,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.9495e-06,-0.53892,-0.53277,1,0
6,GO COLLECTING DUCT DEVELOPMENT,0.00014989,-0.539,-0.55464,1,0
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00040321,-0.53903,-0.57856,1,0
6,GO RESPONSE TO TEMPERATURE STIMULUS,8.3461e-06,-0.53911,-0.51788,1,0
6,GO FATTY ACID DERIVATIVE TRANSPORT,6.6813e-06,-0.53913,-0.53887,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.53921,-0.54177,1,0
6,GO ORGANELLE FUSION,1.1191e-05,-0.53934,-0.57092,1,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.7514e-06,-0.53937,-0.58891,1,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.337e-06,-0.53938,-0.55133,1,0
6,GO PEPTIDYL LYSINE MODIFICATION,5.7533e-06,-0.5394,-0.56013,1,0
6,GO HISTONE H3 K14 ACETYLATION,6.6813e-06,-0.5394,-0.60875,1,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,4.9495e-06,-0.53952,-0.55464,1,0
6,GO REGULATION OF HEAT GENERATION,0.00011593,-0.53956,-0.48251,1,0
6,GO REGULATION OF TOR SIGNALING,4.2539e-06,-0.53956,-0.60091,1,0
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,8.9843e-06,-0.53956,-0.54799,1,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.00035748,-0.53964,-0.54049,1,0
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0403e-05,-0.53964,-0.6721,1,0
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,3.0304e-05,-0.53965,-0.6404,1,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.7533e-06,-0.53983,-0.54809,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.010101,-0.53983,-0.6796,1,0
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00013188,-0.54015,-0.46985,1,0
6,GO CELLULAR RESPONSE TO CAMP,1.2035e-05,-0.54017,-0.50096,1,0
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.5402,-0.56673,1,0
6,GO ANION TRANSPORT,5.7533e-06,-0.54022,-0.51127,1,0
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,5.9985e-05,-0.54033,-0.48074,1,0
6,GO GOLGI VESICLE TRANSPORT,6.6813e-06,-0.54058,-0.55259,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.9936e-05,-0.54063,-0.61429,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1191e-05,-0.54069,-0.55829,1,0
6,GO REGULATION OF CARDIAC CONDUCTION,2.8267e-05,-0.5407,-0.49073,1,0
6,GO EMBRYONIC ORGAN MORPHOGENESIS,7.1973e-06,-0.54084,-0.56249,1,0
6,GO GLIAL CELL FATE COMMITMENT,0.00057531,-0.5409,-0.48365,1,0
6,GO BODY FLUID SECRETION,1.3909e-05,-0.54097,-0.4715,1,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.1191e-05,-0.54098,-0.62728,1,0
6,GO HEAD DEVELOPMENT,7.7514e-06,-0.54104,-0.56523,1,0
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,5.337e-06,-0.54105,-0.53703,1,0
6,GO MEMBRANE BIOGENESIS,1.2035e-05,-0.54106,-0.57112,1,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,4.5891e-06,-0.54108,-0.55792,1,0
6,GO RESPONSE TO VITAMIN,8.3461e-06,-0.54132,-0.57564,1,0
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,6.2007e-06,-0.54135,-0.56324,1,0
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,9.6689e-06,-0.54137,-0.58146,1,0
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,2.1347e-05,-0.54153,-0.52104,1,0
6,GO REGULATION OF CATABOLIC PROCESS,4.9495e-06,-0.54154,-0.53442,1,0
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.1191e-05,-0.54164,-0.5189,1,0
6,GO CELL AGING,6.2007e-06,-0.54179,-0.49695,1,0
6,GO SOMITE DEVELOPMENT,4.9495e-06,-0.5418,-0.5502,1,0
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,4.5891e-06,-0.54181,-0.55107,1,0
6,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0092139,-0.54182,-0.78152,1,0
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.54183,-0.531,1,0
6,GO STORE OPERATED CALCIUM ENTRY,4.2763e-05,-0.54188,-0.57665,1,0
6,GO PIGMENTATION,7.7514e-06,-0.5419,-0.47384,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.3909e-05,-0.54194,-0.5057,1,0
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,4.2539e-06,-0.54195,-0.52911,1,0
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,4.2763e-05,-0.54212,-0.50917,1,0
6,GO OSTEOCLAST DIFFERENTIATION,1.0403e-05,-0.54216,-0.62792,1,0
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00026348,-0.54219,-0.50187,1,0
6,GO REGULATION OF CELLULAR LOCALIZATION,5.337e-06,-0.54226,-0.56536,1,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00014989,-0.54229,-0.60222,1,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.9422e-06,-0.54229,-0.54886,1,0
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.3461e-06,-0.54231,-0.6087,1,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,2.8267e-05,-0.54242,-0.55249,1,0
6,GO MESONEPHROS DEVELOPMENT,8.9843e-06,-0.54244,-0.53066,1,0
6,GO AXONAL TRANSPORT,3.248e-05,-0.5425,-0.61956,1,0
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,4.5891e-06,-0.54251,-0.5613,1,0
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,4.2539e-06,-0.54258,-0.5633,1,0
6,GO ANION HOMEOSTASIS,5.337e-06,-0.54265,-0.56275,1,0
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,6.2007e-06,-0.54271,-0.55398,1,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.6059e-05,-0.54273,-0.60916,1,0
6,GO REGULATION OF RECEPTOR BINDING,2.2907e-05,-0.54288,-0.62998,1,0
6,GO RESPONSE TO METAL ION,6.2007e-06,-0.5429,-0.49533,1,0
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.54293,-0.53672,1,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,6.2007e-06,-0.54302,-0.5478,1,0
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,6.6813e-06,-0.54303,-0.52931,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,5.2428e-05,-0.54303,-0.63063,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.337e-06,-0.54309,-0.5532,1,0
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00031664,-0.54314,-0.51082,1,0
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,5.7533e-06,-0.54316,-0.50676,1,0
6,GO SENSORY ORGAN DEVELOPMENT,7.1973e-06,-0.54321,-0.54331,1,0
6,GO INTERACTION WITH HOST,4.9495e-06,-0.54324,-0.56127,1,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.6689e-06,-0.54327,-0.55909,1,0
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,2.1347e-05,-0.5433,-0.55602,1,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,1.9888e-05,-0.5434,-0.51147,1,0
6,GO MICROVILLUS ORGANIZATION,5.2428e-05,-0.54341,-0.5206,1,0
6,GO MODULATION BY VIRUS OF HOST PROCESS,6.6813e-06,-0.54344,-0.53717,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.2763e-05,-0.54344,-0.59846,1,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,5.337e-06,-0.5435,-0.52487,1,0
6,GO AMYLOID BETA METABOLIC PROCESS,5.337e-06,-0.54359,-0.58048,1,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,4.9495e-06,-0.54372,-0.54628,1,0
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,6.6813e-06,-0.54376,-0.52579,1,0
6,GO FIBROBLAST PROLIFERATION,6.2007e-06,-0.54382,-0.56949,1,0
6,GO MOTILE CILIUM ASSEMBLY,0.00026348,-0.54382,-0.50823,1,0
6,GO SEGMENTATION,4.5891e-06,-0.54417,-0.54803,1,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.3279e-05,-0.54426,-0.62232,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00048214,-0.54427,-0.57733,1,0
6,GO LIPID LOCALIZATION,4.9495e-06,-0.5443,-0.53552,1,0
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.8267e-05,-0.54436,-0.47371,1,0
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.2035e-05,-0.54474,-0.58331,1,0
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,2.4576e-05,-0.54495,-0.55132,1,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.9985e-05,-0.54497,-0.5779,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.6059e-05,-0.54503,-0.47156,1,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,3.7287e-05,-0.54503,-0.57376,1,0
6,GO CELLULAR EXTRAVASATION,3.9936e-05,-0.54509,-0.66298,1,0
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,5.337e-06,-0.54516,-0.54553,1,0
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,4.9495e-06,-0.54526,-0.57278,1,0
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,1.1191e-05,-0.54528,-0.52582,1,0
6,GO B CELL ACTIVATION,1.4947e-05,-0.54535,-0.61383,1,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,3.9422e-06,-0.5455,-0.56071,1,0
6,GO SECRETORY GRANULE ORGANIZATION,1.8524e-05,-0.54562,-0.53713,1,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.2907e-05,-0.54564,-0.60475,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,-0.54581,-0.61951,1,0
6,GO RENAL TUBULE DEVELOPMENT,5.7533e-06,-0.54585,-0.57487,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.337e-06,-0.54587,-0.5484,1,0
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,4.5779e-05,-0.5459,-0.60173,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.6813e-06,-0.5459,-0.54698,1,0
6,GO REGULATION OF CHEMOTAXIS,2.4576e-05,-0.54595,-0.58012,1,0
6,GO REGULATION OF ORGANELLE ORGANIZATION,4.9495e-06,-0.54606,-0.56105,1,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,2.2907e-05,-0.54611,-0.55557,1,0
6,GO PEPTIDYL LYSINE METHYLATION,8.3461e-06,-0.54625,-0.57225,1,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,6.2007e-06,-0.54635,-0.6279,1,0
6,GO ACYLGLYCEROL HOMEOSTASIS,6.6813e-06,-0.54648,-0.53598,1,0
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.8524e-05,-0.54653,-0.58308,1,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,6.6813e-06,-0.54655,-0.57869,1,0
6,GO CERAMIDE TRANSPORT,6.6813e-06,-0.54677,-0.61358,1,0
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,5.337e-06,-0.54686,-0.55448,1,0
6,GO RESPONSE TO IRON ION,9.6689e-06,-0.54693,-0.54245,1,0
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.4576e-05,-0.54703,-0.69946,1,0
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,4.5779e-05,-0.5472,-0.58589,1,0
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,7.1973e-06,-0.54722,-0.51711,1,0
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,5.337e-06,-0.54739,-0.55359,1,0
6,GO PEPTIDYL LYSINE ACETYLATION,6.2007e-06,-0.54741,-0.57087,1,0
6,GO CELL AGGREGATION,0.00057531,-0.54751,-0.4602,1,0
6,GO MYELOID CELL APOPTOTIC PROCESS,3.0304e-05,-0.54753,-0.54502,1,0
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,1.6059e-05,-0.54755,-0.56652,1,0
6,GO LIPID GLYCOSYLATION,6.2007e-06,-0.54757,-0.63207,1,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.9985e-05,-0.54759,-0.59368,1,0
6,GO CELL PROJECTION ASSEMBLY,1.0403e-05,-0.5476,-0.53829,1,0
6,GO CLATHRIN COAT ASSEMBLY,6.2007e-06,-0.54763,-0.60035,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.4576e-05,-0.54772,-0.53732,1,0
6,GO ORGANIC ANION TRANSPORT,5.7533e-06,-0.54777,-0.51393,1,0
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,5.7533e-06,-0.54778,-0.54019,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.1973e-06,-0.54788,-0.56881,1,0
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.0403e-05,-0.5479,-0.58559,1,0
6,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00068502,-0.54799,-0.57112,1,0
6,GO CELL FATE COMMITMENT,7.7514e-06,-0.548,-0.52314,1,0
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,1.6059e-05,-0.54817,-0.53531,1,0
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,5.337e-06,-0.54822,-0.54865,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.337e-06,-0.54822,-0.56696,1,0
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,7.1973e-06,-0.54831,-0.53566,1,0
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,4.2539e-06,-0.54845,-0.55973,1,0
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,6.2007e-06,-0.54847,-0.55758,1,0
6,GO LATERAL MESODERM DEVELOPMENT,5.9985e-05,-0.54851,-0.48219,1,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.9495e-06,-0.54856,-0.53577,1,0
6,GO SMOOTHENED SIGNALING PATHWAY,1.1191e-05,-0.54861,-0.54061,1,0
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,3.4805e-05,-0.54872,-0.56346,1,0
6,GO GLIAL CELL ACTIVATION,0.00024771,-0.54877,-0.67456,1,0
6,GO HISTONE H4 K5 ACETYLATION,1.3909e-05,-0.5488,-0.61258,1,0
6,GO RESPONSE TO DSRNA,1.2035e-05,-0.5488,-0.54976,1,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,3.248e-05,-0.54884,-0.65367,1,0
6,GO SEQUESTERING OF CALCIUM ION,1.0403e-05,-0.54884,-0.57154,1,0
6,GO INOSITOL METABOLIC PROCESS,0.00021879,-0.54933,-0.5386,1,0
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,1.2035e-05,-0.54939,-0.60504,1,0
6,GO SYNAPSE ORGANIZATION,8.3461e-06,-0.54939,-0.59783,1,0
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,6.6813e-06,-0.54939,-0.53319,1,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,8.3461e-06,-0.54948,-0.54586,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,7.7514e-06,-0.54981,-0.55402,1,0
6,GO ENSHEATHMENT OF NEURONS,6.2007e-06,-0.54984,-0.54851,1,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,1.0403e-05,-0.54989,-0.60643,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,4.2539e-06,-0.54992,-0.54346,1,0
6,GO PROTEIN AUTO ADP RIBOSYLATION,2.2907e-05,-0.54995,-0.61499,1,0
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.55,-0.57381,1,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.5891e-06,-0.55004,-0.56824,1,0
6,GO LIPID MODIFICATION,4.2539e-06,-0.55006,-0.53713,1,0
6,GO NERVE DEVELOPMENT,8.9843e-06,-0.55012,-0.62538,1,0
6,GO HISTONE H4 ACETYLATION,8.3461e-06,-0.55018,-0.59325,1,0
6,GO PROTEIN SUMOYLATION,7.1973e-06,-0.5502,-0.55713,1,0
6,GO INTERLEUKIN 13 PRODUCTION,0.0054671,-0.55022,-0.50754,1,0
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00035748,-0.55028,-0.50945,1,0
6,GO POSITIVE T CELL SELECTION,0.0011418,-0.55029,-0.62428,1,0
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,7.1973e-06,-0.55035,-0.52488,1,0
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,2.4576e-05,-0.55045,-0.54537,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,1.8524e-05,-0.55049,-0.65562,1,0
6,GO REGULATION OF TRANSPORT,5.7533e-06,-0.55062,-0.53253,1,0
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.7249e-05,-0.55063,-0.56307,1,0
6,GO CELLULAR GLUCOSE HOMEOSTASIS,5.7533e-06,-0.55082,-0.56067,1,0
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,7.7514e-06,-0.55083,-0.49867,1,0
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,4.9495e-06,-0.55083,-0.56085,1,0
6,GO RESPONSE TO KETONE,9.6689e-06,-0.55097,-0.52909,1,0
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,5.6086e-05,-0.55101,-0.63456,1,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,7.7514e-06,-0.55101,-0.61467,1,0
6,GO NEGATIVE REGULATION OF SIGNALING,5.337e-06,-0.55106,-0.56534,1,0
6,GO FORELIMB MORPHOGENESIS,4.8997e-05,-0.55107,-0.49679,1,0
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.55118,-0.54685,1,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.5891e-06,-0.55123,-0.58739,1,0
6,GO REGULATION OF MITOCHONDRIAL FISSION,7.1973e-06,-0.55131,-0.57645,1,0
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.337e-06,-0.55141,-0.55795,1,0
6,GO PHOSPHOLIPID METABOLIC PROCESS,4.2539e-06,-0.55147,-0.55557,1,0
6,GO NEGATIVE REGULATION OF COAGULATION,0.00012367,-0.55149,-0.59306,1,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,7.1973e-06,-0.55151,-0.5723,1,0
6,GO REGULATION OF HAIR CYCLE,3.7287e-05,-0.55168,-0.51539,1,0
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.7533e-06,-0.55169,-0.55042,1,0
6,GO REGULATION OF MACROAUTOPHAGY,5.7533e-06,-0.55173,-0.56902,1,0
6,GO ORGANELLE INHERITANCE,2.8267e-05,-0.55174,-0.52092,1,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,9.6689e-06,-0.55179,-0.51458,1,0
6,GO OLIGODENDROCYTE DEVELOPMENT,4.5891e-06,-0.55185,-0.58372,1,0
6,GO ASSOCIATIVE LEARNING,7.1973e-06,-0.55188,-0.53719,1,0
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,7.1973e-06,-0.55189,-0.57254,1,0
6,GO RHYTHMIC BEHAVIOR,6.2007e-06,-0.55195,-0.56147,1,0
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.4947e-05,-0.552,-0.63924,1,0
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.9888e-05,-0.55208,-0.53707,1,0
6,GO RENAL VESICLE DEVELOPMENT,1.8524e-05,-0.55209,-0.57087,1,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,1.4947e-05,-0.55212,-0.58573,1,0
6,GO REGULATION OF SPINDLE ASSEMBLY,0.00013188,-0.55212,-0.4434,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.3461e-06,-0.55226,-0.57384,1,0
6,GO RESPONSE TO ATP,8.3461e-06,-0.5523,-0.53947,1,0
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.55231,-0.59202,1,0
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00060992,-0.55253,-0.62425,1,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,8.3461e-06,-0.55274,-0.54522,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.636e-05,-0.55277,-0.62589,1,0
6,GO MEMBRANE DISASSEMBLY,7.7514e-06,-0.55288,-0.63454,1,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.55297,-0.53631,1,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,4.9495e-06,-0.55306,-0.54702,1,0
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,4.5779e-05,-0.5531,-0.58104,1,0
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00023283,-0.55319,-0.66689,1,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,1.2035e-05,-0.55329,-0.52256,1,0
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012367,-0.55331,-0.72046,1,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,1.3909e-05,-0.55336,-0.53459,1,0
6,GO LIPID HOMEOSTASIS,4.2539e-06,-0.55367,-0.53928,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00068502,-0.55374,-0.47962,1,0
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,3.248e-05,-0.55375,-0.52368,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.3909e-05,-0.55389,-0.63721,1,0
6,GO REGULATION OF ORGAN GROWTH,7.7514e-06,-0.55397,-0.53613,1,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,7.7514e-06,-0.55402,-0.54204,1,0
6,GO NOREPINEPHRINE SECRETION,0.00024771,-0.55403,-0.5502,1,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,5.337e-06,-0.55406,-0.57596,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00014989,-0.5541,-0.57977,1,0
6,GO ACTIN MEDIATED CELL CONTRACTION,1.0403e-05,-0.55411,-0.53303,1,0
6,GO OVARIAN FOLLICLE DEVELOPMENT,1.1191e-05,-0.55416,-0.49156,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,5.7533e-06,-0.55429,-0.57117,1,0
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,7.7514e-06,-0.55431,-0.64793,1,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.1347e-05,-0.55437,-0.65819,1,0
6,GO GLUCOSE IMPORT,4.9495e-06,-0.55445,-0.5239,1,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00028019,-0.55445,-0.60121,1,0
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,5.7533e-06,-0.55452,-0.54902,1,0
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,3.9422e-06,-0.55455,-0.5924,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.3461e-06,-0.55455,-0.66647,1,0
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.9495e-06,-0.55456,-0.57954,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,6.8565e-05,-0.55466,-0.56946,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,5.337e-06,-0.55474,-0.56905,1,0
6,GO MICROTUBULE DEPOLYMERIZATION,5.6086e-05,-0.55474,-0.63925,1,0
6,GO VESICLE ORGANIZATION,6.2007e-06,-0.55478,-0.55775,1,0
6,GO REGULATION OF ENDOCRINE PROCESS,9.6689e-06,-0.55479,-0.51051,1,0
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,4.8997e-05,-0.55481,-0.53377,1,0
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00021879,-0.55487,-0.61965,1,0
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.2939e-05,-0.55494,-0.57033,1,0
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,1.3909e-05,-0.55495,-0.59257,1,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,3.9422e-06,-0.55499,-0.65586,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.2539e-06,-0.55509,-0.55451,1,0
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,8.3461e-06,-0.55519,-0.55708,1,0
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.1191e-05,-0.55522,-0.53913,1,0
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.55532,-0.5839,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00013188,-0.55534,-0.62893,1,0
6,GO IMMUNE SYSTEM DEVELOPMENT,5.7533e-06,-0.55535,-0.56826,1,0
6,GO FOREBRAIN DEVELOPMENT,8.3461e-06,-0.55551,-0.56311,1,0
6,GO REGULATION OF ERAD PATHWAY,1.0403e-05,-0.55552,-0.56012,1,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,1.6059e-05,-0.55563,-0.53481,1,0
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.8298e-05,-0.55571,-0.50503,1,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.337e-06,-0.55575,-0.57108,1,0
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,2.1347e-05,-0.55577,-0.67922,1,0
6,GO EPITHELIUM DEVELOPMENT,6.6813e-06,-0.55577,-0.53217,1,0
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.5558,-0.57361,1,0
6,GO REGULATION OF PHOSPHORYLATION,5.337e-06,-0.55601,-0.56992,1,0
6,GO REGULATION OF DEPHOSPHORYLATION,4.9495e-06,-0.55601,-0.59834,1,0
6,GO ORGANELLE MEMBRANE FUSION,8.3461e-06,-0.55613,-0.60411,1,0
6,GO MALE SEX DIFFERENTIATION,4.5891e-06,-0.55621,-0.55363,1,0
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,5.337e-06,-0.55622,-0.52507,1,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,5.7533e-06,-0.55623,-0.57532,1,0
6,GO SNARE COMPLEX ASSEMBLY,2.8267e-05,-0.5563,-0.56379,1,0
6,GO ANATOMICAL STRUCTURE MATURATION,7.7514e-06,-0.55631,-0.54438,1,0
6,GO NEURON MIGRATION,7.1973e-06,-0.5564,-0.62623,1,0
6,GO REGULATION OF SECRETION,5.7533e-06,-0.55652,-0.52828,1,0
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,6.6813e-06,-0.55674,-0.56868,1,0
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.55675,-0.58125,1,0
6,GO NEGATIVE REGULATION OF DNA REPAIR,1.6059e-05,-0.55685,-0.518,1,0
6,GO NEURONAL ION CHANNEL CLUSTERING,7.8298e-05,-0.55689,-0.5989,1,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,4.5891e-06,-0.55694,-0.60024,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,5.337e-06,-0.55708,-0.55853,1,0
6,GO TRANSEPITHELIAL TRANSPORT,6.2007e-06,-0.55715,-0.5635,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,5.7533e-06,-0.55716,-0.54794,1,0
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,8.9843e-06,-0.5572,-0.54537,1,0
6,GO CGMP METABOLIC PROCESS,0.00014062,-0.55731,-0.54896,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,6.2007e-06,-0.55733,-0.57894,1,0
6,GO LEUKOCYTE HOMEOSTASIS,9.6689e-06,-0.55734,-0.6062,1,0
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.2939e-05,-0.55747,-0.60899,1,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,4.2763e-05,-0.5575,-0.68531,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,4.9495e-06,-0.55751,-0.58852,1,0
6,GO CIRCADIAN RHYTHM,7.7514e-06,-0.55756,-0.54728,1,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.3641e-05,-0.55758,-0.4806,1,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.636e-05,-0.55758,-0.64594,1,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0019699,-0.55773,-0.67392,1,0
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.9327e-05,-0.55773,-0.55361,1,0
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.55779,-0.54826,1,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.7533e-06,-0.55786,-0.62149,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,8.3461e-06,-0.55812,-0.60085,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,6.2007e-06,-0.55817,-0.55204,1,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,1.2035e-05,-0.55821,-0.64255,1,0
6,GO POSITIVE REGULATION OF HEART GROWTH,4.9495e-06,-0.55821,-0.54706,1,0
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,4.2539e-06,-0.55834,-0.55356,1,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,5.7533e-06,-0.5584,-0.61514,1,0
6,GO MEMBRANE FISSION,1.8524e-05,-0.55844,-0.61921,1,0
6,GO POLYOL CATABOLIC PROCESS,2.4576e-05,-0.55854,-0.51158,1,0
6,GO RESPONSE TO REDOX STATE,7.8298e-05,-0.55857,-0.51129,1,0
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.006955,-0.5586,-0.67244,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,5.337e-06,-0.55874,-0.57448,1,0
6,GO NEUROBLAST PROLIFERATION,1.6059e-05,-0.55886,-0.57509,1,0
6,GO RESPONSE TO INTERLEUKIN 7,1.1191e-05,-0.55888,-0.62645,1,0
6,GO ER OVERLOAD RESPONSE,5.6086e-05,-0.55888,-0.4749,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00026348,-0.55897,-0.49834,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.55903,-0.58515,1,0
6,GO SYNAPTIC VESICLE RECYCLING,1.4947e-05,-0.55906,-0.62107,1,0
6,GO REGULATION OF TELOMERE MAINTENANCE,8.9843e-06,-0.55914,-0.53543,1,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.4947e-05,-0.5592,-0.53536,1,0
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00072571,-0.55921,-0.50727,1,0
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.1191e-05,-0.55927,-0.52592,1,0
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,5.7533e-06,-0.55957,-0.59065,1,0
6,GO DEVELOPMENTAL PIGMENTATION,7.7514e-06,-0.55966,-0.4984,1,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,1.2035e-05,-0.55972,-0.52597,1,0
6,GO DOSAGE COMPENSATION,3.0304e-05,-0.55972,-0.58708,1,0
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,8.3461e-06,-0.55974,-0.59848,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.7533e-06,-0.5598,-0.56663,1,0
6,GO ADAPTIVE THERMOGENESIS,6.2007e-06,-0.55987,-0.54402,1,0
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,7.3279e-05,-0.56003,-0.64026,1,0
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.9888e-05,-0.56013,-0.56719,1,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,7.7514e-06,-0.56032,-0.5732,1,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.00012367,-0.56038,-0.51493,1,0
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.0403e-05,-0.56045,-0.54129,1,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.4947e-05,-0.56046,-0.54626,1,0
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,1.3909e-05,-0.5605,-0.53607,1,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00057531,-0.56057,-0.48642,1,0
6,GO REGULATION OF EXOCYTOSIS,8.9843e-06,-0.56061,-0.58679,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.2539e-06,-0.56077,-0.59187,1,0
6,GO RESPONSE TO ACETYLCHOLINE,0.00015974,-0.56077,-0.5626,1,0
6,GO NEGATIVE REGULATION OF CELL AGING,6.2007e-06,-0.56078,-0.55014,1,0
6,GO CERAMIDE METABOLIC PROCESS,3.9422e-06,-0.56082,-0.60373,1,0
6,GO SYNAPTIC TRANSMISSION GABAERGIC,7.7514e-06,-0.56097,-0.54336,1,0
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.9495e-06,-0.56102,-0.55072,1,0
6,GO REGULATION OF RECEPTOR RECYCLING,4.5891e-06,-0.56104,-0.56833,1,0
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.5891e-06,-0.56115,-0.55856,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0083971,-0.56124,-0.56203,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.9495e-06,-0.56124,-0.56622,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,5.337e-06,-0.5615,-0.56537,1,0
6,GO VESICLE DOCKING,2.1347e-05,-0.56176,-0.58332,1,0
6,GO PROTEIN DESTABILIZATION,4.9495e-06,-0.56177,-0.59829,1,0
6,GO HYPEROSMOTIC RESPONSE,2.2907e-05,-0.56183,-0.54901,1,0
6,GO REGULATION OF HYDROLASE ACTIVITY,5.337e-06,-0.56185,-0.5626,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,5.337e-06,-0.5619,-0.57245,1,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.6059e-05,-0.56207,-0.61501,1,0
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,1.3909e-05,-0.56208,-0.57584,1,0
6,GO VESICLE LOCALIZATION,7.7514e-06,-0.56218,-0.56602,1,0
6,GO MUSCLE ORGAN DEVELOPMENT,1.0403e-05,-0.5622,-0.53793,1,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,6.6813e-06,-0.56222,-0.53912,1,0
6,GO DENDRITIC SPINE MORPHOGENESIS,1.7249e-05,-0.56256,-0.58443,1,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,7.1973e-06,-0.56263,-0.63565,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,5.337e-06,-0.56265,-0.59948,1,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.2939e-05,-0.56273,-0.5296,1,0
6,GO VESICLE CARGO LOADING,8.9843e-06,-0.56273,-0.57511,1,0
6,GO PROTEIN LOCALIZATION TO NUCLEUS,4.5891e-06,-0.56275,-0.54413,1,0
6,GO CALCIUM ION IMPORT,1.1191e-05,-0.56277,-0.54851,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,5.337e-06,-0.56285,-0.5661,1,0
6,GO PROTEIN HYDROXYLATION,3.248e-05,-0.5629,-0.56498,1,0
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,4.2539e-06,-0.56291,-0.57849,1,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,1.0403e-05,-0.56296,-0.58165,1,0
6,GO RESPONSE TO MONOSACCHARIDE,5.337e-06,-0.56297,-0.55094,1,0
6,GO RESPONSE TO ORGANOPHOSPHORUS,9.6689e-06,-0.56301,-0.52591,1,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,6.2007e-06,-0.56301,-0.57056,1,0
6,GO NEPHRON MORPHOGENESIS,8.3461e-06,-0.56305,-0.55933,1,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,1.6059e-05,-0.56312,-0.48008,1,0
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,6.2007e-06,-0.56319,-0.51028,1,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.1347e-05,-0.56319,-0.55595,1,0
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,4.9495e-06,-0.56319,-0.56736,1,0
6,GO IRON COORDINATION ENTITY TRANSPORT,0.00012367,-0.56342,-0.53477,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.0403e-05,-0.56346,-0.53621,1,0
6,GO CELLULAR RESPONSE TO KETONE,1.3909e-05,-0.56349,-0.52186,1,0
6,GO GENETIC IMPRINTING,2.1347e-05,-0.56351,-0.55285,1,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,8.3461e-06,-0.56355,-0.53363,1,0
6,GO REGULATION OF GLIAL CELL MIGRATION,5.2428e-05,-0.56376,-0.69651,1,0
6,GO FOAM CELL DIFFERENTIATION,1.2939e-05,-0.56387,-0.6001,1,0
6,GO RECEPTOR RECYCLING,4.9495e-06,-0.56393,-0.56737,1,0
6,GO HEART PROCESS,1.2035e-05,-0.5641,-0.51675,1,0
6,GO NEURON DEATH,4.5891e-06,-0.56419,-0.57016,1,0
6,GO PIGMENT CELL DIFFERENTIATION,8.3461e-06,-0.56427,-0.53233,1,0
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.5643,-0.5413,1,0
6,GO SKELETAL MUSCLE ADAPTATION,1.9888e-05,-0.56443,-0.53834,1,0
6,GO UTERUS DEVELOPMENT,3.4805e-05,-0.56446,-0.51832,1,0
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00014989,-0.5645,-0.6203,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.0403e-05,-0.5646,-0.57054,1,0
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,4.9495e-06,-0.56487,-0.57469,1,0
6,GO MATURE B CELL DIFFERENTIATION,3.9936e-05,-0.56508,-0.728,1,0
6,GO ECTODERM DEVELOPMENT,2.2907e-05,-0.5651,-0.46109,1,0
6,GO PEPTIDE SECRETION,6.6813e-06,-0.5651,-0.54049,1,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,5.337e-06,-0.56513,-0.55864,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.7514e-06,-0.56518,-0.53512,1,0
6,GO CALCIUM ION IMPORT INTO CYTOSOL,8.9327e-05,-0.56519,-0.57891,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.5891e-06,-0.56522,-0.57591,1,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.9495e-06,-0.56528,-0.5493,1,0
6,GO RHYTHMIC PROCESS,7.1973e-06,-0.56529,-0.55525,1,0
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.4805e-05,-0.56529,-0.57349,1,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,5.337e-06,-0.56532,-0.56518,1,0
6,GO MESODERM DEVELOPMENT,6.6813e-06,-0.56551,-0.52189,1,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,5.9985e-05,-0.56566,-0.66591,1,0
6,GO REGULATION OF RESPONSE TO WOUNDING,5.337e-06,-0.56575,-0.60039,1,0
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.4947e-05,-0.56576,-0.54055,1,0
6,GO MIDGUT DEVELOPMENT,7.7514e-06,-0.56577,-0.6011,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00091199,-0.56582,-0.6177,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.337e-06,-0.5659,-0.57854,1,0
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.337e-06,-0.56621,-0.56455,1,0
6,GO INTERMEMBRANE LIPID TRANSFER,3.9422e-06,-0.56622,-0.61432,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,6.2007e-06,-0.56636,-0.55329,1,0
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,7.1973e-06,-0.56641,-0.57511,1,0
6,GO PROTEIN PALMITOYLATION,0.00012367,-0.56658,-0.51473,1,0
6,GO NEGATIVE REGULATION OF WOUND HEALING,1.1191e-05,-0.56674,-0.59834,1,0
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.2907e-05,-0.56677,-0.57629,1,0
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.337e-06,-0.56677,-0.5827,1,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,1.2939e-05,-0.56679,-0.55894,1,0
6,GO REGULATION OF LIPID METABOLIC PROCESS,4.5891e-06,-0.56679,-0.56829,1,0
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,7.1973e-06,-0.56686,-0.56361,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,8.9843e-06,-0.56686,-0.61573,1,0
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.56695,-0.60036,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,4.9495e-06,-0.56696,-0.58128,1,0
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,3.9422e-06,-0.56699,-0.58345,1,0
6,GO PRESYNAPTIC ENDOCYTOSIS,1.8524e-05,-0.56702,-0.62542,1,0
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,1.1191e-05,-0.56707,-0.57496,1,0
6,GO PROXIMAL DISTAL PATTERN FORMATION,0.00018128,-0.56707,-0.50668,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,5.2428e-05,-0.5671,-0.62081,1,0
6,GO REGULATION OF SYNAPSE MATURATION,1.9888e-05,-0.56717,-0.66661,1,0
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,8.9327e-05,-0.56733,-0.6269,1,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,6.2007e-06,-0.56741,-0.60974,1,0
6,GO MOLTING CYCLE,1.3909e-05,-0.56744,-0.5397,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,1.3909e-05,-0.56773,-0.52962,1,0
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.7249e-05,-0.56781,-0.5418,1,0
6,GO REGULATION OF MRNA 3 END PROCESSING,9.5377e-05,-0.56792,-0.53329,1,0
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,9.6689e-06,-0.56809,-0.49663,1,0
6,GO PROTEIN POLYMERIZATION,5.337e-06,-0.56813,-0.58469,1,0
6,GO COVALENT CHROMATIN MODIFICATION,5.7533e-06,-0.56815,-0.57609,1,0
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.2539e-06,-0.56819,-0.5808,1,0
6,GO NEURON DIFFERENTIATION,8.3461e-06,-0.56841,-0.58682,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.2907e-05,-0.56848,-0.6611,1,0
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,1.6059e-05,-0.56877,-0.55456,1,0
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,2.4576e-05,-0.56878,-0.55082,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0015882,-0.56897,-0.54893,1,0
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00014989,-0.569,-0.5918,1,0
6,GO REGULATION OF NEURON DIFFERENTIATION,7.7514e-06,-0.56909,-0.61005,1,0
6,GO POSITIVE REGULATION OF WOUND HEALING,4.5891e-06,-0.56911,-0.60466,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.7249e-05,-0.56915,-0.59844,1,0
6,GO RESPONSE TO MISFOLDED PROTEIN,6.6813e-06,-0.56917,-0.65481,1,0
6,GO RESPONSE TO RETINOIC ACID,1.2939e-05,-0.56917,-0.55562,1,0
6,GO CELL CELL ADHESION,6.2007e-06,-0.5692,-0.58317,1,0
6,GO CELLULAR RESPONSE TO HEAT,1.7249e-05,-0.56921,-0.5168,1,0
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.1191e-05,-0.56921,-0.53877,1,0
6,GO GLIOGENESIS,4.9495e-06,-0.56922,-0.56818,1,0
6,GO ORGANIC ACID TRANSPORT,6.2007e-06,-0.56927,-0.52047,1,0
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,7.7514e-06,-0.56929,-0.60839,1,0
6,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.00019306,-0.56941,-0.62798,1,0
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00060992,-0.56945,-0.57098,1,0
6,GO FEMALE SEX DIFFERENTIATION,5.7533e-06,-0.56946,-0.51432,1,0
6,GO REGULATION OF FIBRINOLYSIS,0.00029789,-0.5695,-0.53503,1,0
6,GO ASTROCYTE DEVELOPMENT,1.7249e-05,-0.56954,-0.6485,1,0
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.5696,-0.58232,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.6813e-06,-0.56962,-0.62329,1,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,7.1973e-06,-0.56965,-0.57786,1,0
6,GO KIDNEY MORPHOGENESIS,8.3461e-06,-0.5697,-0.56118,1,0
6,GO RESPIRATORY BURST,8.9327e-05,-0.56975,-0.61259,1,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,9.6689e-06,-0.56978,-0.56276,1,0
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.7249e-05,-0.5699,-0.56522,1,0
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,4.9495e-06,-0.5699,-0.57086,1,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.248e-05,-0.56995,-0.5662,1,0
6,GO MAST CELL MEDIATED IMMUNITY,6.2007e-06,-0.56996,-0.67074,1,0
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00042807,-0.56997,-0.68036,1,0
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,5.7533e-06,-0.57028,-0.57768,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,5.337e-06,-0.57029,-0.56661,1,0
6,GO SOMITOGENESIS,4.9495e-06,-0.5703,-0.57043,1,0
6,GO ERBB2 SIGNALING PATHWAY,4.5891e-06,-0.57039,-0.55491,1,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,1.7249e-05,-0.5704,-0.63038,1,0
6,GO INTESTINAL ABSORPTION,6.8565e-05,-0.57042,-0.55124,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,7.1973e-06,-0.57053,-0.62073,1,0
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,9.6689e-06,-0.57057,-0.55427,1,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,7.1973e-06,-0.57074,-0.5726,1,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,4.5891e-06,-0.57074,-0.61545,1,0
6,GO SECONDARY HEART FIELD SPECIFICATION,0.00048214,-0.57078,-0.56248,1,0
6,GO IMPORT INTO CELL,6.6813e-06,-0.57085,-0.55167,1,0
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,8.9843e-06,-0.57091,-0.53749,1,0
6,GO INTESTINAL LIPID ABSORPTION,0.0027019,-0.571,-0.41347,1,0
6,GO REGULATION OF MRNA POLYADENYLATION,5.2428e-05,-0.57103,-0.58563,1,0
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,7.7514e-06,-0.57106,-0.57336,1,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,7.3279e-05,-0.57116,-0.65483,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.2428e-05,-0.57131,-0.62799,1,0
6,GO CELLULAR RESPONSE TO STARVATION,1.1191e-05,-0.57131,-0.53837,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,4.9495e-06,-0.57137,-0.55105,1,0
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.6813e-06,-0.57139,-0.58959,1,0
6,GO MYELOID CELL DIFFERENTIATION,5.337e-06,-0.57142,-0.60115,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.337e-06,-0.57148,-0.60484,1,0
6,GO RESPONSE TO LEPTIN,2.8267e-05,-0.57151,-0.51689,1,0
6,GO TELOMERE CAPPING,5.337e-06,-0.57157,-0.59117,1,0
6,GO TEMPERATURE HOMEOSTASIS,6.6813e-06,-0.57161,-0.54681,1,0
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,6.6813e-06,-0.57187,-0.54259,1,0
6,GO DIGESTIVE TRACT MORPHOGENESIS,3.7287e-05,-0.57187,-0.51519,1,0
6,GO ANIMAL ORGAN MORPHOGENESIS,5.337e-06,-0.5719,-0.57368,1,0
6,GO NOSE DEVELOPMENT,0.0010798,-0.57203,-0.54519,1,0
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.4947e-05,-0.57209,-0.62134,1,0
6,GO REGULATION OF COLLATERAL SPROUTING,0.00024771,-0.57214,-0.61198,1,0
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,6.2007e-06,-0.57222,-0.55698,1,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,9.5377e-05,-0.57228,-0.47938,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.57238,-0.52571,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,3.4805e-05,-0.57238,-0.54097,1,0
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,4.9495e-06,-0.57244,-0.62614,1,0
6,GO NEUROGENESIS,7.1973e-06,-0.57249,-0.58327,1,0
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,4.5891e-06,-0.57265,-0.57019,1,0
6,GO EMBRYONIC ORGAN DEVELOPMENT,6.2007e-06,-0.57276,-0.5752,1,0
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,4.5891e-06,-0.57279,-0.57924,1,0
6,GO REGULATION OF HISTONE MODIFICATION,4.5891e-06,-0.5729,-0.58802,1,0
6,GO REGULATION OF AUTOPHAGY,5.337e-06,-0.57299,-0.57824,1,0
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,9.6689e-06,-0.573,-0.65871,1,0
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00010181,-0.57306,-0.51013,1,0
6,GO OLFACTORY LOBE DEVELOPMENT,0.00010866,-0.57307,-0.55361,1,0
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00010181,-0.57314,-0.71246,1,0
6,GO MIRNA METABOLIC PROCESS,8.3461e-06,-0.57321,-0.58951,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,4.9495e-06,-0.57322,-0.56316,1,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.57326,-0.62856,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.6059e-05,-0.57331,-0.5837,1,0
6,GO DIACYLGLYCEROL METABOLIC PROCESS,5.337e-06,-0.57337,-0.66001,1,0
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,1.2035e-05,-0.57338,-0.5617,1,0
6,GO SEGMENT SPECIFICATION,1.4947e-05,-0.5737,-0.55032,1,0
6,GO ORGANIC CATION TRANSPORT,8.9843e-06,-0.57379,-0.53457,1,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.1973e-06,-0.57381,-0.5752,1,0
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.57385,-0.54193,1,0
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,2.2907e-05,-0.57401,-0.60516,1,0
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,5.337e-06,-0.5741,-0.65483,1,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,7.1973e-06,-0.57412,-0.55225,1,0
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.0403e-05,-0.57413,-0.61211,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,1.0403e-05,-0.57418,-0.56035,1,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,4.9495e-06,-0.57419,-0.60457,1,0
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,5.337e-06,-0.57425,-0.57108,1,0
6,GO MODIFIED AMINO ACID TRANSPORT,1.8524e-05,-0.57434,-0.51219,1,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.7533e-06,-0.57434,-0.58299,1,0
6,GO RESPONSE TO NERVE GROWTH FACTOR,6.6813e-06,-0.57437,-0.59419,1,0
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,5.7533e-06,-0.57454,-0.55757,1,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,2.8267e-05,-0.57462,-0.59953,1,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,4.5891e-06,-0.5747,-0.59589,1,0
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.017954,-0.57481,-0.75621,1,0
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,7.7514e-06,-0.57494,-0.69835,1,0
6,GO NEURON RECOGNITION,2.2907e-05,-0.57501,-0.59547,1,0
6,GO DISTAL TUBULE DEVELOPMENT,6.8565e-05,-0.57513,-0.69138,1,0
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00015974,-0.57515,-0.60295,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00023283,-0.57524,-0.76863,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,1.3909e-05,-0.57542,-0.53891,1,0
6,GO ACTION POTENTIAL,1.3909e-05,-0.57556,-0.54382,1,0
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00072571,-0.57558,-0.63581,1,0
6,GO RESPONSE TO HORMONE,5.7533e-06,-0.5756,-0.55031,1,0
6,GO PHAGOCYTOSIS,1.2035e-05,-0.57574,-0.66298,1,0
6,GO INTEGRIN ACTIVATION,7.8298e-05,-0.57577,-0.69735,1,0
6,GO MEMBRANE HYPERPOLARIZATION,3.4805e-05,-0.57582,-0.54093,1,0
6,GO CARBOHYDRATE TRANSPORT,5.7533e-06,-0.57587,-0.54697,1,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,1.4947e-05,-0.57592,-0.58242,1,0
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.0304e-05,-0.57593,-0.50785,1,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.7533e-06,-0.57595,-0.58674,1,0
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00040321,-0.57597,-0.75377,1,0
6,GO MUSCLE TISSUE DEVELOPMENT,6.6813e-06,-0.57613,-0.54463,1,0
6,GO MUSCLE CELL PROLIFERATION,7.7514e-06,-0.57628,-0.58399,1,0
6,GO NEGATIVE REGULATION OF NEURON DEATH,4.5891e-06,-0.57636,-0.57105,1,0
6,GO MUSCLE SYSTEM PROCESS,6.2007e-06,-0.57658,-0.54646,1,0
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,1.0403e-05,-0.57662,-0.573,1,0
6,GO POSITIVE REGULATION OF CELL MATURATION,2.1347e-05,-0.57662,-0.55771,1,0
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,8.9843e-06,-0.57665,-0.57702,1,0
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,3.4805e-05,-0.57669,-0.50425,1,0
6,GO HEART GROWTH,5.7533e-06,-0.57682,-0.55623,1,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.2539e-06,-0.57688,-0.63708,1,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00014062,-0.57695,-0.60755,1,0
6,GO SPECIFICATION OF SYMMETRY,9.6689e-06,-0.57712,-0.52431,1,0
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.8267e-05,-0.57717,-0.62344,1,0
6,GO SEQUESTERING OF TRIGLYCERIDE,7.7514e-06,-0.5772,-0.57456,1,0
6,GO CARBOHYDRATE PHOSPHORYLATION,5.7533e-06,-0.57725,-0.60041,1,0
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,5.7533e-06,-0.57729,-0.59218,1,0
6,GO RESPONSE TO TYPE I INTERFERON,0.0010798,-0.5774,-0.6356,1,0
6,GO REGULATION OF GROWTH,6.2007e-06,-0.57751,-0.55818,1,0
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.0304e-05,-0.57753,-0.57687,1,0
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,8.9843e-06,-0.57755,-0.61717,1,0
6,GO CHLORIDE ION HOMEOSTASIS,4.8997e-05,-0.57764,-0.54001,1,0
6,GO ENERGY RESERVE METABOLIC PROCESS,1.4947e-05,-0.57775,-0.52588,1,0
6,GO GLIAL CELL DIFFERENTIATION,5.7533e-06,-0.57779,-0.56441,1,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,8.3461e-06,-0.57795,-0.57148,1,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,9.6689e-06,-0.57803,-0.59266,1,0
6,GO SPHINGOLIPID METABOLIC PROCESS,4.9495e-06,-0.57824,-0.5857,1,0
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,6.6813e-06,-0.5783,-0.57637,1,0
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.57831,-0.56604,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.2007e-06,-0.57838,-0.57382,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.9495e-06,-0.57849,-0.60207,1,0
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.2907e-05,-0.5785,-0.5655,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,6.8565e-05,-0.57853,-0.59792,1,0
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,4.9495e-06,-0.57867,-0.57687,1,0
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,9.6689e-06,-0.57871,-0.67284,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,5.7533e-06,-0.57876,-0.54663,1,0
6,GO RESPONSE TO POTASSIUM ION,1.1191e-05,-0.57882,-0.61274,1,0
6,GO REGULATION OF MUSCLE CONTRACTION,7.1973e-06,-0.57885,-0.51495,1,0
6,GO EMBRYO IMPLANTATION,2.2907e-05,-0.57887,-0.61328,1,0
6,GO REGULATION OF CALCIUM ION IMPORT,3.4805e-05,-0.57891,-0.57001,1,0
6,GO REGULATION OF SYSTEM PROCESS,8.3461e-06,-0.57892,-0.5269,1,0
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00019306,-0.57892,-0.5642,1,0
6,GO DENDRITE MORPHOGENESIS,1.6059e-05,-0.57909,-0.61008,1,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00048214,-0.57913,-0.65479,1,0
6,GO POSITIVE REGULATION OF CELL GROWTH,5.7533e-06,-0.57919,-0.58944,1,0
6,GO MAGNESIUM ION TRANSPORT,1.2939e-05,-0.57924,-0.58517,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,5.337e-06,-0.57927,-0.58351,1,0
6,GO SERTOLI CELL DEVELOPMENT,1.8524e-05,-0.57938,-0.59748,1,0
6,GO REGULATION OF TELOMERE CAPPING,4.9495e-06,-0.57938,-0.62418,1,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.3909e-05,-0.57939,-0.54638,1,0
6,GO MEMBRANE FUSION,7.7514e-06,-0.57939,-0.56527,1,0
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,3.9422e-06,-0.57942,-0.62639,1,0
6,GO DENDRITE DEVELOPMENT,1.2035e-05,-0.5795,-0.60763,1,0
6,GO NEURON DEVELOPMENT,8.3461e-06,-0.57951,-0.60466,1,0
6,GO NEPHRON EPITHELIUM DEVELOPMENT,4.9495e-06,-0.57954,-0.58552,1,0
6,GO NATURAL KILLER CELL DIFFERENTIATION,2.2907e-05,-0.57961,-0.63569,1,0
6,GO MITOPHAGY,7.7514e-06,-0.57964,-0.63131,1,0
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,4.2539e-06,-0.57991,-0.58302,1,0
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.8267e-05,-0.58002,-0.58739,1,0
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,8.9843e-06,-0.58003,-0.57139,1,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00026348,-0.58012,-0.52352,1,0
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,9.5377e-05,-0.58012,-0.62372,1,0
6,GO LIPID STORAGE,4.9495e-06,-0.58014,-0.57297,1,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.9495e-06,-0.58023,-0.61947,1,0
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,1.1191e-05,-0.58036,-0.607,1,0
6,GO RESPONSE TO COLD,9.6689e-06,-0.58046,-0.58108,1,0
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00012367,-0.58056,-0.62453,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.58065,-0.63232,1,0
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00035748,-0.58074,-0.56455,1,0
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,1.4947e-05,-0.58074,-0.64468,1,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,7.7514e-06,-0.58086,-0.54677,1,0
6,GO HETEROCHROMATIN ORGANIZATION,6.6813e-06,-0.58095,-0.59613,1,0
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,7.1973e-06,-0.58107,-0.62651,1,0
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,8.3461e-06,-0.58108,-0.56338,1,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.2939e-05,-0.58133,-0.70211,1,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,5.337e-06,-0.58143,-0.58265,1,0
6,GO RESPONSE TO ENDOGENOUS STIMULUS,5.337e-06,-0.58144,-0.56283,1,0
6,GO RECEPTOR METABOLIC PROCESS,5.337e-06,-0.58148,-0.57488,1,0
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,5.7533e-06,-0.58153,-0.6631,1,0
6,GO MAINTENANCE OF CELL POLARITY,2.8267e-05,-0.5816,-0.54889,1,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,3.0304e-05,-0.58166,-0.59054,1,0
6,GO REGULATION OF MICROTUBULE BINDING,3.7287e-05,-0.58177,-0.68352,1,0
6,GO RESPONSE TO HYPEROXIA,1.3909e-05,-0.58183,-0.56627,1,0
6,GO NEURAL PRECURSOR CELL PROLIFERATION,6.6813e-06,-0.58197,-0.55991,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0034935,-0.58199,-0.54978,1,0
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00051151,-0.58207,-0.48987,1,0
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00072571,-0.58208,-0.574,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.1191e-05,-0.58226,-0.5116,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.6813e-06,-0.58232,-0.53901,1,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,5.6086e-05,-0.58237,-0.59732,1,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,5.337e-06,-0.58238,-0.57304,1,0
6,GO POLYSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.58241,-0.56773,1,0
6,GO REGULATION OF DNA METHYLATION,7.1973e-06,-0.5825,-0.57117,1,0
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,1.2035e-05,-0.58255,-0.66247,1,0
6,GO GROWTH,5.7533e-06,-0.58257,-0.56777,1,0
6,GO REGULATION OF ISOTYPE SWITCHING,8.3461e-06,-0.58265,-0.63636,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00018128,-0.58273,-0.52937,1,0
6,GO KERATAN SULFATE METABOLIC PROCESS,1.7249e-05,-0.58279,-0.62173,1,0
6,GO DIVALENT METAL ION EXPORT,7.3279e-05,-0.58285,-0.54918,1,0
6,GO MUSCLE CONTRACTION,7.1973e-06,-0.58286,-0.53898,1,0
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,8.3641e-05,-0.58305,-0.62191,1,0
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,5.337e-06,-0.58319,-0.58904,1,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,1.0403e-05,-0.58321,-0.63536,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1191e-05,-0.58344,-0.58006,1,0
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,8.9843e-06,-0.58356,-0.5216,1,0
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.337e-06,-0.58362,-0.58532,1,0
6,GO AUTOPHAGOSOME ORGANIZATION,5.337e-06,-0.58375,-0.58035,1,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.58376,-0.63704,1,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.7533e-06,-0.58383,-0.58092,1,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.4576e-05,-0.58388,-0.57775,1,0
6,GO POSITIVE REGULATION OF COAGULATION,1.4947e-05,-0.58396,-0.5954,1,0
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,5.7533e-06,-0.58399,-0.58784,1,0
6,GO RESPONSE TO COCAINE,3.4805e-05,-0.58412,-0.52804,1,0
6,GO OVULATION,4.8997e-05,-0.58431,-0.52417,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.8267e-05,-0.58434,-0.52558,1,0
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,4.8997e-05,-0.58434,-0.52085,1,0
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014989,-0.58438,-0.55584,1,0
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,5.337e-06,-0.58449,-0.57477,1,0
6,GO B CELL HOMEOSTASIS,4.9495e-06,-0.58451,-0.68802,1,0
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.00010181,-0.58464,-0.48628,1,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,6.2007e-06,-0.58466,-0.56958,1,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,4.8997e-05,-0.58474,-0.63858,1,0
6,GO RESPONSE TO CALCIUM ION,1.1191e-05,-0.58482,-0.53167,1,0
6,GO STRIATED MUSCLE CONTRACTION,7.7514e-06,-0.58487,-0.53544,1,0
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,5.7533e-06,-0.58492,-0.55885,1,0
6,GO PEPTIDYL AMINO ACID MODIFICATION,4.5891e-06,-0.58497,-0.56902,1,0
6,GO CARDIAC CONDUCTION,1.9888e-05,-0.58501,-0.53904,1,0
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.8267e-05,-0.58519,-0.61452,1,0
6,GO REGULATION OF WOUND HEALING,5.7533e-06,-0.58521,-0.60082,1,0
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,6.6813e-06,-0.58528,-0.61676,1,0
6,GO PEPTIDYL LYSINE DIMETHYLATION,7.1973e-06,-0.58529,-0.59339,1,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,7.7514e-06,-0.5853,-0.63225,1,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,5.9985e-05,-0.58537,-0.54691,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,4.5891e-06,-0.58538,-0.61495,1,0
6,GO PROSTATE GLAND MORPHOGENESIS,9.5377e-05,-0.58543,-0.54484,1,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.1347e-05,-0.58555,-0.57269,1,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,5.337e-06,-0.58576,-0.5992,1,0
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,1.1191e-05,-0.58577,-0.54935,1,0
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,3.0304e-05,-0.58581,-0.51047,1,0
6,GO MAGNESIUM ION HOMEOSTASIS,3.7287e-05,-0.58585,-0.54656,1,0
6,GO MICROTUBULE POLYMERIZATION,2.636e-05,-0.58587,-0.60757,1,0
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,5.337e-06,-0.58599,-0.54,1,0
6,GO DEVELOPMENTAL GROWTH,6.2007e-06,-0.5861,-0.58711,1,0
6,GO HINDLIMB MORPHOGENESIS,1.4947e-05,-0.58612,-0.55147,1,0
6,GO REGULATION OF CHROMATIN ORGANIZATION,4.2539e-06,-0.58614,-0.58322,1,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,3.9936e-05,-0.58641,-0.56142,1,0
6,GO ENDOSOME TO LYSOSOME TRANSPORT,8.3461e-06,-0.58645,-0.5898,1,0
6,GO NOTCH RECEPTOR PROCESSING,4.5779e-05,-0.58651,-0.58371,1,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00012367,-0.58659,-0.68521,1,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,1.1191e-05,-0.58663,-0.55996,1,0
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.58677,-0.56503,1,0
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.8997e-05,-0.58679,-0.66178,1,0
6,GO RESPONSE TO ACID CHEMICAL,6.2007e-06,-0.58688,-0.5538,1,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,3.9422e-06,-0.58691,-0.6311,1,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00014062,-0.58696,-0.65411,1,0
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00028019,-0.58697,-0.62085,1,0
6,GO REGULATION OF WNT SIGNALING PATHWAY,5.337e-06,-0.58703,-0.55988,1,0
6,GO REGULATION OF MAPK CASCADE,4.9495e-06,-0.58708,-0.6007,1,0
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.9888e-05,-0.58709,-0.51676,1,0
6,GO HISTONE H3 K9 MODIFICATION,5.7533e-06,-0.58724,-0.61027,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,6.2007e-06,-0.58726,-0.62073,1,0
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,1.1191e-05,-0.58733,-0.57173,1,0
6,GO NEUROTRANSMITTER UPTAKE,9.6689e-06,-0.58743,-0.52688,1,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.9422e-06,-0.58745,-0.61161,1,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,4.9495e-06,-0.5875,-0.61108,1,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00011593,-0.58751,-0.55962,1,0
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,2.1347e-05,-0.58756,-0.57618,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.248e-05,-0.58763,-0.54718,1,0
6,GO RESPONSE TO CAMP,1.1191e-05,-0.58768,-0.54451,1,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,5.7533e-06,-0.58783,-0.61461,1,0
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,4.9495e-06,-0.58794,-0.54445,1,0
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,7.7514e-06,-0.58803,-0.60258,1,0
6,GO MITOCHONDRIAL GENOME MAINTENANCE,6.2007e-06,-0.58809,-0.58554,1,0
6,GO REGULATION OF SODIUM ION TRANSPORT,1.4947e-05,-0.58813,-0.52607,1,0
6,GO MEMBRANE DEPOLARIZATION,1.7249e-05,-0.58815,-0.56507,1,0
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,4.9495e-06,-0.58819,-0.62844,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.0304e-05,-0.58824,-0.69552,1,0
6,GO INTERFERON BETA PRODUCTION,4.9495e-06,-0.58832,-0.65546,1,0
6,GO GOLGI ORGANIZATION,7.7514e-06,-0.58836,-0.61489,1,0
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,1.7249e-05,-0.58857,-0.62943,1,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,1.4947e-05,-0.58863,-0.49446,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00029789,-0.58869,-0.6809,1,0
6,GO NEUROTRANSMITTER REUPTAKE,1.2035e-05,-0.58871,-0.53732,1,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,2.2907e-05,-0.58876,-0.62971,1,0
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.5891e-06,-0.58879,-0.58458,1,0
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,7.1973e-06,-0.58881,-0.62835,1,0
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.5377e-05,-0.58883,-0.63086,1,0
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,5.337e-06,-0.5889,-0.58455,1,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,1.0403e-05,-0.58891,-0.5639,1,0
6,GO B CELL DIFFERENTIATION,8.9843e-06,-0.58893,-0.63928,1,0
6,GO INFLAMMATORY RESPONSE TO WOUNDING,9.5377e-05,-0.58896,-0.74597,1,0
6,GO DETERMINATION OF ADULT LIFESPAN,1.6059e-05,-0.589,-0.60043,1,0
6,GO REGULATION OF BLOOD PRESSURE,7.1973e-06,-0.58917,-0.53743,1,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,1.3909e-05,-0.58923,-0.58791,1,0
6,GO CELL PART MORPHOGENESIS,7.7514e-06,-0.58938,-0.62564,1,0
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00081392,-0.58963,-0.51771,1,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,2.8267e-05,-0.58965,-0.6039,1,0
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,3.9422e-06,-0.58981,-0.59605,1,0
6,GO REGULATION OF HISTONE METHYLATION,7.1973e-06,-0.58984,-0.61844,1,0
6,GO HISTONE H3 K27 METHYLATION,1.0403e-05,-0.58994,-0.66534,1,0
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,4.2763e-05,-0.59,-0.54563,1,0
6,GO MAST CELL MIGRATION,5.2428e-05,-0.59003,-0.59584,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.1191e-05,-0.59003,-0.55735,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.59005,-0.59993,1,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.59005,-0.54306,1,0
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,7.1973e-06,-0.59007,-0.59678,1,0
6,GO REGULATION OF PROTEIN MATURATION,6.2007e-06,-0.59008,-0.57625,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0038653,-0.59015,-0.71743,1,0
6,GO EMBRYO DEVELOPMENT,5.7533e-06,-0.59015,-0.57388,1,0
6,GO CELL FATE DETERMINATION,1.4947e-05,-0.59017,-0.54004,1,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,7.7514e-06,-0.59033,-0.63313,1,0
6,GO AMINOGLYCAN METABOLIC PROCESS,5.337e-06,-0.59051,-0.62289,1,0
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.3909e-05,-0.59054,-0.54626,1,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.337e-06,-0.59072,-0.60885,1,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.337e-06,-0.59074,-0.6049,1,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00072571,-0.5908,-0.52612,1,0
6,GO FOREBRAIN NEURON DEVELOPMENT,6.4139e-05,-0.59082,-0.58226,1,0
6,GO MOVEMENT IN HOST ENVIRONMENT,6.6813e-06,-0.59092,-0.57988,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,4.2539e-06,-0.59117,-0.61366,1,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,7.1973e-06,-0.59127,-0.6083,1,0
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,7.7514e-06,-0.59136,-0.62984,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,7.7514e-06,-0.59138,-0.57166,1,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.6059e-05,-0.59146,-0.60749,1,0
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.9495e-06,-0.59152,-0.5842,1,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,5.7533e-06,-0.59159,-0.59955,1,0
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.7249e-05,-0.59182,-0.53261,1,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0011418,-0.5919,-0.57295,1,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.5779e-05,-0.59207,-0.52155,1,0
6,GO REGULATION OF RECEPTOR INTERNALIZATION,1.0403e-05,-0.59218,-0.58414,1,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.1347e-05,-0.59224,-0.59832,1,0
6,GO REGULATION OF TUBULIN DEACETYLATION,2.8267e-05,-0.5924,-0.60212,1,0
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00010866,-0.5924,-0.71152,1,0
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,6.2007e-06,-0.59246,-0.6729,1,0
6,GO LEFT RIGHT PATTERN FORMATION,0.00013188,-0.59251,-0.51084,1,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,4.5891e-06,-0.59257,-0.63466,1,0
6,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00031664,-0.59257,-0.50145,1,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.0304e-05,-0.59258,-0.57468,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,4.2539e-06,-0.59271,-0.58752,1,0
6,GO RESPONSE TO PROSTAGLANDIN E,4.5779e-05,-0.59272,-0.58979,1,0
6,GO MACROMOLECULE DEACYLATION,7.1973e-06,-0.59273,-0.56721,1,0
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,7.3279e-05,-0.5928,-0.5002,1,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0003797,-0.59298,-0.63396,1,0
6,GO PRIMARY MIRNA PROCESSING,8.9327e-05,-0.59305,-0.57987,1,0
6,GO CELL GROWTH,5.7533e-06,-0.59312,-0.58908,1,0
6,GO CELLULAR RESPONSE TO DRUG,4.5891e-06,-0.5932,-0.55602,1,0
6,GO POSITIVE REGULATION OF MAPK CASCADE,5.337e-06,-0.59325,-0.60386,1,0
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,6.6813e-06,-0.59327,-0.53915,1,0
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0010209,-0.59328,-0.55503,1,0
6,GO REGULATION OF GROWTH HORMONE SECRETION,0.0011418,-0.59334,-0.58016,1,0
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,1.2035e-05,-0.59334,-0.58297,1,0
6,GO L AMINO ACID TRANSPORT,5.337e-06,-0.59339,-0.54678,1,0
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,4.2539e-06,-0.59361,-0.60388,1,0
6,GO AXON DEVELOPMENT,7.7514e-06,-0.59374,-0.62643,1,0
6,GO POSITIVE REGULATION OF TISSUE REMODELING,4.5779e-05,-0.59385,-0.57462,1,0
6,GO IN UTERO EMBRYONIC DEVELOPMENT,4.5891e-06,-0.5939,-0.56614,1,0
6,GO PLACENTA DEVELOPMENT,6.6813e-06,-0.59393,-0.59175,1,0
6,GO CELLULAR RESPONSE TO DSRNA,1.3909e-05,-0.59396,-0.60337,1,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,1.0403e-05,-0.59401,-0.57647,1,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,4.9495e-06,-0.59403,-0.60493,1,0
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,8.9843e-06,-0.59408,-0.62724,1,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.00035748,-0.59409,-0.52399,1,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.2007e-06,-0.5942,-0.57571,1,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.2007e-06,-0.59424,-0.58837,1,0
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.6813e-06,-0.59429,-0.62002,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,7.1973e-06,-0.59432,-0.64539,1,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.3461e-06,-0.59447,-0.65117,1,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,8.9327e-05,-0.59447,-0.62336,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,4.8997e-05,-0.5945,-0.67504,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.5945,-0.6151,1,0
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.5891e-06,-0.5945,-0.65448,1,0
6,GO REGULATION OF CELL DEVELOPMENT,6.6813e-06,-0.59456,-0.59481,1,0
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,6.2007e-06,-0.59457,-0.60586,1,0
6,GO REGULATION OF BODY FLUID LEVELS,5.337e-06,-0.59462,-0.58927,1,0
6,GO ADIPOSE TISSUE DEVELOPMENT,1.2035e-05,-0.59481,-0.58766,1,0
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00019306,-0.59486,-0.54978,1,0
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,4.9495e-06,-0.59488,-0.58673,1,0
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,2.2907e-05,-0.59495,-0.67857,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.59506,-0.6574,1,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.59516,-0.54867,1,0
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,6.2007e-06,-0.5955,-0.58765,1,0
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,7.1973e-06,-0.5955,-0.55581,1,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,1.2939e-05,-0.59552,-0.59168,1,0
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,6.2007e-06,-0.59567,-0.60954,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGY,4.9495e-06,-0.59587,-0.59959,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.2007e-06,-0.59628,-0.61476,1,0
6,GO LONG TERM MEMORY,4.5779e-05,-0.59646,-0.54841,1,0
6,GO REGULATION OF CHROMATIN ASSEMBLY,1.1191e-05,-0.59659,-0.60875,1,0
6,GO ENTRY INTO HOST,6.6813e-06,-0.59669,-0.61426,1,0
6,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,4.9495e-06,-0.59681,-0.58395,1,0
6,GO MESENCHYME DEVELOPMENT,5.337e-06,-0.59702,-0.59726,1,0
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.8298e-05,-0.59705,-0.57264,1,0
6,GO CELL CELL SIGNALING BY WNT,5.337e-06,-0.59715,-0.57156,1,0
6,GO POSITIVE REGULATION OF GROWTH,5.337e-06,-0.5972,-0.60031,1,0
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,6.6813e-06,-0.59724,-0.58461,1,0
6,GO REGULATION OF LIPID STORAGE,7.7514e-06,-0.59731,-0.61856,1,0
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0023095,-0.59733,-0.61679,1,0
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,3.7287e-05,-0.59737,-0.592,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,1.8524e-05,-0.59747,-0.5536,1,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00019306,-0.59749,-0.65973,1,0
6,GO SPINDLE LOCALIZATION,7.1973e-06,-0.59749,-0.6134,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.4947e-05,-0.59761,-0.55079,1,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,5.337e-06,-0.59767,-0.59534,1,0
6,GO CELLULAR HYPEROSMOTIC RESPONSE,5.9985e-05,-0.59773,-0.55445,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.337e-06,-0.59774,-0.64687,1,0
6,GO BIOMINERALIZATION,8.3461e-06,-0.59779,-0.60815,1,0
6,GO GLAND DEVELOPMENT,6.6813e-06,-0.59788,-0.57497,1,0
6,GO NEURAL CREST CELL DIFFERENTIATION,6.2007e-06,-0.59792,-0.58638,1,0
6,GO REGULATION OF CELL DIFFERENTIATION,5.337e-06,-0.59797,-0.58588,1,0
6,GO RESPONSE TO WOUNDING,5.337e-06,-0.59797,-0.62169,1,0
6,GO CELL PROLIFERATION IN FOREBRAIN,2.4576e-05,-0.59804,-0.62195,1,0
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,8.3461e-06,-0.59807,-0.64552,1,0
6,GO MAINTENANCE OF ORGANELLE LOCATION,1.2939e-05,-0.59814,-0.6087,1,0
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,4.9495e-06,-0.59816,-0.60493,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,7.7514e-06,-0.59818,-0.61946,1,0
6,GO DEVELOPMENTAL MATURATION,9.6689e-06,-0.59822,-0.55517,1,0
6,GO REGULATION OF PROTEIN BINDING,5.337e-06,-0.59828,-0.58557,1,0
6,GO MUSCLE CELL DEVELOPMENT,6.6813e-06,-0.59853,-0.55298,1,0
6,GO SYNAPSE PRUNING,0.0047188,-0.59872,-0.71417,1,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,5.7533e-06,-0.59877,-0.59124,1,0
6,GO GLYCINE TRANSPORT,0.0013481,-0.5988,-0.52418,1,0
6,GO LIPOPROTEIN LOCALIZATION,3.0304e-05,-0.59889,-0.58756,1,0
6,GO NEURON MATURATION,6.2007e-06,-0.5989,-0.62698,1,0
6,GO CELLULAR GLUCAN METABOLIC PROCESS,1.0403e-05,-0.59896,-0.53385,1,0
6,GO REGULATION OF BIOMINERALIZATION,1.1191e-05,-0.59907,-0.6213,1,0
6,GO PANCREAS DEVELOPMENT,1.4947e-05,-0.59923,-0.56704,1,0
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,5.7533e-06,-0.59931,-0.60631,1,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,5.7533e-06,-0.59932,-0.60803,1,0
6,GO INTRACELLULAR STEROL TRANSPORT,4.5891e-06,-0.59933,-0.63401,1,0
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,5.337e-06,-0.59934,-0.57256,1,0
6,GO SENSORY SYSTEM DEVELOPMENT,5.7533e-06,-0.59948,-0.58927,1,0
6,GO SYNAPTIC VESICLE PRIMING,0.00045436,-0.5995,-0.61433,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,2.2907e-05,-0.59962,-0.51906,1,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.59962,-0.57291,1,0
6,GO MORPHOGENESIS OF AN EPITHELIUM,5.7533e-06,-0.59962,-0.58253,1,0
6,GO OVULATION CYCLE PROCESS,6.6813e-06,-0.59971,-0.57043,1,0
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,5.337e-06,-0.5998,-0.631,1,0
6,GO LENS FIBER CELL DIFFERENTIATION,7.1973e-06,-0.59982,-0.57657,1,0
6,GO MYELOID CELL HOMEOSTASIS,5.7533e-06,-0.59989,-0.59295,1,0
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,1.1191e-05,-0.59995,-0.65428,1,0
6,GO CIRCULATORY SYSTEM PROCESS,6.6813e-06,-0.60007,-0.55509,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.2035e-05,-0.60007,-0.54955,1,0
6,GO REGULATION OF BLOOD CIRCULATION,1.0403e-05,-0.6003,-0.53892,1,0
6,GO GLIAL CELL DEVELOPMENT,4.2539e-06,-0.60032,-0.60452,1,0
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,7.1973e-06,-0.60045,-0.63777,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,1.0403e-05,-0.6005,-0.62284,1,0
6,GO CAMERA TYPE EYE DEVELOPMENT,6.6813e-06,-0.60054,-0.57891,1,0
6,GO HAIR CELL DIFFERENTIATION,4.9495e-06,-0.6006,-0.61761,1,0
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,9.6689e-06,-0.60068,-0.59656,1,0
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.0015041,-0.60093,-0.55285,1,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,1.3909e-05,-0.60099,-0.60065,1,0
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.9843e-06,-0.60128,-0.6146,1,0
6,GO CELLULAR RESPONSE TO CALCIUM ION,2.8267e-05,-0.60136,-0.55153,1,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,6.6813e-06,-0.60169,-0.62397,1,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.4576e-05,-0.60181,-0.54868,1,0
6,GO MAINTENANCE OF CELL NUMBER,7.1973e-06,-0.60181,-0.54099,1,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,2.8267e-05,-0.60193,-0.63602,1,0
6,GO CELL PROJECTION ORGANIZATION,8.3461e-06,-0.60196,-0.58146,1,0
6,GO CARDIAC MUSCLE CONTRACTION,1.3909e-05,-0.60198,-0.55078,1,0
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,5.337e-06,-0.60216,-0.60141,1,0
6,GO TRACHEA DEVELOPMENT,7.7514e-06,-0.60225,-0.6572,1,0
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,1.0403e-05,-0.60227,-0.6008,1,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00081392,-0.60237,-0.64834,1,0
6,GO OSTEOBLAST DIFFERENTIATION,6.2007e-06,-0.60239,-0.58347,1,0
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,5.337e-06,-0.60246,-0.58806,1,0
6,GO REGULATION OF DENDRITE MORPHOGENESIS,1.6059e-05,-0.60247,-0.60775,1,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0403e-05,-0.60274,-0.64505,1,0
6,GO COMMISSURAL NEURON AXON GUIDANCE,0.00010181,-0.60277,-0.59969,1,0
6,GO MEIOTIC SPINDLE ORGANIZATION,1.4947e-05,-0.60277,-0.6567,1,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,5.7533e-06,-0.60282,-0.62211,1,0
6,GO RECEPTOR INTERNALIZATION,8.9843e-06,-0.60311,-0.57438,1,0
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,3.0304e-05,-0.60324,-0.58557,1,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,4.5891e-06,-0.60337,-0.59477,1,0
6,GO EPITHELIAL CELL PROLIFERATION,6.6813e-06,-0.60347,-0.5828,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00014989,-0.60353,-0.56287,1,0
6,GO PLATELET DEGRANULATION,1.9888e-05,-0.60354,-0.63335,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,6.2007e-06,-0.60362,-0.63583,1,0
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.4947e-05,-0.60369,-0.58597,1,0
6,GO ODONTOGENESIS,9.6689e-06,-0.6037,-0.58397,1,0
6,GO REGULATION OF TUBE SIZE,1.0403e-05,-0.60372,-0.52753,1,0
6,GO VOCALIZATION BEHAVIOR,0.00013188,-0.60376,-0.54442,1,0
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,1.9888e-05,-0.60387,-0.56721,1,0
6,GO NOTCH SIGNALING PATHWAY,5.7533e-06,-0.60392,-0.60785,1,0
6,GO RESPONSE TO CARBOHYDRATE,5.7533e-06,-0.60407,-0.55989,1,0
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00010181,-0.60413,-0.56812,1,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,6.2007e-06,-0.60439,-0.60065,1,0
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,5.337e-06,-0.6044,-0.61632,1,0
6,GO DENDRITIC SPINE DEVELOPMENT,1.2035e-05,-0.60442,-0.60312,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.2035e-05,-0.60443,-0.58465,1,0
6,GO REGULATION OF METANEPHROS DEVELOPMENT,2.1347e-05,-0.60465,-0.65903,1,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.2428e-05,-0.60487,-0.58903,1,0
6,GO RESPONSE TO PEPTIDE,5.7533e-06,-0.60516,-0.58097,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.4576e-05,-0.60523,-0.56835,1,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.0403e-05,-0.60582,-0.63344,1,0
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,5.7533e-06,-0.60584,-0.58556,1,0
6,GO MUSCLE STRUCTURE DEVELOPMENT,6.2007e-06,-0.60586,-0.56902,1,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,6.6813e-06,-0.60606,-0.63753,1,0
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.337e-06,-0.60633,-0.64374,1,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,6.6813e-06,-0.60649,-0.6242,1,0
6,GO REGULATION OF VACUOLE ORGANIZATION,6.2007e-06,-0.60666,-0.58795,1,0
6,GO ORGAN GROWTH,5.337e-06,-0.60688,-0.57859,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.5891e-06,-0.60693,-0.60781,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.8524e-05,-0.607,-0.586,1,0
6,GO NEGATIVE REGULATION OF GROWTH,5.7533e-06,-0.60706,-0.57067,1,0
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,1.1191e-05,-0.60727,-0.65452,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.3461e-06,-0.6073,-0.65176,1,0
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,2.4576e-05,-0.60744,-0.65991,1,0
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,6.2007e-06,-0.60748,-0.57399,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.9495e-06,-0.60755,-0.5791,1,0
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,7.7514e-06,-0.60759,-0.58595,1,0
6,GO CELLULAR RESPONSE TO PH,1.6059e-05,-0.6076,-0.56926,1,0
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,6.6813e-06,-0.60764,-0.58685,1,0
6,GO HYALURONAN CATABOLIC PROCESS,8.3461e-06,-0.60779,-0.6202,1,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,8.9843e-06,-0.6078,-0.68656,1,0
6,GO LEUKOCYTE AGGREGATION,0.00068502,-0.60782,-0.67666,1,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.60783,-0.76153,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,8.3461e-06,-0.60788,-0.61651,1,0
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.8524e-05,-0.60814,-0.67382,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00012367,-0.60818,-0.66663,1,0
6,GO CANONICAL WNT SIGNALING PATHWAY,5.7533e-06,-0.60831,-0.56723,1,0
6,GO APOPTOTIC CELL CLEARANCE,6.8565e-05,-0.60842,-0.70924,1,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,2.4576e-05,-0.60846,-0.59154,1,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,8.9843e-06,-0.60849,-0.6178,1,0
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,5.7533e-06,-0.60855,-0.58185,1,0
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,6.2007e-06,-0.60871,-0.68434,1,0
6,GO RESPONSE TO PEPTIDE HORMONE,5.7533e-06,-0.60873,-0.56463,1,0
6,GO REGULATION OF PROTEIN DEACETYLATION,1.1191e-05,-0.6088,-0.58503,1,0
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00048214,-0.6089,-0.70636,1,0
6,GO REGULATION OF ENDOCYTOSIS,6.2007e-06,-0.60895,-0.62495,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,8.9843e-06,-0.60918,-0.64643,1,0
6,GO RESPONSE TO INSULIN,5.337e-06,-0.60922,-0.56494,1,0
6,GO EXCRETION,1.6059e-05,-0.60947,-0.52148,1,0
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,9.5377e-05,-0.60947,-0.56414,1,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,5.7533e-06,-0.60952,-0.56865,1,0
6,GO GAMMA DELTA T CELL DIFFERENTIATION,1.1191e-05,-0.6099,-0.74488,1,0
6,GO PROTEIN KINASE B SIGNALING,6.2007e-06,-0.61004,-0.58173,1,0
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.61005,-0.58043,1,0
6,GO CELLULAR COMPONENT MORPHOGENESIS,7.7514e-06,-0.61007,-0.6215,1,0
6,GO EMBRYONIC DIGIT MORPHOGENESIS,7.1973e-06,-0.61008,-0.57586,1,0
6,GO PHAGOCYTOSIS RECOGNITION,0.00014062,-0.61016,-0.63329,1,0
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,1.9888e-05,-0.61016,-0.59301,1,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,1.1191e-05,-0.61017,-0.60274,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,9.6689e-06,-0.61018,-0.61297,1,0
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,7.7514e-06,-0.61023,-0.72209,1,0
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.8267e-05,-0.61026,-0.66222,1,0
6,GO TISSUE MORPHOGENESIS,5.337e-06,-0.61027,-0.58513,1,0
6,GO NEGATIVE REGULATION OF CELL GROWTH,5.7533e-06,-0.61048,-0.59083,1,0
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.0304e-05,-0.61051,-0.61494,1,0
6,GO BONE RESORPTION,1.4947e-05,-0.61071,-0.65164,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,7.7514e-06,-0.61072,-0.63427,1,0
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0003797,-0.61079,-0.52897,1,0
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,4.2763e-05,-0.61088,-0.66051,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,8.3461e-06,-0.61101,-0.54606,1,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,4.9495e-06,-0.61105,-0.68653,1,0
6,GO OSSIFICATION,5.7533e-06,-0.61146,-0.59866,1,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,5.337e-06,-0.61152,-0.58241,1,0
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.9495e-06,-0.61155,-0.60566,1,0
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.9843e-06,-0.61163,-0.6545,1,0
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,5.337e-06,-0.61163,-0.68276,1,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00029789,-0.61172,-0.52724,1,0
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.2428e-05,-0.61182,-0.61634,1,0
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.6086e-05,-0.6119,-0.65208,1,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,6.4139e-05,-0.61195,-0.67475,1,0
6,GO ERYTHROCYTE HOMEOSTASIS,5.7533e-06,-0.61212,-0.58875,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,9.5377e-05,-0.61212,-0.62961,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0304e-05,-0.61216,-0.59635,1,0
6,GO DEMETHYLATION,5.7533e-06,-0.61221,-0.59533,1,0
6,GO REGULATION OF DENDRITE DEVELOPMENT,1.0403e-05,-0.61224,-0.60443,1,0
6,GO DEVELOPMENTAL CELL GROWTH,7.1973e-06,-0.61227,-0.62746,1,0
6,GO COAGULATION,5.337e-06,-0.61227,-0.63022,1,0
6,GO FIBRINOLYSIS,0.00019306,-0.61239,-0.60371,1,0
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,6.6813e-06,-0.61242,-0.60897,1,0
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00091199,-0.61257,-0.5349,1,0
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,2.4576e-05,-0.61259,-0.5438,1,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,9.6689e-06,-0.6127,-0.63642,1,0
6,GO CELL MOTILITY,5.337e-06,-0.61295,-0.61207,1,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,4.2763e-05,-0.6131,-0.67087,1,0
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,7.7514e-06,-0.61315,-0.6339,1,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,7.7514e-06,-0.61332,-0.62022,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,5.337e-06,-0.61341,-0.60924,1,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,7.7514e-06,-0.61356,-0.66385,1,0
6,GO NEURON REMODELING,2.636e-05,-0.61375,-0.67334,1,0
6,GO ENDOSOMAL TRANSPORT,6.2007e-06,-0.61405,-0.57551,1,0
6,GO HEPATOCYTE APOPTOTIC PROCESS,3.7287e-05,-0.61412,-0.60261,1,0
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,8.9843e-06,-0.61421,-0.60425,1,0
6,GO RESPONSE TO GROWTH HORMONE,1.1191e-05,-0.61422,-0.56547,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.1191e-05,-0.61425,-0.67123,1,0
6,GO VACUOLAR TRANSPORT,6.2007e-06,-0.6144,-0.60758,1,0
6,GO REGULATION OF DEVELOPMENTAL GROWTH,6.6813e-06,-0.61454,-0.58565,1,0
6,GO WOUND HEALING,5.337e-06,-0.6146,-0.64451,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,8.3641e-05,-0.61469,-0.59586,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,3.4805e-05,-0.61482,-0.56288,1,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,1.8524e-05,-0.61482,-0.7197,1,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,7.7514e-06,-0.61489,-0.58479,1,0
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,6.2007e-06,-0.61497,-0.60666,1,0
6,GO MUSCLE CELL MIGRATION,6.6813e-06,-0.61529,-0.66868,1,0
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,1.3909e-05,-0.61538,-0.62931,1,0
6,GO CRANIAL NERVE MORPHOGENESIS,1.8524e-05,-0.61548,-0.62512,1,0
6,GO NEUROTROPHIN SIGNALING PATHWAY,4.9495e-06,-0.61552,-0.60573,1,0
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,1.4947e-05,-0.61556,-0.53681,1,0
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,5.7533e-06,-0.6156,-0.6271,1,0
6,GO HISTONE H3 DEACETYLATION,1.4947e-05,-0.61569,-0.54601,1,0
6,GO I KAPPAB PHOSPHORYLATION,8.3461e-06,-0.61572,-0.70179,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.4576e-05,-0.61582,-0.67363,1,0
6,GO LYMPH NODE DEVELOPMENT,6.6813e-06,-0.61585,-0.69111,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00024771,-0.61587,-0.52319,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.61604,-0.57756,1,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.6059e-05,-0.61611,-0.62767,1,0
6,GO MYOFIBRIL ASSEMBLY,1.1191e-05,-0.6162,-0.59178,1,0
6,GO LOCALIZATION WITHIN MEMBRANE,1.0403e-05,-0.61622,-0.61921,1,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,5.7533e-06,-0.61624,-0.62867,1,0
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.6813e-06,-0.61628,-0.67197,1,0
6,GO SKIN EPIDERMIS DEVELOPMENT,1.0403e-05,-0.61637,-0.56957,1,0
6,GO NEURON PROJECTION EXTENSION,7.1973e-06,-0.6165,-0.64696,1,0
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,6.2007e-06,-0.61656,-0.6171,1,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,7.1973e-06,-0.61658,-0.70421,1,0
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,6.2007e-06,-0.61659,-0.62625,1,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.9843e-06,-0.61685,-0.64275,1,0
6,GO STEM CELL PROLIFERATION,6.6813e-06,-0.61704,-0.59213,1,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.0304e-05,-0.61716,-0.68145,1,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,4.9495e-06,-0.61725,-0.62627,1,0
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,4.5891e-06,-0.6173,-0.57977,1,0
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,5.337e-06,-0.61735,-0.60734,1,0
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.61735,-0.59391,1,0
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,8.3461e-06,-0.61736,-0.64327,1,0
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,2.8267e-05,-0.6174,-0.57257,1,0
6,GO APICAL PROTEIN LOCALIZATION,2.2907e-05,-0.61744,-0.57591,1,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.3909e-05,-0.61753,-0.57092,1,0
6,GO REGULATION OF ANION TRANSPORT,4.9495e-06,-0.61754,-0.55299,1,0
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,9.6689e-06,-0.61768,-0.60545,1,0
6,GO REGULATION OF MYOBLAST FUSION,0.0003797,-0.61782,-0.64642,1,0
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.61791,-0.61901,1,0
6,GO RESPONSE TO ESTROGEN,5.337e-06,-0.61809,-0.59093,1,0
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.61811,-0.58299,1,0
6,GO METANEPHROS MORPHOGENESIS,1.3909e-05,-0.61816,-0.61417,1,0
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,6.2007e-06,-0.6183,-0.61702,1,0
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,7.3279e-05,-0.61831,-0.66326,1,0
6,GO HOMOTYPIC CELL CELL ADHESION,6.2007e-06,-0.61861,-0.66823,1,0
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.61876,-0.66919,1,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,5.7533e-06,-0.61881,-0.62737,1,0
6,GO NEURON PROJECTION REGENERATION,8.9843e-06,-0.61884,-0.6287,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2007e-06,-0.61921,-0.59361,1,0
6,GO REGULATION OF RECEPTOR CLUSTERING,0.00014062,-0.61934,-0.616,1,0
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,4.5891e-06,-0.61952,-0.60991,1,0
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,1.4947e-05,-0.62004,-0.60542,1,0
6,GO LUNG EPITHELIUM DEVELOPMENT,7.8298e-05,-0.62016,-0.52483,1,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,4.2539e-06,-0.62021,-0.62992,1,0
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.8524e-05,-0.62033,-0.61203,1,0
6,GO EMBRYONIC MORPHOGENESIS,7.7514e-06,-0.62034,-0.58899,1,0
6,GO JNK CASCADE,5.337e-06,-0.62105,-0.63287,1,0
6,GO CYTOSKELETON ORGANIZATION,5.7533e-06,-0.6211,-0.59462,1,0
6,GO CYTOPLASM ORGANIZATION,2.8267e-05,-0.62118,-0.63331,1,0
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,6.6813e-06,-0.6212,-0.61912,1,0
6,GO GAMMA DELTA T CELL ACTIVATION,4.2763e-05,-0.6213,-0.68228,1,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,7.7514e-06,-0.62143,-0.59343,1,0
6,GO PEPTIDYL SERINE MODIFICATION,5.337e-06,-0.62149,-0.62051,1,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,2.4576e-05,-0.62152,-0.58887,1,0
6,GO REGULATION OF BONE MINERALIZATION,1.6059e-05,-0.62163,-0.61948,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,5.337e-06,-0.62169,-0.6129,1,0
6,GO BRONCHUS DEVELOPMENT,0.00014989,-0.62171,-0.60098,1,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00012367,-0.62173,-0.76181,1,0
6,GO GLAND MORPHOGENESIS,1.1191e-05,-0.62187,-0.64576,1,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,6.2007e-06,-0.62188,-0.61093,1,0
6,GO REGULATION OF PLATELET ACTIVATION,4.8997e-05,-0.62201,-0.68699,1,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00010866,-0.62201,-0.56039,1,0
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,6.6813e-06,-0.62206,-0.59091,1,0
6,GO NEPHRIC DUCT DEVELOPMENT,1.8524e-05,-0.62208,-0.58921,1,0
6,GO REGULATION OF RUFFLE ASSEMBLY,6.6813e-06,-0.62225,-0.60461,1,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,4.5891e-06,-0.62232,-0.63131,1,0
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,1.7249e-05,-0.62237,-0.75286,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.4805e-05,-0.62248,-0.67667,1,0
6,GO HEPARIN METABOLIC PROCESS,1.9888e-05,-0.62257,-0.66608,1,0
6,GO MUSCLE CELL DIFFERENTIATION,5.337e-06,-0.62257,-0.57761,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,4.9495e-06,-0.62264,-0.67337,1,0
6,GO REGULATION OF OSSIFICATION,8.3461e-06,-0.62279,-0.61028,1,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00033648,-0.62295,-0.52836,1,0
6,GO LUNG MORPHOGENESIS,9.6689e-06,-0.62304,-0.64035,1,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,1.2939e-05,-0.62305,-0.62485,1,0
6,GO REGULATION OF GOLGI ORGANIZATION,4.8997e-05,-0.62324,-0.63356,1,0
6,GO LAMELLIPODIUM ORGANIZATION,6.2007e-06,-0.62327,-0.59061,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,8.3461e-06,-0.62332,-0.64033,1,0
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,4.9495e-06,-0.62336,-0.63509,1,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,4.5891e-06,-0.6234,-0.6196,1,0
6,GO ENDOCYTOSIS,5.7533e-06,-0.62353,-0.61833,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,4.8997e-05,-0.62354,-0.57035,1,0
6,GO STRIATUM DEVELOPMENT,8.3461e-06,-0.62354,-0.59681,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE,5.337e-06,-0.62365,-0.59268,1,0
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,6.4139e-05,-0.62372,-0.55311,1,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,5.7533e-06,-0.62376,-0.61086,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,-0.62399,-0.65199,1,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,4.5891e-06,-0.62417,-0.68709,1,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.2007e-06,-0.62419,-0.6372,1,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00015974,-0.62432,-0.54284,1,0
6,GO RESPONSE TO STEROL DEPLETION,5.7533e-06,-0.62447,-0.65048,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.1191e-05,-0.62447,-0.56774,1,0
6,GO RESPONSE TO AUDITORY STIMULUS,0.00068502,-0.62449,-0.51726,1,0
6,GO AMYLOID BETA CLEARANCE,2.2907e-05,-0.62463,-0.69325,1,0
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,9.6689e-06,-0.62477,-0.61767,1,0
6,GO VESICLE CYTOSKELETAL TRAFFICKING,6.2007e-06,-0.62486,-0.65272,1,0
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,1.9888e-05,-0.62487,-0.63976,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00015974,-0.62488,-0.69656,1,0
6,GO GDP METABOLIC PROCESS,1.1191e-05,-0.62497,-0.53039,1,0
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,1.1191e-05,-0.62501,-0.57695,1,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,8.3461e-06,-0.62513,-0.5978,1,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,6.2007e-06,-0.62529,-0.63608,1,0
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.636e-05,-0.62535,-0.57375,1,0
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.2035e-05,-0.62539,-0.6304,1,0
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,5.337e-06,-0.62546,-0.60049,1,0
6,GO LUNG CELL DIFFERENTIATION,0.00013188,-0.62549,-0.51759,1,0
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.5891e-06,-0.6255,-0.61973,1,0
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.0403e-05,-0.62555,-0.63531,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,6.6813e-06,-0.62561,-0.64642,1,0
6,GO T CELL EXTRAVASATION,0.00029789,-0.62565,-0.66782,1,0
6,GO RUFFLE ASSEMBLY,7.7514e-06,-0.62567,-0.60347,1,0
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.2763e-05,-0.62571,-0.59528,1,0
6,GO SULFUR COMPOUND TRANSPORT,5.337e-06,-0.62596,-0.62855,1,0
6,GO NEGATIVE REGULATION OF TOR SIGNALING,5.337e-06,-0.62605,-0.62127,1,0
6,GO ACTIN FILAMENT BASED MOVEMENT,6.6813e-06,-0.62612,-0.60343,1,0
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.2539e-06,-0.62638,-0.63338,1,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.9936e-05,-0.62665,-0.56867,1,0
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00021879,-0.62725,-0.55989,1,0
6,GO CARDIAC SEPTUM MORPHOGENESIS,5.337e-06,-0.62739,-0.65548,1,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.2035e-05,-0.62746,-0.62784,1,0
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.4576e-05,-0.62761,-0.71727,1,0
6,GO PROTEIN LOCALIZATION TO VACUOLE,7.1973e-06,-0.62766,-0.625,1,0
6,GO REGULATION OF ORGANIC ACID TRANSPORT,1.4947e-05,-0.62767,-0.52228,1,0
6,GO NEURON PROJECTION GUIDANCE,7.1973e-06,-0.62773,-0.6639,1,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,7.1973e-06,-0.62789,-0.65272,1,0
6,GO SCHWANN CELL DEVELOPMENT,4.2539e-06,-0.62802,-0.65517,1,0
6,GO OLIGOPEPTIDE TRANSPORT,9.6689e-06,-0.62815,-0.59857,1,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,1.2035e-05,-0.62818,-0.72607,1,0
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,6.6813e-06,-0.62829,-0.64057,1,0
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,3.4805e-05,-0.62841,-0.605,1,0
6,GO PEPTIDYL TYROSINE MODIFICATION,5.337e-06,-0.62843,-0.64434,1,0
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,5.7533e-06,-0.62857,-0.62278,1,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,7.7514e-06,-0.62864,-0.59026,1,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,5.6086e-05,-0.62883,-0.74907,1,0
6,GO REGULATION OF CELL ADHESION,7.7514e-06,-0.62884,-0.65108,1,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,6.4139e-05,-0.62892,-0.67556,1,0
6,GO MESENCHYMAL CELL PROLIFERATION,1.7249e-05,-0.62904,-0.63066,1,0
6,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.018736,-0.62908,-0.76311,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,3.248e-05,-0.62922,-0.5448,1,0
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.337e-06,-0.62923,-0.57539,1,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,7.7514e-06,-0.62925,-0.60589,1,0
6,GO OPTIC NERVE DEVELOPMENT,0.00015974,-0.62936,-0.56826,1,0
6,GO TRABECULA FORMATION,2.1347e-05,-0.6295,-0.61704,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.9495e-06,-0.62954,-0.61152,1,0
6,GO SCHWANN CELL DIFFERENTIATION,4.2539e-06,-0.62955,-0.63764,1,0
6,GO CARDIOCYTE DIFFERENTIATION,6.2007e-06,-0.6296,-0.58022,1,0
6,GO TAXIS,7.7514e-06,-0.63,-0.59247,1,0
6,GO GERMINAL CENTER FORMATION,4.8997e-05,-0.63009,-0.80626,1,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,5.337e-06,-0.6301,-0.61818,1,0
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,3.9422e-06,-0.63015,-0.63999,1,0
6,GO AMINO ACID IMPORT,4.5891e-06,-0.63019,-0.59454,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.8565e-05,-0.63026,-0.66901,1,0
6,GO VENTRICULAR SYSTEM DEVELOPMENT,1.2035e-05,-0.63029,-0.59577,1,0
6,GO PROSTAGLANDIN TRANSPORT,3.248e-05,-0.63051,-0.58028,1,0
6,GO PHOSPHATE ION TRANSPORT,9.6689e-06,-0.63054,-0.61145,1,0
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,3.0304e-05,-0.63069,-0.60174,1,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,6.6813e-06,-0.63069,-0.6056,1,0
6,GO MEMBRANE RAFT ORGANIZATION,1.2035e-05,-0.63074,-0.71948,1,0
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,6.6813e-06,-0.63075,-0.62819,1,0
6,GO MESENCHYME MORPHOGENESIS,7.1973e-06,-0.63112,-0.65846,1,0
6,GO BIOLOGICAL ADHESION,6.2007e-06,-0.63127,-0.6268,1,0
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.7533e-06,-0.63129,-0.57989,1,0
6,GO INTRACELLULAR LIPID TRANSPORT,6.2007e-06,-0.63178,-0.61512,1,0
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00029789,-0.6318,-0.5871,1,0
6,GO RESPONSE TO MANGANESE ION,1.3909e-05,-0.63185,-0.58416,1,0
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.6059e-05,-0.63207,-0.57811,1,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,1.1191e-05,-0.63223,-0.66824,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,6.2007e-06,-0.63233,-0.62456,1,0
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,5.337e-06,-0.63246,-0.62359,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.1973e-06,-0.63264,-0.58672,1,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,5.337e-06,-0.63284,-0.64412,1,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,9.5377e-05,-0.63288,-0.74796,1,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,2.8267e-05,-0.63302,-0.53778,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,4.9495e-06,-0.63311,-0.58137,1,0
6,GO APPENDAGE DEVELOPMENT,7.7514e-06,-0.63331,-0.59939,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.2035e-05,-0.63348,-0.64163,1,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,3.9422e-06,-0.63349,-0.65688,1,0
6,GO ERBB SIGNALING PATHWAY,4.5891e-06,-0.63355,-0.60662,1,0
6,GO SPHINGOMYELIN METABOLIC PROCESS,2.636e-05,-0.63367,-0.56753,1,0
6,GO MUSCLE ADAPTATION,4.9495e-06,-0.63373,-0.62825,1,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.3909e-05,-0.63376,-0.59373,1,0
6,GO ASTROCYTE ACTIVATION,9.6689e-06,-0.63387,-0.71298,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.6059e-05,-0.63408,-0.62718,1,0
6,GO EPITHELIAL TUBE FORMATION,5.7533e-06,-0.63411,-0.5703,1,0
6,GO REGULATION OF FATTY ACID OXIDATION,4.9495e-06,-0.63415,-0.59106,1,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,3.9422e-06,-0.63417,-0.66632,1,0
6,GO RESPONSE TO ANGIOTENSIN,4.5891e-06,-0.63431,-0.67418,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.1973e-06,-0.63432,-0.64861,1,0
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.3909e-05,-0.63433,-0.55165,1,0
6,GO INOSITOL LIPID MEDIATED SIGNALING,4.5891e-06,-0.63441,-0.64663,1,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,7.7514e-06,-0.63442,-0.6989,1,0
6,GO NEURON PROJECTION ORGANIZATION,8.3461e-06,-0.63447,-0.63504,1,0
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.5779e-05,-0.6348,-0.58728,1,0
6,GO POSITIVE REGULATION OF VASCULOGENESIS,2.1347e-05,-0.63481,-0.61541,1,0
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,2.2907e-05,-0.63498,-0.62869,1,0
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,8.3461e-06,-0.63516,-0.62711,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,6.6813e-06,-0.63524,-0.61535,1,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.3909e-05,-0.63526,-0.59242,1,0
6,GO RESPONSE TO INACTIVITY,1.4947e-05,-0.63546,-0.62765,1,0
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,1.2035e-05,-0.63558,-0.60619,1,0
6,GO GALACTOSE METABOLIC PROCESS,2.1347e-05,-0.63569,-0.58923,1,0
6,GO FAT CELL DIFFERENTIATION,7.7514e-06,-0.63576,-0.58588,1,0
6,GO REGULATION OF AXONOGENESIS,8.3461e-06,-0.63579,-0.68467,1,0
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.7514e-06,-0.63582,-0.7007,1,0
6,GO POST ANAL TAIL MORPHOGENESIS,7.7514e-06,-0.63583,-0.63871,1,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,1.2939e-05,-0.63602,-0.62099,1,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00048214,-0.63614,-0.59226,1,0
6,GO NEGATIVE REGULATION OF JNK CASCADE,5.337e-06,-0.63622,-0.62453,1,0
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.0403e-05,-0.63625,-0.62011,1,0
6,GO STRIATED MUSCLE ADAPTATION,6.6813e-06,-0.63627,-0.63407,1,0
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,3.7287e-05,-0.63641,-0.55834,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.2007e-06,-0.63646,-0.61833,1,0
6,GO MEMBRANE REPOLARIZATION,2.4576e-05,-0.63648,-0.59729,1,0
6,GO CELLULAR COMPONENT MAINTENANCE,6.2007e-06,-0.63654,-0.63917,1,0
6,GO PLATELET AGGREGATION,6.2007e-06,-0.63659,-0.68445,1,0
6,GO PERICARDIUM DEVELOPMENT,1.4947e-05,-0.63674,-0.66512,1,0
6,GO MITRAL VALVE DEVELOPMENT,0.00012367,-0.63697,-0.64524,1,0
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.7533e-06,-0.63707,-0.63869,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,8.3641e-05,-0.6374,-0.75696,1,0
6,GO OVULATION CYCLE,7.1973e-06,-0.63741,-0.59673,1,0
6,GO HYALURONAN METABOLIC PROCESS,8.3461e-06,-0.63748,-0.63733,1,0
6,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00054254,-0.63754,-0.68602,1,0
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,1.2035e-05,-0.63758,-0.63947,1,0
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,3.7287e-05,-0.63764,-0.59476,1,0
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.7533e-06,-0.63765,-0.62451,1,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2939e-05,-0.63774,-0.60507,1,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,3.7287e-05,-0.63776,-0.67216,1,0
6,GO REGULATION OF CELLULAR COMPONENT SIZE,5.337e-06,-0.63803,-0.61789,1,0
6,GO HISTONE DEACETYLATION,9.6689e-06,-0.63812,-0.58744,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,3.9422e-06,-0.63814,-0.6563,1,0
6,GO NEURAL CREST CELL MIGRATION,9.6689e-06,-0.63818,-0.60609,1,0
6,GO APPENDAGE MORPHOGENESIS,1.0403e-05,-0.63821,-0.61092,1,0
6,GO REGULATION OF ACTION POTENTIAL,7.7514e-06,-0.63824,-0.63378,1,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,4.2539e-06,-0.6383,-0.61883,1,0
6,GO REGULATION OF PROTEIN SUMOYLATION,9.6689e-06,-0.63836,-0.57684,1,0
6,GO HISTONE DEUBIQUITINATION,1.0403e-05,-0.63856,-0.66995,1,0
6,GO RESPONSE TO ACIDIC PH,2.4576e-05,-0.63866,-0.61031,1,0
6,GO COPII COATED VESICLE CARGO LOADING,6.2007e-06,-0.63903,-0.66007,1,0
6,GO RDNA HETEROCHROMATIN ASSEMBLY,1.3909e-05,-0.63904,-0.67774,1,0
6,GO LAMELLIPODIUM ASSEMBLY,7.1973e-06,-0.63906,-0.60204,1,0
6,GO ADRENAL GLAND DEVELOPMENT,3.248e-05,-0.63911,-0.59925,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.6059e-05,-0.63926,-0.61834,1,0
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.6086e-05,-0.63948,-0.69988,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.6689e-06,-0.63962,-0.65864,1,0
6,GO CHROMATIN DISASSEMBLY,6.8565e-05,-0.63982,-0.57918,1,0
6,GO CARDIAC ATRIUM DEVELOPMENT,1.0403e-05,-0.6399,-0.67132,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00091199,-0.6399,-0.82134,1,0
6,GO STEM CELL DIVISION,8.3461e-06,-0.63994,-0.65325,1,0
6,GO RUFFLE ORGANIZATION,6.6813e-06,-0.63994,-0.63998,1,0
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,6.2007e-06,-0.64028,-0.63487,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.5891e-06,-0.64028,-0.64197,1,0
6,GO LACTATION,3.0304e-05,-0.64031,-0.5918,1,0
6,GO MULTI ORGANISM CELLULAR PROCESS,1.1191e-05,-0.6405,-0.70565,1,0
6,GO CARDIAC VENTRICLE DEVELOPMENT,4.2539e-06,-0.64053,-0.63796,1,0
6,GO NEUROBLAST DIVISION,6.6813e-06,-0.64056,-0.65198,1,0
6,GO PEPTIDYL LYSINE TRIMETHYLATION,8.3461e-06,-0.64083,-0.65398,1,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,7.1973e-06,-0.641,-0.62133,1,0
6,GO CARDIAC CHAMBER MORPHOGENESIS,5.337e-06,-0.64115,-0.64669,1,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,8.9843e-06,-0.64116,-0.69531,1,0
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,5.6086e-05,-0.64128,-0.63835,1,0
6,GO REGULATION OF SULFUR METABOLIC PROCESS,1.9888e-05,-0.6414,-0.65132,1,0
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.7533e-06,-0.64145,-0.66563,1,0
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,6.6813e-06,-0.64149,-0.65109,1,0
6,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.64151,-0.67412,1,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.7514e-06,-0.64159,-0.62501,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,1.4947e-05,-0.64161,-0.56405,1,0
6,GO EPITHELIAL CELL FATE COMMITMENT,6.4139e-05,-0.64183,-0.57726,1,0
6,GO CARDIAC MYOFIBRIL ASSEMBLY,1.3909e-05,-0.6421,-0.63915,1,0
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,6.6813e-06,-0.64227,-0.63089,1,0
6,GO CELL JUNCTION ORGANIZATION,6.6813e-06,-0.64265,-0.63694,1,0
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,5.337e-06,-0.64276,-0.5884,1,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.2907e-05,-0.64279,-0.60382,1,0
6,GO REGULATION OF TORC1 SIGNALING,5.7533e-06,-0.64309,-0.64899,1,0
6,GO MATERNAL PLACENTA DEVELOPMENT,7.3279e-05,-0.64323,-0.61661,1,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.2035e-05,-0.64357,-0.59359,1,0
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,6.2007e-06,-0.6436,-0.61408,1,0
6,GO ENDOCARDIUM DEVELOPMENT,1.2939e-05,-0.6437,-0.58751,1,0
6,GO RESPIRATORY SYSTEM PROCESS,1.2035e-05,-0.64391,-0.6442,1,0
6,GO KERATINOCYTE PROLIFERATION,1.2939e-05,-0.64397,-0.59013,1,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,5.6086e-05,-0.64412,-0.60018,1,0
6,GO NEGATIVE REGULATION OF OSSIFICATION,7.7514e-06,-0.64434,-0.62698,1,0
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,5.7533e-06,-0.64464,-0.62346,1,0
6,GO TRANSCYTOSIS,1.7249e-05,-0.64487,-0.63573,1,0
6,GO RECEPTOR CLUSTERING,9.6689e-06,-0.64498,-0.64887,1,0
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,2.4576e-05,-0.6451,-0.68756,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,5.337e-06,-0.64512,-0.59523,1,0
6,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,5.337e-06,-0.64519,-0.63901,1,0
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,8.3461e-06,-0.64521,-0.64927,1,0
6,GO SPINAL CORD PATTERNING,3.0304e-05,-0.64525,-0.6662,1,0
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,8.9843e-06,-0.64543,-0.6427,1,0
6,GO STRESS GRANULE ASSEMBLY,1.7249e-05,-0.64547,-0.60733,1,0
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,8.9843e-06,-0.6456,-0.60418,1,0
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.64563,-0.64819,1,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00010181,-0.64564,-0.58472,1,0
6,GO CHOLESTEROL STORAGE,7.1973e-06,-0.64586,-0.7145,1,0
6,GO CAMP METABOLIC PROCESS,1.1191e-05,-0.64597,-0.6543,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,7.1973e-06,-0.64633,-0.64685,1,0
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,8.9843e-06,-0.64643,-0.64524,1,0
6,GO PROTEIN TARGETING TO VACUOLE,8.9843e-06,-0.64651,-0.64413,1,0
6,GO REGULATION OF VASCULOGENESIS,9.6689e-06,-0.64664,-0.64396,1,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.6059e-05,-0.64672,-0.62729,1,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.64682,-0.63628,1,0
6,GO REGULATION OF VASOCONSTRICTION,1.9888e-05,-0.6469,-0.60359,1,0
6,GO EPITHELIAL TUBE MORPHOGENESIS,5.337e-06,-0.64702,-0.60696,1,0
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,1.1191e-05,-0.64718,-0.61357,1,0
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.9936e-05,-0.64721,-0.71411,1,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,6.6813e-06,-0.64725,-0.62054,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.2035e-05,-0.64731,-0.61784,1,0
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.2539e-06,-0.64755,-0.64664,1,0
6,GO POSITIVE REGULATION OF JNK CASCADE,4.5891e-06,-0.64757,-0.67686,1,0
6,GO EMBRYONIC PLACENTA DEVELOPMENT,1.0403e-05,-0.64774,-0.61943,1,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,5.337e-06,-0.6481,-0.64037,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,7.7514e-06,-0.64819,-0.66002,1,0
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,1.2939e-05,-0.64822,-0.68774,1,0
6,GO ACTIN CYTOSKELETON REORGANIZATION,4.2539e-06,-0.64826,-0.67959,1,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,5.337e-06,-0.6483,-0.6783,1,0
6,GO CELL JUNCTION ASSEMBLY,5.7533e-06,-0.6484,-0.63765,1,0
6,GO REGULATION OF EXTENT OF CELL GROWTH,1.0403e-05,-0.64841,-0.66083,1,0
6,GO TELENCEPHALON GLIAL CELL MIGRATION,7.1973e-06,-0.64843,-0.68753,1,0
6,GO EYE MORPHOGENESIS,5.337e-06,-0.64853,-0.60329,1,0
6,GO LOOP OF HENLE DEVELOPMENT,3.4805e-05,-0.64854,-0.69492,1,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2007e-06,-0.64861,-0.7195,1,0
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00033648,-0.64862,-0.83484,1,0
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,7.7514e-06,-0.64871,-0.56453,1,0
6,GO UV PROTECTION,6.2007e-06,-0.64874,-0.60638,1,0
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.1973e-06,-0.64877,-0.64363,1,0
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,5.7533e-06,-0.64891,-0.62856,1,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,8.9843e-06,-0.649,-0.65906,1,0
6,GO PRO B CELL DIFFERENTIATION,2.4576e-05,-0.64901,-0.64424,1,0
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.4947e-05,-0.64915,-0.73217,1,0
6,GO NEGATIVE REGULATION OF AXONOGENESIS,7.7514e-06,-0.64918,-0.66895,1,0
6,GO REGULATION OF CGMP MEDIATED SIGNALING,5.9985e-05,-0.64924,-0.64927,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4947e-05,-0.64939,-0.65846,1,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,2.636e-05,-0.64951,-0.64613,1,0
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.8524e-05,-0.64965,-0.61064,1,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,8.3461e-06,-0.64974,-0.63769,1,0
6,GO CELL JUNCTION MAINTENANCE,3.7287e-05,-0.64994,-0.62615,1,0
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,1.4947e-05,-0.64995,-0.61038,1,0
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.65023,-0.61741,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,1.9888e-05,-0.65024,-0.58195,1,0
6,GO MESODERM MORPHOGENESIS,7.7514e-06,-0.65025,-0.58089,1,0
6,GO CENTRIOLE CENTRIOLE COHESION,1.2035e-05,-0.65045,-0.74139,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,5.337e-06,-0.65053,-0.6253,1,0
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,1.3909e-05,-0.65053,-0.63503,1,0
6,GO ESTROUS CYCLE,3.7287e-05,-0.65054,-0.61477,1,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,6.6813e-06,-0.65064,-0.64491,1,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.7514e-06,-0.65082,-0.73444,1,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,3.4805e-05,-0.65126,-0.66128,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,7.8298e-05,-0.65142,-0.69203,1,0
6,GO PROTEOGLYCAN METABOLIC PROCESS,5.337e-06,-0.65143,-0.65751,1,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,5.7533e-06,-0.65157,-0.62602,1,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,6.6813e-06,-0.65171,-0.63229,1,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.2007e-06,-0.65186,-0.629,1,0
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.2763e-05,-0.65191,-0.54522,1,0
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.3909e-05,-0.65197,-0.64725,1,0
6,GO MAMMARY GLAND MORPHOGENESIS,1.4947e-05,-0.65238,-0.67673,1,0
6,GO KERATINOCYTE DEVELOPMENT,4.5779e-05,-0.65246,-0.60162,1,0
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.65265,-0.65839,1,0
6,GO HAIR FOLLICLE MATURATION,1.6059e-05,-0.65287,-0.59663,1,0
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,8.9327e-05,-0.65302,-0.55135,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.337e-06,-0.65302,-0.6165,1,0
6,GO RESPONSE TO INTERFERON ALPHA,0.00040321,-0.65323,-0.7396,1,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,1.2939e-05,-0.65331,-0.60734,1,0
6,GO RNA DECAPPING,2.4576e-05,-0.65335,-0.5772,1,0
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,6.2007e-06,-0.6534,-0.67258,1,0
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,8.3461e-06,-0.65349,-0.63853,1,0
6,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,3.248e-05,-0.65356,-0.64169,1,0
6,GO CELL MORPHOGENESIS,7.1973e-06,-0.65357,-0.64148,1,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,3.9422e-06,-0.65358,-0.63614,1,0
6,GO SECONDARY PALATE DEVELOPMENT,7.7514e-06,-0.6536,-0.7046,1,0
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,6.6813e-06,-0.65363,-0.6234,1,0
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,4.9495e-06,-0.65366,-0.64407,1,0
6,GO AZOLE TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.65386,-0.7103,1,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,3.9422e-06,-0.65418,-0.71059,1,0
6,GO RENAL SYSTEM PROCESS,6.6813e-06,-0.65438,-0.62082,1,0
6,GO PROTEIN DEMANNOSYLATION,4.9495e-06,-0.65456,-0.72129,1,0
6,GO SKELETAL SYSTEM MORPHOGENESIS,5.7533e-06,-0.65462,-0.63913,1,0
6,GO CELLULAR RESPONSE TO ETHANOL,2.4576e-05,-0.65466,-0.71154,1,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031664,-0.65474,-0.54412,1,0
6,GO REGULATION OF MUSCLE ADAPTATION,5.337e-06,-0.6548,-0.63662,1,0
6,GO TROPHOBLAST CELL MIGRATION,4.8997e-05,-0.65492,-0.59633,1,0
6,GO SELECTIVE AUTOPHAGY,1.0403e-05,-0.65502,-0.59306,1,0
6,GO DISACCHARIDE METABOLIC PROCESS,1.4947e-05,-0.65511,-0.63781,1,0
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,1.2939e-05,-0.65515,-0.66518,1,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,1.8524e-05,-0.65529,-0.55986,1,0
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,9.6689e-06,-0.65541,-0.60608,1,0
6,GO REGULATION OF MAP KINASE ACTIVITY,4.5891e-06,-0.65542,-0.65099,1,0
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.4947e-05,-0.65544,-0.73564,1,0
6,GO MUSCLE ORGAN MORPHOGENESIS,7.1973e-06,-0.65571,-0.60511,1,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,7.7514e-06,-0.65572,-0.6445,1,0
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.6059e-05,-0.65572,-0.58499,1,0
6,GO REGULATION OF TISSUE REMODELING,8.3461e-06,-0.65578,-0.69369,1,0
6,GO ENDOCRINE PANCREAS DEVELOPMENT,2.1347e-05,-0.65579,-0.57229,1,0
6,GO DECIDUALIZATION,0.00015974,-0.65593,-0.6384,1,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.1973e-06,-0.65602,-0.63559,1,0
6,GO RENAL WATER HOMEOSTASIS,2.1347e-05,-0.65632,-0.61498,1,0
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.2007e-06,-0.65645,-0.61856,1,0
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.1973e-06,-0.6566,-0.65184,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.5891e-06,-0.6567,-0.63845,1,0
6,GO MICROTUBULE ANCHORING AT CENTROSOME,2.1347e-05,-0.65678,-0.6947,1,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.65685,-0.69339,1,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.0047188,-0.65687,-0.63825,1,0
6,GO CELLULAR RESPONSE TO ALCOHOL,7.1973e-06,-0.65689,-0.64849,1,0
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,5.337e-06,-0.65706,-0.63853,1,0
6,GO CORTICAL CYTOSKELETON ORGANIZATION,6.2007e-06,-0.65708,-0.63669,1,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,7.7514e-06,-0.6571,-0.67063,1,0
6,GO NEGATIVE REGULATION OF MAPK CASCADE,5.337e-06,-0.6572,-0.64518,1,0
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,1.1191e-05,-0.6572,-0.5904,1,0
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,7.1973e-06,-0.65726,-0.66779,1,0
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,5.7533e-06,-0.65727,-0.64814,1,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.00012367,-0.65741,-0.72227,1,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,3.9936e-05,-0.65771,-0.54024,1,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,5.337e-06,-0.65774,-0.65251,1,0
6,GO DETECTION OF MECHANICAL STIMULUS,8.9843e-06,-0.65804,-0.59423,1,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,6.6813e-06,-0.65816,-0.59841,1,0
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.8524e-05,-0.65838,-0.68768,1,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.00017019,-0.65853,-0.57697,1,0
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.65853,-0.58862,1,0
6,GO HEART DEVELOPMENT,5.337e-06,-0.65915,-0.61202,1,0
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,3.9936e-05,-0.65915,-0.60513,1,0
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.9495e-06,-0.65944,-0.67645,1,0
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,8.3641e-05,-0.65952,-0.71634,1,0
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.5891e-06,-0.65952,-0.6689,1,0
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,5.337e-06,-0.65961,-0.62179,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.6059e-05,-0.66002,-0.58874,1,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,1.1191e-05,-0.66028,-0.61658,1,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.7287e-05,-0.66036,-0.60374,1,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4576e-05,-0.66052,-0.7241,1,0
6,GO PROTEIN DEPOLYMERIZATION,4.9495e-06,-0.66065,-0.69886,1,0
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,1.0403e-05,-0.66078,-0.65069,1,0
6,GO SOMATIC STEM CELL DIVISION,0.00045436,-0.66078,-0.61812,1,0
6,GO ROOF OF MOUTH DEVELOPMENT,7.7514e-06,-0.66101,-0.62541,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.0304e-05,-0.66121,-0.5999,1,0
6,GO CELL VOLUME HOMEOSTASIS,1.0403e-05,-0.66204,-0.58638,1,0
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,6.2007e-06,-0.66222,-0.61009,1,0
6,GO RESPONSE TO INTERLEUKIN 6,1.2035e-05,-0.66231,-0.70575,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00081392,-0.66233,-0.67795,1,0
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00014062,-0.66237,-0.63392,1,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00011593,-0.66257,-0.70198,1,0
6,GO GLIAL CELL MIGRATION,4.2539e-06,-0.66258,-0.68839,1,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00010866,-0.66258,-0.57994,1,0
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.248e-05,-0.66264,-0.68825,1,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,5.337e-06,-0.6627,-0.6485,1,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,5.7533e-06,-0.66272,-0.63627,1,0
6,GO NEGATIVE REGULATION OF AXON EXTENSION,9.6689e-06,-0.66291,-0.6539,1,0
6,GO MUSCLE HYPERTROPHY,4.9495e-06,-0.66296,-0.62384,1,0
6,GO RESPONSE TO GROWTH FACTOR,5.337e-06,-0.66318,-0.62267,1,0
6,GO HISTONE H3 K9 METHYLATION,8.3461e-06,-0.66336,-0.65313,1,0
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.6635,-0.59631,1,0
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.0403e-05,-0.66354,-0.70953,1,0
6,GO POST EMBRYONIC DEVELOPMENT,7.7514e-06,-0.66354,-0.62562,1,0
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,5.9985e-05,-0.66366,-0.75083,1,0
6,GO INCLUSION BODY ASSEMBLY,0.00076864,-0.66375,-0.56924,1,0
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,7.1973e-06,-0.66406,-0.63951,1,0
6,GO TUBE MORPHOGENESIS,5.337e-06,-0.66421,-0.65885,1,0
6,GO SKELETAL SYSTEM DEVELOPMENT,5.337e-06,-0.66428,-0.63388,1,0
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.66439,-0.62097,1,0
6,GO RESPONSE TO LIPOTEICHOIC ACID,0.00035748,-0.66458,-0.6412,1,0
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,5.7533e-06,-0.66458,-0.65807,1,0
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1.8524e-05,-0.66488,-0.71805,1,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.66533,-0.67772,1,0
6,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00017019,-0.66537,-0.66059,1,0
6,GO PROTEIN LOCALIZATION TO AXON,0.00026348,-0.66543,-0.64848,1,0
6,GO PINOCYTOSIS,5.7533e-06,-0.66558,-0.70684,1,0
6,GO ENAMEL MINERALIZATION,2.4576e-05,-0.66562,-0.68392,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,8.3461e-06,-0.66567,-0.62949,1,0
6,GO FIBROBLAST ACTIVATION,5.337e-06,-0.66578,-0.69096,1,0
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,1.2035e-05,-0.66606,-0.67517,1,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,5.7533e-06,-0.66627,-0.65179,1,0
6,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00045436,-0.6663,-0.56577,1,0
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,1.1191e-05,-0.66632,-0.69459,1,0
6,GO CARDIAC ATRIUM MORPHOGENESIS,7.1973e-06,-0.66671,-0.70349,1,0
6,GO DENDRITIC SPINE MAINTENANCE,6.2007e-06,-0.66681,-0.68244,1,0
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,8.9327e-05,-0.66685,-0.63449,1,0
6,GO CAMERA TYPE EYE MORPHOGENESIS,6.6813e-06,-0.66693,-0.58522,1,0
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,7.7514e-06,-0.66698,-0.62299,1,0
6,GO REGULATION OF CELL MORPHOGENESIS,5.7533e-06,-0.667,-0.65973,1,0
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,5.9985e-05,-0.66701,-0.6081,1,0
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,4.2539e-06,-0.66708,-0.6888,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00028019,-0.66726,-0.71324,1,0
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,1.6059e-05,-0.66733,-0.63092,1,0
6,GO ATRIAL SEPTUM DEVELOPMENT,4.5779e-05,-0.6674,-0.63301,1,0
6,GO TUBE DEVELOPMENT,5.337e-06,-0.66757,-0.63634,1,0
6,GO MITOCHONDRION DISTRIBUTION,1.0403e-05,-0.66762,-0.66887,1,0
6,GO MICROTUBULE ANCHORING,1.0403e-05,-0.66794,-0.66314,1,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,7.1973e-06,-0.66803,-0.64314,1,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,2.2907e-05,-0.66826,-0.62915,1,0
6,GO SPHINGOID METABOLIC PROCESS,5.337e-06,-0.66843,-0.66877,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.2539e-06,-0.66851,-0.66404,1,0
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,8.3461e-06,-0.66857,-0.65784,1,0
6,GO REGULATION OF PODOSOME ASSEMBLY,5.337e-06,-0.6688,-0.74055,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.9843e-06,-0.66882,-0.73105,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.8524e-05,-0.66889,-0.62757,1,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,5.7533e-06,-0.6689,-0.70419,1,0
6,GO PROTEIN LOCALIZATION TO LYSOSOME,9.6689e-06,-0.66903,-0.64126,1,0
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.66904,-0.66125,1,0
6,GO NEPHRON DEVELOPMENT,4.5891e-06,-0.66924,-0.6585,1,0
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,8.3461e-06,-0.66926,-0.60476,1,0
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,5.337e-06,-0.66963,-0.67121,1,0
6,GO RETROGRADE AXONAL TRANSPORT,2.1347e-05,-0.66975,-0.70107,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.2939e-05,-0.6699,-0.70113,1,0
6,GO TORC1 SIGNALING,4.9495e-06,-0.6702,-0.69122,1,0
6,GO KERATAN SULFATE CATABOLIC PROCESS,0.00029789,-0.67032,-0.71208,1,0
6,GO HEART MORPHOGENESIS,6.2007e-06,-0.67079,-0.6182,1,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.5779e-05,-0.67096,-0.62719,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,7.7514e-06,-0.67101,-0.64046,1,0
6,GO HISTONE H3 K9 DEMETHYLATION,1.0403e-05,-0.67121,-0.69227,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,3.9936e-05,-0.67137,-0.62745,1,0
6,GO ACTIN FILAMENT ORGANIZATION,5.337e-06,-0.67147,-0.63572,1,0
6,GO GLYCOLIPID CATABOLIC PROCESS,5.7533e-06,-0.6717,-0.75137,1,0
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,1.2035e-05,-0.67181,-0.63421,1,0
6,GO REVERSE CHOLESTEROL TRANSPORT,5.6086e-05,-0.67181,-0.70192,1,0
6,GO PEPTIDYL THREONINE MODIFICATION,5.7533e-06,-0.67187,-0.66038,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.6059e-05,-0.67196,-0.63348,1,0
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.3909e-05,-0.67205,-0.73205,1,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,5.2428e-05,-0.6722,-0.73196,1,0
6,GO CARDIAC VENTRICLE MORPHOGENESIS,4.9495e-06,-0.6722,-0.62917,1,0
6,GO RESPONSE TO STEROL,6.6813e-06,-0.67224,-0.72515,1,0
6,GO RELAXATION OF CARDIAC MUSCLE,2.8267e-05,-0.67239,-0.63916,1,0
6,GO COLLATERAL SPROUTING,1.9888e-05,-0.67249,-0.69132,1,0
6,GO ACTIVATION OF MAPK ACTIVITY,4.5891e-06,-0.67252,-0.62763,1,0
6,GO PLATELET ACTIVATION,4.9495e-06,-0.67288,-0.69775,1,0
6,GO LIPID PHOSPHORYLATION,4.9495e-06,-0.67333,-0.66926,1,0
6,GO REGULATION OF CELL SIZE,5.7533e-06,-0.67364,-0.65936,1,0
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,4.2539e-06,-0.67374,-0.67457,1,0
6,GO XENOBIOTIC TRANSPORT,8.9843e-06,-0.67383,-0.64951,1,0
6,GO BONE MATURATION,2.636e-05,-0.67384,-0.59912,1,0
6,GO REGULATION OF HISTONE DEACETYLATION,1.3909e-05,-0.6739,-0.59293,1,0
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,4.5891e-06,-0.67414,-0.6464,1,0
6,GO MULTICELLULAR ORGANISM GROWTH,5.337e-06,-0.6749,-0.6558,1,0
6,GO LIPID TRANSLOCATION,6.2007e-06,-0.67501,-0.67212,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,5.337e-06,-0.67549,-0.63448,1,0
6,GO REGULATION OF BONE REMODELING,1.1191e-05,-0.6759,-0.68475,1,0
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.67593,-0.69161,1,0
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.0403e-05,-0.67596,-0.64957,1,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00064645,-0.67617,-0.58087,1,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.337e-06,-0.67621,-0.61069,1,0
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,6.2007e-06,-0.67643,-0.71077,1,0
6,GO CELL CELL JUNCTION MAINTENANCE,3.7287e-05,-0.67651,-0.68341,1,0
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.6059e-05,-0.67652,-0.6722,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,8.9843e-06,-0.6766,-0.62045,1,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.4947e-05,-0.67666,-0.66406,1,0
6,GO FILOPODIUM ASSEMBLY,9.6689e-06,-0.67677,-0.66659,1,0
6,GO CYTOSOLIC TRANSPORT,5.337e-06,-0.67719,-0.67061,1,0
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.5891e-06,-0.67732,-0.63879,1,0
6,GO TISSUE MIGRATION,5.7533e-06,-0.67745,-0.67171,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.6689e-06,-0.67795,-0.68938,1,0
6,GO DENDRITIC TRANSPORT,1.9888e-05,-0.67807,-0.77291,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,9.6689e-06,-0.6781,-0.69009,1,0
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,1.0403e-05,-0.67818,-0.66712,1,0
6,GO CARTILAGE DEVELOPMENT,5.337e-06,-0.6782,-0.65862,1,0
6,GO CELLULAR RESPONSE TO STEROL,8.3461e-06,-0.67861,-0.6992,1,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,6.2007e-06,-0.67867,-0.62039,1,0
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,5.7533e-06,-0.67894,-0.64104,1,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,5.337e-06,-0.67896,-0.72679,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,5.337e-06,-0.67899,-0.67278,1,0
6,GO NEURAL TUBE DEVELOPMENT,9.6689e-06,-0.67917,-0.59987,1,0
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,7.7514e-06,-0.67942,-0.67472,1,0
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0028457,-0.67962,-0.50677,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.1191e-05,-0.68001,-0.67192,1,0
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,6.2007e-06,-0.68014,-0.66709,1,0
6,GO P BODY ASSEMBLY,1.2939e-05,-0.6803,-0.69367,1,0
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,5.337e-06,-0.68041,-0.6458,1,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,9.6689e-06,-0.68051,-0.59433,1,0
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,2.636e-05,-0.68061,-0.67884,1,0
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,6.2007e-06,-0.68062,-0.66304,1,0
6,GO MYELOID CELL DEVELOPMENT,4.9495e-06,-0.6809,-0.70626,1,0
6,GO ANIMAL ORGAN MATURATION,1.8524e-05,-0.68123,-0.60075,1,0
6,GO CARNITINE SHUTTLE,1.8524e-05,-0.6816,-0.58858,1,0
6,GO AXON EXTENSION,6.6813e-06,-0.68171,-0.68062,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,4.2539e-06,-0.68234,-0.72311,1,0
6,GO BEHAVIORAL RESPONSE TO PAIN,1.2035e-05,-0.68241,-0.60958,1,0
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,6.2007e-06,-0.68281,-0.68362,1,0
6,GO RESPIRATORY SYSTEM DEVELOPMENT,6.6813e-06,-0.68357,-0.64067,1,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,5.337e-06,-0.68365,-0.68179,1,0
6,GO POSITIVE REGULATION OF AXONOGENESIS,8.3461e-06,-0.68378,-0.70966,1,0
6,GO HEMOGLOBIN METABOLIC PROCESS,1.6059e-05,-0.68395,-0.6116,1,0
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,6.4139e-05,-0.68409,-0.57911,1,0
6,GO LYSOSOMAL TRANSPORT,7.1973e-06,-0.6841,-0.66177,1,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,1.2939e-05,-0.68411,-0.6421,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,4.5891e-06,-0.68421,-0.66246,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,5.337e-06,-0.68441,-0.64155,1,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,5.337e-06,-0.6845,-0.68508,1,0
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,8.3461e-06,-0.68474,-0.67592,1,0
6,GO PROTEIN DEGLYCOSYLATION,5.337e-06,-0.68484,-0.70927,1,0
6,GO RECEPTOR CATABOLIC PROCESS,4.9495e-06,-0.68494,-0.66643,1,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,5.337e-06,-0.68539,-0.68833,1,0
6,GO POSITIVE REGULATION OF PROTEIN BINDING,5.337e-06,-0.68578,-0.63054,1,0
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.636e-05,-0.68584,-0.7004,1,0
6,GO REGULATION OF GASTRULATION,1.4947e-05,-0.68596,-0.62061,1,0
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,8.3461e-06,-0.68605,-0.66758,1,0
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,5.7533e-06,-0.6863,-0.75635,1,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.7514e-06,-0.68649,-0.76146,1,0
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,6.2007e-06,-0.68656,-0.6515,1,0
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.5891e-06,-0.68675,-0.67411,1,0
6,GO VASCULATURE DEVELOPMENT,5.7533e-06,-0.68695,-0.69836,1,0
6,GO ACTIVATION OF MAPKK ACTIVITY,4.9495e-06,-0.68702,-0.72597,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.7514e-06,-0.68733,-0.63843,1,0
6,GO REGULATION OF BONE DEVELOPMENT,1.0403e-05,-0.68738,-0.71335,1,0
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,6.2007e-06,-0.68772,-0.67348,1,0
6,GO BONE MORPHOGENESIS,8.3461e-06,-0.68793,-0.66431,1,0
6,GO PHAGOLYSOSOME ASSEMBLY,5.337e-06,-0.68794,-0.72766,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,1.2035e-05,-0.68805,-0.70038,1,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,6.6813e-06,-0.68813,-0.63785,1,0
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,2.2907e-05,-0.68824,-0.68553,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.0403e-05,-0.68824,-0.62279,1,0
6,GO HEART TRABECULA MORPHOGENESIS,5.337e-06,-0.68871,-0.6915,1,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,8.9843e-06,-0.68875,-0.66573,1,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,4.5891e-06,-0.68878,-0.6929,1,0
6,GO GANGLIOSIDE METABOLIC PROCESS,4.5891e-06,-0.68884,-0.68974,1,0
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,4.2539e-06,-0.68921,-0.7099,1,0
6,GO MEMBRANE LIPID CATABOLIC PROCESS,4.5891e-06,-0.68939,-0.70085,1,0
6,GO REGULATION OF ENDOCYTIC RECYCLING,7.1973e-06,-0.68982,-0.71351,1,0
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,5.7533e-06,-0.68984,-0.72436,1,0
6,GO CARDIAC CHAMBER DEVELOPMENT,4.2539e-06,-0.69028,-0.67302,1,0
6,GO RESPONSE TO HYDROXYUREA,1.9888e-05,-0.69092,-0.59856,1,0
6,GO OSTEOCLAST DEVELOPMENT,5.337e-06,-0.69119,-0.77582,1,0
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,-0.69119,-0.77498,1,0
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.7533e-06,-0.69136,-0.76813,1,0
6,GO RESPONSE TO INTERLEUKIN 2,6.8565e-05,-0.69171,-0.72516,1,0
6,GO EPITHELIAL CELL DEVELOPMENT,5.7533e-06,-0.69175,-0.6592,1,0
6,GO MOTOR NEURON AXON GUIDANCE,2.1347e-05,-0.69193,-0.61334,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,3.4805e-05,-0.69228,-0.67672,1,0
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.2007e-06,-0.69245,-0.63397,1,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,6.2007e-06,-0.69248,-0.64863,1,0
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,1.2035e-05,-0.69252,-0.72074,1,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,8.9843e-06,-0.69266,-0.61652,1,0
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,8.3461e-06,-0.69289,-0.66742,1,0
6,GO TRABECULA MORPHOGENESIS,8.3461e-06,-0.69289,-0.71732,1,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,3.248e-05,-0.69291,-0.66138,1,0
6,GO REGULATION OF MITOPHAGY,6.6813e-06,-0.69324,-0.70636,1,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,7.7514e-06,-0.69326,-0.64699,1,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,8.3461e-06,-0.69331,-0.68421,1,0
6,GO ACTIN FILAMENT BASED PROCESS,4.9495e-06,-0.69336,-0.64526,1,0
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.9888e-05,-0.69389,-0.66009,1,0
6,GO CHONDROCYTE PROLIFERATION,6.6813e-06,-0.69435,-0.71863,1,0
6,GO ERYTHROCYTE MATURATION,3.0304e-05,-0.69463,-0.62564,1,0
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,3.9422e-06,-0.69469,-0.68567,1,0
6,GO HISTONE H3 K4 TRIMETHYLATION,8.3461e-06,-0.69491,-0.75949,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.69507,-0.68492,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.9495e-06,-0.6955,-0.6802,1,0
6,GO SIALYLATION,2.8267e-05,-0.696,-0.61698,1,0
6,GO POSITIVE REGULATION OF BONE RESORPTION,3.4805e-05,-0.69621,-0.62607,1,0
6,GO GASTRULATION,8.9843e-06,-0.69652,-0.65403,1,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,5.337e-06,-0.69673,-0.66771,1,0
6,GO GROWTH HORMONE SECRETION,0.00019306,-0.69674,-0.63446,1,0
6,GO RESPONSE TO LEUCINE,1.1191e-05,-0.69691,-0.70684,1,0
6,GO INNERVATION,0.00012367,-0.69692,-0.74933,1,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,4.5891e-06,-0.69698,-0.70099,1,0
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.2035e-05,-0.69707,-0.65961,1,0
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,7.7514e-06,-0.6971,-0.6733,1,0
6,GO RESPONSE TO PH,8.3461e-06,-0.69742,-0.63853,1,0
6,GO VENTRICULAR SEPTUM DEVELOPMENT,4.9495e-06,-0.69753,-0.66752,1,0
6,GO RESPONSE TO INTERLEUKIN 15,0.00013188,-0.69783,-0.78976,1,0
6,GO BONE REMODELING,1.1191e-05,-0.69797,-0.68745,1,0
6,GO BASIC AMINO ACID TRANSPORT,1.1191e-05,-0.69834,-0.70112,1,0
6,GO EMBRYONIC BODY MORPHOGENESIS,6.6813e-06,-0.69842,-0.69136,1,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,1.4947e-05,-0.69869,-0.66066,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,8.9843e-06,-0.69874,-0.65651,1,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,5.7533e-06,-0.69881,-0.66471,1,0
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,7.1973e-06,-0.69882,-0.71055,1,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.9495e-06,-0.69915,-0.70874,1,0
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,8.3461e-06,-0.69951,-0.68232,1,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,3.0304e-05,-0.69957,-0.67203,1,0
6,GO RESPONSE TO ISCHEMIA,4.9495e-06,-0.69973,-0.69443,1,0
6,GO REGULATION OF CELL SHAPE,5.7533e-06,-0.69974,-0.69384,1,0
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,4.5891e-06,-0.7002,-0.67488,1,0
6,GO BARBED END ACTIN FILAMENT CAPPING,4.9495e-06,-0.70038,-0.69587,1,0
6,GO BLOOD VESSEL MORPHOGENESIS,6.2007e-06,-0.70081,-0.69704,1,0
6,GO NEURAL TUBE FORMATION,6.6813e-06,-0.7009,-0.614,1,0
6,GO OUTFLOW TRACT MORPHOGENESIS,6.2007e-06,-0.70107,-0.65406,1,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,8.9843e-06,-0.70124,-0.69209,1,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,6.6813e-06,-0.70149,-0.66999,1,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.8524e-05,-0.70175,-0.70568,1,0
6,GO REGULATION OF PINOCYTOSIS,3.9422e-06,-0.70188,-0.71882,1,0
6,GO OSTEOBLAST PROLIFERATION,2.1347e-05,-0.70215,-0.66687,1,0
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,8.3461e-06,-0.70221,-0.69935,1,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.4947e-05,-0.70259,-0.6784,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.2007e-06,-0.70264,-0.65057,1,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,4.2763e-05,-0.70336,-0.59802,1,0
6,GO INTRACELLULAR MRNA LOCALIZATION,9.6689e-06,-0.70367,-0.60913,1,0
6,GO CARDIAC SEPTUM DEVELOPMENT,3.9422e-06,-0.70368,-0.70938,1,0
6,GO PROTEIN KINASE C SIGNALING,1.3909e-05,-0.70386,-0.67021,1,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.2007e-06,-0.70395,-0.72096,1,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.2428e-05,-0.70401,-0.7207,1,0
6,GO REGULATION OF STEM CELL DIVISION,1.2939e-05,-0.70451,-0.70335,1,0
6,GO BONE DEVELOPMENT,6.6813e-06,-0.70493,-0.67376,1,0
6,GO PEPTIDE CATABOLIC PROCESS,3.9422e-06,-0.70534,-0.69815,1,0
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,1.6059e-05,-0.70541,-0.65184,1,0
6,GO ENERGY HOMEOSTASIS,8.3461e-06,-0.70562,-0.62612,1,0
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,8.9843e-06,-0.70574,-0.62405,1,0
6,GO AROMATIC AMINO ACID TRANSPORT,5.7533e-06,-0.70592,-0.76307,1,0
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,7.1973e-06,-0.70597,-0.68112,1,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,8.9843e-06,-0.70597,-0.62652,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,9.6689e-06,-0.706,-0.64688,1,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,1.0403e-05,-0.70648,-0.71172,1,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,6.6813e-06,-0.7071,-0.70448,1,0
6,GO METANEPHRIC NEPHRON DEVELOPMENT,5.7533e-06,-0.70735,-0.73706,1,0
6,GO ADHERENS JUNCTION ORGANIZATION,5.337e-06,-0.70772,-0.71233,1,0
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,9.6689e-06,-0.70849,-0.67437,1,0
6,GO CELL CELL JUNCTION ORGANIZATION,5.7533e-06,-0.70865,-0.64363,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.9495e-06,-0.70872,-0.68601,1,0
6,GO REGULATION OF CELL SUBSTRATE ADHESION,6.6813e-06,-0.70903,-0.73276,1,0
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,8.3461e-06,-0.70913,-0.65636,1,0
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.3909e-05,-0.70921,-0.66058,1,0
6,GO CELL SUBSTRATE ADHESION,5.7533e-06,-0.70932,-0.74846,1,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,1.2035e-05,-0.70949,-0.64719,1,0
6,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00091199,-0.70958,-0.64364,1,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.00060992,-0.71015,-0.63928,1,0
6,GO MAMMARY GLAND DEVELOPMENT,5.7533e-06,-0.71015,-0.65904,1,0
6,GO CELL CELL JUNCTION ASSEMBLY,5.337e-06,-0.71023,-0.61342,1,0
6,GO CELL JUNCTION DISASSEMBLY,5.9985e-05,-0.71033,-0.78519,1,0
6,GO TRACHEA MORPHOGENESIS,6.6813e-06,-0.71048,-0.7329,1,0
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,1.0403e-05,-0.71057,-0.65726,1,0
6,GO ESTABLISHMENT OF CELL POLARITY,4.5891e-06,-0.7108,-0.68789,1,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,2.636e-05,-0.71126,-0.73059,1,0
6,GO HISTONE H3 K36 METHYLATION,1.1191e-05,-0.71191,-0.72928,1,0
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,5.337e-06,-0.71234,-0.67794,1,0
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.7533e-06,-0.71251,-0.67372,1,0
6,GO GOLGI TO VACUOLE TRANSPORT,1.0403e-05,-0.71259,-0.71581,1,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,4.5891e-06,-0.71269,-0.68587,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.4805e-05,-0.71286,-0.634,1,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,6.6813e-06,-0.71306,-0.68891,1,0
6,GO EMBRYONIC HEMOPOIESIS,6.6813e-06,-0.71326,-0.70508,1,0
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,5.7533e-06,-0.71361,-0.72892,1,0
6,GO PROTEIN TARGETING TO LYSOSOME,1.1191e-05,-0.71368,-0.65522,1,0
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,1.2939e-05,-0.71369,-0.71938,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.337e-06,-0.71392,-0.69184,1,0
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,1.0403e-05,-0.714,-0.68048,1,0
6,GO REGULATION OF JUN KINASE ACTIVITY,5.337e-06,-0.7149,-0.69573,1,0
6,GO ACTIVATION OF JUN KINASE ACTIVITY,6.2007e-06,-0.71512,-0.74078,1,0
6,GO FORMATION OF PRIMARY GERM LAYER,1.1191e-05,-0.71524,-0.68063,1,0
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,1.9888e-05,-0.71551,-0.67229,1,0
6,GO TISSUE REMODELING,8.3461e-06,-0.71552,-0.71791,1,0
6,GO EMBRYONIC EYE MORPHOGENESIS,6.6813e-06,-0.71655,-0.70294,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.71686,-0.67549,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,9.6689e-06,-0.71704,-0.74511,1,0
6,GO ATRIAL SEPTUM MORPHOGENESIS,5.2428e-05,-0.71713,-0.64765,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,4.9495e-06,-0.71775,-0.69793,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,5.337e-06,-0.71836,-0.71885,1,0
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,4.9495e-06,-0.71862,-0.74864,1,0
6,GO NEGATIVE CHEMOTAXIS,7.1973e-06,-0.71874,-0.70194,1,0
6,GO REGULATION OF HIPPO SIGNALING,7.7514e-06,-0.71893,-0.71096,1,0
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,1.9888e-05,-0.7192,-0.74323,1,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.2007e-06,-0.71923,-0.73268,1,0
6,GO RESPONSE TO BMP,6.2007e-06,-0.71925,-0.66641,1,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,5.337e-06,-0.71992,-0.76192,1,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.6813e-06,-0.71996,-0.67539,1,0
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,7.7514e-06,-0.7203,-0.70359,1,0
6,GO ERYTHROCYTE DEVELOPMENT,7.7514e-06,-0.72058,-0.67808,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,9.6689e-06,-0.72101,-0.72234,1,0
6,GO ENDOTHELIAL CELL CHEMOTAXIS,4.2763e-05,-0.72102,-0.61299,1,0
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,9.6689e-06,-0.72123,-0.73181,1,0
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,1.0403e-05,-0.72129,-0.67001,1,0
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,1.1191e-05,-0.72229,-0.66549,1,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.1347e-05,-0.72254,-0.79197,1,0
6,GO ACTIN CROSSLINK FORMATION,7.7514e-06,-0.72301,-0.68982,1,0
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.2939e-05,-0.72302,-0.72361,1,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,2.8267e-05,-0.72321,-0.66608,1,0
6,GO REPLACEMENT OSSIFICATION,1.8524e-05,-0.7241,-0.66341,1,0
6,GO LAMELLIPODIUM MORPHOGENESIS,1.6059e-05,-0.72493,-0.62363,1,0
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,1.2939e-05,-0.72503,-0.6797,1,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,5.337e-06,-0.7254,-0.76327,1,0
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,4.5891e-06,-0.72574,-0.69137,1,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.2035e-05,-0.72639,-0.66496,1,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,6.4139e-05,-0.72645,-0.73748,1,0
6,GO ACTIVATION OF JNKK ACTIVITY,5.337e-06,-0.72669,-0.77133,1,0
6,GO CORPUS CALLOSUM DEVELOPMENT,1.2939e-05,-0.72682,-0.6955,1,0
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.72753,-0.76668,1,0
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,5.337e-06,-0.72768,-0.72648,1,0
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,5.337e-06,-0.72784,-0.71212,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,5.7533e-06,-0.72795,-0.6833,1,0
6,GO PULMONARY VALVE DEVELOPMENT,7.7514e-06,-0.72831,-0.79159,1,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.1973e-06,-0.7284,-0.73602,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,8.3461e-06,-0.72851,-0.66671,1,0
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,2.1347e-05,-0.72914,-0.59992,1,0
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,1.2035e-05,-0.72997,-0.67801,1,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.8565e-05,-0.73011,-0.83635,1,0
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.73049,-0.67406,1,0
6,GO REGULATION OF FIBROBLAST MIGRATION,4.5891e-06,-0.73053,-0.6884,1,0
6,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00012367,-0.73068,-0.68229,1,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,1.2035e-05,-0.73098,-0.72291,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,1.1191e-05,-0.73108,-0.69468,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.2035e-05,-0.7311,-0.65917,1,0
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.248e-05,-0.73118,-0.59216,1,0
6,GO REGULATION OF GTPASE ACTIVITY,4.9495e-06,-0.7313,-0.68213,1,0
6,GO EPITHELIAL CELL CELL ADHESION,9.6689e-06,-0.7322,-0.76159,1,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,5.337e-06,-0.73222,-0.70852,1,0
6,GO PROTEIN AUTOPHOSPHORYLATION,4.9495e-06,-0.73234,-0.70142,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,7.1973e-06,-0.73248,-0.76795,1,0
6,GO TUBULIN DEACETYLATION,7.8298e-05,-0.7332,-0.67203,1,0
6,GO GOLGI TO ENDOSOME TRANSPORT,6.6813e-06,-0.73321,-0.68715,1,0
6,GO CELL ADHESION MEDIATED BY INTEGRIN,3.248e-05,-0.7333,-0.79186,1,0
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,3.9936e-05,-0.73437,-0.70335,1,0
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.5891e-06,-0.73468,-0.72991,1,0
6,GO P38MAPK CASCADE,8.9843e-06,-0.73485,-0.73282,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,8.9843e-06,-0.73491,-0.66742,1,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.9936e-05,-0.735,-0.78926,1,0
6,GO FIBROBLAST MIGRATION,4.5891e-06,-0.73518,-0.68639,1,0
6,GO PLASMA MEMBRANE ORGANIZATION,4.9495e-06,-0.73522,-0.70015,1,0
6,GO LEYDIG CELL DIFFERENTIATION,0.00040321,-0.7359,-0.58527,1,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.1191e-05,-0.73625,-0.76116,1,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,8.9843e-06,-0.73634,-0.69957,1,0
6,GO REGULATION OF CELL MATRIX ADHESION,6.6813e-06,-0.73672,-0.74345,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,7.7514e-06,-0.73723,-0.72552,1,0
6,GO BONE CELL DEVELOPMENT,4.5891e-06,-0.73761,-0.76449,1,0
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,7.1973e-06,-0.73783,-0.81759,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,9.6689e-06,-0.73798,-0.70159,1,0
6,GO ANOIKIS,7.1973e-06,-0.73805,-0.70717,1,0
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,3.0304e-05,-0.73814,-0.62749,1,0
6,GO REGULATION OF FATTY ACID BETA OXIDATION,5.337e-06,-0.73839,-0.70323,1,0
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.4947e-05,-0.73841,-0.66003,1,0
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,4.9495e-06,-0.73845,-0.6868,1,0
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.7249e-05,-0.73889,-0.71061,1,0
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.2939e-05,-0.73898,-0.74264,1,0
6,GO LUTEINIZATION,1.2939e-05,-0.73944,-0.76493,1,0
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.4947e-05,-0.74054,-0.71606,1,0
6,GO PODOSOME ASSEMBLY,4.5891e-06,-0.74193,-0.80823,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,6.6813e-06,-0.74199,-0.70049,1,0
6,GO ALANINE TRANSPORT,6.6813e-06,-0.74201,-0.74333,1,0
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.7533e-06,-0.74218,-0.74473,1,0
6,GO INHIBITORY SYNAPSE ASSEMBLY,0.00014989,-0.74249,-0.65192,1,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.2907e-05,-0.74315,-0.72692,1,0
6,GO LATERAL VENTRICLE DEVELOPMENT,1.2035e-05,-0.74353,-0.76151,1,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,6.2007e-06,-0.74432,-0.6648,1,0
6,GO APICAL JUNCTION ASSEMBLY,1.3909e-05,-0.74463,-0.58289,1,0
6,GO GASTRULATION WITH MOUTH FORMING SECOND,1.4947e-05,-0.74492,-0.67069,1,0
6,GO DERMATAN SULFATE METABOLIC PROCESS,2.8267e-05,-0.74559,-0.73334,1,0
6,GO CELL MATRIX ADHESION,5.7533e-06,-0.74561,-0.76154,1,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,9.6689e-06,-0.7465,-0.69097,1,0
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,6.6813e-06,-0.74678,-0.72869,1,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,9.6689e-06,-0.7471,-0.75657,1,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,3.248e-05,-0.74792,-0.65838,1,0
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,3.248e-05,-0.74933,-0.72791,1,0
6,GO RNA DESTABILIZATION,1.1191e-05,-0.74961,-0.69927,1,0
6,GO NK T CELL DIFFERENTIATION,2.4576e-05,-0.75051,-0.76529,1,0
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.0403e-05,-0.75086,-0.69375,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,6.2007e-06,-0.75096,-0.66822,1,0
6,GO REGULATION OF VASCULAR PERMEABILITY,6.6813e-06,-0.75136,-0.67799,1,0
6,GO NEGATIVE REGULATION OF ANOIKIS,1.7249e-05,-0.75152,-0.78333,1,0
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.75153,-0.76701,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7533e-06,-0.75203,-0.69827,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.7533e-06,-0.75261,-0.70094,1,0
6,GO ENDOTHELIUM DEVELOPMENT,6.6813e-06,-0.75273,-0.71802,1,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,1.2035e-05,-0.75292,-0.75543,1,0
6,GO POSITIVE REGULATION OF AXON EXTENSION,5.7533e-06,-0.75325,-0.73722,1,0
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,5.337e-06,-0.75342,-0.68341,1,0
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,1.6059e-05,-0.75385,-0.69458,1,0
6,GO ANATOMICAL STRUCTURE REGRESSION,4.2763e-05,-0.75409,-0.68479,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.75435,-0.71748,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.5891e-06,-0.7548,-0.73253,1,0
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00010866,-0.7548,-0.71337,1,0
6,GO PULMONARY VALVE MORPHOGENESIS,8.9843e-06,-0.75484,-0.76671,1,0
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,5.7533e-06,-0.75485,-0.74882,1,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,9.6689e-06,-0.75577,-0.69193,1,0
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.6059e-05,-0.75627,-0.64642,1,0
6,GO COLLAGEN CATABOLIC PROCESS,4.5779e-05,-0.7565,-0.73105,1,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2939e-05,-0.75662,-0.6814,1,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,3.0304e-05,-0.75677,-0.69834,1,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,1.7249e-05,-0.75709,-0.77958,1,0
6,GO REGULATION OF CARTILAGE DEVELOPMENT,6.6813e-06,-0.75729,-0.69896,1,0
6,GO KERATINOCYTE MIGRATION,6.2007e-06,-0.75737,-0.70686,1,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.2907e-05,-0.75778,-0.73623,1,0
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,6.2007e-06,-0.75849,-0.67624,1,0
6,GO REGULATION OF AXON GUIDANCE,6.6813e-06,-0.75852,-0.74786,1,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,1.0403e-05,-0.75903,-0.7079,1,0
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,9.6689e-06,-0.75923,-0.6827,1,0
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.75944,-0.72712,1,0
6,GO HEART VALVE DEVELOPMENT,4.9495e-06,-0.75959,-0.75864,1,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.337e-06,-0.75973,-0.69635,1,0
6,GO REGULATION OF ANOIKIS,1.1191e-05,-0.76024,-0.72505,1,0
6,GO PLATELET MORPHOGENESIS,5.337e-06,-0.76025,-0.73062,1,0
6,GO CELLULAR RESPONSE TO CHOLESTEROL,7.1973e-06,-0.76068,-0.76763,1,0
6,GO CHONDROCYTE DEVELOPMENT,1.2939e-05,-0.76081,-0.74143,1,0
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,1.2035e-05,-0.76091,-0.71564,1,0
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,8.9843e-06,-0.76194,-0.77731,1,0
6,GO STRESS FIBER ASSEMBLY,5.7533e-06,-0.76196,-0.68314,1,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.7249e-05,-0.76228,-0.79939,1,0
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,6.4139e-05,-0.76238,-0.68197,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,4.8997e-05,-0.76294,-0.66562,1,0
6,GO REGULATION OF NEURON MIGRATION,5.337e-06,-0.76295,-0.76017,1,0
6,GO EPITHELIAL CELL MORPHOGENESIS,1.4947e-05,-0.76352,-0.71914,1,0
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,5.337e-06,-0.76392,-0.72242,1,0
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,5.7533e-06,-0.76487,-0.71444,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.7657,-0.70197,1,0
6,GO BLEB ASSEMBLY,3.4805e-05,-0.76591,-0.75789,1,0
6,GO SYNAPTIC VESICLE CLUSTERING,0.00026348,-0.76649,-0.68392,1,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,7.1973e-06,-0.76669,-0.72506,1,0
6,GO ACTIVATION OF GTPASE ACTIVITY,5.7533e-06,-0.76729,-0.72713,1,0
6,GO MEGAKARYOCYTE DEVELOPMENT,6.2007e-06,-0.76735,-0.75173,1,0
6,GO ACTIN FILAMENT BASED TRANSPORT,8.3461e-06,-0.76764,-0.74011,1,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.2907e-05,-0.76766,-0.81946,1,0
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,1.4947e-05,-0.76766,-0.74246,1,0
6,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,3.9936e-05,-0.76817,-0.67461,1,0
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,4.5891e-06,-0.76859,-0.7409,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,1.2035e-05,-0.76861,-0.7089,1,0
6,GO FACIAL NERVE MORPHOGENESIS,5.6086e-05,-0.76879,-0.68939,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.1973e-06,-0.76888,-0.78333,1,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,5.7533e-06,-0.76956,-0.71516,1,0
6,GO CERAMIDE CATABOLIC PROCESS,4.2539e-06,-0.76993,-0.76398,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,7.1973e-06,-0.77066,-0.76937,1,0
6,GO GAP JUNCTION ASSEMBLY,0.00014062,-0.77271,-0.73504,1,0
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.9888e-05,-0.77297,-0.7195,1,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,7.1973e-06,-0.77311,-0.71822,1,0
6,GO GLOMERULUS DEVELOPMENT,3.9422e-06,-0.77377,-0.80259,1,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,1.0403e-05,-0.77548,-0.72549,1,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,7.7514e-06,-0.77559,-0.75625,1,0
6,GO MYELIN MAINTENANCE,9.6689e-06,-0.77577,-0.67372,1,0
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.4947e-05,-0.77591,-0.70306,1,0
6,GO ENDODERM DEVELOPMENT,1.6059e-05,-0.77667,-0.72836,1,0
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.1191e-05,-0.77739,-0.76714,1,0
6,GO BASEMENT MEMBRANE ORGANIZATION,4.9495e-06,-0.77764,-0.78812,1,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,8.9843e-06,-0.77795,-0.76213,1,0
6,GO ENDOCYTIC RECYCLING,5.7533e-06,-0.77876,-0.70465,1,0
6,GO HIPPO SIGNALING,6.2007e-06,-0.78114,-0.74836,1,0
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.5891e-06,-0.78125,-0.76367,1,0
6,GO RESPONSE TO AMYLOID BETA,5.337e-06,-0.78154,-0.77604,1,0
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,2.636e-05,-0.7823,-0.75641,1,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,4.9495e-06,-0.78237,-0.79728,1,0
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,3.4805e-05,-0.78329,-0.66383,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,6.6813e-06,-0.7833,-0.7779,1,0
6,GO PROTEIN ACTIVATION CASCADE,0.00017019,-0.78342,-0.64749,1,0
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,2.8267e-05,-0.78364,-0.80046,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,8.9327e-05,-0.78371,-0.81357,1,0
6,GO ARTERY MORPHOGENESIS,6.2007e-06,-0.78437,-0.74933,1,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,8.9843e-06,-0.78457,-0.71917,1,0
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,4.2539e-06,-0.78531,-0.84163,1,0
6,GO GOLGI RIBBON FORMATION,5.337e-06,-0.78554,-0.80985,1,0
6,GO LUNG ALVEOLUS DEVELOPMENT,1.3909e-05,-0.78628,-0.75084,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,5.337e-06,-0.78813,-0.76121,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,6.6813e-06,-0.78818,-0.73684,1,0
6,GO BODY MORPHOGENESIS,8.3461e-06,-0.78847,-0.72338,1,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,1.1191e-05,-0.78951,-0.77531,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1.0403e-05,-0.78953,-0.74552,1,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.79048,-0.76981,1,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,1.1191e-05,-0.79074,-0.79241,1,0
6,GO NEUTROPHIL HOMEOSTASIS,7.1973e-06,-0.79157,-0.81554,1,0
6,GO COLLAGEN METABOLIC PROCESS,1.2035e-05,-0.7916,-0.79906,1,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,1.0403e-05,-0.79161,-0.757,1,0
6,GO BLOOD VESSEL REMODELING,5.337e-06,-0.79229,-0.78478,1,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,5.337e-06,-0.79277,-0.80649,1,0
6,GO REGULATION OF NEUTROPHIL ACTIVATION,5.9985e-05,-0.79291,-0.83226,1,0
6,GO ASTRAL MICROTUBULE ORGANIZATION,1.7249e-05,-0.79317,-0.72706,1,0
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,6.6813e-06,-0.79407,-0.78511,1,0
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,7.1973e-06,-0.79421,-0.78564,1,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,4.5891e-06,-0.7948,-0.76618,1,0
6,GO HEMIDESMOSOME ASSEMBLY,0.0038653,-0.79576,-0.60698,1,0
6,GO SEMI LUNAR VALVE DEVELOPMENT,5.7533e-06,-0.79617,-0.78048,1,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,4.5891e-06,-0.79731,-0.78783,1,0
6,GO MICROTUBULE NUCLEATION,4.5779e-05,-0.79751,-0.70992,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,4.2539e-06,-0.79856,-0.77969,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.79945,-0.76796,1,0
6,GO FOCAL ADHESION ASSEMBLY,5.7533e-06,-0.79983,-0.78536,1,0
6,GO CORONARY VASCULATURE DEVELOPMENT,3.9422e-06,-0.80022,-0.78345,1,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,5.7533e-06,-0.80024,-0.74731,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.80075,-0.79278,1,0
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,8.3461e-06,-0.80165,-0.73115,1,0
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,2.4576e-05,-0.80309,-0.6842,1,0
6,GO HEAD MORPHOGENESIS,1.3909e-05,-0.80374,-0.75061,1,0
6,GO VASCULAR WOUND HEALING,1.2035e-05,-0.80452,-0.79325,1,0
6,GO ACTIN FILAMENT DEPOLYMERIZATION,4.2539e-06,-0.80482,-0.76011,1,0
6,GO ACTIVATION OF MAPKKK ACTIVITY,1.1191e-05,-0.80531,-0.74529,1,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00011593,-0.80574,-0.85656,1,0
6,GO AORTIC VALVE DEVELOPMENT,5.337e-06,-0.80779,-0.78509,1,0
6,GO EPIBOLY,7.1973e-06,-0.808,-0.75474,1,0
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,5.7533e-06,-0.80959,-0.76826,1,0
6,GO MRNA TRANSCRIPTION,4.5891e-06,-0.81072,-0.77249,1,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,8.9843e-06,-0.81139,-0.77529,1,0
6,GO FACE DEVELOPMENT,8.3461e-06,-0.81235,-0.75564,1,0
6,GO NEURON PROJECTION ARBORIZATION,8.3461e-06,-0.81343,-0.79072,1,0
6,GO LYMPHANGIOGENESIS,8.3461e-06,-0.81586,-0.74789,1,0
6,GO TOOTH MINERALIZATION,1.1191e-05,-0.81815,-0.76566,1,0
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,1.9888e-05,-0.8191,-0.74106,1,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.8997e-05,-0.81925,-0.72703,1,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,8.9843e-06,-0.81929,-0.82329,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.1191e-05,-0.82102,-0.80183,1,0
6,GO DEFINITIVE HEMOPOIESIS,6.2007e-06,-0.82161,-0.79034,1,0
6,GO BONE TRABECULA MORPHOGENESIS,0.00010866,-0.82193,-0.8159,1,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2035e-05,-0.82381,-0.75096,1,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00023283,-0.82477,-0.93304,1,0
6,GO PROTEIN DEMETHYLATION,7.1973e-06,-0.82492,-0.75573,1,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,6.2007e-06,-0.82521,-0.85456,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.8524e-05,-0.82663,-0.83356,1,0
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,5.7533e-06,-0.82673,-0.76831,1,0
6,GO ARTERY DEVELOPMENT,5.7533e-06,-0.82761,-0.76836,1,0
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,9.6689e-06,-0.82837,-0.76377,1,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,6.6813e-06,-0.8295,-0.8653,1,0
6,GO AORTA MORPHOGENESIS,3.9422e-06,-0.83074,-0.83412,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.636e-05,-0.83205,-0.81774,1,0
6,GO RESPONSE TO MAGNESIUM ION,7.3279e-05,-0.83254,-0.69039,1,0
6,GO POSITIVE REGULATION OF MITOPHAGY,8.3461e-06,-0.83661,-0.78417,1,0
6,GO REGULATION OF NEURON MATURATION,1.8524e-05,-0.83774,-0.69381,1,0
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,1.2035e-05,-0.83899,-0.76333,1,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.7514e-06,-0.84009,-0.74299,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,4.5891e-06,-0.84085,-0.83934,1,0
6,GO AORTA DEVELOPMENT,4.5891e-06,-0.8413,-0.8447,1,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,6.6813e-06,-0.84219,-0.79275,1,0
6,GO COLLAGEN BIOSYNTHETIC PROCESS,8.9843e-06,-0.84308,-0.83939,1,0
6,GO TRIGEMINAL NERVE DEVELOPMENT,5.2428e-05,-0.84309,-0.76892,1,0
6,GO ACTIN FILAMENT SEVERING,7.1973e-06,-0.84336,-0.76489,1,0
6,GO SECRETORY GRANULE LOCALIZATION,2.2907e-05,-0.84367,-0.79305,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,6.2007e-06,-0.84392,-0.82502,1,0
6,GO ENDODERM FORMATION,1.8524e-05,-0.8446,-0.77954,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,5.7533e-06,-0.84469,-0.77504,1,0
6,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,2.8267e-05,-0.84571,-0.74751,1,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,4.9495e-06,-0.84584,-0.82321,1,0
6,GO RESPONSE TO FLUID SHEAR STRESS,1.6059e-05,-0.84676,-0.79348,1,0
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,7.7514e-06,-0.85048,-0.74863,1,0
6,GO LYMPH VESSEL MORPHOGENESIS,8.3461e-06,-0.85123,-0.7812,1,0
6,GO LOCOMOTOR RHYTHM,4.5891e-06,-0.85172,-0.81946,1,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,8.9843e-06,-0.85229,-0.7496,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,5.7533e-06,-0.85296,-0.81864,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,5.337e-06,-0.85694,-0.79183,1,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,1.0403e-05,-0.85741,-0.73652,1,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.859,-0.78635,1,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00015974,-0.86143,-0.69956,1,0
6,GO NUCLEAR MIGRATION,4.2539e-06,-0.86204,-0.85697,1,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,5.7533e-06,-0.86213,-0.767,1,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.2539e-06,-0.86471,-0.82258,1,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,6.2007e-06,-0.86679,-0.78726,1,0
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,6.2007e-06,-0.86752,-0.80766,1,0
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,4.9495e-06,-0.87519,-0.80561,1,0
6,GO EXTRACELLULAR MATRIX ASSEMBLY,8.9843e-06,-0.87593,-0.89426,1,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.7249e-05,-0.87614,-0.93082,1,0
6,GO DENSE CORE GRANULE TRANSPORT,8.3641e-05,-0.87745,-0.82323,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.0403e-05,-0.88511,-0.80841,1,0
6,GO PLASMA MEMBRANE TUBULATION,4.5891e-06,-0.8861,-0.81272,1,0
6,GO BASEMENT MEMBRANE ASSEMBLY,6.6813e-06,-0.88748,-0.87753,1,0
6,GO NUCLEUS LOCALIZATION,4.9495e-06,-0.88833,-0.8264,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,4.9495e-06,-0.88962,-0.8692,1,0
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,8.3461e-06,-0.89113,-0.79187,1,0
6,GO MYELIN ASSEMBLY,1.0403e-05,-0.89118,-0.76843,1,0
6,GO CELL MIGRATION IN HINDBRAIN,7.7514e-06,-0.89268,-0.80351,1,0
6,GO COLLAGEN FIBRIL ORGANIZATION,1.8524e-05,-0.89278,-0.90722,1,0
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.7249e-05,-0.89721,-0.86061,1,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,4.9495e-06,-0.89995,-0.84667,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,4.5891e-06,-0.9042,-0.94196,1,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.1191e-05,-0.90568,-0.9381,1,0
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.9843e-06,-0.90669,-0.91182,1,0
6,GO ENDODERMAL CELL DIFFERENTIATION,1.4947e-05,-0.9092,-0.85849,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.1347e-05,-0.91414,-0.92837,1,0
6,GO POSITIVE REGULATION OF NEURON MIGRATION,6.2007e-06,-0.91511,-0.9041,1,0
6,GO LYMPH VESSEL DEVELOPMENT,7.1973e-06,-0.91933,-0.83424,1,0
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,3.4805e-05,-0.92364,-0.76092,1,0
6,GO MACROPHAGE PROLIFERATION,5.6086e-05,-0.92574,-0.87663,1,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,7.1973e-06,-0.92603,-0.87285,1,0
6,GO ADHERENS JUNCTION ASSEMBLY,6.6813e-06,-0.92618,-0.86316,1,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,4.2539e-06,-0.93067,-0.89853,1,0
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,6.2007e-06,-0.93762,-0.85546,1,0
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.7514e-06,-0.93953,-0.86715,1,0
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,8.9843e-06,-0.94111,-0.85936,1,0
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,8.9843e-06,-0.94297,-0.91293,1,0
6,GO DORSAL AORTA DEVELOPMENT,3.9422e-06,-0.94338,-0.88911,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.94764,-0.86321,1,0
6,GO PROTEIN LOCALIZATION TO ENDOSOME,5.337e-06,-0.95664,-0.8634,1,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,1.2939e-05,-0.95881,-0.84194,1,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00023283,-0.95924,-0.7404,1,0
6,GO SKIN MORPHOGENESIS,1.6059e-05,-0.96257,-0.85982,1,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.1191e-05,-0.96551,-0.82319,1,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,3.9936e-05,-0.97458,-0.82561,1,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,1.4947e-05,-0.97533,-0.9131,1,0
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,6.6813e-06,-0.99135,-0.88634,1,0
6,GO ELASTIC FIBER ASSEMBLY,4.5779e-05,-1.0015,-0.94668,1,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.3909e-05,-1.0297,-0.85768,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.7249e-05,-1.0646,-0.89823,1,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,8.9843e-06,-1.1525,-1.0817,1,0
6,GO OXYGEN TRANSPORT,0.85555,0.13041,0.0091313,0,0
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.3148,0.088266,0.021365,0,0
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.41494,0.085132,0.016834,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.16602,0.0847,0.061293,0,0
6,GO XENOBIOTIC CATABOLIC PROCESS,1,0.054967,-0.019455,0,0
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.54223,0.050232,0.023453,0,0
6,GO REGULATION OF APPETITE,0.84314,0.046798,-0.074792,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.26442,0.038252,0.041525,0,0
6,GO TRANSLATIONAL INITIATION,0.33821,0.036647,0.043041,0,0
6,GO TRANSLATIONAL TERMINATION,0.86799,0.02812,-0.03797,0,0
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.33821,0.026493,0.040158,0,0
6,GO MITOCHONDRIAL TRANSLATION,0.48117,0.026256,-0.080946,0,0
6,GO CYTOPLASMIC TRANSLATION,0.93062,0.017048,-0.0088496,0,0
6,GO PROTEASOME ASSEMBLY,0.68646,0.012827,-0.074684,0,0
6,GO PROTEIN NEDDYLATION,0.83078,0.0062265,-0.031709,0,0
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.84314,0.0060465,-0.018951,0,0
6,GO PROTEIN TARGETING TO MEMBRANE,0.64051,-0.017602,0.0062294,0,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.1475,-0.017736,-0.12072,0,0
6,GO GAS TRANSPORT,0.53179,-0.01985,-0.11335,0,0
6,GO TRANSLATIONAL ELONGATION,0.28529,-0.020085,-0.082375,0,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.76963,-0.020305,-0.028234,0,0
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.74555,-0.037637,-0.012516,0,0
6,GO VIRAL GENE EXPRESSION,0.2577,-0.03969,-0.0408,0,0
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.10468,-0.041045,-0.1363,0,0
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.74555,-0.041098,-0.042579,0,0
6,GO RIBOSOME ASSEMBLY,0.27821,-0.043131,-0.049608,0,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.214,-0.043843,-0.097043,0,0
6,GO OXIDATIVE PHOSPHORYLATION,0.52145,-0.045613,-0.059784,0,0
6,GO CHROMATIN REMODELING AT CENTROMERE,0.077559,-0.060854,-0.15666,0,0
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.35442,-0.068361,-0.053504,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.21989,-0.073507,-0.050311,0,0
6,GO PIRNA METABOLIC PROCESS,0.094909,-0.075898,-0.16501,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.96843,-0.077663,0.042598,0,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.077559,-0.07806,-0.12976,0,0
6,GO REGULATION OF RESPONSE TO FOOD,0.37964,-0.079022,-0.11736,0,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.52145,-0.08677,-0.15859,0,0
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.2259,-0.087178,-0.098238,0,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00096503,-0.089489,-0.20593,0,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.026142,-0.091286,-0.18669,0,0
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.056456,-0.09365,-0.12467,0,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.10134,-0.094099,-0.13442,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.17091,-0.11228,-0.14064,0,0
6,GO GTP BIOSYNTHETIC PROCESS,0.037377,-0.1158,-0.15993,0,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0052065,-0.11771,-0.20951,0,0
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.065157,-0.12189,-0.1505,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0003797,-0.12309,-0.19266,0,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.040368,-0.12702,-0.14563,0,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.0042727,-0.12886,-0.19754,0,0
6,GO TRNA 5 LEADER REMOVAL,0.13467,-0.1313,-0.11692,0,0
6,GO TRNA 5 END PROCESSING,0.098083,-0.13262,-0.13649,0,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.46168,-0.13832,-0.079184,0,0
6,GO CELLULAR RESPIRATION,0.00060992,-0.13957,-0.1906,0,0
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.52145,-0.13981,-0.074018,0,0
6,GO SEQUESTERING OF METAL ION,0.094909,-0.14436,-0.17029,0,0
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.15655,-0.14494,-0.14107,0,0
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.021265,-0.14547,-0.17132,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0172,-0.14553,-0.20777,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0021907,-0.14661,-0.19205,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0076456,-0.15,-0.21206,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.0018673,-0.15259,-0.18727,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.034576,-0.15353,-0.19422,0,0
6,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.5959,-0.15709,-0.10359,0,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.077559,-0.15936,-0.25284,0,0
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0031545,-0.16025,-0.25007,0,0
6,GO ANTIMICROBIAL HUMORAL RESPONSE,0.1306,-0.16371,-0.18398,0,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,0.17091,-0.16462,-0.22722,0,0
6,GO REGULATION OF T CELL CHEMOTAXIS,0.060677,-0.16662,-0.39081,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0010209,-0.16798,-0.21953,0,0
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.056456,-0.16886,-0.19816,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0060238,-0.17127,-0.2453,0,0
6,GO PENTOSE METABOLIC PROCESS,0.00048214,-0.17245,-0.29048,0,0
6,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.074935,-0.18206,-0.18944,0,0
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0044907,-0.18932,-0.17437,0,0
6,GO PROTEIN DENEDDYLATION,0.018736,-0.19358,-0.20807,0,0
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00014062,-0.19517,-0.24002,0,0
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00068502,-0.20335,-0.25028,0,0
6,GO KERATINIZATION,0.054439,-0.20476,-0.17752,0,0
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.0029965,-0.20645,-0.2496,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011574,-0.20652,-0.21017,0,0
6,GO AEROBIC RESPIRATION,0.00017019,-0.20673,-0.22746,0,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0054671,-0.20725,-0.2401,0,0
6,GO MATURATION OF LSU RRNA,0.013834,-0.20833,-0.18421,0,0
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0092139,-0.20994,-0.25162,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.037377,-0.21028,-0.19632,0,0
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,5.2428e-05,-0.21036,-0.30247,0,0
6,GO PROTEIN K11 LINKED UBIQUITINATION,4.5779e-05,-0.21638,-0.31295,0,0
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.010101,-0.22515,-0.21884,0,0
6,GO MUCUS SECRETION,0.067497,-0.22769,-0.21559,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0052065,-0.22868,-0.2139,0,0
6,GO EOSINOPHIL CHEMOTAXIS,0.11163,-0.22929,-0.36771,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00020554,-0.22951,-0.32388,0,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00017019,-0.23077,-0.3268,0,0
6,GO CYTOLYSIS,0.11524,-0.23194,-0.3228,0,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00010181,-0.23492,-0.32429,0,0
6,GO CORNIFICATION,0.062884,-0.23804,-0.20051,0,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.013834,-0.23947,-0.19597,0,0
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.54223,-0.24241,-0.27771,0,0
6,GO CORTICOSTEROID HORMONE SECRETION,0.0031545,-0.24251,-0.31743,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00031664,-0.24317,-0.25502,0,0
6,GO TELOMERASE RNA LOCALIZATION,0.00091199,-0.24395,-0.24785,0,0
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.056456,-0.24486,-0.37088,0,0
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.007293,-0.24775,-0.30945,0,0
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.022172,-0.24913,-0.28654,0,0
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.00031664,-0.24984,-0.24763,0,0
6,GO OPSONIZATION,0.015776,-0.2504,-0.41089,0,0
6,GO RNA 5 END PROCESSING,0.0010798,-0.25081,-0.26667,0,0
6,GO CHRONIC INFLAMMATORY RESPONSE,0.11894,-0.25112,-0.35416,0,0
6,GO T CELL TOLERANCE INDUCTION,0.060677,-0.25212,-0.53108,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.00057531,-0.25435,-0.30603,0,0
6,GO TELENCEPHALON REGIONALIZATION,0.056456,-0.25491,-0.32279,0,0
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.08303,-0.25883,-0.22142,0,0
6,GO NUCLEOSIDE SALVAGE,0.00011593,-0.26034,-0.29325,0,0
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00017019,-0.26561,-0.2933,0,0
6,GO VIRION ASSEMBLY,8.3461e-06,-0.26624,-0.33809,0,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,2.4576e-05,-0.26813,-0.34657,0,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.058535,-0.26901,-0.37458,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00011593,-0.26967,-0.33776,0,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,4.8997e-05,-0.27032,-0.30075,0,0
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00023283,-0.2733,-0.34519,0,0
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00029789,-0.27527,-0.33433,0,0
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.012106,-0.27629,-0.18852,0,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.00057531,-0.27821,-0.32855,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.00019306,-0.28189,-0.32794,0,0
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00076864,-0.28267,-0.2998,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0024341,-0.28362,-0.25907,0,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.00072571,-0.2879,-0.29106,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,8.9327e-05,-0.29036,-0.33004,0,0
6,GO RESPONSE TO SALT,0.00028019,-0.29653,-0.34144,0,0
6,GO DENTATE GYRUS DEVELOPMENT,0.00051151,-0.29809,-0.33773,0,0
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.013235,-0.29961,-0.32626,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00042807,-0.30014,-0.29852,0,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.011063,-0.30031,-0.23457,0,0
6,GO CELLULAR RESPONSE TO ZINC ION,0.015776,-0.30123,-0.3495,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,3.0304e-05,-0.30743,-0.3748,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0010209,-0.30766,-0.31001,0,0
6,GO GROOMING BEHAVIOR,0.0040644,-0.30947,-0.33231,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,5.9985e-05,-0.30969,-0.36649,0,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00091199,-0.311,-0.3634,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,4.8997e-05,-0.3126,-0.36223,0,0
6,GO EOSINOPHIL MIGRATION,0.062884,-0.31542,-0.45265,0,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.0083971,-0.31684,-0.3525,0,0
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,1.8524e-05,-0.31819,-0.37487,0,0
6,GO REGULATION OF RELAXATION OF MUSCLE,0.011574,-0.31951,-0.4012,0,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0019699,-0.32046,-0.27782,0,0
6,GO RESPONSE TO ZINC ION,5.9985e-05,-0.32206,-0.37088,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.074935,-0.32244,-0.39606,0,0
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,2.8267e-05,-0.32471,-0.37661,0,0
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,7.8298e-05,-0.33061,-0.35373,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.00035748,-0.33455,-0.36789,0,0
6,GO TRICARBOXYLIC ACID CYCLE,8.9843e-06,-0.33456,-0.39654,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,1.9888e-05,-0.34,-0.3773,0,0
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0014241,-0.34232,-0.45067,0,0
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,3.248e-05,-0.34254,-0.36431,0,0
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00012367,-0.34711,-0.32748,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00013188,-0.34715,-0.34019,0,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00057531,-0.34816,-0.35915,0,0
6,GO VIRAL TRANSLATION,0.00012367,-0.34827,-0.35141,0,0
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,8.9327e-05,-0.34936,-0.39053,0,0
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,1.6059e-05,-0.35107,-0.38069,0,0
6,GO GLYCINE METABOLIC PROCESS,4.5779e-05,-0.35267,-0.38773,0,0
6,GO CARDIAC CELL FATE COMMITMENT,0.00060992,-0.35598,-0.34938,0,0
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.011574,-0.35696,-0.34977,0,0
6,GO ZINC ION TRANSPORT,8.9843e-06,-0.35978,-0.39027,0,0
6,GO SLEEP,2.4576e-05,-0.36027,-0.39984,0,0
6,GO REGULATION OF ACROSOME REACTION,0.0034935,-0.36395,-0.33349,0,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,1.6059e-05,-0.36494,-0.44086,0,0
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.054439,-0.36537,-0.4053,0,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00019306,-0.36741,-0.39649,0,0
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,5.6086e-05,-0.36947,-0.3835,0,0
6,GO REGULATION OF GTP BINDING,0.00048214,-0.37464,-0.40398,0,0
6,GO RESPONSE TO COPPER ION,0.0013481,-0.37642,-0.35735,0,0
6,GO MITOTIC CELL CYCLE ARREST,0.00012367,-0.37645,-0.41145,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,6.2007e-06,-0.3776,-0.40039,0,0
6,GO MESODERMAL CELL FATE SPECIFICATION,3.9936e-05,-0.3796,-0.43118,0,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.00042807,-0.38364,-0.35243,0,0
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,1.7249e-05,-0.38394,-0.36694,0,0
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,5.2428e-05,-0.38566,-0.41225,0,0
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.4805e-05,-0.38623,-0.37258,0,0
6,GO SUBSTANTIA NIGRA DEVELOPMENT,1.6059e-05,-0.38719,-0.42505,0,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00021879,-0.38891,-0.44126,0,0
6,GO PEPTIDYL PROLINE MODIFICATION,5.7533e-06,-0.38981,-0.40813,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.025096,-0.39554,-0.29525,0,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,6.6813e-06,-0.39567,-0.48188,0,0
6,GO STEROID HORMONE SECRETION,0.00011593,-0.39726,-0.42236,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.00060992,-0.40076,-0.365,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,7.8298e-05,-0.40077,-0.36548,0,0
6,GO RESPONSE TO DIETARY EXCESS,4.5779e-05,-0.40146,-0.46635,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.013235,-0.40218,-0.36024,0,0
6,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,5.9985e-05,-0.40236,-0.37478,0,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,5.9985e-05,-0.40378,-0.40505,0,0
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00076864,-0.40746,-0.48326,0,0
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00024771,-0.40976,-0.49123,0,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,1.0403e-05,-0.41021,-0.47734,0,0
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0034935,-0.41347,-0.47069,0,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,7.7514e-06,-0.41631,-0.47988,0,0
6,GO BIOLOGICAL PHASE,0.0024341,-0.41651,-0.39184,0,0
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,2.636e-05,-0.418,-0.40154,0,0
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.9327e-05,-0.42181,-0.44706,0,0
6,GO FRUCTOSE METABOLIC PROCESS,1.6059e-05,-0.4275,-0.52729,0,0
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00024771,-0.42962,-0.46755,0,0
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.1191e-05,-0.43097,-0.44074,0,0
6,GO GABAERGIC NEURON DIFFERENTIATION,0.14312,-0.43295,-0.42333,0,0
6,GO CARDIAC VENTRICLE FORMATION,0.0014241,-0.43312,-0.43859,0,0
6,GO MITOCHONDRIAL DEPOLARIZATION,5.9985e-05,-0.43434,-0.52031,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.2907e-05,-0.43826,-0.45098,0,0
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,9.5377e-05,-0.44063,-0.44252,0,0
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.00018128,-0.44072,-0.47794,0,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,2.8267e-05,-0.44205,-0.45541,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.00035748,-0.44247,-0.45372,0,0
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00031664,-0.44344,-0.46096,0,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,7.7514e-06,-0.44351,-0.45791,0,0
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,6.2007e-06,-0.44441,-0.48674,0,0
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00048214,-0.44693,-0.44607,0,0
6,GO MYOBLAST DIFFERENTIATION,8.9843e-06,-0.44806,-0.51292,0,0
6,GO CELLULAR RESPONSE TO IRON ION,0.00035748,-0.44885,-0.49761,0,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,5.7533e-06,-0.44949,-0.45688,0,0
6,GO IMP METABOLIC PROCESS,0.0044907,-0.44987,-0.37578,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00033648,-0.45073,-0.41802,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,1.7249e-05,-0.45119,-0.50724,0,0
6,GO PENILE ERECTION,0.00033648,-0.4512,-0.48037,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,4.9495e-06,-0.45151,-0.52027,0,0
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.00054254,-0.45282,-0.47636,0,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00020554,-0.45411,-0.38089,0,0
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00014062,-0.45576,-0.49761,0,0
6,GO SARCOMERE ORGANIZATION,3.7287e-05,-0.45694,-0.41571,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.45879,-0.45421,0,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,2.1347e-05,-0.46196,-0.4401,0,0
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0020776,-0.46288,-0.49441,0,0
6,GO HEART FORMATION,3.248e-05,-0.46306,-0.49473,0,0
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.5377e-05,-0.46458,-0.44828,0,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,3.9422e-06,-0.46475,-0.57609,0,0
6,GO ANIMAL ORGAN FORMATION,1.2035e-05,-0.46627,-0.50284,0,0
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,5.6086e-05,-0.46741,-0.42907,0,0
6,GO GLUTAMINE METABOLIC PROCESS,2.1347e-05,-0.46811,-0.48337,0,0
6,GO VIRAL RNA GENOME REPLICATION,8.3461e-06,-0.47123,-0.52297,0,0
6,GO POSITIVE REGULATION OF HEART RATE,4.8997e-05,-0.4714,-0.45778,0,0
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,1.9888e-05,-0.47161,-0.4736,0,0
6,GO LIPID EXPORT FROM CELL,2.8267e-05,-0.47319,-0.43005,0,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,7.7514e-06,-0.47356,-0.44594,0,0
6,GO REGULATION OF HEART MORPHOGENESIS,1.8524e-05,-0.47397,-0.57881,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.47436,-0.48947,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,7.8298e-05,-0.47529,-0.50478,0,0
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.9843e-06,-0.47613,-0.50173,0,0
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.47673,-0.48202,0,0
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00017019,-0.47792,-0.4204,0,0
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,3.0304e-05,-0.47818,-0.51615,0,0
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,1.2939e-05,-0.47899,-0.5313,0,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,4.5779e-05,-0.47962,-0.49681,0,0
6,GO GLIAL CELL APOPTOTIC PROCESS,1.9888e-05,-0.48056,-0.56741,0,0
6,GO RESPONSE TO ETHER,3.9936e-05,-0.48161,-0.46098,0,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,4.2539e-06,-0.48235,-0.49373,0,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00042807,-0.48287,-0.54814,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00017019,-0.48516,-0.48009,0,0
6,GO RESPONSE TO MUSCLE ACTIVITY,7.1973e-06,-0.48543,-0.50213,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.058535,-0.48736,-0.47432,0,0
6,GO RESPONSE TO VITAMIN D,3.248e-05,-0.48767,-0.54769,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,2.8267e-05,-0.48934,-0.46488,0,0
6,GO HEART TRABECULA FORMATION,8.3641e-05,-0.48987,-0.49666,0,0
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.4805e-05,-0.49088,-0.47499,0,0
6,GO RESPONSE TO CORTICOSTERONE,0.0014241,-0.49148,-0.48097,0,0
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00096503,-0.49168,-0.47217,0,0
6,GO POLYOL TRANSPORT,0.00012367,-0.49169,-0.50379,0,0
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,7.7514e-06,-0.49174,-0.52037,0,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,2.4576e-05,-0.49207,-0.4807,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.0304e-05,-0.49288,-0.60574,0,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.00068502,-0.49388,-0.45319,0,0
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.9843e-06,-0.49446,-0.51749,0,0
6,GO COPULATION,0.00012367,-0.4947,-0.46328,0,0
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,4.5891e-06,-0.49582,-0.49477,0,0
6,GO FOREBRAIN NEURON FATE COMMITMENT,0.33029,-0.49779,-0.34816,0,0
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,7.8298e-05,-0.49937,-0.43042,0,0
6,GO MATING BEHAVIOR,0.00013188,-0.49952,-0.47982,0,0
6,GO POSITIVE CHEMOTAXIS,6.8565e-05,-0.5003,-0.50708,0,0
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0034935,-0.5005,-0.5019,0,0
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,1.8524e-05,-0.5016,-0.45137,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS,3.7287e-05,-0.50216,-0.53284,0,0
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0003797,-0.5026,-0.46758,0,0
6,GO NEPHRIC DUCT MORPHOGENESIS,2.4576e-05,-0.50295,-0.51459,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.3909e-05,-0.50483,-0.52078,0,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.00057531,-0.50653,-0.42169,0,0
6,GO GONADOTROPIN SECRETION,8.3641e-05,-0.50704,-0.47214,0,0
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00018128,-0.50861,-0.45476,0,0
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,1.6059e-05,-0.50885,-0.51876,0,0
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,5.6086e-05,-0.50897,-0.46908,0,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.50957,-0.47797,0,0
6,GO SODIUM ION HOMEOSTASIS,2.4576e-05,-0.5111,-0.48455,0,0
6,GO L GLUTAMATE IMPORT,2.1347e-05,-0.51615,-0.46693,0,0
6,GO ENDODERMAL CELL FATE COMMITMENT,0.00045436,-0.51701,-0.43624,0,0
6,GO CELLULAR SODIUM ION HOMEOSTASIS,1.8524e-05,-0.51895,-0.52269,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.52059,-0.55039,0,0
6,GO L SERINE METABOLIC PROCESS,3.0304e-05,-0.52171,-0.50307,0,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,5.9985e-05,-0.5219,-0.49141,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.008797,-0.52302,-0.48032,0,0
6,GO RESPONSE TO GONADOTROPIN,2.636e-05,-0.52511,-0.51657,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,6.2007e-06,-0.52547,-0.58457,0,0
6,GO ANTEROGRADE AXONAL TRANSPORT,2.2907e-05,-0.52577,-0.5995,0,0
6,GO GOLGI LOCALIZATION,1.2035e-05,-0.52612,-0.48768,0,0
6,GO REGULATION OF GLIAL CELL PROLIFERATION,5.6086e-05,-0.52655,-0.48753,0,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,1.1191e-05,-0.5268,-0.48126,0,0
6,GO REGULATION OF EXCRETION,3.0304e-05,-0.52726,-0.51229,0,0
6,GO REGULATION OF PEPTIDE SECRETION,6.2007e-06,-0.52857,-0.53728,0,0
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.1191e-05,-0.52877,-0.55068,0,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00051151,-0.5295,-0.45802,0,0
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,1.1191e-05,-0.53078,-0.53778,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00010866,-0.53084,-0.52903,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,1.0403e-05,-0.53094,-0.5023,0,0
6,GO REGULATION OF ODONTOGENESIS,1.3909e-05,-0.53149,-0.52567,0,0
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.7249e-05,-0.53237,-0.53298,0,0
6,GO RENAL SODIUM EXCRETION,3.7287e-05,-0.53237,-0.53049,0,0
6,GO ASTROCYTE DIFFERENTIATION,7.7514e-06,-0.53296,-0.5851,0,0
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,3.7287e-05,-0.53328,-0.47271,0,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00024771,-0.53451,-0.49719,0,0
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.00017019,-0.53457,-0.47884,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,5.2428e-05,-0.53578,-0.5624,0,0
6,GO CARDIOBLAST DIFFERENTIATION,1.7249e-05,-0.53627,-0.56194,0,0
6,GO LYTIC VACUOLE ORGANIZATION,4.5891e-06,-0.53739,-0.59212,0,0
6,GO AUTOPHAGY OF MITOCHONDRION,6.6813e-06,-0.53747,-0.54935,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,4.2763e-05,-0.53869,-0.5239,0,0
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.1191e-05,-0.54133,-0.55881,0,0
6,GO RESPONSE TO EPINEPHRINE,7.1973e-06,-0.54171,-0.56702,0,0
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00017019,-0.54185,-0.49469,0,0
6,GO REGULATION OF HEART GROWTH,6.6813e-06,-0.54242,-0.52696,0,0
6,GO REGULATION OF TRANSFERASE ACTIVITY,4.9495e-06,-0.54294,-0.55941,0,0
6,GO POSITIVE REGULATION OF CELL DIVISION,8.3461e-06,-0.54383,-0.50886,0,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,1.4947e-05,-0.5444,-0.58831,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,8.9843e-06,-0.54453,-0.57297,0,0
6,GO POSITIVE REGULATION OF VESICLE FUSION,8.9327e-05,-0.54659,-0.54363,0,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,6.2007e-06,-0.54797,-0.56421,0,0
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0012071,-0.54799,-0.49354,0,0
6,GO SEROTONIN TRANSPORT,1.3909e-05,-0.54811,-0.57176,0,0
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,3.9422e-06,-0.54853,-0.56087,0,0
6,GO RESPONSE TO HEAT,1.2035e-05,-0.54896,-0.50852,0,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00014989,-0.55016,-0.66654,0,0
6,GO REGULATION OF TELOMERASE ACTIVITY,9.6689e-06,-0.55136,-0.51237,0,0
6,GO RESPONSE TO FORSKOLIN,0.00014062,-0.55158,-0.59532,0,0
6,GO REGULATION OF ICOSANOID SECRETION,5.9985e-05,-0.55526,-0.45376,0,0
6,GO PROSTATIC BUD FORMATION,8.9327e-05,-0.55547,-0.56247,0,0
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00011593,-0.55622,-0.54199,0,0
6,GO NATURAL KILLER CELL CHEMOTAXIS,0.21989,-0.55703,-0.40063,0,0
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,8.9843e-06,-0.5574,-0.50792,0,0
6,GO POSITIVE REGULATION OF MYELINATION,1.8524e-05,-0.55796,-0.60184,0,0
6,GO CARTILAGE MORPHOGENESIS,2.8267e-05,-0.55806,-0.6166,0,0
6,GO REGULATION OF POSITIVE CHEMOTAXIS,5.6086e-05,-0.55814,-0.52184,0,0
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,5.337e-06,-0.56125,-0.54462,0,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.337e-06,-0.56166,-0.58808,0,0
6,GO MITOCHONDRIAL FISSION,6.6813e-06,-0.5624,-0.58582,0,0
6,GO CELLULAR RESPONSE TO VITAMIN,2.4576e-05,-0.56502,-0.5915,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.2035e-05,-0.56559,-0.55049,0,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,4.8997e-05,-0.56879,-0.55621,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.7514e-06,-0.57,-0.52755,0,0
6,GO AUTOPHAGY OF NUCLEUS,4.9495e-06,-0.5707,-0.58785,0,0
6,GO REGULATION OF FATTY ACID TRANSPORT,1.4947e-05,-0.57177,-0.52686,0,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,1.9888e-05,-0.57209,-0.53533,0,0
6,GO RESPONSE TO AXON INJURY,6.2007e-06,-0.57306,-0.58346,0,0
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.57353,-0.54987,0,0
6,GO PROSTAGLANDIN SECRETION,6.4139e-05,-0.57433,-0.50557,0,0
6,GO NEUTRAL AMINO ACID TRANSPORT,6.2007e-06,-0.57569,-0.57816,0,0
6,GO METANEPHROS DEVELOPMENT,5.7533e-06,-0.57604,-0.59824,0,0
6,GO VACUOLE ORGANIZATION,5.337e-06,-0.57635,-0.58112,0,0
6,GO CELLULAR RESPONSE TO NUTRIENT,1.2939e-05,-0.57684,-0.60987,0,0
6,GO CELLULAR RESPONSE TO X RAY,2.8267e-05,-0.57752,-0.60676,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014989,-0.57947,-0.51363,0,0
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,4.5891e-06,-0.5801,-0.58216,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,5.337e-06,-0.58286,-0.60314,0,0
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.7287e-05,-0.58309,-0.56682,0,0
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.6059e-05,-0.58416,-0.64449,0,0
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.337e-06,-0.58549,-0.57544,0,0
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,6.6813e-06,-0.5861,-0.58199,0,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,1.7249e-05,-0.58665,-0.63454,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.337e-06,-0.58687,-0.61337,0,0
6,GO REGULATION OF HORMONE METABOLIC PROCESS,1.1191e-05,-0.58766,-0.67419,0,0
6,GO BONE MINERALIZATION,9.6689e-06,-0.58805,-0.59744,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,6.2007e-06,-0.58814,-0.57959,0,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,8.3461e-06,-0.58869,-0.55175,0,0
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,9.6689e-06,-0.58967,-0.60975,0,0
6,GO REGULATION OF URINE VOLUME,1.4947e-05,-0.59006,-0.55834,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,4.8997e-05,-0.59065,-0.60254,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.1347e-05,-0.59274,-0.57737,0,0
6,GO KIDNEY MESENCHYME DEVELOPMENT,7.7514e-06,-0.59317,-0.62126,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,1.6059e-05,-0.5934,-0.58338,0,0
6,GO REGULATION OF RESPIRATORY BURST,1.6059e-05,-0.59365,-0.56836,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.59496,-0.54583,0,0
6,GO LYSOSOME LOCALIZATION,3.9422e-06,-0.59499,-0.63628,0,0
6,GO RESPONSE TO TESTOSTERONE,5.7533e-06,-0.59684,-0.51954,0,0
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,8.9843e-06,-0.59794,-0.63209,0,0
6,GO REPLICATIVE SENESCENCE,0.00011593,-0.59799,-0.44546,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.0304e-05,-0.59941,-0.56164,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,2.4576e-05,-0.6012,-0.59063,0,0
6,GO POSITIVE REGULATION OF OSSIFICATION,9.6689e-06,-0.60202,-0.60707,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,2.1347e-05,-0.60221,-0.56654,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,8.9843e-06,-0.60285,-0.57707,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.08881,-0.6031,-0.50927,0,0
6,GO AXIS ELONGATION,1.3909e-05,-0.6031,-0.55102,0,0
6,GO CARDIAC CELL DEVELOPMENT,5.337e-06,-0.6082,-0.55358,0,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,1.6059e-05,-0.60934,-0.57074,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.6689e-06,-0.61039,-0.61461,0,0
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,5.337e-06,-0.61075,-0.62745,0,0
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,7.1973e-06,-0.61404,-0.60842,0,0
6,GO RESPONSE TO MECHANICAL STIMULUS,6.2007e-06,-0.61464,-0.60981,0,0
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.9495e-06,-0.61747,-0.57772,0,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,5.337e-06,-0.61927,-0.59248,0,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,1.9888e-05,-0.61984,-0.60423,0,0
6,GO RESPONSE TO PROGESTERONE,1.7249e-05,-0.6221,-0.60191,0,0
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.00018128,-0.62273,-0.55863,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,7.7514e-06,-0.62716,-0.62336,0,0
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,2.636e-05,-0.62773,-0.64486,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4947e-05,-0.62813,-0.60703,0,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,2.636e-05,-0.62859,-0.53084,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,1.8524e-05,-0.6288,-0.71343,0,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,4.5891e-06,-0.62888,-0.61292,0,0
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,1.6059e-05,-0.63088,-0.58837,0,0
6,GO POSITIVE REGULATION OF NEURON DEATH,4.9495e-06,-0.63097,-0.60235,0,0
6,GO TUBE FORMATION,5.7533e-06,-0.63109,-0.57074,0,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.63203,-0.57,0,0
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00010181,-0.63388,-0.60368,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.0403e-05,-0.63416,-0.59487,0,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,1.2035e-05,-0.63978,-0.5654,0,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,1.2035e-05,-0.63983,-0.64231,0,0
6,GO SMOOTH MUSCLE CONTRACTION,6.2007e-06,-0.64098,-0.56496,0,0
6,GO REGULATION OF NEURON PROJECTION REGENERATION,1.7249e-05,-0.64411,-0.62284,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,3.9936e-05,-0.64704,-0.62853,0,0
6,GO REGULATION OF GLOMERULAR FILTRATION,3.9936e-05,-0.64761,-0.71001,0,0
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00068502,-0.65021,-0.4927,0,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,5.7533e-06,-0.65349,-0.66227,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,1.2035e-05,-0.65364,-0.63632,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,5.2428e-05,-0.65367,-0.5725,0,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,2.2907e-05,-0.65377,-0.60784,0,0
6,GO MICROVILLUS ASSEMBLY,6.2007e-06,-0.65844,-0.62401,0,0
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.65935,-0.58324,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,8.3461e-06,-0.66018,-0.63035,0,0
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,2.4576e-05,-0.66295,-0.6353,0,0
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.00014062,-0.66804,-0.59786,0,0
6,GO ENDOTHELIAL CELL MIGRATION,6.2007e-06,-0.66985,-0.67118,0,0
6,GO MESODERMAL CELL DIFFERENTIATION,1.8524e-05,-0.67242,-0.60151,0,0
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.67312,-0.64881,0,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0040644,-0.67724,-0.49713,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,1.7249e-05,-0.68154,-0.63184,0,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,9.6689e-06,-0.6826,-0.67934,0,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00033648,-0.68265,-0.60783,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00011593,-0.68299,-0.66425,0,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.6059e-05,-0.68573,-0.72672,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,1.6059e-05,-0.68663,-0.72311,0,0
6,GO VASCULOGENESIS,7.7514e-06,-0.68683,-0.69869,0,0
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.4947e-05,-0.68862,-0.64207,0,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,6.6813e-06,-0.68935,-0.62045,0,0
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,5.7533e-06,-0.69391,-0.65055,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,5.6086e-05,-0.69409,-0.58774,0,0
6,GO SALIVARY GLAND DEVELOPMENT,8.9843e-06,-0.69467,-0.69411,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6059e-05,-0.69807,-0.63494,0,0
6,GO ACTIN FILAMENT NETWORK FORMATION,6.4139e-05,-0.6992,-0.62519,0,0
6,GO SMOOTH MUSCLE CELL MIGRATION,7.1973e-06,-0.70045,-0.73199,0,0
6,GO ENDOCARDIAL CUSHION FORMATION,7.7514e-06,-0.70131,-0.71273,0,0
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,1.0403e-05,-0.70312,-0.64545,0,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,7.7514e-06,-0.70367,-0.66148,0,0
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,6.6813e-06,-0.70487,-0.6759,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,7.1973e-06,-0.70966,-0.64862,0,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.4805e-05,-0.71194,-0.77023,0,0
6,GO N GLYCAN PROCESSING,5.7533e-06,-0.71337,-0.71513,0,0
6,GO NOREPINEPHRINE METABOLIC PROCESS,3.4805e-05,-0.71454,-0.64454,0,0
6,GO CONVERGENT EXTENSION,1.2939e-05,-0.71753,-0.65202,0,0
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,3.0304e-05,-0.7183,-0.69954,0,0
6,GO INACTIVATION OF MAPK ACTIVITY,1.7249e-05,-0.71969,-0.63312,0,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,8.9843e-06,-0.72024,-0.71669,0,0
6,GO CHONDROCYTE DIFFERENTIATION,6.6813e-06,-0.72163,-0.71302,0,0
6,GO ENDOTHELIAL CELL PROLIFERATION,7.1973e-06,-0.72397,-0.67073,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.248e-05,-0.72579,-0.64293,0,0
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,7.1973e-06,-0.72585,-0.67736,0,0
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,1.7249e-05,-0.72949,-0.77583,0,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,7.1973e-06,-0.73008,-0.69024,0,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,4.9495e-06,-0.73106,-0.76202,0,0
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.6059e-05,-0.73358,-0.68374,0,0
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,1.4947e-05,-0.73603,-0.6407,0,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,6.6813e-06,-0.73675,-0.69345,0,0
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.7514e-06,-0.73693,-0.69843,0,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,5.7533e-06,-0.73858,-0.70256,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,3.4805e-05,-0.74462,-0.72744,0,0
6,GO BONE GROWTH,5.7533e-06,-0.74557,-0.69662,0,0
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,7.1973e-06,-0.75361,-0.76877,0,0
6,GO SPROUTING ANGIOGENESIS,7.1973e-06,-0.75733,-0.71691,0,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,0.00012367,-0.7576,-0.71518,0,0
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,7.1973e-06,-0.76062,-0.78896,0,0
6,GO CORONARY VASCULATURE MORPHOGENESIS,9.6689e-06,-0.76304,-0.76157,0,0
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,1.4947e-05,-0.76487,-0.7168,0,0
6,GO RESPONSE TO MUSCLE STRETCH,3.7287e-05,-0.76981,-0.7018,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,5.9985e-05,-0.77132,-0.70133,0,0
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,7.7514e-06,-0.77772,-0.71194,0,0
6,GO RENAL FILTRATION,1.2939e-05,-0.82191,-0.83322,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.1191e-05,-0.83214,-0.74887,0,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.8524e-05,-0.85518,-0.82255,0,0
6,GO ENDOTHELIAL CELL DEVELOPMENT,5.7533e-06,-0.87074,-0.80775,0,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,1.1191e-05,-0.88187,-0.82601,0,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,5.7533e-06,-0.89294,-0.82075,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.3909e-05,-0.91214,-0.82689,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,5.337e-06,-0.92655,-0.89904,0,0
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,1.2035e-05,-1.0072,-1.0078,0,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,9.6689e-06,-1.0288,-0.99691,0,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,5.337e-06,-1.0345,-0.95198,0,0
7,GO OUTER DYNEIN ARM ASSEMBLY,0.00011593,0.76036,0.78617,1,1
7,GO INNER DYNEIN ARM ASSEMBLY,0.0010798,0.68926,0.63533,1,1
7,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,9.5377e-05,0.67795,0.70091,1,1
7,GO LOOP OF HENLE DEVELOPMENT,0.00011593,0.65891,0.61083,1,1
7,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0019699,0.63229,0.50498,1,1
7,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,3.7287e-05,0.63035,0.63516,1,1
7,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0014241,0.5861,0.52679,1,1
7,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0018673,0.57554,0.50357,1,1
7,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,5.9985e-05,0.55906,0.64578,1,1
7,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00015974,0.53059,0.72251,1,1
7,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00060992,0.52838,0.58115,1,1
7,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00028019,0.52327,0.50497,1,1
7,GO SYNAPTIC VESICLE DOCKING,0.00010866,0.52171,0.70853,1,1
7,GO PONS DEVELOPMENT,8.9327e-05,0.52057,0.63466,1,1
7,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00014989,0.51429,0.5162,1,1
7,GO AXONEME ASSEMBLY,4.8997e-05,0.51202,0.58776,1,1
7,GO ADHESION OF SYMBIONT TO HOST,0.019548,0.50612,0.42412,1,1
7,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0020776,0.50342,0.52083,1,1
7,GO SPONTANEOUS SYNAPTIC TRANSMISSION,8.3641e-05,0.50158,0.66258,1,1
7,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0052065,0.50042,0.47818,1,1
7,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00028019,0.5003,0.4714,1,1
7,GO REGULATION OF CGMP MEDIATED SIGNALING,0.00017019,0.49961,0.51867,1,1
7,GO COLLECTING DUCT DEVELOPMENT,0.00040321,0.49288,0.48741,1,1
7,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0013481,0.49205,0.59085,1,1
7,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0014241,0.49095,0.4862,1,1
7,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00064645,0.48895,0.67952,1,1
7,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0054671,0.4884,0.37708,1,1
7,GO MICROTUBULE BUNDLE FORMATION,4.2763e-05,0.48161,0.49694,1,1
7,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.017954,0.48149,0.36138,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0031545,0.48005,0.42677,1,1
7,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00021879,0.47841,0.6479,1,1
7,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00332,0.47746,0.40886,1,1
7,GO RESPONSE TO POTASSIUM ION,0.00057531,0.47527,0.50806,1,1
7,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00010866,0.47462,0.49639,1,1
7,GO PREPULSE INHIBITION,0.00096503,0.46915,0.5032,1,1
7,GO MRNA SPLICE SITE SELECTION,0.00054254,0.46784,0.39225,1,1
7,GO SENSORY PERCEPTION OF BITTER TASTE,0.0003797,0.46721,0.37017,1,1
7,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0013481,0.46652,0.5198,1,1
7,GO DENDRITIC TRANSPORT,0.0020776,0.46586,0.41667,1,1
7,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.0057394,0.46244,0.33843,1,1
7,GO EXTRACELLULAR TRANSPORT,4.2763e-05,0.46198,0.53749,1,1
7,GO IRON COORDINATION ENTITY TRANSPORT,0.00014062,0.46072,0.51881,1,1
7,GO CELL AGGREGATION,0.0031545,0.45763,0.36106,1,1
7,GO CILIUM MOVEMENT,6.8565e-05,0.45725,0.45931,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0014241,0.44991,0.3774,1,1
7,GO MOTILE CILIUM ASSEMBLY,0.00019306,0.44981,0.47763,1,1
7,GO DETECTION OF CALCIUM ION,0.00081392,0.44883,0.42867,1,1
7,GO DENSE CORE GRANULE TRANSPORT,0.00064645,0.44643,0.55769,1,1
7,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.013235,0.44547,0.38742,1,1
7,GO PARENTAL BEHAVIOR,0.0040644,0.44354,0.49676,1,1
7,GO MEIOTIC CHROMOSOME SEPARATION,0.0052065,0.44209,0.33853,1,1
7,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0027019,0.44198,0.4377,1,1
7,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00051151,0.44088,0.47396,1,1
7,GO CELL JUNCTION MAINTENANCE,0.00028019,0.44008,0.39894,1,1
7,GO SYNAPTIC MEMBRANE ADHESION,0.0034935,0.43507,0.40462,1,1
7,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0015041,0.43263,0.46335,1,1
7,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,8.9327e-05,0.42887,0.5476,1,1
7,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00024771,0.42678,0.37676,1,1
7,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00054254,0.42469,0.61463,1,1
7,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00040321,0.42465,0.46863,1,1
7,GO REGULATION OF GLUTAMATE SECRETION,0.0049572,0.42336,0.38531,1,1
7,GO AXO DENDRITIC PROTEIN TRANSPORT,0.00048214,0.42275,0.46313,1,1
7,GO NEURON REMODELING,0.0096484,0.42252,0.3605,1,1
7,GO INTESTINAL LIPID ABSORPTION,0.00028019,0.42125,0.48423,1,1
7,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,7.3279e-05,0.4212,0.44594,1,1
7,GO SEGMENT SPECIFICATION,0.00024771,0.42079,0.41887,1,1
7,GO SYNAPSE MATURATION,0.022172,0.41524,0.32235,1,1
7,GO STARTLE RESPONSE,0.00040321,0.41521,0.40873,1,1
7,GO INHIBITORY SYNAPSE ASSEMBLY,0.00091199,0.4146,0.5246,1,1
7,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00023283,0.41394,0.37306,1,1
7,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00086166,0.4134,0.66473,1,1
7,GO MALE SEX DETERMINATION,0.0063209,0.41277,0.33775,1,1
7,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.7249e-05,0.4125,0.45109,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,3.248e-05,0.41247,0.4004,1,1
7,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0025648,0.41244,0.45601,1,1
7,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00010866,0.41097,0.41087,1,1
7,GO INTRACILIARY RETROGRADE TRANSPORT,0.00023283,0.40963,0.42059,1,1
7,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00021879,0.40904,0.45004,1,1
7,GO NEURON CELLULAR HOMEOSTASIS,0.0092139,0.40735,0.3167,1,1
7,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00018128,0.40261,0.4624,1,1
7,GO NEURON MATURATION,0.00033648,0.40218,0.36703,1,1
7,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00072571,0.40205,0.36117,1,1
7,GO INTERLEUKIN 5 PRODUCTION,0.030713,0.40089,0.30586,1,1
7,GO MEMBRANE DEPOLARIZATION,8.9327e-05,0.40087,0.41292,1,1
7,GO REGULATION OF CILIUM ASSEMBLY,4.8997e-05,0.40019,0.40503,1,1
7,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00023283,0.39976,0.41558,1,1
7,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00013188,0.39875,0.41035,1,1
7,GO PROTEIN LOCALIZATION TO CILIUM,0.00042807,0.39872,0.35626,1,1
7,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0036751,0.39357,0.46434,1,1
7,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0052065,0.39343,0.39985,1,1
7,GO SPERM MOTILITY,0.00017019,0.39151,0.36351,1,1
7,GO PROTEIN POLYGLUTAMYLATION,0.00026348,0.39094,0.39025,1,1
7,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0015041,0.3906,0.44683,1,1
7,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.015776,0.39054,0.32484,1,1
7,GO GLUTAMATE SECRETION,0.00021879,0.39021,0.40003,1,1
7,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00091199,0.3894,0.54928,1,1
7,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00081392,0.38926,0.30811,1,1
7,GO REGULATION OF APPETITE,0.00029789,0.38734,0.41854,1,1
7,GO LUTEINIZATION,0.006955,0.38564,0.38426,1,1
7,GO REGULATION OF NEURON MIGRATION,0.010572,0.38437,0.34294,1,1
7,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.8267e-05,0.38298,0.41351,1,1
7,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00020554,0.38272,0.53489,1,1
7,GO NEURONAL ION CHANNEL CLUSTERING,0.0038653,0.3827,0.37361,1,1
7,GO MICROTUBULE SEVERING,0.00028019,0.38245,0.37021,1,1
7,GO RESPONSE TO AUDITORY STIMULUS,0.0054671,0.38211,0.3228,1,1
7,GO HISTONE H3 K27 METHYLATION,0.00051151,0.38176,0.42689,1,1
7,GO HISTONE H3 K9 DEMETHYLATION,0.00048214,0.38086,0.38627,1,1
7,GO FEAR RESPONSE,0.00029789,0.38038,0.32622,1,1
7,GO MICROTUBULE BASED MOVEMENT,4.2763e-05,0.37968,0.3667,1,1
7,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00091199,0.37909,0.41294,1,1
7,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0015041,0.37905,0.4032,1,1
7,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0003797,0.3788,0.4617,1,1
7,GO INTRACILIARY TRANSPORT,0.00033648,0.37801,0.34809,1,1
7,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0012071,0.37699,0.36497,1,1
7,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0027019,0.37601,0.34287,1,1
7,GO CHEMOSENSORY BEHAVIOR,3.7287e-05,0.37545,0.44712,1,1
7,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00015974,0.37492,0.56027,1,1
7,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00091199,0.37382,0.3905,1,1
7,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0040644,0.37282,0.38432,1,1
7,GO MICROTUBULE ANCHORING,0.00026348,0.37273,0.40486,1,1
7,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0025648,0.37252,0.37403,1,1
7,GO RETINA LAYER FORMATION,0.0052065,0.37236,0.40095,1,1
7,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00060992,0.37231,0.38515,1,1
7,GO DERMATAN SULFATE METABOLIC PROCESS,0.0076456,0.37131,0.36233,1,1
7,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0014241,0.37121,0.42356,1,1
7,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00048214,0.37118,0.41914,1,1
7,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0047188,0.37052,0.38032,1,1
7,GO PANCREATIC JUICE SECRETION,0.0011418,0.37003,0.34389,1,1
7,GO LYSINE METABOLIC PROCESS,0.00011593,0.36906,0.36583,1,1
7,GO LIPID DIGESTION,0.00060992,0.36899,0.42965,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00068502,0.36835,0.33213,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00096503,0.36792,0.3548,1,1
7,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00023283,0.36784,0.31932,1,1
7,GO LONG TERM SYNAPTIC DEPRESSION,0.00081392,0.36633,0.37352,1,1
7,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00072571,0.36576,0.50257,1,1
7,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,9.5377e-05,0.36453,0.33292,1,1
7,GO ADULT BEHAVIOR,0.00068502,0.36361,0.32877,1,1
7,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0034935,0.36319,0.31858,1,1
7,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0015041,0.36152,0.36561,1,1
7,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00096503,0.36132,0.40063,1,1
7,GO NODAL SIGNALING PATHWAY,4.5779e-05,0.36126,0.38737,1,1
7,GO SECRETORY GRANULE LOCALIZATION,0.0042727,0.35989,0.38736,1,1
7,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017696,0.35788,0.39364,1,1
7,GO LATERAL VENTRICLE DEVELOPMENT,0.00035748,0.35721,0.39986,1,1
7,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,8.9327e-05,0.35585,0.3769,1,1
7,GO EXCITATORY SYNAPSE ASSEMBLY,0.00064645,0.35564,0.4651,1,1
7,GO CILIUM ORGANIZATION,6.8565e-05,0.35506,0.36511,1,1
7,GO DRUG CATABOLIC PROCESS,0.0040644,0.35505,0.3086,1,1
7,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0011418,0.35472,0.40308,1,1
7,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0010209,0.35456,0.45537,1,1
7,GO SECONDARY PALATE DEVELOPMENT,0.0027019,0.35449,0.38996,1,1
7,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00086166,0.35273,0.42704,1,1
7,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.9327e-05,0.35259,0.37956,1,1
7,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0011418,0.35217,0.39177,1,1
7,GO LEYDIG CELL DIFFERENTIATION,0.0010209,0.35206,0.45303,1,1
7,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0038653,0.35201,0.34541,1,1
7,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00060992,0.35155,0.43876,1,1
7,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0031545,0.35103,0.38675,1,1
7,GO CALCIUM ION IMPORT INTO CYTOSOL,0.011574,0.35078,0.34485,1,1
7,GO PHOTORECEPTOR CELL DEVELOPMENT,4.8997e-05,0.35049,0.36887,1,1
7,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0017696,0.35047,0.36702,1,1
7,GO DOSAGE COMPENSATION,0.0013481,0.34923,0.32785,1,1
7,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0019699,0.34899,0.41853,1,1
7,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00023283,0.34876,0.3788,1,1
7,GO POSITIVE REGULATION OF BEHAVIOR,0.0015882,0.34805,0.29246,1,1
7,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0031545,0.34767,0.34082,1,1
7,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00045436,0.34634,0.39846,1,1
7,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0015882,0.3447,0.30416,1,1
7,GO FACIAL NERVE MORPHOGENESIS,0.0042727,0.34466,0.38945,1,1
7,GO POSITIVE REGULATION OF HAIR CYCLE,0.027226,0.34393,0.27338,1,1
7,GO MITOCHONDRIAL RNA PROCESSING,0.0025648,0.34383,0.25173,1,1
7,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0092139,0.34251,0.3007,1,1
7,GO SEX DETERMINATION,0.00018128,0.34248,0.37655,1,1
7,GO ADRENAL GLAND DEVELOPMENT,0.0016767,0.3424,0.35585,1,1
7,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0083971,0.34116,0.30219,1,1
7,GO HAIR CELL DIFFERENTIATION,3.0304e-05,0.34035,0.38375,1,1
7,GO SYNAPTIC VESICLE BUDDING,0.0076456,0.33957,0.2871,1,1
7,GO SYNAPSE ASSEMBLY,0.00035748,0.33956,0.4105,1,1
7,GO SPERM AXONEME ASSEMBLY,0.00040321,0.33886,0.31482,1,1
7,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0018673,0.33858,0.36986,1,1
7,GO WATER HOMEOSTASIS,0.0013481,0.33816,0.29535,1,1
7,GO SYNAPTIC VESICLE LOCALIZATION,0.00042807,0.33698,0.37352,1,1
7,GO NEURON CELL CELL ADHESION,0.0012071,0.3366,0.47163,1,1
7,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00091199,0.33529,0.33948,1,1
7,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0024341,0.33453,0.35932,1,1
7,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.011574,0.33421,0.27872,1,1
7,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0172,0.33395,0.52805,1,1
7,GO LEARNING,0.00064645,0.33369,0.32967,1,1
7,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00010866,0.33325,0.39398,1,1
7,GO BASEMENT MEMBRANE ASSEMBLY,0.0025648,0.33321,0.42598,1,1
7,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0060238,0.33301,0.28249,1,1
7,GO CGMP MEDIATED SIGNALING,0.0011418,0.33288,0.34934,1,1
7,GO SENSORY PERCEPTION OF TASTE,0.00035748,0.33266,0.30524,1,1
7,GO O GLYCAN PROCESSING,0.0015882,0.33224,0.30646,1,1
7,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00042807,0.33167,0.50331,1,1
7,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00081392,0.33156,0.30528,1,1
7,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0083971,0.33139,0.31042,1,1
7,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0057394,0.33063,0.41898,1,1
7,GO DORSAL SPINAL CORD DEVELOPMENT,0.0044907,0.33037,0.31367,1,1
7,GO HISTONE H3 K4 TRIMETHYLATION,0.0017696,0.32952,0.37958,1,1
7,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00028019,0.32915,0.39322,1,1
7,GO CHROMATIN SILENCING AT TELOMERE,0.0013481,0.32864,0.29305,1,1
7,GO PROTEIN DEMETHYLATION,0.00017019,0.32807,0.40943,1,1
7,GO INNERVATION,0.02951,0.32694,0.31001,1,1
7,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0016767,0.32655,0.2738,1,1
7,GO SPECIFICATION OF SYMMETRY,0.00013188,0.32648,0.31767,1,1
7,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0076456,0.32646,0.30752,1,1
7,GO OTIC VESICLE DEVELOPMENT,0.0172,0.32644,0.23618,1,1
7,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0010798,0.32644,0.37796,1,1
7,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0027019,0.32573,0.33342,1,1
7,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.024086,0.32548,0.31539,1,1
7,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0172,0.32541,0.24889,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0063209,0.32535,0.31407,1,1
7,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00021879,0.32533,0.34324,1,1
7,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0025648,0.32482,0.31416,1,1
7,GO EMBRYONIC BODY MORPHOGENESIS,0.0012071,0.32463,0.36353,1,1
7,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00081392,0.32459,0.32574,1,1
7,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0036751,0.32457,0.28875,1,1
7,GO NEUROTRANSMITTER TRANSPORT,0.00042807,0.32436,0.38181,1,1
7,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057394,0.32407,0.3614,1,1
7,GO INOSITOL METABOLIC PROCESS,0.0023095,0.32389,0.29811,1,1
7,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012758,0.32381,0.4502,1,1
7,GO COLLATERAL SPROUTING,0.0038653,0.32345,0.35055,1,1
7,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0018673,0.32215,0.40451,1,1
7,GO REGULATION OF SYNAPSE ASSEMBLY,0.0012071,0.32193,0.35634,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.008797,0.32191,0.35125,1,1
7,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0040644,0.32186,0.39822,1,1
7,GO MICROTUBULE BASED TRANSPORT,9.5377e-05,0.32144,0.33142,1,1
7,GO SPERM CAPACITATION,0.00029789,0.3207,0.31115,1,1
7,GO REGULATION OF COLLATERAL SPROUTING,0.0096484,0.31941,0.33192,1,1
7,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0023095,0.31939,0.34604,1,1
7,GO MECHANOSENSORY BEHAVIOR,0.017954,0.31917,0.29055,1,1
7,GO MICROTUBULE POLYMERIZATION,0.00096503,0.31907,0.31387,1,1
7,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0016767,0.31876,0.39621,1,1
7,GO SYNAPSE ORGANIZATION,0.0010798,0.31874,0.3336,1,1
7,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00048214,0.31786,0.36756,1,1
7,GO PIGMENT GRANULE LOCALIZATION,0.0012758,0.31714,0.29722,1,1
7,GO TUBULIN DEACETYLATION,0.0010209,0.31714,0.36832,1,1
7,GO REGULATION OF AXON GUIDANCE,0.0010798,0.31684,0.37691,1,1
7,GO CAMP METABOLIC PROCESS,0.00045436,0.31683,0.37861,1,1
7,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00045436,0.31665,0.34693,1,1
7,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0034935,0.31602,0.32089,1,1
7,GO ACIDIC AMINO ACID TRANSPORT,7.8298e-05,0.31563,0.34874,1,1
7,GO ADHERENS JUNCTION ORGANIZATION,0.00064645,0.31542,0.32418,1,1
7,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0020776,0.31538,0.32707,1,1
7,GO MUSCLE FIBER DEVELOPMENT,0.0012071,0.31504,0.27361,1,1
7,GO FOREBRAIN NEURON DEVELOPMENT,0.0057394,0.31489,0.29527,1,1
7,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00048214,0.31477,0.30295,1,1
7,GO RECEPTOR CLUSTERING,0.0066311,0.31438,0.30904,1,1
7,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0047188,0.31421,0.35655,1,1
7,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00086166,0.31349,0.31082,1,1
7,GO NEUROEPITHELIAL CELL DIFFERENTIATION,2.8267e-05,0.31332,0.38718,1,1
7,GO NEUROTRANSMITTER SECRETION,0.00051151,0.31287,0.40703,1,1
7,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.007293,0.31274,0.36751,1,1
7,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.02951,0.31235,0.27071,1,1
7,GO REPRODUCTIVE BEHAVIOR,0.0021907,0.31231,0.32206,1,1
7,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0015882,0.31206,0.2908,1,1
7,GO GOLGI RIBBON FORMATION,0.0010209,0.31199,0.35449,1,1
7,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0012071,0.31144,0.38126,1,1
7,GO NON MOTILE CILIUM ASSEMBLY,0.00028019,0.31136,0.312,1,1
7,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00017019,0.31118,0.35636,1,1
7,GO REPLICATION FORK PROCESSING,0.022172,0.31076,0.25986,1,1
7,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.007293,0.3107,0.25841,1,1
7,GO RESPONSE TO GLUCAGON,0.0052065,0.31057,0.2497,1,1
7,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0023095,0.30985,0.3663,1,1
7,GO ASSOCIATIVE LEARNING,0.00081392,0.30977,0.32008,1,1
7,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.035953,0.30961,0.23712,1,1
7,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.006955,0.30905,0.30452,1,1
7,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00064645,0.30897,0.44172,1,1
7,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00091199,0.30886,0.38628,1,1
7,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.015104,0.30868,0.31292,1,1
7,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0016767,0.30828,0.28931,1,1
7,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00057531,0.3082,0.42457,1,1
7,GO BEHAVIORAL RESPONSE TO COCAINE,0.00076864,0.3079,0.34872,1,1
7,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0052065,0.30767,0.27789,1,1
7,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00068502,0.30761,0.26788,1,1
7,GO SYNAPTIC SIGNALING,0.00035748,0.30755,0.34798,1,1
7,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0054671,0.30738,0.3161,1,1
7,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0013481,0.30714,0.27546,1,1
7,GO INSEMINATION,0.030713,0.30695,0.25411,1,1
7,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.8565e-05,0.30618,0.36859,1,1
7,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.00024771,0.30585,0.30079,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0013481,0.30561,0.3798,1,1
7,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.025096,0.30548,0.25541,1,1
7,GO MITOCHONDRION LOCALIZATION,0.00021879,0.30535,0.32522,1,1
7,GO ENTRY OF BACTERIUM INTO HOST CELL,0.01266,0.30532,0.26386,1,1
7,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0054671,0.30526,0.36673,1,1
7,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0015882,0.30489,0.29902,1,1
7,GO AXON EXTENSION,0.0010798,0.30477,0.33202,1,1
7,GO UV DAMAGE EXCISION REPAIR,0.00019306,0.30452,0.3357,1,1
7,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00081392,0.30415,0.31781,1,1
7,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0042727,0.3037,0.24404,1,1
7,GO BRAIN MORPHOGENESIS,0.00064645,0.30299,0.33116,1,1
7,GO DENDRITE MORPHOGENESIS,0.0021907,0.30281,0.31118,1,1
7,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00024771,0.3028,0.39331,1,1
7,GO LIPID TRANSLOCATION,0.0031545,0.30259,0.29881,1,1
7,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.9936e-05,0.3025,0.36307,1,1
7,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,4.2763e-05,0.30173,0.38362,1,1
7,GO ACROSOME REACTION,0.00026348,0.30067,0.27748,1,1
7,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0010209,0.30041,0.3256,1,1
7,GO MEIOTIC CHROMOSOME SEGREGATION,0.011574,0.30034,0.23409,1,1
7,GO RESPONSE TO COCAINE,0.0027019,0.30032,0.28726,1,1
7,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0003797,0.30021,0.37943,1,1
7,GO CELL PROJECTION ORGANIZATION,0.00054254,0.30013,0.28366,1,1
7,GO FUCOSYLATION,0.0015041,0.29996,0.30585,1,1
7,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0024341,0.29991,0.3295,1,1
7,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0025648,0.29927,0.27537,1,1
7,GO MICROTUBULE BASED PROCESS,0.00018128,0.29916,0.2958,1,1
7,GO SYNAPTIC VESICLE RECYCLING,0.00020554,0.29899,0.39229,1,1
7,GO PROTEIN PALMITOYLATION,4.2763e-05,0.2987,0.36935,1,1
7,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0038653,0.29864,0.30663,1,1
7,GO TRANSCYTOSIS,0.0027019,0.29851,0.32441,1,1
7,GO ACTIVATION OF JNKK ACTIVITY,0.024086,0.29778,0.25697,1,1
7,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00091199,0.29749,0.3459,1,1
7,GO LYMPH VESSEL DEVELOPMENT,0.010572,0.29692,0.34193,1,1
7,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00072571,0.2968,0.35109,1,1
7,GO REGULATION OF RESPONSE TO FOOD,0.0010209,0.29648,0.34986,1,1
7,GO RESPONSE TO NERVE GROWTH FACTOR,0.00091199,0.29648,0.28457,1,1
7,GO HISTONE H3 K9 TRIMETHYLATION,0.00033648,0.2962,0.34272,1,1
7,GO PRESYNAPTIC ENDOCYTOSIS,0.00026348,0.29597,0.39057,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00086166,0.29568,0.29616,1,1
7,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00019306,0.29563,0.33891,1,1
7,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.010572,0.29552,0.29587,1,1
7,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.0029965,0.29544,0.27334,1,1
7,GO NUCLEUS LOCALIZATION,0.00076864,0.29535,0.42559,1,1
7,GO HOMOLOGOUS RECOMBINATION,0.0080134,0.29451,0.24839,1,1
7,GO REGULATION OF CHOLESTEROL EFFLUX,0.0063209,0.29441,0.28751,1,1
7,GO NEURON PROJECTION EXTENSION,0.00054254,0.29439,0.3339,1,1
7,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0066311,0.29434,0.29352,1,1
7,GO PEPTIDYL ARGININE METHYLATION,0.00057531,0.29422,0.29336,1,1
7,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0010798,0.29413,0.33779,1,1
7,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0010209,0.29411,0.30432,1,1
7,GO FAT CELL PROLIFERATION,0.0015041,0.29392,0.29773,1,1
7,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.021265,0.29383,0.26592,1,1
7,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.0024341,0.29364,0.34081,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0063209,0.2936,0.34743,1,1
7,GO REFLEX,0.010101,0.29338,0.32794,1,1
7,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0040644,0.29327,0.38297,1,1
7,GO GENETIC IMPRINTING,0.0031545,0.2931,0.30731,1,1
7,GO REGULATION OF AMINO ACID TRANSPORT,0.00060992,0.29302,0.31673,1,1
7,GO MECHANORECEPTOR DIFFERENTIATION,0.00031664,0.293,0.33278,1,1
7,GO SYNAPTIC VESICLE TRANSPORT,0.00051151,0.29257,0.32639,1,1
7,GO REGULATION OF TELOMERE CAPPING,0.0003797,0.29226,0.31096,1,1
7,GO NOTCH RECEPTOR PROCESSING,0.0034935,0.2921,0.35887,1,1
7,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0012071,0.29206,0.31263,1,1
7,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.014457,0.29158,0.31337,1,1
7,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0024341,0.29142,0.33456,1,1
7,GO NEUROMUSCULAR PROCESS,0.0018673,0.29141,0.29848,1,1
7,GO SMOOTHENED SIGNALING PATHWAY,0.0012758,0.2914,0.26633,1,1
7,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0076456,0.29136,0.31081,1,1
7,GO POTASSIUM ION TRANSPORT,0.00018128,0.29097,0.34043,1,1
7,GO SCHWANN CELL DEVELOPMENT,0.018736,0.29085,0.25142,1,1
7,GO CELL PROJECTION ASSEMBLY,0.00014062,0.29032,0.29348,1,1
7,GO CYTOPLASM ORGANIZATION,0.0025648,0.28991,0.31774,1,1
7,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028457,0.28976,0.34341,1,1
7,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0054671,0.28973,0.35291,1,1
7,GO NEURAL RETINA DEVELOPMENT,0.0080134,0.2897,0.23354,1,1
7,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0024341,0.28964,0.3023,1,1
7,GO HISTONE H3 K9 MODIFICATION,0.00081392,0.28919,0.31343,1,1
7,GO NEURON PROJECTION GUIDANCE,0.0024341,0.2889,0.29415,1,1
7,GO AXO DENDRITIC TRANSPORT,0.00051151,0.28878,0.32875,1,1
7,GO HISTONE METHYLATION,0.00045436,0.2886,0.30747,1,1
7,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0017696,0.28847,0.35509,1,1
7,GO NOREPINEPHRINE SECRETION,0.017954,0.28839,0.29583,1,1
7,GO SUCKLING BEHAVIOR,0.027226,0.28798,0.2295,1,1
7,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00045436,0.28789,0.31389,1,1
7,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0021907,0.28785,0.30461,1,1
7,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00072571,0.28773,0.33004,1,1
7,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.027226,0.28765,0.23657,1,1
7,GO DIVALENT METAL ION EXPORT,0.011063,0.28761,0.27422,1,1
7,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0029965,0.28754,0.30389,1,1
7,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0080134,0.28751,0.32069,1,1
7,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00048214,0.28704,0.28416,1,1
7,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0034935,0.28692,0.33462,1,1
7,GO CELLULAR COMPONENT MAINTENANCE,0.0003797,0.28674,0.31371,1,1
7,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.011574,0.28666,0.26272,1,1
7,GO CELL PART MORPHOGENESIS,0.00081392,0.28643,0.2897,1,1
7,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0016767,0.28616,0.42141,1,1
7,GO MYOTUBE CELL DEVELOPMENT,0.0010798,0.28613,0.25999,1,1
7,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00332,0.28605,0.28844,1,1
7,GO LOCOMOTORY BEHAVIOR,0.0014241,0.28585,0.30379,1,1
7,GO RESPONSE TO PAIN,0.0028457,0.28577,0.33492,1,1
7,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0034935,0.28554,0.30122,1,1
7,GO DOPAMINE TRANSPORT,0.00040321,0.28554,0.43445,1,1
7,GO REGULATION OF DENDRITE DEVELOPMENT,0.0012758,0.2855,0.29569,1,1
7,GO NOREPINEPHRINE TRANSPORT,0.018736,0.28544,0.30621,1,1
7,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00024771,0.28544,0.39332,1,1
7,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0025648,0.28514,0.28382,1,1
7,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00048214,0.28512,0.29772,1,1
7,GO POSITIVE REGULATION OF AXONOGENESIS,0.0014241,0.2851,0.32311,1,1
7,GO REGULATION OF CHROMATIN ASSEMBLY,0.0018673,0.28507,0.29444,1,1
7,GO TRANSPORT ALONG MICROTUBULE,0.00024771,0.28484,0.2944,1,1
7,GO AMMONIUM ION METABOLIC PROCESS,0.0096484,0.28454,0.29028,1,1
7,GO CELLULAR COMPONENT MORPHOGENESIS,0.00072571,0.28389,0.28755,1,1
7,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0013481,0.28372,0.30195,1,1
7,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0066311,0.28359,0.2976,1,1
7,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00068502,0.28349,0.34199,1,1
7,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.010572,0.28338,0.29939,1,1
7,GO AZOLE TRANSMEMBRANE TRANSPORT,0.011063,0.28338,0.28704,1,1
7,GO DENDRITE DEVELOPMENT,0.0021907,0.28332,0.28643,1,1
7,GO ADULT LOCOMOTORY BEHAVIOR,0.0015041,0.28312,0.28199,1,1
7,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.010101,0.28303,0.20871,1,1
7,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0049572,0.28302,0.31416,1,1
7,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.00086166,0.28245,0.29751,1,1
7,GO NEGATIVE CHEMOTAXIS,0.0020776,0.2824,0.35384,1,1
7,GO PEPTIDYL LYSINE METHYLATION,0.00051151,0.28238,0.31524,1,1
7,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00091199,0.28238,0.28224,1,1
7,GO HISTONE H4 K5 ACETYLATION,0.00042807,0.28208,0.3061,1,1
7,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0057394,0.28154,0.27197,1,1
7,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0015882,0.28153,0.30059,1,1
7,GO SULFATION,0.016475,0.28139,0.24886,1,1
7,GO MEMBRANE DOCKING,0.00020554,0.28133,0.28026,1,1
7,GO PROTEIN O LINKED GLYCOSYLATION,0.00029789,0.2813,0.30639,1,1
7,GO LONG TERM MEMORY,0.020391,0.28126,0.28163,1,1
7,GO POSTSYNAPSE ORGANIZATION,0.0018673,0.28126,0.29578,1,1
7,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00024771,0.28098,0.34358,1,1
7,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0021907,0.28085,0.26603,1,1
7,GO CELL JUNCTION ASSEMBLY,0.00060992,0.28082,0.31244,1,1
7,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.021265,0.2804,0.20739,1,1
7,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.027226,0.28011,0.24847,1,1
7,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0063209,0.28002,0.24037,1,1
7,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0054671,0.27988,0.32669,1,1
7,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.0016767,0.27983,0.30602,1,1
7,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.023112,0.27983,0.28051,1,1
7,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.018736,0.27973,0.30159,1,1
7,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00091199,0.27964,0.26911,1,1
7,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.008797,0.27925,0.31813,1,1
7,GO NEURON PROJECTION ARBORIZATION,0.008797,0.27923,0.28722,1,1
7,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0012758,0.27868,0.32254,1,1
7,GO BODY MORPHOGENESIS,0.0020776,0.27866,0.30287,1,1
7,GO REGULATION OF GONAD DEVELOPMENT,0.0044907,0.27864,0.25632,1,1
7,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0012758,0.27857,0.29435,1,1
7,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0060238,0.27825,0.22199,1,1
7,GO REGULATION OF TUBULIN DEACETYLATION,0.00057531,0.27797,0.37755,1,1
7,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00060992,0.27782,0.36919,1,1
7,GO MONOAMINE TRANSPORT,0.00068502,0.27778,0.34354,1,1
7,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00014062,0.27763,0.35079,1,1
7,GO OXIDATIVE DEMETHYLATION,0.00051151,0.27741,0.35638,1,1
7,GO CGMP METABOLIC PROCESS,0.0011418,0.27663,0.36487,1,1
7,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0016767,0.27639,0.31497,1,1
7,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0024341,0.27639,0.37198,1,1
7,GO REGULATION OF HIPPO SIGNALING,0.0012071,0.27612,0.32667,1,1
7,GO MEMORY,0.0017696,0.27595,0.30324,1,1
7,GO AMINE TRANSPORT,0.00057531,0.27593,0.32783,1,1
7,GO OOCYTE MATURATION,0.00054254,0.2759,0.27575,1,1
7,GO TRANSMISSION OF NERVE IMPULSE,0.0054671,0.27571,0.31275,1,1
7,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0015882,0.27566,0.27909,1,1
7,GO BEHAVIOR,0.0017696,0.27497,0.27123,1,1
7,GO DENDRITIC SPINE MORPHOGENESIS,0.0027019,0.27488,0.32711,1,1
7,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0036751,0.27466,0.24621,1,1
7,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0029965,0.27441,0.28992,1,1
7,GO REGULATION OF MRNA PROCESSING,0.00096503,0.27435,0.25974,1,1
7,GO DENDRITE SELF AVOIDANCE,0.035953,0.27339,0.26517,1,1
7,GO EXTRACELLULAR MATRIX ASSEMBLY,0.018736,0.27325,0.32731,1,1
7,GO AXONAL TRANSPORT,0.0010798,0.27295,0.31192,1,1
7,GO AXON DEVELOPMENT,0.0015882,0.2728,0.27897,1,1
7,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00057531,0.27274,0.43334,1,1
7,GO MAINTENANCE OF ORGANELLE LOCATION,0.0018673,0.27258,0.2897,1,1
7,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.022172,0.27248,0.2505,1,1
7,GO SECONDARY METABOLIC PROCESS,0.00054254,0.27232,0.26904,1,1
7,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00076864,0.27201,0.28711,1,1
7,GO NEUROTRANSMITTER REUPTAKE,0.0017696,0.27193,0.30871,1,1
7,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0017696,0.27175,0.28366,1,1
7,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0057394,0.27175,0.26776,1,1
7,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00019306,0.27171,0.29502,1,1
7,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0038653,0.27158,0.28991,1,1
7,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00023283,0.27157,0.32569,1,1
7,GO LYMPHANGIOGENESIS,0.018736,0.2713,0.3007,1,1
7,GO DEFINITIVE HEMOPOIESIS,0.011574,0.27111,0.30453,1,1
7,GO VISUAL BEHAVIOR,0.00010181,0.27105,0.33037,1,1
7,GO SODIUM ION TRANSPORT,0.00020554,0.27101,0.34366,1,1
7,GO HYALURONAN BIOSYNTHETIC PROCESS,0.028348,0.27088,0.30576,1,1
7,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.013834,0.27083,0.26468,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0027019,0.27018,0.3213,1,1
7,GO CELLULAR RESPONSE TO VITAMIN D,0.028348,0.27001,0.23356,1,1
7,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0011418,0.2699,0.25496,1,1
7,GO HINDBRAIN DEVELOPMENT,0.0015882,0.26966,0.25068,1,1
7,GO REGULATION OF EXTENT OF CELL GROWTH,0.0042727,0.26964,0.30023,1,1
7,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.019548,0.26931,0.24556,1,1
7,GO CATECHOLAMINE UPTAKE,0.00332,0.26925,0.35106,1,1
7,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0096484,0.26921,0.24381,1,1
7,GO CATECHOLAMINE SECRETION,0.00021879,0.26877,0.40771,1,1
7,GO HISTONE H3 DEACETYLATION,0.0003797,0.26874,0.31338,1,1
7,GO OOGENESIS,8.3641e-05,0.26867,0.27149,1,1
7,GO REGULATION OF LYASE ACTIVITY,0.0057394,0.26858,0.22991,1,1
7,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0052065,0.26818,0.22775,1,1
7,GO OOCYTE DIFFERENTIATION,4.8997e-05,0.26802,0.30256,1,1
7,GO REGULATION OF MRNA POLYADENYLATION,0.0003797,0.26786,0.32971,1,1
7,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0031545,0.26783,0.33775,1,1
7,GO NEURONAL ACTION POTENTIAL,0.00332,0.26767,0.38473,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.007293,0.26761,0.34283,1,1
7,GO DNA DOUBLE STRAND BREAK PROCESSING,0.034576,0.26754,0.19943,1,1
7,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.048745,0.26727,0.21208,1,1
7,GO REGULATION OF VESICLE FUSION,0.0054671,0.26716,0.32441,1,1
7,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0083971,0.26703,0.24361,1,1
7,GO PARTURITION,0.00060992,0.26688,0.30865,1,1
7,GO REGULATION OF HEART RATE,0.0040644,0.26683,0.28548,1,1
7,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.00332,0.26675,0.2424,1,1
7,GO POSITIVE REGULATION OF AXON EXTENSION,0.0027019,0.26665,0.30214,1,1
7,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00076864,0.26648,0.3074,1,1
7,GO SOMITE DEVELOPMENT,0.00060992,0.26639,0.2716,1,1
7,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0028457,0.26631,0.26576,1,1
7,GO PHOTORECEPTOR CELL MAINTENANCE,0.00020554,0.26617,0.32017,1,1
7,GO EMBRYONIC BRAIN DEVELOPMENT,0.035953,0.2659,0.21406,1,1
7,GO HEAD MORPHOGENESIS,0.0080134,0.26586,0.3075,1,1
7,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.024086,0.2656,0.20053,1,1
7,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0076456,0.26549,0.32012,1,1
7,GO REGULATION OF CYCLASE ACTIVITY,0.0057394,0.26528,0.239,1,1
7,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0040644,0.26512,0.28001,1,1
7,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00012367,0.26506,0.34962,1,1
7,GO TELOMERE CAPPING,0.00035748,0.26501,0.28933,1,1
7,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0003797,0.26498,0.25213,1,1
7,GO ALANINE TRANSPORT,0.02951,0.26493,0.27423,1,1
7,GO RESPONSE TO REDOX STATE,0.0021907,0.26486,0.32236,1,1
7,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.013235,0.26484,0.23495,1,1
7,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00086166,0.26464,0.29096,1,1
7,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0016767,0.26457,0.36709,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0172,0.26448,0.32431,1,1
7,GO NEURON DEVELOPMENT,0.00081392,0.26446,0.28557,1,1
7,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.010572,0.26444,0.26921,1,1
7,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00042807,0.26433,0.28715,1,1
7,GO THYROID GLAND DEVELOPMENT,0.0080134,0.26414,0.23899,1,1
7,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.01266,0.26409,0.25135,1,1
7,GO BASE EXCISION REPAIR AP SITE FORMATION,0.00048214,0.26399,0.26065,1,1
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00332,0.26385,0.32312,1,1
7,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0013481,0.26382,0.32293,1,1
7,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0057394,0.26376,0.24043,1,1
7,GO MEIOSIS I CELL CYCLE PROCESS,0.0092139,0.26339,0.22514,1,1
7,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0015882,0.26339,0.27436,1,1
7,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0013481,0.2633,0.29284,1,1
7,GO NEURON MIGRATION,0.007293,0.26304,0.25415,1,1
7,GO REGULATION OF RNA SPLICING,0.00040321,0.26296,0.26233,1,1
7,GO DEVELOPMENTAL CELL GROWTH,0.0012758,0.26295,0.29382,1,1
7,GO METHIONINE BIOSYNTHETIC PROCESS,0.0042727,0.26264,0.22007,1,1
7,GO OLIGODENDROCYTE DEVELOPMENT,0.00048214,0.26264,0.27333,1,1
7,GO CARDIAC CONDUCTION,0.0012758,0.26261,0.32281,1,1
7,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0015882,0.26254,0.29446,1,1
7,GO REGULATION OF BLOOD CIRCULATION,0.0018673,0.26254,0.27235,1,1
7,GO HISTONE H3 K9 METHYLATION,0.00091199,0.26238,0.33385,1,1
7,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0042727,0.26233,0.32039,1,1
7,GO PROTEIN METHYLATION,0.00057531,0.2619,0.28613,1,1
7,GO RENAL WATER HOMEOSTASIS,0.0014241,0.26175,0.31794,1,1
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0018673,0.26168,0.32789,1,1
7,GO PROTEIN O LINKED MANNOSYLATION,0.00072571,0.26155,0.27398,1,1
7,GO CELL JUNCTION ORGANIZATION,0.0012758,0.26133,0.29764,1,1
7,GO NUCLEAR MIGRATION,0.0011418,0.26116,0.40962,1,1
7,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00033648,0.26112,0.3122,1,1
7,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.018736,0.26112,0.28633,1,1
7,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00017019,0.26093,0.30628,1,1
7,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0013481,0.26086,0.2995,1,1
7,GO DEVELOPMENTAL MATURATION,0.00076864,0.26076,0.27432,1,1
7,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0092139,0.26057,0.29518,1,1
7,GO THALAMUS DEVELOPMENT,0.008797,0.26054,0.26768,1,1
7,GO ADHERENS JUNCTION ASSEMBLY,0.0015041,0.26054,0.3345,1,1
7,GO RESPONSE TO INACTIVITY,0.019548,0.25973,0.23225,1,1
7,GO REGULATION OF SYNAPTIC PLASTICITY,0.0010798,0.2597,0.3492,1,1
7,GO CLATHRIN COAT ASSEMBLY,0.00060992,0.25966,0.34626,1,1
7,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00045436,0.25956,0.28418,1,1
7,GO SOMITOGENESIS,0.0021907,0.25945,0.25629,1,1
7,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0034935,0.25945,0.31187,1,1
7,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0011418,0.25924,0.30912,1,1
7,GO PROTEIN KINASE A SIGNALING,0.0047188,0.25893,0.23326,1,1
7,GO PROTEIN AUTO ADP RIBOSYLATION,0.016475,0.25892,0.2326,1,1
7,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00040321,0.25886,0.33567,1,1
7,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00072571,0.2588,0.27358,1,1
7,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0015882,0.25831,0.32955,1,1
7,GO HISTONE DEUBIQUITINATION,0.0029965,0.25829,0.28394,1,1
7,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045436,0.25823,0.37149,1,1
7,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00076864,0.25797,0.26247,1,1
7,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00068502,0.25782,0.28648,1,1
7,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0021907,0.25754,0.29037,1,1
7,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0020776,0.25733,0.36828,1,1
7,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0049572,0.25713,0.25882,1,1
7,GO LENS FIBER CELL DEVELOPMENT,0.0036751,0.25701,0.26701,1,1
7,GO GLOMERULUS DEVELOPMENT,0.019548,0.25687,0.2943,1,1
7,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00091199,0.25683,0.31511,1,1
7,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00086166,0.2568,0.254,1,1
7,GO DIET INDUCED THERMOGENESIS,0.013834,0.25678,0.25546,1,1
7,GO SUBPALLIUM DEVELOPMENT,0.027226,0.25676,0.24161,1,1
7,GO RESPONSE TO LEAD ION,0.00048214,0.25644,0.28976,1,1
7,GO CAMERA TYPE EYE MORPHOGENESIS,0.0015041,0.25641,0.27119,1,1
7,GO PROTEIN HETEROTETRAMERIZATION,0.0019699,0.25623,0.2376,1,1
7,GO NEURON DIFFERENTIATION,0.00096503,0.2561,0.26855,1,1
7,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0172,0.25609,0.23399,1,1
7,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00096503,0.25595,0.27693,1,1
7,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0028457,0.25572,0.27944,1,1
7,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0028457,0.25568,0.29766,1,1
7,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0012071,0.25568,0.32888,1,1
7,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0014241,0.25566,0.27697,1,1
7,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00072571,0.25528,0.38108,1,1
7,GO LEFT RIGHT PATTERN FORMATION,0.0012071,0.25523,0.3025,1,1
7,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0019699,0.25512,0.32677,1,1
7,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0092139,0.25496,0.34392,1,1
7,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0025648,0.25479,0.37019,1,1
7,GO PRESYNAPSE ORGANIZATION,0.0011418,0.25448,0.3584,1,1
7,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0010798,0.25423,0.26574,1,1
7,GO STRIATUM DEVELOPMENT,0.011063,0.25416,0.26875,1,1
7,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00017019,0.25392,0.32132,1,1
7,GO BASEMENT MEMBRANE ORGANIZATION,0.0063209,0.25385,0.32663,1,1
7,GO OLIGOPEPTIDE TRANSPORT,0.0038653,0.2537,0.2735,1,1
7,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.034576,0.25365,0.23214,1,1
7,GO REGULATION OF ACTION POTENTIAL,0.0025648,0.25349,0.33098,1,1
7,GO EXPORT ACROSS PLASMA MEMBRANE,0.0010209,0.25334,0.3111,1,1
7,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.008797,0.25326,0.28705,1,1
7,GO CARDIAC MUSCLE CELL CONTRACTION,0.0060238,0.25306,0.30614,1,1
7,GO POLYOL CATABOLIC PROCESS,0.00054254,0.25286,0.29672,1,1
7,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0044907,0.25276,0.24754,1,1
7,GO REGULATION OF HISTONE DEACETYLATION,0.0013481,0.2526,0.27114,1,1
7,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0029965,0.25245,0.24843,1,1
7,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.0054671,0.25244,0.24792,1,1
7,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0015041,0.25237,0.30134,1,1
7,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.034576,0.25224,0.20883,1,1
7,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00018128,0.25167,0.34932,1,1
7,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.013834,0.25164,0.29232,1,1
7,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0020776,0.25156,0.30075,1,1
7,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0083971,0.25129,0.23913,1,1
7,GO REGULATION OF AXONOGENESIS,0.0044907,0.2512,0.29603,1,1
7,GO HINDLIMB MORPHOGENESIS,0.0052065,0.25119,0.25865,1,1
7,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0083971,0.25116,0.30751,1,1
7,GO REGULATION OF METANEPHROS DEVELOPMENT,0.031957,0.25109,0.25918,1,1
7,GO TOXIN METABOLIC PROCESS,0.018736,0.25097,0.22181,1,1
7,GO PROTEIN KINASE C SIGNALING,0.014457,0.25082,0.28676,1,1
7,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00068502,0.25062,0.3472,1,1
7,GO SPINAL CORD DEVELOPMENT,0.0057394,0.25043,0.2658,1,1
7,GO BONE MATURATION,0.0083971,0.2504,0.26578,1,1
7,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0096484,0.25038,0.25821,1,1
7,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0076456,0.25019,0.31713,1,1
7,GO SKELETAL MUSCLE ADAPTATION,0.0080134,0.25015,0.30055,1,1
7,GO CARNITINE SHUTTLE,0.0057394,0.25013,0.27685,1,1
7,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00332,0.25004,0.2558,1,1
7,GO MITOTIC RECOMBINATION,0.0052065,0.24995,0.26533,1,1
7,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.026142,0.24992,0.19628,1,1
7,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00042807,0.2498,0.26727,1,1
7,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00076864,0.24965,0.37841,1,1
7,GO MAINTENANCE OF CELL POLARITY,0.011574,0.24953,0.25265,1,1
7,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0049572,0.24945,0.26113,1,1
7,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.006955,0.24932,0.28845,1,1
7,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0013481,0.24907,0.28973,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010101,0.24905,0.26689,1,1
7,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.024086,0.2489,0.2413,1,1
7,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0012071,0.24888,0.25231,1,1
7,GO HISTONE H3 K4 METHYLATION,0.0018673,0.24875,0.27453,1,1
7,GO MELANOCYTE DIFFERENTIATION,0.0042727,0.24854,0.26422,1,1
7,GO LEFT RIGHT AXIS SPECIFICATION,0.045233,0.24803,0.20404,1,1
7,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0066311,0.2479,0.27669,1,1
7,GO SENSORY PERCEPTION OF SMELL,0.0057394,0.24776,0.20637,1,1
7,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0023095,0.24751,0.2939,1,1
7,GO AMINE BIOSYNTHETIC PROCESS,0.0013481,0.24741,0.25551,1,1
7,GO CELL VOLUME HOMEOSTASIS,0.00068502,0.2474,0.301,1,1
7,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0076456,0.24712,0.24239,1,1
7,GO CRISTAE FORMATION,0.00068502,0.24688,0.23641,1,1
7,GO NEURAL TUBE PATTERNING,0.01266,0.24653,0.23676,1,1
7,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0063209,0.24646,0.2815,1,1
7,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.007293,0.24642,0.30448,1,1
7,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014062,0.24642,0.32341,1,1
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0015882,0.24622,0.26116,1,1
7,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0092139,0.24617,0.31495,1,1
7,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.02951,0.24606,0.23858,1,1
7,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0013481,0.246,0.31902,1,1
7,GO PROTEIN MANNOSYLATION,0.00020554,0.24586,0.28998,1,1
7,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0014241,0.24573,0.33408,1,1
7,GO NEGATIVE REGULATION OF BEHAVIOR,0.038848,0.24573,0.16345,1,1
7,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0018673,0.2457,0.27365,1,1
7,GO REGULATION OF HORMONE SECRETION,0.00057531,0.24568,0.25508,1,1
7,GO EYE MORPHOGENESIS,0.0012758,0.24563,0.26761,1,1
7,GO POTASSIUM ION HOMEOSTASIS,0.00033648,0.24535,0.3072,1,1
7,GO ACROSOME ASSEMBLY,0.019548,0.24528,0.22392,1,1
7,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.024086,0.24521,0.25335,1,1
7,GO HISTONE H4 ACETYLATION,0.00054254,0.24509,0.27812,1,1
7,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0060238,0.24506,0.28075,1,1
7,GO REGULATION OF CELL SIZE,0.0018673,0.245,0.28005,1,1
7,GO LOCALIZATION WITHIN MEMBRANE,0.013834,0.245,0.26172,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0018673,0.2447,0.27477,1,1
7,GO PHOTOPERIODISM,0.00076864,0.24438,0.26619,1,1
7,GO PROTEIN DEPOLYMERIZATION,0.0024341,0.24431,0.27715,1,1
7,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00332,0.24411,0.23329,1,1
7,GO REGULATION OF MITOPHAGY,0.00048214,0.24398,0.37808,1,1
7,GO REGULATION OF GLUCONEOGENESIS,0.00017019,0.24393,0.32633,1,1
7,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.021265,0.24355,0.2472,1,1
7,GO HISTONE H4 K16 ACETYLATION,0.0029965,0.24351,0.26626,1,1
7,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00031664,0.24334,0.31047,1,1
7,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.0021907,0.24328,0.2436,1,1
7,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.015104,0.24313,0.29463,1,1
7,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0042727,0.2431,0.25698,1,1
7,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0034935,0.24307,0.26999,1,1
7,GO SPERMATID DIFFERENTIATION,6.4139e-05,0.24302,0.28615,1,1
7,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.00040321,0.24294,0.31437,1,1
7,GO RESPONSE TO ALKALOID,0.0014241,0.24292,0.23449,1,1
7,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00040321,0.24291,0.30417,1,1
7,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01266,0.24266,0.24657,1,1
7,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0019699,0.24257,0.31408,1,1
7,GO EXPLORATION BEHAVIOR,0.016475,0.24228,0.26959,1,1
7,GO LENS FIBER CELL DIFFERENTIATION,0.0036751,0.24228,0.24131,1,1
7,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.015104,0.24211,0.27148,1,1
7,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0014241,0.24206,0.29834,1,1
7,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0016767,0.24203,0.28053,1,1
7,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00024771,0.24188,0.24134,1,1
7,GO HISTONE DEACETYLATION,0.00096503,0.24174,0.27625,1,1
7,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0011418,0.24168,0.27866,1,1
7,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0018673,0.24161,0.28753,1,1
7,GO ACTION POTENTIAL,0.0018673,0.24156,0.3287,1,1
7,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0038653,0.24156,0.25131,1,1
7,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00076864,0.2414,0.34801,1,1
7,GO GLYCEROLIPID CATABOLIC PROCESS,0.0015882,0.24122,0.25409,1,1
7,GO EMBRYONIC AXIS SPECIFICATION,0.0018673,0.24106,0.23032,1,1
7,GO METANEPHROS MORPHOGENESIS,0.0047188,0.24099,0.2566,1,1
7,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0012071,0.24085,0.37184,1,1
7,GO PEPTIDYL LYSINE MODIFICATION,0.00068502,0.24067,0.24837,1,1
7,GO PROTEIN HETEROOLIGOMERIZATION,0.00081392,0.24066,0.2723,1,1
7,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0036751,0.24064,0.27506,1,1
7,GO MITOPHAGY,0.00051151,0.24062,0.30415,1,1
7,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0038653,0.2403,0.2538,1,1
7,GO CATECHOLAMINE METABOLIC PROCESS,0.0012071,0.24027,0.29021,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.007293,0.24026,0.29194,1,1
7,GO TOOTH MINERALIZATION,0.0076456,0.24015,0.30869,1,1
7,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00014062,0.24014,0.25307,1,1
7,GO LIPID DROPLET ORGANIZATION,0.00019306,0.24008,0.24666,1,1
7,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0034935,0.24004,0.25007,1,1
7,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00091199,0.23993,0.28683,1,1
7,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00086166,0.23965,0.25327,1,1
7,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0080134,0.23958,0.26151,1,1
7,GO HEART FIELD SPECIFICATION,0.013235,0.23958,0.25522,1,1
7,GO DIOL BIOSYNTHETIC PROCESS,0.0015041,0.23949,0.25082,1,1
7,GO SENSORY SYSTEM DEVELOPMENT,0.0012758,0.23943,0.25194,1,1
7,GO CHLORIDE TRANSPORT,0.0040644,0.23937,0.28544,1,1
7,GO SEXUAL REPRODUCTION,0.00015974,0.23936,0.24262,1,1
7,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.013235,0.23926,0.22404,1,1
7,GO MEIOTIC SPINDLE ORGANIZATION,0.0083971,0.23923,0.27703,1,1
7,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,8.3641e-05,0.23904,0.33287,1,1
7,GO NEUROTRANSMITTER UPTAKE,0.0031545,0.23891,0.24839,1,1
7,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0066311,0.23886,0.26191,1,1
7,GO LONG TERM SYNAPTIC POTENTIATION,0.0092139,0.23884,0.29395,1,1
7,GO MALE MEIOTIC NUCLEAR DIVISION,0.019548,0.23884,0.21297,1,1
7,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018736,0.23877,0.25445,1,1
7,GO COGNITION,0.0023095,0.23864,0.26588,1,1
7,GO DOPAMINE METABOLIC PROCESS,0.0076456,0.23854,0.27276,1,1
7,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0076456,0.23839,0.20844,1,1
7,GO PEPTIDYL LYSINE DIMETHYLATION,0.0044907,0.23835,0.28288,1,1
7,GO REGULATION OF TORC1 SIGNALING,0.0012071,0.23818,0.29469,1,1
7,GO MEIOTIC CELL CYCLE,0.0036751,0.23817,0.2219,1,1
7,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.015776,0.2381,0.30198,1,1
7,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00015974,0.23803,0.39552,1,1
7,GO MITOCHONDRION DISTRIBUTION,0.0013481,0.2378,0.31819,1,1
7,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0012071,0.23779,0.28135,1,1
7,GO MANGANESE ION TRANSPORT,0.0063209,0.23778,0.2256,1,1
7,GO REGULATION OF TUBE SIZE,0.0038653,0.23777,0.22271,1,1
7,GO NEURON PROJECTION ORGANIZATION,0.0044907,0.23767,0.28778,1,1
7,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0021907,0.23766,0.29538,1,1
7,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.015104,0.23751,0.19387,1,1
7,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,8.9327e-05,0.23747,0.24078,1,1
7,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0080134,0.23744,0.31665,1,1
7,GO G0 TO G1 TRANSITION,0.011063,0.23737,0.23836,1,1
7,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00068502,0.2373,0.3067,1,1
7,GO REGULATION OF PROTEIN DEACETYLATION,0.00086166,0.23721,0.28465,1,1
7,GO ORGANELLE LOCALIZATION,0.00021879,0.23699,0.24793,1,1
7,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00045436,0.23693,0.34586,1,1
7,GO GOLGI TO VACUOLE TRANSPORT,0.00086166,0.23687,0.33779,1,1
7,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0092139,0.23687,0.25503,1,1
7,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0019699,0.23683,0.2896,1,1
7,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.010572,0.23681,0.27986,1,1
7,GO HISTONE H2A MONOUBIQUITINATION,0.0013481,0.23676,0.30299,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0047188,0.23673,0.27207,1,1
7,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00029789,0.23671,0.27189,1,1
7,GO STRIATED MUSCLE ADAPTATION,0.0012071,0.23651,0.32682,1,1
7,GO CHROMATIN REMODELING,0.0012758,0.23647,0.24472,1,1
7,GO MIRNA METABOLIC PROCESS,0.0010798,0.23645,0.26495,1,1
7,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0016767,0.23635,0.32489,1,1
7,GO HISTONE H3 K9 ACETYLATION,0.0057394,0.23632,0.23165,1,1
7,GO TORC1 SIGNALING,0.0011418,0.23627,0.30463,1,1
7,GO REGULATION OF HISTONE H4 ACETYLATION,0.00064645,0.23623,0.2303,1,1
7,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0012758,0.23597,0.34426,1,1
7,GO SINGLE STRAND BREAK REPAIR,0.00040321,0.23589,0.31662,1,1
7,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0063209,0.23544,0.28131,1,1
7,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0083971,0.2354,0.23846,1,1
7,GO REGULATION OF NEURON DIFFERENTIATION,0.0027019,0.2353,0.25336,1,1
7,GO LUNG ALVEOLUS DEVELOPMENT,0.0020776,0.23526,0.33356,1,1
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0027019,0.2351,0.26791,1,1
7,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.033245,0.23507,0.17716,1,1
7,GO NERVOUS SYSTEM PROCESS,0.00051151,0.23507,0.26015,1,1
7,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0042727,0.23504,0.33506,1,1
7,GO PEPTIDYL LYSINE ACETYLATION,0.00057531,0.23487,0.25789,1,1
7,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00042807,0.23439,0.28439,1,1
7,GO MACROMOLECULE DEACYLATION,0.00068502,0.23419,0.26915,1,1
7,GO METHYLATION,0.00054254,0.23415,0.22754,1,1
7,GO MALE GAMETE GENERATION,0.00020554,0.2341,0.2422,1,1
7,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0052065,0.23409,0.27913,1,1
7,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0012071,0.23365,0.28372,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0063209,0.23356,0.30494,1,1
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0010798,0.23351,0.29611,1,1
7,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.010572,0.23327,0.21522,1,1
7,GO PHOSPHOLIPID CATABOLIC PROCESS,0.014457,0.23327,0.2349,1,1
7,GO ERYTHROCYTE MATURATION,0.0027019,0.2332,0.30415,1,1
7,GO HEAD DEVELOPMENT,0.00086166,0.23318,0.24566,1,1
7,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00091199,0.23296,0.2757,1,1
7,GO REGULATION OF GOLGI ORGANIZATION,0.0042727,0.23281,0.31444,1,1
7,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015882,0.2326,0.2898,1,1
7,GO CAMERA TYPE EYE DEVELOPMENT,0.0018673,0.23249,0.24491,1,1
7,GO PEPTIDE HORMONE SECRETION,0.00040321,0.23247,0.28613,1,1
7,GO SPHINGOMYELIN METABOLIC PROCESS,0.0025648,0.23247,0.2574,1,1
7,GO METENCEPHALON DEVELOPMENT,0.0023095,0.23231,0.26388,1,1
7,GO NEURAL NUCLEUS DEVELOPMENT,0.00026348,0.23227,0.29497,1,1
7,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0027019,0.23215,0.23117,1,1
7,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00081392,0.23208,0.28713,1,1
7,GO NEUROGENESIS,0.0010798,0.23203,0.25457,1,1
7,GO CENTRIOLE ASSEMBLY,0.013834,0.23187,0.23781,1,1
7,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0015041,0.23185,0.2662,1,1
7,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0013481,0.23182,0.27455,1,1
7,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.010572,0.23177,0.22437,1,1
7,GO MICROTUBULE NUCLEATION,0.0063209,0.23159,0.27854,1,1
7,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.0038653,0.23129,0.24497,1,1
7,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0015882,0.23122,0.27194,1,1
7,GO INSULIN SECRETION,0.00048214,0.23118,0.28129,1,1
7,GO GAMETE GENERATION,0.00012367,0.2311,0.24792,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0034935,0.23085,0.29148,1,1
7,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0024341,0.23076,0.27749,1,1
7,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.02951,0.23072,0.24967,1,1
7,GO CARDIAC SEPTUM MORPHOGENESIS,0.022172,0.23068,0.21423,1,1
7,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.017954,0.23059,0.28164,1,1
7,GO DENDRITIC SPINE DEVELOPMENT,0.0042727,0.23053,0.28514,1,1
7,GO RESPONSE TO DOPAMINE,0.0021907,0.23047,0.22853,1,1
7,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00031664,0.2304,0.31499,1,1
7,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00064645,0.23039,0.27581,1,1
7,GO HYPEROSMOTIC RESPONSE,0.010572,0.23037,0.27519,1,1
7,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.016475,0.23024,0.27442,1,1
7,GO MEGAKARYOCYTE DEVELOPMENT,0.0019699,0.23022,0.31007,1,1
7,GO BRONCHUS DEVELOPMENT,0.013834,0.23014,0.33197,1,1
7,GO HISTONE H4 DEACETYLATION,0.0057394,0.23012,0.20729,1,1
7,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.013834,0.23011,0.22268,1,1
7,GO LYMPH VESSEL MORPHOGENESIS,0.014457,0.23004,0.30501,1,1
7,GO RNA POLYADENYLATION,0.00048214,0.22998,0.28426,1,1
7,GO HEART PROCESS,0.0031545,0.22997,0.25562,1,1
7,GO GLUCOCORTICOID METABOLIC PROCESS,0.007293,0.2299,0.24244,1,1
7,GO ORGANELLE ASSEMBLY,8.3641e-05,0.22968,0.25964,1,1
7,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.030713,0.22964,0.22065,1,1
7,GO ESTROUS CYCLE,0.011574,0.22946,0.26408,1,1
7,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.017954,0.22938,0.27163,1,1
7,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00026348,0.22927,0.29306,1,1
7,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.046961,0.22918,0.2026,1,1
7,GO CORNIFICATION,0.035953,0.22911,0.16069,1,1
7,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0029965,0.22899,0.2183,1,1
7,GO PHOTOTRANSDUCTION VISIBLE LIGHT,5.6086e-05,0.22895,0.23585,1,1
7,GO COVALENT CHROMATIN MODIFICATION,0.0010798,0.22852,0.26411,1,1
7,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00068502,0.22819,0.27801,1,1
7,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0013481,0.22816,0.25252,1,1
7,GO REGULATION OF MEMBRANE POTENTIAL,0.00076864,0.22816,0.30705,1,1
7,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0013481,0.22815,0.24099,1,1
7,GO PROTEIN ACYLATION,0.00033648,0.22797,0.26381,1,1
7,GO REGULATION OF MEIOTIC CELL CYCLE,0.00068502,0.22796,0.24231,1,1
7,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013834,0.22793,0.25742,1,1
7,GO CHLORIDE ION HOMEOSTASIS,0.0023095,0.22783,0.28718,1,1
7,GO MYELIN ASSEMBLY,0.0040644,0.22773,0.30756,1,1
7,GO REGULATION OF ORGANELLE ASSEMBLY,0.00064645,0.22766,0.24697,1,1
7,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0011418,0.22765,0.23903,1,1
7,GO SEGMENTATION,0.0027019,0.22761,0.22595,1,1
7,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0016767,0.22745,0.30436,1,1
7,GO HISTONE H3 ACETYLATION,0.0020776,0.22726,0.22547,1,1
7,GO SECRETORY GRANULE ORGANIZATION,0.0080134,0.22725,0.24033,1,1
7,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.00086166,0.2272,0.25159,1,1
7,GO CELL MATURATION,0.00054254,0.22718,0.24317,1,1
7,GO EPIDERMAL CELL DIFFERENTIATION,0.0083971,0.22717,0.18714,1,1
7,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00076864,0.22717,0.26196,1,1
7,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.014457,0.22699,0.17906,1,1
7,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.00096503,0.22694,0.33594,1,1
7,GO REGULATION OF DENDRITE EXTENSION,0.0018673,0.22693,0.4725,1,1
7,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0027019,0.22685,0.31756,1,1
7,GO POST EMBRYONIC DEVELOPMENT,0.0017696,0.22677,0.25822,1,1
7,GO CELL MORPHOGENESIS,0.0019699,0.22666,0.26047,1,1
7,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00332,0.22633,0.22969,1,1
7,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0024341,0.22623,0.23647,1,1
7,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00086166,0.22613,0.19759,1,1
7,GO COBALAMIN METABOLIC PROCESS,0.00060992,0.22601,0.27199,1,1
7,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0013481,0.22591,0.30045,1,1
7,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00060992,0.22583,0.28019,1,1
7,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0080134,0.22574,0.2206,1,1
7,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.043559,0.2257,0.19994,1,1
7,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.00072571,0.22566,0.24671,1,1
7,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0015041,0.22555,0.28516,1,1
7,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0047188,0.22551,0.24445,1,1
7,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.014457,0.22549,0.23072,1,1
7,GO REGULATION OF CARDIAC CONDUCTION,0.0011418,0.22545,0.31185,1,1
7,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012758,0.22542,0.28929,1,1
7,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.014457,0.22537,0.21583,1,1
7,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0028457,0.22534,0.29613,1,1
7,GO GERM CELL DEVELOPMENT,0.00010181,0.22523,0.26924,1,1
7,GO POSITIVE REGULATION OF RNA SPLICING,0.0012758,0.22523,0.22593,1,1
7,GO RESPONSE TO CATECHOLAMINE,0.0031545,0.22507,0.23617,1,1
7,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.0024341,0.22494,0.23804,1,1
7,GO SCHWANN CELL DIFFERENTIATION,0.015104,0.22493,0.2337,1,1
7,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0042727,0.2249,0.21532,1,1
7,GO PATTERN SPECIFICATION PROCESS,0.0025648,0.22481,0.22521,1,1
7,GO PIGMENTATION,0.00057531,0.22464,0.26425,1,1
7,GO REGULATION OF FEEDING BEHAVIOR,0.0020776,0.22457,0.23775,1,1
7,GO IMPORT ACROSS PLASMA MEMBRANE,0.0034935,0.22454,0.23466,1,1
7,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0020776,0.22445,0.26163,1,1
7,GO REGULATION OF EXOCYTOSIS,0.0034935,0.22437,0.27722,1,1
7,GO DENDRITE EXTENSION,0.0010798,0.22435,0.40886,1,1
7,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0027019,0.22429,0.24999,1,1
7,GO PARAXIAL MESODERM DEVELOPMENT,0.015104,0.22413,0.22312,1,1
7,GO REGULATION OF JUN KINASE ACTIVITY,0.0083971,0.22337,0.26544,1,1
7,GO PANCREAS DEVELOPMENT,0.0029965,0.22315,0.2686,1,1
7,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.007293,0.22312,0.29775,1,1
7,GO DETECTION OF VISIBLE LIGHT,0.00015974,0.2231,0.21744,1,1
7,GO G2 DNA DAMAGE CHECKPOINT,0.006955,0.22308,0.2337,1,1
7,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0052065,0.22305,0.25001,1,1
7,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024341,0.22293,0.24011,1,1
7,GO DICARBOXYLIC ACID TRANSPORT,6.4139e-05,0.22286,0.29964,1,1
7,GO HISTONE H3 K14 ACETYLATION,0.0010209,0.22273,0.32889,1,1
7,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0028457,0.22244,0.27972,1,1
7,GO PURINE NUCLEOTIDE TRANSPORT,0.00033648,0.22243,0.2373,1,1
7,GO REGULATION OF INSULIN SECRETION,0.00040321,0.22212,0.28315,1,1
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00076864,0.22185,0.25619,1,1
7,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00068502,0.22183,0.2692,1,1
7,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0010209,0.22174,0.32166,1,1
7,GO CHOLESTEROL EFFLUX,0.050584,0.22155,0.18913,1,1
7,GO CATION TRANSMEMBRANE TRANSPORT,0.00086166,0.22125,0.2618,1,1
7,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.040368,0.22122,0.23496,1,1
7,GO ANIMAL ORGAN MATURATION,0.011574,0.22119,0.24718,1,1
7,GO REGULATION OF SODIUM ION TRANSPORT,0.0015882,0.22099,0.28649,1,1
7,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00076864,0.22089,0.28797,1,1
7,GO MESENCHYMAL CELL DIFFERENTIATION,0.011574,0.2208,0.2153,1,1
7,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0080134,0.22067,0.23622,1,1
7,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0014241,0.2206,0.29347,1,1
7,GO MEIOTIC CELL CYCLE PROCESS,0.007293,0.22047,0.21536,1,1
7,GO KERATAN SULFATE METABOLIC PROCESS,0.048745,0.22043,0.20314,1,1
7,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.016475,0.22042,0.23084,1,1
7,GO METHIONINE METABOLIC PROCESS,0.0015882,0.2204,0.23369,1,1
7,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0017696,0.22035,0.26063,1,1
7,GO SENSORY PERCEPTION,0.00054254,0.2203,0.23285,1,1
7,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0034935,0.22011,0.27828,1,1
7,GO HORMONE TRANSPORT,0.00060992,0.21997,0.25169,1,1
7,GO CALCIUM ION IMPORT,0.00068502,0.21996,0.31602,1,1
7,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0034935,0.21986,0.23423,1,1
7,GO AXIS SPECIFICATION,0.0010798,0.21985,0.2185,1,1
7,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0016767,0.21982,0.26914,1,1
7,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0018673,0.21974,0.27551,1,1
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0092139,0.21972,0.24975,1,1
7,GO AMINOGLYCAN METABOLIC PROCESS,0.017954,0.21971,0.22136,1,1
7,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.022172,0.2195,0.20833,1,1
7,GO PEPTIDYL THREONINE MODIFICATION,0.00081392,0.21915,0.27942,1,1
7,GO LOCOMOTOR RHYTHM,0.0015882,0.21889,0.35985,1,1
7,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0013481,0.21881,0.23417,1,1
7,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00013188,0.21878,0.25545,1,1
7,GO IMPORT INTO CELL,0.0021907,0.21859,0.24686,1,1
7,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00010181,0.21852,0.29605,1,1
7,GO RNA DESTABILIZATION,0.010572,0.21844,0.25866,1,1
7,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00045436,0.21798,0.28834,1,1
7,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.007293,0.21798,0.27773,1,1
7,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0024341,0.21789,0.26847,1,1
7,GO RESPONSE TO AMPHETAMINE,0.01266,0.21782,0.21735,1,1
7,GO REGULATION OF PH,0.0023095,0.21781,0.20415,1,1
7,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0013481,0.21773,0.23408,1,1
7,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0024341,0.21768,0.31298,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.21759,0.23281,1,1
7,GO ANATOMICAL STRUCTURE MATURATION,0.00086166,0.21759,0.24455,1,1
7,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00086166,0.21755,0.24482,1,1
7,GO NEGATIVE REGULATION OF JNK CASCADE,0.0021907,0.21751,0.24547,1,1
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.037377,0.21746,0.25102,1,1
7,GO REGULATION OF HISTONE MODIFICATION,0.0015882,0.21737,0.23294,1,1
7,GO PROTEIN ACETYLATION,0.00068502,0.21719,0.24668,1,1
7,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,6.4139e-05,0.21714,0.23894,1,1
7,GO ACTIN CROSSLINK FORMATION,0.027226,0.21711,0.23798,1,1
7,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.00057531,0.21709,0.25005,1,1
7,GO TRIGLYCERIDE CATABOLIC PROCESS,0.011063,0.21706,0.2087,1,1
7,GO DNA METHYLATION,0.0060238,0.21678,0.21124,1,1
7,GO ION TRANSMEMBRANE TRANSPORT,0.00081392,0.21676,0.25929,1,1
7,GO ESCRT COMPLEX DISASSEMBLY,0.00072571,0.21664,0.22646,1,1
7,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.017954,0.21652,0.22062,1,1
7,GO REGULATION OF HISTONE METHYLATION,0.00096503,0.21648,0.27391,1,1
7,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.045233,0.21636,0.18199,1,1
7,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0096484,0.21614,0.20626,1,1
7,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.006955,0.21597,0.22764,1,1
7,GO FEMALE GAMETE GENERATION,0.00042807,0.21597,0.23287,1,1
7,GO NEURAL TUBE DEVELOPMENT,0.0092139,0.21587,0.2235,1,1
7,GO RESPONSE TO IMMOBILIZATION STRESS,0.015776,0.21583,0.22472,1,1
7,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00024771,0.21582,0.23116,1,1
7,GO NUCLEOTIDE TRANSPORT,0.00081392,0.21547,0.21371,1,1
7,GO DETECTION OF LIGHT STIMULUS,0.00014989,0.21546,0.22036,1,1
7,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.037377,0.21538,0.23464,1,1
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.028348,0.21528,0.25409,1,1
7,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.012106,0.21524,0.21658,1,1
7,GO NOTCH SIGNALING PATHWAY,0.0010798,0.21511,0.2636,1,1
7,GO REGULATION OF CHROMATIN ORGANIZATION,0.0019699,0.21508,0.23064,1,1
7,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0014241,0.21501,0.27566,1,1
7,GO PROTON TRANSMEMBRANE TRANSPORT,7.3279e-05,0.21494,0.22885,1,1
7,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00068502,0.21493,0.32564,1,1
7,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.035953,0.21491,0.20216,1,1
7,GO MESENCHYME DEVELOPMENT,0.0052065,0.21489,0.22277,1,1
7,GO CYTOSKELETON ORGANIZATION,0.0012758,0.21489,0.2446,1,1
7,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0010798,0.21486,0.25183,1,1
7,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.028348,0.21485,0.24201,1,1
7,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.007293,0.21484,0.27172,1,1
7,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.008797,0.2148,0.29126,1,1
7,GO ATP DEPENDENT CHROMATIN REMODELING,0.023112,0.21478,0.1949,1,1
7,GO HISTONE MONOUBIQUITINATION,0.0021907,0.21468,0.25677,1,1
7,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0021907,0.21422,0.25927,1,1
7,GO CELL CELL JUNCTION ORGANIZATION,0.0010798,0.2142,0.25061,1,1
7,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0025648,0.21404,0.2663,1,1
7,GO AMINO ACID BETAINE METABOLIC PROCESS,0.025096,0.21403,0.226,1,1
7,GO DIOL METABOLIC PROCESS,0.0057394,0.21402,0.24207,1,1
7,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.035953,0.214,0.16232,1,1
7,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.21387,0.27557,1,1
7,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0021907,0.21374,0.25681,1,1
7,GO POSITIVE REGULATION OF DNA REPLICATION,0.0023095,0.21357,0.22545,1,1
7,GO ORGANIC CATION TRANSPORT,0.026142,0.21319,0.19403,1,1
7,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0010798,0.2131,0.24387,1,1
7,GO MRNA 3 END PROCESSING,0.00332,0.21299,0.2117,1,1
7,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0063209,0.21295,0.27456,1,1
7,GO EPITHELIAL TUBE FORMATION,0.0036751,0.21282,0.22661,1,1
7,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.016475,0.21281,0.22034,1,1
7,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.00076864,0.21277,0.22821,1,1
7,GO NUCLEAR CHROMOSOME SEGREGATION,0.043559,0.21257,0.16055,1,1
7,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0076456,0.21254,0.25003,1,1
7,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.008797,0.21237,0.23339,1,1
7,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.02951,0.21236,0.19786,1,1
7,GO CHONDROCYTE PROLIFERATION,0.041938,0.21224,0.258,1,1
7,GO CHROMATIN DISASSEMBLY,0.025096,0.21221,0.21851,1,1
7,GO AROMATIC AMINO ACID TRANSPORT,0.040368,0.21208,0.24011,1,1
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0036751,0.21202,0.33367,1,1
7,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00081392,0.21195,0.27416,1,1
7,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0031545,0.21195,0.27456,1,1
7,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0028457,0.21183,0.22218,1,1
7,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.019548,0.21174,0.23311,1,1
7,GO RECOMBINATIONAL REPAIR,0.034576,0.21174,0.19588,1,1
7,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0047188,0.21174,0.27658,1,1
7,GO AMINO ACID TRANSPORT,0.00026348,0.21171,0.26891,1,1
7,GO EXOCYTIC PROCESS,0.0029965,0.21166,0.29038,1,1
7,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00048214,0.21123,0.2674,1,1
7,GO SENSORY ORGAN MORPHOGENESIS,0.0034935,0.21112,0.21972,1,1
7,GO SPHINGOID METABOLIC PROCESS,0.010101,0.21085,0.24458,1,1
7,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0049572,0.2106,0.25872,1,1
7,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0028457,0.21054,0.25038,1,1
7,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.21051,0.23919,1,1
7,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00064645,0.21046,0.25963,1,1
7,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.01266,0.21043,0.23878,1,1
7,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0063209,0.21032,0.24756,1,1
7,GO FACE DEVELOPMENT,0.021265,0.20997,0.25308,1,1
7,GO STRIATED MUSCLE CONTRACTION,0.0025648,0.20997,0.27898,1,1
7,GO TRANSFERRIN TRANSPORT,0.00018128,0.20996,0.27277,1,1
7,GO NUCLEAR BODY ORGANIZATION,0.00045436,0.20989,0.272,1,1
7,GO REGULATION OF NEURON MATURATION,0.0083971,0.20986,0.27133,1,1
7,GO MATING,0.0066311,0.20958,0.25068,1,1
7,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0054671,0.20953,0.24065,1,1
7,GO LIPID OXIDATION,0.0027019,0.2095,0.20971,1,1
7,GO PROTEIN AUTOUBIQUITINATION,0.00019306,0.20934,0.25787,1,1
7,GO SIGNAL RELEASE,0.0025648,0.20933,0.2397,1,1
7,GO FUCOSE METABOLIC PROCESS,0.010572,0.20922,0.19877,1,1
7,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0010209,0.20916,0.30478,1,1
7,GO RESPONSE TO FOOD,0.0054671,0.20914,0.22639,1,1
7,GO FOCAL ADHESION ASSEMBLY,0.0076456,0.20912,0.27154,1,1
7,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.012106,0.20906,0.19019,1,1
7,GO CENTROSOME DUPLICATION,0.020391,0.20905,0.21188,1,1
7,GO NEPHRON DEVELOPMENT,0.0057394,0.20904,0.25089,1,1
7,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.00060992,0.20893,0.24475,1,1
7,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0057394,0.20888,0.26254,1,1
7,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.052482,0.2088,0.25041,1,1
7,GO DEMETHYLATION,0.0011418,0.20876,0.26987,1,1
7,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0038653,0.20863,0.24947,1,1
7,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0019699,0.2086,0.22364,1,1
7,GO SENSORY ORGAN DEVELOPMENT,0.0038653,0.20848,0.21857,1,1
7,GO MEMBRANE REPOLARIZATION,0.0019699,0.20837,0.33028,1,1
7,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011063,0.20823,0.23424,1,1
7,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.017954,0.20822,0.23827,1,1
7,GO REGULATION OF CELL MATURATION,0.0031545,0.20774,0.2001,1,1
7,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.037377,0.20762,0.28284,1,1
7,GO P BODY ASSEMBLY,0.0076456,0.20747,0.2619,1,1
7,GO REGULATION OF SPINDLE ORGANIZATION,0.0080134,0.20734,0.20983,1,1
7,GO OVARIAN FOLLICLE DEVELOPMENT,0.0092139,0.20732,0.20456,1,1
7,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.037377,0.20728,0.26112,1,1
7,GO ALCOHOL CATABOLIC PROCESS,0.0047188,0.20726,0.20339,1,1
7,GO OVULATION CYCLE,0.0096484,0.20721,0.25524,1,1
7,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00086166,0.20702,0.25252,1,1
7,GO IRON SULFUR CLUSTER ASSEMBLY,0.0012758,0.20692,0.17963,1,1
7,GO COPII COATED VESICLE BUDDING,0.0015882,0.20675,0.22788,1,1
7,GO PHOTOTRANSDUCTION,8.9327e-05,0.20675,0.20184,1,1
7,GO DEVELOPMENTAL GROWTH,0.0015882,0.2066,0.23658,1,1
7,GO HETEROCHROMATIN ORGANIZATION,0.0015041,0.20655,0.27824,1,1
7,GO POSITIVE REGULATION OF MITOPHAGY,0.0012758,0.20636,0.39978,1,1
7,GO CALCINEURIN MEDIATED SIGNALING,0.0080134,0.20632,0.22837,1,1
7,GO HISTONE H2A UBIQUITINATION,0.00332,0.20628,0.24479,1,1
7,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.028348,0.20625,0.21129,1,1
7,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.038848,0.20618,0.1984,1,1
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0010209,0.20594,0.20449,1,1
7,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0038653,0.20562,0.2169,1,1
7,GO FATTY ACID BETA OXIDATION,0.0012758,0.20502,0.23423,1,1
7,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0027019,0.20489,0.25767,1,1
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.019548,0.20486,0.29985,1,1
7,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0063209,0.20477,0.23831,1,1
7,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0052065,0.20471,0.31045,1,1
7,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0012758,0.20464,0.24231,1,1
7,GO CELLULAR RESPONSE TO ALKALOID,0.0034935,0.20436,0.20646,1,1
7,GO RESPONSE TO UV,0.0021907,0.20435,0.1979,1,1
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0010209,0.20401,0.1983,1,1
7,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0013481,0.20384,0.23453,1,1
7,GO ENERGY HOMEOSTASIS,0.0021907,0.20371,0.2762,1,1
7,GO REGULATION OF HORMONE LEVELS,0.00091199,0.20352,0.22399,1,1
7,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.031957,0.20345,0.21779,1,1
7,GO REGULATION OF CELLULAR PH,0.0031545,0.20344,0.20511,1,1
7,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.2034,0.21365,1,1
7,GO TISSUE REGENERATION,0.034576,0.20339,0.17294,1,1
7,GO ENDOCYTIC RECYCLING,0.0036751,0.20337,0.27839,1,1
7,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.013834,0.20323,0.34906,1,1
7,GO SECOND MESSENGER MEDIATED SIGNALING,0.021265,0.2031,0.19361,1,1
7,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0012071,0.20306,0.25336,1,1
7,GO SULFUR COMPOUND CATABOLIC PROCESS,0.023112,0.20298,0.21053,1,1
7,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0018673,0.20297,0.20706,1,1
7,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.022172,0.20295,0.23662,1,1
7,GO REGULATION OF TOR SIGNALING,0.00081392,0.20288,0.23767,1,1
7,GO ERYTHROCYTE DEVELOPMENT,0.0029965,0.20279,0.24753,1,1
7,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0014241,0.20255,0.23232,1,1
7,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0021907,0.20255,0.19133,1,1
7,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.012106,0.20254,0.27192,1,1
7,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0010798,0.20244,0.22008,1,1
7,GO PLASMA MEMBRANE ORGANIZATION,0.008797,0.20244,0.24787,1,1
7,GO ACTIVATION OF JUN KINASE ACTIVITY,0.011574,0.2023,0.29518,1,1
7,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.20215,0.19302,1,1
7,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.010572,0.20215,0.2098,1,1
7,GO CELL CELL JUNCTION ASSEMBLY,0.00096503,0.20214,0.25151,1,1
7,GO GOLGI ORGANIZATION,0.00086166,0.20213,0.27631,1,1
7,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0172,0.20212,0.17737,1,1
7,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.017954,0.20207,0.35207,1,1
7,GO REGULATION OF CILIUM MOVEMENT,0.0047188,0.20205,0.2995,1,1
7,GO PROTEIN POLYUBIQUITINATION,0.00096503,0.20193,0.19891,1,1
7,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0060238,0.20193,0.21351,1,1
7,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00091199,0.2019,0.20303,1,1
7,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0019699,0.20165,0.26861,1,1
7,GO INORGANIC ANION TRANSPORT,0.00332,0.2015,0.24136,1,1
7,GO LIPID PHOSPHORYLATION,0.011063,0.20143,0.21758,1,1
7,GO REGULATION OF ION TRANSPORT,0.0028457,0.20137,0.2445,1,1
7,GO HEART MORPHOGENESIS,0.0083971,0.20115,0.215,1,1
7,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.018736,0.20095,0.20006,1,1
7,GO CHROMOSOME SEGREGATION,0.048745,0.20068,0.15562,1,1
7,GO 3 UTR MEDIATED MRNA STABILIZATION,0.010101,0.20064,0.23828,1,1
7,GO CARDIAC MUSCLE CONTRACTION,0.0040644,0.20055,0.2712,1,1
7,GO MULTI ORGANISM PROCESS,0.00033648,0.20051,0.21623,1,1
7,GO ANION TRANSMEMBRANE TRANSPORT,0.0010209,0.20033,0.24091,1,1
7,GO OLIGODENDROCYTE DIFFERENTIATION,0.0066311,0.2003,0.18675,1,1
7,GO SPLEEN DEVELOPMENT,0.008797,0.20019,0.22989,1,1
7,GO CELLULAR PIGMENTATION,0.0010798,0.20018,0.23942,1,1
7,GO RESPONSE TO MISFOLDED PROTEIN,0.0015882,0.20016,0.26413,1,1
7,GO REGULATION OF DNA REPAIR,0.0029965,0.20003,0.22213,1,1
7,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0017696,0.19995,0.23011,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0019699,0.1999,0.22965,1,1
7,GO GLUTAMATE METABOLIC PROCESS,0.00040321,0.19986,0.2665,1,1
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0054671,0.19966,0.28155,1,1
7,GO MRNA PROCESSING,0.00086166,0.1996,0.21102,1,1
7,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0080134,0.19952,0.22696,1,1
7,GO MYOFIBRIL ASSEMBLY,0.0027019,0.19949,0.24932,1,1
7,GO INTRA S DNA DAMAGE CHECKPOINT,0.0052065,0.19937,0.27012,1,1
7,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0066311,0.19935,0.21955,1,1
7,GO RNA SPLICING,0.0015041,0.19919,0.19664,1,1
7,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0012758,0.19907,0.2399,1,1
7,GO ADAPTATION OF SIGNALING PATHWAY,0.025096,0.19898,0.2838,1,1
7,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.027226,0.19895,0.19781,1,1
7,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0076456,0.19895,0.22841,1,1
7,GO MANNOSYLATION,0.0013481,0.19886,0.21181,1,1
7,GO CARNITINE METABOLIC PROCESS,0.020391,0.19885,0.20517,1,1
7,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0054671,0.19881,0.22928,1,1
7,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.010572,0.19865,0.18689,1,1
7,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.019548,0.19856,0.20615,1,1
7,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0040644,0.19847,0.22933,1,1
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0028457,0.19831,0.20857,1,1
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0047188,0.19817,0.24582,1,1
7,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0052065,0.19813,0.24886,1,1
7,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.010572,0.198,0.24238,1,1
7,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.018736,0.19795,0.23035,1,1
7,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.01266,0.19792,0.25385,1,1
7,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00086166,0.19792,0.27575,1,1
7,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0036751,0.19792,0.26016,1,1
7,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0036751,0.1976,0.21619,1,1
7,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.007293,0.19757,0.20837,1,1
7,GO REGULATION OF SYSTEM PROCESS,0.0014241,0.19751,0.24143,1,1
7,GO METAL ION TRANSPORT,0.0015041,0.1974,0.24802,1,1
7,GO KERATINIZATION,0.019548,0.19738,0.16563,1,1
7,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0066311,0.1973,0.2376,1,1
7,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0018673,0.19728,0.25696,1,1
7,GO RESPONSE TO AMINE,0.010572,0.19728,0.2095,1,1
7,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00024771,0.19722,0.24414,1,1
7,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0024341,0.19703,0.21986,1,1
7,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0019699,0.19697,0.21695,1,1
7,GO DIGESTION,0.017954,0.19697,0.16546,1,1
7,GO DNA PACKAGING,0.014457,0.19692,0.19563,1,1
7,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0080134,0.19687,0.2725,1,1
7,GO NEURAL CREST CELL DIFFERENTIATION,0.017954,0.19674,0.20714,1,1
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0049572,0.19671,0.19858,1,1
7,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.010101,0.19669,0.23432,1,1
7,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0060238,0.19654,0.27733,1,1
7,GO ACTIN MEDIATED CELL CONTRACTION,0.0049572,0.19652,0.2496,1,1
7,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.031957,0.1965,0.17123,1,1
7,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.038848,0.19641,0.23784,1,1
7,GO PRO B CELL DIFFERENTIATION,0.046961,0.19634,0.24743,1,1
7,GO FOREBRAIN DEVELOPMENT,0.0066311,0.19633,0.21261,1,1
7,GO MULTICELLULAR ORGANISM GROWTH,0.0028457,0.19633,0.24999,1,1
7,GO CHROMATIN ORGANIZATION,0.0011418,0.19629,0.25558,1,1
7,GO AMEBOIDAL TYPE CELL MIGRATION,0.038848,0.19614,0.19146,1,1
7,GO REGULATION OF ENDOCRINE PROCESS,0.024086,0.19612,0.18173,1,1
7,GO GPI ANCHOR METABOLIC PROCESS,0.00086166,0.19588,0.20224,1,1
7,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00091199,0.19582,0.29897,1,1
7,GO ATP TRANSPORT,0.00054254,0.19565,0.22884,1,1
7,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0011418,0.19561,0.22273,1,1
7,GO CIRCULATORY SYSTEM PROCESS,0.0044907,0.19556,0.22583,1,1
7,GO LUNG EPITHELIUM DEVELOPMENT,0.0060238,0.19555,0.27403,1,1
7,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00072571,0.19539,0.23684,1,1
7,GO RESPONSE TO LIGHT STIMULUS,0.00019306,0.19537,0.23174,1,1
7,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0014241,0.19525,0.24105,1,1
7,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.027226,0.19524,0.16324,1,1
7,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00045436,0.19507,0.20205,1,1
7,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.019548,0.19497,0.19892,1,1
7,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.007293,0.19496,0.21831,1,1
7,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0036751,0.19473,0.21872,1,1
7,GO NUCLEAR ENVELOPE ORGANIZATION,0.0020776,0.19468,0.21156,1,1
7,GO REGULATION OF HAIR CYCLE,0.010572,0.19466,0.22663,1,1
7,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0014241,0.19465,0.21869,1,1
7,GO PEPTIDE CATABOLIC PROCESS,0.0172,0.19456,0.21955,1,1
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.024086,0.19455,0.17652,1,1
7,GO REGULATION OF PROTEIN POLYMERIZATION,0.0017696,0.19453,0.23996,1,1
7,GO POSITIVE REGULATION OF CELL GROWTH,0.00086166,0.19452,0.25657,1,1
7,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0021907,0.19434,0.28194,1,1
7,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.018736,0.1943,0.27548,1,1
7,GO REGULATION OF CELL DEVELOPMENT,0.0028457,0.19429,0.22111,1,1
7,GO POSITIVE REGULATION OF TOR SIGNALING,0.0010798,0.19403,0.23831,1,1
7,GO POSITIVE REGULATION OF DNA REPAIR,0.0029965,0.19403,0.23899,1,1
7,GO STRESS FIBER ASSEMBLY,0.0047188,0.19384,0.24593,1,1
7,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00023283,0.19374,0.21701,1,1
7,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0044907,0.19363,0.18733,1,1
7,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0011418,0.19345,0.27188,1,1
7,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019548,0.19342,0.24641,1,1
7,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00091199,0.1933,0.27826,1,1
7,GO REGULATION OF MYELINATION,0.050584,0.19321,0.17552,1,1
7,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0063209,0.19318,0.21334,1,1
7,GO NEGATIVE REGULATION OF AXONOGENESIS,0.013834,0.19317,0.2983,1,1
7,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.019548,0.19306,0.16554,1,1
7,GO REPRODUCTION,0.00068502,0.19305,0.20943,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE,0.0010798,0.19289,0.20746,1,1
7,GO RESPONSE TO OSMOTIC STRESS,0.020391,0.19288,0.1862,1,1
7,GO SENSORY PERCEPTION OF PAIN,0.0060238,0.19284,0.19898,1,1
7,GO POSITIVE REGULATION OF GROWTH,0.0010798,0.19279,0.25111,1,1
7,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0076456,0.19275,0.36022,1,1
7,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0010798,0.19272,0.22336,1,1
7,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.010572,0.19271,0.24446,1,1
7,GO REGULATION OF SISTER CHROMATID COHESION,0.028348,0.19269,0.1914,1,1
7,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.019548,0.19269,0.24535,1,1
7,GO GLYCOSYLATION,0.0014241,0.1926,0.21762,1,1
7,GO MRNA METHYLATION,0.0096484,0.19258,0.20085,1,1
7,GO ION TRANSPORT,0.0014241,0.19253,0.23107,1,1
7,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0029965,0.19252,0.24173,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.012106,0.1923,0.21482,1,1
7,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.010572,0.1923,0.19438,1,1
7,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0018673,0.19199,0.21793,1,1
7,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0019699,0.19188,0.24244,1,1
7,GO SULFATE TRANSPORT,0.018736,0.19186,0.2034,1,1
7,GO PEPTIDYL SERINE MODIFICATION,0.0020776,0.19169,0.23573,1,1
7,GO ENDOCARDIUM DEVELOPMENT,0.0066311,0.19168,0.22873,1,1
7,GO CARBOHYDRATE HOMEOSTASIS,0.0015041,0.19143,0.2023,1,1
7,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.011574,0.19137,0.21949,1,1
7,GO REGULATION OF CELL MORPHOGENESIS,0.0063209,0.19131,0.23075,1,1
7,GO SELECTIVE AUTOPHAGY,0.0019699,0.1913,0.24776,1,1
7,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0044907,0.19128,0.26363,1,1
7,GO PROTEIN HOMOOLIGOMERIZATION,0.0042727,0.19122,0.21831,1,1
7,GO VESICLE LOCALIZATION,0.00033648,0.19106,0.27491,1,1
7,GO SNARE COMPLEX ASSEMBLY,0.0092139,0.19105,0.29751,1,1
7,GO MUSCLE CONTRACTION,0.0029965,0.19095,0.23663,1,1
7,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0038653,0.1908,0.2277,1,1
7,GO OVULATION CYCLE PROCESS,0.008797,0.19078,0.2605,1,1
7,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0031545,0.19066,0.2495,1,1
7,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.006955,0.19043,0.21344,1,1
7,GO ENAMEL MINERALIZATION,0.048745,0.19033,0.22792,1,1
7,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.013834,0.19022,0.18902,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0018673,0.19006,0.24977,1,1
7,GO REGULATION OF CARTILAGE DEVELOPMENT,0.023112,0.18996,0.22724,1,1
7,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.040368,0.18992,0.20523,1,1
7,GO AORTA DEVELOPMENT,0.028348,0.1899,0.25033,1,1
7,GO MAGNESIUM ION TRANSPORT,0.0096484,0.18983,0.27468,1,1
7,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.031957,0.18982,0.18636,1,1
7,GO REGULATION OF TRANSPORTER ACTIVITY,0.00332,0.18981,0.27236,1,1
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.015776,0.18977,0.19882,1,1
7,GO HISTONE UBIQUITINATION,0.0018673,0.18969,0.24437,1,1
7,GO LUNG CELL DIFFERENTIATION,0.019548,0.18968,0.27199,1,1
7,GO DNA MODIFICATION,0.0049572,0.18961,0.17851,1,1
7,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0025648,0.18953,0.25318,1,1
7,GO CHROMATIN SILENCING,0.0049572,0.18933,0.22424,1,1
7,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.012106,0.18929,0.27423,1,1
7,GO CATION TRANSPORT,0.00091199,0.18923,0.24076,1,1
7,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0018673,0.18914,0.25313,1,1
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0172,0.1891,0.24077,1,1
7,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0021907,0.18897,0.2201,1,1
7,GO MOLTING CYCLE,0.0036751,0.18871,0.24036,1,1
7,GO REGULATION OF DNA CATABOLIC PROCESS,0.0092139,0.18869,0.17092,1,1
7,GO RESPONSE TO CAFFEINE,0.011574,0.18863,0.25088,1,1
7,GO MESONEPHROS DEVELOPMENT,0.043559,0.18862,0.17241,1,1
7,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0038653,0.18861,0.24514,1,1
7,GO UV PROTECTION,0.0012071,0.18859,0.28302,1,1
7,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00051151,0.18857,0.2766,1,1
7,GO NEURAL CREST CELL MIGRATION,0.0172,0.18849,0.22737,1,1
7,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0017696,0.18841,0.228,1,1
7,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.010101,0.1883,0.27966,1,1
7,GO CELL CELL SIGNALING,0.0019699,0.18819,0.2344,1,1
7,GO REGULATION OF ACTIN NUCLEATION,0.035953,0.1881,0.18618,1,1
7,GO CELL GROWTH,0.0014241,0.18808,0.23285,1,1
7,GO FERTILIZATION,0.00064645,0.18798,0.19472,1,1
7,GO REGULATION OF CHROMATIN BINDING,0.025096,0.18796,0.19316,1,1
7,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0057394,0.18786,0.21407,1,1
7,GO ORGANELLE FISSION,0.0083971,0.18777,0.18496,1,1
7,GO RESPONSE TO CALCIUM ION,0.0014241,0.1874,0.26459,1,1
7,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0047188,0.18739,0.20745,1,1
7,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0025648,0.18732,0.214,1,1
7,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.043559,0.1873,0.21393,1,1
7,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0036751,0.18718,0.20494,1,1
7,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0038653,0.18718,0.21177,1,1
7,GO CARDIAC MUSCLE CELL PROLIFERATION,0.014457,0.18709,0.19983,1,1
7,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.018736,0.18687,0.23726,1,1
7,GO ACTIN FILAMENT BASED PROCESS,0.0054671,0.18674,0.22968,1,1
7,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0054671,0.18666,0.21816,1,1
7,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0020776,0.18653,0.23617,1,1
7,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.015104,0.18648,0.2093,1,1
7,GO PIGMENT CELL DIFFERENTIATION,0.0060238,0.1863,0.22915,1,1
7,GO DETECTION OF ABIOTIC STIMULUS,0.00015974,0.18621,0.23222,1,1
7,GO CARDIAC CHAMBER MORPHOGENESIS,0.024086,0.18616,0.19946,1,1
7,GO ARTERY DEVELOPMENT,0.025096,0.18613,0.2289,1,1
7,GO CELLULAR ION HOMEOSTASIS,0.043559,0.18584,0.1574,1,1
7,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0020776,0.18578,0.1956,1,1
7,GO ARTERY MORPHOGENESIS,0.020391,0.18562,0.24106,1,1
7,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0038653,0.18549,0.2218,1,1
7,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0172,0.1853,0.23944,1,1
7,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.006955,0.18516,0.20594,1,1
7,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.015104,0.18513,0.25375,1,1
7,GO ADAPTIVE THERMOGENESIS,0.014457,0.18511,0.17772,1,1
7,GO MRNA CLEAVAGE,0.00035748,0.18495,0.2344,1,1
7,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013481,0.1848,0.23892,1,1
7,GO ORGANELLE MEMBRANE FUSION,0.0052065,0.18477,0.24915,1,1
7,GO CIRCULATORY SYSTEM DEVELOPMENT,0.034576,0.18468,0.18325,1,1
7,GO SKIN DEVELOPMENT,0.014457,0.1846,0.18182,1,1
7,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0057394,0.18457,0.20744,1,1
7,GO RNA 3 END PROCESSING,0.0029965,0.18455,0.18494,1,1
7,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0016767,0.18453,0.27449,1,1
7,GO HISTONE H2A ACETYLATION,0.0017696,0.18447,0.25194,1,1
7,GO DEPHOSPHORYLATION,0.0012758,0.18438,0.23188,1,1
7,GO ANION TRANSPORT,0.0013481,0.18435,0.2181,1,1
7,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0013481,0.18428,0.27998,1,1
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.010101,0.18421,0.21747,1,1
7,GO METAL ION HOMEOSTASIS,0.046961,0.18416,0.15836,1,1
7,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.012106,0.18403,0.27134,1,1
7,GO REGULATION OF CENTROSOME CYCLE,0.015776,0.18399,0.1888,1,1
7,GO COCHLEA DEVELOPMENT,0.034576,0.1838,0.17477,1,1
7,GO DNA RECOMBINATION,0.033245,0.18373,0.168,1,1
7,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00086166,0.1837,0.22762,1,1
7,GO TRANSMEMBRANE TRANSPORT,0.00096503,0.18363,0.22983,1,1
7,GO GOLGI VESICLE BUDDING,0.0024341,0.18349,0.22529,1,1
7,GO POLYSACCHARIDE METABOLIC PROCESS,0.0027019,0.18344,0.22159,1,1
7,GO RESPONSE TO UV C,0.017954,0.18331,0.20485,1,1
7,GO RNA INTERFERENCE,0.01266,0.18329,0.20024,1,1
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0021907,0.18328,0.22108,1,1
7,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0013481,0.18321,0.2004,1,1
7,GO GLUCOSE METABOLIC PROCESS,0.0013481,0.18316,0.20242,1,1
7,GO REGULATION OF MUSCLE CONTRACTION,0.0060238,0.1831,0.20236,1,1
7,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0024341,0.18308,0.33495,1,1
7,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.046961,0.18291,0.20085,1,1
7,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0017696,0.18275,0.19199,1,1
7,GO RNA EXPORT FROM NUCLEUS,0.0054671,0.18261,0.19086,1,1
7,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.01266,0.18251,0.24282,1,1
7,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0029965,0.18247,0.25338,1,1
7,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.013235,0.18246,0.2528,1,1
7,GO CARDIAC VENTRICLE DEVELOPMENT,0.0063209,0.18244,0.22402,1,1
7,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.046961,0.18222,0.19318,1,1
7,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0080134,0.18218,0.24948,1,1
7,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00068502,0.18213,0.20848,1,1
7,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0019699,0.18186,0.2104,1,1
7,GO REGULATION OF DEPHOSPHORYLATION,0.0020776,0.18167,0.23157,1,1
7,GO REGULATION OF ORGANELLE ORGANIZATION,0.0012071,0.1816,0.21394,1,1
7,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0024341,0.1816,0.2424,1,1
7,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00332,0.18147,0.18506,1,1
7,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00096503,0.18145,0.24753,1,1
7,GO POLYOL METABOLIC PROCESS,0.00040321,0.18137,0.22831,1,1
7,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0025648,0.18135,0.22792,1,1
7,GO EAR MORPHOGENESIS,0.012106,0.18125,0.18328,1,1
7,GO HEART DEVELOPMENT,0.0031545,0.18121,0.22189,1,1
7,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0017696,0.18115,0.31102,1,1
7,GO TRNA MODIFICATION,0.0044907,0.18095,0.17296,1,1
7,GO TOR SIGNALING,0.00064645,0.18083,0.22582,1,1
7,GO MRNA MODIFICATION,0.024086,0.18081,0.15375,1,1
7,GO MITOTIC SISTER CHROMATID COHESION,0.050584,0.18079,0.17887,1,1
7,GO EPITHELIAL CELL DIFFERENTIATION,0.0044907,0.18075,0.19548,1,1
7,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0020776,0.18063,0.25679,1,1
7,GO ION HOMEOSTASIS,0.02951,0.18057,0.16786,1,1
7,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.018736,0.1805,0.24648,1,1
7,GO CYTOKINESIS,0.0024341,0.1804,0.21123,1,1
7,GO REGULATION OF SENSORY PERCEPTION,0.013235,0.18033,0.20878,1,1
7,GO ORGANIC ACID TRANSPORT,0.0012071,0.18032,0.21323,1,1
7,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.1803,0.26064,1,1
7,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0057394,0.18028,0.24097,1,1
7,GO REGULATION OF PROTEIN ACETYLATION,0.0015041,0.18024,0.2138,1,1
7,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0025648,0.18011,0.21105,1,1
7,GO CELLULAR RESPONSE TO PH,0.013235,0.18003,0.23138,1,1
7,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021907,0.17991,0.21404,1,1
7,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00332,0.17984,0.29336,1,1
7,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00042807,0.17956,0.17136,1,1
7,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0019699,0.17946,0.30307,1,1
7,GO EXCRETION,0.0083971,0.17933,0.24165,1,1
7,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0080134,0.17931,0.27493,1,1
7,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0025648,0.1793,0.17832,1,1
7,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.030713,0.17913,0.17035,1,1
7,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.025096,0.17885,0.20842,1,1
7,GO CYTOSOLIC TRANSPORT,0.00064645,0.17869,0.28156,1,1
7,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0052065,0.17862,0.26648,1,1
7,GO ACTIN FILAMENT BASED MOVEMENT,0.0057394,0.17861,0.2471,1,1
7,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.020391,0.17857,0.17012,1,1
7,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.025096,0.17834,0.22002,1,1
7,GO REGULATION OF TELOMERE MAINTENANCE,0.0029965,0.17777,0.21917,1,1
7,GO REGULATION OF BLOOD PRESSURE,0.007293,0.17759,0.20669,1,1
7,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0044907,0.17758,0.22715,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0012758,0.17746,0.34246,1,1
7,GO INNER EAR MORPHOGENESIS,0.0080134,0.17735,0.20678,1,1
7,GO DEVELOPMENTAL PIGMENTATION,0.0025648,0.17721,0.23772,1,1
7,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.040368,0.17713,0.16301,1,1
7,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0052065,0.17712,0.19771,1,1
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.020391,0.17708,0.21675,1,1
7,GO INTRACELLULAR STEROL TRANSPORT,0.050584,0.17707,0.17272,1,1
7,GO CELLULAR RESPONSE TO STEROL,0.019548,0.17707,0.2566,1,1
7,GO REGULATION OF CELL CYCLE,0.0024341,0.17686,0.18823,1,1
7,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.00064645,0.17684,0.19952,1,1
7,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0024341,0.17683,0.19736,1,1
7,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0025648,0.17682,0.2065,1,1
7,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0040644,0.17679,0.21736,1,1
7,GO HORMONE METABOLIC PROCESS,0.008797,0.17668,0.16138,1,1
7,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0010798,0.17662,0.18441,1,1
7,GO TRNA WOBBLE BASE MODIFICATION,0.0060238,0.17662,0.17446,1,1
7,GO ECTODERMAL PLACODE DEVELOPMENT,0.046961,0.17655,0.17496,1,1
7,GO CHROMOSOME ORGANIZATION,0.0023095,0.17654,0.21748,1,1
7,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00096503,0.17641,0.26982,1,1
7,GO EMBRYONIC PATTERN SPECIFICATION,0.0021907,0.17632,0.25344,1,1
7,GO MEGAKARYOCYTE DIFFERENTIATION,0.0012758,0.17628,0.2489,1,1
7,GO GENE SILENCING,0.0016767,0.17626,0.20801,1,1
7,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0042727,0.17612,0.18807,1,1
7,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0014241,0.17609,0.23424,1,1
7,GO MRNA EXPORT FROM NUCLEUS,0.0021907,0.17605,0.21765,1,1
7,GO ERBB2 SIGNALING PATHWAY,0.012106,0.17591,0.22751,1,1
7,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.025096,0.17583,0.21291,1,1
7,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.019548,0.17582,0.15817,1,1
7,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0038653,0.17562,0.24784,1,1
7,GO RESPONSE TO MONOSACCHARIDE,0.0015041,0.1756,0.21621,1,1
7,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.006955,0.17551,0.23934,1,1
7,GO PROTEIN LOCALIZATION TO VACUOLE,0.0092139,0.17551,0.20627,1,1
7,GO DNA REPLICATION,0.048745,0.17527,0.161,1,1
7,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.014457,0.1752,0.16118,1,1
7,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00086166,0.17518,0.21074,1,1
7,GO TOXIN TRANSPORT,0.019548,0.17512,0.20767,1,1
7,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.014457,0.17509,0.20909,1,1
7,GO NEPHRON MORPHOGENESIS,0.041938,0.17507,0.1794,1,1
7,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0012071,0.17507,0.20971,1,1
7,GO LIPOPROTEIN METABOLIC PROCESS,0.0010209,0.17506,0.19066,1,1
7,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.050584,0.17495,0.16885,1,1
7,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0060238,0.17493,0.23925,1,1
7,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0049572,0.17487,0.19853,1,1
7,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0031545,0.17485,0.23959,1,1
7,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.011063,0.17448,0.28583,1,1
7,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.011063,0.1744,0.21319,1,1
7,GO EXIT FROM MITOSIS,0.011574,0.17434,0.184,1,1
7,GO DORSAL VENTRAL PATTERN FORMATION,0.013235,0.17428,0.20447,1,1
7,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0076456,0.17427,0.20509,1,1
7,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0025648,0.17393,0.2518,1,1
7,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.010572,0.17389,0.25917,1,1
7,GO ENDOTHELIUM DEVELOPMENT,0.052482,0.17388,0.2043,1,1
7,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0027019,0.17381,0.23367,1,1
7,GO DEVELOPMENTAL INDUCTION,0.013834,0.17355,0.1981,1,1
7,GO RHYTHMIC PROCESS,0.0036751,0.17352,0.20793,1,1
7,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0172,0.17328,0.21334,1,1
7,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0049572,0.17328,0.21082,1,1
7,GO PHOSPHOLIPID METABOLIC PROCESS,0.0031545,0.17323,0.21151,1,1
7,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0031545,0.17306,0.20174,1,1
7,GO MEMBRANE FUSION,0.0042727,0.17299,0.22725,1,1
7,GO ORGANELLE FUSION,0.0017696,0.1729,0.2426,1,1
7,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.038848,0.17278,0.23562,1,1
7,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0172,0.17278,0.19735,1,1
7,GO REGULATION OF VASCULAR PERMEABILITY,0.024086,0.17277,0.23178,1,1
7,GO NON RECOMBINATIONAL REPAIR,0.0057394,0.17275,0.1929,1,1
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.011574,0.17273,0.21681,1,1
7,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.050584,0.17271,0.18504,1,1
7,GO EPIDERMIS DEVELOPMENT,0.01266,0.17267,0.17797,1,1
7,GO REGULATION OF VASOCONSTRICTION,0.050584,0.17266,0.20132,1,1
7,GO HISTONE H2B UBIQUITINATION,0.020391,0.1726,0.16597,1,1
7,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0172,0.17246,0.20615,1,1
7,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0066311,0.17243,0.19933,1,1
7,GO MUSCLE STRUCTURE DEVELOPMENT,0.0049572,0.17239,0.20959,1,1
7,GO REGULATION OF ANION TRANSPORT,0.01266,0.17238,0.18488,1,1
7,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0028457,0.17223,0.22415,1,1
7,GO REGULATION OF CELLULAR LOCALIZATION,0.0047188,0.17222,0.21083,1,1
7,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.015776,0.17221,0.20498,1,1
7,GO REGULATION OF MESODERM DEVELOPMENT,0.024086,0.1722,0.19385,1,1
7,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00042807,0.17206,0.28487,1,1
7,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.018736,0.17201,0.22629,1,1
7,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0016767,0.172,0.22329,1,1
7,GO REGULATION OF CELL CYCLE CHECKPOINT,0.048745,0.17187,0.1817,1,1
7,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0054671,0.1718,0.23774,1,1
7,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0042727,0.17174,0.25685,1,1
7,GO ACID SECRETION,0.0014241,0.17167,0.25069,1,1
7,GO VESICLE BUDDING FROM MEMBRANE,0.0042727,0.17143,0.20233,1,1
7,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00332,0.17143,0.20668,1,1
7,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0063209,0.17123,0.22959,1,1
7,GO GROWTH,0.0017696,0.17123,0.20801,1,1
7,GO LIPID MODIFICATION,0.0023095,0.17121,0.22323,1,1
7,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0020776,0.17121,0.18692,1,1
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028457,0.1711,0.2477,1,1
7,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0014241,0.17109,0.22777,1,1
7,GO GLYCEROLIPID METABOLIC PROCESS,0.0027019,0.17103,0.22051,1,1
7,GO CELLULAR RESPONSE TO SALT STRESS,0.028348,0.17101,0.20975,1,1
7,GO RENAL SYSTEM PROCESS,0.011063,0.17084,0.23124,1,1
7,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0083971,0.17072,0.20616,1,1
7,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0038653,0.17067,0.21963,1,1
7,GO NUCLEOSOME ORGANIZATION,0.011063,0.17063,0.1865,1,1
7,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00051151,0.17061,0.17825,1,1
7,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0021907,0.1706,0.21284,1,1
7,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0019699,0.17053,0.22438,1,1
7,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.01266,0.17051,0.19976,1,1
7,GO REGULATION OF CIRCADIAN RHYTHM,0.0047188,0.17046,0.21774,1,1
7,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0036751,0.17042,0.26713,1,1
7,GO TRNA PROCESSING,0.0031545,0.1704,0.15834,1,1
7,GO RESPONSE TO LEPTIN,0.013235,0.17032,0.23423,1,1
7,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00048214,0.17029,0.20545,1,1
7,GO RESPONSE TO STEROL,0.035953,0.17006,0.21536,1,1
7,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.02951,0.17006,0.17449,1,1
7,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0054671,0.16994,0.23798,1,1
7,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0044907,0.16994,0.20741,1,1
7,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0036751,0.16993,0.22137,1,1
7,GO ISOPRENOID METABOLIC PROCESS,0.025096,0.16986,0.13213,1,1
7,GO MRNA TRANSPORT,0.0052065,0.1698,0.19215,1,1
7,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.014457,0.16978,0.19402,1,1
7,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.00020554,0.1697,0.17904,1,1
7,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.0029965,0.16958,0.2695,1,1
7,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0060238,0.16956,0.1818,1,1
7,GO ENSHEATHMENT OF NEURONS,0.016475,0.16954,0.17451,1,1
7,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0028457,0.16952,0.17289,1,1
7,GO SISTER CHROMATID COHESION,0.027226,0.16946,0.18422,1,1
7,GO REGULATION OF CENTROSOME DUPLICATION,0.01266,0.16935,0.19002,1,1
7,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.008797,0.16931,0.25398,1,1
7,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.014457,0.1693,0.20241,1,1
7,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0013481,0.16917,0.33427,1,1
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0044907,0.16917,0.1918,1,1
7,GO MUSCLE ORGAN DEVELOPMENT,0.00332,0.16916,0.21012,1,1
7,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.010101,0.16908,0.25147,1,1
7,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0023095,0.16904,0.34336,1,1
7,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.028348,0.16901,0.16792,1,1
7,GO ORGANIC ANION TRANSPORT,0.0017696,0.16894,0.20046,1,1
7,GO CEREBELLAR CORTEX FORMATION,0.0052065,0.16885,0.27278,1,1
7,GO PROTEOGLYCAN METABOLIC PROCESS,0.011063,0.16878,0.22635,1,1
7,GO ERAD PATHWAY,0.0020776,0.16866,0.21837,1,1
7,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0092139,0.16851,0.28896,1,1
7,GO REGULATION OF FATTY ACID OXIDATION,0.026142,0.16845,0.20686,1,1
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.027226,0.16844,0.16099,1,1
7,GO REGULATION OF MIRNA METABOLIC PROCESS,0.040368,0.16833,0.23552,1,1
7,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0049572,0.16833,0.19479,1,1
7,GO STRESS GRANULE ASSEMBLY,0.007293,0.16827,0.22568,1,1
7,GO LYSOSOMAL TRANSPORT,0.0031545,0.16822,0.27009,1,1
7,GO PROTEIN AUTOPHOSPHORYLATION,0.028348,0.16822,0.20899,1,1
7,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0036751,0.16821,0.18016,1,1
7,GO CELLULAR RESPONSE TO CALCIUM ION,0.0028457,0.16816,0.25921,1,1
7,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00072571,0.16814,0.19387,1,1
7,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0066311,0.16809,0.20416,1,1
7,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.010572,0.16807,0.25535,1,1
7,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0021907,0.16806,0.18906,1,1
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0040644,0.16806,0.21553,1,1
7,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00332,0.16804,0.19248,1,1
7,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0029965,0.16799,0.23901,1,1
7,GO MESENCHYME MORPHOGENESIS,0.052482,0.16783,0.19463,1,1
7,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.046961,0.16778,0.20471,1,1
7,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0025648,0.16764,0.18384,1,1
7,GO ERBB SIGNALING PATHWAY,0.011063,0.1676,0.20707,1,1
7,GO EPITHELIUM DEVELOPMENT,0.0040644,0.16751,0.19407,1,1
7,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0047188,0.1673,0.19614,1,1
7,GO CARDIAC CHAMBER DEVELOPMENT,0.01266,0.16724,0.2183,1,1
7,GO SPINDLE ORGANIZATION,0.040368,0.16722,0.19005,1,1
7,GO CELL CYCLE,0.0028457,0.16715,0.19124,1,1
7,GO MUSCLE CELL DIFFERENTIATION,0.0038653,0.16711,0.21895,1,1
7,GO VESICLE TARGETING,0.00060992,0.16703,0.23482,1,1
7,GO ALCOHOL METABOLIC PROCESS,0.00332,0.16701,0.18939,1,1
7,GO CELLULAR RESPONSE TO ALCOHOL,0.020391,0.16699,0.20662,1,1
7,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.027226,0.16682,0.16719,1,1
7,GO RESPONSE TO GROWTH FACTOR,0.00332,0.16682,0.21879,1,1
7,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0063209,0.16662,0.17992,1,1
7,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0012758,0.16658,0.18518,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.020391,0.16652,0.15405,1,1
7,GO POSITIVE REGULATION OF ANION TRANSPORT,0.033245,0.16652,0.17553,1,1
7,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.013235,0.16648,0.18909,1,1
7,GO PEPTIDYL CYSTEINE MODIFICATION,0.0014241,0.16634,0.20875,1,1
7,GO REGULATION OF GROWTH,0.0020776,0.1663,0.20291,1,1
7,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011063,0.16616,0.20029,1,1
7,GO GLYCOPROTEIN METABOLIC PROCESS,0.0057394,0.16615,0.19488,1,1
7,GO REGIONALIZATION,0.011574,0.16606,0.19198,1,1
7,GO CELL CYCLE PROCESS,0.0052065,0.166,0.1842,1,1
7,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00057531,0.166,0.17266,1,1
7,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.015776,0.1659,0.18755,1,1
7,GO CIRCADIAN RHYTHM,0.0060238,0.16585,0.19691,1,1
7,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0052065,0.16578,0.2645,1,1
7,GO REGULATION OF RIBOSOME BIOGENESIS,0.030713,0.16577,0.17558,1,1
7,GO ANIMAL ORGAN MORPHOGENESIS,0.007293,0.16575,0.19735,1,1
7,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0016767,0.16574,0.21392,1,1
7,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0054671,0.16563,0.22818,1,1
7,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.020391,0.16556,0.21974,1,1
7,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0020776,0.16553,0.28286,1,1
7,GO MUSCLE CELL FATE COMMITMENT,0.033245,0.16553,0.22443,1,1
7,GO PROTEIN K63 LINKED UBIQUITINATION,0.0060238,0.16534,0.18529,1,1
7,GO EMBRYO DEVELOPMENT,0.0031545,0.16534,0.21185,1,1
7,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.020391,0.16533,0.19929,1,1
7,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.030713,0.16532,0.27587,1,1
7,GO REGULATION OF MITOCHONDRIAL FISSION,0.0012071,0.16516,0.24853,1,1
7,GO FATTY ACID CATABOLIC PROCESS,0.00091199,0.16512,0.22196,1,1
7,GO PROTEIN POLYMERIZATION,0.0024341,0.1649,0.21883,1,1
7,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.025096,0.16488,0.20995,1,1
7,GO NEURON PROJECTION REGENERATION,0.012106,0.16479,0.2232,1,1
7,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.010101,0.16469,0.2112,1,1
7,GO LACTATION,0.018736,0.16465,0.21813,1,1
7,GO C4 DICARBOXYLATE TRANSPORT,0.0040644,0.16461,0.18959,1,1
7,GO REGULATION OF TRANSPORT,0.0054671,0.16459,0.20445,1,1
7,GO DNA CONFORMATION CHANGE,0.017954,0.16458,0.18637,1,1
7,GO CELLULAR LIPID CATABOLIC PROCESS,0.0060238,0.16447,0.18174,1,1
7,GO VESICLE DOCKING,0.00072571,0.16428,0.30665,1,1
7,GO CELL CYCLE ARREST,0.010572,0.16416,0.16598,1,1
7,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.013235,0.16403,0.1844,1,1
7,GO BODY FLUID SECRETION,0.0047188,0.16386,0.19557,1,1
7,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0036751,0.16367,0.18286,1,1
7,GO KETONE BODY METABOLIC PROCESS,0.0019699,0.16366,0.24037,1,1
7,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0038653,0.1634,0.22326,1,1
7,GO TUBE DEVELOPMENT,0.041938,0.16335,0.18039,1,1
7,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.016475,0.1633,0.17889,1,1
7,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0052065,0.16318,0.15955,1,1
7,GO REGULATION OF CELL DIVISION,0.012106,0.16318,0.17723,1,1
7,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0019699,0.16311,0.21956,1,1
7,GO MUSCLE SYSTEM PROCESS,0.0063209,0.16297,0.21436,1,1
7,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.041938,0.16292,0.16276,1,1
7,GO RNA PROCESSING,0.0015882,0.16284,0.17148,1,1
7,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0020776,0.16279,0.19612,1,1
7,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0047188,0.16277,0.16449,1,1
7,GO HAIR FOLLICLE MATURATION,0.025096,0.16266,0.21629,1,1
7,GO CELLULAR RESPONSE TO UV,0.0049572,0.1625,0.17229,1,1
7,GO ACTIN NUCLEATION,0.024086,0.16249,0.17505,1,1
7,GO TISSUE HOMEOSTASIS,0.01266,0.16237,0.20279,1,1
7,GO REGULATION OF MRNA 3 END PROCESSING,0.0096484,0.16227,0.21273,1,1
7,GO RESPONSE TO ESTRADIOL,0.015104,0.16215,0.17259,1,1
7,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.031957,0.16201,0.18049,1,1
7,GO DETECTION OF STIMULUS,0.00057531,0.16187,0.18504,1,1
7,GO NUCLEUS ORGANIZATION,0.00054254,0.16182,0.21757,1,1
7,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.015776,0.16175,0.18066,1,1
7,GO MACROMOLECULE DEPALMITOYLATION,0.0031545,0.16175,0.17296,1,1
7,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00096503,0.16172,0.20883,1,1
7,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0015882,0.16167,0.20717,1,1
7,GO CHEMICAL HOMEOSTASIS,0.013834,0.16144,0.17908,1,1
7,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0014241,0.16135,0.25581,1,1
7,GO SINGLE FERTILIZATION,0.0018673,0.16132,0.17546,1,1
7,GO RETINAL CONE CELL DIFFERENTIATION,0.0044907,0.16128,0.20671,1,1
7,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.01266,0.16126,0.21313,1,1
7,GO HEART TRABECULA MORPHOGENESIS,0.048745,0.16102,0.1885,1,1
7,GO FATTY ACID METABOLIC PROCESS,0.0049572,0.16085,0.17051,1,1
7,GO IRON ION TRANSPORT,0.0020776,0.16082,0.21507,1,1
7,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0031545,0.1606,0.19758,1,1
7,GO MITOCHONDRION MORPHOGENESIS,0.00068502,0.16057,0.19046,1,1
7,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0044907,0.16054,0.21464,1,1
7,GO AUTOPHAGOSOME MATURATION,0.0013481,0.16052,0.26679,1,1
7,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040368,0.16038,0.20053,1,1
7,GO PROTEIN DEPHOSPHORYLATION,0.0017696,0.16035,0.21369,1,1
7,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.010572,0.16031,0.21975,1,1
7,GO VASODILATION,0.045233,0.16025,0.17256,1,1
7,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0021907,0.16025,0.20675,1,1
7,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.028348,0.16012,0.22324,1,1
7,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.006955,0.15978,0.16494,1,1
7,GO CELLULAR RESPONSE TO KETONE,0.033245,0.15964,0.15117,1,1
7,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.030713,0.15958,0.19587,1,1
7,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0066311,0.15948,0.22936,1,1
7,GO NEUTRAL LIPID METABOLIC PROCESS,0.011574,0.15937,0.19321,1,1
7,GO NEGATIVE REGULATION OF CELL CYCLE,0.015104,0.15937,0.15182,1,1
7,GO RESPONSE TO CARBOHYDRATE,0.00332,0.15934,0.19747,1,1
7,GO RESPONSE TO RADIATION,0.00068502,0.15929,0.19287,1,1
7,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.011063,0.15922,0.17453,1,1
7,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0042727,0.15916,0.18932,1,1
7,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0038653,0.15906,0.23816,1,1
7,GO REGULATION OF GLUCOSE IMPORT,0.0057394,0.15901,0.20328,1,1
7,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0044907,0.15898,0.21351,1,1
7,GO POSITIVE REGULATION OF SECRETION,0.015776,0.15894,0.18489,1,1
7,GO MITOTIC NUCLEAR DIVISION,0.048745,0.15886,0.15795,1,1
7,GO GLIAL CELL DEVELOPMENT,0.046961,0.15886,0.15533,1,1
7,GO DNA REPAIR,0.0040644,0.1588,0.19364,1,1
7,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0019699,0.15879,0.23908,1,1
7,GO PH REDUCTION,0.021265,0.15868,0.15001,1,1
7,GO REGULATION OF SECRETION,0.010572,0.15857,0.19985,1,1
7,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.045233,0.15849,0.16938,1,1
7,GO TRNA METHYLATION,0.01266,0.15821,0.15783,1,1
7,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0034935,0.15817,0.18817,1,1
7,GO ENDOCRINE HORMONE SECRETION,0.019548,0.15809,0.17385,1,1
7,GO OSSIFICATION,0.041938,0.15807,0.16326,1,1
7,GO BASE EXCISION REPAIR,0.0080134,0.15793,0.18548,1,1
7,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0049572,0.15765,0.23699,1,1
7,GO UTP METABOLIC PROCESS,0.00332,0.1575,0.22559,1,1
7,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0027019,0.15736,0.20211,1,1
7,GO KERATINOCYTE DIFFERENTIATION,0.040368,0.15715,0.1411,1,1
7,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00332,0.15676,0.19621,1,1
7,GO LATERAL MESODERM DEVELOPMENT,0.023112,0.15659,0.20618,1,1
7,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.050584,0.15651,0.22359,1,1
7,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0044907,0.15651,0.21096,1,1
7,GO PROTEIN TARGETING TO VACUOLE,0.0054671,0.15636,0.21673,1,1
7,GO REGULATION OF FERTILIZATION,0.011063,0.15633,0.16222,1,1
7,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.018736,0.15594,0.19533,1,1
7,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.015104,0.15593,0.15723,1,1
7,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0096484,0.15584,0.22337,1,1
7,GO RNA STABILIZATION,0.014457,0.15583,0.17703,1,1
7,GO LIPID CATABOLIC PROCESS,0.012106,0.15574,0.16131,1,1
7,GO SULFUR COMPOUND TRANSPORT,0.0012071,0.15572,0.23123,1,1
7,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.012106,0.15559,0.19944,1,1
7,GO CELLULAR RESPONSE TO RADIATION,0.0060238,0.15553,0.14887,1,1
7,GO POSITIVE REGULATION OF ION TRANSPORT,0.0092139,0.15552,0.19184,1,1
7,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.016475,0.1555,0.15922,1,1
7,GO MIDBRAIN DEVELOPMENT,0.0060238,0.15532,0.16077,1,1
7,GO SPERM EGG RECOGNITION,0.0010209,0.15526,0.15197,1,1
7,GO ENDOCRINE PROCESS,0.043559,0.15523,0.15117,1,1
7,GO MUSCLE TISSUE DEVELOPMENT,0.0044907,0.15503,0.20528,1,1
7,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0023095,0.15498,0.21263,1,1
7,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.006955,0.15497,0.20922,1,1
7,GO GOLGI TO ENDOSOME TRANSPORT,0.0052065,0.15492,0.30469,1,1
7,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0172,0.15485,0.18844,1,1
7,GO EAR DEVELOPMENT,0.011574,0.15475,0.18322,1,1
7,GO CARBOHYDRATE PHOSPHORYLATION,0.031957,0.15474,0.1822,1,1
7,GO RESPONSE TO CAMP,0.046961,0.15465,0.14929,1,1
7,GO DNA METHYLATION OR DEMETHYLATION,0.015104,0.1546,0.17183,1,1
7,GO RESPONSE TO STEROID HORMONE,0.015104,0.15455,0.18146,1,1
7,GO GOLGI VESICLE TRANSPORT,0.00048214,0.15447,0.23734,1,1
7,GO ENDOSOMAL TRANSPORT,0.0011418,0.1544,0.23318,1,1
7,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.018736,0.15439,0.22662,1,1
7,GO REGULATION OF METAL ION TRANSPORT,0.014457,0.15432,0.20855,1,1
7,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0025648,0.1543,0.20991,1,1
7,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0021907,0.15421,0.17457,1,1
7,GO KETONE BIOSYNTHETIC PROCESS,0.0057394,0.15403,0.20674,1,1
7,GO PEPTIDYL METHIONINE MODIFICATION,0.011063,0.15389,0.18754,1,1
7,GO REGULATION OF ATPASE ACTIVITY,5.9985e-05,0.15388,0.19144,1,1
7,GO EMBRYONIC MORPHOGENESIS,0.0092139,0.15387,0.20106,1,1
7,GO CARDIOLIPIN METABOLIC PROCESS,0.021265,0.15386,0.14208,1,1
7,GO EMBRYONIC ORGAN DEVELOPMENT,0.014457,0.15382,0.19475,1,1
7,GO MUSCLE HYPERTROPHY,0.037377,0.15345,0.18128,1,1
7,GO REGULATION OF PROTEIN BINDING,0.0083971,0.15326,0.1973,1,1
7,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0044907,0.15303,0.21104,1,1
7,GO FAT CELL DIFFERENTIATION,0.030713,0.15301,0.1694,1,1
7,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0018673,0.15299,0.25519,1,1
7,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0015882,0.15297,0.18942,1,1
7,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.018736,0.15295,0.19637,1,1
7,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0038653,0.15266,0.18666,1,1
7,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0047188,0.1525,0.17945,1,1
7,GO DIENCEPHALON DEVELOPMENT,0.016475,0.15245,0.20354,1,1
7,GO KIDNEY MORPHOGENESIS,0.017954,0.15243,0.20425,1,1
7,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.010572,0.15242,0.18767,1,1
7,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0096484,0.15241,0.14887,1,1
7,GO VACUOLAR TRANSPORT,0.0015041,0.15239,0.25375,1,1
7,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0034935,0.15231,0.16275,1,1
7,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.024086,0.15225,0.2095,1,1
7,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011063,0.15224,0.16073,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.007293,0.1522,0.18747,1,1
7,GO NEGATIVE REGULATION OF CELL GROWTH,0.0083971,0.15216,0.19575,1,1
7,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00054254,0.15214,0.19538,1,1
7,GO PEPTIDYL ARGININE MODIFICATION,0.030713,0.15208,0.11972,1,1
7,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00042807,0.15196,0.21052,1,1
7,GO RNA MODIFICATION,0.0047188,0.15191,0.1529,1,1
7,GO TRANSITION METAL ION TRANSPORT,0.0025648,0.15191,0.18453,1,1
7,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.013235,0.15172,0.23848,1,1
7,GO RESPONSE TO INORGANIC SUBSTANCE,0.0092139,0.15171,0.16528,1,1
7,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.022172,0.15162,0.21845,1,1
7,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.048745,0.15158,0.15201,1,1
7,GO REGULATION OF MACROAUTOPHAGY,0.00048214,0.15157,0.23157,1,1
7,GO REGULATION OF GTPASE ACTIVITY,0.016475,0.15121,0.22117,1,1
7,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.015776,0.15118,0.1882,1,1
7,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.035953,0.15111,0.14143,1,1
7,GO ESTABLISHMENT OF CELL POLARITY,0.0063209,0.151,0.22806,1,1
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0031545,0.15091,0.21761,1,1
7,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0047188,0.15089,0.24649,1,1
7,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0066311,0.15049,0.15047,1,1
7,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0042727,0.15033,0.20529,1,1
7,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0015882,0.15031,0.20224,1,1
7,GO AUTOPHAGOSOME ORGANIZATION,0.00048214,0.15013,0.24916,1,1
7,GO ORGANELLE DISASSEMBLY,0.0003797,0.15009,0.22465,1,1
7,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.011574,0.15002,0.1907,1,1
7,GO NEURAL PRECURSOR CELL PROLIFERATION,0.02951,0.14985,0.18678,1,1
7,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0011418,0.14985,0.18454,1,1
7,GO FEMALE SEX DIFFERENTIATION,0.019548,0.14984,0.17153,1,1
7,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00081392,0.14983,0.19981,1,1
7,GO NEGATIVE REGULATION OF CELL AGING,0.026142,0.14979,0.1602,1,1
7,GO ACTIVATION OF GTPASE ACTIVITY,0.013834,0.14966,0.27789,1,1
7,GO STEROL BIOSYNTHETIC PROCESS,0.0063209,0.14961,0.16163,1,1
7,GO REGULATION OF CYTOKINESIS,0.010572,0.1496,0.19246,1,1
7,GO MOTOR NEURON AXON GUIDANCE,0.046961,0.1495,0.20454,1,1
7,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0024341,0.14943,0.18023,1,1
7,GO MESODERM DEVELOPMENT,0.019548,0.14936,0.16856,1,1
7,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0040644,0.14932,0.19088,1,1
7,GO RETINA HOMEOSTASIS,0.00091199,0.14931,0.26796,1,1
7,GO RESPONSE TO PEPTIDE HORMONE,0.0057394,0.1493,0.17822,1,1
7,GO MACROAUTOPHAGY,0.00042807,0.14929,0.21963,1,1
7,GO PROTEIN K48 LINKED UBIQUITINATION,0.010572,0.14925,0.17591,1,1
7,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.018736,0.14902,0.17888,1,1
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0040644,0.14888,0.16312,1,1
7,GO RNA METHYLATION,0.0063209,0.14885,0.1654,1,1
7,GO CELLULAR HOMEOSTASIS,0.023112,0.14865,0.15232,1,1
7,GO NUCLEOTIDE PHOSPHORYLATION,0.0092139,0.1486,0.17027,1,1
7,GO POSITIVE REGULATION OF CYTOKINESIS,0.011063,0.14844,0.18738,1,1
7,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0042727,0.1483,0.17825,1,1
7,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.024086,0.14824,0.17847,1,1
7,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.019548,0.14821,0.18806,1,1
7,GO NADP METABOLIC PROCESS,0.017954,0.14817,0.13612,1,1
7,GO LAMELLIPODIUM ASSEMBLY,0.018736,0.14809,0.19917,1,1
7,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0054671,0.14803,0.22907,1,1
7,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0047188,0.14789,0.18125,1,1
7,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.041938,0.14788,0.16892,1,1
7,GO MONOCARBOXYLIC ACID TRANSPORT,0.020391,0.14788,0.17027,1,1
7,GO DIVALENT INORGANIC CATION TRANSPORT,0.019548,0.14787,0.19298,1,1
7,GO LIMBIC SYSTEM DEVELOPMENT,0.0172,0.1478,0.17847,1,1
7,GO PROTEIN CATABOLIC PROCESS,0.0018673,0.14779,0.18325,1,1
7,GO CELLULAR RESPONSE TO CHOLESTEROL,0.012106,0.14766,0.27709,1,1
7,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.011574,0.14761,0.18295,1,1
7,GO TISSUE MORPHOGENESIS,0.011063,0.14755,0.18416,1,1
7,GO RESPONSE TO METAL ION,0.0066311,0.14737,0.17215,1,1
7,GO NEUROTROPHIN SIGNALING PATHWAY,0.037377,0.1472,0.17511,1,1
7,GO LAMELLIPODIUM ORGANIZATION,0.024086,0.14706,0.1877,1,1
7,GO PIRNA METABOLIC PROCESS,0.034576,0.14691,0.14319,1,1
7,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0092139,0.1469,0.19247,1,1
7,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0040644,0.14683,0.21751,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.008797,0.14679,0.18144,1,1
7,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0016767,0.14651,0.18332,1,1
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0052065,0.14645,0.19195,1,1
7,GO INTRACELLULAR TRANSPORT,0.0003797,0.14641,0.19136,1,1
7,GO RRNA TRANSCRIPTION,0.0096484,0.1463,0.18532,1,1
7,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.017954,0.14605,0.15643,1,1
7,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.050584,0.14605,0.18817,1,1
7,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0066311,0.14588,0.15452,1,1
7,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0049572,0.14587,0.19137,1,1
7,GO RESPONSE TO HORMONE,0.013834,0.14574,0.17177,1,1
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0015041,0.14566,0.17721,1,1
7,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.015776,0.14554,0.15489,1,1
7,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0040644,0.14545,0.17865,1,1
7,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0020776,0.14541,0.19304,1,1
7,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.00091199,0.14538,0.1745,1,1
7,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00332,0.1452,0.1988,1,1
7,GO EPITHELIAL TUBE MORPHOGENESIS,0.011574,0.1452,0.20646,1,1
7,GO REGULATION OF REPRODUCTIVE PROCESS,0.014457,0.14503,0.14986,1,1
7,GO HOMEOSTATIC PROCESS,0.010101,0.14503,0.17015,1,1
7,GO CELL FATE DETERMINATION,0.0076456,0.14485,0.22104,1,1
7,GO NCRNA TRANSCRIPTION,0.0015041,0.14475,0.18912,1,1
7,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00033648,0.14457,0.23796,1,1
7,GO DNA METABOLIC PROCESS,0.0057394,0.14445,0.17075,1,1
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.006955,0.14432,0.23264,1,1
7,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0016767,0.14427,0.17527,1,1
7,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00051151,0.14425,0.20466,1,1
7,GO NEGATIVE REGULATION OF SIGNALING,0.007293,0.14421,0.19181,1,1
7,GO VIRAL BUDDING,0.0015882,0.14416,0.16746,1,1
7,GO PROTEIN MONOUBIQUITINATION,0.0036751,0.14391,0.21183,1,1
7,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011574,0.14391,0.19455,1,1
7,GO EMBRYONIC EYE MORPHOGENESIS,0.014457,0.1438,0.25073,1,1
7,GO PEPTIDE SECRETION,0.021265,0.14361,0.18445,1,1
7,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0031545,0.1436,0.17798,1,1
7,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0080134,0.14356,0.1809,1,1
7,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.008797,0.14351,0.17737,1,1
7,GO REGULATION OF MRNA METABOLIC PROCESS,0.0021907,0.14349,0.18288,1,1
7,GO MONOSACCHARIDE METABOLIC PROCESS,0.0057394,0.14331,0.16585,1,1
7,GO REGULATION OF DNA REPLICATION,0.030713,0.1433,0.15651,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.014457,0.14329,0.15662,1,1
7,GO ANION HOMEOSTASIS,0.027226,0.14316,0.18072,1,1
7,GO MAMMARY GLAND DEVELOPMENT,0.0092139,0.14311,0.22345,1,1
7,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.006955,0.14303,0.19498,1,1
7,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0034935,0.14275,0.22837,1,1
7,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0042727,0.14264,0.19198,1,1
7,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.015776,0.1426,0.17021,1,1
7,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.028348,0.14255,0.15663,1,1
7,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0044907,0.14252,0.1926,1,1
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.015776,0.14251,0.1539,1,1
7,GO NEGATIVE REGULATION OF RNA SPLICING,0.019548,0.14251,0.16621,1,1
7,GO AMINO ACID ACTIVATION,0.011063,0.14237,0.13156,1,1
7,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0060238,0.14233,0.22752,1,1
7,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0016767,0.14209,0.20633,1,1
7,GO DORSAL VENTRAL AXIS SPECIFICATION,0.022172,0.14207,0.23257,1,1
7,GO ESTABLISHMENT OF RNA LOCALIZATION,0.007293,0.14206,0.1684,1,1
7,GO SMALL MOLECULE CATABOLIC PROCESS,0.0054671,0.14195,0.15713,1,1
7,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0025648,0.14175,0.21445,1,1
7,GO ACTIN FILAMENT ORGANIZATION,0.010572,0.14175,0.20843,1,1
7,GO VESICLE ORGANIZATION,0.0013481,0.14173,0.22596,1,1
7,GO RESPONSE TO INSULIN,0.0063209,0.1416,0.1803,1,1
7,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0025648,0.14157,0.178,1,1
7,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0057394,0.14156,0.18526,1,1
7,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.026142,0.14148,0.26213,1,1
7,GO MODULATION BY VIRUS OF HOST PROCESS,0.0096484,0.14147,0.17171,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.041938,0.14139,0.14729,1,1
7,GO EMBRYONIC ORGAN MORPHOGENESIS,0.015104,0.14134,0.19651,1,1
7,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.020391,0.14125,0.1719,1,1
7,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.040368,0.14118,0.22857,1,1
7,GO DNA CATABOLIC PROCESS,0.0042727,0.14115,0.1712,1,1
7,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0017696,0.14112,0.18993,1,1
7,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0042727,0.14107,0.16635,1,1
7,GO REGULATION OF CATABOLIC PROCESS,0.0023095,0.141,0.1854,1,1
7,GO REGULATION OF PROTEIN FOLDING,0.0038653,0.14079,0.20542,1,1
7,GO CELLULAR COMPONENT DISASSEMBLY,0.0025648,0.14069,0.16899,1,1
7,GO STEM CELL DIFFERENTIATION,0.026142,0.14065,0.15248,1,1
7,GO RNA SURVEILLANCE,0.022172,0.1406,0.13658,1,1
7,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0080134,0.14058,0.17787,1,1
7,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0015041,0.14051,0.17044,1,1
7,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0031545,0.14047,0.19933,1,1
7,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.012106,0.14039,0.17547,1,1
7,GO MORPHOGENESIS OF AN EPITHELIUM,0.021265,0.14033,0.18006,1,1
7,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0076456,0.14032,0.1865,1,1
7,GO PROTEOLYSIS,0.0042727,0.14017,0.17771,1,1
7,GO PEPTIDYL AMINO ACID MODIFICATION,0.0040644,0.1401,0.20031,1,1
7,GO MITOTIC CELL CYCLE CHECKPOINT,0.033245,0.14007,0.17768,1,1
7,GO PIGMENT BIOSYNTHETIC PROCESS,0.00054254,0.14006,0.15878,1,1
7,GO CELLULAR LIPID METABOLIC PROCESS,0.0052065,0.13998,0.18061,1,1
7,GO RESPONSE TO NITROGEN COMPOUND,0.0083971,0.13995,0.17467,1,1
7,GO PHAGOSOME MATURATION,0.006955,0.1399,0.22003,1,1
7,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00086166,0.13985,0.22905,1,1
7,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0017696,0.13975,0.16774,1,1
7,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0042727,0.1397,0.2454,1,1
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00040321,0.13965,0.16625,1,1
7,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.011063,0.13961,0.18081,1,1
7,GO NEGATIVE REGULATION OF NEURON DEATH,0.017954,0.13949,0.17752,1,1
7,GO REGULATION OF PROTEIN LOCALIZATION,0.0042727,0.13937,0.18213,1,1
7,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.026142,0.13935,0.27603,1,1
7,GO SPHINGOLIPID METABOLIC PROCESS,0.0096484,0.13934,0.18362,1,1
7,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.013834,0.13917,0.20117,1,1
7,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0012071,0.13914,0.17356,1,1
7,GO REGULATION OF CELL CYCLE PROCESS,0.007293,0.13912,0.17012,1,1
7,GO SEX DIFFERENTIATION,0.0172,0.13909,0.16086,1,1
7,GO CELL DIVISION,0.013834,0.13902,0.17499,1,1
7,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0044907,0.13898,0.19869,1,1
7,GO SNRNA TRANSCRIPTION,0.0047188,0.13895,0.17327,1,1
7,GO PHAGOSOME ACIDIFICATION,0.0054671,0.13852,0.18957,1,1
7,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0012758,0.13839,0.2111,1,1
7,GO CELL CELL SIGNALING BY WNT,0.00332,0.13825,0.20008,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.035953,0.13799,0.1674,1,1
7,GO REGULATION OF ENDOCYTOSIS,0.033245,0.13793,0.20056,1,1
7,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0024341,0.1379,0.20172,1,1
7,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.013834,0.13779,0.14238,1,1
7,GO HORMONE BIOSYNTHETIC PROCESS,0.0040644,0.13777,0.16666,1,1
7,GO GLUCOSE IMPORT,0.006955,0.13733,0.1922,1,1
7,GO POSITIVE REGULATION OF HEART GROWTH,0.038848,0.1372,0.17882,1,1
7,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0054671,0.13716,0.19822,1,1
7,GO DNA GEOMETRIC CHANGE,0.038848,0.13715,0.16321,1,1
7,GO NEGATIVE REGULATION OF GROWTH,0.021265,0.13712,0.16257,1,1
7,GO HEART GROWTH,0.020391,0.1371,0.18002,1,1
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.015776,0.137,0.20594,1,1
7,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0096484,0.13696,0.21172,1,1
7,GO REGULATION OF PROTEIN TARGETING,0.0066311,0.13669,0.20327,1,1
7,GO ORGAN GROWTH,0.014457,0.13664,0.1882,1,1
7,GO PROTEIN TARGETING TO MITOCHONDRION,0.0014241,0.13655,0.13369,1,1
7,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.010572,0.13649,0.16624,1,1
7,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.010101,0.13634,0.21949,1,1
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.028348,0.13629,0.12354,1,1
7,GO NUCLEAR EXPORT,0.0063209,0.13591,0.17819,1,1
7,GO MITOTIC CELL CYCLE,0.012106,0.13588,0.16832,1,1
7,GO EPITHELIAL CELL DEVELOPMENT,0.0040644,0.13585,0.22463,1,1
7,GO SULFUR COMPOUND METABOLIC PROCESS,0.0028457,0.13582,0.166,1,1
7,GO REGULATION OF ATP METABOLIC PROCESS,0.0080134,0.13582,0.16304,1,1
7,GO MUSCLE ORGAN MORPHOGENESIS,0.017954,0.13579,0.21381,1,1
7,GO MAINTENANCE OF CELL NUMBER,0.0063209,0.13575,0.19367,1,1
7,GO REGULATION OF PEPTIDE TRANSPORT,0.012106,0.13563,0.17394,1,1
7,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.022172,0.1356,0.15694,1,1
7,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.016475,0.13553,0.18437,1,1
7,GO SNRNA PROCESSING,0.0066311,0.13537,0.13518,1,1
7,GO STRIATED MUSCLE CELL PROLIFERATION,0.035953,0.13531,0.16925,1,1
7,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.013235,0.13523,0.20305,1,1
7,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015104,0.13522,0.18134,1,1
7,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0024341,0.13503,0.14718,1,1
7,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0031545,0.13499,0.17446,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00076864,0.13464,0.21844,1,1
7,GO TEMPERATURE HOMEOSTASIS,0.016475,0.1346,0.16793,1,1
7,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.02951,0.13448,0.1615,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.020391,0.13441,0.17424,1,1
7,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0049572,0.13423,0.16541,1,1
7,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035953,0.13423,0.13082,1,1
7,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.006955,0.13415,0.19038,1,1
7,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.008797,0.13396,0.21933,1,1
7,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0049572,0.13382,0.18552,1,1
7,GO MITOCHONDRIAL DNA REPLICATION,0.027226,0.13374,0.14955,1,1
7,GO LIPID METABOLIC PROCESS,0.0047188,0.13361,0.17911,1,1
7,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0047188,0.13322,0.17735,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0024341,0.13318,0.20454,1,1
7,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.026142,0.13312,0.17866,1,1
7,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.010572,0.13296,0.18515,1,1
7,GO REGULATION OF DEACETYLASE ACTIVITY,0.007293,0.13278,0.25771,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.010572,0.13275,0.15109,1,1
7,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.019548,0.13267,0.18559,1,1
7,GO EXECUTION PHASE OF APOPTOSIS,0.0080134,0.13267,0.172,1,1
7,GO PEROXISOMAL MEMBRANE TRANSPORT,0.011063,0.13264,0.20448,1,1
7,GO RESPONSE TO PEPTIDE,0.01266,0.1326,0.17009,1,1
7,GO RESPONSE TO DRUG,0.013834,0.13258,0.15629,1,1
7,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0063209,0.1323,0.17184,1,1
7,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0014241,0.13225,0.24167,1,1
7,GO MUSCLE CELL DEVELOPMENT,0.0057394,0.13192,0.20663,1,1
7,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0057394,0.13181,0.20163,1,1
7,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0042727,0.13175,0.18374,1,1
7,GO INTRACELLULAR PROTEIN TRANSPORT,0.00040321,0.13154,0.17352,1,1
7,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0029965,0.13137,0.17946,1,1
7,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0066311,0.1312,0.18167,1,1
7,GO VIRAL RELEASE FROM HOST CELL,0.0031545,0.13109,0.16907,1,1
7,GO MODIFIED AMINO ACID TRANSPORT,0.0049572,0.13107,0.22438,1,1
7,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.026142,0.13094,0.17191,1,1
7,GO POLYOL BIOSYNTHETIC PROCESS,0.0049572,0.13061,0.16793,1,1
7,GO INTRACELLULAR LIPID TRANSPORT,0.031957,0.13,0.17705,1,1
7,GO RESPONSE TO PH,0.048745,0.12997,0.19538,1,1
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.013834,0.12968,0.21358,1,1
7,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.038848,0.12962,0.10904,1,1
7,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0096484,0.1293,0.16627,1,1
7,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.010572,0.12907,0.13294,1,1
7,GO STEROID BIOSYNTHETIC PROCESS,0.0054671,0.12873,0.14792,1,1
7,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0080134,0.12872,0.22338,1,1
7,GO NUCLEOTIDE EXCISION REPAIR,0.0029965,0.12864,0.15616,1,1
7,GO CARTILAGE DEVELOPMENT,0.046961,0.12863,0.17955,1,1
7,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0036751,0.12862,0.15351,1,1
7,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0049572,0.12845,0.15485,1,1
7,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0080134,0.12814,0.18328,1,1
7,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.013834,0.12783,0.17793,1,1
7,GO TETRAPYRROLE METABOLIC PROCESS,0.0054671,0.12722,0.14652,1,1
7,GO CYTOKINETIC PROCESS,0.00051151,0.12694,0.19825,1,1
7,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.035953,0.12688,0.15603,1,1
7,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0096484,0.12678,0.17318,1,1
7,GO CELL CYCLE G2 M PHASE TRANSITION,0.026142,0.12678,0.14898,1,1
7,GO MRNA METABOLIC PROCESS,0.0052065,0.12674,0.13492,1,1
7,GO MITOCHONDRIAL FUSION,0.00332,0.12643,0.1914,1,1
7,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0011418,0.12641,0.15913,1,1
7,GO REGULATION OF AUTOPHAGY,0.0040644,0.12626,0.21084,1,1
7,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.013834,0.12621,0.16375,1,1
7,GO MULTIVESICULAR BODY ORGANIZATION,0.0012071,0.12616,0.1596,1,1
7,GO CELLULAR RESPONSE TO STARVATION,0.0052065,0.12613,0.18797,1,1
7,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0025648,0.12603,0.15731,1,1
7,GO REGULATION OF PROTEIN STABILITY,0.0047188,0.12588,0.15495,1,1
7,GO CARBOHYDRATE METABOLIC PROCESS,0.0040644,0.12579,0.17278,1,1
7,GO CERAMIDE METABOLIC PROCESS,0.0080134,0.12563,0.18537,1,1
7,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0057394,0.12547,0.17306,1,1
7,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0027019,0.12537,0.18043,1,1
7,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.012106,0.12536,0.1772,1,1
7,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.010101,0.12532,0.13824,1,1
7,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0014241,0.12512,0.19781,1,1
7,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.023112,0.12509,0.13035,1,1
7,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.02951,0.12481,0.15764,1,1
7,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.021265,0.12434,0.15613,1,1
7,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.010101,0.12432,0.19043,1,1
7,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0036751,0.12423,0.18269,1,1
7,GO REGULATION OF BEHAVIOR,0.048745,0.12417,0.13672,1,1
7,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0024341,0.12413,0.20143,1,1
7,GO RESPONSE TO AMINO ACID STARVATION,0.010101,0.12399,0.17523,1,1
7,GO COENZYME A METABOLIC PROCESS,0.011574,0.12385,0.14401,1,1
7,GO REGULATION OF MITOTIC CELL CYCLE,0.010572,0.1238,0.16254,1,1
7,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.007293,0.12367,0.14021,1,1
7,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.046961,0.12365,0.11785,1,1
7,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.024086,0.1234,0.14858,1,1
7,GO NUCLEAR TRANSPORT,0.014457,0.12338,0.15588,1,1
7,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.050584,0.12324,0.17539,1,1
7,GO REGULATION OF GENE SILENCING,0.0096484,0.12284,0.17638,1,1
7,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0083971,0.12276,0.1666,1,1
7,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.013834,0.1227,0.16079,1,1
7,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.00332,0.1226,0.14852,1,1
7,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.026142,0.12224,0.15202,1,1
7,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0023095,0.12219,0.14571,1,1
7,GO PROTEIN DESTABILIZATION,0.0063209,0.12182,0.1767,1,1
7,GO PEROXISOME ORGANIZATION,0.011063,0.12169,0.15271,1,1
7,GO NEGATIVE REGULATION OF ION TRANSPORT,0.022172,0.12129,0.17222,1,1
7,GO ESTROGEN METABOLIC PROCESS,0.050584,0.12112,0.18285,1,1
7,GO ORGANELLE INHERITANCE,0.0018673,0.12108,0.17655,1,1
7,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.015104,0.12107,0.1649,1,1
7,GO RNA LOCALIZATION,0.013235,0.12101,0.1518,1,1
7,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.0080134,0.12096,0.13322,1,1
7,GO MACROMOLECULE CATABOLIC PROCESS,0.0025648,0.12084,0.15275,1,1
7,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00045436,0.1207,0.17561,1,1
7,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.013235,0.12065,0.14968,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.046961,0.12064,0.15679,1,1
7,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.013834,0.12056,0.17559,1,1
7,GO QUINONE METABOLIC PROCESS,0.025096,0.12055,0.10151,1,1
7,GO CELL CYCLE PHASE TRANSITION,0.026142,0.11996,0.14564,1,1
7,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0060238,0.11967,0.16906,1,1
7,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.020391,0.11894,0.16314,1,1
7,GO REGULATION OF CELL DIFFERENTIATION,0.016475,0.11886,0.17652,1,1
7,GO ENDOSOME ORGANIZATION,0.0019699,0.11873,0.18616,1,1
7,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0042727,0.11872,0.14259,1,1
7,GO PROTEIN TETRAMERIZATION,0.023112,0.11867,0.1619,1,1
7,GO REGULATION OF DNA METABOLIC PROCESS,0.0057394,0.11848,0.17394,1,1
7,GO PIGMENT GRANULE ORGANIZATION,0.046961,0.11835,0.15025,1,1
7,GO MITOCHONDRIAL TRANSPORT,0.00076864,0.1181,0.15239,1,1
7,GO SKELETAL MUSCLE CONTRACTION,0.0054671,0.11793,0.28627,1,1
7,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.035953,0.11764,0.1603,1,1
7,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.016475,0.11751,0.17159,1,1
7,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0034935,0.11734,0.14122,1,1
7,GO UBIQUINONE METABOLIC PROCESS,0.0038653,0.1173,0.1471,1,1
7,GO RESPONSE TO ABIOTIC STIMULUS,0.0049572,0.11721,0.15724,1,1
7,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.023112,0.1171,0.17144,1,1
7,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.010572,0.11695,0.17757,1,1
7,GO REGULATION OF STEROID METABOLIC PROCESS,0.016475,0.11688,0.14671,1,1
7,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.037377,0.11684,0.17163,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.018736,0.11683,0.1485,1,1
7,GO CARDIOCYTE DIFFERENTIATION,0.02951,0.11673,0.18732,1,1
7,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.015104,0.11655,0.16547,1,1
7,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.024086,0.11651,0.13006,1,1
7,GO MAINTENANCE OF PROTEIN LOCATION,0.0076456,0.11643,0.15212,1,1
7,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.010101,0.11633,0.24132,1,1
7,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.023112,0.11632,0.14592,1,1
7,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0060238,0.11619,0.16878,1,1
7,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.006955,0.11601,0.16377,1,1
7,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.024086,0.11594,0.15474,1,1
7,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.040368,0.11567,0.20248,1,1
7,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0042727,0.11564,0.14862,1,1
7,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0172,0.11554,0.13082,1,1
7,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010572,0.11508,0.19324,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.007293,0.11502,0.16404,1,1
7,GO RRNA CATABOLIC PROCESS,0.034576,0.11483,0.16221,1,1
7,GO NEURON APOPTOTIC PROCESS,0.014457,0.11468,0.16862,1,1
7,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007293,0.11464,0.17943,1,1
7,GO REGULATION OF DNA RECOMBINATION,0.037377,0.11456,0.16706,1,1
7,GO PROTEIN SUMOYLATION,0.0076456,0.1144,0.1875,1,1
7,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.018736,0.11439,0.15043,1,1
7,GO NCRNA CATABOLIC PROCESS,0.0060238,0.1139,0.17877,1,1
7,GO FATTY ACYL COA METABOLIC PROCESS,0.011574,0.11357,0.15843,1,1
7,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.027226,0.11352,0.11046,1,1
7,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.02951,0.11305,0.1724,1,1
7,GO CELLULAR RESPONSE TO PEPTIDE,0.015776,0.11293,0.17388,1,1
7,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0034935,0.11288,0.14549,1,1
7,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.045233,0.11287,0.12637,1,1
7,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.011574,0.11284,0.17158,1,1
7,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.027226,0.11255,0.11666,1,1
7,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.015776,0.11247,0.1466,1,1
7,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.040368,0.11242,0.10763,1,1
7,GO NEGATIVE REGULATION OF TRANSPORT,0.052482,0.11235,0.13283,1,1
7,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0063209,0.1121,0.17011,1,1
7,GO HEMOGLOBIN METABOLIC PROCESS,0.0092139,0.11206,0.19737,1,1
7,GO COPII COATED VESICLE CARGO LOADING,0.026142,0.11202,0.21286,1,1
7,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0076456,0.11202,0.1757,1,1
7,GO MEMBRANE LIPID METABOLIC PROCESS,0.0054671,0.11161,0.1828,1,1
7,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.043559,0.1114,0.14933,1,1
7,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.007293,0.11137,0.17361,1,1
7,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.007293,0.11082,0.2068,1,1
7,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.033245,0.11067,0.15496,1,1
7,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.052482,0.11056,0.11991,1,1
7,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.038848,0.11042,0.14711,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.030713,0.11017,0.12944,1,1
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.040368,0.1101,0.14025,1,1
7,GO TELOMERE ORGANIZATION,0.031957,0.10998,0.15403,1,1
7,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.021265,0.10944,0.1573,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.035953,0.10933,0.16073,1,1
7,GO ENERGY RESERVE METABOLIC PROCESS,0.010101,0.1088,0.19057,1,1
7,GO TRNA WOBBLE URIDINE MODIFICATION,0.038848,0.10844,0.12763,1,1
7,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.027226,0.10799,0.14194,1,1
7,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0054671,0.10792,0.15353,1,1
7,GO REGULATION OF NUCLEAR DIVISION,0.016475,0.10741,0.15686,1,1
7,GO NEURON DEATH,0.030713,0.10724,0.16788,1,1
7,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.011063,0.1065,0.17853,1,1
7,GO SNRNA METABOLIC PROCESS,0.0080134,0.10648,0.13322,1,1
7,GO MITOCHONDRION ORGANIZATION,0.00029789,0.10643,0.14458,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0172,0.10628,0.16965,1,1
7,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.046961,0.1062,0.21593,1,1
7,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.035953,0.10611,0.13273,1,1
7,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.026142,0.10598,0.14258,1,1
7,GO REGULATION OF MULTI ORGANISM PROCESS,0.038848,0.10586,0.12906,1,1
7,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.019548,0.10561,0.1611,1,1
7,GO PEROXISOMAL TRANSPORT,0.015104,0.10487,0.12857,1,1
7,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.013235,0.10478,0.16294,1,1
7,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.007293,0.10451,0.14233,1,1
7,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.023112,0.10433,0.17809,1,1
7,GO MALE SEX DIFFERENTIATION,0.017954,0.10403,0.17221,1,1
7,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0060238,0.10297,0.14122,1,1
7,GO RESPONSE TO TEMPERATURE STIMULUS,0.014457,0.10295,0.15317,1,1
7,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0172,0.10294,0.19791,1,1
7,GO RNA CAPPING,0.017954,0.10206,0.11556,1,1
7,GO PIGMENT METABOLIC PROCESS,0.00332,0.10166,0.14265,1,1
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0036751,0.101,0.14855,1,1
7,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.038848,0.099996,0.14776,1,1
7,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.02951,0.099414,0.16805,1,1
7,GO PROTEIN FOLDING,0.0015882,0.099096,0.14457,1,1
7,GO LIPOSACCHARIDE METABOLIC PROCESS,0.010101,0.098486,0.16152,1,1
7,GO OXIDATION REDUCTION PROCESS,0.0040644,0.098447,0.13568,1,1
7,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.022172,0.097858,0.16182,1,1
7,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0025648,0.097562,0.153,1,1
7,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0013481,0.095874,0.13537,1,1
7,GO GLAND DEVELOPMENT,0.018736,0.095794,0.17708,1,1
7,GO ALPHA AMINO ACID METABOLIC PROCESS,0.007293,0.095451,0.14044,1,1
7,GO BLASTOCYST DEVELOPMENT,0.0052065,0.095012,0.14504,1,1
7,GO DNA BIOSYNTHETIC PROCESS,0.0054671,0.092366,0.15086,1,1
7,GO MITOTIC CYTOKINETIC PROCESS,0.0017696,0.091713,0.15559,1,1
7,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.041938,0.091597,0.18492,1,1
7,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.019548,0.091378,0.13723,1,1
7,GO REGULATION OF ERAD PATHWAY,0.028348,0.091008,0.15873,1,1
7,GO REGULATION OF ORGAN GROWTH,0.048745,0.090125,0.1607,1,1
7,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.012106,0.088387,0.14387,1,1
7,GO MULTIVESICULAR BODY SORTING PATHWAY,0.022172,0.087166,0.14357,1,1
7,GO RESPONSE TO ETHANOL,0.038848,0.085623,0.14244,1,1
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.052482,0.083488,0.13195,1,1
7,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.024086,0.082631,0.11277,1,1
7,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.045233,0.079268,0.077172,1,1
7,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0054671,0.076435,0.10505,1,1
7,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.046961,0.076038,0.16871,1,1
7,GO PEPTIDE BIOSYNTHETIC PROCESS,0.021265,0.071909,0.074566,1,1
7,GO AMIDE BIOSYNTHETIC PROCESS,0.01266,0.069997,0.088409,1,1
7,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.046961,0.065361,0.080892,1,1
7,GO PEPTIDE METABOLIC PROCESS,0.0052065,0.062985,0.090118,1,1
7,GO CELLULAR AMIDE METABOLIC PROCESS,0.0042727,0.062788,0.10211,1,1
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.027226,0.056418,0.063004,1,1
7,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0054671,0.57552,0.47552,1,0
7,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0047188,0.4513,0.36226,1,0
7,GO MICROTUBULE DEPOLYMERIZATION,0.0049572,0.44021,0.34564,1,0
7,GO CENTRIOLE CENTRIOLE COHESION,0.0044907,0.43717,0.40037,1,0
7,GO DISTAL TUBULE DEVELOPMENT,0.030713,0.42786,0.35046,1,0
7,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0044907,0.40892,0.43638,1,0
7,GO POSTSYNAPSE ASSEMBLY,0.0025648,0.38387,0.43334,1,0
7,GO LIMB BUD FORMATION,0.020391,0.38023,0.30958,1,0
7,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0034935,0.37444,0.39744,1,0
7,GO VOCALIZATION BEHAVIOR,0.006955,0.37224,0.3533,1,0
7,GO SYNAPTIC VESICLE CLUSTERING,0.0012758,0.3581,0.48736,1,0
7,GO REGULATION OF MICROTUBULE BINDING,0.0012758,0.35772,0.33263,1,0
7,GO REGULATION OF SYNAPSE MATURATION,0.026142,0.34354,0.29474,1,0
7,GO SYNAPTIC VESICLE PRIMING,0.00045436,0.34193,0.52784,1,0
7,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0042727,0.33131,0.31106,1,0
7,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0011418,0.32868,0.52694,1,0
7,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0054671,0.32156,0.35694,1,0
7,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.019548,0.32056,0.35928,1,0
7,GO ATRIAL SEPTUM DEVELOPMENT,0.0083971,0.30933,0.30639,1,0
7,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0080134,0.30656,0.38734,1,0
7,GO CARDIAC CHAMBER FORMATION,0.045233,0.30527,0.22401,1,0
7,GO RETROGRADE AXONAL TRANSPORT,0.008797,0.30425,0.32845,1,0
7,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0040644,0.3039,0.3417,1,0
7,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0016767,0.30283,0.38663,1,0
7,GO SYNAPTIC VESICLE MATURATION,0.0015882,0.30073,0.477,1,0
7,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0063209,0.29651,0.32318,1,0
7,GO CEREBRAL CORTEX CELL MIGRATION,0.00332,0.29636,0.30424,1,0
7,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0029965,0.28974,0.33212,1,0
7,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0029965,0.28604,0.4209,1,0
7,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.010572,0.28538,0.32148,1,0
7,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.02951,0.28458,0.25014,1,0
7,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0025648,0.28344,0.33333,1,0
7,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.020391,0.2824,0.32272,1,0
7,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0060238,0.28046,0.33415,1,0
7,GO REGULATION OF DOPAMINE SECRETION,0.0018673,0.27208,0.44062,1,0
7,GO EPITHELIAL CELL MORPHOGENESIS,0.0052065,0.26946,0.29336,1,0
7,GO MEMBRANE HYPERPOLARIZATION,0.013235,0.26649,0.26521,1,0
7,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.015104,0.26618,0.27325,1,0
7,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0015882,0.26483,0.3118,1,0
7,GO CARDIAC ATRIUM DEVELOPMENT,0.019548,0.26172,0.27231,1,0
7,GO RESPONSE TO ACETYLCHOLINE,0.015776,0.26063,0.28082,1,0
7,GO NEURON RECOGNITION,0.016475,0.25975,0.28743,1,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.020391,0.25974,0.31032,1,0
7,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.006955,0.25902,0.26528,1,0
7,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.013235,0.258,0.30169,1,0
7,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.043559,0.25672,0.20302,1,0
7,GO HISTONE H3 K36 METHYLATION,0.0060238,0.25456,0.32849,1,0
7,GO SECONDARY HEART FIELD SPECIFICATION,0.016475,0.24844,0.32329,1,0
7,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.052482,0.24824,0.37418,1,0
7,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.023112,0.24685,0.23182,1,0
7,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.033245,0.24159,0.29979,1,0
7,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.050584,0.23717,0.20836,1,0
7,GO SPERMATID NUCLEUS DIFFERENTIATION,0.0083971,0.2363,0.22504,1,0
7,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.048745,0.23609,0.23481,1,0
7,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.045233,0.23563,0.24373,1,0
7,GO FIBROBLAST ACTIVATION,0.041938,0.23431,0.19084,1,0
7,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00332,0.2338,0.28166,1,0
7,GO RETINAL GANGLION CELL AXON GUIDANCE,0.031957,0.23333,0.25155,1,0
7,GO ASTRAL MICROTUBULE ORGANIZATION,0.0052065,0.23229,0.37133,1,0
7,GO FOREGUT MORPHOGENESIS,0.031957,0.2315,0.22271,1,0
7,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0015041,0.23142,0.30908,1,0
7,GO SPINDLE LOCALIZATION,0.0012071,0.22995,0.25555,1,0
7,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.016475,0.2293,0.26337,1,0
7,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0025648,0.22915,0.30751,1,0
7,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.013834,0.22899,0.20961,1,0
7,GO POSITIVE REGULATION OF ACROSOME REACTION,0.0012071,0.22851,0.2509,1,0
7,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.01266,0.2277,0.25097,1,0
7,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0012071,0.22729,0.35372,1,0
7,GO CELL MIGRATION IN HINDBRAIN,0.035953,0.2268,0.25817,1,0
7,GO FOREBRAIN CELL MIGRATION,0.0172,0.22499,0.22703,1,0
7,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0066311,0.22466,0.23369,1,0
7,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0063209,0.2244,0.29155,1,0
7,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.050584,0.2242,0.22454,1,0
7,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.01266,0.22399,0.28653,1,0
7,GO CRANIAL NERVE MORPHOGENESIS,0.050584,0.22377,0.2274,1,0
7,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.007293,0.22181,0.25495,1,0
7,GO PHAGOLYSOSOME ASSEMBLY,0.035953,0.22104,0.25982,1,0
7,GO HIPPO SIGNALING,0.027226,0.2209,0.23907,1,0
7,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.046961,0.21984,0.23968,1,0
7,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0063209,0.21805,0.23963,1,0
7,GO RESPONSE TO NICOTINE,0.046961,0.21547,0.1698,1,0
7,GO AXONAL FASCICULATION,0.045233,0.21462,0.26038,1,0
7,GO BONE CELL DEVELOPMENT,0.052482,0.21255,0.20888,1,0
7,GO ETHANOL CATABOLIC PROCESS,0.050584,0.21136,0.20821,1,0
7,GO ACTIVATION OF MAPKKK ACTIVITY,0.046961,0.21093,0.24695,1,0
7,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.023112,0.20989,0.19306,1,0
7,GO OSTEOBLAST DEVELOPMENT,0.038848,0.20975,0.20191,1,0
7,GO AORTA MORPHOGENESIS,0.011063,0.20974,0.30763,1,0
7,GO ENDOTHELIAL CELL MORPHOGENESIS,0.019548,0.20909,0.2987,1,0
7,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.019548,0.20886,0.22778,1,0
7,GO FEEDING BEHAVIOR,0.0080134,0.20864,0.22968,1,0
7,GO PROTEIN LOCALIZATION TO LYSOSOME,0.027226,0.20853,0.21436,1,0
7,GO CARDIAC SEPTUM DEVELOPMENT,0.026142,0.20812,0.23129,1,0
7,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.008797,0.20619,0.23281,1,0
7,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.018736,0.20592,0.2577,1,0
7,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.013834,0.20576,0.25571,1,0
7,GO PALLIUM DEVELOPMENT,0.015776,0.20552,0.19729,1,0
7,GO CEREBRAL CORTEX DEVELOPMENT,0.0096484,0.20542,0.23124,1,0
7,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.050584,0.2052,0.21122,1,0
7,GO REGULATION OF BODY FLUID LEVELS,0.041938,0.2046,0.17489,1,0
7,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.012106,0.20421,0.24778,1,0
7,GO MEMBRANE BIOGENESIS,0.0040644,0.20209,0.30564,1,0
7,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.013235,0.20098,0.2233,1,0
7,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.024086,0.20065,0.20355,1,0
7,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.016475,0.20044,0.20897,1,0
7,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.010101,0.19994,0.31675,1,0
7,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.028348,0.1995,0.22665,1,0
7,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.023112,0.19803,0.22501,1,0
7,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.035953,0.19731,0.21012,1,0
7,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.019548,0.19723,0.25212,1,0
7,GO NEURAL TUBE FORMATION,0.0083971,0.19646,0.22046,1,0
7,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0096484,0.1961,0.26074,1,0
7,GO NERVE DEVELOPMENT,0.052482,0.19606,0.20438,1,0
7,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.024086,0.19543,0.1979,1,0
7,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.0044907,0.19469,0.26488,1,0
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.040368,0.19373,0.2176,1,0
7,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0054671,0.1925,0.25122,1,0
7,GO MULTICELLULAR ORGANISM AGING,0.022172,0.19192,0.1816,1,0
7,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.025096,0.19094,0.22238,1,0
7,GO XENOBIOTIC TRANSPORT,0.030713,0.19036,0.24629,1,0
7,GO APICAL JUNCTION ASSEMBLY,0.0023095,0.1899,0.24262,1,0
7,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.037377,0.1885,0.20898,1,0
7,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0063209,0.18768,0.21305,1,0
7,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.026142,0.18767,0.21823,1,0
7,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.008797,0.18761,0.33203,1,0
7,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.025096,0.18758,0.24047,1,0
7,GO MYOTUBE DIFFERENTIATION,0.021265,0.18662,0.20381,1,0
7,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.037377,0.18647,0.16955,1,0
7,GO RESPONSE TO IRON ION,0.046961,0.18566,0.18608,1,0
7,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.035953,0.18363,0.20626,1,0
7,GO ACTIVATION OF MAPKK ACTIVITY,0.016475,0.18312,0.25695,1,0
7,GO RESPONSE TO STEROL DEPLETION,0.01266,0.1823,0.21777,1,0
7,GO CEREBELLAR CORTEX DEVELOPMENT,0.0083971,0.18127,0.22571,1,0
7,GO CELL CELL JUNCTION MAINTENANCE,0.030713,0.18102,0.268,1,0
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.012106,0.18072,0.21295,1,0
7,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0047188,0.18012,0.24157,1,0
7,GO BLOOD VESSEL REMODELING,0.043559,0.17952,0.24788,1,0
7,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0044907,0.1789,0.2893,1,0
7,GO DRUG METABOLIC PROCESS,0.023112,0.17851,0.21659,1,0
7,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0052065,0.17821,0.26396,1,0
7,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.045233,0.17808,0.19715,1,0
7,GO RESPONSE TO LITHIUM ION,0.011063,0.17766,0.23976,1,0
7,GO PHOSPHOLIPID TRANSPORT,0.035953,0.177,0.18027,1,0
7,GO GROWTH HORMONE SECRETION,0.038848,0.17682,0.26717,1,0
7,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0047188,0.17579,0.19875,1,0
7,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.007293,0.1752,0.25172,1,0
7,GO ROOF OF MOUTH DEVELOPMENT,0.0172,0.17506,0.22653,1,0
7,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.030713,0.17459,0.31581,1,0
7,GO LIPID LOCALIZATION,0.01266,0.17321,0.18511,1,0
7,GO APICAL PROTEIN LOCALIZATION,0.035953,0.17308,0.2376,1,0
7,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0042727,0.17203,0.18335,1,0
7,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.031957,0.17034,0.20654,1,0
7,GO PROGESTERONE METABOLIC PROCESS,0.037377,0.16919,0.17726,1,0
7,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0049572,0.16903,0.23184,1,0
7,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0049572,0.1688,0.20999,1,0
7,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.02951,0.16879,0.16395,1,0
7,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.035953,0.16875,0.18153,1,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00332,0.16853,0.29572,1,0
7,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.013834,0.16824,0.16654,1,0
7,GO STEROL TRANSPORT,0.015776,0.16749,0.21339,1,0
7,GO RESPONSE TO BMP,0.013235,0.16697,0.2239,1,0
7,GO POSITIVE REGULATION OF AUTOPHAGY,0.0172,0.16607,0.19864,1,0
7,GO CELL DIFFERENTIATION IN HINDBRAIN,0.024086,0.16599,0.21422,1,0
7,GO GANGLION DEVELOPMENT,0.037377,0.16582,0.23881,1,0
7,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.010101,0.16579,0.18942,1,0
7,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.034576,0.16579,0.23332,1,0
7,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.041938,0.16545,0.18234,1,0
7,GO CELLULAR HYPEROSMOTIC RESPONSE,0.037377,0.16491,0.18869,1,0
7,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.037377,0.16313,0.23943,1,0
7,GO FILOPODIUM ASSEMBLY,0.040368,0.16308,0.19801,1,0
7,GO PLATELET MORPHOGENESIS,0.011063,0.16281,0.2617,1,0
7,GO POSITIVE REGULATION OF MRNA PROCESSING,0.011063,0.16239,0.17352,1,0
7,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0052065,0.16204,0.2292,1,0
7,GO REGULATION OF RUFFLE ASSEMBLY,0.038848,0.16195,0.18706,1,0
7,GO MALE MEIOSIS I,0.034576,0.16178,0.19915,1,0
7,GO EATING BEHAVIOR,0.021265,0.16113,0.19965,1,0
7,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.046961,0.16109,0.17298,1,0
7,GO NADH METABOLIC PROCESS,0.012106,0.16023,0.19498,1,0
7,GO ACTIN FILAMENT DEPOLYMERIZATION,0.020391,0.15993,0.21422,1,0
7,GO REGULATION OF ERBB SIGNALING PATHWAY,0.037377,0.15965,0.18069,1,0
7,GO CEREBELLAR CORTEX MORPHOGENESIS,0.011574,0.15965,0.25403,1,0
7,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.026142,0.15961,0.14606,1,0
7,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.034576,0.15953,0.19333,1,0
7,GO SKIN EPIDERMIS DEVELOPMENT,0.007293,0.15917,0.23025,1,0
7,GO MYELOID CELL DEVELOPMENT,0.050584,0.15914,0.19907,1,0
7,GO DOUBLE STRAND BREAK REPAIR,0.011574,0.15887,0.19648,1,0
7,GO REGULATION OF FILOPODIUM ASSEMBLY,0.052482,0.15788,0.18014,1,0
7,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.01266,0.15756,0.1749,1,0
7,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.01266,0.15747,0.22235,1,0
7,GO TELENCEPHALON DEVELOPMENT,0.023112,0.15721,0.1894,1,0
7,GO REGULATION OF OOGENESIS,0.017954,0.15667,0.17108,1,0
7,GO POSITIVE REGULATION OF FERTILIZATION,0.0096484,0.15576,0.20096,1,0
7,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.027226,0.15558,0.18763,1,0
7,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0063209,0.15544,0.26529,1,0
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.015776,0.15494,0.21854,1,0
7,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.027226,0.15474,0.20059,1,0
7,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.022172,0.15448,0.30699,1,0
7,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.028348,0.15434,0.22538,1,0
7,GO HINDBRAIN MORPHOGENESIS,0.0096484,0.154,0.23946,1,0
7,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.023112,0.15335,0.18437,1,0
7,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.010572,0.153,0.21304,1,0
7,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.034576,0.15269,0.17775,1,0
7,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.033245,0.15235,0.16358,1,0
7,GO HIPPOCAMPUS DEVELOPMENT,0.025096,0.15223,0.17317,1,0
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.018736,0.15202,0.21099,1,0
7,GO SIGNAL PEPTIDE PROCESSING,0.027226,0.15188,0.1944,1,0
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.018736,0.15183,0.18874,1,0
7,GO REGULATION OF PROTEIN SUMOYLATION,0.0096484,0.15136,0.23045,1,0
7,GO DIGESTIVE SYSTEM PROCESS,0.048745,0.1502,0.14824,1,0
7,GO ADIPOSE TISSUE DEVELOPMENT,0.037377,0.14964,0.17487,1,0
7,GO NEGATIVE REGULATION OF DNA REPAIR,0.045233,0.14938,0.15642,1,0
7,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.007293,0.1492,0.18925,1,0
7,GO GLIAL CELL DIFFERENTIATION,0.040368,0.14861,0.15057,1,0
7,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013235,0.14858,0.23214,1,0
7,GO PROTEIN DEMANNOSYLATION,0.045233,0.14834,0.20245,1,0
7,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.023112,0.14833,0.17014,1,0
7,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.013235,0.14798,0.22404,1,0
7,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.038848,0.14696,0.21348,1,0
7,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.046961,0.14665,0.14903,1,0
7,GO C21 STEROID HORMONE METABOLIC PROCESS,0.048745,0.14648,0.15072,1,0
7,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.013834,0.14641,0.3127,1,0
7,GO DNA INTEGRITY CHECKPOINT,0.018736,0.14633,0.19512,1,0
7,GO MEMBRANE FISSION,0.033245,0.14624,0.25114,1,0
7,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.02951,0.14624,0.17944,1,0
7,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.027226,0.14554,0.29869,1,0
7,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.025096,0.14544,0.15637,1,0
7,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.028348,0.14455,0.21715,1,0
7,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.050584,0.14403,0.18903,1,0
7,GO TRNA METABOLIC PROCESS,0.0044907,0.14383,0.15043,1,0
7,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.048745,0.14355,0.14246,1,0
7,GO MEMBRANE ORGANIZATION,0.0060238,0.14309,0.19093,1,0
7,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0083971,0.14295,0.20108,1,0
7,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.011063,0.14274,0.1902,1,0
7,GO STEM CELL PROLIFERATION,0.019548,0.14252,0.21091,1,0
7,GO CANONICAL WNT SIGNALING PATHWAY,0.0083971,0.14193,0.1897,1,0
7,GO STEROL METABOLIC PROCESS,0.018736,0.14088,0.17168,1,0
7,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.038848,0.14086,0.17848,1,0
7,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.024086,0.14074,0.24184,1,0
7,GO RENAL TUBULE DEVELOPMENT,0.011063,0.14028,0.20523,1,0
7,GO CELL CYCLE CHECKPOINT,0.027226,0.13977,0.18634,1,0
7,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.050584,0.13962,0.20474,1,0
7,GO REGULATION OF WNT SIGNALING PATHWAY,0.0096484,0.13955,0.17989,1,0
7,GO NEGATIVE REGULATION OF AUTOPHAGY,0.033245,0.13938,0.18467,1,0
7,GO MISMATCH REPAIR,0.0080134,0.13935,0.2055,1,0
7,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.031957,0.13918,0.18446,1,0
7,GO FOREBRAIN NEURON DIFFERENTIATION,0.025096,0.13895,0.21071,1,0
7,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.025096,0.13864,0.1863,1,0
7,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.019548,0.13863,0.20726,1,0
7,GO DIGESTIVE TRACT MORPHOGENESIS,0.022172,0.13835,0.24896,1,0
7,GO RESPIRATORY SYSTEM PROCESS,0.014457,0.13781,0.27334,1,0
7,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.028348,0.13752,0.19884,1,0
7,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.048745,0.13751,0.20119,1,0
7,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.0060238,0.13744,0.17172,1,0
7,GO JNK CASCADE,0.02951,0.13721,0.19221,1,0
7,GO AMELOGENESIS,0.043559,0.13706,0.15205,1,0
7,GO NON CANONICAL WNT SIGNALING PATHWAY,0.021265,0.13584,0.15877,1,0
7,GO CARBOHYDRATE TRANSPORT,0.016475,0.13584,0.19074,1,0
7,GO AMYLOID BETA METABOLIC PROCESS,0.037377,0.13507,0.18676,1,0
7,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0172,0.13454,0.20079,1,0
7,GO HEXOSE CATABOLIC PROCESS,0.050584,0.1344,0.13472,1,0
7,GO PROTEIN MATURATION,0.043559,0.1341,0.12363,1,0
7,GO PLASMA MEMBRANE TUBULATION,0.040368,0.13391,0.23007,1,0
7,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.01266,0.1338,0.23565,1,0
7,GO NEGATIVE REGULATION OF BINDING,0.023112,0.13355,0.1567,1,0
7,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0052065,0.13251,0.15192,1,0
7,GO ORGANIC ACID CATABOLIC PROCESS,0.0027019,0.13026,0.17742,1,0
7,GO REGULATION OF MITOCHONDRIAL FUSION,0.050584,0.13019,0.16529,1,0
7,GO DETECTION OF MECHANICAL STIMULUS,0.038848,0.12954,0.1926,1,0
7,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0172,0.12934,0.13559,1,0
7,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.011063,0.12924,0.24333,1,0
7,GO IRON ION HOMEOSTASIS,0.034576,0.129,0.16108,1,0
7,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.019548,0.12867,0.14917,1,0
7,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.025096,0.1285,0.1826,1,0
7,GO REGULATION OF MAP KINASE ACTIVITY,0.046961,0.1283,0.17664,1,0
7,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.033245,0.1279,0.16359,1,0
7,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.052482,0.12744,0.14877,1,0
7,GO NEGATIVE REGULATION OF MAPK CASCADE,0.033245,0.12652,0.18879,1,0
7,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.013235,0.1265,0.20202,1,0
7,GO REGULATION OF CELL CYCLE ARREST,0.027226,0.12607,0.16406,1,0
7,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.027226,0.12591,0.18448,1,0
7,GO FOREBRAIN GENERATION OF NEURONS,0.02951,0.12566,0.19239,1,0
7,GO REGULATION OF LIPID METABOLIC PROCESS,0.038848,0.12552,0.15271,1,0
7,GO STEROID METABOLIC PROCESS,0.008797,0.12531,0.16481,1,0
7,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013235,0.12521,0.19079,1,0
7,GO ACTIVATION OF MAPK ACTIVITY,0.048745,0.12482,0.18326,1,0
7,GO ENDOCRINE PANCREAS DEVELOPMENT,0.041938,0.12449,0.21042,1,0
7,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.023112,0.12437,0.156,1,0
7,GO PROTEIN LOCALIZATION TO CHROMATIN,0.035953,0.1242,0.18415,1,0
7,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.043559,0.12391,0.20063,1,0
7,GO CARBOHYDRATE CATABOLIC PROCESS,0.033245,0.12355,0.14287,1,0
7,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.027226,0.12351,0.17434,1,0
7,GO REGULATION OF MICROVILLUS ORGANIZATION,0.040368,0.1235,0.25942,1,0
7,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.025096,0.12345,0.15317,1,0
7,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.043559,0.12337,0.13489,1,0
7,GO POSITIVE REGULATION OF PROTEIN BINDING,0.038848,0.12302,0.17165,1,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.038848,0.12223,0.1741,1,0
7,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.035953,0.12125,0.14903,1,0
7,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.046961,0.12117,0.17578,1,0
7,GO POSITIVE REGULATION OF TRANSPORT,0.02951,0.12114,0.16773,1,0
7,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.030713,0.12113,0.18626,1,0
7,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.045233,0.1207,0.21129,1,0
7,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0038653,0.12036,0.20621,1,0
7,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.017954,0.11995,0.17485,1,0
7,GO ENDOCYTOSIS,0.043559,0.11989,0.18481,1,0
7,GO THIOESTER METABOLIC PROCESS,0.015104,0.11982,0.13153,1,0
7,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0052065,0.11964,0.15077,1,0
7,GO REGULATION OF ACTIN FILAMENT LENGTH,0.022172,0.119,0.17981,1,0
7,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.01266,0.11883,0.25756,1,0
7,GO RESPONSE TO OXIDATIVE STRESS,0.037377,0.11837,0.13652,1,0
7,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.011063,0.11833,0.20306,1,0
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.011063,0.11808,0.13424,1,0
7,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.035953,0.11784,0.1519,1,0
7,GO PYRUVATE METABOLIC PROCESS,0.028348,0.11774,0.14611,1,0
7,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.025096,0.11765,0.15875,1,0
7,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0038653,0.11745,0.17284,1,0
7,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.040368,0.11697,0.17557,1,0
7,GO APPENDAGE DEVELOPMENT,0.050584,0.11694,0.17211,1,0
7,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.011063,0.11675,0.1326,1,0
7,GO RESPONSE TO WATER,0.043559,0.11632,0.18429,1,0
7,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.01266,0.11605,0.15751,1,0
7,GO SKELETAL SYSTEM DEVELOPMENT,0.040368,0.11566,0.17543,1,0
7,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0057394,0.1148,0.1857,1,0
7,GO GASTRULATION,0.037377,0.11422,0.18492,1,0
7,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0020776,0.11381,0.19804,1,0
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.034576,0.11366,0.15399,1,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.050584,0.11348,0.17178,1,0
7,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.02951,0.11261,0.14846,1,0
7,GO REGULATION OF PHOSPHORYLATION,0.024086,0.11244,0.16883,1,0
7,GO LIPID BIOSYNTHETIC PROCESS,0.0036751,0.11236,0.17369,1,0
7,GO RESPONSE TO ESTROGEN,0.045233,0.11235,0.17153,1,0
7,GO SULFUR AMINO ACID METABOLIC PROCESS,0.026142,0.11231,0.14959,1,0
7,GO REGULATION OF VACUOLE ORGANIZATION,0.0049572,0.11216,0.21776,1,0
7,GO RUFFLE ASSEMBLY,0.046961,0.11106,0.19079,1,0
7,GO ONE CARBON METABOLIC PROCESS,0.034576,0.11065,0.12742,1,0
7,GO PROTEIN STABILIZATION,0.01266,0.10945,0.14273,1,0
7,GO POSITIVE REGULATION OF SIGNALING,0.041938,0.1091,0.15277,1,0
7,GO REGULATION OF CELLULAR RESPIRATION,0.014457,0.10841,0.13193,1,0
7,GO REGULATION OF BINDING,0.028348,0.10808,0.15006,1,0
7,GO REGULATION OF HYDROLASE ACTIVITY,0.031957,0.10737,0.16623,1,0
7,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.023112,0.10734,0.14434,1,0
7,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.02951,0.10666,0.15667,1,0
7,GO NCRNA 3 END PROCESSING,0.015776,0.10624,0.11191,1,0
7,GO RESPONSE TO STARVATION,0.010572,0.10568,0.17088,1,0
7,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.048745,0.10535,0.15769,1,0
7,GO CONNECTIVE TISSUE DEVELOPMENT,0.050584,0.10533,0.17837,1,0
7,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.017954,0.10505,0.14415,1,0
7,GO REGULATION OF CELL AGING,0.040368,0.10462,0.1279,1,0
7,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.043559,0.10407,0.25716,1,0
7,GO NCRNA PROCESSING,0.02951,0.10377,0.11074,1,0
7,GO ORGANIC ACID METABOLIC PROCESS,0.0040644,0.10366,0.15293,1,0
7,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.008797,0.10341,0.1152,1,0
7,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.031957,0.10338,0.1674,1,0
7,GO PROTEIN LOCALIZATION TO NUCLEUS,0.040368,0.10264,0.14405,1,0
7,GO PROTEIN IMPORT,0.02951,0.10149,0.13831,1,0
7,GO POLYAMINE METABOLIC PROCESS,0.035953,0.10148,0.11743,1,0
7,GO REGULATION OF PROTON TRANSPORT,0.0080134,0.10073,0.19581,1,0
7,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.050584,0.10043,0.18252,1,0
7,GO POST ANAL TAIL MORPHOGENESIS,0.043559,0.10013,0.23123,1,0
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.025096,0.099458,0.15902,1,0
7,GO NCRNA METABOLIC PROCESS,0.013235,0.099344,0.11947,1,0
7,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.028348,0.099107,0.15366,1,0
7,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.048745,0.099007,0.16631,1,0
7,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.046961,0.097118,0.1553,1,0
7,GO ACETYL COA METABOLIC PROCESS,0.038848,0.097089,0.13962,1,0
7,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.043559,0.09704,0.13983,1,0
7,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0038653,0.096451,0.15292,1,0
7,GO REGULATION OF HISTONE UBIQUITINATION,0.033245,0.096272,0.15664,1,0
7,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.052482,0.095829,0.14388,1,0
7,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.045233,0.094904,0.13974,1,0
7,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.01266,0.094555,0.16759,1,0
7,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.037377,0.094511,0.19973,1,0
7,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.052482,0.094392,0.09888,1,0
7,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.035953,0.093458,0.16735,1,0
7,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.035953,0.092199,0.14225,1,0
7,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.041938,0.091667,0.1566,1,0
7,GO THYMUS DEVELOPMENT,0.045233,0.091431,0.13571,1,0
7,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.038848,0.089941,0.1462,1,0
7,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0096484,0.089787,0.13555,1,0
7,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.031957,0.089603,0.14267,1,0
7,GO MITOTIC CYTOKINESIS,0.023112,0.088881,0.1733,1,0
7,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.01266,0.08853,0.10591,1,0
7,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.027226,0.087986,0.12594,1,0
7,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.048745,0.085939,0.14382,1,0
7,GO REGULATION OF MRNA CATABOLIC PROCESS,0.015776,0.085773,0.13063,1,0
7,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0057394,0.085668,0.12489,1,0
7,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.02951,0.084826,0.15909,1,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.031957,0.083654,0.2353,1,0
7,GO AGING,0.046961,0.081129,0.14363,1,0
7,GO POSITIVE REGULATION OF TRANSLATION,0.023112,0.08073,0.11007,1,0
7,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.015776,0.078718,0.14718,1,0
7,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.037377,0.075845,0.12988,1,0
7,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.018736,0.075178,0.11432,1,0
7,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0060238,0.074138,0.12207,1,0
7,GO MIDBODY ABSCISSION,0.045233,0.07228,0.11984,1,0
7,GO ATP METABOLIC PROCESS,0.0063209,0.071412,0.10258,1,0
7,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.034576,0.069668,0.10964,1,0
7,GO CELLULAR SENESCENCE,0.048745,0.069425,0.13477,1,0
7,GO CELL AGING,0.031957,0.068681,0.1365,1,0
7,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.048745,0.061339,0.11032,1,0
7,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.038848,0.054605,0.12107,1,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.031957,0.048507,0.085462,1,0
7,GO PROTEIN TARGETING,0.0040644,0.048247,0.081848,1,0
7,GO PROTEIN INSERTION INTO MEMBRANE,0.030713,0.046825,0.10392,1,0
7,GO RESPONSE TO CADMIUM ION,0.050584,-0.09837,-0.099018,1,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.052482,-0.14755,-0.1771,1,0
7,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.038848,-0.17263,-0.22545,1,0
7,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.045233,-0.18515,-0.21548,1,0
7,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.013235,-0.19387,-0.1676,1,0
7,GO NATURAL KILLER CELL CHEMOTAXIS,0.020391,-0.82214,-0.58622,1,0
7,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.080256,0.38609,0.27154,0,1
7,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.16602,0.36177,0.24201,0,1
7,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.060677,0.34553,0.27859,0,1
7,GO SHORT TERM MEMORY,0.062884,0.32311,0.23078,0,1
7,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.069906,0.31122,0.24209,0,1
7,GO REVERSE CHOLESTEROL TRANSPORT,0.13885,0.30951,0.22065,0,1
7,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.12273,0.30907,0.26235,0,1
7,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.08303,0.29809,0.19899,0,1
7,GO EPITHELIAL CELL CELL ADHESION,0.056456,0.29212,0.2176,0,1
7,GO LIPOXYGENASE PATHWAY,0.15655,0.28232,0.15178,0,1
7,GO PARAXIAL MESODERM MORPHOGENESIS,0.098083,0.27132,0.20426,0,1
7,GO BIOLOGICAL PHASE,0.054439,0.26835,0.21433,0,1
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.080256,0.26379,0.24788,0,1
7,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.19156,0.26128,0.20416,0,1
7,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.23203,0.2593,0.14607,0,1
7,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.14312,0.24038,0.16651,0,1
7,GO CORTICOSTEROID HORMONE SECRETION,0.33029,0.24001,0.098638,0,1
7,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.18624,0.23882,0.12883,0,1
7,GO NEGATIVE REGULATION OF WOUND HEALING,0.058535,0.23282,0.19862,0,1
7,GO STEROID HORMONE SECRETION,0.11524,0.23205,0.11785,0,1
7,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.11524,0.22638,0.15828,0,1
7,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.37964,0.22116,0.091647,0,1
7,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.074935,0.21987,0.15987,0,1
7,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.072385,0.21864,0.18527,0,1
7,GO XENOBIOTIC CATABOLIC PROCESS,0.41494,0.21694,0.10001,0,1
7,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.077559,0.21674,0.16581,0,1
7,GO KINETOCHORE ORGANIZATION,0.15197,0.2152,0.17055,0,1
7,GO CELL DIFFERENTIATION IN SPINAL CORD,0.077559,0.21481,0.16063,0,1
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.10468,0.21303,0.16321,0,1
7,GO METANEPHRIC NEPHRON DEVELOPMENT,0.080256,0.21285,0.19689,0,1
7,GO REGULATION OF NECROTIC CELL DEATH,0.067497,0.21118,0.14611,0,1
7,GO CELLULAR RESPONSE TO VITAMIN,0.080256,0.21116,0.20013,0,1
7,GO TYPE B PANCREATIC CELL PROLIFERATION,0.056456,0.21003,0.20228,0,1
7,GO CARDIOBLAST DIFFERENTIATION,0.15655,0.20912,0.16333,0,1
7,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.15655,0.20893,0.17273,0,1
7,GO PHOSPHATE ION TRANSPORT,0.08881,0.20783,0.17661,0,1
7,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.17091,0.20647,0.12481,0,1
7,GO ICOSANOID METABOLIC PROCESS,0.065157,0.20567,0.15754,0,1
7,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.26442,0.20401,0.12919,0,1
7,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.2998,0.20114,0.11217,0,1
7,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.065157,0.1985,0.19884,0,1
7,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.054439,0.19822,0.20295,0,1
7,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.11163,0.19784,0.19234,0,1
7,GO RESPONSE TO PROGESTERONE,0.08881,0.19709,0.17034,0,1
7,GO REGULATION OF STEROL TRANSPORT,0.1475,0.19615,0.13218,0,1
7,GO CHROMOSOME SEPARATION,0.060677,0.19579,0.15771,0,1
7,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.11163,0.19405,0.16086,0,1
7,GO RESPONSE TO MUSCLE STRETCH,0.054439,0.19347,0.28846,0,1
7,GO BONE GROWTH,0.072385,0.19271,0.20825,0,1
7,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.065157,0.19181,0.14721,0,1
7,GO SISTER CHROMATID SEGREGATION,0.074935,0.19151,0.146,0,1
7,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.08588,0.19067,0.21561,0,1
7,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.23827,0.18826,0.1146,0,1
7,GO OSTEOBLAST PROLIFERATION,0.11163,0.18726,0.16921,0,1
7,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.12662,0.18642,0.18719,0,1
7,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.28529,0.18641,0.14122,0,1
7,GO ENDOTHELIAL CELL MIGRATION,0.098083,0.18616,0.17487,0,1
7,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.065157,0.18453,0.25399,0,1
7,GO TISSUE MIGRATION,0.072385,0.18385,0.18255,0,1
7,GO OUTFLOW TRACT MORPHOGENESIS,0.069906,0.18354,0.16817,0,1
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.060677,0.18225,0.16694,0,1
7,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.11524,0.1821,0.17724,0,1
7,GO RECEPTOR RECYCLING,0.080256,0.18161,0.15834,0,1
7,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.072385,0.17987,0.15642,0,1
7,GO TUBE MORPHOGENESIS,0.08303,0.17938,0.17314,0,1
7,GO ANIMAL ORGAN FORMATION,0.091819,0.17928,0.14065,0,1
7,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.14312,0.17922,0.18412,0,1
7,GO VASCULOGENESIS,0.1475,0.17896,0.16979,0,1
7,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.10811,0.17845,0.16775,0,1
7,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.10468,0.17808,0.18993,0,1
7,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.16123,0.1779,0.12386,0,1
7,GO PROTEIN OXIDATION,0.054439,0.17784,0.14772,0,1
7,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.3148,0.17737,0.12368,0,1
7,GO SPROUTING ANGIOGENESIS,0.13467,0.17716,0.17544,0,1
7,GO HEART VALVE DEVELOPMENT,0.072385,0.17715,0.2142,0,1
7,GO AMINO ACID IMPORT,0.080256,0.17696,0.13855,0,1
7,GO REGULATION OF KERATINOCYTE MIGRATION,0.072385,0.17624,0.24409,0,1
7,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.069906,0.17535,0.23403,0,1
7,GO ARACHIDONIC ACID METABOLIC PROCESS,0.16123,0.17507,0.12583,0,1
7,GO NUCLEOSOME ASSEMBLY,0.069906,0.17484,0.13314,0,1
7,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.058535,0.17468,0.16903,0,1
7,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.077559,0.17449,0.20209,0,1
7,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18624,0.17278,0.13162,0,1
7,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.11524,0.17253,0.14286,0,1
7,GO REGULATION OF POSITIVE CHEMOTAXIS,0.19156,0.17135,0.12519,0,1
7,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.11894,0.17123,0.12353,0,1
7,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.058535,0.17073,0.18323,0,1
7,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.058535,0.16956,0.22077,0,1
7,GO CHAPERONE MEDIATED AUTOPHAGY,0.072385,0.16917,0.17888,0,1
7,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.065157,0.16897,0.18008,0,1
7,GO INTERSTRAND CROSS LINK REPAIR,0.054439,0.16891,0.16934,0,1
7,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.062884,0.16794,0.15085,0,1
7,GO BLOOD VESSEL MORPHOGENESIS,0.18624,0.1667,0.14608,0,1
7,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.065157,0.16634,0.16052,0,1
7,GO CENTROSOME SEPARATION,0.067497,0.16628,0.16784,0,1
7,GO SPINDLE ASSEMBLY,0.062884,0.16623,0.16442,0,1
7,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.08303,0.16565,0.15956,0,1
7,GO MESENCHYMAL CELL PROLIFERATION,0.11163,0.16475,0.17989,0,1
7,GO RESPONSE TO GONADOTROPIN,0.094909,0.16458,0.13333,0,1
7,GO KERATINOCYTE MIGRATION,0.12662,0.16451,0.1747,0,1
7,GO MITOTIC METAPHASE PLATE CONGRESSION,0.1475,0.16422,0.10759,0,1
7,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.058535,0.16422,0.17422,0,1
7,GO CERAMIDE TRANSPORT,0.058535,0.164,0.24285,0,1
7,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.060677,0.16344,0.18056,0,1
7,GO MITOTIC SISTER CHROMATID SEGREGATION,0.091819,0.16328,0.13089,0,1
7,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.074935,0.16328,0.16736,0,1
7,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.13467,0.16258,0.17546,0,1
7,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.21989,0.16252,0.14712,0,1
7,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.29248,0.16241,0.12212,0,1
7,GO CHROMOSOME LOCALIZATION,0.10468,0.16212,0.13654,0,1
7,GO POSITIVE REGULATION OF OSSIFICATION,0.12273,0.16078,0.14518,0,1
7,GO ENDOCARDIAL CUSHION FORMATION,0.094909,0.16021,0.16711,0,1
7,GO REGULATION OF HORMONE METABOLIC PROCESS,0.080256,0.15983,0.16808,0,1
7,GO KERATINOCYTE PROLIFERATION,0.17591,0.15873,0.13256,0,1
7,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.24463,0.15862,0.10923,0,1
7,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.094909,0.15691,0.13485,0,1
7,GO VENTRAL SPINAL CORD DEVELOPMENT,0.094909,0.15642,0.14351,0,1
7,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.065157,0.15638,0.16334,0,1
7,GO SEROTONIN TRANSPORT,0.11524,0.15551,0.16611,0,1
7,GO TERPENOID METABOLIC PROCESS,0.058535,0.1547,0.1258,0,1
7,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.20256,0.15402,0.14443,0,1
7,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.069906,0.15387,0.13127,0,1
7,GO RRNA 3 END PROCESSING,0.08588,0.15381,0.11361,0,1
7,GO DNA DEPENDENT DNA REPLICATION,0.17091,0.15327,0.12651,0,1
7,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.10468,0.15282,0.15104,0,1
7,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.08588,0.15196,0.21043,0,1
7,GO REGULATION OF RECEPTOR RECYCLING,0.18624,0.15193,0.14499,0,1
7,GO BLASTOCYST GROWTH,0.08588,0.1517,0.12596,0,1
7,GO BEHAVIORAL RESPONSE TO PAIN,0.19156,0.15152,0.14905,0,1
7,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.14312,0.15089,0.14684,0,1
7,GO BIOLOGICAL ADHESION,0.065157,0.15062,0.17823,0,1
7,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.30724,0.15005,0.095325,0,1
7,GO V D J RECOMBINATION,0.4521,0.14997,0.060087,0,1
7,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.34626,0.14979,0.11664,0,1
7,GO SEQUESTERING OF CALCIUM ION,0.12662,0.14822,0.16592,0,1
7,GO DNA LIGATION,0.14312,0.14785,0.098046,0,1
7,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.11894,0.14781,0.20219,0,1
7,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.062884,0.14774,0.12169,0,1
7,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.054439,0.14755,0.18226,0,1
7,GO RADIAL GLIAL CELL DIFFERENTIATION,0.062884,0.14704,0.18098,0,1
7,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.10468,0.14696,0.22461,0,1
7,GO LIPOPROTEIN LOCALIZATION,0.13467,0.1458,0.16732,0,1
7,GO VASCULATURE DEVELOPMENT,0.16602,0.14444,0.1512,0,1
7,GO METAPHASE PLATE CONGRESSION,0.11524,0.14379,0.11997,0,1
7,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.062884,0.14379,0.16034,0,1
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.15197,0.14313,0.13155,0,1
7,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.062884,0.14289,0.15802,0,1
7,GO NEGATIVE REGULATION OF SECRETION,0.074935,0.14271,0.13267,0,1
7,GO REGULATION OF GASTRIC ACID SECRETION,0.12273,0.14256,0.1686,0,1
7,GO RESPONSE TO ORGANOPHOSPHORUS,0.062884,0.14214,0.13683,0,1
7,GO SKELETAL MUSCLE TISSUE REGENERATION,0.08881,0.14142,0.12842,0,1
7,GO REGULATION OF FAT CELL DIFFERENTIATION,0.060677,0.14093,0.1788,0,1
7,GO REGULATION OF CHROMOSOME SEGREGATION,0.15197,0.14048,0.12239,0,1
7,GO MUSCLE ADAPTATION,0.062884,0.13913,0.15691,0,1
7,GO N GLYCAN PROCESSING,0.08303,0.13872,0.19956,0,1
7,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.26442,0.13772,0.11695,0,1
7,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.21989,0.13679,0.098829,0,1
7,GO EMBRYONIC DIGIT MORPHOGENESIS,0.060677,0.13658,0.16988,0,1
7,GO RESPONSE TO OXYGEN RADICAL,0.10468,0.13636,0.11252,0,1
7,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.08588,0.13527,0.12015,0,1
7,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.060677,0.13354,0.1505,0,1
7,GO CELLULAR HORMONE METABOLIC PROCESS,0.062884,0.1329,0.11409,0,1
7,GO RELAXATION OF CARDIAC MUSCLE,0.17091,0.13253,0.23487,0,1
7,GO MAINTENANCE OF LOCATION IN CELL,0.069906,0.13219,0.1476,0,1
7,GO REGULATION OF TRANSLATIONAL ELONGATION,0.072385,0.13203,0.092025,0,1
7,GO INOSITOL LIPID MEDIATED SIGNALING,0.13885,0.1319,0.14581,0,1
7,GO CELLULAR RESPONSE TO RETINOIC ACID,0.12273,0.13077,0.14339,0,1
7,GO RESPONSE TO MANGANESE ION,0.13467,0.13074,0.13129,0,1
7,GO CELLULAR RESPONSE TO ATP,0.074935,0.13014,0.16483,0,1
7,GO CALCIUM MEDIATED SIGNALING,0.12662,0.1301,0.15447,0,1
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.13467,0.1299,0.14986,0,1
7,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.23203,0.12982,0.1454,0,1
7,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.10811,0.12878,0.14525,0,1
7,GO MESODERM MORPHOGENESIS,0.054439,0.12848,0.16102,0,1
7,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.20256,0.12784,0.10439,0,1
7,GO RESPONSE TO CORTICOSTEROID,0.11894,0.12745,0.12046,0,1
7,GO REGULATION OF CHROMOSOME SEPARATION,0.20256,0.12697,0.10781,0,1
7,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.094909,0.12679,0.16497,0,1
7,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.11524,0.12543,0.14479,0,1
7,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.058535,0.12473,0.12386,0,1
7,GO MAINTENANCE OF LOCATION,0.067497,0.12374,0.14581,0,1
7,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.080256,0.12302,0.14452,0,1
7,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.091819,0.12024,0.19299,0,1
7,GO BILE ACID METABOLIC PROCESS,0.067497,0.11988,0.14472,0,1
7,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.11894,0.11879,0.19175,0,1
7,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.214,0.11868,0.10828,0,1
7,GO INTERMEMBRANE LIPID TRANSFER,0.13467,0.11863,0.13653,0,1
7,GO L AMINO ACID TRANSPORT,0.091819,0.11812,0.13765,0,1
7,GO GLUTATHIONE METABOLIC PROCESS,0.067497,0.11788,0.12705,0,1
7,GO RECEPTOR INTERNALIZATION,0.067497,0.11714,0.16828,0,1
7,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.2259,0.11691,0.065597,0,1
7,GO RESPONSE TO UV B,0.25111,0.11562,0.10542,0,1
7,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.10811,0.11512,0.11962,0,1
7,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.062884,0.11475,0.12937,0,1
7,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10134,0.11419,0.15537,0,1
7,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.27126,0.11383,0.098056,0,1
7,GO RESPONSE TO ATP,0.12273,0.11314,0.13984,0,1
7,GO SNORNA 3 END PROCESSING,0.08881,0.11272,0.11291,0,1
7,GO REGULATION OF CALCIUM ION TRANSPORT,0.067497,0.11217,0.18361,0,1
7,GO RESPONSE TO KETONE,0.15655,0.11198,0.1244,0,1
7,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.080256,0.11185,0.15835,0,1
7,GO GASTRIC ACID SECRETION,0.094909,0.11182,0.14425,0,1
7,GO REGULATION OF TRANSLATIONAL TERMINATION,0.072385,0.1103,0.1305,0,1
7,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.12273,0.10971,0.1466,0,1
7,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.12662,0.10709,0.12649,0,1
7,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.18102,0.1064,0.11132,0,1
7,GO PROTEIN HOMOTETRAMERIZATION,0.062884,0.10567,0.14883,0,1
7,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.069906,0.1049,0.13,0,1
7,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.098083,0.10411,0.11991,0,1
7,GO MUSCLE FILAMENT SLIDING,0.08588,0.10375,0.14611,0,1
7,GO HEAT GENERATION,0.16123,0.10358,0.13244,0,1
7,GO NUCLEAR PORE ORGANIZATION,0.10468,0.10279,0.16267,0,1
7,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.058535,0.10138,0.16194,0,1
7,GO INACTIVATION OF MAPK ACTIVITY,0.15655,0.10082,0.15912,0,1
7,GO REGENERATION,0.054439,0.098172,0.14554,0,1
7,GO REGULATION OF MUSCLE ADAPTATION,0.13885,0.096944,0.13091,0,1
7,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.38829,0.096584,0.06328,0,1
7,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.19156,0.095246,0.13234,0,1
7,GO REGULATION OF HEART GROWTH,0.074935,0.094836,0.1451,0,1
7,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.21989,0.094659,0.099347,0,1
7,GO NCRNA EXPORT FROM NUCLEUS,0.098083,0.093808,0.15472,0,1
7,GO INTRACELLULAR MRNA LOCALIZATION,0.054439,0.093416,0.16471,0,1
7,GO RESPONSE TO ALCOHOL,0.060677,0.091835,0.14966,0,1
7,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.30724,0.091661,0.087706,0,1
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.080256,0.08979,0.090223,0,1
7,GO LIPID EXPORT FROM CELL,0.36271,0.087875,0.053833,0,1
7,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.42405,0.087734,0.043578,0,1
7,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.10134,0.086866,0.10177,0,1
7,GO TRNA TRANSPORT,0.12662,0.083462,0.14982,0,1
7,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.20822,0.082447,0.10233,0,1
7,GO TRICARBOXYLIC ACID CYCLE,0.1306,0.07875,0.088147,0,1
7,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12662,0.078555,0.12852,0,1
7,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.10134,0.075861,0.12507,0,1
7,GO BLASTOCYST FORMATION,0.08303,0.074149,0.1058,0,1
7,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.080256,0.068918,0.087371,0,1
7,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.3148,0.068847,0.093605,0,1
7,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.214,0.065647,0.079127,0,1
7,GO AEROBIC RESPIRATION,0.11524,0.064301,0.053991,0,1
7,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.21989,0.061887,0.060716,0,1
7,GO TRANSLATIONAL ELONGATION,0.197,0.036172,0.037966,0,1
7,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0060238,0.42661,0.47945,0,0
7,GO RESPONSE TO FORSKOLIN,0.00072571,0.41349,0.44313,0,0
7,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.026142,0.3605,0.30014,0,0
7,GO INTERLEUKIN 13 PRODUCTION,0.29248,0.33333,0.15324,0,0
7,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0029965,0.33006,0.55669,0,0
7,GO HEMIDESMOSOME ASSEMBLY,0.11524,0.31317,0.28626,0,0
7,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0017696,0.30297,0.55901,0,0
7,GO NEPHRIC DUCT DEVELOPMENT,0.058535,0.30029,0.23346,0,0
7,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0012758,0.29641,0.36583,0,0
7,GO ANTEROGRADE AXONAL TRANSPORT,0.0011418,0.29373,0.32337,0,0
7,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0010798,0.29143,0.37408,0,0
7,GO OPSONIZATION,0.25111,0.28104,0.14,0,0
7,GO ELASTIC FIBER ASSEMBLY,0.10468,0.27774,0.31159,0,0
7,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00332,0.27631,0.31611,0,0
7,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0021907,0.27139,0.34584,0,0
7,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.054439,0.26773,0.23118,0,0
7,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0052065,0.26772,0.25632,0,0
7,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0080134,0.26691,0.31075,0,0
7,GO POSITIVE REGULATION OF NEURON MIGRATION,0.1306,0.26589,0.23361,0,0
7,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.11894,0.26311,0.22959,0,0
7,GO SOMATIC STEM CELL DIVISION,0.060677,0.2618,0.26385,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.17091,0.25871,0.17442,0,0
7,GO AXONAL TRANSPORT OF MITOCHONDRION,0.022172,0.25125,0.21258,0,0
7,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.006955,0.25069,0.36703,0,0
7,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.072385,0.24877,0.18502,0,0
7,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.13467,0.24846,0.22083,0,0
7,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.65188,0.24745,0.1085,0,0
7,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.012106,0.24743,0.29951,0,0
7,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.13467,0.24626,0.24912,0,0
7,GO CARDIAC VENTRICLE FORMATION,0.08588,0.24239,0.18347,0,0
7,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00068502,0.24187,0.35494,0,0
7,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.10468,0.23507,0.19403,0,0
7,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.08588,0.2348,0.22862,0,0
7,GO REGULATION OF RECEPTOR CLUSTERING,0.072385,0.23462,0.23115,0,0
7,GO COMMISSURAL NEURON AXON GUIDANCE,0.26442,0.23418,0.13782,0,0
7,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.34626,0.23274,0.13491,0,0
7,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.16123,0.23088,0.1583,0,0
7,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.067497,0.23049,0.19517,0,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.052482,0.22922,0.2303,0,0
7,GO REGULATION OF GROWTH HORMONE SECRETION,0.062884,0.22855,0.28093,0,0
7,GO MATING BEHAVIOR,0.021265,0.22722,0.25321,0,0
7,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.031957,0.22719,0.2056,0,0
7,GO PROTEIN ACTIVATION CASCADE,0.33029,0.22648,0.11245,0,0
7,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.16123,0.22452,0.20764,0,0
7,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.072385,0.22337,0.19382,0,0
7,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.022172,0.22056,0.30078,0,0
7,GO COPULATION,0.046961,0.21828,0.2717,0,0
7,GO THYROID HORMONE METABOLIC PROCESS,0.11163,0.21811,0.145,0,0
7,GO DETECTION OF TEMPERATURE STIMULUS,0.031957,0.21779,0.25668,0,0
7,GO RESPONSE TO ELECTRICAL STIMULUS,0.069906,0.21638,0.15243,0,0
7,GO POSITIVE REGULATION OF LIPID STORAGE,0.069906,0.21518,0.20614,0,0
7,GO REGULATION OF GTP BINDING,0.016475,0.2148,0.24041,0,0
7,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.17091,0.21401,0.20209,0,0
7,GO FOREBRAIN REGIONALIZATION,0.26442,0.21195,0.12286,0,0
7,GO PENILE ERECTION,0.214,0.21145,0.23329,0,0
7,GO REGULATION OF CELL PROJECTION SIZE,0.069906,0.2095,0.23486,0,0
7,GO MITOTIC CHROMOSOME CONDENSATION,0.1475,0.20878,0.18595,0,0
7,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.26442,0.20809,0.18685,0,0
7,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.072385,0.20778,0.21938,0,0
7,GO STEM CELL DIVISION,0.098083,0.20691,0.1789,0,0
7,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.27821,0.20653,0.10616,0,0
7,GO AMINOGLYCAN CATABOLIC PROCESS,0.13467,0.20651,0.1544,0,0
7,GO CELL PROLIFERATION IN FOREBRAIN,0.11163,0.20461,0.19805,0,0
7,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.17591,0.20133,0.16011,0,0
7,GO REGULATION OF WATER LOSS VIA SKIN,0.031957,0.20117,0.17835,0,0
7,GO NOSE DEVELOPMENT,0.18102,0.20111,0.21115,0,0
7,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0015882,0.20058,0.27367,0,0
7,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.11894,0.2005,0.13589,0,0
7,GO KERATINOCYTE DEVELOPMENT,0.065157,0.20017,0.22273,0,0
7,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.080256,0.20005,0.21857,0,0
7,GO SPINAL CORD PATTERNING,0.10811,0.19825,0.19903,0,0
7,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.041938,0.19779,0.22784,0,0
7,GO SEMI LUNAR VALVE DEVELOPMENT,0.11524,0.19776,0.19679,0,0
7,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.098083,0.19745,0.1621,0,0
7,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.15655,0.19733,0.13571,0,0
7,GO ANTIBACTERIAL HUMORAL RESPONSE,0.16123,0.19732,0.22301,0,0
7,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.11163,0.19681,0.20689,0,0
7,GO AORTIC VALVE DEVELOPMENT,0.11163,0.19549,0.1987,0,0
7,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.077559,0.19528,0.27941,0,0
7,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.054439,0.19424,0.20214,0,0
7,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.069906,0.19373,0.18321,0,0
7,GO MALE GENITALIA DEVELOPMENT,0.08588,0.1937,0.1532,0,0
7,GO EPIDERMIS MORPHOGENESIS,0.08588,0.19354,0.20714,0,0
7,GO REGULATION OF WOUND HEALING,0.11524,0.19192,0.15357,0,0
7,GO GLYCINE TRANSPORT,0.57414,0.19053,0.076849,0,0
7,GO NEGATIVE REGULATION OF COAGULATION,0.26442,0.19048,0.13266,0,0
7,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.25111,0.1894,0.11977,0,0
7,GO AMYLOID FIBRIL FORMATION,0.27821,0.18876,0.12481,0,0
7,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.013834,0.18874,0.2384,0,0
7,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.17091,0.18844,0.146,0,0
7,GO MACROPHAGE PROLIFERATION,0.49108,0.18825,0.11256,0,0
7,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.20256,0.18799,0.11881,0,0
7,GO CELL MATRIX ADHESION,0.065157,0.18787,0.20722,0,0
7,GO ANATOMICAL STRUCTURE REGRESSION,0.062884,0.18714,0.24352,0,0
7,GO MITRAL VALVE DEVELOPMENT,0.197,0.18699,0.17926,0,0
7,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.16123,0.18614,0.16716,0,0
7,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.056456,0.18609,0.23882,0,0
7,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.062884,0.18598,0.1795,0,0
7,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.034576,0.18511,0.2224,0,0
7,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.094909,0.1844,0.20183,0,0
7,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12662,0.18425,0.1749,0,0
7,GO REGULATION OF ICOSANOID SECRETION,0.08881,0.1837,0.14442,0,0
7,GO SALIVARY GLAND DEVELOPMENT,0.052482,0.18352,0.21219,0,0
7,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.021265,0.1819,0.25626,0,0
7,GO REGULATION OF CELL SUBSTRATE ADHESION,0.15655,0.18174,0.17331,0,0
7,GO CHROMOSOME CONDENSATION,0.077559,0.1817,0.18595,0,0
7,GO TUBE FORMATION,0.0049572,0.18154,0.219,0,0
7,GO SKIN MORPHOGENESIS,0.43329,0.18124,0.12409,0,0
7,GO NOREPINEPHRINE METABOLIC PROCESS,0.058535,0.17996,0.24064,0,0
7,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.10811,0.17993,0.14998,0,0
7,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.025096,0.17943,0.24335,0,0
7,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.20256,0.1786,0.1917,0,0
7,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.1306,0.17857,0.14668,0,0
7,GO LIPID GLYCOSYLATION,0.054439,0.17839,0.18,0,0
7,GO MEMBRANE DISASSEMBLY,0.054439,0.17832,0.18658,0,0
7,GO HEART FORMATION,0.014457,0.17811,0.21341,0,0
7,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0031545,0.17804,0.30809,0,0
7,GO SODIUM ION HOMEOSTASIS,0.010101,0.17703,0.2688,0,0
7,GO ENDODERMAL CELL DIFFERENTIATION,0.17091,0.17694,0.22378,0,0
7,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21989,0.17687,0.16785,0,0
7,GO RESPONSE TO CORTICOSTERONE,0.15655,0.1767,0.16394,0,0
7,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.098083,0.17663,0.14136,0,0
7,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.51122,0.17622,0.072893,0,0
7,GO MAGNESIUM ION HOMEOSTASIS,0.094909,0.1762,0.22438,0,0
7,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.045233,0.17588,0.19613,0,0
7,GO BONE MINERALIZATION,0.10811,0.17531,0.14255,0,0
7,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0011418,0.17451,0.1769,0,0
7,GO CELL SUBSTRATE ADHESION,0.072385,0.1741,0.20071,0,0
7,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.214,0.17376,0.19189,0,0
7,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.2259,0.17341,0.14005,0,0
7,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.091819,0.1734,0.22643,0,0
7,GO REGULATION OF SPINDLE CHECKPOINT,0.077559,0.17288,0.1638,0,0
7,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.11894,0.17275,0.19055,0,0
7,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.19156,0.17194,0.15142,0,0
7,GO KINETOCHORE ASSEMBLY,0.069906,0.17142,0.20762,0,0
7,GO WOUND HEALING,0.13885,0.17114,0.16105,0,0
7,GO RESPONSE TO DIETARY EXCESS,0.006955,0.17107,0.2842,0,0
7,GO PULMONARY VALVE MORPHOGENESIS,0.098083,0.17079,0.21547,0,0
7,GO RETINAL ROD CELL DIFFERENTIATION,0.072385,0.17065,0.16688,0,0
7,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.37964,0.17003,0.05676,0,0
7,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.12662,0.16934,0.16928,0,0
7,GO REGULATION OF BONE DEVELOPMENT,0.27126,0.16919,0.13339,0,0
7,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.16123,0.16905,0.19317,0,0
7,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0042727,0.16899,0.18828,0,0
7,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.08588,0.16876,0.19246,0,0
7,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.58498,0.16874,0.030707,0,0
7,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13885,0.16874,0.18118,0,0
7,GO EXOCRINE SYSTEM DEVELOPMENT,0.040368,0.16851,0.22582,0,0
7,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.57414,0.16746,0.092104,0,0
7,GO OSTEOCLAST DEVELOPMENT,0.33821,0.16745,0.11893,0,0
7,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0028457,0.16723,0.15923,0,0
7,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.060677,0.16691,0.16719,0,0
7,GO MYOBLAST FUSION,0.11894,0.16684,0.19265,0,0
7,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.26442,0.16654,0.13487,0,0
7,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.3148,0.16635,0.10652,0,0
7,GO BIOMINERALIZATION,0.074935,0.16611,0.15273,0,0
7,GO RESPONSE TO ISCHEMIA,0.067497,0.1661,0.17224,0,0
7,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.3148,0.16588,0.12241,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.12662,0.1657,0.17389,0,0
7,GO DETERMINATION OF ADULT LIFESPAN,0.11163,0.16533,0.18285,0,0
7,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.28529,0.16521,0.1207,0,0
7,GO MIDDLE EAR MORPHOGENESIS,0.29248,0.1651,0.094487,0,0
7,GO ACTIN FILAMENT BASED TRANSPORT,0.072385,0.16505,0.2238,0,0
7,GO RETINOL METABOLIC PROCESS,0.15197,0.16504,0.10256,0,0
7,GO RECEPTOR CATABOLIC PROCESS,0.08588,0.16484,0.15629,0,0
7,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.046961,0.16458,0.19499,0,0
7,GO RESPONSE TO PARATHYROID HORMONE,0.069906,0.16449,0.17731,0,0
7,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.040368,0.16444,0.19971,0,0
7,GO ACTIN FILAMENT NETWORK FORMATION,0.037377,0.16382,0.24824,0,0
7,GO TONGUE DEVELOPMENT,0.080256,0.16364,0.13907,0,0
7,GO FLUID TRANSPORT,0.17591,0.1636,0.15938,0,0
7,GO PLATELET DEGRANULATION,0.4521,0.16358,0.092174,0,0
7,GO RETINAL METABOLIC PROCESS,0.14312,0.16342,0.13092,0,0
7,GO RESPONSE TO LEUCINE,0.072385,0.1632,0.2058,0,0
7,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.050584,0.16304,0.2985,0,0
7,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.32248,0.16295,0.13477,0,0
7,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.007293,0.16243,0.27259,0,0
7,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.08881,0.16225,0.2045,0,0
7,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.062884,0.16213,0.21714,0,0
7,GO BILE ACID AND BILE SALT TRANSPORT,0.091819,0.16161,0.16182,0,0
7,GO DNA REPLICATION CHECKPOINT,0.15655,0.16097,0.17235,0,0
7,GO REGULATION OF CENTRIOLE REPLICATION,0.11894,0.16091,0.14556,0,0
7,GO RENAL FILTRATION,0.077559,0.16078,0.27126,0,0
7,GO GLIAL CELL FATE COMMITMENT,0.065157,0.16077,0.23527,0,0
7,GO VITAMIN D METABOLIC PROCESS,0.88046,0.16042,0.025348,0,0
7,GO REGULATION OF AMYLOID BETA FORMATION,0.1306,0.16035,0.13071,0,0
7,GO TRNA CATABOLIC PROCESS,0.3148,0.16021,0.10177,0,0
7,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.021265,0.16016,0.21581,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.15197,0.16011,0.14413,0,0
7,GO RENAL VESICLE DEVELOPMENT,0.39705,0.16003,0.080268,0,0
7,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.010101,0.15961,0.2348,0,0
7,GO ATRIAL SEPTUM MORPHOGENESIS,0.16123,0.15933,0.17274,0,0
7,GO PEPTIDE CROSS LINKING,0.52145,0.1592,0.085566,0,0
7,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.49108,0.15891,0.076727,0,0
7,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.08588,0.15891,0.20867,0,0
7,GO CONVERGENT EXTENSION,0.031957,0.15864,0.24873,0,0
7,GO CELLULAR RESPONSE TO NUTRIENT,0.041938,0.15857,0.22257,0,0
7,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.27821,0.15819,0.1587,0,0
7,GO GROOMING BEHAVIOR,0.098083,0.15816,0.2418,0,0
7,GO CORONARY VASCULATURE MORPHOGENESIS,0.1306,0.15814,0.21737,0,0
7,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.022172,0.15785,0.2257,0,0
7,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.20822,0.15755,0.10349,0,0
7,GO TELENCEPHALON REGIONALIZATION,0.81845,0.1574,0.010396,0,0
7,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.050584,0.15651,0.16896,0,0
7,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.091819,0.15646,0.13379,0,0
7,GO PULMONARY VALVE DEVELOPMENT,0.16602,0.15637,0.20163,0,0
7,GO TRACHEA DEVELOPMENT,0.10811,0.15611,0.17617,0,0
7,GO REGULATION OF CELL MATRIX ADHESION,0.15655,0.15595,0.17377,0,0
7,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.094909,0.15568,0.16805,0,0
7,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.08303,0.15562,0.13995,0,0
7,GO ENDODERM DEVELOPMENT,0.08881,0.15483,0.20443,0,0
7,GO RESPONSE TO FLUID SHEAR STRESS,0.19156,0.15429,0.15671,0,0
7,GO CENTROMERE COMPLEX ASSEMBLY,0.29248,0.15419,0.10344,0,0
7,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.214,0.154,0.1725,0,0
7,GO TONGUE MORPHOGENESIS,0.17091,0.15399,0.12977,0,0
7,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.13885,0.15394,0.14475,0,0
7,GO PROTEIN DEGLYCOSYLATION,0.060677,0.15371,0.18725,0,0
7,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.42405,0.15343,0.14331,0,0
7,GO POSITIVE REGULATION OF WOUND HEALING,0.26442,0.1533,0.11869,0,0
7,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.080256,0.15293,0.19293,0,0
7,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.08303,0.15236,0.13958,0,0
7,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.17591,0.15227,0.12132,0,0
7,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.074935,0.15212,0.24061,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.074935,0.15177,0.1827,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.08303,0.15165,0.18588,0,0
7,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42405,0.15138,0.11043,0,0
7,GO REGULATION OF ACROSOME REACTION,0.018736,0.15119,0.18386,0,0
7,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.054439,0.15103,0.1973,0,0
7,GO ENDODERM FORMATION,0.214,0.15089,0.17515,0,0
7,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.39705,0.15081,0.10746,0,0
7,GO REGULATION OF LIPID STORAGE,0.10811,0.15047,0.15065,0,0
7,GO REGULATION OF RESPIRATORY BURST,0.1306,0.15029,0.15086,0,0
7,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.062884,0.15002,0.21169,0,0
7,GO RESPONSE TO WOUNDING,0.1306,0.15,0.15602,0,0
7,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.067497,0.14968,0.14912,0,0
7,GO CARDIAC ATRIUM MORPHOGENESIS,0.11894,0.14954,0.18363,0,0
7,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.08588,0.14951,0.13055,0,0
7,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.2577,0.14945,0.1134,0,0
7,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.094909,0.14891,0.16961,0,0
7,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.098083,0.14875,0.14261,0,0
7,GO REGULATION OF FATTY ACID TRANSPORT,0.19156,0.14874,0.11538,0,0
7,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.29248,0.14863,0.14305,0,0
7,GO REGULATION OF RESPONSE TO WOUNDING,0.14312,0.14856,0.14931,0,0
7,GO REGULATION OF NEUROBLAST PROLIFERATION,0.11894,0.14854,0.1634,0,0
7,GO EPOXYGENASE P450 PATHWAY,0.077559,0.14851,0.19981,0,0
7,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.072385,0.14841,0.19521,0,0
7,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.033245,0.1484,0.17085,0,0
7,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.2259,0.14831,0.14325,0,0
7,GO HISTONE EXCHANGE,0.23203,0.14824,0.090355,0,0
7,GO POLYOL TRANSPORT,0.27821,0.14783,0.11674,0,0
7,GO MAMMARY GLAND MORPHOGENESIS,0.11894,0.14774,0.18838,0,0
7,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.054439,0.14754,0.21807,0,0
7,GO CELLULAR SODIUM ION HOMEOSTASIS,0.08881,0.14733,0.16478,0,0
7,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.30724,0.14721,0.12241,0,0
7,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0076456,0.14712,0.31416,0,0
7,GO COLLAGEN FIBRIL ORGANIZATION,0.28529,0.147,0.17042,0,0
7,GO HISTONE SERINE PHOSPHORYLATION,0.33821,0.14683,0.068829,0,0
7,GO DISACCHARIDE METABOLIC PROCESS,0.062884,0.1467,0.24729,0,0
7,GO SECRETION BY TISSUE,0.056456,0.14651,0.146,0,0
7,GO REGULATION OF KIDNEY DEVELOPMENT,0.15197,0.14615,0.13879,0,0
7,GO COAGULATION,0.18624,0.14603,0.13984,0,0
7,GO METANEPHROS DEVELOPMENT,0.046961,0.14535,0.17479,0,0
7,GO LABYRINTHINE LAYER DEVELOPMENT,0.11894,0.1452,0.1369,0,0
7,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.1475,0.14518,0.18318,0,0
7,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.60692,0.14518,0.038036,0,0
7,GO TRABECULA MORPHOGENESIS,0.1475,0.14503,0.17241,0,0
7,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.10468,0.14488,0.14595,0,0
7,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.030713,0.14482,0.16723,0,0
7,GO STORE OPERATED CALCIUM ENTRY,0.3148,0.1446,0.12107,0,0
7,GO FATTY ACID DERIVATIVE TRANSPORT,0.20256,0.14446,0.11312,0,0
7,GO GENITALIA DEVELOPMENT,0.25111,0.14423,0.11062,0,0
7,GO STABILIZATION OF MEMBRANE POTENTIAL,0.091819,0.14406,0.2117,0,0
7,GO POSITIVE REGULATION OF HEART CONTRACTION,0.011574,0.14402,0.28853,0,0
7,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.074935,0.14388,0.18028,0,0
7,GO REGULATION OF PEPTIDE SECRETION,0.027226,0.14379,0.17458,0,0
7,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.077559,0.14371,0.19297,0,0
7,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.70989,0.14368,0.099037,0,0
7,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.062884,0.14362,0.15938,0,0
7,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0040644,0.14362,0.23222,0,0
7,GO REGULATION OF EXIT FROM MITOSIS,0.19156,0.14351,0.10034,0,0
7,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.16123,0.14343,0.22409,0,0
7,GO GLUCOSE CATABOLIC PROCESS,0.08881,0.14339,0.15732,0,0
7,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.13467,0.14336,0.12063,0,0
7,GO CELLULAR RESPONSE TO ETHANOL,0.48117,0.14253,0.11745,0,0
7,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.25111,0.1424,0.11852,0,0
7,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.050584,0.14193,0.19196,0,0
7,GO REGULATION OF BMP SIGNALING PATHWAY,0.038848,0.14185,0.20845,0,0
7,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.14312,0.14177,0.13253,0,0
7,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.38829,0.14162,0.10501,0,0
7,GO NEUROBLAST PROLIFERATION,0.08588,0.14155,0.1824,0,0
7,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.53179,0.14154,0.1395,0,0
7,GO MITOTIC SPINDLE ORGANIZATION,0.1306,0.14103,0.13914,0,0
7,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.098083,0.14092,0.12495,0,0
7,GO RESPONSE TO AXON INJURY,0.0096484,0.14066,0.18661,0,0
7,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.069906,0.1406,0.17239,0,0
7,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.18102,0.14027,0.20311,0,0
7,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.32248,0.14023,0.11562,0,0
7,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.30724,0.1402,0.24689,0,0
7,GO CELL FATE SPECIFICATION,0.08588,0.14017,0.16143,0,0
7,GO HEART VALVE FORMATION,0.14312,0.14014,0.16789,0,0
7,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.11163,0.1395,0.21608,0,0
7,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24463,0.1394,0.1299,0,0
7,GO HEART INDUCTION,0.08588,0.13938,0.19902,0,0
7,GO PROTEIN ADP RIBOSYLATION,0.10134,0.13937,0.12227,0,0
7,GO CELL MOTILITY,0.054439,0.13935,0.16667,0,0
7,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.056456,0.13925,0.17661,0,0
7,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.17091,0.13906,0.12437,0,0
7,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.067497,0.1389,0.14723,0,0
7,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.045233,0.13885,0.17608,0,0
7,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.23827,0.13869,0.12068,0,0
7,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.13885,0.13816,0.16147,0,0
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.069906,0.1374,0.25996,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.48117,0.13736,0.082813,0,0
7,GO PROTEIN PROCESSING,0.10811,0.13734,0.12119,0,0
7,GO CHROMATIN REMODELING AT CENTROMERE,0.49108,0.13711,0.040551,0,0
7,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.013834,0.13709,0.19041,0,0
7,GO SUBSTANTIA NIGRA DEVELOPMENT,0.015776,0.13661,0.15542,0,0
7,GO GONADOTROPIN SECRETION,0.020391,0.13659,0.20247,0,0
7,GO NEGATIVE REGULATION OF ANOIKIS,0.23827,0.13659,0.16601,0,0
7,GO REGULATION OF COAGULATION,0.53179,0.13646,0.082806,0,0
7,GO REGULATION OF STEM CELL PROLIFERATION,0.08588,0.13634,0.16517,0,0
7,GO TRANSEPITHELIAL TRANSPORT,0.091819,0.13629,0.17684,0,0
7,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.19156,0.13627,0.16018,0,0
7,GO ECTODERM DEVELOPMENT,0.062884,0.13611,0.15419,0,0
7,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.098083,0.13605,0.21054,0,0
7,GO AUTOPHAGY OF MITOCHONDRION,0.0029965,0.13573,0.21681,0,0
7,GO KIDNEY MESENCHYME DEVELOPMENT,0.10811,0.13534,0.15957,0,0
7,GO COPPER ION TRANSPORT,0.20822,0.13516,0.111,0,0
7,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.16123,0.1351,0.17452,0,0
7,GO PROTEIN LOCALIZATION TO AXON,0.33821,0.13508,0.16017,0,0
7,GO RESPONSE TO MINERALOCORTICOID,0.34626,0.13504,0.091649,0,0
7,GO HYPOTONIC RESPONSE,0.23203,0.13495,0.13505,0,0
7,GO REGULATION OF STEM CELL DIVISION,0.25111,0.13456,0.15709,0,0
7,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.08303,0.13454,0.17532,0,0
7,GO PROTEIN KINASE B SIGNALING,0.18102,0.13423,0.1347,0,0
7,GO WALKING BEHAVIOR,0.10811,0.134,0.19182,0,0
7,GO REGULATION OF PINOCYTOSIS,0.060677,0.13399,0.23791,0,0
7,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.34626,0.13382,0.14768,0,0
7,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.90549,0.13378,0.0080719,0,0
7,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.20256,0.1337,0.16616,0,0
7,GO VACUOLE ORGANIZATION,0.0017696,0.13335,0.22589,0,0
7,GO ETHANOL METABOLIC PROCESS,0.35442,0.13288,0.090633,0,0
7,GO L GLUTAMATE IMPORT,0.077559,0.13276,0.15964,0,0
7,GO LIPID HOMEOSTASIS,0.060677,0.13271,0.14718,0,0
7,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.30724,0.13244,0.12979,0,0
7,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.080256,0.13242,0.17099,0,0
7,GO PLATELET ACTIVATION,0.29248,0.13241,0.12877,0,0
7,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.19156,0.1323,0.13362,0,0
7,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.08588,0.13202,0.1671,0,0
7,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.36271,0.13188,0.069462,0,0
7,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.091819,0.13172,0.16681,0,0
7,GO POSITIVE REGULATION OF CELL DIVISION,0.02951,0.13163,0.15357,0,0
7,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.61803,0.13153,0.056532,0,0
7,GO INNER CELL MASS CELL PROLIFERATION,0.072385,0.13139,0.15707,0,0
7,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.13885,0.1312,0.17666,0,0
7,GO LYTIC VACUOLE ORGANIZATION,0.019548,0.13113,0.19361,0,0
7,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.11524,0.13103,0.14182,0,0
7,GO MEMBRANE PROTEIN PROTEOLYSIS,0.214,0.13101,0.14492,0,0
7,GO GLAND MORPHOGENESIS,0.20256,0.13087,0.14473,0,0
7,GO REGULATION OF HEART MORPHOGENESIS,0.11163,0.13076,0.17248,0,0
7,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.13885,0.13057,0.13819,0,0
7,GO SARCOMERE ORGANIZATION,0.00332,0.13057,0.1972,0,0
7,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.21989,0.13034,0.1005,0,0
7,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.68646,0.13009,0.089623,0,0
7,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.32248,0.12999,0.13238,0,0
7,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.88046,0.1297,0.033495,0,0
7,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.48117,0.12959,0.084763,0,0
7,GO CYTOCHROME COMPLEX ASSEMBLY,0.0012071,0.12948,0.13135,0,0
7,GO REGULATION OF EXCRETION,0.077559,0.12928,0.20233,0,0
7,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.074935,0.12917,0.15688,0,0
7,GO REGULATION OF HISTONE PHOSPHORYLATION,0.2259,0.12915,0.10641,0,0
7,GO KERATAN SULFATE CATABOLIC PROCESS,0.50109,0.12891,0.1148,0,0
7,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.11894,0.12873,0.15652,0,0
7,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.094909,0.12862,0.11711,0,0
7,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.10134,0.1286,0.14926,0,0
7,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.2577,0.12825,0.14818,0,0
7,GO ER NUCLEUS SIGNALING PATHWAY,0.080256,0.12793,0.12755,0,0
7,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0049572,0.12787,0.15864,0,0
7,GO LONG CHAIN FATTY ACID TRANSPORT,0.08303,0.12774,0.12981,0,0
7,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.17091,0.12766,0.13108,0,0
7,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.080256,0.12744,0.15719,0,0
7,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.25111,0.12674,0.094062,0,0
7,GO MOVEMENT IN HOST ENVIRONMENT,0.38829,0.12669,0.094663,0,0
7,GO REGULATION OF SPINDLE ASSEMBLY,0.054439,0.12668,0.15952,0,0
7,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.25111,0.12666,0.065638,0,0
7,GO POSITIVE REGULATION OF VESICLE FUSION,0.013235,0.12656,0.29985,0,0
7,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.93062,0.12649,0.0064772,0,0
7,GO APPENDAGE MORPHOGENESIS,0.069906,0.12624,0.1788,0,0
7,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.02951,0.12602,0.15822,0,0
7,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.38829,0.12597,0.10023,0,0
7,GO ENDOTHELIAL CELL DEVELOPMENT,0.045233,0.12593,0.21445,0,0
7,GO GDP METABOLIC PROCESS,0.14312,0.12564,0.14943,0,0
7,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.23827,0.12545,0.15704,0,0
7,GO CHONDROCYTE DIFFERENTIATION,0.058535,0.1253,0.19669,0,0
7,GO AMYLOID BETA FORMATION,0.13885,0.12494,0.13374,0,0
7,GO POSITIVE REGULATION OF MYELINATION,0.13467,0.12491,0.17463,0,0
7,GO DORSAL AORTA DEVELOPMENT,0.27821,0.12489,0.16249,0,0
7,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.17091,0.12484,0.15905,0,0
7,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.62923,0.1247,0.091024,0,0
7,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.13467,0.12456,0.14406,0,0
7,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.2259,0.12455,0.17944,0,0
7,GO CELLULAR IRON ION HOMEOSTASIS,0.062884,0.12451,0.14781,0,0
7,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0054671,0.1245,0.16188,0,0
7,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.4521,0.1245,0.11518,0,0
7,GO HYALURONAN METABOLIC PROCESS,0.10811,0.12449,0.19476,0,0
7,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.072385,0.12448,0.16393,0,0
7,GO REGULATION OF ENDOCYTIC RECYCLING,0.11163,0.12448,0.17599,0,0
7,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.08303,0.12436,0.14053,0,0
7,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.48117,0.12429,0.078945,0,0
7,GO POSITIVE REGULATION OF CELL MATURATION,0.08881,0.12427,0.14864,0,0
7,GO POSITIVE REGULATION OF BONE RESORPTION,0.1306,0.12416,0.18985,0,0
7,GO RESPONSE TO RETINOIC ACID,0.12273,0.12392,0.14122,0,0
7,GO HEPARIN METABOLIC PROCESS,0.33029,0.12363,0.19972,0,0
7,GO SEQUESTERING OF TRIGLYCERIDE,0.20822,0.12339,0.1375,0,0
7,GO FORELIMB MORPHOGENESIS,0.18624,0.12328,0.14462,0,0
7,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.098083,0.12318,0.15451,0,0
7,GO TRIGEMINAL NERVE DEVELOPMENT,0.4521,0.12314,0.11071,0,0
7,GO MIDGUT DEVELOPMENT,0.1475,0.12311,0.20722,0,0
7,GO BONE DEVELOPMENT,0.10468,0.12303,0.15741,0,0
7,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.15197,0.12289,0.13113,0,0
7,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.20822,0.12288,0.13098,0,0
7,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.34626,0.12285,0.071319,0,0
7,GO POSITIVE REGULATION OF ORGAN GROWTH,0.08588,0.12269,0.16018,0,0
7,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.36271,0.12265,0.086398,0,0
7,GO ACTIN CYTOSKELETON REORGANIZATION,0.094909,0.12246,0.16682,0,0
7,GO CELLULAR RESPONSE TO LITHIUM ION,0.21989,0.12242,0.087246,0,0
7,GO MITOCHONDRIAL DEPOLARIZATION,0.054439,0.12234,0.18744,0,0
7,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.072385,0.12213,0.18078,0,0
7,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.68646,0.12208,0.057605,0,0
7,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.13467,0.12203,0.19903,0,0
7,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.074935,0.12174,0.17355,0,0
7,GO ETHER BIOSYNTHETIC PROCESS,0.49108,0.12166,0.056909,0,0
7,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.197,0.12149,0.13482,0,0
7,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.11524,0.12146,0.16332,0,0
7,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.18102,0.12134,0.16591,0,0
7,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.15197,0.12126,0.12673,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.214,0.12113,0.16435,0,0
7,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.2998,0.12112,0.094702,0,0
7,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.2577,0.12109,0.097613,0,0
7,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.78176,0.12108,0.029124,0,0
7,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.058535,0.12101,0.2284,0,0
7,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.091819,0.12086,0.13723,0,0
7,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.16123,0.12081,0.13744,0,0
7,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0028457,0.12078,0.19596,0,0
7,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.074935,0.12061,0.13967,0,0
7,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0172,0.12057,0.15714,0,0
7,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.3148,0.12057,0.12003,0,0
7,GO UROGENITAL SYSTEM DEVELOPMENT,0.026142,0.12043,0.19052,0,0
7,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.27126,0.12006,0.14569,0,0
7,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.091819,0.11993,0.12411,0,0
7,GO RENAL ABSORPTION,0.27821,0.11977,0.14282,0,0
7,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.66333,0.11976,0.041872,0,0
7,GO MITOCHONDRIAL GENOME MAINTENANCE,0.21989,0.11954,0.1208,0,0
7,GO REGULATION OF CALCIUM ION IMPORT,0.197,0.11914,0.14009,0,0
7,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.37964,0.11909,0.097439,0,0
7,GO EPITHELIAL CELL PROLIFERATION,0.11163,0.11896,0.14376,0,0
7,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.11524,0.11895,0.21649,0,0
7,GO TRIGLYCERIDE METABOLIC PROCESS,0.069906,0.1188,0.14921,0,0
7,GO OXYGEN TRANSPORT,0.46168,0.11863,0.073119,0,0
7,GO FIBROBLAST MIGRATION,0.1475,0.11861,0.14678,0,0
7,GO AMINO SUGAR METABOLIC PROCESS,0.17091,0.11811,0.12067,0,0
7,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.10811,0.11808,0.16384,0,0
7,GO REGULATION OF BONE MINERALIZATION,0.27126,0.11757,0.11353,0,0
7,GO RESPONSE TO GROWTH HORMONE,0.1475,0.11729,0.12484,0,0
7,GO POSITIVE REGULATION OF URINE VOLUME,0.13467,0.11726,0.17533,0,0
7,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.098083,0.11712,0.20978,0,0
7,GO REGULATION OF PROTEOLYSIS,0.060677,0.11707,0.13324,0,0
7,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.010572,0.11705,0.14936,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.15655,0.11694,0.18604,0,0
7,GO NEGATIVE REGULATION OF GLIOGENESIS,0.077559,0.1169,0.14828,0,0
7,GO ALDEHYDE CATABOLIC PROCESS,0.16123,0.1167,0.077759,0,0
7,GO REGULATION OF LYSOSOMAL LUMEN PH,0.47137,0.11667,0.063853,0,0
7,GO RRNA MODIFICATION,0.10468,0.11656,0.091959,0,0
7,GO ENDODERMAL CELL FATE COMMITMENT,0.23827,0.11653,0.10585,0,0
7,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.17591,0.11629,0.15017,0,0
7,GO FATTY ACID TRANSPORT,0.1475,0.11598,0.11519,0,0
7,GO ARACHIDONIC ACID SECRETION,0.13467,0.11588,0.11349,0,0
7,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.16123,0.11586,0.23102,0,0
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.13467,0.11562,0.1438,0,0
7,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.54223,0.11551,0.094413,0,0
7,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.08303,0.11541,0.12101,0,0
7,GO SECRETION,0.062884,0.11514,0.14321,0,0
7,GO SYNCYTIUM FORMATION,0.19156,0.11511,0.15356,0,0
7,GO CELL CELL ADHESION,0.1475,0.1149,0.14282,0,0
7,GO RESPONSE TO DEXAMETHASONE,0.25111,0.11489,0.10267,0,0
7,GO REGULATION OF FIBROBLAST MIGRATION,0.14312,0.11487,0.1438,0,0
7,GO REGULATION OF VASCULATURE DEVELOPMENT,0.4521,0.11481,0.10191,0,0
7,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.069906,0.11447,0.15544,0,0
7,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.37964,0.11432,0.13713,0,0
7,GO RESPONSE TO INSECTICIDE,0.060677,0.11431,0.21459,0,0
7,GO NEUTRAL AMINO ACID TRANSPORT,0.037377,0.11426,0.18084,0,0
7,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.1306,0.11426,0.17455,0,0
7,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.10468,0.11426,0.20085,0,0
7,GO LINOLEIC ACID METABOLIC PROCESS,0.074935,0.11409,0.16447,0,0
7,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.048745,0.11404,0.15575,0,0
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.35442,0.11403,0.11863,0,0
7,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.18624,0.114,0.1169,0,0
7,GO REGULATION OF LIPID LOCALIZATION,0.15655,0.11398,0.11367,0,0
7,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.12273,0.11351,0.13506,0,0
7,GO OVULATION,0.35442,0.11351,0.092251,0,0
7,GO MICROVILLUS ASSEMBLY,0.17091,0.11344,0.11517,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.20256,0.11336,0.13668,0,0
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.27821,0.11327,0.10769,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.214,0.11308,0.12739,0,0
7,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.21989,0.11282,0.081863,0,0
7,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.43329,0.11272,0.094037,0,0
7,GO PROGRAMMED NECROTIC CELL DEATH,0.41494,0.11269,0.080154,0,0
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.13885,0.11268,0.16563,0,0
7,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.36271,0.11262,0.11077,0,0
7,GO BONE TRABECULA MORPHOGENESIS,0.34626,0.11254,0.1708,0,0
7,GO ACTIN FILAMENT SEVERING,0.34626,0.11235,0.15045,0,0
7,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.024086,0.11199,0.22515,0,0
7,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.08303,0.11192,0.15362,0,0
7,GO LIPID IMPORT INTO CELL,0.11524,0.11191,0.15011,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.39705,0.11177,0.10318,0,0
7,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.056456,0.11168,0.22117,0,0
7,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.30724,0.11159,0.13009,0,0
7,GO ACUTE PHASE RESPONSE,0.62923,0.11156,0.040628,0,0
7,GO MONOSACCHARIDE CATABOLIC PROCESS,0.08303,0.11155,0.11408,0,0
7,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.23827,0.11144,0.18059,0,0
7,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.37111,0.11138,0.157,0,0
7,GO RESPONSE TO HYDROXYUREA,0.15655,0.11125,0.15507,0,0
7,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.33821,0.11114,0.11482,0,0
7,GO FORMATION OF PRIMARY GERM LAYER,0.08881,0.11111,0.17842,0,0
7,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.10468,0.11108,0.1695,0,0
7,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.080256,0.11102,0.13057,0,0
7,GO PINOCYTOSIS,0.37111,0.11093,0.11148,0,0
7,GO RRNA METHYLATION,0.054439,0.11058,0.1189,0,0
7,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.1306,0.11041,0.13239,0,0
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.14312,0.11036,0.14972,0,0
7,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.080256,0.11021,0.14594,0,0
7,GO VITAMIN TRANSPORT,0.072385,0.11008,0.14997,0,0
7,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.35442,0.10999,0.096561,0,0
7,GO REGULATION OF LIPASE ACTIVITY,0.56341,0.10996,0.057301,0,0
7,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.29248,0.10995,0.096128,0,0
7,GO LUNG MORPHOGENESIS,0.12662,0.1099,0.17321,0,0
7,GO SKELETAL SYSTEM MORPHOGENESIS,0.12662,0.1097,0.15874,0,0
7,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.69814,0.10969,0.12,0,0
7,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.30724,0.10969,0.12611,0,0
7,GO RESPONSE TO LIPID,0.13467,0.10963,0.12714,0,0
7,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.18102,0.10961,0.14995,0,0
7,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.60692,0.1096,0.059838,0,0
7,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.15655,0.10942,0.13546,0,0
7,GO PIGMENT ACCUMULATION,0.08881,0.10929,0.17807,0,0
7,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.7336,0.10913,0.041314,0,0
7,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.052482,0.10907,0.25753,0,0
7,GO OSTEOBLAST DIFFERENTIATION,0.12273,0.10904,0.13517,0,0
7,GO BROWN FAT CELL DIFFERENTIATION,0.1475,0.10897,0.12004,0,0
7,GO CELL CYCLE G1 S PHASE TRANSITION,0.056456,0.10891,0.13105,0,0
7,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0023095,0.10877,0.17411,0,0
7,GO LYSOSOME LOCALIZATION,0.16123,0.10868,0.13924,0,0
7,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.35442,0.1086,0.1112,0,0
7,GO REGULATION OF PROTEIN IMPORT,0.056456,0.10855,0.13886,0,0
7,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.20822,0.10837,0.15816,0,0
7,GO GLIOGENESIS,0.080256,0.10829,0.14717,0,0
7,GO DNA DEALKYLATION,0.11524,0.10815,0.11337,0,0
7,GO LYMPH NODE DEVELOPMENT,0.43329,0.10812,0.10696,0,0
7,GO MITOTIC CELL CYCLE ARREST,0.11524,0.10789,0.12576,0,0
7,GO NEUROBLAST DIVISION,0.15655,0.10778,0.1446,0,0
7,GO PROTEIN LOCALIZATION TO ENDOSOME,0.1475,0.10759,0.18244,0,0
7,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.79394,0.10723,0.040464,0,0
7,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.28529,0.10718,0.10375,0,0
7,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.12273,0.10718,0.19781,0,0
7,GO PERICARDIUM DEVELOPMENT,0.23203,0.10717,0.13553,0,0
7,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.10811,0.10706,0.12991,0,0
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.21989,0.10704,0.12805,0,0
7,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.50109,0.10693,0.029065,0,0
7,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.069906,0.10692,0.1671,0,0
7,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.60692,0.10682,0.047356,0,0
7,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.11163,0.10628,0.15166,0,0
7,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.067497,0.10628,0.13611,0,0
7,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.094909,0.10607,0.11982,0,0
7,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.21989,0.10597,0.11508,0,0
7,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.2577,0.10587,0.14007,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.023112,0.1057,0.16077,0,0
7,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.027226,0.10564,0.15773,0,0
7,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.17091,0.10531,0.13674,0,0
7,GO REGULATION OF ODONTOGENESIS,0.16602,0.1053,0.1333,0,0
7,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.33821,0.10513,0.13426,0,0
7,GO RESPONSE TO NUTRIENT,0.20256,0.1051,0.11562,0,0
7,GO REGULATION OF URINE VOLUME,0.067497,0.10489,0.19217,0,0
7,GO EPITHELIAL CELL FATE COMMITMENT,0.21989,0.10475,0.1489,0,0
7,GO REGULATION OF PROSTAGLANDIN SECRETION,0.39705,0.10474,0.088247,0,0
7,GO BONE MORPHOGENESIS,0.26442,0.10468,0.12768,0,0
7,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.23203,0.10465,0.12338,0,0
7,GO RESPONSE TO MECHANICAL STIMULUS,0.072385,0.10445,0.1626,0,0
7,GO CORONARY VASCULATURE DEVELOPMENT,0.08588,0.10436,0.1895,0,0
7,GO REGULATION OF ANIMAL ORGAN FORMATION,0.40594,0.10426,0.078162,0,0
7,GO REGULATION OF PEPTIDASE ACTIVITY,0.2259,0.10399,0.10784,0,0
7,GO REGULATION OF PLATELET ACTIVATION,0.78176,0.10379,0.025713,0,0
7,GO PROTEIN TARGETING TO LYSOSOME,0.3148,0.10371,0.12803,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.062884,0.10367,0.16769,0,0
7,GO RIG I SIGNALING PATHWAY,0.091819,0.10359,0.14452,0,0
7,GO RESPONSE TO MURAMYL DIPEPTIDE,0.29248,0.10353,0.13074,0,0
7,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.52145,0.10349,0.077009,0,0
7,GO STEROL HOMEOSTASIS,0.2577,0.10349,0.088478,0,0
7,GO RESPONSE TO MAGNESIUM ION,0.17591,0.10342,0.19307,0,0
7,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.16123,0.10328,0.19286,0,0
7,GO REGULATION OF BIOMINERALIZATION,0.21989,0.10327,0.12657,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.052482,0.10324,0.14245,0,0
7,GO REGULATION OF LIPID CATABOLIC PROCESS,0.056456,0.10316,0.15269,0,0
7,GO ENDOTHELIAL CELL PROLIFERATION,0.23203,0.1031,0.13202,0,0
7,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.11163,0.10305,0.15831,0,0
7,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.2259,0.10299,0.14316,0,0
7,GO ACYLGLYCEROL HOMEOSTASIS,0.28529,0.10282,0.09704,0,0
7,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.49108,0.1027,0.093372,0,0
7,GO VACUOLAR ACIDIFICATION,0.20256,0.10257,0.098467,0,0
7,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.019548,0.10244,0.17285,0,0
7,GO SERTOLI CELL DIFFERENTIATION,0.18624,0.10241,0.15066,0,0
7,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.072385,0.10233,0.11766,0,0
7,GO CELL CYCLE DNA REPLICATION,0.39705,0.10231,0.077769,0,0
7,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.1475,0.10222,0.14888,0,0
7,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.20822,0.10214,0.11787,0,0
7,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.43329,0.10201,0.11291,0,0
7,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.70989,0.10201,0.043169,0,0
7,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.062884,0.1019,0.16088,0,0
7,GO POSITIVE REGULATION OF HEART RATE,0.077559,0.10189,0.17724,0,0
7,GO REGULATION OF GASTRULATION,0.19156,0.10187,0.13435,0,0
7,GO RENAL SODIUM EXCRETION,0.026142,0.10178,0.26647,0,0
7,GO INTERACTION WITH HOST,0.27126,0.10171,0.11068,0,0
7,GO HEPATOCYTE DIFFERENTIATION,0.58498,0.10149,0.036615,0,0
7,GO MATERNAL PLACENTA DEVELOPMENT,0.2998,0.10142,0.12032,0,0
7,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.53179,0.10139,0.081728,0,0
7,GO LEUKOTRIENE METABOLIC PROCESS,0.48117,0.10134,0.067739,0,0
7,GO ENTRY INTO HOST,0.48117,0.10125,0.084068,0,0
7,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.66333,0.1011,0.03914,0,0
7,GO RNA DECAPPING,0.14312,0.10108,0.1523,0,0
7,GO CARDIAC CELL DEVELOPMENT,0.033245,0.10098,0.17961,0,0
7,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.15197,0.10093,0.12659,0,0
7,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.25111,0.10091,0.11576,0,0
7,GO VIRAL RNA GENOME REPLICATION,0.11163,0.1009,0.1334,0,0
7,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.37111,0.10081,0.115,0,0
7,GO REGULATION OF ANOIKIS,0.2259,0.1008,0.14758,0,0
7,GO REGULATION OF CELL POPULATION PROLIFERATION,0.11163,0.10076,0.13484,0,0
7,GO EMBRYONIC PLACENTA DEVELOPMENT,0.18624,0.10069,0.14378,0,0
7,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.89296,0.10068,0.037702,0,0
7,GO POSITIVE CHEMOTAXIS,0.56341,0.10061,0.074156,0,0
7,GO SMOOTH MUSCLE CONTRACTION,0.062884,0.10058,0.14006,0,0
7,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.214,0.10045,0.14847,0,0
7,GO BICARBONATE TRANSPORT,0.18102,0.10039,0.10706,0,0
7,GO REGULATION OF RENAL SYSTEM PROCESS,0.12662,0.10024,0.18152,0,0
7,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.30724,0.10012,0.12883,0,0
7,GO CRANIAL NERVE DEVELOPMENT,0.11524,0.10006,0.17946,0,0
7,GO IMP METABOLIC PROCESS,0.56341,0.099904,0.064458,0,0
7,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.24463,0.099796,0.14019,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.10134,0.099671,0.1674,0,0
7,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.27126,0.099658,0.10932,0,0
7,GO REGULATION OF RECEPTOR BINDING,0.68646,0.099597,0.058747,0,0
7,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.2998,0.099581,0.11589,0,0
7,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.197,0.099541,0.16774,0,0
7,GO REGULATION OF OSSIFICATION,0.17591,0.099517,0.13781,0,0
7,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17091,0.099332,0.093047,0,0
7,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.08303,0.099312,0.14882,0,0
7,GO PLACENTA DEVELOPMENT,0.13467,0.099155,0.13068,0,0
7,GO RESPONSE TO TYPE I INTERFERON,0.98106,0.099138,0.0040396,0,0
7,GO CELL FATE COMMITMENT,0.072385,0.099053,0.15544,0,0
7,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.48117,0.099018,0.047179,0,0
7,GO COLLAGEN BIOSYNTHETIC PROCESS,0.32248,0.098965,0.16794,0,0
7,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.067497,0.098846,0.11626,0,0
7,GO PSEUDOURIDINE SYNTHESIS,0.08588,0.098844,0.076665,0,0
7,GO ENDOTHELIAL CELL CHEMOTAXIS,0.197,0.09868,0.15531,0,0
7,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.26442,0.098507,0.14656,0,0
7,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.10811,0.098478,0.13991,0,0
7,GO BILE ACID BIOSYNTHETIC PROCESS,0.060677,0.09827,0.14034,0,0
7,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.056456,0.098257,0.13825,0,0
7,GO REGULATION OF TRANSFERASE ACTIVITY,0.016475,0.098187,0.16885,0,0
7,GO POSITIVE REGULATION OF PROTEOLYSIS,0.069906,0.09806,0.13484,0,0
7,GO ASYMMETRIC CELL DIVISION,0.13885,0.098032,0.13248,0,0
7,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.15197,0.097837,0.10736,0,0
7,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.35442,0.09776,0.10096,0,0
7,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.37964,0.097648,0.10863,0,0
7,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.57414,0.097526,0.088131,0,0
7,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.080256,0.097332,0.11878,0,0
7,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.1475,0.097125,0.13473,0,0
7,GO PHOSPHOLIPID HOMEOSTASIS,0.16602,0.097099,0.13293,0,0
7,GO POSITIVE REGULATION OF JNK CASCADE,0.15655,0.096682,0.15994,0,0
7,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.10811,0.09662,0.16334,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.43329,0.09649,0.079126,0,0
7,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.1306,0.096408,0.15071,0,0
7,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.18624,0.096268,0.10006,0,0
7,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.12273,0.096217,0.17044,0,0
7,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.098083,0.09614,0.090674,0,0
7,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.12273,0.096136,0.12725,0,0
7,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.79394,0.096084,0.014061,0,0
7,GO IMMUNOLOGICAL MEMORY PROCESS,0.52145,0.095909,0.10472,0,0
7,GO NECROTIC CELL DEATH,0.52145,0.095881,0.056999,0,0
7,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.18624,0.095863,0.099818,0,0
7,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.60692,0.095857,0.066407,0,0
7,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.060677,0.095756,0.15476,0,0
7,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.056456,0.095526,0.2043,0,0
7,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.069906,0.095415,0.09527,0,0
7,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.24463,0.095296,0.093867,0,0
7,GO NEGATIVE REGULATION OF DNA REPLICATION,0.23827,0.095149,0.094362,0,0
7,GO PROTEIN K11 LINKED UBIQUITINATION,0.054439,0.095045,0.11123,0,0
7,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.52145,0.094941,0.071869,0,0
7,GO MYOBLAST DIFFERENTIATION,0.28529,0.094939,0.10751,0,0
7,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.46168,0.094857,0.081054,0,0
7,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.016475,0.094857,0.19027,0,0
7,GO PITUITARY GLAND DEVELOPMENT,0.17091,0.094801,0.18133,0,0
7,GO VASCULAR WOUND HEALING,0.66333,0.09467,0.090214,0,0
7,GO REGULATION OF LIPID KINASE ACTIVITY,0.23827,0.094538,0.12608,0,0
7,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.28529,0.094499,0.10445,0,0
7,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.3148,0.094365,0.12474,0,0
7,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.021265,0.094233,0.19603,0,0
7,GO TRACHEA MORPHOGENESIS,0.20256,0.094209,0.14927,0,0
7,GO GANGLIOSIDE METABOLIC PROCESS,0.20822,0.094191,0.11501,0,0
7,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.33821,0.093948,0.15333,0,0
7,GO HISTONE PHOSPHORYLATION,0.19156,0.093915,0.11034,0,0
7,GO TRANSPOSITION,0.27821,0.093629,0.087318,0,0
7,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.16123,0.0935,0.14456,0,0
7,GO RESPONSE TO VITAMIN,0.38829,0.093401,0.10206,0,0
7,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72171,0.093299,0.063529,0,0
7,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.062884,0.093154,0.14611,0,0
7,GO REGULATION OF TRANSLATIONAL FIDELITY,0.056456,0.093071,0.1347,0,0
7,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.069906,0.092587,0.21804,0,0
7,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.93062,0.092331,0.043472,0,0
7,GO EXOCYTOSIS,0.23203,0.092267,0.11459,0,0
7,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.13885,0.092222,0.12266,0,0
7,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.24463,0.092122,0.097247,0,0
7,GO VESICLE CARGO LOADING,0.08881,0.091987,0.16832,0,0
7,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.2577,0.091984,0.10754,0,0
7,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.197,0.091787,0.13194,0,0
7,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.23203,0.091729,0.097911,0,0
7,GO CELLULAR RESPONSE TO AMYLOID BETA,0.2577,0.091698,0.13957,0,0
7,GO CORPUS CALLOSUM DEVELOPMENT,0.21989,0.091481,0.16043,0,0
7,GO NEUTROPHIL HOMEOSTASIS,1,0.091444,0.034491,0,0
7,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.46168,0.091384,0.077515,0,0
7,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.43329,0.091339,0.075653,0,0
7,GO MITOCHONDRIAL FISSION,0.0049572,0.091312,0.20729,0,0
7,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.36271,0.091306,0.11399,0,0
7,GO POSTREPLICATION REPAIR,0.094909,0.091257,0.097542,0,0
7,GO PEPTIDYL PROLINE HYDROXYLATION,0.70989,0.091216,0.042635,0,0
7,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.37111,0.091201,0.10394,0,0
7,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.2577,0.091075,0.12612,0,0
7,GO ANDROGEN METABOLIC PROCESS,0.37964,0.090822,0.037021,0,0
7,GO PEPTIDYL PROLINE MODIFICATION,0.038848,0.090536,0.11202,0,0
7,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.58498,0.090535,0.07237,0,0
7,GO PROTEIN DENEDDYLATION,0.17091,0.090518,0.075664,0,0
7,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.18624,0.09051,0.14941,0,0
7,GO MATURE B CELL DIFFERENTIATION,0.89296,0.090504,-0.019347,0,0
7,GO CELLULAR RESPONSE TO CAMP,0.10134,0.090481,0.13118,0,0
7,GO PYROPTOSIS,0.42405,0.090401,0.075847,0,0
7,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.44264,0.090293,0.12518,0,0
7,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.11894,0.090249,0.098536,0,0
7,GO REGULATION OF SPROUTING ANGIOGENESIS,0.36271,0.090152,0.12812,0,0
7,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.050584,0.08999,0.12667,0,0
7,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.18624,0.089981,0.065212,0,0
7,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.27126,0.089754,0.17801,0,0
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.1306,0.089653,0.12089,0,0
7,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.38829,0.089624,0.10094,0,0
7,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.90549,0.089381,0.03024,0,0
7,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.35442,0.089274,0.087905,0,0
7,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.24463,0.089173,0.12525,0,0
7,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.18102,0.089153,0.08865,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.69814,0.088822,0.047842,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.15197,0.088689,0.14601,0,0
7,GO CELLULAR RESPONSE TO DSRNA,0.56341,0.08857,0.063363,0,0
7,GO RESPONSE TO L GLUTAMATE,0.30724,0.088464,0.090549,0,0
7,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.23203,0.08845,0.1279,0,0
7,GO MUSCLE CELL PROLIFERATION,0.26442,0.088376,0.12323,0,0
7,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.70989,0.088328,0.046804,0,0
7,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.44264,0.088166,0.097776,0,0
7,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.065157,0.088155,0.13096,0,0
7,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.17091,0.088078,0.12819,0,0
7,GO POSITIVE REGULATION OF BINDING,0.098083,0.087913,0.11669,0,0
7,GO GAS TRANSPORT,0.48117,0.087726,0.079707,0,0
7,GO TRANSLESION SYNTHESIS,0.091819,0.08769,0.09379,0,0
7,GO ODONTOGENESIS,0.17091,0.087154,0.13323,0,0
7,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.18624,0.087104,0.12996,0,0
7,GO HEART TRABECULA FORMATION,0.36271,0.087069,0.083776,0,0
7,GO LIPID STORAGE,0.15197,0.08685,0.12191,0,0
7,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.074935,0.086793,0.2116,0,0
7,GO PROSTATIC BUD FORMATION,0.57414,0.086635,0.053137,0,0
7,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23203,0.086542,0.14054,0,0
7,GO REGULATION OF STEM CELL DIFFERENTIATION,0.29248,0.086275,0.062057,0,0
7,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.13885,0.086135,0.099613,0,0
7,GO NEPHRON TUBULE FORMATION,0.2259,0.086048,0.094468,0,0
7,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19156,0.085927,0.24513,0,0
7,GO GLIAL CELL MIGRATION,0.33029,0.085846,0.13131,0,0
7,GO ESTABLISHMENT OF TISSUE POLARITY,0.054439,0.085538,0.11976,0,0
7,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.33821,0.085497,0.07455,0,0
7,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.08588,0.085417,0.11827,0,0
7,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.48117,0.085379,0.097905,0,0
7,GO NEURON FATE COMMITMENT,0.2577,0.085318,0.13586,0,0
7,GO REGULATION OF LIPID TRANSPORT,0.2259,0.08528,0.093062,0,0
7,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.60692,0.085118,0.071518,0,0
7,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.2577,0.085093,0.10283,0,0
7,GO REGULATION OF MEMBRANE PERMEABILITY,0.12662,0.085007,0.10974,0,0
7,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.34626,0.08492,0.074794,0,0
7,GO COENZYME A BIOSYNTHETIC PROCESS,0.11524,0.084657,0.10501,0,0
7,GO P38MAPK CASCADE,0.54223,0.084648,0.088492,0,0
7,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.13467,0.084601,0.12498,0,0
7,GO REGULATION OF TELOMERASE ACTIVITY,0.13885,0.084527,0.11698,0,0
7,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.045233,0.084479,0.12602,0,0
7,GO RECEPTOR METABOLIC PROCESS,0.08881,0.084319,0.15149,0,0
7,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.39705,0.084255,0.12425,0,0
7,GO CARDIAC CELL FATE COMMITMENT,0.36271,0.083942,0.091824,0,0
7,GO REGULATION OF MAPK CASCADE,0.18624,0.083766,0.13271,0,0
7,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.33029,0.083651,0.14278,0,0
7,GO MEMBRANE LIPID CATABOLIC PROCESS,0.52145,0.083647,0.091013,0,0
7,GO RESPONSE TO IONIZING RADIATION,0.1475,0.083563,0.1155,0,0
7,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.48117,0.083555,0.065452,0,0
7,GO PROTEIN HYDROXYLATION,0.41494,0.083387,0.10379,0,0
7,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.16602,0.083327,0.11431,0,0
7,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.11894,0.083225,0.11008,0,0
7,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.52145,0.083207,0.076052,0,0
7,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.18624,0.083184,0.083192,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.28529,0.083131,0.089747,0,0
7,GO HYPEROSMOTIC SALINITY RESPONSE,0.10468,0.083005,0.22663,0,0
7,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.18102,0.08289,0.10544,0,0
7,GO BASIC AMINO ACID TRANSPORT,0.37111,0.082679,0.11813,0,0
7,GO FATTY ACID BIOSYNTHETIC PROCESS,0.2577,0.082604,0.080951,0,0
7,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.50109,0.082471,0.050482,0,0
7,GO ERYTHROCYTE HOMEOSTASIS,0.11163,0.082174,0.13535,0,0
7,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38829,0.082166,0.10478,0,0
7,GO DNA STRAND ELONGATION,0.2998,0.082159,0.10131,0,0
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.21989,0.082036,0.12465,0,0
7,GO MACROPHAGE CYTOKINE PRODUCTION,0.41494,0.081993,0.14871,0,0
7,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.33821,0.081753,0.12769,0,0
7,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.99368,0.081526,0.00277,0,0
7,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.060677,0.081215,0.11593,0,0
7,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.40594,0.08112,0.10703,0,0
7,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.054439,0.080986,0.11344,0,0
7,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.15197,0.080919,0.14147,0,0
7,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.197,0.080911,0.14359,0,0
7,GO NUCLEAR ENVELOPE REASSEMBLY,0.046961,0.080893,0.12347,0,0
7,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.75756,0.080877,0.040796,0,0
7,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.12662,0.080822,0.12868,0,0
7,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.056456,0.080799,0.10313,0,0
7,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.27821,0.080795,0.097319,0,0
7,GO I KAPPAB PHOSPHORYLATION,0.53179,0.080767,0.091286,0,0
7,GO SIALYLATION,0.18624,0.080721,0.17668,0,0
7,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.53179,0.080709,0.10086,0,0
7,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.030713,0.080689,0.11744,0,0
7,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.077559,0.08052,0.14707,0,0
7,GO RESPONSE TO ACIDIC PH,0.16602,0.080459,0.16564,0,0
7,GO NEGATIVE REGULATION OF GENE SILENCING,0.26442,0.08042,0.11465,0,0
7,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.65188,0.079801,-0.034892,0,0
7,GO POSITIVE REGULATION OF MAPK CASCADE,0.30724,0.079701,0.1109,0,0
7,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.29248,0.079632,0.09983,0,0
7,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.11524,0.079557,0.14379,0,0
7,GO ANTIMICROBIAL HUMORAL RESPONSE,0.57414,0.079547,0.063896,0,0
7,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.080256,0.079532,0.16484,0,0
7,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.50109,0.079503,0.070356,0,0
7,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.41494,0.079385,0.10174,0,0
7,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.2577,0.079363,0.12823,0,0
7,GO RESPONSE TO FATTY ACID,0.23827,0.079311,0.10704,0,0
7,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.054439,0.079247,0.12631,0,0
7,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.11524,0.079247,0.12205,0,0
7,GO NOTOCHORD DEVELOPMENT,0.39705,0.079206,0.10429,0,0
7,GO REGULATION OF GLOMERULAR FILTRATION,0.17591,0.079107,0.20277,0,0
7,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.52145,0.079094,0.08295,0,0
7,GO VITAMIN D BIOSYNTHETIC PROCESS,0.85555,0.078989,-0.032149,0,0
7,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.10468,0.078831,0.1016,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.091819,0.078736,0.12932,0,0
7,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.1306,0.078731,0.12607,0,0
7,GO EPIBOLY,0.34626,0.078671,0.13234,0,0
7,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.091819,0.0786,0.1334,0,0
7,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.08303,0.078588,0.08834,0,0
7,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.054439,0.078519,0.14529,0,0
7,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.16602,0.078503,0.14655,0,0
7,GO REGULATION OF NEURON PROJECTION REGENERATION,0.12662,0.078179,0.1914,0,0
7,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.23203,0.078114,0.11453,0,0
7,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.29248,0.07808,0.13925,0,0
7,GO MITOTIC SPINDLE ASSEMBLY,0.47137,0.07803,0.079725,0,0
7,GO CELLULAR RESPONSE TO MANGANESE ION,0.10811,0.077993,0.15025,0,0
7,GO HEME METABOLIC PROCESS,0.26442,0.077951,0.084779,0,0
7,GO RESPONSE TO TOXIC SUBSTANCE,0.072385,0.077942,0.10544,0,0
7,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.75756,0.077821,0.042518,0,0
7,GO MRNA TRANSCRIPTION,0.29248,0.077733,0.12393,0,0
7,GO SEQUESTERING OF ACTIN MONOMERS,0.49108,0.077506,0.045121,0,0
7,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.25111,0.077465,0.10395,0,0
7,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.78176,0.077441,0.063568,0,0
7,GO DNA DEMETHYLATION,0.27126,0.07743,0.091986,0,0
7,GO SNORNA METABOLIC PROCESS,0.17591,0.077415,0.096202,0,0
7,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.16123,0.077304,0.13171,0,0
7,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21989,0.077288,0.17925,0,0
7,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.10134,0.077283,0.10351,0,0
7,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.080256,0.077225,0.18884,0,0
7,GO THIOESTER BIOSYNTHETIC PROCESS,0.054439,0.077183,0.1309,0,0
7,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.24463,0.077117,0.12886,0,0
7,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.33821,0.077041,0.10439,0,0
7,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.27126,0.07692,0.11172,0,0
7,GO TRANSITION METAL ION HOMEOSTASIS,0.48117,0.076872,0.052598,0,0
7,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.18624,0.076747,0.14548,0,0
7,GO ANOIKIS,0.15655,0.076734,0.16506,0,0
7,GO POSITIVE REGULATION OF TISSUE REMODELING,0.18624,0.076697,0.16376,0,0
7,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.214,0.076687,0.10641,0,0
7,GO RELAXATION OF MUSCLE,0.20256,0.076535,0.18377,0,0
7,GO REGULATION OF DNA METHYLATION,0.37964,0.076481,0.091379,0,0
7,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.098083,0.076437,0.13581,0,0
7,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.61803,0.076341,0.077969,0,0
7,GO IMPORT INTO NUCLEUS,0.065157,0.076287,0.13267,0,0
7,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.18102,0.076261,0.12883,0,0
7,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.26442,0.075844,0.127,0,0
7,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.47137,0.075596,0.13119,0,0
7,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.21989,0.075478,0.17384,0,0
7,GO AUTOPHAGY OF NUCLEUS,0.062884,0.07547,0.14528,0,0
7,GO GABAERGIC NEURON DIFFERENTIATION,0.55277,0.075439,0.13506,0,0
7,GO SEQUESTERING OF METAL ION,0.90549,0.075379,-0.031584,0,0
7,GO SMOOTH MUSCLE CELL MIGRATION,0.25111,0.075356,0.14537,0,0
7,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.08881,0.074987,0.12341,0,0
7,GO RESPONSE TO OXYGEN LEVELS,0.091819,0.074747,0.1117,0,0
7,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.40594,0.074737,0.1251,0,0
7,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.53179,0.074719,0.11722,0,0
7,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.4521,0.074619,0.13669,0,0
7,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.23203,0.074598,0.10809,0,0
7,GO SMOOTH MUSCLE CELL PROLIFERATION,0.38829,0.074597,0.11314,0,0
7,GO PROSTAGLANDIN TRANSPORT,0.33029,0.074504,0.11345,0,0
7,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.55277,0.074499,0.055482,0,0
7,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.41494,0.074295,0.10649,0,0
7,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.3148,0.074265,0.13405,0,0
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.16602,0.074203,0.12973,0,0
7,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.95582,0.074172,0.0063276,0,0
7,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.24463,0.074115,0.10751,0,0
7,GO RESPONSE TO ACID CHEMICAL,0.058535,0.074099,0.14937,0,0
7,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.058535,0.073992,0.092166,0,0
7,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.54223,0.07389,0.095223,0,0
7,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.35442,0.073832,0.10897,0,0
7,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36271,0.073801,0.10847,0,0
7,GO APOPTOTIC PROCESS,0.08588,0.073703,0.1308,0,0
7,GO NEURAL CREST FORMATION,0.94321,0.073683,0.026444,0,0
7,GO MESODERMAL CELL DIFFERENTIATION,0.17091,0.073666,0.14579,0,0
7,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.27126,0.07362,0.094375,0,0
7,GO RRNA METABOLIC PROCESS,0.11894,0.073516,0.079877,0,0
7,GO MUSCLE CELL MIGRATION,0.27126,0.073412,0.12498,0,0
7,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.2998,0.07337,0.097895,0,0
7,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.46168,0.073263,0.083747,0,0
7,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0038653,0.073058,0.14004,0,0
7,GO CERAMIDE CATABOLIC PROCESS,0.60692,0.072927,0.069179,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.197,0.072588,0.15102,0,0
7,GO SKELETAL MUSCLE CELL PROLIFERATION,0.52145,0.072421,0.053187,0,0
7,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.37964,0.071861,0.081952,0,0
7,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.38829,0.071799,0.080438,0,0
7,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.20822,0.071779,0.098393,0,0
7,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.27126,0.071774,0.098813,0,0
7,GO RESPONSE TO INTERFERON ALPHA,0.81845,0.071769,0.047131,0,0
7,GO RETINOIC ACID METABOLIC PROCESS,0.38829,0.071712,0.084226,0,0
7,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.47137,0.071699,0.077619,0,0
7,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.56341,0.071471,0.057973,0,0
7,GO REGULATION OF FIBRINOLYSIS,0.54223,0.071438,0.068815,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.062884,0.071383,0.1579,0,0
7,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.091819,0.071336,0.14365,0,0
7,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.16602,0.071313,0.22247,0,0
7,GO MYOBLAST PROLIFERATION,0.1475,0.071233,0.1927,0,0
7,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.15197,0.071085,0.15349,0,0
7,GO COCHLEA MORPHOGENESIS,0.72171,0.07108,0.049579,0,0
7,GO RESPONSE TO INTERLEUKIN 2,0.74555,0.070962,0.081337,0,0
7,GO TAXIS,0.197,0.070668,0.13951,0,0
7,GO NEGATIVE REGULATION OF CELL ADHESION,0.2998,0.070667,0.13192,0,0
7,GO ZINC ION TRANSPORT,0.058535,0.070591,0.10824,0,0
7,GO PROTEIN N LINKED GLYCOSYLATION,0.065157,0.070571,0.10294,0,0
7,GO RNA 5 END PROCESSING,0.065157,0.070333,0.077096,0,0
7,GO REGULATION OF MUSCLE HYPERTROPHY,0.42405,0.069945,0.098504,0,0
7,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.35442,0.069863,0.10193,0,0
7,GO GLYCEROL ETHER METABOLIC PROCESS,0.17591,0.069774,0.1522,0,0
7,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.11894,0.06972,0.084616,0,0
7,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.10468,0.069618,0.15483,0,0
7,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.20822,0.069578,0.13325,0,0
7,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.68646,0.069561,0.056752,0,0
7,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.66333,0.06931,0.056813,0,0
7,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.054439,0.069303,0.10545,0,0
7,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.48117,0.069279,0.088999,0,0
7,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.28529,0.069158,0.088263,0,0
7,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.48117,0.069134,0.077981,0,0
7,GO CHONDROCYTE DEVELOPMENT,0.28529,0.069053,0.13901,0,0
7,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.55277,0.069024,0.071487,0,0
7,GO REGULATION OF TRANSPOSITION,0.37964,0.068872,0.076953,0,0
7,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.197,0.068832,0.10295,0,0
7,GO BARBED END ACTIN FILAMENT CAPPING,0.3148,0.068654,0.12993,0,0
7,GO CELLULAR RESPONSE TO LIPID,0.214,0.068625,0.11581,0,0
7,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.32248,0.068604,0.13449,0,0
7,GO PROTEIN AUTOPROCESSING,0.17091,0.068487,0.13335,0,0
7,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.38829,0.068192,0.1513,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.20822,0.068104,0.15701,0,0
7,GO PLASMA MEMBRANE FUSION,0.14312,0.068085,0.15911,0,0
7,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.13885,0.068005,0.20895,0,0
7,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.43329,0.06792,0.075106,0,0
7,GO PRIMARY MIRNA PROCESSING,0.11163,0.067843,0.14372,0,0
7,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.23203,0.067441,0.10841,0,0
7,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.54223,0.06717,0.043532,0,0
7,GO RUFFLE ORGANIZATION,0.2259,0.067061,0.14116,0,0
7,GO RESPONSE TO ACTIVITY,0.16602,0.067012,0.11391,0,0
7,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.13467,0.066925,0.14948,0,0
7,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.83078,0.066903,-0.05202,0,0
7,GO REGULATION OF RESPONSE TO STRESS,0.10468,0.066754,0.12146,0,0
7,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.32248,0.066604,0.092194,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.14312,0.06645,0.10088,0,0
7,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.78176,0.066278,0.044168,0,0
7,GO MUCUS SECRETION,0.50109,0.06592,0.074595,0,0
7,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.19156,0.065815,0.088923,0,0
7,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.47137,0.065776,0.092823,0,0
7,GO DNA REPLICATION INITIATION,0.52145,0.065567,0.043912,0,0
7,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.74555,0.065352,0.098201,0,0
7,GO TISSUE REMODELING,0.33029,0.065217,0.13982,0,0
7,GO PROSTANOID METABOLIC PROCESS,0.44264,0.065183,0.078901,0,0
7,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.43329,0.064978,0.086987,0,0
7,GO REPLACEMENT OSSIFICATION,0.43329,0.064632,0.1081,0,0
7,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.060677,0.06449,0.13787,0,0
7,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.40594,0.06444,0.11635,0,0
7,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.15197,0.064241,0.10232,0,0
7,GO RESPONSE TO SALT STRESS,0.214,0.064039,0.1433,0,0
7,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.16123,0.064002,0.10174,0,0
7,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.38829,0.063934,0.10329,0,0
7,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.48117,0.063822,0.092925,0,0
7,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.25111,0.063765,0.14078,0,0
7,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.37111,0.063551,0.091004,0,0
7,GO MULTI ORGANISM LOCALIZATION,0.10134,0.063509,0.12621,0,0
7,GO MATURATION OF 5 8S RRNA,0.094909,0.063443,0.10168,0,0
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.12273,0.063436,0.14743,0,0
7,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.89296,0.063427,0.014508,0,0
7,GO REGULATION OF VASCULOGENESIS,0.50109,0.063421,0.097665,0,0
7,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.74555,0.063346,0.062679,0,0
7,GO MYELOID CELL HOMEOSTASIS,0.23203,0.063245,0.11608,0,0
7,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29248,0.063207,0.10356,0,0
7,GO MUSCLE CELL APOPTOTIC PROCESS,0.13885,0.063205,0.11517,0,0
7,GO RHYTHMIC BEHAVIOR,0.27126,0.063104,0.10181,0,0
7,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.89296,0.063046,0.025615,0,0
7,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.43329,0.063023,0.052915,0,0
7,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.24463,0.062894,0.094703,0,0
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.28529,0.062719,0.11719,0,0
7,GO CELLULAR OXIDANT DETOXIFICATION,0.86799,0.062592,0.0083157,0,0
7,GO INTESTINAL ABSORPTION,0.26442,0.062439,0.1403,0,0
7,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.43329,0.062192,0.099084,0,0
7,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.75756,0.062153,0.061419,0,0
7,GO NEGATIVE REGULATION OF CELL DEATH,0.20822,0.062086,0.10852,0,0
7,GO OLFACTORY LOBE DEVELOPMENT,0.21989,0.062045,0.14932,0,0
7,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.40594,0.062015,0.071557,0,0
7,GO REGULATION OF CELL DEATH,0.10811,0.061974,0.12498,0,0
7,GO REGULATION OF CELLULAR EXTRAVASATION,1,0.061956,0.0062324,0,0
7,GO VIRAL LATENCY,0.41494,0.061715,0.068036,0,0
7,GO EXTRACELLULAR VESICLE BIOGENESIS,0.11894,0.061501,0.13288,0,0
7,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.29248,0.061414,0.10868,0,0
7,GO HOMOTYPIC CELL CELL ADHESION,0.60692,0.061348,0.067652,0,0
7,GO OPTIC NERVE DEVELOPMENT,0.29248,0.061248,0.15763,0,0
7,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.48117,0.061099,0.086839,0,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.24463,0.060825,0.10576,0,0
7,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.32248,0.06065,0.10445,0,0
7,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1,0.060586,0.031522,0,0
7,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.056456,0.060519,0.13292,0,0
7,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.55277,0.060455,0.093284,0,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.27821,0.060322,0.11467,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.08588,0.060173,0.11387,0,0
7,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.67486,0.060152,0.03454,0,0
7,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.17591,0.059966,0.064416,0,0
7,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.66333,0.059814,0.10868,0,0
7,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.75756,0.059731,0.025728,0,0
7,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.34626,0.059701,0.07773,0,0
7,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.7336,0.059584,0.039347,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.15197,0.059536,0.11553,0,0
7,GO THYMOCYTE APOPTOTIC PROCESS,0.80618,0.059477,0.062394,0,0
7,GO BLASTODERM SEGMENTATION,0.3148,0.059444,0.10475,0,0
7,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.10811,0.05942,0.13311,0,0
7,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.53179,0.05938,0.082402,0,0
7,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.091819,0.059308,0.093559,0,0
7,GO DENDRITIC SPINE MAINTENANCE,0.28529,0.059241,0.15563,0,0
7,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.27126,0.059069,0.11889,0,0
7,GO WHITE FAT CELL DIFFERENTIATION,0.11524,0.059023,0.13695,0,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.29248,0.058888,0.12039,0,0
7,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.76963,0.058757,0.036414,0,0
7,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1,0.058744,0.0063859,0,0
7,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.1306,0.058699,0.089056,0,0
7,GO RESPONSE TO HYDROGEN PEROXIDE,0.15655,0.058624,0.11561,0,0
7,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.35442,0.058604,0.12964,0,0
7,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.39705,0.058547,0.13019,0,0
7,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.12662,0.058505,0.16473,0,0
7,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.11894,0.057901,0.13598,0,0
7,GO FIBROBLAST PROLIFERATION,0.55277,0.057847,0.089539,0,0
7,GO CELLULAR KETONE METABOLIC PROCESS,0.13885,0.057753,0.081343,0,0
7,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.70989,0.057615,-0.050909,0,0
7,GO HYPOTHALAMUS DEVELOPMENT,0.17091,0.057476,0.13375,0,0
7,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.54223,0.057466,0.056798,0,0
7,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.12662,0.057256,0.13826,0,0
7,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.72171,0.057252,0.026805,0,0
7,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.41494,0.057143,0.08898,0,0
7,GO REGULATION OF PLATELET AGGREGATION,0.56341,0.056988,0.06873,0,0
7,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.38829,0.056923,0.086956,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.94321,0.056883,0.020403,0,0
7,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.62923,0.056778,0.038302,0,0
7,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.90549,0.056752,-0.062518,0,0
7,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.74555,0.05652,0.031087,0,0
7,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.2577,0.056506,0.082846,0,0
7,GO REGULATION OF SULFUR METABOLIC PROCESS,0.46168,0.056428,0.088394,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.89296,0.055956,0.0035793,0,0
7,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.072385,0.055815,0.10948,0,0
7,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.56341,0.055815,0.074922,0,0
7,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.61803,0.055756,0.08671,0,0
7,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.197,0.05565,0.1254,0,0
7,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.19156,0.055456,0.11682,0,0
7,GO GTP BIOSYNTHETIC PROCESS,0.17591,0.055295,0.12131,0,0
7,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.2259,0.055096,0.10054,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32248,0.054958,0.057175,0,0
7,GO ETHER METABOLIC PROCESS,0.15655,0.054944,0.15104,0,0
7,GO LIVER REGENERATION,0.27126,0.054854,0.10289,0,0
7,GO IMP BIOSYNTHETIC PROCESS,0.95582,0.05475,0.02034,0,0
7,GO NEGATIVE REGULATION OF CELL DIVISION,0.15197,0.054561,0.17357,0,0
7,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.43329,0.054556,0.086295,0,0
7,GO MAST CELL MEDIATED IMMUNITY,0.80618,0.054482,0.051172,0,0
7,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.62923,0.054372,0.052633,0,0
7,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.69814,0.054288,0.055889,0,0
7,GO GLYCINE METABOLIC PROCESS,0.86799,0.054085,-0.066626,0,0
7,GO FRUCTOSE METABOLIC PROCESS,0.34626,0.053763,0.085835,0,0
7,GO TRIPARTITE REGIONAL SUBDIVISION,0.33029,0.05369,0.10989,0,0
7,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.50109,0.053224,0.11674,0,0
7,GO RESPONSE TO AMYLOID BETA,0.32248,0.053136,0.13675,0,0
7,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.16602,0.05306,0.072922,0,0
7,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.62923,0.05295,0.084665,0,0
7,GO DEFENSE RESPONSE TO BACTERIUM,0.79394,0.05294,0.030076,0,0
7,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.75756,0.052911,-0.037877,0,0
7,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.90549,0.052823,0.019713,0,0
7,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.25111,0.052802,0.11932,0,0
7,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.85555,0.052372,-0.028084,0,0
7,GO ER OVERLOAD RESPONSE,0.32248,0.052262,0.093824,0,0
7,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.069906,0.052193,0.15312,0,0
7,GO NEGATIVE REGULATION OF OSSIFICATION,0.28529,0.052184,0.13491,0,0
7,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.038848,0.052126,0.11569,0,0
7,GO TERPENOID BIOSYNTHETIC PROCESS,0.30724,0.052087,0.069648,0,0
7,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.13467,0.05202,0.13026,0,0
7,GO HISTONE MRNA METABOLIC PROCESS,0.61803,0.051937,0.029562,0,0
7,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.41494,0.051655,0.083881,0,0
7,GO RESPONSE TO TESTOSTERONE,0.5959,0.051606,0.058405,0,0
7,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.46168,0.051439,0.055871,0,0
7,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.80618,0.051352,0.062028,0,0
7,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.74555,0.051326,0.02906,0,0
7,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.5959,0.051106,0.085927,0,0
7,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.52145,0.050996,0.074162,0,0
7,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.5959,0.050991,0.085289,0,0
7,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.20256,0.05084,0.088579,0,0
7,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.19156,0.050772,0.10865,0,0
7,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.29248,0.050664,0.061861,0,0
7,GO RESPONSE TO X RAY,0.50109,0.050428,0.06698,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.19156,0.050346,0.10182,0,0
7,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.26442,0.050175,0.1042,0,0
7,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.67486,0.050084,0.070356,0,0
7,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.20256,0.049877,0.10692,0,0
7,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.37111,0.049864,0.079658,0,0
7,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.49108,0.049825,0.067476,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.46168,0.049527,0.087705,0,0
7,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.38829,0.049521,0.045465,0,0
7,GO MICROVILLUS ORGANIZATION,0.13885,0.049504,0.14694,0,0
7,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.17091,0.049446,0.11233,0,0
7,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.29248,0.049106,0.11746,0,0
7,GO PEPTIDYL TYROSINE MODIFICATION,0.29248,0.049048,0.1261,0,0
7,GO GLYCOSIDE METABOLIC PROCESS,0.46168,0.048993,0.037215,0,0
7,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.74555,0.048969,0.038755,0,0
7,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.76963,0.04855,0.034292,0,0
7,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.64051,0.048535,0.091882,0,0
7,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.2577,0.048421,0.14527,0,0
7,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.67486,0.04831,0.048792,0,0
7,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.90549,0.048309,0.023824,0,0
7,GO MITOTIC DNA REPLICATION,0.80618,0.048054,0.0037194,0,0
7,GO PROSTATE GLAND DEVELOPMENT,0.5959,0.04776,0.057105,0,0
7,GO GLIAL CELL APOPTOTIC PROCESS,0.23203,0.047618,0.1252,0,0
7,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.11524,0.047487,0.13561,0,0
7,GO PROSTATE GLAND MORPHOGENESIS,0.62923,0.047376,0.067344,0,0
7,GO INTERFERON BETA PRODUCTION,0.56341,0.047361,0.080684,0,0
7,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.89296,0.047283,-0.028666,0,0
7,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.5959,0.047209,0.075934,0,0
7,GO RESPONSE TO HEAT,0.060677,0.04716,0.12623,0,0
7,GO DEFENSE RESPONSE TO VIRUS,0.85555,0.047142,0.031019,0,0
7,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.33821,0.04707,0.12468,0,0
7,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.35442,0.046934,0.082257,0,0
7,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.08588,0.046642,0.099565,0,0
7,GO CELLULAR RESPONSE TO FATTY ACID,0.51122,0.046528,0.063709,0,0
7,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.49108,0.046454,0.089222,0,0
7,GO RNA CATABOLIC PROCESS,0.19156,0.04631,0.043168,0,0
7,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.19156,0.046268,0.13419,0,0
7,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.72171,0.046246,0.049281,0,0
7,GO PROSTATE GLAND GROWTH,0.2998,0.046232,0.079388,0,0
7,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.43329,0.046202,0.070265,0,0
7,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.55277,0.046185,0.070434,0,0
7,GO DETECTION OF OTHER ORGANISM,0.91805,0.045969,0.017164,0,0
7,GO BRANCH ELONGATION OF AN EPITHELIUM,0.7336,0.045869,0.033004,0,0
7,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.23203,0.045838,0.091641,0,0
7,GO RESPONSE TO HYDROPEROXIDE,0.66333,0.04575,0.058954,0,0
7,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.46168,0.045536,0.040114,0,0
7,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.46168,0.045532,0.1116,0,0
7,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.11163,0.045497,0.11642,0,0
7,GO FIBRINOLYSIS,0.75756,0.045471,0.035205,0,0
7,GO AMP METABOLIC PROCESS,0.38829,0.045202,0.070307,0,0
7,GO APOPTOTIC SIGNALING PATHWAY,0.18624,0.045014,0.10381,0,0
7,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.90549,0.044895,-0.029405,0,0
7,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.50109,0.044783,0.048604,0,0
7,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15197,0.044761,0.12215,0,0
7,GO REGULATION OF AMYLOID BETA CLEARANCE,0.5959,0.044008,0.077408,0,0
7,GO MITOCHONDRIAL GENE EXPRESSION,0.23827,0.043988,0.045306,0,0
7,GO MYELIN MAINTENANCE,0.36271,0.043899,0.12336,0,0
7,GO RESPONSE TO ANTIBIOTIC,0.42405,0.043765,0.078327,0,0
7,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.79394,0.043739,-0.037385,0,0
7,GO TRABECULA FORMATION,0.72171,0.043722,0.064959,0,0
7,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.20822,0.043599,0.081872,0,0
7,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.11894,0.043463,0.062034,0,0
7,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.66333,0.043342,0.048655,0,0
7,GO CELL RECOGNITION,0.20822,0.043286,0.11833,0,0
7,GO POSITIVE REGULATION OF CELL DEATH,0.14312,0.043139,0.12541,0,0
7,GO MACROPHAGE CHEMOTAXIS,0.89296,0.043115,0.035037,0,0
7,GO CELL ADHESION MOLECULE PRODUCTION,0.48117,0.043006,0.12771,0,0
7,GO FEMALE GENITALIA DEVELOPMENT,0.65188,0.042694,0.043376,0,0
7,GO POLYAMINE BIOSYNTHETIC PROCESS,0.28529,0.042641,0.059482,0,0
7,GO LACTATE METABOLIC PROCESS,0.5959,0.04264,0.040918,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.57414,0.042631,0.066448,0,0
7,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.94321,0.042482,0.01626,0,0
7,GO ICOSANOID BIOSYNTHETIC PROCESS,0.90549,0.042468,-0.01276,0,0
7,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.17591,0.042331,0.083789,0,0
7,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.60692,0.042285,-0.093178,0,0
7,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.23827,0.042205,0.068203,0,0
7,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.56341,0.042157,0.06628,0,0
7,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.57414,0.04187,0.097643,0,0
7,GO ERROR PRONE TRANSLESION SYNTHESIS,0.53179,0.041742,0.049639,0,0
7,GO UTERUS DEVELOPMENT,0.56341,0.04168,0.04602,0,0
7,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.072385,0.041642,0.12143,0,0
7,GO PLATELET AGGREGATION,0.68646,0.041616,0.070726,0,0
7,GO GMP METABOLIC PROCESS,0.69814,0.041553,0.042478,0,0
7,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.2577,0.041424,0.090124,0,0
7,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.49108,0.04131,0.078027,0,0
7,GO REGULATION OF CELL SHAPE,0.41494,0.04128,0.12301,0,0
7,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.36271,0.041228,0.05747,0,0
7,GO VITAMIN METABOLIC PROCESS,0.52145,0.041161,0.058312,0,0
7,GO GOLGI LOCALIZATION,0.27821,0.041133,0.074857,0,0
7,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.50109,0.040829,0.10602,0,0
7,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.19156,0.040615,0.093673,0,0
7,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.4521,0.040531,0.089145,0,0
7,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.65188,0.040516,0.072247,0,0
7,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.78176,0.040358,-0.022264,0,0
7,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.56341,0.040343,0.09805,0,0
7,GO T CELL CYTOKINE PRODUCTION,0.79394,0.040108,-0.034987,0,0
7,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.32248,0.040018,0.099484,0,0
7,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.2577,0.039988,0.10093,0,0
7,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.12662,0.03998,0.13034,0,0
7,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.37964,0.039962,0.093413,0,0
7,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.37964,0.039852,0.065202,0,0
7,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.95582,0.039806,0.106,0,0
7,GO RESPONSE TO ETHER,0.27821,0.039775,0.099355,0,0
7,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.88046,0.039757,0.040469,0,0
7,GO NAD BIOSYNTHETIC PROCESS,0.93062,0.039548,-1.8622e-05,0,0
7,GO VIRAL LIFE CYCLE,0.36271,0.039533,0.094039,0,0
7,GO POSITIVE REGULATION OF VASCULOGENESIS,0.33029,0.039486,0.1092,0,0
7,GO VIRAL GENOME REPLICATION,0.47137,0.039375,0.07947,0,0
7,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.81845,0.039271,0.063354,0,0
7,GO POSITIVE REGULATION OF ERAD PATHWAY,0.54223,0.039258,0.089821,0,0
7,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.91805,0.039168,0.0017792,0,0
7,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.54223,0.038991,0.077524,0,0
7,GO NUCLEOTIDE SALVAGE,0.95582,0.038928,0.014344,0,0
7,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.7336,0.038915,0.059309,0,0
7,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.43329,0.03879,0.092353,0,0
7,GO MITOCHONDRIAL TRANSLATION,0.55277,0.038668,0.021607,0,0
7,GO CELLULAR RESPIRATION,0.040368,0.038617,0.064029,0,0
7,GO RESPONSE TO HYPEROXIA,0.58498,0.038495,0.07764,0,0
7,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.16602,0.038429,0.109,0,0
7,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.30724,0.038338,0.11413,0,0
7,GO DENTATE GYRUS DEVELOPMENT,0.78176,0.03829,0.0045139,0,0
7,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.96843,0.038142,-0.0013681,0,0
7,GO RIBOSOME BIOGENESIS,0.23827,0.037987,0.056248,0,0
7,GO URONIC ACID METABOLIC PROCESS,0.98106,0.037923,-0.0097706,0,0
7,GO NAD METABOLIC PROCESS,0.37964,0.037831,0.088147,0,0
7,GO CELLULAR RESPONSE TO DRUG,0.18624,0.037823,0.099242,0,0
7,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.65188,0.037732,0.051943,0,0
7,GO REGULATION OF ISOTYPE SWITCHING,0.50109,0.037527,0.10806,0,0
7,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.25111,0.037257,0.090441,0,0
7,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.41494,0.037229,0.090687,0,0
7,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.091819,0.037199,0.088297,0,0
7,GO REGULATION OF DNA BINDING,0.43329,0.037187,0.084758,0,0
7,GO REGULATION OF MACROPHAGE MIGRATION,0.96843,0.037142,0.0042273,0,0
7,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.76963,0.037105,0.05217,0,0
7,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.55277,0.036975,0.07279,0,0
7,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.90549,0.036889,0.048822,0,0
7,GO GLIAL CELL PROLIFERATION,0.52145,0.036875,0.092624,0,0
7,GO REGULATION OF CELL ADHESION,0.55277,0.036753,0.10174,0,0
7,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.60692,0.036705,0.050919,0,0
7,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.25111,0.036674,0.13663,0,0
7,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.18624,0.036618,0.11924,0,0
7,GO COLLAGEN METABOLIC PROCESS,0.36271,0.03661,0.15351,0,0
7,GO HUMORAL IMMUNE RESPONSE,0.99368,0.036605,-0.0036479,0,0
7,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.34626,0.036523,0.09556,0,0
7,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.85555,0.036429,0.037221,0,0
7,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.66333,0.036095,0.06529,0,0
7,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.44264,0.036023,0.058972,0,0
7,GO NEURON FATE SPECIFICATION,0.48117,0.035854,0.11175,0,0
7,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.88046,0.035761,0.031286,0,0
7,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.69814,0.035537,0.045807,0,0
7,GO PROTEIN REFOLDING,0.53179,0.035092,0.050825,0,0
7,GO MATURATION OF SSU RRNA,0.30724,0.035026,0.063092,0,0
7,GO SLEEP,0.34626,0.035017,0.075376,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.18102,0.034864,0.10834,0,0
7,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.44264,0.034723,0.065507,0,0
7,GO VITAMIN CATABOLIC PROCESS,0.7336,0.034624,0.001359,0,0
7,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.61803,0.034545,0.064672,0,0
7,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62923,0.034449,0.080214,0,0
7,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.21989,0.034167,0.096854,0,0
7,GO REGULATION OF VIRAL TRANSCRIPTION,0.27821,0.034163,0.084772,0,0
7,GO MULTI ORGANISM CELLULAR PROCESS,0.52145,0.034008,0.095182,0,0
7,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.53179,0.033802,0.080206,0,0
7,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.2577,0.033544,0.077201,0,0
7,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.95582,0.033398,-0.010434,0,0
7,GO MITOCHONDRIAL TRANSCRIPTION,0.26442,0.033395,0.070898,0,0
7,GO BONE RESORPTION,0.61803,0.032681,0.078637,0,0
7,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.83078,0.032513,-0.034209,0,0
7,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.47137,0.032503,0.070096,0,0
7,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.49108,0.032325,0.06722,0,0
7,GO APOPTOTIC DNA FRAGMENTATION,0.2998,0.032125,0.07697,0,0
7,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.60692,0.032033,0.00056683,0,0
7,GO NEPHRIC DUCT MORPHOGENESIS,0.49108,0.032003,0.078045,0,0
7,GO AXIS ELONGATION,0.27821,0.031869,0.13988,0,0
7,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.72171,0.031857,0.055285,0,0
7,GO POSITIVE REGULATION OF NEURON DEATH,0.25111,0.031742,0.10977,0,0
7,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.2998,0.031517,0.065202,0,0
7,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.83078,0.031446,0.053989,0,0
7,GO FEVER GENERATION,0.43329,0.031436,0.092804,0,0
7,GO RESPONSE TO NITROSATIVE STRESS,0.38829,0.031311,0.048539,0,0
7,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.88046,0.031185,-0.022864,0,0
7,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.18624,0.031133,0.15704,0,0
7,GO CYTOKINE PRODUCTION,0.80618,0.030996,0.041786,0,0
7,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.51122,0.030889,0.077384,0,0
7,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.61803,0.03069,0.063177,0,0
7,GO GLUTAMINE METABOLIC PROCESS,0.17091,0.030299,0.10821,0,0
7,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.27821,0.030133,0.092796,0,0
7,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.78176,0.030123,0.0018499,0,0
7,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.20822,0.03011,0.086272,0,0
7,GO BONE REMODELING,0.50109,0.03002,0.11135,0,0
7,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.89296,0.029952,0.0085354,0,0
7,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.75756,0.029808,0.040277,0,0
7,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.4521,0.029781,0.093463,0,0
7,GO VIRION ASSEMBLY,0.054439,0.029703,0.097814,0,0
7,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.34626,0.02939,0.10689,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.98106,0.029376,-0.002812,0,0
7,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.91805,0.02921,0.0057688,0,0
7,GO INTERLEUKIN 4 PRODUCTION,0.80618,0.029207,-0.035806,0,0
7,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.84314,0.029046,-0.008946,0,0
7,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.41494,0.028944,0.089293,0,0
7,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.25111,0.028909,0.082417,0,0
7,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.43329,0.028802,0.083563,0,0
7,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.89296,0.028645,0.015853,0,0
7,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.15197,0.028303,0.081093,0,0
7,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.76963,0.028068,-0.015281,0,0
7,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.89296,0.027795,0.027793,0,0
7,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.37964,0.027662,0.11874,0,0
7,GO VITAMIN BIOSYNTHETIC PROCESS,0.86799,0.027591,0.019576,0,0
7,GO REGULATION OF BONE REMODELING,0.61803,0.027462,0.085902,0,0
7,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.65188,0.027356,0.076974,0,0
7,GO HYALURONAN CATABOLIC PROCESS,0.85555,0.027265,-0.0027452,0,0
7,GO ORGAN INDUCTION,0.36271,0.027232,0.072185,0,0
7,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.65188,0.027229,0.023715,0,0
7,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.2577,0.027187,0.12885,0,0
7,GO LIVER MORPHOGENESIS,0.84314,0.027137,0.044725,0,0
7,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.47137,0.027049,0.061394,0,0
7,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.51122,0.027022,0.11029,0,0
7,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.69814,0.026906,0.046559,0,0
7,GO ANIMAL ORGAN REGENERATION,0.32248,0.026883,0.090841,0,0
7,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.96843,0.026862,0.02615,0,0
7,GO RESPONSE TO CYTOKINE,0.72171,0.026838,0.047143,0,0
7,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.4521,0.026781,0.10055,0,0
7,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99368,0.026645,0.029463,0,0
7,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17091,0.026569,0.12157,0,0
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.41494,0.026437,0.063697,0,0
7,GO NEGATIVE REGULATION OF DNA BINDING,0.27126,0.026263,0.0906,0,0
7,GO HORMONE CATABOLIC PROCESS,0.58498,0.026252,0.046919,0,0
7,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.80618,0.026204,0.049194,0,0
7,GO RESPONSE TO VIRUS,0.83078,0.026013,0.024363,0,0
7,GO HOMEOSTASIS OF NUMBER OF CELLS,0.47137,0.025995,0.087684,0,0
7,GO GLYCOPROTEIN CATABOLIC PROCESS,0.57414,0.025971,0.11052,0,0
7,GO CELL ADHESION MEDIATED BY INTEGRIN,0.83078,0.025942,0.061533,0,0
7,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.83078,0.025908,0.025349,0,0
7,GO PROTEIN NEDDYLATION,0.70989,0.025842,0.029466,0,0
7,GO URETER DEVELOPMENT,0.66333,0.025803,0.029471,0,0
7,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.60692,0.025756,0.096417,0,0
7,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.29248,0.02567,0.0793,0,0
7,GO APOPTOTIC CELL CLEARANCE,0.96843,0.025615,-0.01042,0,0
7,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.51122,0.025597,0.067358,0,0
7,GO POSITIVE REGULATION OF VIRAL PROCESS,0.43329,0.025595,0.082041,0,0
7,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.67486,0.025555,-0.040018,0,0
7,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.16602,0.025327,0.12921,0,0
7,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.66333,0.025319,0.076402,0,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.4521,0.025294,0.061379,0,0
7,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.84314,0.025218,-0.011068,0,0
7,GO RESPONSE TO SALT,0.99368,0.025106,-0.0021502,0,0
7,GO NK T CELL DIFFERENTIATION,0.83078,0.025088,-0.017183,0,0
7,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.88046,0.025058,0.049656,0,0
7,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.65188,0.02504,-0.0042574,0,0
7,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.58498,0.024952,0.074759,0,0
7,GO RESPONSE TO DSRNA,0.7336,0.024938,0.053895,0,0
7,GO CELL CELL RECOGNITION,0.53179,0.024833,0.058417,0,0
7,GO ASTROCYTE ACTIVATION,0.86799,0.02477,0.042861,0,0
7,GO CELL PROLIFERATION IN HINDBRAIN,0.56341,0.024639,0.067341,0,0
7,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.40594,0.024618,0.099514,0,0
7,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.30724,0.024404,0.039884,0,0
7,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.48117,0.024357,0.037807,0,0
7,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.72171,0.02424,0.049333,0,0
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.20256,0.024023,0.10305,0,0
7,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.44264,0.023946,0.091813,0,0
7,GO NEGATIVE REGULATION OF LIPID STORAGE,0.96843,0.023933,0.022896,0,0
7,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44264,0.023902,0.091419,0,0
7,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.33029,0.023894,0.12446,0,0
7,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.85555,0.023886,0.0025962,0,0
7,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.95582,0.023838,0.043569,0,0
7,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.52145,0.023807,0.10585,0,0
7,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.5959,0.023615,0.10029,0,0
7,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.90549,0.02346,0.047318,0,0
7,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.54223,0.023388,0.090262,0,0
7,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.57414,0.023362,0.086067,0,0
7,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.75756,0.023289,-0.054364,0,0
7,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.46168,0.02323,0.09165,0,0
7,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.44264,0.023158,0.12199,0,0
7,GO COLLAGEN CATABOLIC PROCESS,0.48117,0.023051,0.11809,0,0
7,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.84314,0.022692,0.027693,0,0
7,GO RESPONSE TO BACTERIUM,0.7336,0.022496,0.036883,0,0
7,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.35442,0.022486,0.12951,0,0
7,GO HEPATOCYTE APOPTOTIC PROCESS,0.84314,0.022401,0.051544,0,0
7,GO ACETYL COA BIOSYNTHETIC PROCESS,0.52145,0.022265,0.075183,0,0
7,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.75756,0.022233,0.04434,0,0
7,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.57414,0.022056,0.097688,0,0
7,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.95582,0.022013,0.0092707,0,0
7,GO T CELL HOMEOSTASIS,0.54223,0.021967,0.071723,0,0
7,GO AMINE METABOLIC PROCESS,0.11524,0.02192,0.10907,0,0
7,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.69814,0.02169,0.04014,0,0
7,GO REGULATION OF VIRAL GENOME REPLICATION,0.61803,0.021502,0.064885,0,0
7,GO INTERMEDIATE FILAMENT ORGANIZATION,0.33029,0.021496,0.094379,0,0
7,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.65188,0.021147,0.025926,0,0
7,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.64051,0.021126,0.082347,0,0
7,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.38829,0.020902,0.1303,0,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43329,0.020831,0.076686,0,0
7,GO MACROPHAGE DIFFERENTIATION,0.95582,0.020753,0.02021,0,0
7,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.98106,0.020731,0.023865,0,0
7,GO FOLIC ACID METABOLIC PROCESS,0.3148,0.020709,0.083191,0,0
7,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.23827,0.020625,0.094791,0,0
7,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.53179,0.02062,0.071535,0,0
7,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.39705,0.02036,0.082049,0,0
7,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.88046,0.020209,0.01703,0,0
7,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.46168,0.019858,0.091294,0,0
7,GO MEMBRANE RAFT ORGANIZATION,0.67486,0.019765,0.073786,0,0
7,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.39705,0.019486,0.068254,0,0
7,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,1,0.019396,0.016185,0,0
7,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.51122,0.019269,-0.11952,0,0
7,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.23203,0.019224,0.093708,0,0
7,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.28529,0.019195,0.13498,0,0
7,GO TRNA 5 LEADER REMOVAL,0.62923,0.019152,0.024588,0,0
7,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.99368,0.019082,0.011167,0,0
7,GO INDOLALKYLAMINE METABOLIC PROCESS,0.19156,0.019023,0.1464,0,0
7,GO BLEB ASSEMBLY,0.96843,0.018634,0.004877,0,0
7,GO POLYSACCHARIDE CATABOLIC PROCESS,0.76963,0.018537,0.057988,0,0
7,GO MESODERMAL CELL FATE SPECIFICATION,1,0.018529,0.020808,0,0
7,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.88046,0.018315,0.026118,0,0
7,GO PEPTIDYL ASPARAGINE MODIFICATION,0.94321,0.018314,0.0082417,0,0
7,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.37111,0.01826,0.05806,0,0
7,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.95582,0.01823,-0.0033433,0,0
7,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.80618,0.018182,0.0096478,0,0
7,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.89296,0.018098,0.011628,0,0
7,GO REGULATION OF GLIAL CELL PROLIFERATION,0.68646,0.018077,0.056602,0,0
7,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.39705,0.017947,0.077644,0,0
7,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.50109,0.017934,0.062829,0,0
7,GO IMMUNE SYSTEM DEVELOPMENT,0.52145,0.017731,0.082472,0,0
7,GO RESPONSE TO COLD,0.16602,0.017454,0.17252,0,0
7,GO DETOXIFICATION,0.65188,0.017181,-0.03372,0,0
7,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.99368,0.017094,0.00089724,0,0
7,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.84314,0.017014,0.063861,0,0
7,GO TYPE I INTERFERON PRODUCTION,0.69814,0.01683,0.06077,0,0
7,GO MYELOID CELL DIFFERENTIATION,0.4521,0.016797,0.092823,0,0
7,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.62923,0.016428,0.021725,0,0
7,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.75756,0.016282,0.046883,0,0
7,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.7336,0.016182,-0.012648,0,0
7,GO MACROPHAGE MIGRATION,0.90549,0.01611,-0.0034791,0,0
7,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.91805,0.016097,-0.0085289,0,0
7,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.20256,0.016013,0.085357,0,0
7,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.37111,0.015983,0.079987,0,0
7,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.90549,0.015893,0.01266,0,0
7,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.40594,0.015577,0.059781,0,0
7,GO REGULATION OF TRANSLATIONAL INITIATION,0.33029,0.015492,0.08038,0,0
7,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.55277,0.015469,0.079161,0,0
7,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.57414,0.015195,0.087812,0,0
7,GO ATP BIOSYNTHETIC PROCESS,0.94321,0.014892,0.028101,0,0
7,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.2998,0.014862,0.11273,0,0
7,GO NATURAL KILLER CELL DIFFERENTIATION,0.65188,0.014759,0.076018,0,0
7,GO WATER TRANSPORT,0.37964,0.014752,0.13048,0,0
7,GO CELLULAR RESPONSE TO VIRUS,0.41494,0.014544,0.080809,0,0
7,GO RESPONSE TO EPINEPHRINE,0.18624,0.01453,0.21047,0,0
7,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.5959,0.014477,0.047106,0,0
7,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.95582,0.014381,0.011504,0,0
7,GO NEUTROPHIL EXTRAVASATION,0.98106,0.014373,0.025575,0,0
7,GO POSITIVE REGULATION OF CELL ADHESION,0.84314,0.014347,0.041768,0,0
7,GO ELECTRON TRANSPORT CHAIN,0.86799,0.014214,0.0075102,0,0
7,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.64051,0.014197,0.054231,0,0
7,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.90549,0.014146,-0.01141,0,0
7,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.4521,0.013961,0.070118,0,0
7,GO GAP JUNCTION ASSEMBLY,0.67486,0.013461,0.080072,0,0
7,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.75756,0.013389,0.021781,0,0
7,GO VIRAL TRANSLATION,0.23203,0.013286,0.079323,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.46168,0.013226,0.11556,0,0
7,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.65188,0.013154,0.059516,0,0
7,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.67486,0.013133,0.057271,0,0
7,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.27126,0.012936,0.067942,0,0
7,GO DEFENSE RESPONSE TO OTHER ORGANISM,1,0.012835,0.0080817,0,0
7,GO RESPONSE TO ANGIOTENSIN,0.5959,0.012827,-0.0048845,0,0
7,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.69814,0.012762,0.061747,0,0
7,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.68646,0.012609,0.072251,0,0
7,GO REGULATION OF VIRAL LIFE CYCLE,0.64051,0.012436,0.062315,0,0
7,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.61803,0.012287,0.050533,0,0
7,GO TRNA 5 END PROCESSING,0.93062,0.012284,0.0042922,0,0
7,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.33821,0.012242,0.087629,0,0
7,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.7336,0.012188,0.080328,0,0
7,GO REGULATION OF RNA BINDING,0.58498,0.012161,0.048312,0,0
7,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.69814,0.011766,0.068606,0,0
7,GO T CELL DIFFERENTIATION IN THYMUS,0.70989,0.011724,0.055653,0,0
7,GO T CELL MEDIATED IMMUNITY,0.67486,0.011657,-0.058366,0,0
7,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.74555,0.011568,0.059283,0,0
7,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.94321,0.011542,0.017253,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.95582,0.011359,0.009771,0,0
7,GO PENTOSE METABOLIC PROCESS,0.66333,0.011229,-0.028288,0,0
7,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.83078,0.011044,0.030415,0,0
7,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.75756,0.010924,0.038028,0,0
7,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.67486,0.010594,-0.030305,0,0
7,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.86799,0.010446,0.024912,0,0
7,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.89296,0.010135,0.015686,0,0
7,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.38829,0.010131,0.083094,0,0
7,GO REGULATION OF CELL FATE COMMITMENT,0.53179,0.010091,0.10755,0,0
7,GO STEROID CATABOLIC PROCESS,0.90549,0.010064,-0.0067979,0,0
7,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.72171,0.0099944,0.024711,0,0
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.94321,0.0098831,0.01666,0,0
7,GO REGULATION OF PROTEIN MATURATION,0.95582,0.0094675,0.024056,0,0
7,GO DEFENSE RESPONSE,0.74555,0.0094606,0.042966,0,0
7,GO ENGULFMENT OF APOPTOTIC CELL,0.32248,0.0094597,0.13689,0,0
7,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.74555,0.0093227,0.028855,0,0
7,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.4521,0.0089636,0.050157,0,0
7,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.23827,0.0088831,0.10832,0,0
7,GO RESPONSE TO BIOTIC STIMULUS,0.79394,0.0088165,0.032183,0,0
7,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.76963,0.0086865,0.053688,0,0
7,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.34626,0.008585,0.064786,0,0
7,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.76963,0.0085203,0.03168,0,0
7,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.4521,0.008454,0.11509,0,0
7,GO DETECTION OF BIOTIC STIMULUS,0.74555,0.0083526,-0.044258,0,0
7,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.75756,0.0082711,0.056729,0,0
7,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.81845,0.0082103,0.0013448,0,0
7,GO EMBRYO IMPLANTATION,0.57414,0.0080224,0.097027,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.1306,0.0080144,0.11514,0,0
7,GO POSITIVE REGULATION OF COAGULATION,0.80618,0.007745,-0.012325,0,0
7,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.58498,0.0076742,0.072133,0,0
7,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.85555,0.0075855,0.035401,0,0
7,GO DE NOVO PROTEIN FOLDING,0.38829,0.007366,0.079638,0,0
7,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.75756,0.0073602,0.056176,0,0
7,GO REGULATION OF MEMBRANE INVAGINATION,0.99368,0.0073174,0.024409,0,0
7,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.84314,0.0071098,-0.0016622,0,0
7,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.80618,0.007064,0.027086,0,0
7,GO RESPONSE TO PROSTAGLANDIN E,0.7336,0.0069846,0.06291,0,0
7,GO CARTILAGE MORPHOGENESIS,0.95582,0.0068697,0.0075273,0,0
7,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.94321,0.0066924,0.022728,0,0
7,GO REGULATION OF INTEGRIN ACTIVATION,0.75756,0.0066012,0.054536,0,0
7,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.32248,0.0064678,0.07064,0,0
7,GO ERK1 AND ERK2 CASCADE,0.79394,0.0064387,0.046332,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.65188,0.0062707,0.058946,0,0
7,GO SYMBIOTIC PROCESS,0.33029,0.0057864,0.078394,0,0
7,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.83078,0.0057549,-0.038557,0,0
7,GO LAMELLIPODIUM MORPHOGENESIS,0.25111,0.0055736,0.15768,0,0
7,GO OXIDATIVE PHOSPHORYLATION,0.96843,0.0055238,0.0037291,0,0
7,GO RESPONSE TO PROSTAGLANDIN,0.56341,0.0052692,0.06278,0,0
7,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.74555,0.0050934,0.049842,0,0
7,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.84314,0.0050885,0.04012,0,0
7,GO TRANSLATIONAL TERMINATION,0.76963,0.0048938,0.010258,0,0
7,GO REGULATION OF DEFENSE RESPONSE,0.78176,0.0048649,0.045066,0,0
7,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.91805,0.0048578,-0.002149,0,0
7,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.79394,0.0045909,0.014979,0,0
7,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.58498,0.0044681,0.080898,0,0
7,GO EPITHELIAL CELL MATURATION,0.84314,0.0044297,0.055082,0,0
7,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.72171,0.0042528,-0.059088,0,0
7,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.81845,0.0041431,-0.048568,0,0
7,GO COPPER ION HOMEOSTASIS,0.91805,0.0039922,0.013462,0,0
7,GO RESPONSE TO ZINC ION,0.86799,0.0036532,-0.03735,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.81845,0.0036085,-0.029866,0,0
7,GO FOREBRAIN NEURON FATE COMMITMENT,0.90549,0.0035908,0.11728,0,0
7,GO REGULATION OF SYMBIOTIC PROCESS,0.58498,0.0032718,0.065525,0,0
7,GO ASTROCYTE DIFFERENTIATION,0.95582,0.0029733,0.042529,0,0
7,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.79394,0.0029429,0.052541,0,0
7,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.72171,0.0023873,0.062,0,0
7,GO TETRAHYDROFOLATE INTERCONVERSION,0.7336,0.002195,0.0081058,0,0
7,GO AMINE CATABOLIC PROCESS,0.75756,0.002184,0.04681,0,0
7,GO REGULATION OF INFLAMMATORY RESPONSE,0.91805,0.0021492,0.026281,0,0
7,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.81845,0.0021334,-0.022386,0,0
7,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.78176,0.0018916,0.034447,0,0
7,GO ASTROCYTE DEVELOPMENT,0.76963,0.0017991,-0.002021,0,0
7,GO GERMINAL CENTER FORMATION,0.80618,0.001527,0.036992,0,0
7,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.37964,0.00097735,0.13786,0,0
7,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.96843,0.00092134,0.027588,0,0
7,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.7336,0.00079501,0.012232,0,0
7,GO MEMBRANE INVAGINATION,0.90549,0.0005683,0.0013251,0,0
7,GO ERROR FREE TRANSLESION SYNTHESIS,0.70989,0.00051613,0.033814,0,0
7,GO CELLULAR COPPER ION HOMEOSTASIS,0.79394,0.00024907,-0.00485,0,0
7,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.94321,0.00023963,0.016635,0,0
7,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.74555,0.00013716,0.064005,0,0
7,GO INCLUSION BODY ASSEMBLY,0.43329,-0.00029774,0.13158,0,0
7,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.93062,-0.00042236,0.021212,0,0
7,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.7336,-0.00077072,0.074166,0,0
7,GO CORTICAL CYTOSKELETON ORGANIZATION,0.49108,-0.00085672,0.098274,0,0
7,GO REGULATION OF MYOBLAST FUSION,0.66333,-0.00094241,0.078509,0,0
7,GO REGULATION OF GLIOGENESIS,0.58498,-0.0012275,0.06526,0,0
7,GO GENITALIA MORPHOGENESIS,0.98106,-0.0012532,0.0034709,0,0
7,GO TROPHOBLAST CELL MIGRATION,0.61803,-0.0012681,0.093211,0,0
7,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.76963,-0.0012865,-0.046892,0,0
7,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.89296,-0.0013232,0.0029731,0,0
7,GO IMMUNE EFFECTOR PROCESS,0.98106,-0.0013301,0.013353,0,0
7,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.96843,-0.0017949,0.062062,0,0
7,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.89296,-0.0018755,0.027297,0,0
7,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.93062,-0.001978,-0.022664,0,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.74555,-0.0028161,0.031575,0,0
7,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.98106,-0.0028477,0.058163,0,0
7,GO MAST CELL ACTIVATION,0.91805,-0.0030241,0.0030406,0,0
7,GO NUCLEOSIDE SALVAGE,0.93062,-0.0031649,0.017755,0,0
7,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.79394,-0.0032045,0.032117,0,0
7,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.90549,-0.0033223,0.0090204,0,0
7,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.7336,-0.0038196,-0.062608,0,0
7,GO PROSTAGLANDIN SECRETION,0.66333,-0.0038874,0.053049,0,0
7,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.88046,-0.0039199,0.040387,0,0
7,GO SPINDLE MIDZONE ASSEMBLY,0.88046,-0.0041251,0.04936,0,0
7,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.86799,-0.0043432,0.047672,0,0
7,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.95582,-0.0045708,-0.0082123,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.83078,-0.0047,0.056668,0,0
7,GO REGULATION OF HEAT GENERATION,0.55277,-0.0047539,0.088607,0,0
7,GO INTERLEUKIN 6 PRODUCTION,0.83078,-0.0050799,-0.0081053,0,0
7,GO NUCLEOSIDE METABOLIC PROCESS,0.65188,-0.0052413,0.044155,0,0
7,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.84314,-0.0054054,0.034929,0,0
7,GO INFLAMMATORY RESPONSE,0.96843,-0.0055312,0.010971,0,0
7,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.78176,-0.0055403,0.040275,0,0
7,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.55277,-0.0058777,0.093573,0,0
7,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.84314,-0.0059045,0.027195,0,0
7,GO LEUKOCYTE MEDIATED IMMUNITY,0.98106,-0.0059061,0.00018151,0,0
7,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.86799,-0.0060385,-0.03272,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.68646,-0.0063479,-0.085296,0,0
7,GO MYELOID LEUKOCYTE ACTIVATION,0.76963,-0.006495,-0.018587,0,0
7,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.95582,-0.0065035,0.010159,0,0
7,GO INNATE IMMUNE RESPONSE,0.90549,-0.0067145,-0.0077076,0,0
7,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.85555,-0.0068741,0.045018,0,0
7,GO RESPONSE TO VITAMIN D,0.66333,-0.0068931,0.068776,0,0
7,GO HISTAMINE TRANSPORT,0.65188,-0.0072449,0.052634,0,0
7,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.80618,-0.0072697,0.045903,0,0
7,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.80618,-0.0079587,-0.018111,0,0
7,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.80618,-0.0080384,0.036612,0,0
7,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.39705,-0.0081384,0.087042,0,0
7,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.53179,-0.0081982,-0.036307,0,0
7,GO FIBROBLAST APOPTOTIC PROCESS,0.95582,-0.0082456,0.038712,0,0
7,GO REGULATION OF TISSUE REMODELING,0.49108,-0.0084071,0.093969,0,0
7,GO PLASMINOGEN ACTIVATION,0.88046,-0.0086201,-0.034315,0,0
7,GO HOMOCYSTEINE METABOLIC PROCESS,0.93062,-0.008638,0.0033561,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.91805,-0.0091656,0.0025113,0,0
7,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.89296,-0.0094053,0.0012198,0,0
7,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.80618,-0.0096976,0.035669,0,0
7,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.99368,-0.0097082,0.024526,0,0
7,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.74555,-0.0098235,-0.057702,0,0
7,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.52145,-0.010043,0.089716,0,0
7,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.76963,-0.010068,-0.025001,0,0
7,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.89296,-0.010185,0.017906,0,0
7,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.96843,-0.01023,0.011756,0,0
7,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.89296,-0.010381,0.040654,0,0
7,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.95582,-0.010394,0.031225,0,0
7,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.96843,-0.010461,0.028378,0,0
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.99368,-0.010923,-0.014147,0,0
7,GO ZYMOGEN ACTIVATION,0.86799,-0.011317,0.030611,0,0
7,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.81845,-0.011351,0.036771,0,0
7,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.83078,-0.011431,0.038951,0,0
7,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.83078,-0.011448,0.026193,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.86799,-0.011452,-0.037835,0,0
7,GO GRANULOCYTE DIFFERENTIATION,0.51122,-0.011677,0.10927,0,0
7,GO POSITIVE REGULATION OF CELL AGING,0.84314,-0.011789,-0.020555,0,0
7,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.96843,-0.011854,-0.014659,0,0
7,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.74555,-0.011973,0.046754,0,0
7,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.47137,-0.012043,-0.11334,0,0
7,GO PROTEIN TRIMERIZATION,0.61803,-0.01207,0.076778,0,0
7,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.98106,-0.012267,0.00072773,0,0
7,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.72171,-0.012287,-0.025531,0,0
7,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.65188,-0.012491,0.10401,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.65188,-0.012492,0.068754,0,0
7,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.91805,-0.012613,0.018583,0,0
7,GO POSITIVE REGULATION OF HEAT GENERATION,0.66333,-0.013033,0.078601,0,0
7,GO RESPONSE TO MUSCLE ACTIVITY,0.80618,-0.013083,0.05271,0,0
7,GO CELLULAR RESPONSE TO HEAT,0.26442,-0.013894,0.10941,0,0
7,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.99368,-0.013956,0.014198,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.54223,-0.014239,0.10118,0,0
7,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.78176,-0.014299,0.049283,0,0
7,GO REGULATION OF HELICASE ACTIVITY,0.74555,-0.0145,0.055617,0,0
7,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.93062,-0.014847,0.029949,0,0
7,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.78176,-0.014979,0.035615,0,0
7,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.72171,-0.014984,0.062331,0,0
7,GO RESPONSE TO INTERLEUKIN 18,0.69814,-0.015078,0.067356,0,0
7,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.85555,-0.01515,0.034163,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.69814,-0.01516,0.050983,0,0
7,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.52145,-0.015311,0.0602,0,0
7,GO B CELL DIFFERENTIATION,0.78176,-0.015324,0.043118,0,0
7,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.94321,-0.015591,0.019606,0,0
7,GO MAST CELL MIGRATION,0.85555,-0.015646,0.062963,0,0
7,GO AMYLOID BETA CLEARANCE,0.93062,-0.015674,6.2344e-05,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.74555,-0.015793,-0.010617,0,0
7,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.72171,-0.015799,-0.016586,0,0
7,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.95582,-0.015877,0.02563,0,0
7,GO IRON ION TRANSMEMBRANE TRANSPORT,0.86799,-0.016183,-0.0005091,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.38829,-0.01653,-0.17486,0,0
7,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.58498,-0.01699,0.071138,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.95582,-0.017141,0.0010011,0,0
7,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.5959,-0.017364,0.081082,0,0
7,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.89296,-0.017685,-0.016261,0,0
7,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.84314,-0.017706,-0.024574,0,0
7,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.58498,-0.017722,0.057419,0,0
7,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.68646,-0.017731,-0.013973,0,0
7,GO PROTEIN TARGETING TO MEMBRANE,0.67486,-0.018442,-0.024102,0,0
7,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.96843,-0.018464,0.035629,0,0
7,GO RESPONSE TO INTERLEUKIN 4,0.85555,-0.018533,0.037748,0,0
7,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.81845,-0.018957,0.034403,0,0
7,GO T CELL APOPTOTIC PROCESS,0.68646,-0.019138,-0.056538,0,0
7,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.67486,-0.019147,0.045951,0,0
7,GO HETEROTYPIC CELL CELL ADHESION,0.91805,-0.019341,0.0020456,0,0
7,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.85555,-0.019364,-0.011479,0,0
7,GO LABYRINTHINE LAYER MORPHOGENESIS,0.89296,-0.019613,0.027685,0,0
7,GO CHOLESTEROL STORAGE,0.86799,-0.019663,-0.0068454,0,0
7,GO INTERFERON GAMMA PRODUCTION,0.75756,-0.019666,-0.069508,0,0
7,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.68646,-0.020014,0.11794,0,0
7,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.91805,-0.020357,0.020679,0,0
7,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.86799,-0.020463,0.06367,0,0
7,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.81845,-0.020518,0.023787,0,0
7,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.86799,-0.020543,0.010096,0,0
7,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.41494,-0.0206,0.12902,0,0
7,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.96843,-0.02074,0.028209,0,0
7,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.65188,-0.021094,0.085259,0,0
7,GO REGULATION OF MAST CELL ACTIVATION,0.91805,-0.02141,-0.0067974,0,0
7,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.79394,-0.021436,0.063906,0,0
7,GO RESPONSE TO INTERLEUKIN 6,0.99368,-0.021548,0.027989,0,0
7,GO CYSTEINE METABOLIC PROCESS,0.58498,-0.021583,0.092805,0,0
7,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.99368,-0.021625,0.028637,0,0
7,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,1,-0.021701,0.0010744,0,0
7,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.96843,-0.021782,0.034382,0,0
7,GO FOAM CELL DIFFERENTIATION,0.95582,-0.0218,0.0008708,0,0
7,GO L ASCORBIC ACID METABOLIC PROCESS,0.70989,-0.021875,0.030789,0,0
7,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.65188,-0.022106,-0.018294,0,0
7,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.81845,-0.022269,0.036874,0,0
7,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.91805,-0.022291,0.014735,0,0
7,GO FATTY ACID HOMEOSTASIS,0.81845,-0.022363,0.024704,0,0
7,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.65188,-0.022578,-0.049676,0,0
7,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.42405,-0.023281,0.090728,0,0
7,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.4521,-0.023405,-0.015736,0,0
7,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.70989,-0.023763,-0.018011,0,0
7,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.67486,-0.023789,0.074779,0,0
7,GO TYPE 2 IMMUNE RESPONSE,0.55277,-0.02388,-0.098368,0,0
7,GO ACTIVATED T CELL PROLIFERATION,0.84314,-0.024236,0.037633,0,0
7,GO SERTOLI CELL DEVELOPMENT,0.72171,-0.024604,0.075196,0,0
7,GO CELL ACTIVATION,0.89296,-0.024977,0.02494,0,0
7,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.85555,-0.025254,0.017509,0,0
7,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.93062,-0.025508,0.01124,0,0
7,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.81845,-0.025862,-0.04093,0,0
7,GO RECEPTOR BIOSYNTHETIC PROCESS,0.81845,-0.026005,0.038857,0,0
7,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.96843,-0.026113,0.035325,0,0
7,GO REGULATION OF CHEMOTAXIS,0.70989,-0.026164,0.061055,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.76963,-0.026391,0.052577,0,0
7,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.95582,-0.026394,0.015629,0,0
7,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.44264,-0.02643,-0.061809,0,0
7,GO BRANCHING MORPHOGENESIS OF A NERVE,0.90549,-0.026554,0.036945,0,0
7,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.58498,-0.02661,-0.10978,0,0
7,GO REGULATION OF T CELL MIGRATION,0.84314,-0.026647,-0.040518,0,0
7,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.81845,-0.026699,0.032261,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.98106,-0.027032,0.014928,0,0
7,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.88046,-0.027157,0.030982,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.81845,-0.027297,0.056076,0,0
7,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.90549,-0.027432,0.0076009,0,0
7,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.69814,-0.027622,-0.013095,0,0
7,GO DECIDUALIZATION,0.99368,-0.027645,0.019544,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.94321,-0.027657,-0.014122,0,0
7,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.99368,-0.027946,0.01737,0,0
7,GO B CELL HOMEOSTASIS,0.93062,-0.028009,0.018427,0,0
7,GO LYMPHOCYTE APOPTOTIC PROCESS,0.76963,-0.028247,-0.039756,0,0
7,GO INTERACTION WITH SYMBIONT,0.86799,-0.028276,0.022177,0,0
7,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.96843,-0.028372,0.030331,0,0
7,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.81845,-0.029038,-0.037211,0,0
7,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.88046,-0.029377,0.040578,0,0
7,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.54223,-0.029403,-0.020902,0,0
7,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.83078,-0.029615,0.050161,0,0
7,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.98106,-0.029782,0.014047,0,0
7,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.68646,-0.029823,0.059435,0,0
7,GO MESODERMAL CELL FATE COMMITMENT,0.69814,-0.030007,0.015046,0,0
7,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.93062,-0.030125,-0.0048734,0,0
7,GO MYOBLAST MIGRATION,0.75756,-0.030197,0.023076,0,0
7,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.70989,-0.030243,-0.025683,0,0
7,GO VIRAL GENE EXPRESSION,0.32248,-0.030262,-0.058193,0,0
7,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.90549,-0.0305,-0.0040883,0,0
7,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.75756,-0.030537,0.030029,0,0
7,GO AMINO SUGAR CATABOLIC PROCESS,0.68646,-0.030572,-0.078615,0,0
7,GO NADPH REGENERATION,0.85555,-0.030691,0.020999,0,0
7,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.90549,-0.031116,0.043416,0,0
7,GO RESPONSE TO FUNGUS,0.52145,-0.031123,-0.085531,0,0
7,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.91805,-0.031723,0.036116,0,0
7,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20822,-0.031916,-0.065631,0,0
7,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.35442,-0.031991,0.16584,0,0
7,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.55277,-0.032035,-0.077044,0,0
7,GO PORE COMPLEX ASSEMBLY,0.84314,-0.032037,0.023045,0,0
7,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.98106,-0.032088,0.029262,0,0
7,GO PHAGOCYTOSIS,0.96843,-0.032761,0.012963,0,0
7,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.75756,-0.033017,0.019401,0,0
7,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.57414,-0.03341,-0.040401,0,0
7,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.75756,-0.033472,0.061219,0,0
7,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.75756,-0.033564,-0.030566,0,0
7,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.99368,-0.033602,-0.017979,0,0
7,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.54223,-0.033667,-0.013703,0,0
7,GO RESPONSE TO INTERLEUKIN 7,0.93062,-0.033698,0.042257,0,0
7,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.91805,-0.033847,0.04392,0,0
7,GO EMBRYONIC HEMOPOIESIS,0.58498,-0.03385,0.12115,0,0
7,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.79394,-0.034068,0.021133,0,0
7,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.76963,-0.034277,0.061584,0,0
7,GO CELL JUNCTION DISASSEMBLY,0.78176,-0.034844,0.052897,0,0
7,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.69814,-0.035513,0.065493,0,0
7,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.84314,-0.035685,0.002007,0,0
7,GO REGULATION OF RELAXATION OF MUSCLE,0.90549,-0.035721,0.1488,0,0
7,GO INTEGRIN ACTIVATION,0.99368,-0.035838,0.0073696,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.55277,-0.036501,0.09125,0,0
7,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.62923,-0.036577,-0.015987,0,0
7,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.98106,-0.036634,0.012085,0,0
7,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.23203,-0.03678,-0.033874,0,0
7,GO POSITIVE REGULATION OF GLIOGENESIS,0.95582,-0.037014,0.032517,0,0
7,GO REGULATION OF MRNA BINDING,0.95582,-0.037103,0.01278,0,0
7,GO REGULATION OF HEMOPOIESIS,0.91805,-0.037225,0.040878,0,0
7,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.99368,-0.037483,0.015642,0,0
7,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.74555,-0.037866,0.059877,0,0
7,GO HISTAMINE SECRETION,0.81845,-0.038222,-0.020719,0,0
7,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.83078,-0.03839,0.016964,0,0
7,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.64051,-0.038701,-0.018587,0,0
7,GO RIBOSOME ASSEMBLY,0.27821,-0.038745,-0.064198,0,0
7,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.70989,-0.038782,-0.0067627,0,0
7,GO CELL CHEMOTAXIS,0.81845,-0.038893,-0.010207,0,0
7,GO SEROTONIN SECRETION,0.93062,-0.038894,0.0039769,0,0
7,GO RESPONSE TO GAMMA RADIATION,0.85555,-0.038917,0.050748,0,0
7,GO FC RECEPTOR SIGNALING PATHWAY,0.94321,-0.039195,0.026241,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.94321,-0.039287,-0.013092,0,0
7,GO REGULATION OF INNATE IMMUNE RESPONSE,1,-0.039908,0.0054204,0,0
7,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.94321,-0.040153,0.0023294,0,0
7,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.93062,-0.040566,0.00056928,0,0
7,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.48117,-0.040742,-0.066684,0,0
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.39705,-0.040994,-0.0072368,0,0
7,GO B CELL APOPTOTIC PROCESS,0.90549,-0.041003,0.031633,0,0
7,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.90549,-0.041005,0.024202,0,0
7,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.83078,-0.041101,-0.028899,0,0
7,GO MATURATION OF LSU RRNA,0.80618,-0.041134,0.0065965,0,0
7,GO LYMPHOCYTE DIFFERENTIATION,0.91805,-0.041139,0.017932,0,0
7,GO PODOSOME ASSEMBLY,0.99368,-0.041386,0.032244,0,0
7,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.78176,-0.041814,0.017606,0,0
7,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.60692,-0.04182,-0.016432,0,0
7,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.96843,-0.042039,0.034158,0,0
7,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.54223,-0.042619,-0.12962,0,0
7,GO RESPONSE TO THYROID HORMONE,0.30724,-0.042768,-0.069497,0,0
7,GO DEFENSE RESPONSE TO FUNGUS,0.80618,-0.042884,-0.049411,0,0
7,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.40594,-0.043239,-0.13575,0,0
7,GO ARGININE METABOLIC PROCESS,0.65188,-0.043978,-0.011649,0,0
7,GO OSTEOCLAST DIFFERENTIATION,0.89296,-0.044381,0.026637,0,0
7,GO MODULATION BY HOST OF VIRAL PROCESS,0.93062,-0.044613,0.018725,0,0
7,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.65188,-0.044623,-0.049926,0,0
7,GO RESPONSE TO INTERFERON BETA,0.67486,-0.044679,-0.055978,0,0
7,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.96843,-0.044851,0.023895,0,0
7,GO GTP METABOLIC PROCESS,0.85555,-0.044937,0.0449,0,0
7,GO REGULATION OF LIGASE ACTIVITY,0.99368,-0.045024,0.0065542,0,0
7,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.86799,-0.045132,-0.019728,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.93062,-0.045892,-0.01348,0,0
7,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.99368,-0.046301,0.001118,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.29248,-0.046582,-0.095737,0,0
7,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.88046,-0.046726,-0.018122,0,0
7,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.95582,-0.046812,0.016208,0,0
7,GO CELLULAR RESPONSE TO IRON ION,0.81845,-0.047345,0.067776,0,0
7,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.94321,-0.047364,0.0087589,0,0
7,GO POSITIVE REGULATION OF DNA BINDING,0.99368,-0.047618,0.022247,0,0
7,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.85555,-0.04777,0.044277,0,0
7,GO REGULATION OF EXOSOMAL SECRETION,0.38829,-0.048041,0.10192,0,0
7,GO NIK NF KAPPAB SIGNALING,0.96843,-0.048101,0.011384,0,0
7,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.98106,-0.048264,0.037677,0,0
7,GO T CELL DIFFERENTIATION,0.95582,-0.048377,0.00083416,0,0
7,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.89296,-0.048526,-0.016314,0,0
7,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.18624,-0.048904,-0.11402,0,0
7,GO LEUKOCYTE MIGRATION,0.79394,-0.048924,-0.0059178,0,0
7,GO GAMMA DELTA T CELL DIFFERENTIATION,0.53179,-0.048927,0.11367,0,0
7,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.94321,-0.049255,0.0042234,0,0
7,GO PSEUDOPODIUM ORGANIZATION,0.86799,-0.049263,0.017159,0,0
7,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.95582,-0.049266,0.025105,0,0
7,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.50109,-0.049348,-0.098274,0,0
7,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.78176,-0.049478,-0.025283,0,0
7,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.85555,-0.049605,-0.0099032,0,0
7,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.93062,-0.04974,0.028131,0,0
7,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.98106,-0.050212,0.0014179,0,0
7,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.57414,-0.050541,-0.068462,0,0
7,GO RESPONSE TO NITRIC OXIDE,0.88046,-0.050793,0.013427,0,0
7,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.88046,-0.050947,-0.0017628,0,0
7,GO CYTOPLASMIC TRANSLATION,0.2259,-0.051238,-0.056851,0,0
7,GO REGULATION OF CELL CELL ADHESION,0.98106,-0.051376,0.010375,0,0
7,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.58498,-0.051518,-0.0023974,0,0
7,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.7336,-0.051554,-0.039733,0,0
7,GO REGULATION OF MONOCYTE DIFFERENTIATION,1,-0.051621,0.021853,0,0
7,GO STEROID ESTERIFICATION,0.53179,-0.051977,-0.034826,0,0
7,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.83078,-0.052145,-0.0010578,0,0
7,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.93062,-0.0526,0.027349,0,0
7,GO LEUKOCYTE DIFFERENTIATION,0.96843,-0.052665,0.02103,0,0
7,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.7336,-0.052735,-0.072238,0,0
7,GO TRANSLATIONAL INITIATION,0.18102,-0.052768,-0.090887,0,0
7,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.93062,-0.052801,0.026281,0,0
7,GO RESPONSE TO INTERLEUKIN 1,0.5959,-0.053012,-0.041018,0,0
7,GO DNA DEAMINATION,0.49108,-0.053414,-0.086796,0,0
7,GO TELOMERASE RNA LOCALIZATION,0.78176,-0.053522,0.0097658,0,0
7,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.88046,-0.053814,0.010744,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.95582,-0.054158,0.013837,0,0
7,GO LYMPHOCYTE HOMEOSTASIS,0.95582,-0.054662,0.0088566,0,0
7,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.67486,-0.05473,-0.032141,0,0
7,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.7336,-0.054831,-0.025384,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.65188,-0.055588,-0.048398,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1,-0.055639,0.031143,0,0
7,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.75756,-0.055699,-0.070928,0,0
7,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.88046,-0.05575,-0.030946,0,0
7,GO SUPEROXIDE METABOLIC PROCESS,0.99368,-0.056229,-0.0038564,0,0
7,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.66333,-0.056769,-0.04112,0,0
7,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.57414,-0.056774,-0.020612,0,0
7,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.94321,-0.056954,0.0002982,0,0
7,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.56341,-0.05715,-0.077609,0,0
7,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.75756,-0.057406,-0.043762,0,0
7,GO ACUTE INFLAMMATORY RESPONSE,0.81845,-0.057533,-0.025916,0,0
7,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.96843,-0.057558,0.012609,0,0
7,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.12273,-0.057576,-0.087825,0,0
7,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.60692,-0.057612,-0.0081705,0,0
7,GO T CELL RECEPTOR SIGNALING PATHWAY,0.85555,-0.057797,-0.0095493,0,0
7,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.93062,-0.057829,0.0060236,0,0
7,GO REGULATION OF RESPONSE TO TUMOR CELL,0.84314,-0.058176,-0.025967,0,0
7,GO TUMOR NECROSIS FACTOR SECRETION,0.98106,-0.05875,0.021188,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.86799,-0.058829,-0.013793,0,0
7,GO PROTEASOME ASSEMBLY,0.56341,-0.058932,-0.022146,0,0
7,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.81845,-0.059084,0.030012,0,0
7,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.50109,-0.059104,-0.098828,0,0
7,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.7336,-0.05985,-0.052969,0,0
7,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.68646,-0.059972,-0.046831,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.78176,-0.06013,-0.015581,0,0
7,GO INTERFERON ALPHA PRODUCTION,0.84314,-0.060732,0.028182,0,0
7,GO CYTOKINE METABOLIC PROCESS,0.86799,-0.061464,-0.037343,0,0
7,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.85555,-0.062211,-0.0080226,0,0
7,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.98106,-0.063661,0.045774,0,0
7,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.65188,-0.064031,-0.029918,0,0
7,GO CELLULAR RESPONSE TO X RAY,0.46168,-0.064163,-0.037775,0,0
7,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.4521,-0.064642,-0.094795,0,0
7,GO LEUKOCYTE TETHERING OR ROLLING,0.93062,-0.065091,-0.021242,0,0
7,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.76963,-0.065156,-0.054933,0,0
7,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.36271,-0.065265,-0.055614,0,0
7,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.2577,-0.065379,-0.07218,0,0
7,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.60692,-0.065708,-0.032156,0,0
7,GO INTERLEUKIN 1 PRODUCTION,0.46168,-0.066046,-0.109,0,0
7,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.70989,-0.066203,-0.053995,0,0
7,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.80618,-0.06662,-0.0025704,0,0
7,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.47137,-0.066764,-0.030663,0,0
7,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.79394,-0.067037,-0.050896,0,0
7,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.93062,-0.067083,0.013868,0,0
7,GO INFLAMMATORY RESPONSE TO WOUNDING,0.66333,-0.067236,-0.070048,0,0
7,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.90549,-0.067238,0.023004,0,0
7,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.96843,-0.067409,0.0051821,0,0
7,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.38829,-0.067691,-0.046764,0,0
7,GO ACTIVATION OF IMMUNE RESPONSE,0.95582,-0.067784,-0.0020102,0,0
7,GO LIPOPROTEIN CATABOLIC PROCESS,0.61803,-0.067875,-0.037334,0,0
7,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.48117,-0.067991,-0.013795,0,0
7,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.95582,-0.068064,0.022224,0,0
7,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.94321,-0.068081,0.026971,0,0
7,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.85555,-0.068255,-0.044232,0,0
7,GO T HELPER 2 CELL DIFFERENTIATION,0.78176,-0.068401,-0.05432,0,0
7,GO GALACTOSE METABOLIC PROCESS,0.69814,-0.069036,-0.0045297,0,0
7,GO GLYCOLIPID CATABOLIC PROCESS,0.52145,-0.069285,-0.049316,0,0
7,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.36271,-0.069468,-0.052348,0,0
7,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.7336,-0.069482,-0.063084,0,0
7,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.69814,-0.070038,-0.047027,0,0
7,GO IMMUNOGLOBULIN PRODUCTION,0.96843,-0.070596,0.0072178,0,0
7,GO PROTEIN CONTAINING COMPLEX REMODELING,0.81845,-0.070819,-0.018639,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.52145,-0.07098,-0.080265,0,0
7,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.49108,-0.071076,-0.048239,0,0
7,GO REGULATION OF IMMUNE RESPONSE,0.91805,-0.071196,-0.010177,0,0
7,GO REGULATION OF PHAGOCYTOSIS,0.70989,-0.071257,-0.04,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.81845,-0.071498,-0.029551,0,0
7,GO PROXIMAL DISTAL PATTERN FORMATION,0.67486,-0.071879,-0.065346,0,0
7,GO RESPONSE TO TUMOR CELL,0.58498,-0.071992,-0.056158,0,0
7,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.38829,-0.07222,-0.097971,0,0
7,GO SUPEROXIDE ANION GENERATION,0.47137,-0.072796,-0.077437,0,0
7,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.4521,-0.07332,-0.11984,0,0
7,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.95582,-0.073496,-0.0026637,0,0
7,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.21989,-0.073712,-0.055395,0,0
7,GO CELLULAR RESPONSE TO INTERFERON BETA,0.75756,-0.073762,-0.011185,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.39705,-0.074091,-0.10575,0,0
7,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.89296,-0.074253,-0.0088465,0,0
7,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.57414,-0.074396,-0.053749,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION,0.62923,-0.074684,-0.026113,0,0
7,GO REGULATION OF CELL ACTIVATION,0.89296,-0.074915,-0.012649,0,0
7,GO COMPLEMENT ACTIVATION,0.91805,-0.074991,-0.028592,0,0
7,GO LYMPHOCYTE ACTIVATION,0.89296,-0.075092,-0.0076867,0,0
7,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.96843,-0.075328,0.0097765,0,0
7,GO RESPONSE TO PROTOZOAN,0.68646,-0.075337,-0.061254,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.56341,-0.076746,-0.0009775,0,0
7,GO ETHANOL OXIDATION,0.79394,-0.076793,-0.043777,0,0
7,GO RESPONSE TO VITAMIN A,0.62923,-0.07741,-0.029617,0,0
7,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.12662,-0.077816,-0.13375,0,0
7,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.78176,-0.077906,-0.01733,0,0
7,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.61803,-0.078583,-0.05301,0,0
7,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.64051,-0.078641,-0.065451,0,0
7,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.74555,-0.078852,-0.035309,0,0
7,GO POSITIVE REGULATION OF CHEMOTAXIS,0.76963,-0.078894,0.0012694,0,0
7,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.88046,-0.079107,0.047741,0,0
7,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.64051,-0.079232,-0.011066,0,0
7,GO CYTIDINE TO URIDINE EDITING,0.40594,-0.079534,-0.13279,0,0
7,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.53179,-0.079692,-0.024452,0,0
7,GO AUTOPHAGIC CELL DEATH,0.23203,-0.079755,-0.05725,0,0
7,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.48117,-0.08026,-0.066679,0,0
7,GO CIRCADIAN SLEEP WAKE CYCLE,0.53179,-0.080575,-0.0020882,0,0
7,GO LEUKOCYTE APOPTOTIC PROCESS,0.60692,-0.08069,-0.065841,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.90549,-0.080703,0.04911,0,0
7,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.38829,-0.08171,-0.15298,0,0
7,GO CHEMOKINE PRODUCTION,0.68646,-0.08199,-0.039889,0,0
7,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.5959,-0.08217,-0.056952,0,0
7,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.60692,-0.082207,-0.037714,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.4521,-0.082554,-0.10144,0,0
7,GO RESPONSE TO INTERFERON GAMMA,0.53179,-0.082687,-0.10191,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.51122,-0.082801,-0.021764,0,0
7,GO REGULATION OF B CELL DIFFERENTIATION,0.94321,-0.083363,-0.022441,0,0
7,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.51122,-0.083664,-0.077504,0,0
7,GO REGULATION OF CELL FATE SPECIFICATION,0.95582,-0.083754,0.048388,0,0
7,GO POSITIVE REGULATION OF HEMOPOIESIS,0.95582,-0.084086,0.0089591,0,0
7,GO PURINE CONTAINING COMPOUND SALVAGE,0.12273,-0.084175,-0.081618,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.49108,-0.08436,-0.091869,0,0
7,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.98106,-0.084893,-0.0049843,0,0
7,GO T CELL ACTIVATION,0.80618,-0.084907,-0.02863,0,0
7,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.18624,-0.085606,-0.088725,0,0
7,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.75756,-0.085687,-0.084481,0,0
7,GO LYMPHOCYTE MEDIATED IMMUNITY,0.90549,-0.086114,-0.02944,0,0
7,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.4521,-0.08648,-0.12344,0,0
7,GO REGULATION OF PODOSOME ASSEMBLY,0.5959,-0.086894,-0.034159,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.72171,-0.087635,-0.071691,0,0
7,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.61803,-0.08764,-0.0020956,0,0
7,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.81845,-0.087984,-0.021541,0,0
7,GO CELLULAR EXTRAVASATION,0.86799,-0.088203,-0.018483,0,0
7,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.96843,-0.088445,0.038677,0,0
7,GO T CELL PROLIFERATION,0.67486,-0.088673,-0.061104,0,0
7,GO INTERLEUKIN 1 BETA PRODUCTION,0.39705,-0.088696,-0.12397,0,0
7,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.76963,-0.089187,-0.037471,0,0
7,GO LEUKOCYTE CHEMOTAXIS,0.66333,-0.089189,-0.051893,0,0
7,GO NUCLEOSIDE CATABOLIC PROCESS,0.32248,-0.089504,-0.068761,0,0
7,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.78176,-0.08959,0.00041417,0,0
7,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.56341,-0.08974,-0.036333,0,0
7,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.52145,-0.089985,-0.075594,0,0
7,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.66333,-0.091371,-0.042094,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.52145,-0.092137,-0.072893,0,0
7,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.66333,-0.092648,-0.023578,0,0
7,GO B CELL MEDIATED IMMUNITY,0.99368,-0.092802,0.0025305,0,0
7,GO REPLICATIVE SENESCENCE,0.50109,-0.093631,-0.0057413,0,0
7,GO MONONUCLEAR CELL DIFFERENTIATION,0.62923,-0.094291,-0.030163,0,0
7,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.88046,-0.094385,0.0036845,0,0
7,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.55277,-0.095615,-0.08366,0,0
7,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.95582,-0.095793,0.013313,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.61803,-0.096143,-0.053792,0,0
7,GO REGULATION OF LEUKOCYTE MIGRATION,0.66333,-0.096567,-0.046564,0,0
7,GO VAGINA DEVELOPMENT,0.60692,-0.096589,-0.060302,0,0
7,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.88046,-0.096847,-0.0076927,0,0
7,GO SALIVA SECRETION,0.69814,-0.096977,-0.04848,0,0
7,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.96843,-0.097404,0.0015788,0,0
7,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.98106,-0.097557,-0.00036219,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.50109,-0.097676,-0.083931,0,0
7,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.74555,-0.09832,-0.039266,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.5959,-0.099008,-0.062488,0,0
7,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.2998,-0.099526,-0.082633,0,0
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.091819,-0.099581,-0.13529,0,0
7,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.72171,-0.09983,-0.0513,0,0
7,GO RESPONSE TO INTERLEUKIN 15,0.75756,-0.10011,-0.051961,0,0
7,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.50109,-0.10025,-0.094616,0,0
7,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.58498,-0.10027,-0.081229,0,0
7,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.16123,-0.10058,-0.13632,0,0
7,GO ALPHA BETA T CELL ACTIVATION,0.67486,-0.10074,-0.060508,0,0
7,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.91805,-0.10087,0.010554,0,0
7,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.7336,-0.10088,-0.02831,0,0
7,GO B CELL ACTIVATION,0.96843,-0.10103,0.0039336,0,0
7,GO LEUKOCYTE HOMEOSTASIS,1,-0.1011,0.001508,0,0
7,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.68646,-0.10168,-0.062546,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.52145,-0.10175,-0.090548,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.58498,-0.10223,-0.075902,0,0
7,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.74555,-0.10259,-0.050694,0,0
7,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.52145,-0.10269,-0.10686,0,0
7,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.33821,-0.10281,-0.14023,0,0
7,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.66333,-0.10285,-0.058738,0,0
7,GO ALPHA BETA T CELL DIFFERENTIATION,0.65188,-0.10306,-0.047163,0,0
7,GO PROSTANOID BIOSYNTHETIC PROCESS,0.26442,-0.10373,-0.11541,0,0
7,GO RESPONSE TO INTERLEUKIN 12,0.13885,-0.10407,-0.097947,0,0
7,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.64051,-0.1042,-0.060852,0,0
7,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.99368,-0.10457,0.016041,0,0
7,GO ALDITOL METABOLIC PROCESS,0.08881,-0.10602,-0.085408,0,0
7,GO LYMPHOCYTE MIGRATION,0.5959,-0.10679,-0.087455,0,0
7,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.5959,-0.10724,-0.075452,0,0
7,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.51122,-0.10733,-0.054987,0,0
7,GO T CELL EXTRAVASATION,0.5959,-0.10787,-0.059092,0,0
7,GO MACROPHAGE ACTIVATION,0.55277,-0.1088,-0.076404,0,0
7,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.85555,-0.10893,0.045619,0,0
7,GO REGULATION OF LYMPHOCYTE MIGRATION,0.68646,-0.1095,-0.059583,0,0
7,GO CHEMOKINE SECRETION,0.58498,-0.10969,-0.078288,0,0
7,GO CYTOKINE SECRETION,0.70989,-0.11033,-0.042471,0,0
7,GO CD40 SIGNALING PATHWAY,0.39705,-0.11057,-0.090122,0,0
7,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.85555,-0.11175,-0.027694,0,0
7,GO INTERLEUKIN 8 PRODUCTION,0.44264,-0.11192,-0.092596,0,0
7,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.53179,-0.11246,-0.07688,0,0
7,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.51122,-0.11253,-0.084168,0,0
7,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.58498,-0.11328,-0.061949,0,0
7,GO CELL REDOX HOMEOSTASIS,0.18624,-0.11384,-0.075481,0,0
7,GO MYELOID LEUKOCYTE MIGRATION,0.5959,-0.11419,-0.064832,0,0
7,GO IMMUNOGLOBULIN SECRETION,0.47137,-0.11468,-0.087311,0,0
7,GO GLIAL CELL ACTIVATION,0.64051,-0.11476,-0.073098,0,0
7,GO RESPONSE TO COPPER ION,0.08303,-0.11528,-0.14339,0,0
7,GO REGULATORY T CELL DIFFERENTIATION,0.72171,-0.1154,-0.052832,0,0
7,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.57414,-0.11554,-0.033161,0,0
7,GO KILLING OF CELLS OF OTHER ORGANISM,0.5959,-0.1157,-0.062675,0,0
7,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.57414,-0.11592,-0.039582,0,0
7,GO ZYMOGEN INHIBITION,0.72171,-0.11595,-0.042937,0,0
7,GO ADAPTIVE IMMUNE RESPONSE,0.69814,-0.11596,-0.076754,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.57414,-0.11608,0.070275,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.47137,-0.11874,-0.045399,0,0
7,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.66333,-0.1193,-0.055758,0,0
7,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.21989,-0.11932,-0.069866,0,0
7,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.79394,-0.11987,-0.013469,0,0
7,GO POSITIVE REGULATION OF CELL ACTIVATION,0.70989,-0.12013,-0.060521,0,0
7,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.85555,-0.12045,-0.028677,0,0
7,GO LEUKOCYTE PROLIFERATION,0.65188,-0.1223,-0.065398,0,0
7,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.88046,-0.12341,-0.020472,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.81845,-0.12396,-0.027055,0,0
7,GO REGULATION OF T CELL DIFFERENTIATION,0.85555,-0.12516,-0.017068,0,0
7,GO INTERLEUKIN 2 PRODUCTION,0.55277,-0.12529,-0.095796,0,0
7,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.61803,-0.1257,-0.038834,0,0
7,GO NUCLEOBASE METABOLIC PROCESS,0.10134,-0.12598,-0.070699,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.67486,-0.12635,-0.052708,0,0
7,GO PROTEIN NITROSYLATION,0.42405,-0.12668,-0.067413,0,0
7,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.60692,-0.12673,-0.080914,0,0
7,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.14312,-0.1274,-0.13998,0,0
7,GO REGULATION OF PLASMINOGEN ACTIVATION,0.2998,-0.12748,-0.15644,0,0
7,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.76963,-0.12777,-0.043401,0,0
7,GO POSITIVE REGULATION OF T CELL MIGRATION,0.36271,-0.12785,-0.1391,0,0
7,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.65188,-0.12816,-0.021182,0,0
7,GO T CELL LINEAGE COMMITMENT,0.86799,-0.12853,0.0035848,0,0
7,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.96843,-0.12867,0.0015551,0,0
7,GO REGULATION OF B CELL ACTIVATION,0.7336,-0.12927,-0.049746,0,0
7,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.33029,-0.13036,-0.15425,0,0
7,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.50109,-0.13055,-0.095878,0,0
7,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.60692,-0.13125,-0.055756,0,0
7,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.60692,-0.1319,-0.010341,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.48117,-0.13207,-0.1129,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.94321,-0.13214,0.0014749,0,0
7,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.5959,-0.13219,-0.085965,0,0
7,GO REGULATION OF CELL KILLING,0.53179,-0.13248,-0.08998,0,0
7,GO HYPERSENSITIVITY,0.49108,-0.13353,-0.1701,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.72171,-0.13411,-0.040402,0,0
7,GO CELL KILLING,0.48117,-0.1358,-0.098946,0,0
7,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.13467,-0.13615,-0.12669,0,0
7,GO NEUROINFLAMMATORY RESPONSE,0.62923,-0.13648,-0.068753,0,0
7,GO GRANULOCYTE CHEMOTAXIS,0.4521,-0.13736,-0.10398,0,0
7,GO ZINC ION HOMEOSTASIS,0.056456,-0.13739,-0.18487,0,0
7,GO IMMUNE RESPONSE TO TUMOR CELL,0.37111,-0.1378,-0.096391,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.93062,-0.13881,-0.0088082,0,0
7,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.47137,-0.13909,-0.10655,0,0
7,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.67486,-0.13913,-0.027709,0,0
7,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.66333,-0.13952,-0.067216,0,0
7,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.46168,-0.14036,-0.12839,0,0
7,GO T CELL MIGRATION,0.47137,-0.14121,-0.12486,0,0
7,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.56341,-0.14247,-0.076089,0,0
7,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.57414,-0.14254,-0.097591,0,0
7,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.44264,-0.14346,-0.1294,0,0
7,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.99368,-0.14386,0.019494,0,0
7,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.46168,-0.14418,-0.12615,0,0
7,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.37964,-0.1444,-0.14146,0,0
7,GO GRANULOCYTE MIGRATION,0.42405,-0.14483,-0.10241,0,0
7,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.7336,-0.14515,-0.038903,0,0
7,GO NATURAL KILLER CELL ACTIVATION,0.62923,-0.14543,-0.05571,0,0
7,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.75756,-0.14575,-0.048729,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.69814,-0.14631,-0.056259,0,0
7,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.55277,-0.1468,-0.080524,0,0
7,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.58498,-0.14685,-0.08093,0,0
7,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.5959,-0.14692,-0.050347,0,0
7,GO REGULATION OF MACROPHAGE ACTIVATION,0.49108,-0.1481,-0.090358,0,0
7,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.48117,-0.14837,-0.055007,0,0
7,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.55277,-0.14871,-0.11163,0,0
7,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.33029,-0.14881,-0.12525,0,0
7,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.67486,-0.14939,-0.085516,0,0
7,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.53179,-0.15012,-0.11258,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.32248,-0.15038,-0.14913,0,0
7,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.33029,-0.15051,-0.15511,0,0
7,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.017954,-0.15053,-0.14814,0,0
7,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.65188,-0.15181,-0.097351,0,0
7,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.50109,-0.15206,-0.11386,0,0
7,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.16123,-0.15256,-0.10944,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.13467,-0.15258,-0.1303,0,0
7,GO REGULATION OF T CELL ACTIVATION,0.74555,-0.15283,-0.047503,0,0
7,GO LYMPHOCYTE COSTIMULATION,0.86799,-0.15302,-0.043047,0,0
7,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.080256,-0.1539,-0.18592,0,0
7,GO LEUKOCYTE CELL CELL ADHESION,0.68646,-0.15574,-0.059756,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.52145,-0.15674,-0.10006,0,0
7,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.20256,-0.15859,-0.13123,0,0
7,GO REGULATION OF NUCLEASE ACTIVITY,0.17591,-0.15938,-0.086098,0,0
7,GO REGULATION OF NEUTROPHIL MIGRATION,0.65188,-0.15957,-0.060545,0,0
7,GO LEUKOCYTE AGGREGATION,0.13467,-0.16053,-0.25653,0,0
7,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.98106,-0.16101,-0.024965,0,0
7,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.39705,-0.16141,-0.14054,0,0
7,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.42405,-0.16152,-0.15051,0,0
7,GO MYELOID CELL APOPTOTIC PROCESS,0.53179,-0.16157,-0.0474,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.43329,-0.16241,-0.11489,0,0
7,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.70989,-0.16389,-0.06113,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.43329,-0.16475,-0.12444,0,0
7,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.48117,-0.1653,-0.087971,0,0
7,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.074935,-0.16701,-0.16891,0,0
7,GO REGULATION OF GLIAL CELL MIGRATION,0.56341,-0.16814,-0.059555,0,0
7,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.41494,-0.16818,-0.10966,0,0
7,GO CELLULAR RESPONSE TO ZINC ION,0.16123,-0.16995,-0.23716,0,0
7,GO REGULATION OF NEUTROPHIL ACTIVATION,0.44264,-0.17084,-0.15102,0,0
7,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.60692,-0.17087,-0.091142,0,0
7,GO CELLULAR RESPONSE TO COPPER ION,0.13885,-0.17253,-0.20898,0,0
7,GO B CELL RECEPTOR SIGNALING PATHWAY,0.5959,-0.17307,-0.11369,0,0
7,GO PHAGOCYTOSIS RECOGNITION,0.30724,-0.17455,-0.13544,0,0
7,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.70989,-0.17471,-0.065589,0,0
7,GO T HELPER 1 CELL DIFFERENTIATION,0.32248,-0.17516,-0.15618,0,0
7,GO TONIC SMOOTH MUSCLE CONTRACTION,0.29248,-0.1768,-0.090237,0,0
7,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.47137,-0.17744,-0.10319,0,0
7,GO DENDRITIC CELL DIFFERENTIATION,0.41494,-0.17878,-0.13685,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.34626,-0.17969,-0.11123,0,0
7,GO RESPIRATORY BURST,0.54223,-0.18081,-0.092266,0,0
7,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.43329,-0.18088,-0.16073,0,0
7,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.37964,-0.18092,-0.17058,0,0
7,GO L SERINE METABOLIC PROCESS,0.37964,-0.18121,-0.10377,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.29248,-0.18135,-0.17277,0,0
7,GO NEUTROPHIL MIGRATION,0.30724,-0.18171,-0.14169,0,0
7,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24463,-0.18185,-0.21009,0,0
7,GO NEGATIVE REGULATION OF BONE REMODELING,0.37111,-0.18279,-0.12206,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.47137,-0.1829,-0.13128,0,0
7,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.33821,-0.18385,-0.16933,0,0
7,GO RESPONSE TO LIPOTEICHOIC ACID,0.3148,-0.18423,-0.12846,0,0
7,GO NEUTROPHIL CHEMOTAXIS,0.2998,-0.18502,-0.15653,0,0
7,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.42405,-0.18508,-0.1015,0,0
7,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.41494,-0.18523,-0.11396,0,0
7,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.47137,-0.18534,-0.088073,0,0
7,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.41494,-0.18761,-0.13371,0,0
7,GO REGULATION OF B CELL PROLIFERATION,0.49108,-0.18898,-0.12518,0,0
7,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.93062,-0.1927,-0.021147,0,0
7,GO POSITIVE REGULATION OF CELL KILLING,0.39705,-0.19271,-0.12788,0,0
7,GO T CELL SELECTION,0.74555,-0.19332,-0.048754,0,0
7,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.41494,-0.19385,-0.11021,0,0
7,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.85555,-0.19395,-0.024349,0,0
7,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.34626,-0.19448,-0.12851,0,0
7,GO CELLULAR RESPONSE TO CADMIUM ION,0.023112,-0.19573,-0.20249,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.51122,-0.19651,-0.093464,0,0
7,GO INTERLEUKIN 17 PRODUCTION,0.38829,-0.19672,-0.12316,0,0
7,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.40594,-0.19833,-0.12378,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.69814,-0.1994,-0.072704,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.2998,-0.20046,-0.16052,0,0
7,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.47137,-0.20213,-0.10152,0,0
7,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.64051,-0.20236,-0.081324,0,0
7,GO SYNAPSE PRUNING,0.4521,-0.20368,-0.16314,0,0
7,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.49108,-0.20426,-0.12763,0,0
7,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.58498,-0.20445,-0.073738,0,0
7,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.39705,-0.20497,-0.087893,0,0
7,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.23827,-0.20532,-0.17283,0,0
7,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.33029,-0.20562,-0.11019,0,0
7,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.38829,-0.20771,-0.13354,0,0
7,GO THYMIC T CELL SELECTION,0.61803,-0.20852,-0.08216,0,0
7,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.61803,-0.20866,-0.064018,0,0
7,GO MONONUCLEAR CELL MIGRATION,0.20256,-0.20942,-0.18555,0,0
7,GO ALPHA BETA T CELL PROLIFERATION,0.37964,-0.20993,-0.13083,0,0
7,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.010101,-0.20994,-0.19274,0,0
7,GO T CELL MEDIATED CYTOTOXICITY,0.30724,-0.20997,-0.18049,0,0
7,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.27821,-0.21025,-0.21032,0,0
7,GO CELLULAR DEFENSE RESPONSE,0.26442,-0.21447,-0.17949,0,0
7,GO MACROPHAGE APOPTOTIC PROCESS,0.27821,-0.21482,-0.13293,0,0
7,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.37964,-0.21595,-0.086204,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.32248,-0.21602,-0.1183,0,0
7,GO INTERLEUKIN 10 PRODUCTION,0.38829,-0.21935,-0.13883,0,0
7,GO T HELPER CELL LINEAGE COMMITMENT,0.70989,-0.22301,-0.05871,0,0
7,GO NEGATIVE REGULATION OF CELL KILLING,0.34626,-0.22314,-0.17125,0,0
7,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.42405,-0.22427,-0.12109,0,0
7,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.10468,-0.22546,-0.1748,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.41494,-0.22597,-0.16944,0,0
7,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.25111,-0.22724,-0.19142,0,0
7,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.52145,-0.23042,-0.097718,0,0
7,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.197,-0.23168,-0.15149,0,0
7,GO B CELL PROLIFERATION,0.37964,-0.23195,-0.15709,0,0
7,GO RESPONSE TO CHEMOKINE,0.37111,-0.23243,-0.14956,0,0
7,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.33029,-0.23253,-0.1593,0,0
7,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.10468,-0.2326,-0.17433,0,0
7,GO RESPONSE TO PEPTIDOGLYCAN,0.33029,-0.2375,-0.18814,0,0
7,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.5959,-0.23857,-0.10811,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.39705,-0.24182,-0.15515,0,0
7,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.56341,-0.24487,-0.10249,0,0
7,GO CYCLOOXYGENASE PATHWAY,0.26442,-0.24589,-0.17642,0,0
7,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.34626,-0.24643,-0.20045,0,0
7,GO LYMPHOCYTE CHEMOTAXIS,0.27126,-0.25115,-0.20896,0,0
7,GO POSITIVE T CELL SELECTION,0.57414,-0.25169,-0.076683,0,0
7,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.26442,-0.25256,-0.1836,0,0
7,GO GAMMA DELTA T CELL ACTIVATION,0.65188,-0.25598,-0.054754,0,0
7,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.2259,-0.25603,-0.21393,0,0
7,GO REGULATION OF T CELL CHEMOTAXIS,0.17591,-0.26082,-0.19121,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.50109,-0.26377,-0.17654,0,0
7,GO MONOCYTE CHEMOTAXIS,0.16123,-0.26566,-0.25239,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.23203,-0.2672,-0.16024,0,0
7,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.42405,-0.26782,-0.15776,0,0
7,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.34626,-0.27781,-0.11006,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.38829,-0.28092,-0.13872,0,0
7,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.13467,-0.28097,-0.19685,0,0
7,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.35442,-0.28212,-0.17174,0,0
7,GO T CELL CHEMOTAXIS,0.16602,-0.28919,-0.25311,0,0
7,GO DENDRITIC CELL APOPTOTIC PROCESS,0.34626,-0.29018,-0.25882,0,0
7,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.27821,-0.29379,-0.15997,0,0
7,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.28529,-0.29528,-0.19519,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.32248,-0.30495,-0.18703,0,0
7,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.067497,-0.30583,-0.23852,0,0
7,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.13885,-0.30635,-0.22852,0,0
7,GO TOLERANCE INDUCTION,0.33029,-0.31203,-0.22326,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.16123,-0.31436,-0.21652,0,0
7,GO INTERLEUKIN 12 PRODUCTION,0.32248,-0.3147,-0.1595,0,0
7,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.33029,-0.31573,-0.1641,0,0
7,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.3148,-0.32228,-0.18965,0,0
7,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.15197,-0.32383,-0.28661,0,0
7,GO MYELOID DENDRITIC CELL ACTIVATION,0.25111,-0.32889,-0.19581,0,0
7,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.34626,-0.33162,-0.14563,0,0
7,GO DENDRITIC CELL CHEMOTAXIS,0.14312,-0.33865,-0.27534,0,0
7,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.15197,-0.3404,-0.27359,0,0
7,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.16602,-0.34247,-0.171,0,0
7,GO DENDRITIC CELL MIGRATION,0.11524,-0.34363,-0.26534,0,0
7,GO REGULATION OF TOLERANCE INDUCTION,0.4521,-0.3466,-0.1815,0,0
7,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.48117,-0.35884,-0.17311,0,0
7,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.27821,-0.35901,-0.1798,0,0
7,GO T CELL TOLERANCE INDUCTION,0.36271,-0.36633,-0.22006,0,0
7,GO NEGATIVE T CELL SELECTION,0.35442,-0.37495,-0.19464,0,0
7,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.074935,-0.3866,-0.25782,0,0
7,GO POSITIVE THYMIC T CELL SELECTION,0.35442,-0.38782,-0.17213,0,0
7,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.33029,-0.41579,-0.23263,0,0
7,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10811,-0.41811,-0.35338,0,0
7,GO CYTOLYSIS,0.1475,-0.42077,-0.28381,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.16602,-0.44877,-0.2781,0,0
7,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.1475,-0.4629,-0.37187,0,0
7,GO DETOXIFICATION OF INORGANIC COMPOUND,0.0083971,-0.48931,-0.57078,0,0
7,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.08881,-0.49897,-0.28384,0,0
7,GO CHRONIC INFLAMMATORY RESPONSE,0.08303,-0.50392,-0.36089,0,0
7,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.11524,-0.53783,-0.4243,0,0
7,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.10811,-0.56863,-0.42755,0,0
7,GO EOSINOPHIL MIGRATION,0.037377,-0.61441,-0.40283,0,0
7,GO EOSINOPHIL CHEMOTAXIS,0.024086,-0.64841,-0.42796,0,0
